Citrus Sinensis ID: 002149
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | yes | no | 0.937 | 0.954 | 0.483 | 0.0 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.781 | 0.733 | 0.312 | 2e-79 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.791 | 0.636 | 0.325 | 5e-75 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.767 | 0.589 | 0.296 | 1e-72 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.763 | 0.726 | 0.289 | 8e-68 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.760 | 0.582 | 0.290 | 2e-66 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.526 | 0.821 | 0.325 | 1e-65 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.800 | 0.671 | 0.295 | 2e-65 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.329 | 0.445 | 0.426 | 2e-65 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.468 | 0.5 | 0.333 | 5e-65 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/946 (48%), Positives = 606/946 (64%), Gaps = 47/946 (4%)
Query: 35 ATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPCWKHVFCSNS-RVTQIQVSSVGLKG 93
A GD+ + +K+L P W DPC W H+ C+ + RVT+IQ+ GL+G
Sbjct: 23 ADSDGDLSAMLSLKKSLNPPSSFGWSDP-DPCK---WTHIVCTGTKRVTRIQIGHSGLQG 78
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
TL +L LS+LE + LQ N G +PS SGL++L+ L NNFD+IP+D F GL +LQ
Sbjct: 79 TLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQ 138
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLG--NFASLQNLKLSG 211
+ +D+N F K W P+ L++++ L N S S N++G LP FLG F L L L+
Sbjct: 139 SVEIDNNPF---KSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAF 195
Query: 212 NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF 271
NNL G +P S G + +LWLN QK TG I VL NM L+ +WLH N FSG +P+ F
Sbjct: 196 NNLEGELPMSLAGSQVQSLWLNGQK---LTGDITVLQNMTGLKEVWLHSNKFSGPLPD-F 251
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP---KSKAYKYSYSSN 327
L L+ L+L N F G +P SL SL SL ++L NN GPVP S + SN
Sbjct: 252 SGLKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSN 311
Query: 328 AFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNL 387
+FC + G C P V +L+ +YPPRL SW GNDPC +W+G++C +N +TV++L
Sbjct: 312 SFCLSSPG-ECDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIAC-SNGNITVISL 369
Query: 388 PNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF 447
L+GT+SP G + SL +I L NN++G IP T L +L LD+S N L +P F
Sbjct: 370 EKMELTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGF 429
Query: 448 SGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTI 507
V ++ +GNP + G SS + P + S S S GD K + I
Sbjct: 430 RSNVVVNTNGNPDI-----GKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGII 484
Query: 508 LVAIIAPVASVGVILLVAIPISICYYRKRKE---ASQASGSLVIHPRDPSDPDNMVKIVV 564
+ +++ + S+ +I L+ C+Y+KR++ S++S ++V+HPR + VKI V
Sbjct: 485 VGSVLGGLLSIFLIGLLVF----CWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITV 540
Query: 565 ANNS---NGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGR 621
A +S G + T GT S ++EAGN++IS+QVLR+VT NF+S+N LG
Sbjct: 541 AGSSVSVGGISDTYTLPGT----SEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGS 596
Query: 622 GGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681
GGFGVVYKGEL DGTKIAVKRME GVI+ K EF SEIAVL+KVRHRHLV+LLGY + G
Sbjct: 597 GGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDG 656
Query: 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHR 741
E+LLVYEYMPQG LS+H+F W L+PL WK+RL +ALDVARG+EYLH LAHQSFIHR
Sbjct: 657 NEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHR 716
Query: 742 DLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDV 801
DLK SNILLGDD RAKV+DFGLV+LAP+ + S+ TR+AGTFGYLAPEYAVTG++TTKVDV
Sbjct: 717 DLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDV 776
Query: 802 FSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE-KLRAAIDPILEVNDDTFET 860
+SFGV+LMEL+TG +LDES+PEE +L +WF + +KE + AID ++++++T +
Sbjct: 777 YSFGVILMELITGRKSLDESQPEESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLAS 836
Query: 861 FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQMVK 920
T+AELAGHC +REP QRPDMGHAVN+L+ LVE WKP D PE+ GID + L Q +K
Sbjct: 837 VHTVAELAGHCCAREPYQRPDMGHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALK 896
Query: 921 DWQEAEGK-------DLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
WQ EG+ SL++++ SIP RP GFAESFTS DGR
Sbjct: 897 KWQAYEGRSDLESSTSSLLPSLDNTQMSIPTRPYGFAESFTSVDGR 942
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 272/871 (31%), Positives = 391/871 (44%), Gaps = 122/871 (14%)
Query: 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG-LSNLKYAYLDGNN 137
S V + ++S L G++PQ L QLS L + LQ N+ G L S G LSNL + N
Sbjct: 206 SSVEYLGLASNNLSGSIPQELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISSNK 265
Query: 138 FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF 197
F D F L L + SN FN P+ L +S ++ LS + L+GQ+
Sbjct: 266 FSGKIPDVFLELNKLWYFSAQSNLFNGE----MPRSLSNSRSISLLSLRNNTLSGQIYLN 321
Query: 198 LGNFASLQNLKLSGNNLTGPIP------------------------ESFKGL-NLVNLWL 232
+L +L L+ N+ +G IP ESFK +L +L
Sbjct: 322 CSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSF 381
Query: 233 NDQKGGGFTGTIDVLGNMDQLRTLWLHGN-------------------------HFSGTI 267
++ + +++L + L+TL L N GT+
Sbjct: 382 SNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTV 441
Query: 268 PESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSS 326
P+ SL+ L+L+ NQ G IPP L SL SL +LDL+NN F+G +P S S S
Sbjct: 442 PQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVS 501
Query: 327 --NAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384
NA +P+ P P GGL Y N P +S +
Sbjct: 502 KENAVEEPS---PDFPFFKKKNTNAGGLQY----------NQP-----------SSFPPM 537
Query: 385 LNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--- 441
++L +L+G++ P G+L L + L++NN+SG IP N + + SL +LDLS NNLS
Sbjct: 538 IDLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNI 597
Query: 442 -PPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSS--SSSSSSPGDSTAETT 498
P L K S S+ N L +G P P S +G+ +SP T ++
Sbjct: 598 PPSLVKLSFLSTFSVAYNKL-SGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSP 656
Query: 499 KPKSSKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDN 558
+ K + I VA VG L +++ + S+ + P +D D
Sbjct: 657 HGSAVKSKKNIRKIVAVA-VGTGLGTVFLLTVTLLIILRTTSRGE----VDPEKKADADE 711
Query: 559 MVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENE 618
+ GS SV S N +S+ + T +F N
Sbjct: 712 I--------ELGSRSVVLFHNKDS---------------NNELSLDDILKSTSSFNQANI 748
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
+G GGFG+VYK L DGTK+A+KR+ + + EF +E+ LS+ +H +LV LLGY
Sbjct: 749 IGCGGFGLVYKATLPDGTKVAIKRLSGD--TGQMDREFQAEVETLSRAQHPNLVHLLGYC 806
Query: 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
++LL+Y YM G+L + H K L WK RL IA A G+ YLH
Sbjct: 807 NYKNDKLLIYSYMDNGSL-DYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHI 865
Query: 739 IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTK 798
+HRD+KSSNILL D F A ++DFGL +L + V T L GT GY+ PEY T K
Sbjct: 866 LHRDIKSSNILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYK 925
Query: 799 VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTF 858
DV+SFGVVL+ELLTG +D +P + L +W +K++K + DP + + D
Sbjct: 926 GDVYSFGVVLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKRE-SEIFDPFI-YDKDHA 983
Query: 859 ETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
E + E+A C P RP V+ L
Sbjct: 984 EEMLLVLEIACRCLGENPKTRPTTQQLVSWL 1014
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 5e-75, Method: Compositional matrix adjust.
Identities = 290/892 (32%), Positives = 404/892 (45%), Gaps = 133/892 (14%)
Query: 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFD 139
+ + ++S L G++P+ L LE I L N G + F G S+L L N +
Sbjct: 355 LKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQIN 414
Query: 140 -TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFL 198
+IP D + L L LDSNNF PK L S L + L G LP +
Sbjct: 415 GSIPEDLWK--LPLMALDLDSNNFTGE----IPKSLWKSTNLMEFTASYNRLEGYLPAEI 468
Query: 199 GNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV-LGNMDQLRTLW 257
GN ASL+ L LS N LTG IP L +L + + F G I V LG+ L TL
Sbjct: 469 GNAASLKRLVLSDNQLTGEIPREIG--KLTSLSVLNLNANMFQGKIPVELGDCTSLTTLD 526
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP--PS-------LASLS-LDH---LD 304
L N+ G IP+ L L+ L L+ N G IP PS + LS L H D
Sbjct: 527 LGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFD 586
Query: 305 LNNNMFMGPVPKSKA-----YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLV 359
L+ N GP+P+ + S S+N + E+ A + L L +
Sbjct: 587 LSYNRLSGPIPEELGECLVLVEISLSNNHL---------SGEIPASLSRLTNLT-----I 632
Query: 360 TSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQ 419
SGN S + G + KL LNL N L+G + S G L SL ++ L N + G
Sbjct: 633 LDLSGNALTGS-IPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGP 691
Query: 420 IPTNWTNLKSLTLLDLSQNNLSPPLP-----------------KFSGAVKLSLDGN---- 458
+P + NLK LT +DLS NNLS L KF+G + L GN
Sbjct: 692 VPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSEL-GNLTQL 750
Query: 459 -------PLLNGKSP--------------------GSGSSSGNPPSPTKGSSSSSSSSPG 491
LL+G+ P G S G P+K S + G
Sbjct: 751 EYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCG 810
Query: 492 DSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPR 551
K + +K I G++L I + + + R+ A + R
Sbjct: 811 RVVGSDCKIEGTKLRSAWGI------AGLMLGFTIIVFVFVFSLRRWAMTKR----VKQR 860
Query: 552 DPSDPDNM----VKIVVANNSNGSTSVATESGTGSRYS-SGNGASHVIEAGNLVISVQVL 606
D DP+ M +K V N + SG+ SR S N A + E L + + +
Sbjct: 861 D--DPERMEESRLKGFVDQN------LYFLSGSRSREPLSINIA--MFEQPLLKVRLGDI 910
Query: 607 RNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
T +F+ +N +G GGFG VYK L +AVK++ + EF +E+ L KV
Sbjct: 911 VEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEA--KTQGNREFMAEMETLGKV 968
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHW---KSLNLEPLSWKRRLNIALDV 723
+H +LVSLLGY E+LLVYEYM G+L HW ++ LE L W +RL IA+
Sbjct: 969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLD----HWLRNQTGMLEVLDWSKRLKIAVGA 1024
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
ARG+ +LH IHRD+K+SNILL DF KV+DFGL +L E V T +AGTFG
Sbjct: 1025 ARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFG 1084
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALD-ESRPEERQYLAAWFWNIKSDKEK 842
Y+ PEY + + TTK DV+SFGV+L+EL+TG + + E L W K ++ K
Sbjct: 1085 YIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQ-KINQGK 1143
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
IDP+L V+ + + ++A C + P++RP+M ++VL L E
Sbjct: 1144 AVDVIDPLL-VSVALKNSQLRLLQIAMLCLAETPAKRPNM---LDVLKALKE 1191
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 275 bits (704), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 261/879 (29%), Positives = 398/879 (45%), Gaps = 143/879 (16%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG-LSNLKYAYLDGNNFDTIPADFFDGL 149
L+G LP+ ++ L KLE + L +N+F GE+P G ++LK + GN+F+ L
Sbjct: 420 LEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRL 479
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKL 209
+ L +L L N P L + QL L L+G +P G L+ L L
Sbjct: 480 KELNLLHLRQNELVGG----LPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLML 535
Query: 210 SGNNLTGPIPESF---KGLNLVNLWLN------------------DQKGGGFTGTIDV-L 247
N+L G +P+S + L +NL N D GF I + L
Sbjct: 536 YNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLEL 595
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA-SLSLDHLDLN 306
GN L L L N +G IP + GK+ L L+++SN G IP L L H+DLN
Sbjct: 596 GNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLN 655
Query: 307 NNMFMGPVPK-----SKAYKYSYSSNAFCQ--PTEGVPCAPEVMALIDFLGGLNYPPRLV 359
NN GP+P S+ + SSN F + PTE C ++ +D
Sbjct: 656 NNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDG----------- 704
Query: 360 TSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQ 419
S +G+ P + G L VLNL SG+L ++G L L +++L N+++G+
Sbjct: 705 NSLNGSIPQE------IGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGE 758
Query: 420 IPTNWTNLKSL-TLLDLSQNNLSPPLPKFSGAVK----LSLDGNPLLNGKSPGS------ 468
IP L+ L + LDLS NN + +P G + L L N L G+ PGS
Sbjct: 759 IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQL-TGEVPGSVGDMKS 817
Query: 469 ----GSSSGNPPSPTKGSSSSSSSSPGDSTAETT-------------------KPKSSKR 505
S N K S P DS T + S++
Sbjct: 818 LGYLNVSFNNLGGKLK---KQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARS 874
Query: 506 TILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVA 565
++++ I+ + ++G+++LV ++++R + + V
Sbjct: 875 VVIISAISALTAIGLMILVIA----LFFKQRHDFFKK---------------------VG 909
Query: 566 NNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFG 625
+ S TS ++ S + NGAS I + + T N + E +G GG G
Sbjct: 910 HGSTAYTSSSSSSQATHKPLFRNGASKS------DIRWEDIMEATHNLSEEFMIGSGGSG 963
Query: 626 VVYKGELDDGTKIAVKRM--EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683
VYK EL++G +AVK++ + ++S K+ F E+ L ++RHRHLV L+GY + E
Sbjct: 964 KVYKAELENGETVAVKKILWKDDLMSNKS---FSREVKTLGRIRHRHLVKLMGYCSSKSE 1020
Query: 684 --RLLVYEYMPQGALSKHIFHWKSLNLEP----LSWKRRLNIALDVARGMEYLHSLAHQS 737
LL+YEYM G++ + K + LE L W+ RL IA+ +A+G+EYLH
Sbjct: 1021 GLNLLIYEYMKNGSIWDWLHEDKPV-LEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPP 1079
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAP---DSERSVVTRLAGTFGYLAPEYAVTGK 794
+HRD+KSSN+LL + A + DFGL K+ D+ T A ++GY+APEYA + K
Sbjct: 1080 IVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLK 1139
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEER---QYLAAWFWNIKSDKEKL-RAAIDPI 850
T K DV+S G+VLME++TG M D E +++ S ++KL + P+
Sbjct: 1140 ATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPL 1199
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
L +D + E+A CT P +RP A + L
Sbjct: 1200 LPFEED---AACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 250/865 (28%), Positives = 379/865 (43%), Gaps = 133/865 (15%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
L G +P++L L +L +G+Q+N+ G L LS+L + N F D FD L
Sbjct: 208 LTGNIPEDLFHLKRLNLLGIQENRLSGSLSREIRNLSSLVRLDVSWNLFSGEIPDVFDEL 267
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSS------------------------AQLTNLSC 185
L+ +N F PK L +S L +L
Sbjct: 268 PQLKFFLGQTNGFIGG----IPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDL 323
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLW-LNDQKGGGFTGTI 244
+ G+LP+ L + L+N+ L+ N G +PESFK ++ + L++ + +
Sbjct: 324 GTNRFNGRLPENLPDCKRLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANISSAL 383
Query: 245 DVLGNMDQLRTLWL----HGN--------HF-------------SGTIPESFGKLTSLKD 279
+L + L TL L HG HF +G++P L+
Sbjct: 384 GILQHCKNLTTLVLTLNFHGEALPDDSSLHFEKLKVLVVANCRLTGSMPRWLSSSNELQL 443
Query: 280 LNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPC 338
L+L+ N+ G IP + +L +LDL+NN F G +PKS S +S E P
Sbjct: 444 LDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSRNI-SVNEPSPD 502
Query: 339 APEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP 398
P M + L Y G P + L + NLSG +
Sbjct: 503 FPFFMKRNESARALQY-----NQIFGFPP----------------TIELGHNNLSGPIWE 541
Query: 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP----KFSGAVKLS 454
GNL L L+ N +SG IP++ + + SL LDLS N LS +P + S K S
Sbjct: 542 EFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFS 601
Query: 455 LDGNPLLNGKSPGSGSSSGNPPSPTKGSS-SSSSSSPGDSTAETTKPKSSKRT----ILV 509
+ N L +G P G P S + + P E+ K S+R+ I +
Sbjct: 602 VAYNNL-SGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALIKRSRRSRGGDIGM 660
Query: 510 AIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSN 569
AI SV + +S+ R R+ + + DP+
Sbjct: 661 AIGIAFGSV----FLLTLLSLIVLRARRRSGEV------------DPE------------ 692
Query: 570 GSTSVATESGTGSRYSSGNGASHVI---EAGNLVISVQVLRNVTKNFASENELGRGGFGV 626
ES + +R G S ++ ++ + +S L + T +F N +G GGFG+
Sbjct: 693 -----IEESESMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGM 747
Query: 627 VYKGELDDGTKIAVKRM--EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684
VYK L DG K+A+K++ + G I + EF +E+ LS+ +H +LV L G+ +R
Sbjct: 748 VYKATLPDGKKVAIKKLSGDCGQIER----EFEAEVETLSRAQHPNLVLLRGFCFYKNDR 803
Query: 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLK 744
LL+Y YM G+L + H ++ L WK RL IA A+G+ YLH +HRD+K
Sbjct: 804 LLIYSYMENGSLD-YWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIK 862
Query: 745 SSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSF 804
SSNILL ++F + ++DFGL +L E V T L GT GY+ PEY T K DV+SF
Sbjct: 863 SSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSF 922
Query: 805 GVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTI 864
GVVL+ELLT +D +P+ + L +W +K + + DP++ ++ E F +
Sbjct: 923 GVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHES-RASEVFDPLIYSKENDKEMF-RV 980
Query: 865 AELAGHCTSREPSQRPDMGHAVNVL 889
E+A C S P QRP V+ L
Sbjct: 981 LEIACLCLSENPKQRPTTQQLVSWL 1005
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 256/882 (29%), Positives = 384/882 (43%), Gaps = 153/882 (17%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
L+G +P+ + L KLE + L +N+F GE+P + L+ GN L
Sbjct: 421 LEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRL 480
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKL 209
++L L L N + P L + Q+T + L+G +P G +L+ +
Sbjct: 481 KDLTRLHLRENELVGN----IPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMI 536
Query: 210 SGNNLTGPIPESF---KGLNLVNLWLNDQKGG------------------GFTGTIDV-L 247
N+L G +P+S K L +N N G GF G I + L
Sbjct: 537 YNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLEL 596
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA-SLSLDHLDLN 306
G L L L N F+G IP +FGK++ L L+++ N G+IP L L H+DLN
Sbjct: 597 GKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLN 656
Query: 307 NNMFMGPVPKSKAY-----KYSYSSNAFCQ--PTEGVPCAPEVMALIDFLGGLNYPPRLV 359
NN G +P + SSN F PTE + ++ L FL G
Sbjct: 657 NNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTE-IFSLTNILTL--FLDG-------- 705
Query: 360 TSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQ 419
S +G+ P + G L LNL LSG L ++G L L +++L N ++G+
Sbjct: 706 NSLNGSIPQE------IGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGE 759
Query: 420 IPTNWTNLKSL-TLLDLSQNNLSPPLPKFSGAV----KLSLDGNPLLNGKSPGS------ 468
IP L+ L + LDLS NN + +P + L L N L+ G+ PG
Sbjct: 760 IPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLV-GEVPGQIGDMKS 818
Query: 469 ----GSSSGNPPSPTK------------------GSSSSSSSSPGDSTAETTKPKSSKRT 506
S N K GS S + G + PK+
Sbjct: 819 LGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKT---- 874
Query: 507 ILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVAN 566
V II+ ++S+ I L+ + I + + + + G
Sbjct: 875 --VVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNS------------------- 913
Query: 567 NSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGV 626
+ S + S +S+G GA I+ +++ + L E +G GG G
Sbjct: 914 ----AFSSNSSSSQAPLFSNG-GAKSDIKWDDIMEATHYLN-------EEFMIGSGGSGK 961
Query: 627 VYKGELDDGTKIAVKRM--EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY--SVAGY 682
VYK EL +G IAVK++ + ++S K+ F+ E+ L +RHRHLV L+GY S A
Sbjct: 962 VYKAELKNGETIAVKKILWKDDLMSNKS---FNREVKTLGTIRHRHLVKLMGYCSSKADG 1018
Query: 683 ERLLVYEYMPQGALSKHIFHWKSLN-----LEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
LL+YEYM G+ ++ W N E L W+ RL IAL +A+G+EYLH
Sbjct: 1019 LNLLIYEYMANGS----VWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPP 1074
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAP---DSERSVVTRLAGTFGYLAPEYAVTGK 794
+HRD+KSSN+LL + A + DFGL K+ D+ T AG++GY+APEYA + K
Sbjct: 1075 IVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLK 1134
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI------KSDKEKL-RAAI 847
T K DV+S G+VLME++TG M E+ +E + W + +EKL + +
Sbjct: 1135 ATEKSDVYSMGIVLMEIVTGKMP-TEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL 1193
Query: 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
+L + E + + E+A CT P +RP A L
Sbjct: 1194 KSLLPCEE---EAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 196/602 (32%), Positives = 292/602 (48%), Gaps = 97/602 (16%)
Query: 355 PPRLVTSWSGN--DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQ 412
P +++ SW PC +W ++C +++ +T ++L N NLSG L +G L +L ++L
Sbjct: 42 PNKVLQSWDATLVTPC-TWFHVTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELY 100
Query: 413 SNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVK-------------------- 452
SNNI+G IP NL L LDL NNLS P+P G +K
Sbjct: 101 SNNITGTIPEQLGNLTELVSLDLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSL 160
Query: 453 --------LSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSK 504
L L NPL G P +GS S P + + + T P +
Sbjct: 161 TAVLTLQVLDLSNNPL-TGDIPVNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAG 219
Query: 505 RTILVAIIAPVASVGVILLVAIP-ISICYYRKRKEASQASGSLVIHPRD-----PSDPDN 558
+ IA + G LL A+P I++ ++R++K P+D P++ D
Sbjct: 220 SNRITGAIAGGVAAGAALLFAVPAIALAWWRRKK------------PQDHFFDVPAEEDP 267
Query: 559 MVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENE 618
V + G R+S ++ L+ + NF+++N
Sbjct: 268 EVHL----------------GQLKRFS-----------------LRELQVASDNFSNKNI 294
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
LGRGGFG VYKG L DGT +AVKR++ + +F +E+ ++S HR+L+ L G+
Sbjct: 295 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRGFC 353
Query: 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
+ ERLLVY YM G+++ + + PL W +R IAL ARG+ YLH
Sbjct: 354 MTPTERLLVYPYMANGSVAS-CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 412
Query: 739 IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTK 798
IHRD+K++NILL ++F A V DFGL KL + V T + GT G++APEY TGK + K
Sbjct: 413 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 472
Query: 799 VDVFSFGVVLMELLTGLMALDESR--PEERQYLAAWFWNIKSDKEKLRAAIDPILEVN-- 854
DVF +GV+L+EL+TG A D +R ++ L W + +K KL A +D L+ N
Sbjct: 473 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYK 531
Query: 855 DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA--PLVEKWKPLDDEPEEYSGIDYS 912
D+ E +A L CT P +RP M V +L L E+W+ + + EE D++
Sbjct: 532 DEEVEQLIQVALL---CTQSSPMERPKMSEVVRMLEGDGLAERWE--EWQKEEMFRQDFN 586
Query: 913 LP 914
P
Sbjct: 587 YP 588
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 260/879 (29%), Positives = 388/879 (44%), Gaps = 111/879 (12%)
Query: 77 SNSRVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLD 134
S S + + +S+ + G P L L+ + L N G+ P S S +L+ A
Sbjct: 299 SCSWLQSLDLSNNNISGPFPNTILRSFGSLQILLLSNNLISGDFPTSISACKSLRIADFS 358
Query: 135 GNNFD-TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQ 193
N F IP D G +L+ L L N P + ++L + L G
Sbjct: 359 SNRFSGVIPPDLCPGAASLEELRLPDNLVTGE----IPPAISQCSELRTIDLSLNYLNGT 414
Query: 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTID-VLGNMD 251
+P +GN L+ NN+ G IP L NL +L LN+ + TG I N
Sbjct: 415 IPPEIGNLQKLEQFIAWYNNIAGEIPPEIGKLQNLKDLILNNNQ---LTGEIPPEFFNCS 471
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMF 310
+ + N +G +P+ FG L+ L L L +N F G IPP L + L LDLN N
Sbjct: 472 NIEWVSFTSNRLTGEVPKDFGILSRLAVLQLGNNNFTGEIPPELGKCTTLVWLDLNTNHL 531
Query: 311 MGPVPK-------SKAYKYSYSSN--AFCQPTEGVPCAPEVMALIDFLGGLNYPPRL--V 359
G +P SKA S N AF + G C V L++F G P RL +
Sbjct: 532 TGEIPPRLGRQPGSKALSGLLSGNTMAFVRNV-GNSCK-GVGGLVEFSG--IRPERLLQI 587
Query: 360 TSWSGNDPCKSWLG--LSCGTNSK-LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNI 416
S D + + G LS T + + L+L L G + +G + +L ++L N +
Sbjct: 588 PSLKSCDFTRMYSGPILSLFTRYQTIEYLDLSYNQLRGKIPDEIGEMIALQVLELSHNQL 647
Query: 417 SGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGKSPGSGSSS 472
SG+IP LK+L + D S N L +P+ S V++ L N L G P G S
Sbjct: 648 SGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNE-LTGPIPQRGQLS 706
Query: 473 GNP---------------PSPTKGSSS-SSSSSPGDSTAETTKPKSSKRTILVAIIAPVA 516
P P G++ + + G T+ S +I++ ++ A
Sbjct: 707 TLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAKHGTRAASWANSIVLGVLISAA 766
Query: 517 SVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVAT 576
SV ++++ AI + A + ++H + KI ++
Sbjct: 767 SVCILIVWAIAVR-------ARRRDADDAKMLHSLQAVNSATTWKI-----EKEKEPLSI 814
Query: 577 ESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGT 636
T R S +IEA T F++ + +G GGFG V+K L DG+
Sbjct: 815 NVATFQRQLRKLKFSQLIEA-------------TNGFSAASMIGHGGFGEVFKATLKDGS 861
Query: 637 KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696
+A+K++ +S + EF +E+ L K++HR+LV LLGY G ERLLVYE+M G+L
Sbjct: 862 SVAIKKLIR--LSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSL 919
Query: 697 SKHIFHWKSL--NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754
+ + H L W+ R IA A+G+ +LH IHRD+KSSN+LL D
Sbjct: 920 -EEVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDM 978
Query: 755 RAKVSDFGLVKL--APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELL 812
A+VSDFG+ +L A D+ SV T LAGT GY+ PEY + + T K DV+S GVV++E+L
Sbjct: 979 EARVSDFGMARLISALDTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEIL 1037
Query: 813 TGLMALDESRPEERQY-----LAAWFWNIKSDKEKLRAAIDPIL-------EVND-DTFE 859
+G RP +++ L W +K+ + K ID L +N+ + FE
Sbjct: 1038 SG------KRPTDKEEFGDTNLVGW-SKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFE 1090
Query: 860 ------TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892
E+A C PS+RP+M V L L
Sbjct: 1091 GGVIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLREL 1129
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 139/326 (42%), Positives = 194/326 (59%), Gaps = 10/326 (3%)
Query: 568 SNGSTSVATESGTGSRYSSGNGA-SHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGV 626
SN S ++ G G SG+ S V+ +G + + L ++T+ F+ N LG GGFG
Sbjct: 307 SNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGC 366
Query: 627 VYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686
VYKG+L+DG +AVK+++ G S + EF +E+ ++S+V HRHLVSL+GY +A ERLL
Sbjct: 367 VYKGKLNDGKLVAVKQLKVG--SGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLL 424
Query: 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSS 746
+YEY+P L H+ H K + L W RR+ IA+ A+G+ YLH H IHRD+KS+
Sbjct: 425 IYEYVPNQTLEHHL-HGKGRPV--LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSA 481
Query: 747 NILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGV 806
NILL D+F A+V+DFGL KL ++ V TR+ GTFGYLAPEYA +GK+T + DVFSFGV
Sbjct: 482 NILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGV 541
Query: 807 VLMELLTGLMALDESRPEERQYLAAW---FWNIKSDKEKLRAAIDPILEVNDDTFETFWT 863
VL+EL+TG +D+ +P + L W + + +D LE + E F
Sbjct: 542 VLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRM 601
Query: 864 IAELAGHCTSREPSQRPDMGHAVNVL 889
I E A C +RP M V L
Sbjct: 602 I-ETAAACVRHSGPKRPRMVQVVRAL 626
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 180/540 (33%), Positives = 275/540 (50%), Gaps = 91/540 (16%)
Query: 360 TSWSGNDPCKS----WLGLSCGTN-----SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410
T+W G DPC W GL+C ++T ++ NF L+GT++ + L+ L ++
Sbjct: 402 TNWQG-DPCVPIQFIWTGLNCSNMFPSIPPRITSIDFSNFGLNGTITSDIQYLNQLQKLD 460
Query: 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGS 470
L +NN++G++P +K LT ++LS NNLS +P+ LLN + G +
Sbjct: 461 LSNNNLTGKVPEFLAKMKLLTFINLSGNNLSGSIPQ------------SLLNMEKNGLIT 508
Query: 471 SSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISI 530
N + S S + PG++ K+ +LV I+A ASVG+I+ V + ++I
Sbjct: 509 LLYNGNNLCLDPSCESETGPGNN----------KKKLLVPILASAASVGIIIAVLLLVNI 558
Query: 531 CYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGA 590
RK+K + + S+V + R
Sbjct: 559 LLLRKKKPSKASRSSMVANKR--------------------------------------- 579
Query: 591 SHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK 650
S+ E ++V +T NF E LG GGFGVVY G ++D ++AVK + S
Sbjct: 580 SYTYEE----VAV-----ITNNF--ERPLGEGGFGVVYHGNVNDNEQVAVKVLSES--SA 626
Query: 651 KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP 710
+ +F +E+ +L +V H +LV+L+GY G +L+YEYM G L +H+ S + P
Sbjct: 627 QGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQHLVLIYEYMSNGNLKQHLSGENSRS--P 684
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP-D 769
LSW+ RL IA + A+G+EYLH IHRD+KS NILL ++F+AK+ DFGL + P
Sbjct: 685 LSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIKSMNILLDNNFQAKLGDFGLSRSFPVG 744
Query: 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829
SE V T +AG+ GYL PEY T +T K DVFSFGVVL+E++T +D++R E+ ++
Sbjct: 745 SETHVSTNVAGSPGYLDPEYYRTNWLTEKSDVFSFGVVLLEIITSQPVIDQTR--EKSHI 802
Query: 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
W K ++ +DP + + D+ + W ELA C S S RP+M N L
Sbjct: 803 GEWV-GFKLTNGDIKNIVDPSMNGDYDS-SSLWKALELAMSCVSPSSSGRPNMSQVANEL 860
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | ||||||
| 255583590 | 961 | Serine/threonine-protein kinase PBS1, pu | 0.961 | 0.959 | 0.728 | 0.0 | |
| 224091435 | 948 | predicted protein [Populus trichocarpa] | 0.977 | 0.988 | 0.734 | 0.0 | |
| 359482053 | 960 | PREDICTED: probable receptor protein kin | 0.986 | 0.985 | 0.704 | 0.0 | |
| 224138334 | 855 | predicted protein [Populus trichocarpa] | 0.890 | 0.998 | 0.736 | 0.0 | |
| 449437466 | 946 | PREDICTED: probable receptor protein kin | 0.980 | 0.993 | 0.707 | 0.0 | |
| 224059228 | 936 | predicted protein [Populus trichocarpa] | 0.957 | 0.980 | 0.662 | 0.0 | |
| 356537188 | 950 | PREDICTED: probable receptor protein kin | 0.978 | 0.987 | 0.659 | 0.0 | |
| 356498699 | 957 | PREDICTED: probable receptor protein kin | 0.980 | 0.982 | 0.652 | 0.0 | |
| 359479100 | 994 | PREDICTED: probable receptor protein kin | 0.971 | 0.937 | 0.636 | 0.0 | |
| 296084035 | 917 | unnamed protein product [Vitis vinifera] | 0.948 | 0.992 | 0.631 | 0.0 |
| >gi|255583590|ref|XP_002532551.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223527740|gb|EEF29845.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1366 bits (3536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/933 (72%), Positives = 771/933 (82%), Gaps = 11/933 (1%)
Query: 34 SATDPGDIDILNQFRKNLENPELLQWPKSGD--PCGPPCWKHVFCSNSRVTQIQVSSVGL 91
S TDP D+ IL FR LENPELL+WP SGD PCG WKHV C +SRVTQIQV ++ L
Sbjct: 33 SDTDPNDLAILKAFRDGLENPELLEWPASGDEDPCGQ-SWKHVHCVDSRVTQIQVENMRL 91
Query: 92 KGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
KG LP+NLNQL+ L N+GLQ+NQF G LPSFSGLSNL++AYLD N FDTIP+DFF GL N
Sbjct: 92 KGPLPENLNQLTMLVNLGLQRNQFTGPLPSFSGLSNLQFAYLDYNQFDTIPSDFFTGLVN 151
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
LQVLALD N FNA+ GW+F K LQ S+QLTNLSCMSCNL G LPDFLG+ SLQNLKLSG
Sbjct: 152 LQVLALDGNPFNATTGWTFSKDLQDSSQLTNLSCMSCNLVGPLPDFLGSLVSLQNLKLSG 211
Query: 212 NNLTGPIPESFKG-LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES 270
NNL+G IP SFKG ++L NLWLN+QKGGG +GTID++ M+ + LWLHGN F+G IPES
Sbjct: 212 NNLSGEIPPSFKGGMSLQNLWLNNQKGGGLSGTIDLVATMESVTVLWLHGNQFTGKIPES 271
Query: 271 FGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC 330
G+LT LKDLNLN N+ VGL+P SLA+L L+HLDLNNN MGP+PK KA K S +SN FC
Sbjct: 272 IGRLTQLKDLNLNGNKLVGLVPDSLANLPLEHLDLNNNQLMGPIPKFKATKVSCTSNPFC 331
Query: 331 QPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNF 390
Q T GV CAPEVMAL++FL GL+YPPRLV+SW+ NDPC SW+G+ C +N K+ + LPN
Sbjct: 332 QSTAGVSCAPEVMALLEFLDGLSYPPRLVSSWTSNDPCSSWMGVECVSN-KVYSIALPNQ 390
Query: 391 NLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA 450
NLSGTLSPSV NL SL QIKL NN+SGQ+PTNWTNL SL LDLS NN+ PP PKFS
Sbjct: 391 NLSGTLSPSVANLGSLHQIKLGGNNLSGQVPTNWTNLASLETLDLSNNNILPPFPKFSST 450
Query: 451 VKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSS----SSSSPGDSTAETTKPKSSKRT 506
V + + GNP+LNG S PPS ++ S SS + SSP S+AE+ KS KR+
Sbjct: 451 VNVVIAGNPMLNGGKTAP-SPDKYPPSGSRDSPSSQAKGTQSSPAGSSAESITQKSPKRS 509
Query: 507 ILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVAN 566
LVA+IAP+ASV V+ ++ IP+SI + +KR++ QA SLVIHPRDPSD +N VKIVVA+
Sbjct: 510 TLVAVIAPLASVAVVAILIIPLSIYFCKKRRDTIQAPSSLVIHPRDPSDSNN-VKIVVAH 568
Query: 567 NSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGV 626
++NGSTS T S + S SSG G SHVIEAG+LVISVQVLRNVTKNFA +NELGRGGFGV
Sbjct: 569 HTNGSTSTRTGSDSASINSSGIGESHVIEAGSLVISVQVLRNVTKNFAPDNELGRGGFGV 628
Query: 627 VYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686
VYKGELDDGTKIAVKRME+GVIS KA+DEF +EIAVLSKVRHRHLVSLLGYS+ G ER+L
Sbjct: 629 VYKGELDDGTKIAVKRMESGVISSKALDEFQAEIAVLSKVRHRHLVSLLGYSIEGNERIL 688
Query: 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSS 746
VYEYMPQGALSKH+FHWKS LEPLSWKRRLNIALDVARGMEYLH+LAH+SFIHRDLKSS
Sbjct: 689 VYEYMPQGALSKHLFHWKSFELEPLSWKRRLNIALDVARGMEYLHNLAHRSFIHRDLKSS 748
Query: 747 NILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGV 806
NILLGDDFRAKVSDFGLVKLAPD ++SVVTRLAGTFGYLAPEYAVTGKITTK DVFSFGV
Sbjct: 749 NILLGDDFRAKVSDFGLVKLAPDGDKSVVTRLAGTFGYLAPEYAVTGKITTKADVFSFGV 808
Query: 807 VLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAE 866
VLMELLTGL+ALDE RPEE QYLAAWFW+I SDK+KLRAAIDP L+V D+TFE+ IAE
Sbjct: 809 VLMELLTGLVALDEDRPEETQYLAAWFWHISSDKQKLRAAIDPALDVKDETFESISIIAE 868
Query: 867 LAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQMVKDWQEAE 926
LAGHCT+REP+QRPDM HAVNVLAPLVEKWKP D+ EEY GIDYSLPLNQMVK WQEAE
Sbjct: 869 LAGHCTAREPNQRPDMSHAVNVLAPLVEKWKPSGDDTEEYCGIDYSLPLNQMVKGWQEAE 928
Query: 927 GKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
GKD SYV LEDSK SIPARP GFAESFTSADGR
Sbjct: 929 GKDFSYVDLEDSKGSIPARPTGFAESFTSADGR 961
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091435|ref|XP_002309250.1| predicted protein [Populus trichocarpa] gi|222855226|gb|EEE92773.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1366 bits (3535), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 701/955 (73%), Positives = 782/955 (81%), Gaps = 18/955 (1%)
Query: 16 MRTHLVSAIVLAF--VTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGD--PCGPPCW 71
MR H ++ F T+V SATDP D I+ FR+ LENPELL+WP GD PCG W
Sbjct: 1 MRKHHKKLVLALFSLFTVVFSATDPNDFAIIKAFREGLENPELLEWPADGDDDPCGQ-SW 59
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
KHVFCS SRVTQIQV ++ LKGTLPQNLNQL+KL+ +GLQ+NQF G LPS SGLS L+
Sbjct: 60 KHVFCSGSRVTQIQVQNMSLKGTLPQNLNQLTKLQRLGLQRNQFTGALPSLSGLSELQSV 119
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
YLD N FD+IP+D FD L +LQ LALD NNFNAS GWSFP+GLQ SAQLTNLSCM CNLA
Sbjct: 120 YLDFNQFDSIPSDCFDRLVSLQSLALDKNNFNASTGWSFPEGLQDSAQLTNLSCMFCNLA 179
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFK-GLNLVNLWLNDQKGGGFTGTIDVLGNM 250
G LP FLG +SLQNL+LSGNNL+G IP SFK +L NLWLNDQ GGG +GT+DV+ M
Sbjct: 180 GPLPYFLGALSSLQNLRLSGNNLSGEIPASFKRSTSLQNLWLNDQNGGGLSGTLDVVTTM 239
Query: 251 DQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMF 310
D + LWLHGN F+GTIPES G LT L+DLNLN N+ VG +P SLA + L+HLDLNNN
Sbjct: 240 DSVNVLWLHGNQFTGTIPESIGNLTVLQDLNLNGNKLVGFVPDSLAKMPLEHLDLNNNQL 299
Query: 311 MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS 370
MGP+P KA + SY+SNAFCQ T GVPCAPEVMAL++FLG LNYP RLV+SW+GNDPC S
Sbjct: 300 MGPIPNFKATEVSYASNAFCQSTPGVPCAPEVMALLEFLGSLNYPSRLVSSWTGNDPC-S 358
Query: 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSL 430
WLGL+C N + + LP+ NLSGTLSPSV L SL QIKL SNN+SGQ+P NWT+L SL
Sbjct: 359 WLGLAC-HNGNVNSIALPSSNLSGTLSPSVATLGSLIQIKLGSNNLSGQVPENWTSLTSL 417
Query: 431 TLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGS------SS 484
LDLS NN+SPPLPKF+ V + GNPLL G SP + + S S +
Sbjct: 418 KTLDLSTNNISPPLPKFADTVNVVTVGNPLLTGGSPSNPNPSPGSGSSGSPPSNPSSPTK 477
Query: 485 SSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASG 544
+ SSPGDS+ E KPK R+ LVAIIAPVASV V+ L+AIP+SI Y+KRK+ QA
Sbjct: 478 GTGSSPGDSS-EPVKPK---RSTLVAIIAPVASVVVVALLAIPLSIYCYKKRKDTFQAPS 533
Query: 545 SLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQ 604
SLVIHPRDPSD DN VKIVVA+N+NGS S T SG+ SR SSG G SHVIEAGNLVISVQ
Sbjct: 534 SLVIHPRDPSDSDNTVKIVVASNTNGSASTITGSGSASRNSSGVGESHVIEAGNLVISVQ 593
Query: 605 VLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS 664
VLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRME+GVIS KA+DEF +EIAVLS
Sbjct: 594 VLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMESGVISSKAIDEFQAEIAVLS 653
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
KVRHRHLVSLLGYSV GYER+LVYEYMPQGALSKH+FHWKS LEPLSWKRRLNIALDVA
Sbjct: 654 KVRHRHLVSLLGYSVEGYERILVYEYMPQGALSKHLFHWKSSKLEPLSWKRRLNIALDVA 713
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
RGMEYLH+LAH+SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD E+S+VTRLAGTFGY
Sbjct: 714 RGMEYLHNLAHRSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGEKSMVTRLAGTFGY 773
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
LAPEYAVTGKITTKVDVFSFG+VLMELLTGLMALDE RPEE QYLAAWFW IKSDK+KLR
Sbjct: 774 LAPEYAVTGKITTKVDVFSFGIVLMELLTGLMALDEDRPEESQYLAAWFWRIKSDKQKLR 833
Query: 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPE 904
AAIDP L+V D+TFE+ IAELAGHCT+REP+QRPDMGHAVNVLAPLVEKWKP+DD+ E
Sbjct: 834 AAIDPALDVKDETFESISIIAELAGHCTAREPNQRPDMGHAVNVLAPLVEKWKPMDDDTE 893
Query: 905 EYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
+Y GIDYSLPLNQMVK WQEAEGKDLSYV LEDSKSSIPARP GFAESFTSADGR
Sbjct: 894 DYCGIDYSLPLNQMVKGWQEAEGKDLSYVDLEDSKSSIPARPTGFAESFTSADGR 948
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482053|ref|XP_002274910.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1352 bits (3500), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/965 (70%), Positives = 779/965 (80%), Gaps = 19/965 (1%)
Query: 8 CKSERSS--AMRTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGD- 64
K RS+ A +T LV ++ + V +V +ATDP D+ ILNQFRK L+NPELL WP++GD
Sbjct: 2 VKRHRSAMEADQTKLVFGVLFSLVAVVFTATDPNDLAILNQFRKGLKNPELLNWPENGDD 61
Query: 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG 124
PCG P W HVFCS SRV+QIQV ++GLKG LPQNLNQLS L ++GLQ+NQF G+LPS SG
Sbjct: 62 PCGIPRWDHVFCSGSRVSQIQVQNLGLKGPLPQNLNQLSMLTSLGLQRNQFSGQLPSLSG 121
Query: 125 LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184
LS L+YAY D N FD+IP+DFFDGL NL+VL LD+NN N + GWS P LQ+SAQL NL+
Sbjct: 122 LSELRYAYFDFNEFDSIPSDFFDGLVNLEVLELDNNNLNVTTGWSLPSQLQNSAQLRNLT 181
Query: 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
++ NL G LP+FLGN +SL LKLS N ++G IP SFK NL LWLN+QKGG TG I
Sbjct: 182 LVNSNLVGPLPEFLGNMSSLAVLKLSMNTISGGIPASFKDSNLEILWLNNQKGGQMTGPI 241
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLD 304
DV+ M L TLWLHGN FSG IPE+ G LTSLKDLNLNSNQ VGLIP SLASL L+ LD
Sbjct: 242 DVVATMLSLTTLWLHGNKFSGPIPENIGDLTSLKDLNLNSNQLVGLIPDSLASLELNSLD 301
Query: 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364
LNNN MGP+P KA SY SN CQ GVPCA EVM L++FLGGLNYP LV+SWSG
Sbjct: 302 LNNNQLMGPIPNFKAVNVSYDSNQLCQSKPGVPCAKEVMVLLEFLGGLNYPNHLVSSWSG 361
Query: 365 NDPCKS-WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
NDPC+ WLGLSC + K++++NLP F +GTLSPS+ NL+SL+QI+L SNNI+GQ+PTN
Sbjct: 362 NDPCEGPWLGLSCA-DQKVSIINLPKFGFNGTLSPSLANLESLSQIRLPSNNITGQVPTN 420
Query: 424 WTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSP----- 478
WT+LKSLT LDLS NN+SPP P FS VKL L GNPLL+ + +S +
Sbjct: 421 WTSLKSLTYLDLSGNNISPPFPNFSKTVKLVLYGNPLLSSNQSTTPGNSPSSGGSQSSSG 480
Query: 479 ----TKGSSSSSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYR 534
T GS+S +S DS+ E TK K+SK LV I+ P+AS +++ + P+SI Y +
Sbjct: 481 SASPTMGSNSGTS----DSSEEPTKNKNSKGPKLVVIVVPLASFALLVFLVAPLSIYYCK 536
Query: 535 KRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVI 594
KRK +QAS SLVIHPRDPSD +NMVKIVVAN++NGS S + +GSR SSG G SHVI
Sbjct: 537 KRKNTNQASSSLVIHPRDPSDSENMVKIVVANSNNGSVSTLG-ACSGSRNSSGTGESHVI 595
Query: 595 EAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVD 654
EAGNLVISVQVLRNVTKNFA EN LGRGGFGVVYKGELDDGTKIAVKRMEAG+IS KA+D
Sbjct: 596 EAGNLVISVQVLRNVTKNFAPENVLGRGGFGVVYKGELDDGTKIAVKRMEAGIISSKALD 655
Query: 655 EFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWK 714
EF +EIAVLSKVRHRHLVSLLGYSV G ER+LVYEYMPQGALSKH+FHWKSL LEPLSWK
Sbjct: 656 EFQAEIAVLSKVRHRHLVSLLGYSVEGNERILVYEYMPQGALSKHLFHWKSLKLEPLSWK 715
Query: 715 RRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774
RRLNIALDVARGMEYLH+LAHQ+FIHRDLKSSNILLGDD+RAKVSDFGLVKLAPD E+SV
Sbjct: 716 RRLNIALDVARGMEYLHTLAHQTFIHRDLKSSNILLGDDYRAKVSDFGLVKLAPDGEKSV 775
Query: 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834
VT+LAGTFGYLAPEYAVTGKIT KVDVFSFGVVLMELLTGLMALDE RPEE QYLAAWFW
Sbjct: 776 VTKLAGTFGYLAPEYAVTGKITVKVDVFSFGVVLMELLTGLMALDEDRPEESQYLAAWFW 835
Query: 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
+IKS+KEKL AAIDP+L+ ++T E+ TIAELAGHCT+REPSQRP+MGHAVNVLAPLVE
Sbjct: 836 HIKSNKEKLMAAIDPVLDKKEETLESISTIAELAGHCTAREPSQRPEMGHAVNVLAPLVE 895
Query: 895 KWKPLDDEPEEYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFT 954
KWKP DD+ EEYSGIDYSLPLNQMVK WQEAEGKD SY+ LEDSK SIPARP GFA+SFT
Sbjct: 896 KWKPFDDDTEEYSGIDYSLPLNQMVKGWQEAEGKDFSYLDLEDSKGSIPARPTGFADSFT 955
Query: 955 SADGR 959
SADGR
Sbjct: 956 SADGR 960
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138334|ref|XP_002322788.1| predicted protein [Populus trichocarpa] gi|222867418|gb|EEF04549.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1284 bits (3323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/872 (73%), Positives = 720/872 (82%), Gaps = 18/872 (2%)
Query: 89 VGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDG 148
+ LKGTLPQNLN+L+KL+ +GLQ+NQF G LPS GLS L+Y YLD N FD+IP++ FD
Sbjct: 1 MSLKGTLPQNLNKLTKLQRLGLQRNQFTGALPSLGGLSELQYVYLDFNQFDSIPSNCFDD 60
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
L +LQ LALDSNNFNAS GWSFP+GLQ SAQLTNLSCM CNLAG LP FLG+ SLQ+LK
Sbjct: 61 LVSLQFLALDSNNFNASTGWSFPEGLQDSAQLTNLSCMFCNLAGPLPVFLGSLPSLQSLK 120
Query: 209 LSGNNLTGPIPESFKG-LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI 267
LSGNNL+G IP SFKG ++L NLWLNDQ GGG +GTIDV+ MD + LWLHGN F+GTI
Sbjct: 121 LSGNNLSGEIPVSFKGGMSLQNLWLNDQNGGGLSGTIDVVTTMDSVNVLWLHGNQFTGTI 180
Query: 268 PESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
PES G LT L+DLNLN NQ VG +P SLA + L HLDLNNN MGP+PK KA + SY+SN
Sbjct: 181 PESIGNLTVLQDLNLNGNQLVGFVPDSLAKMPLQHLDLNNNQLMGPIPKFKATEVSYASN 240
Query: 328 AFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNL 387
AFCQ T GVPCAPEVMAL++FLG LNYP RLV+SW+GN+PC WLGL+C NSK+ + L
Sbjct: 241 AFCQSTPGVPCAPEVMALLEFLGSLNYPSRLVSSWTGNNPCL-WLGLACDPNSKVNSIVL 299
Query: 388 PNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF 447
PN NLSGTLSPSV L SL Q+KL SNN+ G IP NWT+L SL LDLS NN+SPPLPKF
Sbjct: 300 PNHNLSGTLSPSVAKLGSLFQVKLASNNLGGHIPDNWTSLTSLKTLDLSANNISPPLPKF 359
Query: 448 SGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTI 507
SG V + + GNPL NG SP + P P+ G++ SS SS + ++ K
Sbjct: 360 SGTVNVVISGNPLFNGGSPAN-------PVPSPGNNPSSGSSDSPPSNPSSPNKG----- 407
Query: 508 LVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANN 567
IAPVASV I ++ IP+SI +KRK+ QA SLVIHPRDPSD DN VK+VV+++
Sbjct: 408 ----IAPVASVAFIAILVIPLSIYCCKKRKDTFQAPSSLVIHPRDPSDSDNTVKVVVSHD 463
Query: 568 SNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVV 627
+NGS S T +G+ SR SSG G SHV EAGNLVISVQVLRNVTKNFASENELGRGGFGVV
Sbjct: 464 TNGSASTITGNGSASRTSSGIGESHVFEAGNLVISVQVLRNVTKNFASENELGRGGFGVV 523
Query: 628 YKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687
YKGELDDGTKIAVKRMEAGVIS K +DEF +EIAVLSKVRHRHLVSLLGYS+ G ER+LV
Sbjct: 524 YKGELDDGTKIAVKRMEAGVISSKGLDEFQAEIAVLSKVRHRHLVSLLGYSIEGCERILV 583
Query: 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSN 747
YEY+PQGALS+H+FHWKSL LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSN
Sbjct: 584 YEYVPQGALSRHLFHWKSLELEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSN 643
Query: 748 ILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVV 807
ILLGDDFRAKVSDFGLVKLAPD E+SVVTRLAGTFGYLAPEYAVTGKITTK DVFSFGVV
Sbjct: 644 ILLGDDFRAKVSDFGLVKLAPDGEKSVVTRLAGTFGYLAPEYAVTGKITTKADVFSFGVV 703
Query: 808 LMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAEL 867
LMELLTGLMALD+ RPEE QYLAAWFW IKSDK+KLRAAIDP L+V D+TFE+ +AEL
Sbjct: 704 LMELLTGLMALDDDRPEESQYLAAWFWQIKSDKQKLRAAIDPALDVKDETFESISIVAEL 763
Query: 868 AGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQMVKDWQEAEG 927
AGHCT+REP+QRPDMGHAVNVLAPLVE WKPLDD+ EEY GIDYSLPLNQMVK WQEAEG
Sbjct: 764 AGHCTAREPNQRPDMGHAVNVLAPLVEIWKPLDDDTEEYCGIDYSLPLNQMVKGWQEAEG 823
Query: 928 KDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
KDLSYV L+DSKSSIPARP GFAESFTSADGR
Sbjct: 824 KDLSYVDLKDSKSSIPARPTGFAESFTSADGR 855
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437466|ref|XP_004136513.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] gi|449515404|ref|XP_004164739.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1261 bits (3263), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 670/947 (70%), Positives = 769/947 (81%), Gaps = 7/947 (0%)
Query: 16 MRTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWP-KSGDPCGPPCWKHV 74
++T L A++LA V++ ATDP D+ ILN FRK LENPELL+WP K DPCG W V
Sbjct: 4 LKTELALALLLAVVSVGFCATDPNDLAILNDFRKGLENPELLKWPSKDNDPCGNK-WPSV 62
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLD 134
FC SRV QIQV GLKG LPQN NQLS L NIGLQKNQF G LPSF+GL NL+YA+L+
Sbjct: 63 FCDGSRVAQIQVQGFGLKGPLPQNFNQLSMLSNIGLQKNQFSGPLPSFNGLKNLQYAFLN 122
Query: 135 GNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL 194
NNF +IPADFF GL+NL+VLALD NN N S GW FP L +S QLTNL+CMSCNL G L
Sbjct: 123 YNNFTSIPADFFTGLDNLEVLALDGNNLNGSSGWMFPPALSNSVQLTNLTCMSCNLVGPL 182
Query: 195 PDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLR 254
PDFLG+ +SL L LSGN LTG IP SFK + L WLN+Q G G +G+IDV+ M L
Sbjct: 183 PDFLGSMSSLSVLSLSGNRLTGGIPASFKDMVLTRFWLNNQVGDGMSGSIDVVTTMTSLN 242
Query: 255 TLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPV 314
+LWLHGNHFSGTIP++ G L+ L+DLNLN N+FVGLIP SL +SL +LDLNNN FMGP+
Sbjct: 243 SLWLHGNHFSGTIPDNIGDLSLLQDLNLNGNEFVGLIPKSLGDMSLKNLDLNNNNFMGPI 302
Query: 315 PKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS-WLG 373
PK KA K SYSSN CQ EGV CAP+VMALI+FLG + YP RLV++W+GNDPC+ WLG
Sbjct: 303 PKFKASKVSYSSNQLCQTEEGVACAPQVMALIEFLGAMGYPLRLVSAWTGNDPCEGPWLG 362
Query: 374 LSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLL 433
L+C + ++V+NLP FNL+GTLSPS+ NL SL +++LQ+NN+SG IP+NWT LKSLTLL
Sbjct: 363 LNC-RSGDVSVINLPKFNLNGTLSPSLANLISLAEVRLQNNNLSGTIPSNWTGLKSLTLL 421
Query: 434 DLSQNNLSPPLPKFSGAVKLSLDGNPLLNGK-SPGSGSSSGNPPSPTKGSSSSSSSSPGD 492
DLS NN+SPP+P+FS VKLS GNPLL+GK SP S +P ++ SS+ G+
Sbjct: 422 DLSGNNISPPVPRFSSTVKLSTGGNPLLDGKQSPSSEIGGPSPSDSRSPPATEPSSNSGN 481
Query: 493 STAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRD 552
+T+ SK +I+V+ + PV SV V+ VAIP+SI + +KRK QA SLV+HPRD
Sbjct: 482 GVRQTSS--RSKASIIVSTVVPVVSVVVVAFVAIPLSIYFCKKRKRNGQAPSSLVVHPRD 539
Query: 553 PSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKN 612
PSDP+N+VKIVVANN+N STS A+ SG+GSR SG G SHVIE GNLVISVQVLRNVT N
Sbjct: 540 PSDPNNLVKIVVANNTNNSTSTASGSGSGSRNYSGFGDSHVIETGNLVISVQVLRNVTNN 599
Query: 613 FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
F+SENELGRGGFGVVY+GELDDGTKIAVKRME+GVIS KA+DEF SEIAVLSKVRHRHLV
Sbjct: 600 FSSENELGRGGFGVVYRGELDDGTKIAVKRMESGVISSKALDEFQSEIAVLSKVRHRHLV 659
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
SLLGYSVAG ERLLVYEYMP+GALS+H+FHW+S LEPLSWKRRLNIALDVARGMEYLHS
Sbjct: 660 SLLGYSVAGNERLLVYEYMPEGALSRHLFHWESFKLEPLSWKRRLNIALDVARGMEYLHS 719
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792
LAHQSFIHRDLKSSNILLGDDFRAK+SDFGLVKLAPD ERSVVTRLAGTFGYLAPEYAVT
Sbjct: 720 LAHQSFIHRDLKSSNILLGDDFRAKISDFGLVKLAPDGERSVVTRLAGTFGYLAPEYAVT 779
Query: 793 GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILE 852
GKITTK DVFSFGVVLMELLTGLMALDE R EE QYLAAWFW+IKSDKEKL AA+DP L
Sbjct: 780 GKITTKADVFSFGVVLMELLTGLMALDEDRSEESQYLAAWFWHIKSDKEKLMAAVDPSLG 839
Query: 853 VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYS 912
+D E+ IAELAGHCT+REP+QRPDMGHAVNVLAPLVEKWKP+DD+ EEYSGIDYS
Sbjct: 840 CKEDISESICIIAELAGHCTAREPTQRPDMGHAVNVLAPLVEKWKPIDDDTEEYSGIDYS 899
Query: 913 LPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
LPLNQMVK WQE+EG D SYV L+DSK SIP+RP GFA+SFTS DGR
Sbjct: 900 LPLNQMVKGWQESEGSDFSYVDLQDSKGSIPSRPTGFADSFTSVDGR 946
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059228|ref|XP_002299778.1| predicted protein [Populus trichocarpa] gi|222847036|gb|EEE84583.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1222 bits (3163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 619/934 (66%), Positives = 728/934 (77%), Gaps = 16/934 (1%)
Query: 29 VTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGD-PCGPPCWKHVFCSNSRVTQIQVS 87
VTL S TDP D+ IL F+K LENPELL+WP +GD PCGPP W HVFCS+ RVTQIQV
Sbjct: 16 VTLGYSVTDPNDLKILLDFQKGLENPELLKWPANGDDPCGPPLWPHVFCSDGRVTQIQVQ 75
Query: 88 SVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFD 147
S+GLKG LPQN NQLSKL NIGLQ+N F G+LP+F GLS L++A+LD NNFDTIP+DFF
Sbjct: 76 SMGLKGPLPQNFNQLSKLYNIGLQRNNFTGKLPTFKGLSELEFAFLDYNNFDTIPSDFFV 135
Query: 148 GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNL 207
GL +++VLALDSN N S GWS P L S QLTNLS S NLAG LPDFLG+ SL NL
Sbjct: 136 GLSSIRVLALDSNPLNESTGWSLPSELADSVQLTNLSVSSSNLAGSLPDFLGSMQSLSNL 195
Query: 208 KLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI 267
+LS N L+G IP SF + L LN+Q+GGG +G IDV+ +M L LWLHGN F+GTI
Sbjct: 196 RLSYNRLSGEIPASFGKSLMSTLLLNNQEGGGMSGPIDVIASMTSLSQLWLHGNSFTGTI 255
Query: 268 PESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
PE+ G L+ L+DLNLN N+ VGL+P SLA + LD LDLNNN MGPVPK KA K SY SN
Sbjct: 256 PENIGGLSLLRDLNLNGNKLVGLVPQSLADMPLDDLDLNNNQLMGPVPKFKAGKVSYESN 315
Query: 328 AFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK-SWLGLSCGTNSKLTVLN 386
FCQ GV CAPEV AL+DFLGG+NYP L + WSGNDPC+ SWLGL+C +NSK++V+N
Sbjct: 316 PFCQSKPGVECAPEVNALLDFLGGVNYPSILTSQWSGNDPCQGSWLGLNCDSNSKVSVIN 375
Query: 387 LPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK 446
L NL+GTLSPS+ LDSL +I L N+I G IP+N+TNL SL LLD+S NNL PPLPK
Sbjct: 376 LLRHNLTGTLSPSIARLDSLIEIDLGGNSIKGTIPSNFTNLNSLRLLDVSGNNLGPPLPK 435
Query: 447 FSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRT 506
F +VKL +DGNPLL+ ++P GS+ PPSP S+ P + T+ +++RT
Sbjct: 436 FRTSVKLVVDGNPLLD-ENPPRGSA---PPSP--------STMPFSPPSPTSISNTNQRT 483
Query: 507 ILVAIIAPVASVGVILLVAIPISI-CYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVA 565
LV I+ + + ++ +V I +S+ C ++KRKE S S+V+HPRDPSD +N+VKI +
Sbjct: 484 KLV-IVGGIFAGSLLAIVLIALSLYCCFKKRKETSNPPSSIVVHPRDPSDRENIVKIAFS 542
Query: 566 NNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFG 625
NN+ S S T + S S+ S ++E+GN+VISVQVLR VT NFA +N+LG GGFG
Sbjct: 543 NNTIRSLSTQTGISSVSNTSNLTENSSLVESGNVVISVQVLRKVTDNFAQKNQLGSGGFG 602
Query: 626 VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685
+VYKGEL+DGTKIAVKRMEAGV+ KA DEF +EIAVLSKVRHRHLVSLLGYS+ G ERL
Sbjct: 603 IVYKGELEDGTKIAVKRMEAGVMGSKAGDEFQAEIAVLSKVRHRHLVSLLGYSIEGNERL 662
Query: 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKS 745
LVYEYMPQGALS H+FHWK LNLEPLSW RRL+IALDVARG+EYLHSLA Q+FIHRDLKS
Sbjct: 663 LVYEYMPQGALSMHLFHWKKLNLEPLSWMRRLSIALDVARGVEYLHSLARQTFIHRDLKS 722
Query: 746 SNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFG 805
SNILLGDDF AKVSDFGLVKLAPD E+SV TRLAGTFGYLAPEYAV GKITTKVDVFS+G
Sbjct: 723 SNILLGDDFHAKVSDFGLVKLAPDREQSVATRLAGTFGYLAPEYAVMGKITTKVDVFSYG 782
Query: 806 VVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIA 865
VVLMELLTGL ALDE RPEE +YLA WFW IKS KEKL AAIDP L VND+TFE+ +IA
Sbjct: 783 VVLMELLTGLTALDEERPEESRYLAEWFWRIKSSKEKLMAAIDPALNVNDETFESISSIA 842
Query: 866 ELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQMVKDWQEA 925
ELAGHCTSR+P+ RPDMGHAVNVL PLVEKWKP++DE E++ GIDYS PL +M+K WQ+A
Sbjct: 843 ELAGHCTSRDPNHRPDMGHAVNVLVPLVEKWKPVNDESEDFYGIDYSQPLPEMLKVWQDA 902
Query: 926 EGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
+ LSY SL DSK SIPARPAGFAESFTSADGR
Sbjct: 903 DSTGLSYTSLSDSKGSIPARPAGFAESFTSADGR 936
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537188|ref|XP_003537111.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1218 bits (3152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 630/955 (65%), Positives = 736/955 (77%), Gaps = 17/955 (1%)
Query: 16 MRTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSG-DPCGPPCWKHV 74
MR + + + F TLV+S TDP D+ ILN FR+ L N ELL WP+ G DPCG P WK++
Sbjct: 2 MRLNFL--LCFCFFTLVVSETDPNDVKILNTFRRGLNNSELLPWPEEGGDPCGSPPWKYI 59
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLD 134
FC+ +RV QIQ ++GL G LPQNLNQL LEN+GLQ N G LPSF GL+NLKY +L
Sbjct: 60 FCNGNRVAQIQTKNLGLVGPLPQNLNQLVMLENLGLQNNNLNGPLPSFKGLNNLKYIFLG 119
Query: 135 GNNFDTIPADFFDGLENLQVLALDSNN-FNASKG-WSFPKGLQSSAQLTNLSCMSCNLAG 192
N+FD+IP DFF+GL++L+VLALD N NAS G WSFP L SAQL NLSCMSCNL G
Sbjct: 120 RNDFDSIPLDFFEGLKSLEVLALDYNEKLNASSGGWSFPAALADSAQLRNLSCMSCNLVG 179
Query: 193 QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMD 251
+P FLG+ ASL L LSGNNLTG IP + + L LWLN+Q+G G TG IDVL +M
Sbjct: 180 PIPGFLGDMASLSVLLLSGNNLTGEIPATLNAVPALQVLWLNNQRGEGLTGKIDVLASMI 239
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFM 311
L +LWLHGN F G++P+S L SLKDL+LN N+FVGLIP L + LD LDLNNN F+
Sbjct: 240 SLTSLWLHGNKFEGSVPDSIADLVSLKDLDLNGNEFVGLIPSGLGGMKLDRLDLNNNHFV 299
Query: 312 GPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS- 370
GP+P A K S+ +N FC GV C EVM L++FLGGL YP LV WSGNDPC
Sbjct: 300 GPIPDFAASKVSFENNEFCVAKPGVMCGFEVMVLLEFLGGLGYPRILVDEWSGNDPCDGP 359
Query: 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSL 430
WLG+ C + K+ ++ L FN+SGTLSPSV LDSL +I+L N+ISG IP+NWT+L+SL
Sbjct: 360 WLGIRCNGDGKVDMILLEKFNISGTLSPSVAKLDSLVEIRLGGNDISGGIPSNWTSLRSL 419
Query: 431 TLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSP 490
TLLDLS NN+S PLP F +KL +D NP ++ +P S S + + + +
Sbjct: 420 TLLDLSGNNISGPLPSFRKGLKLVIDENPHVS--APEGSLPSPVSSSGSGSADKHNPNPS 477
Query: 491 GDSTAETTKPKSSKRTI------LVAIIAPVASVGVILLVAIPISICYYRKRKEASQASG 544
GDS+ S + LV I+AP+A V + V IP+ + +RK+K S+ G
Sbjct: 478 GDSSPNPKSSSSFESNKSSIGKKLVPIVAPIAGVAAVAFVLIPLYVYCFRKKKGVSEGPG 537
Query: 545 SLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQ 604
SLVIHPRD SD DN++KIVVANNSNGS V+T +G+GS ++G+ S VIEAGNLVISVQ
Sbjct: 538 SLVIHPRDASDLDNVLKIVVANNSNGS--VSTVTGSGSGITTGSSESRVIEAGNLVISVQ 595
Query: 605 VLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS 664
VLRNVTKNFA ENE+GRGGFGVVYKGEL+DGTKIAVKRME+GVI+ KA+DEF SEIAVLS
Sbjct: 596 VLRNVTKNFARENEVGRGGFGVVYKGELEDGTKIAVKRMESGVITSKALDEFQSEIAVLS 655
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
KVRHRHLVSLLGYSV G ER+LVYEYMPQGALS H+FHWKSL LEPLSWKRRLNIALDVA
Sbjct: 656 KVRHRHLVSLLGYSVEGNERILVYEYMPQGALSMHLFHWKSLKLEPLSWKRRLNIALDVA 715
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
RGMEYLHSLAHQ FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD ++SVVTRLAGTFGY
Sbjct: 716 RGMEYLHSLAHQIFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGKKSVVTRLAGTFGY 775
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
LAPEYAVTGK+TTK DVFSFGVVLMELLTGLMALDE RPEE QYLA+WFW+IKSDKEKL
Sbjct: 776 LAPEYAVTGKVTTKADVFSFGVVLMELLTGLMALDEDRPEETQYLASWFWHIKSDKEKLM 835
Query: 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPE 904
+AIDP L++ ++ F+ IAELAGHC++REP+QRPDM HAVNVL+PLV+KWKPLDDE E
Sbjct: 836 SAIDPALDIKEEMFDVVSIIAELAGHCSAREPNQRPDMSHAVNVLSPLVQKWKPLDDETE 895
Query: 905 EYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
EYSGIDYSLPLNQMVKDWQE EGKDLSYV L+DSKSSIPARP GFAESFTS DGR
Sbjct: 896 EYSGIDYSLPLNQMVKDWQETEGKDLSYVDLQDSKSSIPARPTGFAESFTSVDGR 950
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498699|ref|XP_003518187.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1209 bits (3128), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/960 (65%), Positives = 736/960 (76%), Gaps = 20/960 (2%)
Query: 16 MRTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSG-DPCGPPCWKHV 74
M +LV + L F TLV+S TD D+ ILN F++ L N ELL WP+ G DPCG P WK++
Sbjct: 2 MMKNLVLFLCLCFFTLVVSETDSNDVKILNSFKRGLNNSELLPWPEEGGDPCGSPPWKYI 61
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLD 134
FC+ +RV QIQ ++GL G LP NLN+L+ LEN+GLQ N G LPSF GL+NLKY +L
Sbjct: 62 FCNGNRVAQIQTKNLGLVGPLPPNLNELTMLENLGLQNNNLNGPLPSFKGLTNLKYIFLG 121
Query: 135 GNNFDTIPADFFDGLENLQVLALDSNN-FNASKG-WSFPKGLQSSAQLTNLSCMSCNLAG 192
N+FD+IP DFF+GL++L+VLALD N NAS G W+FP L+ SAQL NLSCMSCNL G
Sbjct: 122 HNDFDSIPVDFFEGLKSLEVLALDYNEKLNASNGGWNFPATLEDSAQLRNLSCMSCNLVG 181
Query: 193 QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMD 251
+P F G+ ASL L LSGNNLTG IP + + L LWLN+Q+G G G IDVL +M
Sbjct: 182 PIPGFFGDMASLSVLLLSGNNLTGEIPATLNAVPALQVLWLNNQRGEGLGGKIDVLASMV 241
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFM 311
L +L L GN F G++P + G L SLKDL+LN N+FVGLIP L + LD LDLNNN FM
Sbjct: 242 SLTSLLLRGNSFEGSVPMNIGDLVSLKDLDLNGNEFVGLIPSGLGGMILDKLDLNNNHFM 301
Query: 312 GPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS- 370
GP+P+ A K SY +N FC+ GV CA EVM L++FLGGL YP LV SWSGNDPC
Sbjct: 302 GPIPEFAASKVSYENNEFCEAKAGVMCAFEVMVLLEFLGGLGYPWILVDSWSGNDPCHGP 361
Query: 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSL 430
WLG+ C + K+ ++ L FNLSGTLSPSV LDSL +I+L N+ISG IP+NWT+LKSL
Sbjct: 362 WLGIRCNGDGKVDMIILEKFNLSGTLSPSVAKLDSLVEIRLGGNDISGTIPSNWTSLKSL 421
Query: 431 TLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSP-GSGSSSGNPPSPTKGSSSSSSSS 489
TLLDLS NN+S PLP F +KL +DG+P +G +P GS S G S TKG S S+
Sbjct: 422 TLLDLSGNNISRPLPSFGKGLKLVIDGDP--HGSAPEGSLSLPGTGSSSTKGESPSTDKH 479
Query: 490 PGDSTAETTKPKSSKRTI----------LVAIIAPVASVGVILLVAIPISICYYRKRKEA 539
+ + +++ S + +V I+ P+A V V IP+ + +RK+K
Sbjct: 480 NPNPSEDSSPNPKSSSSFESNNSSNGKKIVPIVVPIAGVAAAAFVLIPLYVYCFRKKKGV 539
Query: 540 SQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNL 599
S+ GSLVIHPRD SDPDN++KIVVANNS+ S S T SG+G+ SG S VIEAGNL
Sbjct: 540 SEGPGSLVIHPRDASDPDNVLKIVVANNSSRSVSTVTGSGSGTMTRSGE--SRVIEAGNL 597
Query: 600 VISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSE 659
VISVQVLRNVTKNFA ENE+GRGGFGVVYKGEL+DGTKIAVKRME+GVI+ KA+DEF SE
Sbjct: 598 VISVQVLRNVTKNFARENEVGRGGFGVVYKGELEDGTKIAVKRMESGVITSKALDEFQSE 657
Query: 660 IAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
IAVLSKVRHRHLVSLLGYSV G ER+LVYEYMPQGALS H+FHWKSL LEPLSWKRRLNI
Sbjct: 658 IAVLSKVRHRHLVSLLGYSVEGKERILVYEYMPQGALSMHLFHWKSLQLEPLSWKRRLNI 717
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
ALDVARGMEYLHSLAHQ FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD ++SVVTRLA
Sbjct: 718 ALDVARGMEYLHSLAHQIFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDGKKSVVTRLA 777
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839
GTFGYLAPEYAVTGK+TTK DVFSFGVVLMELLTGLMALDE RPEE QYLA+WF +IKSD
Sbjct: 778 GTFGYLAPEYAVTGKVTTKADVFSFGVVLMELLTGLMALDEDRPEETQYLASWFRHIKSD 837
Query: 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899
KEKL AAIDP L++ ++ F+ +AELAGHCT+REP++RPDM HAVNVL+PLV+KWKPL
Sbjct: 838 KEKLMAAIDPALDIKEEMFDVVSIVAELAGHCTTREPNERPDMSHAVNVLSPLVQKWKPL 897
Query: 900 DDEPEEYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
DD+ EEY+G+DYSLPLNQMVK+WQE EGKDLSYV L+DSKSSIP RP G AESFTS DGR
Sbjct: 898 DDDTEEYAGVDYSLPLNQMVKEWQETEGKDLSYVDLQDSKSSIPERPTGLAESFTSIDGR 957
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359479100|ref|XP_002274506.2| PREDICTED: probable receptor protein kinase TMK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1207 bits (3123), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 602/946 (63%), Positives = 712/946 (75%), Gaps = 14/946 (1%)
Query: 17 RTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGD-PCGPPCWKHVF 75
++ L ++L + ATDP D+ ILN FRK LEN ELL+WP GD PCGPP W HVF
Sbjct: 60 QSKLWVVLILCIFRVAHCATDPSDMKILNDFRKGLENSELLKWPDDGDDPCGPPLWPHVF 119
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
CS RV QIQV +GLKG LPQN NQLS L N+GLQ+N F G+LPSF GLS L++A+LD
Sbjct: 120 CSGDRVAQIQVEGLGLKGPLPQNFNQLSMLYNLGLQRNHFNGKLPSFRGLSELQFAFLDY 179
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N FDTIPADFFDGL ++++LAL+ N FNA+ GWS P LQ S QLT LS +CNL G LP
Sbjct: 180 NEFDTIPADFFDGLTSIRILALNDNPFNATTGWSIPDELQKSVQLTTLSLGNCNLVGPLP 239
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
+FLG SL LKL N L+G IP SF + LWLNDQ GGG +G +DV+G+M L
Sbjct: 240 EFLGTLPSLTTLKLPYNRLSGEIPASFGQSLMQILWLNDQDGGGMSGPMDVIGSMVSLTQ 299
Query: 256 LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVP 315
LWLHGN F+GTIPES G LTSL+DLNLN N+ VGL+P SLA++ L LDLNNN MGP+P
Sbjct: 300 LWLHGNQFTGTIPESIGDLTSLRDLNLNGNKLVGLVPESLANMELQKLDLNNNHLMGPIP 359
Query: 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS-WLGL 374
K + SY+SN+FCQ G+ C+PEV AL+DFL +NYP L + WSGNDPC+ WLGL
Sbjct: 360 KFTSGNVSYASNSFCQSEPGLQCSPEVNALLDFLAAVNYPLGLASEWSGNDPCEQPWLGL 419
Query: 375 SCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLD 434
C NSK++++NLPNF L+GTLSPS+GNLDSL +I+L NN++G IP N T L SL LD
Sbjct: 420 GCNPNSKVSIVNLPNFRLNGTLSPSIGNLDSLVEIRLGGNNLTGTIPMNLTKLTSLKKLD 479
Query: 435 LSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDST 494
+S NN PP+P+F +VK+ +GNP L G + S S P S
Sbjct: 480 VSGNNFEPPVPRFQESVKVITNGNPRLAGNQ-----------TEPSPPPGSPPSPPPGSP 528
Query: 495 AETTKPKS-SKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDP 553
KPKS SKR V I+A +++ ++ ++ I +++ +KRK+ +A S+V+HPRDP
Sbjct: 529 PSPFKPKSTSKRLKTVIIVAAISAFAILAMLVILLTLYCRKKRKDQVEAPSSIVVHPRDP 588
Query: 554 SDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNF 613
DPDNMVKI V++N+ GS T S SR SSG SH IE+GNL+ISVQVLR VT NF
Sbjct: 589 FDPDNMVKIAVSSNTTGSLFTQTGSSIESRDSSGVHNSHKIESGNLIISVQVLRKVTDNF 648
Query: 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
A ENELGRGGFG VYKGEL+DGTKIAVKRMEAGV+S A+DEF +EIAVLSKVRHRHLVS
Sbjct: 649 APENELGRGGFGAVYKGELEDGTKIAVKRMEAGVVSNTALDEFQAEIAVLSKVRHRHLVS 708
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LLG+S+ G ERLLVYE+M GALS+H+FHWK+L LEPLSWK RL+IALDVARGMEYLH L
Sbjct: 709 LLGHSIEGNERLLVYEFMSHGALSRHLFHWKNLKLEPLSWKMRLSIALDVARGMEYLHGL 768
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
A +SFIHRDLKSSNILLGDDFRAKV+DFGLVKLAPD +SV TRLAGTFGYLAPEYAV G
Sbjct: 769 ARESFIHRDLKSSNILLGDDFRAKVADFGLVKLAPDRGKSVATRLAGTFGYLAPEYAVMG 828
Query: 794 KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853
KITTK DVFS+GVVLMELLTGL ALDE R EE +YLA WFW IKS KEKL AA+DP +
Sbjct: 829 KITTKADVFSYGVVLMELLTGLAALDEGRSEECRYLAEWFWRIKSSKEKLMAAVDPAIGA 888
Query: 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSL 913
++TFE+ +AELAGHCT+REPS RPDMGHAVNVL+PLVEKWKP D+E E YSGIDYSL
Sbjct: 889 TEETFESISVVAELAGHCTAREPSHRPDMGHAVNVLSPLVEKWKPFDNETESYSGIDYSL 948
Query: 914 PLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
PL QM+K WQEAE KD S+ SLEDSK SIPARPAGFAESFTS+DGR
Sbjct: 949 PLPQMLKGWQEAETKDFSHTSLEDSKGSIPARPAGFAESFTSSDGR 994
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084035|emb|CBI24423.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1204 bits (3116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/946 (63%), Positives = 707/946 (74%), Gaps = 36/946 (3%)
Query: 17 RTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGD-PCGPPCWKHVF 75
++ L ++L + ATDP D+ ILN FRK LEN ELL+WP GD PCGPP W HVF
Sbjct: 5 QSKLWVVLILCIFRVAHCATDPSDMKILNDFRKGLENSELLKWPDDGDDPCGPPLWPHVF 64
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
CS RV QIQV +GLKG LPQN NQLS L N+GLQ+N F G+LPSF GLS L++A+LD
Sbjct: 65 CSGDRVAQIQVEGLGLKGPLPQNFNQLSMLYNLGLQRNHFNGKLPSFRGLSELQFAFLDY 124
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N FDTIPADFFDGL ++++LAL+ N FNA+ GWS P LQ S QLT LS +CNL G LP
Sbjct: 125 NEFDTIPADFFDGLTSIRILALNDNPFNATTGWSIPDELQKSVQLTTLSLGNCNLVGPLP 184
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
+FLG SL LKL N L+G IP SF + LWLNDQ GGG +G +DV+G+M L
Sbjct: 185 EFLGTLPSLTTLKLPYNRLSGEIPASFGQSLMQILWLNDQDGGGMSGPMDVIGSMVSLTQ 244
Query: 256 LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVP 315
LWLHGN F+GTIPES G LTSL+DLNLN N+ VGL+P SLA++ L LDLNNN MGP+P
Sbjct: 245 LWLHGNQFTGTIPESIGDLTSLRDLNLNGNKLVGLVPESLANMELQKLDLNNNHLMGPIP 304
Query: 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS-WLGL 374
K + SY+SN+FCQ G+ C+PEV AL+DFL +NYP L + WSGNDPC+ WLGL
Sbjct: 305 KFTSGNVSYASNSFCQSEPGLQCSPEVNALLDFLAAVNYPLGLASEWSGNDPCEQPWLGL 364
Query: 375 SCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLD 434
C NSK++++NLPNF L+GTLSPS+GNLDSL +I+L NN++G IP N T L SL LD
Sbjct: 365 GCNPNSKVSIVNLPNFRLNGTLSPSIGNLDSLVEIRLGGNNLTGTIPMNLTKLTSLKKLD 424
Query: 435 LSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDST 494
+S NN PP+P+F +VK+ +GNP L
Sbjct: 425 VSGNNFEPPVPRFQESVKVITNGNPRL--------------------------------- 451
Query: 495 AETTKPKS-SKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEASQASGSLVIHPRDP 553
A +PKS SKR V I+A +++ ++ ++ I +++ +KRK+ +A S+V+HPRDP
Sbjct: 452 AVHPEPKSTSKRLKTVIIVAAISAFAILAMLVILLTLYCRKKRKDQVEAPSSIVVHPRDP 511
Query: 554 SDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNF 613
DPDNMVKI V++N+ GS T S SR SSG SH IE+GNL+ISVQVLR VT NF
Sbjct: 512 FDPDNMVKIAVSSNTTGSLFTQTGSSIESRDSSGVHNSHKIESGNLIISVQVLRKVTDNF 571
Query: 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
A ENELGRGGFG VYKGEL+DGTKIAVKRMEAGV+S A+DEF +EIAVLSKVRHRHLVS
Sbjct: 572 APENELGRGGFGAVYKGELEDGTKIAVKRMEAGVVSNTALDEFQAEIAVLSKVRHRHLVS 631
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LLG+S+ G ERLLVYE+M GALS+H+FHWK+L LEPLSWK RL+IALDVARGMEYLH L
Sbjct: 632 LLGHSIEGNERLLVYEFMSHGALSRHLFHWKNLKLEPLSWKMRLSIALDVARGMEYLHGL 691
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
A +SFIHRDLKSSNILLGDDFRAKV+DFGLVKLAPD +SV TRLAGTFGYLAPEYAV G
Sbjct: 692 ARESFIHRDLKSSNILLGDDFRAKVADFGLVKLAPDRGKSVATRLAGTFGYLAPEYAVMG 751
Query: 794 KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853
KITTK DVFS+GVVLMELLTGL ALDE R EE +YLA WFW IKS KEKL AA+DP +
Sbjct: 752 KITTKADVFSYGVVLMELLTGLAALDEGRSEECRYLAEWFWRIKSSKEKLMAAVDPAIGA 811
Query: 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSL 913
++TFE+ +AELAGHCT+REPS RPDMGHAVNVL+PLVEKWKP D+E E YSGIDYSL
Sbjct: 812 TEETFESISVVAELAGHCTAREPSHRPDMGHAVNVLSPLVEKWKPFDNETESYSGIDYSL 871
Query: 914 PLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSADGR 959
PL QM+K WQEAE KD S+ SLEDSK SIPARPAGFAESFTS+DGR
Sbjct: 872 PLPQMLKGWQEAETKDFSHTSLEDSKGSIPARPAGFAESFTSSDGR 917
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 959 | ||||||
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.955 | 0.972 | 0.460 | 6.8e-214 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.903 | 0.918 | 0.468 | 2e-207 | |
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.422 | 0.436 | 0.584 | 3.1e-201 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.435 | 0.471 | 0.550 | 3.2e-188 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.288 | 0.264 | 0.449 | 1.3e-76 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.299 | 0.221 | 0.414 | 3.2e-76 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.299 | 0.278 | 0.420 | 3e-75 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.296 | 0.292 | 0.415 | 4e-74 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.316 | 0.321 | 0.391 | 8.1e-74 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.348 | 0.351 | 0.381 | 1.8e-73 |
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2067 (732.7 bits), Expect = 6.8e-214, P = 6.8e-214
Identities = 444/965 (46%), Positives = 592/965 (61%)
Query: 17 RTHLVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPCWKHVFC 76
RT L+ + + + A GD+ + +K+L P W DPC W H+ C
Sbjct: 5 RTFLLFSFTFLLLLSLSKADSDGDLSAMLSLKKSLNPPSSFGW-SDPDPCK---WTHIVC 60
Query: 77 SNS-RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
+ + RVT+IQ+ GL+GTL +L LS+LE + LQ N G +PS SGL++L+ L
Sbjct: 61 TGTKRVTRIQIGHSGLQGTLSPDLRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSN 120
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
NNFD+IP+D F GL +LQ + +D+N F K W P+ L++++ L N S S N++G LP
Sbjct: 121 NNFDSIPSDVFQGLTSLQSVEIDNNPF---KSWEIPESLRNASALQNFSANSANVSGSLP 177
Query: 196 DFLG--NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
FLG F L L L+ NNL G +P S G + +LWLN QK TG I VL NM L
Sbjct: 178 GFLGPDEFPGLSILHLAFNNLEGELPMSLAGSQVQSLWLNGQK---LTGDITVLQNMTGL 234
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPXXXXXXXXXXXXXXXMFM-G 312
+ +WLH N FSG +P+ F L L+ L+L N F G +P + G
Sbjct: 235 KEVWLHSNKFSGPLPD-FSGLKELESLSLRDNSFTGPVPASLLSLESLKVVNLTNNHLQG 293
Query: 313 PVPXXXXXXXXXX---XNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369
PVP N+FC + G C P V +L+ +YPPRL SW GNDPC
Sbjct: 294 PVPVFKSSVSVDLDKDSNSFCLSSPG-ECDPRVKSLLLIASSFDYPPRLAESWKGNDPCT 352
Query: 370 SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKS 429
+W+G++C +N +TV++L L+GT+SP G + SL +I L NN++G IP T L +
Sbjct: 353 NWIGIAC-SNGNITVISLEKMELTGTISPEFGAIKSLQRIILGINNLTGMIPQELTTLPN 411
Query: 430 LTLLDLSQNNLSPPLPKFSGAVKLSLDGNXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 489
L LD+S N L +P F V ++ +GN
Sbjct: 412 LKTLDVSSNKLFGKVPGFRSNVVVNTNGNPDIGKDKSSLSSPGSSSPSGGSGSGINGDK- 470
Query: 490 XXXXXAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISI-CYYRKRKE---ASQASGS 545
+ KSS T + I+ V G++ + I + + C+Y+KR++ S++S +
Sbjct: 471 ------DRRGMKSS--TFIGIIVGSVLG-GLLSIFLIGLLVFCWYKKRQKRFSGSESSNA 521
Query: 546 LVIHPRDPSDPDNMVKIVVANNS---NGSTSVATESGTGSRYSSGNGASHVIEAGNLVIS 602
+V+HPR + VKI VA +S G + T GT G+ ++EAGN++IS
Sbjct: 522 VVVHPRHSGSDNESVKITVAGSSVSVGGISDTYTLPGTSE---VGDNIQ-MVEAGNMLIS 577
Query: 603 VQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV 662
+QVLR+VT NF+S+N LG GGFGVVYKGEL DGTKIAVKRME GVI+ K EF SEIAV
Sbjct: 578 IQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRMENGVIAGKGFAEFKSEIAV 637
Query: 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
L+KVRHRHLV+LLGY + G E+LLVYEYMPQG LS+H+F W L+PL WK+RL +ALD
Sbjct: 638 LTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEWSEEGLKPLLWKQRLTLALD 697
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF 782
VARG+EYLH LAHQSFIHRDLK SNILLGDD RAKV+DFGLV+LAP+ + S+ TR+AGTF
Sbjct: 698 VARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGLVRLAPEGKGSIETRIAGTF 757
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE- 841
GYLAPEYAVTG++TTKVDV+SFGV+LMEL+TG +LDES+PEE +L +WF + +KE
Sbjct: 758 GYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQPEESIHLVSWFKRMYINKEA 817
Query: 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDD 901
+ AID ++++++T + T+AELAGHC +REP QRPDMGHAVN+L+ LVE WKP D
Sbjct: 818 SFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDMGHAVNILSSLVELWKPSDQ 877
Query: 902 EPEEYSGIDYSLPLNQMVKDWQEAEGK-DLS------YVSLEDSKSSIPARPAGFAESFT 954
PE+ GID + L Q +K WQ EG+ DL SL++++ SIP RP GFAESFT
Sbjct: 878 NPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSLDNTQMSIPTRPYGFAESFT 937
Query: 955 SADGR 959
S DGR
Sbjct: 938 SVDGR 942
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2006 (711.2 bits), Expect = 2.0e-207, P = 2.0e-207
Identities = 429/916 (46%), Positives = 570/916 (62%)
Query: 69 PC-WKHVFCSNS-RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLS 126
PC W+ V C S RVT+IQ+ G++GTLP NL LS+L + L N+ G +P SGLS
Sbjct: 53 PCKWQSVQCDGSNRVTKIQLKQKGIRGTLPTNLQSLSELVILELFLNRISGPIPDLSGLS 112
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
L+ L N F ++P + F G+ +LQ + L++N F+ W P ++ + L NL+
Sbjct: 113 RLQTLNLHDNLFTSVPKNLFSGMSSLQEMYLENNPFDP---WVIPDTVKEATSLQNLTLS 169
Query: 187 SCNLAGQLPDFLGN--FASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
+C++ G++PDF G+ SL NLKLS N L G +P SF G ++ +L+LN QK G+I
Sbjct: 170 NCSIIGKIPDFFGSQSLPSLTNLKLSQNGLEGELPMSFAGTSIQSLFLNGQK---LNGSI 226
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPXXXXXXXXXXX 304
VLGNM L + L GN FSG IP+ G L SL+ N+ NQ G++P
Sbjct: 227 SVLGNMTSLVEVSLQGNQFSGPIPDLSG-LVSLRVFNVRENQLTGVVPQSLVSLSSLTTV 285
Query: 305 XXXXMFM-GPVPXXXXXXXXXXXN---AFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT 360
++ GP P N +FC G C P V L+ YP +L
Sbjct: 286 NLTNNYLQGPTPLFGKSVGVDIVNNMNSFCTNVAGEACDPRVDTLVSVAESFGYPVKLAE 345
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420
SW GN+PC +W+G++C + +TV+N+ +LSGT+SPS+ L SL I L N +SG I
Sbjct: 346 SWKGNNPCVNWVGITC-SGGNITVVNMRKQDLSGTISPSLAKLTSLETINLADNKLSGHI 404
Query: 421 PTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNXXXXXXXXXXXXXXXXXXXXXX 480
P T L L LLD+S N+ PKF V L +GN
Sbjct: 405 PDELTTLSKLRLLDVSNNDFYGIPPKFRDTVTLVTEGNANMGKNGPNKTSDAPGASPGSK 464
Query: 481 XXXXXXXXXXXXXXAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYRKRKEAS 540
+ET+K KSS I+V ++ V VG + LV + + + Y +KRK +
Sbjct: 465 PSGGSDG-------SETSK-KSSNVKIIVPVVGGV--VGALCLVGLGVCL-YAKKRKRPA 513
Query: 541 QA---SGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGAS--HVIE 595
+ S ++VIHP D D+ +K+ VA ++S+ + G+ S SG+ AS HV+E
Sbjct: 514 RVQSPSSNMVIHPHHSGDNDD-IKLTVA-----ASSLNSGGGSDSYSHSGSAASDIHVVE 567
Query: 596 AGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDE 655
AGNLVIS+QVLRNVT NF+ EN LGRGGFG VYKGEL DGTKIAVKRME+ V+S K + E
Sbjct: 568 AGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTKIAVKRMESSVVSDKGLTE 627
Query: 656 FHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKR 715
F SEI VL+K+RHRHLV+LLGY + G ERLLVYEYMPQG LS+H+FHWK +PL W R
Sbjct: 628 FKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLSQHLFHWKEEGRKPLDWTR 687
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
RL IALDVARG+EYLH+LAHQSFIHRDLK SNILLGDD RAKVSDFGLV+LAPD + S+
Sbjct: 688 RLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAKVSDFGLVRLAPDGKYSIE 747
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
TR+AGTFGYLAPEYAVTG++TTKVD+FS GV+LMEL+TG ALDE++PE+ +L WF
Sbjct: 748 TRVAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKALDETQPEDSVHLVTWFRR 807
Query: 836 IKSDKEK--LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893
+ + K++ + AIDP + ++DDT + + ELAGHC +REP QRPDM H VNVL+ L
Sbjct: 808 VAASKDENAFKNAIDPNISLDDDTVASIEKVWELAGHCCAREPYQRPDMAHIVNVLSSLT 867
Query: 894 EKWKPLDDEPEEYSGIDYSLPLNQMVKDWQEAEG----------KDLSYVSLEDSKSSIP 943
+WKP + +P++ GIDY +PL Q++K WQ EG +Y S +++++SIP
Sbjct: 868 VQWKPTETDPDDVYGIDYDMPLPQVLKKWQAFEGLSQTADDSGSSSSAYGSKDNTQTSIP 927
Query: 944 ARPAGFAESFTSADGR 959
RP+GFA+SFTS DGR
Sbjct: 928 TRPSGFADSFTSVDGR 943
|
|
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1224 (435.9 bits), Expect = 3.1e-201, Sum P(2) = 3.1e-201
Identities = 246/421 (58%), Positives = 309/421 (73%)
Query: 554 SDPDNMVKIVVAN--NSNGSTSVATESGTGSRY-------SSGNGASH-VIEAGNLVISV 603
+DP+ + KI+V++ ++ GS + +G G+ SSG+ + ++E G++ I +
Sbjct: 509 TDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNALNSPSSGDNSDRFLLEGGSVTIPM 568
Query: 604 QVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVL 663
+VLR VT NF+ +N LGRGGFGVVY GEL DGTK AVKRME + K + EF +EIAVL
Sbjct: 569 EVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVL 628
Query: 664 SKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
+KVRHRHLV+LLGY V G ERLLVYEYMPQG L +H+F W L PL+WK+R++IALDV
Sbjct: 629 TKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDV 688
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
ARG+EYLHSLA QSFIHRDLK SNILLGDD RAKV+DFGLVK APD + SV TRLAGTFG
Sbjct: 689 ARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 748
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
YLAPEYA TG++TTKVDV++FGVVLME+LTG ALD+S P+ER +L WF I +KE +
Sbjct: 749 YLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDSLPDERSHLVTWFRRILINKENI 808
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEP 903
A+D LE +++T E+ + +AELAGHCT+REP QRPDMGHAVNVL PLVEKWKP E
Sbjct: 809 PKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEKWKPSCQEE 868
Query: 904 EEYSGIDYSLPLNQMVKDWQEAEGKDLSYV-----SLEDSKSSIPARPAGFAESFTSADG 958
EE GID ++ L Q ++ WQ EG S + S ++SSIP + +GF +F SADG
Sbjct: 869 EESFGIDVNMSLPQALQRWQN-EGTSSSTMFHGDFSYSQTQSSIPPKASGFPNTFDSADG 927
Query: 959 R 959
R
Sbjct: 928 R 928
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 3.2e-188, Sum P(2) = 3.2e-188
Identities = 245/445 (55%), Positives = 310/445 (69%)
Query: 518 VGVIL-LVAIPISICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVAT 576
+G++L L+ I ++I + K+K +HP+ S + KI + N G +
Sbjct: 466 IGILLALLLIGVAIFFLVKKKMQYHK-----MHPQQQSSDQDAFKITIENLCTG----VS 516
Query: 577 ESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGT 636
ESG SGN A H+ EAGN+VIS+QVLR+ T NF +N LGRGGFG+VYKGEL DGT
Sbjct: 517 ESGF-----SGNDA-HLGEAGNIVISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGT 570
Query: 637 KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696
KIAVKRME+ +IS K +DEF SEIAVL++VRHR+LV L GY + G ERLLVY+YMPQG L
Sbjct: 571 KIAVKRMESSIISGKGLDEFKSEIAVLTRVRHRNLVVLHGYCLEGNERLLVYQYMPQGTL 630
Query: 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756
S+HIF+WK L PL W RRL IALDVARG+EYLH+LAHQSFIHRDLK SNILLGDD A
Sbjct: 631 SRHIFYWKEEGLRPLEWTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHA 690
Query: 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLM 816
KV+DFGLV+LAP+ +S+ T++AGTFGYLAPEYAVTG++TTKVDV+SFGV+LMELLTG
Sbjct: 691 KVADFGLVRLAPEGTQSIETKIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELLTGRK 750
Query: 817 ALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREP 876
ALD +R EE +LA WF + +K AID +EVN++T + +AELA C+SREP
Sbjct: 751 ALDVARSEEEVHLATWFRRMFINKGSFPKAIDEAMEVNEETLRSINIVAELANQCSSREP 810
Query: 877 SQRPDMGHAVNVLAPLVEKWKPLD--DEPEEYSGIDYSLPLNQMVKDWQEAEGKDLSYVS 934
RPDM H VNVL LV +WKP + + E+ GIDY PL Q++ D S
Sbjct: 811 RDRPDMNHVVNVLVSLVVQWKPTERSSDSEDIYGIDYDTPLPQLILD---------SCFF 861
Query: 935 LEDSKSSIPARPAGFAESFTSADGR 959
+++ +SIP+RP+ +F S GR
Sbjct: 862 GDNTLTSIPSRPSELESTFKSGQGR 886
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 1.3e-76, Sum P(3) = 1.3e-76
Identities = 128/285 (44%), Positives = 174/285 (61%)
Query: 606 LRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
L+N T++F N+LG GGFG VYKG L+DG ++AVK++ G S++ +F +EI +S
Sbjct: 703 LKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIG--SRQGKGQFVAEIIAISS 760
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
V HR+LV L G G RLLVYEY+P G+L + +F KSL+L+ W R I L VAR
Sbjct: 761 VLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLD---WSTRYEICLGVAR 817
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
G+ YLH A IHRD+K+SNILL + KVSDFGL KL D + + TR+AGT GYL
Sbjct: 818 GLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIGYL 877
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845
APEYA+ G +T K DV++FGVV +EL++G DE+ E ++YL W WN+ +
Sbjct: 878 APEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDVEL 937
Query: 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890
D + E N + + IA L CT + RP M V +L+
Sbjct: 938 IDDELSEYNMEEVKRMIGIALL---CTQSSYALRPPMSRVVAMLS 979
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 3.2e-76, Sum P(2) = 3.2e-76
Identities = 121/292 (41%), Positives = 167/292 (57%)
Query: 599 LVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS 658
L ++ + T+NF+ + +G GGFG VYK L +G ++A+KR+ G + EF +
Sbjct: 988 LRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGH-QFQGDREFLA 1046
Query: 659 EIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN 718
E+ + KV+H +LV LLGY V G ER L+YEYM G+L + + ++ LE L W RL
Sbjct: 1047 EMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRN-RADALEALGWPDRLK 1105
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
I L ARG+ +LH IHRD+KSSNILL ++F +VSDFGL ++ E V T +
Sbjct: 1106 ICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDI 1165
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWF-WNIK 837
AGTFGY+ PEY +T K TTK DV+SFGVV++ELLTG + + L W W I
Sbjct: 1166 AGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRWMIA 1225
Query: 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
K+ DP L V+ E + +A CT+ EP +RP M V L
Sbjct: 1226 RGKQN--ELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGL 1275
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 582 (209.9 bits), Expect = 3.0e-75, Sum P(3) = 3.0e-75
Identities = 124/295 (42%), Positives = 176/295 (59%)
Query: 600 VISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSE 659
+ + L++ T++F N+LG GGFG VYKG L+DG +AVK + G S++ +F +E
Sbjct: 681 IFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVG--SRQGKGQFVAE 738
Query: 660 IAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
I +S V HR+LV L G G R+LVYEY+P G+L + +F K+L+L+ W R I
Sbjct: 739 IVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLD---WSTRYEI 795
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
L VARG+ YLH A +HRD+K+SNILL ++SDFGL KL D + + TR+A
Sbjct: 796 CLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVA 855
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839
GT GYLAPEYA+ G +T K DV++FGVV +EL++G DE+ EE++YL W WN+
Sbjct: 856 GTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEK 915
Query: 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
+ D + + N + + IA L CT + RP M V +L+ VE
Sbjct: 916 SRDIELIDDKLTDFNMEEAKRMIGIALL---CTQTSHALRPPMSRVVAMLSGDVE 967
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 4.0e-74, Sum P(2) = 4.0e-74
Identities = 123/296 (41%), Positives = 173/296 (58%)
Query: 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIA 661
S + L+ +T NF+ +ELG GG+G VYKG L DG +A+KR + G S + EF +EI
Sbjct: 627 SYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQG--STQGGLEFKTEIE 684
Query: 662 VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
+LS+V H++LV L+G+ E++LVYEYM G+L + + L+ WKRRL +AL
Sbjct: 685 LLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLD---WKRRLRVAL 741
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAG 780
ARG+ YLH LA IHRD+KS+NILL ++ AKV+DFGL KL D + V T++ G
Sbjct: 742 GSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDCTKGHVSTQVKG 801
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840
T GYL PEY T K+T K DV+SFGVV+MEL+T +++ + R+ N KSD
Sbjct: 802 TLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKLVM--N-KSDD 858
Query: 841 E--KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
+ LR +D L + T ELA C +RP M V + +++
Sbjct: 859 DFYGLRDKMDRSLR-DVGTLPELGRYMELALKCVDETADERPTMSEVVKEIEIIIQ 913
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 8.1e-74, Sum P(4) = 8.1e-74
Identities = 127/324 (39%), Positives = 176/324 (54%)
Query: 597 GNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEF 656
G + + L T NF+ N++G GG+G VYKG L +G IA+KR + G S + EF
Sbjct: 618 GTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG--SMQGAFEF 675
Query: 657 HSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
+EI +LS+V H+++V LLG+ E++LVYEY+P G+L + N L W RR
Sbjct: 676 KTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGL---SGKNGVKLDWTRR 732
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VV 775
L IAL +G+ YLH LA IHRD+KS+NILL + AKV+DFGL KL D E++ V
Sbjct: 733 LKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPEKAHVT 792
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
T++ GT GYL PEY +T ++T K DV+ FGVV++ELLTG +D Y+
Sbjct: 793 TQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRG-----SYVVKEVKK 847
Query: 836 IKSDKEK----LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891
K DK + L+ +D + N + F ++A C E RP M V L
Sbjct: 848 -KMDKSRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELES 906
Query: 892 LVEK--WKPLDDEP--EEYSGIDY 911
++ P D EE SG Y
Sbjct: 907 ILRLVGLNPNADSATYEEASGDPY 930
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 1.8e-73, Sum P(3) = 1.8e-73
Identities = 138/362 (38%), Positives = 198/362 (54%)
Query: 582 SRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVK 641
SR S + AS ++ +G S + L T +F+S +GRGG+G VY+G L D T A+K
Sbjct: 596 SRRRSSSKAS-LLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIK 654
Query: 642 RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIF 701
R + G S + EF +EI +LS++ HR+LVSL+GY E++LVYE+M G L
Sbjct: 655 RADEG--SLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRD--- 709
Query: 702 HWKSLN-LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760
W S E LS+ R+ +AL A+G+ YLH+ A+ HRD+K+SNILL +F AKV+D
Sbjct: 710 -WLSAKGKESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVAD 768
Query: 761 FGLVKLAP---DSE---RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
FGL +LAP D E + V T + GT GYL PEY +T K+T K DV+S GVV +ELLTG
Sbjct: 769 FGLSRLAPVLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTG 828
Query: 815 LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV-NDDTFETFWTIAELAGHCTS 873
+ A+ + R+ A ++ + + ID +E + ++ E F A LA C+
Sbjct: 829 MHAISHGKNIVREVKTA------EQRDMMVSLIDKRMEPWSMESVEKF---AALALRCSH 879
Query: 874 REPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDY-SLPLNQMVKDWQEAE---GKD 929
P RP M V L L++ + E S S + + +D E+ G D
Sbjct: 880 DSPEMRPGMAEVVKELESLLQASPDRETRVELASSSSVLSTSSSNVTRDLYESSSLLGSD 939
Query: 930 LS 931
LS
Sbjct: 940 LS 941
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43298 | TMK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4830 | 0.9374 | 0.9543 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_VI001038 | hypothetical protein (948 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 959 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-36 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-32 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-31 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-29 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 9e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 616 ENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG G FG VYKG+L ++AVK ++ S++ ++EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V LLG +V EYM G L ++ N LS L+ AL +ARGMEYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
S ++FIHRDL + N L+G++ K+SDFGL + D + ++APE
Sbjct: 119 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
GK T+K DV+SFGV+L E+ T
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 2e-53
Identities = 76/203 (37%), Positives = 113/203 (55%), Gaps = 12/203 (5%)
Query: 616 ENELGRGGFGVVYKGELDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG G FG VYKG L ++AVK ++ S++ ++EF E ++ K+ H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V LLG ++V EYMP G L ++ + + LS L+ AL +ARGMEYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
S ++FIHRDL + N L+G++ K+SDFGL + D + V ++APE
Sbjct: 120 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
GK T+K DV+SFGV+L E+ T
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 77/217 (35%), Positives = 109/217 (50%), Gaps = 21/217 (9%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG GGFG VY G K+A+K ++ S ++E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-SSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
LV EY G+L + + LS L I L + G+EYLHS
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHS---NG 112
Query: 738 FIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE-YAVTGKI 795
IHRDLK NILL D+ + K++DFGL KL + S++ + GT Y+APE G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 796 TTKVDVFSFGVVLME------LLTGLMALDESRPEER 826
+ K D++S GV+L E L+ ++ D PE+R
Sbjct: 172 SEKSDIWSLGVILYELPELKDLIRKMLQKD---PEKR 205
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 76/206 (36%), Positives = 108/206 (52%), Gaps = 13/206 (6%)
Query: 617 NELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+LG G FG VYKG+L T++AVK ++ S++ +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEARVMKKLGHPNVV 59
Query: 673 SLLGYSVAGYERLLVYEYMPQGAL----SKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
LLG LV EYM G L K + S LS K L+ A+ +A+GME
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAP 787
YL S + F+HRDL + N L+G+D K+SDFGL + D + ++AP
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLT 813
E G T+K DV+SFGV+L E+ T
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 77/205 (37%), Positives = 115/205 (56%), Gaps = 18/205 (8%)
Query: 618 ELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+LG G FG VYKG L TK+AVK ++ G S++ +EF E +++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNIV 64
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LLG G +V EYMP G L + + + E L+ K L +AL +A+GMEYL S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFL---RK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG---YLAPEY 789
++F+HRDL + N L+ ++ K+SDFGL + + + G ++APE
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPES 175
Query: 790 AVTGKITTKVDVFSFGVVLMELLTG 814
GK T+K DV+SFGV+L E+ T
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 4e-49
Identities = 87/272 (31%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG G FG VYK G +AVK ++ K EI +L ++ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
LV EY G L ++ PLS IAL + RG+EYLHS
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLHS---NG 118
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE-YAVTGKIT 796
IHRDLK NILL ++ K++DFGL K S +T GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 797 TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856
KVDV+S GV+L ELLTG NI + +R + P LE ++
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGE-------------NILDQLQLIRRILGPPLEFDEP 224
Query: 857 TFETFW-TIAELAGHCTSREPSQRPDMGHAVN 887
+ + +L C +++PS+RP +
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+LG G FG VY + G +A+K ++ I K + EI +L K++H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD-RERILREIKILKKLKHPNIVRLY 63
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ LV EY G L + L+ + + +EYLHS
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED-----EARFYLRQILSALEYLHS--- 115
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ +HRDLK NILL +D K++DFGL + E+ T GT Y+APE +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD++S GV+L ELLTG
Sbjct: 174 GKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-44
Identities = 213/833 (25%), Positives = 332/833 (39%), Gaps = 160/833 (19%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNF-DTIPADFFD- 147
L G +P + L+ L ++ L N G +P S L NL+Y +L N IP F
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 148 ----------------------GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185
L+NL++L L SNNF P L S +L L
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGK----IPVALTSLPRLQVLQL 339
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF-KGLNLVNLWLNDQKGGGFTGTI 244
S +G++P LG +L L LS NNLTG IPE NL L L F+ ++
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL-------FSNSL 392
Query: 245 D-----VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL- 298
+ LG LR + L N FSG +P F KL + L++++N G I +
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
Query: 299 SLDHLDLNNNMFMGPVPKS----KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNY 354
SL L L N F G +P S + S N F
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF------------------------- 487
Query: 355 PPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSN 414
SG P G+ S+L L L LSG + + + L + L N
Sbjct: 488 --------SGAVP------RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533
Query: 415 NISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA----VKLSLDGNPLLNGKSPGSGS 470
+SGQIP +++ + L+ LDLSQN LS +PK G V++++ N L+G P +G+
Sbjct: 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN-HLHGSLPSTGA 592
Query: 471 SSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISI 530
S G+ GD+T+ K ++T ++G L++A+
Sbjct: 593 FLAINASAVAGNIDLCG---GDTTSGLPPCKRVRKTPSWWFYI-TCTLGAFLVLALVAFG 648
Query: 531 CYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGA 590
+ + + + V E GT +
Sbjct: 649 FVFIRGRNNLELK-----------------------------RVENEDGTWELQFFDSKV 679
Query: 591 SHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVIS 649
S I +++ S++ EN + RG G YKG+ + +G + VK +
Sbjct: 680 SKSITINDILSSLK----------EENVISRGKKGASYKGKSIKNGMQFVVKEI------ 723
Query: 650 KKAVDEF-HSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNL 708
V+ SEIA + K++H ++V L+G + L++EY+ LS+ L
Sbjct: 724 -NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE--------VL 774
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768
LSW+RR IA+ +A+ + +LH + + +L I++ D ++L+
Sbjct: 775 RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII------DGKDEPHLRLSL 828
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828
T+ + Y+APE T IT K D++ FG++L+ELLTG D +
Sbjct: 829 PGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGS 887
Query: 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFET-FWTIAELAGHCTSREPSQRP 880
+ W SD L IDP + + + + LA HCT+ +P+ RP
Sbjct: 888 IVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG- 676
LGRG FG VY + D G +AVK +E S++ ++ EI +LS ++H ++V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 677 -YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ EY+ G+LS + + L EP+ R+ + G+ YLHS
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVI--RKY--TRQILEGLAYLHS--- 119
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPEYAVTGK 794
+HRD+K +NIL+ D K++DFG K D E T + GT ++APE +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 795 ITTKVDVFSFGVVLMELLTG 814
D++S G ++E+ TG
Sbjct: 180 YGRAADIWSLGCTVIEMATG 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-36
Identities = 137/462 (29%), Positives = 205/462 (44%), Gaps = 76/462 (16%)
Query: 24 IVLAFVTLVLSATDPGDIDILNQFRKNLENP--ELLQWPKSGDPCGPPCWKHVFCSN-SR 80
+L F+ L S ++++L F+ ++ +P L W S D C W+ + C+N SR
Sbjct: 14 FMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL---WQGITCNNSSR 70
Query: 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNF 138
V I +S + G + + +L ++ I L NQ G +P F+ S+L+Y L NNF
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 139 D-TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF 197
+IP LE L + SNN L+G++P+
Sbjct: 131 TGSIPRGSIPNLETLDL----SNNM---------------------------LSGEIPND 159
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV-LGNMDQLRTL 256
+G+F+SL+ L L GN L G IP S NL +L G I LG M L+ +
Sbjct: 160 IGSFSSLKVLDLGGNVLVGKIPNSLT--NLTSLEFLTLASNQLVGQIPRELGQMKSLKWI 217
Query: 257 WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVP 315
+L N+ SG IP G LTSL L+L N G IP SL +L L +L L N GP+P
Sbjct: 218 YLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP 277
Query: 316 KS-----KAYKYSYSSNAFCQPTEGVPCAPEVMALI-----------DFLG----GLNYP 355
S K S N+ PE++ + +F G L
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEI------PELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 356 PRL--VTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS 413
PRL + WS + + G ++ LTVL+L NL+G + + + +L ++ L S
Sbjct: 332 PRLQVLQLWSNK--FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSL 455
N++ G+IP + +SL + L N+ S LP S KL L
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELP--SEFTKLPL 429
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 75/219 (34%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 618 ELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
ELG G FG V+ GE +D +AVK ++ S A +F E +L+ +H ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENI 70
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSK----HIFHWKSLNLE-----PLSWKRRLNIALD 722
V G G ++V+EYM G L+K H L L+ + L IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT----RL 778
+A GM Y LA Q F+HRDL + N L+G D K+ DFG+ R V T R+
Sbjct: 131 IASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRV 180
Query: 779 AGT----FGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
G ++ PE + K TT+ DV+SFGVVL E+ T
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 18/201 (8%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
++G+GGFG VYK G ++A+K ++ + SK+ ++ +EI +L K +H ++V G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 677 -YSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
Y E +V E+ G+L + ++L +++ + ++ +G+EYLHS
Sbjct: 65 SYLKKD-ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-----VCKELLKGLEYLHS-- 116
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
IHRD+K++NILL D K+ DFGL +L+ R+ + GT ++APE
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172
Query: 794 KITTKVDVFSFGVVLMELLTG 814
K D++S G+ +EL G
Sbjct: 173 PYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 72/200 (36%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V + D G A+K ++ +I +K V+ +E +LS++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ E+L LV EY P G L H+ + E R A ++ +EYLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE---RARF--YAAEIVLALEYLHS--- 111
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
I+RDLK NILL D K++DFGL K T GT YLAPE +
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY 170
Query: 796 TTKVDVFSFGVVLMELLTGL 815
VD +S GV+L E+LTG
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 71/195 (36%), Positives = 111/195 (56%), Gaps = 18/195 (9%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
+G+G FG V G+ G K+AVK ++ A F +E +V++ +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
+ G +V EYM +G+L + + +S ++ ++L ALDV GMEYL ++F
Sbjct: 70 LQGNPLYIVTEYMAKGSL---VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 739 IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYAVTGKIT 796
+HRDL + N+L+ +D AKVSDFGL K ++ + + G + APE K +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWTAPEALREKKFS 177
Query: 797 TKVDVFSFGVVLMEL 811
TK DV+SFG++L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 77/201 (38%), Positives = 114/201 (56%), Gaps = 21/201 (10%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
LG G FG V+ G + TK+AVK ++ G +S +A F E ++ K+RH LV L Y+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQL--YA 68
Query: 679 VAGYER--LLVYEYMPQGALSKHIF--HWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
V E +V EYM +G+L + K L L L +++A +A GM YL S
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLES-- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYAVT 792
+++IHRDL + NIL+G++ K++DFGL +L D E + R F + APE A
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT--AREGAKFPIKWTAPEAANY 178
Query: 793 GKITTKVDVFSFGVVLMELLT 813
G+ T K DV+SFG++L E++T
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 27/212 (12%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+ F E +LG G FG V++G + ++A+K +++ +F E+ L ++RH+H
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIF----HWKSLNLEPLSWKRRLNIALDVARG 726
L+SL G ++ E M +G+L F + L + L +++A VA G
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASL-----IDMACQVAEG 116
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD-----SERSVVTRLAGT 781
M YL Q+ IHRDL + NIL+G+D KV+DFGL +L + S++ + +
Sbjct: 117 MAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---- 169
Query: 782 FGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ APE A G +TK DV+SFG++L E+ T
Sbjct: 170 --WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ +GRG FGVVYKG L+ G +A+K++ I ++A+ EI +L ++H ++V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA---RGMEYLHS 732
G ++ EY G+L + I + E L +A+ V +G+ YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESL-------VAVYVYQVLQGLAYLHE 117
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAV 791
Q IHRD+K++NIL D K++DFG+ KL S+ + GT ++APE
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIE 172
Query: 792 TGKITTKVDVFSFGVVLMELLTG 814
+T D++S G ++ELLTG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 73/208 (35%), Positives = 104/208 (50%), Gaps = 21/208 (10%)
Query: 617 NELGRGGFGVVYKGELD---DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+LG G FG V D D T ++AVK + + D F EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENI 68
Query: 672 VSLLG--YSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGME 728
V G G L+ EY+P G+L ++ H +NL KR L + + +GM+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL-----KRLLLFSSQICKGMD 123
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG---TFGYL 785
YL S Q +IHRDL + NIL+ + K+SDFGL K+ P+ + + G F Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLT 813
APE T K ++ DV+SFGV L EL T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-31
Identities = 74/199 (37%), Positives = 114/199 (57%), Gaps = 12/199 (6%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+LG G FG V+ G + TK+AVK ++ G +S ++ F E ++ K+RH LV L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQL- 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
Y+V E + +V EYM +G+L + K L +++A VA GM Y+ +
Sbjct: 67 -YAVVSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++IHRDL+S+NIL+GD K++DFGL +L D+E + + APE A+ G+
Sbjct: 122 --NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 795 ITTKVDVFSFGVVLMELLT 813
T K DV+SFG++L EL+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 72/199 (36%), Positives = 118/199 (59%), Gaps = 12/199 (6%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +LG+G FG V+ G + T++A+K ++ G +S +A F E V+ K+RH LV L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL- 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
Y+V E + +V EYM +G+L + K + L + +++A +A GM Y+ +
Sbjct: 67 -YAVVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERM- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+++HRDL+++NIL+G++ KV+DFGL +L D+E + + APE A+ G+
Sbjct: 122 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 795 ITTKVDVFSFGVVLMELLT 813
T K DV+SFG++L EL T
Sbjct: 180 FTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 68/198 (34%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
ELG G FGVV+ G+ +A+K + G +S+ D+F E V+ K+ H +LV L G
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 678 SVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+V EYM G L ++ L E L L++ DV MEYL S
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLES---N 119
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
FIHRDL + N L+G+D KVSDFGL + D + + + PE + +
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 797 TKVDVFSFGVVLMELLTG 814
+K DV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/199 (32%), Positives = 111/199 (55%), Gaps = 17/199 (8%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
LG G FG V++G ++ T +AVK ++ G + +F +E ++ K+RH L+ L Y+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQL--YA 68
Query: 679 VAGYER--LLVYEYMPQGALSKHIFH--WKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
V E +V E M G+L +++ ++L L L +++A VA GM YL +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-----IDMAAQVASGMAYLEA-- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
Q++IHRDL + N+L+G++ KV+DFGL ++ + + APE A+ +
Sbjct: 122 -QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 795 ITTKVDVFSFGVVLMELLT 813
+ K DV+SFG++L E++T
Sbjct: 181 FSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 2e-29
Identities = 92/357 (25%), Positives = 143/357 (40%), Gaps = 28/357 (7%)
Query: 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDE-FHSEIAVLSKVRH-R 669
++ +LG G FG VY D +A+K + + SK E F EI +L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V L + LV EY+ G+L + K PLS L I + +EY
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEY 116
Query: 730 LHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERSVVTR-----LAGTFG 783
LHS + IHRD+K NILL D K+ DFGL KL PD + GT G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 784 YLAPEYA---VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840
Y+APE ++ D++S G+ L ELLTG P E + ++
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG------LPPFEGEKNSSATSQTLKII 227
Query: 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLD 900
+L + ++L +++P R + ++ L+ K +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS--SSDLSHDLLAHLKLKE 285
Query: 901 DEPEEYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPAGFAESFTSAD 957
+ + D S PL + EA L+ SL S S + + F++
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEALISSLN--SLAISGSDLKLDDSNFSKELAPNG 340
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
E+G G FG+V+ G + K+A+K + G +S+ ++F E V+ K+ H LV L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
LV+E+M G LS ++ + S + L + LDV GM YL S +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLES---SN 120
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITT 797
IHRDL + N L+G++ KVSDFG+ + D + + T + +PE K ++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 798 KVDVFSFGVVLMELLT 813
K DV+SFGV++ E+ +
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 70/199 (35%), Positives = 119/199 (59%), Gaps = 12/199 (6%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ +LG+G FG V+ G + TK+A+K ++ G + +A F E ++ K+RH LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL- 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
Y+V E + +V E+M +G+L + K + + L + +++A +A GM Y+ +
Sbjct: 67 -YAVVSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIERM- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++IHRDL+++NIL+GD+ K++DFGL +L D+E + + APE A+ G+
Sbjct: 122 --NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 795 ITTKVDVFSFGVVLMELLT 813
T K DV+SFG++L EL+T
Sbjct: 180 FTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 53/296 (17%)
Query: 618 ELGRGGFGVVYKGELDD------GTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRH 670
ELG+G FG+VY+G T++A+K + E + ++ EF +E +V+ + H
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEFNCHH 70
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL--------NLEPLSWKRRLNIALD 722
+V LLG G L+V E M +G L ++ +S L P + ++ + +A +
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYL---RSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-------PDSERSVV 775
+A GM YL + F+HRDL + N ++ +D K+ DFG+ + + +
Sbjct: 128 IADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
R ++APE G TTK DV+SFGVVL E+ T LA +
Sbjct: 185 VR------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQ 223
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891
S++E L+ ID + EL C P RP V+ L
Sbjct: 224 GLSNEEVLKFVIDGGHLDLPENCPDKLL--ELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+ ++G+G FG VY DG +K ++ +S+K ++ +E+ +L K+ H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
++ + +V EY G LS+ I K +P ++ L+ + + ++YL
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYL 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE-- 788
HS + +HRD+K NI L + K+ DFG+ K+ S + + GT YL+PE
Sbjct: 120 HS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLSPELC 175
Query: 789 ----YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
Y K D++S G VL EL T P E + L I L+
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTL------KHPFEGENLLELALKI------LK 217
Query: 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD 881
PI + + + L ++P +RP
Sbjct: 218 GQYPPI----PSQYSSE--LRNLVSSLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 619 LGRGGFGVVYKGEL--DDGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
LG G FG V +G+L DDG+ K+AVK M+ + + ++EF SE A + H +++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 675 LGYSVAGYER------LLVYEYMPQGALSKHIFHWK-SLNLEPLSWKRRLNIALDVARGM 727
+G +++ +M G L + + + E L + L +D+A GM
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLA 786
EYL + ++FIHRDL + N +L +D V+DFGL K + R+A ++A
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
E T+K DV++FGV + E+ T
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 26/213 (12%)
Query: 610 TKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH 668
+ + + ++G G G VYK + G ++A+K+M + K+ + +EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74
Query: 669 RHLVSLLG-YSVAGYERL-LVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVAR 725
++V Y V L +V EYM G+L+ I ++ +N +++ + +V +
Sbjct: 75 PNIVDYYDSYLVGDE--LWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQ 127
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSER--SVVTRLAGTF 782
G+EYLHS Q+ IHRD+KS NILL D K++DFG +L + + SVV GT
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTP 180
Query: 783 GYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTG 814
++APE + K KVD++S G++ +E+ G
Sbjct: 181 YWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 618 ELGRGGFGVVYKGELDDGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+LG G FGVV +GE +AVK +++ +S +D+F E A++ + H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIR 60
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
L G V + ++V E P G+L + + L + A+ +A GM YL S
Sbjct: 61 LYGV-VLTHPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT--RLAGTFGYLAPEYAV 791
+ FIHRDL + NILL D + K+ DFGL++ P +E V L F + APE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 792 TGKITTKVDVFSFGVVLMELLT 813
T + DV+ FGV L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 20/205 (9%)
Query: 619 LGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG+G FG V D G +AVK+++ + + + +F EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVK 69
Query: 674 LLG--YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
G YS LV EY+P G+L ++ + E L ++ L A + +GMEYL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG---TFGYLAPE 788
S + ++HRDL + NIL+ + R K+ DFGL K+ P + R G F Y APE
Sbjct: 126 S---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
K + DV+SFGVVL EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 71/213 (33%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 618 ELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
ELG G FG VYKGEL T +A+K ++ K EF E ++S ++H ++
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNI 70
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKH-IFHWKSLNLE----------PLSWKRRLNIA 720
V LLG +++EY+ G L + + + ++ L L+IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL--APDSERSVVTRL 778
+ +A GMEYL S F+HRDL + N L+G+ K+SDFGL + + D R L
Sbjct: 131 IQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMEL 811
++ PE + GK TT+ D++SFGVVL E+
Sbjct: 188 L-PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 73/199 (36%), Positives = 111/199 (55%), Gaps = 24/199 (12%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
+G G FG V +GE G K+AVK ++ V ++ F E AV++K+ H++LV LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLG-- 66
Query: 679 VAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
V + L +V E M +G L + ++ +S + L +LDVA GMEYL S +
Sbjct: 67 VILHNGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAP---DSERSVVTRLAGTFGYLAPEYAVTGK 794
+HRDL + NIL+ +D AKVSDFGL ++ D+ + V + APE K
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKK 173
Query: 795 ITTKVDVFSFGVVLMELLT 813
++K DV+S+GV+L E+ +
Sbjct: 174 FSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVK--RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G+G FG VYKG L T++AVK R K+ +F E +L + H ++V L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKLIG 59
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
V +V E +P G+L + K+ L+ K+ L ++LD A GMEYL S +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLES---K 112
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAPEYAVTGKI 795
+ IHRDL + N L+G++ K+SDFG+ + +V L + APE G+
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 796 TTKVDVFSFGVVLMELLTG 814
T++ DV+S+G++L E +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 85/270 (31%), Positives = 134/270 (49%), Gaps = 38/270 (14%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM---EAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
LG G FG VY+G LDDG AVK + + G ++AV + EIA+LSK++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 675 LGYSVAGYERLLVY-EYMPQGALSKHIFHWKSLNLEPL--SWKRRLNIALDVARGMEYLH 731
LG + L ++ E +P G+L+K + + S EP+ + R++ L G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFP-EPVIRLYTRQI---LL---GLEYLH 119
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
++ +HRD+K +NIL+ + K++DFG+ K E S G+ ++APE
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIA 174
Query: 792 -TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
G D++S G ++E+ TG P + A + I KE + PI
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKIGRSKE-----LPPI 223
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRP 880
+ D + F I + C R+PS RP
Sbjct: 224 PDHLSDEAKDF--ILK----CLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 71/194 (36%), Positives = 109/194 (56%), Gaps = 16/194 (8%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
+G+G FG V G+ G K+AVK ++ ++ F +E +V++++RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGVI 68
Query: 679 VAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
V L +V EYM +G+L ++ +S L L +LDV MEYL + +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITT 797
F+HRDL + N+L+ +D AKVSDFGL K A ++ + + T APE K +T
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 798 KVDVFSFGVVLMEL 811
K DV+SFG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-26
Identities = 115/384 (29%), Positives = 168/384 (43%), Gaps = 48/384 (12%)
Query: 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNN 137
+ + + ++S L G +P+ L Q+ L+ I L N GE+P GL++L + L NN
Sbjct: 188 TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNN 247
Query: 138 FD-TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPD 196
IP+ + L+NLQ L L N + P + S +L +L +L+G++P+
Sbjct: 248 LTGPIPSSLGN-LKNLQYLFLYQNKLSGP----IPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 197 FLGNFASLQNLKLSGNNLTGPIPE---SFKGLNLVNLWLNDQKGGGFTGTIDV-LGNMDQ 252
+ +L+ L L NN TG IP S L ++ LW N F+G I LG +
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK-----FSGEIPKNLGKHNN 357
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL-ASLSLDHLDLNNNMFM 311
L L L N+ +G IPE +L L L SN G IP SL A SL + L +N F
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 312 GPVPKS-----KAYKYSYSSNAFCQPTEGVPCAPEVMALID-----FLGGLNYPPRLVTS 361
G +P Y S+N + ++ F GGL P S
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL---PDSFGS 474
Query: 362 WSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP 421
+L L+L SG + +G+L L Q+KL N +SG+IP
Sbjct: 475 ------------------KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
Query: 422 TNWTNLKSLTLLDLSQNNLSPPLP 445
++ K L LDLS N LS +P
Sbjct: 517 DELSSCKKLVSLDLSHNQLSGQIP 540
|
Length = 968 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 617 NELGRGGFGVVYKG--ELDDGTKI--AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
ELG G FG V KG + G ++ AVK ++ I EF E +V++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLREASVMAQLDHPCIV 59
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
L+G G +LV E P G L K++ + + + L +A VA GM YL S
Sbjct: 60 RLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLES 113
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVTRLAGTF--GYLAPEY 789
+ F+HRDL + N+LL + +AK+SDFG+ + L S+ T AG + + APE
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPEC 169
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
GK ++K DV+S+GV L E +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 80/292 (27%), Positives = 137/292 (46%), Gaps = 48/292 (16%)
Query: 616 ENELGRGGFGVVYKGELDDGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
E +G G FG V +G L K +A+K ++AG S K +F +E +++ + H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNI 67
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ L G +++ EYM G+L K + N + + + + +A GM+YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIASGMKYL- 122
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG--YLAPEY 789
+ +++HRDL + NIL+ + KVSDFGL + DSE + T+ G + APE
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEA 179
Query: 790 AVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWN----IKS--DKEK 842
K T+ DV+SFG+V+ E+++ G ER Y W + IK+ D +
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYG----------ERPY---WDMSNQDVIKAVEDGYR 226
Query: 843 LRAAID-PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893
L +D P + +L C ++ ++RP V+ L ++
Sbjct: 227 LPPPMDCPS------------ALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 8e-26
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 618 ELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
ELG G FG V+ E D +AVK ++ S+ A +F E +L+ ++H+H+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHI 69
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSK---------HIF-HWKSLNLEPLSWKRRLNIAL 721
V G G L+V+EYM G L++ I + + L+ + L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLA 779
+A GM YL SL F+HRDL + N L+G K+ DFG+ + + D R V R
Sbjct: 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-VGGRTM 185
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++ PE + K TT+ D++SFGVVL E+ T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 64/199 (32%), Positives = 113/199 (56%), Gaps = 12/199 (6%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+LG G FG V+ G + TK+A+K ++ G +S +A F +E ++ +++H LV L
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL- 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
Y+V E + ++ EYM G+L + K+ L+ + +++A +A GM ++
Sbjct: 67 -YAVVTQEPIYIITEYMENGSLVDFL---KTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+++IHRDL+++NIL+ + K++DFGL +L D+E + + APE G
Sbjct: 121 -KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 795 ITTKVDVFSFGVVLMELLT 813
T K DV+SFG++L E++T
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 77/203 (37%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 619 LGRGGFGVVYKGEL--DDGTKI--AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+G+G FG VY G L DG KI AVK + + + V++F E ++ H +++SL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 675 LGYSVAGY-ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LG + L+V YM G L I +S P + K + L VA+GMEYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFI---RSETHNP-TVKDLIGFGLQVAKGMEYL--- 114
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT---FGYLAPEYA 790
A + F+HRDL + N +L + F KV+DFGL + D E V G ++A E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
T K TTK DV+SFGV+L EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 74/220 (33%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 612 NFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
N + ELG G FG V+ E D +AVK ++ S A +FH E +L+
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTN 63
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNL-------EPLSWKRRL 717
++H H+V G V G ++V+EYM G L+K + H L L+ + L
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
+IA +A GM Y LA Q F+HRDL + N L+G++ K+ DFG+ + D + R
Sbjct: 124 HIAQQIAAGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYR 177
Query: 778 LAG----TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ G ++ PE + K TT+ DV+S GVVL E+ T
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 67/196 (34%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
ELG G FGVV+ G+ K+A+K + G +S+ ++F E V+ K+ H LV L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
+V E+M G L ++ LS L++ DV GMEYL S
Sbjct: 68 CTQQKPLYIVTEFMENGCL----LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNS 120
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITT 797
FIHRDL + N L+ KVSDFG+ + D E + + + PE K ++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 798 KVDVFSFGVVLMELLT 813
K DV+SFGV++ E+ T
Sbjct: 181 KSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 616 ENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+++LG G +G VY+G +AVK ++ + V+EF E AV+ +++H +LV L
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQL 67
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
LG ++ E+M G L ++ + N + ++ L +A ++ MEYL
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEK-- 122
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT---FGYLAPEYAV 791
++FIHRDL + N L+G++ KV+DFGL +L T AG + APE
Sbjct: 123 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLA 178
Query: 792 TGKITTKVDVFSFGVVLMELLTGLMA 817
K + K DV++FGV+L E+ T M+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMS 204
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 72/199 (36%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
ELG G FGVV G+ +A+K ++ G +S+ DEF E V+ K+ H LV L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 678 SVAGYERLLVYEYMPQGALSKHIF-HWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+V EYM G L ++ H K L L + DV GM YL S Q
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLES--KQ 120
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVTGK 794
FIHRDL + N L+ D KVSDFGL + D E SV ++ + PE + K
Sbjct: 121 -FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSK 177
Query: 795 ITTKVDVFSFGVVLMELLT 813
++K DV++FGV++ E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 619 LGRGGFGVVYKG---ELDDGTKI--AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G FG VYKG + KI A+K + S KA E E V++ V H H+V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVR 73
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LLG + + L+ + MP G L ++ + K N+ LN + +A+GM YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYL---LNWCVQIAKGMSYLEE- 127
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAPEYAVT 792
+ +HRDL + N+L+ K++DFGL KL E+ ++A E +
Sbjct: 128 --KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 793 GKITTKVDVFSFGVVLMELLT 813
T K DV+S+GV + EL+T
Sbjct: 186 RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/291 (26%), Positives = 134/291 (46%), Gaps = 41/291 (14%)
Query: 614 ASENELGRGGFGVVYKGELDDGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ +G G FG V++G L + +A+K ++ G K+ D F SE +++ + H
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHH 66
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+++ L G +++ EYM GAL K++ L +A GM+Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLR---GIAAGMKY 122
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG--YLAP 787
L + +++HRDL + NIL+ + KVSDFGL ++ D T G + AP
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847
E K T+ DV+SFG+V+ E +M+ E RP +W++ S+ E ++A
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWE----VMSFGE-RP---------YWDM-SNHEVMKA-- 222
Query: 848 DPILEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893
+ND + + +L C ++ ++RP VN+L L+
Sbjct: 223 -----INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
N++G G FG VY LD G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G V + + EY G L + + H + + R + L G+ YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQL--LEGLAYLHS--- 117
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDS--ERSVVTRLAGTFGYLAPEYAVT 792
+HRD+K +NI L + K+ DFG VKL ++ V LAGT Y+APE
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 793 GKITTK---VDVFSFGVVLMELLTG 814
GK D++S G V++E+ TG
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 74/213 (34%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 619 LGRGGFGVVYKG----ELDDGT---KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
LG G FG VY+G L G+ ++AVK + G ++ EF E ++S H ++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP--LSWKRRLNIALDVARGMEY 729
V LLG + + ++ E M G L ++ + P L+ K L+I LDVA+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 730 LHSLAHQSFIHRDLKSSNILL----GDDFR-AKVSDFGLVKLAPDSERSVVTRLAGT--- 781
L + FIHRDL + N L+ D R K+ DFGL + D +S R G
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLL 175
Query: 782 -FGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++APE + GK TT+ DV+SFGV++ E+LT
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKV-R 667
+F +G G F V E + + A+K ++ +I +K V E VL+++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 668 HRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
H ++ L Y+ E L V EY P G L ++I + SL+ + + A ++
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLA 114
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA------- 779
+EYLHS IHRDLK NILL D K++DFG K+ + +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 780 ------------GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y++PE D+++ G ++ ++LTG
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 13/198 (6%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+LG G FG V+ G ++ TK+AVK ++ G +S V F E ++ ++H LV L Y
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRL--Y 67
Query: 678 SVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+V E ++ EYM +G+L + KS + + ++ + +A GM Y+
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQIAEGMAYIER--- 121
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+++IHRDL+++N+L+ + K++DFGL ++ D+E + + APE G
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 796 TTKVDVFSFGVVLMELLT 813
T K DV+SFG++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/206 (34%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 618 ELGRGGFGVV----YKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
LG G FG V Y D G +AVK ++ ++ + EI +L + H ++V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIV 69
Query: 673 SLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
G + L+ EY+P G+L ++ LNL L L A + GM YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQL-----LLFAQQICEGMAYL 123
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG---TFGYLAP 787
HS Q +IHRDL + N+LL +D K+ DFGL K P+ R G F Y A
Sbjct: 124 HS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AV 179
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLT 813
E K + DV+SFGV L ELLT
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 68/211 (32%), Positives = 111/211 (52%), Gaps = 22/211 (10%)
Query: 618 ELGRGGFGVVY----KGELDDG--TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
ELG+G FG+VY KG + D T++A+K + ++ + EF +E +V+ + H+
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHV 71
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWK-----SLNLEPLSWKRRLNIALDVARG 726
V LLG G L++ E M +G L ++ + + P S K+ + +A ++A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT----F 782
M YL++ F+HRDL + N ++ +DF K+ DFG+ + D + R G
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPV 185
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+++PE G TT DV+SFGVVL E+ T
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 619 LGRGGFGVVYKGEL----DDGTKIAVK-RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G FG VY+G D ++ V + S++ +F E ++SK H+++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHW--KSLNLEPLSWKRRLNIALDVARGMEYLH 731
L+G S R ++ E M G L + + L+ K L A DVA+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 732 SLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGT----FGY 784
FIHRD+ + N LL G AK++DFG+ + D R+ R G +
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRKGGRAMLPIKW 187
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLT-GLM 816
+ PE + G T+K DV+SFGV+L E+ + G M
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM 220
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 28/206 (13%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVRHRHLVS 673
LG G + VVYK + G +A+K+++ G K+A D + EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGER-KEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 674 LLGYSVAGYERL--LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
LL V G++ LV+E+M L K + KS+ L P K + + L RG+EYLH
Sbjct: 67 LL--DVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIKSYMLMTL---RGLEYLH 119
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER----SVVTRLAGTFGYLAP 787
S +HRDLK +N+L+ D K++DFGL + R VVTR Y AP
Sbjct: 120 SN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAP 171
Query: 788 EYAVTGKI-TTKVDVFSFGVVLMELL 812
E + VD++S G + ELL
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 29/219 (13%)
Query: 616 ENELGRGGFGVVYKGE------LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ ELG G FG V+ E D +AVK ++ ++ A +F E +L+ ++H
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAELLTNLQHE 67
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKS----LNLEPLSWK------RRLN 718
H+V G G ++V+EYM G L+K + H ++ +P K + L+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
IA +A GM YL A Q F+HRDL + N L+G + K+ DFG+ + D + R+
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRV 181
Query: 779 AG----TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
G ++ PE + K TT+ DV+SFGV+L E+ T
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 619 LGRGGFGVVYKGELDDGTKI-----------------AVKRMEAGVISKKAVDEFHSEIA 661
LG G FG V+ E D AVK + S A ++F E+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVK 71
Query: 662 VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL----SKHIFHWKSL--NLEPLSWKR 715
+LS++ ++ LLG ++ EYM G L KH+ L N + LS+
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
L +A +A GM YL SL +F+HRDL + N L+G ++ K++DFG+ + + S
Sbjct: 132 LLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSSDY 185
Query: 776 TRLAGT----FGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
R+ G ++A E + GK TTK DV++FGV L E+LT
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-22
Identities = 73/248 (29%), Positives = 115/248 (46%), Gaps = 34/248 (13%)
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLD 134
CS+ + ++ + S L+G +P++L L + LQ N F GELPS F+ L + + +
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 135 GNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL 194
NN + +LQ+L+L N F SF S +L NL +G +
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-----GSKRLENLDLSRNQFSGAV 491
Query: 195 PDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
P LG+ + L LKLS N L+G IP+ LV+L L+
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH------------------- 532
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312
N SG IP SF ++ L L+L+ NQ G IP +L ++ SL +++++N G
Sbjct: 533 -------NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585
Query: 313 PVPKSKAY 320
+P + A+
Sbjct: 586 SLPSTGAF 593
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 73/212 (34%), Positives = 108/212 (50%), Gaps = 29/212 (13%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISK--KAVDEFHSEIAVLSKVRHRHLVS 673
+G G VVY L + K+A+KR++ + K +VDE E+ +S+ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 674 LLGYSVAGYERLLVYEYMPQGALS---KHIFHWKSLNLEPLSWKRRLNIAL---DVARGM 727
V G E LV Y+ G+L K + L+ E + IA +V +G+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD-EAI-------IATVLKEVLKGL 115
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTR--LAGTFGY 784
EYLHS IHRD+K+ NILLG+D K++DFG+ LA +R+ R GT +
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 785 LAPE--YAVTGKITTKVDVFSFGVVLMELLTG 814
+APE V G K D++SFG+ +EL TG
Sbjct: 173 MAPEVMEQVHG-YDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-22
Identities = 95/312 (30%), Positives = 143/312 (45%), Gaps = 64/312 (20%)
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE-------SFKGLNLV 228
+S+++ ++ N++G++ + +Q + LS N L+GPIP+ S + LNL
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 229 NLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV 288
N FTG+I G++ L TL L N SG IP G +SLK L+L N V
Sbjct: 127 N--------NNFTGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177
Query: 289 GLIPPSLASL-SLDHLDLNNNMFMGPVP----KSKAYKYSYSSNAFCQPTEGVPCAPEVM 343
G IP SL +L SL+ L L +N +G +P + K+ K+ Y
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY------------------- 218
Query: 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNL 403
L Y + SG P G + L L+L NL+G + S+GNL
Sbjct: 219 --------LGY-----NNLSGEIP------YEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259
Query: 404 DSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVK----LSLDGNP 459
+L + L N +SG IP + +L+ L LDLS N+LS +P+ ++ L L N
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319
Query: 460 LLNGKSPGSGSS 471
GK P + +S
Sbjct: 320 -FTGKIPVALTS 330
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 612 NFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
N ++G+G FG V++ + T +AVK ++ S +F E A++++
Sbjct: 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE 64
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE---------------- 709
H ++V LLG G L++EYM G L++ + H
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 710 -PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--L 766
PLS +L IA VA GM YL + + F+HRDL + N L+G++ K++DFGL +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ D ++ ++ PE + TT+ DV+++GVVL E+ +
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-22
Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 32/216 (14%)
Query: 618 ELGRGGFGVVY--------KGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
ELG+G FG+VY KGE + T++AVK + ++ + EF +E +V+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAE--TRVAVKTVNESASLRERI-EFLNEASVMKGFTCH 69
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE--------PLSWKRRLNIAL 721
H+V LLG G L+V E M G L ++ +SL E P + + + +A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL---RSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
++A GM YL++ + F+HRDL + N ++ DF K+ DFG+ + D + R G
Sbjct: 127 EIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYRKGGK 180
Query: 782 ----FGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++APE G TT D++SFGVVL E+ +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 91/316 (28%), Positives = 148/316 (46%), Gaps = 46/316 (14%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKI--AVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHL 671
++ +G G FG V K + DG ++ A+KRM+ SK +F E+ VL K+ H ++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP-----------LSWKRRLNIA 720
++LLG L EY P G L + + L +P LS ++ L+ A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
DVARGM+YL + + FIHRDL + NIL+G+++ AK++DFGL + + + RL
Sbjct: 131 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP- 186
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMEL--LTGLMALDESRPEERQYLAAWFWNIKS 838
++A E TT DV+S+GV+L E+ L G + E + L +
Sbjct: 187 -VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 240
Query: 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898
++ L +D+ + +L C +P +RP + L ++E+ K
Sbjct: 241 -------RLEKPLNCDDEVY-------DLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286
Query: 899 LDD----EPEEYSGID 910
+ E Y+GID
Sbjct: 287 YVNTTLYEKFTYAGID 302
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 66/201 (32%), Positives = 111/201 (55%), Gaps = 16/201 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +LG G FG V+ + TK+AVK M+ G +S V+ F +E V+ ++H LV L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL- 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
++V E + ++ E+M +G+L + KS + ++ + +A GM ++
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIE--- 119
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYAVT 792
+++IHRDL+++NIL+ K++DFGL ++ D+E R F + APE
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINF 177
Query: 793 GKITTKVDVFSFGVVLMELLT 813
G T K DV+SFG++LME++T
Sbjct: 178 GSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+F +LG+G +G VYK + L D A+K ++ G +S+K ++ +EI +L+ V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNL---EPLSWKRRLNIALDVARGM 727
++S + G + +V EY P G LSK I K E W I + + RG+
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
+ LH Q +HRDLKS+NILL + K+ D G+ K+ + GT Y+AP
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAP 170
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E + K D++S G +L E+ T
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 8/195 (4%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678
LG+G FG V+KG L D T +AVK + + + + +F SE +L + H ++V L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGVC 61
Query: 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
+V E +P G + K + L K+ + ALD A GM YL S ++
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 739 IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTK 798
IHRDL + N L+G++ K+SDFG+ + D S + APE G+ +++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 799 VDVFSFGVVLMELLT 813
DV+S+G++L E +
Sbjct: 175 SDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 82/297 (27%), Positives = 135/297 (45%), Gaps = 57/297 (19%)
Query: 616 ENELGRGGFGVVYKGELDDGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
E +G G FG V G L K +A+K ++AG K+ D F SE +++ + H ++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALS----KHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
+ L G ++V EYM G+L KH + + L + + +A GM
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL--------VGMLRGIASGM 119
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG--YL 785
+YL + ++HRDL + NIL+ + KVSDFGL ++ D + T G +
Sbjct: 120 KYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN------IKSD 839
APE K T+ DV+S+G+V+ E +M+ E RP +W IK+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWE----VMSYGE-RP---------YWEMSNQDVIKAI 222
Query: 840 KE--KLRAAID-PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893
+E +L A +D P + +L C ++ ++RP V++L L+
Sbjct: 223 EEGYRLPAPMDCPA------------ALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDEFH-SEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ K+ A K+++ + K+ ++ +E +L KV R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ + L LV M G L HI++ + R + A + G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYN---VGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++RDLK N+LL D ++SD GL V+L + AGT GY+APE
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 795 ITTKVDVFSFGVVLMELLTG 814
VD F+ G L E++ G
Sbjct: 171 YDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 71/265 (26%), Positives = 111/265 (41%), Gaps = 34/265 (12%)
Query: 620 GRGGFGVVYKGELDDGTKI-AVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
G+G FG V + D K+ A+K M + + K +V +E +L ++ H LV+L Y
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-Y 67
Query: 678 SVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
S E + LV + + G L H+ + E + + I ++ +EYLHS +
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV----KFWIC-EIVLALEYLHS---K 119
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
IHRD+K NILL + ++DF + + T +GT GY+APE +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST--SGTPGYMAPEVLCRQGYS 177
Query: 797 TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856
VD +S GV E L G RP + S +R I E D
Sbjct: 178 VAVDWWSLGVTAYECLRG------KRP----------YRGHS--RTIRDQIRAKQETADV 219
Query: 857 TFETFWTIA--ELAGHCTSREPSQR 879
+ W+ + R+P +R
Sbjct: 220 LYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 1e-21
Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 43/214 (20%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM-----EAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
LG G +GVVYK + G +A+K++ E G I A+ EI++L +++H ++V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTAL----REISLLKELKHPNIV 61
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LL + LV+EY L K++ PLS +I + RG+ Y HS
Sbjct: 62 KLLDVIHTERKLYLVFEYCDMD-LKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-----VKLAPDSERSVVTRLAGTFGYLAP 787
+HRDLK NIL+ D K++DFGL + L + V T Y AP
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV------TLWYRAP 167
Query: 788 E-------YAVTGKITTKVDVFSFGVVLMELLTG 814
E Y +T VD++S G + E++TG
Sbjct: 168 EILLGSKHY------STAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 48/286 (16%)
Query: 619 LGRGGFGVVYKGEL--DDGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G FG V + +L +DG+ K+AVK ++A + S ++EF E A + + H +++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 675 LGYSVAGYER------LLVYEYMPQGALSKHIFHWKS-LNLEP--LSWKRRLNIALDVAR 725
+G S+ + +++ +M G L H F S + EP L + + +D+A
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERS-VVTRLAGTF 782
GMEYL S ++FIHRDL + N +L ++ V+DFGL K + D R ++L
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP--V 179
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELL----TGLMALDESRPEERQYLAAWFWNIKS 838
+LA E TT DV++FGV + E++ T ++ S E YL
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK------- 230
Query: 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGH 884
+L+ D + +V + L C S EP RP H
Sbjct: 231 -GNRLKQPPDCLEDVYE-----------LMCQCWSPEPKCRPSFQH 264
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 619 LGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
LGRG FG V+ + T + VK ++ + EF E+ + K+ H+++V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKS----LNLEPLSWKRRLNIALDVARGME 728
LLG ++ EY G L + + KS L PLS K+++ + +A GM+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
+L ++ F+HRDL + N L+ KVS L K +SE + +LAPE
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+TK DV+SFGV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 619 LGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
LG G FG V +G+L D K+AVK M+ + ++ +++F SE + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 676 GYSVAGYER------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL--DVARGM 727
G + E +++ +M G L + + L P ++ + D+A GM
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLA 786
EYL S +SFIHRDL + N +L ++ V+DFGL K + + R+A ++A
Sbjct: 126 EYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
E TTK DV+SFGV + E+ T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 27/219 (12%)
Query: 618 ELGRGGFGVVYKGELDDGTK---------------IAVKRMEAGVISKKAVDEFHSEIAV 662
+LG G FG V+ E + + +AVK + A V +K A ++F EI +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKI 70
Query: 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFH-------WKSLNLEPLSWKR 715
+S++++ +++ LLG V+ ++ EYM G L++ + + N+ +S
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSV 774
L +A+ +A GM+YL SL +F+HRDL + N L+G+ + K++DFG+ + L +
Sbjct: 131 LLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
R ++A E + GK TT DV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 618 ELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G GVVYK G A+K++ +K + E+ L ++V
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKC 64
Query: 675 LG-YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
G + G + V EYM G+L+ + + L++ IA + +G++YLH+
Sbjct: 65 YGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTK 118
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS---ERSVVTRLAGTFGYLAPEYA 790
H IHRD+K SN+L+ K++DFG+ K+ ++ + V GT Y++PE
Sbjct: 119 RHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERI 172
Query: 791 VTGKITTKVDVFSFGVVLMELLTG 814
+ D++S G+ L+E G
Sbjct: 173 QGESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 5e-21
Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 618 ELGRGGFGVVYKGELDDGTK-----------------IAVKRMEAGVISKKAVDEFHSEI 660
+LG G FG V+ E+ + +AVK + +K A ++F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEV 70
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL----SKHIFHWKSLNLEP------ 710
+LS+++ +++ LLG V ++ EYM G L S H K N
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 711 ----LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK- 765
+S+ L++AL +A GM+YL SL +F+HRDL + N L+G++ K++DFG+ +
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 766 -LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELL 812
A D R + R ++A E + GK TT DV++FGV L E+L
Sbjct: 188 LYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEA-GVISKKAVDEFHSEIAVLSKVR 667
NF E ++G+G F VVYK L DG +A+K+++ ++ KA + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKS---LNLEPLSWKRRLNIALDVA 724
H +++ L + E +V E G LS+ I H+K L E WK + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK----YFVQLC 116
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+E++HS + +HRD+K +N+ + K+ D GL + S+ + L GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYY 172
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI-KSDKEKL 843
++PE K D++S G +L E + AL ++ L + I K D L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888
A D + + +L C + +P +RPD+ + + V
Sbjct: 229 PA----------DHYSE--ELRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 75/275 (27%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+F N++G+G FGVV+K D A+K+++ ++++ +E E VL+K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS----WKRRLNIALDVARG 726
++ + + +V EY G L K + K PL W+ + I L G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILL----G 113
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+ +LHS + +HRD+KS N+ L K+ D G+ KL D+ T + GT YL+
Sbjct: 114 LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLS 169
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846
PE K DV++ GVVL E TG P + A I +R
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTG------KHPFDANNQGALILKI------IRGV 217
Query: 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD 881
P+ ++ +A+L C +++ QRPD
Sbjct: 218 FPPVSQMYSQ------QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 24/215 (11%)
Query: 618 ELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
ELG FG +YKG L D +A+K ++ + + + EF E ++++++ H ++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLN------------LEPLSWKRRLNIA 720
LLG +++EY+ QG L + + + L L+IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRL 778
+ +A GMEYL S F+H+DL + NIL+G+ K+SD GL + + D R V +
Sbjct: 131 IQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR-VQPKS 186
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++ PE + GK ++ D++SFGVVL E+ +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 613 FASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVI----SKKAVDEFHSEIAVLSKVR 667
F +G+G FG VYK + +A+K VI ++ +++ EI LS+ R
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
++ G + G + ++ EY G+ L L I +V G+
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD------LLKPGKLDETYIAFILREVLLGL 111
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--LAGTFGYL 785
EYLH + IHRD+K++NILL ++ K++DFG ++ ++ R GT ++
Sbjct: 112 EYLHE---EGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWM 165
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE K D++S G+ +EL G
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 618 ELGRGGFGVV----YKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+LG G FG V Y E D+ G ++AVK ++ D EI +L + H ++V
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIV 69
Query: 673 SLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
G L+ E++P G+L +++ N ++ K++L A+ + +GM+YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER--SVVTRLAGTFGYLAPE 788
S + ++HRDL + N+L+ + + K+ DFGL K + +V L + APE
Sbjct: 126 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ K DV+SFGV L ELLT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 619 LGRGGFGVVYKG-ELDDGTKI----AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G FG V+KG + +G I A+K ++ ++ E + + + H ++V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LLG G LV + P G+L H+ + +L+P +R LN + +A+GM YL
Sbjct: 74 LLGI-CPGASLQLVTQLSPLGSLLDHVRQHRD-SLDP---QRLLNWCVQIAKGMYYLE-- 126
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-PDSERSVVTRLAGTFGYLAPEYAVT 792
+HR+L + NILL D +++DFG+ L PD ++ + ++A E +
Sbjct: 127 -EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 793 GKITTKVDVFSFGVVLMELLT 813
G+ T + DV+S+GV + E+++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 74/233 (31%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+ +G +G V+ + G A+K + +A +I K VD+ +E +LS+ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS G + L LV EY+P G L+ + + SL R ++ +EYLHS
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSL---DEDVAR--IYIAEIVLALEYLHSN-- 112
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVK-------LAPDSERSVVTRLAGTFGYLAPE 788
IHRDLK NIL+ + K++DFGL K + + + R+ GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 789 YAVTGKITTK-VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840
+ G+ +K VD +S G +L E L G+ PEE F NI + K
Sbjct: 172 -VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILNGK 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 50/221 (22%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVRHRHL 671
++G G +G VYK G +A+K++ + + F EI +L K+RH ++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI----RMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 672 VSLLGYSVAGYER---LLVYEYMP---QGALSKHIFHW-----KSLNLEPLSWKRRLNIA 720
V L V + +V+EYM G L + K + L
Sbjct: 61 VRLKEI-VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------- 111
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
G++YLHS +HRD+K SNIL+ +D K++DFGL + + T
Sbjct: 112 -----GLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 781 TFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
T Y PE Y +VD++S G +L EL G
Sbjct: 164 TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+G G +GVVYK + G +A+K++ E+ I K A+ EI +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELNHPNIIK 62
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LL + LV+E+M ++ L + + +G+ + HS
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS- 116
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLAGTFGYLAPEY 789
+HRDLK N+L+ + K++DFGL + R VVTR Y APE
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPEL 169
Query: 790 AVTGKI-TTKVDVFSFGVVLMELLTG 814
+ K +T VD++S G + ELL+
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 8e-20
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 23/214 (10%)
Query: 616 ENELGRGGFGVVYKGELD-DGTKI-AVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLV 672
E+ +G G FG V + + DG K+ A +M S+ +F E+ VL K+ H +++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP-----------LSWKRRLNIAL 721
+LLG + EY P G L + + L +P L+ ++ L A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
DVA GM+YL + + FIHRDL + N+L+G++ +K++DFGL + E V + G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179
Query: 782 FG--YLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++A E TTK DV+SFGV+L E+++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 21/209 (10%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVIS-------KKAVDEFHSEIAVLSKVRHRH 670
+G G FG VY G G +AVK++E +S + +D EIA+L +++H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V LG S+ + EY+P G+++ + ++ + E L N + +G+ YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-ETLV----RNFVRQILKGLNYL 122
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-----LAGTFGYL 785
H+ + IHRD+K +NIL+ + K+SDFG+ K + S T L G+ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE T K D++S G +++E+LTG
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 619 LGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHL 671
LG G FG V K E ++ + +AVK ++ K D SE+ ++ + +H+++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKNI 78
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHI--------FHWKSLNLEP---LSWKRRLNIA 720
++LLG +V EY G L + + P L+ K ++ A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVVTR 777
VARGME+L A + IHRDL + N+L+ +D K++DFGL + + ++ R
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 778 LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
L ++APE T + DV+SFGV+L E+ T
Sbjct: 196 LP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFH-SEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ G A K++E I K+ + +E +L KV R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ + L LV M G L HI+H E R + A ++ G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLH---Q 120
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ ++RDLK NILL D ++SD GL P+ + + GT GY+APE +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERY 178
Query: 796 TTKVDVFSFGVVLMELLTG 814
T D ++ G +L E++ G
Sbjct: 179 TFSPDWWALGCLLYEMIAG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 59/206 (28%), Positives = 111/206 (53%), Gaps = 17/206 (8%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEF-HSEIAVLSKVRHR 669
+ ++G G G+V + G ++AVK+M+ + K+ E +E+ ++ +H
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHP 76
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V + + G E +V E++ GAL+ + H + +N E ++ + L V + + +
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIA-----TVCLAVLKALSF 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV-KLAPDSERSVVTRLAGTFGYLAPE 788
LH+ Q IHRD+KS +ILL D R K+SDFG +++ + R L GT ++APE
Sbjct: 131 LHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPE 185
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTG 814
T+VD++S G++++E++ G
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 619 LGRGGFGVVYKGE------LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
LG G FG V K T +AVK ++ S + D SE +L +V H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVI 66
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL-------------------NLEPLSW 713
L G LL+ EY G+L + + + + L+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 714 KRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773
++ A ++RGM+YL A +HRDL + N+L+ + + K+SDFGL + + E S
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE-EDS 182
Query: 774 VVTRLAGTF--GYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
V R G ++A E TT+ DV+SFGV+L E++T
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 67/222 (30%), Positives = 114/222 (51%), Gaps = 20/222 (9%)
Query: 596 AGNLVISVQVLRNVTKNFASENELGRGGFGVV-YKGELDDGTKIAVKRMEAGVISKKAVD 654
A LV+S R +F ++G G G+V E G ++AVK+M+ ++ +
Sbjct: 10 ALQLVVSPGDPREYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL- 65
Query: 655 EFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWK 714
+E+ ++ H ++V + + G E +V E++ GAL+ + H + +N E ++
Sbjct: 66 -LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIA-- 121
Query: 715 RRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774
+ L V R + YLH+ Q IHRD+KS +ILL D R K+SDFG + V
Sbjct: 122 ---TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEV 172
Query: 775 VTR--LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
R L GT ++APE T+VD++S G++++E++ G
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 72/220 (32%), Positives = 97/220 (44%), Gaps = 42/220 (19%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
+F LG G FG V K A+K + A ++ K V+ +E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 669 RHLVSLLG-YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR- 725
LV+L G + L LV EY+P G L F L R VAR
Sbjct: 61 PFLVNLYGSFQDDSN--LYLVMEYVPGGEL----FSH-------LRKSGRFP--EPVARF 105
Query: 726 -------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR- 777
+EYLHSL ++RDLK N+LL D K++DFG K V R
Sbjct: 106 YAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRT 155
Query: 778 --LAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTG 814
L GT YLAPE + K K VD ++ G+++ E+L G
Sbjct: 156 YTLCGTPEYLAPE-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 617 NELGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G+G FG V K DG + K ++ G +++K + SE+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 676 GYSVAGYERL---------LVYEYMPQGALSKHIFHWKSLNL---EPLSWK--RRLNIAL 721
Y Y+R+ +V EY G L++ I K E W+ +L +AL
Sbjct: 63 RY----YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 722 DVARGMEYLHSLAH--QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
H+ + + +HRDLK +NI L + K+ DFGL K+ S
Sbjct: 119 Y------ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYV 171
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y++PE K D++S G ++ EL
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 16/206 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
E +G G FG V +G L K +A+K +++G K+ D F SE +++ + H ++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNI 67
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ L G +++ E+M GAL + N + + + + +A GM+YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYL- 122
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD--SERSVVTRLAGTFG--YLAP 787
+ +++HRDL + NIL+ + KVSDFGL + D S+ + + L G + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLT 813
E K T+ DV+S+G+V+ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+G G G+V+K + + G +A+K++ + ++ EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 678 SVAGYERLLVYEYMPQG--ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G +LV EYMP + + PL + + + +G+ Y+H+
Sbjct: 68 FPHGSGFVLVMEYMPSDLSEVLRDEER-------PLPEAQVKSYMRMLLKGVAYMHAN-- 118
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE--YAVTG 793
+HRDLK +N+L+ D K++DFGL +L + E + + T Y APE Y
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-AR 176
Query: 794 KITTKVDVFSFGVVLMELLTG 814
K VD+++ G + ELL G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG G +G VYK + G +A+K + ++ + E EI++L + ++V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN------IALDVARGMEYLH 731
+ +V EY G++S + K N + L I +G+EYLH
Sbjct: 67 YFKNTDLWIVMEYCGAGSVSDIM---KITN-------KTLTEEEIAAILYQTLKGLEYLH 116
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
S IHRD+K+ NILL ++ +AK++DFG+ D+ T + GT ++APE
Sbjct: 117 S---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQ 172
Query: 792 TGKITTKVDVFSFGVVLMELLTGLMALDESRP 823
K D++S G+ +E MA E +P
Sbjct: 173 EIGYNNKADIWSLGITAIE-----MA--EGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 68/227 (29%), Positives = 109/227 (48%), Gaps = 43/227 (18%)
Query: 613 FASENELGRGGFGVVYKG---ELDDGTKIAVKRMEAGV-----ISKKAVDEFHSEIAVLS 664
+ E +GRG +G VYK DG + A+K+ + IS+ A EIA+L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALLR 57
Query: 665 KVRHRHLVSLLGYSVAGYERL--LVYEYMPQGALSKHIFHW----KSLNLEPLSWKRRLN 718
+++H ++VSL+ + ++ L+++Y I + K +++ P K L
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLW--QIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDF---RAKVSDFGLVKL--AP---- 768
L+ G+ YLHS +HRDLK +NIL+ G+ K+ D GL +L AP
Sbjct: 116 QILN---GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 769 -DSERSVVTRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLT 813
D + VV T Y APE + + TK +D+++ G + ELLT
Sbjct: 170 ADLDPVVV-----TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 75/269 (27%), Positives = 129/269 (47%), Gaps = 27/269 (10%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
K + ++G+G G VY ++ G ++A+K+M KK + +EI V+ + +H
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHP 76
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V+ L + G E +V EY+ G+L+ + + + + + + +E+
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEF 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPE 788
LHS IHRD+KS NILLG D K++DFG ++ P E+S + + GT ++APE
Sbjct: 131 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD---KEKLRA 845
KVD++S G++ +E++ G P YL A N + EKL A
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNGTPELQNPEKLSA 243
Query: 846 A----IDPILEVNDDTFETFWTIAELAGH 870
++ LE++ E + EL H
Sbjct: 244 IFRDFLNRCLEMD---VEKRGSAKELLQH 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 55/220 (25%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS--------EIAVLSKV-R 667
+LG G FG VY + G +A+K+M KK +F+S E+ L K+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM------KK---KFYSWEECMNLREVKSLRKLNE 56
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
H ++V L E V+EYM +G L + + K +P S +I + +G+
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGL 112
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-------VVTRLAG 780
++H F HRDLK N+L+ K++DFGL + RS V TR
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRW-- 163
Query: 781 TFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLT 813
Y APE Y ++ VD+++ G ++ EL T
Sbjct: 164 ---YRAPEILLRSTSY------SSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 618 ELGRGGFGVVYKGE-------------LDDGTK----IAVKRMEAGVISKKAVDEFHSEI 660
+LG G FG V+ E LD +AVK + +K A ++F EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEI 70
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL----SKHIFHWKSL--NLEPLSWK 714
++S+++ +++ LL + ++ EYM G L S+H + ++ +S+
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 715 RRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERS 773
+ +A +A GM+YL SL +F+HRDL + N L+G ++ K++DFG+ + L
Sbjct: 131 TLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ R +++ E + GK TT DV++FGV L E+LT
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G FG VY ++D G ++AVK++ S KK V+ EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G + EYMP G++ + + +L E ++ K I G+EYLHS
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQIL----EGVEYLHS-- 122
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK------LAPDSERSVVTRLAGTFGYLAPE 788
+HRD+K +NIL K+ DFG K + +SV GT +++PE
Sbjct: 123 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT----GTPYWMSPE 177
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
K DV+S G ++E+LT
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 44/217 (20%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRM-----EAGV-ISKKAVDEFHSEIAVLSKVR-- 667
E+G G +G VYK +L+ G +A+K++ E G+ +S EIA+L ++
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL------REIALLKQLESF 58
Query: 668 -HRHLVSLLGYSVAGYER------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
H ++V LL G LV+E++ Q L+ ++ L P + K ++
Sbjct: 59 EHPNIVRLLDVC-HGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIK---DLM 113
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ RG+++LHS +HRDLK NIL+ D + K++DFGL ++ S +T +
Sbjct: 114 RQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVV 168
Query: 781 TFGYLAPE------YAVTGKITTKVDVFSFGVVLMEL 811
T Y APE YA T VD++S G + EL
Sbjct: 169 TLWYRAPEVLLQSSYA------TPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 69/211 (32%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 619 LGRGGFGVVYKGELD-DGTKI-AVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
+G G FG V K + DG ++ A + SK +F E+ VL K+ H ++++LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP-----------LSWKRRLNIALDVA 724
G L EY P G L + + L +P LS ++ L+ A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG- 783
RGM+YL + + FIHRDL + NIL+G+++ AK++DFGL + + V + G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPV 175
Query: 784 -YLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++A E TT DV+S+GV+L E+++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS---EIAVLSKVRHRHLV 672
+G G +G VYK ++ G +A+K VI + D+F EI++L + RH ++V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL---DVARGMEY 729
+ G + + +V EY G+L I+ + PLS L IA + +G+ Y
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQD-IYQ---VTRGPLS---ELQIAYVCRETLKGLAY 116
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--LAGTFGYLAP 787
LH IHRD+K +NILL +D K++DFG ++ ++ R GT ++AP
Sbjct: 117 LH---ETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 788 EYA---VTGKITTKVDVFSFGVVLMEL 811
E A G K D+++ G+ +EL
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFH-SEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ G A KR+E I K+ + +E +L KV + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ + L LV M G L HI++ + E +R L A ++ G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLH---R 120
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++ ++RDLK NILL D ++SD GL P+ E S+ R+ GT GY+APE +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPEVLNNQRY 178
Query: 796 TTKVDVFSFGVVLMELLTG 814
T D + G ++ E++ G
Sbjct: 179 TLSPDYWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-18
Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 618 ELGRGGFGVV-YKGELDDGTKIAVKRMEAGVISKKAVDEF-HSEIAVLSKVRHRHLVSLL 675
++G G G+V E G ++AVK M+ + K+ E +E+ ++ +H+++V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ G E ++ E++ GAL+ I LN E ++ + V + + YLHS
Sbjct: 85 KSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIA-----TVCESVLQALCYLHS--- 135
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
Q IHRD+KS +ILL D R K+SDFG +++ D + L GT ++APE
Sbjct: 136 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTP 193
Query: 795 ITTKVDVFSFGVVLMELLTG 814
T+VD++S G++++E++ G
Sbjct: 194 YGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDEFH-SEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ K+ A K++E I K+ + +E +L KV R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ + L LV M G L HI++ + + +R + A ++ G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLEDLHR--- 120
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ ++RDLK NILL D ++SD GL P+ E + GT GY+APE +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERY 178
Query: 796 TTKVDVFSFGVVLMELLTG 814
T D + G ++ E++ G
Sbjct: 179 TFSPDWWGLGCLIYEMIEG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 58/233 (24%), Positives = 91/233 (39%), Gaps = 62/233 (26%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVRHRHLVS 673
LG G FG VYK ++ G +A+K+ ++ D F EI +L K++H ++V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKK----ILMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIF---------------HWKSLNLEPLSWKRRLN 718
L+ + E + + S+ L K
Sbjct: 72 LID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK---C 119
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL-----------A 767
L + G+ YLH +HRD+K++NIL+ + K++DFGL +
Sbjct: 120 YMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 768 PDSERS----VVTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLTG 814
R VVTR Y PE + G + TT VD++ G V E+ T
Sbjct: 177 GGGTRKYTNLVVTRW-----YRPPEL-LLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 69/220 (31%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 605 VLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVK--RM--EAGVISKKAVDEFHSE 659
R+VT F N +G G +G+VY+ + G +A+K RM E I ++ E
Sbjct: 2 RCRSVT-EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL----RE 56
Query: 660 IAVLSKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKR 715
I +L +RH ++V L V + L LV EY Q L+ + + + P S +
Sbjct: 57 ITLLLNLRHPNIVELK--EVVVGKHLDSIFLVMEYCEQD-LASLLDNMPT----PFSESQ 109
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
+ L + RG++YLH IHRDLK SN+LL D K++DFGL + + +
Sbjct: 110 VKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 776 TRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLTG 814
++ T Y APE + TT +D+++ G +L ELL
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVIS--------KKAVDEFHSEIAVLSKVRHR 669
+G+G +G VY + G +AVK++E K V SEI L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V LG+ + EY+P G++ + + E L V G+ Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE-EQLV----RFFTEQVLEGLAY 123
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV-TRLAGTFGYLAPE 788
LHS + +HRDLK+ N+L+ D K+SDFG+ K + D + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 789 YAVTGK--ITTKVDVFSFGVVLMELLTG 814
+ + KVD++S G V++E+ G
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-17
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 612 NFASENELGRGGFGVVY----KGELDDGTKIAVKRMEAGVISKKAVDEFHS--EIAVLSK 665
NF LG G +G V+ G D G A+K ++ I +KA H+ E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 666 VRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
VR + L Y+ +L L+ +Y+ G L H++ + + R+ IA ++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIV 115
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTF 782
+++LH L I+RD+K NILL + ++DFGL K LA + ER+ GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA--YSFCGTI 170
Query: 783 GYLAPEYAVTGKI--TTKVDVFSFGVVLMELLTG 814
Y+APE G VD +S GV+ ELLTG
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAG-VISKKAVDEFHSEIAVL---SKVRHRHLVS 673
LGRG FG V E ++ A+K ++ G +I++ V+ E + + RH LV+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
L V EY G L HI + + S R + A V G++YLH
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI------HTDVFSEPRAVFYAACVVLGLQYLHE- 119
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPEYAV 791
++RDLK N+LL + K++DFGL K + S GT +LAPE
Sbjct: 120 --NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST---FCGTPEFLAPEVLT 174
Query: 792 TGKITTKVDVFSFGVVLMELLTG 814
T VD + GV++ E+L G
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHS-EIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ + G A K+++ + KK+ ++ E +L KV +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ L LV M G L HI++ LE +R ++ + + G+ +LHS+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE---MERVIHYSAQITCGILHLHSM-- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++RD+K N+LL D ++SD GL D + +T+ AGT GY+APE
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPY 171
Query: 796 TTKVDVFSFGVVLMELLTG 814
+ VD F+ G + E++ G
Sbjct: 172 SYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
ELG G GVV K G +AVK + I++ + E+ +L K ++V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 676 GYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G + + EYM G+L K + + L IA+ V +G+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH 120
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
IHRD+K SNIL+ + K+ DFG+ +S + GT Y+APE
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGND 175
Query: 795 ITTKVDVFSFGVVLMELLTG 814
+ K D++S G+ L+EL TG
Sbjct: 176 YSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 612 NFASENELGRGGFGVVYKGELDDGT-------KIAVKRMEAGVISK---KAVDEFHSEIA 661
+A LG G FG VYK + +I V G + K++ + SE+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 662 VLSK-VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
++ + +RH ++V + +V + + L +H K + + +R NI
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIF 119
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ + + YLH + +HRDL +NI+LG+D + ++DFGL K S +T + G
Sbjct: 120 VQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVG 175
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW--NIKS 838
T Y PE K DV++FG +L ++ T L F+ N+ S
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT---------------LQPPFYSTNMLS 220
Query: 839 DKEKL-RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
K+ A +P + + + + ++ C + + RPD+
Sbjct: 221 LATKIVEAVYEP---LPEGMYSE--DVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG- 676
LG+G +G+VY +L +IA+K + + V H EIA+ S ++HR++V LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 677 YSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNI--ALDVARGMEYLHSL 733
S G+ ++ + E +P G+LS + W PL + I + G++YLH
Sbjct: 74 DSENGFFKIFM-EQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHD- 126
Query: 734 AHQSFIHRDLKSSNILLGD-DFRAKVSDFG----LVKLAPDSERSVVTRLAGTFGYLAPE 788
+HRD+K N+L+ K+SDFG L + P +E GT Y+APE
Sbjct: 127 --NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE-----TFTGTLQYMAPE 179
Query: 789 YAVTGK--ITTKVDVFSFGVVLMELLTG 814
G D++S G ++E+ TG
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 613 FASENELGRGGFGVVYKG-ELDDGTKI----AVKRMEAGVISKKAVDEFHSEIAVLSKVR 667
F LG G FG VYKG + +G K+ A+K + S KA E E V++ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
+ H+ LLG + +L + + MP G L ++ + + + + LN + +A+GM
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGM 122
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLA 786
YL + +HRDL + N+L+ K++DFGL KL E+ ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
E + T + DV+S+GV + EL+T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 617 NELGRGGFGVVYKGELDDGTKIA---VKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+E+G G FG V GE G A VK + A + F E+ ++ H +++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LG + LLV E+ P G L ++ + + + +A +VA G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT--RLAGTFGYLAPEYA- 790
FIH DL N L D K+ D+GL L E +T A +LAPE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 791 ------VTGKITTKVDVFSFGVVLMELLT 813
+ T K +++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
K F E+G G FG VY ++ +A+K+M +G S + + E+ L ++RH
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA---LDVAR 725
+ + G + + LV EY A H K L + + IA +
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL--------QEVEIAAICHGALQ 126
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
G+ YLHS IHRD+K+ NILL + K++DFG L + V GT ++
Sbjct: 127 GLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWM 178
Query: 786 APEYAVT---GKITTKVDVFSFGVVLMEL 811
APE + G+ KVDV+S G+ +EL
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVK---RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
LG G FG VYKG + +G + + ++ KA EF E +++ + H HLV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
LG ++ +L V + MP G L ++ K + + + LN + +A+GM YL
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE--- 126
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAPEYAVTG 793
+ +HRDL + N+L+ K++DFGL +L E+ ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 794 KITTKVDVFSFGVVLMELLT 813
K T + DV+S+GV + EL+T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 7e-17
Identities = 86/289 (29%), Positives = 127/289 (43%), Gaps = 59/289 (20%)
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL---NLVNLWL 232
SSA + ++CN N + + ++ LSG N++G I + L +NL
Sbjct: 53 SSADVCLWQGITCN----------NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL-S 101
Query: 233 NDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292
N+Q G D+ LR L L N+F+G+IP G + +L+ L+L++N G IP
Sbjct: 102 NNQLSGPIPD--DIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
Query: 293 PSLASLS-LDHLDLNNNMFMGPVPKS--KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFL 349
+ S S L LDL N+ +G +P S + + A Q +P L
Sbjct: 158 NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE---------L 208
Query: 350 GGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQI 409
G + KS + G N NLSG + +G L SL +
Sbjct: 209 GQM----------------KSLKWIYLGYN-----------NLSGEIPYEIGGLTSLNHL 241
Query: 410 KLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--FSGAVKLSLD 456
L NN++G IP++ NLK+L L L QN LS P+P FS +SLD
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290
|
Length = 968 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
K + ++G+G G VY ++ G ++A+++M KK + +EI V+ + ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNP 77
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V+ L + G E +V EY+ G+L+ + + + + + + +E+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEF 131
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPE 788
LHS IHRD+KS NILLG D K++DFG ++ P E+S + + GT ++APE
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 186
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAA 831
KVD++S G++ +E++ G P YL A
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 71/201 (35%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSK-VRHRHLVSLL 675
+G+G FG V + DG AVK ++ ++ KK +E VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
YS ++L V +Y+ G L H+ +S EP R A ++A + YLHSL
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSF-PEP----RARFYAAEIASALGYLHSL- 115
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK NILL ++DFGL K + ++ T GT YLAPE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQP 172
Query: 795 ITTKVDVFSFGVVLMELLTGL 815
VD + G VL E+L GL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 619 LGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHR 669
LG G FG V + E D +AVK ++ K D SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-LISEMELMKLIGKHK 78
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHI-----------FHWKSLNLEPLSWKRRLN 718
++++LLG ++ EY +G L + + F + E LS+K ++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVV 775
A VARGMEYL S + IHRDL + N+L+ +D K++DFGL + D + ++
Sbjct: 139 CAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
RL ++APE T + DV+SFG+++ E+ T
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 70/274 (25%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 613 FASENELGRGGFGVVYKGELDDGTK--IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
F ++G+G FG V+KG +D+ T+ +A+K ++ ++ +++ EI VLS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPY 63
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ G + + ++ EY+ G+ L PL + I ++ +G++YL
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA------LDLLEPGPLDETQIATILREILKGLDYL 117
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--LAGTFGYLAPE 788
HS + IHRD+K++N+LL + K++DFG+ D++ + R GT ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPE 171
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
+K D++S G+ +EL G E P + +L
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------------------- 212
Query: 849 PILEVNDDTFETFWT--IAELAGHCTSREPSQRP 880
I + N T E ++ + E C ++EPS RP
Sbjct: 213 -IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-16
Identities = 66/223 (29%), Positives = 95/223 (42%), Gaps = 54/223 (24%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS-----EIAVLSKVRHRHLV 672
+G G +GVV G K+A+K+ IS D + EI +L +RH +++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKK-----ISNVFDDLIDAKRILREIKLLRHLRHENII 62
Query: 673 SLLGYSVAGYERL-------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
LL + +V E M + L K + +PL+ + R
Sbjct: 63 GLL--DILRPPSPEDFNDVYIVTELM-ETDLHK-VIKSP----QPLTDDHIQYFLYQILR 114
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-------VVTRL 778
G++YLHS A+ IHRDLK SNIL+ + K+ DFGL + E VVTR
Sbjct: 115 GLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 779 AGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y APE Y T +D++S G + ELLT
Sbjct: 172 -----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 56/199 (28%), Positives = 106/199 (53%), Gaps = 15/199 (7%)
Query: 618 ELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
++G G G+V + G +AVK+M+ ++ + +E+ ++ +H ++V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRDYQHENVVEMYN 84
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+ G E +V E++ GAL+ + H + +N E ++ + L V + + LH+ Q
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIA-----AVCLAVLKALSVLHA---Q 135
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
IHRD+KS +ILL D R K+SDFG +++ + R L GT ++APE
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPY 193
Query: 796 TTKVDVFSFGVVLMELLTG 814
+VD++S G++++E++ G
Sbjct: 194 GPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 34/285 (11%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEA-GVISKKAVDEFHSEIAVLSKVRHR 669
NF E ++GRG F VY+ L D +A+K+++ ++ KA + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKS---LNLEPLSWKRRLNIALDVARG 726
+++ L + E +V E G LS+ I ++K L E WK + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL----CSA 118
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+E++HS + +HRD+K +N+ + K+ D GL + S+ + L GT Y++
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846
PE K D++S G +L E+ L + F+ DK L +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAA---------------LQSPFY---GDKMNLFSL 216
Query: 847 IDPILEVNDDTFET---FWTIAELAGHCTSREPSQRPDMGHAVNV 888
I + + T + EL C +P QRPD+G+ +
Sbjct: 217 CQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 616 ENELGRGGFGVVYKGELDDGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
E LG G FG + +G L +K +A+ + AG S K F +E L + H ++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNI 68
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V L G G ++V EYM GAL + + L + + + +A GM+Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKY-- 122
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL--APEY 789
L+ ++H+ L + +L+ D K+S F +L D ++ T ++G L APE
Sbjct: 123 -LSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID- 848
++ DV+SFG+V+ E +M+ E RP +W++ S ++ ++A D
Sbjct: 180 IQYHHFSSASDVWSFGIVMWE----VMSYGE-RP---------YWDM-SGQDVIKAVEDG 224
Query: 849 -----PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893
P N + +L C +E +RP ++L+ +V
Sbjct: 225 FRLPAPRNCPN--------LLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
K + ++G+G G VY ++ G ++A+K+M KK + +EI V+ + ++
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNP 76
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V+ L + G E +V EY+ G+L+ + + + + + + +++
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDF 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPE 788
LHS IHRD+KS NILLG D K++DFG ++ P E+S + + GT ++APE
Sbjct: 131 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAA 831
KVD++S G++ +E++ G P YL A
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 619 LGRGGFG--VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG +Y+ +D + + K + +S+K + +EI +LS ++H ++++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+ + L+ EY G L I K E + L + + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIHK---A 120
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
+HRD+K+ NI L K+ DFG+ K+ SE S+ + GT Y++PE K
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 797 TKVDVFSFGVVLMELLTGLMALDESRP 823
K D+++ G VL ELLT D + P
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 619 LGRGGFGVVY------KGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
LG+GGFG V G+L K+ KR++ +K + E +L+KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK----KRKGYEGAMVEKRILAKVHSRFIV 56
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
SL + LV M G L HI++ N R + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLH- 114
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAV 791
+ I+RDLK N+LL +D ++SD GL V+L ++ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAGTPGFMAPELLQ 170
Query: 792 TGKITTKVDVFSFGVVLMELL 812
+ VD F+ GV L E++
Sbjct: 171 GEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 613 FASENELGRGGFGVVYKGELDDGTK--IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
F +G+G FG VYKG +D+ TK +A+K ++ ++ +++ EI VLS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPY 63
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNL---EPLSWKRRLNIALDVARGM 727
+ G + G + ++ EY+ G+ +L+L PL I ++ +G+
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGS---------ALDLLKPGPLEETYIATILREILKGL 114
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
+YLHS + IHRD+K++N+LL + K++DFG+ D++ T GT ++AP
Sbjct: 115 DYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAP 170
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E K D++S G+ +EL G
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFH-SEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ G A K++E I K+ + +E +L KV R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ + L LV M G L HI++ + + +R + A ++ G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE---QRAIFYAAELCCGLEDLQ---R 120
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ ++RDLK NILL D ++SD GL P+ E V GT GY+APE K
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKY 178
Query: 796 TTKVDVFSFGVVLMELLTG 814
T D + G ++ E++ G
Sbjct: 179 TFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G G FG V+ + A+K M VI K H+E VL +V H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
++ EY+P G L ++ N S L A ++ +EYLHS
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-----RNSGRFSNSTGLFYASEIVCALEYLHSK--- 120
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
++RDLK NILL + K++DFG K D + L GT YLAPE +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGTPEYLAPEVIQSKGHN 176
Query: 797 TKVDVFSFGVVLMELLTG 814
VD ++ G+++ E+L G
Sbjct: 177 KAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAV-DEFHSEIAVLSKVRHRHLVSLL 675
+LG G G V K + + GT +A K + G +K +V + E+ ++ + R ++VS
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G + + E+M G+L + + +E L IA+ V G+ YL+++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR 124
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+HRD+K SNIL+ + K+ DFG+ + + S+ GT Y++PE GK
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGV---SGELINSIADTFVGTSTYMSPERIQGGKY 179
Query: 796 TTKVDVFSFGVVLMELLTGLMALDES 821
T K DV+S G+ ++EL G S
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 618 ELGRGGFGVVYKGELDDGTK---IAVKRMEAGVISKKAV-DEFHSEIAVLSKVRHRHLVS 673
ELG G FG V KG K +A+K ++ ++K+V DE E ++ ++ + ++V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 674 LLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
++G A E L LV E G L+K + K + ++ + + V+ GM+YL
Sbjct: 60 MIGVCEA--EALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG 113
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYA 790
++F+HRDL + N+LL + AK+SDFGL K + R AG + + APE
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
K +++ DV+S+G+ + E +
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 29/218 (13%)
Query: 619 LGRGGFGVVYKGE---LDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHR 669
LG G FG V E LD TK+AVK +++ ++K + + SE+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHK 84
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHI-----------FHWKSLNLEPLSWKRRLN 718
++++LLG ++ EY +G L +++ ++ + E LS+K ++
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVV 775
A VARGMEYL A + IHRDL + N+L+ +D K++DFGL + + ++
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
RL ++APE T + DV+SFGV+L E+ T
Sbjct: 202 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ +G FG VY + G A+K + ++ +I+K V +E A++ V+ L
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
YS + L LV EY+ G + I K+L P W + +V G+E LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQ-- 115
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ IHRD+K N+L+ K++DFGL + ++++ V GT YLAPE +
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVG 169
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
D +S G V+ E L G P+
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 619 LGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHR 669
LG G FG V E + +AVK ++ ++K + + SE+ ++ + +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHK 81
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE-----------PLSWKRRLN 718
++++LLG ++ EY +G L +++ + +E +++K ++
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVV 775
VARGMEYL A Q IHRDL + N+L+ ++ K++DFGL + + + ++
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
RL ++APE T + DV+SFGV++ E+ T
Sbjct: 199 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 613 FASENELGRGGFGVVYKGELDDGTK--IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
F +G+G FG V+KG +D+ T+ +A+K ++ ++ +++ EI VLS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPY 63
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ G + G + ++ EY+ G+ L P + + ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA------LDLLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS + IHRD+K++N+LL + K++DFG+ D++ T GT ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 791 VTGKITTKVDVFSFGVVLMELLTG 814
+K D++S G+ +EL G
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-16
Identities = 74/201 (36%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSK-VRHRHLVSLL 675
+G+G FG V+ DG+ AVK ++ I KK + +E VL K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
YS E+L V +Y+ G L H+ + LEP R A +VA + YLHSL
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCF-LEP----RARFYAAEVASAIGYLHSL- 115
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK NILL ++DFGL K + E + T GT YLAPE
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEP 172
Query: 795 ITTKVDVFSFGVVLMELLTGL 815
VD + G VL E+L GL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEA-GVISKKAVDEFHSEIAVLSKVRHR 669
NF E ++GRG F VY+ L DG +A+K+++ ++ KA + EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKS---LNLEPLSWKRRLNIALDVARG 726
+++ + E +V E G LS+ I H+K L E WK + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+E++HS + +HRD+K +N+ + K+ D GL + S+ + L GT Y++
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846
PE K D++S G +L E + AL ++ N+ S +K+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYE----MAALQSPFYGDKM-------NLYSLCKKIEQC 223
Query: 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888
P L + + E + +L C + +P +RPD+ + +V
Sbjct: 224 DYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+G G +GVV K G +A+K+ + + K A+ E+ VL ++RH ++V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQLRHENIV 63
Query: 673 SLL-GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+L + G RL LV+EY+ + L + L P + + + + + Y
Sbjct: 64 NLKEAFRRKG--RLYLVFEYVERTLL--ELLEASPGGLPPDAVRS---YIWQLLQAIAYC 116
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS + IHRD+K NIL+ + K+ DFG + S +T T Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173
Query: 791 VT----GKITTKVDVFSFGVVLMELLTG 814
V GK VDV++ G ++ ELL G
Sbjct: 174 VGDTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 619 LGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHR 669
LG G FG V E + +AVK ++ K D SE+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMIGKHK 78
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHI-----------FHWKSLNLEPLSWKRRLN 718
++++LLG ++ EY +G L +++ F L E L++K ++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVV 775
A VARGMEYL A Q IHRDL + N+L+ +D K++DFGL + + + ++
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
RL ++APE T + DV+SFGV+L E+ T
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G F Y+ ++ GT +AVK++ ++ V+ EI +++++ H H++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
+LG + L E+M G++S H+ +N + RG+ YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVS-HLLS----KYGAFKEAVIINYTEQLLRGLSYLHE- 121
Query: 734 AHQSFIHRDLKSSNILL---GDDFRAKVSDFG-LVKLAPDSERS--VVTRLAGTFGYLAP 787
IHRD+K +N+L+ G R ++DFG +LA + +L GT ++AP
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E + DV+S G V++E+ T
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-16
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 47/207 (22%)
Query: 633 DDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL-VYEY 690
G ++A+K + + F E A+ +++ H ++V+LL A L V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 691 MP----------QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM-EYLHSLAH---Q 736
+P GAL A + R M + L +LA Q
Sbjct: 61 VPGRTLREVLAADGALP----------------------AGETGRLMLQVLDALACAHNQ 98
Query: 737 SFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLA------GTFGYLAP 787
+HRDLK NI++ G AKV DFG+ L P + V L GT Y AP
Sbjct: 99 GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E +T D++++G++ +E LTG
Sbjct: 159 EQLRGEPVTPNSDLYAWGLIFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-15
Identities = 59/223 (26%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
K + ++G+G G V+ ++ G ++A+K++ KK + +EI V+ ++++
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNP 76
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V+ L + G E +V EY+ G+L+ + + + + + + +E+
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEF 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPE 788
LH+ IHRD+KS N+LLG D K++DFG ++ P E+S + + GT ++APE
Sbjct: 131 LHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAA 831
KVD++S G++ +E++ G P YL A
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 54/281 (19%)
Query: 619 LGRGGFGVVYKG---ELDDGTKIAVKRMEAGVISKK---AVDEFHSEIAVLSKVRHRHLV 672
LG+G F ++KG E+ D ++ + V+ K + F +++S++ H+HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY-LH 731
G V G E ++V EY+ G+L ++ K+ NL +SWK L+VA+ + + LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWK------LEVAKQLAWALH 114
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-PDSERSVVTR--LAGTFGYLAPE 788
L + H ++ + N+LL + K + +KL+ P +V+ + L ++ PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 789 YAVTGK-ITTKVDVFSFGVVLMELLTG----LMALDESRP----EERQYLAAWFWNIKSD 839
+ ++ D +SFG L E+ +G L ALD + E+R L A W
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT---- 230
Query: 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
+A L C EP RP
Sbjct: 231 -----------------------ELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 619 LGRGGFGVVYKG-ELDDGTKI----AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G FG VYKG + DG + A+K + S KA E E V++ V ++
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCR 73
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
LLG + +L V + MP G L ++ N + + + LN + +A+GM YL +
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRE----NKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAPEYAVT 792
+HRDL + N+L+ K++DFGL +L E ++A E +
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 793 GKITTKVDVFSFGVVLMELLT 813
+ T + DV+S+GV + EL+T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 80/255 (31%), Positives = 118/255 (46%), Gaps = 30/255 (11%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKK-AVDEFHSEIAVLSKVRH 668
K+F ++G+GG+G V+ + D +I A+KRM+ ++ K V +E +L+ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 669 RHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSL--NLEPLSWKR-RLNIALDVA 724
LV LL Y+ E L L EY+P G ++L NL LS R +A
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDF-------RTLLNNLGVLSEDHARFYMAEMFE 112
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
++ LH L +IHRDLK N L+ K++DFGL K SVV G+ Y
Sbjct: 113 -AVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDY 164
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
+APE VD +S G +L E L G S P E + N+K KE L+
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKETLQ 218
Query: 845 AAI--DPILEVNDDT 857
+ DP ++D+
Sbjct: 219 RPVYDDPRFNLSDEA 233
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 619 LGRGGFGVVYK------GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHL 671
LG G FG V + + D K+AVK ++ S + + SE+ ++S + H ++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMSHLGNHENI 101
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V+LLG G L++ EY G L + K + L+ + L+ + VA+GM +L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESF--LTLEDLLSFSYQVAKGMAFL- 157
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV---TRLAGTFGYLAPE 788
A ++ IHRDL + N+LL K+ DFGL + + VV RL ++APE
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPE 213
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
T + DV+S+G++L E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGT---KI-AVKRMEAGVISKKAVDEFHS--EIAVLSKVRHRHLV 672
LG+GG+G V++ G KI A+K ++ I + D H+ E +L V+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
L+ G + L+ EY+ G L H+ + + +E + I+L +E+LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISL----ALEHLH- 117
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792
Q I+RDLK NILL K++DFGL K + E +V GT Y+APE +
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI-HEGTVTHTFCGTIEYMAPEILMR 174
Query: 793 GKITTKVDVFSFGVVLMELLTG 814
VD +S G ++ ++LTG
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVK--RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
LG+G FG V+ E G A+K R E +I+K V +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEV-IIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI-ALDVARGMEYLHSL 733
Y+ ++RL V EY G L FH L+ E + + R ++ +EYLHS
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL---FFH---LSRERVFTEERARFYGAEIVSALEYLHS- 113
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
+ ++RD+K N++L D K++DFGL K ++ T GT YLAPE
Sbjct: 114 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDN 170
Query: 794 KITTKVDVFSFGVVLMELLTG 814
VD + GVV+ E++ G
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 619 LGRGGFGVVYKGEL-DDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG GGFG V ++ A+K + + ++ + SE +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPL--SWKRRLNIALDVARGMEYLHSLA 734
++ EY G L W L L + R IA V EYLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL------WTILRDRGLFDEYTARFYIAC-VVLAFEYLHN-- 111
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N+LL + K+ DFG K +++ GT Y+APE + K
Sbjct: 112 -RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPE-IILNK 167
Query: 795 -ITTKVDVFSFGVVLMELLTG 814
VD +S G++L ELLTG
Sbjct: 168 GYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-15
Identities = 66/199 (33%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V+ EL A+K ++ V+ V+ E VLS ++ L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 677 YSVAGYERLL-VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ E L V EY+ G L HI +L R A ++ G+++LHS
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDL-----PRATFYAAEIICGLQFLHS--- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ ++RDLK NILL D K++DFG+ K + T GT Y+APE + K
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
T VD +SFGV+L E+L G
Sbjct: 174 NTSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 618 ELGRGGFGVVYKG--ELDDGTK-IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
ELG G FG V KG ++ K +AVK ++ DE E V+ ++ + ++V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+G +LV E G L+K + K + + ++ + V+ GM+YL
Sbjct: 62 IGI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLE--- 112
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYAVT 792
+F+HRDL + N+LL AK+SDFGL K E + G + + APE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 793 GKITTKVDVFSFGVVLME 810
K ++K DV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-15
Identities = 43/131 (32%), Positives = 74/131 (56%), Gaps = 4/131 (3%)
Query: 339 APEVMALIDFLGGLNYPPRLVTSW-SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS 397
A E+ L+ F +N P + +++W S D C W G++C +S++ ++L N+SG +S
Sbjct: 28 AEELELLLSFKSSINDPLKYLSNWNSSADVCL-WQGITCNNSSRVVSIDLSGKNISGKIS 86
Query: 398 PSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLD 456
++ L + I L +N +SG IP + +T SL L+LS NN + +P+ S +LD
Sbjct: 87 SAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLD 146
Query: 457 -GNPLLNGKSP 466
N +L+G+ P
Sbjct: 147 LSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL- 675
ELG G FG VYK + + G A K ++ S++ +++F EI +LS+ +H ++V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE-PLSWKRRLNIALDVARGMEYLHSLA 734
Y +L+ E+ GAL + L LE L+ + + + + +LHS
Sbjct: 70 AYFYENKLWILI-EFCDGGALDSIM-----LELERGLTEPQIRYVCRQMLEALNFLHS-- 121
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV--T 792
IHRDLK+ NILL D K++DFG V S GT ++APE T
Sbjct: 122 -HKVIHRDLKAGNILLTLDGDVKLADFG-VSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 793 GKIT---TKVDVFSFGVVLMEL 811
K K D++S G+ L+EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-15
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 16/211 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G+G FG V + D +I A+K + +A ++S+ V +E VL++V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+S E+L LV ++ G L H+ +L + R A ++ +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF-- 112
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKL-APDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK NILL + DFGL KL D +++ GT YLAPE +
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPELLLGHG 169
Query: 795 ITTKVDVFSFGVVLMELLTGLMAL-DESRPE 824
T VD ++ GV+L E+LTGL DE+ E
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 9e-15
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
K F+ E+G G FG VY ++ + +A+K+M +G S + + E+ L K+RH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+ + G + + LV EY A H K PL + +G+
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLA 129
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
YLHS + IHRD+K+ NILL + K+ DFG + + GT ++APE
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPE 181
Query: 789 YAVT---GKITTKVDVFSFGVVLMEL 811
+ G+ KVDV+S G+ +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 63/199 (31%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVI-SKKAVDEFHSEIAVLS-KVRHRHLVSLL 675
LG+G FG V EL + A+K ++ V+ V+ E VL+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
V EY+ G L HI + R A ++ G+++LH
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----RARFYAAEIICGLQFLHK--- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ I+RDLK N+LL D K++DFG+ K + E T GT Y+APE K
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD +SFGV+L E+L G
Sbjct: 174 NESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 38/213 (17%)
Query: 618 ELGRGGFGVV-YKGELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
++G G +G V + G K+A+K++ ++ + +K+A + E+ +L ++H +++
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA----YRELRLLKHMKHENVI 77
Query: 673 SLLGYSVAG------YERLLVYEYMPQ--GALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
LL ++ LV +M G L KH E LS R + +
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFLVYQML 128
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS--VVTRLAGTF 782
+G++Y+H+ IHRDLK N+ + +D K+ DFGL + DSE + VVTR
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT-DSEMTGYVVTRW---- 180
Query: 783 GYLAPEYAVTG-KITTKVDVFSFGVVLMELLTG 814
Y APE + T VD++S G ++ E+LTG
Sbjct: 181 -YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+GRG FG+V+ D + +K++ ++K +E VL + H +++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY-------L 730
+ ++V EY P G L+++I ++R N LD + + L
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYI-------------QKRCNSLLDEDTILHFFVQILLAL 114
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFR--AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
H + + +HRDLK+ NILL D + K+ DFG+ K+ S +S + GT Y++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILL-DKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPE 171
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
K D+++ G VL EL +
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVD----EFHSEIAVLSKVRHRHLV 672
LG+G +G VY G + G IAVK++E + A + + E+ +L ++H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LG + + E++P G++S + + L EP+ K I LD G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTKQI-LD---GVAYLHN 120
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL-----APDSERSVVTRLAGTFGYLAP 787
+HRD+K +N++L + K+ DFG + + +++ + GT ++AP
Sbjct: 121 ---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E K D++S G + E+ TG
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-14
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 48/230 (20%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEF-HS------- 658
+V + + + +G G +G+V G K+A+K++ F H
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP----------FEHQTFCQRTL 51
Query: 659 -EIAVLSKVRHRHLVSLLGYSVAG-YERL----LVYEYMPQGALSKHIFHWKSLNLEPLS 712
EI +L + +H +++ +L +E +V E M +K + + LS
Sbjct: 52 REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDL-------YKLIKTQHLS 104
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-PDSE 771
+ RG++Y+HS + +HRDLK SN+LL + K+ DFGL ++A P+ +
Sbjct: 105 NDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 772 RS------VVTRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTG 814
+ V TR Y APE + K TK +D++S G +L E+L+
Sbjct: 162 HTGFLTEYVATRW-----YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 618 ELGRGGFGVVYKGELDDGTK---IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
++GRG +G VYK + DG A+K++E IS A EIA+L +++H +++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISL 63
Query: 675 LGYSVAGYER--LLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRL--NIALDVARGMEY 729
++ +R L+++Y FH S N +P+ R + ++ + G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 730 LHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGLVKL--APDSERSVVTRLAGTFG 783
LH+ +HRDLK +NIL+ + R K++D G +L +P + + + TF
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 784 YLAPEYAVTGKITTK-VDVFSFGVVLMELLT 813
Y APE + + TK +D+++ G + ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 57/236 (24%)
Query: 607 RNVTKNFASENELGRGGFGVVYKGELDDGTK--IAVKRMEAGVISKKAVDEFHS------ 658
+++ + + +LG+G +G+V+K +D TK +A+K K D F +
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKA-IDRRTKEVVALK---------KIFDAFRNATDAQR 52
Query: 659 ---EIAVLSKVR-HRHLVSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLS 712
EI L ++ H ++V LL A ++ LV+EYM + L I
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI------------ 99
Query: 713 WKRRLNIALDV---------ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763
R NI DV + ++Y+HS + IHRDLK SNILL D R K++DFGL
Sbjct: 100 ---RANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153
Query: 764 VK----LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTG 814
+ L + E V+T T Y APE + TK VD++S G +L E+L G
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 618 ELGRGGFGVVYKGELDDGT---KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
++GRG +G VYK + DG + A+K++E IS A EIA+L +++H ++++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVIAL 63
Query: 675 LGYSVAGYER--LLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRL--NIALDVARGMEY 729
++ +R L+++Y FH S N +P+ R + ++ + G+ Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 730 LHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGLVKL--APDSERSVVTRLAGTFG 783
LH+ +HRDLK +NIL+ + R K++D G +L +P + + + TF
Sbjct: 124 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 784 YLAPEYAVTGKITTK-VDVFSFGVVLMELLT 813
Y APE + + TK +D+++ G + ELLT
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 65/199 (32%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V+ E G A+K ++ VI +K V +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS ++RL V EY G L H+ + S R ++ + YLHS
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVF-----SEDRARFYGAEIVSALGYLHS--- 113
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++RDLK N++L D K++DFGL K ++ T GT YLAPE
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD + GVV+ E++ G
Sbjct: 173 GRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+G G +GVV+K + G +A+K+ + VI K A+ EI +L +++H +LV+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL----REIRMLKQLKHPNLVN 64
Query: 674 LLGYSVAGYERL--LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
L+ V +R LV+EY L++ + + + + I + + + H
Sbjct: 65 LI--EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCH 117
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL--APDSERS--VVTRLAGTFGYLAP 787
+ IHRD+K NIL+ + K+ DFG ++ P + + V TR Y AP
Sbjct: 118 K---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----YRAP 169
Query: 788 EYAVTG-KITTKVDVFSFGVVLMELLTG 814
E V + VDV++ G V ELLTG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS---EIAVLSKVRHRHLVSL 674
ELG G FG VYK + + +A A VI K+ +E EI +L+ H ++V L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAA----AKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
LG + ++ E+ P GA+ + EP I + + +E L L
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLH 127
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT-----RLAGTFGYLAPEY 789
IHRDLK+ N+LL D K++DFG+ S ++V T GT ++APE
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 790 AV--TGKITT---KVDVFSFGVVLMEL 811
+ T K T K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V+ E G A+K ++ VI +K V +E VL RH L SL
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS +RL V EY+ G L H+ + S R ++ ++YLHS
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVF-----SEDRTRFYGAEIVSALDYLHS--- 113
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++RDLK N++L D K++DFGL K ++ + + GT YLAPE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD + GVV+ E++ G
Sbjct: 173 GRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-14
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 611 KNFASENELGRGGFGVVY-KGELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
K F E+G G FG VY ++ +A+K+M +G S + + E+ L +++H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+ + G + + LV EY A H K PL I +G+
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLA 139
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
YLHS + IHRD+K+ NILL + + K++DFG +A S GT ++APE
Sbjct: 140 YLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPE 191
Query: 789 YAVT---GKITTKVDVFSFGVVLMEL 811
+ G+ KVDV+S G+ +EL
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 74/275 (26%), Positives = 117/275 (42%), Gaps = 39/275 (14%)
Query: 613 FASENELGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRH 670
F +E+G G FG VY ++ AVK+M +G + + + E+ L +++H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ G + + LV EY A H K PL I +G+ YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYL 137
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS + IHRD+K+ NILL + + K++DFG + S GT ++APE
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVI 189
Query: 791 VT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847
+ G+ KVDV+S G+ +EL E +P + N S +
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELA-------ERKP------PLFNMNAMSALYHIAQND 236
Query: 848 DPILEVND--DTFETFWTIAELAGHCTSREPSQRP 880
P L+ N+ D+F F +C + P +RP
Sbjct: 237 SPTLQSNEWTDSFRGF------VDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVK--RMEA---GVISKKAVDEFHSEIAVLSKVRHRHLV 672
+G G +GVVYK + G +A+K R+E GV S A+ EI++L ++ H ++V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPST-AI----REISLLKELNHPNIV 61
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LL + + LV+E++ L K++ L+P K L L +G+ Y HS
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLDPPLIKSYLYQLL---QGIAYCHS 117
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792
+HRDLK N+L+ + K++DFGL + R T T Y APE +
Sbjct: 118 ---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLG 173
Query: 793 GK-ITTKVDVFSFGVVLMELLT 813
+ +T VD++S G + E++
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
NF ++G G +GVVYK G +A+K++ ++ EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V LL + LV+E++ Q L K + + L + + + +G+ +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-LKKFM---DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS H+ +HRDLK N+L+ + K++DFGL + R+ T T Y APE
Sbjct: 117 HS--HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEIL 172
Query: 791 VTGKI-TTKVDVFSFGVVLMELLT 813
+ K +T VD++S G + E++T
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 618 ELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
ELG FG VYKG L + +A+K ++ +EF E + S+++H ++
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHW---------------KSLNLEPLSWKRR 716
V LLG +++ Y L + + KS LEP +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS-TLEPADF--- 126
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSV 774
++I +A GME+L S +H+DL + N+L+ D K+SD GL + A D + +
Sbjct: 127 VHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
L +++PE + GK + D++S+GVVL E+ +
Sbjct: 184 GNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 615 SENELGRGGFGVVYKGELDD-GTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHR 669
+ + +G G +G V G K+A+K++ ++ + +K+ + E+ +L + H
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT----YRELRLLKHMDHE 74
Query: 670 HLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
+++ LL S+ ++ + LV M GA +I + L+ + + + + +
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF-----LVYQI 127
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS--VVTRLAGT 781
RG++Y+HS A IHRDLK SNI + +D K+ DFGL + D E + V TR
Sbjct: 128 LRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHT-DDEMTGYVATRW--- 180
Query: 782 FGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTG 814
Y APE + VD++S G ++ ELLTG
Sbjct: 181 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH---RHLVSL 674
+GRG +G VY+G + G +A+K + V + E+A+LS++R ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITKY 67
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSL-NLEPLSWKRRLNIALDVARGMEYLHSL 733
G + G ++ EY G++ ++L P++ K I +V ++Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSV-------RTLMKAGPIAEKYISVIIREVLVALKYIH-- 118
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
IHRD+K++NIL+ + K+ DFG+ L + S + GT ++APE G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 794 KI-TTKVDVFSFGVVLMELLTG 814
K TK D++S G+ + E+ TG
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 618 ELGRGGFG-VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
++G G FG + +DG + +K + +S K +E E+AVLS ++H ++V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ--- 63
Query: 677 YSVAGYER---LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
Y + E +V +Y G L K I + + + L+ + + ++++H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHD- 119
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
+ +HRD+KS NI L D K+ DFG+ ++ +S + GT YL+PE
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENR 176
Query: 794 KITTKVDVFSFGVVLMELLT 813
K D+++ G VL E+ T
Sbjct: 177 PYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G FG VY ++D G ++A K+++ S K V EI +L ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 675 LGYSVAGYERLLV--YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
G E+ L EYMP G++ + + +L E ++ K I GM YLHS
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT-ESVTRKYTRQIL----EGMSYLHS 124
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK------LAPDSERSVVTRLAGTFGYLA 786
+HRD+K +NIL K+ DFG K ++ RSV GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV----TGTPYWMS 177
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
PE K DV+S G ++E+LT
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 62/240 (25%)
Query: 618 ELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFH------SEIAVLSKVRHRH 670
LG+G G V+ L G A+K V+ KK + + + +E +L+ + H
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALK-----VLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR----- 725
L +L LV +Y P G L ++ L +P + L+ +VAR
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGEL------FRLLQRQP---GKCLSE--EVARFYAAE 111
Query: 726 ---GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA--- 779
+EYLH L ++RDLK NILL + +SDF L K + V L
Sbjct: 112 VLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 780 -------------------------GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y+APE + VD ++ G++L E+L G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 39/228 (17%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM------EAGVISKKAVDEFHSE 659
R V K F ++G G +G VYK + D G +A+K++ E I+ A+ E
Sbjct: 4 RCVDK-FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT--AI----RE 56
Query: 660 IAVLSKVRHRHLVSLLGYSVAGYERL----------LVYEYMPQ---GALSKHIFHWKSL 706
I +L ++ HR++V+L + L LV+EYM G L + H+
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED 116
Query: 707 NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766
+++ S+ ++L L+ G+ Y H ++F+HRD+K SNILL + + K++DFGL +L
Sbjct: 117 HIK--SFMKQL---LE---GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
Query: 767 APDSERSVVTRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLT 813
E T T Y PE + + +DV+S G +L EL T
Sbjct: 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 65/199 (32%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V+ E G A+K ++ VI +K V +E VL RH L +L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS ++RL V EY G L FH + S R ++ ++YLH +
Sbjct: 62 YSFQTHDRLCFVMEYANGGEL---FFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++ ++RDLK N++L D K++DFGL K ++ T GT YLAPE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD + GVV+ E++ G
Sbjct: 174 GRAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 619 LGRGGFGVVY--KGELD---------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR 667
+G G FG +Y K + D D TK+ VK EA SKK E+ +L+K++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEA---SKK-------EVILLAKMK 57
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP---LSWKRRLNIALDVA 724
H ++V+ +V EY G L K I + + LSW + ++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFR-AKVSDFGLVKLAPDSERSVVTRLAGTFG 783
G++++H + +HRD+KS NI L + AK+ DFG+ + DS T GT
Sbjct: 112 LGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPY 167
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
YL+PE K D++S G VL EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 618 ELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V+ G L D T +AVK + +F E +L + H ++V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP-LSWKRRLNIALDVARGMEYLHSLAH 735
+V E + G + P L K + + + A GMEYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL-----RTEGPRLKVKELIQMVENAAAGMEYLES--- 112
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT----FGYLAPEYAV 791
+ IHRDL + N L+ + K+SDFG+ + + E V G + APE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 792 TGKITTKVDVFSFGVVLME 810
G+ +++ DV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG+G FG V EL ++ AVK ++ VI V+ +E VL+ +H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61
Query: 676 GYSV-AGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
+S +RL V EY+ G L HI + R A ++ G+++LH
Sbjct: 62 -HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHE- 114
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTR-LAGTFGYLAPEYA 790
+ I+RDLK N+LL + K++DFG+ K + V T GT Y+APE
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPEIL 168
Query: 791 VTGKITTKVDVFSFGVVLMELLTG 814
VD ++ GV+L E+L G
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 63/224 (28%), Positives = 108/224 (48%), Gaps = 38/224 (16%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKR--MEAGVISKKAVDEFH----SE 659
R+V + N + G +GVVY+ + G +A+K+ ME K + F E
Sbjct: 2 RSV-DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLRE 54
Query: 660 IAVLSKVRHRHLVSL----LGYSVAGYERL-LVYEYMPQGALSKHIFHWKSL---NLEPL 711
I +L K++H ++V++ +G + +++ +V EY+ +H KSL +P
Sbjct: 55 INILLKLQHPNIVTVKEVVVG---SNLDKIYMVMEYV------EH--DLKSLMETMKQPF 103
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771
+ L + G+ +LH +HRDLK+SN+LL + K+ DFGL +
Sbjct: 104 LQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 772 RSVVTRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLTG 814
+ T+L T Y APE + + +T +D++S G + ELLT
Sbjct: 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 619 LGRGGFGVVY-----KGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG+G FG V+ G D G A+K ++ + + E +L++V H +V
Sbjct: 4 LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 674 LLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL-DVARGMEYLH 731
L Y+ +L L+ +++ G L + L+ E + + + L ++A +++LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
SL I+RDLK NILL ++ K++DFGL K + D E+ + GT Y+APE
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVN 171
Query: 792 TGKITTKVDVFSFGVVLMELLTG 814
T D +SFGV++ E+LTG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKA------VDE--FH----SEIAVL 663
LG G +G V K G +A+K+++ IS V H E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 664 SKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
++++H +++ L+ V G LV + M L K + K L+ + I L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIR----LTESQVKCILLQI 128
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-------------VKLAPDS 770
G+ LH F+HRDL +NI + K++DFGL K
Sbjct: 129 LNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 771 ERSVVTRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLTG 814
R +T T Y APE + K VD++S G + ELLTG
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 35/220 (15%)
Query: 609 VTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVL 663
+ + + S ++G G +G V + G K+A+K++ ++ + +K+A + E+ +L
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA----YRELTLL 68
Query: 664 SKVRHRHLVSLLGYSVAG------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
++H +++ LL + + LV YM Q L K + H PLS +
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGH-------PLSEDKVQ 120
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS--VV 775
+ + G++Y+HS IHRDLK N+ + +D K+ DFGL + A D+E + VV
Sbjct: 121 YLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVV 176
Query: 776 TRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTG 814
TR Y APE + + VD++S G ++ E+LTG
Sbjct: 177 TRW-----YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRME---AGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+G G FGVV+ + DG ++A+K+M ++S K V E+ +L +H +++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV---FRELKMLCFFKHDNVLSA 64
Query: 675 LGY----SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
L + +E + V + Q L K I ++ +PLS + RG++YL
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKII-----VSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS A +HRD+K N+L+ + K+ DFGL ++ E +T+ T Y APE
Sbjct: 120 HS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 791 VTGK-ITTKVDVFSFGVVLMELLTG 814
+ + T+ VD++S G + ELL
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 619 LGRGGFGVVYKGELDD--GTKIAVKRMEAGVISKKAVDE-FHSEIAVLSKVRHRHLVSLL 675
+G G FG VY+G KIAV + +V E F E ++ + H H+V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G + +V E P G L ++ +N L + + ++ + YL S
Sbjct: 74 GV-ITENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVTG 793
+ F+HRD+ + N+L+ K+ DFGL + D ++ +L ++APE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAPESINFR 183
Query: 794 KITTKVDVFSFGVVLMELL 812
+ T+ DV+ FGV + E+L
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 609 VTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVL 663
+T + +G G FG+V + G +A+K++ V++K+ + E+ +L
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT----YRELKLL 63
Query: 664 SKVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN---- 718
+RH +++SL ++ E + V E + +L L R L
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELL-------------GTDLHRLLTSRPLEKQFI 110
Query: 719 --IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776
+ RG++Y+HS +HRDLK SNIL+ ++ K+ DFGL ++ + +T
Sbjct: 111 QYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMT 163
Query: 777 RLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTG 814
T Y APE +T K +VD++S G + E+L G
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 43/108 (39%), Positives = 62/108 (57%), Gaps = 8/108 (7%)
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--- 765
EPL+ + ++ + VARGME+L A + IHRDL + NILL ++ K+ DFGL +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
PD R RL ++APE TT+ DV+SFGV+L E+ +
Sbjct: 225 KDPDYVRKGDARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS-KVRHRHLVSLL 675
ELGRG +GVV K + GT +AVKR+ A V S+ E + L +R +
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTV 63
Query: 676 GYSVAGYERLLVY---EYMPQG--ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ A + V+ E M K ++ E + K IA+ + + +EYL
Sbjct: 64 TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK----IAVSIVKALEYL 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE-- 788
HS S IHRD+K SN+L+ + + K+ DFG+ DS T AG Y+APE
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMAPERI 175
Query: 789 --------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y V K DV+S G+ ++EL TG
Sbjct: 176 NPELNQKGYDV------KSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V EL G AVK ++ V+ V+ E VL+ ++ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 677 YSVAGYERLL-VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ E L V E++ G L HI +L R A ++ G+++LHS
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVCGLQFLHS--- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ I+RDLK N++L D K++DFG+ K + T GT Y+APE K
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
T VD +SFGV+L E+L G
Sbjct: 174 TFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 25/111 (22%)
Query: 190 LAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGN 249
L G +P+ + LQ++ LSGN++ G IP S G+
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-------------------------GS 464
Query: 250 MDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSL 300
+ L L L N F+G+IPES G+LTSL+ LNLN N G +P +L L
Sbjct: 465 ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKV 666
+ + LG G G V K L + I + I+ + E+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALK----TITTDPNPDLQKQILRELEINKSC 56
Query: 667 RHRHLVSLLG--YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
+ ++V G + + EY G+L K + K IA V
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVL 115
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG- 783
+G+ YLHS + IHRD+K SNILL + K+ DFG+ +V LAGTF
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV-------SGELVNSLAGTFTG 165
Query: 784 ---YLAPEYAVTGKITTKVDVFSFGVVLMEL 811
Y+APE + DV+S G+ L+E+
Sbjct: 166 TSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 612 NFASENELGRGGFGVVY-----KGELDDGTKIAVKRMEAGVISKKAVDEFHS--EIAVLS 664
NF LG G +G V+ G D G A+K ++ I +KA H+ E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 665 KVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL-D 722
+R + L Y+ +L L+ +Y+ G L H+ + ++ + I +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK------EQEVQIYSGE 113
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAG 780
+ +E+LH L I+RD+K NILL + ++DFGL K + ER+ G
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCG 168
Query: 781 TFGYLAPEYAVTGKI--TTKVDVFSFGVVLMELLTG 814
T Y+AP+ G VD +S GV++ ELLTG
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 68/236 (28%), Positives = 96/236 (40%), Gaps = 58/236 (24%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V+ + D G A+K + ++ +I + + +E +L+ +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 677 YSVAGYERL-LVYEYMPQG----ALSK-HIFHWKSLNLEPLSWKR----RLNIALDVARG 726
YS E L LV EYMP G L + +F P R L +ALD
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF--------PEETARFYIAELVLALD---- 115
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK------------------LAP 768
+H L FIHRD+K NIL+ D K++DFGL K L
Sbjct: 116 --SVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 769 DSERSVVTRL----------AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
D+ GT Y+APE + D +S GV+L E+L G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 341 EVMALIDFLGGLNYPPRLVTSWSGNDPC----KSWLGLSCGTNSK-----LTVLNLPNFN 391
EV AL L P R W+G DPC W G C +S + L L N
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQG 429
Query: 392 LSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAV 451
L G + + L L I L N+I G IP + ++ SL +LDLS N+ + +P+ G +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 452 ----KLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTI 507
L+L+GN L+G+ P + +S + + + G + ++
Sbjct: 490 TSLRILNLNGN-SLSGRVPAALGG-----RLLHRASFNFTDNAGLCGIPGLRACGPHLSV 543
Query: 508 LVAI-IAPVASVGVILLVAIPISICYYRKRKEASQA 542
I IA SV + LV ++C++++R+ +A
Sbjct: 544 GAKIGIAFGVSVAFLFLVI--CAMCWWKRRQNILRA 577
|
Length = 623 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 71/204 (34%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVISKKAVDEFH--SEIAVLSK-VRHRHLVSL 674
+G+G FG V+ + AVK ++ I KK +E H SE VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK-EEKHIMSERNVLLKNVKHPFLVGL 61
Query: 675 LGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
+S ++L V +Y+ G L H+ + LEP R A ++A + YLHSL
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEP----RARFYAAEIASALGYLHSL 115
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPEYAV 791
+ ++RDLK NILL ++DFGL K + + S GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST---FCGTPEYLAPEVLH 169
Query: 792 TGKITTKVDVFSFGVVLMELLTGL 815
VD + G VL E+L GL
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)
Query: 612 NFASENELGRGGFGVVY----KGELDDGTKIAVKRMEAGVISKKAVDEFHS--EIAVLSK 665
NF LG G +G V+ D G A+K ++ + +KA H+ E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 666 VRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
VR + L Y+ +L L+ +Y+ G + H++ + + + + R ++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSG-EII 115
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+E+LH L ++RD+K NILL + ++DFGL K E+ GT Y
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
Query: 785 LAPEYAVT----GKITTKVDVFSFGVVLMELLTG 814
+APE GK VD +S G+++ ELLTG
Sbjct: 173 MAPEIIRGKGGHGKA---VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G FG VY + D G ++AVK+++ S K V+ EI +L + H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 675 LGYSVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
G ER L E+MP G++ + + +L E ++ K I G+ YLHS
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT-ENVTRKYTRQIL----EGVSYLHS 124
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK------LAPDSERSVVTRLAGTFGYLA 786
+HRD+K +NIL K+ DFG K L+ +SV GT +++
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----TGTPYWMS 177
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
PE K D++S G ++E+LT
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 68/201 (33%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSK-VRHRHLVSLL 675
+G+G FG V+ DG AVK ++ ++ ++K +E VL K V+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
YS E+L V +++ G L H+ +S EP + R A ++A + YLHS+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-EP---RARFYAA-EIASALGYLHSI- 115
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ ++RDLK NILL ++DFGL K ++ T GT YLAPE
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 795 ITTKVDVFSFGVVLMELLTGL 815
VD + G VL E+L GL
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGL 193
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+G G +G+V K + G +A+K+ + ++ K A+ EI +L ++RH +LV+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM----REIRMLKQLRHENLVN 64
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP--LSWKRRLNIALDVARGMEYLH 731
L+ LV+E++ L L P L R + RG+E+ H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDD-------LEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVTRLAGTFGYLAPEYA 790
S + IHRD+K NIL+ K+ DFG + LA E V T T Y APE
Sbjct: 118 S---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELL 172
Query: 791 VTG-KITTKVDVFSFGVVLMELLTG 814
V K VD+++ G ++ E+LTG
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 59/284 (20%)
Query: 619 LGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVD--EFHSEIAVLSKVRHRH 670
LG+G F +YKG L D + V+ D F +++S++ H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L G V E ++V EY+ G L F + N L WK L++A +A + YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDV--FLHREKNNVSLHWK--LDVAKQLASALHYL 117
Query: 731 HSLAHQSFIHRDLKSSNILL---GDDFR----AKVSDFGL-VKLAPDSERSVVTRLAGTF 782
+ +H ++ NIL+ G + K+SD G+ + + ER V R+
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERIP--- 169
Query: 783 GYLAPEYAVTG--KITTKVDVFSFGVVLMELLTG----LMALDESRPEERQYLAAWFWNI 836
++APE G +T D +SFG L+E+ + L L S E
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------- 220
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
P+ + +A L C + +P++RP
Sbjct: 221 -------DQHRLPMPDCA--------ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 29/222 (13%)
Query: 622 GGFGVVYKGELDDGT-----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
G FG ++ G L D ++ VK ++ S+ V E +L + H++++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 677 YSVAGYERLLV-YEYMPQGALSKHI---FHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
+ E V Y YM G L + ++ N + LS ++ +++A+ +A GM YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAP-------DSERSVVTRLAGTFGY 784
IH+D+ + N ++ ++ + K++D L + L P D+E V +
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-------W 185
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEE 825
+A E V + ++ DV+SFGV+L EL+T G E P E
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 618 ELGRGGFGVVYKG---ELDDGTKIAVKRMEAGVISKKAVDEFH-SEIAVLSKVR-HRHLV 672
ELG+G +G+V E + +A+K++ V SKK + + E+ +L R H+++
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 673 SLLGYSV---AGYERLLVYEYMPQGALSKHI--------FHWKSLNLEPLSWKRRLNIAL 721
L + + L +YE + + L + I H++S + L
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL---------- 115
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK---LAPDSERSVVTRL 778
G++Y+HS + +HRDLK N+L+ D K+ DFGL + P +T
Sbjct: 116 ---CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 779 AGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTG 814
T Y APE ++ + TK +DV+S G +L ELL
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 77/285 (27%), Positives = 119/285 (41%), Gaps = 46/285 (16%)
Query: 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS---EIAVLSKVRHRHLVSL 674
ELG G FG VYK + + +A A VI K+ +E EI +L+ H ++V L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAA----AKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
L ++ E+ GA+ + + EP I + + +E L+ L
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEP-------QIRVVCKQTLEALNYLH 120
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--LAGTFGYLAPEYAV- 791
IHRDLK+ NIL D K++DFG ++ + R++ R GT ++APE +
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 792 -TGK---ITTKVDVFSFGVVLMEL------------LTGLMALDESRPEERQYLAAWFWN 835
T K K DV+S G+ L+E+ + L+ + +S P + W
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
K +K LE N D WT +L H S +P
Sbjct: 238 FKDFLKK-------CLEKNVD---ARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 55/304 (18%)
Query: 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS---------KKAV-DEFHSEIA 661
+F ELG G GVV K V +G+I K A+ ++ E+
Sbjct: 2 DFEKLGELGAGNGGVVTK----------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 662 VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
VL + ++V G + E + E+M G+L + + K P + +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIA- 107
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
V RG+ YL +HRD+K SNIL+ K+ DFG+ D S+ GT
Sbjct: 108 -VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGT 161
Query: 782 FGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841
Y++PE T + D++S G+ L+E+ G + P + + L A F S+ E
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKELEAMFGRPVSEGE 218
Query: 842 KLRAAIDPILEVNDDT-----FETFWTIA-----------------ELAGHCTSREPSQR 879
+ D FE I + C + P +R
Sbjct: 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278
Query: 880 PDMG 883
D+
Sbjct: 279 ADLK 282
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 618 ELGRGGFGVVYKGELDDG---TKIAVK--RMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
E+G G FG V GE++ G ++ VK R+ A V + +F E ++H +L+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM---KFLEEAQPYRSLQHSNLL 58
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWK---SLNLEPLSWKRRLNIALDVARGMEY 729
LG LLV E+ P G L ++ + + +P + +R +A ++A G+ +
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGLLH 115
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT-RLAGTFGYLAPE 788
LH +FIH DL N LL D K+ D+GL + V +L ++APE
Sbjct: 116 LHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 789 YA--VTGKI-----TTKVDVFSFGVVLMELL 812
V G + T + +V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISK---KAVDEFHSEIAVLSKVRHRHLVSL 674
LGRG FG VY + D G ++AVK++ S+ K V+ EI +L +RH +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 675 LGYSVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
G E+ L EYMP G++ + + +L E ++ + I +G+ YLHS
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT-ENVTRRYTRQIL----QGVSYLHS 124
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS--VVTRLAGTFGYLAPEYA 790
+HRD+K +NIL K+ DFG K S + + GT +++PE
Sbjct: 125 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
K DV+S ++E+LT
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-12
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 36/212 (16%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+G G +GVV + G K+A+K++ + ++K+ E+ +L +H ++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT----LRELKILRHFKHDNIIA 68
Query: 674 L---------LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
+ V +V + M + L HI H +PL+ + +
Sbjct: 69 IRDILRPPGADFKDV-----YVVMDLM-ESDL-HHIIHSD----QPLTEEHIRYFLYQLL 117
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA---PDSERSVVTRLAGT 781
RG++Y+HS + IHRDLK SN+L+ +D ++ DFG+ + P + +T T
Sbjct: 118 RGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 782 FGYLAPEYAVT-GKITTKVDVFSFGVVLMELL 812
Y APE ++ + TT +D++S G + E+L
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEF---HSEIAV 662
RN ++ +G G +G VYK L G AVK +I + D+F EI +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVK-----IIKLEPGDDFSLIQQEIFM 59
Query: 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
+ + +H ++V+ G ++ + + EY G+L + I+H PLS + + +
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTG----PLSELQIAYVCRE 114
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--LAG 780
+G+ YLHS +HRD+K +NILL D+ K++DFG +A ++ R G
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIG 168
Query: 781 TFGYLAPEYAV---TGKITTKVDVFSFGVVLMEL 811
T ++APE A G D+++ G+ +EL
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-12
Identities = 45/114 (39%), Positives = 63/114 (55%), Gaps = 12/114 (10%)
Query: 703 WKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762
WKS PL+ + + + VARGME+L A + IHRDL + NILL ++ K+ DFG
Sbjct: 167 WKS----PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFG 219
Query: 763 LVK---LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
L + PD R RL ++APE TT+ DV+SFGV+L E+ +
Sbjct: 220 LARDIYKDPDYVRKGSARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 61/218 (27%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEI-----AVLSKVRHRHL 671
E+G G G VYK G +AVK+M + E + I VL ++
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEENKRILMDLDVVLKSHDCPYI 76
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN----------IAL 721
V GY + + + E M S L+ L +R+ + +
Sbjct: 77 VKCYGYFITDSDVFICMELM-------------STCLDKL--LKRIQGPIPEDILGKMTV 121
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
+ + + YL IHRD+K SNILL K+ DFG+ DS+ TR AG
Sbjct: 122 AIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGC 177
Query: 782 FGYLAPEY----AVTGKITTKVDVFSFGVVLMELLTGL 815
Y+APE K + DV+S G+ L+EL TG
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 607 RNVTKNFASENELGRGGFGVVYK------GELDDGTKIAVKRMEAGVISKKAVDEFHSEI 660
RN ++F +G G +G VYK GEL I V ++E G + EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
++ +H ++V+ G + + + E+ G+L + I+H PLS + ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTG----PLSESQIAYVS 112
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR--L 778
+ +G+ YLHS + +HRD+K +NILL D+ K++DFG ++ ++ R
Sbjct: 113 RETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSF 166
Query: 779 AGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMEL 811
GT ++APE A G D+++ G+ +EL
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 619 LGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V L + G AVK ++ VI V+ +E +LS R+ ++ L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 677 YSVAGYERLL-VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+RL V E++ G L HI + + E R A ++ + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EA----RARFYAAEITSALMFLHD--- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ I+RDLK N+LL + K++DFG+ K + ++ T GT Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLY 173
Query: 796 TTKVDVFSFGVVLMELLTG 814
VD ++ GV+L E+L G
Sbjct: 174 GPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 618 ELGRGGFGVVYKG-ELDDGTK-IAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLV 672
E+G G +G V+K +L +G + +A+KR+ + E+AVL + H ++V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 673 SLLGY-SVAGYER----LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
L +V+ +R LV+E++ Q L+ ++ + + K ++ + RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIK---DMMFQLLRGL 123
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
++LHS +HRDLK NIL+ + K++DFGL ++ S + +T + T Y AP
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAP 178
Query: 788 EYAVTGKITTKVDVFSFGVVLMELL 812
E + T VD++S G + E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 79/298 (26%), Positives = 113/298 (37%), Gaps = 80/298 (26%)
Query: 616 ENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
E+GRG FG V K GT +AVKR+ + V +K ++ V+ + S
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRS------SD 61
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFH----WKSLNLEPLSW-----------KRRLN- 718
Y V Y GAL F W + L +S K +
Sbjct: 62 CPYIVKFY-----------GAL----FREGDCWICMELMDISLDKFYKYVYEVLKSVIPE 106
Query: 719 -----IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773
IA+ + + YL IHRD+K SNILL + K+ DFG+ DS
Sbjct: 107 EILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--I 162
Query: 774 VVTRLAGTFGYLAPEYAVTGKITT--------KVDVFSFGVVLMELLTGLMALDESRPEE 825
TR AG Y+APE +I + DV+S G+ L E+ TG +
Sbjct: 163 AKTRDAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK----- 212
Query: 826 RQYLAAWFWNIKSDKEKLRAAID---PILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
WN S ++L + PIL N + E + C ++ S+RP
Sbjct: 213 --------WN--SVFDQLTQVVKGDPPIL-SNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 619 LGRGGFGVVYKGELDDGTK--IAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
LG+G FG V E GT A+K ++ V I V+ E VL+ ++ L
Sbjct: 8 LGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+RL V EY+ G L HI EP + + A ++A G+ +LHS
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK-EPHA----VFYAAEIAIGLFFLHS-- 119
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK---LAPDSERSVVTRLAGTFGYLAPE--- 788
+ I+RDLK N++L + K++DFG+ K + R+ GT Y+APE
Sbjct: 120 -KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----FCGTPDYIAPEIIA 174
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
Y GK VD ++FGV+L E+L G D +E
Sbjct: 175 YQPYGK---SVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 10/204 (4%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+F +ELG G GVV K + I +++ I ++ E+ VL + +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V G + E + E+M G+L + + K + E L +++ V RG+ YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HQ +HRD+K SNIL+ K+ DFG+ DS + GT Y++PE
Sbjct: 120 RE-KHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL 174
Query: 791 VTGKITTKVDVFSFGVVLMELLTG 814
+ + D++S G+ L+EL G
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 33/228 (14%)
Query: 602 SVQVLRN---VTKNFASENELGRGGFGVVYKGELDD--GTKIAVKRMEAGVISKKAVDEF 656
SVQV + V K + +G G G+V D G +AVK++ ++
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRA 67
Query: 657 HSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
+ E+ +L V H++++SLL + PQ +L + + + L + +
Sbjct: 68 YRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQV 115
Query: 717 LNIALDVAR----------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766
+++ LD R G+++LHS IHRDLK SNI++ D K+ DFGL +
Sbjct: 116 IHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172
Query: 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
A ++T T Y APE + VD++S G ++ EL+ G
Sbjct: 173 A--CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 612 NFASENELGRGGFGVV----YKGELDDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKV 666
+F LG G FG V +KG G A+K ++ I K K V E ++L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 667 RHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
H +V+++ S R+ + E++ G L H+ ++ DVA+
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHL-------------RKAGRFPNDVAK 121
Query: 726 --------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
EYLHS I+RDLK N+LL + KV+DFG K PD +
Sbjct: 122 FYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT---- 174
Query: 778 LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
L GT YLAPE + VD ++ GV+L E + G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 68/209 (32%), Positives = 95/209 (45%), Gaps = 35/209 (16%)
Query: 619 LGRGGFGVV----YKGELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
LG G FG V YK E D +A+KR E + +I +K VD SE +L+ + H V+
Sbjct: 38 LGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN-----IALDVARGME 728
L G LV E++ G F + N KR N A + E
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRN------KRFPNDVGCFYAAQIVLIFE 145
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR---LAGTFGYL 785
YL SL + ++RDLK N+LL D K++DFG K+ V TR L GT Y+
Sbjct: 146 YLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-------VDTRTYTLCGTPEYI 195
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE + D ++ G+ + E+L G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 24/189 (12%)
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--- 765
+ L+ + + + VA+GME+L A + IHRDL + NILL ++ K+ DFGL +
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
PD R RL ++APE T + DV+SFGV+L E+ + L S P
Sbjct: 231 KDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGAS-PYP 283
Query: 826 RQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885
+ F + ++RA + T E + T+ + C EPSQRP
Sbjct: 284 GVKIDEEFCRRLKEGTRMRAP-------DYTTPEMYQTMLD----CWHGEPSQRPTFSEL 332
Query: 886 VNVLAPLVE 894
V L L++
Sbjct: 333 VEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 39/213 (18%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSL 674
++G G F V K G A+K M+ S + V+ EI L ++ H +++ L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNL--------EPLSWKRRLNIALDVARG 726
+ ++++ G L+ +F +NL PL KR + + +
Sbjct: 64 IE---------VLFD-RKTGRLAL-VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA-----GT 781
++++H + F HRD+K NIL+ DD K++DFG S R + ++ T
Sbjct: 113 LDHMH--RNGIF-HRDIKPENILIKDD-ILKLADFG-------SCRGIYSKPPYTEYIST 161
Query: 782 FGYLAPEYAVT-GKITTKVDVFSFGVVLMELLT 813
Y APE +T G K+D+++ G V E+L+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRM-----EAGVISKKAVDEFHSEIAVLSK 665
++ ++G G +GVVYKG G +A+K++ E GV S A+ EI++L +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPST-AI----REISLLKE 55
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLN-LEPLSWKRRLNIALDVA 724
++H ++V L + L++E++ L K++ ++ K L L
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ-- 112
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
G+ + HS + +HRDLK N+L+ + K++DFGL + R V T T Y
Sbjct: 113 -GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVVTLWY 167
Query: 785 LAPEYAVTG-KITTKVDVFSFGVVLMELLT 813
APE + + +T VD++S G + E+ T
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-11
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 29/262 (11%)
Query: 566 NNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFG 625
+G + + S N A + ++ + + R+ K++ N +G G FG
Sbjct: 22 KGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDN-DINRSPNKSYKLGNIIGNGSFG 80
Query: 626 VVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY----SVA 680
VVY+ +D K+A+K++ K + E+ ++ + H +++ L Y
Sbjct: 81 VVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLKDYYYTECFK 134
Query: 681 GYERLL----VYEYMPQGALSKHIFHWKSLNLE-PLSWKRRLNIALDVARGMEYLHSLAH 735
E+ + V E++PQ + K++ H+ N PL + + L R + Y+HS
Sbjct: 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIHS--- 188
Query: 736 QSFI-HRDLKSSNILLGDDFRA-KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-T 792
FI HRDLK N+L+ + K+ DFG K +RS V+ + F Y APE +
Sbjct: 189 -KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS-VSYICSRF-YRAPELMLGA 245
Query: 793 GKITTKVDVFSFGVVLMELLTG 814
TT +D++S G ++ E++ G
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 604 QVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV 662
+ + V + + + + +G G +G V + G ++AVK++ S + E+ +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 663 LSKVRHRHLVSLL-----GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
L ++H +++ LL S+ + + + ++ GA +I + L + + +
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQF---- 124
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
+ + RG++Y+HS IHRDLK SN+ + +D K+ DFGL + D +T
Sbjct: 125 -LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTG 176
Query: 778 LAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTG 814
T Y APE + VD++S G ++ ELLTG
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 613 FASENELGRGGFGVVYKGELDDGT-------KIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
+ ++G G +GVVYK D T KI +++ + GV S EI++L +
Sbjct: 4 YEKVEKIGEGTYGVVYKAR-DRVTNETIALKKIRLEQEDEGVPSTAI-----REISLLKE 57
Query: 666 VRHRHLVSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
++H ++V L V E+ LV+EY+ L KH+ P K L +
Sbjct: 58 MQHGNIVRL--QDVVHSEKRLYLVFEYLDLD-LKKHMDSSPDFAKNPRLIKTYL---YQI 111
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA---KVSDFGLVKLAPDSERSVVTRLAG 780
RG+ Y HS +HRDLK N+L+ D R K++DFGL + R+ T
Sbjct: 112 LRGIAYCHS---HRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRT-FTHEVV 165
Query: 781 TFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLT 813
T Y APE + + +T VD++S G + E++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKV 666
NF +LG G + VYKG G +A+K + E G S A+ EI+++ ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPST-AI----REISLMKEL 55
Query: 667 RHRHLVSLLGYSVAGYER--LLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDV 723
+H ++V L + V E +LV+EYM + L K++ H L+P + K + +
Sbjct: 56 KHENIVRL--HDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVK---SFTYQL 109
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL--APDSERS--VVTRLA 779
+G+ + H +HRDLK N+L+ K++DFGL + P + S VV
Sbjct: 110 LKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---- 162
Query: 780 GTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGL 815
T Y AP+ + + +T +D++S G ++ E++TG
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 17/197 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG G G VYK L +AVK + I+ + + SE+ +L K +++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS 737
+ E+M G+L + K E + + IA+ V +G+ YL SL
Sbjct: 68 FFVENRISICTEFMDGGSLD---VYRKIP--EHVLGR----IAVAVVKGLTYLWSL---K 115
Query: 738 FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITT 797
+HRD+K SN+L+ + K+ DFG+ + S+ GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGV---STQLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 798 KVDVFSFGVVLMELLTG 814
DV+S G+ MEL G
Sbjct: 173 HSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 61/216 (28%)
Query: 20 LVSAIVLAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPC--WKHVFC- 76
+++AI + + S T ++ L + +L P W +GDPC P W C
Sbjct: 353 IINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW--NGDPCVPQQHPWSGADCQ 410
Query: 77 -----SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
+ + + + GL+G +P ++++L L++I L N RG +P
Sbjct: 411 FDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP---------- 460
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
+ +I + L+VL L N+FN
Sbjct: 461 -----SLGSITS--------LEVLDLSYNSFN---------------------------- 479
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNL 227
G +P+ LG SL+ L L+GN+L+G +P + G L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVI-SKKAVDEFHSE--IAVLSKVRHRHLVSL 674
+G+G FG VY+ D +I A+K + I +KK V E I V + + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 675 LGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
L +S L LV +YM G L H+ + + + + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED----RAKFYIA-ELVLALEHLHK- 114
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
++RDLK NILL + DFGL K A ++ GT YLAPE +
Sbjct: 115 --YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 794 KITTK-VDVFSFGVVLMELLTG 814
K TK VD +S GV++ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 93/351 (26%), Positives = 143/351 (40%), Gaps = 54/351 (15%)
Query: 611 KNFASENELGRGGFGVVY-KGELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRH 668
K+F ++ +GRG FG V E G A+K M ++ +++++ V F E +LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 669 RHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD----- 722
+ L Y+ + L LV EY P G L LS R D
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDL--------------LSLLNRYEDQFDEDMAQ 105
Query: 723 --VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL-A 779
+A + +HS+ ++HRD+K N+L+ K++DFG + + V ++L
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPV 164
Query: 780 GTFGYLAPEYAVT----GKITTKV--DVFSFGVVLMELLTGLMALDESRPEERQYLAAWF 833
GT Y+APE T GK T V D +S GV+ E++ G P A +
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG------RSPFHEGTSAKTY 218
Query: 834 WNIKSDKEKLRAAIDPILEVN-DDTFETFWTIAE----LAGHCTSREPSQRPDMGHAVNV 888
NI + + L+ DP + + D ++ + G C S+ D + N
Sbjct: 219 NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSK-IDWNNIRNS 277
Query: 889 LAPLVEKWKPLDD-----EPEEYSGI-DYSLPLNQMVKDWQEAEGKDLSYV 933
L P V K DD EPE+ S S + GKDL +V
Sbjct: 278 LPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFS---GKDLPFV 325
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 618 ELGRGGFGVVYKGELDDGTKIA---VKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
E+G G FG V E+ T +A VK ++A SK+ +EF + ++H +++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQC 60
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFH--WKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LG V LLV+EY G L ++ W N + L +R +A ++A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMHK 117
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-------VKLAPDSERSVVTRLAGTFGYL 785
+F+H DL N L D KV D+G+ + + ++ V R +L
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR------WL 168
Query: 786 APEYA-------VTGKITTKVDVFSFGVVLMELL 812
APE +T + T +V++ GV L EL
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 49/218 (22%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+GRG +G+V + K+A+K++ ++ EI +L + H +++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 678 SVAGYER-----LLVYEYM----------PQGALSKH--IFHWKSLNLEPLSWKRRLNIA 720
+ +VYE M Q H F ++ L
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL-------------- 118
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE----RSVVT 776
RG++Y+HS + +HRDLK SN+LL + K+ DFGL + + VVT
Sbjct: 119 ----RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 777 RLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLT 813
R Y APE + + TT +DV+S G + ELL
Sbjct: 172 RW-----YRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 67/244 (27%), Positives = 115/244 (47%), Gaps = 27/244 (11%)
Query: 601 ISVQVLRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSE 659
I + LR+ F +G G +G VYKG + G A+K M+ +++ +E E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 660 IAVLSKV-RHRHLVSLLGY----SVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLS 712
I +L K HR++ + G S G++ LV E+ G+++ + + K L+
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
W I ++ RG+ +LH AH+ IHRD+K N+LL ++ K+ DFG ++ +R
Sbjct: 122 WIAY--ICREILRGLAHLH--AHK-VIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDR 173
Query: 773 SVVTR--LAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
+V R GT ++APE + D++S G+ +E+ G L + P
Sbjct: 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 826 RQYL 829
+L
Sbjct: 234 ALFL 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL--- 674
+GRGGFG VY + D G A+K + KK + E L++ LVS
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 675 -----LGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+ Y+ ++L + + M G L H+ + + + + A ++ G+E
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLE 111
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
++H+ + ++RDLK +NILL + ++SD G LA D + GT GY+APE
Sbjct: 112 HMHN---RFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMAPE 165
Query: 789 YAVTGKI-TTKVDVFSFGVVLMELLTG 814
G + D FS G +L +LL G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V EL ++ A+K ++ VI VD +E +L+ ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 677 YSVAGYERLL-VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+RL V EY+ G L I + + EP R A +V + +LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-EP----RSRFYAAEVTLALMFLHR--- 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPEYAVTG 793
I+RDLK NILL + K++DFG+ K + T GT Y+APE
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQEL 171
Query: 794 KITTKVDVFSFGVVLMELLTG 814
+ VD ++ GV++ E++ G
Sbjct: 172 EYGPSVDWWALGVLMYEMMAG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL--- 674
+GRGGFG VY + D G A+K + KK + E L++ LVS
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK-----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 675 -----LGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+ Y+ ++L + + M G L H+ + + + A ++ G+E
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-----YAAEIILGLE 111
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
++H+ + ++RDLK +NILL + ++SD G LA D + GT GY+APE
Sbjct: 112 HMHN---RFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMAPE 165
Query: 789 YAVTG-KITTKVDVFSFGVVLMELLTG 814
G + D FS G +L +LL G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV-DEFHSEIAVLSKVRHRHLVSLLG 676
+G+GG G VY + ++A+K++ + + F E + + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV-- 67
Query: 677 YSVAGYERLLVYEYMP--QGALSKHIFH--WKSLNL-----EPLSWKRRLNIALDVARGM 727
YS+ + VY MP +G K + W+ +L E S L+I + +
Sbjct: 68 YSICS-DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK---------LAPD--------S 770
EY+HS + +HRDLK NILLG + D+G L D S
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
++ ++ GT Y+APE + + D+++ GV+L ++LT
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 659 EIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN 718
E +L V H ++ + V+G +V +P S ++ + + PL + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPH--YSSDLYTYLTKRSRPLPIDQALI 161
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL---APDSERSVV 775
I + G+ YLH+ Q IHRD+K+ NI + D + + D G + AP
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF----- 213
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELL 812
LAGT APE K +K D++S G+VL E+L
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 44/195 (22%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 627 VYKGELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685
+YKG ++ ++ ++ + K +D +EI L ++ +++ + G+ + + L
Sbjct: 36 IYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 686 ----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHR 741
L+ EY +G L + + K L S+K +L++A+D +G+ L+ + + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKDL-----SFKTKLDMAIDCCKGLYNLYK--YTNKPYK 147
Query: 742 DLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA--VTGKITTKV 799
+L S + L+ ++++ K+ GL K+ V + Y + + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 800 DVFSFGVVLMELLTG 814
D++S GVVL E+ TG
Sbjct: 204 DIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 35/85 (41%), Positives = 48/85 (56%), Gaps = 1/85 (1%)
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPE 788
+H + + IHRD+KS+NILL + K+ DFG K+ + V R GT Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ K D+FS GV+L ELLT
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 17/156 (10%)
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS-WKRRLNIALDVARGME 728
++V L Y V+ LV ++ G L HI + ++ E + W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD------ 99
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG-LVKLAPDSERSVVTRLAGTFGYLAP 787
+L + + RDL +NILL D +++ F ++ + V + Y AP
Sbjct: 100 ---ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRP 823
E + T D +S G +L ELLTG L E P
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG-KTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL-- 675
+G G +G V + K+AVK++ S + E+ +L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 676 ---GYSVAGY-ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
S+ + E LV M GA +I + L+ E + + + + RG++Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIH 135
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
S IHRDLK SN+ + +D ++ DFGL + A D +T T Y APE +
Sbjct: 136 S---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIML 188
Query: 792 TG-KITTKVDVFSFGVVLMELLTG 814
VD++S G ++ ELL G
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 606 LRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS 664
LR+ F +G G +G VYKG + G A+K M+ ++ +E EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLK 57
Query: 665 KV-RHRHLVSLLGYSVAGY------ERLLVYEYMPQGALSKHIFHWK--SLNLEPLSWKR 715
K HR++ + G + + LV E+ G+++ I + K +L E +++
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-- 115
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG ++ +R+V
Sbjct: 116 ---ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVG 166
Query: 776 TR--LAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828
R GT ++APE K D++S G+ +E+ G L + P +
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
Query: 829 L 829
L
Sbjct: 227 L 227
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 609 VTKNFASENELGRGGFGVV---YKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
V K + + +G G G+V Y LD +A+K++ ++ + E+ ++
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
V H++++SLL + PQ +L + + + L + + + + LD R
Sbjct: 73 VNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 726 ----------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS---ER 772
G+++LHS IHRDLK SNI++ D K+ DFGL + A S
Sbjct: 121 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELL 812
VVTR Y APE + VD++S G ++ E++
Sbjct: 178 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRM-----EAGVISKKAVDEFHSEIAVLSKVRHRHL 671
++G G +G V+K + +A+KR+ + GV S A+ EI +L +++H+++
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-AL----REICLLKELKHKNI 61
Query: 672 VSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
V L Y V ++ LV+EY Q L K+ + S N + + + +G+ +
Sbjct: 62 VRL--YDVLHSDKKLTLVFEYCDQD-LKKY---FDSCNGDIDPEIVKS-FMFQLLKGLAF 114
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
HS + +HRDLK N+L+ + K++DFGL + R + T Y P+
Sbjct: 115 CHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 170
Query: 790 AVTGKI-TTKVDVFSFGVVLMEL 811
K+ +T +D++S G + EL
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 38/222 (17%)
Query: 609 VTKNFASENELGRGGFGVV---YKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
V K + + +G G G+V Y L+ +A+K++ ++ + E+ ++
Sbjct: 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
V H++++ LL + PQ +L + + + L + + + + LD R
Sbjct: 80 VNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 127
Query: 726 ----------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS---ER 772
G+++LHS IHRDLK SNI++ D K+ DFGL + A S
Sbjct: 128 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 184
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
VVTR Y APE + VD++S G ++ E++ G
Sbjct: 185 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V E ++ A+K ++ V I V+ E VL+ ++ L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+RL V EY+ G L HI EP + + A +++ G+ +LH
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK-EP----QAVFYAAEISVGLFFLH---R 119
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPEYAVTGK 794
+ I+RDLK N++L + K++DFG+ K V TR GT Y+APE
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
VD +++GV+L E+L G D +E
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV--TRLAGTF 782
R ++Y+H+ + HRDLK NIL D + K+ DFGL ++A + + + T T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 783 GYLAPEY--AVTGKITTKVDVFSFGVVLMELLTG 814
Y APE + K T +D++S G + E+LTG
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 64/269 (23%), Positives = 101/269 (37%), Gaps = 79/269 (29%)
Query: 576 TESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYK------ 629
S + S SS S A +L +V N +G G G VYK
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERV-----------NRIGSGAGGTVYKVIHRPT 98
Query: 630 ----------GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV 679
G +D + + R EI +L V H ++V
Sbjct: 99 GRLYALKVIYGNHEDTVRRQICR----------------EIEILRDVNHPNVVKCHDMFD 142
Query: 680 AGYERLLVYEYMPQGALS-KHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
E ++ E+M G+L HI + L ++A + G+ YLH +
Sbjct: 143 HNGEIQVLLEFMDGGSLEGTHIADEQFLA----------DVARQILSGIAYLHR---RHI 189
Query: 739 IHRDLKSSNILLGDDFRAKVSDFGLVKL---APDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+HRD+K SN+L+ K++DFG+ ++ D S V GT Y++PE +I
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----GTIAYMSPE-----RI 240
Query: 796 TTKV----------DVFSFGVVLMELLTG 814
T + D++S GV ++E G
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 49/247 (19%)
Query: 651 KAVDEFHSEIAV--------LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFH 702
K +D H +IA+ +S+V H HL + G V G E ++V E++ G L +
Sbjct: 50 KVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCL 107
Query: 703 WKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-------GDDFR 755
K P++WK + +A +A + YL ++ +H ++ + NILL G
Sbjct: 108 RKEKGRVPVAWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMEL-LT 813
K+SD G V S V R+ ++APE G ++T D +SFG L+E+
Sbjct: 163 IKLSDPG-VSFTALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217
Query: 814 GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTS 873
G + L E P E++ F+ EK +P + +A L C +
Sbjct: 218 GEVPLKERTPSEKER----FY------EKKHRLPEPSCK----------ELATLISQCLT 257
Query: 874 REPSQRP 880
EP+QRP
Sbjct: 258 YEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 58/285 (20%)
Query: 619 LGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAV--------LSKV 666
LGRG +Y G L DD E VI K +D H +I++ + +V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILK-VLDPSHRDISLAFFETASMMRQV 61
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
H+H+V L G V E ++V E++ G L + H KS + L+ + +A +A
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM-HRKS---DVLTTPWKFKVAKQLASA 117
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDD--------FRAKVSDFGLVKLAPDSERSVVTRL 778
+ YL + +H ++ + NILL + F K+SD G + + S + V R+
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPF-IKLSDPG-IPITVLSRQECVERI 172
Query: 779 AGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMEL-LTGLMAL-DESRPEERQYLAAWFWN 835
++APE K ++ D +SFG L E+ G + L D++ E+ ++
Sbjct: 173 P----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML 228
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
+ ++L A+L HC + +P+QRP
Sbjct: 229 VTPSCKEL---------------------ADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 66/234 (28%), Positives = 98/234 (41%), Gaps = 11/234 (4%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+NL L L ++ L N+ R + L+NL LD NN IP NL+
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLK 143
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L L N S P L++ L NL +L+ LP L N ++L NL LSGN
Sbjct: 144 ELDLSDNKIE-----SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273
++ +P + L+ L D + L N+ L L L N +PES G
Sbjct: 198 IS-DLPPEIELLS--ALEELDLSNNSIIELLSSLSNLKNLSGLELSNN-KLEDLPESIGN 253
Query: 274 LTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
L++L+ L+L++NQ + I + +L LDL+ N +P
Sbjct: 254 LSNLETLDLSNNQ-ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL 306
|
Length = 394 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 53/159 (33%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
SE+ L+ H +V + + LL+ EY G L+K I K E L ++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYE 170
Query: 718 NIAL--DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS-ERSV 774
L + ++ +HS + +HRDLKS+NI L K+ DFG K DS V
Sbjct: 171 VGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ GT YLAPE + + K D++S GV+L ELLT
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-09
Identities = 35/92 (38%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS---ERSVVTRLAGTF 782
G+++LHS IHRDLK SNI++ D K+ DFGL + A S VVTR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
Y APE + VD++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 55/247 (22%)
Query: 611 KNFASENELGRGGFG----VVYKGELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSK 665
+F S +GRG FG V K D G A+K++ ++ ++ K+ V +E +L++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKK---DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE 57
Query: 666 VRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
+ +V L YS L L+ EY+P G + + + E + R IA +
Sbjct: 58 ADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIA-ETI 111
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL----------------VKLAP 768
++ +H L +IHRD+K N+LL K+SDFGL P
Sbjct: 112 LAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 769 DSERSVVTR-----------------LA----GTFGYLAPEYAVTGKITTKVDVFSFGVV 807
+ +++ LA GT Y+APE + + D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 808 LMELLTG 814
+ E+L G
Sbjct: 229 MYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V E ++ A+K ++ V I V+ E VL+ ++ L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+RL V EY+ G L I EP + + A ++A G+ +LHS
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK-EPHA----VFYAAEIAIGLFFLHS--- 119
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPEYAVTGK 794
+ I+RDLK N++L + K++DFG+ K + V T+ GT Y+APE
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
VD ++FGV+L E+L G + +E
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 65/259 (25%), Positives = 99/259 (38%), Gaps = 64/259 (24%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G G FG V D + A+K + A V+ + +E +L++ + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 677 YSVAGYERL-LVYEYMPQGAL-----SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
YS + L V +Y+P G + IF E L+ R IA ++ +E +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE------EDLA---RFYIA-ELTCAIESV 117
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL--------------------------- 763
H + FIHRD+K NIL+ D K++DFGL
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 764 ---------------VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVL 808
+ +R + L GT Y+APE + T D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 809 MELLTGLMALDESRPEERQ 827
E+L G P E Q
Sbjct: 235 YEMLVGQPPFLADTPAETQ 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 37/230 (16%)
Query: 606 LRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS 664
L + T F +G G +G VYK G +A+K M+ ++ + E E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILR 57
Query: 665 KV-RHRHLVSLLG------YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
K H ++ + G + LV E G+++ + K L +RL
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGL----RKKGKRL 110
Query: 718 N------IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771
I + RG+ YLH ++ IHRD+K NILL + K+ DFG ++ +
Sbjct: 111 KEEWIAYILRETLRGLAYLHE--NK-VIHRDIKGQNILLTKNAEVKLVDFG---VSAQLD 164
Query: 772 RSVVTR--LAGTFGYLAPE-----YAVTGKITTKVDVFSFGVVLMELLTG 814
++ R GT ++APE + DV+S G+ +EL G
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+F +ELG G GVV+K I +++ I ++ E+ VL + ++
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V G + E + E+M G+L + + K P +++IA V +G+ YL
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKGLTYLR 120
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
+HRD+K SNIL+ K+ DFG+ D S+ GT Y++PE
Sbjct: 121 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 175
Query: 792 TGKITTKVDVFSFGVVLMELLTG 814
+ + D++S G+ L+E+ G
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 12/201 (5%)
Query: 616 ENELGRGGFGVVY-----KGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+ LG+G FG VY K ++ K+ +K + G ++ + + E +LSK+ H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V + ++ EY L + K + LS + + + G+ Y+
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYM 122
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
H + +HRDLK+ NI L ++ K+ DFG+ +L S + T GT Y++PE
Sbjct: 123 H---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEAL 177
Query: 791 VTGKITTKVDVFSFGVVLMEL 811
+K D++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVS 673
E+G G +G VYK + G +A+K + E+A+L ++ H ++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 674 LLGYSVAGYERL-------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
L+ V R LV+E++ Q L ++ L P + L RG
Sbjct: 67 LM--DVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGL-PAETIKDLMRQF--LRG 120
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+++LH+ +HRDLK NIL+ + K++DFGL ++ S + +T + T Y A
Sbjct: 121 LDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRA 175
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELL 812
PE + T VD++S G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-08
Identities = 52/164 (31%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKI-AVKRM-EAGVISKKAVDEFHSEIAVLSKVRH 668
+ F + RG FG VY G + +K+ AVK + +A +I+K V + +E L+ +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 669 RHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
+V L YS+ + LV EY+ G + K + H E ++ K I+ +VA +
Sbjct: 64 PFIVHLY-YSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKY---IS-EVALAL 117
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771
+YLH IHRDLK N+L+ ++ K++DFGL K+ + E
Sbjct: 118 DYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 36/212 (16%)
Query: 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSE---------IAVLSKVR 667
++LG G + V+KG ++ +++ K + H E +++L ++
Sbjct: 11 DKLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK 61
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
H ++V+L LV+EY+ L +++ + +L +S + RG+
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNL----MSMHNVKIFMFQLLRGL 116
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG----TFG 783
Y H + +HRDLK N+L+ + K++DFGL + +SV T+ T
Sbjct: 117 SYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVVTLW 168
Query: 784 YLAPEYAV-TGKITTKVDVFSFGVVLMELLTG 814
Y P+ + + + +T +D++ G +L E+ TG
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 63/252 (25%), Positives = 102/252 (40%), Gaps = 46/252 (18%)
Query: 611 KNFASENELGRGGFGVV-YKGELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRH 668
++F S +GRG FG V + D G A+K + +A ++ K+ V +E +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 669 RHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
+V + YS L L+ E++P G + + +L E + +A +
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--------IAETV 111
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL---VKLAPDSE------------- 771
+ S+ FIHRD+K N+LL K+SDFGL +K A +E
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 772 ------------------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
R + GT Y+APE + D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 814 GLMALDESRPEE 825
G P+E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 705 SLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764
+L+ E L L+ + VA+GM +L A ++ IHRDL + NILL K+ DFGL
Sbjct: 210 ALDTEDL-----LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 765 K-LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ + DS V ++APE T + DV+S+G++L E+ +
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 619 LGRGGFG--VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G G FG ++ + D K A+K + S AV++ E +L+K++H ++V+
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
A +V EY G L + I K + L + + G++++H +
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTILQWFVQMCLGVQHIHE---K 119
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
+HRD+KS NI L + + K+ DFG +L S + GT Y+ PE
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 797 TKVDVFSFGVVLMELLT 813
K D++S G +L EL T
Sbjct: 179 NKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG G G+V+ + D ++AVK++ + ++V EI ++ ++ H ++V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 678 SVAGYERL--------------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
L +V EYM + L+ L PLS + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN------VLEQGPLSEEHARLFMYQL 123
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFGLVK-LAPD-SERSVVTRLAG 780
RG++Y+HS + +HRDLK +N+ + +D K+ DFGL + + P S + ++
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 781 TFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTGLM 816
T Y +P ++ TK +D+++ G + E+LTG
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 34/113 (30%), Positives = 53/113 (46%), Gaps = 17/113 (15%)
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--------------LAPDSER 772
+EYLH+ +HRDLK N+L+ K++DFGL K + D+
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
+ ++ GT Y+APE + VD ++ G++L E L G + PEE
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 37/116 (31%), Positives = 50/116 (43%), Gaps = 9/116 (7%)
Query: 711 LSWKRR------LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764
L+ KR L I V R ++YLH IHRD+K+ NI + + DFG
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDE 820
D + AGT APE VD++S G+VL E+ T +L E
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKR----MEAGVISKKAVDEFHSEIAVLSKVRHR-HLV 672
+G G +G VYK + + G +A+K+ M+ I A+ EI++L + ++V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIYIV 64
Query: 673 SLLGYSVAGYER-------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
LL V E LV+EY+ L K + PL K + + +
Sbjct: 65 RLL--DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
G+ + H +HRDLK N+L+ K++D GL + +S + T Y
Sbjct: 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWY 177
Query: 785 LAPEYAVTGK-ITTKVDVFSFGVVLMELLTG 814
APE + +T VD++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 63/251 (25%), Positives = 102/251 (40%), Gaps = 46/251 (18%)
Query: 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRM--EAGVISKKAVDEFHSEIAVLSKVRHR 669
+F S +GRG FG V + D I ++ +A ++ K+ V +E +L +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 670 HLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+V + YS L L+ E++P G + + +L+ E + IA + ++
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIA-ETVLAID 115
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL---VKLAPDSE-------------- 771
+H L FIHRD+K N+LL K+SDFGL +K A +E
Sbjct: 116 AIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 772 -----------------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
R + GT Y+APE + D +S GV++ E+L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 815 LMALDESRPEE 825
P+E
Sbjct: 233 YPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+ELG+G +G VYK G +A+K R+E + + ++ E+ +L K ++V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVD 63
Query: 674 LLGYSVAGYERLLVY---EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
G A + VY EYM G+L K + P RR I V +G+++L
Sbjct: 64 FYG---AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFL 118
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
H IHRD+K +N+L+ + + K+ DFG ++ + S+ G Y+APE
Sbjct: 119 KE-EHN-IIHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTNIGCQSYMAPERI 173
Query: 791 VTGKI------TTKVDVFSFGVVLMELLTG 814
+G T + DV+S G+ ++E+ G
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPD 769
LS+ + + VA GME+L A ++ +HRDL + N+L+ + K+ DFGL + + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
S ++APE TT DV+SFG++L E+ T
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 9e-08
Identities = 36/105 (34%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 710 PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAP 768
PL L + VA+GM++L A ++ IHRD+ + N+LL D AK+ DFGL + +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
DS V ++APE T + DV+S+G++L E+ +
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISK-KAVDEFHSEIAVLSKV-RHRHLVSLL 675
+GRG + V L +I A+K ++ +++ + +D +E V + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
V EY+ G L +FH + P R + + +A + YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--LNYLH---E 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPEYAVTG 793
+ I+RDLK N+LL + K++D+G+ K L P S GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEILRGE 171
Query: 794 KITTKVDVFSFGVVLMELLTGLMALD 819
VD ++ GV++ E++ G D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 599 LVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDEFH 657
+ LR ++F +GRG FG V ++ A+K + + K++ F
Sbjct: 31 AAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFF 90
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLE-----PL 711
E + + + L Y+ + L +V EYMP G L +NL P
Sbjct: 91 WEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL---------VNLMSNYDIPE 141
Query: 712 SWKR----RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKL 766
W R + +ALD +HS+ FIHRD+K N+LL K++DFG +K+
Sbjct: 142 KWARFYTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 767 APDSERSVVTRLA-GTFGYLAPEY----AVTGKITTKVDVFSFGVVLMELLTG 814
D+ V A GT Y++PE G + D +S GV L E+L G
Sbjct: 193 --DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG + V L +I A+K ++ ++ + +D +E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
RL LV EY+ G L H+ + L E + A ++ + +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-----YAAEICIALNFLH---E 114
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPEYAVTG 793
+ I+RDLK N+LL D K++D+G+ K L P S GT Y+APE
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPEILRGE 171
Query: 794 KITTKVDVFSFGVVLMELLTGLMALD 819
+ VD ++ GV++ E++ G D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 40/196 (20%)
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LA 767
E L+ L+ VARGME+L A ++ +HRDL + N+LL K+ DFGL + +
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 768 PDSERSVVTRLAGTF---GYLAPEYAVTGKITTKVDVFSFGVVLMEL--LTGL----MAL 818
DS + V++ TF ++APE TT DV+S+G++L E+ L G M +
Sbjct: 289 HDS--NYVSK-GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 819 DESRPEERQYLAAWFWN-IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPS 877
D + F+N IKS + P + + ++ C + EP
Sbjct: 346 DST-----------FYNKIKSGYRMAK----PDHATQE--------VYDIMVKCWNSEPE 382
Query: 878 QRPDMGHAVNVLAPLV 893
+RP H +++ L+
Sbjct: 383 KRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 57/221 (25%), Positives = 109/221 (49%), Gaps = 30/221 (13%)
Query: 617 NELGRGGFGVVYKG--ELDDGTKIAVK--RMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
++LG G + VYKG +L D +A+K R+E + A E+++L ++H ++V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIV 67
Query: 673 SLLGYSVAGYER--LLVYEYMPQGALSKHIFHW-KSLNLEPLSWKRRLNIAL---DVARG 726
+L + + E+ LV+EY+ + L +++ S+N+ N+ L + RG
Sbjct: 68 TL--HDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMH--------NVKLFLFQLLRG 116
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+ Y H + +HRDLK N+L+ + K++DFGL + ++ + T Y
Sbjct: 117 LNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRP 172
Query: 787 PEYAV-TGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826
P+ + + +T++D++ G + E+ TG S EE+
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 67/264 (25%), Positives = 105/264 (39%), Gaps = 58/264 (21%)
Query: 613 FASENELGRGGFG-VVYKGELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRH 670
F LG G FG V ++D A+K + + V+++ V +E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 671 LVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+V L YS + L V +Y+P G + + + E L+ R IA ++ +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP-EVLA---RFYIA-ELTLAIES 116
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK----------------LAPDS--- 770
+H + FIHRD+K NIL+ D K++DFGL + DS
Sbjct: 117 VHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 771 ---------------------------ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFS 803
+R + L GT Y+APE + T D +S
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 804 FGVVLMELLTGLMALDESRPEERQ 827
GV+L E+L G P E Q
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 19/60 (31%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
L++L L N + +F L +LK L+L+ N + P + + L SL LDL+ N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 37/218 (16%)
Query: 618 ELGR----GGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673
+G+ + K + T +AVK++ SK+ + EI +++H +++
Sbjct: 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL---DVARGMEYL 730
+ + E +V M G+ + K+ E L L IA DV ++Y+
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL---KTHFPEGLP---ELAIAFILKDVLNALDYI 117
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDF-GLVKLAPDSERSVVTRLAGTFG-----Y 784
HS FIHR +K+S+ILL D + +S V + +R V +
Sbjct: 118 HSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 785 LAPE--------YAVTGKITTKVDVFSFGVVLMELLTG 814
L+PE Y K D++S G+ EL G
Sbjct: 175 LSPEVLQQNLQGY------NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 603 VQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDEFHSEIA 661
++ LR +++ +GRG FG V K+ A+K + + K++ F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 662 VLSKVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
+ + V L Y+ L +V EYMP G L + ++ P W R
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFYTA- 149
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLA 779
+V ++ +HS+ FIHRD+K N+LL K++DFG +K+ + T +
Sbjct: 150 -EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 780 GTFGYLAPEYAVT----GKITTKVDVFSFGVVLMELLTG 814
GT Y++PE + G + D +S GV L E+L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 618 ELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHS--EIAVLSKVRHRHLVSL 674
+LG G + VYKG+ +G +A+K + + ++ F + E ++L ++H ++V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIV-L 67
Query: 675 LGYSVAGYERL-LVYEYMPQGA---LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
L + E L LV+EY+ + KH L P + K L + RG+ Y+
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMDKH-----PGGLHPENVKLFL---FQLLRGLSYI 119
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
H + +HRDLK N+L+ D K++DFGL + A + T Y P+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 791 V-TGKITTKVDVFSFGVVLMELLTGLMAL 818
+ + + +T +D++ G + +E++ G+ A
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 619 LGRGGFG-VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+G+G +G V DG + +K++ S++ E +LS+++H ++V+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY-RE 66
Query: 678 SVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
S G + LL V + G L + K + L + + + +A ++YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---E 120
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ +HRDLK+ N+ L KV D G+ ++ +++ + + L GT Y++PE
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 796 TTKVDVFSFGVVLMELLT 813
K DV++ G + E+ T
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAV------DEFHSEIAVLSKV-RHRH 670
+GRG + V EL +I A+K VI K+ V D +E V H
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK-----VIKKELVNDDEDIDWVQTEKHVFETASNHPF 57
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L V E++ G L H+ + L E + + +++ + +L
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-----YSAEISLALNFL 112
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LAPDSERSVVTRLAGTFGYLAPE 788
H + I+RDLK N+LL + K++D+G+ K + P S GT Y+APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST---FCGTPNYIAPE 166
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALD 819
VD ++ GV++ E++ G D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 66/264 (25%), Positives = 101/264 (38%), Gaps = 58/264 (21%)
Query: 613 FASENELGRGGFG-VVYKGELDDGTKIAVKRM-EAGVISKKAVDEFHSEIAVLSKVRHRH 670
F LG G FG V ++D A+K + + V+ + V +E +L++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 671 LVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+V L YS + L V +Y+P G + + + + P R L A +E
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCA--VES 116
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV------------------------- 764
+H + FIHRD+K NIL+ D K++DFGL
Sbjct: 117 VHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 765 --------------KLAP-------DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFS 803
+L P +R + L GT Y+APE + T D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 804 FGVVLMELLTGLMALDESRPEERQ 827
GV+L E+L G P E Q
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 104 KLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNN 161
L+++ L N+ +P +F GL NLK L GNN +I + F GL +L+ L L NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 162 F 162
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVD--EFHS--EIAVLSKVRHRHLV 672
+LG G + VYKG +G +A+K VIS K + F + E ++L ++H ++V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALK-----VISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 673 SLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
LL + E L V+EYM I H L+ + RL + RG+ Y+H
Sbjct: 67 -LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH----PYNVRL-FMFQLLRGLAYIH 120
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
Q +HRDLK N+L+ K++DFGL + ++ + + T Y P+ +
Sbjct: 121 ---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLL 176
Query: 792 -TGKITTKVDVFSFGVVLMELLTG 814
++ +D++ G + +E+L G
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 50/227 (22%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSE---------IAVLSKVR 667
+LG G + V+KG ++ +++ K + H E +++L ++
Sbjct: 12 EKLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
H ++V+L LV+EY L K + + +S + RG+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG----TFG 783
Y H + +HRDLK N+L+ + K++DFGL + +SV T+ T
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVVTLW 169
Query: 784 YLAPEYAV-TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829
Y P+ + + + +T++D++ G + E+ +G S E+ +L
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 13/180 (7%)
Query: 637 KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV---SLLGYSVAGYERLLVYEYMPQ 693
++ KR++AG +A + +EI L ++ H +++ +L Y Y++
Sbjct: 194 RLIAKRVKAG---SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLY 250
Query: 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753
+ F WK PL + R I + +EY+H + IHRD+K NI L D
Sbjct: 251 SFMYDEAFDWKD---RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCD 303
Query: 754 FRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813
+ + DFG + GT +PE D++S G++L+++L+
Sbjct: 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 73/321 (22%), Positives = 110/321 (34%), Gaps = 26/321 (8%)
Query: 135 GNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL 194
N L L L L S + +S S +L+ N
Sbjct: 52 LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL---NRLRSN 108
Query: 195 PDFLGNFASLQNLKLSGNNLTGPIPESFK-GLNLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
L +L +L L NN+T P NL L L+D K L N+ L
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK---IESLPSPLRNLPNL 165
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNM---F 310
+ L L N S +P+ L++L +L+L+ N+ L P +L+ LDL+NN
Sbjct: 166 KNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIEL 224
Query: 311 MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS 370
+ + K SN E +P + ++ ++ L N ++S S +
Sbjct: 225 LSSLSNLKNLSGLELSNN---KLEDLPESIGNLSNLETLDLSN---NQISSISSLGSLTN 278
Query: 371 WLGLSCGTNSKLTVLNLP---------NFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP 421
L NS L L NL TL L+S+ +N P
Sbjct: 279 LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSP 338
Query: 422 TNWTNLKSLTLLDLSQNNLSP 442
+ L+SL L N L
Sbjct: 339 EALSILESLNNLWTLDNALDE 359
|
Length = 394 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 42/247 (17%)
Query: 600 VISVQVLRNVTKNFASENELGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHS 658
++ ++ L + T + +G+G +G VYK DG+ AVK ++ +E +
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVDEEIEA 67
Query: 659 EIAVLSKV-RHRHLVSLLGY-----SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS 712
E +L + H ++V G + G + LV E G++++ + K L L
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGL----LI 120
Query: 713 WKRRLN------IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766
+RL+ I G+++LH+ IHRD+K +NILL + K+ DFG+
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGV--- 174
Query: 767 APDSERSVVTRL-----AGTFGYLAPEYAVTGK-----ITTKVDVFSFGVVLMELLTGLM 816
S + TRL GT ++APE + + DV+S G+ +EL G
Sbjct: 175 ---SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
Query: 817 ALDESRP 823
L + P
Sbjct: 232 PLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 659 EIAVLSKVRHRHLVSLLG-YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
E +L ++ H +++LL V G L++ +Y ++ + L PL +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY------RSDLYTYLGARLRPLGLAQVT 263
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
+A + ++Y+H + IHRD+K+ N+L+ + DFG A S +
Sbjct: 264 AVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 778 -LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMAL------DESRPEERQYL 829
+AGT APE T VD++S G+V+ E +L DE RP + Q L
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379
|
Length = 461 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 31/208 (14%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+G G +GVV K + +I A+K+ + +++ + E+ +L ++ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 678 SVAGYERLLVYEY-----------MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
+ LV+EY MP G + + + ++ + W + +I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI------- 121
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+HRD+K N+L+ + K+ DFG + + + T T Y +
Sbjct: 122 ------------VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTG 814
PE + VD++S G +L EL G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG-LVKLAPDSERSVVTRLA-GTFGYLAP 787
+HS+ ++HRD+K N+LL + +++DFG +K+ D +V + +A GT Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 788 EYAVT-----GKITTKVDVFSFGVVLMELLTG 814
E GK + D +S GV + E+L G
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 15/222 (6%)
Query: 599 LVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDE--F 656
+V ++ L+ +++ +GRG FG V K+ ++ + K D F
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 657 HSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
E +++ +V L +V EYMP G L + ++ P W +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV----PEKWAKF 146
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776
+V ++ +HS+ IHRD+K N+LL K++DFG ++
Sbjct: 147 YTA--EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 777 RLAGTFGYLAPEYAVT----GKITTKVDVFSFGVVLMELLTG 814
GT Y++PE + G + D +S GV L E+L G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 612 NFASENELGRGGFGVV-YKGELDDGTKIAVKRMEAGVISKK-AVDEFHSEIAVLSKVRHR 669
+F + +G+G FG V + D G A+K + + KK + +E VL++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 670 HLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+VSL YS + L L+ E++P G L + + + + E ++ R +A + +E
Sbjct: 62 WVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVT---RFYMA-ECVLAIE 115
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763
+H L FIHRD+K NIL+ K+SDFGL
Sbjct: 116 AVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVRHRHL 671
++G+G FG V+K +A+K+ V+ + + F EI +L ++H ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKK----VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 672 VSLL-----------GYSVAGYERLLVYEYMPQ---GALSKHIFHWKSLNLEPLSWKRRL 717
V+L+ Y + Y LV+E+ G LS K++ K+ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFY---LVFEFCEHDLAGLLSN-----KNVKFTLSEIKKVM 125
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
+ L+ G+ Y+H +HRD+K++NIL+ D K++DFGL + S+ S R
Sbjct: 126 KMLLN---GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 778 LAG---TFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLT 813
T Y PE + + +D++ G ++ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 58/234 (24%)
Query: 619 LGRGGFGVVYKGELD-DGTKIAVK--RMEAGVISKKAVDE---FHS--EIAVLSKVRHRH 670
LG G + VYKG G +A+K R+E +E F + E ++L ++H +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEH--------EEGAPFTAIREASLLKDLKHAN 64
Query: 671 LVSLLGYSVAGYERLL--VYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIAL---DVA 724
+V+L + + ++ L V+EY+ L +++ L++ N+ L +
Sbjct: 65 IVTL--HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH--------NVRLFLFQLL 113
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG---- 780
RG+ Y H + +HRDLK N+L+ + K++DFGL + +SV ++
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-----AKSVPSKTYSNEVV 165
Query: 781 TFGYLAP-------EYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQ 827
T Y P EY +T +D++ G + E+ TG S E Q
Sbjct: 166 TLWYRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 41/176 (23%), Positives = 58/176 (32%), Gaps = 26/176 (14%)
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768
PL+ + + L + LH A KS NILL D K+ G V
Sbjct: 12 RPLNEEEIWAVCLQCLGALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKT 60
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828
E+S ++APE T K D++S G+ L E L + +E R
Sbjct: 61 P-EQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL 114
Query: 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGH 884
A DP N + + + C SR P +R H
Sbjct: 115 EIL---------LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANH 161
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 41/173 (23%), Positives = 65/173 (37%), Gaps = 44/173 (25%)
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL----------- 706
EI +L + HR +++L+ H + WKS
Sbjct: 135 REIDILKTISHRAIINLI-----------------------HAYRWKSTVCMVMPKYKCD 171
Query: 707 ------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760
PL ++ + I + + YLH + IHRD+K+ NI L + A + D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGD 228
Query: 761 FGLV-KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELL 812
FG KL + +GT +PE K D++S G+VL E+
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG-LVKLAPDSERSVVTRLA-GTFGYLAP 787
+ S+ ++HRD+K N+LL + +++DFG ++L D +V + +A GT Y++P
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGTPDYISP 172
Query: 788 EY--AV---TGKITTKVDVFSFGVVLMELLTG 814
E A+ G+ + D +S GV + E+L G
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 26/54 (48%), Positives = 34/54 (62%), Gaps = 1/54 (1%)
Query: 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKS 317
G IP KL L+ +NL+ N G IPPSL S+ SL+ LDL+ N F G +P+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
|
Length = 623 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 1e-04
Identities = 34/106 (32%), Positives = 44/106 (41%), Gaps = 25/106 (23%)
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK----VSDFGLVKLAPDSERS 773
I + + LH H IH D+K N+L RAK + D+GL K+ + S
Sbjct: 113 KIIRQLVEALNDLHK--HN-IIHNDIKLENVLY---DRAKDRIYLCDYGLCKII-GTP-S 164
Query: 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSF-----GVVLMELLTG 814
GT Y +PE KI SF GV+ ELLTG
Sbjct: 165 C---YDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 54/230 (23%), Positives = 84/230 (36%), Gaps = 35/230 (15%)
Query: 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNN 137
+ +T + + + + P S L+ + L N+ L NLK L N+
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND 174
Query: 138 FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF 197
+P + L NL L L N + P ++ + L L +S N +L
Sbjct: 175 LSDLPKLLSN-LSNLNNLDLSGNKIS-----DLPPEIELLSALEELD-LSNNSIIELLSS 227
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257
L N +L L+LS N L + +GN+ L TL
Sbjct: 228 LSNLKNLSGLELSNNKLEDL--------------------------PESIGNLSNLETLD 261
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNN 307
L N + S G LT+L++L+L+ N +P L L L LN
Sbjct: 262 LSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNL 309
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 4/62 (6%)
Query: 381 KLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQN 438
L L+L N N + L +L + L NN++ I + L SL LDLS N
Sbjct: 1 NLKSLDLSN-NRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGN 58
Query: 439 NL 440
NL
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRMEAGVISKKAVDE-FHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V +L + K+ A+K + + K+A F E VL ++ ++ L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ-WITTLH 67
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLS--WKRRLNIALDVARGMEYLHSL 733
Y+ L LV +Y G L + ++ E ++ + + IA+D + Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFG-LVKLAPDSERSVVTRLA-GTFGYLAPEYAV 791
+HRD+K NIL+ + +++DFG +KL D +V + +A GT Y++PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQ 176
Query: 792 T-----GKITTKVDVFSFGVVLMELLTG 814
GK + D +S GV + E+L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 619 LGRGGFGVVYK-GELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLG 676
+G+G +G V+K +G+K AVK ++ +E +E +L + H ++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP---IHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 677 Y-----SVAGYERLLVYEYMPQGA---LSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
G + LV E G+ L K EP+ IA + +
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI-------IAYILHEALM 135
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
L L IHRD+K +NILL + K+ DFG V S R GT ++APE
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 789 Y-AVTGKITT----KVDVFSFGVVLMELLTGLMALDESRP 823
A ++ + + DV+S G+ +EL G L + P
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 9e-04
Identities = 30/88 (34%), Positives = 36/88 (40%), Gaps = 28/88 (31%)
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
NLK L N IP F GL NL+VL L NN LT++S
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNN------------------LTSIS-- 40
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSGNNL 214
P+ SL++L LSGNNL
Sbjct: 41 --------PEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 9e-04
Identities = 51/235 (21%), Positives = 97/235 (41%), Gaps = 31/235 (13%)
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
C + T++++ +GL T+P + + ++ + L N+ + + G N+K Y +
Sbjct: 175 CLKNNKTELRLKILGLT-TIPACIPE--QITTLILDNNELKSLPENLQG--NIKTLYANS 229
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N +IPA D +Q + L N P+ L S+ Q +L N LP
Sbjct: 230 NQLTSIPATLPD---TIQEMELSINRIT-----ELPERLPSALQSLDL---FHNKISCLP 278
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
+ L L+ L + N++ +P + +L + T+ L+T
Sbjct: 279 ENLPE--ELRYLSVYDNSIRT-LPAHLPS-GITHLNVQSNSLTALPETLPP-----GLKT 329
Query: 256 LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL---IPPSLASLSLDHLDLNN 307
L N + ++P S L+ L+++ NQ L +PP++ +L + L N
Sbjct: 330 LEAGENALT-SLPASLPP--ELQVLDVSKNQITVLPETLPPTITTLDVSRNALTN 381
|
Length = 754 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 68/275 (24%), Positives = 105/275 (38%), Gaps = 45/275 (16%)
Query: 203 SLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD-QLRTLWLHGN 261
L +L L+ N L I E + NL +L L++ T ++G + L+ L L N
Sbjct: 94 PLPSLDLNLNRLRSNISELLELTNLTSLDLDNNN---ITDIPPLIGLLKSNLKELDLSDN 150
Query: 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYK 321
++P L +LK+L+L+ N L +L++LDL+ N
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI----------- 198
Query: 322 YSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381
++ I+ L L S N + LS
Sbjct: 199 ------------------SDLPPEIELLSALEEL-----DLSNNSIIELLSSLS--NLKN 233
Query: 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
L+ L L N L +GNL +L + L +N IS ++ +L +L LDLS N+LS
Sbjct: 234 LSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS 290
Query: 442 PPLP-KFSGAVKLSLDGNPLLNGKSPGSGSSSGNP 475
LP + L L N LL K+ +S
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALELKLNSILL 325
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 25/85 (29%), Positives = 36/85 (42%), Gaps = 25/85 (29%)
Query: 203 SLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262
+L++L LS N LT +FKGL L+ L L GN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLP-------------------------NLKVLDLSGNN 35
Query: 263 FSGTIPESFGKLTSLKDLNLNSNQF 287
+ PE+F L SL+ L+L+ N
Sbjct: 36 LTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.28 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.95 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.95 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.91 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.65 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.45 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-80 Score=783.38 Aligned_cols=795 Identities=27% Similarity=0.408 Sum_probs=468.0
Q ss_pred HHhhhcCCChhhHHHHHHHHHhcCCCC--CCCCCCCCCCCCCCCCcceEecC-CcEEEEEecCCcccccCcccccCCCCC
Q 002149 29 VTLVLSATDPGDIDILNQFRKNLENPE--LLQWPKSGDPCGPPCWKHVFCSN-SRVTQIQVSSVGLKGTLPQNLNQLSKL 105 (959)
Q Consensus 29 ~~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~w~~~~~~C~~~~w~gv~C~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L 105 (959)
+.+..+..+|+|+.||++||+++.++. +.+|+...++|. |.||.|++ ++|+.|+|++++++|.+++.+..+++|
T Consensus 19 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~---w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L 95 (968)
T PLN00113 19 LFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL---WQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYI 95 (968)
T ss_pred HHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCc---CcceecCCCCcEEEEEecCCCccccCChHHhCCCCC
Confidence 333445558899999999999997663 678977667775 99999984 689999999999999999999999999
Q ss_pred cEEeccCCcCCCCCC-C-ccCCCCccEEecCCCCCCC----------------------CChhhhcCCCCCcEEEccCcc
Q 002149 106 ENIGLQKNQFRGELP-S-FSGLSNLKYAYLDGNNFDT----------------------IPADFFDGLENLQVLALDSNN 161 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~----------------------i~~~~~~~l~~L~~L~Ls~N~ 161 (959)
+.|+|++|++.+.+| . +.++++|++|+|++|++++ ..+..|+++++|++|+|++|.
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 999999999987666 3 4467777777777666653 223335555555555555555
Q ss_pred cCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCC--
Q 002149 162 FNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGG-- 238 (959)
Q Consensus 162 l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~-- 238 (959)
+.+ .+|..+.++++|++|++++|++.+.+|..++++++|+.|+|++|++++.+|..+..+ +++.|.+..+...
T Consensus 176 l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 176 LVG----KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred ccc----cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc
Confidence 543 345555555555555555555555555555555555555555555555555544443 3333333332211
Q ss_pred -------------------Ccccc-cccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc
Q 002149 239 -------------------GFTGT-IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL 298 (959)
Q Consensus 239 -------------------~l~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 298 (959)
.+.+. +..+.++++|++|+|++|.+++.+|..+.++++|++|+|++|.+++.+|..+..+
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l 331 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331 (968)
T ss_pred cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC
Confidence 11111 1123334444444444444444444444444444444444444444444444444
Q ss_pred -cCCeEeCCCCcCCCCCCcccc-----cccccccCcccCCCCCCCCc------------------hhhHH----------
Q 002149 299 -SLDHLDLNNNMFMGPVPKSKA-----YKYSYSSNAFCQPTEGVPCA------------------PEVMA---------- 344 (959)
Q Consensus 299 -~L~~L~L~~N~l~~~ip~~~~-----~~~~~~~~~~~~~~~~~~~~------------------~~~~~---------- 344 (959)
+|+.|+|++|.+++.+|.... ..+.+++|.+.+..+...+. +....
T Consensus 332 ~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 355555555555555553211 11233333332211100000 00000
Q ss_pred --------HHhhccCCC---------------------CCcccccc-----------------------cCCCCCCCccc
Q 002149 345 --------LIDFLGGLN---------------------YPPRLVTS-----------------------WSGNDPCKSWL 372 (959)
Q Consensus 345 --------~~~~~~~~~---------------------~~~~l~~~-----------------------~~~~~~~~~~~ 372 (959)
....+..+. .++.+... ....+......
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~ 491 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAV 491 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCcc
Confidence 000000000 00000000 00011111111
Q ss_pred ccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC----CC
Q 002149 373 GLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FS 448 (959)
Q Consensus 373 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~ 448 (959)
+..+..+++|+.|+|++|++.+.+|..++++++|++|+|++|.++|.+|..|.++++|+.|||++|++++.+|. +.
T Consensus 492 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 571 (968)
T PLN00113 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571 (968)
T ss_pred ChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCc
Confidence 22244556677777777777777777777777777777777777777777777778888888888888777774 33
Q ss_pred CcceecccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCceEEEEehhHHHHHHHHHHHHHH
Q 002149 449 GAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPI 528 (959)
Q Consensus 449 ~~~~~~l~~N~~~c~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~~~l~~~~~ 528 (959)
.+..+++.+|++.+.-+.. +...........+...-+...++...+.. ....+....+.++++++++ +++++++++
T Consensus 572 ~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~~~~~~~c--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 647 (968)
T PLN00113 572 SLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCGGDTTSGLPPC--KRVRKTPSWWFYITCTLGA-FLVLALVAF 647 (968)
T ss_pred ccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccCCccccCCCCC--ccccccceeeeehhHHHHH-HHHHHHHHH
Confidence 4566777777766533211 11000000000000000000000000000 0000111122222222222 222222222
Q ss_pred HhhhhhhcccccccCCCccccCCCCCCCCCceeeEeecCCCCCcccccCCCCCccccCCCCCccccccCceeecHHHHHH
Q 002149 529 SICYYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRN 608 (959)
Q Consensus 529 ~~~~~r~rk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 608 (959)
+++++|+|++...... .... ..... ..+. ......+++ ..
T Consensus 648 ~~~~~~~~~~~~~~~~-----~~~~----~~~~~-------------------~~~~---------~~~~~~~~~---~~ 687 (968)
T PLN00113 648 GFVFIRGRNNLELKRV-----ENED----GTWEL-------------------QFFD---------SKVSKSITI---ND 687 (968)
T ss_pred HHHHHHhhhccccccc-----cccc----ccccc-------------------cccc---------cccchhhhH---HH
Confidence 2222232221110000 0000 00000 0000 000001222 23
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+...|...+.||+|+||.||+|.. .++..||||++..... ....|++.+++++|||||++++++.+....++|
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 345677888999999999999976 5789999998864321 123468899999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.++++ .++|.++.+++.|||+||+|||..+.++|+||||||+||+++.++..++. ||.+...
T Consensus 762 ~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 762 HEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred EeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 99999999999983 37899999999999999999996555899999999999999999888876 6665533
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ....||+.|+|||++.+..++.|+|||||||++|||+||+.||+..... ...+..|+..... .......+
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~ 905 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYS-DCHLDMWI 905 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcC-ccchhhee
Confidence 221 1236789999999999999999999999999999999999999643321 1233444433222 22344455
Q ss_pred CCcccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 DPILEV-NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
++.+.. .....+...++.+++.+|++.||++||+|.||++.|+.+.+..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 555432 2334566678889999999999999999999999998876643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=452.19 Aligned_cols=291 Identities=48% Similarity=0.788 Sum_probs=251.8
Q ss_pred CceeecHHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEE
Q 002149 597 GNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676 (959)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 676 (959)
....|++.+++.+|++|...+.||+|+||.||+|.+.+|+.||||++....... .++|.+|++++.+++|||+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 345699999999999999999999999999999999999999999887642221 456999999999999999999999
Q ss_pred EEEeCc-eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 677 YSVAGY-ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 677 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
||.+.+ +.+||||||++|+|.++++..... +++|.+|++||.++|+||+|||+.+.++||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999998 599999999999999999763321 8899999999999999999999988789999999999999999999
Q ss_pred EEEeeccccccCCC-CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPD-SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+|+..+. .... .+...||.+|+|||++..+..+.|+|||||||+++|++||+.+.+...+.....++.|++
T Consensus 216 aKlsDFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999986654 2221 111189999999999999999999999999999999999999998776555556888887
Q ss_pred hhhcchHHHHHhcCCcccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTF-ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..... ..+.+++|+.+....+.. .....+.+++.+|++.+|.+||+|.||++.|+.+..
T Consensus 295 ~~~~~-~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 295 PLLEE-GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHC-cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 66664 389999999987444443 678889999999999999999999999998865443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=401.65 Aligned_cols=260 Identities=36% Similarity=0.528 Sum_probs=216.2
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-eEEEEEEecCC
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-ERLLVYEYMPQ 693 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 693 (959)
..+.||+|+||+||+|.++....||||++..........++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 44569999999999999984444999999876555555789999999999999999999999999887 79999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCEEECCCC-cEEEeeccccccCCCCC
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS-FIHRDLKSSNILLGDDF-RAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dik~~NiLl~~~~-~~ki~DfGla~~~~~~~ 771 (959)
|+|.++++.. ....+++..++++|.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999763 34789999999999999999999999 66 99999999999999997 99999999998665432
Q ss_pred cceeeccccccccccccccc--cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 772 RSVVTRLAGTFGYLAPEYAV--TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+......+ +. ....
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v--~~----------~~~R- 264 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV--VV----------GGLR- 264 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hh----------cCCC-
Confidence 2234468999999999999 569999999999999999999999999988763321111 00 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
+.........+..++.+||..||++||++.+++..|+.+......
T Consensus 265 ----p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 ----PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 111112445788999999999999999999999999999876554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=378.23 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=213.5
Q ss_pred cccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-eEEEEEEec
Q 002149 614 ASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-ERLLVYEYM 691 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 691 (959)
+....||+|..|+|||+.++ +++.+|+|++... ......+++.+|+++++..+||+||+++|+|.... +..++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34578999999999999765 7888999999543 46677889999999999999999999999999888 599999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
.+|+|++++... +.+++...-+|+.+|++||.|||+. ++||||||||+|||++..|+|||||||.++...+.
T Consensus 161 DgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 999999998542 5699999999999999999999963 79999999999999999999999999999977654
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRP--EERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+ ..... -+..+++.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~-------------Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE-------------LLCAIVDE 297 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH-------------HHHHHhcC
Confidence 45668999999999999999999999999999999999999999987511 11111 12223332
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+..... ....++..++..||++||.+||++.|+++ ++++.++..
T Consensus 298 ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~~~ 343 (364)
T KOG0581|consen 298 PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKFED 343 (364)
T ss_pred CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhccc
Confidence 11111111 23347889999999999999999999987 677766544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=374.52 Aligned_cols=316 Identities=25% Similarity=0.356 Sum_probs=253.3
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-----Cc
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-----GY 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 682 (959)
+...|...+.||+|+||.|+.|. ..+|+.||||++...+......++..+|+.+++.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 44567778899999999999995 4579999999999877788889999999999999999999999998765 35
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..|+|+|+| +.+|.+.++. .+.++...+.-+++|+++||+|+|+ .+|+|||+||+|++++.++.+||+|||
T Consensus 100 DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 789999999 7889888854 2458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCC-CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc--
Q 002149 763 LVKLAPD-SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS-- 838 (959)
Q Consensus 763 la~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 838 (959)
+||.... .....++.++.|.+|+|||.+.. ..|+.+.||||.|||+.||++|+.-|.+....++..++..+-....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 9996643 23345678899999999999865 6799999999999999999999999999876665444432222111
Q ss_pred -----chHHHHHhcCCcccCCCCCHHH-----HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 839 -----DKEKLRAAIDPILEVNDDTFET-----FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 839 -----~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
..+..+..+......+..++.. .....+|+.+||..||.+|+|++|+++ ++|+..|+.++|||.....
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~--hPYl~~~hdp~dEP~~~~~ 328 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA--HPYLAPYHDPEDEPVCQPI 328 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc--ChhhhhhcCCccCCCCCCC
Confidence 1123334444433333333322 225669999999999999999999987 8999999999999977554
Q ss_pred cccCCChhhhHHHHHHhhCCCcceeecc
Q 002149 909 IDYSLPLNQMVKDWQEAEGKDLSYVSLE 936 (959)
Q Consensus 909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 936 (959)
.+.... ....++|++..+.+...+...
T Consensus 329 ~~~~~~-~~~~~~~r~~i~~e~~~~~~~ 355 (359)
T KOG0660|consen 329 FDSFEH-ELTEEELRELIYKEILDFHPD 355 (359)
T ss_pred Cccccc-cccHHHHHHHHHHHHHhhCcc
Confidence 442222 267899999999887766643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=373.39 Aligned_cols=207 Identities=33% Similarity=0.520 Sum_probs=187.4
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|...+.||+|+||+||+|+++ ++..||||.+.+....++..+-+..|+.+++.++|||||++++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999764 6899999999887767788888999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC------CcEEEeecc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD------FRAKVSDFG 762 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~------~~~ki~DfG 762 (959)
|||.||+|.++++.. +.+++.++..++.|+|.||++||+ ++||||||||.|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999652 478999999999999999999999 999999999999999764 569999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
+||..... ......+|++-|||||+++..+|+.|+|+||+|+++|+|++|+.||+...+.+-
T Consensus 161 fAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 161 FARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 99977643 344567999999999999999999999999999999999999999998776653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=391.96 Aligned_cols=252 Identities=34% Similarity=0.506 Sum_probs=211.8
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.++.||+|-||.||.|.++....||||.++.. ....+.|.+|+++|++|+|+|||+++|+|..+...+||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 45789999999999999997779999999865 233467889999999999999999999999988999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.++|+. .....+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||||...++....
T Consensus 287 sLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 287 SLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999965 344778999999999999999999999 899999999999999999999999999999555544333
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC--cc
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP--IL 851 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 851 (959)
.....-+..|.|||++..+.++.|||||||||+||||+| |+.|+.+....+... .++. ++
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----------------~le~GyRl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----------------LLERGYRL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH-----------------HHhccCcC
Confidence 333344679999999999999999999999999999999 788888776544221 1111 23
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.++. ++..+.+++..||+.+|++|||++.+...++.+...
T Consensus 424 p~P~~---CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEG---CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCC---CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 33333 344677899999999999999999888888777654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=389.87 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=216.7
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+|...+.||+|||+.||.++. .+|+.||+|++.+... .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999976 8899999999987533 3455678899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|+|++++|..++.+ .+++++.++..+..||+.||.|||+ .+|||||||..|++++++.++||+|||||....
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999988842 3789999999999999999999999 899999999999999999999999999999776
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.+.. .....+|||.|.|||++.....+..+||||+||++|-|+.|++||+...-.+....+ +.. +..
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------k~~-----~Y~- 236 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------KLN-----EYS- 236 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH------Hhc-----Ccc-
Confidence 4433 234579999999999999999999999999999999999999999987655432211 110 110
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
++ .....+..+||.++|+.+|.+|||+++|+. ++.+..
T Consensus 237 --~P-----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff~~ 274 (592)
T KOG0575|consen 237 --MP-----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFFKS 274 (592)
T ss_pred --cc-----cccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhhhC
Confidence 10 122336779999999999999999999976 677744
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=404.37 Aligned_cols=262 Identities=31% Similarity=0.473 Sum_probs=216.0
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.+....+.||+|+||.||+|+.. +...||||.++.. .+.+..++|++|++++..++|||||+|+|+|.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34456788999999999999743 3467999999876 3555789999999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLN---------LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
++|+|||..|||.++|+...... ..+++..+.+.||.|||.||+||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 99999999999999997543221 2238999999999999999999999 89999999999999999999
Q ss_pred EEEeecccccc-CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 002149 756 AKVSDFGLVKL-APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 756 ~ki~DfGla~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 833 (959)
|||+||||+|. +..+......+..-+.+|||||.|+.+++|.++|||||||+|||+++ |+.|+.+...++....++
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 99999999994 44333333334455789999999999999999999999999999998 899999887665433221
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+. .+..++ ..+.++..|+..||+..|++||+++||...|..+.+
T Consensus 720 ------~g~-------lL~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 ------AGQ-------LLSCPE---NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ------cCC-------cccCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 011 122222 345578899999999999999999999988877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.08 Aligned_cols=261 Identities=26% Similarity=0.378 Sum_probs=214.1
Q ss_pred cCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEE-EEEeCce-EEEE
Q 002149 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG-YSVAGYE-RLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 687 (959)
.+|+++++||+|.||+|||+ ...+|..||.|.++-...+....++...|+.++++|+|||||++++ .+.+..+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35778899999999999999 5678999999999877777888889999999999999999999998 3444444 7899
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
|||+..|+|...+++++.. .+.+++.++++++.|+++||.++|+..++ -|+||||||.||+++.+|.+|++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999887754 47899999999999999999999994433 388999999999999999999999999998
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
+.... .....++|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+..--+. . .++.+-
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L---~----------~KI~qg 243 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL---C----------KKIEQG 243 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH---H----------HHHHcC
Confidence 86543 345678999999999999999999999999999999999999999998742221 1 111111
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
+ .. +.........+.+|+..|+..||+.||+...+++.+.
T Consensus 244 -d--~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 -D--YP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -C--CC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 0 00 0111234457889999999999999998555444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=373.41 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=205.9
Q ss_pred HhcCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHH-----HHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 609 VTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKK-----AVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
..+.|.+.+.||+|+||.|-+| ..++|+.||||++++...... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999 466899999999987644331 2334579999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~ki~ 759 (959)
..|+||||++||+|.+.+-.. +.+.+..-..+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999998543 556777788999999999999999 899999999999999765 789999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCC---CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI---TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
|||+|+.... ...+...+||+.|.|||++.+..+ ..|+|+||+||+||-+++|.+||.+..... .+.
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~------ 391 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK------ 391 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH------
Confidence 9999998763 345677899999999999977543 347899999999999999999998654211 011
Q ss_pred hcchHHHHHhcCCcccCCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVND-DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.++......... .-.+...+..++|.+||..||++||++.|+++
T Consensus 392 -------eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 392 -------EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -------HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111222121 12234457889999999999999999999988
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=354.81 Aligned_cols=271 Identities=21% Similarity=0.303 Sum_probs=216.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|+...++|+|+||.|||++.+ +|+.||||++.....++...+-..+|++++++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35778889999999999999765 69999999998765555666778899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++..=| +.+.+ ....++.+.+.++++|+++|+.|+|+ +++|||||||+|||++.++.+||||||.||....
T Consensus 82 ~~dhTvL-~eLe~----~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVL-HELER----YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHH-HHHHh----ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9965444 44433 22568899999999999999999999 8999999999999999999999999999997764
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.....+.++.|.+|+|||.+.+ .+|...+||||+||++.||++|.+-|.+..+-++.+.+...-.-.. ....+.+.
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~--prhq~iF~ 230 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI--PRHQSIFS 230 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC--HHHHHHhc
Confidence 2345677899999999999988 6899999999999999999999999999988877666543322111 12222222
Q ss_pred Ccc-------cCCC--C-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 849 PIL-------EVND--D-----TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~-------~~~~--~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
... +... . -......+.++++.|+..||++|++-++++. +++++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~--H~yFd 288 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH--HPYFD 288 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc--ChHHH
Confidence 110 0000 0 1122235779999999999999999999875 45544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.52 Aligned_cols=274 Identities=23% Similarity=0.345 Sum_probs=223.7
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCc-eEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGY-ERL 685 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 685 (959)
+-++|.+.++||.|.||.||+|+ ..+|+.||||+|++...+.++. .-.||+..+++++ |||||++.+++.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45689999999999999999996 5579999999999887665443 3468999999998 999999999999888 999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||| ..+|++++++. .+.|++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||
T Consensus 87 fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 999999 88999999652 4899999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH---
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE--- 841 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 841 (959)
...... ..+.++-|.+|+|||++.. +-|+.+.||||+|||++|+.+-++-|.+....++.+.+..+-.......
T Consensus 159 ev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 159 EVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred ccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 765433 3577899999999999854 6789999999999999999999999999988877766655543322221
Q ss_pred --HHHHhcCCccc-CCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 842 --KLRAAIDPILE-VNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 842 --~~~~~~~~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+...+.-.++ ...... ....+.++++.+|+++||.+|||++|+++ .++++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~--~pffq~ 296 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ--HPFFQV 296 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc--Cccccc
Confidence 22222222221 111111 23457789999999999999999999988 555553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.68 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=216.4
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 687 (959)
+.|+..++||+|.||.||+|+ ..+|+.||+|++..............+||.+|++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778899999999999994 67899999999987765566677788999999999999999999987765 689999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
+|||+. +|.-++. ...-.|++.++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||||+++
T Consensus 197 FeYMdh-DL~GLl~----~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS----SPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred Eecccc-hhhhhhc----CCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 999954 7766662 334579999999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH-
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA- 845 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 845 (959)
........+..+-|.+|+|||.+.+ ..|+.++|+||.||||.||++|++.|.+....++...+--+-... .+....
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP--~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP--TEDYWPV 346 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC--Chhcccc
Confidence 7766666778889999999999988 479999999999999999999999999988776655442221111 111111
Q ss_pred -hcCC--cc-cCCCCCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 846 -AIDP--IL-EVNDDTF-------ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 846 -~~~~--~~-~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
.+.. .. ....+.. .......+|+..+|..||++|.|+.++++ .+++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF 403 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYF 403 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--Cccc
Confidence 1110 00 0011111 11235569999999999999999999976 4555
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=354.36 Aligned_cols=243 Identities=28% Similarity=0.378 Sum_probs=203.5
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.|+..++||+|+||.||.++. ++++.+|+|++++..+.. ...+...+|..++..++||+||+++-.|++.+..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 5688999999999999999954 578899999998875544 46778899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+.||.|..+|.+ ...+++..+.-++..|+.||.|||+ ++||||||||+|||+|++|+++|+||||++...
T Consensus 105 d~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 105 DYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred eccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999853 2679999999999999999999999 899999999999999999999999999999554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ....++||+.|||||++.+..|+..+|.||+|+++|||++|.+||.......... .+....
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~------~I~~~k-------- 241 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD------KILKGK-------- 241 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH------HHhcCc--------
Confidence 3322 2345899999999999999999999999999999999999999998776433211 111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP 880 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 880 (959)
....+. -......+++.+++..||++|.
T Consensus 242 -~~~~p~---~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPG---YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCc---cCCHHHHHHHHHHhccCHHHhc
Confidence 011011 1123567999999999999996
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=334.37 Aligned_cols=272 Identities=24% Similarity=0.342 Sum_probs=216.4
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.+|...+++|+|.||.||+|+ ..+|+.||||+++.............+|++.++.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467888999999999999995 5689999999998775554445677899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|| ..+|+..+++ ....++..++..++.++++|++|+|+ +.|+||||||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm-~tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ec-cccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99 6799998854 23679999999999999999999999 8999999999999999999999999999998876
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH-----
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL----- 843 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 843 (959)
....... .+-|.+|+|||.+.+ ..|+..+||||.||++.||+-|.+-|.+..+-++...+ +.......+..
T Consensus 154 p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I--f~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI--FRALGTPTPDQWPEMT 230 (318)
T ss_pred CCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH--HHHcCCCCcccCcccc
Confidence 5543333 377999999999988 56899999999999999999999999988776654333 22221111111
Q ss_pred --HHhcC----CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 --RAAID----PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 --~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+.+. +.......-........+++.+++..||.+|++++|+++ ++++..
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhc
Confidence 11110 000000011122335579999999999999999999977 666665
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=381.14 Aligned_cols=289 Identities=26% Similarity=0.415 Sum_probs=230.4
Q ss_pred CcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 613 FASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..++++||.|.||+||+|+++- ...||||.++.. .+.++..+|..|+.+|.++.||||++|.|+.......++|+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567899999999999998752 347999999876 46677889999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|||++|+|+.+|+.. ...|++.+...+.++||.||+||.+ .++|||||.++|||++.+..+||+|||++|...
T Consensus 710 EyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999653 2569999999999999999999999 899999999999999999999999999999775
Q ss_pred CCCcceeeccc--cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLA--GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
++.....+... -+.+|.|||++..++++.++|||||||++||.++ |.+|+-+....+.. +
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-----------------k 845 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-----------------K 845 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-----------------H
Confidence 54433333222 2569999999999999999999999999999876 88998776644321 1
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCC---Ccc--cCcc---cCCChhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEP---EEY--SGID---YSLPLNQ 917 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~---~~~--~~~~---~~~~~~~ 917 (959)
.++.... ...+++++..+.+|+..||++|-.+||.+.+|+..|+++++.-....... ... ...+ .+.....
T Consensus 846 aIe~gyR-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~~~~~~~f~ 924 (996)
T KOG0196|consen 846 AIEQGYR-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRSGSDFTPFR 924 (996)
T ss_pred HHHhccC-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCCCCCCcccC
Confidence 1221111 23345667789999999999999999999999999999987633221111 111 1111 1223456
Q ss_pred hHHHHHHhhC
Q 002149 918 MVKDWQEAEG 927 (959)
Q Consensus 918 ~~~~~~~~~~ 927 (959)
++.+|.+...
T Consensus 925 sv~~WL~aIk 934 (996)
T KOG0196|consen 925 SVGDWLEAIK 934 (996)
T ss_pred CHHHHHHHhh
Confidence 7788887764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.21 Aligned_cols=264 Identities=28% Similarity=0.382 Sum_probs=213.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+.....++||+|-||+|..+....+..||||+++.. .......+|.+|+++|.+++|||||+++|+|..++.+++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34566788999999999999999987899999999875 34556789999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc-cC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~-~~ 767 (959)
|||++|+|.+++..+.. ..+......+|+.|||.||+||.+ .++|||||.++|+|+|.++++||+|||++| .+
T Consensus 615 EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccc
Confidence 99999999999976432 224556677899999999999999 799999999999999999999999999999 45
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT--GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
..+......+.+-+.+|||||.+..++++.++|||+||+++||+++ ...||.....++...- ...
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-------------~~~ 755 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-------------AGE 755 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-------------hhh
Confidence 4444455566777889999999999999999999999999999876 5678776654332111 111
Q ss_pred hcCCcc--cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 846 AIDPIL--EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 846 ~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+++... .....+.-.+..+.+++.+||+.|-++||+++++...|.+.
T Consensus 756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111100 01111223445788999999999999999999998877653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.85 Aligned_cols=260 Identities=26% Similarity=0.470 Sum_probs=211.9
Q ss_pred CCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
.+.+.+.||+|.||+||+|.|. ..||||++.....+++..+.|+.|+.++++-+|.||+-+.|||..+.. .+|+.+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC 469 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC 469 (678)
T ss_pred Hhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence 3456789999999999999986 359999999887788899999999999999999999999999998877 9999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC-C
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD-S 770 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~-~ 770 (959)
+|-+|+.++|..+ ..|...+.+.||.|||+||.|||. ++|||||||+.||++.+++.|||+||||+..... .
T Consensus 470 eGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 470 EGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred cCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999997633 668899999999999999999999 9999999999999999999999999999873221 1
Q ss_pred Ccceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.........|..-|||||++.. .+|+..+||||||||+|||+||..||.....+.. ++.... +.+....
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------ifmVGr--G~l~pd~ 614 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------IFMVGR--GYLMPDL 614 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe------EEEecc--cccCccc
Confidence 1122333467889999999965 4689999999999999999999999985443322 111111 1111000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.......+.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 615 ------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 615 ------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111224455788999999999999999999999988887764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.44 Aligned_cols=258 Identities=25% Similarity=0.341 Sum_probs=212.3
Q ss_pred HHhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHH-HHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKK-AVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 684 (959)
.--++|..++.||+|+|++|++|+ ..+++.+|||++.+..+.++ ..+-+.+|-++|.+| .||.|++|+..|++...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 344679999999999999999995 55799999999987644433 355677899999999 899999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
|+|+||+++|+|.+++.+. +.|++.....+|.+|+.||+|||+ +|||||||||+|||+|+++++||+|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999764 568889999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCcc------------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 765 KLAPDSERS------------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 765 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
+.+...... ....++||..|.+||++..+..+..+|+|+|||++|+|+.|++||....+--.
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------ 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------ 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------
Confidence 865432211 12458999999999999999999999999999999999999999987654221
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
+.++++-....+ ...+..+.+|+++.|..||.+|++.++|.+ +++++
T Consensus 296 ----------FqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~--HpFF~ 342 (604)
T KOG0592|consen 296 ----------FQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKA--HPFFE 342 (604)
T ss_pred ----------HHHHHHhcccCC---CCCCHHHHHHHHHHHccCccccccHHHHhh--Ccccc
Confidence 111111111111 111246779999999999999999999876 55554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.95 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=210.3
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+.|+..+.||.|.-++||+|+ ...++.||||++..+..... .+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3578899999999999999995 56789999999987654444 788999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
.||.+|++.+.++..-. ..+.+..+..|..++++||.|||. +|.||||||+.||||+.+|.|||+|||.+-...
T Consensus 104 pfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999976332 458999999999999999999999 899999999999999999999999999866332
Q ss_pred CCCcc---eeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 769 DSERS---VVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 769 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
+.... ....++||+.|||||+++. ..|+.|+||||||++..||.+|..||...++.....+. +.+. ...+
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~---pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQND---PPTL 252 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCC---CCCc
Confidence 22221 1145799999999999644 57999999999999999999999999998876532211 1110 0000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ...+. .+........+.+++..|+..||++|||++++++
T Consensus 253 ~---t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 L---TSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred c---cccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 00000 1111222347889999999999999999999876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=341.29 Aligned_cols=272 Identities=27% Similarity=0.432 Sum_probs=203.9
Q ss_pred CcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc--CCCCceeEEEEEEeCc----eEEE
Q 002149 613 FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV--RHRHLVSLLGYSVAGY----ERLL 686 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 686 (959)
....++||+|.||.||||.++ ++.||||++. .+..+.|+.|-++++.. +|+||++++++-..+. +++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 345578999999999999987 6999999875 45677889998888875 7999999999887666 8999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL------AHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
|+||.+.|+|.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||++||||.+++++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999965 6799999999999999999999974 356899999999999999999999999
Q ss_pred ccccccCCCCC-cceeeccccccccccccccccCC-CC-----ccchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 002149 761 FGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGK-IT-----TKVDVFSFGVVLMELLTGLMALD-ESRPEERQYLAAW 832 (959)
Q Consensus 761 fGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlG~ll~elltg~~p~~-~~~~~~~~~~~~~ 832 (959)
||+|..+.... .......+||.+|||||++.+.. +. .+.||||+|.|||||+++...++ +..+.-..-....
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998664332 23334479999999999997642 22 36999999999999999865543 1111110000000
Q ss_pred HHhhhcchHH-----HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 833 FWNIKSDKEK-----LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 833 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
+..... -+. +++...+.++........+..+.+.+..||..||+.|.|+.=|.+.+.++...+.
T Consensus 440 vG~hPt-~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPT-LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCC-HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 110000 111 1111222222111222455678899999999999999999999888888766554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=351.52 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=198.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc--eEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY--ERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 688 (959)
++...+.||+|+||.||++... +|+..|||.+... .....+.+.+|+.+|.+++|||||+.+|...... .+++.|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4667789999999999999754 5899999998765 2222677899999999999999999999855544 688999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla~~~ 767 (959)
||+++|+|.+++... +. .+++..+..++.||++||+|||+ ++||||||||+|||++. ++.+||+|||+++..
T Consensus 96 Ey~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999652 22 69999999999999999999999 99999999999999999 799999999999866
Q ss_pred CC--CCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHHhhhcchHHH
Q 002149 768 PD--SERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDES-RPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 768 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
.. ..........||+.|||||++..+ ....++||||+||++.||+||+.||... ...+. +.....
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~------~~~ig~----- 237 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA------LLLIGR----- 237 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH------HHHHhc-----
Confidence 53 222233457899999999999864 3345999999999999999999999874 11111 111111
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.... +...........+++.+|+..||++|||+++++++
T Consensus 238 ----~~~~--P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 238 ----EDSL--PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred ----cCCC--CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 0000 11111233467899999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=355.60 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=215.3
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+....++..+.+.+|+++++.++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 478888999999999999995 4578899999998887778888999999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+.| +|..++.+ ...++++.+..|+.|++.||.|||+ .+|+|||+||.|||++.++.+|+||||+||....
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9955 99999844 3679999999999999999999999 8999999999999999999999999999997654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.+...+...|||-|||||...+..|+..+|+||+||++||+++|++||..... ...+..+..+.
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d~--------- 216 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKDP--------- 216 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcCC---------
Confidence 44567788999999999999999999999999999999999999999974322 11122222111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. .........+..++...+.+||.+|.+..+++. +++.+.
T Consensus 217 -v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~--HpF~k~ 256 (808)
T KOG0597|consen 217 -V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG--HPFWKG 256 (808)
T ss_pred -C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc--ChHHhh
Confidence 1 111133446789999999999999999999876 444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.50 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=214.0
Q ss_pred cCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..|....+||+|+.|.||.| +..+++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.|..+++.|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46888899999999999999 456789999999987532 334557899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
||++|+|.+.+.. ..+++.++..|+.+++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+..
T Consensus 351 ym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred ecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999998843 458999999999999999999999 8999999999999999999999999999886655
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... .....+|||.|||||+.....|..|+||||||++++||+-|.+||-...+-...+++. ..-.+
T Consensus 422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------------~ng~P 487 (550)
T KOG0578|consen 422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------TNGTP 487 (550)
T ss_pred ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------------hcCCC
Confidence 443 4566899999999999999999999999999999999999999998766544333332 00011
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.+. ........+.+++.+||..|+.+||++.|+++ +++++..
T Consensus 488 ~lk---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl~~a 529 (550)
T KOG0578|consen 488 KLK---NPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFLKMA 529 (550)
T ss_pred CcC---CccccCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhhhhc
Confidence 111 11222346789999999999999999999988 6666443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.81 Aligned_cols=274 Identities=23% Similarity=0.378 Sum_probs=213.7
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc--CCCCceeEEEEEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV--RHRHLVSLLGYSV 679 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~ 679 (959)
++-..+.+.++....+.||+|.||+||+|+|+ |+.||||++.. .+.+.+.+|.++++.. +|+||+.+++.-.
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 34556788888999999999999999999998 89999999863 3345677888888764 9999999999865
Q ss_pred eC----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCCEEE
Q 002149 680 AG----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS-----LAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 680 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dik~~NiLl 750 (959)
.+ .++|||++|.+.|||.|+|.. ..++.+..++++..+|.||+|||. ..++.|.|||||+.||||
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 44 378999999999999999954 678999999999999999999995 346789999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcc---eeeccccccccccccccccCC----C--CccchHHHHHHHHHHHHhC-------
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPEYAVTGK----I--TTKVDVFSFGVVLMELLTG------- 814 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlG~ll~elltg------- 814 (959)
.+++.+.|+|+|||-........ .....+||.+|||||++...- + -..+||||||.|+||+..+
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ 429 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIV 429 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEe
Confidence 99999999999999866544221 234468999999999985532 2 2359999999999999874
Q ss_pred ---CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 815 ---LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 815 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
+.||.+.-+.+...- + .. .....+.+.+.++......+.+..+.++++.||..+|+.|-|+-.+-+.|.+
T Consensus 430 eey~~Pyyd~Vp~DPs~e-e-Mr-----kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 430 EEYQLPYYDVVPSDPSFE-E-MR-----KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred hhhcCCcccCCCCCCCHH-H-Hh-----cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 566655433221100 0 00 0011122233344345566788899999999999999999999999988887
Q ss_pred hHh
Q 002149 892 LVE 894 (959)
Q Consensus 892 ~~~ 894 (959)
+.+
T Consensus 503 l~~ 505 (513)
T KOG2052|consen 503 LSN 505 (513)
T ss_pred Hhc
Confidence 764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=355.09 Aligned_cols=251 Identities=31% Similarity=0.456 Sum_probs=207.4
Q ss_pred ceeecHHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEE
Q 002149 598 NLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677 (959)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 677 (959)
.+.++++++-. .+-||.|+.|.||+|+++ ++.||||+++.- -..+|+-|++|+|+||+.+.|+
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeee
Confidence 35566666543 478999999999999998 789999987532 1357889999999999999999
Q ss_pred EEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 678 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
|....-++||||||..|-|...|+. .++++....+.+..+||.||.|||. +.|||||||+-||||..+..||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEE
Confidence 9999999999999999999999954 3678888999999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+|||.++...+. .....++||..|||||++...+.+.|+||||||||||||+||..|+...... +.+|...
T Consensus 253 IsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGVG 324 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGVG 324 (904)
T ss_pred eccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEecc
Confidence 9999999977654 2334589999999999999999999999999999999999999999765432 1233332
Q ss_pred cchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.. .+. +..+ ..++..+.-|+++||+-.|..||++.+++.+|+-.
T Consensus 325 sN--sL~------LpvP---stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 325 SN--SLH------LPVP---STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred CC--ccc------ccCc---ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 21 111 1112 23344567789999999999999999999998743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=361.86 Aligned_cols=262 Identities=30% Similarity=0.448 Sum_probs=212.9
Q ss_pred CCcccCcccccCceEEEEEEEcC--C---cEEEEEEccc-ccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGRGGFGVVYKGELDD--G---TKIAVKRMEA-GVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~--~---~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+....++||+|+||.||+|.+.. + ..||||..+. ........++|.+|+++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34455899999999999997643 2 2389999885 3356788899999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+|||+|.||+|.++|...+ ..++..++..++.++|+||+|||+ +++|||||.++|+|++.++.+||+|||+++
T Consensus 238 ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999996532 369999999999999999999999 899999999999999999999999999988
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
......... ....-+.+|+|||.+..+.++.++|||||||++||+++ |..|+.+....+... ++. .
T Consensus 311 ~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~---kI~---------~ 377 (474)
T KOG0194|consen 311 AGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA---KIV---------K 377 (474)
T ss_pred CCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH---HHH---------h
Confidence 554211111 11234679999999999999999999999999999999 788999887643211 110 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.. -++..+. ..+..+..++.+|+..+|++||+|.++.+.++.+......
T Consensus 378 ~~--~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 378 NG--YRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred cC--ccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 00 1111112 3445677888999999999999999999999988776554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=323.24 Aligned_cols=238 Identities=29% Similarity=0.406 Sum_probs=203.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+..+ ...+.+...+|..+++.+.||+++++.+.+.+....++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999765 678899999977533 3456777889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||++||.|..++++. +++++..+.-+|.||+.||+|||+ .+|++||+||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999652 679999999999999999999999 899999999999999999999999999999775
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. ....+|||.|+|||.+....+..++|.|||||++|||+.|..||....+... ...+....-.++..+.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKILEGKVKFPSYFS 265 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHHhCcccCCcccC
Confidence 53 4567999999999999999999999999999999999999999998776332 2222232222333332
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQR 879 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 879 (959)
+ .+.+|+.++++.|-.+|
T Consensus 266 ~-------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 S-------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred H-------------HHHHHHHHHHhhhhHhh
Confidence 2 56689999999999988
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.94 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=210.1
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.-.++|+.+..||+|+||.||.|+. .+|+.+|+|++++... ...+.+.+..|-.+|....+|.||+|+-.|++.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3457899999999999999999964 5799999999987532 3456778889999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
|||||++||++..+|.. ...+++..+..++.+++-|++.||. .|+|||||||+|+|||..|++||+||||+.
T Consensus 218 LiMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccc
Confidence 99999999999999854 3679999999999999999999999 899999999999999999999999999984
Q ss_pred cCCC-----------------------CCcc-----------------------eeeccccccccccccccccCCCCccc
Q 002149 766 LAPD-----------------------SERS-----------------------VVTRLAGTFGYLAPEYAVTGKITTKV 799 (959)
Q Consensus 766 ~~~~-----------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 799 (959)
-... +... .....+|||.|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 1110 0000 01235799999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC
Q 002149 800 DVFSFGVVLMELLTGLMALDESRPEERQ-YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ 878 (959)
Q Consensus 800 DvwSlG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 878 (959)
|.||+|||+|||+.|.+||....+.+.- .+..|-..... + .......+..+||.+|+. ||++
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P-~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------P-EEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------C-CcCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999999999988876642 22222211111 0 111112467799999999 9999
Q ss_pred CCC---HHHHHHHHHHhHh
Q 002149 879 RPD---MGHAVNVLAPLVE 894 (959)
Q Consensus 879 RPt---~~ev~~~L~~~~~ 894 (959)
|.- ++||.+ +++++
T Consensus 433 RLG~~G~~EIK~--HPfF~ 449 (550)
T KOG0605|consen 433 RLGSKGAEEIKK--HPFFK 449 (550)
T ss_pred hcCcccHHHHhc--CCccc
Confidence 985 666654 45555
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.31 Aligned_cols=265 Identities=26% Similarity=0.407 Sum_probs=206.9
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC-
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG- 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 681 (959)
.++|++.++||+|+||.||+|.. .+++.||||++... ......+.+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 45789999999999999999964 23568999998754 2344556789999999999 899999999988764
Q ss_pred ceEEEEEEecCCCchhhHHhhcccC-------------------------------------------------------
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSL------------------------------------------------------- 706 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 706 (959)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999998653210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc-eeeccccccc
Q 002149 707 --NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFG 783 (959)
Q Consensus 707 --~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~ 783 (959)
...++++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 02358899999999999999999999 89999999999999999999999999999855332221 1223456788
Q ss_pred cccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHH
Q 002149 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFW 862 (959)
Q Consensus 784 y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (959)
|+|||++.+..++.++|||||||++|||++ |..||......+.. ...+ . .... ... ......
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~~~---~-------~~~~--~~~---~~~~~~ 304 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQRL---K-------DGTR--MRA---PENATP 304 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHHH---h-------cCCC--CCC---CCCCCH
Confidence 999999999999999999999999999997 99999875432211 0000 0 0000 000 111234
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 863 TIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 863 ~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+.+++.+||+.||++||++.++++.|+.++++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.07 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=210.7
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEccccccc---HHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceE
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 684 (959)
..+|...+.||+|+||.|+.|. ..+++.||||++.+.... ....+.+.+|+.+++.++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4689999999999999999995 457899999977664222 133556778999999998 99999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeeccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGL 763 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfGl 763 (959)
++||||+.+|+|.+++.. ..++.+.++..++.|++.|++|+|+ ++|+||||||+|||++.+ +++||+|||+
T Consensus 96 ~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999954 3678899999999999999999999 899999999999999999 9999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGK-IT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....... ...+....-
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------YRKIRKGEF 240 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------HHHHhcCCc
Confidence 99774 2223456679999999999999977 86 679999999999999999999998543221 111111111
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.++..+. ..++..++.+|+..||.+|+++.+++ .+++++.
T Consensus 241 ~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred cCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 1111110 34678999999999999999999997 4666664
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=379.36 Aligned_cols=265 Identities=30% Similarity=0.441 Sum_probs=215.3
Q ss_pred CCcccCcccccCceEEEEEEEcC--Cc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGRGGFGVVYKGELDD--GT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+.+..+.||+|+||.||.|...+ |. .||||.+.+. .+.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44567889999999999997643 33 4899998865 46677899999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLN--LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
+++|||++|+|..++++.+... ...++..+.+.++.|||+|+.||++ +++|||||.++|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998753322 3568999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
||..-+...+ ......-+.+|||||++..+.++.|+|||||||++||++| |..||......+....+ . .
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~--~----~--- 919 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV--L----E--- 919 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH--H----h---
Confidence 9943332222 2222234569999999999999999999999999999999 78888876654421111 1 0
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..++..+.++ +..+.+++..||+.+|++||++..+++.+..+......
T Consensus 920 ------ggRL~~P~~C---P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 920 ------GGRLDPPSYC---PEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ------CCccCCCCCC---ChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 1133334443 34677999999999999999999999998888775443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.67 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=216.9
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
-|..++.||+|+-|.|-.|++ .+|+.+|||++.+. ..+......+.+|+-+|+-+.||||+++++++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 467788999999999999964 68999999999876 3445556778999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|-|.+++.. .+++++.++.+++.||+.|+.|+|. .+|+|||+||+|+|+|..+++||+|||+|.....
T Consensus 93 yv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999854 3789999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
+ ......+|++.|++||++++.+|. .++||||.|||||.|+||+.||++...... +.........+..
T Consensus 165 g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L------LlKV~~G~f~MPs--- 233 (786)
T KOG0588|consen 165 G--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL------LLKVQRGVFEMPS--- 233 (786)
T ss_pred C--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH------HHHHHcCcccCCC---
Confidence 2 345567999999999999999986 689999999999999999999996543322 1122221112221
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDE 902 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 902 (959)
....+.++|+.+|+..||++|.|++||++ ++++..+....+.
T Consensus 234 ----------~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 234 ----------NISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSGYTSLPSS 275 (786)
T ss_pred ----------cCCHHHHHHHHHHhccCccccccHHHHhh--CchhhcCCCCChh
Confidence 22336789999999999999999999988 6777766554443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=324.19 Aligned_cols=271 Identities=24% Similarity=0.314 Sum_probs=209.9
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 687 (959)
+.|+..+.|++|+||.||+|+. ++++.||+|+++.......-.-...+||.++.+.+|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3577788999999999999964 578999999998654322223446799999999999999999887654 4578999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+ .-+|..++...+ ++|...++..++.|+++|++|||. +.|+|||||++|+|++..|.+||+|||+||.+
T Consensus 156 Me~~-EhDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYV-EHDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHH-HhhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999 458888885432 689999999999999999999999 89999999999999999999999999999988
Q ss_pred CCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... ...+..+-|.+|+|||.+.+ ..|+...|+||+|||+.||+++++-|.+....++.+.+ +.-.....+....-
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPte~iwpg 304 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPSEAIWPG 304 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCccccCCC
Confidence 7653 34667788999999999987 46999999999999999999999999998766554433 22222222222211
Q ss_pred cCCcc-----cCCCCC-------H---HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 847 IDPIL-----EVNDDT-------F---ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~-----~~~~~~-------~---~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
++... ...... + .....-.+|+..++..||.+|-|+++.++ +.++.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~ 365 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFR 365 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccc
Confidence 11111 000000 0 01235568999999999999999999877 44444
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=341.69 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=207.8
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..|...+.||+|+||.||||. ..+++.||+|++.... .....+++++|+.++.+++++||.++++.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 356777899999999999995 4578999999998753 44556789999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
||.+|++.+.+.. ...+++..+.-++.++..|+.|||+ ++.+|||||+.|||+..+|.+|++|||.+-....
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999843 2344777788899999999999999 8999999999999999999999999999986655
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.... ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..... .+.+
T Consensus 164 ~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----------------lIpk 225 (467)
T KOG0201|consen 164 TVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----------------LIPK 225 (467)
T ss_pred hhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----------------eccC
Confidence 4433 366899999999999998899999999999999999999999998776522111 1111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+ +..+......+.+++..|+..||+.||++.++++
T Consensus 226 ~~P-P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAP-PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCC-CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111 1112233346889999999999999999999887
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.24 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=211.5
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
...+|++.+.||+|.||.|-+|. ...|+.||||.+++..+. +++.-.+.+|+++|..|+||||+.++.+|+..+..++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34578889999999999999995 578999999999876543 3456678899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||..+|.|++++.. .+.+++.+...|+.||+.|+.|+|. ++++|||||.+|||+|.++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhh
Confidence 9999999999999954 3678999999999999999999999 8999999999999999999999999999998
Q ss_pred CCCCCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
+.+.. ..+.++|++-|.+||++.+..|. +.+|-||+||+||-|+.|..||++...... + ..+.. + .
T Consensus 203 y~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---v---rQIs~--G---a 269 (668)
T KOG0611|consen 203 YADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---V---RQISR--G---A 269 (668)
T ss_pred hcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---H---HHhhc--c---c
Confidence 86643 45678999999999999998885 679999999999999999999998754321 1 11111 0 1
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
...+ ..+....-||++||..+|++|.|..+|..+-
T Consensus 270 YrEP---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 270 YREP---------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccCC---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111 1122456899999999999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=343.19 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=204.3
Q ss_pred cCCcccCcccccCceEEEEEEEcC-----------------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCcee
Q 002149 611 KNFASENELGRGGFGVVYKGELDD-----------------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 673 (959)
++|...++||+|+||.||+|.+++ +..||+|.+.... ......++.+|++++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 578889999999999999997532 3369999887542 3445678999999999999999999
Q ss_pred EEEEEEeCceEEEEEEecCCCchhhHHhhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002149 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKS--------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFI 739 (959)
Q Consensus 674 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 739 (959)
+++++.+....++||||+++|+|.+++..... .....+++..+..++.||+.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 99999999999999999999999998854221 112357889999999999999999999 8999
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh--CCC
Q 002149 740 HRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT--GLM 816 (959)
Q Consensus 740 H~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt--g~~ 816 (959)
||||||+|||++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999985533222 12233456789999999998999999999999999999987 567
Q ss_pred CCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 817 ALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 817 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
||......+..... .. .......... .......+..+.+++.+||+.||++||++.+|.+.|+
T Consensus 241 p~~~~~~~~~~~~~---~~------~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENA---GE------FFRDQGRQVY--LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHH---HH------Hhhhcccccc--ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77765443321111 00 0000000000 0001122346889999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=341.86 Aligned_cols=268 Identities=18% Similarity=0.250 Sum_probs=205.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999765 67899999987654444456678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++++.+..+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE-----MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 998877755432 12468999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH----
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA---- 845 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 845 (959)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||......+............. ......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP-AEQMKLFYSN 231 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC-HHHHHhhhcc
Confidence 333233445789999999999998999999999999999999999999987654332221111110000 000000
Q ss_pred -----hcCCcccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 -----AIDPILEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 -----~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...+....... .......+.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0012345889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.96 Aligned_cols=261 Identities=28% Similarity=0.418 Sum_probs=205.8
Q ss_pred HHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHH------------HHHHHHHHHHHHHhcCCCCcee
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKK------------AVDEFHSEIAVLSKVRHRHLVS 673 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~ 673 (959)
+...++|+..+.||+|.||.|-+|.. .+++.||||++.+...... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34457899999999999999999964 4789999999976432211 1357889999999999999999
Q ss_pred EEEEEEeC--ceEEEEEEecCCCchhhHHhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 674 LLGYSVAG--YERLLVYEYMPQGALSKHIFHWKSLNLEP-LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 674 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
|+.+..+. +..|||+|||..|.+...- . .++ +++.++++++.+++.||+|||. ++||||||||+|+|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~-d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl 243 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----P-DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLL 243 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----C-CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEE
Confidence 99998764 5789999999999885432 2 244 9999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCC----cceeeccccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 751 GDDFRAKVSDFGLVKLAPDSE----RSVVTRLAGTFGYLAPEYAVTGK----ITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
+++|++||+|||.+..++... .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999988663321 11233478999999999987743 3467999999999999999999998765
Q ss_pred hHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 823 PEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..+. ...++...+..+.. .+....+.+||+++|.+||++|.+..+|.. ++++..
T Consensus 324 ~~~l----------------~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~--Hpwvt~ 377 (576)
T KOG0585|consen 324 ELEL----------------FDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKL--HPWVTR 377 (576)
T ss_pred HHHH----------------HHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhhee--cceecc
Confidence 4221 22333333332222 244557889999999999999999999965 444433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.77 Aligned_cols=248 Identities=20% Similarity=0.329 Sum_probs=200.5
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceEEEEEEec
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYERLLVYEYM 691 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 691 (959)
..||+|++|.||+|.+ +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 48999999987643222 225678899999999999999999999877 34678999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++|+|.+++.. ...+++.....++.|++.||+|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999854 24688999999999999999999972 378899999999999999999999999998654322
Q ss_pred cceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 772 RSVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... +. . .. .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~---i~---~------~~--~ 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---II---N------KN--N 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH---h------cC--C
Confidence 23468899999999976 6899999999999999999999999987654332111 00 0 00 0
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
... .+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 240 ~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011 11123446889999999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.87 Aligned_cols=244 Identities=29% Similarity=0.384 Sum_probs=204.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|....+||+|+||.|+++..+ +++.+|||++++..+ ..++.+....|-+++... +||.++.++..++..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457889999999999999999765 688999999988754 456678888999998888 59999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+.||++..+. ..+.+++..+.-+|..|+.||+|||+ ++|||||||.+|||+|.+|.+||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~------~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI------HTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEE------ecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999953332 22679999999999999999999999 9999999999999999999999999999995
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... .....++|||.|||||++.+..|+.++|.|||||+||||+.|..||.+...++.- ..+..+
T Consensus 518 ~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~d------- 583 (694)
T KOG0694|consen 518 GMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVND------- 583 (694)
T ss_pred cCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhcC-------
Confidence 43222 2456789999999999999999999999999999999999999999987765431 112111
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
. ..++.-...+...++++++.++|++|.-+
T Consensus 584 ---~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ---E---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---C---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 11222334467899999999999999966
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.46 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=205.9
Q ss_pred cCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|++.+.||+|+||.||+|.++ .+..||+|.++... +......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46888999999999999999653 35689999987653 34445678999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999998542 2468999999999999999999999 8999999999999999999999999998765
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.............++..|+|||++.+..++.++|||||||++||+++ |+.||......+.... + .+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~---~----------~~ 223 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA---V----------ED 223 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---H----------HC
Confidence 43222111122345678999999999999999999999999999775 9999987654332110 0 00
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
... .. .....+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 224 ~~~--~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 224 GFR--LP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC--CC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 00 1112344688999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=308.18 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=208.3
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++++.||+|.||.||.|+. +++-.||+|++.+..+.. ....++.+|+++..+|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4688999999999999999965 467789999997754332 33577899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||.++|.+...|+.. ....+++.....++.|+|.|+.|+|. ++||||||||+|+|++..+.+||+|||-+...+
T Consensus 102 Eya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999643 33678888999999999999999999 899999999999999999999999999887654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
. ......+||..|.+||...+..++.++|+|++|++.||++.|..||......+.... +. ..+-.+
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr------I~----k~~~~~- 241 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR------IR----KVDLKF- 241 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH------HH----HccccC-
Confidence 3 334567999999999999999999999999999999999999999987653222110 00 010011
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
+ ........++|.+|+..+|.+|.+..|++++
T Consensus 242 p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P--------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C--------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 1223367899999999999999999999873
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=352.17 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 683 (959)
++|+..+.||+|+||.||+|... ++..||||++.... .......+.+|+++++.+ +|+||+++++++.....
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46888999999999999998632 34579999997543 334456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhccc----------------------------------------------------------
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS---------------------------------------------------------- 705 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 705 (959)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998864221
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc-eeec
Q 002149 706 -------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTR 777 (959)
Q Consensus 706 -------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~-~~~~ 777 (959)
....++++.++++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 011358899999999999999999999 89999999999999999999999999999855432221 1122
Q ss_pred cccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 778 LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 778 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
..++..|||||++.+..++.++|||||||++|||++ |+.||......... .. . ......... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~~----~------~~~~~~~~~--~~- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--YK----M------VKRGYQMSR--PD- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--HH----H------HHcccCccC--CC-
Confidence 345678999999999999999999999999999997 99999765432210 00 0 000000000 00
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
.....+.+++.+||+.||++||++.+|++.|++++
T Consensus 339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11246889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=351.91 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=205.4
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|+..+.||+|+||.||+|.. .++..||||+++... .....+.+.+|++++..+ +||||+++++++..+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34688899999999999999963 245689999987542 234456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhccc---------------------------------------------------------
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKS--------------------------------------------------------- 705 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 705 (959)
..++||||+++|+|.+++...+.
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999864221
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 706 -------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 706 -------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
.....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 011357899999999999999999999 8999999999999999999999999999986543322
Q ss_pred c-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 773 S-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 773 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||........ ....+. ......
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~----------~~~~~~ 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIK----------EGYRML 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHH----------hCccCC
Confidence 1 1122345678999999999999999999999999999998 8889876543221 111110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
. . .....++.+++.+|++.||++||++.+|++.|++.
T Consensus 338 ~--~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 S--P---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C--C---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0 01124688999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.99 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=201.7
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.|+..+.||+|+||.||+|.. .+|+.||||.+...... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999965 57899999988754322 2334567899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998887542 22468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||............. .... ..
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---------~~~~---~~ 220 (285)
T cd05631 155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---------RRVK---ED 220 (285)
T ss_pred CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---------HHhh---cc
Confidence 22 2234578999999999999999999999999999999999999998765422111000 0000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.. .........+.+|+.+||+.||.+||+ ++++++
T Consensus 221 ~~---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QE---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cc---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 111112346789999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.36 Aligned_cols=273 Identities=24% Similarity=0.333 Sum_probs=207.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----eE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-----ER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 684 (959)
-.|...+++|.|+||.||+|... +++.||||++-.... --.+|+++|+.++|||||+++-+|.... ..
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 35777899999999999999765 568999998764311 1247999999999999999998876432 22
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeeccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGL 763 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfGl 763 (959)
.+||||| ..+|.+.++++.. ....++.-.+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.
T Consensus 98 nlVleym-P~tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 4899999 5699998876432 23667788888899999999999999 899999999999999976 9999999999
Q ss_pred cccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
|+........ ..+.-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....++...+.-+...... +.
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~-e~ 249 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR-ED 249 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH-HH
Confidence 9977655443 34466899999999988 57999999999999999999999999998776654433322222221 11
Q ss_pred HHHhcC-------CcccCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 843 LRAAID-------PILEVND----DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 843 ~~~~~~-------~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
+..+-. +.+.... .......+..+++.+++..+|.+|.++.|+++ +++++....+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~--h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA--HPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc--chhhHHhhCc
Confidence 111110 1111111 11223446789999999999999999999976 7777776665
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.11 Aligned_cols=274 Identities=23% Similarity=0.312 Sum_probs=208.2
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC-ceeEEEEEEeCc------
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH-LVSLLGYSVAGY------ 682 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 682 (959)
..|...++||+|+||+||+|+ ..+|+.||+|++......+.......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667889999999999996 457899999999765332233455689999999999999 999999998877
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++|+||+ .-+|.+++....... ..++...+..++.||++||+|||+ ++|+||||||.||||++.|.+||+|||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 779999986533211 457778999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+|+.+.-... ..+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+....++...+ +.-.....+
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I--f~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI--FRLLGTPNE 242 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH--HHHcCCCCc
Confidence 9996553332 24556789999999999886 7999999999999999999999999988764433222 222222111
Q ss_pred HHHHhcC----CcccCCCCC------HHH---HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 842 KLRAAID----PILEVNDDT------FET---FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 842 ~~~~~~~----~~~~~~~~~------~~~---~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
....-+. -........ ... .....+++.+|++.+|.+|.+++.+++ ++++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~--h~yf~ 306 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT--HPYFS 306 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc--Chhhc
Confidence 1111111 110000000 000 125679999999999999999999977 44444
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=332.53 Aligned_cols=259 Identities=31% Similarity=0.489 Sum_probs=208.1
Q ss_pred cCCcccCcccccCceEEEEEEEcC------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|+..+.||+|+||.||+|.... ...||+|.+.... .......+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 467888999999999999997542 2579999887542 344566789999999999999999999999998999
Q ss_pred EEEEEecCCCchhhHHhhcccCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNL-----------EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
+++|||+++|+|.+++........ ..+++.++..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999865322111 568899999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAA 831 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~ 831 (959)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-- 238 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-- 238 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--
Confidence 9999999999985433221 22333466889999999998999999999999999999998 9999987665432111
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
+. . ... .......+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 239 -i~---~----------~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 -IR---S----------RQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HH---c----------CCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 10 0 000 01112234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=345.28 Aligned_cols=272 Identities=26% Similarity=0.353 Sum_probs=205.6
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----eEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-----ERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 685 (959)
+|+..+.||+|+||.||+|.. .+++.||||++..........+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999975 57899999998765444455677889999999999999999999998776 789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+. ++|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999995 678777632 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-----
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD----- 839 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 839 (959)
..............+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+.+..............
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6544333333445789999999998774 5789999999999999999999999877655432222111000000
Q ss_pred -hHHHHHhcCCcccCCC-------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 840 -KEKLRAAIDPILEVND-------DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 840 -~~~~~~~~~~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.......+........ ........+.+++.+|++.||++|||+.++++ ++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~ 292 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA--HPYLD 292 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc--CHhhC
Confidence 0011111111000000 00111346789999999999999999999977 44443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.00 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=208.0
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 568899999999999999998888889999987653 23356789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 83 MAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999998542 23568899999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||++....++.++|||||||++|||++ |+.||......+.... +. ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~----------~~~~- 222 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA---LQ----------RGYR- 222 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH---HH----------cCCC-
Confidence 3222233446778999999988889999999999999999998 9999976554332111 10 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.. ........+.+++.+|+..+|++||+++++.+.|+.+
T Consensus 223 -~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 -MP---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00 0011234678999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=341.40 Aligned_cols=277 Identities=23% Similarity=0.341 Sum_probs=205.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ceEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 685 (959)
+|++.+.||+|+||.||+|.. .+++.||||++............+.+|+++++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578889999999999999975 4789999999875433444556788999999999999999999987543 2479
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+ +++|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~-~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELM-ESDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecC-CCCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999999 5788888743 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCC--cceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--
Q 002149 766 LAPDSE--RSVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-- 839 (959)
Q Consensus 766 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 839 (959)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...................
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543221 112244679999999999865 67899999999999999999999999876543322111110000000
Q ss_pred -----hHHHHHhcCCcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 840 -----KEKLRAAIDPILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 840 -----~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
.......+.......... ......+.+++.+|++.||++||+++++++ ++++......
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~--hp~f~~~~~~ 299 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA--DPYFKGLAKV 299 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc--CchhhhcCcc
Confidence 000011111000000000 011235679999999999999999999987 6776655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.81 Aligned_cols=270 Identities=23% Similarity=0.313 Sum_probs=208.7
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 367999999999999999999765 68889999887542 3445677999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999998542 4588999999999999999999982 369999999999999999999999999998554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc-c--------
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS-D-------- 839 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-------- 839 (959)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +..... .
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSI 229 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCcccc
Confidence 322 2345789999999999999999999999999999999999999976554332111 100000 0
Q ss_pred -----------------------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 840 -----------------------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 840 -----------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.......+................+.+++.+||+.||++|||+.++++ ++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 306 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN--HTFIKR 306 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc--ChHHhh
Confidence 000000000000000001112346889999999999999999999987 455543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.23 Aligned_cols=246 Identities=26% Similarity=0.318 Sum_probs=201.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 689999999865322 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999854 2468899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... . ..
T Consensus 153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~------i----------~~ 212 (291)
T cd05612 153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK------I----------LA 212 (291)
T ss_pred CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H----------Hh
Confidence 32 2235789999999999998999999999999999999999999987654332110 0 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
...... ......+.+++.+|++.||.+||+ ++++++
T Consensus 213 ~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 GKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 011101 011236789999999999999995 777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=345.35 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=208.0
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 682 (959)
.++|.+.++||+|+||.||+|... .+..||||++... ......+.+.+|+++++++. ||||+++++++.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 457888999999999999999752 2346999998754 23444567899999999996 999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccC--------------------------------------------------------
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL-------------------------------------------------------- 706 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 706 (959)
..++||||+++|+|.++++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988653210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 707 -----------------------------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 707 -----------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
....+++..+..++.||++||+|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11358899999999999999999999 8999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002149 752 DDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYL 829 (959)
Q Consensus 752 ~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~ 829 (959)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~- 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY- 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-
Confidence 9999999999999855432221 1223456788999999999999999999999999999997 999987653322110
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. ....... .. ........+.+++.+||+.||++||++.+|.+.|.++++
T Consensus 351 -~----------~~~~~~~--~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 -N----------KIKSGYR--MA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -H----------HHhcCCC--CC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 0000000 00 111233468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=341.95 Aligned_cols=309 Identities=23% Similarity=0.330 Sum_probs=222.6
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC---
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--- 681 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 681 (959)
...+.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 344567899999999999999999965 5788999999876533444556788999999999999999999877533
Q ss_pred ---ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 682 ---YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 682 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEE
Confidence 4568999998 8899877632 468999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+............
T Consensus 160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999865432 234578999999999877 568899999999999999999999998765433211110000000
Q ss_pred c-------chHHHHHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCc
Q 002149 838 S-------DKEKLRAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE 905 (959)
Q Consensus 838 ~-------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~ 905 (959)
. ........+........... .....+.+++.+|++.||.+|||+.|+++ ++++..+..+..++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~--hp~~~~~~~~~~~~~~ 313 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA--HPYFSQYHDPEDEPEA 313 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhccCCCcccccc
Confidence 0 00011111111100011000 01124679999999999999999999987 6777777665544333
Q ss_pred ccCcccCCChhhhHHHHHHhhCCCc
Q 002149 906 YSGIDYSLPLNQMVKDWQEAEGKDL 930 (959)
Q Consensus 906 ~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (959)
.............+.+|++....+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (343)
T cd07878 314 EPYDESPENKERTIEEWKELTYEEV 338 (343)
T ss_pred CccccchhhhhccHHHHHHHHHHHH
Confidence 2111122233566677777665443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=335.91 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=211.5
Q ss_pred CCcccCcccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+....++||.|-||.||.|.|+. .-.||||.++.. ....++|..|+.+|+.++|||+|+|+|+|......|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34566899999999999998864 457999999853 45678999999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
|..|+|.++|+.+. ...++.-..+.+|.||+.||+||.. +++|||||.++|+|+.++..|||+||||+|....+
T Consensus 345 M~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999997644 3567777889999999999999999 89999999999999999999999999999976543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........-+..|.|||.+....++.|+|||+|||+|||+.| |-.|+.+....+...+ .+. +-
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-------LEk--------gy 483 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-------LEK--------GY 483 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-------Hhc--------cc
Confidence 3222222233678999999999999999999999999999998 6678877654332211 110 01
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
++..+ ..++..+.+|++.||++.|.+||++.|+.+.++.++..
T Consensus 484 RM~~P---eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 484 RMDGP---EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccCC---CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 12222 23455788999999999999999999999999988765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=341.70 Aligned_cols=243 Identities=27% Similarity=0.330 Sum_probs=197.4
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999965 4789999999875422 2334567789999999999999999999999999999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cc
Confidence 99988853 2568999999999999999999999 899999999999999999999999999998533222 12
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (959)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... + .. .....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~---~---~~----------~~~~~- 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---I---LM----------EEIRF- 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH---H---Hc----------CCCCC-
Confidence 3345799999999999999999999999999999999999999976543321111 0 00 00010
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 855 DDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 855 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.......+.+++.+||+.||++|| ++.++++
T Consensus 215 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111234678999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=333.31 Aligned_cols=266 Identities=22% Similarity=0.318 Sum_probs=198.3
Q ss_pred cCCcccCcccccCceEEEEEEE-c-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc---CCCCceeEEEEEEe-----
Q 002149 611 KNFASENELGRGGFGVVYKGEL-D-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSVA----- 680 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 680 (959)
++|++.+.||+|+||.||+|.. . +++.||+|++............+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3788999999999999999975 3 467899998875433333344566788777766 69999999998852
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
....++||||+. ++|.+++... ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 346789999994 7898888542 23568999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh-cc
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK-SD 839 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~ 839 (959)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... +.... ..
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i--~~~~~~~~ 229 (290)
T cd07862 154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI--LDVIGLPG 229 (290)
T ss_pred ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH--HHHhCCCC
Confidence 9999865433 2233457899999999998889999999999999999999999999877654322111 11000 00
Q ss_pred hHHHHHhcC---Cccc-CCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAID---PILE-VNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~---~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......+. .... ...... .....+.+++.+|++.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 011100000 0000 000000 12235679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=346.30 Aligned_cols=268 Identities=19% Similarity=0.215 Sum_probs=201.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|++.+.||+|+||.||+|.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 35799999999999999999965 5788999996432 34678999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|++ .++|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 163 e~~-~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRY-KTDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecC-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999 5788887743 2468899999999999999999999 899999999999999999999999999997543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHhhhc-----
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPE-----ERQYLAAWFWNIKS----- 838 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~----- 838 (959)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+...+.....
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 32222334567999999999999999999999999999999999999887543210 01111111110000
Q ss_pred ---chHHHHHhc-------CCcccCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 839 ---DKEKLRAAI-------DPILEVN---DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 839 ---~~~~~~~~~-------~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....+.... ....... .........+.+++.+||+.||++|||++|+++ +++++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~--hp~f~~~ 382 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD--FAAFQDI 382 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc--ChhhccC
Confidence 000000000 0000000 001123456889999999999999999999987 5565543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.59 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=201.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999765 688999999875422 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999998854 2467899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. ..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i----------~~ 229 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KI----------LA 229 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HH----------hc
Confidence 322 23579999999999999999999999999999999999999998765432211 01 11
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.....+. .....+.+++.+||+.||.+||+ +++++.
T Consensus 230 ~~~~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GRLKFPN---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCcCCCC---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111111 01235779999999999999997 577765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=309.03 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=207.6
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|++.+.||+|.|+.||++. ..+|+.+|+|.+.....+....+++.+|+.+.+.|+|||||++.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34578888899999999999994 56799999999887777777888999999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~DfGla 764 (959)
+|+|+|++|..-+-.. ..+++..+-..+.||+++|.|+|. ++|||||+||+|+++.. .--+|++|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999997655331 457888889999999999999999 99999999999999953 345999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
.... ........+|||+|||||++...+|+..+|||+-||+||-|+.|.+||.+...... +..+..
T Consensus 161 i~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~------ 226 (355)
T KOG0033|consen 161 IEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKA------ 226 (355)
T ss_pred EEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhc------
Confidence 9776 34456678999999999999999999999999999999999999999987443221 111111
Q ss_pred HhcCCcccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTF-ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....+...+ ....+..+|+++||..||++|.|+.|++.
T Consensus 227 ----g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 227 ----GAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----cccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111111011 12235679999999999999999999876
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.75 Aligned_cols=303 Identities=21% Similarity=0.288 Sum_probs=220.2
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------ 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 681 (959)
+.++|+..+.||+|+||.||+|.. ..++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999965 4688999999876544455567788999999999999999999987543
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||++ +++.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999995 56766652 347889999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK- 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 840 (959)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... +.......
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~~ 246 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--IEQLGTPCP 246 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCH
Confidence 9998653321 223457899999999999999999999999999999999999999876654322111 11000000
Q ss_pred -------HHHHHhcCCcccCCC-----------------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 841 -------EKLRAAIDPILEVND-----------------DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 841 -------~~~~~~~~~~~~~~~-----------------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
......+........ ........+.+++.+|++.||.+|||+.++++ ++++..|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~--hp~~~~~ 324 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYINVW 324 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc--Ccccccc
Confidence 001111111100000 00111236789999999999999999999987 5777766
Q ss_pred CCCCCCCCcccCc--ccCCChhhhHHHHHHhhCC
Q 002149 897 KPLDDEPEEYSGI--DYSLPLNQMVKDWQEAEGK 928 (959)
Q Consensus 897 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 928 (959)
..+...+...... ..........++|++...+
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (364)
T cd07875 325 YDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYK 358 (364)
T ss_pred cCcccCCCCCCCCCCccchhhhccHHHHHHHHHH
Confidence 5554443222111 1111235666778775443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.13 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|... +++.||||++...... ......+.+|++++..++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 5889999998764322 234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999853 2468899999999999999999999 899999999999999999999999999998554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... . ....+.
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~---~-------~~~~~~ 218 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---Y-------WKETLQ 218 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH---h-------cccccc
Confidence 3 2234579999999999999999999999999999999999999998776544221110 0 000010
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.. ............+.+++.+|+..+|.+||++.+++++
T Consensus 219 ~~-~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RP-VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CC-CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 0010011223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.72 Aligned_cols=260 Identities=25% Similarity=0.331 Sum_probs=219.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce-EEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE-RLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 688 (959)
++|..++.+|+|+||.++.++.+ ++..+++|++.....+....+...+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999644 67899999998877777777788999999999999999999999988877 89999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
+|++||++.+.+.+.+ ...++++.++.++.|++.|+.|||+ +.|+|||||+.||+++.+..|||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997654 4679999999999999999999998 899999999999999999999999999999776
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|....-... + . ...+..+.
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i---~------ki~~~~~~ 224 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I---L------KINRGLYS 224 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H---H------HHhhccCC
Confidence 544 234557899999999999999999999999999999999999999987654332 1 1 11111222
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
+ .+.....++..++..|++.+|+.||++.+++.. +.+..+.
T Consensus 225 P------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~--P~l~~~~ 265 (426)
T KOG0589|consen 225 P------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR--PHLLRYL 265 (426)
T ss_pred C------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC--hhhhhHH
Confidence 2 222344578899999999999999999999875 5555444
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.84 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..|...+.||+|+||.||+|... +++.||+|.+... ....+++.+|+++++.++|+||+++++++......++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 35778889999999999999654 5889999988753 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999988542 23568999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........++..|+|||++.+..++.++|||||||++|||++ |..||......+.... +.....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------------~~~~~~ 223 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------------LEKGYR 223 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------------HHCCCC
Confidence 32222222334678999999999999999999999999999998 9999976544321110 001000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
. .........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 224 ~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 M-----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred C-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 11112234688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.40 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=206.9
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++|+||+++++++......++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 35688899999999999999988778899999987542 234668899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++..+..++.|++.|+.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999998542 23568999999999999999999999 8999999999999999999999999999986653
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
...........+..|+|||++.+..++.++||||||+++|||++ |+.||........... + .....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~----------~~~~~ 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ---V----------DQGYR 222 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---H----------HcCCC
Confidence 32211122223458999999999899999999999999999999 9999987654321110 0 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
. .........+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 223 --~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 --M---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --C---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 01112235788999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.16 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=205.8
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe-Cc
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA-GY 682 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 682 (959)
++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 47889999999999999999532 35789999987542 334456788999999999 79999999998764 45
Q ss_pred eEEEEEEecCCCchhhHHhhcccC--------------------------------------------------------
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL-------------------------------------------------------- 706 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 706 (959)
..+++|||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988542210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc-eeeccccccccc
Q 002149 707 NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYL 785 (959)
Q Consensus 707 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~ 785 (959)
...++++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........ ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 01368999999999999999999999 89999999999999999999999999999865332221 122345677899
Q ss_pred cccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHH
Q 002149 786 APEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTI 864 (959)
Q Consensus 786 aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 864 (959)
|||++.+..++.++|||||||++|||++ |..||......+. +... +...... . ........+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~----------~~~~~~~--~---~~~~~~~~~ 305 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRR----------LKEGTRM--R---APEYATPEI 305 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHH----------HhccCCC--C---CCccCCHHH
Confidence 9999999999999999999999999998 9999976543221 1100 0000000 0 011123467
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 865 AELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 865 ~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+++.+|++.+|++||++.+++++|+.+++
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=332.44 Aligned_cols=267 Identities=21% Similarity=0.312 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..++||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 46889999999999999999654 68899999986542 22234567789999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ |+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 996 5898887432 2457899999999999999999999 8999999999999999999999999999985433
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc--------ch
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS--------DK 840 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 840 (959)
... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+............. ..
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred CCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 221 2233568999999999865 5689999999999999999999999987765543322211111000 00
Q ss_pred HHHHHhcCCcccCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 841 EKLRAAIDPILEVND---DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.......+...... ..........+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111111000000 00011235679999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.45 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=202.4
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...+++.+|+++++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3577888999999999999998888899999876542 2245688999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999885421 358899999999999999999999 89999999999999999999999999999865433
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+.... + ... ..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~---i---~~~--------~~ 219 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM---I---SRG--------FR 219 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H---HCC--------CC
Confidence 2222222345678999999988889999999999999999999 8999976654322111 1 000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
... .. .....+.+++.+|++.+|++||++.++++.|
T Consensus 220 ~~~-~~---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYR-PK---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCC-CC---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000 11 1123678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.64 Aligned_cols=273 Identities=21% Similarity=0.298 Sum_probs=207.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..++||+|+||.||+|... +++.+|+|.+.... .......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 367999999999999999999765 68889999887542 3445677899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999854 24578999999999999999999972 479999999999999999999999999997553
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc---------
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD--------- 839 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 839 (959)
... .....||..|+|||++.+..++.++|||||||++|||++|+.||......+..............
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 321 23357899999999999889999999999999999999999999865443321111000000000
Q ss_pred ------------------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 840 ------------------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 840 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
...+...+...............++.+++.+||+.||++||++.|+++ +++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~--h~~~~~ 304 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 304 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh--CHHHhc
Confidence 000000000000000000012245789999999999999999999976 566653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=349.24 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=210.7
Q ss_pred hcCCcccCcccccCceEEEEEEEcCC-cEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEE-EEe------
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDG-TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGY-SVA------ 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------ 680 (959)
..++++++.|.+|||+.||.|....+ ..||+|++... .+.....+.+|+++|+.|+ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34667889999999999999987655 99999998765 7788889999999999996 9999999993 221
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
..+.+|.||||++|.|-|++..... ..|++.++++|+.|+++|+++||. ++.+|||||||-+||||+.++..||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence 2477899999999999999965322 349999999999999999999999 447899999999999999999999999
Q ss_pred ccccccC-CCC-Ccce------eecccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 761 FGLVKLA-PDS-ERSV------VTRLAGTFGYLAPEYA---VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 761 fGla~~~-~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
||.|.-. ... .... .-...-|+-|+|||++ .+..+++|+|||||||+||-|+....||++....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 9998722 111 1110 0113568999999987 4568999999999999999999999999875321
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
.+++.....+.. ......+.+||+.||+.||.+||++.+|+..+.++....-+.
T Consensus 265 ---------------aIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 265 ---------------AILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred ---------------eEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 122222222222 345668899999999999999999999999988887654443
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=354.43 Aligned_cols=260 Identities=26% Similarity=0.307 Sum_probs=209.3
Q ss_pred HHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc---
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY--- 682 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 682 (959)
+...++|.+.+.||+|+||.||+|.. .+|+.||||++............+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999964 57899999999776556666778899999999999999999988765332
Q ss_pred -----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 683 -----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 683 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEE
Confidence 3679999999999999986532 233678999999999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 758 VSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 758 i~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HH
Confidence 999999986543221 22334679999999999999999999999999999999999999998765432111 00
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
. .....+ ........+.+++.+||+.||.+||++.+++++
T Consensus 258 ~------~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L------AGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h------cCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 000111 111223468899999999999999999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=337.69 Aligned_cols=275 Identities=24% Similarity=0.315 Sum_probs=206.6
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----- 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 682 (959)
+.++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999965 46899999998765445556677889999999999999999999886443
Q ss_pred -eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 683 -ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 683 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
..++||||++ +++.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 5689999995 56665552 347889999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-- 839 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 839 (959)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ........
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~~~~~ 243 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK--VIEQLGTPSA 243 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCcH
Confidence 9997543321 22345789999999999999999999999999999999999999987654321110 00000000
Q ss_pred ------hHHHHHhcCCcccCCCC-----------------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 840 ------KEKLRAAIDPILEVNDD-----------------TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 840 ------~~~~~~~~~~~~~~~~~-----------------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.......+......... .......+.+++.+|++.||++|||+.|+++ ++++..|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~~ 321 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR--HPYITVW 321 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc--Cchhhhh
Confidence 00011111110000000 0011235789999999999999999999987 5666665
Q ss_pred CCCC
Q 002149 897 KPLD 900 (959)
Q Consensus 897 ~~~~ 900 (959)
..+.
T Consensus 322 ~~~~ 325 (359)
T cd07876 322 YDPA 325 (359)
T ss_pred cCcc
Confidence 5433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.36 Aligned_cols=239 Identities=27% Similarity=0.331 Sum_probs=193.2
Q ss_pred ccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||+|... +++.||+|++.... ........+.+|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 68899999986532 2334556788999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 998854 2468999999999999999999999 899999999999999999999999999998543322 1233
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ..........
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~----------~~~~~~~~~~-- 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------R----------KILQEPLRFP-- 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------H----------HHHcCCCCCC--
Confidence 467999999999999999999999999999999999999999875543211 1 1111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRPDMGHA 885 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 885 (959)
......+.+++.+||+.||++||++..+
T Consensus 214 -~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 214 -DGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred -CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 1122467899999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.58 Aligned_cols=259 Identities=26% Similarity=0.387 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.+|+..+.||+|+||.||+|.+. +++ .||+|++... ......+++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46889999999999999999753 344 3899998643 2345567889999999999999999999998765 567
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999998642 2458899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcce-eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSERSV-VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+..... . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~---~----~~--- 227 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----KG--- 227 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---h----CC---
Confidence 664432221 122334678999999999999999999999999999998 99999876543321110 0 00
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
...... ......+.+++.+|+..+|++||++.++++.+..+..+.
T Consensus 228 -----~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 -----ERLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -----CCCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 000001 112236789999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=327.98 Aligned_cols=257 Identities=25% Similarity=0.432 Sum_probs=211.7
Q ss_pred CcccCcccccCceEEEEEEEcC---Cc--EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 613 FASENELGRGGFGVVYKGELDD---GT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
....++||+|-||.||+|.+.+ |+ .||||.-+... .....+.|..|..+|++++|||||+++|+|.+. ..|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 3456789999999999997532 33 58999888754 444578899999999999999999999998765 78999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||.++-|.|..++... ...++..+...++.||..||+|||+ ..+|||||..+|||+....-||++|||++|..
T Consensus 469 mEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999653 3678999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.++..+..+...-+..|||||.+.-.+++.++|||-|||.+||++. |..||.+....+. ....+.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEn------- 607 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIEN------- 607 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecC-------
Confidence 7765555554455779999999999999999999999999999887 8999988754331 001110
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..+++.++ .++..+..|+.+||..||.+||++.++...|..+++..
T Consensus 608 -GeRlP~P~---nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 608 -GERLPCPP---NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred -CCCCCCCC---CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 11222233 33446778999999999999999999999999988743
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.79 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=206.6
Q ss_pred cCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|+..+.||+|+||.||+|.+.. ...||||.+.... ......++.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 468889999999999999997642 3579999887542 34456778999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999998542 2468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 767 APDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 767 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.. ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~---~~~~---------- 222 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI---KAVE---------- 222 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH---HHHH----------
Confidence 642222 11222345678999999999999999999999999999998 99998765433211 1010
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
... .. .........+.+++.+|++.+|++||++.++++.|..+
T Consensus 223 ~~~--~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGY--RL---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCC--CC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00 00112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.65 Aligned_cols=264 Identities=26% Similarity=0.342 Sum_probs=208.1
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ce
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 683 (959)
.++|++.+.+|+|||+.||.++ ..+++.+|+|++... ..++.+...+|++..++++|||+++++++...+ .+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4689999999999999999996 667889999999865 467778899999999999999999999876433 45
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.|++++|...|+|.+.+...+. ....+++.+++.|+.+|++||++||+.. .+++||||||.|||+.+.+.++|.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999976543 3468999999999999999999999932 4599999999999999999999999999
Q ss_pred cccCCCCCc--------ceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 764 VKLAPDSER--------SVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 764 a~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
++..+-... ........|.-|+|||.+. +...+.++|||||||+||+|+.|..||+...... ..++
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSla-- 252 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLA-- 252 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEE--
Confidence 874432111 1122234688999999873 4568899999999999999999999997543211 0000
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
-......+..+... .....+.+++++|++.||.+||+..+++..++.+
T Consensus 253 -----------LAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 -----------LAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------EeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 01111122212111 2456788999999999999999999999888765
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=340.51 Aligned_cols=246 Identities=25% Similarity=0.318 Sum_probs=200.7
Q ss_pred cCCcccCcccccCceEEEEEEEcC--CcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD--GTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
++|...+.||+|+||.||+|..+. +..||+|++..... .....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999997542 36899998865322 233456788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999854 2468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+..... .. .
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i----------~ 241 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KI----------L 241 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HH----------h
Confidence 432 234579999999999999889999999999999999999999998765432111 00 1
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
......+. .....+.+++.+|++.||++|+ +++++.+
T Consensus 242 ~~~~~~p~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 242 EGIIYFPK---FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred cCCCCCCC---CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11111111 1123567999999999999995 7888876
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.03 Aligned_cols=255 Identities=30% Similarity=0.470 Sum_probs=205.5
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.++||+|+||.||+|...+...||+|++..... ..+.+.+|+++++.++|+||+++++++.. ...++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 56889999999999999999877777899999875432 23568899999999999999999998754 567899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999998542 22467999999999999999999999 89999999999999999999999999999865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||+..+..++.++|||||||++|||++ |+.||......+..... .....
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------------~~~~~- 221 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGYR- 221 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------------hcCCC-
Confidence 3222223456778999999998899999999999999999999 88888766543221100 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
..........+.+++.+|++.+|++||++.++++.|+.++
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233457889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.94 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=209.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+|++.+.||+|+||.||+|.. .+++.||||.+... .........+.+|+++++.++||||+++++++.+....++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999975 47899999987642 223455667889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++..... ....+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999988865332 23568899999999999999999999 899999999999999999999999999988654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... +.....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~----------~~~~~~ 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQK----------IEQCDY 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHH----------HhcCCC
Confidence 3222 12234688899999999988899999999999999999999999865432111 11110 000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+ ..........+.+++.+||..+|++||++.+|++.++++
T Consensus 226 ~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 P----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 111112335688999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.34 Aligned_cols=272 Identities=21% Similarity=0.336 Sum_probs=201.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc-ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 367999999999999999999765 68899999987542 1222345778999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+ .++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYV-HTDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECC-CcCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999 57887777432 2568899999999999999999999 899999999999999999999999999987543
Q ss_pred CCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH-HHHH-
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE-KLRA- 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 845 (959)
... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....... +............ ....
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ-LERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhCCCChhhccch
Confidence 222 12234568999999999865 45888999999999999999999999875432211 1111110000000 0000
Q ss_pred ----hcCC-ccc-CCCCCHH-------HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 846 ----AIDP-ILE-VNDDTFE-------TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 846 ----~~~~-~~~-~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+.+ ... ....... ....+.+++.+|++.||++|||+.|+++ ++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~--h~~f~ 292 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS--HEYFS 292 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc--Ccccc
Confidence 0000 000 0000000 1135679999999999999999999976 45544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.14 Aligned_cols=243 Identities=27% Similarity=0.338 Sum_probs=196.8
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
+.||+|+||.||++.. .+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999965 4689999999876422 2344566788999999999999999999999999999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence 99888743 2468999999999999999999999 899999999999999999999999999987532221 12
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (959)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ........
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~----------------~~~~~~~p 215 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------LMEEIRFP 215 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----------------hcCCCCCC
Confidence 23457999999999999999999999999999999999999999866543321110 00000000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 855 DDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 855 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11224678999999999999998 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=349.82 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=203.3
Q ss_pred CCcccCcccccCceEEEEEEEc-C-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-D-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++|||||++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3888899999999999999543 4 678899876543 34445678889999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ....++++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999886422 223578999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... . ......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~------~~~~~~ 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------V------LYGKYD 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H------HhCCCC
Confidence 322 223446799999999999999999999999999999999999999986554321110 0 000001
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+ ........+.+++.+||..||++||++.++++
T Consensus 290 ~------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 01112236789999999999999999999875
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.99 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=207.7
Q ss_pred CCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+|++.+.||+|+||.||+|... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999643 23578999887542 3344577899999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002149 686 LVYEYMPQGALSKHIFHWKS-------------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSS 746 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~ 746 (959)
+||||+.+|+|.+++..... .....+++.+++.++.|++.||+|||+ .+++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999998864221 112458899999999999999999999 89999999999
Q ss_pred CEEECCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 002149 747 NILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPE 824 (959)
Q Consensus 747 NiLl~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~ 824 (959)
||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999854332221 1122345678999999988899999999999999999999 99999876543
Q ss_pred HHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 825 ERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+..... ...... .........+.+++.+|++.+|++||++.++++.|+.++.+
T Consensus 237 ~~~~~~-------------~~~~~~-----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RLFNLL-------------KTGYRM-----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHH-------------hCCCCC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 321110 000000 01112234688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.28 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=206.0
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999965 4788999999876532 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999998653 2468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeeccccccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAV------TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~---- 223 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMN---- 223 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHc----
Confidence 44333334457999999999986 4567899999999999999999999998765433211 0000
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. ....... ........+.+++.+|++ +|++||++.++++ ++++.
T Consensus 224 ---~-~~~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~--h~~~~ 267 (330)
T cd05601 224 ---F-QRFLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC--HPFFS 267 (330)
T ss_pred ---C-CCccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC--CCCcC
Confidence 0 0001100 111223467789999998 9999999999875 44443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.91 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=196.3
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..++||+|+||.||+|... +++.||||++.... .....+.+.+|+++++.++|+||+++++++......++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4556788999999999999754 68999999986542 344457789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+. ....+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999998543 234677888999999999999999 89999999999999999999999999999865432
Q ss_pred Ccceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+...+.
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----------- 289 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----------- 289 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----------
Confidence 21 1234579999999998743 234568999999999999999999997443222111111000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.... ..........+.+++.+||+.||++||++.|+++ ++++.+
T Consensus 290 -~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~ 333 (353)
T PLN00034 290 -MSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILR 333 (353)
T ss_pred -ccCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccccc
Confidence 0000 0111122346889999999999999999999987 455544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=325.79 Aligned_cols=263 Identities=31% Similarity=0.478 Sum_probs=209.6
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
..+|.+.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35688899999999999999964 23456899988754 44556789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhccc--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS--------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
.++||||+++++|.+++..... .....+++.++..++.|++.||+|||+ ++++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999999864321 122358999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 833 (959)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~---- 234 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---- 234 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----
Confidence 99999999985433221 11223445778999999998899999999999999999998 8999977654332110
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... . .. .... ......+.+++.+|++.||.+||++.++.+.|+.+.+.
T Consensus 235 --i~~--~----~~---~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 --ITQ--G----RV---LQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred --HHc--C----Cc---CCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0 00 0000 11224688999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.00 Aligned_cols=244 Identities=27% Similarity=0.334 Sum_probs=197.5
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
+.||+|+||.||++.. .+++.||||++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999965 4689999999876432 2344567889999999999999999999999999999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-AT 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cc
Confidence 99888743 2468999999999999999999999 899999999999999999999999999987533221 12
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (959)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .. .....+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~----------~~~~~p 215 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM----------EDIKFP 215 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------cc----------CCccCC
Confidence 33457999999999999999999999999999999999999999865543221110 00 000000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002149 855 DDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNV 888 (959)
Q Consensus 855 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 888 (959)
......+.+++.+||..||++|| ++.+++++
T Consensus 216 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 ---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11223678999999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.20 Aligned_cols=250 Identities=34% Similarity=0.531 Sum_probs=194.5
Q ss_pred ccCcccccCceEEEEEEEc-----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 615 SENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..+.||.|.||.||+|.+. .+..|+||.++.. ......+.+.+|++.+++++||||++++|++......++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 3467999999999999876 3568999999653 345567889999999999999999999999998888999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++.++..++.||++||+|||+ .+++|+||+++||+++.++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999763 23678999999999999999999999 8999999999999999999999999999986632
Q ss_pred CCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 770 SER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... .......+...|+|||.+....++.++||||||+++|||++ |+.|+......+... .+ .
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~---~~----------~--- 219 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE---KL----------K--- 219 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH---HH----------H---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc----------c---
Confidence 222 22233456789999999999999999999999999999999 789987765433111 01 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
+... ..........+.+++.+||+.||++||++.++++.|
T Consensus 220 ~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0000 001111234678999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.61 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=202.3
Q ss_pred CcccCcccccCceEEEEEEEcC-Cc--EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------ce
Q 002149 613 FASENELGRGGFGVVYKGELDD-GT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------YE 683 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 683 (959)
|.+.+.||+|+||.||+|.... ++ .||+|.++.........+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999997654 33 689999876655566678899999999999999999999987532 24
Q ss_pred EEEEEEecCCCchhhHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
.++||||+++|+|.+++...+. .....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988743221 123458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcce-eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSERSV-VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+... .+. . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~---~~~---~-~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD---YLR---Q-G 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHH---c-C
Confidence 998654432211 122345678999999999999999999999999999999 789997654432111 010 0 0
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.... ........+.+++.+||+.||++||++.++++.|+++
T Consensus 231 --------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 --------NRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --------CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0112234678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=336.85 Aligned_cols=273 Identities=22% Similarity=0.316 Sum_probs=206.4
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------ 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 681 (959)
+.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999965 4688999999876544555567788999999999999999999987643
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||++ +++.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 35689999995 56666552 347889999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-- 839 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 839 (959)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... +......
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~ 239 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCP 239 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCH
Confidence 9998653321 223457899999999999999999999999999999999999999876543321111 0000000
Q ss_pred ------hHHHHHhcCCccc----------------CC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 840 ------KEKLRAAIDPILE----------------VN-DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 840 ------~~~~~~~~~~~~~----------------~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.......++.... .. .........+.+++.+|++.||++|||+.|+++ ++++..|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~--hp~~~~~ 317 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ--HPYINVW 317 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc--Ccchhcc
Confidence 0011111110000 00 001112346789999999999999999999987 5666655
Q ss_pred CC
Q 002149 897 KP 898 (959)
Q Consensus 897 ~~ 898 (959)
..
T Consensus 318 ~~ 319 (355)
T cd07874 318 YD 319 (355)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.57 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=205.1
Q ss_pred HhcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
..++|+..+.||+|+||.||+|... +++.||||++.... ......++.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567999999999999999999653 35679999886432 3344567889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL-----NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
..++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653211 12346889999999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHh
Q 002149 758 VSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 758 i~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 835 (959)
|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~----- 234 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV----- 234 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence 9999998754332221 1122345788999999999899999999999999999999 78899876543321110
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
...... .........+.+++.+|++.+|++||++.|+++.|+
T Consensus 235 -----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 -----------MEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -----------HcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000000 001112346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.80 Aligned_cols=258 Identities=31% Similarity=0.458 Sum_probs=206.6
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|.+.+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45778899999999999999753 34789999987542 333567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 685 LLVYEYMPQGALSKHIFHWKS---------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
++||||+++++|.+++..... .....+++.++..++.|++.|++|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999965321 123458899999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 833 (959)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~---~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---I 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---H
Confidence 99999999975432221 11223456788999999999999999999999999999999 9999976654332111 1
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
. ..... .........+.+++.+||..||++||++.|+++.|+
T Consensus 238 ~-------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-------------QGRLL--QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-------------cCCcC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 00000 001123346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=343.63 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=205.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|.+.+.||+|+||.||+|... +++.||||++....... .....+.+|++++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999765 78999999987643222 44567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999998542 568999999999999999999999 899999999999999999999999999998654
Q ss_pred CCC----------------------------cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 002149 769 DSE----------------------------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDE 820 (959)
Q Consensus 769 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~ 820 (959)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1122345799999999999999999999999999999999999999987
Q ss_pred CChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 002149 821 SRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-MGHAVN 887 (959)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 887 (959)
....+..... .... .....+.. ......+.+++.+|+. ||.+||+ +.++++
T Consensus 233 ~~~~~~~~~i-------------~~~~-~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQETYNKI-------------INWK-ESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHHHHHH-------------hccC-CcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 7643321110 0000 00110100 0123467899999997 9999999 999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.02 Aligned_cols=273 Identities=23% Similarity=0.329 Sum_probs=222.2
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 675 (959)
..+++..-..+++...++-+|.||.||+|.|. +.+.|-||.++.. .++.+...+..|..++..+.|||+.++.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 34455555667888889999999999999554 3456778887765 4677788899999999999999999999
Q ss_pred EEEEe-CceEEEEEEecCCCchhhHHhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 676 GYSVA-GYERLLVYEYMPQGALSKHIFHWKS---LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 676 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
+++.+ ....+.+|.++.-|+|..++..++. ...+.++..+.+.+|.|++.|++|||. ++|||.||.++|++||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceeh
Confidence 98865 4567888999999999999985442 234568888999999999999999999 8999999999999999
Q ss_pred CCCcEEEeeccccc-cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002149 752 DDFRAKVSDFGLVK-LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYL 829 (959)
Q Consensus 752 ~~~~~ki~DfGla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~ 829 (959)
+..++||+|-.++| .++.+..........+..||+||.+....|+.++|||||||++|||+| |+.|+.+-.|.|....
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 99999999999999 555555555555667889999999999999999999999999999998 8999988877664322
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
. .+.. ++ ..+..++.++..++..||..+|++||+++|+++.|.++....
T Consensus 511 l-------kdGy--------Rl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 511 L-------KDGY--------RL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred H-------hccc--------ee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 1 1011 11 223344557888999999999999999999999998876543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.07 Aligned_cols=268 Identities=23% Similarity=0.305 Sum_probs=211.0
Q ss_pred cCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-C-----CCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-H-----RHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 683 (959)
.+|.+.+.||+|+||.|.+| +.++++.||||+++.. +.-..+...|+.+|..|+ | -|+|++++++...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 38999999999999999999 5567999999999864 445566778999999997 4 389999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC--CcEEEeec
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD--FRAKVSDF 761 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~--~~~ki~Df 761 (959)
.|||+|.+ .-+|+++++. .....++...+..|+.||+.||..||+ .+|||+||||+||||... ..+||+||
T Consensus 263 lciVfELL-~~NLYellK~---n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKN---NKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred eeeeehhh-hhhHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEec
Confidence 99999999 7899999965 455779999999999999999999999 899999999999999653 47999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-- 839 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 839 (959)
|.|+...... ..+.-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+....++...+..+......
T Consensus 336 GSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 336 GSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred ccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998765432 2456788999999999999999999999999999999998889888776654433322211000
Q ss_pred ---hHHHHHhcCC--------------------------------cccC-CC------CCHHHHHHHHHHHHhcccCCCC
Q 002149 840 ---KEKLRAAIDP--------------------------------ILEV-ND------DTFETFWTIAELAGHCTSREPS 877 (959)
Q Consensus 840 ---~~~~~~~~~~--------------------------------~~~~-~~------~~~~~~~~l~~l~~~cl~~dP~ 877 (959)
......+++. .... .. ........+.+++++|+.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0000111111 0000 00 0112344678999999999999
Q ss_pred CCCCHHHHHHHHHHhHh
Q 002149 878 QRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 878 ~RPt~~ev~~~L~~~~~ 894 (959)
+|+|..++++ ++++.
T Consensus 492 ~R~tp~qal~--Hpfl~ 506 (586)
T KOG0667|consen 492 ERITPAQALN--HPFLT 506 (586)
T ss_pred hcCCHHHHhc--Ccccc
Confidence 9999999977 55554
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=324.97 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=204.8
Q ss_pred cCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
..|+..+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+++++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4577889999999999999974 246789999987542 3445577899999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 686 LVYEYMPQGALSKHIFHWKS------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
+||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999999853211 012358899999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAA 831 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~ 831 (959)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~- 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV- 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 9999999999985433221 12233456778999999988889999999999999999999 99999776543221111
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.. ...+. ........+.+++.+|++.||++||++.+|.+.|..
T Consensus 240 --~~------------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 --RK------------RQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --Hc------------CCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 00001 011123467899999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=337.85 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=198.4
Q ss_pred CCcccCcccccCceEEEEEEE----cCCcEEEEEEcccccc--cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceE
Q 002149 612 NFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVI--SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 684 (959)
+|++.+.||+|+||.||+++. .+++.||+|++.+... .....+.+.+|+.++..+ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999864 3678999999865322 123345678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999998853 2468899999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||............ .
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~--------- 220 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---S--------- 220 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---H---------
Confidence 86544333333456799999999999765 4788999999999999999999999754322111000 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
......... ........+.+++.+|++.||++|| +++++++
T Consensus 221 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 RRILKCDPP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHhcCCCC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 000110000 0111233578999999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.46 Aligned_cols=255 Identities=30% Similarity=0.467 Sum_probs=209.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..+|+..++||.|+||.||+|...+++.+|+|.+... .......+.+|+.+++.++|+||+++++++......++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3468888999999999999998888899999998754 33345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999642 23568999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+.... +. ....
T Consensus 157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~---~~----------~~~~ 222 (261)
T cd05148 157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ---IT----------AGYR 222 (261)
T ss_pred cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH---HH----------hCCc
Confidence 3222 223456778999999988899999999999999999998 8999977654332111 10 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
. .........+.+++.+|++.||.+|||+.++.+.|+.
T Consensus 223 --~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 --M---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0 0111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=320.80 Aligned_cols=251 Identities=29% Similarity=0.423 Sum_probs=202.1
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|...+.||+|+||.||+|+..++..+|||.+..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35778889999999999999887777899998875422 235688999999999999999999999988889999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ...+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999988542 2368999999999999999999999 89999999999999999999999999998855443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... + ......
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~---~----------~~~~~~ 220 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK---V----------SQGLRL 220 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---H----------hcCCCC
Confidence 2222222345678999999988889999999999999999999 9999976654321110 0 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
.. . ......+.+++.+||+.+|.+||++.++++.+
T Consensus 221 ~~--~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 221 YR--P---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CC--C---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 00 0 01234788999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=341.06 Aligned_cols=255 Identities=22% Similarity=0.260 Sum_probs=202.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|+..+.||+|+||.||+|... +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999754 688999999865322 223445678899999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 122 MEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999998843 347888899999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTG----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .+....
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~--- 263 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHK--- 263 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCC---
Confidence 43322223345799999999998653 47889999999999999999999998765432110 000000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNV 888 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 888 (959)
..+..+ ........+.+++.+|++.+|.+ ||++.+++++
T Consensus 264 -----~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 -----NSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001101 11112346789999999999988 9999999773
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.45 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.|+..+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999965 4688999999875422 33456678999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998854 2458899999999999999999999 8999999999999999999999999999763311
Q ss_pred CCc----------------------------------------------ceeeccccccccccccccccCCCCccchHHH
Q 002149 770 SER----------------------------------------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFS 803 (959)
Q Consensus 770 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 803 (959)
... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 0012357999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHh--cccCCCCCCCC
Q 002149 804 FGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGH--CTSREPSQRPD 881 (959)
Q Consensus 804 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt 881 (959)
|||++|||++|+.||....+.+..... .. . ....... .......++.+++.+ |+..+|..||+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i------~~-------~-~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKV------IN-------W-ENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHH------Hc-------c-ccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCC
Confidence 999999999999999876654321110 00 0 0000000 000112356678877 55566667999
Q ss_pred HHHHHHHHHHhHh
Q 002149 882 MGHAVNVLAPLVE 894 (959)
Q Consensus 882 ~~ev~~~L~~~~~ 894 (959)
+.++++ ++++.
T Consensus 299 ~~~~l~--hp~f~ 309 (381)
T cd05626 299 ADDIKA--HPFFS 309 (381)
T ss_pred HHHHhc--CcccC
Confidence 999987 45543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=337.90 Aligned_cols=262 Identities=27% Similarity=0.388 Sum_probs=206.4
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 683 (959)
++|.+.+.||+|+||.||+|.+. .++.||||++.... .....+.+.+|++++..+. ||||+++++++.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 45778899999999999999753 34689999997643 3334557889999999997 9999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhccc----------------------------------------------------------
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS---------------------------------------------------------- 705 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 705 (959)
.++||||+++|+|.++++..+.
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 706 -----------------------------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 706 -----------------------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
.....+++..+..++.|++.||+|||+ ++++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 011347888999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999985433221 11223457889999999998889999999999999999998 889987654332110
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
..+. .-. .+. ........+.+++.+||..+|.+||++++|++.|+.++
T Consensus 353 --~~~~----------~~~--~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 353 --NAIK----------RGY--RMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHH----------cCC--CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000 000 000 01112347889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=326.53 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=201.6
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|+..+.||+|+||.||++.. .+++.||+|++....... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999975 468999999987542222 234557789999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999887542 22568999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... .....|++.|+|||++.+..++.++||||+||++|||++|+.||........... +...+..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-------------~~~~~~~ 219 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-------------VERRVKE 219 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-------------HHHHhhh
Confidence 222 2334789999999999988999999999999999999999999987554321110 0011110
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.. ..........+.+++.+|++.||++|| +++++++
T Consensus 220 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 DQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cc--cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00 011112334678999999999999999 7778755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=334.39 Aligned_cols=243 Identities=27% Similarity=0.381 Sum_probs=195.7
Q ss_pred CcccccCceEEEEEEE----cCCcEEEEEEcccccc--cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 617 NELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVI--SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+.||+|+||.||++.. .+++.||||++..... .......+.+|+++++.++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999964 3578999999875422 123345678899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.. ...+.+..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999998854 2457888999999999999999999 89999999999999999999999999998754322
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~----------------~~~~~~ 216 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID----------------KILKGK 216 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH----------------HHHcCC
Confidence 21 2234579999999999999889999999999999999999999998765432110 111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
..... .....+.+++.+|++.||++|| ++.++++
T Consensus 217 ~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPP---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCC---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111 1123578999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=311.87 Aligned_cols=258 Identities=29% Similarity=0.380 Sum_probs=214.2
Q ss_pred CCcccCcccccCceEEEEEEEcC-CcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.|+..+.||+|.-|+||.+++++ +..+|+|++.+.... .....+.+.|-+||+.++||.++.|++.++.+...++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45567889999999999998763 588999999876443 4556778899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
||+||+|...+++ ...+.+++..+.-+|..|+-||+|||- .|||+|||||+||||.++|++-|+||.|+.....
T Consensus 158 yCpGGdL~~Lrqk---Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK---QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred cCCCccHHHHHhh---CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999988865 344789999999999999999999999 8999999999999999999999999998642110
Q ss_pred ---------------------------------CCc----------------------ceeeccccccccccccccccCC
Q 002149 770 ---------------------------------SER----------------------SVVTRLAGTFGYLAPEYAVTGK 794 (959)
Q Consensus 770 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 794 (959)
... .....++||-.|.|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112368999999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccC
Q 002149 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSR 874 (959)
Q Consensus 795 ~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 874 (959)
.+.++|.|+|||++|||+.|+.||.+.... +.+..++.+.+..+... .......+||+++|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhcc
Confidence 999999999999999999999999987653 33455555555544433 4556788999999999
Q ss_pred CCCCCCC----HHHHHHHHHHhHh
Q 002149 875 EPSQRPD----MGHAVNVLAPLVE 894 (959)
Q Consensus 875 dP~~RPt----~~ev~~~L~~~~~ 894 (959)
||.+|.. +.||-+ +++++
T Consensus 375 dP~kRlg~~rGA~eIK~--HpFF~ 396 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR--HPFFE 396 (459)
T ss_pred ChhhhhccccchHHhhc--Ccccc
Confidence 9999998 778865 45554
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.78 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=204.7
Q ss_pred CcccCcccccCceEEEEEEEc-C---CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce-----
Q 002149 613 FASENELGRGGFGVVYKGELD-D---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE----- 683 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 683 (959)
|...+.||+|+||.||+|... + +..||+|+++...........+.+|++.++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999754 2 3679999988665555667789999999999999999999998866554
Q ss_pred -EEEEEEecCCCchhhHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 684 -RLLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 684 -~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
.++||||+++|+|..++..... .....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 6899999999999988865322 123468999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcce-eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 762 GLVKLAPDSERSV-VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 762 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+. ...+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~~~--- 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLRHG--- 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC---
Confidence 9998554332211 112335678999999988899999999999999999999 8899876554321 1111100
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.... ........+.+++.+|++.||++||++.++++.|.++
T Consensus 232 ---------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 ---------NRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 1112234688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.09 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=203.3
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
...++|++.+.||+|+||.||+|... +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 33578999999999999999999765 578999999865322 2234556889999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+
T Consensus 120 lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999998843 347889999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTG----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
..............||+.|+|||++.+. .++.++||||+||++|||++|+.||..........
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------------- 257 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------------- 257 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 6644332223456799999999998654 37889999999999999999999998765432110
Q ss_pred HHHHhcCC--cccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhHh
Q 002149 842 KLRAAIDP--ILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNVLAPLVE 894 (959)
Q Consensus 842 ~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L~~~~~ 894 (959)
..++. .+.. .........+.+++.+|+..++.+ ||++.++++ +++++
T Consensus 258 ---~i~~~~~~~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~ 308 (370)
T cd05621 258 ---KIMDHKNSLNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFK 308 (370)
T ss_pred ---HHHhCCcccCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccC
Confidence 11110 0110 111122345678899999865544 889999987 44443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.91 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=202.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..+.||+|+||.||+|.+. +++ .|++|.+... .......++..|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 46778899999999999999763 444 4777877533 233445678889999999999999999998754 4577
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+++||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+||++++++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 899999999999998542 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
....... .......++..|+|||++.++.++.++|||||||++||+++ |+.||.+.......... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~----~--- 227 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---EK----G--- 227 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC----C---
Confidence 6543222 22233457789999999999999999999999999999998 99999876543321111 00 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
........ ....+.+++.+|+..+|++||++.|+++.|..+.+
T Consensus 228 -----~~~~~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 -----ERLAQPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CcCCCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00000111 12356789999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.16 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=203.4
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.++||+|+||.||+|...++..||+|.+...... .+.+.+|+.++++++|+|++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 468889999999999999998888889999998764332 356889999999999999999999875 4567899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 82 MSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999998542 23568999999999999999999999 89999999999999999999999999999865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||++.+..++.++||||||+++|||++ |..||......+... .+. ....
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~----------~~~~- 221 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QVE----------RGYR- 221 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH----------cCCC-
Confidence 2222223345678999999988899999999999999999999 899997654332111 000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
. .........+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 222 -~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -M---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -C---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 1111223468899999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=318.88 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=198.9
Q ss_pred cccccCceEEEEEEE---cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 618 ELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.||+|+||.||+|.+ .+++.+|+|++..........+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 35788999998765444556778999999999999999999999875 45678999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||.||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99998843 2468999999999999999999999 899999999999999999999999999998654433211
Q ss_pred --eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 775 --VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 775 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
.....++..|+|||.+....++.++|||||||++|||++ |+.||......+.... +. . .. ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---i~---~-------~~--~~ 217 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM---IE---S-------GE--RM 217 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH---C-------CC--CC
Confidence 122234678999999988889999999999999999998 9999987654332111 10 0 00 00
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.........+.+++.+|++.||++||++.+|++.|+.+
T Consensus 218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01112234688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.58 Aligned_cols=262 Identities=29% Similarity=0.437 Sum_probs=209.3
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.+|...+.||+|+||.||+|... ++..+++|.+... .....+.+.+|++++++++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 35778899999999999999642 3456899988654 344456789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 685 LLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
++||||+++++|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999865321 112358999999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAA 831 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~ 831 (959)
+.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+...
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--- 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999999985433221 12233456789999999999999999999999999999999 999997765433211
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ..... ......+..+.+++.+|++.+|++||++.+|++.|..+...
T Consensus 237 ~~~-------------~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CIT-------------QGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHh-------------CCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 000 00000 00111234688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.26 Aligned_cols=250 Identities=30% Similarity=0.441 Sum_probs=201.4
Q ss_pred CCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
+|+..+.||+|+||.||+|..+++..+|+|.+..... ....+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4778899999999999999887777899998865422 2346788999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...+..
T Consensus 82 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 82 ANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999985421 368999999999999999999999 899999999999999999999999999998654322
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... .......
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------~~~~~~~- 220 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES-------------VSAGYRL- 220 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH-------------HHcCCcC-
Confidence 221122234568999999999999999999999999999999 8999976654332110 1000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
. ........+.+++.+|+..+|++||++.++++.|
T Consensus 221 -~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 -Y---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 0111334788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.11 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=200.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +++.||||++..... .......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999764 689999999875422 2334566889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999854 2468999999999999999999999 899999999999999999999999999987432
Q ss_pred CCCcc-------------------------------------eeeccccccccccccccccCCCCccchHHHHHHHHHHH
Q 002149 769 DSERS-------------------------------------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMEL 811 (959)
Q Consensus 769 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~el 811 (959)
..... .....+||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124699999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 002149 812 LTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD---MGHAVN 887 (959)
Q Consensus 812 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~ 887 (959)
++|..||......+.... +... ....... ........+.+++.+|+. +|.+|++ +.++++
T Consensus 233 ~~G~~Pf~~~~~~~~~~~---i~~~-----------~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQETYRK---IINW-----------KETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHHHHH---HHcC-----------CCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999987665332110 0000 0000000 001122356789999996 9999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.21 Aligned_cols=264 Identities=30% Similarity=0.417 Sum_probs=207.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc--EEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
++|++.+.||+|+||.||+|... ++. .+++|.++.. ......+.+.+|++++.++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57889999999999999999764 343 4788887642 2444567789999999999 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 687 VYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999998653211 12358899999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 158 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------ 229 (297)
T cd05089 158 SKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------ 229 (297)
T ss_pred EEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence 99999999874322111 111223567999999998899999999999999999997 999998765433111
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
........ . ........+.+++.+|++.+|.+||+++++++.|..+++.+..
T Consensus 230 -------~~~~~~~~--~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 -------KLPQGYRM--E---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -------HHhcCCCC--C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00000000 0 0111234678999999999999999999999999999887755
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=298.28 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=209.4
Q ss_pred HHHHhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccc------cHHHHHHHHHHHHHHHhc-CCCCceeEEEE
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVI------SKKAVDEFHSEIAVLSKV-RHRHLVSLLGY 677 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 677 (959)
-+....+|...+.+|+|..+.|.++. ..+|..+|+|++..... .....+...+|+.+++++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 34556778889999999999999985 45788999998854321 122345567899999999 69999999999
Q ss_pred EEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 678 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
++.+...++|+|.|+.|.|.|++. ..-.+++....+|+.|+..|++|||. +.||||||||+|||++++.++|
T Consensus 92 yes~sF~FlVFdl~prGELFDyLt-----s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLT-----SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhh-----hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceE
Confidence 999999999999999999999993 33679999999999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCcceeecccccccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAA 831 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~ 831 (959)
|+|||.|+...... .....+|||+|.|||.+.- ..|+..+|+||.||++|.|+.|..||......- +
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml---M-- 236 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML---M-- 236 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH---H--
Confidence 99999999776543 4567899999999998732 458889999999999999999999987532211 1
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTF-ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
++-+...........+ +......+|+.+|++.||.+|.|++|+++ ++++..
T Consensus 237 -----------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La--Hpff~q 288 (411)
T KOG0599|consen 237 -----------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA--HPFFIQ 288 (411)
T ss_pred -----------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc--ChHHHH
Confidence 1112222222122222 23346789999999999999999999987 455533
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.56 Aligned_cols=246 Identities=28% Similarity=0.378 Sum_probs=194.7
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHH---HhcCCCCceeEEEEEEeCceEEEE
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVL---SKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
|++.+.||+|+||.||+|... +++.||||+++.... .....+.+.+|++++ +.++||||+++++++..+...++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999754 689999999875422 223345666776665 456799999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|...+.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999887732 468999999999999999999999 89999999999999999999999999998743
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+.... . .
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i----------~ 214 (324)
T cd05589 152 MGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------I----------V 214 (324)
T ss_pred CCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------H----------H
Confidence 3222 123346799999999999999999999999999999999999999987654332110 0 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
....... ......+.+++.+||+.||++||+ +.++++
T Consensus 215 ~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 215 NDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0000101 112345779999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.73 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=205.3
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.+++.++|+||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 457888999999999999999988899999999875432 3457889999999999999999999864 456899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 81 YMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999988542 23568999999999999999999999 8999999999999999999999999999986653
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........++..|+|||++.+..++.++||||||+++||+++ |+.||......+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------------~~~~~~ 221 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-------------LERGYR 221 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-------------HHcCCC
Confidence 32222233456778999999998899999999999999999999 9999986654332110 000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.. ........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 --~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 --MP---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00 011123468899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=331.93 Aligned_cols=243 Identities=28% Similarity=0.359 Sum_probs=192.2
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||||+++.... .....+.+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 578899999876432 223344556677777655 899999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999988853 2468999999999999999999999 899999999999999999999999999998543322 2
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~----------~~~~- 214 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILN----------DRPH- 214 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc----------CCCC-
Confidence 2344679999999999999999999999999999999999999998765433211 0100 0000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG-HAVN 887 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~ 887 (959)
........+.+++.+||+.||++||++. ++.+
T Consensus 215 --~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 --FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0111223577999999999999999875 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=322.14 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=211.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcC-----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-Cce
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 683 (959)
.++|+..+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.+++.++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4678889999999999999998765 688999988643 345567788999999999999999999998776 467
Q ss_pred EEEEEEecCCCchhhHHhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL---NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
.++++||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998653221 12568999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 761 FGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 761 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
||+++........ ......++..|+|||++.+..++.++|||||||++||+++ |+.||....+.+. ..++.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHHHH----
Confidence 9999855433222 1223456778999999998889999999999999999999 9999987654331 11111
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.... .. ........+.+++.+|++.||++||++.++++.|..+.++
T Consensus 234 ------~~~~--~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 ------DGYR--LA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------cCCC--CC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0000 00 0111234688999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=324.46 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=203.7
Q ss_pred CCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++..++||||+++++++......+
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4667788999999999999753 24789999987542 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 686 LVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
+++||+++++|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 99999999999998853110 112358899999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAW 832 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 832 (959)
.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||.+....+....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM--- 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999885543221 12233456789999999988899999999999999999998 8888877654332111
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
+. +... ..........+.+++.+|++.+|++||++.+|++.|+.
T Consensus 239 i~-------------~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IR-------------NRQV--LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-------------cCCc--CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 10 1000 01111233467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=323.74 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=196.2
Q ss_pred ccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||++.. .+++.||+|++....... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999965 478899999987542222 2345678899999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++.... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 88875422 223568999999999999999999999 8999999999999999999999999999986544322 223
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......+..... .
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~~~~---~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILNDSVT---Y 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhcccCCC---C
Confidence 4578999999999999999999999999999999999999997653221100 000111111111 1
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.......+.+++.+|++.||++|| +++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 112334678999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=337.64 Aligned_cols=207 Identities=26% Similarity=0.418 Sum_probs=177.7
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|.. .+++.||||++.+... .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999999965 4688999999875422 2334567888999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999854 2568999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCc----------------------------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 002149 769 DSER----------------------------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814 (959)
Q Consensus 769 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg 814 (959)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001235799999999999999999999999999999999999
Q ss_pred CCCCCCCChHH
Q 002149 815 LMALDESRPEE 825 (959)
Q Consensus 815 ~~p~~~~~~~~ 825 (959)
+.||......+
T Consensus 233 ~~Pf~~~~~~~ 243 (363)
T cd05628 233 YPPFCSETPQE 243 (363)
T ss_pred CCCCCCCCHHH
Confidence 99998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=341.56 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=198.4
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|.. .+++.||||++.+... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999965 4789999999865321 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999998854 2568899999999999999999999 899999999999999999999999999996332
Q ss_pred CCCcc----------------------------------------------eeeccccccccccccccccCCCCccchHH
Q 002149 769 DSERS----------------------------------------------VVTRLAGTFGYLAPEYAVTGKITTKVDVF 802 (959)
Q Consensus 769 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvw 802 (959)
..... .....+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCC---
Q 002149 803 SFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQR--- 879 (959)
Q Consensus 803 SlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R--- 879 (959)
||||++|||++|..||......+..... .. . ...+..+. .......+.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i------~~-------~-~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKI------IN-------W-RETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHH------Hc-------c-CCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 9999999999999999876543321100 00 0 00011010 01122367799999997 66665
Q ss_pred CCHHHHHH
Q 002149 880 PDMGHAVN 887 (959)
Q Consensus 880 Pt~~ev~~ 887 (959)
+++.++++
T Consensus 297 ~~~~~~l~ 304 (377)
T cd05629 297 GGAHEIKS 304 (377)
T ss_pred CCHHHHhc
Confidence 59988876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.95 Aligned_cols=240 Identities=26% Similarity=0.351 Sum_probs=195.4
Q ss_pred CcccccCceEEEEEEE----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 617 NELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
+.||+|+||.||++.. .+|+.||+|++............+.+|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 367899999987654333445567889999999999999999999999999999999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999998843 2468999999999999999999999 8999999999999999999999999999986543322
Q ss_pred ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCccc
Q 002149 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILE 852 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .......
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----------------i~~~~~~ 216 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM----------------ILKAKLG 216 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH----------------HHcCCCC
Confidence 23346799999999999988899999999999999999999999987654332110 0011111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 002149 853 VNDDTFETFWTIAELAGHCTSREPSQRPDMGH 884 (959)
Q Consensus 853 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 884 (959)
.+. .....+.+++.+||+.||++||++.+
T Consensus 217 ~p~---~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQ---FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 12235779999999999999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.50 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=212.5
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYER 684 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 684 (959)
.....|...+.||+|.||.||+++.+ +|+.+|+|.+.+..... .....+.+|+++|+++. |||||.+.+++++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567888899999999999999765 59999999998764322 34568899999999998 99999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC----CCcEEEee
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD----DFRAKVSD 760 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~----~~~~ki~D 760 (959)
++|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .||+||||||+|+|+.. ++.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999998653 29999999999999999999999 89999999999999953 35799999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
||+|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........
T Consensus 183 FGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------------ 248 (382)
T KOG0032|consen 183 FGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------------ 248 (382)
T ss_pred CCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------------
Confidence 999997766 345667899999999999999999999999999999999999999999876544321
Q ss_pred HHHHHhcCCcccCCCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTF-ETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.............+ .......+++..++..||.+|+++.+++++
T Consensus 249 ----~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ----AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111112222222 223467799999999999999999999983
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=331.12 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=209.1
Q ss_pred ccCcccccCceEEEEEEE-cCCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 615 SENELGRGGFGVVYKGEL-DDGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..++||.|+||+||||.+ .+|+ +||||++... ...+..+++.+|+-+|..++|||+++|+|+|.... ..||++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 457899999999999965 3444 6899987654 45566788999999999999999999999998876 789999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
||+.|+|.++++.++ ..+.....+.+..|||+||.|||+ +++|||||.++||||.+-..+||.|||+|+....
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999997643 678889999999999999999999 8999999999999999999999999999997655
Q ss_pred CCcce-eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 770 SERSV-VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
+.... .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++.+..+...+.. .-
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle--------------~g 916 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE--------------KG 916 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh--------------cc
Confidence 44332 222334678999999999999999999999999999998 899999988766433221 11
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
++ +..++ -....+..++.+||..|+..||+++++...+.++.+.
T Consensus 917 eR-LsqPp---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ER-LSQPP---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cc-CCCCC---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11 22122 2334677889999999999999999999999887765
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.80 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=197.6
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCc
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGA 695 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 695 (959)
+.||+|+||.||+|.. .+++.||+|.+... ........+.+|+++++.++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999976 47899999987654 344556779999999999999999999999999999999999999999
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce-
Q 002149 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV- 774 (959)
Q Consensus 696 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~- 774 (959)
|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRT----EGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9998853 12468899999999999999999999 899999999999999999999999999987543321111
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
.....++..|+|||.+.++.++.++|||||||++|||++ |..||......+..... ......
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------------~~~~~~---- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------------EQGVRL---- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------------HcCCCC----
Confidence 111123457999999999999999999999999999998 88888765443211110 000000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.........+.+++.+|++.+|++||++.++.+.|.
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 -PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011122346889999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.48 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=209.7
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+|+..+.||+|+||.||+|.. .+++.+|||.+.... ......+++.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999974 578999999876532 23344567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.... .....+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999886432 223568999999999999999999999 899999999999999999999999999988654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......|+..|+|||++.+..++.++||||||+++|||++|..||........ .... .+.....
T Consensus 158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~----------~~~~~~~ 225 (267)
T cd08229 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK----------KIEQCDY 225 (267)
T ss_pred cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhh----------hhhcCCC
Confidence 3322 12335688999999999988899999999999999999999999975432211 1100 1111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+.. ........+.+++.+|+..||.+|||+.+|++.++++
T Consensus 226 ~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 PPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 1112344788999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.07 Aligned_cols=256 Identities=20% Similarity=0.263 Sum_probs=198.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||++... +++.||+|++.+.. ......+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999754 68899999986532 22334566889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999998542 2468899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
...........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.... .....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~------i~~~~--- 224 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHK--- 224 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH------HHcCC---
Confidence 433322333579999999999863 4578899999999999999999999987654332110 00000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCC--CCCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPS--QRPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~ev~~ 887 (959)
...............+.+++.+|+..+++ .||++.++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 225 -----EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred -----CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 00010111111234667888887765444 3789999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.41 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=199.8
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
++||+|+||.||+|...+++.||+|.+.... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999988888999999887542 344455788999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++... ...+++..+..++.|++.||.|+|+ ++++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9988532 2457899999999999999999999 89999999999999999999999999998754332222122
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVND 855 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (959)
...++..|+|||++.+..++.++||||||+++||+++ |..||........... ...... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-------------~~~~~~--~~--- 214 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-------------VEKGYR--MS--- 214 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------------HHcCCC--CC---
Confidence 2344678999999998999999999999999999998 9999976654321110 000000 00
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 856 DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 856 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
........+.+++.+|++.+|++||++.++++.|.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01122347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.04 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=203.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+++|...+.||+|+||.||+|... .+..||+|.+... ........+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 467889999999999999999764 3567899987643 234445678999999999999999999999999889
Q ss_pred EEEEEEecCCCchhhHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---cEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL--NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF---RAKV 758 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~---~~ki 758 (959)
.++||||+++++|.+++...+.. ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999998654321 12358999999999999999999999 8999999999999998654 5999
Q ss_pred eeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||......+.... +...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---VTGG 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHcC
Confidence 999999865322111 1112234568999999999999999999999999999997 9999987654332111 1000
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.. ..........+.+++.+|++.+|++||++.+|+++|.
T Consensus 238 ------------~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 ------------GR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------------Cc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 0011122346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.73 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=203.5
Q ss_pred cCCcccCcccccCceEEEEEEEcC---------------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD---------------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 675 (959)
++|++.+.||+|+||.||++.... ...||+|.+... ........+.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 578899999999999999986532 234899998764 2445566799999999999999999999
Q ss_pred EEEEeCceEEEEEEecCCCchhhHHhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 002149 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSL-------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNI 748 (959)
Q Consensus 676 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~Ni 748 (959)
+++......++||||+++++|.+++...... ....+++..++.++.|+++||+|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9999999999999999999999988542211 11247899999999999999999999 8999999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCChHH
Q 002149 749 LLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT--GLMALDESRPEE 825 (959)
Q Consensus 749 Ll~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt--g~~p~~~~~~~~ 825 (959)
+++.++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999985433221 11223345778999999999999999999999999999998 567777654433
Q ss_pred HHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 826 RQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
........ .... ..... .......+..+.+++.+|++.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~---------~~~~-~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEF---------FRNQ-GRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHh---------hhhc-ccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 21111000 0000 00000 0001112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.84 Aligned_cols=266 Identities=28% Similarity=0.389 Sum_probs=206.8
Q ss_pred hcCCcccCcccccCceEEEEEEEcC-----------------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD-----------------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 672 (959)
.++|++.+.||+|+||.||+|.... +..||+|.+.... .....+.+.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578899999999999999986542 2458999887542 345567899999999999999999
Q ss_pred eEEEEEEeCceEEEEEEecCCCchhhHHhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002149 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSS 746 (959)
Q Consensus 673 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~ 746 (959)
++++++..+...++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999998764421 22378999999999999999999999 89999999999
Q ss_pred CEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCCh
Q 002149 747 NILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT--GLMALDESRP 823 (959)
Q Consensus 747 NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt--g~~p~~~~~~ 823 (959)
||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999985433221 22234456789999999988899999999999999999998 6778876543
Q ss_pred HHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 824 EERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.+.. ........ ....... ..........+.+++.+|++.||++||++.++++.|+
T Consensus 240 ~~~~---~~~~~~~~-------~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVI---ENAGHFFR-------DDGRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHH---HHHHhccc-------ccccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 3321 11110000 0000000 0011112347889999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=316.38 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=210.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999765 78999999886432 23344678899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.... .....+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 9999999999886532 223568999999999999999999999 899999999999999999999999999988554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||........ .... .......
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----------~~~~~~~ 225 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK----------KIEKCDY 225 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HHHh----------hhhcCCC
Confidence 3222 12334688999999999988999999999999999999999999865432110 1110 0000000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+ ..........+.+++.+|+..+|++||++.+|++.++.+
T Consensus 226 ~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 P----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 001112334688999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.21 Aligned_cols=253 Identities=29% Similarity=0.469 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|+++++.++|+|++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 4588889999999999999988777789999876532 23456889999999999999999999875 4567899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999998542 23458999999999999999999999 89999999999999999999999999999865433
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||......+... .+ ......
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~----------~~~~~~ 222 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QV----------ERGYRM 222 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH----------HcCCCC
Confidence 2222223346778999999998899999999999999999999 899998765433211 00 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.........+.+++.+|++.||++||+++++.+.|+.
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.30 Aligned_cols=264 Identities=30% Similarity=0.407 Sum_probs=209.1
Q ss_pred cCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC
Q 002149 611 KNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 681 (959)
++|.+.+.||+|+||.||+|... +...+|+|.+.... ......++.+|+++++.+ +|+||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46889999999999999999642 23569999987542 344556788999999999 799999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++||||+++|+|.+++...+.. ....+++.+++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 9999999999999999999653321 12358999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcce-eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERSV-VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999998554322111 112234578999999999899999999999999999998 889987665433211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.. .. . ... .........+.+++.+|+..+|++||++.++++.|++++...
T Consensus 254 ~~------~~-------~--~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 254 LL------KE-------G--HRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HH------Hc-------C--CCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 11 00 0 000 111122347789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.55 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=209.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
..+|.+.+.||+|+||.||+|... ++..||+|.+... ......+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 356788899999999999999631 2457999988754 2345567889999999999 89999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
....++||||+++|+|.+++...... ....+++.++..++.||+.||+|||+ ++++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999998653221 12468899999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQ 827 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~ 827 (959)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999999865433222 1222345778999999999899999999999999999998 78888766543321
Q ss_pred HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 828 YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. ... . ... .........+.+++.+|++.+|++||++.++++.|++++..
T Consensus 250 ~~------~~~-------~--~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KL------LKE-------G--HRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HH------HHc-------C--CcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11 000 0 000 01112334688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.62 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=208.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|+..+.||+|+||.||+|... ....+|+|.+.... ......++.+|+++++.+ +|+||+++++++..+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 356888899999999999999753 23679999987642 344556788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
..++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 99999999999999999864321 223578999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002149 752 DDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYL 829 (959)
Q Consensus 752 ~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~ 829 (959)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999865443221 1122335678999999998999999999999999999998 9999876654332111
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
. .... .. .........+.+++.+|+..||++|||+.++++.|+.++
T Consensus 247 ~-------------~~~~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 L-------------KEGY--RM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------------HcCC--cC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0 0000 00 111122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.01 Aligned_cols=270 Identities=26% Similarity=0.350 Sum_probs=204.5
Q ss_pred cCC-cccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--c
Q 002149 611 KNF-ASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--Y 682 (959)
Q Consensus 611 ~~~-~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 682 (959)
++| ...+.||+|+||.||++.. .+++.||+|.+.... .....+.+.+|+++++.++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 344 7889999999999988643 357889999987542 334456788999999999999999999987653 4
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence 67899999999999998853 358999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ ........ ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~-~~~~ 230 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQG-QMTV 230 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccc-ccch
Confidence 998654432211 1223456679999999888999999999999999999999999875432211 11100000 0001
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
..+.+.++.... .......+..+.+++.+|++.+|++||+++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 231 VRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 112222222111 1111223457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.69 Aligned_cols=260 Identities=26% Similarity=0.371 Sum_probs=205.4
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..++||+|+||.||+|.+ .+++ .||+|++... ........+.+|+.+++.++|+||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4688889999999999999975 3454 4899988754 2444567788999999999999999999998754 567
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
++|||+++|+|.++++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCcee
Confidence 999999999999998542 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ..++....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~------ 228 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEKGE------ 228 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCC------
Confidence 66432221 1122345678999999999999999999999999999998 8999976554332 11111000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. .........+.+++.+|+..||++||++.++++.+..+..++.
T Consensus 229 ------~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 ------RL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred ------cC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 00 0011123467899999999999999999999998888766553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=315.76 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=206.8
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|...+.||+|+||.||+|... +++.|++|.+..........+.+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3677889999999999999764 688999999876544566677899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999998652 23578999999999999999999999 89999999999999999999999999998865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|++.|+|||+..+..++.++|||||||++|||++|+.||......+. .. ......
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~-------------~~~~~~ 217 (256)
T cd08529 155 TN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL-------------KIIRGV 217 (256)
T ss_pred cc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHHcCC
Confidence 22 22335688999999999999999999999999999999999999986653221 10 001111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..........+.+++.+|++.+|++||++.++++
T Consensus 218 ~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 218 F--PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred C--CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1 0111123347889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=339.85 Aligned_cols=271 Identities=22% Similarity=0.352 Sum_probs=199.4
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------ 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 681 (959)
...+|+..+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346799999999999999999975 468899999875431 2235799999999999999999876432
Q ss_pred --ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEE
Q 002149 682 --YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKV 758 (959)
Q Consensus 682 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki 758 (959)
...++||||++ +++.+++.... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 24578999995 57777765432 233678999999999999999999999 8999999999999998664 7999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+..... +....
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i--~~~~~ 288 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI--IQVLG 288 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhC
Confidence 99999986543222 2345789999999998764 6899999999999999999999999877654332211 11111
Q ss_pred cc-hHHHHHhcCCcc---cCC---CC------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 838 SD-KEKLRAAIDPIL---EVN---DD------TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 838 ~~-~~~~~~~~~~~~---~~~---~~------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. .+.+.. ..+.. ..+ .. .......+.+++.+||+.||.+|||+.|+++ +++++...
T Consensus 289 ~p~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~--hp~f~~~~ 358 (440)
T PTZ00036 289 TPTEDQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA--DPFFDDLR 358 (440)
T ss_pred CCCHHHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC--ChhHHhhh
Confidence 00 111110 00000 000 00 0012246789999999999999999999977 56666543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=342.60 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=197.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|++.+.||+|+||.||+|+. .+++.||||++.+... .......+.+|+++++.++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999965 4688999999865322 22345668899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..+..
T Consensus 82 ~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999854 2457889999999999999999999 8999999999999999999999999999753210
Q ss_pred CC------------------------------------------cceeeccccccccccccccccCCCCccchHHHHHHH
Q 002149 770 SE------------------------------------------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVV 807 (959)
Q Consensus 770 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~l 807 (959)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC---CHHH
Q 002149 808 LMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP---DMGH 884 (959)
Q Consensus 808 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~e 884 (959)
+|||++|+.||....+.+..... .... ...... ........+.+++.+|+ .+|.+|+ ++.+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i---~~~~-----------~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKV---INWE-----------TTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHH---hccC-----------ccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999877654422111 0000 000000 00112235667788866 5999999 8888
Q ss_pred HHH
Q 002149 885 AVN 887 (959)
Q Consensus 885 v~~ 887 (959)
+++
T Consensus 298 ll~ 300 (376)
T cd05598 298 IKA 300 (376)
T ss_pred HhC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=315.04 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=197.0
Q ss_pred cccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 618 ELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.||+|+||.||+|.+. .+..||+|++... ......+.+.+|+.++++++|+||+++++++.. ...++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999753 3557999988754 234455779999999999999999999998764 5779999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ....+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99998853 12568999999999999999999999 899999999999999999999999999998554332211
Q ss_pred e--eccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 775 V--TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 775 ~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
. ....++..|+|||++.+..++.++|||||||++||+++ |..||......+.... +... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~--------------~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---IEQG--------------K 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---HHCC--------------C
Confidence 1 11233578999999988889999999999999999996 9999987655332111 1000 0
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
. ...+.....++.+++.+||..+|++||++.+|.+.|+.++
T Consensus 216 ~-~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 216 R-LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 0 0111122347789999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=337.95 Aligned_cols=276 Identities=22% Similarity=0.238 Sum_probs=201.6
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCC------CceeEEEEE
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR------HLVSLLGYS 678 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~ 678 (959)
+....++|++.++||+|+||.||+|.. .+++.||||+++.. ......+..|+++++.++|. +++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344567899999999999999999965 46788999998642 22334566788888777554 588888888
Q ss_pred EeC-ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---
Q 002149 679 VAG-YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF--- 754 (959)
Q Consensus 679 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~--- 754 (959)
... ...++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+. .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccc
Confidence 764 4778999998 8888888754 24689999999999999999999972 4999999999999998765
Q ss_pred -------------cEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 755 -------------RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 755 -------------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 223468999999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHHHHHhhhc-------chHHHHHhcCCcccC-CC---------------CCHHHHHHHHHHHHhcccCCCCC
Q 002149 822 RPEERQYLAAWFWNIKS-------DKEKLRAAIDPILEV-ND---------------DTFETFWTIAELAGHCTSREPSQ 878 (959)
Q Consensus 822 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~---------------~~~~~~~~l~~l~~~cl~~dP~~ 878 (959)
...+............. ........++..... .. ........+.+|+.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 65443332211110000 000000111000000 00 00011235679999999999999
Q ss_pred CCCHHHHHHHHHHhHhhcCC
Q 002149 879 RPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 879 RPt~~ev~~~L~~~~~~~~~ 898 (959)
|||++|+++ ++++.++..
T Consensus 429 R~ta~e~L~--Hp~~~~~~~ 446 (467)
T PTZ00284 429 RLNARQMTT--HPYVLKYYP 446 (467)
T ss_pred CCCHHHHhc--CccccccCC
Confidence 999999987 677766544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=330.99 Aligned_cols=243 Identities=26% Similarity=0.329 Sum_probs=194.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeCceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 688 (959)
+|+..+.||+|+||.||+|... +++.||||++.+... .....+.+..|++++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999754 578999999876432 23445678889999999976 56888999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999988853 2458899999999999999999999 899999999999999999999999999987432
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... + ..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---i-------------~~ 215 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS---I-------------ME 215 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---H-------------Hc
Confidence 2211 22345799999999999999999999999999999999999999987654332110 0 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.... ........+.+++.+|+..||.+|++.
T Consensus 216 ~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 HNVS---YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCC---CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111 001122367799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=331.56 Aligned_cols=243 Identities=25% Similarity=0.310 Sum_probs=195.2
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||||++..... .....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999764 578999999875422 233455677899998876 799999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999988853 2468899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~------~i~~----------~~~~~ 215 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE------SILH----------DDVLY 215 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH------HHHc----------CCCCC
Confidence 2334579999999999999999999999999999999999999998766433211 1110 00000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRP-------DMGHAVN 887 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~ev~~ 887 (959)
+. .....+.+++.+|++.||++|| ++.++++
T Consensus 216 p~---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PV---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00 1123678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.27 Aligned_cols=245 Identities=27% Similarity=0.323 Sum_probs=196.9
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
+.||+|+||.||++.. .+|+.||+|++..... .......+.+|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999965 4789999999876432 2334566788999999999999999999999999999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
+|.+++.. ...+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99888743 24689999999999999999999962 5999999999999999999999999999875432221 2
Q ss_pred eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC
Q 002149 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (959)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... . .......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---~-------------~~~~~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---L-------------MEEIRFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---h-------------cCCCCCC
Confidence 23457999999999999999999999999999999999999999876543321111 0 0000000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 002149 855 DDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNV 888 (959)
Q Consensus 855 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 888 (959)
......+.+++.+|++.||++|+ ++.+++++
T Consensus 217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 ---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11223678999999999999997 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=350.89 Aligned_cols=266 Identities=22% Similarity=0.315 Sum_probs=207.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.++||+|+||.||+|... +|+.||||++..... .....+++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999754 689999999875432 2344567899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 689 EYMPQGALSKHIFHWKSL------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
||+++|+|.+++...... .....++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642111 12346788899999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc-----------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH
Q 002149 763 LVKLAPDSER-----------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825 (959)
Q Consensus 763 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~ 825 (959)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9985521100 01123579999999999999999999999999999999999999997644322
Q ss_pred HHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHhHhh
Q 002149 826 RQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-DMGHAVNVLAPLVEK 895 (959)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~ 895 (959)
.... .... ++ ... ......+..+.+++.+|++.||++|| +++++.+.|.++++.
T Consensus 239 i~~~-----~~i~---------~P-~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ISYR-----DVIL---------SP-IEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhh-----hhcc---------Ch-hhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1100 0000 00 000 00012234678999999999999996 567777777777653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.81 Aligned_cols=238 Identities=25% Similarity=0.338 Sum_probs=191.8
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|..+ +++.||||++.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999764 688999999875422 223456677888888877 699999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~ 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence 999988854 2468899999999999999999999 899999999999999999999999999987532221 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .. ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i~----------~~~~~~ 215 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------IL----------NDEVVY 215 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------Hh----------cCCCCC
Confidence 23345799999999999999999999999999999999999999987654332110 00 000110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.. .....+.+++.+|++.||++||++
T Consensus 216 ~~---~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PT---WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CC---CCCHHHHHHHHHHcccCHHHCCCC
Confidence 11 122367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.29 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=194.0
Q ss_pred CcccccCceEEEEEEEcC---CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELDD---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|...+ +..+|+|.+.... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 358999999999997643 4579999887543 234456788999999999999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++...+.......++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999975443333456788889999999999999999 89999999999999999999999999999754332221
Q ss_pred e-eeccccccccccccccccC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 774 V-VTRLAGTFGYLAPEYAVTG-------KITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 774 ~-~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
. .....|+..|+|||++... .++.++||||||+++|||++ |+.||......+..... .. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~---~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-----VR---EQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----hh---cccC
Confidence 1 1234578899999998642 35789999999999999996 99999766543321110 00 0000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
....+ .........+.+++.+|+ .+|++||++++|++.|
T Consensus 229 ~~~~~-----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 229 KLPKP-----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCCCC-----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 11111 111112235678999998 6899999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=335.97 Aligned_cols=260 Identities=22% Similarity=0.236 Sum_probs=201.6
Q ss_pred HHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 605 VLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 605 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
+.+...++|++.+.||+|+||.||+|... +++.||+|++.+.. ......+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34444578999999999999999999765 68899999986532 12234456788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999998843 347888999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTG----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||.......... .+..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHHc
Confidence 9986544332223456799999999998654 37889999999999999999999998765432110 0000
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNV 888 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 888 (959)
.. ..+... ........+.+++.+|+..++.+ ||++.+++++
T Consensus 262 -------~~-~~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 -------HK-NSLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -------CC-CcccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 001100 11122345778999999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.05 Aligned_cols=264 Identities=31% Similarity=0.455 Sum_probs=206.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCc--EEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 685 (959)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.+... ........+.+|++++.++ +|+||+++++++..+...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 357888899999999999999764 454 4577776543 2445567888999999999 8999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 686 LVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
+||||+++|+|.++++..... ....+++.+++.++.|++.||+|||+ ++++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCC
Confidence 999999999999999754321 12368999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~ 833 (959)
.+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||+| |..||......+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----- 234 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 234 (303)
T ss_pred cEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH-----
Confidence 999999999864321111 111234678999999988889999999999999999998 999997655432110
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
. ..... .. .........+.+++.+|++.+|++||++.++++.+.++++...
T Consensus 235 -~-------~~~~~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 -K-------LPQGY--RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -H-------HhcCC--cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0 00000 00 0111123467899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=323.41 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=205.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|...+.||+|+||.||+|... ++..||||+++... .....+.+.+|+++++++ +|+||+++++++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 356889999999999999999641 34579999887542 234456789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ ++|+|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999985422 2348999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+... .
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~--------- 255 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--K--------- 255 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--H---------
Confidence 99855433221 1222346778999999999999999999999999999998 999987665432211 0
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.+..... ..........+.+++.+|++.+|++||++.++++.|.++
T Consensus 256 -----~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 -----LIKEGYR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HHHcCCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000 000111234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=321.46 Aligned_cols=265 Identities=26% Similarity=0.402 Sum_probs=203.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-----------------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCcee
Q 002149 611 KNFASENELGRGGFGVVYKGELD-----------------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS 673 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 673 (959)
++|++.+.||+|+||.||++... ++..||+|++... .......++.+|+++++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 56899999999999999998532 2346899988754 23445678999999999999999999
Q ss_pred EEEEEEeCceEEEEEEecCCCchhhHHhhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 002149 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSN 747 (959)
Q Consensus 674 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~N 747 (959)
+++++...+..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 999999999999999999999999998653211 12358889999999999999999999 899999999999
Q ss_pred EEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh--CCCCCCCCChH
Q 002149 748 ILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT--GLMALDESRPE 824 (959)
Q Consensus 748 iLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt--g~~p~~~~~~~ 824 (959)
|+++.++.++|+|||+++....... .......++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999985533221 11222345678999999988899999999999999999998 77888765443
Q ss_pred HHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 825 ERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
+...... ......... .. ..........+.+++.+|++.||.+||++.+|++.|.
T Consensus 241 ~~~~~~~---------~~~~~~~~~-~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTG---------EFFRDQGRQ-VY-LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHH---------HHHhhcccc-cc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 3211100 000000000 00 0001112357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.09 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=206.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 567999999999999999999643 24579999876542 23344568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL-----NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
.++||||+++|+|.+++...... .....++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999653211 12456788899999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||......+... .+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~---~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK---FV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HH---
Confidence 99999985433221 11122345678999999999999999999999999999999 788987654432111 00
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+.... .........+.+++.+|++.||++||++.++++.++..+..
T Consensus 235 ----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 235 ----------MDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred ----------HcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 000000 00111234788999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=339.74 Aligned_cols=252 Identities=24% Similarity=0.309 Sum_probs=196.1
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|+..++||+|+||.||+|.. .+++.||+|++..... .......+.+|++++++++|+||+++++++.++...++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999965 4688999999875422 23445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999988542 457899999999999999999999 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------cceeeccccccccccccccccCCCCccchHHH
Q 002149 770 SE----------------------------------------------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFS 803 (959)
Q Consensus 770 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 803 (959)
.. .......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012347999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC--
Q 002149 804 FGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-- 881 (959)
Q Consensus 804 lG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-- 881 (959)
|||++|||++|+.||....+.+...... .. ......+ ..........+++.+++ .+|.+|++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~-------------~~-~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~ 297 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVI-------------NW-QTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKN 297 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHH-------------cc-CCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence 9999999999999998766543211110 00 0000000 00111234567777765 59999997
Q ss_pred -HHHHHH
Q 002149 882 -MGHAVN 887 (959)
Q Consensus 882 -~~ev~~ 887 (959)
+.++++
T Consensus 298 ~~~ei~~ 304 (382)
T cd05625 298 GADEIKA 304 (382)
T ss_pred CHHHHhc
Confidence 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=317.27 Aligned_cols=254 Identities=31% Similarity=0.509 Sum_probs=203.9
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|+..+.||+|+||+||+++.. +++.||+|++..............+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567889999999999999765 5678999999876444444445567999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-N 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-T
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 99999999862 2668999999999999999999999 8999999999999999999999999999986422 2
Q ss_pred cceeeccccccccccccccc-cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 772 RSVVTRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
........++..|+|||++. +..++.++||||+|+++|+|++|..||......+.......... .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~- 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-----RPLPSSSQQ- 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-----THHHHHTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-----ccccccccc-
Confidence 22344567899999999998 88899999999999999999999999997743333222211110 001000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001157889999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=308.70 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=206.0
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|.++++||+|+||.||+|.+ .+|+.||||++... .+.+++..|+.+|++++.|++|+++|.|......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 55678999999999999954 57999999998743 55778899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
-.|++.+.++. ..+++++.++..+....++||+|||. ..-||||||+.|||++-+|.+|++|||.|-...+..
T Consensus 111 GAGSiSDI~R~----R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRA----RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHH----hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999854 34889999999999999999999999 567999999999999999999999999998766544
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
.. .....||+.|||||++..-.|+.++||||+|++..||..|++|+..-.+..... ++....
T Consensus 184 AK-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----------------MIPT~P 245 (502)
T KOG0574|consen 184 AK-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----------------MIPTKP 245 (502)
T ss_pred Hh-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----------------eccCCC
Confidence 32 345789999999999999999999999999999999999999998765532110 011111
Q ss_pred cCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 852 EVNDDTFE-TFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 852 ~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
+......+ -...+.+++++||-..|++|-|+.++.++
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11111112 22467899999999999999999988763
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=329.32 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=204.1
Q ss_pred cCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe-Cc
Q 002149 611 KNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA-GY 682 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 682 (959)
++|+..+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +|+||+++++++.. +.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5789999999999999999963 357889999987542 334456788999999999 68999999998765 45
Q ss_pred eEEEEEEecCCCchhhHHhhcccC--------------------------------------------------------
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL-------------------------------------------------------- 706 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 706 (959)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998642210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc-ceeeccc
Q 002149 707 ------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLA 779 (959)
Q Consensus 707 ------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~ 779 (959)
....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 01347889999999999999999999 8999999999999999999999999999985433221 1122234
Q ss_pred cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCH
Q 002149 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTF 858 (959)
Q Consensus 780 gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (959)
++..|+|||++.+..++.++||||||+++|||++ |..||......... ...+ .... .......
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~----------~~~~--~~~~~~~-- 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL----------KEGT--RMRAPDY-- 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHH----------hccC--CCCCCCC--
Confidence 5678999999999999999999999999999997 89998765432210 0000 0000 0000111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 859 ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 859 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
....+.+++.+|++.||++||++.+++++|+.+++.
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 123578999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.13 Aligned_cols=255 Identities=26% Similarity=0.429 Sum_probs=205.7
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.++||+|+||.||+|...++..+|+|.+... ....+.+.+|+++++.++|+||+++.+++.. ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4578899999999999999998877888999988753 3345678899999999999999999999887 67899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 81 FMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999998542 23567899999999999999999999 8999999999999999999999999999986544
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........++..|+|||++....++.++|+|||||++||+++ |+.||......+... .+. ...
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~----------~~~- 220 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALE----------RGY- 220 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHh----------CCC-
Confidence 32222223345678999999998889999999999999999999 899998654432211 000 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
... ........+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 221 -~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 221 -RMP---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -CCC---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 000 1112234688999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.36 Aligned_cols=243 Identities=29% Similarity=0.377 Sum_probs=192.9
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||||+++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999764 578999999876432 123345566788888765 899999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999998853 2468899999999999999999999 8999999999999999999999999999875322221
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... . . ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i---~---~--------~~~~~~- 216 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI---R---M--------DNPCYP- 216 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---h--------CCCCCC-
Confidence 223457999999999999999999999999999999999999999876543321110 0 0 001110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG-HAVN 887 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~ 887 (959)
......+.+++.+|++.||++||++. ++.+
T Consensus 217 ----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 ----RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01223577999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.47 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=206.5
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.+.||+|+||.||+|..++++.||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46788999999999999999988878899999987542 234578899999999999999999999998889999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999998542 22568999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........++..|+|||.+.+..++.++||||||+++||+++ |+.||.......... . . .....
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--~-~----------~~~~~ 222 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE--Q-V----------ERGYR 222 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--H-H----------HcCCC
Confidence 22221222334678999999998899999999999999999999 999997654322111 0 0 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.. .....+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 --~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --MP---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 011123468899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=316.34 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=204.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CC---cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DG---TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|+..+.||+|+||.||+|... ++ ..+|+|++.... .....+.+..|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 46788899999999999999764 33 379999886542 34456778999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999998542 2568999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcceee--ccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 767 APDSERSVVT--RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 767 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
.......... ....+..|+|||++....++.++|||||||++|||++ |+.||......+.. . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~---~---~i~------ 224 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM---K---AIN------ 224 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---H---HHh------
Confidence 5433222111 1223467999999998899999999999999999998 99999765432211 1 000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.... .....+....+.+++.+|++.+|++||++.+|++.|+++
T Consensus 225 -----~~~~-~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 -----DGFR-LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----cCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 111112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.49 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc---HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999965 46899999988654222 2234678899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999988542 458899999999999999999999 8999999999999999999999999999975
Q ss_pred CCCCCccee--eccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 767 APDSERSVV--TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 767 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
......... ....|+..|+|||++.+..++.++||||||+++|||++|+.||......+... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~------- 220 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIA------- 220 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------HHh-------
Confidence 533221111 33567889999999999889999999999999999999999997654322110 000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
..... ..........+.+++.+|+..+|.+||++.+++++
T Consensus 221 ---~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 ---TQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---ccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00000 01111223467899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=318.64 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=194.5
Q ss_pred ccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||++.. .+|+.||+|++....... ...+.+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 468999999986542222 2334556799999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 8887542 23468899999999999999999999 899999999999999999999999999988654432 223
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...|+..|+|||++.+..++.++||||+||++|||++|+.||......... .. .....+........
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~----------~~~~~~~~~~~~~~- 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EE----------LKRRTLEDEVKFEH- 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HH----------HHHHhhcccccccc-
Confidence 457899999999999989999999999999999999999999764321110 00 00111111111000
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....++.+++.+||+.||++||++.|+++
T Consensus 220 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 -QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 112336789999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.79 Aligned_cols=254 Identities=25% Similarity=0.333 Sum_probs=191.2
Q ss_pred cccccCceEEEEEEEcC---CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 618 ELGRGGFGVVYKGELDD---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.||+|+||.||+|...+ ...+|+|.+... ........+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 346888877643 23445567889999999999999999999999999999999999999
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc-c
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER-S 773 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~-~ 773 (959)
+|.+++...+.......++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976443333456788899999999999999999 8999999999999999999999999999875432211 1
Q ss_pred eeecccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 774 VVTRLAGTFGYLAPEYAVT-------GKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+.. ...+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~~~---------- 225 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVVRE---------- 225 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHhhc----------
Confidence 1123346778999998743 356789999999999999999 78888766543321 110000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
....+............+.+++..|+ .||++||++++|++.|
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 -QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00011111111122345667888888 5999999999998865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.13 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=193.5
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||+|++.+... .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 678999999876532 233456678899988877 799999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 999888743 2468999999999999999999999 8999999999999999999999999999875322211
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE--RQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++.. .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~i~~~~~ 222 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---------VILEKQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------HHhcCCC
Confidence 2234579999999999999999999999999999999999999996322111 0000111110 0111111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPD------MGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~ 887 (959)
..+ ......+.+++.+||+.||++||+ +.++++
T Consensus 223 ~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 223 RIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111 112235779999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.59 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=195.1
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+|...+.||+|+||.||+|... +++.||||++.+... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999755 578999999876432 223345567788888877 5899999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988843 2458899999999999999999999 899999999999999999999999999997543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... + ..
T Consensus 153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~---i-------------~~ 215 (323)
T cd05616 153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS---I-------------ME 215 (323)
T ss_pred CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH---H-------------Hh
Confidence 221 123346799999999999999999999999999999999999999987654332111 0 01
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.....+ ......+.+++.+|++.||++|++.
T Consensus 216 ~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HNVAYP---KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCC---CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111101 1123467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.88 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=205.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|+..+.||+|+||.||+|... ++..||+|.+... ......+++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 457889999999999999999753 4678999998754 234456779999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhccc-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS-----------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSS 746 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~ 746 (959)
.++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999864321 112357899999999999999999999 89999999999
Q ss_pred CEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChH
Q 002149 747 NILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPE 824 (959)
Q Consensus 747 NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~ 824 (959)
||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875432211 11222345678999999998999999999999999999998 88888766543
Q ss_pred HHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 825 ERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
+... .+ . +.... .........+.+++.+|++.||++||++.|+++.|+
T Consensus 240 ~~~~---~~---~----------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIY---YV---R----------DGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHH---HH---h----------cCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3211 00 0 00000 001112346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=375.82 Aligned_cols=368 Identities=29% Similarity=0.415 Sum_probs=262.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|.+|++.+.+|..++++++|++|+|++|++.+..| .|.++++|++|+|++|++.+..+..+.++++|++|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 578889999999999999999999999999999999988777 6889999999999999998777777888999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~ 236 (959)
++|.+.+ .+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.+|..+..+ ++..|.+..+.
T Consensus 292 s~n~l~~----~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~ 367 (968)
T PLN00113 292 SDNSLSG----EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367 (968)
T ss_pred cCCeecc----CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCe
Confidence 9998876 577888888888888888888888888888888888888888888888888777655 45555554433
Q ss_pred CCC---------------------cccc-cccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccc
Q 002149 237 GGG---------------------FTGT-IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS 294 (959)
Q Consensus 237 ~~~---------------------l~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 294 (959)
... +.+. +..+.++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..
T Consensus 368 l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 447 (968)
T PLN00113 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447 (968)
T ss_pred eEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChh
Confidence 221 1111 112334444555555555554444444555555555555555555444444
Q ss_pred cccc-cCCeEeCCCCcCCCCCCccc----ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCC
Q 002149 295 LASL-SLDHLDLNNNMFMGPVPKSK----AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369 (959)
Q Consensus 295 ~~~~-~L~~L~L~~N~l~~~ip~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 369 (959)
+..+ +|+.|+|++|.+.+.+|... ...+.+++|.+.+..+.. +..++.+.......+...
T Consensus 448 ~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~---------------~~~l~~L~~L~Ls~N~l~ 512 (968)
T PLN00113 448 KWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK---------------LGSLSELMQLKLSENKLS 512 (968)
T ss_pred hccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChh---------------hhhhhccCEEECcCCcce
Confidence 4333 35555555555555444321 112233444443221110 011222333333344444
Q ss_pred cccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC---
Q 002149 370 SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--- 446 (959)
Q Consensus 370 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~--- 446 (959)
...+..++.+++|+.|+|++|.++|.+|..+.++++|+.|+|++|+++|.+|..+.++++|+.|++++|+++|.+|.
T Consensus 513 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~ 592 (968)
T PLN00113 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592 (968)
T ss_pred eeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcch
Confidence 44555677889999999999999999999999999999999999999999999999999999999999999999996
Q ss_pred CCCcceecccCCCCCCCCC
Q 002149 447 FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 447 ~~~~~~~~l~~N~~~c~~~ 465 (959)
+.......+.||+.+||..
T Consensus 593 ~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 593 FLAINASAVAGNIDLCGGD 611 (968)
T ss_pred hcccChhhhcCCccccCCc
Confidence 3444566789999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.79 Aligned_cols=256 Identities=19% Similarity=0.231 Sum_probs=199.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+++.. +++.||+|.+.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999764 67889999986532 12233456788999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998642 2468899999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
...........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+.... .....
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~--- 224 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHE--- 224 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH------HHcCC---
Confidence 433323334579999999999875 4678899999999999999999999987654332110 00000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~ 887 (959)
.....+.........+.+++.+|+..++++ |++++++++
T Consensus 225 -----~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 225 -----ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 001111111112346778999998866554 467877765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.81 Aligned_cols=242 Identities=28% Similarity=0.371 Sum_probs=192.2
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +|+.||+|+++..... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 6889999998764221 23345567788888765 899999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-N 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-C
Confidence 999988743 2468899999999999999999999 899999999999999999999999999987432221 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ... . .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~------~~~-------~-~~~~~- 216 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES------IRV-------D-TPHYP- 216 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-------C-CCCCC-
Confidence 23446799999999999999999999999999999999999999987654321110 000 0 01111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG-HAV 886 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 886 (959)
. .....+.+++.+|++.||++||++. ++.
T Consensus 217 -~---~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 -R---WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -C---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 1223677999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=314.80 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=205.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-C---CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-D---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999753 2 3379999887542 34456788999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999998542 2468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceee--ccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 767 APDSERSVVT--RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 767 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
.......... ...++..|+|||++.+..++.++|||||||++||+++ |..||......+... .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~~~--------- 223 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---AIE--------- 223 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---HHh---------
Confidence 5443322221 1233568999999998899999999999999999887 999997765433211 010
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+... . ......+..+.+++.+|++.+|.+||++.++++.|..+
T Consensus 224 -~~~~--~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 -EGYR--L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCCc--C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000 0 01112234678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=322.40 Aligned_cols=274 Identities=23% Similarity=0.303 Sum_probs=207.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||.||++... ++..+|+|.+... .......++.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 36888999999999999999654 6788999988654 234455678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ..+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 99999999998542 5688999999999999999999972 4899999999999999999999999999875433
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc----------
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD---------- 839 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 839 (959)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 21 23457899999999998888999999999999999999999999755432211111000000000
Q ss_pred ----------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 840 ----------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 840 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.+.....+..... ..........+.+++.+|+..+|++||++.++++ ++++..+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~~ 295 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPP-KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK--HPFIKRAEL 295 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCc-cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhhccc
Confidence 0000000100000 0000012345889999999999999999999977 556655443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.40 Aligned_cols=274 Identities=19% Similarity=0.287 Sum_probs=204.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++..+...++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 56889999999999999999754 67889999987542 22233457789999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 995 5887777432 2457899999999999999999999 8999999999999999999999999999975433
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+............. .........
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT-EETWPGISS 234 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHhhhcc
Confidence 222 1233467899999998865 5688999999999999999999999987765443222211111000 000000000
Q ss_pred ------Ccc-cCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 ------PIL-EVND-----DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ------~~~-~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
... .... ........+.+++.+|++.||.+|||+.|+++ +++++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~ 293 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK--HAYFRSLG 293 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--Chhhhhcc
Confidence 000 0000 00112235679999999999999999999977 56666544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.58 Aligned_cols=257 Identities=30% Similarity=0.443 Sum_probs=204.1
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|...++||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 56788899999999999999532 3567899987754 455567899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 685 LLVYEYMPQGALSKHIFHWKS----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
++||||+++|+|.+++..... .....+++..+..++.|++.|++|||+ ++++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCC
Confidence 999999999999999865321 111358999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAW 832 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 832 (959)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-- 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence 999999999975433221 11222345788999999999999999999999999999998 89998765543321110
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
..... .......+..+.+++.+||+.||.+||++.+|.+.|+
T Consensus 238 --------------~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --------------TQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------------HcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00000 0001122346789999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.25 Aligned_cols=259 Identities=29% Similarity=0.459 Sum_probs=206.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 357888999999999999999754 24689999986542 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL-----NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
.++||||+++|+|.+++...... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999998653321 12357899999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||......+..... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV---I-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH---h--
Confidence 99999985443221 12233456789999999988889999999999999999998 99999766543321111 0
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
. ........ .....+.+++.+|++.+|++|||+.++++.|+
T Consensus 236 --------~--~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 --------D--GGHLDLPE---NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --------c--CCCCCCCC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0 00001011 12457889999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.59 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=199.6
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
|+..+.||+|+||+||+|.. .+++.||+|.+....... .....+.+|+++++.++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678899999999999965 478899999986543222 2345578899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999887542 22469999999999999999999999 89999999999999999999999999999765432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||............. . .... ..
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~-------~~~~---~~ 221 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--R-------RVLE---TE 221 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--H-------hhhc---cc
Confidence 21 233578999999999999999999999999999999999999998765433211110 0 0000 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.. ........+.+++.+|++.||++||+ +.++++
T Consensus 222 ~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 01112235789999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=326.56 Aligned_cols=247 Identities=27% Similarity=0.429 Sum_probs=203.1
Q ss_pred ccCcccccCceEEEEEEEc--CCc--EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 615 SENELGRGGFGVVYKGELD--DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
..++||+|+||.|++|.|. +|+ .||||.+....... ...+|.+|+.+|.+|+|||+++|+|+..+ ....+|+|+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3578999999999999775 344 58999998765443 67899999999999999999999999887 678899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
++.|+|.+.|++ .....|-......++.|||.||.||.+ +++|||||.++|+|+-..-.|||+||||+|-....
T Consensus 192 aplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999976 233678889999999999999999999 89999999999999999999999999999966554
Q ss_pred Ccce-ee-ccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 771 ERSV-VT-RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 771 ~~~~-~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... +. ...-...|+|||.+....++.++|||+|||++|||+| |..||-+.........++ +.
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~------- 331 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AG------- 331 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------cc-------
Confidence 4322 22 2334668999999999999999999999999999999 688999887644322111 01
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.++.... .+.+.|.++++.||..+|++||++..|.+
T Consensus 332 -erLpRPk---~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 -ERLPRPK---YCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -ccCCCCC---CChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1222233 34557889999999999999999999974
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=314.64 Aligned_cols=253 Identities=32% Similarity=0.468 Sum_probs=197.8
Q ss_pred CcccccCceEEEEEEEc-CCc--EEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecC
Q 002149 617 NELGRGGFGVVYKGELD-DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
+.||+|+||.||+|... ++. .+|+|.++.. ........+.+|++++.++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999764 343 4688887643 2345556788999999999 79999999999999999999999999
Q ss_pred CCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 693 QGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 693 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
+|+|.+++...+.. ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 99999998653321 12358899999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|+++....... ......+..|+|||++....++.++|||||||++|||++ |..||......+... ...
T Consensus 157 gl~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~~--- 225 (270)
T cd05047 157 GLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLP--- 225 (270)
T ss_pred CCccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HHh---
Confidence 99863221111 111233567999999988899999999999999999997 999997654322110 000
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
... ... ........+.+++.+|++.+|.+||++.++++.|++++
T Consensus 226 ----~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 ----QGY--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----CCC--CCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 000 11112346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.83 Aligned_cols=250 Identities=20% Similarity=0.342 Sum_probs=194.4
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||||+++..... ....+.+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999754 6889999999764332 23456688999999998 799999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999888743 2568999999999999999999999 899999999999999999999999999987432211 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE--RQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+... .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------VILEKQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------HHHcCCC
Confidence 2234679999999999999999999999999999999999999997432211 0000011110 0111111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPD------MGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~ 887 (959)
..+. .....+.+++.+|++.||.+||+ +.++++
T Consensus 223 ~~p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 223 RIPR---SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1111 12235789999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=320.17 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=195.6
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc---CCCCceeEEEEEEe-----Cc
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSVA-----GY 682 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 682 (959)
+|++.+.||+|+||.||+|... +++.||+|.+............+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788899999999999999654 688999998875432222234456777777665 69999999998764 34
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||++ ++|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999996 5888887542 22458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||......+............. ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~-~~~ 230 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDD 230 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC-hhh
Confidence 998654322 12345689999999999998999999999999999999999999977654332211100000000 000
Q ss_pred HHHh-------cCCcccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAA-------IDPILEV--NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~-------~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... +.+.... ..........+.+++.+|++.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 0000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=321.11 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=207.8
Q ss_pred cCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC
Q 002149 611 KNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 681 (959)
.+|...+.||+|+||.||+|... ....||+|.+.... ......++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 46788899999999999999642 24578999887542 344567788999999999 699999999999998
Q ss_pred ceEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ ++++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 999999999999999999965321 122468999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432211 1112234568999999999899999999999999999999 889997765433211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... .. .... ........+.+++.+|++.+|++||++.++++.|..+...
T Consensus 248 ~~~-------------~~--~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 LLR-------------EG--HRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHH-------------cC--CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 110 00 0000 1112234677999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.94 Aligned_cols=239 Identities=28% Similarity=0.362 Sum_probs=189.6
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHH-HHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIA-VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +|+.||||++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999764 789999999875422 1223344555554 56778999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999988853 2468899999999999999999999 899999999999999999999999999987532222 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~----------------~i~~~~~~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD----------------NILNKPLRL 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH----------------HHHcCCCCC
Confidence 2334579999999999999999999999999999999999999998765432110 011111110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
.. .....+.+++.+|++.||++||++.
T Consensus 216 ~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KP---NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 1234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=327.44 Aligned_cols=257 Identities=20% Similarity=0.249 Sum_probs=199.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.++||+|+||.||++..+ +++.+|+|++.+... .......+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999765 577899999864321 2233455888999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999998542 2468999999999999999999999 899999999999999999999999999997554
Q ss_pred CCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.... ......
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~~-- 225 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHKE-- 225 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH------HhCCCc--
Confidence 33333333457999999999986 34678899999999999999999999987654332111 100000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNV 888 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 888 (959)
..............+.+++.+|+..++.+ |+++.+++++
T Consensus 226 ------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 ------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00011111122346778899988665544 7899998773
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.66 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=201.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35789999999999999999975 56889999998654 2234456889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999998853 2468899999999999999999999 899999999999999999999999999998653
Q ss_pred CCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.+..... . ...
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~--~~~--- 225 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------S--KSN--- 225 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------e--cCC---
Confidence 3221 122346889999999884 345788999999999999999999998654432211000 0 000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
...+.. .........+.+++.+||+.+|++||+++++++++
T Consensus 226 ~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKL---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCC---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 01112234788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.57 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=201.7
Q ss_pred cCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--Cce
Q 002149 611 KNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 683 (959)
++|+..+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4678889999999999999964 35789999998754 44556788999999999999999999998754 346
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 78999999999999998542 2458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCccee--eccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERSVV--TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
++.......... ....++..|+|||++.+..++.++|||||||++|||++|..++......-.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG-QMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccc-ccchH
Confidence 986644332111 112334569999999988999999999999999999999877643321100000000000 00000
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.+.+.+..... ..........+.+++.+|+..+|++|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111111111 011112234688999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.75 Aligned_cols=243 Identities=26% Similarity=0.339 Sum_probs=195.1
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||||++.+... .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 578999999876422 223456677899999888 699999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999888743 2468999999999999999999999 8999999999999999999999999999874322221
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ... .....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~----------~~~~~- 214 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SIL----------EDEVR- 214 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHH----------cCCCC-
Confidence 2233568999999999999999999999999999999999999998665432211 000 00010
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDM-----GHAVN 887 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~ 887 (959)
........+.+++.+||+.||++||++ .++++
T Consensus 215 --~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 --YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011123467899999999999999999 77755
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.32 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=203.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+..+...++||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 35788999999999999999975 468899999887542 233467889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred cccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 99999999998843 357899999999999999999999 899999999999999999999999999988543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+....... . .. ..
T Consensus 168 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~--~~--------~~ 233 (296)
T cd06654 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A--TN--------GT 233 (296)
T ss_pred cccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---h--cC--------CC
Confidence 3221 123346889999999998888999999999999999999999999766543221100 0 00 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.. .........+.+++.+|+..+|++||++.++++
T Consensus 234 ~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 111123346789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=317.76 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=207.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 688 (959)
...|+..++||+||.+.||++...+.+.+|+|++.....+.....-|..|+..|.+|+ |.+||+|++|-..+...|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3468888999999999999998888889999998877778888899999999999994 999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||= ..+|.++|..... ....| .+..+..|++.++.++|. +||||.||||.|+|+-. |.+||+|||+|....
T Consensus 440 E~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 996 7899999965322 22334 788899999999999999 89999999999999864 589999999999665
Q ss_pred CCCcce-eeccccccccccccccccCC-----------CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 769 DSERSV-VTRLAGTFGYLAPEYAVTGK-----------ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 769 ~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
...+.. ....+||+.||+||++.... .++++||||+|||||+|+.|+.||.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------- 577 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------- 577 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------------
Confidence 544443 34578999999999985432 56899999999999999999999975321
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...++..+.++.-..+.......+++.++++.||.+||.+||+..++++
T Consensus 578 --~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 --QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 0123445555543322222233345889999999999999999999987
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=316.35 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..++||+|+||.||+|.. .+++.||+|.+.... .......+.+|++++++++||||+++++++......++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 577889999999999999964 578899999886542 344556789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|..+ ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999998644 246788899999999999999999 89999999999999999999999999999855432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ........+..
T Consensus 149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~~~ 216 (279)
T cd06619 149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVDED 216 (279)
T ss_pred c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhccC
Confidence 2 23357899999999999999999999999999999999999999754322111000 00000111110
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ..........+.+++.+|++.+|++||+++++++
T Consensus 217 ~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 217 PP-VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CC-CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00 0001112235789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=292.01 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=202.3
Q ss_pred ccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEecC
Q 002149 615 SENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
.+..||.|+-|.||+++.+ +|...|||.+.... ..+..+++.+.+.++..-+ +|+||+.+|||..+...++.||.|
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 3467999999999999765 58889999998753 5566788888888887775 899999999999999999999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
...+++++... .+++++..+-++...+++||.||.+. ++|||||+||+|||+|+.|.+|+||||++-+..+...
T Consensus 174 s~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 STCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 55566666442 26789999999999999999999985 7999999999999999999999999999987765443
Q ss_pred ceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 773 SVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.+..+|-+.|||||.+.- ..|+-++||||||+.++||.||+.||.+...+- +.+...++.
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF---------------e~ltkvln~ 310 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF---------------EVLTKVLNE 310 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH---------------HHHHHHHhc
Confidence 355689999999999854 468889999999999999999999998743211 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+...........+.+++..||+.|+.+||.+.++++ +++...|..
T Consensus 311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~--h~Fi~~ye~ 357 (391)
T KOG0983|consen 311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE--HPFIKRYET 357 (391)
T ss_pred CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc--Ccceeecch
Confidence 11111122223346789999999999999999999987 455544443
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.43 Aligned_cols=252 Identities=26% Similarity=0.380 Sum_probs=199.5
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
|+..+.||+|+||.||+|.. .+++.||||.+...... ....+.+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778899999999999965 46889999988654322 22345677899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999888542 22468999999999999999999999 89999999999999999999999999998755432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||..............+. .......
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~------~~~~~~~--- 224 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV------KEVQEEY--- 224 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh------hhhhhhc---
Confidence 22 223478999999999999999999999999999999999999998654321111000000 0000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.......+.+++.+|++.||++||+ +.|+++
T Consensus 225 ------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 ------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0011235779999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.20 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=202.0
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.|...+.||.|+||.||-|+ ..+.+.||||++.-. .-+.+.-.++..|+..+.+++|||++.+-|+|......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346677889999999999995 457889999998643 223344577889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||| -|+-.|++.- ..+++.+-++..|..+.+.||+|||+ .+.||||||+.|||+++.|.||++|||.|....
T Consensus 106 EYC-lGSAsDlleV----hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYC-LGSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHH-hccHHHHHHH----HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999 7788888743 33789999999999999999999999 899999999999999999999999999988654
Q ss_pred CCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
. ...++|||.|||||++. .+.|+-|+||||+|++..||.-.++|+.........+ .+. +
T Consensus 178 P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------HIA-------Q 239 (948)
T KOG0577|consen 178 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIA-------Q 239 (948)
T ss_pred c-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------HHH-------h
Confidence 4 34579999999999985 4789999999999999999999999988766543322 111 1
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.-.+.+. ..+-...+..++..||+.-|.+|||.++++.
T Consensus 240 NesPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 240 NESPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred cCCCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1112222 1122336789999999999999999998765
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=311.26 Aligned_cols=249 Identities=32% Similarity=0.490 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|... |+.||+|.+.... ...+++.+|+.+++.++|+||+++++++.+....++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 46788899999999999999876 7899999987642 2567789999999999999999999999989999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||.++.....
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999998542 22468999999999999999999999 89999999999999999999999999999866332
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.. ...++..|+|||++.++.++.++||||||+++||+++ |..||......+.... +. ....
T Consensus 156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~----------~~~~- 217 (256)
T cd05039 156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH---VE----------KGYR- 217 (256)
T ss_pred cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---Hh----------cCCC-
Confidence 21 2234668999999998899999999999999999997 9999976654332110 10 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.. ........+.+++.+|+..+|++||++.++++.|..
T Consensus 218 -~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 -ME---APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CC---CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 00 011123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.31 Aligned_cols=265 Identities=29% Similarity=0.401 Sum_probs=209.3
Q ss_pred cCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC
Q 002149 611 KNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 681 (959)
.+|.+.+.||+|+||.||+|... .+..||+|.+... ......+++.+|+++++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46888999999999999999642 1236899988754 2345567899999999999 799999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999865321 123458999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999865432211 1122334568999999999999999999999999999998 889987765433211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. .. ... .+........+.+++.+|++.+|++||++.++++.|++++....
T Consensus 248 ~~------~~----------~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 248 LL------KE----------GHR--MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HH------Hc----------CCC--CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 10 00 000 01111223468899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=328.47 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=194.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|+|||++++++..+...++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 346999999999999999999764 578899995321 23568999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|++ .++|.+++... ...+++.+++.++.||++||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 57888887431 2469999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHhhhcch--
Q 002149 769 DSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPE-----ERQYLAAWFWNIKSDK-- 840 (959)
Q Consensus 769 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~-- 840 (959)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..++...... ....+...+.......
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 3222 1223457999999999999999999999999999999999988665332110 0011111111100000
Q ss_pred ------HHHHHhc------CCcccCCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 841 ------EKLRAAI------DPILEVNDDTF----ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 841 ------~~~~~~~------~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+.... ..........+ .....+.+|+.+||+.||.+|||+.|+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 00000000011 11125779999999999999999999987
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.76 Aligned_cols=304 Identities=22% Similarity=0.315 Sum_probs=222.4
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG----- 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 681 (959)
.+.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457899999999999999999965 4789999999875544455566788999999999999999999987643
Q ss_pred -ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 682 -YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 682 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
...++||||+ .++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 3569999999 5688777632 27889999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
||+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......+.... .........
T Consensus 162 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~ 237 (353)
T cd07850 162 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK--IIEQLGTPS 237 (353)
T ss_pred CccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHhcCCCC
Confidence 99998654322 12334678999999999999999999999999999999999999976653221110 000000000
Q ss_pred HH--------HHHhcCCcccC------------------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 841 EK--------LRAAIDPILEV------------------NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 841 ~~--------~~~~~~~~~~~------------------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.. ....+...... ..........+.+++.+|++.||++||++.|+++ +++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~--~~~~~ 315 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ--HPYIN 315 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc--ChhHh
Confidence 00 00011100000 0001122446789999999999999999999987 78888
Q ss_pred hcCCCCCCCCcc-cCccc-CCChhhhHHHHHHhhCC
Q 002149 895 KWKPLDDEPEEY-SGIDY-SLPLNQMVKDWQEAEGK 928 (959)
Q Consensus 895 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~ 928 (959)
.|....+..... ...+. ..+....+++|++...+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (353)
T cd07850 316 VWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYK 351 (353)
T ss_pred hccCCccCCCCCCCccccccccccccHHHHHHHHHh
Confidence 777655443321 11111 12346667888886544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.13 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=207.7
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||.++. .+++.+++|.+..........+++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999964 5688999999876655566677899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999885422 3568999999999999999999999 89999999999999999999999999999865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|++.|+|||++.+..++.++||||||+++|||++|..||......+.... .....
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----------------~~~~~ 217 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK----------------IVQGN 217 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----------------HHcCC
Confidence 32 23345789999999999888899999999999999999999999987554332110 00011
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.. .........+.+++.+|++.+|++||++.+++++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT--PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC--CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11 1112223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=311.19 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=200.0
Q ss_pred CcccccCceEEEEEEEcC--C--cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 617 NELGRGGFGVVYKGELDD--G--TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
+.||+|+||.||+|.+.+ + ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999997643 3 36899999876433 567789999999999999999999999888 88899999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|+|.+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999865221 568999999999999999999999 8999999999999999999999999999986544222
Q ss_pred c--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 773 S--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 773 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+..... . .. ..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~----------~~-~~ 218 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---D----------KE-GE 218 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----------hc-CC
Confidence 1 1122457789999999998899999999999999999999 99999766543321111 0 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
... .....+..+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLE---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCC---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011 11122347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=314.02 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=202.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CC---cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DG---TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.|++.+.||+|+||.||+|... ++ ..||||.+... .......+|..|+.+++.++||||+++++++..+...++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4778899999999999999764 33 36999998754 2455567899999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999988542 2468999999999999999999999 89999999999999999999999999998755
Q ss_pred CCCCcce-ee-ccc--cccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 768 PDSERSV-VT-RLA--GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 768 ~~~~~~~-~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
....... .. ... .+..|+|||++.+..++.++|||||||++||+++ |..||......+. ..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~-------- 225 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIE-------- 225 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHH--------
Confidence 4322111 11 111 2457999999999999999999999999999886 9999976654321 11110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
... ... ...+.+..+.+++.+|+..+|++||++.++++.|+.+
T Consensus 226 --~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 --QDY--RLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --cCC--cCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 001 0112234678999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.92 Aligned_cols=241 Identities=26% Similarity=0.333 Sum_probs=190.4
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHH-HHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIA-VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|.. .+|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999965 4789999999875422 2233445556655 46778999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|..++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 999888743 2568999999999999999999999 8999999999999999999999999999875322211
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~----------------~~~~~~~~~ 215 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----------------NILHKPLVL 215 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH----------------HHHcCCccC
Confidence 2234579999999999999999999999999999999999999998765433211 011111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 885 (959)
.. .....+.+++.+|++.+|.+||++.+.
T Consensus 216 ~~---~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 216 RP---GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CC---CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 11 122356789999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.87 Aligned_cols=242 Identities=27% Similarity=0.343 Sum_probs=189.6
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHH-HHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEI-AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||+|++...... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999765 5788999998754221 22233444444 456788999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~ 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-G 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-C
Confidence 999988853 2457888899999999999999999 899999999999999999999999999997543222 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. .......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i----------~~~~~~~ 215 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NI----------LNKPLQL 215 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH------HH----------HhCCcCC
Confidence 2334679999999999999999999999999999999999999998765433211 00 0000110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 886 (959)
. ......+.+++.+|++.||.+||++.+.+
T Consensus 216 ~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 K---PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred C---CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0 11223678999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=346.94 Aligned_cols=264 Identities=20% Similarity=0.335 Sum_probs=204.3
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERL 685 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 685 (959)
...+|.+.+.||+|+||.||+|... +++.||+|.+............+..|+.+++.++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3468999999999999999999654 57789999987655556667789999999999999999999998754 35689
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEecCCCCCCEEECC---------
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA----HQSFIHRDLKSSNILLGD--------- 752 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~Dik~~NiLl~~--------- 752 (959)
+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999865322 2256999999999999999999999832 145999999999999964
Q ss_pred --------CCcEEEeeccccccCCCCCcceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 753 --------DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 753 --------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2459999999998654322 2234579999999999864 458899999999999999999999997654
Q ss_pred hHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 823 PEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.... +.. ... .. +.+... .....+.+|+..||+.+|.+||++.++++ .+++..
T Consensus 248 ~~~q--li~---~lk-------~~--p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~--h~~ik~ 300 (1021)
T PTZ00266 248 NFSQ--LIS---ELK-------RG--PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG--YQIIKN 300 (1021)
T ss_pred cHHH--HHH---HHh-------cC--CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc--cHHHhh
Confidence 3221 111 000 00 111111 11246789999999999999999999986 344443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.29 Aligned_cols=239 Identities=23% Similarity=0.408 Sum_probs=188.2
Q ss_pred CcccccCceEEEEEEEcC-------------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 617 NELGRGGFGVVYKGELDD-------------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+.||+|+||.||+|.+.+ ...||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 225888987653 23445678889999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc-------E
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR-------A 756 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~-------~ 756 (959)
.++||||+++|+|..++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999998887431 2468999999999999999999999 89999999999999987654 8
Q ss_pred EEeeccccccCCCCCcceeeccccccccccccccc-cCCCCccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHH
Q 002149 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-TGKITTKVDVFSFGVVLMELL-TGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 757 ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~ll~ell-tg~~p~~~~~~~~~~~~~~~~~ 834 (959)
+++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+......+.... .
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~----~ 222 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF----Y 222 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH----H
Confidence 99999998754322 2245788999999886 467899999999999999998 58888876543321110 0
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
. ...... ......+.+++.+||+.||.+||++.++++.+
T Consensus 223 ----------~---~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 ----------E---GQCMLV---TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------h---cCccCC---CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 000000 01124678999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.10 Aligned_cols=248 Identities=30% Similarity=0.424 Sum_probs=196.5
Q ss_pred CcccccCceEEEEEEEc-C---CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 617 NELGRGGFGVVYKGELD-D---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
++||+|+||.||+|.+. . +..+|+|.+...... ...+++.+|+.+++.++|+||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999643 2 268999998765333 45677899999999999999999999876 456799999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999998542 368999999999999999999999 8999999999999999999999999999985543322
Q ss_pred ceee--ccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 773 SVVT--RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 773 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.... ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ...+... .+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~~-----------~~ 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLESG-----------ER 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcC-----------Cc
Confidence 2111 1223568999999999999999999999999999998 9999976654321 1111100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
. . ........+.+++.+|+..+|++||++.++++.|+.+
T Consensus 217 ~-~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 L-P---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred C-C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0 0 1111234678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=311.16 Aligned_cols=248 Identities=30% Similarity=0.439 Sum_probs=199.2
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE-eCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV-AGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... |+.||+|.+... ...+.+.+|+.+++.++|+|++++++++. .+...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 46888899999999999999765 788999988643 23457889999999999999999999764 4567899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999998542 22458899999999999999999999 8999999999999999999999999999885433
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+. ....
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~----------~~~~ 217 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----------KGYK 217 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----------cCCC
Confidence 22 12344678999999998899999999999999999998 9999876543221 11010 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
. ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 M-----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0 0111223467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.78 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=194.4
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 688 (959)
+|+..+.||+|+||.||+|.. .+|+.||+|++.+... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999999965 4688999999875422 2234566778999998885 577888999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999988843 2468999999999999999999999 899999999999999999999999999988543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... + ..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~---i-------------~~ 215 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS---I-------------ME 215 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---H-------------Hh
Confidence 2221 22345699999999999999999999999999999999999999987654322110 0 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
...... ......+.+++.+|++.+|.+|++..
T Consensus 216 ~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 216 HNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011101 11223677999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=321.80 Aligned_cols=199 Identities=27% Similarity=0.431 Sum_probs=161.5
Q ss_pred cCcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEEEEEe
Q 002149 616 ENELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLLVYEY 690 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 690 (959)
..+||+|+||.||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999754 467899998865422 2346789999999999999999998854 4567899999
Q ss_pred cCCCchhhHHhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCcEEEeecc
Q 002149 691 MPQGALSKHIFHWKS----LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFG 762 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----~~~~~~ki~DfG 762 (959)
+ +++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 8 5688777643221 112358999999999999999999999 899999999999999 456789999999
Q ss_pred ccccCCCCCc--ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 763 LVKLAPDSER--SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 763 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9986543322 12234678999999999877 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.31 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=198.6
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 567788999999999999765 5778899988653 3455677889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|..++.. ...++++..+..++.|++.||+|||+ .+++||||||+||+++.++++||+|||+++......
T Consensus 85 ~~~~l~~~~~~----~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLE----LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999888753 12568999999999999999999999 899999999999999999999999999987543322
Q ss_pred cceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 772 RSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
. ......++..|+|||++. +..++.++|||||||++|||++|+.||......+.. ..... .
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~-----------~ 223 (282)
T cd06643 158 Q-RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK-----------S 223 (282)
T ss_pred c-ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh-----------c
Confidence 1 223356899999999984 345778999999999999999999999765532211 10000 0
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+... ........+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 224 EPPTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000110 11112346789999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.79 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=203.0
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+.+|+.+++.++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 4778899999999999999654 68899999886432 344567788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ....+++..+..++.|++.||.|||+ ++|+|+||||+||++++++.++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999887532 23568899999999999999999999 89999999999999999999999999999865433
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .... ....+
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~~------~~~~~- 219 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KVCQ------GSYKP- 219 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HHhc------CCCCC-
Confidence 22 2234578999999999998889999999999999999999999998654322111 0000 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........+.+++.+||+.||++||++.+++.
T Consensus 220 -----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 220 -----LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred -----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 01112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=326.05 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=191.9
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999754 6789999999765322 23456688999999988 699999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 999888743 2468999999999999999999999 8999999999999999999999999999875322211
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+... .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ---------VILEKPIRI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH---------HHHhCCCCC
Confidence 23346799999999999999999999999999999999999999964322111100111110 011111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
+ ......+.+++.+|++.||++|+++.
T Consensus 223 p---~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 P---RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C---CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1 11223577999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.44 Aligned_cols=258 Identities=23% Similarity=0.362 Sum_probs=204.6
Q ss_pred cCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|...+.||+|+||.||+|...+ ...||||...... .....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457888999999999999997543 2468999886542 34556789999999999999999999998875 45789
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 99999999999998542 2458999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.............++..|+|||.+....++.++||||||+++||+++ |..||......+... .+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~~~---~------- 223 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---RIE---N------- 223 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHH---c-------
Confidence 54433222223345568999999988889999999999999999996 999998765433211 010 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. ...... ......+.+++.+|+..+|++||++.++++.|..+...
T Consensus 224 ~--~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 G--ERLPMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C--CcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 000001 12234688999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=341.18 Aligned_cols=281 Identities=17% Similarity=0.204 Sum_probs=196.5
Q ss_pred HHhcCCcccCcccccCceEEEEEEEcC--CcEEEEEE--------------cccc-cccHHHHHHHHHHHHHHHhcCCCC
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELDD--GTKIAVKR--------------MEAG-VISKKAVDEFHSEIAVLSKVRHRH 670 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~n 670 (959)
...++|++.+.||+|+||.||+|..+. ++.+++|. +.+. .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 446789999999999999999986532 22222221 1110 112234566889999999999999
Q ss_pred ceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 671 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
|+++++++...+..++|+|++ .+++.+++...............+..++.||+.||+|||+ ++||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 999999999999999999998 5677777654222112334466788899999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCC-CCCCCChHHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLM-ALDESRPEERQYL 829 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~-p~~~~~~~~~~~~ 829 (959)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765543333344679999999999999999999999999999999999875 4443322222222
Q ss_pred HHHHHhhhcch-------HHHHHhcCCccc-CCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 830 AAWFWNIKSDK-------EKLRAAIDPILE-VNDDT-------FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 830 ~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
...+....... ..+.+.++.... ..... ......+.+++.+||+.||.+||++.|+++ ++++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~--hp~f~ 458 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA--LPLFS 458 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh--Chhhh
Confidence 22111111000 111111111000 00000 011224567899999999999999999977 44443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.31 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=212.3
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.-|..++.||+|.|..|-.|+ .-+|+.||||++.+.....-....+.+|++.|+.++|||||+++.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457778899999999999995 3479999999998877777777889999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-CCCCcEEEeeccccccCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl-~~~~~~ki~DfGla~~~~ 768 (959)
+-.+|+|.+|+.++. ..+.++...+++.||+.|+.|+|. ..+|||||||+||.+ ..-|-||++|||++..+.
T Consensus 98 LGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred ecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999997643 568999999999999999999999 789999999999977 456889999999998665
Q ss_pred CCCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ..+..+|+..|-|||++.+..|+ +++||||+|||||-|++|+.||+...+.+.. ..++
T Consensus 171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmIm 232 (864)
T KOG4717|consen 171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMIM 232 (864)
T ss_pred Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhhh
Confidence 433 35667999999999999999987 4699999999999999999999987765532 2223
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
|-... .+.....+..+||..||..||.+|.+.++|+.
T Consensus 233 DCKYt---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYT---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccc---CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 32222 12234457789999999999999999999976
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=317.59 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=207.5
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||.|+||.||+|.. .+++.||+|.+... .....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 5689999999999999999964 57899999988654 22335678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998743 458999999999999999999999 8999999999999999999999999999885443
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..... . ....+
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~----------~~~~~ 233 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A----------TNGTP 233 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----------hcCCc
Confidence 222 123356889999999999888999999999999999999999999876553321111 0 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
... ........+.+++.+||..||.+||++.++++ ++++....
T Consensus 234 ~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~ 276 (296)
T cd06655 234 ELQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAK 276 (296)
T ss_pred ccC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhcc
Confidence 000 11122336779999999999999999999976 56665433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.67 Aligned_cols=250 Identities=31% Similarity=0.486 Sum_probs=201.3
Q ss_pred CCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
+|+..+.||+|+||.||+|.+.+++.+|+|.+...... ...+.+|++++++++|||++++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 57778899999999999998777889999988754332 346889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|.+++... ...++++.+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 82 EHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999988542 2457899999999999999999999 899999999999999999999999999988554332
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
........++.+|+|||++.++.++.++||||||+++|||++ |..||......+... .. ......
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------~~-------~~~~~~- 220 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE------TI-------NAGFRL- 220 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH------HH-------hCCCCC-
Confidence 221222345678999999998899999999999999999998 999997655332111 00 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
.. .. .....+.+++.+|++.+|++||++.++++.|
T Consensus 221 ~~-~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 YK-PR---LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CC-CC---CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00 01 1124688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.17 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=200.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|++.++||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 56888999999999999999765 5889999998754 45566788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|..++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 90 FCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999998877432 2468999999999999999999999 8999999999999999999999999999875433
Q ss_pred CCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 770 SERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
... ......+++.|+|||++. ...++.++|||||||++|||++|..||........ ... . .
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----~-------~ 228 (292)
T cd06644 163 TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----I-------A 228 (292)
T ss_pred ccc-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH----H-------h
Confidence 221 123346889999999985 34578899999999999999999999976543221 010 0 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+.. .........+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 229 KSEPPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 011122336789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.41 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.+|+..+.||+|+||.||+|..+ +|+ .||+|.+.... .......+.+|+.+++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 46788899999999999999754 333 58999876542 34456778899999999999999999999887 7889
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999998542 2458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCccee-eccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSERSVV-TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
.......... ....++..|+|||.+....++.++|+|||||++||+++ |+.||......+... .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~-------- 226 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLEK-------- 226 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHhC--------
Confidence 6543322111 11223568999999988899999999999999999999 999998765533211 1100
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
. . ..... ......+.+++.+|+..+|.+||++.++++.|..+.+++
T Consensus 227 --~-~-~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 227 --G-E-RLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred --C-C-CCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0 0 00001 112235779999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=315.32 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=199.3
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC----
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG---- 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 681 (959)
.+...|+..+.||+|+||.||+|... +++.||+|++... ......+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 34567888899999999999999754 6889999998653 23345688999999998 699999999998753
Q ss_pred --ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 682 --YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 682 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
...++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 4678999999999999988542 22568999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
|||+++....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.......
T Consensus 154 Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---- 228 (272)
T cd06637 154 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 228 (272)
T ss_pred cCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence 9999985533221 233457899999999986 345788999999999999999999999765443221110
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
......... .......+.+++.+|+..+|.+||++.++++
T Consensus 229 ---------~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 ---------PRNPAPRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---------hcCCCCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000001111 1112346789999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=324.68 Aligned_cols=239 Identities=28% Similarity=0.353 Sum_probs=188.8
Q ss_pred CcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHH-HHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIA-VLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|+.. +++.||+|++.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999764 688999999875422 2223344555554 57888999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999887743 2568889999999999999999999 899999999999999999999999999987532222 1
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~----------------~i~~~~~~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD----------------NILHKPLQL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH----------------HHhcCCCCC
Confidence 2344579999999999999899999999999999999999999998765322110 111111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
.. .....+.+++.+|++.||.+||+..
T Consensus 216 ~~---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PG---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1223678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.55 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=206.4
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|... +++.||+|.+... ........+.+|++++++++|+||+++++++......++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5788899999999999999765 7899999988654 2344557788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|..++... .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 9999998887542 1134789999999999999999999962 58999999999999999999999999998755332
Q ss_pred CcceeeccccccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG------KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
. .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+.
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------------~~~ 220 (286)
T cd06622 157 L---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------------QLS 220 (286)
T ss_pred c---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-------------HHH
Confidence 2 2234678899999998554 35789999999999999999999997643322111 011
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
....... ..........+.+++.+|++.+|++||++.++++ ++++..+...
T Consensus 221 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~~~ 271 (286)
T cd06622 221 AIVDGDP--PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYKNA 271 (286)
T ss_pred HHhhcCC--CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--ChhhhhccCC
Confidence 1111110 1111123456789999999999999999999987 5666655543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.76 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=201.9
Q ss_pred CCcccCcccccCceEEEEEEEcCCcEEEEEEcccccc----cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVI----SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+|...+.||+|+||.||+|...+++.+|||.+..... .......+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999888899999998864322 123446688999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998542 457899999999999999999999 89999999999999999999999999998754
Q ss_pred CCCC-----cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 768 PDSE-----RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 768 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||............ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~---- 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GA---- 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hh----
Confidence 2211 11223356899999999999988999999999999999999999999765432211100 00
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ..+.. .......+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~-~~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 HRG-LMPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccC-CCCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00001 1122346789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=320.80 Aligned_cols=265 Identities=19% Similarity=0.259 Sum_probs=196.5
Q ss_pred ccCccccc--CceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 615 SENELGRG--GFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 615 ~~~~lG~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
..++||+| +||+||++.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7889999965 57899999998765444555677889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999985422 2458999999999999999999999 899999999999999999999999998754322111
Q ss_pred c------ceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc-----
Q 002149 772 R------SVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS----- 838 (959)
Q Consensus 772 ~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 838 (959)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 233 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 233 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccc
Confidence 1 01112356778999999976 45889999999999999999999999865432211 100000000
Q ss_pred ---chHHHHHh-----cCCcc----------------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 ---DKEKLRAA-----IDPIL----------------EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ---~~~~~~~~-----~~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+.+... .+... ............+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000 00000 000011122346789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=322.24 Aligned_cols=191 Identities=26% Similarity=0.369 Sum_probs=164.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++..+...++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 457999999999999999999765 5678999975432 2346899999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|++ .++|.+++.. ....+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~-~~~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHY-SSDLYTYLTK----RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred Ecc-CCcHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999 5788888743 23578999999999999999999999 899999999999999999999999999997433
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMAL 818 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~ 818 (959)
... ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 123457899999999999999999999999999999999976555
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.93 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=202.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-CceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 689 (959)
+|++.+.||+|+||.||++... +++.||+|++..........+.+.+|+++++.++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999654 57899999987654455566778999999999999999999988764 446789999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ....+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999988642 23568999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.......... ... ...+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~------~~~------~~~~-- 219 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY------RII------EGKL-- 219 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHH------hcCC--
Confidence 222 2334568899999999999999999999999999999999999998654322111 000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..........+.+++.+|++.+|++||++.++++
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111123346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.48 Aligned_cols=271 Identities=24% Similarity=0.382 Sum_probs=202.0
Q ss_pred cCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ce
Q 002149 611 KNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 683 (959)
+.|++.+.||+|+||.||++.. .++..||+|.+.... .....+.+.+|+++++.++||||+++.+++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3468889999999999999974 357889999987542 344567799999999999999999999998775 56
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++++|.+++... ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcc
Confidence 78999999999999988432 2468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
++........ ......++..|+|||++.+..++.++|||||||++|||++++.|.......... ....... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~-~~~~~ 233 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHG-QMTVT 233 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccc-cccHH
Confidence 9865433221 122345677899999998888999999999999999999987664322110000 0000000 00000
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.....+..... ..........+.+++.+|++.+|++||++.++++.++.+
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000000 001112335788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=331.29 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=197.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +++.||+|++..... .......+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999654 689999999875321 2334567888999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999998853 2568999999999999999999999 899999999999999999999999999987432
Q ss_pred CCCc----------------------------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhC
Q 002149 769 DSER----------------------------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814 (959)
Q Consensus 769 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg 814 (959)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 001235799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 002149 815 LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD---MGHAVN 887 (959)
Q Consensus 815 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~ 887 (959)
+.||....+.+....+ . .. ...+..+.. ......+.+++.+++ .||.+|++ +.++++
T Consensus 233 ~~Pf~~~~~~~~~~~i---~----------~~-~~~~~~p~~-~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 233 YPPFCSETPQETYRKV---M----------NW-KETLVFPPE-VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCHHHHHHHH---H----------cC-CCceecCCC-CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999877654321111 0 00 000000000 011235667888866 49999995 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.75 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|.. .+++.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 4677888999999999999965 46889999998754 23344568899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999998853 2468999999999999999999999 8999999999999999999999999999875533
Q ss_pred CCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 770 SERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.. .......|+..|+|||++. ...++.++|||||||++|||++|..||....+........ . ...
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~-----~~~ 226 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------K-----SNF 226 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------c-----cCC
Confidence 21 1223457899999999874 4568899999999999999999999986554322211100 0 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+... ........+.+++.+|++.+|++||+++++++
T Consensus 227 ~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLK---DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCccc---ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 00112235789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=324.53 Aligned_cols=307 Identities=23% Similarity=0.319 Sum_probs=220.0
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----c
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----Y 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 682 (959)
+.++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 356899999999999999999964 478999999986431 233456678899999999999999999987644 3
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++|+||+. +++.+.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 5799999995 577776632 568999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc--ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 763 LVKLAPDSER--SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 763 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
+++....... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..............+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~~ 230 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PS 230 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-CC
Confidence 9985533221 12233578999999998755 56889999999999999999999999765432211111000000 00
Q ss_pred hHHHHHhcCCc--------ccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCc-
Q 002149 840 KEKLRAAIDPI--------LEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE- 905 (959)
Q Consensus 840 ~~~~~~~~~~~--------~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~- 905 (959)
.+.+....+.. ....... ......+.+++.+|++.||++||++.++++ +++++.+....+++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~--hp~~~~~~~~~~~~~~~ 308 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA--HPYLEQYHDPSDEPVAE 308 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc--CccccccCCCCCcccCC
Confidence 01111111000 0000000 012346789999999999999999999987 6777777665555544
Q ss_pred -ccCcccCCChhhhHHHHHHhhCCC
Q 002149 906 -YSGIDYSLPLNQMVKDWQEAEGKD 929 (959)
Q Consensus 906 -~~~~~~~~~~~~~~~~~~~~~~~~ 929 (959)
...+|++.......++.||..-.+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (336)
T cd07849 309 EPFPFDFELFDDLPKEKLKELIFEE 333 (336)
T ss_pred CCCChhhccccccCHHHHHHHHHHH
Confidence 234555544455566666665433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.05 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=206.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 46799999999999999999975 578999999987542 233466889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999998843 457899999999999999999999 899999999999999999999999999987554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....... . . .-.
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~---~-------~~~ 232 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A---T-------NGT 232 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---c---c-------CCC
Confidence 3322 123356889999999999888999999999999999999999999765432211000 0 0 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
+. ..........+.+++.+|+..+|++||++.++++ +++++..
T Consensus 233 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~ 275 (297)
T cd06656 233 PE---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLA 275 (297)
T ss_pred CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhccc
Confidence 00 0111122345779999999999999999999987 4555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=313.55 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=200.4
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999764 689999999875433333456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
++ ++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 96 68888875422 23568999999999999999999999 89999999999999999999999999998754332
Q ss_pred CcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh----------cc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK----------SD 839 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~ 839 (959)
. .......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+... ....... ..
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchh
Confidence 2 122334678899999988654 57889999999999999999999998765432211 1110000 00
Q ss_pred hHHHHHhcCCcccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEV--NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......+...... .........++.+++.+|+..||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00111111100000 0000012235679999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.48 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=203.8
Q ss_pred cCCcccCcccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|...+ ++.+|+|.+... ...+++.+|+++++.++|+||+++++++......++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578889999999999999998764 789999998653 226789999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~----~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKI----TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHh----CccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999998843 22578999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....+....... ......
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~ 217 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PNKPPP 217 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------ccCCCC
Confidence 322 223346889999999999989999999999999999999999999865443211100 000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..........+.+++.+|++.+|++||++.++++
T Consensus 218 ~---~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 T---LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred C---CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 1111122346789999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.82 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=199.4
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
++||+|+||.||+|...+++.||+|++..... ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999877699999998876533 24567889999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCccee-
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV- 775 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~- 775 (959)
.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9988542 2467899999999999999999999 8999999999999999999999999999985542221111
Q ss_pred eccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC
Q 002149 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854 (959)
Q Consensus 776 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (959)
....++..|+|||.+.++.++.++|||||||++|||++ |..||............ .... ...
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------------~~~~--~~~-- 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------------ESGY--RMP-- 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------------hcCC--CCC--
Confidence 11234567999999998899999999999999999999 88888766543221111 0000 000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 855 DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 855 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
........+.+++.+|+..+|.+||++.|+++.|+
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11122347889999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.85 Aligned_cols=265 Identities=22% Similarity=0.311 Sum_probs=202.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999765 68999999886543233334567899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++++.+..+... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999888776532 2458999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHHhhhcchHHHHHhc
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAA-WFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 847 (959)
... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+...... ...... .......
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI---PRHQQIF 228 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---hHHhhhc
Confidence 321 1233467889999999876 557899999999999999999999998766544322111 110000 0000000
Q ss_pred CC------cc-c--CCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DP------IL-E--VNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~------~~-~--~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+. .. . ..... ......+.+++.+|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00 0 00000 012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.03 Aligned_cols=305 Identities=22% Similarity=0.343 Sum_probs=229.5
Q ss_pred HHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-CceE
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYER 684 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 684 (959)
..++++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34678899999999999999999964 478999999886543344455678899999999999999999998865 5678
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+ +++|.+++.. .++++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 86 ~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 8999998 6788887742 457888899999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHhh------
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL-AAWFWNI------ 836 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~-~~~~~~~------ 836 (959)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........... .......
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754321 123467889999998766 5689999999999999999999999987654332111 1110000
Q ss_pred -hcchHHHHHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcc
Q 002149 837 -KSDKEKLRAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGID 910 (959)
Q Consensus 837 -~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 910 (959)
..... ..+.+........... .....+.+++.+|++.+|++||++.+++. +++++.+..+.+++...+.++
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~--~~~~~~~~~~~~~~~~~~~~~ 308 (328)
T cd07856 232 TICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA--HPYLAPYHDPTDEPVAEEKFD 308 (328)
T ss_pred hccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CCccccccCCccccCchhhcC
Confidence 00000 0000000000001111 12347889999999999999999999976 788888888888887777776
Q ss_pred cCC-ChhhhHHHHHHhhCC
Q 002149 911 YSL-PLNQMVKDWQEAEGK 928 (959)
Q Consensus 911 ~~~-~~~~~~~~~~~~~~~ 928 (959)
+.. ....++.-|+-+.+.
T Consensus 309 ~~~~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 309 WSFNDADLPVDTWKVMMYS 327 (328)
T ss_pred CchhcccCCHHHHHHHhcC
Confidence 654 336667788877654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.45 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=200.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
..+|.+.+.||+|+||.||+|... .++.||+|.+... +...+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 457999999999999999999643 3578999987643 234689999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
|||++ .++|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.
T Consensus 164 v~e~~-~~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKY-KCDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred Eehhc-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999 5788887732 2578999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHhhhcc-----
Q 002149 767 APDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER-QYLAAWFWNIKSD----- 839 (959)
Q Consensus 767 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~----- 839 (959)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ..+...+......
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 222346799999999999999999999999999999999999999976543221 1111111100000
Q ss_pred ---h----HHHHHhc---CCcccCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 840 ---K----EKLRAAI---DPILEVND--DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 840 ---~----~~~~~~~---~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. ..+.... .+...... ........+.+++.+|+..||++||++.+++. ++++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~--~p~f~ 379 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS--LPLFT 379 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh--Cchhh
Confidence 0 0000000 00000000 00011235778999999999999999999977 45554
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=306.83 Aligned_cols=252 Identities=31% Similarity=0.429 Sum_probs=194.0
Q ss_pred CcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE-eCceEEEEEEec
Q 002149 617 NELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV-AGYERLLVYEYM 691 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 691 (959)
+.||+|+||.||+|... ++..||+|++... ......+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999753 2457999987542 23445678889999999999999999999876 455678999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
.+|+|.+++... ....++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999998542 2346788889999999999999999 899999999999999999999999999998543321
Q ss_pred cc---eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 772 RS---VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG-LMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 772 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.. ......++..|+|||++.+..++.++|||||||++|||++| ..||......+. ...+.. .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~~~~----------~- 218 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI---TVYLLQ----------G- 218 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhc----------C-
Confidence 11 11233467789999999888999999999999999999995 556655433221 111110 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. ... .....+..+.+++.+||..+|++||++.++++.|+.++.
T Consensus 219 ~-~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 R-RLL---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C-CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 000 011123468899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.52 Aligned_cols=267 Identities=22% Similarity=0.305 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999765 68899999987654444556788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++++.+..+... ...+++.++..++.||+.||+|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9988777655422 2458999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||......+............. ........
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 230 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLP--PSHQELFS 230 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC--HHHhhhcc
Confidence 433233446788999999999888 889999999999999999999999987654432221111111000 00000000
Q ss_pred --Ccc------cCCC-------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 --PIL------EVND-------DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 --~~~------~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.. .... .......++.+++.+||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000 00011456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.78 Aligned_cols=238 Identities=25% Similarity=0.423 Sum_probs=186.8
Q ss_pred cccccCceEEEEEEEcC-------------------------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCce
Q 002149 618 ELGRGGFGVVYKGELDD-------------------------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 672 (959)
.||+|+||.||+|.+.. ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999996421 135889988653 233456788899999999999999
Q ss_pred eEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 002149 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD 752 (959)
Q Consensus 673 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~ 752 (959)
++++++......++||||+++|+|..++.. ....+++..+..++.||++||+|||+ ++|+||||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRK----EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 999999999999999999999999888853 22568899999999999999999999 89999999999999976
Q ss_pred CC-------cEEEeeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCh
Q 002149 753 DF-------RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELL-TGLMALDESRP 823 (959)
Q Consensus 753 ~~-------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~ell-tg~~p~~~~~~ 823 (959)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 43 4899999998643221 12357788999998865 56899999999999999984 79999977654
Q ss_pred HHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 824 EERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
.+.... .. .. .... .. ....+.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~~~~~---~~----------~~--~~~~-~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERF---YE----------KK--HRLP-EP----SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH---HH----------hc--cCCC-CC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 332111 00 00 0000 11 112578999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.70 Aligned_cols=310 Identities=23% Similarity=0.335 Sum_probs=222.8
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----c
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----Y 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 682 (959)
+.++|.+.+.||+|+||.||+|.. .+++.||||.+............+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 346799999999999999999965 4789999999876433444456778899999999999999999987644 3
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+ +++|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 479999999 5788887743 2568999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-- 839 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 839 (959)
+++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.......+......
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 154 LARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 998654432 22234567899999998865 46889999999999999999999999876543322211111100000
Q ss_pred -----hHHHHHhcCCcccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCc
Q 002149 840 -----KEKLRAAIDPILEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGI 909 (959)
Q Consensus 840 -----~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~ 909 (959)
.......+......... .......+.+++.+|++.+|++||++.++++ ++++.......+++..-..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~--h~~~~~~~~~~~~~~~~~~~ 310 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA--HPYLASLHDPSDEPVCQTPF 310 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc--CcchhhhcCcccCccCCCcc
Confidence 01111111110000000 0122346789999999999999999999987 56666666655555554455
Q ss_pred ccCCCh-hhhHHHHHHhhCCCc
Q 002149 910 DYSLPL-NQMVKDWQEAEGKDL 930 (959)
Q Consensus 910 ~~~~~~-~~~~~~~~~~~~~~~ 930 (959)
+++++. .-..++.+|....+.
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~ 332 (337)
T cd07858 311 SFDFEEDALTEEDIKELIYNEM 332 (337)
T ss_pred chhhhhhhcCHHHHHHHHHHHH
Confidence 554433 233345555554443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.10 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=204.0
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.|.....||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999975 46889999988653 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999988732 458899999999999999999999 89999999999999999999999999998754332
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ....+...
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~~ 237 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IRDNLPPR 237 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhcCCCc
Confidence 22 12335689999999999888899999999999999999999999986554322110 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.. ........+.+++.+|+..||.+|||+.++++ +++++....
T Consensus 238 ~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~ 280 (292)
T cd06658 238 VK---DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGP 280 (292)
T ss_pred cc---cccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCC
Confidence 11 11112336779999999999999999999987 455554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=318.58 Aligned_cols=306 Identities=23% Similarity=0.357 Sum_probs=227.6
Q ss_pred CCcccCcccccCceEEEEEEEc-C--CcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC----ce
Q 002149 612 NFASENELGRGGFGVVYKGELD-D--GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG----YE 683 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 683 (959)
+|...+.||+|+||.||++... + +..||+|++..........+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999764 3 67899999875433334456788999999999 599999999875432 45
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++++||+ +++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~-~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEecc-cCCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 68889998 5788888742 2568999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc---ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 764 VKLAPDSER---SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 764 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
++....... .......||..|+|||++.+ ..++.++||||+||++|+|++|+.||.................. ..
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT-PD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC-CC
Confidence 985543221 11233578999999998766 46889999999999999999999999876543211110000000 00
Q ss_pred hHHHHHh--------cCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcc
Q 002149 840 KEKLRAA--------IDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEY 906 (959)
Q Consensus 840 ~~~~~~~--------~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~ 906 (959)
.+.+... +........... .....+.+++.+|++.||++||++.++++ ++++.+|+.+...+..-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~--~~~~~~~~~~~~~~~~~ 308 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE--HPYLAIWHDPDDEPVCQ 308 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhhhhcCcccccccc
Confidence 0000000 000000000000 11346889999999999999999999976 79999999988888887
Q ss_pred cCcccCCChhhhHHHHHHhhCCC
Q 002149 907 SGIDYSLPLNQMVKDWQEAEGKD 929 (959)
Q Consensus 907 ~~~~~~~~~~~~~~~~~~~~~~~ 929 (959)
...+++++..++.++.+.+..++
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~ 331 (332)
T cd07857 309 KPFDFSFESEDSMEELRDMIIEE 331 (332)
T ss_pred ccccCCccccccHHHHHHHHhhc
Confidence 88888888888888888776554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.29 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEE-
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSV- 679 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 679 (959)
++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556678999999999999999999965 46789999987642 22235678899999999 6999999999874
Q ss_pred ----eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 680 ----AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 680 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
.+...++||||+++++|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence 34568999999999999998764322 23568899999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
+||+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||......... .
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 99999999886543221 1233468999999998753 45788999999999999999999999765432211 0
Q ss_pred HHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 831 AWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
. . .....+... ........+.+++.+|++.||++||++.|++++
T Consensus 240 ~----~-------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 K----I-------PRNPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred h----c-------cccCCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0 000000000 000112357899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=309.81 Aligned_cols=252 Identities=31% Similarity=0.463 Sum_probs=198.2
Q ss_pred CcccccCceEEEEEEEcC-------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 617 NELGRGGFGVVYKGELDD-------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.||+|+||.||+|...+ ++.+|||.+... ........+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999997542 257999988654 223446678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-----cEEEeecc
Q 002149 690 YMPQGALSKHIFHWKSL--NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-----RAKVSDFG 762 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-----~~ki~DfG 762 (959)
|+++++|.+++...... ....+++.++..++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999998653221 22458899999999999999999999 8999999999999999877 89999999
Q ss_pred ccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+.... + ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~---~---~~-- 228 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---V---TA-- 228 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH---H---hc--
Confidence 9875433221 11222345788999999999999999999999999999998 9999976544322110 0 00
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.... .........+.+++.+|+..+|.+||++.++++.|.
T Consensus 229 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 -------GGRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------CCcc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0000 111123456789999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.18 Aligned_cols=251 Identities=35% Similarity=0.503 Sum_probs=202.7
Q ss_pred CcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 617 NELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|+++++.++|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999997653 7889999987653332 46789999999999999999999999999999999999999
Q ss_pred CCchhhHHhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 693 QGALSKHIFHWKSL----NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 693 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
+++|.+++...... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999998653111 13678999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 769 DSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 769 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... .......++..|+|||.+....++.++||||+||++|||++ |..||......+.... +..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------~~~- 222 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY-------------LRK- 222 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------------HHc-
Confidence 4321 12233467889999999988899999999999999999999 6999987754332110 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
.... .........+.+++.+|+..+|++||++.++++.|
T Consensus 223 -~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 -GYRL---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -CCCC---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0000 11112244788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=312.10 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=201.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||.|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 46888899999999999999764 6889999998654 44556788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 83 FCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred ccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 99999999988542 2568999999999999999999999 8999999999999999999999999999875433
Q ss_pred CCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 770 SERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||......... .. ..
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~-----------~~ 221 (280)
T cd06611 156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK-----------IL 221 (280)
T ss_pred ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH-----------Hh
Confidence 222 123356899999999875 345778999999999999999999999765432211 10 00
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+... ........+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 222 KSEPPTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCCCCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00001111 11112346789999999999999999999977
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.46 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=205.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 35777889999999999999764 58899999887542 34456788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. .++++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999998743 457899999999999999999999 8999999999999999999999999999976543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......++..|+|||++.+..++.++|||||||++|||++|+.||....+....... ..
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~ 215 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PK 215 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hc
Confidence 322 223346788999999999888999999999999999999999999866543221100 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.. ...........+.+++.+|++.+|++||++.+++++
T Consensus 216 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NN-PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CC-CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00 012223445678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.95 Aligned_cols=296 Identities=22% Similarity=0.344 Sum_probs=222.5
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 684 (959)
..+|+..+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46899999999999999999965 468999999987654334456678889999999999999999987753 3567
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~-~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehh-hhhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 9999999 5788888742 2458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCc---ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc--
Q 002149 765 KLAPDSER---SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS-- 838 (959)
Q Consensus 765 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 838 (959)
+....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 75433221 12234578999999999865 4688999999999999999999999987654332211110000000
Q ss_pred -----chHHHHHhcCCcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 839 -----DKEKLRAAIDPILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 839 -----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
......+.+.......... ......+.+++.+|++.+|++||++.++++ +++++++....+++.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~--~~~~~~~~~~~~~~~~~~~ 312 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ--HPFLAQYHDPDDEPTCPPP 312 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh--ChhhhhccCCcccccCCCC
Confidence 0011111111111111111 122457889999999999999999999977 7899999888888877676
Q ss_pred cccCCChh
Q 002149 909 IDYSLPLN 916 (959)
Q Consensus 909 ~~~~~~~~ 916 (959)
++.+.+..
T Consensus 313 ~~~~~~~~ 320 (334)
T cd07855 313 FDFDFEAI 320 (334)
T ss_pred CCCChhhh
Confidence 77665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=314.45 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=203.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+.... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 46778899999999999999753 454 47888876542 334455788999999999999999999998754 467
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 899999999999988542 2468899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+..... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~--- 227 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---EK----G--- 227 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HC----C---
Confidence 65432221 1222345778999999998999999999999999999997 89999776543321111 10 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....... .....+.+++.+|+..+|++||++.++++.++.+.+..
T Consensus 228 -----~~~~~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 -----ERLPQPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -----CCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0000011 12236789999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.65 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=202.7
Q ss_pred CcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------
Q 002149 613 FASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------ 682 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 682 (959)
|.+.+.||+|+||.||+|.+. +++.||||++..........+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999653 4688999999876556666778999999999999999999999886542
Q ss_pred eEEEEEEecCCCchhhHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
..++++||+++|+|.+++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24788999999999888754221 122357899999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 762 GLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 762 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||......+. ..++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~--- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIKG--- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHcC---
Confidence 999865432211 1122345678999999998889999999999999999999 8899876554321 1111100
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
. ... ........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 232 --------~-~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 --------N-RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------C-cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 000 0112234788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=306.67 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=204.6
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||++.. .+|+.||+|++..........+++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 578889999999999999965 4688999999875544455567889999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999988542 22457899999999999999999999 89999999999999999999999999999865432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ..+...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~----------~~~~~~ 217 (256)
T cd08218 155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------L----------KIIRGS 217 (256)
T ss_pred hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------H----------HHhcCC
Confidence 21 122346888999999999989999999999999999999999999765433211 0 001000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..........+.+++.+|++.+|++||++.+|++
T Consensus 218 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 218 Y--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 0011122346889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.84 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=199.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46889999999999999999754 68899999886542 22233457789999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ ++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 995 6888887542 2468899999999999999999999 8999999999999999999999999999975433
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+............. .......++
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILS 234 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhc
Confidence 221 1223457889999998865 4578899999999999999999999987765433211111100000 011111110
Q ss_pred Cc----ccCCCC--------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 PI----LEVNDD--------TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ~~----~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ...... .......+.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 000000 0112235779999999999999999999977
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=316.25 Aligned_cols=286 Identities=26% Similarity=0.352 Sum_probs=211.2
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC--ce
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG--YE 683 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 683 (959)
.+.++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34678899999999999999999764 688999998865433444556778899999999 999999999988643 46
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 799999995 688887743 267899999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc----ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 764 VKLAPDSER----SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 764 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
++....... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 985543321 12334578999999998765 4578899999999999999999999987654432211111100000
Q ss_pred c-------hHHHHHhcCCcccC-----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCc
Q 002149 839 D-------KEKLRAAIDPILEV-----NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE 905 (959)
Q Consensus 839 ~-------~~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~ 905 (959)
. .......++..... ..........+.+++.+|++.||++||++.++++ .+++.++.....++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~--~~~~~~~~~~~~~~~~ 310 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE--HPYVAQFHNPSDEPVL 310 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh--ChhhhhhccCCCCCCC
Confidence 0 00000111100000 0000112346789999999999999999999987 6777776655544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=305.64 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=204.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++..+...+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 57888999999999999999764 6788999998754 23356788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 81 YCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999987542 2468899999999999999999999 8999999999999999999999999999886543
Q ss_pred CCcceeeccccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTG---KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+........ ...
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------------~~~ 220 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------------KSN 220 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hcc
Confidence 221 22335688899999999776 88999999999999999999999998765433221110 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.+. ...........+.+++.+|+..+|.+||++.+++.
T Consensus 221 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 01112233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.30 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=188.9
Q ss_pred CcccccCceEEEEEEEcCCc---EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELDDGT---KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|...++. .+++|.+... ......+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 35999999999999654333 4566665543 2334567899999999999999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC-c
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE-R 772 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~-~ 772 (959)
|+|.+++...... ....++..+..++.||++||+|||+ .+++||||||+|||++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 80 GDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999998653221 2456778889999999999999999 899999999999999999999999999986432211 1
Q ss_pred ceeecccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 773 SVVTRLAGTFGYLAPEYAVT-------GKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||......+..... . .+...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~------~~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--I------KDQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--H------hhccc
Confidence 12234567899999998743 245789999999999999997 56788765543321110 0 01111
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
...++... ......+.+++..|+ .+|++||++++|++.|
T Consensus 228 ~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 228 KLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 11222211 112235677889999 6799999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=309.93 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=206.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||.|+||.||+|... +++.||+|.+.... .......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 36788899999999999999754 68899999987542 34455678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. .++++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999998843 378999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....+...... ......+
T Consensus 151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~~~~~ 216 (274)
T cd06609 151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------IPKNNPP 216 (274)
T ss_pred ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------hhhcCCC
Confidence 322 22345688899999999998899999999999999999999999976543221110 0011111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... .......+.+++.+|+..+|++||+++++++ ++++.+
T Consensus 217 ~~~----~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~~ 256 (274)
T cd06609 217 SLE----GNKFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIKK 256 (274)
T ss_pred CCc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhh--ChhhcC
Confidence 111 0012346789999999999999999999977 455543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.20 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=202.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|..+ +++.||+|++..........+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999765 58999999987654344445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++++++.++... ...+++.++..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888876532 2358999999999999999999999 8999999999999999999999999999886544
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHHhhhcchHHHHHhc
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY-LAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 847 (959)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... +..+...... ......
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 228 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP---RHQEIF 228 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch---hhHHHh
Confidence 322 2334568899999999875 457889999999999999999999997655432211 1111111000 000000
Q ss_pred CCc-----ccCCCC---------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPI-----LEVNDD---------TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~-----~~~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.. ...... .......+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 000000 0122356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.30 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=203.2
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSV 679 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 679 (959)
+.+.+..+.++|.+.+.||+|+||.||+|.. .+++.+|+|.+... ......+.+|+.+++++ +|||++++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3444556678899999999999999999976 46889999988643 22345677899999999 7999999999987
Q ss_pred eC-----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 680 AG-----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 680 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
.. ...++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 54 35799999999999999886432 223568999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCcceeeccccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
.+||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||....+....
T Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 999999999886543221 12234688999999987543 3688999999999999999999999765442211
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. . .....+... ........+.+++.+|++.+|++||++.++++
T Consensus 243 ~~----~-------~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FK----I-------PRNPPPTLL---HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH----H-------hcCCCCCCC---cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 0 000000111 01122346889999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.85 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=205.6
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 688 (959)
+|+..+.||.|+||.||+|.. .+++.||+|.+..........+.+..|+++++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999964 468899999987655566667789999999999999999999997754 45678999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA--HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999986543 22367899999999999999999999321 28999999999999999999999999999986
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
...... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+. ...+ ...
T Consensus 160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~----------~~~ 225 (265)
T cd08217 160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL---ASKI----------KEG 225 (265)
T ss_pred ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH---HHHH----------hcC
Confidence 654332 12335689999999999998899999999999999999999999987653221 1111 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ..........+.+++.+|++.+|++||++.+|++
T Consensus 226 ---~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 ---KF--RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CC--CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 1111223357889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.25 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=204.7
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.|+..+.||+|+||.||+|... +++.||+|.+.... .....+.+.+|+++++.++||||+++++++..+...++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4666788999999999999654 57889999886542 234567789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.. ..+++..+..++.|+++|+.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 84 LGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999988742 468899999999999999999999 89999999999999999999999999999865432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.|+....+..... . ......
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~-------~~~~~~-- 218 (277)
T cd06642 155 QI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L-------IPKNSP-- 218 (277)
T ss_pred ch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h-------hhcCCC--
Confidence 21 1223467889999999999899999999999999999999999987554322110 0 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
..........+.+++.+|++.+|++||++.++++ ++++.++.
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~ 260 (277)
T cd06642 219 ---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK--HKFITRYT 260 (277)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH--hHHHHHHh
Confidence 1111123456889999999999999999999988 45555443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=307.41 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=200.3
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc-------HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS-------KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+|.....||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999965 46889999988654221 1234678899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999998542 467889999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc-----ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 764 VKLAPDSER-----SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 764 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
++....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---------- 222 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF---------- 222 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----------
Confidence 985542111 11123468899999999999889999999999999999999999998654322110
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......+. ........+.+++.+|++.||.+||++.++++
T Consensus 223 ---~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ---KIGENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHhccCCCc-----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000111111 11123346789999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=316.92 Aligned_cols=199 Identities=26% Similarity=0.420 Sum_probs=160.7
Q ss_pred cCcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEEEEEe
Q 002149 616 ENELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLLVYEY 690 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 690 (959)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 357999999999999764 45789999886542 22357789999999999999999998854 4577899999
Q ss_pred cCCCchhhHHhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCcEEEeecc
Q 002149 691 MPQGALSKHIFHWKS----LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFG 762 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----~~~~~~ki~DfG 762 (959)
+. ++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 84 577777643211 112358899999999999999999999 899999999999999 566799999999
Q ss_pred ccccCCCCCc--ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 763 LVKLAPDSER--SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 763 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9986543322 12234578999999999876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=317.81 Aligned_cols=307 Identities=21% Similarity=0.337 Sum_probs=225.5
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc--
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-- 682 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 682 (959)
+..+.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 445677899999999999999999964 47899999998654334445567889999999999999999999887543
Q ss_pred ----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 683 ----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 683 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 458999999 7889887732 468999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
+|||+++..... .....+++.|+|||.+.+ ..++.++|+|||||++|++++|+.||.......... .......
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~--~~~~~~~ 233 (343)
T cd07880 160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM--EIMKVTG 233 (343)
T ss_pred eecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcC
Confidence 999999865432 223467889999999876 458899999999999999999999998665422111 0000000
Q ss_pred cchHHH---------HHhcCCcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCC
Q 002149 838 SDKEKL---------RAAIDPILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEP 903 (959)
Q Consensus 838 ~~~~~~---------~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~ 903 (959)
.....+ .............. ......+.+++.+|++.||++||++.++++ +++++.+.....++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~--~~~~~~~~~~~~~~ 311 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA--HPYFEEFHDPEDET 311 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc--CccHhhhcCccccc
Confidence 000000 01111000000000 011235779999999999999999999986 78888877665554
Q ss_pred CcccCcccCCChhhhHHHHHHhhCCCc
Q 002149 904 EEYSGIDYSLPLNQMVKDWQEAEGKDL 930 (959)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (959)
....-.+.....++..+||+...-.+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (343)
T cd07880 312 EAPPYDDSFDEVDQSLEEWKRLTFTEI 338 (343)
T ss_pred CCCCccccHHhhccchHHHHHHHHHHH
Confidence 443322222244788899998765443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=306.74 Aligned_cols=258 Identities=29% Similarity=0.422 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||.|+||.||+|.. .++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4688899999999999999975 467899999987543333 56789999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
++++++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999986422 12468999999999999999999999 8999999999999999999999999999885544
Q ss_pred CCcc---eeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 770 SERS---VVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 770 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.... ......|+..|+|||++... .++.++|||||||++|||++|+.||........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----------- 221 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----------- 221 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc-----------
Confidence 3222 22335689999999998877 789999999999999999999999976544221 111000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.-.+..............+.+++.+|+..||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000111101101123356789999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.02 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=200.3
Q ss_pred cccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 618 ELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
+||+|.||+||.|+.. +...+|||.+... ..+..+-+..|+.+.++++|+|||+++|.+.++...-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 6999999999999654 4567899998754 445567789999999999999999999999999988999999999999
Q ss_pred hhHHhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCcEEEeeccccccCCCCCcc
Q 002149 697 SKHIFHWKSLNLEPL--SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~-~~~~~ki~DfGla~~~~~~~~~ 773 (959)
.++++. ..+++ .+.++--+..||++||.|||+ ..|||||||-.||||+ ..|.+||+|||.+++...-..
T Consensus 660 SsLLrs----kWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP- 731 (1226)
T KOG4279|consen 660 SSLLRS----KWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP- 731 (1226)
T ss_pred HHHHHh----ccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc-
Confidence 999853 23555 677888899999999999999 8999999999999995 579999999999987654332
Q ss_pred eeeccccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 774 VVTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
....+.||.-|||||++..+ .|..++|||||||++.||.||++||-........- +. . .+. .+.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM----Fk---V---Gmy-KvH--- 797 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM----FK---V---GMY-KVH--- 797 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----hh---h---cce-ecC---
Confidence 34557899999999999765 58889999999999999999999997654322110 00 0 000 011
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
+..+.+...+...+|.+|+.+||.+||+++++++ .++++
T Consensus 798 --P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~--DpFlq 836 (1226)
T KOG4279|consen 798 --PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ--DPFLQ 836 (1226)
T ss_pred --CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc--Ccccc
Confidence 2223345557789999999999999999999976 55554
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.16 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=204.4
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999764 689999999876644445567899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+ +++|.+++.... ..+++.++..++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999885422 568999999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-hHHHHHhcC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-KEKLRAAID 848 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 848 (959)
.........|+..|+|||.+.+. .++.++||||+||++|||++|..+|......+..... ....... ........+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV--FRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH--HHHcCCCChHHHhhccC
Confidence 32223345789999999998664 4688999999999999999998888765543321111 1000000 000000000
Q ss_pred -----C-cccC-CC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 -----P-ILEV-ND-----DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 -----~-~~~~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .... .. ...+....+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000 00 00112357889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=309.22 Aligned_cols=259 Identities=29% Similarity=0.416 Sum_probs=203.4
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|+..+.||+|+||.||+|..+ +.+.||+|.+.... .....+.+.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46888899999999999999754 34679999876531 223467799999999999999999999999998999
Q ss_pred EEEEEecCCCchhhHHhhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLN----LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986533111 1268999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||........ .. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~---~~~~- 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN---RLQA- 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH---HHHc-
Confidence 99987443322222333456788999999988889999999999999999999 7888865443221 11 0100
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.... ..........+.+++.+|++.+|++||++.++++.|.
T Consensus 234 ---------~~~~-~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 ---------GKLE-LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---------CCcC-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0001112347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=311.40 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=203.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 46778899999999999999654 68899999876542 34456788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999988743 24689999999999999999999973 5899999999999999999999999999875432
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHHHHhhhcchHHHH
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER-----QYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 844 (959)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+. .....++ .
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~ 223 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----------Q 223 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH----------H
Confidence 21 1235789999999999888999999999999999999999999986544211 0011111 1
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
..+..... ..........+.+++.+|++.||++||++.|++++
T Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 224 QIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111100 00011233468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=317.20 Aligned_cols=312 Identities=22% Similarity=0.348 Sum_probs=227.0
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
...+..+.++|...+.||+|+||.||+|.. .+++.||+|++..........+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345667789999999999999999999964 5789999999876433444456788999999999999999999987643
Q ss_pred ------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 682 ------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 682 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888887 8899887632 458999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI--LR 232 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HH
Confidence 999999998854332 233467899999998866 56888999999999999999999999765543321111 00
Q ss_pred hhhcchHHH---------HHh---cCCcccCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 002149 835 NIKSDKEKL---------RAA---IDPILEVN--DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLD 900 (959)
Q Consensus 835 ~~~~~~~~~---------~~~---~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 900 (959)
......... +.. +....... .........+.+++.+|++.||.+||++.++++ ++++.++..++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~--h~~f~~~~~~~ 310 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPD 310 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc--ChhhhhcCCCC
Confidence 000000000 000 11100000 000011235789999999999999999999987 67888888777
Q ss_pred CCCCcccCcccCCCh-hhhHHHHHHhhCCCccee
Q 002149 901 DEPEEYSGIDYSLPL-NQMVKDWQEAEGKDLSYV 933 (959)
Q Consensus 901 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 933 (959)
.++... .+++.... ...+++|....++++..+
T Consensus 311 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (345)
T cd07877 311 DEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISF 343 (345)
T ss_pred ccccCC-CccCcchhcccCHHHHHHHHHHHHHhc
Confidence 666443 33333222 333467777666655443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=307.06 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=197.8
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++++.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+++++.++|+||+++++++..++..++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445566667899999999999975 46788999988754 344567889999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPL--SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla 764 (959)
+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.++|+|||++
T Consensus 84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 84 MEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999986421 234 788889999999999999999 89999999999999986 679999999998
Q ss_pred ccCCCCCcceeeccccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
........ ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||............ . .
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-----~-----~ 225 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-----V-----G 225 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-----h-----h
Confidence 75533221 223346889999999986643 788999999999999999999999754322111000 0 0
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ..+ .........+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~-~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 226 MFK-IHP-----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhc-cCC-----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000 000 111122346789999999999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=305.77 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=195.8
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc---cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI---SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 684 (959)
.+|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999965 4688999998864322 22345678899999999999999999998865 3567
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
+++|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999988531 457899999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCC--cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSE--RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+...... ........++..|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~-------------- 219 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF-------------- 219 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH--------------
Confidence 7543211 111223568899999999999889999999999999999999999997654322110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...... ............+.+++ +|+..+|++||+++||++
T Consensus 220 --~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 220 --KIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --HHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000 00111112223456666 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=311.46 Aligned_cols=271 Identities=28% Similarity=0.412 Sum_probs=205.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--Cce
Q 002149 611 KNFASENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 683 (959)
+.|...+.||+|+||.||+|.+. +++.||||.+...... ...+.+.+|+++++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 35677789999999999999753 3678999998765332 356789999999999999999999999877 567
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999985422 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHH
Confidence 9866532221 1112345667999999988899999999999999999999999986543221100000 00000011
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.+.+.+...... .........+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111110 11112235788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=314.07 Aligned_cols=254 Identities=25% Similarity=0.316 Sum_probs=203.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +++.||+|.+....... ...+.+.+|+++++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999765 58999999987653332 35667889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999988532 23568999999999999999999999 899999999999999999999999999987443
Q ss_pred CCCcc----------------------------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 002149 769 DSERS----------------------------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDE 820 (959)
Q Consensus 769 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~ 820 (959)
..... ......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 21110 11134688999999999998899999999999999999999999986
Q ss_pred CChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 002149 821 SRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD----MGHAVN 887 (959)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~~ 887 (959)
....... ............ .......+.+++.+|+..||++||+ +.++++
T Consensus 235 ~~~~~~~----------------~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDETF----------------SNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHHH----------------HHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 6543211 111111111111 1113457889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=306.10 Aligned_cols=257 Identities=23% Similarity=0.391 Sum_probs=202.7
Q ss_pred CCcccCcccccCceEEEEEEEcC--CcEEEEEEccccc--------ccHHHHHHHHHHHHHHHh-cCCCCceeEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELDD--GTKIAVKRMEAGV--------ISKKAVDEFHSEIAVLSK-VRHRHLVSLLGYSVA 680 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 680 (959)
.|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998654 6889999875321 223345667788888875 699999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
+...++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988754222 235689999999999999999999952 5899999999999999999999999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........... +
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~---~------- 225 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK---I------- 225 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---H-------
Confidence 99998654432 23445789999999999998899999999999999999999999976543221110 0
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
...... ..........+.+++.+|++.||++||++.|+.+++.
T Consensus 226 ------~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 ------VEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------hhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000 0001112346789999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.58 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=204.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.|+.-++||+||||.||-++. .+|+-+|.|++.+..+.. ........|-.++..++.+.||.+--+|+..+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577788999999999999964 479999999987765544 33455778999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
..|.||+|.-++.. .+...+++..++-+|.+|+.||++||. .+||.||+||+|||+|+.|+++|+|.|||..++
T Consensus 265 tlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999887744 334689999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..... ...+||.+|||||++.+..|+...|.||+||++|||+.|+.||......... +.+.+.+-
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr~~ 403 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRRTL 403 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHHHh
Confidence 75543 3348999999999999999999999999999999999999999765432211 11111110
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.. ...++..-..+...+.+..|+.||.+|. .+++|.+
T Consensus 404 ~~--~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 404 ED--PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred cc--hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 00 0111222233566888899999999997 4556654
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.59 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=203.3
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|...+.||+|+||.||+|... +++.||+|.+..........+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999754 688999999876644445678899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999998853 2457899999999999999999999 89999999999999999999999999999865443
Q ss_pred Cccee---eccccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 771 ERSVV---TRLAGTFGYLAPEYAVTGK---ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 771 ~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..... ....++..|+|||++.+.. ++.++||||||+++||+++|+.||........... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-----~~~~------ 221 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-----HVGA------ 221 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-----HHhc------
Confidence 32211 2356788999999998766 88999999999999999999999976532211100 0000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...+... ........+.+++.+|++.+|.+||++.+++.
T Consensus 222 -~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000111 11112346779999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=313.15 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=200.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||++... +++.||+|.+..... .....+.+.+|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999754 578999998875422 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999843 2468999999999999999999999 899999999999999999999999999987321
Q ss_pred CCCc--------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 769 DSER--------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 769 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
.... .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------ 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 1100 01112457889999999988889999999999999999999999998655432111
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
. ..................+.+++.+|++.||++||++.++.+.+.
T Consensus 227 ~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 Q----------VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred H----------HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0 000000001111122346789999999999999999765555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.20 Aligned_cols=246 Identities=32% Similarity=0.472 Sum_probs=197.9
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.+.||+|+||.||+|.. +++.||+|.+... ...+.+.+|+.+++.++|||++++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4588899999999999999975 5788999988643 2335688999999999999999999998654 47899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999998542 22468899999999999999999999 89999999999999999999999999998754332
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
. .....+..|+|||++.+..++.++|||||||++|||++ |+.||......+..... ....
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------------~~~~-- 214 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------------EKGY-- 214 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------------hCCC--
Confidence 1 12234568999999998899999999999999999998 99999876543321110 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.+. ........+.+++.+|++.+|++||+++++++.|+
T Consensus 215 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 215 RME---PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCC---CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 000 01122346789999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.67 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=197.3
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|... +|+.||+|++............+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999764 689999999875433333345678899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
++ ++|.+++... ...+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 95 6787776431 2468999999999999999999999 89999999999999999999999999999855432
Q ss_pred CcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-hHHH---HH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-KEKL---RA 845 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~ 845 (959)
.. ......++..|+|||++.+. .++.++|||||||++|||++|..|+......+.. +.......... .... ..
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhh
Confidence 22 12334678999999998764 4689999999999999999999886443332211 11100000000 0000 00
Q ss_pred hcCCc-cc-C-C-----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPI-LE-V-N-----DDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~-~~-~-~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+.. .. . . .........+.+++.+|++.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 00 0 0 000112346779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=312.71 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=198.1
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|.....||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 34455799999999999965 46899999998654 2233466889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999887632 458899999999999999999999 899999999999999999999999999987554322
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.... +. .......
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~----------~~~~~~~ 237 (297)
T cd06659 172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LR----------DSPPPKL 237 (297)
T ss_pred c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---Hh----------ccCCCCc
Confidence 2 12335689999999999988999999999999999999999999986554332110 00 0000000
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ........+.+++.+|++.+|.+||++.++++
T Consensus 238 ~---~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 238 K---NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred c---ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 00112235789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.86 Aligned_cols=242 Identities=26% Similarity=0.313 Sum_probs=187.1
Q ss_pred ccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc---CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 619 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
||+|+||.||+|... +++.||||++.+... .......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999754 689999999865322 222334455677777665 699999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 999988743 2568999999999999999999999 8999999999999999999999999999875432221
Q ss_pred eeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCccc
Q 002149 774 VVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILE 852 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (959)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ...... ...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~i~~~--------~~~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RNIAFG--------KVRFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HHHHcC--------CCCCC
Confidence 22345799999999998764 4789999999999999999999999875543211 001000 00011
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCC----CHHHHHH
Q 002149 853 VNDDTFETFWTIAELAGHCTSREPSQRP----DMGHAVN 887 (959)
Q Consensus 853 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~ev~~ 887 (959)
.. .....+.+++.+||+.||.+|| ++.++++
T Consensus 218 --~~--~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 --KN--VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --Cc--cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00 1123567999999999999998 4556544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=303.70 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=203.4
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|.. .+++.+|||.+............+.+|+++++.++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999965 4688999999876555556677899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfGla~~~~~ 769 (959)
+++++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||||+||+++.+ +.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999998542 23568999999999999999999999 899999999999999865 4689999999986544
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ......+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~---------~~~~~~~ 220 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI---------MSGTFAP 220 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH---------HhcCCCC
Confidence 321 2235688999999999988899999999999999999999999976543221 1000 0000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........+.+++.+|++.+|++|||+.++++
T Consensus 221 ------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=306.22 Aligned_cols=256 Identities=25% Similarity=0.422 Sum_probs=199.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc--------HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS--------KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... ....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999964 46889999987532111 112356788999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998542 468899999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcc-eeeccccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 763 LVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 763 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
+++........ ......|+..|+|||.+.... ++.++||||||+++||+++|..||......+... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~- 226 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLGN- 226 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhhc-
Confidence 99855432211 123356889999999987654 7899999999999999999999997543322110 0000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
......+. ..........+.+++.+|+..+|++||++.+|+++
T Consensus 227 -~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 -KRSAPPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -cccCCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000000 11111234578899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.45 Aligned_cols=239 Identities=23% Similarity=0.399 Sum_probs=187.6
Q ss_pred CcccccCceEEEEEEEcC--------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 617 NELGRGGFGVVYKGELDD--------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999996532 234888877543 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc--------EEEee
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR--------AKVSD 760 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~--------~ki~D 760 (959)
||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999998542 2368999999999999999999999 89999999999999987665 69999
Q ss_pred ccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHhhhc
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGL-MALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
||++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+............
T Consensus 152 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------- 218 (258)
T cd05078 152 PGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------- 218 (258)
T ss_pred cccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--------
Confidence 9998754321 22467889999999977 45789999999999999999995 555544332211100
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
......+. ....++.+++.+|++.||++||+++++++.|
T Consensus 219 ---------~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 ---------EDRHQLPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---------HccccCCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000011 1124678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=319.47 Aligned_cols=310 Identities=25% Similarity=0.364 Sum_probs=228.4
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce---
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE--- 683 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 683 (959)
.+.++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++|+||+++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999764 67899999987543344455678889999999999999999987766554
Q ss_pred ---EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 684 ---RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 684 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcc
Confidence 89999999 7799888743 468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc-
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS- 838 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 838 (959)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+......-......
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 9999865432 233467889999999865 4678999999999999999999999986654332111000000000
Q ss_pred ------chHHHHHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCccc
Q 002149 839 ------DKEKLRAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYS 907 (959)
Q Consensus 839 ------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 907 (959)
........+........... .....+.+++.+|++.||++|||+.+|++ ++++++|....+++.. .
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~--h~~~~~~~~~~~~~~~-~ 314 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA--HPYLAEYHDPEDEPVA-P 314 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc--CCCccccCCCcccccc-c
Confidence 00001111111111011111 11346889999999999999999999976 6888888777665432 2
Q ss_pred CcccCCCh-hhhHHHHHHhhCCCcceee
Q 002149 908 GIDYSLPL-NQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 908 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 934 (959)
..+.+++. ...+++|++..+.++..++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (343)
T cd07851 315 PYDQSFESRDLTVDEWKELVYKEIMNFK 342 (343)
T ss_pred ccCcchhhhhcCHHHHHHHhHHHHHhcc
Confidence 22222222 5667889998887766543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.39 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=201.1
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc---ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV---ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+|+..+.||+|+||.||+|... +++.||+|.+.... ...+..+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999765 78999999886532 1234567889999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998542 458899999999999999999999 89999999999999999999999999998855
Q ss_pred CCCCcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||......... .. ... . ..
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~----~~~----~-~~ 219 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FK----IGR----S-KE 219 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HH----HHh----c-cc
Confidence 4332 223456889999999987766 899999999999999999999999765532211 00 000 0 00
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..........+.+++.+|++.+|++||++.++++
T Consensus 220 ~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 L------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 0011112346789999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.06 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=200.8
Q ss_pred CCcccCcccccCceEEEEEEEcCCc-EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELDDGT-KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.|.++..||.|+||.||+|..++.. ..|.|++... +....++|.-|++++..+.||+||+|++.|...+..|+..||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3556678999999999999766433 3466776543 667788999999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
|.||-++..+... .+.+++.++.-+++|++.||.|||+ ..|||||||+.|||++-+|.++++|||.+......
T Consensus 111 C~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred cCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999998887542 2789999999999999999999999 89999999999999999999999999987643322
Q ss_pred Ccceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
......+.|||.|||||+.+ ..+|+.++||||||++|.||..+.+|.....+......+ .+.
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-----aKS------- 250 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-----AKS------- 250 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-----hhc-------
Confidence 22345689999999999874 357999999999999999999999998776654321111 111
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.++....+..-...+.+++.+||..+|..||++.++++
T Consensus 251 ----ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 ----EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ----CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11101111122346789999999999999999999876
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=308.97 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=202.6
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSV 679 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 679 (959)
++.++......|++.+.||+|+||.||+|.. .+++.||+|.+... .....++..|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 3445555667899999999999999999975 46889999987643 33446688999999998 6999999999885
Q ss_pred e------CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 680 A------GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 680 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
. ....++||||+++|+|.+++...+ ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCC
Confidence 3 457899999999999999885422 2457888999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~ 828 (959)
+.++|+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.....
T Consensus 158 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999999999875432211 123356899999999875 3468889999999999999999999997654432211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ......... .......+.+++.+||+.||.+||++.|+++
T Consensus 237 ~~-------------~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LI-------------PRNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hH-------------hhCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000011111 1122346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=289.58 Aligned_cols=208 Identities=27% Similarity=0.411 Sum_probs=173.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc---C--CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-Cce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD---D--GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 683 (959)
...|+....||+|.||.||+|.-. + ...+|||+++.............+|+.+++.++||||+.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356889999999999999999432 2 2368999998653222223456799999999999999999998877 778
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC----CcEEEe
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD----FRAKVS 759 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~----~~~ki~ 759 (959)
.++++||.+. +|...++.++....+.++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 8999999955 78888877666666789999999999999999999999 889999999999999877 899999
Q ss_pred eccccccCCCCCcc--eeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 760 DFGLVKLAPDSERS--VVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 760 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
|||+||.+.+.-.. .....+-|.+|+|||.+.+. .|+.+.||||.|||+.||+|-++-|.+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999977654332 23456779999999999884 6899999999999999999987777654
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.80 Aligned_cols=257 Identities=26% Similarity=0.433 Sum_probs=204.7
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.|...+.||+|++|.||+|.. .+++.+|+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344557899999999999975 47889999988643 334456688999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999998843 458899999999999999999999 89999999999999999999999999988754432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.+.... ......+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-------------~~~~~~~~ 234 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-------------IRDNLPPK 234 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-------------HHhcCCCC
Confidence 22 12335689999999999888899999999999999999999999976544322110 11111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.. ........+.+++.+|++.+|++||++.++++ ++++.+..+
T Consensus 235 ~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~ 277 (285)
T cd06648 235 LK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP 277 (285)
T ss_pred Cc---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence 11 11112346889999999999999999999976 566655444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=308.31 Aligned_cols=259 Identities=28% Similarity=0.370 Sum_probs=197.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHH-HHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAV-LSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +|+.||+|++........ ..++..|+.. ++.++||||+++++++..+...++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 36888899999999999999764 689999999876533333 3455566665 56668999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||++ |+|.+++...... ...+++..++.++.||+.||+|||+ + +++||||||+||+++.++.+||+|||+++..
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9994 7888887653322 2578999999999999999999998 5 8999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVT----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
.... ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||........ .+....
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~---------- 221 (283)
T cd06617 155 VDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVV---------- 221 (283)
T ss_pred cccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHH----------
Confidence 4322 1223468899999998865 4568899999999999999999999964322110 111000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
....+... .......+.+++.+|+..+|++||++.++++ ++++.+
T Consensus 222 -~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 266 (283)
T cd06617 222 -EEPSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFEL 266 (283)
T ss_pred -hcCCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhh
Confidence 00011111 0112346889999999999999999999977 444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=309.66 Aligned_cols=268 Identities=21% Similarity=0.282 Sum_probs=197.5
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+++++.++|+||+++.+++..+...++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46799999999999999999965 468899999986542 2223345678999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+. +++.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9994 7777766431 2457888899999999999999999 899999999999999999999999999987543
Q ss_pred CCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH-----
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK----- 842 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 842 (959)
..... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.............|..........
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 32211 2234578999999998764 5788999999999999999999999866543222111110000000000
Q ss_pred -HHHhcCCc--------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 -LRAAIDPI--------LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 -~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........ .............+.+++.+|+..||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000000111346779999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.36 Aligned_cols=251 Identities=34% Similarity=0.521 Sum_probs=200.1
Q ss_pred cccCcccccCceEEEEEEEcC-----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 614 ASENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++.+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|+++++.++|+||+++++++.+....+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 466889999999999997653 3789999987542 2335678999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999854221 228999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
...........+++.|+|||.+.+..++.++||||+|+++|||++ |..||......+... .+. . .
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~---~~~---~-------~- 220 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE---YLK---K-------G- 220 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHh---c-------C-
Confidence 442222222347789999999988889999999999999999998 788887644322111 010 0 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
... .........+.+++.+|+..||++|||+.++++.|
T Consensus 221 -~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 -YRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 01111344688999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.58 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=197.0
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc---cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI---SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 684 (959)
.+|++.+.||+|+||.||+|.. .+++.||||.+..... .....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999975 4689999998754321 223456788999999999999999999988764 467
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999988532 457889999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCc--ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~----------- 220 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--FK----------- 220 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--HH-----------
Confidence 85432111 1123346889999999998888999999999999999999999999765332211 00
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... ............+.+++.+|+. +|++||+++++++
T Consensus 221 ---~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 ---IATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---HhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00000 0011122333467789999984 9999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=303.83 Aligned_cols=237 Identities=26% Similarity=0.444 Sum_probs=187.9
Q ss_pred CcccccCceEEEEEEEcCCc-----------EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 617 NELGRGGFGVVYKGELDDGT-----------KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+.||+|+||.||+|...+.. .|++|.+.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999765332 47788765431 226778899999999999999999999888 7789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-------cEEE
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-------RAKV 758 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-------~~ki 758 (959)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999986422 268999999999999999999999 8999999999999999887 7999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccC--CCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHh
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 835 (959)
+|||+++..... ....++..|+|||++.+. .++.++|||||||++|||++ |..||......+.... ..
T Consensus 150 ~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~~- 220 (259)
T cd05037 150 SDPGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQ- 220 (259)
T ss_pred CCCCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---Hh-
Confidence 999999865431 223567789999999776 78999999999999999999 5777766543221110 00
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
. ........ ...+.+++.+|+..+|.+||++.++++.|
T Consensus 221 ----------~-~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ----------D-QHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----------c-CCCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00011011 15788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=315.07 Aligned_cols=304 Identities=25% Similarity=0.328 Sum_probs=224.0
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----eEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-----ERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 685 (959)
+|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999764 5899999998765433555678899999999999999999999988765 789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999996 588887743 2378999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc--ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc----
Q 002149 766 LAPDSER--SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS---- 838 (959)
Q Consensus 766 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 838 (959)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 6544321 123345678999999999887 889999999999999999999999987765443221111000000
Q ss_pred ---chHHHHHhcCCcccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcc
Q 002149 839 ---DKEKLRAAIDPILEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGID 910 (959)
Q Consensus 839 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 910 (959)
........+......... .......+.+++.+||+.+|++||++.++++ +++++.+....+++-.....+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~~~~~~~~~~~~~~~~~~~~~ 309 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA--HPYLAQLHDPEDEPVAKPPFD 309 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CccHHhhcccccCCCCCCccc
Confidence 000001111100000000 0112346789999999999999999999976 778888777666655555444
Q ss_pred c--CCChhhhHHHHHHhh
Q 002149 911 Y--SLPLNQMVKDWQEAE 926 (959)
Q Consensus 911 ~--~~~~~~~~~~~~~~~ 926 (959)
. -.+.....++.++..
T Consensus 310 ~~~~~~~~~~~~~~~~~~ 327 (330)
T cd07834 310 FDFFDDDELTEEELKELI 327 (330)
T ss_pred ccccchhhcCHHHHhHHh
Confidence 3 122233444444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.13 Aligned_cols=272 Identities=25% Similarity=0.309 Sum_probs=204.2
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc---HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+|+..+.||+|+||.||+|... +++.||||++...... ......+..|+++++.++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999754 6899999998765333 23345677899999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||+ ++|+|+||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 999999885411 368999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-hHHHH-
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-KEKLR- 844 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~- 844 (959)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+.+..... ....... .....
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 229 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI--FEALGTPTEENWPG 229 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH--HHHcCCCchhhhhh
Confidence 44322 1223356788999998865 46788999999999999999998888765543321111 1100000 00000
Q ss_pred -----HhcCCcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 845 -----AAIDPILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 845 -----~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
...... ...... ......+.+++.+|++.||++||++.++++ .++++...
T Consensus 230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~ 289 (298)
T cd07841 230 VTSLPDYVEFK-PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDP 289 (298)
T ss_pred ccccccccccc-ccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCC
Confidence 000000 000000 112346789999999999999999999987 55555433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.02 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=200.0
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999764 688999999875543344456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+. ++|.+++... ....+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6888887542 23568999999999999999999999 89999999999999999999999999998755332
Q ss_pred CcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH-------
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK------- 842 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 842 (959)
.. ......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+.. ...+.........
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhhhhH
Confidence 21 123345788999999887644 588999999999999999999999876543321 1111111100000
Q ss_pred ---HHHhcCCcccCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 ---LRAAIDPILEVN--DDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ---~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+....... .........+.+++.+|++.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 000011235678999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.90 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=202.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC---CCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 687 (959)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......+++.+|+++++.++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477788999999999999975 57899999988654 23445567889999999997 99999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999988743 368899999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......|+..|+|||.+.++ .++.++|||||||++|||++|+.||........... . ...
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------~-------~~~ 217 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------I-------PKS 217 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc------c-------ccC
Confidence 54332 23345789999999998754 468899999999999999999999986543221100 0 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..+.+... .....+.+++.+|++.||++||++.+++. .++++
T Consensus 218 ~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~ 259 (277)
T cd06917 218 KPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK--SKWIK 259 (277)
T ss_pred CCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhh
Confidence 00111100 13346889999999999999999999976 34443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.68 Aligned_cols=262 Identities=27% Similarity=0.371 Sum_probs=198.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|...+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4556678999999999999654 689999999875432 245567889999999996 9999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+. +++.++...........+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 984 5655543211111235789999999999999999999972 4899999999999999999999999999985543
Q ss_pred CCcceeeccccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTG---KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||....... +.+.+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~ 223 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF---------------DQLTQV 223 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH---------------HHHhhh
Confidence 221 1234688999999998776 68899999999999999999999997543110 001111
Q ss_pred cC---CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 847 ID---PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 847 ~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. +.+. ..........+.+++.+|++.+|++||++.+|++ +++++.+.
T Consensus 224 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~~~~ 274 (288)
T cd06616 224 VKGDPPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIKDYE 274 (288)
T ss_pred cCCCCCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhhchh
Confidence 11 1111 1111223457889999999999999999999977 55555433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.11 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=201.2
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc----HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS----KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999964 57899999998653211 2245778999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVK 765 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~ 765 (959)
||||+++++|.+++... .++++..+..++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999988542 468899999999999999999999 8999999999999998775 59999999988
Q ss_pred cCCCCCc---ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSER---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
....... .......|+..|+|||.+.+..++.++||||+|+++|||++|..||.............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----------- 221 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF----------- 221 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-----------
Confidence 6543321 11223468899999999988889999999999999999999999997543222111110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.... .............+.+++.+|+..+|++||++.++++
T Consensus 222 --~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 --KIASA-TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --HHhcc-CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00000 0001122233456889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=318.80 Aligned_cols=275 Identities=27% Similarity=0.381 Sum_probs=209.1
Q ss_pred CcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------ceEE
Q 002149 613 FASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------YERL 685 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 685 (959)
+...+.||+|+||.||+|+ ..+|+.||||.+.... .....+...+|++++++++|+|||++++.-.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455789999999999998 5689999999987643 445567788999999999999999999976544 3668
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--CCCC--cEEEeec
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL--GDDF--RAKVSDF 761 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl--~~~~--~~ki~Df 761 (959)
+|||||.+|||+..+.. ..+...+++.+.+.+..+++.||.|||+ ++||||||||.||++ .++| -.||+||
T Consensus 94 lvmEyC~gGsL~~~L~~--PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS--PENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcC--cccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 99999999999999965 4455789999999999999999999999 899999999999998 3334 4899999
Q ss_pred cccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|.|+...+.. ....++||..|.+||.... +.|+..+|.|||||++||++||..||..........-..|........
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999887654 6778899999999999984 888999999999999999999999997544321111111111111100
Q ss_pred HHHHHhc----------CCcccC-CCCCHHHHHHHHHHHHhcccCCCCCCC--CHHHHHHHHHHhHhhc
Q 002149 841 EKLRAAI----------DPILEV-NDDTFETFWTIAELAGHCTSREPSQRP--DMGHAVNVLAPLVEKW 896 (959)
Q Consensus 841 ~~~~~~~----------~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~ev~~~L~~~~~~~ 896 (959)
...-.. ...++. ..........+-..+..++..+|++|- ...+....+..++..-
T Consensus 247 -~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 247 -GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred -ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 000000 011111 112233444566788888899999999 8888888888777653
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.22 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=204.5
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|.. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5788899999999999999964 46889999988643 23345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999998843 357899999999999999999999 8999999999999999999999999999875543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|++.|+|||.+.+..++.++|||||||++||+++|+.||......+.... ... ..
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~---------~~ 231 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT---------NG 231 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhc---------CC
Confidence 322 22334688999999999888899999999999999999999999976543221100 000 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ..........+.+++.+||..+|++||++.+++. +++++.
T Consensus 232 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~ 274 (293)
T cd06647 232 TPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKI 274 (293)
T ss_pred CCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 000 0111122346789999999999999999999976 445543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=333.87 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=209.6
Q ss_pred cccCcccccCceEEEEEEEc----C----CcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceE
Q 002149 614 ASENELGRGGFGVVYKGELD----D----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 684 (959)
...+.+|+|.||.||+|... . ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++|+|......
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 44558999999999999643 1 457999999876544 7788999999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcc---------cCCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 685 LLVYEYMPQGALSKHIFHWK---------SLNLE--PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
++|+||+..|+|.++++..+ ..... .++....+.++.|||.||+||++ .++|||||.++|||++++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCC
Confidence 99999999999999998766 11112 38999999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCcceeecccc--ccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSERSVVTRLAG--TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLA 830 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~ 830 (959)
..+||+|||+|+..............| +..|||||.+....|+.|+|||||||+||||+| |..|+.+....+.. .
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l--~ 532 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL--L 532 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH--H
Confidence 999999999999665544443332332 457999999999999999999999999999999 67888774422211 1
Q ss_pred HHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 831 AWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.++..- .++..+..+ ..++.++++.||+.+|++||++.++++.+...+..
T Consensus 533 ~~l~~G------------~r~~~P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 533 EFLKEG------------NRMEQPEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHhcC------------CCCCCCCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 111100 012223333 44677999999999999999999999999986553
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.58 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=205.9
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||+|... +++.||+|.+.... .....+++.+|+++++.++||||+++++++......++|+||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5777889999999999999765 68899999987653 235567788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.... ..+++..+..++.|++.||+|||+. .+++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999985422 5788999999999999999999983 58999999999999999999999999998755332
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||........ .... .........
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~----------~~~~~~~~~ 220 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFE----------LLQYIVNEP 220 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHH----------HHHHHhcCC
Confidence 211 15788999999999999999999999999999999999999975431110 0000 011111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.. ..........+.+++.+|+..+|++||++.+++. ++++++|
T Consensus 221 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~--~~~~~~~ 263 (265)
T cd06605 221 PP-RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE--HPFIKKY 263 (265)
T ss_pred CC-CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh--Cchhhcc
Confidence 00 0000013346889999999999999999999976 5555554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.89 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=196.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +++.||||.+..... ......+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999765 688999999865422 2223456789999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+. ++|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 996 5898887542 2468899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......... .................+.
T Consensus 156 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 156 PSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhhh
Confidence 211 1122356889999999876 458899999999999999999999997655222111 1000000000000000000
Q ss_pred Cc-------cc--------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 PI-------LE--------VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ~~-------~~--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. .. ...........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 00000111246679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=305.74 Aligned_cols=246 Identities=27% Similarity=0.363 Sum_probs=201.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||++... +++.||+|++..... .....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999754 689999999865422 2334567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999988542 568899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. .....|++.|+|||.+.+...+.++||||||+++|||++|+.||.......... ....
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------~~~~ 212 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE----------------KILE 212 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHhc
Confidence 43 233568999999999988889999999999999999999999997655322110 0001
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
....... .....+.+++.+||..||.+|| +++++++
T Consensus 213 ~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 GKVRFPS---FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccCCc---cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111011 1134678999999999999999 6667654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.43 Aligned_cols=272 Identities=23% Similarity=0.313 Sum_probs=198.8
Q ss_pred CCcccCcccccCceEEEEEEEc---CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEE
Q 002149 612 NFASENELGRGGFGVVYKGELD---DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 685 (959)
+|+..+.||+|+||.||+|... +++.||+|.+..... .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999764 478999999876321 122345678899999999999999999999988 7899
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC----CCcEEEeec
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD----DFRAKVSDF 761 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~----~~~~ki~Df 761 (959)
+||||++ +++.+.+..........+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999995 567776654333333478999999999999999999999 89999999999999999 899999999
Q ss_pred cccccCCCCCc--ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHH
Q 002149 762 GLVKLAPDSER--SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEE-------RQYLAA 831 (959)
Q Consensus 762 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~-------~~~~~~ 831 (959)
|+++....... .......++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112335678999999988764 57899999999999999999999997654322 111111
Q ss_pred HHHhhhcchHHHH----------Hh--cCCcccCCCCCH--------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 832 WFWNIKSDKEKLR----------AA--IDPILEVNDDTF--------ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 832 ~~~~~~~~~~~~~----------~~--~~~~~~~~~~~~--------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+........... .. ............ .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111110000000 00 000000000000 11235789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.95 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=201.4
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
-|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 366788999999999999965 468899999876442 234557789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 84 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999988742 458899999999999999999999 89999999999999999999999999998755432
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......++..|+|||.+.+..++.++|||||||++|||++|..||........... .. ....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-------~~~~-- 218 (277)
T cd06641 155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------IP-------KNNP-- 218 (277)
T ss_pred hh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------Hh-------cCCC--
Confidence 21 12334688899999999888899999999999999999999999976543221110 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
..........+.+++.+|++.+|.+||++.+++++
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11111233467899999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=303.91 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=201.7
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 688 (959)
+|+..+.||.|++|.||+|.. .+++.+|+|.+.... ......++.+|+++++.++||||+++++++.+. ...++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 577889999999999999976 468899999887542 234567789999999999999999999988653 4679999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999988754322 23568999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHHhhhcchHHHHHh
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRP--EERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ........++.... ...+
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~--- 228 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPEL--- 228 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhh---
Confidence 3221 234578899999999999999999999999999999999999986532 11111121111100 0000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ..........+.+++.+|+..+|++|||+.|+++
T Consensus 229 -~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 -KDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -ccC---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 1111123456889999999999999999999977
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.66 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=200.3
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc----
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY---- 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 682 (959)
.+++|+..+.||+|+||.||+|... +++.+|+|++... ....+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4578999999999999999999764 6789999988754 23446789999999999 6999999999987644
Q ss_pred --eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 683 --ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 683 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999998865321 23578999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 835 (959)
||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||......... ..
T Consensus 157 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~---- 229 (275)
T cd06608 157 FGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FK---- 229 (275)
T ss_pred Cccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HH----
Confidence 999875543222 2233568899999998753 34678999999999999999999999754332211 00
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ....+.. .........+.+++.+|+..||++|||+.++++
T Consensus 230 ~~-------~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IP-------RNPPPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hh-------ccCCCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 0000111 111123346889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.30 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=200.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 687 (959)
++|+..+.||+|+||.||+|... +++.+|+|.++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999765 688999999876533333345677899999999999999999998877 889999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||++ ++|.+++... ...+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99995 5898887542 1368999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHHhhhcchHHHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA-AWFWNIKSDKEKLRA 845 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 845 (959)
..... ......+++.|+|||.+.+. .++.++|+||||+++|||++|..||......+..... ..+. ... ......
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~-~~~~~~ 233 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG-TPT-EKIWPG 233 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCc-hHHHHH
Confidence 54322 12334678899999998764 4688999999999999999999999876554322111 1000 000 000000
Q ss_pred h------c--------CCcccCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 A------I--------DPILEVNDDTFE-TFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~------~--------~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. . ...+. ...... ....+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0 00000 000000 2345779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.36 Aligned_cols=276 Identities=23% Similarity=0.367 Sum_probs=204.9
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------ 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 681 (959)
+..+|...+.||+|+||.||+|.. .+|+.||||++............+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357899999999999999999975 4689999999876433344456688999999999999999999988654
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++|+||+. .++..+. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ceEEEEecccc-cCHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 35689999994 4666544 1358899999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ........
T Consensus 162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~ 235 (342)
T cd07879 162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPG 235 (342)
T ss_pred CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCC
Confidence 998854332 223467889999999876 46889999999999999999999999876543321111 10000000
Q ss_pred HHH---------HHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCC
Q 002149 841 EKL---------RAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEP 903 (959)
Q Consensus 841 ~~~---------~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~ 903 (959)
..+ ...+........... .....+.+++.+|++.||++||++++++. +++++...+.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~--h~~f~~~~~~~~~~ 310 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE--HPYFDSFRDADEET 310 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CcchhhcccccccC
Confidence 000 000100000000000 11235779999999999999999999976 67777776644443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.66 Aligned_cols=270 Identities=20% Similarity=0.240 Sum_probs=198.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCce-----
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYE----- 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 683 (959)
++|+..+.||+|+||.||+|... +++.||+|++............+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999764 6899999987654333333467888999999995 6999999999887665
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeecc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFG 762 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfG 762 (959)
.++||||++ ++|.+++..........+++..++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 799999996 488888765333223578999999999999999999999 89999999999999998 8999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......+... ..+........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--HIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHhCCCCh
Confidence 9885533221 1222356889999998865 457899999999999999999999998765433211 11110000000
Q ss_pred -HHHHh------c--CCccc--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 842 -KLRAA------I--DPILE--VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 842 -~~~~~------~--~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... . ..... ...........+.+++.+|+..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0 00000 00000112346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=343.74 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=206.6
Q ss_pred HHHHhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
+..++-+++....||.|.||.||.|. .++|+-.|+|.++.........+.+.+|+.++..++|||+|+++|+-...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 45566788888999999999999995 66899999998877655566677889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
+|.||||++|+|.+.+... +..++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|.+|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999998552 335566667789999999999999 89999999999999999999999999999
Q ss_pred ccCCCCC---cceeeccccccccccccccccC---CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 765 KLAPDSE---RSVVTRLAGTFGYLAPEYAVTG---KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 765 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
....... .......+||+.|||||++.+. ....++||||+|||+.||+||++||......-. -+.. +.
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-IMy~-V~---- 1455 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-IMYH-VA---- 1455 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-HHhH-Hh----
Confidence 8554432 2234467999999999999764 356789999999999999999999986543211 0000 00
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+ ..+..+.....+-.+++.+|+..||++|.++.|+++
T Consensus 1456 -~g----------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 -AG----------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -cc----------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 00 011122223345679999999999999999887765
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.46 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=207.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++.|+..+.||+|+||.||+|..+ +++.||+|++..... ..+.+.+|+++++.++|+||+++++++......++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4567888899999999999999765 688999999875422 456788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999986522 478999999999999999999999 89999999999999999999999999998754
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||....+....... .
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~----------------~ 229 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI----------------T 229 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------H
Confidence 43222 123345788999999998888999999999999999999999999866543321110 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
................+.+++.+|++.+|.+||++.++++ ++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~ 275 (286)
T cd06614 230 TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK 275 (286)
T ss_pred hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence 0000001111112346889999999999999999999976 455544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=308.20 Aligned_cols=276 Identities=25% Similarity=0.328 Sum_probs=203.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 686 (959)
.++|+..+.||+|+||.||+|... +|+.||+|++............+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357899999999999999999764 689999999875432232234566899999999999999999998755 46899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+. ++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999995 5888887542 2568999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....+.+........ ..........
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL--LGTPNESIWP 234 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cCCCChhhch
Confidence 544321 1223346788999999866 45789999999999999999999999876654432211110 0000001100
Q ss_pred hcCCc-------ccCCC-CC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 846 AIDPI-------LEVND-DT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 846 ~~~~~-------~~~~~-~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.++.. ..... .. ......+.+++.+|++.||++||++.++++ +++++++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~ 298 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPL 298 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCC
Confidence 00000 00000 00 011345679999999999999999999976 566655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=302.99 Aligned_cols=274 Identities=22% Similarity=0.288 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +|+.||+|++..........+.+.+|+++++.++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999764 68899999986543333445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeeccccccCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLVKLAP 768 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla~~~~ 768 (959)
|++ +++.+++.. .....+++..+..++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHh---CCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 994 678777643 222346888899999999999999999 89999999999999985 5679999999997553
Q ss_pred CCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH---
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR--- 844 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 844 (959)
.... ......+++.|+|||++.+. .++.++|||||||++|||+||+.||......+..... +...........
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI--FRILGTPNEETWPGV 231 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChhhcccc
Confidence 3221 12334678899999988664 5789999999999999999999999876543321111 110000000000
Q ss_pred ----HhcCCcccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 845 ----AAIDPILEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 845 ----~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
............ .......+.+++.+|++.+|++||++.++++ +++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~~~~~~~ 290 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--HEYFKDL 290 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--CchHhHH
Confidence 000000000000 0111235779999999999999999999987 4555443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=303.67 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=203.0
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCc
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGA 695 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 695 (959)
.+||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 5799999999999976 47899999987643 33455678899999999999999999999999999999999999999
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCccee
Q 002149 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775 (959)
Q Consensus 696 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~ 775 (959)
|.+++.. ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........ ..
T Consensus 104 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~ 173 (292)
T cd06657 104 LTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 173 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cc
Confidence 9887632 357899999999999999999999 8999999999999999999999999999875543221 12
Q ss_pred eccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCC
Q 002149 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVND 855 (959)
Q Consensus 776 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (959)
....|++.|+|||.+.+..++.++|+||||+++|||++|..||......+..... .........
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------------~~~~~~~~~--- 237 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLPPKLK--- 237 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhhCCcccC---
Confidence 3356889999999998888999999999999999999999999865443321111 111111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 856 DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 856 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
........+.+++.+|++.+|.+||++.++++ ++++.++..
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~ 278 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 278 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCC
Confidence 00112235778999999999999999999987 677777665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.71 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=202.1
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|...+.||+|+||.||+|... +|..||+|.+..........+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999764 588999999865433344556788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~~~~~ 769 (959)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999988542 22457999999999999999999999 8999999999999999875 469999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... ......|++.|+|||+..+..++.++||||||+++|||++|..||......+. +.... ...+.+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~------~~~~~~ 221 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKIC------QGYFAP 221 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh------cccCCC
Confidence 322 22334688999999999888899999999999999999999999976543221 11110 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .......+.+++.+|+..+|++||++.++++
T Consensus 222 ~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 I------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred C------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1 1112246889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=307.39 Aligned_cols=265 Identities=24% Similarity=0.380 Sum_probs=201.5
Q ss_pred cCCcccCcccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|..++ ++.||||.+..... ......+.+|+.++.... |+||+++++++.++...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 568888999999999999998764 88999999875432 233456677887777774 999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+ ++++.+++... ...+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~-~~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELM-STCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ecc-CcCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 998 55776666431 24789999999999999999999972 489999999999999999999999999988654
Q ss_pred CCCcceeeccccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGK----ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
.... .....++..|+|||++.+.. ++.++||||||+++|||++|+.||....... ..+..
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~------------- 230 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTK------------- 230 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHH-------------
Confidence 4322 22345788999999987554 7889999999999999999999997543211 11111
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDE 902 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 902 (959)
.+................+.+++.+|++.||++||++.++++ .+++..+....++
T Consensus 231 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~~~~~~~~ 285 (296)
T cd06618 231 -ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ--HPFIRRYETAEVD 285 (296)
T ss_pred -HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--ChhhhccchhHHH
Confidence 111110000011112346889999999999999999999987 4666665554443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=304.07 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=198.4
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.+.|...+.||+|+||.||+|... +++.||+|++.... ......+++.+|+++++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999764 68999999886432 2334556788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+. |++.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99995 6776666431 2468999999999999999999999 89999999999999999999999999998755
Q ss_pred CCCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||............. .
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~------~------ 228 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------Q------ 228 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh------c------
Confidence 332 2346788999999874 4568899999999999999999999997665433211100 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
...+.. ........+.+++.+||+.+|++||++.+++++
T Consensus 229 -~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 -NDSPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 011233468899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.27 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=207.0
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|++.+.||+|+||.||++.. .+++.+|+|.+............+.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999964 4788999999876554555667788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.... .....+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999886532 223568999999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
. .....+++.|+|||...+..++.++|+||||+++|||++|+.||......+.... + ....
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~---~-------------~~~~ 217 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---V-------------QRGK 217 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H-------------hcCC
Confidence 1 2234678999999999999999999999999999999999999987654321110 0 0000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..........+.+++.+|++.+|++||++.++++
T Consensus 218 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 Y--PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C--CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 1111234456889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.18 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=202.4
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|+..+.||.|+||.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999765 689999999875432 22456789999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999988431 478899999999999999999999 8999999999999999999999999999886544
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............. ....
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------~~~~ 216 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA--------------KQET 216 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH--------------Hhcc
Confidence 32 2233568889999999988889999999999999999999999998765421111110 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDM--GHAV 886 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~ev~ 886 (959)
............+.+++.+|++.||.+||++ +|++
T Consensus 217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011111223578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=297.11 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=208.1
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|++|.||+|... +++.||||++...... ...+.+.+|+..+..++|+||+++++++......++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 6788899999999999999765 5899999998765322 4567899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ..+++..+..++.|+++|++|||+. .+++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998542 5689999999999999999999983 59999999999999999999999999998865433
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..............+ ....
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------~~~~ 219 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-------------CDGP 219 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-------------hcCC
Confidence 322 22346789999999999999999999999999999999999999776421111111111 1111
Q ss_pred ccCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 851 LEVNDDTFE-TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 851 ~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. ..... ....+.+++.+|+..+|++||++.++++ .++++.
T Consensus 220 ~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~~~ 261 (264)
T cd06623 220 PP--SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFIKK 261 (264)
T ss_pred CC--CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHHHh
Confidence 10 11111 3457889999999999999999999987 455543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.40 Aligned_cols=260 Identities=16% Similarity=0.177 Sum_probs=183.8
Q ss_pred hcCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHH---------HHHHHHHHHHHHhcCCCCceeEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKA---------VDEFHSEIAVLSKVRHRHLVSLLG 676 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~ 676 (959)
.++|.+.++||+|+||.||+|...+ +..+|+|+.......... ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999997654 345666654322111100 011223334456678999999999
Q ss_pred EEEeCc----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 002149 677 YSVAGY----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD 752 (959)
Q Consensus 677 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~ 752 (959)
++.... ..++++|++ ..++.+.+... ...++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 766543 446788877 44666655321 335788899999999999999999 89999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 753 DFRAKVSDFGLVKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 753 ~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
++.++|+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999865332211 11224699999999999999999999999999999999999999987643221
Q ss_pred HHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 827 QYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
..... . .+...+......... .....+.+++..|+..+|++||++.++++.+
T Consensus 242 ~~~~~--~-----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAA--K-----CDFIKRLHEGKIKIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHh--H-----HHHHHHhhhhhhccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11000 0 000111111111111 1134688999999999999999999998865
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.86 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=203.8
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.|+..+.||+|++|.||++... +++.+++|++.... ....+.+.+|+++++.++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 3677889999999999999765 68899999987652 24567889999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999885421 578999999999999999999999 89999999999999999999999999998866543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+...... ....+.
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~~ 216 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA-------------TNGPPG 216 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-------------hcCCCC
Confidence 32 234568899999999988889999999999999999999999998664322211110 000000
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .........+.+++.+|++.||++|||+.++++
T Consensus 217 ~---~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 L---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred c---CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 111111346889999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=302.86 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=199.6
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|+..+.||.|++|.||+|.. .+|+.||+|++..........+.+.+|+++++.++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999975 47899999998765333344567889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
+++|.+++.... ...+++..+..++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 -DLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred -CcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 578988885422 2468999999999999999999999 899999999999999999999999999997553322
Q ss_pred cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH---------
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE--------- 841 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 841 (959)
.. .....++..|+|||++.+. .++.++||||||+++|||++|+.||.......... ..+.......+
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF--RIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChHHhhhhhhc
Confidence 11 2223568899999988664 57889999999999999999999998765433211 11111000000
Q ss_pred -HHHHhcCCcc--cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 842 -KLRAAIDPIL--EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 842 -~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....+.... ............+.+++.+|++.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000001112246789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.04 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=198.6
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.|...+.||+|+||.||+|.. .+++.||+|++.... ........+.+|+++++.++|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477788999999999999975 468899999886432 233445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+. |++.+.+... ..++++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 995 5777766431 2568999999999999999999999 8999999999999999999999999999875433
Q ss_pred CCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 770 SERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||............ .
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~------------- 237 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A------------- 237 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--H-------------
Confidence 2 2346888999999974 456889999999999999999999998765432221100 0
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
..... ..........+.+++.+|++.+|.+||++.+++++..-+
T Consensus 238 -~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 238 -QNESP-TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -hccCC-CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00000 011112234678999999999999999999998865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=307.49 Aligned_cols=268 Identities=20% Similarity=0.286 Sum_probs=196.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-------
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------- 682 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 682 (959)
++|+..+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57899999999999999999764 6899999988654333333445678999999999999999999987654
Q ss_pred -eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 683 -ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 683 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
..++||||+. +++.+.+.. ....+++.++..++.||+.||+|||+ ++++|+||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN----KNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 4499999994 578777643 12468999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCc---ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 762 GLVKLAPDSER---SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 762 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|++........ .......++..|+|||.+.+. .++.++||||||+++|||++|..||..............+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99985543221 112234678899999988664 47889999999999999999999998766543322222111100
Q ss_pred cchHHHHH-----hcCCc-ccCCCC--------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 838 SDKEKLRA-----AIDPI-LEVNDD--------TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 838 ~~~~~~~~-----~~~~~-~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .+.... ..+.. ...... .......+.+++.+|+..||++||+++++++
T Consensus 244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 T-PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred C-hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 000000 00000 000000 0001134568999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.29 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=207.8
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|+||.||++... +++.||+|++..........+.+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999754 688999999887655556677899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++..... ....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999998865321 23679999999999999999999999 89999999999999999999999999999865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||......+... . .......+.
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~------~~~~~~~~~ 223 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL------K------ILKGQYPPI 223 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH------H------HhcCCCCCC
Confidence 3 12333578899999999988889999999999999999999999997654322110 0 000111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......+.+++.+|+..+|++||++.++++
T Consensus 224 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 ------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=300.79 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=199.6
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEEEE
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLVYE 689 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 689 (959)
|++.+.||+|+||.||+|... +++.+|+|++............+.+|+++++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999765 588999999986532334456788999999999999999999999887 88999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ ++|.+++... ...+++..++.++.||++||+|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 996 5888877431 1468999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH---
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA--- 845 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 845 (959)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.................... ......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWPGVSK 231 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhcccccc
Confidence 43222333467889999998765 4578999999999999999999999987664332111110000000 000000
Q ss_pred -----hcCCcccCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 -----AIDPILEVND-----DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 -----~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......... ........+.+++.+|++.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000 00001346789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.23 Aligned_cols=244 Identities=24% Similarity=0.282 Sum_probs=196.1
Q ss_pred ccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 5889999998764332 34457799999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++... ..+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||+++...... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 9998542 458899999999999999999999 899999999999999999999999999998665432 123
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...|+..|+|||.+.+..++.++|+||||+++|||++|..||.......... .......... ...
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~-~~~ 215 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI--------------YNDILKGNGK-LEF 215 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH--------------HHHHhccCCC-CCC
Confidence 3468899999999988889999999999999999999999998665211100 1111100000 011
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.......+.+++.+|++.+|++||+ +.|+++
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111447889999999999999999 667665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=303.21 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=199.8
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----- 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 682 (959)
..++|++.+.||+|+||.||+|..+ +|+.||+|++............+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4568899999999999999999765 6889999998765333334456788999999999999999999887654
Q ss_pred -----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 683 -----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 683 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
..++|+||+++ ++.+.+.. ....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+|
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES----GLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999965 67666633 12468999999999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...... ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~--~~~ 234 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS--RLC 234 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHh
Confidence 99999998654433222233456788999998865 457889999999999999999999998655433221111 110
Q ss_pred hcchHHHHHhcCCc---------ccC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 837 KSDKEKLRAAIDPI---------LEV----NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 837 ~~~~~~~~~~~~~~---------~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..........+... ... ..........+.+++.+|++.||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000000 000 0000012346889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.13 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=208.3
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
...|.+...||+|.|+.|..|.. .++..||||.+.+..........+.+|+++|+.++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45788899999999999999964 47999999999887766666667999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||..+|.+.+++... ....+..+..++.|+.++++|+|+ +.|||||||++|||++.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999653 334557888999999999999999 899999999999999999999999999999775
Q ss_pred CCCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
. .......+|++-|.|||++.+..|. +++|+||+|+++|-|+.|..||++..-.+-. .. .+
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr------------~r----vl 268 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR------------PR----VL 268 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc------------ch----he
Confidence 3 3345668999999999999998764 6899999999999999999999976533211 01 11
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
...+..+ .-...+..+++++++-.+|.+|++.+++.+.-
T Consensus 269 ~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 269 RGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeeeccc---ceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 1111100 01112456899999999999999999997743
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.37 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=194.9
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeC--ceEEEEE
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAG--YERLLVY 688 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 688 (959)
|++.+.||+|+||.||+|.. .+++.||+|+++....... .....+|+.++.++. |+|++++++++.+. +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56778999999999999965 4688999999876432222 234457899999985 99999999999887 8899999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||++ |++.+.+... ...+++.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9995 6887777432 2568999999999999999999999 89999999999999999 999999999998654
Q ss_pred CCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .....++..|+|||++.. ..++.++|||||||++|||++|+.||......+........ .......+...+
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 226 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV--LGTPDAEVLKKF 226 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH--cCCCCHHHHHhh
Confidence 3222 123467899999997654 55788999999999999999999999876654321111100 001111111111
Q ss_pred CCcccC----CC--------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEV----ND--------DTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~----~~--------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...... .. ........+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 110000 00 00122457889999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=310.52 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=195.3
Q ss_pred ccCcccccCceEEEEEEE-cCCcEEEEEEccccc--ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce--EEEEEE
Q 002149 615 SENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV--ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE--RLLVYE 689 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 689 (959)
..++||+|+|-+||||.. .+|-.||--.++... .++...++|..|+++|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346799999999999954 467777654333222 244556899999999999999999999998876654 679999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeeccccccCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLVKLAP 768 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla~~~~ 768 (959)
.|..|+|..|+.++ +.++.+.+..++.||++||.|||+. .++|||||||-.||+|+. .|.|||+|.|||....
T Consensus 124 L~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999764 4567789999999999999999994 479999999999999976 4899999999999765
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... .....|||.|||||.+. ..|+..+||||||+.++||+|+..|+..-...-..|.. .. .+..+..+.
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK-----V~--SGiKP~sl~ 266 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK-----VT--SGIKPAALS 266 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH-----HH--cCCCHHHhh
Confidence 432 23478999999999876 78999999999999999999999999754432221111 00 111111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.- ..++.++|.+|+.. .++||++.|+++ ++++..
T Consensus 267 kV~---------dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~ 301 (632)
T KOG0584|consen 267 KVK---------DPEVREFIEKCLAT-KSERLSAKELLK--DPFFDE 301 (632)
T ss_pred ccC---------CHHHHHHHHHHhcC-chhccCHHHHhh--Chhhcc
Confidence 111 12678999999999 999999999976 555543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=298.17 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=199.4
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|++|.||+|... +|+.||||++..... ....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 5788899999999999999764 688999999875422 23345677899999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
++ ++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 80 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MD-KDLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CC-ccHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 96 58888875422 12468999999999999999999999 89999999999999999999999999999754332
Q ss_pred CcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC-
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID- 848 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 848 (959)
.. ......++..|++||++.+. .++.++|||||||++|||++|+.||......+........... ...........
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT-PTESTWPGISQL 231 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC-CChhhHHHHhcC
Confidence 21 12234578899999988664 5788999999999999999999999876543321111000000 00000000000
Q ss_pred ----Cc-ccCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 ----PI-LEVNDD-----TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ----~~-~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ...... .......+.+++.+|++.||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000000 0112346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=282.64 Aligned_cols=250 Identities=28% Similarity=0.337 Sum_probs=203.2
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
-++|...++||+|.||.|..++ ..+++.+|+|++++.++ .+.....-..|-++++..+||.+..+--.++..+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3568888999999999999996 45789999999998754 345566777899999999999999999899999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||..||.|.-++.+ .+.+++....-+-..|+.||.|||+ ++||.||+|.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999887743 3678898889999999999999999 89999999999999999999999999999843
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
-.. ......++|||.|.|||++....|.+++|.|.+||++|||++|+.||........-.++ ....-++++.
T Consensus 319 I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI------l~ed~kFPr~- 390 (516)
T KOG0690|consen 319 IKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI------LMEDLKFPRT- 390 (516)
T ss_pred ccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH------HhhhccCCcc-
Confidence 222 22356689999999999999999999999999999999999999999866543321111 0101111111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
...+...|+...+..||.+|. ++.||.+
T Consensus 391 ------------ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 391 ------------LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ------------CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 112456788889999999997 4556644
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=299.19 Aligned_cols=243 Identities=24% Similarity=0.293 Sum_probs=186.5
Q ss_pred cccccCceEEEEEEE-cCCcEEEEEEcccccccHH-HHHHHHHHHHHHHh---cCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 618 ELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKK-AVDEFHSEIAVLSK---VRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
.||+|+||.||++.. .+++.+|+|.+........ ....+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 4688999998875433222 22334445444433 479999999999999999999999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999988753 2468999999999999999999999 899999999999999999999999999987553322
Q ss_pred ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 773 SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|..||............... ......
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------~~~~~~- 217 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----------LTVNVE- 217 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-----------hcCCcC-
Confidence 123468999999999864 56889999999999999999999999765432221111100 000111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
........+.+++.+|++.||++|| +++++++
T Consensus 218 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 ----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1112234678999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=292.39 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=205.7
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 688 (959)
+|...+.||+|++|.||+|... +++.|++|++..........+.+.+|++++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999765 788999999876544456678899999999999999999999999988 8899999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999998542 378999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......++..|+|||.+.+...+.++||||||+++|+|++|..||......... .+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~---------- 217 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKIG---------- 217 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhcc----------
Confidence 43321 123356889999999998888999999999999999999999999876521110 01000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ............+.+++.+|+..+|++||++.++++
T Consensus 218 ~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 218 SSG-EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccC-CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000 001111122457889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=326.02 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=190.8
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------ 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 681 (959)
...+|+..+.||+||||.|||++.+ ||+.+|||++.... +......+.+|+..+.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456788889999999999999765 89999999998775 677788899999999999999999997311000
Q ss_pred --------------------------------------------------------------------------------
Q 002149 682 -------------------------------------------------------------------------------- 681 (959)
Q Consensus 682 -------------------------------------------------------------------------------- 681 (959)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 002149 682 ---------------------------------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728 (959)
Q Consensus 682 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 728 (959)
...||=||||+...+.+++.+..... .....++++.+|++||+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence 11256788888888877775422211 45678899999999999
Q ss_pred HHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC------C-----------CCcceeeccccccccccccccc
Q 002149 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP------D-----------SERSVVTRLAGTFGYLAPEYAV 791 (959)
Q Consensus 729 yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~ 791 (959)
|+|+ .|||||||||.||+++++..|||+|||+|+... + ......+..+||.-|+|||++.
T Consensus 712 YIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 9999 899999999999999999999999999998511 0 0112345678999999999996
Q ss_pred cC---CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC-CCCHHHHHHHHHH
Q 002149 792 TG---KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN-DDTFETFWTIAEL 867 (959)
Q Consensus 792 ~~---~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 867 (959)
+. .|+.|+|+||+|||++||+. ||. ...++.....-+ + +..++.+ +...+....-+.+
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~L----------R---~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNL----------R---KGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhc----------c---cCCCCCCcccccccchHHHHH
Confidence 64 59999999999999999997 443 234443322211 1 1112111 1122333355689
Q ss_pred HHhcccCCCCCCCCHHHHHH
Q 002149 868 AGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 868 ~~~cl~~dP~~RPt~~ev~~ 887 (959)
|+++++.||++|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=257.81 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=201.2
Q ss_pred CCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|...++||+|.||+||+|+ .++++.||+|++......+.......+|+.+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667899999999999996 45789999999987644444556788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+ ..+|.++... . ...++.+.+..++.|+++||.++|+ +++.|||+||.|.||+.+|++|++|||+|+.+.-.
T Consensus 83 c-dqdlkkyfds---l-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDS---L-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred h-hHHHHHHHHh---c-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 9 6688777632 2 3678999999999999999999999 89999999999999999999999999999977654
Q ss_pred CcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMA-LDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ....+-|.+|++|.++.+.+ |+...|+||.||++.|+.....| |.+....++ +...++......+.-...+.
T Consensus 155 vrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred eEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccc
Confidence 433 23345689999999998865 78899999999999999875555 555544333 33334433322222222222
Q ss_pred CcccC---CCC----CHHH-----HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 849 PILEV---NDD----TFET-----FWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 849 ~~~~~---~~~----~~~~-----~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... +.+ .+.. ...-.+++.+.+.-+|.+|.+++++++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 21111 111 1111 112347888888889999999999877
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=293.10 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=197.5
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc---ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV---ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 684 (959)
.+|+..+.||+|+||.||+|.. .+++.||+|.+.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999965 468999999875321 1234557889999999999999999999998764 457
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999988843 1457899999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCC--cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSE--RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~----------- 220 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FK----------- 220 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HH-----------
Confidence 8543211 11123356889999999999888999999999999999999999999865432211 00
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....... ...+......+.+++.+|+. +|.+||++.+++.
T Consensus 221 ---~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 ---IATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0000000 11112233468899999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=302.67 Aligned_cols=262 Identities=19% Similarity=0.294 Sum_probs=194.3
Q ss_pred Cccccc--CceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRG--GFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
..||+| +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999975 4799999999876544555667899999999999999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|++.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999886532 2458899999999999999999999 89999999999999999999999999865422211100
Q ss_pred ---e---eeccccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh--------
Q 002149 774 ---V---VTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK-------- 837 (959)
Q Consensus 774 ---~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 837 (959)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||......+.. ........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccc
Confidence 0 0112346679999998763 4789999999999999999999999865432211 11000000
Q ss_pred ---------cchHHHH--------------HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 838 ---------SDKEKLR--------------AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 838 ---------~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....... ...+..+. ..........+.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000 00000000 1111223457889999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.29 Aligned_cols=264 Identities=22% Similarity=0.302 Sum_probs=202.4
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|+..+.||+|++|.||+|... +++.+|+|++............+.+|+++++.++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566788999999999999764 6889999998765444445677889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
+ +++.+++... ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~-~~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 D-TDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CCHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 5 5888777542 1578999999999999999999999 899999999999999999999999999998665433
Q ss_pred cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC-
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP- 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 849 (959)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+...... .............+..
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSL 229 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhh
Confidence 122334678899999998876 78999999999999999999999997766433221111 0000000000000000
Q ss_pred ------------cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ------------ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..............+.+++.+|++.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000001123457889999999999999999999976
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=296.72 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=192.5
Q ss_pred ccccCceEEEEEEE-cCCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||+||+|.. .+|+.||+|.+...... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999964 46889999988654222 22345567899999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 99885422 2468999999999999999999999 899999999999999999999999999988654321 223
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+........ ...
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~~~~--~~~ 217 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTLEMA--VEY 217 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhcccccc--ccC
Confidence 3467889999999988889999999999999999999999997654311100 0000000000 001
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.......+.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 111234678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=296.92 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=197.7
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc---CCCCceeEEEEEEeCce-----
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSVAGYE----- 683 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 683 (959)
|++.+.||+|+||.||+|..+ +++.||+|++............+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999876 489999999875433333345566788877776 59999999999988776
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999995 58888875422 2358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-hHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-KEK 842 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 842 (959)
+........ .....++..|+|||++.+..++.++|||||||++|||++|+.||......+... ......... ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHh
Confidence 986543321 223457889999999999999999999999999999999999998765443211 111111000 000
Q ss_pred H-------HHhcCCcccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 L-------RAAIDPILEV--NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~-------~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ...+...... ..........+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 0001122356779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=281.64 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=204.7
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
+++....+ .+.||+|+|+.|--+ .+.+|..+|||++.+. ......++.+|++++.+. .|+||++++++|++
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45555443 367999999999998 4778999999999875 455677889999999999 49999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAK 757 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~k 757 (959)
+...|||||.|.||+|..++++. +.+++.++.++..+|+.||.+||. +||.|||+||+|||.... .-+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence 99999999999999999988652 678999999999999999999999 999999999999999654 3489
Q ss_pred EeeccccccCCCCC------cceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 758 VSDFGLVKLAPDSE------RSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 758 i~DfGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
||||.++....... +......+|+..|||||+.. ...|+.+.|.||+|||+|-|++|..||.+....+-
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 99999876322111 11233468999999999862 23588899999999999999999999987765331
Q ss_pred H----HHHHHHHhhhcchHH-HHHhcCCcccCCCCCHHHH-HHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 827 Q----YLAAWFWNIKSDKEK-LRAAIDPILEVNDDTFETF-WTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 827 ~----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ...... ... +..+-+.....++.++..+ .+..+++..++..|+.+|.++.++++
T Consensus 300 GWdrGe~Cr~C------Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVC------QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHH------HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 000000 111 2222233344455555443 35568999999999999999998876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=290.42 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=204.5
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|+..+.||+|++|.||+|... +++.||+|.+..........+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999654 678999999987654445677899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999988432 568999999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
... .....++..|+|||...+..++.++||||+|+++|+|++|+.||......... . .... . ..
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~----~~~~------~---~~ 216 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--F----RIVQ------D---DH 216 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--H----HHhc------c---CC
Confidence 322 23356889999999998888899999999999999999999999765432211 0 0000 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..........+.+++.+|+..+|++||++.+++.
T Consensus 217 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 ---PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0011112346789999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=301.81 Aligned_cols=271 Identities=20% Similarity=0.236 Sum_probs=198.3
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCc
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGA 695 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 695 (959)
.+.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455556666666554 68999999987654456667889999999999999999999999999999999999999999
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc---
Q 002149 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER--- 772 (959)
Q Consensus 696 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~--- 772 (959)
|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999986422 2458899999999999999999999 8999999999999999999999999998874432111
Q ss_pred ---ceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc---chHHHH
Q 002149 773 ---SVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS---DKEKLR 844 (959)
Q Consensus 773 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 844 (959)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||......... ......... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchh
Confidence 11223457789999999866 35889999999999999999999999876543211 110000000 000000
Q ss_pred H-----------hcCCccc---CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 845 A-----------AIDPILE---VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 845 ~-----------~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
. ..+.... ...........+.+++.+||+.||++||+++++++ ++++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~--~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN--HSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc--CchHhhhc
Confidence 0 0000000 00111122346779999999999999999999987 55655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=298.86 Aligned_cols=245 Identities=23% Similarity=0.378 Sum_probs=204.3
Q ss_pred cCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.+.||.|-||+||-|.. ++|+.||||++.+..+.......+++|+.++++++||.||.+-..|+..+..++|||.+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 57899999999999965 58999999999998888888899999999999999999999999999999999999999 66
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEEEeeccccccCCCCC
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~ki~DfGla~~~~~~~ 771 (959)
+..+.+.. .....+++....-++.||+.||.|||. ++|+|+||||+|||+... .++||||||.||+.++.
T Consensus 648 DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 648 DMLEMILS---SEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 66665533 334678999999999999999999999 899999999999999654 56999999999988664
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
......+||+.|.|||++....|.+.-|+||.||++|--++|..||.+..+..++..- ..++
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN-------------AaFM---- 782 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN-------------AAFM---- 782 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc-------------cccc----
Confidence 3455679999999999999999999999999999999999999999876543321100 0111
Q ss_pred cCCCCCHHHH-HHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 852 EVNDDTFETF-WTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~-~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+..++.++ ....++|...|+..-.+|.+.+..+.
T Consensus 783 -yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 783 -YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 123333333 34568999999999999999887765
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.91 Aligned_cols=270 Identities=24% Similarity=0.304 Sum_probs=196.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------ 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 682 (959)
.++|++.+.||+|+||.||+|... +++.||||++............+.+|+++++.++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999754 6889999988654333333446778999999999999999998775433
Q ss_pred --eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 683 --ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 683 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
..++||||+. +++...+.. ....+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~----~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN----PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 4689999995 567666643 22568999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcc----------eeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 761 FGLVKLAPDSERS----------VVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 761 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
||+++........ ..+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999854332211 11234678899999988654 578999999999999999999999987665443222
Q ss_pred HHHHHhhhcch-----HHHHHhcCCc-ccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 830 AAWFWNIKSDK-----EKLRAAIDPI-LEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 830 ~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........... ..+....+.. ........ .....+.+++.+|++.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111100000 0000000000 00000000 11146789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.13 Aligned_cols=280 Identities=21% Similarity=0.308 Sum_probs=204.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-------
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------- 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 681 (959)
..+|...+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999965 468899999886542 24456788999999999999999999765543
Q ss_pred -------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-C
Q 002149 682 -------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-D 753 (959)
Q Consensus 682 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~ 753 (959)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999995 688877632 458899999999999999999999 89999999999999974 5
Q ss_pred CcEEEeeccccccCCCCCcc--eeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSERS--VVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
+.+|++|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+.....
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 67899999999754322111 1123467889999998754 56788999999999999999999999876553322111
Q ss_pred HHHHhhhcc-h---HH----HHHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 831 AWFWNIKSD-K---EK----LRAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 831 ~~~~~~~~~-~---~~----~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
....... . .. ................ .....+.+++.+|++.||.+||++.++++ +++++.+.
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~--h~~~~~~~ 307 (342)
T cd07854 232 --LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM--HPYMSCYS 307 (342)
T ss_pred --HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC--CCcccccc
Confidence 1100000 0 00 0000000000000000 12246779999999999999999999977 78888776
Q ss_pred CCCCCCCc
Q 002149 898 PLDDEPEE 905 (959)
Q Consensus 898 ~~~~~~~~ 905 (959)
.+.+++..
T Consensus 308 ~~~~~~~~ 315 (342)
T cd07854 308 CPFDEPVS 315 (342)
T ss_pred CCccccCC
Confidence 66555544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.84 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=196.1
Q ss_pred ccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||++... +|+.+|+|.+..... .....+.+.+|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 489999999865422 224567788999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc----
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER---- 772 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~---- 772 (959)
.+++... ..+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998542 368999999999999999999999 8999999999999999999999999999875433211
Q ss_pred ---ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 773 ---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 773 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.......++..|+|||.......+.++||||||+++||+++|+.||......+.... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----------------~~~~ 216 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN----------------ILNG 216 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----------------HhcC
Confidence 122335678899999999888899999999999999999999999986654332110 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
...... .......+.+++.+|++.+|++||++.++.+.+
T Consensus 217 ~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 217 KIEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CcCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 011000 111234678999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=297.45 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=195.5
Q ss_pred CCcccCcccccCceEEEEEEE----cCCcEEEEEEcccccc--cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceE
Q 002149 612 NFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVI--SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 684 (959)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.+++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 3688999999875321 123346678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999998854 2457899999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHhhhcchH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLTGLMALDESRPEER-QYLAAWFWNIKSDKE 841 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 841 (959)
+..............|+..|+|||.+... .++.++||||||+++|||++|+.||........ .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---------- 222 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---------- 222 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH----------
Confidence 86544332223345689999999998753 467899999999999999999999964322111 11110
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
....... .........+.+++.+|++.||++|| +..+++.
T Consensus 223 ---~~~~~~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 223 ---RILKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---HhhccCC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000000 01111234678999999999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=291.95 Aligned_cols=249 Identities=21% Similarity=0.225 Sum_probs=191.1
Q ss_pred HHHHHHhcCCcccCcc--cccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEE
Q 002149 604 QVLRNVTKNFASENEL--GRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSV 679 (959)
Q Consensus 604 ~~~~~~~~~~~~~~~l--G~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 679 (959)
.+.....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3344445677777776 9999999999965 468889999876532211 122222222 6999999999999
Q ss_pred eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEE
Q 002149 680 AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKV 758 (959)
Q Consensus 680 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki 758 (959)
..+..++||||+++|+|.+++... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 999999999999999999998531 378999999999999999999999 8999999999999999988 9999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+|||+++...... ...|+..|+|||++.+..++.++||||||+++|||++|+.||......+. ....+..
T Consensus 152 ~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---- 221 (267)
T PHA03390 152 CDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLK---- 221 (267)
T ss_pred ecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHH----
Confidence 9999987554321 23688999999999998999999999999999999999999985543221 1111111
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-MGHAVN 887 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 887 (959)
....... ........+.+++.+|++.+|.+||+ ++++++
T Consensus 222 -------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 -------RQQKKLP---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------hhcccCC---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111111 00123346789999999999999996 688875
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=291.36 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=188.3
Q ss_pred CcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHH-HhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVL-SKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|.. .+++.||+|.+..... .......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999965 4688999999865422 122233445555544 445899999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999988542 468899999999999999999999 8999999999999999999999999999875433
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||......+..... .. ..... .
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~------~~~~~--~- 213 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LS------RRINW--P- 213 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh------cccCC--C-
Confidence 12346888999999998888899999999999999999999999866543321100 00 00000 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 854 NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 854 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
..........+.+++.+|++.+|++||++.++.+.
T Consensus 214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 00011223467899999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=280.97 Aligned_cols=260 Identities=26% Similarity=0.339 Sum_probs=202.9
Q ss_pred cCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
...||.|+||+|+|-.+ ..|+..|||++..... ....+++..|.+...+- +.||||+++|++......|+.||+| .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 46799999999999965 4799999999987644 45667888888876555 7999999999999989999999999 7
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
-|++.+-...-......+++..+-.|..-.++||.||-+. ..|||||+||+|||++..|.+|+||||++-...+..
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-- 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-- 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--
Confidence 7876654332233346788888889999999999999885 789999999999999999999999999987554432
Q ss_pred eeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC---
Q 002149 774 VVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID--- 848 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 848 (959)
..+.-+|-.-|||||.+.. ..|+-++||||+|++|||+.||+.|+.+....- +++...+.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf---------------eql~~Vv~gdp 287 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF---------------EQLCQVVIGDP 287 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH---------------HHHHHHHcCCC
Confidence 2344578889999999954 358999999999999999999999988654311 12222222
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
+.+.....+.+....+..++.-|+..|-++||.+.++.+ .++.+.|..
T Consensus 288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~--~~fyr~y~~ 335 (361)
T KOG1006|consen 288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK--FPFYRMYAV 335 (361)
T ss_pred CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc--Cchhhhhhh
Confidence 222333444556678899999999999999999999876 344444443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=296.72 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=198.0
Q ss_pred CCcccCcccccCceEEEEEEE----cCCcEEEEEEccccccc--HHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceE
Q 002149 612 NFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 684 (959)
+|+..+.||+|+||.||++.. .+++.||||.+...... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999964 35788999988653221 23346688999999999 599999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999988843 2468899999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCcceeeccccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHhhhcchH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEER-QYLAAWFWNIKSDKE 841 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 841 (959)
+..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||........ .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---------- 222 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---------- 222 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH----------
Confidence 865433322223356889999999987765 78899999999999999999999964322110 00000
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
........ ........+.+++.+|++.||++|||+.++.+.|+
T Consensus 223 ---~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 223 ---RILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ---HHHccCCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 00111000 11112236789999999999999999888876554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=292.92 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=186.5
Q ss_pred cccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHH---HHHhcCCCCceeEEEEEEeCceEEEEEEecC
Q 002149 618 ELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIA---VLSKVRHRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
.||+|+||.||+|.. .+++.||+|.+....... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 468899999987643322 11222334433 4444579999999999999999999999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999888743 2568999999999999999999999 899999999999999999999999999987553322
Q ss_pred ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 773 SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||............. .........
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~ 218 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------MTLTMAVEL 218 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-----------HhhccCCCC
Confidence 1234689999999998754 68999999999999999999999998653322111000 000001111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
. ......+.+++.+|+..+|++|| ++.++++
T Consensus 219 ~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 P-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 11134688999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=297.52 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=195.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.|...+.||+|+||.||+|... +++.+|+|.+... .......+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677788999999999999754 6788999988643 123344567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+. |++.+.+... ...+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9995 6887776432 2468899999999999999999999 899999999999999999999999999987553
Q ss_pred CCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.. ....|++.|+|||.+. ...++.++|||||||++|||++|+.||......+..... . .
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~-----------~ 228 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A-----------Q 228 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--h-----------h
Confidence 32 2346789999999974 356788999999999999999999998765432221100 0 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
...+. .........+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 NESPA----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cCCCC----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 00000 0111223467899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.02 Aligned_cols=280 Identities=21% Similarity=0.267 Sum_probs=210.9
Q ss_pred CceeecHHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC--CC----
Q 002149 597 GNLVISVQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR--HR---- 669 (959)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~---- 669 (959)
|..++...+ ..+++|.+...+|+|.||.|-.+.. ..+..||||+++.- ..-.+...-|+++++++. .|
T Consensus 77 GH~v~~~gD--~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 77 GHYVYQVGD--ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred ceEEEEecc--ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCce
Confidence 334444333 3478999999999999999999954 45789999998742 233445677999999994 23
Q ss_pred CceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 670 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
-+|++.+|+....+.++|+|.+ |-|+.+++.. .+..+++..++..+++|++++++|||+ .+++|-||||+|||
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENIL 224 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENIL 224 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEE
Confidence 3778888999999999999999 7799999954 455789999999999999999999999 89999999999999
Q ss_pred ECC--------------------CCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHH
Q 002149 750 LGD--------------------DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLM 809 (959)
Q Consensus 750 l~~--------------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ 809 (959)
+.. +..+||+|||.|+...+.. ...+.|..|+|||++.+-.++.++||||+||||+
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 821 3469999999998654432 4457799999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH-----Hhc--------------------CCcc---cCCCCCHHHH
Q 002149 810 ELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR-----AAI--------------------DPIL---EVNDDTFETF 861 (959)
Q Consensus 810 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--------------------~~~~---~~~~~~~~~~ 861 (959)
|++||..-|+.....|...++..+-.... ...+. +.+ +... ..-.....+.
T Consensus 301 ElytG~~LFqtHen~EHLaMMerIlGp~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLEHLAMMERILGPIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EeeccceecccCCcHHHHHHHHHhhCCCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 99999999988776554444333222110 00000 000 0000 0001112344
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 862 WTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 862 ~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.++.+|+++||..||.+|+|+.|+++ ++++..
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~--HpFF~~ 411 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALS--HPFFAR 411 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhc--CHHhhc
Confidence 57889999999999999999999976 555543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=294.83 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=194.3
Q ss_pred CcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999975 4688999999865322 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+. |++.+++.. ...++++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~----~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 94 677777643 22568999999999999999999999 8999999999999999999999999999864322
Q ss_pred Ccceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.....|+..|+|||++. ...++.++|||||||++|||++|..||............ .. ..
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~-------~~ 236 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQ-------ND 236 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------Hh-------cC
Confidence 12346889999999984 456888999999999999999999998766543221100 00 00
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+.. ........+.+++.+|++.+|.+||++.+++.
T Consensus 237 ~~~~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 SPTL----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01112235789999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=278.66 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=208.2
Q ss_pred CcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ceEEE
Q 002149 613 FASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YERLL 686 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 686 (959)
.+..+.||.|+||.||.+. -++|+.||.|++...+.+-...+.+.+|++++..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4567899999999999995 46899999999987655556678899999999999999999998876543 35678
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
|+|.| ..+|.+.+ .+...++.+.+.-+.+||++||+|||+ .+|.||||||.|.|++.++.+||||||+||.
T Consensus 135 ~TELm-QSDLHKII-----VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELM-QSDLHKII-----VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHH-Hhhhhhee-----ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 89998 66777766 345788999999999999999999999 8999999999999999999999999999997
Q ss_pred CCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc------
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD------ 839 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 839 (959)
...+....++..+-|..|+|||.+++ ..|+.+.||||.||++.|++..+.-|+...+.+...++...-....-
T Consensus 206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 66555555666677899999999998 46899999999999999999999999888877766555433221110
Q ss_pred -hHHHHHhcCCcccCCCC--------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 840 -KEKLRAAIDPILEVNDD--------TFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 840 -~~~~~~~~~~~~~~~~~--------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
++.-..++....+.+.. ....-.+...+..+++..||++|.+..++++++
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111122221111111 112223455788889999999999999887754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-32 Score=323.38 Aligned_cols=147 Identities=29% Similarity=0.453 Sum_probs=131.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|.+.++||+|+||.||+|... +++.||||++.... ........+.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999765 68999999987542 23444577889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
||+.+++|.+++... ..+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998542 457889999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.81 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=197.8
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
|++.+.||+|+||.||+|... +++.||||++...... .......+|+..+++++ |+||+++++++.++...++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567789999999999999875 5788999998764322 22334557999999998 99999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+ +|+|.+++.... ...+++..+..++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||+++.....
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889988885422 2568999999999999999999999 89999999999999999999999999999865432
Q ss_pred Ccceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-----hHHHH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-----KEKLR 844 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 844 (959)
.. .....++..|+|||++.. ..++.++|+||||+++|||++|+.||......+.............. .....
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 22 233567889999998754 55789999999999999999999999776543322111100000000 00000
Q ss_pred HhcCCcccCC-CCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVN-DDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~-~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..++...... .... .....+.+++.+|++.+|++||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0011000000 0000 11246889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=293.58 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=202.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 687 (959)
++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++ |+||+++++++..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999764 789999999875322 3344577889999999998 99999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999998542 368999999999999999999999 89999999999999999999999999998855
Q ss_pred CCCCc-------------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 002149 768 PDSER-------------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828 (959)
Q Consensus 768 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~ 828 (959)
..... .......|+..|+|||......++.++||||||++++++++|..||........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 230 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-- 230 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH--
Confidence 43221 122335678999999999888899999999999999999999999986642211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM----GHAVN 887 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~ev~~ 887 (959)
.. ....... .........+.+++.+|++.+|.+||++ .++++
T Consensus 231 ~~--------------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQ--------------KILKLEY---SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH--------------HHHhcCC---CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0000000 0111123467899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=297.88 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=199.0
Q ss_pred hcCCcc-cCcccccCceEEEEEEEc-CCcEEEEEEcccccccHH------------HHHHHHHHHHHHHhcCCCCceeEE
Q 002149 610 TKNFAS-ENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKK------------AVDEFHSEIAVLSKVRHRHLVSLL 675 (959)
Q Consensus 610 ~~~~~~-~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~ 675 (959)
.++|.. .+.||+|+||.||+|... +++.||||++........ ....+.+|+++++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 346654 467999999999999754 689999998865422210 012467899999999999999999
Q ss_pred EEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 676 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
+++..++..++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999995 789888743 2458999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCC-------------cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 756 AKVSDFGLVKLAPDSE-------------RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
+||+|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987554110 1111223568899999998764 4689999999999999999999999877
Q ss_pred ChHHHHHHHHHHHhhhcchHHHHHhcC-----CcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 822 RPEERQYLAAWFWNIKSDKEKLRAAID-----PILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
...+............. ...+..... +........ ......+.+++.+|++.+|++||++++++. ++
T Consensus 238 ~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~--~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPN-EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK--HE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCc-hhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc--Cc
Confidence 65432211100000000 000000000 000000000 011245779999999999999999999976 55
Q ss_pred hHhhc
Q 002149 892 LVEKW 896 (959)
Q Consensus 892 ~~~~~ 896 (959)
+++.+
T Consensus 315 ~~~~~ 319 (335)
T PTZ00024 315 YFKSD 319 (335)
T ss_pred ccCCC
Confidence 55443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=272.21 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=202.1
Q ss_pred HhcCCccc-CcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe----C
Q 002149 609 VTKNFASE-NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA----G 681 (959)
Q Consensus 609 ~~~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 681 (959)
++++|.+- ++||-|-.|.|-.+.. .+++.+|+|++... ...++|++..-.. .|||||.++++|.. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 34555543 5799999999999954 57999999988642 2356788876666 59999999998764 3
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKV 758 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki 758 (959)
....+|||.|+||.|...+.+ .+...+++.++-+|+.||+.|+.|||+ .+|.||||||+|+|.+. +..+|+
T Consensus 132 kcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEe
Confidence 456789999999999998855 445789999999999999999999999 89999999999999964 567999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+|||.|+..... ......+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||........
T Consensus 206 tDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------------ 271 (400)
T KOG0604|consen 206 TDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------ 271 (400)
T ss_pred cccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC------------
Confidence 999999865432 234456779999999999999999999999999999999999999976543110
Q ss_pred chHHHHHhcCCcccCCCCCHHHHH-HHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFW-TIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~-~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+.-+++.......+...+.+.. ...++|+.+|..+|.+|.|..+++. ++++..+..
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi~~~~~ 330 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWINQYEA 330 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--Cchhccccc
Confidence 011111222222333444455443 4569999999999999999999977 555555443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=286.32 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=196.2
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccc---cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAG---VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+|.+.+.||+|+||.||++... .+..+++|.++.. ........++.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999754 3445666655432 12233445677899999999999999999999988899999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++. +.+||+|||+++..
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999998865332 23578999999999999999999999 89999999999999975 56999999998865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......... . ...
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~--~--------------~~~ 218 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV--L--------------RIV 218 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--H--------------HHH
Confidence 43222 223356888999999998888999999999999999999999999754322110 0 000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... ..........+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 EGPT--PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cCCC--CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0000 1111233457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=288.89 Aligned_cols=264 Identities=26% Similarity=0.350 Sum_probs=200.3
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|+..+.||+|+||.||+|... +++.||+|++..........+.+..|+++++.++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999765 5899999998865433444567788999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
+ ++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 6 68999885421 468999999999999999999999 899999999999999999999999999998654432
Q ss_pred cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC-
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP- 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 849 (959)
. ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......+..... ........+.....+..
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI--FQILGTPTEESWPGVTKL 229 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--HHHhCCCcHHHHHhhccc
Confidence 2 12234567889999998776 8899999999999999999999999776543221100 00000000111100000
Q ss_pred -----cccCC-CCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 -----ILEVN-DDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 -----~~~~~-~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... ... ......+.+++.+|+..||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 000 011346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-33 Score=269.83 Aligned_cols=268 Identities=21% Similarity=0.310 Sum_probs=197.9
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--------Cc
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--------GY 682 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 682 (959)
.|+...+||+|.||+||+|+. ++|+.||+|++........-.....+|+.++..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 455667899999999999964 568889998764322122223456789999999999999999987753 23
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..|+|+++++ -+|.-.+.. ....++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||
T Consensus 98 t~ylVf~~ce-hDLaGlLsn----~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSN----RKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcC----ccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence 5789999994 477777632 23678999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc---ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 763 LVKLAPDSER---SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 763 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+||.+..... ...+..+-|.+|++||.+.+ ..|+++.|||..||++.||+||.+-+++........+++..-....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9986544332 22344567999999999987 5689999999999999999999999998876665554443211111
Q ss_pred c-------hHHHHHhcCCc-ccCCCCC--HHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 D-------KEKLRAAIDPI-LEVNDDT--FET------FWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ~-------~~~~~~~~~~~-~~~~~~~--~~~------~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .-.+.+.+... +...... .+. -...++|+.+++..||.+|+++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0 11122222111 1101100 011 115679999999999999999999976
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=280.41 Aligned_cols=238 Identities=31% Similarity=0.380 Sum_probs=193.1
Q ss_pred ccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCch
Q 002149 619 LGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGAL 696 (959)
Q Consensus 619 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 696 (959)
||+|+||.||++... +++.+|+|.+...... ....+.+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 5889999998765332 23566789999999999999999999999999999999999999999
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceee
Q 002149 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 697 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 9998542 368999999999999999999999 8999999999999999999999999999886544321 223
Q ss_pred ccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCC
Q 002149 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDD 856 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (959)
...++..|+|||...+...+.++|+||||+++||+++|+.||........ . . ...........
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~---~----------~~~~~~~~~~~- 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---Y---E----------KILKDPLRFPE- 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H---H----------HHhcCCCCCCC-
Confidence 45688899999999888899999999999999999999999976543211 0 0 01111111111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 002149 857 TFETFWTIAELAGHCTSREPSQRPDMGH 884 (959)
Q Consensus 857 ~~~~~~~l~~l~~~cl~~dP~~RPt~~e 884 (959)
.....+.+++.+|+..||++||++.+
T Consensus 215 --~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 --FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11346789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=284.46 Aligned_cols=259 Identities=26% Similarity=0.367 Sum_probs=197.4
Q ss_pred HhcCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHH-----HHHHHHHHHHHHhcCCCCceeEEEEEE-eC
Q 002149 609 VTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA-----VDEFHSEIAVLSKVRHRHLVSLLGYSV-AG 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 681 (959)
+.++|-..++||+|||+.||+| ++...+.||||+-.......+. .+...+|..+.+.|.||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3467888899999999999999 5667889999975443222222 345668999999999999999999886 55
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCcEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG---DDFRAKV 758 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~---~~~~~ki 758 (959)
+..|-|+||++|.+|+-+|... +.+++.++..|+.||+.||.||.+. +.+|||-||||.|||+- .-|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6778999999999999998653 5688999999999999999999984 47999999999999994 4588999
Q ss_pred eeccccccCCCCCcc------eeeccccccccccccccccC----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 002149 759 SDFGLVKLAPDSERS------VVTRLAGTFGYLAPEYAVTG----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828 (959)
Q Consensus 759 ~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~ 828 (959)
+|||+++...++... ......||.+|++||.+.-+ +++.|+||||.|||+|.++.|+.||........
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999977554322 23457899999999988543 578899999999999999999999987654322
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 886 (959)
+...-. +.. ...-.+.+. .....+...+|++||+..-++|.+..++.
T Consensus 693 ILqeNT-Ilk---AtEVqFP~K-------PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ILQENT-ILK---ATEVQFPPK-------PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHhhhc-hhc---ceeccCCCC-------CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111000 000 000011111 11223567899999999999999877764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=314.00 Aligned_cols=266 Identities=23% Similarity=0.287 Sum_probs=210.0
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA 680 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 680 (959)
+..++--.++|.++++||+|+||.|..++.+ +++.+|.|++.+... ......-|..|-.+|..-+.+-|+.++-+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455666788999999999999999999764 688899999976322 23445678899999999999999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
..+.|+|||||+||+|-.++..+ .++++..+.-++..|+-||.-||+ .|+|||||||.|||+|..|++|++|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 99999999999999999998542 368999999999999999999999 7999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 835 (959)
||.+-....++.-.....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||....-.+... .
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------K 292 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------K 292 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------H
Confidence 99887766555555666899999999999843 568899999999999999999999998654333211 1
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHHHHhHh
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD---MGHAVNVLAPLVE 894 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~L~~~~~ 894 (959)
+..- .+ .+..+ ...+......+||.+.+. +|+.|.. ++++-. ++++.
T Consensus 293 Im~h----k~----~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~--HpFF~ 342 (1317)
T KOG0612|consen 293 IMNH----KE----SLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN--HPFFE 342 (1317)
T ss_pred Hhch----hh----hcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh--Ccccc
Confidence 1110 00 11112 122344466677777665 7778877 888754 45543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=271.30 Aligned_cols=308 Identities=23% Similarity=0.333 Sum_probs=225.3
Q ss_pred hcCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------c
Q 002149 610 TKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------Y 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 682 (959)
..+|.....+|.|.- .|..| +.-.+++||+|++...+......++..+|..++..+.|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888889999998 56666 344689999999987766667788899999999999999999999988643 3
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
+.|+|||+| .++|...++ -.++-+++..+..|+++|++|||+ .+|+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence 568999999 889988875 235567788999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------------
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA------------ 830 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~------------ 830 (959)
+|+.-... -..+.++.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+...-+.-..+
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 99854332 3567788999999999999988999999999999999999999988865433211110
Q ss_pred ----HHHHhhhcchHHH-HHhcCCccc-----C-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 831 ----AWFWNIKSDKEKL-RAAIDPILE-----V-NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 831 ----~~~~~~~~~~~~~-~~~~~~~~~-----~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
..+.......++. .-.+....+ . .+.+.-......+++.+||..+|++|-++++++. ++|++-|..
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~--HPY~~vw~~- 318 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR--HPYIKVWYD- 318 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc--CCeeeeecc-
Confidence 0000000000000 000111110 0 0111112234568999999999999999999987 899987744
Q ss_pred CCCCCcccC--cccCC-ChhhhHHHHHHhhCCCcceee
Q 002149 900 DDEPEEYSG--IDYSL-PLNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 900 ~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~ 934 (959)
++++++... .+... ....+.++|+|...++...+-
T Consensus 319 ~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~ 356 (369)
T KOG0665|consen 319 PDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFE 356 (369)
T ss_pred cccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhc
Confidence 333333222 21111 224558999999887776665
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=292.04 Aligned_cols=244 Identities=26% Similarity=0.325 Sum_probs=195.0
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++.|.....+|.|+|+.|-++. ..+++..+||++.+. ..+..+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 35677788889999999999985 457889999998764 22345677777666 69999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-CCCCcEEEeeccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVK 765 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl-~~~~~~ki~DfGla~ 765 (959)
|||++.++-+.+.++.. +.+. ..+..|+.+|+.++.|||+ +||||||+||+|||+ +..++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~~-----~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK-----PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHhc-----chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 99999999887776431 2222 6778899999999999999 899999999999999 688999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
..... ....+-|..|.|||+.....|+.++|+||||++||+|++|+.||...+.... +..
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--i~~-------------- 524 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--IHT-------------- 524 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH--HHH--------------
Confidence 76554 2223558899999999999999999999999999999999999987765411 111
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
.+ ..+...........+|+.+||+.||.+||+|.++.. ++++
T Consensus 525 ~i----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 525 RI----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred hh----cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 11 111122233346779999999999999999999976 4444
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=293.50 Aligned_cols=379 Identities=24% Similarity=0.292 Sum_probs=289.2
Q ss_pred CCCCCCCCcc---eEecCC----------------cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccC
Q 002149 64 DPCGPPCWKH---VFCSNS----------------RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG 124 (959)
Q Consensus 64 ~~C~~~~w~g---v~C~~~----------------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 124 (959)
.+||.+|.|. ..|+.. .+..|++++|.|..+-+..|.+|++|++++|..|.++. +|.|+.
T Consensus 44 ~~cpa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~ 122 (873)
T KOG4194|consen 44 SECPATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGH 122 (873)
T ss_pred ccCCCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccc
Confidence 3566666544 567643 46669999999998888889999999999999999985 455555
Q ss_pred -CCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCC
Q 002149 125 -LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS 203 (959)
Q Consensus 125 -l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 203 (959)
..+|+.|+|.+|.|+.+....+..++.|+.||||.|.|+.++-..+|. -.++++|+|++|.|+..-.+.|.++.+
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~----~~ni~~L~La~N~It~l~~~~F~~lns 198 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPA----KVNIKKLNLASNRITTLETGHFDSLNS 198 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCC----CCCceEEeeccccccccccccccccch
Confidence 556999999999999999999999999999999999999655444443 458999999999999888889999999
Q ss_pred CCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeC
Q 002149 204 LQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNL 282 (959)
Q Consensus 204 L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 282 (959)
|..|.|+.|+++...+..|+.| .|+.|.++.+......+.. |..+++|+.|.|..|++...-...|..+.++++|+|
T Consensus 199 L~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt--FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L 276 (873)
T KOG4194|consen 199 LLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT--FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNL 276 (873)
T ss_pred heeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh--hcCchhhhhhhhhhcCcccccCcceeeecccceeec
Confidence 9999999999998888888877 5778888887766655544 778888888888888888666777888888888888
Q ss_pred CCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccc-----cccccccCcccCCCCCCCCchhhHHHHhhccCCCCCc
Q 002149 283 NSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKA-----YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPP 356 (959)
Q Consensus 283 s~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (959)
..|+++..-..++..+ .|+.|+||+|.+...-++++. ..+++++|+++..+++.. ..... +..
T Consensus 277 ~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf---~~L~~---Le~----- 345 (873)
T KOG4194|consen 277 ETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF---RVLSQ---LEE----- 345 (873)
T ss_pred ccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH---HHHHH---hhh-----
Confidence 8888887766666666 588888888888766555432 334667777766555432 11111 111
Q ss_pred ccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCc---cccCcCcCCEEeCcccccccccCCCccCCCCCCeE
Q 002149 357 RLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP---SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLL 433 (959)
Q Consensus 357 ~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L 433 (959)
.-.+.|.....-...|..+++|+.|||++|.|+..|.+ .|..|++|+.|+|.+|+|....-.+|..+..|+.|
T Consensus 346 ----LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 346 ----LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred ----hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 11222333334445567789999999999999987754 57889999999999999995555789999999999
Q ss_pred eCCCCccCCCCCC-CC--CcceecccCCCCCCCC
Q 002149 434 DLSQNNLSPPLPK-FS--GAVKLSLDGNPLLNGK 464 (959)
Q Consensus 434 ~Ls~N~l~~~~p~-~~--~~~~~~l~~N~~~c~~ 464 (959)
||.+|.+-..-|. |. .+.++.+..-.++|.+
T Consensus 422 dL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 422 DLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC 455 (873)
T ss_pred cCCCCcceeecccccccchhhhhhhcccceEEec
Confidence 9999999766553 32 4556677777777776
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.77 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=207.2
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
++.+..-+..|++.+.||.|.+|.||+++ .++++.+|||++... .+..+++..|.++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 33444456678899999999999999995 567899999988754 34456678899999998 69999999998863
Q ss_pred -----CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 681 -----GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 681 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
++++|||||||.+|+.-|++..-. ...+.|..+..|+..+++|+.|||. ..++|||||-.|||++.++.
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCc
Confidence 579999999999999999997644 5789999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
||++|||.+....... .......||+.|||||++.- ..|+.++|+||+|++..||--|.+|+.+..+.....
T Consensus 162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-- 238 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-- 238 (953)
T ss_pred EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc--
Confidence 9999999988664433 23445789999999999954 347788999999999999999999998876533211
Q ss_pred HHHHhhhcchHHHHHhcCCcccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 831 AWFWNIKSDKEKLRAAIDPILEV-NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+ .+.++. ......-..++.++|..|+..|..+||++.++++
T Consensus 239 --------------~I-pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 --------------LI-PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------------cC-CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 111110 1111223347889999999999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=274.28 Aligned_cols=243 Identities=26% Similarity=0.330 Sum_probs=194.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
.+|..+.+||+|+||.|..|.-+ +.+.+|||++++.++-. .+.+--..|-+++... +-|.+++++.+++.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 35777889999999999999644 56789999999876543 3344445666777766 568999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+.||+|--++++. ..+.+..++-+|..||-||-+||+ +|||.||||..|||+|.+|++||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999997777542 457788899999999999999999 99999999999999999999999999999844
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.-.. .....++|||.|+|||++...+|+..+|.|||||+||||+.|+.||++....+.- ..+.
T Consensus 501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF----------------~aI~ 563 (683)
T KOG0696|consen 501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----------------QAIM 563 (683)
T ss_pred ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHHH
Confidence 3322 2245689999999999999999999999999999999999999999987654421 1111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPD 881 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 881 (959)
+.... ++.....+...+.+..+...|.+|..
T Consensus 564 ehnvs---yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHNVS---YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HccCc---CcccccHHHHHHHHHHhhcCCccccC
Confidence 21111 12223345668888999999999963
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=300.93 Aligned_cols=274 Identities=20% Similarity=0.207 Sum_probs=176.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-C----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEE------E
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-D----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY------S 678 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 678 (959)
.++|...++||+|+||.||+|... + +..||||++.... . .+....| .+....+.+++.++.. .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--A--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--h--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 468999999999999999999764 4 6899999876431 1 1111111 1122222222222211 2
Q ss_pred EeCceEEEEEEecCCCchhhHHhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002149 679 VAGYERLLVYEYMPQGALSKHIFHWKSL---------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDL 743 (959)
Q Consensus 679 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di 743 (959)
..+.+.++||||+.+++|.+++...... .........+..++.||+.||+|||+ ++|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence 4567889999999999999988642110 00111234566899999999999999 89999999
Q ss_pred CCCCEEECC-CCcEEEeeccccccCCCCCcceeeccccccccccccccccC----------------------CCCccch
Q 002149 744 KSSNILLGD-DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG----------------------KITTKVD 800 (959)
Q Consensus 744 k~~NiLl~~-~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 800 (959)
||+|||++. ++.+||+|||+|+..............+|+.|||||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986544433444557889999999965322 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC-CCCHH----HHHHHHHHHHhcccCC
Q 002149 801 VFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN-DDTFE----TFWTIAELAGHCTSRE 875 (959)
Q Consensus 801 vwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~l~~l~~~cl~~d 875 (959)
||||||++|||+++..+++... ......+.....+...+...+.+..... ....+ ......+|+.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999876644221 1111111111111122222222211000 00000 0113448999999999
Q ss_pred CCCCCCHHHHHHHHHHhHhhcCC
Q 002149 876 PSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 876 P~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
|++|||+.++++ ++++.....
T Consensus 438 P~kR~ta~e~L~--Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALA--HPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhC--CcCcCCCCc
Confidence 999999999988 577665443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.96 Aligned_cols=221 Identities=22% Similarity=0.196 Sum_probs=175.2
Q ss_pred cCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCchhhHH
Q 002149 622 GGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHI 700 (959)
Q Consensus 622 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 700 (959)
|.||.||++.. .+++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999965 578999999986531 2334555555667999999999999999999999999999999988
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccc
Q 002149 701 FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780 (959)
Q Consensus 701 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~g 780 (959)
... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+...... .....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCc
Confidence 542 358999999999999999999999 89999999999999999999999999987654332 122355
Q ss_pred ccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHH
Q 002149 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFET 860 (959)
Q Consensus 781 t~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (959)
+..|+|||.+.+..++.++||||+|+++|||++|+.|+........ ....... + ...
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------------~~~~~~~--~---~~~ 201 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------------THTTLNI--P---EWV 201 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------------cccccCC--c---ccC
Confidence 7789999999888899999999999999999999987654321100 0000000 0 112
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHH
Q 002149 861 FWTIAELAGHCTSREPSQRPDMGH 884 (959)
Q Consensus 861 ~~~l~~l~~~cl~~dP~~RPt~~e 884 (959)
...+.+++.+|++.||++||++.+
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCc
Confidence 236789999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=288.79 Aligned_cols=267 Identities=19% Similarity=0.243 Sum_probs=180.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-----------------cCCcEEEEEEcccccccHHHH--------------HHHHH
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-----------------DDGTKIAVKRMEAGVISKKAV--------------DEFHS 658 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~~~ 658 (959)
.++|++.++||+|+||.||+|.. ..++.||||++.... .... +....
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccchhHH
Confidence 56899999999999999999953 235689999986431 1111 22345
Q ss_pred HHHHHHhcCCCCc-----eeEEEEEEe--------CceEEEEEEecCCCchhhHHhhccc-------------------C
Q 002149 659 EIAVLSKVRHRHL-----VSLLGYSVA--------GYERLLVYEYMPQGALSKHIFHWKS-------------------L 706 (959)
Q Consensus 659 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~ 706 (959)
|+.++.+++|.++ ++++++|.. ....++||||+++|+|.++++.... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777888876654 677777653 3467999999999999999864211 0
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccccccccc
Q 002149 707 NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786 (959)
Q Consensus 707 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~a 786 (959)
....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 11245788899999999999999999 899999999999999999999999999997543322211222345889999
Q ss_pred ccccccCCC----------------------CccchHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 787 PEYAVTGKI----------------------TTKVDVFSFGVVLMELLTGLM-ALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 787 PE~~~~~~~----------------------~~~~DvwSlG~ll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
||.+..... ..+.||||+||+++||++|.. |+......... . .........+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~----~~~~~~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-L----RQYDNDLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-H----hhccchHHHH
Confidence 998754321 234799999999999999975 66533211110 0 0000000111
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCC---CCCCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREP---SQRPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~ev~~ 887 (959)
+........... .........+++.+++..+| .+|+|++|+++
T Consensus 454 r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 454 RMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111111110 00112356789999999766 68999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=281.53 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=201.4
Q ss_pred CCcccCcccccCceEEEEEEEcCCc-EEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELDDGT-KIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~-~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++..+..||-|+||.|-.+..+... .+|+|.+++. .....+.+.+..|-.+|...+.|.||+++-.|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455678999999999999776433 3889988765 3345566778899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
-|-||.+...+++ ...++..+..-++..+++|++|||+ ++||.|||||+|.+++.+|-+||.|||.|+....
T Consensus 501 aClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999854 2568888889999999999999999 8999999999999999999999999999997765
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.. ....++|||.|.|||++.+...+.++|.||+|+++|||++|.+||.+..+.....++- .. +.
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------kG---id----- 636 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------KG---ID----- 636 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------hh---hh-----
Confidence 43 3566899999999999999999999999999999999999999999988765433221 10 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPD 881 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 881 (959)
.-..+........++++++...+|.+|..
T Consensus 637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 ---KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 01111222335668999999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=289.81 Aligned_cols=246 Identities=30% Similarity=0.426 Sum_probs=190.2
Q ss_pred CcccCcccccCce-EEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFG-VVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
|...+.+|.|+-| .||+|... |+.||||++-. +..+..++|+..++.- .|||||++++.-.+....|++.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 4556778999987 57999887 88999998754 3445678999999998 599999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-----CCcEEEeeccccc
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-----DFRAKVSDFGLVK 765 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-----~~~~ki~DfGla~ 765 (959)
| ..+|.+++... ........-...+.+..|++.||+|||+ .+||||||||.||||+. ..+++|+|||+++
T Consensus 585 C-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 C-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred h-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9 88999999652 1111111113457789999999999999 79999999999999965 3579999999999
Q ss_pred cCCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG-LMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
......... .....||.+|+|||.+....-+.++||+|+||++|+.++| .+||......+. ++......
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccc
Confidence 776554432 3346899999999999998888999999999999999997 899987544331 11111111
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.. +.... +. +..+||.+|+++||..||++.+|+.
T Consensus 732 L~~-----L~~~~---d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVH-----LEPLP---DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eee-----eccCc---hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 110 11011 11 6679999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=245.01 Aligned_cols=202 Identities=30% Similarity=0.379 Sum_probs=168.0
Q ss_pred cccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEEec
Q 002149 614 ASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
.....||+|+||.|-+-++ .+|+..|+|++.... ..+..++..+|+.+..+. .+|.+|.++|........|+.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3456799999999988854 579999999998764 455567788888876665 7999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
..||..+-.+.- .....+++..+-+||..|++||.|||+. ..+||||+||+|||++.+|++||||||++-...+..
T Consensus 128 -~tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 128 -DTSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred -hhhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 778876654422 2346789999999999999999999995 789999999999999999999999999998665543
Q ss_pred cceeecccccccccccccccc----CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 772 RSVVTRLAGTFGYLAPEYAVT----GKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
. .+.-.|-.-|||||.+.. ..|+-|+||||+|+.+.||.+++.|++...
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2 222467788999998854 368899999999999999999999997544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=278.21 Aligned_cols=209 Identities=27% Similarity=0.413 Sum_probs=178.1
Q ss_pred CCcccCcccccCceEEEEEE-EcCCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
-|..++.||-|+||+|.+++ .++...+|.|.+.+. +.....+..++.|-.||..-..+-||+|+-.|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36778899999999999995 455677899988764 3445567778899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC--
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-- 767 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~-- 767 (959)
|++||++-.+|.+ ...|.+..+.-++..+.+|+++.|. .|+|||||||.|||||.+|++||+||||+.-+
T Consensus 710 YIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999888854 2568888889999999999999999 89999999999999999999999999997421
Q ss_pred -------CCCCcc--------------------------------eeeccccccccccccccccCCCCccchHHHHHHHH
Q 002149 768 -------PDSERS--------------------------------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVL 808 (959)
Q Consensus 768 -------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll 808 (959)
...... .....+||+.|+|||++....++.-.|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 111000 01235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHH
Q 002149 809 MELLTGLMALDESRPEERQY 828 (959)
Q Consensus 809 ~elltg~~p~~~~~~~~~~~ 828 (959)
|||+.|+.||....+.+.++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~ 881 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQY 881 (1034)
T ss_pred HHHhhCCCCccCCCCCccee
Confidence 99999999998887766543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=263.18 Aligned_cols=239 Identities=30% Similarity=0.399 Sum_probs=191.7
Q ss_pred CceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCchhhHHh
Q 002149 623 GFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIF 701 (959)
Q Consensus 623 ~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 701 (959)
+||.||+|... +++.+|+|++........ .+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999876 489999999876532221 6789999999999999999999999999999999999999999999885
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeeccccc
Q 002149 702 HWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781 (959)
Q Consensus 702 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt 781 (959)
.. ..+++..+..++.++++++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 42 228899999999999999999999 899999999999999999999999999998665432 23345688
Q ss_pred cccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHH
Q 002149 782 FGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETF 861 (959)
Q Consensus 782 ~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 861 (959)
..|++||.+.+..++.++||||||+++|++++|..||......+. ...... ..............
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~ 214 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIG-------------KPKPPFPPPEWKIS 214 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHh-------------ccCCCCccccccCC
Confidence 899999999988899999999999999999999999976322111 111110 00110001000033
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 862 WTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 862 ~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 47889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=254.65 Aligned_cols=202 Identities=24% Similarity=0.384 Sum_probs=176.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
++|...++||+|+|..|..++++ +.+.+|+|++++..... +..+..+.|-.+..+- +||.+|.++.+++.....++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56888999999999999999754 67889999998875443 4566777888888887 699999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
.||++||+|--++.+ .+.++++.+.-+...|.-||.|||+ +|||.||+|..|+|+|.+|++|++|+|+.+..
T Consensus 330 ieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999666543 2668999999999999999999999 99999999999999999999999999999854
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
-... .....++|||.|.|||.+.+..|...+|.|++||+++||+.|+.||+-.
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3322 2345689999999999999999999999999999999999999999743
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=246.88 Aligned_cols=276 Identities=18% Similarity=0.261 Sum_probs=226.5
Q ss_pred cCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 688 (959)
-+|++.++||+|+||.++.|+ +-+++.||||.-... ...-++..|...++.|. .++|...+-|...+.+-.||+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 479999999999999999994 567999999976543 23446778999999994 799999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-----CcEEEeeccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-----FRAKVSDFGL 763 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-----~~~ki~DfGl 763 (959)
|++ |.+|+|+.. ...+.|+..++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.|+|||+
T Consensus 104 dLL-GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 999 999998873 445889999999999999999999999 899999999999999653 4599999999
Q ss_pred cccCCCCCcce------eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 764 VKLAPDSERSV------VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 764 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+.+.+..+.. .....||.+||+...+.+.+.+++.|+-|+|-++.+++-|..||++.........
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-------- 247 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-------- 247 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--------
Confidence 99877655422 2346899999999999999999999999999999999999999998875442111
Q ss_pred cchHHHHHhcCCcc--cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCccc
Q 002149 838 SDKEKLRAAIDPIL--EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDY 911 (959)
Q Consensus 838 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~ 911 (959)
...+-+..- ...+.+...+.++...+...-+.+..+-|+++.+...+..++++.+..+|..+||.+..-
T Consensus 248 -----YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~ 318 (449)
T KOG1165|consen 248 -----YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNN 318 (449)
T ss_pred -----HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCC
Confidence 111111110 111223334557778888888889999999999999999999999999999999987663
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=237.34 Aligned_cols=264 Identities=16% Similarity=0.267 Sum_probs=197.0
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCc--eEE
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGY--ERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 685 (959)
.++|++.+++|+|.|++||.|. ..+++.++||+++. -..+.+.+|+.++..|+ ||||+++++...+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 3578899999999999999995 56788999999874 34567899999999996 999999999987654 557
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeecccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGLV 764 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfGla 764 (959)
||+||+.+.+...+- ..++...+..++.++++||.|+|+ .||.|||+||.|++||.. -.++|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999888876654 567778889999999999999999 899999999999999865 56999999999
Q ss_pred ccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc-----
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS----- 838 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 838 (959)
.++...... ...+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||.......++ ++..+.-...
T Consensus 181 EFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 181 EFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYA 257 (338)
T ss_pred hhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHH
Confidence 987665433 22356788999999876 56888999999999999999999998765543322 1111111000
Q ss_pred --------chHHHHHhcCCcccC-------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 839 --------DKEKLRAAIDPILEV-------NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 839 --------~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
-.......+...... .+...-...+..+++.+.+..|-.+|||++|++. ++++.
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~--HpyF~ 326 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA--HPYFA 326 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc--CchHH
Confidence 001111111110000 0000011246679999999999999999999966 45544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=264.87 Aligned_cols=277 Identities=19% Similarity=0.231 Sum_probs=216.7
Q ss_pred eeecHHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC------CCc
Q 002149 599 LVISVQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH------RHL 671 (959)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~ni 671 (959)
..+.+..-+.+-.+|.+....|+|-|++|.+|.. .-|+.||||++... ....+.=.+|+++|++|+. -|.
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence 3455666666778999999999999999999964 35789999999864 4445666789999999952 489
Q ss_pred eeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 672 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
++++-.|...+++|||+|-+ .-+|.++|..+.. ...+....+..++.|+.-||..|-. .+|+|.||||.|||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEec
Confidence 99999999999999999998 7899999987543 3568889999999999999999998 8999999999999998
Q ss_pred CC-CcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 752 DD-FRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 752 ~~-~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
+. ..+||||||.|....+.. .+.+.-+..|.|||++.+-.|+...|+||.||.||||.||+.-|.+........+.
T Consensus 571 E~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred cCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 75 568999999998665432 34455577899999999999999999999999999999999999987655433222
Q ss_pred HHHHhhhc-----------------------------------------chHHHHHhcCCcccCCCCCHHHHHHHHHHHH
Q 002149 831 AWFWNIKS-----------------------------------------DKEKLRAAIDPILEVNDDTFETFWTIAELAG 869 (959)
Q Consensus 831 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 869 (959)
..+..... ....+...+-.....++.++.....+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 11110000 0011111111111234455667778899999
Q ss_pred hcccCCCCCCCCHHHHHH
Q 002149 870 HCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 870 ~cl~~dP~~RPt~~ev~~ 887 (959)
+|+..||++|.|..++++
T Consensus 728 kml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccChhhcCCHHHHhc
Confidence 999999999999999876
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=250.37 Aligned_cols=131 Identities=28% Similarity=0.414 Sum_probs=112.7
Q ss_pred cCCcccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-----C---CCceeEEEEEE--
Q 002149 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-----H---RHLVSLLGYSV-- 679 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~-- 679 (959)
.+|.+.++||-|.|++||+| +....+.||+|+.+.. ..-.+....||++|++++ | ..||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 68999999999999999999 5667889999998753 233455678999999984 3 36999999886
Q ss_pred --eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 680 --AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 680 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
.+.+.++|+|++ |.+|..++... ..+.++...+.+|++||+.||.|||.. .+|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 457899999999 88999999654 347799999999999999999999996 699999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=237.63 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=187.2
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEE-EEEeCceEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLG-YSVAGYERL 685 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~ 685 (959)
..+.|.+.+.+|+|.||.+-.+.++ +.+.+++|.++.. ....++|.+|...--.| .|.||+.-++ .++..+.++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3467888999999999999999765 6778999988764 44567899998877777 4899998776 567778889
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-C-CCCcEEEeeccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-G-DDFRAKVSDFGL 763 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl-~-~~~~~ki~DfGl 763 (959)
+++||++.|+|..-+.. ..+.+....+++.|++.|+.|||+ +++||||||.+|||| + +..++|+||||+
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence 99999999999887632 557788889999999999999999 899999999999999 3 335799999999
Q ss_pred cccCCCCCcceeeccccccccccccccccC-----CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTG-----KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
.+..+..- ....-+..|.+||..... ...+.+|||.||++++.++||+.||+.....+..+ ..|..-...
T Consensus 170 t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y-~~~~~w~~r 244 (378)
T KOG1345|consen 170 TRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY-WEWEQWLKR 244 (378)
T ss_pred ccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH-HHHHHHhcc
Confidence 87554322 122335679999987543 35677999999999999999999999554433322 333222222
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 886 (959)
....+++.+.+. .....++.++-+..+|++|=...++.
T Consensus 245 k~~~~P~~F~~f----------s~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 245 KNPALPKKFNPF----------SEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cCccCchhhccc----------CHHHHHHHHHhcCCcccccchhHHHH
Confidence 122222222221 12567888999999999994444443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-29 Score=265.97 Aligned_cols=318 Identities=22% Similarity=0.279 Sum_probs=251.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
++++.|+|.+|-++..-.+++..++.|+.||||.|.|+.++. .|..-.++++|+|++|.|+.+..+.|+++.+|..|.|
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 579999999999997777889999999999999999988765 7888889999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCc-cccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-Cccccccccc
Q 002149 158 DSNNFNASKGWSFPK-GLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQ 235 (959)
Q Consensus 158 s~N~l~~~~~~~lp~-~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~ 235 (959)
+.|+|+ .+|. .+.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|++...--..|-++ +++.|.+..+
T Consensus 205 srNrit-----tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N 279 (873)
T KOG4194|consen 205 SRNRIT-----TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETN 279 (873)
T ss_pred ccCccc-----ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccc
Confidence 999998 4554 45559999999999999885545678889999999999999987777777666 4556665555
Q ss_pred CCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCcccccccc-CCeEeCCCCcCCCCC
Q 002149 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPV 314 (959)
Q Consensus 236 ~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~-L~~L~L~~N~l~~~i 314 (959)
+...... .++.++++|+.|+||+|.|..+-++.+.-.++|+.|+|++|+|+...+..|..++ |++|+|++|.++-.-
T Consensus 280 ~l~~vn~--g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~ 357 (873)
T KOG4194|consen 280 RLQAVNE--GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA 357 (873)
T ss_pred hhhhhhc--ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence 5444333 2367788999999999999888888888889999999999999988888888884 899999999886311
Q ss_pred Ccc-----cccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCC
Q 002149 315 PKS-----KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPN 389 (959)
Q Consensus 315 p~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 389 (959)
-.. ....+++.+|.+.+..+. -...|.++++|+.|+|.+
T Consensus 358 e~af~~lssL~~LdLr~N~ls~~IED------------------------------------aa~~f~gl~~LrkL~l~g 401 (873)
T KOG4194|consen 358 EGAFVGLSSLHKLDLRSNELSWCIED------------------------------------AAVAFNGLPSLRKLRLTG 401 (873)
T ss_pred hhHHHHhhhhhhhcCcCCeEEEEEec------------------------------------chhhhccchhhhheeecC
Confidence 100 001112222222211111 123456689999999999
Q ss_pred CcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCcc
Q 002149 390 FNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL 440 (959)
Q Consensus 390 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l 440 (959)
|+|....-.+|.++.+|++|||.+|.|...-|.+|..+ .|+.|-++.-.|
T Consensus 402 Nqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 402 NQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred ceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 99996666799999999999999999999999999999 999988765433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=227.60 Aligned_cols=278 Identities=19% Similarity=0.226 Sum_probs=223.3
Q ss_pred HhcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 686 (959)
+..+|.++++||.|+||.+|.|. ..+|+.||||+-..... ..++..|..+++.|++ ..|..+..|..+...-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 35689999999999999999994 67899999998765422 2346789999999974 788888889999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~ki~DfGl 763 (959)
|||.+ |.+|+++..-+ .+.++..+++.+|.|++.-++|+|. +++|||||||+|+|..-+ ..+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99999 99999988543 3779999999999999999999999 899999999999999643 4699999999
Q ss_pred cccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 764 VKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 764 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+.+.+..+. ......||.+|.+-.++.+...+++.|+-|+|++|.++.-|..||++..+........-+...
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek- 239 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK- 239 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-
Confidence 9977654332 123478999999999999999999999999999999999999999998876654332212111
Q ss_pred cchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCc
Q 002149 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGI 909 (959)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~ 909 (959)
.+.-.+ ...+...+.++.-.+..|-....++-|++..+-+.+.-++.......|-.+||...
T Consensus 240 --------K~s~~i--e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 240 --------KMSTPI--EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred --------hcCCCH--HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHH
Confidence 111111 11122334467788899999999999999999999999998888877877777643
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-29 Score=261.36 Aligned_cols=370 Identities=25% Similarity=0.331 Sum_probs=250.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
-++.+++.++.+. ++|++++.+..++.|+.++|++...++++..+.+|..|+.++|.+..++++ ++.+..|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 3677888888888 788888888888888888888887777888888888888888888888876 66777888888888
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGG 238 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~ 238 (959)
|+++ .+|.++..+.+|..|++.+|++....|..+. ++.|++||...|-++ .+|+.++++ ++..|++..++..
T Consensus 147 N~i~-----slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~ 219 (565)
T KOG0472|consen 147 NQIS-----SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR 219 (565)
T ss_pred cccc-----cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc
Confidence 8887 5777777777777777777777654444444 666667776666666 556666655 4555555555544
Q ss_pred Cccccc--------------------ccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc
Q 002149 239 GFTGTI--------------------DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL 298 (959)
Q Consensus 239 ~l~~~~--------------------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 298 (959)
.++... ....++++|..|||.+|+++ ..|+.+.-+.+|++||||+|.|++ .|..++++
T Consensus 220 ~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl 297 (565)
T KOG0472|consen 220 FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL 297 (565)
T ss_pred cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc
Confidence 444321 12457888889999999998 788888889999999999999985 56677888
Q ss_pred cCCeEeCCCCcCCCC----CCcccc------------------------------------------cccccccCcccCC
Q 002149 299 SLDHLDLNNNMFMGP----VPKSKA------------------------------------------YKYSYSSNAFCQP 332 (959)
Q Consensus 299 ~L~~L~L~~N~l~~~----ip~~~~------------------------------------------~~~~~~~~~~~~~ 332 (959)
.|+.|.+.+|.+... +.+... ..+.++...++.+
T Consensus 298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V 377 (565)
T KOG0472|consen 298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV 377 (565)
T ss_pred eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccC
Confidence 888888888887421 110000 0001111111111
Q ss_pred CCCCCCchhh----------HHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccC
Q 002149 333 TEGVPCAPEV----------MALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGN 402 (959)
Q Consensus 333 ~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 402 (959)
+..++.+.+. .++.+.-..+.....+++.....+....|.+..++.+++|..|+|++|-+. .+|.+++.
T Consensus 378 PdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~ 456 (565)
T KOG0472|consen 378 PDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS 456 (565)
T ss_pred CHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh
Confidence 1111111000 000000000111112222222233344677777888899999999998887 88889999
Q ss_pred cCcCCEEeCccccccc----------------------ccCC-CccCCCCCCeEeCCCCccCCCCCCC---CCcceeccc
Q 002149 403 LDSLTQIKLQSNNISG----------------------QIPT-NWTNLKSLTLLDLSQNNLSPPLPKF---SGAVKLSLD 456 (959)
Q Consensus 403 l~~L~~L~L~~N~l~g----------------------~~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~~~~~l~ 456 (959)
+..|+.|||++|++.. .++. .+.+|.+|..|||.+|.+...+|.+ .++..+.+.
T Consensus 457 lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~ 536 (565)
T KOG0472|consen 457 LVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELD 536 (565)
T ss_pred hhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEec
Confidence 9999999999887751 2333 3778999999999999999888864 456788999
Q ss_pred CCCCC
Q 002149 457 GNPLL 461 (959)
Q Consensus 457 ~N~~~ 461 (959)
|||+.
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=235.26 Aligned_cols=211 Identities=35% Similarity=0.565 Sum_probs=181.8
Q ss_pred ccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCchh
Q 002149 619 LGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALS 697 (959)
Q Consensus 619 lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 697 (959)
||+|.+|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997754 8999999987652221 3567899999999999999999999999989999999999989999
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeeccccccCCCCCcceee
Q 002149 698 KHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLVKLAPDSERSVVT 776 (959)
Q Consensus 698 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla~~~~~~~~~~~~ 776 (959)
+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9885421 468899999999999999999999 89999999999999999 89999999999986654321 123
Q ss_pred ccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCC
Q 002149 777 RLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVND 855 (959)
Q Consensus 777 ~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (959)
...+...|++||..... ..+.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34578899999999887 888999999999999999
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 856 DTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 856 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 256789999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-29 Score=270.30 Aligned_cols=318 Identities=24% Similarity=0.350 Sum_probs=161.2
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccC-------------------------CCCccEEecC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG-------------------------LSNLKYAYLD 134 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-------------------------l~~L~~L~L~ 134 (959)
+++-|.|...+|. .+|++++.|.+|++|.+++|++..+..+++. +..|+.||||
T Consensus 33 ~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLS 111 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLS 111 (1255)
T ss_pred heeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecc
Confidence 4444555554544 4555555555555555555555444444444 4444555555
Q ss_pred CCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCcc-ccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCc
Q 002149 135 GNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213 (959)
Q Consensus 135 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 213 (959)
+|++.++|.+ +...+++-+|+||+|+|. .+|.. +.+|+.|-.|+|++|++. .+|..+..|..|++|+|++|.
T Consensus 112 hNqL~EvP~~-LE~AKn~iVLNLS~N~Ie-----tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP 184 (1255)
T KOG0444|consen 112 HNQLREVPTN-LEYAKNSIVLNLSYNNIE-----TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP 184 (1255)
T ss_pred hhhhhhcchh-hhhhcCcEEEEcccCccc-----cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence 5555444443 444444445555555444 23332 234444555555555444 334444444555555555554
Q ss_pred CCCCCCcccccC-CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCc
Q 002149 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292 (959)
Q Consensus 214 l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 292 (959)
+....-..+..+ ++..|.+.+. ...+...+..+..+.+|..+|||.|++. .+|+.+.++++|+.|+||+|+|+..-
T Consensus 185 L~hfQLrQLPsmtsL~vLhms~T-qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~- 261 (1255)
T KOG0444|consen 185 LNHFQLRQLPSMTSLSVLHMSNT-QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELN- 261 (1255)
T ss_pred hhHHHHhcCccchhhhhhhcccc-cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeee-
Confidence 432111111111 1222222211 1222233344666778888888888888 78888888888888888888887432
Q ss_pred cccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCC-c
Q 002149 293 PSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK-S 370 (959)
Q Consensus 293 ~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~ 370 (959)
...... +|++|+||.|+++. +|..... +..+.. .+..++... .
T Consensus 262 ~~~~~W~~lEtLNlSrNQLt~-LP~avcK---------------------L~kL~k-------------Ly~n~NkL~Fe 306 (1255)
T KOG0444|consen 262 MTEGEWENLETLNLSRNQLTV-LPDAVCK---------------------LTKLTK-------------LYANNNKLTFE 306 (1255)
T ss_pred ccHHHHhhhhhhccccchhcc-chHHHhh---------------------hHHHHH-------------HHhccCccccc
Confidence 222222 68888888888873 3432110 000000 000000000 0
Q ss_pred ccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC
Q 002149 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP 445 (959)
Q Consensus 371 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p 445 (959)
-++..+|.+.+|+.+..++|++. .+|..+..+.+|+.|.|++|+|- .+|+.+.-|+.|++|||..|.-.-.+|
T Consensus 307 GiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 307 GIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred CCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 11122445556666666666665 55666666666666666666665 566666666666666666665443333
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-28 Score=257.85 Aligned_cols=198 Identities=22% Similarity=0.297 Sum_probs=167.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHH------HHHHHHHHHHHHHhcC---CCCceeEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKK------AVDEFHSEIAVLSKVR---HRHLVSLLGYSVA 680 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 680 (959)
..|...+.+|+|+||.|+.|.++ +...|+||.+.+.++-.. ..-.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999765 456789998877643221 1122446999999997 9999999999999
Q ss_pred CceEEEEEEecC-CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 681 GYERLLVYEYMP-QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 681 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
++.+||+||-.. +-+|.+++.. ...+++.++.-|+.||+.|+++||+ .+|||||||-+||.++.+|-+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 999999999763 4477888733 3678999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCc-cchHHHHHHHHHHHHhCCCCCC
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITT-KVDVFSFGVVLMELLTGLMALD 819 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlG~ll~elltg~~p~~ 819 (959)
|||.|...... ....++||.+|.|||++.+.+|-- .-|||++|++||.++....||.
T Consensus 713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998765443 345678999999999999988754 4899999999999998888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=260.14 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred hcCCcccCcccccCceEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+....+|.|.||.|||++ ..+++..|||+++.. .....+-+++|+-+++..+|||||.++|.+...+..|++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4678899999999999999995 457999999999875 4455677889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+.+|+|.+.-+ ...++++.++..+.....+|++|||+ .+-+|||||-.|||+++.|.+|++|||.+-.+.
T Consensus 92 EycgggslQdiy~-----~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH-----VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EecCCCcccceee-----ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhh
Confidence 9999999987643 23689999999999999999999999 788999999999999999999999999987554
Q ss_pred CCCcceeecccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYA---VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
... .....+.||+.|||||+. ..+.|..++|||+.|+...|+---+.|.....+.....+.. ..
T Consensus 164 ati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------------kS 230 (829)
T KOG0576|consen 164 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------------KS 230 (829)
T ss_pred hhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------------cc
Confidence 332 234567899999999987 45679999999999999999988888877665544333221 11
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+++.-. .....-...+.++++.|+..+|++||+++.+++
T Consensus 231 ~~qpp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 GFQPPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111 111112235679999999999999999987654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=244.57 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=169.2
Q ss_pred HHHHHhcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEE
Q 002149 605 VLRNVTKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSV 679 (959)
Q Consensus 605 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 679 (959)
....+.+.|..+++||+|.|++||++... ..+.||+|.+... .....+..|+++|..+ .+.||+++.+++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34556678999999999999999999543 4678999988643 3345688999999999 5999999999999
Q ss_pred eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEE
Q 002149 680 AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKV 758 (959)
Q Consensus 680 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki 758 (959)
..+...+|+||++...-.++. ..++...+..+++.+..||+|+|. .|||||||||+|+|.+. .+.-.|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred cCCeeEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceE
Confidence 999999999999999998887 346788899999999999999999 99999999999999975 577899
Q ss_pred eeccccccCCCC------------------C-------------------------cceeecccccccccccccccc-CC
Q 002149 759 SDFGLVKLAPDS------------------E-------------------------RSVVTRLAGTFGYLAPEYAVT-GK 794 (959)
Q Consensus 759 ~DfGla~~~~~~------------------~-------------------------~~~~~~~~gt~~y~aPE~~~~-~~ 794 (959)
+|||+|..+... . .......+||++|+|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 999998621100 0 000112579999999999976 56
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 795 ITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 795 ~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
.+.++||||.|||++-+++++.||....
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred cCCccceeeccceeehhhccccccccCc
Confidence 7899999999999999999999997554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-28 Score=264.95 Aligned_cols=312 Identities=26% Similarity=0.312 Sum_probs=235.1
Q ss_pred CcEEEEEecCCccc-ccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.++.++.+..|+|. .-||+.+..|..|+.||||+|++...+..+.+.+++..|+||+|+|..||...|.+|+.|-+|||
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 34666777778875 35899999999999999999999988888999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCC-CCCCcccccC-Cccccccccc
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT-GPIPESFKGL-NLVNLWLNDQ 235 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l-~l~~L~~~~~ 235 (959)
|+|++. .+|+.+..|..|++|.|++|.+...--..+-.+++|+.|.+++.+=+ ..+|.++..+ ++..+ +.
T Consensus 158 S~NrLe-----~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dv---Dl 229 (1255)
T KOG0444|consen 158 SNNRLE-----MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDV---DL 229 (1255)
T ss_pred ccchhh-----hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhc---cc
Confidence 999998 79999999999999999999887554445556778888888877543 3567666554 33333 44
Q ss_pred CCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC-C
Q 002149 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG-P 313 (959)
Q Consensus 236 ~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~-~ 313 (959)
+.+.++..++.+.++.+|+.|+||+|+|+ .+........+|++|+||.|+++ .+|+.+..+ .|+.|++.+|+++= -
T Consensus 230 S~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeG 307 (1255)
T KOG0444|consen 230 SENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEG 307 (1255)
T ss_pred cccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccC
Confidence 55566666677888899999999999998 66666777788999999999998 678888887 49999999998862 2
Q ss_pred CCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 314 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
||..++.. ..+-.+....+ .....+..++.+..|+.|.|++|++.
T Consensus 308 iPSGIGKL---------------------~~Levf~aanN--------------~LElVPEglcRC~kL~kL~L~~NrLi 352 (1255)
T KOG0444|consen 308 IPSGIGKL---------------------IQLEVFHAANN--------------KLELVPEGLCRCVKLQKLKLDHNRLI 352 (1255)
T ss_pred Cccchhhh---------------------hhhHHHHhhcc--------------ccccCchhhhhhHHHHHhccccccee
Confidence 44332211 11111111111 01223344556789999999999998
Q ss_pred ccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCC
Q 002149 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436 (959)
Q Consensus 394 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 436 (959)
.+|+++.-++.|+.|||.+|.=.--.|+--..-++|+.-++.
T Consensus 353 -TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID 394 (1255)
T KOG0444|consen 353 -TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID 394 (1255)
T ss_pred -echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence 899999999999999999997542344333333566654443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=234.13 Aligned_cols=200 Identities=34% Similarity=0.467 Sum_probs=171.9
Q ss_pred CcccCcccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 613 FASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
|...+.||.|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4567889999999999997764 889999998765322 25678899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
++++|.+++.... ..+++..+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999885422 117899999999999999999999 799999999999999999999999999998665543
Q ss_pred cceeecccccccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 002149 772 RSVVTRLAGTFGYLAPEYA-VTGKITTKVDVFSFGVVLMELLTGLMALDE 820 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~ll~elltg~~p~~~ 820 (959)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1122345678899999998 667788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=239.19 Aligned_cols=273 Identities=22% Similarity=0.267 Sum_probs=207.7
Q ss_pred CCcccCcccccCceEEEEEEEcCC--cEEEEEEcccccccHHHHHHHHHHHHHHHhcCC----CCceeEEEEE-EeCceE
Q 002149 612 NFASENELGRGGFGVVYKGELDDG--TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH----RHLVSLLGYS-VAGYER 684 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~ 684 (959)
+|.+.++||+|+||.||.+..... ..+|+|....... .....+..|..++..+.. +++..+++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~--~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG--SKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc--CCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999976543 4788887765311 111257788899888863 6899999998 477788
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-----CcEEEe
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-----FRAKVS 759 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-----~~~ki~ 759 (959)
++||+.+ |.+|.++..... .+.++..++.+|+.|++.+|++||+ .|+|||||||.|+++... ..++|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999998 999999875432 4789999999999999999999999 899999999999999865 469999
Q ss_pred eccccc--cCCCCCcc----e---eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHH
Q 002149 760 DFGLVK--LAPDSERS----V---VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER-QYL 829 (959)
Q Consensus 760 DfGla~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-~~~ 829 (959)
|||+|+ .+...... . .....||.+|++++++.+...+++.|+||+++++.|++.|..||........ ...
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999999 43222211 1 1235699999999999999999999999999999999999999976553222 111
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
.. ......... .... .+..+.++...+-..+..++|.+..+...+...+.......+++++|..
T Consensus 250 ~~---------~~~~~~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~ 313 (322)
T KOG1164|consen 250 EK---------DPRKLLTDR---FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV 313 (322)
T ss_pred HH---------Hhhhhcccc---ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence 10 000001110 0111 2234556666666689999999999999999999888777778877664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=217.58 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=195.4
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCc
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGA 695 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 695 (959)
..+|.+...|+.|+|+++ |..+++|++.....+....++|..|.-.++-+.||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 356888899999999998 6677888887766666677889999999999999999999999999999999999999999
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE-ecCCCCCCEEECCCCcEEEeeccccccCCCCCcce
Q 002149 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFI-HRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774 (959)
Q Consensus 696 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv-H~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~ 774 (959)
|+..++... .-.++-.+++++|.+||+|++|||+. .+++ ---+.+..+++|++.+++|+ ++-+++.-+..
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad~kfsfqe~--- 344 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEV--- 344 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-cccceeeeecc---
Confidence 999997633 25678889999999999999999996 4555 44689999999999988875 22122111111
Q ss_pred eeccccccccccccccccCCCC---ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 775 VTRLAGTFGYLAPEYAVTGKIT---TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 775 ~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
...-.|.||+||.++..+-+ +++|+|||++++||+.|...||.+..+.+..-.+. -+.++..+.+.
T Consensus 345 --gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------leglrv~ippg- 413 (448)
T KOG0195|consen 345 --GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------LEGLRVHIPPG- 413 (448)
T ss_pred --ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------hccccccCCCC-
Confidence 11236899999999876543 57999999999999999999999998877543221 23344333332
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
....+.+++.-|+..||.+||.+..|+-.|+++
T Consensus 414 --------is~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 414 --------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 234678999999999999999999998877764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=272.57 Aligned_cols=195 Identities=17% Similarity=0.196 Sum_probs=138.6
Q ss_pred hcCC-CCceeEEEEE-------EeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 002149 665 KVRH-RHLVSLLGYS-------VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736 (959)
Q Consensus 665 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 736 (959)
.++| +||+++++++ ......+.++||+ +++|.+++.. ....+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN----PDRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc----ccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 3445 5777888876 2234567889988 7799999853 23569999999999999999999999 8
Q ss_pred CeEecCCCCCCEEECC-------------------CCcEEEeeccccccCCCCCc---------------ceeecccccc
Q 002149 737 SFIHRDLKSSNILLGD-------------------DFRAKVSDFGLVKLAPDSER---------------SVVTRLAGTF 782 (959)
Q Consensus 737 ~ivH~Dik~~NiLl~~-------------------~~~~ki~DfGla~~~~~~~~---------------~~~~~~~gt~ 782 (959)
+||||||||+||||+. ++.+|++|||+++....... ......+||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 44566667776653211000 0011246899
Q ss_pred ccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHH
Q 002149 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFW 862 (959)
Q Consensus 783 ~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 862 (959)
.|||||++.+..++.++|||||||++|||++|..|+..... ...... ...+.+.. .....
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~----------~~~~~~~~------~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLR----------HRVLPPQI------LLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHH----------HhhcChhh------hhcCH
Confidence 99999999999999999999999999999998887543211 000000 00111100 01122
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 863 TIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 863 ~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....++.+||+.+|.+||++.|+++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 4567888999999999999999987
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-26 Score=236.65 Aligned_cols=292 Identities=28% Similarity=0.388 Sum_probs=191.4
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++.++|+.+|-++ ++|+.++.|.+|..|+|.+|+|...+ +|.++..|++|++..|+|..+|......+.+|.+|||.+
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccc
Confidence 4555666655554 78888888888888888888887544 888888888888888888888888888888888888888
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCc-------------------
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE------------------- 220 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~------------------- 220 (959)
|++. ++|..+.-+++|++|++++|.|+ .+|..++++ .|+.|.+.||.+..+--+
T Consensus 262 Nklk-----e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~ 334 (565)
T KOG0472|consen 262 NKLK-----EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKD 334 (565)
T ss_pred cccc-----cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhcc
Confidence 8887 67888888888888888888888 467778888 888888888887521100
Q ss_pred -------------------ccccC-CcccccccccCCCCccccccccc---CCcCCcEEEccCcccc-------------
Q 002149 221 -------------------SFKGL-NLVNLWLNDQKGGGFTGTIDVLG---NMDQLRTLWLHGNHFS------------- 264 (959)
Q Consensus 221 -------------------~~~~l-~l~~L~~~~~~~~~l~~~~~~l~---~l~~L~~L~L~~N~l~------------- 264 (959)
.|... .+.+....+.+..+++..++.+. .-.-...++++.|++.
T Consensus 335 dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelv 414 (565)
T KOG0472|consen 335 DGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELV 414 (565)
T ss_pred CCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHH
Confidence 00000 01111111222222222221111 1111344445555444
Q ss_pred ----------ccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCC
Q 002149 265 ----------GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPT 333 (959)
Q Consensus 265 ----------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~ 333 (959)
+.+|..++.+++|..|+|++|.+.. +|..+..+ .|+.|||++|+|. .+|
T Consensus 415 T~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP------------------ 474 (565)
T KOG0472|consen 415 TDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLP------------------ 474 (565)
T ss_pred HHHHhhcCccccchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cch------------------
Confidence 1344444555555555555555552 23333333 3555555555443 122
Q ss_pred CCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcc
Q 002149 334 EGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS 413 (959)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 413 (959)
+.. -.+..|+.+-.++|++....|..+.+|.+|..|||.+
T Consensus 475 -------~~~---------------------------------y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~n 514 (565)
T KOG0472|consen 475 -------ECL---------------------------------YELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQN 514 (565)
T ss_pred -------HHH---------------------------------hhHHHHHHHHhccccccccChHHhhhhhhcceeccCC
Confidence 111 1123466666777888866666699999999999999
Q ss_pred cccccccCCCccCCCCCCeEeCCCCccC
Q 002149 414 NNISGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 414 N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
|.|. .||+.+++|++|+.|+|++|+|.
T Consensus 515 Ndlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 515 NDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred Cchh-hCChhhccccceeEEEecCCccC
Confidence 9999 89999999999999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=209.57 Aligned_cols=169 Identities=25% Similarity=0.279 Sum_probs=126.4
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++... ...+++.+++.++.||++||+|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6888888542 2569999999999999999999999 45 999999999999999 99988654322
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 853 (959)
..||+.|||||++.+..++.++|||||||++|||++|+.||........ .+..+..... . ..+ ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-------~-~~~--~~ 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMP-------A-DDP--RD 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhc-------c-CCc--cc
Confidence 2589999999999999999999999999999999999999975432111 1111111000 0 000 00
Q ss_pred CCCCHHHH--HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 854 NDDTFETF--WTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 854 ~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
........ ..+.+++.+|+..+|++||++.++++++.....
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00111111 258899999999999999999999998876644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=224.45 Aligned_cols=169 Identities=25% Similarity=0.196 Sum_probs=131.4
Q ss_pred HHHhcCCcccCcccccCceEEEEEEEc--CCcEEEEEEcccccc---cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGELD--DGTKIAVKRMEAGVI---SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
+.+..+|...+.||+|+||.||+|... +++.||||++..... .....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 455678999999999999999999764 577889998653311 23345679999999999999999853322 2
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEECCCCcEEEee
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDL-KSSNILLGDDFRAKVSD 760 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-k~~NiLl~~~~~~ki~D 760 (959)
...++||||+++++|.. +. .. . ...++.|+++||+|||+ +||+|||| ||+|||++.++.+||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---PH--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---cc--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence 45799999999999962 21 00 1 14678999999999999 89999999 99999999999999999
Q ss_pred ccccccCCCCCcc-------eeeccccccccccccccccC
Q 002149 761 FGLVKLAPDSERS-------VVTRLAGTFGYLAPEYAVTG 793 (959)
Q Consensus 761 fGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 793 (959)
||+|+........ ......+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999965443221 11356788999999998654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=241.43 Aligned_cols=267 Identities=23% Similarity=0.320 Sum_probs=204.6
Q ss_pred EecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcE
Q 002149 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154 (959)
Q Consensus 75 ~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 154 (959)
.|-..+-..|+|++++|+ .+|+.+. ++|+.|+|++|+|+.++. .+++|++|+|++|+|+.+|.. .++|+.
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~l----p~sL~~ 266 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPVL----PPGLLE 266 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccCc----ccccce
Confidence 465566677999999999 7888876 489999999999997653 257899999999999999853 478999
Q ss_pred EEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccc
Q 002149 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLND 234 (959)
Q Consensus 155 L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~ 234 (959)
|+|++|+|.. +|.. ..+|+.|++++|+++. +|. .+++|+.|+|++|+|++ +|.... ++..|++.+
T Consensus 267 L~Ls~N~L~~-----Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~lp~--~L~~L~Ls~ 331 (788)
T PRK15387 267 LSIFSNPLTH-----LPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-LPALPS--ELCKLWAYN 331 (788)
T ss_pred eeccCCchhh-----hhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-CCCCcc--ccccccccc
Confidence 9999999984 4442 2568899999999984 454 24789999999999996 444322 344555555
Q ss_pred cCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCC
Q 002149 235 QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPV 314 (959)
Q Consensus 235 ~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~i 314 (959)
+....++.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|... .+|+.|+|++|+|++ +
T Consensus 332 N~L~~LP~l------p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l~--~~L~~LdLs~N~Lt~-L 397 (788)
T PRK15387 332 NQLTSLPTL------PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALP--SGLKELIVSGNRLTS-L 397 (788)
T ss_pred Ccccccccc------ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Ccccc--cccceEEecCCcccC-C
Confidence 544443321 147888999999888 46653 3567888888888885 45433 258888888888874 3
Q ss_pred CcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccc
Q 002149 315 PKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394 (959)
Q Consensus 315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 394 (959)
|. ..++|+.|+|++|+|++
T Consensus 398 P~-------------------------------------------------------------l~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 398 PV-------------------------------------------------------------LPSELKELMVSGNRLTS 416 (788)
T ss_pred CC-------------------------------------------------------------cccCCCEEEccCCcCCC
Confidence 32 01579999999999984
Q ss_pred cCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC
Q 002149 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK 446 (959)
Q Consensus 395 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 446 (959)
+|... .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|.
T Consensus 417 -IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 417 -LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred -CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 66543 46889999999999 7999999999999999999999988765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-24 Score=220.50 Aligned_cols=147 Identities=26% Similarity=0.421 Sum_probs=111.7
Q ss_pred CCCCCCCCCc------ceEecCC-----------cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccC
Q 002149 63 GDPCGPPCWK------HVFCSNS-----------RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSG 124 (959)
Q Consensus 63 ~~~C~~~~w~------gv~C~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~ 124 (959)
...||.+|.| -|+|+.. ..++|+|..|+|+...|.+|..+++|+.||||+|+|+.+-| +|.+
T Consensus 34 ~~~CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~G 113 (498)
T KOG4237|consen 34 ASACPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKG 113 (498)
T ss_pred cccCCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhh
Confidence 4567766533 3889864 35567788888886666778888888888888888888777 6888
Q ss_pred CCCccEEecCC-CCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCC
Q 002149 125 LSNLKYAYLDG-NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS 203 (959)
Q Consensus 125 l~~L~~L~L~~-N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 203 (959)
+.+|..|.+.+ |+|+.++.++|++|..|+.|.+.-|++.. .....+..+++|..|.+.+|.+...--..|..+.+
T Consensus 114 L~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~C----ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~ 189 (498)
T KOG4237|consen 114 LASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINC----IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAA 189 (498)
T ss_pred hHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcc----hhHHHHHHhhhcchhcccchhhhhhccccccchhc
Confidence 88877777666 88888888888888888888888888875 34556777888888888888877544457777888
Q ss_pred CCEEEecCCc
Q 002149 204 LQNLKLSGNN 213 (959)
Q Consensus 204 L~~L~Ls~N~ 213 (959)
++.+.+..|.
T Consensus 190 i~tlhlA~np 199 (498)
T KOG4237|consen 190 IKTLHLAQNP 199 (498)
T ss_pred cchHhhhcCc
Confidence 8888888777
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=232.86 Aligned_cols=315 Identities=21% Similarity=0.334 Sum_probs=216.7
Q ss_pred hcCCChhhHHHHHHHHHhcCCCC-CCC----CCCCCCCCCCCC-------------CcceEecCCcEEEEEecCCccccc
Q 002149 33 LSATDPGDIDILNQFRKNLENPE-LLQ----WPKSGDPCGPPC-------------WKHVFCSNSRVTQIQVSSVGLKGT 94 (959)
Q Consensus 33 ~~~~~~~~~~~l~~~~~~~~~~~-~~~----w~~~~~~C~~~~-------------w~gv~C~~~~v~~l~l~~~~l~g~ 94 (959)
.+.+.++|...++++.+.+..|. +.+ |...++.|-.+- -..|.|..+.||.+...+......
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 46678999999999999998875 444 988899995321 224899999898887765322110
Q ss_pred C---------------------c-------ccc-----cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCC
Q 002149 95 L---------------------P-------QNL-----NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTI 141 (959)
Q Consensus 95 ~---------------------~-------~~l-----~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i 141 (959)
- + ..+ +-..+...|+|+++.++.++..+. ++|+.|+|++|+|+.+
T Consensus 137 ~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsL 214 (754)
T PRK15370 137 ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLTTIPACIP--EQITTLILDNNELKSL 214 (754)
T ss_pred CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcC
Confidence 0 0 001 112467788999888887655453 4788999999999988
Q ss_pred ChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcc
Q 002149 142 PADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPES 221 (959)
Q Consensus 142 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 221 (959)
|...+ .+|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|++|+|+ .+|..
T Consensus 215 P~~l~---~nL~~L~Ls~N~Lt-----sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~ 280 (754)
T PRK15370 215 PENLQ---GNIKTLYANSNQLT-----SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPEN 280 (754)
T ss_pred Chhhc---cCCCEEECCCCccc-----cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccc
Confidence 87654 47889999999887 3555443 36888899988887 5676654 57888999988888 45654
Q ss_pred cccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCC
Q 002149 222 FKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLD 301 (959)
Q Consensus 222 ~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 301 (959)
+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++.. |..+. .+|+
T Consensus 281 l~---------------------------~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~L-P~~l~-~sL~ 328 (754)
T PRK15370 281 LP---------------------------EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTAL-PETLP-PGLK 328 (754)
T ss_pred cC---------------------------CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccC-Ccccc-ccce
Confidence 31 46788888888887 4555442 4678888888888754 33222 2578
Q ss_pred eEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCc
Q 002149 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381 (959)
Q Consensus 302 ~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 381 (959)
.|++++|.+++ +|.. -.++
T Consensus 329 ~L~Ls~N~Lt~-LP~~------------------------------------------------------------l~~s 347 (754)
T PRK15370 329 TLEAGENALTS-LPAS------------------------------------------------------------LPPE 347 (754)
T ss_pred eccccCCcccc-CChh------------------------------------------------------------hcCc
Confidence 88888887764 3321 0156
Q ss_pred ccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC---CC----CCcceec
Q 002149 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP---KF----SGAVKLS 454 (959)
Q Consensus 382 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p---~~----~~~~~~~ 454 (959)
|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+..+. .+ ..+..+.
T Consensus 348 L~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~ 421 (754)
T PRK15370 348 LQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRII 421 (754)
T ss_pred ccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEE
Confidence 888888888887 4666553 57888888888888 5666554 368888888888874322 11 3345677
Q ss_pred ccCCCCCC
Q 002149 455 LDGNPLLN 462 (959)
Q Consensus 455 l~~N~~~c 462 (959)
+.+||+..
T Consensus 422 L~~Npls~ 429 (754)
T PRK15370 422 VEYNPFSE 429 (754)
T ss_pred eeCCCccH
Confidence 88887753
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-24 Score=222.35 Aligned_cols=313 Identities=23% Similarity=0.289 Sum_probs=218.5
Q ss_pred CCCCC---CCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCC
Q 002149 64 DPCGP---PCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFD 139 (959)
Q Consensus 64 ~~C~~---~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~ 139 (959)
-.|.. .|..+++|++..-..|+..+.+|+ .+|..+.. .-..++|..|+|+.+++ +|+.+++|+.||||+|+|+
T Consensus 28 ~~C~~~~~~CP~pC~Cs~~~g~~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is 104 (498)
T KOG4237|consen 28 PTCAHSASACPAPCTCSDVEGGIVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS 104 (498)
T ss_pred hhhhhccccCCCCcccCCCCCceEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchh
Confidence 45654 688899998755667889999998 66766643 45778899999998888 7999999999999999999
Q ss_pred CCChhhhcCCCCCcEEEccC-cccCCCCCCCCCc-cccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCC
Q 002149 140 TIPADFFDGLENLQVLALDS-NNFNASKGWSFPK-GLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217 (959)
Q Consensus 140 ~i~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~lp~-~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 217 (959)
.|.+++|.+|.+|..|-+-+ |+|+. +|+ .+.+|.+|+.|.+.-|++.-...+.|..|++|..|.+.+|.+..+
T Consensus 105 ~I~p~AF~GL~~l~~Lvlyg~NkI~~-----l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i 179 (498)
T KOG4237|consen 105 FIAPDAFKGLASLLSLVLYGNNKITD-----LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSI 179 (498)
T ss_pred hcChHhhhhhHhhhHHHhhcCCchhh-----hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhh
Confidence 99999999999988876655 88884 554 356777788888888887777777778888888888888877733
Q ss_pred CCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc------------ccCchhhcCCCCCCEEeCCCC
Q 002149 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS------------GTIPESFGKLTSLKDLNLNSN 285 (959)
Q Consensus 218 ~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L~~L~Ls~N 285 (959)
-... |..+..++++.+..|.+- -..|-.++...-..-..|.++
T Consensus 180 ~~~t-------------------------f~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~ 234 (498)
T KOG4237|consen 180 CKGT-------------------------FQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYK 234 (498)
T ss_pred cccc-------------------------ccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHH
Confidence 3324 344566666666666632 111222222222222223333
Q ss_pred cCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCC
Q 002149 286 QFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365 (959)
Q Consensus 286 ~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 365 (959)
++..+.+..|..- ++.+ ++.+.....-.
T Consensus 235 Ri~q~~a~kf~c~-~esl---------------------------------------------------~s~~~~~d~~d 262 (498)
T KOG4237|consen 235 RINQEDARKFLCS-LESL---------------------------------------------------PSRLSSEDFPD 262 (498)
T ss_pred Hhcccchhhhhhh-HHhH---------------------------------------------------HHhhccccCcC
Confidence 3332222211110 0000 00000000000
Q ss_pred CCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC
Q 002149 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP 445 (959)
Q Consensus 366 ~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p 445 (959)
..|. ...|..+++|+.|+|++|+|++.-+.+|..+..|++|.|..|+|...--..|.++..|+.|+|.+|+++...|
T Consensus 263 ~~cP---~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~ 339 (498)
T KOG4237|consen 263 SICP---AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP 339 (498)
T ss_pred CcCh---HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence 1111 1126778999999999999999999999999999999999999996666789999999999999999997777
Q ss_pred C----CCCcceecccCCCCCCCC
Q 002149 446 K----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 446 ~----~~~~~~~~l~~N~~~c~~ 464 (959)
. ...+..+++-+|||.|..
T Consensus 340 ~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 340 GAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred ccccccceeeeeehccCcccCcc
Confidence 4 344678899999999986
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-24 Score=240.47 Aligned_cols=369 Identities=25% Similarity=0.291 Sum_probs=226.6
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++..|++++|.+. ..|..+..+.+|+.|+++.|.|...+.+.+++.+|++|.|.+|++..+|.. +..+.+|++||+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 4888999888776 789999999999999999999998877889999999999999999999887 88999999999999
Q ss_pred cccCCCCCCCCCccccCccccCeeccccc-------------------ccCCCCChhhcCCCCCCEEEecCCcCCCCCCc
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSC-------------------NLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE 220 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n-------------------~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 220 (959)
|++. .+|..+..++.++.+.+++| .+.+.++..+..++. .|+|.+|++....-.
T Consensus 124 N~f~-----~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~dls 196 (1081)
T KOG0618|consen 124 NHFG-----PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVLDLS 196 (1081)
T ss_pred hccC-----CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhhhhh
Confidence 9998 56776666666666555555 444455555555444 588888887732222
Q ss_pred ccccCC--------cccccccccCCCCcccc------cccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCc
Q 002149 221 SFKGLN--------LVNLWLNDQKGGGFTGT------IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ 286 (959)
Q Consensus 221 ~~~~l~--------l~~L~~~~~~~~~l~~~------~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 286 (959)
.+..++ +..+.+.+-+...+... .+.-..-.+|+++++++|+++ .+|++++.+.+|+.|+..+|+
T Consensus 197 ~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~ 275 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNR 275 (1081)
T ss_pred hccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccchh
Confidence 222221 11121111111111111 111223467899999999998 677999999999999999998
Q ss_pred CCCCCccccccccCCeEeCCCCcCCCCCCccc----ccccccccCcccCCCCCCCCchhhHHHHhhccC----C------
Q 002149 287 FVGLIPPSLASLSLDHLDLNNNMFMGPVPKSK----AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGG----L------ 352 (959)
Q Consensus 287 l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------ 352 (959)
|+..+...+...+|+.|++.+|.+.-..|... .-.+++..|.+...+...... .....+.+.. +
T Consensus 276 l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v--~~~~l~~ln~s~n~l~~lp~~ 353 (1081)
T KOG0618|consen 276 LVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAV--LNASLNTLNVSSNKLSTLPSY 353 (1081)
T ss_pred HHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhh--hhHHHHHHhhhhccccccccc
Confidence 86443333333345555555554443222211 111233333332222210000 0000000000 0
Q ss_pred --CCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccc------------
Q 002149 353 --NYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG------------ 418 (959)
Q Consensus 353 --~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g------------ 418 (959)
.....+...+..+|....-.-..+-+..+|+.|+|++|+|.......+.++..|++|+||+|+|+.
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLH 433 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhH
Confidence 001111222222222221111123445778888888887774444456777777777777777762
Q ss_pred ----------ccCCCccCCCCCCeEeCCCCccCC-CCCC---CCCcceecccCCCCC
Q 002149 419 ----------QIPTNWTNLKSLTLLDLSQNNLSP-PLPK---FSGAVKLSLDGNPLL 461 (959)
Q Consensus 419 ----------~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~---~~~~~~~~l~~N~~~ 461 (959)
..| ++..+++|+.+|||.|+|+. .+|. +.++..+++.||.++
T Consensus 434 tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 434 TLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred HHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 345 67788999999999999984 3342 467889999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-20 Score=205.98 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=198.6
Q ss_pred CcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHH-HHHHHHHHHHHHHhcCCC-CceeEEEEEEeCceEEEEEEe
Q 002149 613 FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKK-AVDEFHSEIAVLSKVRHR-HLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 690 (959)
|...+.||.|+||.||++... ..+|+|.+........ ....+.+|+.++..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999876 7899999887644443 577899999999999988 799999999777778999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~~~~~ 769 (959)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++... .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999666431110 368899999999999999999999 8999999999999999988 799999999985544
Q ss_pred CCcc-----eeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHhhhcch
Q 002149 770 SERS-----VVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPE-ERQYLAAWFWNIKSDK 840 (959)
Q Consensus 770 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~ 840 (959)
.... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 3321 2355789999999999987 57888999999999999999999997765531 000111111111000
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
....... ..........+.+++.+|+..+|..|.+..+....
T Consensus 234 -----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000 00001223467799999999999999999887664
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=229.06 Aligned_cols=252 Identities=22% Similarity=0.411 Sum_probs=194.7
Q ss_pred eEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCc
Q 002149 74 VFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153 (959)
Q Consensus 74 v~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 153 (959)
..|-..+.+.+++.+++++ .+|..+. ++|+.|+|++|+|+.++..+. ++|++|+|++|+|+.+|.... .+|+
T Consensus 173 ~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l~---~~L~ 244 (754)
T PRK15370 173 RDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATLP---DTIQ 244 (754)
T ss_pred HhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhhh---cccc
Confidence 4677778899999999998 5777664 589999999999997766554 589999999999999987543 4799
Q ss_pred EEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccccccc
Q 002149 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLN 233 (959)
Q Consensus 154 ~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~ 233 (959)
.|+|++|++. .+|..+. .+|+.|++++|++. .+|..+. ++|+.|+|++|+|++ +|..+.
T Consensus 245 ~L~Ls~N~L~-----~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp---------- 303 (754)
T PRK15370 245 EMELSINRIT-----ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP---------- 303 (754)
T ss_pred EEECcCCccC-----cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch----------
Confidence 9999999998 4666554 48999999999998 4676654 589999999999984 454321
Q ss_pred ccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCC
Q 002149 234 DQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGP 313 (959)
Q Consensus 234 ~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ 313 (959)
++|+.|+|++|+++ .+|..+. ++|+.|++++|.|++ +|..+. .+|+.|+|++|+|+.
T Consensus 304 -----------------~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~-~sL~~L~Ls~N~L~~- 360 (754)
T PRK15370 304 -----------------SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP-PELQVLDVSKNQITV- 360 (754)
T ss_pred -----------------hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc-CcccEEECCCCCCCc-
Confidence 46788888999888 4665442 688899999998886 444443 368899999998863
Q ss_pred CCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 314 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
+|.. -.++|+.|+|++|+|+
T Consensus 361 LP~~------------------------------------------------------------lp~~L~~LdLs~N~Lt 380 (754)
T PRK15370 361 LPET------------------------------------------------------------LPPTITTLDVSRNALT 380 (754)
T ss_pred CChh------------------------------------------------------------hcCCcCEEECCCCcCC
Confidence 4421 0146889999999988
Q ss_pred ccCCccccCcCcCCEEeCcccccccccCCCcc----CCCCCCeEeCCCCccC
Q 002149 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT----NLKSLTLLDLSQNNLS 441 (959)
Q Consensus 394 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~----~l~~L~~L~Ls~N~l~ 441 (959)
.+|..+. .+|+.|++++|+|+ .+|..+. .++++..|+|.+|+|+
T Consensus 381 -~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 381 -NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 5666554 36889999999998 5665543 4578889999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-22 Score=232.95 Aligned_cols=255 Identities=21% Similarity=0.248 Sum_probs=186.8
Q ss_pred cccCcccccCceEEEEEEE-cCCcEEEEEEcc----cccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 614 ASENELGRGGFGVVYKGEL-DDGTKIAVKRME----AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
...+.+|.|++|.|+.+.. ...+..+.|... ...........+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998877743 334445555443 11111222233667888888899999988877776666666669
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++ +|..++.. ...++..++..++.|+.+|++|+|+ .||.|||+|++|++++.+|.+||+|||.+..+.
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99988843 1467888899999999999999999 899999999999999999999999999988543
Q ss_pred CCCc---ceeeccccccccccccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 769 DSER---SVVTRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 769 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
-... ......+|+..|+|||++.+..|++. .||||.|+++..|++|+.||......+..+... ... .
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~--~--- 542 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYS--D--- 542 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----ccc--c---
Confidence 3222 44566889999999999999999875 999999999999999999997665443321000 000 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+.............+.....++.+++++||.+|.|+++|++
T Consensus 543 -~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 543 -QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000001111233446678999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=188.17 Aligned_cols=142 Identities=18% Similarity=0.202 Sum_probs=109.7
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHH------------------------HHHHHHHHHHHHhcCCCCc
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKA------------------------VDEFHSEIAVLSKVRHRHL 671 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 671 (959)
...||+|+||.||+|...+|+.||||+++........ ......|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999998764321111 1223459999999988877
Q ss_pred eeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEE
Q 002149 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL-HSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 672 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dik~~NiLl 750 (959)
.....+.. ...++||||++++++..... ....+++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL-----KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh-----hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 54433322 23389999998877654431 124688999999999999999999 67 799999999999999
Q ss_pred CCCCcEEEeeccccccCC
Q 002149 751 GDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~ 768 (959)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=229.29 Aligned_cols=221 Identities=23% Similarity=0.315 Sum_probs=137.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCC-CCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNN-FDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~-l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.++.|.+.++.++ .+|..+ ...+|+.|+|++|++......+..+++|++|+|++|. +..+|. +..+++|++|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEec
Confidence 4677777777665 666666 4678888888888887666567778888888888764 555653 6778888888888
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|..-. .+|..+..+++|+.|++++|+....+|..+ ++++|+.|+|++|.....+|.... ++..|.+.++...
T Consensus 666 ~c~~L~----~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~--nL~~L~L~~n~i~ 738 (1153)
T PLN03210 666 DCSSLV----ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIST--NISWLDLDETAIE 738 (1153)
T ss_pred CCCCcc----ccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccC--CcCeeecCCCccc
Confidence 765432 577788888888888888876666677655 677888888888765555554332 3444555444433
Q ss_pred CcccccccccCCcCCcEEEccCcccc-------ccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcC
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFS-------GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l 310 (959)
.++.. ..+++|++|++.++... ...|..+...++|+.|+|++|...+.+|..+..+ +|+.|+|++|..
T Consensus 739 ~lP~~----~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~ 814 (1153)
T PLN03210 739 EFPSN----LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCIN 814 (1153)
T ss_pred ccccc----ccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCC
Confidence 33321 13455555555543211 1112222233456666666665555556555555 366666666544
Q ss_pred CCCCC
Q 002149 311 MGPVP 315 (959)
Q Consensus 311 ~~~ip 315 (959)
.+.+|
T Consensus 815 L~~LP 819 (1153)
T PLN03210 815 LETLP 819 (1153)
T ss_pred cCeeC
Confidence 44444
|
syringae 6; Provisional |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-20 Score=189.06 Aligned_cols=176 Identities=14% Similarity=0.173 Sum_probs=136.1
Q ss_pred HHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHH-HHH------HHHHHHHHHhcCCCCceeEEEEEE
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKA-VDE------FHSEIAVLSKVRHRHLVSLLGYSV 679 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~E~~~l~~l~h~niv~l~~~~~ 679 (959)
..+.++|+..+++|.|+||.||.+.. ++..+|||.+.......+. ... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34568899999999999999999866 4778999999765332222 222 578999999999999999988865
Q ss_pred eC--------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 680 AG--------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 680 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
.. ...++||||++|.+|.++. .++. ....+++.++..+|. .|++|||+||+||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~---------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP---------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh---------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 43 3578999999999997763 1222 246699999999999 8999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh
Q 002149 752 DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813 (959)
Q Consensus 752 ~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt 813 (959)
.++ ++|+|||..+........ . .+.....+..++|+|||||.+.-+..
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--d-----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--D-----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--H-----------HHHHHhHhcccccccceeEeehHHHH
Confidence 988 999999988755332211 1 13344556779999999999876643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=216.76 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=192.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++.+|+|+ .+|.. +++|++|+|++|+|+.+++. .++|+.|+|++|.|+.+|.. ..+|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsLP~l---p~sL~~L~Ls~N~L~~Lp~l----p~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSLPVL---PPGLLELSIFSNPLTHLPAL----PSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcccCc---ccccceeeccCCchhhhhhc----hhhcCEEECc
Confidence 36889999999999 46653 57899999999999976532 46899999999999988762 3678899999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|+|+. +|.. .++|+.|++++|++++ +|.. ..+|+.|++++|+|++ +|.... +|..|.+.++...
T Consensus 291 ~N~Lt~-----LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~lp~--~Lq~LdLS~N~Ls 355 (788)
T PRK15387 291 GNQLTS-----LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTLPS--GLQELSVSDNQLA 355 (788)
T ss_pred CCcccc-----cccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccccc--ccceEecCCCccC
Confidence 999984 5542 4679999999999986 4442 2468888999999984 554222 4566766666655
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCccc
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSK 318 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~ 318 (959)
.++.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|... -+|+.|++++|+|++ +|..
T Consensus 356 ~LP~l------p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt~-LP~l~--s~L~~LdLS~N~Lss-IP~l- 420 (788)
T PRK15387 356 SLPTL------PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLP--SELKELMVSGNRLTS-LPML- 420 (788)
T ss_pred CCCCC------Ccccceehhhccccc-cCccc---ccccceEEecCCcccC-CCCcc--cCCCEEEccCCcCCC-CCcc-
Confidence 54432 257889999999999 57754 3579999999999996 44432 269999999999985 4521
Q ss_pred ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCc
Q 002149 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
..+|+.|+|++|+|+ .+|.
T Consensus 421 ------------------------------------------------------------~~~L~~L~Ls~NqLt-~LP~ 439 (788)
T PRK15387 421 ------------------------------------------------------------PSGLLSLSVYRNQLT-RLPE 439 (788)
T ss_pred ------------------------------------------------------------hhhhhhhhhccCccc-ccCh
Confidence 146888999999998 7899
Q ss_pred cccCcCcCCEEeCcccccccccCCCccCC
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNL 427 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l 427 (959)
.+.++++|+.|+|++|.|+|.+|..+..+
T Consensus 440 sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 440 SLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred HHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 99999999999999999999888777544
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-21 Score=219.15 Aligned_cols=266 Identities=24% Similarity=0.363 Sum_probs=206.6
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
++|+.|+.++|.+....+.+. -.+|+++++++|+++.+| .+++.+.+|+.|+..+|+|. .+|..+...++|+.
T Consensus 219 ~~l~~L~a~~n~l~~~~~~p~-p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-----~lp~ri~~~~~L~~ 291 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDVHPV-PLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-----ALPLRISRITSLVS 291 (1081)
T ss_pred cchheeeeccCcceeeccccc-cccceeeecchhhhhcch-HHHHhcccceEecccchhHH-----hhHHHHhhhhhHHH
Confidence 466677777777763333222 367999999999999999 88999999999999999997 78999999999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccc-cccCCcCCcEEEccCc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTID-VLGNMDQLRTLWLHGN 261 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~-~l~~l~~L~~L~L~~N 261 (959)
|.+..|.+. .+|..+..++.|++|+|..|+|. ..|..+-..-...|...++..+.+...+. .=..++.|+.|++.+|
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 999999998 66778888999999999999998 45554332222334444444444444331 1234578999999999
Q ss_pred cccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCch
Q 002149 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 262 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (959)
.|+...-..|.+.++|+.|+|++|+|...+.+.+.++ .|++|+||+|+|+. +|.
T Consensus 370 ~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~-Lp~------------------------ 424 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT-LPD------------------------ 424 (1081)
T ss_pred cccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh-hhH------------------------
Confidence 9998877788999999999999999997777778888 59999999999973 332
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccc-c
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG-Q 419 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g-~ 419 (959)
+...++.|++|...+|+|. ..| ++.+++.|+.+||+.|+|+- .
T Consensus 425 ----------------------------------tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~ 468 (1081)
T KOG0618|consen 425 ----------------------------------TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVT 468 (1081)
T ss_pred ----------------------------------HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhh
Confidence 1223477888888888888 666 78889999999999999873 3
Q ss_pred cCCCccCCCCCCeEeCCCCc
Q 002149 420 IPTNWTNLKSLTLLDLSQNN 439 (959)
Q Consensus 420 ~p~~l~~l~~L~~L~Ls~N~ 439 (959)
+|..... ++|++|||++|.
T Consensus 469 l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 469 LPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred hhhhCCC-cccceeeccCCc
Confidence 4443333 789999999987
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-18 Score=219.76 Aligned_cols=311 Identities=19% Similarity=0.208 Sum_probs=212.0
Q ss_pred CcEEEEEecCC------cccccCcccccCCC-CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCC
Q 002149 79 SRVTQIQVSSV------GLKGTLPQNLNQLS-KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151 (959)
Q Consensus 79 ~~v~~l~l~~~------~l~g~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 151 (959)
.++..|.+..+ ++...+|..+..++ +|+.|++.+|.+...+..| ...+|+.|+|++|++..++.. +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 35666776544 33446777777764 6999999999998777666 578999999999999988776 678999
Q ss_pred CcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccccc
Q 002149 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLW 231 (959)
Q Consensus 152 L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~ 231 (959)
|+.|+|++|..-. .+| .+..+++|+.|+|.+|.....+|..+.++++|+.|++++|..-..+|..+...+|..|.
T Consensus 636 Lk~L~Ls~~~~l~----~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~ 710 (1153)
T PLN03210 636 LRNIDLRGSKNLK----EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLN 710 (1153)
T ss_pred CCEEECCCCCCcC----cCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEe
Confidence 9999999875322 455 47889999999999998888899999999999999999986555777765333566666
Q ss_pred ccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCC-------CCCcccccc-ccCCeE
Q 002149 232 LNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV-------GLIPPSLAS-LSLDHL 303 (959)
Q Consensus 232 ~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~~p~~~~~-~~L~~L 303 (959)
+.++.. +...+ ...++|++|+|++|.++ .+|..+ .+++|++|++.++... ...+..... .+|+.|
T Consensus 711 Lsgc~~--L~~~p---~~~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 711 LSGCSR--LKSFP---DISTNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred CCCCCC--ccccc---cccCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchhe
Confidence 555432 11111 12468999999999998 677765 6889999999875432 111111111 269999
Q ss_pred eCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCccc
Q 002149 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT 383 (959)
Q Consensus 304 ~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~ 383 (959)
+|++|...+.+|........+. .....++....-++..+ .+++|+
T Consensus 784 ~Ls~n~~l~~lP~si~~L~~L~----------------------------------~L~Ls~C~~L~~LP~~~-~L~sL~ 828 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQNLHKLE----------------------------------HLEIENCINLETLPTGI-NLESLE 828 (1153)
T ss_pred eCCCCCCccccChhhhCCCCCC----------------------------------EEECCCCCCcCeeCCCC-CccccC
Confidence 9999998888886432111111 00000000000011111 356788
Q ss_pred EEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCC-CccCC
Q 002149 384 VLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQ-NNLSP 442 (959)
Q Consensus 384 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~-N~l~~ 442 (959)
.|+|++|.....+|.. .++|++|+|++|.++ .+|..+..+++|+.|+|++ |+|..
T Consensus 829 ~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 829 SLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred EEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc
Confidence 8888877655555543 356778888888887 6777788888888888887 44444
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.4e-19 Score=173.73 Aligned_cols=188 Identities=20% Similarity=0.118 Sum_probs=140.0
Q ss_pred cccCcccccCceEEEEEEEcCCcEEEEEEcccccccH--HHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEe
Q 002149 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK--KAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
.+...|++|+||+||.+.- .+++++.+.+....... .....+.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998865 57888888776542211 12235789999999995 5889999886 346899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEECCCCcEEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDL-KSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-k~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
+.|.+|.+.... ....++.|++++|+++|+ .||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999888654310 113578899999999999 89999999 79999999999999999999985543
Q ss_pred CCcc----e--------eeccccccccccccccccC-CCC-ccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 770 SERS----V--------VTRLAGTFGYLAPEYAVTG-KIT-TKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 770 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
.... . ......++.|++|+...-- ..+ ...+.++-|+-+|.++|+..+.-..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 2210 0 0112357788888754321 233 4578889999999999999886544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-19 Score=177.87 Aligned_cols=144 Identities=19% Similarity=0.183 Sum_probs=111.8
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccH------------------------HHHHHHHHHHHHHHhcCCCCc
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK------------------------KAVDEFHSEIAVLSKVRHRHL 671 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~h~ni 671 (959)
...||+|+||.||+|...+|+.||||++....... .....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987789999999987642110 012234689999999999987
Q ss_pred eeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 672 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
.....+... ..++||||++++++...... ...++..++..++.|++.++.|+|+. .||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE
Confidence 554444332 34899999988755433211 14567889999999999999999983 5999999999999999
Q ss_pred CCCcEEEeeccccccCCC
Q 002149 752 DDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 752 ~~~~~ki~DfGla~~~~~ 769 (959)
++.++|+|||+|+....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-20 Score=202.68 Aligned_cols=188 Identities=27% Similarity=0.339 Sum_probs=158.5
Q ss_pred cccccCceEEEEEE----EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEecC
Q 002149 618 ELGRGGFGVVYKGE----LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 618 ~lG~G~fg~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
.+|+|+||.|+.++ .+.|.-+|.|+.++.............|..++...+ ||.+|++.-.++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999773 345677899888765333322235567888999997 9999999999999999999999999
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~ 772 (959)
+|.+...+.. ...+++.....+...++-+++++|+ .+++|||+|++||+++.+|++++.|||+++...+...
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999876632 3567788888899999999999999 8999999999999999999999999999996644332
Q ss_pred ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 002149 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDE 820 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~ 820 (959)
. +||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 2 8999999999988 567889999999999999999999986
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=192.77 Aligned_cols=216 Identities=25% Similarity=0.390 Sum_probs=161.5
Q ss_pred HHhcCCCCceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-Eec
Q 002149 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF-IHR 741 (959)
Q Consensus 663 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~ 741 (959)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.. ....++|.....++.+|+.||+|+|. .+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 3568899999999999999999999999999999999954 33678999999999999999999999 444 999
Q ss_pred CCCCCCEEECCCCcEEEeeccccccCCCCC-cceeeccccccccccccccccC-------CCCccchHHHHHHHHHHHHh
Q 002149 742 DLKSSNILLGDDFRAKVSDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTG-------KITTKVDVFSFGVVLMELLT 813 (959)
Q Consensus 742 Dik~~NiLl~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~ll~ellt 813 (959)
.++++|+++|..+.+||+|||+........ ........-..-|.|||.+... ..+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999999999999999999987664311 1111112234579999998663 14677999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 814 GLMALDESRPEER-QYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 814 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.+.||+.....+. ..++..+.. .....+.+.+.... +....+..++.+||..+|++||++++|-..++.+
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999987543322 122222211 01111111111011 2333688999999999999999999998877766
Q ss_pred Hh
Q 002149 893 VE 894 (959)
Q Consensus 893 ~~ 894 (959)
..
T Consensus 225 ~~ 226 (484)
T KOG1023|consen 225 NK 226 (484)
T ss_pred cc
Confidence 55
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-18 Score=179.64 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=151.5
Q ss_pred CcccCcccccCceEEEEEEEc-CCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCC----------CCceeEEEE---
Q 002149 613 FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRH----------RHLVSLLGY--- 677 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~--- 677 (959)
+...+.||.|+++.||.++.. +|+++|+|+..... ......+++++|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999765 68999999875432 233456777777655544322 122222221
Q ss_pred ------EEeC---c-----eEEEEEEecCCCchhhHHhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 002149 678 ------SVAG---Y-----ERLLVYEYMPQGALSKHIFHWKSLN--LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHR 741 (959)
Q Consensus 678 ------~~~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 741 (959)
.... . ..+++|+-+ .++|.+++....... ...+....+..+..|+++.+++||+ .|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1111 1 236788888 788887754211111 2234455667788999999999999 899999
Q ss_pred CCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccccccccccccccc--------CCCCccchHHHHHHHHHHHHh
Q 002149 742 DLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT--------GKITTKVDVFSFGVVLMELLT 813 (959)
Q Consensus 742 Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~ll~ellt 813 (959)
||||+|++++++|.++|+||+......... .....+..|.+||.... -.++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999877554321 11345678999997643 247889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 002149 814 GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQR 879 (959)
Q Consensus 814 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 879 (959)
|..||+...+... .+. ... .+.+.+..+..||..+|+++|.+|
T Consensus 246 ~~lPf~~~~~~~~-------------~~~---------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEAD-------------PEW---------DFS-RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGST-------------SGG---------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccc-------------ccc---------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence 9999987643221 000 111 122667789999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=201.22 Aligned_cols=248 Identities=23% Similarity=0.272 Sum_probs=175.9
Q ss_pred CCcccCcccccCceEEEEEEEcCCcEEEEEEccccc--ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGV--ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+|..++.||.+.|=.|.+|+.++|. |+||++-+.. .+-....+-..|++ ...++|||.+++.-+-......|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777889999999999999988887 8899886542 12222333334444 555689999999887777777788888
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc--cC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK--LA 767 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~--~~ 767 (959)
|. .-+|+|.+. ....+..-+..-||.|++.||.-+|. .||+|||||.+||||+.-.=+.|+||..-+ ..
T Consensus 102 yv-khnLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HH-hhhhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 88 558888762 22456777788899999999999999 899999999999999998889999998765 33
Q ss_pred CCCCcceeeccc----cccccccccccccC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002149 768 PDSERSVVTRLA----GTFGYLAPEYAVTG----------K-ITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAA 831 (959)
Q Consensus 768 ~~~~~~~~~~~~----gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~ 831 (959)
+.+.....+-+. .-..|.|||.+... . .+++.||||+||+++||++ |+++|.-. .+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 443333322222 23469999977441 1 6778999999999999998 46666521 1111
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
+-..-....+.+-+.+.. ..+..++..|++.||++|.++++.++.
T Consensus 247 Yr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111101111222111111 146689999999999999999998876
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-20 Score=169.90 Aligned_cols=183 Identities=27% Similarity=0.517 Sum_probs=151.2
Q ss_pred cccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCc
Q 002149 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177 (959)
Q Consensus 98 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l 177 (959)
.+.++.+++.|.||+|+++..+|.+..+.+|+.|++++|+|..+|.. ++.+++|+.|+++-|++. .+|.+++.+
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~-issl~klr~lnvgmnrl~-----~lprgfgs~ 101 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTS-ISSLPKLRILNVGMNRLN-----ILPRGFGSF 101 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChh-hhhchhhhheecchhhhh-----cCccccCCC
Confidence 35667788888888888888888888888888888888888888876 788888888888888887 578888888
Q ss_pred cccCeecccccccCC-CCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEE
Q 002149 178 AQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256 (959)
Q Consensus 178 ~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L 256 (959)
+.|+.|+|..|++.. .+|..|..++.|+.|+|++|.+. .+|+. ++++++|+.|
T Consensus 102 p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~d-------------------------vg~lt~lqil 155 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPD-------------------------VGKLTNLQIL 155 (264)
T ss_pred chhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChh-------------------------hhhhcceeEE
Confidence 888888888888864 57888888889999999999988 55655 5778999999
Q ss_pred EccCccccccCchhhcCCCCCCEEeCCCCcCCCCCcccccccc----CCeEeCCCCcCCCCC
Q 002149 257 WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS----LDHLDLNNNMFMGPV 314 (959)
Q Consensus 257 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----L~~L~L~~N~l~~~i 314 (959)
.+.+|.+- .+|..++.++.|++|.+.+|+++ .+|..++.+. =+.+.+.+|.+-..|
T Consensus 156 ~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pI 215 (264)
T KOG0617|consen 156 SLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPI 215 (264)
T ss_pred eeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChH
Confidence 99999998 79999999999999999999999 5555666653 345667777775443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=166.94 Aligned_cols=136 Identities=15% Similarity=0.174 Sum_probs=105.2
Q ss_pred cccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-----CCCCceeEEEEEEeCc---e-E
Q 002149 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-----RHRHLVSLLGYSVAGY---E-R 684 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 684 (959)
...+.||+|+||.||. ...++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. . .
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 4467899999999996 3334444 799876542 23456789999999999 5799999999998864 3 3
Q ss_pred EEEEEe--cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCEEECC----CCcEE
Q 002149 685 LLVYEY--MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM-EYLHSLAHQSFIHRDLKSSNILLGD----DFRAK 757 (959)
Q Consensus 685 ~lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dik~~NiLl~~----~~~~k 757 (959)
.+|+|| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||+ ++||||||||+|||++. ++.++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEE
Confidence 378999 557999999943 224444 35678888888 99999 89999999999999974 34799
Q ss_pred Eeecccc
Q 002149 758 VSDFGLV 764 (959)
Q Consensus 758 i~DfGla 764 (959)
|+||+.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.5e-18 Score=194.19 Aligned_cols=210 Identities=26% Similarity=0.377 Sum_probs=148.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.+|..++.|..|+||.||..+++ +.+++|.| +.+... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee-----------------
Confidence 56788899999999999999765 46788884 433210 0110 22222333333
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+-...+.. . ++++. +++.+++|+|+ .+|+|||+||+|.+|+.-|++|++|||+++....
T Consensus 136 ----gDc~tllk~---~--g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKN---I--GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhccc---C--CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 555454422 2 23332 23889999999 8999999999999999999999999999873321
Q ss_pred CCc--------------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh
Q 002149 770 SER--------------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 770 ~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 835 (959)
... -.....+||+.|.|||++....|...+|.|++|+++||++.|+.||.+..+++..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-------- 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------- 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--------
Confidence 110 0123468999999999999999999999999999999999999999998876632
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
..++.......+.+.....+.++++.++++.+|.+|--..
T Consensus 268 --------g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 268 --------GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred --------hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 1112222222333444455788999999999999997433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=168.54 Aligned_cols=144 Identities=18% Similarity=0.164 Sum_probs=111.7
Q ss_pred CCcccCcccccCceEEEEEE--EcCCcEEEEEEccccccc--------------------H--HHHHHHHHHHHHHHhcC
Q 002149 612 NFASENELGRGGFGVVYKGE--LDDGTKIAVKRMEAGVIS--------------------K--KAVDEFHSEIAVLSKVR 667 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~--~~~~~~vavK~~~~~~~~--------------------~--~~~~~~~~E~~~l~~l~ 667 (959)
-|++.+.||+|+||.||+|. ..+|+.||||++...... . .....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 568999999998753210 0 01234678999999997
Q ss_pred CC--CceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCC
Q 002149 668 HR--HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS-FIHRDLK 744 (959)
Q Consensus 668 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dik 744 (959)
+. .+.+++++ ...++||||++++++...... .......+...++.|++.+++|||+ .+ |+|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence 53 34444543 235899999988888665421 1345566778999999999999999 78 9999999
Q ss_pred CCCEEECCCCcEEEeeccccccCC
Q 002149 745 SSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 745 ~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|+||+++ ++.++|+|||.|....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-19 Score=195.31 Aligned_cols=80 Identities=25% Similarity=0.227 Sum_probs=39.5
Q ss_pred EEecCCccc-ccCcccccCCCCCcEEeccCCcCCCC----CC-CccCCCCccEEecCCCCCCCCC------hhhhcCCCC
Q 002149 84 IQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGE----LP-SFSGLSNLKYAYLDGNNFDTIP------ADFFDGLEN 151 (959)
Q Consensus 84 l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~i~------~~~~~~l~~ 151 (959)
|+|..+.++ +.....+..+.+|+.|+|+++.++.. ++ .+...++|++|+++++.+..++ ...|..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 445555554 23344455555566666666665432 11 2344455666666665554211 123444555
Q ss_pred CcEEEccCcccC
Q 002149 152 LQVLALDSNNFN 163 (959)
Q Consensus 152 L~~L~Ls~N~l~ 163 (959)
|++|+|++|.+.
T Consensus 83 L~~L~l~~~~~~ 94 (319)
T cd00116 83 LQELDLSDNALG 94 (319)
T ss_pred eeEEEccCCCCC
Confidence 555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=166.90 Aligned_cols=197 Identities=23% Similarity=0.229 Sum_probs=139.0
Q ss_pred CCCCceeEEEEEEeC---------------------------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHH
Q 002149 667 RHRHLVSLLGYSVAG---------------------------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719 (959)
Q Consensus 667 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 719 (959)
+|||||++.++|.+. ...|+||..+ ..+|..++.. +..+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc------CCCchHHHHHH
Confidence 599999998876432 3558999888 6789988843 45667778889
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC----CCCcEEEeeccccccCCC-----CCcceeecccccccccccccc
Q 002149 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLG----DDFRAKVSDFGLVKLAPD-----SERSVVTRLAGTFGYLAPEYA 790 (959)
Q Consensus 720 ~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~----~~~~~ki~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~ 790 (959)
+.|+++|+.|||. +||.|||+|+.|||+. +-..+.|+|||++--... ...+......|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999999 8999999999999993 234589999998642211 111122234678889999988
Q ss_pred ccCC------CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHH
Q 002149 791 VTGK------ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTI 864 (959)
Q Consensus 791 ~~~~------~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 864 (959)
...+ -..|+|.|+.|-+.||+++...||........ .... ..+..+.. .....+..+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~------Yqe~qLPa----------lp~~vpp~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT------YQESQLPA----------LPSRVPPVA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh------hhhhhCCC----------CcccCChHH
Confidence 6543 23589999999999999999999987432110 1111 00111111 111223367
Q ss_pred HHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 865 AELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 865 ~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.+++...++.||++|++..-+...++
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 79999999999999999876555443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-17 Score=191.66 Aligned_cols=192 Identities=24% Similarity=0.297 Sum_probs=154.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC---CCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 686 (959)
...|.+.+.||+|+||.||+|...+|+.||+|+-+.... -+|.--.+++.+|+ -+-|..+..++...+.-++
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 456888899999999999999887899999998765422 12222334444444 2344555555566677799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------CCcEEEe
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-------DFRAKVS 759 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-------~~~~ki~ 759 (959)
|+||.+.|+|.+++. ..+.++|.-++.++.|+++.+++||. .+|||+||||+|+||.. ...++|+
T Consensus 772 v~ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 999999999999984 44778999999999999999999999 89999999999999943 3459999
Q ss_pred eccccc---cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002149 760 DFGLVK---LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLM 816 (959)
Q Consensus 760 DfGla~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~ 816 (959)
|||.+. .+++. .......+|-.+--+|...+..++.++|.|.++-+++-|+.|+.
T Consensus 844 DfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999986 33333 34555678899999999999999999999999999999999853
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=161.52 Aligned_cols=147 Identities=20% Similarity=0.182 Sum_probs=112.8
Q ss_pred HHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccH--------------------HHHHHHHHHHHHHH
Q 002149 605 VLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK--------------------KAVDEFHSEIAVLS 664 (959)
Q Consensus 605 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~ 664 (959)
++......|...+.||+|+||.||+|...+|+.||||++....... .....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333334488889999999999999988889999999865432100 01123678899999
Q ss_pred hcCCC--CceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002149 665 KVRHR--HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRD 742 (959)
Q Consensus 665 ~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 742 (959)
.+.|+ .+.+.++. ...++||||+++++|.+... ......++.+++.++.++|+ .+|+|||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 99877 44444442 35589999999999876531 02346789999999999999 8999999
Q ss_pred CCCCCEEECCCCcEEEeeccccccCCC
Q 002149 743 LKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 743 ik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=162.75 Aligned_cols=136 Identities=24% Similarity=0.334 Sum_probs=113.8
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccH------HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK------KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+.||+|++|.||+|.. .|..|++|+........ .....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57889999865432211 1234678899999999999998877777777888999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
++|++|.+++... .+ .+..++.+++.+|.++|+ .+++|||++|.||+++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887431 12 788999999999999999 8999999999999999 78999999998864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-18 Score=192.58 Aligned_cols=279 Identities=24% Similarity=0.247 Sum_probs=199.0
Q ss_pred EEeccCCcCCCCCC--CccCCCCccEEecCCCCCCCC----ChhhhcCCCCCcEEEccCcccCC--CCCCCCCccccCcc
Q 002149 107 NIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTI----PADFFDGLENLQVLALDSNNFNA--SKGWSFPKGLQSSA 178 (959)
Q Consensus 107 ~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i----~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~lp~~l~~l~ 178 (959)
.|+|.++.+++.-. -|..+.+|++|+|+++.++.. ....+...++|++|++++|.+.. .....++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 57888888874333 367788899999999999642 23346678889999999998862 11123445677788
Q ss_pred ccCeecccccccCCCCChhhcCCCC---CCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCC-cCCc
Q 002149 179 QLTNLSCMSCNLAGQLPDFLGNFAS---LQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM-DQLR 254 (959)
Q Consensus 179 ~L~~L~l~~n~l~~~~p~~l~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l-~~L~ 254 (959)
+|+.|++++|.+.+..+..+..+.+ |++|++++|+++......+ ...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l---------------------~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL---------------------AKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH---------------------HHHHHhCCCCce
Confidence 9999999999998777777766666 9999999999874221111 0113445 7899
Q ss_pred EEEccCcccccc----CchhhcCCCCCCEEeCCCCcCCCCC----ccccccc-cCCeEeCCCCcCCCCCCcccccccccc
Q 002149 255 TLWLHGNHFSGT----IPESFGKLTSLKDLNLNSNQFVGLI----PPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYS 325 (959)
Q Consensus 255 ~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~ 325 (959)
.|+|++|.+++. ++..+..+++|++|+|++|.+++.. +..+... +|+.|+|++|.+++....
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------- 211 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS--------- 211 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH---------
Confidence 999999999843 4556777889999999999998532 2223332 699999999998742111
Q ss_pred cCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCcccc----
Q 002149 326 SNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVG---- 401 (959)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~---- 401 (959)
. +...+..+++|++|++++|.+++.....+.
T Consensus 212 ------------------~---------------------------l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~ 246 (319)
T cd00116 212 ------------------A---------------------------LAETLASLKSLEVLNLGDNNLTDAGAAALASALL 246 (319)
T ss_pred ------------------H---------------------------HHHHhcccCCCCEEecCCCcCchHHHHHHHHHHh
Confidence 0 001123458899999999999864333332
Q ss_pred -CcCcCCEEeCcccccc----cccCCCccCCCCCCeEeCCCCccCCCC--------CCC-CCcceecccCCCC
Q 002149 402 -NLDSLTQIKLQSNNIS----GQIPTNWTNLKSLTLLDLSQNNLSPPL--------PKF-SGAVKLSLDGNPL 460 (959)
Q Consensus 402 -~l~~L~~L~L~~N~l~----g~~p~~l~~l~~L~~L~Ls~N~l~~~~--------p~~-~~~~~~~l~~N~~ 460 (959)
..+.|++|++++|.++ ..+...+..+++|+.||+++|.++... ..+ ..+..+++.+|||
T Consensus 247 ~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 247 SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 2479999999999997 234556777799999999999998542 123 4566777777775
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.6e-19 Score=160.52 Aligned_cols=183 Identities=28% Similarity=0.474 Sum_probs=161.6
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
..++|.+.|++|.++ .+|+.+.+|.+|+.|++++|+|+..+++++.+++|+.|++.-|++..+|.+ |+.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprg-fgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRG-FGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccc-cCCCchhhhhhc
Confidence 357899999999999 889999999999999999999999999999999999999999999999887 999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~ 237 (959)
.+|++..- .+|..+..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|..
T Consensus 110 tynnl~e~---~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpke---------------- 168 (264)
T KOG0617|consen 110 TYNNLNEN---SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKE---------------- 168 (264)
T ss_pred cccccccc---cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHH----------------
Confidence 99999753 68999999999999999999998 78999999999999999999998 56766
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCC---CCEEeCCCCcCCCCCcc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS---LKDLNLNSNQFVGLIPP 293 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~ 293 (959)
++.++.|++|++.+|+++ .+|..++++.- =+.+.+.+|.....+.+
T Consensus 169 ---------ig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 169 ---------IGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ---------HHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 567799999999999999 88888877642 34556667766544443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-16 Score=160.32 Aligned_cols=133 Identities=24% Similarity=0.368 Sum_probs=107.7
Q ss_pred cccccCceEEEEEEEcCCcEEEEEEccccccc------HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS------KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
.||+|+||.||+|.+ ++..|++|+....... .....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 4788999986543211 112366788999999999887666555666667779999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
++++|.+.+... .. .++.+++.+|.+||+ .+++|||++|+||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998877331 00 789999999999999 8999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-16 Score=183.35 Aligned_cols=142 Identities=24% Similarity=0.334 Sum_probs=114.4
Q ss_pred HHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEc-cccccc-----HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRM-EAGVIS-----KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
.....|...+.||+|+||.||+|.+... .+++|+. .+.... ....+.+.+|+++++.++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3345567789999999999999987643 4444443 221111 12245688999999999999999888888777
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||+++++|.+++. ....++.|++++|.|||+ .+++||||||+||++ .++.++|+||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 78899999999999988873 346799999999999999 899999999999999 6789999999
Q ss_pred cccccC
Q 002149 762 GLVKLA 767 (959)
Q Consensus 762 Gla~~~ 767 (959)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.3e-17 Score=174.55 Aligned_cols=123 Identities=33% Similarity=0.488 Sum_probs=106.4
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++.|++++..+|.+++.+.+ ....-++.....++.|++.|++| ++.+|||+||.||....+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 5689999999999999996532 23556788899999999999999 489999999999999999999999999
Q ss_pred ccccCCCCC-----cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh
Q 002149 763 LVKLAPDSE-----RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT 813 (959)
Q Consensus 763 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt 813 (959)
+........ ....+...||..||+||.+.+..|+.|+||||+|++|+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987554433 223455789999999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=146.72 Aligned_cols=140 Identities=20% Similarity=0.200 Sum_probs=100.8
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHH----------------------HHHHHHHHHhcCCCC--c
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDE----------------------FHSEIAVLSKVRHRH--L 671 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~n--i 671 (959)
.+.||+|+||.||+|...+++.||||++............ ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999988754222221111 135666677765443 4
Q ss_pred eeEEEEEEeCceEEEEEEecCCCchhhH-HhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 672 VSLLGYSVAGYERLLVYEYMPQGALSKH-IFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 672 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|.. .+|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEE
Confidence 455543 245899999988654321 1110 001 56788999999999999983 689999999999999
Q ss_pred CCCCcEEEeeccccccCCC
Q 002149 751 GDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~ 769 (959)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=139.20 Aligned_cols=136 Identities=21% Similarity=0.187 Sum_probs=114.5
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC--CCceeEEEEEEeCceEEEEEEecC
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH--RHLVSLLGYSVAGYERLLVYEYMP 692 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 692 (959)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 35679999999999998764 7899998865422 4578899999999976 589999998888888999999998
Q ss_pred CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 693 QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 693 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 8777432 55667789999999999999855458999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=172.32 Aligned_cols=158 Identities=26% Similarity=0.495 Sum_probs=122.8
Q ss_pred hcCCChhhHHHHHHHHHhcCCCCCCCCCCCCCCCCCC--CCcceEecC------CcEEEEEecCCcccccCcccccCCCC
Q 002149 33 LSATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPP--CWKHVFCSN------SRVTQIQVSSVGLKGTLPQNLNQLSK 104 (959)
Q Consensus 33 ~~~~~~~~~~~l~~~~~~~~~~~~~~w~~~~~~C~~~--~w~gv~C~~------~~v~~l~l~~~~l~g~~~~~l~~l~~ 104 (959)
.+.+.+.|+.||++||+++.++...+|. +++|.+. .|.||.|+. ..|+.|+|.++++.|.+|+.+..|++
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 4567889999999999999776556885 5788533 399999952 14889999999999999999999999
Q ss_pred CcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 105 LENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 105 L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
|+.|+|++|.|.|.+| .++++++|+.|+|++|+|++..+..++++++|++|+|++|++++
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g------------------- 504 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG------------------- 504 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccc-------------------
Confidence 9999999999988777 58888888888888888887666667788888888887777654
Q ss_pred cccccccCCCCChhhcCC-CCCCEEEecCCcCCCCCCc
Q 002149 184 SCMSCNLAGQLPDFLGNF-ASLQNLKLSGNNLTGPIPE 220 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~ 220 (959)
.+|..+..+ .++..+++.+|......|.
T Consensus 505 ---------~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 505 ---------RVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred ---------cCChHHhhccccCceEEecCCccccCCCC
Confidence 445554442 4567788888876554443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.7e-14 Score=146.73 Aligned_cols=138 Identities=19% Similarity=0.218 Sum_probs=106.1
Q ss_pred cCccc-ccCceEEEEEEEcCCcEEEEEEcccccc-----------cHHHHHHHHHHHHHHHhcCCCCc--eeEEEEEEeC
Q 002149 616 ENELG-RGGFGVVYKGELDDGTKIAVKRMEAGVI-----------SKKAVDEFHSEIAVLSKVRHRHL--VSLLGYSVAG 681 (959)
Q Consensus 616 ~~~lG-~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 681 (959)
...|| .|+.|+||++... ++.++||.+..... +......+.+|++++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999876 77899998754211 11234567899999999998875 6777764432
Q ss_pred c----eEEEEEEecCC-CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcE
Q 002149 682 Y----ERLLVYEYMPQ-GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756 (959)
Q Consensus 682 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ 756 (959)
. ..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+ .||+||||||.|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 2 23599999987 688888743 234443 36789999999999 899999999999999998999
Q ss_pred EEeeccccccC
Q 002149 757 KVSDFGLVKLA 767 (959)
Q Consensus 757 ki~DfGla~~~ 767 (959)
+|+|||.++..
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.2e-16 Score=179.73 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=188.3
Q ss_pred CCcccCcccccCceEEEEEEEc--CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD--DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 688 (959)
.|...+.||+|+|+.|-..... ....+|+|.+..........+....|..+-..+. |+|++++++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4666777999999999888543 2345666766544323344455666888888886 999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCEEECCCC-cEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH-SLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~~ 766 (959)
+|..++++.+-+.. ......+......++.|+..++.|+| . .++.||||||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~---~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH---PDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred Cccccccccccccc---CCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999877631 11124556667789999999999999 6 8999999999999999999 999999999986
Q ss_pred CCC--CCcceeecccc-ccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 767 APD--SERSVVTRLAG-TFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 767 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+.. .........+| ++.|+|||...+. ......|+||.|+++.-+++|..||+........+ ..|.... ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~----~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK----GR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc----cc
Confidence 655 33334455678 9999999999885 44567999999999999999999998765443211 1111100 00
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... ... .......+++.+++..+|..|.+.+++..
T Consensus 250 ~~~~-----~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 FTQL-----PWN----SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccC-----ccc----cCChhhhhcccccccCCchhccccccccc
Confidence 0000 000 11124557888999999999999888743
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-13 Score=161.41 Aligned_cols=90 Identities=29% Similarity=0.463 Sum_probs=81.8
Q ss_pred cCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCCC-----CCc
Q 002149 376 CGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF-----SGA 450 (959)
Q Consensus 376 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-----~~~ 450 (959)
++.+++|+.|+|++|++.|.+|..++++++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|.. ..+
T Consensus 438 i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~ 517 (623)
T PLN03150 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR 517 (623)
T ss_pred HhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccC
Confidence 456789999999999999999999999999999999999999999999999999999999999999999963 234
Q ss_pred ceecccCCCCCCCCC
Q 002149 451 VKLSLDGNPLLNGKS 465 (959)
Q Consensus 451 ~~~~l~~N~~~c~~~ 465 (959)
..+++.+|+.+|+.+
T Consensus 518 ~~l~~~~N~~lc~~p 532 (623)
T PLN03150 518 ASFNFTDNAGLCGIP 532 (623)
T ss_pred ceEEecCCccccCCC
Confidence 578899999999853
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.9e-12 Score=142.59 Aligned_cols=144 Identities=25% Similarity=0.274 Sum_probs=101.6
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHH--------------------------------------HHHHHH
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKK--------------------------------------AVDEFH 657 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 657 (959)
.+.||.|++|.||+|++++|+.||||+.+......- ..-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999865421100 001345
Q ss_pred HHHHHHHhcC----CCCceeEEEEE-EeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 002149 658 SEIAVLSKVR----HRHLVSLLGYS-VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR-GMEYLH 731 (959)
Q Consensus 658 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH 731 (959)
+|++.+.+++ |.+-+.+-.++ ......++||||++|++|.+...... ... .+.+++.++++ .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHHH
Confidence 5666666653 33333332222 22345799999999999988764211 112 23457777766 467888
Q ss_pred hcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 732 ~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
. .|++|+|+||.||+++.+++++++|||++.....
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 8999999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-11 Score=139.13 Aligned_cols=149 Identities=20% Similarity=0.223 Sum_probs=97.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcC-CcEEEEEEcccccccH--------------------------------HHH---
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISK--------------------------------KAV--- 653 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~--- 653 (959)
...|+. +.||.|++|.||+|++++ |+.||||+.++..... +..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445666 789999999999999887 9999999987542100 001
Q ss_pred ---HHHHHHHHHHHhcC----CCCceeEEEEEEe-CceEEEEEEecCCCchhhHHhhcc-cCCCCCCCHHHHHHHHHHHH
Q 002149 654 ---DEFHSEIAVLSKVR----HRHLVSLLGYSVA-GYERLLVYEYMPQGALSKHIFHWK-SLNLEPLSWKRRLNIALDVA 724 (959)
Q Consensus 654 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia 724 (959)
-++.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.+.-.-.. ......+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12445555555553 4444444444433 456789999999999977421100 0011122233333333333
Q ss_pred HHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEeeccccccCCC
Q 002149 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVSDFGLVKLAPD 769 (959)
Q Consensus 725 ~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~DfGla~~~~~ 769 (959)
+. .|++|+|+||.||+++.++ +++++|||++.....
T Consensus 277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 6999999999999999888 999999999876643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-13 Score=149.58 Aligned_cols=124 Identities=23% Similarity=0.442 Sum_probs=67.0
Q ss_pred ecCCCCCCCCChhhhc-CCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEec
Q 002149 132 YLDGNNFDTIPADFFD-GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLS 210 (959)
Q Consensus 132 ~L~~N~l~~i~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls 210 (959)
.|++-+++.+|..++. .+.--...||+.|++. ++|..+..+-.|+.|.|..|.+. .+|..+.++..|..|||+
T Consensus 56 ~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-----elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 56 LLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-----ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLS 129 (722)
T ss_pred ccccchhhcCCCccccccccchhhhhccccccc-----cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhc
Confidence 3444444444433332 2333344555555555 45555555555555555555555 455666666666666666
Q ss_pred CCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCC
Q 002149 211 GNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289 (959)
Q Consensus 211 ~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 289 (959)
.|+++ ..|..+.. | -|+.|-+++|+++ .+|..++.+..|..||.+.|.+..
T Consensus 130 ~NqlS-~lp~~lC~-------------------------l-pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s 180 (722)
T KOG0532|consen 130 SNQLS-HLPDGLCD-------------------------L-PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS 180 (722)
T ss_pred cchhh-cCChhhhc-------------------------C-cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhh
Confidence 66666 33333221 1 2566666666666 566666666666666666666663
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.4e-12 Score=143.86 Aligned_cols=64 Identities=42% Similarity=0.579 Sum_probs=41.5
Q ss_pred CcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC
Q 002149 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK 446 (959)
Q Consensus 380 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 446 (959)
.++..|.+.+|++. .++..++.+++|+.|++++|+++ .++. +..+.+|+.|++++|.++..+|.
T Consensus 232 ~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 232 KNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 45555556666655 23555666677777777777777 4444 77777777777777777766654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.5e-13 Score=149.24 Aligned_cols=192 Identities=24% Similarity=0.361 Sum_probs=154.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
..+.+||+.|.+. .+|..+..+..|+.|.|..|.|..+++.+.++..|++|||+.|+++.+|... ..| -|+.|-+++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~l-C~l-pLkvli~sN 152 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGL-CDL-PLKVLIVSN 152 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhh-hcC-cceeEEEec
Confidence 4556788888887 8888888888999999999999888778899999999999999999888873 334 588899999
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~ 239 (959)
|+++ .+|..++.+..|..|+.+.|++. .+|..++.+.+|+.|++..|++. .+|..+..
T Consensus 153 Nkl~-----~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~--------------- 210 (722)
T KOG0532|consen 153 NKLT-----SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS--------------- 210 (722)
T ss_pred Cccc-----cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC---------------
Confidence 9988 68888888888999999988887 56788888889999999999888 44544322
Q ss_pred cccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc---c-CCeEeCCCCc
Q 002149 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL---S-LDHLDLNNNM 309 (959)
Q Consensus 240 l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~-L~~L~L~~N~ 309 (959)
-.|..||++.|+++ .||-.|.+|+.|++|-|.+|.|+. +|..+... . .++|+..-++
T Consensus 211 -----------LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 211 -----------LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -----------CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence 24788999999999 899999999999999999999995 45544433 2 5666665553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.4e-12 Score=143.29 Aligned_cols=194 Identities=34% Similarity=0.543 Sum_probs=94.7
Q ss_pred EeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCC-CCcEEEccCcccCCCCCCCCCccccCccccCeeccc
Q 002149 108 IGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLE-NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186 (959)
Q Consensus 108 L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~ 186 (959)
|+++.|.+...+..+..++.++.|++.+|.++.+++. ...+. +|+.|++++|++. .+|..+..+++|+.|+++
T Consensus 98 l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~-----~l~~~~~~l~~L~~L~l~ 171 (394)
T COG4886 98 LDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIE-----SLPSPLRNLPNLKNLDLS 171 (394)
T ss_pred eeccccccccCchhhhcccceeEEecCCcccccCccc-cccchhhcccccccccchh-----hhhhhhhccccccccccC
Confidence 4444444433333333334444444444444444442 22221 4444444444444 233444444444444444
Q ss_pred ccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCC-cccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLN-LVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 187 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
+|++. .+|...+.+++|+.|++++|+++ .+|.....++ +..+.+..+. ....+..+.++.++..|.+.+|++.
T Consensus 172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~---~~~~~~~~~~~~~l~~l~l~~n~~~- 245 (394)
T COG4886 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS---IIELLSSLSNLKNLSGLELSNNKLE- 245 (394)
T ss_pred Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc---ceecchhhhhcccccccccCCceee-
Confidence 44444 22333334445555555555554 2232211111 2222222221 0111112456667777777777776
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
.++..++.+++|++|++++|+++.... +..+ +++.|++++|.++...|
T Consensus 246 ~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 246 DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 446677777777777777777775433 4443 57777777777776544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-11 Score=125.71 Aligned_cols=204 Identities=22% Similarity=0.308 Sum_probs=140.6
Q ss_pred HHHHHhcCCCCceeEEEEEEeC-----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 002149 660 IAVLSKVRHRHLVSLLGYSVAG-----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734 (959)
Q Consensus 660 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 734 (959)
..-+-++.|-|||+++.|..+. .+..+++|||..|++..+|++-+. ....+......+++.||..||.|||+ +
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 3445566799999999887654 346799999999999999987543 34677888889999999999999999 6
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeeccccccCCC---CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHH
Q 002149 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD---SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMEL 811 (959)
Q Consensus 735 ~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~el 811 (959)
.++|+|+++..+-|++..++-+||.----...... ........-.+-++|.|||+-.....+.++|||+||....||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 68999999999999999999888742111100000 000011122456899999988777888899999999999999
Q ss_pred HhCCCC-CCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 812 LTGLMA-LDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 812 ltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..+..- -......+. ++.....+-. +. .. .-++++.+|+...|..||+|.+++.
T Consensus 276 ailEiq~tnseS~~~~-------------ee~ia~~i~~-le---n~-----lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEV-------------EENIANVIIG-LE---NG-----LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeeh-------------hhhhhhheee-cc---Cc-----cccCcCcccccCCCCCCcchhhhhc
Confidence 887543 221111000 1111111110 00 00 0126788999999999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.6e-12 Score=139.76 Aligned_cols=249 Identities=22% Similarity=0.229 Sum_probs=178.9
Q ss_pred CCcccCcccc--cCceEEEEEEE---cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGR--GGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~--G~fg~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 685 (959)
.|.....+|. |.+|.||.+.. .++..+|+|+-+...........=.+|+...+.++ |++.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999965 46888999985544333333344456777777774 999999888888999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEee
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR----GMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSD 760 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~D 760 (959)
+-+|++ +.++..+.+.. ...++....+.+..+... |+.++|+ .+++|-|+||.||+...+ ...+++|
T Consensus 195 iqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCC
Confidence 999998 67887776432 234666777778888888 9999999 899999999999999999 8899999
Q ss_pred ccccccCCCCCc----ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 761 FGLVKLAPDSER----SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 761 fGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
||+.....+..- ....+..|...|++||.. .+-++.++|+||+|.++.|..++.......... .|.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~--- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWS--- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccc---
Confidence 999986655442 122334678899999976 446788999999999999999986554322100 010
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.++... ...+++......+...+..++..+|..|++.+.+..
T Consensus 337 -----~~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -----QLRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----cccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111 111222222224445788899999999998876643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.9e-13 Score=136.55 Aligned_cols=62 Identities=24% Similarity=0.267 Sum_probs=40.2
Q ss_pred CcccEEECCCCcccccCCcccc-----CcCcCCEEeCccccccc----ccCCCccCCCCCCeEeCCCCccC
Q 002149 380 SKLTVLNLPNFNLSGTLSPSVG-----NLDSLTQIKLQSNNISG----QIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 380 ~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~g----~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
++|+.|++++|.++.....+|. ..++|+.|.|.+|.++- .+-..+...+.|+.|+|++|.|.
T Consensus 241 ~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 241 PHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred chheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 5677777777777655443332 34677777777777762 23334555777888888888774
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.4e-11 Score=117.78 Aligned_cols=130 Identities=19% Similarity=0.136 Sum_probs=95.9
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCce-eEEEEEEeCceEEEEEEecCCC
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV-SLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.+.++.|.++.||++... ++.|++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356899999999999876 78899998764321 123467899999999765554 444443 33458999999998
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA--HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
++.+.. .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 875420 011346789999999999932 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-10 Score=112.67 Aligned_cols=138 Identities=16% Similarity=0.136 Sum_probs=98.7
Q ss_pred CcccccCceEEEEEEEcC-------CcEEEEEEcccccc--------------------cHHHH----HHHHHHHHHHHh
Q 002149 617 NELGRGGFGVVYKGELDD-------GTKIAVKRMEAGVI--------------------SKKAV----DEFHSEIAVLSK 665 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~--------------------~~~~~----~~~~~E~~~l~~ 665 (959)
..||.|--+.||.|...+ +..+|||+.+.... ..... ....+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47899997632110 00111 223389999999
Q ss_pred cCC--CCceeEEEEEEeCceEEEEEEecCCCchhh-HHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 002149 666 VRH--RHLVSLLGYSVAGYERLLVYEYMPQGALSK-HIFHWKSLNLEPLSWKRRLNIALDVARGMEYL-HSLAHQSFIHR 741 (959)
Q Consensus 666 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~ 741 (959)
+.. -++.+++++ ...++||||+.++.+.. .+.+ ..++..+...+..+++.+|.+| |. .++||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 953 466677765 46689999996644421 2211 2344556778889999999999 77 899999
Q ss_pred CCCCCCEEECCCCcEEEeeccccccCC
Q 002149 742 DLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 742 Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|+++.||+++ ++.++|+|||.|....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.5e-11 Score=116.51 Aligned_cols=128 Identities=29% Similarity=0.373 Sum_probs=39.8
Q ss_pred ccCCCCccEEecCCCCCCCCChhhhc-CCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhh-c
Q 002149 122 FSGLSNLKYAYLDGNNFDTIPADFFD-GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFL-G 199 (959)
Q Consensus 122 ~~~l~~L~~L~L~~N~l~~i~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l-~ 199 (959)
+.+..++++|+|++|+|+.|.. ++ .+.+|+.|||++|.|+.+ +++..++.|+.|++++|+|+.. ...+ .
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l------~~l~~L~~L~~L~L~~N~I~~i-~~~l~~ 85 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKL------EGLPGLPRLKTLDLSNNRISSI-SEGLDK 85 (175)
T ss_dssp ---------------------S----TT-TT--EEE-TTS--S--------TT----TT--EEE--SS---S--CHHHHH
T ss_pred cccccccccccccccccccccc--hhhhhcCCCEEECCCCCCccc------cCccChhhhhhcccCCCCCCcc-ccchHH
Confidence 4444455556666666555532 33 355566666666665532 1334455555555555555533 2233 3
Q ss_pred CCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccC---chhhcCCCC
Q 002149 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI---PESFGKLTS 276 (959)
Q Consensus 200 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~ 276 (959)
.+++|++|+|++|+|.... .+ ..+..+++|+.|+|.+|.++..- .-.+..+|+
T Consensus 86 ~lp~L~~L~L~~N~I~~l~--~l----------------------~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~ 141 (175)
T PF14580_consen 86 NLPNLQELYLSNNKISDLN--EL----------------------EPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPS 141 (175)
T ss_dssp H-TT--EEE-TTS---SCC--CC----------------------GGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT
T ss_pred hCCcCCEEECcCCcCCChH--Hh----------------------HHHHcCCCcceeeccCCcccchhhHHHHHHHHcCh
Confidence 5778888888888886321 11 12566788888888888887321 124566778
Q ss_pred CCEEeC
Q 002149 277 LKDLNL 282 (959)
Q Consensus 277 L~~L~L 282 (959)
|+.||-
T Consensus 142 Lk~LD~ 147 (175)
T PF14580_consen 142 LKVLDG 147 (175)
T ss_dssp -SEETT
T ss_pred hheeCC
Confidence 877764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-10 Score=126.53 Aligned_cols=167 Identities=16% Similarity=0.210 Sum_probs=127.1
Q ss_pred EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCC
Q 002149 631 ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP 710 (959)
Q Consensus 631 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 710 (959)
+..++.+|.|...+.. +........+-++.++.++||||++++.........|+|+|.+ -.|..++..
T Consensus 33 ~k~~~~~vsVF~~~~~--~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRS--NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------- 100 (690)
T ss_pred eeccCCceEEEEEeCC--CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH--------
Confidence 4557888999887754 2344556778889999999999999999999999999999998 456666632
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccccccccccccc
Q 002149 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790 (959)
Q Consensus 711 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 790 (959)
++...+.-.+.||+.||.+||+. .+++|++|.-.-|++++.|+.||++|-++........ ......---.|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 33566777899999999999974 7899999999999999999999999998764433221 00111112246667655
Q ss_pred ccCCCCccchHHHHHHHHHHHHhC
Q 002149 791 VTGKITTKVDVFSFGVVLMELLTG 814 (959)
Q Consensus 791 ~~~~~~~~~DvwSlG~ll~elltg 814 (959)
.... -..|.|-|||+++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 4333 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.1e-09 Score=104.47 Aligned_cols=134 Identities=24% Similarity=0.328 Sum_probs=103.9
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHH------HHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKK------AVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
..+++|+-+.+|.+.+. |.++.+|.-.++..... ...+..+|+.++..++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 55577775433322211 234566899999999876776666677788888999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
++|..|.+.+... ...++..+-+-+.-||. .+|||+|+.++||.+..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9998888888431 24577888888899999 8999999999999998764 999999998743
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-11 Score=129.15 Aligned_cols=211 Identities=25% Similarity=0.294 Sum_probs=128.3
Q ss_pred cCCCCccEEecCCCCCCCCCh-hhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCC
Q 002149 123 SGLSNLKYAYLDGNNFDTIPA-DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNF 201 (959)
Q Consensus 123 ~~l~~L~~L~L~~N~l~~i~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l 201 (959)
+++.+|+.+.|.+..+...+. .....+++++.||||.|-|..+. .+-.....|
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~--------------------------~v~~i~eqL 171 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWF--------------------------PVLKIAEQL 171 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHH--------------------------HHHHHHHhc
Confidence 456778888888877765553 45667778888888888765321 112334567
Q ss_pred CCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc-CchhhcCCCCCCEE
Q 002149 202 ASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT-IPESFGKLTSLKDL 280 (959)
Q Consensus 202 ~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L 280 (959)
++|+.|+|+.|++........ -..+++|+.|.|+.|.|+.. +-..+..+|+|+.|
T Consensus 172 p~Le~LNls~Nrl~~~~~s~~------------------------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L 227 (505)
T KOG3207|consen 172 PSLENLNLSSNRLSNFISSNT------------------------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVL 227 (505)
T ss_pred ccchhcccccccccCCccccc------------------------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHh
Confidence 888888888888874333221 12457888899999988732 33445567899999
Q ss_pred eCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccc
Q 002149 281 NLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLV 359 (959)
Q Consensus 281 ~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 359 (959)
+|..|.....-.....-+ .|+.|||++|.+...-
T Consensus 228 ~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~--------------------------------------------- 262 (505)
T KOG3207|consen 228 YLEANEIILIKATSTKILQTLQELDLSNNNLIDFD--------------------------------------------- 262 (505)
T ss_pred hhhcccccceecchhhhhhHHhhccccCCcccccc---------------------------------------------
Confidence 999886322222222222 4888888888875310
Q ss_pred cccCCCCCCCcccccccCCCCcccEEECCCCccccc-CCcc-----ccCcCcCCEEeCcccccccccC--CCccCCCCCC
Q 002149 360 TSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT-LSPS-----VGNLDSLTQIKLQSNNISGQIP--TNWTNLKSLT 431 (959)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~g~~p--~~l~~l~~L~ 431 (959)
.....+.++.|+.|+++.|.+... +|+. ...+++|++|++..|++. ..+ ..+..+.+|+
T Consensus 263 ------------~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk 329 (505)
T KOG3207|consen 263 ------------QGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLK 329 (505)
T ss_pred ------------cccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhh
Confidence 011234567788888888887754 2332 345667777777777774 122 2233344444
Q ss_pred eEeCCCCccC
Q 002149 432 LLDLSQNNLS 441 (959)
Q Consensus 432 ~L~Ls~N~l~ 441 (959)
.|....|.|+
T Consensus 330 ~l~~~~n~ln 339 (505)
T KOG3207|consen 330 HLRITLNYLN 339 (505)
T ss_pred hhhccccccc
Confidence 4444444443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=112.96 Aligned_cols=143 Identities=20% Similarity=0.293 Sum_probs=110.4
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCC--CceeEEEEEEeCc---eEEEEEEec
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR--HLVSLLGYSVAGY---ERLLVYEYM 691 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~ 691 (959)
+.|+.|.++.||++...+|+.+++|........ .....+.+|+++++.+++. .+.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998876789999987653211 1345688999999999753 4577777766532 568999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA------------------------------------- 734 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 734 (959)
++.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99888765411 34677888889999999999998521
Q ss_pred ----------------CCCeEecCCCCCCEEECC--CCcEEEeecccccc
Q 002149 735 ----------------HQSFIHRDLKSSNILLGD--DFRAKVSDFGLVKL 766 (959)
Q Consensus 735 ----------------~~~ivH~Dik~~NiLl~~--~~~~ki~DfGla~~ 766 (959)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.7e-09 Score=99.40 Aligned_cols=145 Identities=21% Similarity=0.238 Sum_probs=107.5
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccH------HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK------KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
....+-+|+-+.|+++.+. |+...||.-..+.... -..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4577889999999999887 8888888654332221 23466778999999987656655555566666778999
Q ss_pred EecCC-CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---cEEEeecccc
Q 002149 689 EYMPQ-GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF---RAKVSDFGLV 764 (959)
Q Consensus 689 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~---~~ki~DfGla 764 (959)
||+++ .++.+++...-. ..........++.+|-+.+.-||. .+|||+||..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99955 378888765222 222233337899999999999999 8999999999999996543 4689999998
Q ss_pred cc
Q 002149 765 KL 766 (959)
Q Consensus 765 ~~ 766 (959)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.3e-10 Score=129.69 Aligned_cols=248 Identities=19% Similarity=0.151 Sum_probs=173.7
Q ss_pred HhcCCcccCcccccCceEEEEEEEc--CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD--DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 685 (959)
...+|..+..||.|.|+.|++...+ ++..+++|.+.+..........-..|+.+...+ .|.++++....+...+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999998643 577899998877644444333344677777766 4888888777666666777
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeecccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFGLV 764 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfGla 764 (959)
+=-||++++++..... -...++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||++
T Consensus 343 ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred CchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccc
Confidence 8899999999876551 12456778889999999999999999 899999999999999886 88999999998
Q ss_pred ccCCCCCcceeeccccccccc--cccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYL--APEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
....-. ......+-+++ +++......+-.+.|++|||.-+.|.++|..--.....
T Consensus 415 t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------- 471 (524)
T KOG0601|consen 415 TRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------- 471 (524)
T ss_pred ccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------------
Confidence 642211 11122233444 55555566788899999999999999998543221110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
............. .....+..+.+.++..++..||.+.+...+.+
T Consensus 472 ~~~i~~~~~p~~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 SLTIRSGDTPNLP---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ceeeecccccCCC---chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000011111011 11145667788899999999999887755433
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-10 Score=110.24 Aligned_cols=123 Identities=26% Similarity=0.309 Sum_probs=41.5
Q ss_pred cEEEEEecCCcccccCccccc-CCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLN-QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
++.+|+|.++.++ .+. .++ .+.+|+.|+|++|.|+.+ +.+..+++|++|+|++|+|+.+.......+++|++|+|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 4566777777776 332 344 467777777777777643 356667777777777777777765433457777777777
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCC---ChhhcCCCCCCEEE
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL---PDFLGNFASLQNLK 208 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~---p~~l~~l~~L~~L~ 208 (959)
+|+|..... -..+..+++|+.|+|.+|.++..- ...+..+|+|+.||
T Consensus 97 ~N~I~~l~~---l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 97 NNKISDLNE---LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp TS---SCCC---CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCcCCChHH---hHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 777765321 134455666666666666665331 12344566666665
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.9e-11 Score=123.84 Aligned_cols=189 Identities=21% Similarity=0.249 Sum_probs=87.6
Q ss_pred CCCCCcEEeccCCcCCCCCC----C-ccCCCCccEEecCCCCCCCCChhh-------------hcCCCCCcEEEccCccc
Q 002149 101 QLSKLENIGLQKNQFRGELP----S-FSGLSNLKYAYLDGNNFDTIPADF-------------FDGLENLQVLALDSNNF 162 (959)
Q Consensus 101 ~l~~L~~L~Ls~N~l~~~~~----~-~~~l~~L~~L~L~~N~l~~i~~~~-------------~~~l~~L~~L~Ls~N~l 162 (959)
..++|++||||+|-|....+ + +.++..|++|+|.+|.+...-... ...-++|++++.++|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 33455555555555533221 1 344555555555555554222111 22234555555555555
Q ss_pred CCCCCCCCCccccCccccCeecccccccCCC----CChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 163 NASKGWSFPKGLQSSAQLTNLSCMSCNLAGQ----LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 163 ~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
...+...+...+...+.|+.+.+..|.|... +...|..+++|+.|||.+|-++......++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La--------------- 234 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA--------------- 234 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH---------------
Confidence 5444444444445555555555555554321 123344555555555555555432222111
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhh----c-CCCCCCEEeCCCCcCCCCCcccc----ccc-cCCeEeCCCC
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF----G-KLTSLKDLNLNSNQFVGLIPPSL----ASL-SLDHLDLNNN 308 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~----~~~-~L~~L~L~~N 308 (959)
+.+..+++|+.|++++|.++..-..+| . ..++|+.|.|.+|.|+..-...+ ... .|..|+|++|
T Consensus 235 ------kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 235 ------KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred ------HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcc
Confidence 124445566666666666653322222 1 24566666666666653211111 111 3666666666
Q ss_pred cC
Q 002149 309 MF 310 (959)
Q Consensus 309 ~l 310 (959)
.+
T Consensus 309 ~l 310 (382)
T KOG1909|consen 309 RL 310 (382)
T ss_pred cc
Confidence 66
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.4e-10 Score=135.29 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=171.2
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccc-cccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.+.+.+.+-.|+++.++.+.-. .|...++|..... .+.....+....+-.+.-..+||-+++..--+.-....+||++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 4555667888999988877532 2433444433221 0111122233333333444455666655444445667799999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+.++++...++.. ...+.+........+..+.+|||. ..++|||++|.|++...++..+++|||.......
T Consensus 885 ~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HhccCCchhhhhcC-----CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999998888652 234555556677888899999999 6699999999999999999999999984321110
Q ss_pred C---------------------C---------cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCC
Q 002149 770 S---------------------E---------RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALD 819 (959)
Q Consensus 770 ~---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~ 819 (959)
. . ........||+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 001223579999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 820 ESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
...+... ++.+....+..............+++...+..+|.+|-.+.
T Consensus 1037 a~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7765332 23333333333444445556778899999999999998877
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.7e-11 Score=118.81 Aligned_cols=131 Identities=24% Similarity=0.297 Sum_probs=90.4
Q ss_pred CCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCC
Q 002149 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQ 205 (959)
Q Consensus 126 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 205 (959)
+.|++||||+|.|+.|... ..-++.++.|++|+|.|.. + ..+..+++|+.|+|++|.++ .+..+-..+.|++
T Consensus 284 q~LtelDLS~N~I~~iDES-vKL~Pkir~L~lS~N~i~~-----v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 284 QELTELDLSGNLITQIDES-VKLAPKLRRLILSQNRIRT-----V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred hhhhhccccccchhhhhhh-hhhccceeEEeccccceee-----e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 3466666666666666554 4556666666777666653 2 23566666666777666665 2334445677888
Q ss_pred EEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc-CchhhcCCCCCCEEeCCC
Q 002149 206 NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT-IPESFGKLTSLKDLNLNS 284 (959)
Q Consensus 206 ~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~ 284 (959)
.|.|++|.|... ++ ++.+-+|..||+++|+|... --..++++|-|+.|.|.+
T Consensus 356 tL~La~N~iE~L-----SG----------------------L~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~ 408 (490)
T KOG1259|consen 356 TLKLAQNKIETL-----SG----------------------LRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTG 408 (490)
T ss_pred eeehhhhhHhhh-----hh----------------------hHhhhhheeccccccchhhHHHhcccccccHHHHHhhcC
Confidence 999999988621 11 56778899999999999732 235889999999999999
Q ss_pred CcCCCCC
Q 002149 285 NQFVGLI 291 (959)
Q Consensus 285 N~l~~~~ 291 (959)
|.+.+.+
T Consensus 409 NPl~~~v 415 (490)
T KOG1259|consen 409 NPLAGSV 415 (490)
T ss_pred CCccccc
Confidence 9998654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.1e-11 Score=117.86 Aligned_cols=186 Identities=24% Similarity=0.260 Sum_probs=134.0
Q ss_pred cCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCC----hh-------------------hhcCCC
Q 002149 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIP----AD-------------------FFDGLE 150 (959)
Q Consensus 94 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~----~~-------------------~~~~l~ 150 (959)
.+|=.+.-+++|+.+.+|.+.-..+..-...-+.|++|...+..++..+ .. ....-+
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq 284 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQ 284 (490)
T ss_pred ccccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHh
Confidence 3444566677888888887754433221222356777777766655222 11 122335
Q ss_pred CCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccc
Q 002149 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL 230 (959)
Q Consensus 151 ~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L 230 (959)
.|++||||+|.|+ .+..++.-++.++.|++++|.+... ..+..+++|+.||||+|.++.. -.+
T Consensus 285 ~LtelDLS~N~I~-----~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gw--------- 347 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-----QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGW--------- 347 (490)
T ss_pred hhhhccccccchh-----hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhh---------
Confidence 6999999999998 5778888889999999999999843 3488899999999999999832 222
Q ss_pred cccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCC-cccccccc-CCeEeCCCC
Q 002149 231 WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI-PPSLASLS-LDHLDLNNN 308 (959)
Q Consensus 231 ~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~~~-L~~L~L~~N 308 (959)
-..+.++++|.|+.|.|.. -..+.++-+|..||+++|+|...- -..++++. |+.+.|.+|
T Consensus 348 ----------------h~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~N 409 (490)
T KOG1259|consen 348 ----------------HLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGN 409 (490)
T ss_pred ----------------HhhhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCC
Confidence 2346789999999999972 245777889999999999997432 23456665 999999999
Q ss_pred cCCCCC
Q 002149 309 MFMGPV 314 (959)
Q Consensus 309 ~l~~~i 314 (959)
.+.+.+
T Consensus 410 Pl~~~v 415 (490)
T KOG1259|consen 410 PLAGSV 415 (490)
T ss_pred Cccccc
Confidence 998743
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.7e-10 Score=122.34 Aligned_cols=207 Identities=25% Similarity=0.233 Sum_probs=101.6
Q ss_pred cCCCCCcEEeccCCcCCCCCC--CccCCCCccEEecCCCCCCCCC--hhhhcCCCCCcEEEccCcccCCCCCCCCCcccc
Q 002149 100 NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIP--ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQ 175 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~ 175 (959)
.++.+|+...|.+..+..... ....|++++.|||++|-|.... ......|++|+.|+|+.|++..-.+.. .-.
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~---~~~ 194 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN---TTL 194 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc---chh
Confidence 455666666666665543332 2455666666666666666422 234556666666666666665211100 012
Q ss_pred CccccCeecccccccCCC-CChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcccccccccCCcCC
Q 002149 176 SSAQLTNLSCMSCNLAGQ-LPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQL 253 (959)
Q Consensus 176 ~l~~L~~L~l~~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L 253 (959)
.+++|+.|.|++|.++-. +...+..+++|+.|+|..|..-........-+ .+..|.+.++..-.+... ...++++.|
T Consensus 195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~-~~~~~l~~L 273 (505)
T KOG3207|consen 195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQG-YKVGTLPGL 273 (505)
T ss_pred hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccc-cccccccch
Confidence 455666667777766621 22233456677777777774211111111101 122222222222111110 124556666
Q ss_pred cEEEccCcccccc-Cchh-----hcCCCCCCEEeCCCCcCCCCCccccccc----cCCeEeCCCCcCCC
Q 002149 254 RTLWLHGNHFSGT-IPES-----FGKLTSLKDLNLNSNQFVGLIPPSLASL----SLDHLDLNNNMFMG 312 (959)
Q Consensus 254 ~~L~L~~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~L~~L~L~~N~l~~ 312 (959)
+.|.++.+.+... +|+. ...+++|++|+++.|++..- ..+..+ +|+.|.+..|+|+.
T Consensus 274 ~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w--~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 274 NQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW--RSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hhhhccccCcchhcCCCccchhhhcccccceeeecccCccccc--cccchhhccchhhhhhcccccccc
Confidence 6666666666532 2333 34456677777777766421 112221 45666666666653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-10 Score=130.74 Aligned_cols=217 Identities=28% Similarity=0.306 Sum_probs=123.4
Q ss_pred CCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcccc
Q 002149 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQL 180 (959)
Q Consensus 101 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L 180 (959)
.+..++.++++.|.|......+..+++|+.|+|.+|+|..+... +..+.+|++|+|++|.|+.+
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i--------------- 133 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL--------------- 133 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc---------------
Confidence 45555666666666665333456666666666666666665543 45566666666666666532
Q ss_pred CeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccC
Q 002149 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG 260 (959)
Q Consensus 181 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~ 260 (959)
. .+..++.|+.|++++|.|+.. .. +..+++|+.+++++
T Consensus 134 -------------~--~l~~l~~L~~L~l~~N~i~~~-~~--------------------------~~~l~~L~~l~l~~ 171 (414)
T KOG0531|consen 134 -------------E--GLSTLTLLKELNLSGNLISDI-SG--------------------------LESLKSLKLLDLSY 171 (414)
T ss_pred -------------c--chhhccchhhheeccCcchhc-cC--------------------------CccchhhhcccCCc
Confidence 1 234445577777777777622 11 33356777777777
Q ss_pred ccccccCchh-hcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCC
Q 002149 261 NHFSGTIPES-FGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPC 338 (959)
Q Consensus 261 N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~ 338 (959)
|++...-+ . ...+.+|+.+++.+|.+...- .+... .+..+++..|.++..-+.
T Consensus 172 n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~l---------------------- 226 (414)
T KOG0531|consen 172 NRIVDIEN-DELSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEGL---------------------- 226 (414)
T ss_pred chhhhhhh-hhhhhccchHHHhccCCchhccc--chHHHHHHHHhhcccccceeccCc----------------------
Confidence 77763322 2 456677777777777776331 12222 344446666666532110
Q ss_pred chhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCC--cccEEECCCCcccccCCccccCcCcCCEEeCccccc
Q 002149 339 APEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNS--KLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNI 416 (959)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 416 (959)
..+. .|+.+++++|.+. .++..+..+..+..|++.+|++
T Consensus 227 --------------------------------------~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~ 267 (414)
T KOG0531|consen 227 --------------------------------------NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRI 267 (414)
T ss_pred --------------------------------------ccchhHHHHHHhcccCccc-cccccccccccccccchhhccc
Confidence 0011 2667777777776 3334566667777777777777
Q ss_pred ccccCCCccCCCCCCeEeCCCCccC
Q 002149 417 SGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 417 ~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
... ..+.....+..+.++.|.+.
T Consensus 268 ~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 268 SNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ccc--ccccccchHHHhccCcchhc
Confidence 632 22444555666666666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.5e-08 Score=102.17 Aligned_cols=142 Identities=15% Similarity=0.144 Sum_probs=101.3
Q ss_pred cccccCceEEEEEEEcCCcEEEEEEcccccccH---------HHHHHHHHHHHHHHhcCCCC--ceeEEEEEEe-----C
Q 002149 618 ELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK---------KAVDEFHSEIAVLSKVRHRH--LVSLLGYSVA-----G 681 (959)
Q Consensus 618 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~ 681 (959)
.+-+.....|++..+. |+.+.||......... .....+.+|...+..+...+ .++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3443444457777664 7889999764332111 01114778999998885444 3455666643 2
Q ss_pred ceEEEEEEecCCC-chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-------C
Q 002149 682 YERLLVYEYMPQG-ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-------D 753 (959)
Q Consensus 682 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-------~ 753 (959)
..-++|||++++. +|.+++..+.. .+.+...+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 3568999999876 78888754321 345667788999999999999999 89999999999999975 5
Q ss_pred CcEEEeecccccc
Q 002149 754 FRAKVSDFGLVKL 766 (959)
Q Consensus 754 ~~~ki~DfGla~~ 766 (959)
+.+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998763
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.3e-09 Score=85.87 Aligned_cols=60 Identities=42% Similarity=0.636 Sum_probs=51.1
Q ss_pred CCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCccc
Q 002149 103 SKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNF 162 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 162 (959)
++|++|+|++|+|+.+++ .|.++++|++|++++|+|+.+++.+|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 467888888888888777 588888888888888888888888888888888888888865
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=5e-08 Score=96.95 Aligned_cols=128 Identities=22% Similarity=0.295 Sum_probs=83.9
Q ss_pred EEEEEEEcCCcEEEEEEcccccc------------------------cHHHHHHHHHHHHHHHhcCCC--CceeEEEEEE
Q 002149 626 VVYKGELDDGTKIAVKRMEAGVI------------------------SKKAVDEFHSEIAVLSKVRHR--HLVSLLGYSV 679 (959)
Q Consensus 626 ~V~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 679 (959)
.||.|...+|+.+|||..+.... .........+|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999888899999997632100 111235577899999999765 566666552
Q ss_pred eCceEEEEEEecC--CCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEECCCCcE
Q 002149 680 AGYERLLVYEYMP--QGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL-HSLAHQSFIHRDLKSSNILLGDDFRA 756 (959)
Q Consensus 680 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dik~~NiLl~~~~~~ 756 (959)
..++||||++ |..+.. +... .++......++.+++..+..+ |. .|+||+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~------~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV------DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC------GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhh-HHhc------cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 4479999997 544543 3221 111334566888888866664 67 899999999999999988 99
Q ss_pred EEeeccccccCC
Q 002149 757 KVSDFGLVKLAP 768 (959)
Q Consensus 757 ki~DfGla~~~~ 768 (959)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7.8e-10 Score=126.25 Aligned_cols=214 Identities=27% Similarity=0.311 Sum_probs=144.2
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCc
Q 002149 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 160 (959)
+..+.+..+.+. .+-..+..+++|+.|+|.+|+|..+...+..+++|++|+|++|+|+.+.. +..++.|+.|++++|
T Consensus 74 l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N 150 (414)
T KOG0531|consen 74 LKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGN 150 (414)
T ss_pred HHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheeccC
Confidence 333445555555 34455888999999999999998766558889999999999999998876 677888999999999
Q ss_pred ccCCCCCCCCCccccCccccCeecccccccCCCCC-hhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCC
Q 002149 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239 (959)
Q Consensus 161 ~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~ 239 (959)
.|+.+ ..+..+..|+.+++++|.+...-+ . +..+.+|+.+++.+|.+.....-.. ...+..+.+.++....
T Consensus 151 ~i~~~------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~-~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 151 LISDI------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDL-LKKLVLLSLLDNKISK 222 (414)
T ss_pred cchhc------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHH-HHHHHHhhccccccee
Confidence 99854 344558899999999999986554 2 5778899999999999874322111 0112222233333333
Q ss_pred cccccccccCCcC--CcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCC
Q 002149 240 FTGTIDVLGNMDQ--LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFM 311 (959)
Q Consensus 240 l~~~~~~l~~l~~--L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~ 311 (959)
+.+ +..+.. |+.+++++|.+. .++..+..+..+..|++.+|++...-. .-....+..+.+..|.+.
T Consensus 223 ~~~----l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~-~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 223 LEG----LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG-LERLPKLSELWLNDNKLA 290 (414)
T ss_pred ccC----cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc-ccccchHHHhccCcchhc
Confidence 322 222232 778888888877 444566677778888888887774311 111113555566666654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.8e-09 Score=83.16 Aligned_cols=61 Identities=38% Similarity=0.547 Sum_probs=57.4
Q ss_pred CcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCcc
Q 002149 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL 440 (959)
Q Consensus 380 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l 440 (959)
++|+.|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999988778999999999999999999988888999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.9e-07 Score=97.16 Aligned_cols=170 Identities=19% Similarity=0.267 Sum_probs=125.6
Q ss_pred eEEEEEE-EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE----eCceEEEEEEecCC-Cchhh
Q 002149 625 GVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV----AGYERLLVYEYMPQ-GALSK 698 (959)
Q Consensus 625 g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 698 (959)
.+.||+. ..||..|+.|+++.... ........-+++++++.|.|||++.+++. .+...++||+|+++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 5789995 45899999999943311 11112234578899999999999998776 34577899999986 45766
Q ss_pred HHhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 699 HIFHWKS----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 699 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
.-+.... ......+++.+|.++.|++.||.++|+ .|+.-+-+.+++|+++.+.+++|+-.|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5543221 122457889999999999999999999 899999999999999999999998888766443
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMA 817 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p 817 (959)
.+.. |-+ .--.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 3220 101 112467888999999999999543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.2e-07 Score=94.28 Aligned_cols=136 Identities=21% Similarity=0.196 Sum_probs=99.0
Q ss_pred CcccCcccccCceEEEEEEEcCCcEEEEEEcccccc------------------c--HHHHHHHHHHHHHHHhcCCC--C
Q 002149 613 FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVI------------------S--KKAVDEFHSEIAVLSKVRHR--H 670 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~--~~~~~~~~~E~~~l~~l~h~--n 670 (959)
+.+..+||-|.-+.||.|...+|.++|||.=..... + .......++|.++|..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999998999999993211100 1 11234567899999999654 6
Q ss_pred ceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 671 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
+.+.+++ +...+||||+++--|...- ++.+..-.++..|++-+.-+-. .||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 7777765 4568999999886664432 1233344455555555555555 799999999999999
Q ss_pred CCCCcEEEeeccccc
Q 002149 751 GDDFRAKVSDFGLVK 765 (959)
Q Consensus 751 ~~~~~~ki~DfGla~ 765 (959)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.4e-08 Score=121.54 Aligned_cols=298 Identities=22% Similarity=0.249 Sum_probs=169.6
Q ss_pred cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCC--CCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCc
Q 002149 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNN--FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~--l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l 177 (959)
.+....+.+.+.+|.+....... ..++|++|-+..|. +..++..+|..++.|++|||++|.=- ..+|..++.|
T Consensus 520 ~~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l----~~LP~~I~~L 594 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSL----SKLPSSIGEL 594 (889)
T ss_pred cchhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCcc----CcCChHHhhh
Confidence 33467788888888876544333 33479999999997 88899889999999999999986432 2799999999
Q ss_pred cccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcccccccccCCcCCcEE
Q 002149 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256 (959)
Q Consensus 178 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L 256 (959)
-+|++|+++...+. .+|..+.+|..|.+|++..+.-...+|.....+ +|+.|.+.......-......+.++.+|+.|
T Consensus 595 i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~l 673 (889)
T KOG4658|consen 595 VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENL 673 (889)
T ss_pred hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhh
Confidence 99999999999988 789999999999999999887665666554433 4555554443311111112334455555555
Q ss_pred EccCccccccCchhhcCCCCC----CEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccC
Q 002149 257 WLHGNHFSGTIPESFGKLTSL----KDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQ 331 (959)
Q Consensus 257 ~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~ 331 (959)
........ +-..+..++.| +.+.+..+... ..+..+..+ +|+.|.+.++.+....-....... .+.
T Consensus 674 s~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~------~~~ 744 (889)
T KOG4658|consen 674 SITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLI------VLL 744 (889)
T ss_pred eeecchhH--hHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccc------hhh
Confidence 54333321 11111222222 22332222222 222333444 577777777776532111000000 000
Q ss_pred CCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCccccccc-CCCCcccEEECCCCcccccCCccccCcCcCCEEe
Q 002149 332 PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC-GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410 (959)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 410 (959)
+.+..... ....|......+. .-.++|+.|++..+.....+.+....+..+.++-
T Consensus 745 ------~f~~l~~~------------------~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i 800 (889)
T KOG4658|consen 745 ------CFPNLSKV------------------SILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELI 800 (889)
T ss_pred ------hHHHHHHH------------------HhhccccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEE
Confidence 00000000 0001111111110 1237888888888887777777677777777766
Q ss_pred Ccccccccc-cCCCccCCCCCCeEeCC
Q 002149 411 LQSNNISGQ-IPTNWTNLKSLTLLDLS 436 (959)
Q Consensus 411 L~~N~l~g~-~p~~l~~l~~L~~L~Ls 436 (959)
+..+.+.+. .-.....++++..+.++
T Consensus 801 ~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 801 LPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred ecccccccceeeecCCCCceeEecccC
Confidence 777777654 23344455555544444
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=9.4e-10 Score=122.96 Aligned_cols=58 Identities=34% Similarity=0.462 Sum_probs=38.9
Q ss_pred cCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCC
Q 002149 251 DQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFM 311 (959)
Q Consensus 251 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~ 311 (959)
..|...+.+.|.+. .+..++.-++.|+.|||++|+++..- .+..+ .|++|||++|.+.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~ 222 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR 222 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc
Confidence 35667777777777 56666766777788888888777542 44444 4666666666665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.7e-06 Score=90.55 Aligned_cols=262 Identities=16% Similarity=0.137 Sum_probs=158.9
Q ss_pred ccCcccccCceEEEEE-EEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEE------EEeCc-eEE
Q 002149 615 SENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGY------SVAGY-ERL 685 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~-~~~ 685 (959)
..+.||+|+.+.+|-. ... ..+.|+++... ..... +-++.|... .||-+-.-+.| .-++. ..-
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pp--pa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPP--PAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCC--chHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 4567999999999975 222 23447766542 22221 122333443 56644332222 11222 256
Q ss_pred EEEEecCCCc-hhhHHhh-cccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 686 LVYEYMPQGA-LSKHIFH-WKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 686 lv~e~~~~gs-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
+.|..+++.- +..+..- .+........|...++++..+|.+.+.||. .|.+-+|+.++|+|+.+++.+.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccc
Confidence 7788776542 2222211 112333568899999999999999999999 8999999999999999999999998654
Q ss_pred cccCCCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhC-CCCCCCCCh-------HHHHHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTG-LMALDESRP-------EERQYLA 830 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg-~~p~~~~~~-------~~~~~~~ 830 (959)
-....+. ....-.+|...|.+||... +-.-+...|.|.+|+++++++.| ++||.+... -|. .+.
T Consensus 164 fqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~-~Ia 240 (637)
T COG4248 164 FQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET-DIA 240 (637)
T ss_pred eeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh-hhh
Confidence 3333222 2233457899999999764 23456679999999999999987 999976532 110 111
Q ss_pred HHHHhhhcchHHHHHhcCCcccCCCCCHH-HHHHHHHHHHhcccCC--CCCCCCHHHHHHHHHHhHhh
Q 002149 831 AWFWNIKSDKEKLRAAIDPILEVNDDTFE-TFWTIAELAGHCTSRE--PSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~d--P~~RPt~~ev~~~L~~~~~~ 895 (959)
.. ....... +-...........+. .+..+.-+..+|+... +.-||+++.-+..|..+.++
T Consensus 241 ~g---~f~ya~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HG---RFAYASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cc---eeeechh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00 0000000 000000111112222 2235667777887753 56899999988888877665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=88.13 Aligned_cols=107 Identities=24% Similarity=0.355 Sum_probs=84.3
Q ss_pred HHHHHHHHHHHHhcCCC--CceeEEEEEEeC----ceEEEEEEecCCC-chhhHHhhcccCCCCCCCHHHHHHHHHHHHH
Q 002149 653 VDEFHSEIAVLSKVRHR--HLVSLLGYSVAG----YERLLVYEYMPQG-ALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725 (959)
Q Consensus 653 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 725 (959)
.....+|...+..+... .+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 44677898888888543 355667776653 2458999999874 7888885422 1556677889999999
Q ss_pred HHHHHHhcCCCCeEecCCCCCCEEECCCC---cEEEeeccccccC
Q 002149 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDF---RAKVSDFGLVKLA 767 (959)
Q Consensus 726 gL~yLH~~~~~~ivH~Dik~~NiLl~~~~---~~ki~DfGla~~~ 767 (959)
.++-||+ .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 8999999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-07 Score=115.38 Aligned_cols=179 Identities=21% Similarity=0.246 Sum_probs=92.4
Q ss_pred cEEEEEecCCc--ccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEE
Q 002149 80 RVTQIQVSSVG--LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156 (959)
Q Consensus 80 ~v~~l~l~~~~--l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 156 (959)
.+++|-+.++. +.-..+..|..++.|+.|||++|.=-+..| .+++|-+|++|+|++..++.+|.+ +.+|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~LP~~-l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISHLPSG-LGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccccchH-HHHHHhhheec
Confidence 45555555554 332233446667777777777665444444 567777777777777777777766 67777777777
Q ss_pred ccCcccCCCCCCCCCccccCccccCeecccccccC--CCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccc
Q 002149 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA--GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLND 234 (959)
Q Consensus 157 Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~ 234 (959)
+.++.-.. .+|..+..+.+|++|.+...... ...-..+.++.+|+.|........ .+-.-.....+..+...-
T Consensus 625 l~~~~~l~----~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~-~~e~l~~~~~L~~~~~~l 699 (889)
T KOG4658|consen 625 LEVTGRLE----SIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVL-LLEDLLGMTRLRSLLQSL 699 (889)
T ss_pred cccccccc----cccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhH-hHhhhhhhHHHHHHhHhh
Confidence 77665432 22444455777777776554421 222233344444444443222220 000000000111111100
Q ss_pred c-CCCCcccccccccCCcCCcEEEccCcccc
Q 002149 235 Q-KGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264 (959)
Q Consensus 235 ~-~~~~l~~~~~~l~~l~~L~~L~L~~N~l~ 264 (959)
. ...........+..+.+|+.|.+.++.+.
T Consensus 700 ~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 700 SIEGCSKRTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hhcccccceeecccccccCcceEEEEcCCCc
Confidence 0 11233333445666777777777777775
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.8e-08 Score=100.39 Aligned_cols=196 Identities=19% Similarity=0.192 Sum_probs=99.1
Q ss_pred cEEEEEecCCcccc----cCcccccCCCCCcEEeccCCcCCC-----------CCCCccCCCCccEEecCCCCCCC-CCh
Q 002149 80 RVTQIQVSSVGLKG----TLPQNLNQLSKLENIGLQKNQFRG-----------ELPSFSGLSNLKYAYLDGNNFDT-IPA 143 (959)
Q Consensus 80 ~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~Ls~N~l~~-----------~~~~~~~l~~L~~L~L~~N~l~~-i~~ 143 (959)
.++.++|++|.+.. .+...+.+-.+|+..+++.-...- ..+.+.+|++|+..+||.|.|.. .|+
T Consensus 31 ~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~e 110 (388)
T COG5238 31 ELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPE 110 (388)
T ss_pred ceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccch
Confidence 46667777766643 233445556666666666532221 11234556666666666666652 221
Q ss_pred ---hhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCc
Q 002149 144 ---DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE 220 (959)
Q Consensus 144 ---~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 220 (959)
..++.-+.|++|.|++|.+..+.+..+..++.++...+ -..+-|.|+.+....|++......
T Consensus 111 ~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nK---------------Kaa~kp~Le~vicgrNRlengs~~ 175 (388)
T COG5238 111 ELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNK---------------KAADKPKLEVVICGRNRLENGSKE 175 (388)
T ss_pred HHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHh---------------hhccCCCceEEEeccchhccCcHH
Confidence 34555566666666666665444433333333322111 123446677777777777632222
Q ss_pred ccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc-----CchhhcCCCCCCEEeCCCCcCCCCCcccc
Q 002149 221 SFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT-----IPESFGKLTSLKDLNLNSNQFVGLIPPSL 295 (959)
Q Consensus 221 ~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 295 (959)
....+ +..-.+|+++.+..|.|.-. +-..+..+.+|+.|||.+|.++-.....+
T Consensus 176 ~~a~~---------------------l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~L 234 (388)
T COG5238 176 LSAAL---------------------LESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYL 234 (388)
T ss_pred HHHHH---------------------HHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHH
Confidence 11100 11224667777777766421 11123345667777777776664433332
Q ss_pred c----ccc-CCeEeCCCCcCC
Q 002149 296 A----SLS-LDHLDLNNNMFM 311 (959)
Q Consensus 296 ~----~~~-L~~L~L~~N~l~ 311 (959)
+ ..+ |+.|.+.+|-++
T Consensus 235 a~al~~W~~lrEL~lnDClls 255 (388)
T COG5238 235 ADALCEWNLLRELRLNDCLLS 255 (388)
T ss_pred HHHhcccchhhhccccchhhc
Confidence 2 222 455555555554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-07 Score=107.40 Aligned_cols=151 Identities=18% Similarity=0.233 Sum_probs=102.3
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcce--------eeccccccccccccccc
Q 002149 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV--------VTRLAGTFGYLAPEYAV 791 (959)
Q Consensus 720 ~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 791 (959)
+.+++.|+.|+|.. .++||++|.|++|.+++++..||+.|+.+.......... ..-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999985 799999999999999999999999999865332211110 01123456899999999
Q ss_pred cCCCCccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHh
Q 002149 792 TGKITTKVDVFSFGVVLMELL-TGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGH 870 (959)
Q Consensus 792 ~~~~~~~~DvwSlG~ll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 870 (959)
+...+.++|+||+||++|.+. .|+.-+............ ...+. .....+.-..+.++.+=+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~-~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLN-AGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccc-cccccccccCcHHHHHHHHH
Confidence 988999999999999999999 454444333221111000 00000 00111223445577888899
Q ss_pred cccCCCCCCCCHHHHHH
Q 002149 871 CTSREPSQRPDMGHAVN 887 (959)
Q Consensus 871 cl~~dP~~RPt~~ev~~ 887 (959)
++..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999998777654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-05 Score=80.62 Aligned_cols=140 Identities=21% Similarity=0.195 Sum_probs=102.3
Q ss_pred ccccCceEEEEEEEcCCcEEEEEEcccccc-c---HHHHHHHHHHHHHHHhcCC--CCceeEEEEEEe----CceEEEEE
Q 002149 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVI-S---KKAVDEFHSEIAVLSKVRH--RHLVSLLGYSVA----GYERLLVY 688 (959)
Q Consensus 619 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----~~~~~lv~ 688 (959)
-|+||-+-|++-... |..+=+|+-..... + +.....|.+|...+.++.. -.+.+++.+... ...-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477899999998776 45688887542211 1 3356789999999999953 235555522222 12457999
Q ss_pred EecCC-CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc--EEEeeccccc
Q 002149 689 EYMPQ-GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR--AKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~--~ki~DfGla~ 765 (959)
|-+.+ -+|.+++..+ ...+.+...+..+..+++..+.-||+ .|+.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98843 4787777432 22456777888999999999999999 89999999999999986666 9999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-05 Score=80.65 Aligned_cols=156 Identities=22% Similarity=0.231 Sum_probs=104.7
Q ss_pred ecHHHHHHHhcCCcccCccc---ccCceEEEEEEEcCCcEEEEEEcccccccHH----------------------HHHH
Q 002149 601 ISVQVLRNVTKNFASENELG---RGGFGVVYKGELDDGTKIAVKRMEAGVISKK----------------------AVDE 655 (959)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~lG---~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~ 655 (959)
.+.+.++.+..+..+.+..| .|.-+.||+|...++..+|||+++.....-. ....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666777777766666554 5666799999888899999998754311100 1122
Q ss_pred HHHHHHHHHhcC--CCCceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 002149 656 FHSEIAVLSKVR--HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733 (959)
Q Consensus 656 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 733 (959)
..+|+.-|+++. +-.+.+.+++. .-.|||||+...-. .......-++..++...+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~-----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGL-----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCC-----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 346777777773 44555666553 44799999954311 01112222334446777888888888887653
Q ss_pred CCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 734 ~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
.++||+||..-|||+. ++.+.|+|||.|....
T Consensus 186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 7999999999999999 8899999999886543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.6e-08 Score=87.71 Aligned_cols=81 Identities=22% Similarity=0.326 Sum_probs=41.7
Q ss_pred EEEEEecCCcccccCccc---ccCCCCCcEEeccCCcCCCCCCCccC-CCCccEEecCCCCCCCCChhhhcCCCCCcEEE
Q 002149 81 VTQIQVSSVGLKGTLPQN---LNQLSKLENIGLQKNQFRGELPSFSG-LSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~---l~~l~~L~~L~Ls~N~l~~~~~~~~~-l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 156 (959)
...++|+++.|- .+++. +....+|+..+|++|.|...++.|.. ++.++.|+|++|.|+.+|.. |..++.|+.|+
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lN 106 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLN 106 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcc
Confidence 444555555543 33332 33344445555566655555554432 34555555555555555555 55555555555
Q ss_pred ccCcccC
Q 002149 157 LDSNNFN 163 (959)
Q Consensus 157 Ls~N~l~ 163 (959)
+++|.|.
T Consensus 107 l~~N~l~ 113 (177)
T KOG4579|consen 107 LRFNPLN 113 (177)
T ss_pred cccCccc
Confidence 5555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3e-06 Score=97.08 Aligned_cols=143 Identities=22% Similarity=0.259 Sum_probs=93.2
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccH----------------------------HH----------HHHHHH
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK----------------------------KA----------VDEFHS 658 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----------------------------~~----------~~~~~~ 658 (959)
+.|+.++-|.||+|++++|+.||||+.+...... .. .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999774331100 00 112334
Q ss_pred HHHHHHhcC----CCCceeEEEEEE-eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHh
Q 002149 659 EIAVLSKVR----HRHLVSLLGYSV-AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM-EYLHS 732 (959)
Q Consensus 659 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~ 732 (959)
|+..+.+++ ..--+++=.++. .....+|+|||++|-.+.+...... ..++ +..++..++++. ..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 555555552 222223333332 3456789999999988888742211 2233 233444444432 22222
Q ss_pred cCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 733 ~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
.|++|.|..|.||+++.++++.+.|||+......
T Consensus 284 ---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 ---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5899999999999999999999999999876544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 959 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-50 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-42 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-27 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-27 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-26 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-26 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-26 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-26 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-26 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-26 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-26 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-26 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-26 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-26 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-26 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-25 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-21 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-21 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-21 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-14 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 1e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 4e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-128
Identities = 113/303 (37%), Positives = 170/303 (56%), Gaps = 20/303 (6%)
Query: 600 VISVQVLRNVTKNFASE------NELGRGGFGVVYKGELDDGTKIAVKRMEAGVI--SKK 651
S L+NVT NF N++G GGFGVVYKG ++ T +AVK++ A V +++
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 652 AVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPL 711
+F EI V++K +H +LV LLG+S G + LVY YMP G+L + PL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPL 130
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771
SW R IA A G+ +LH IHRD+KS+NILL + F AK+SDFGL + +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 772 RSVV-TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830
++V+ +R+ GT Y+APE + G+IT K D++SFGVVL+E++TGL A+DE R Q L
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLL 244
Query: 831 AWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890
I+ +++ + ID + D + + +A C + ++RPD+ +L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 891 PLV 893
+
Sbjct: 303 EMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-127
Identities = 112/315 (35%), Positives = 172/315 (54%), Gaps = 9/315 (2%)
Query: 576 TESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDG 635
S + + +S+++ + + + L T NF + +G G FG VYKG L DG
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 636 TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGA 695
K+A+KR S + ++EF +EI LS RH HLVSL+G+ E +L+Y+YM G
Sbjct: 64 AKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755
L +H+ + L +SW++RL I + ARG+ YLH+ ++ IHRD+KS NILL ++F
Sbjct: 122 LKRHL-YGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 756 AKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
K++DFG+ K + +++ + T + GT GY+ PEY + G++T K DV+SFGVVL E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 815 LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSR 874
A+ +S P E LA W + +L +DP L E+ + A C +
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRP-ESLRKFGDTAVKCLAL 295
Query: 875 EPSQRPDMGHAVNVL 889
RP MG + L
Sbjct: 296 SSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-120
Identities = 119/297 (40%), Positives = 174/297 (58%), Gaps = 10/297 (3%)
Query: 606 LRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVD-EFHSEIAVLS 664
L+ + NF+++N LGRGGFG VYKG L DGT +AVKR++ + + +F +E+ ++S
Sbjct: 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQFQTEVEMIS 82
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
HR+L+ L G+ + ERLLVY YM G+++ + + + PL W +R IAL A
Sbjct: 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-RERPESQPPLDWPKRQRIALGSA 141
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
RG+ YLH IHRD+K++NILL ++F A V DFGL KL + V T + GT G+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRP--EERQYLAAWFWNIKSDKEK 842
+APEY TGK + K DVF +GV+L+EL+TG A D +R ++ L W + +K K
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-K 260
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA--PLVEKWK 897
L A +D L+ N E + ++A CT P +RP M V +L L E+W+
Sbjct: 261 LEALVDVDLQGNYKDEEVE-QLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 4e-76
Identities = 69/314 (21%), Positives = 115/314 (36%), Gaps = 33/314 (10%)
Query: 601 ISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEI 660
+ + L + RG FG V+K +L +AVK K + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI---QDKQSWQNEYEV 69
Query: 661 AVLSKVRHRHLVSLLGYSVAG----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
L ++H +++ +G G + L+ + +G+LS L +SW
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF------LKANVVSWNEL 123
Query: 717 LNIALDVARGMEYLHSLAHQS-------FIHRDLKSSNILLGDDFRAKVSDFGL-VKLAP 768
+IA +ARG+ YLH HRD+KS N+LL ++ A ++DFGL +K
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 769 DSERSVVTRLAGTFGYLAPEYA-----VTGKITTKVDVFSFGVVLMELLTGLMALDESRP 823
GT Y+APE ++D+++ G+VL EL + A D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 824 EERQYLAAWFWNIKSDKEKLRAAI-----DPILEVNDDTFETFWTIAELAGHCTSREPSQ 878
E S E ++ + P+L + E C +
Sbjct: 244 EYMLPFEEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 879 RPDMGHAVNVLAPL 892
R G + +
Sbjct: 303 RLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 5e-67
Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 22/283 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ ++G G FG V++ E G+ +AVK + + V+EF E+A++ ++RH ++V +
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G +V EY+ +G+L + + H KS E L +RRL++A DVA+GM YLH+ +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLL-H-KSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+HR+LKS N+L+ + KV DFGL +L + S AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPS 216
Query: 796 TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVND 855
K DV+SFGV+L EL T P + + + R LE+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--------KCKR------LEIPR 262
Query: 856 DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898
+ A + C + EP +RP +++L PL++ P
Sbjct: 263 NLNPQV---AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 6e-67
Identities = 87/317 (27%), Positives = 140/317 (44%), Gaps = 35/317 (11%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +GRG FGVV K + +A+K++E S+ F E+ LS+V H ++V L
Sbjct: 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G + LV EY G+L + + L + ++ L ++G+ YLHS+
Sbjct: 68 GACLNPV--CLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 736 QSFIHRDLKSSNILLGDDFR-AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++ IHRDLK N+LL K+ DFG ++ +T G+ ++APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854
+ K DVFS+G++L E++T DE + + A R +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-------TR------PPLI 226
Query: 855 DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLP 914
+ + L C S++PSQRP M V ++ L+ P DEP +Y +SLP
Sbjct: 227 KNLPKPI---ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY-FPGADEPLQYPCQ-HSLP 281
Query: 915 LNQMVKDWQEAEGKDLS 931
+ D + D +
Sbjct: 282 PGE---DGRVEPYVDFA 295
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 5e-65
Identities = 107/426 (25%), Positives = 171/426 (40%), Gaps = 78/426 (18%)
Query: 40 DIDILNQFRKNLENPELLQ-WPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLK---GTL 95
+I L F+ L + LL W + +PC + V C + +VT I +SS L +
Sbjct: 13 EIHQLISFKDVLPDKNLLPDWSSNKNPCT---FDGVTCRDDKVTSIDLSSKPLNVGFSAV 69
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNF-DTIPADFFDG-LENLQ 153
+L L+ LE++ L + G + F ++L L N+ + G L+
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 129
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPD---FLGNFASLQNLKLS 210
L + SN + GL+ + L L + +++G L++L +S
Sbjct: 130 FLNVSSNTLDFP--GKVSGGLKLN-SLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 211 GNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES 270
GN ++G + S + +NL L ++ F+ I LG+ L+ L + GN SG +
Sbjct: 187 GNKISGDVDVS-RCVNLEFLDVSSNN---FSTGIPFLGDCSALQHLDISGNKLSGDFSRA 242
Query: 271 FGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC 330
T LK LN++SNQFVG IPP SL +L L + N F
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLK-SLQYLSL-------------------AENKF- 281
Query: 331 QPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNF 390
+G P +L +C LT L+L
Sbjct: 282 --------------------------------TGEIP--DFLSGAC---DTLTGLDLSGN 304
Query: 391 NLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQNNLSPPLPKFSG 449
+ G + P G+ L + L SNN SG++P + ++ L +LDLS N S LP+
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 450 AVKLSL 455
+ SL
Sbjct: 365 NLSASL 370
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 7e-62
Identities = 108/408 (26%), Positives = 175/408 (42%), Gaps = 54/408 (13%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNL---NQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
+ + + +S+ + G + +L+++ + N+ G++ S NL++
Sbjct: 147 GLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFL 205
Query: 132 YLDGNNFD-TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
+ NNF IP F LQ L + N + G F + + + +L L+ S
Sbjct: 206 DVSSNNFSTGIP--FLGDCSALQHLDISGNKLS---G-DFSRAISTCTELKLLNISSNQF 259
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL--NLVNLWLNDQKGGGFTGTI-DVL 247
G +P SLQ L L+ N TG IP+ G L L L+ F G +
Sbjct: 260 VGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH---FYGAVPPFF 314
Query: 248 GNMDQLRTLWLHGNHFSGTIP-ESFGKLTSLKDLNLNSNQFVGLIPPSLASLS--LDHLD 304
G+ L +L L N+FSG +P ++ K+ LK L+L+ N+F G +P SL +LS L LD
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 305 LNNNMFMGPVPKSKAYKYSY-------SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPR 357
L++N F GP+ + +N F T +P L +
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGF---TGKIP---------PTLSNCSELVS 422
Query: 358 LVTSW---SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSN 414
L S+ SG P S G+ SKL L L L G + + + +L + L N
Sbjct: 423 LHLSFNYLSGTIP------SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 415 NISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA----VKLSLDGN 458
+++G+IP+ +N +L + LS N L+ +PK+ G L L N
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-61
Identities = 101/388 (26%), Positives = 161/388 (41%), Gaps = 29/388 (7%)
Query: 79 SRVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDG 135
S + + +SS G LP + L ++ L+ + L N+F GELP + ++L L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 136 NNFD-TIPADFFDG-LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQ 193
NNF I + LQ L L +N F P L + ++L +L L+G
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFT----GKIPPTLSNCSELVSLHLSFNYLSGT 433
Query: 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVLGNMD 251
+P LG+ + L++LKL N L G IP+ + L L L+ TG I L N
Sbjct: 434 IPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND---LTGEIPSGLSNCT 490
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
L + L N +G IP+ G+L +L L L++N F G IP L SL LDLN N+F
Sbjct: 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550
Query: 311 MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS 370
G +P + + + + ++ + + + +
Sbjct: 551 NGTIPAA-----------MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF-QG 598
Query: 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSL 430
S N+ + G SP+ N S+ + + N +SG IP ++ L
Sbjct: 599 IRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL 658
Query: 431 TLLDLSQNNLSPPLPK-FSGAVKL-SLD 456
+L+L N++S +P L LD
Sbjct: 659 FILNLGHNDISGSIPDEVGDLRGLNILD 686
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-61
Identities = 97/388 (25%), Positives = 143/388 (36%), Gaps = 43/388 (11%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAY 132
+ +T + +S G +P S LE++ L N F GELP + + LK
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349
Query: 133 LDGNNF-DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL--QSSAQLTNLSCMSCN 189
L N F +P + +L L L SNNF+ G L L L +
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFS---G-PILPNLCQNPKNTLQELYLQNNG 405
Query: 190 LAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF---KGLNLVNLWLNDQKGGGFTGTI-D 245
G++P L N + L +L LS N L+G IP S L + LWLN G I
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM-----LEGEIPQ 460
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLD 304
L + L TL L N +G IP T+L ++L++N+ G IP + L L L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 305 LNNNMFMGPVPKSKAYKYSY------SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRL 358
L+NN F G +P ++N F +P + +
Sbjct: 521 LSNNSFSGNIPAELG-DCRSLIWLDLNTNLF---NGTIP--AAMFKQSGKIAANFI---- 570
Query: 359 VTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418
+G + + K G S + L + + S G
Sbjct: 571 ----AGKRY----VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 419 QIPTNWTNLKSLTLLDLSQNNLSPPLPK 446
+ N S+ LD+S N LS +PK
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-60
Identities = 111/403 (27%), Positives = 152/403 (37%), Gaps = 72/403 (17%)
Query: 87 SSVGLKGTLP-QNLNQLSKLENIGLQKNQFRGELPS----FSGLSNLKYAYLDGNNFD-T 140
SS L +L+ LE + L N G G LK+ + GN
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193
Query: 141 IPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGN 200
+ NL+ L + SNNF+ P L + L +L L+G +
Sbjct: 194 VD---VSRCVNLEFLDVSSNNFS---T-GIP-FLGDCSALQHLDISGNKLSGDFSRAIST 245
Query: 201 FASLQNLKLSGNNLTGPIPES-FKGLNLVNLWLNDQKGGGFTGTI--DVLGNMDQLRTLW 257
L+ L +S N GPIP K L ++L N FTG I + G D L L
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN-----KFTGEIPDFLSGACDTLTGLD 300
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP-SLASL-SLDHLDLNNNMFMGPVP 315
L GNHF G +P FG + L+ L L+SN F G +P +L + L LDL+ N F G +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 316 KS------KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369
+S SSN F SG
Sbjct: 361 ESLTNLSASLLTLDLSSNNF---------------------------------SGPIL-- 385
Query: 370 SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKS 429
L + L L L N +G + P++ N L + L N +SG IP++ +L
Sbjct: 386 PNLCQNPKNT--LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443
Query: 430 LTLLDLSQNNLSPPLPKFSGAVK----LSLDGNPLLNGKSPGS 468
L L L N L +P+ VK L LD N L G+ P
Sbjct: 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFN-DLTGEIPSG 485
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-58
Identities = 108/449 (24%), Positives = 166/449 (36%), Gaps = 62/449 (13%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLS-KLENIGLQKNQFRGELPSFSG---LSNLKY 130
+ + +S G LP++L LS L + L N F G + + L+
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 131 AYLDGNNFD-TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN 189
YL N F IP + L L L N + G + P L S ++L +L
Sbjct: 399 LYLQNNGFTGKIPPTLSN-CSELVSLHLSFNYLS---G-TIPSSLGSLSKLRDLKLWLNM 453
Query: 190 LAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVL 247
L G++P L +L+ L L N+LTG IP NL + L++ + TG I +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR---LTGEIPKWI 510
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNN 307
G ++ L L L N FSG IP G SL L+LN+N F G IP ++ S +
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK---IAA 567
Query: 308 NMFMGPVPKS----KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363
N G K + + + ++ L N +
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS------EQLNRLSTRNPCNITSRVYG 621
Query: 364 GNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
G+ + N + L++ LSG + +G++ L + L N+ISG IP
Sbjct: 622 GHTS------PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE 675
Query: 424 WTNLKSLTLLDLSQNNLSPPLP-----------------KFSGAV----------KLSLD 456
+L+ L +LDLS N L +P SG +
Sbjct: 676 VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL 735
Query: 457 GNPLLNGKS-PGSGSSSGNPPSPTKGSSS 484
NP L G P S+ + + + S
Sbjct: 736 NNPGLCGYPLPRCDPSNADGYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-34
Identities = 58/300 (19%), Positives = 92/300 (30%), Gaps = 80/300 (26%)
Query: 182 NLSCMSCNLA-GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGF 240
+LS N+ + L + L++L LS +++ G +
Sbjct: 56 DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-------------------- 95
Query: 241 TGTIDVLGNMDQLRTLWLHGNHFSGTIPE--SFGKLTSLKDLNLNSNQFVGLIP-PSLAS 297
L +L L N SG + S G + LK LN++SN
Sbjct: 96 ------FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLK 149
Query: 298 L-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPP 356
L SL+ LDL+ N G G
Sbjct: 150 LNSLEVLDLSANSISGANVVG----------------------------WVLSDGC---G 178
Query: 357 RLVT------SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410
L SG+ + L L++ + N S + P +G+ +L +
Sbjct: 179 ELKHLAISGNKISGD--------VDVSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLD 229
Query: 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF--SGAVKLSLDGNPLLNGKSPGS 468
+ N +SG + L LL++S N P+P LSL N G+ P
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN-KFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-22
Identities = 51/255 (20%), Positives = 82/255 (32%), Gaps = 76/255 (29%)
Query: 224 GLNLVNLWLNDQKGGGFTGTI-DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNL 282
++L + LN + L ++ L +L+L +H +G++ F SL L+L
Sbjct: 54 SIDLSSKPLN-----VGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDL 107
Query: 283 NSNQFVGLIPP--SLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCA 339
+ N G + SL S S L L++ SSN
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNV-------------------SSNTL---------- 138
Query: 340 PEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPS 399
L L+ L VL+L ++SG
Sbjct: 139 -----------------------DFPGKVSGGLKLN-----SLEVLDLSANSISGANVVG 170
Query: 400 V---GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKL--- 453
L + + N ISG + + +L LD+S NN S +P L
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHL 228
Query: 454 SLDGNPLLNGKSPGS 468
+ GN L+G +
Sbjct: 229 DISGN-KLSGDFSRA 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-19
Identities = 46/233 (19%), Positives = 71/233 (30%), Gaps = 66/233 (28%)
Query: 249 NMDQLRTLWLHGNHFS---GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
D++ ++ L + + S LT L+ L L+++ G + S SL LDL
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 306 NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365
+ N SG
Sbjct: 108 SRNSL----------------------------------------------------SGP 115
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS-PSVGNLDSLTQIKLQSNNISGQIPTNW 424
+ LG SC S L LN+ + L L+SL + L +N+ISG W
Sbjct: 116 VTTLTSLG-SC---SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171
Query: 425 T---NLKSLTLLDLSQNNLSPPLP--KFSGAVKLSLDGNPLLNGKSPGSGSSS 472
L L +S N +S + + L + N + P G S
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN-NFSTGIPFLGDCS 223
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-14
Identities = 26/114 (22%), Positives = 46/114 (40%), Gaps = 1/114 (0%)
Query: 377 GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
+ L ++L N L+G + +G L++L +KL +N+ SG IP + +SL LDL+
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 437 QNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSP 490
N + +P + N + GK + G +
Sbjct: 547 TNLFNGTIPAAMFKQSGKIAAN-FIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-11
Identities = 26/139 (18%), Positives = 48/139 (34%), Gaps = 33/139 (23%)
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384
+S + E LI F L L WS N ++ G++C + K+T
Sbjct: 4 ASPSQSLYREI-------HQLISFKDVLPDKNLL-PDWSSNKNPCTFDGVTC-RDDKVTS 54
Query: 385 LNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPL 444
++L + L+ + ++ +L L L LS ++++ +
Sbjct: 55 IDLSSKPLNVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSV 93
Query: 445 PKFSGAVKL---SLDGNPL 460
F + L L N L
Sbjct: 94 SGFKCSASLTSLDLSRNSL 112
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-64
Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 39/290 (13%)
Query: 616 ENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKA-----VDEFHSEIAVLSKVRHR 669
E ++G+GGFG+V+KG + D + +A+K + G + EF E+ ++S + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V L G +V E++P G L + K+ P+ W +L + LD+A G+EY
Sbjct: 84 NIVKLYGLMHNPP--RMVMEFVPCGDLYHRL-LDKA---HPIKWSVKLRLMLDIALGIEY 137
Query: 730 LHSLAHQSFIHRDLKSSNILL-----GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+ + + +HRDL+S NI L AKV+DFGL + + S V+ L G F +
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 785 LAPE--YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842
+APE A T K D +SF ++L +LTG DE + +++ +E
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM------IREEG 246
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892
LR + +D + C S +P +RP + V L+ L
Sbjct: 247 LR------PTIPEDCPPRL---RNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 75/323 (23%), Positives = 121/323 (37%), Gaps = 48/323 (14%)
Query: 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV--LSKVR 667
N +GRG +G VYKG LD +AVK S F +E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF-----SFANRQNFINEKNIYRVPLME 65
Query: 668 HRHLVSLLGYSVAGY-----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
H ++ + E LLV EY P G+L K+ L+L W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY------LSLHTSDWVSSCRLAHS 119
Query: 723 VARGMEYLHSLAHQSF------IHRDLKSSNILLGDDFRAKVSDFGL-------VKLAPD 769
V RG+ YLH+ + HRDL S N+L+ +D +SDFGL + P
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 770 SERSVVTRLAGTFGYLAPEYA-------VTGKITTKVDVFSFGVVLMELLTGLMALDESR 822
E + GT Y+APE +VD+++ G++ E+ L
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 823 PEERQYLAAWFWNIKSDK--EKLRAAID------PILEVNDDTFETFWTIAELAGHCTSR 874
+Y A+ + + E ++ + E + ++ E C +
Sbjct: 240 SVP-EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 875 EPSQRPDMGHAVNVLAPLVEKWK 897
+ R A +A L+ W+
Sbjct: 299 DAEARLTAQXAEERMAELMMIWE 321
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 78/284 (27%), Positives = 124/284 (43%), Gaps = 37/284 (13%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRHRHLVS 673
E +G GGFG VY+ G ++AVK + ++ E + + ++H ++++
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 674 LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
L G + LV E+ G L++ L+ + + +N A+ +ARGM YLH
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRV------LSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 734 AHQSFIHRDLKSSNILLGDDFR--------AKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
A IHRDLKSSNIL+ K++DFGL + + + AG + ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWM 181
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845
APE + DV+S+GV+L ELLTG + Y A KL
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--------NKLA- 232
Query: 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
L + E F A+L C + +P RP + ++ L
Sbjct: 233 -----LPIPSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 7e-62
Identities = 78/285 (27%), Positives = 133/285 (46%), Gaps = 29/285 (10%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G G FG VYKG+ +AVK + + + + F +E+ VL K RH +++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
GYS A +L +V ++ +L H+ H K+ ++IA ARGM+YLH+
Sbjct: 87 GYSTA--PQLAIVTQWCEGSSLYHHL-HASE---TKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL-APDSERSVVTRLAGTFGYLAPE---YA 790
+S IHRDLKS+NI L +D K+ DFGL + S +L+G+ ++APE
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
+ + + DV++FG+VL EL+TG + ++ ++ D K+R+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895
+ L C ++ +RP + + L +
Sbjct: 258 M-------------KRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 1e-60
Identities = 60/286 (20%), Positives = 110/286 (38%), Gaps = 35/286 (12%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+L G ++KG G I VK ++ S + +F+ E L H +++ +L
Sbjct: 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 676 GYSVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
G + + +MP G+L + + + + ALD+ARGM +LH+L
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 734 AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
L S ++++ +D A++S + ++APE A+
Sbjct: 131 EPL-IPRHALNSRSVMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPE-ALQK 182
Query: 794 K----ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K D++SF V+L EL+T + + E A E LR
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL--------EGLR----- 229
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895
+ ++L C + +P++RP V +L + +K
Sbjct: 230 -PTIPPGISPHV---SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-60
Identities = 73/307 (23%), Positives = 120/307 (39%), Gaps = 42/307 (13%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
LG+G FG K + G + +K + ++ F E+ V+ + H +++
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+G + EY+ G L I W +R++ A D+A GM YLHS
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGII-KSMD---SQYPWSQRVSFAKDIASGMAYLHS-- 126
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE-------------RSVVTRLAGT 781
+ IHRDL S N L+ ++ V+DFGL +L D + R + G
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 782 FGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841
++APE KVDVFSFG+VL E++ + A + P + + +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------GLNVRG 238
Query: 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL---VEKWKP 898
L + +F + C +P +RP + L L + P
Sbjct: 239 FLD------RYCPPNCPPSF---FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 899 LDDEPEE 905
L + E+
Sbjct: 290 LGPQLEQ 296
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-57
Identities = 59/305 (19%), Positives = 119/305 (39%), Gaps = 41/305 (13%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G+G FG VY G ++A++ ++ ++ + F E+ + RH ++V +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
G ++ ++ L + K L + IA ++ +GM YLH+
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKL----APDSERSVVTRLAGTFGYLAPE--- 788
+ +H+DLKS N+ D+ + ++DFGL + + G +LAPE
Sbjct: 149 KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 789 ------YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842
+ DVF+ G + EL P + Q A W +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW------PFKTQPAEAIIWQM---GTG 258
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDE 902
++ + + + + I+++ C + E +RP +++L L ++ + L
Sbjct: 259 MKPNL-SQIGMGKE-------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL-SH 309
Query: 903 PEEYS 907
P +
Sbjct: 310 PGHFW 314
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-56
Identities = 67/318 (21%), Positives = 125/318 (39%), Gaps = 45/318 (14%)
Query: 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSE-- 659
S+Q R V ++ +G+G +G V++G G +AVK + S + + E
Sbjct: 1 SMQ--RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETE 52
Query: 660 IAVLSKVRHRHLVSLLGYSVAGY----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKR 715
+ +RH +++ + + + L+ Y G+L + L L L
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY------LQLTTLDTVS 106
Query: 716 RLNIALDVARGMEYLHSLAHQSF-----IHRDLKSSNILLGDDFRAKVSDFGLVKL---A 767
L I L +A G+ +LH + HRDLKS NIL+ + + ++D GL + +
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 768 PDSERSVVTRLAGTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTGLMALDES 821
+ GT Y+APE +VD+++FG+VL E+ +++
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 822 RP-----EERQYLAAWFWNIKSD--KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSR 874
+ F +++ ++ R P + + T ++A+L C +
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQ 282
Query: 875 EPSQRPDMGHAVNVLAPL 892
PS R L +
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-55
Identities = 80/309 (25%), Positives = 134/309 (43%), Gaps = 27/309 (8%)
Query: 36 TDPGDIDILNQFRKNLENPELLQ-WPKSGDPCGPPCWKHVFCSN----SRVTQIQVSSVG 90
+P D L Q +K+L NP L W + D C W V C RV + +S +
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 91 LKGT--LPQNLNQLSKLENIGLQK-NQFRGELP-SFSGLSNLKYAYLDGNNFD-TIPADF 145
L +P +L L L + + N G +P + + L+ L Y Y+ N IP DF
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DF 120
Query: 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL- 204
++ L L N + G + P + S L ++ ++G +PD G+F+ L
Sbjct: 121 LSQIKTLVTLDFSYNALS---G-TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 205 QNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI-DVLGNMDQLRTLWLHGNHF 263
++ +S N LTG IP +F LNL + L+ G + G+ + + L N
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNM---LEGDASVLFGSDKNTQKIHLAKNSL 233
Query: 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK----SK 318
+ + G +L L+L +N+ G +P L L L L+++ N G +P+ +
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 319 AYKYSYSSN 327
+Y++N
Sbjct: 293 FDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 71/303 (23%), Positives = 103/303 (33%), Gaps = 80/303 (26%)
Query: 169 SFPKGLQSSAQL----TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG--PIPESF 222
K L + L C + G L D + NL LSG NL PIP S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS- 71
Query: 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG-NHFSGTIPESFGKLTSLKDLN 281
L N+ L L++ G N+ G IP + KLT L L
Sbjct: 72 ------------------------LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 282 LNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340
+ G IP L+ + L LD + N G +P S
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS----------------------- 144
Query: 341 EVMALIDFLGGLNYPPRLVT------SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394
+ L P LV SG P S+ S T + + L+G
Sbjct: 145 --------ISSL---PNLVGITFDGNRISGAIP-DSYGSFS----KLFTSMTISRNRLTG 188
Query: 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKL- 453
+ P+ NL +L + L N + G + + K+ + L++N+L+ L K + L
Sbjct: 189 KIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLN 247
Query: 454 SLD 456
LD
Sbjct: 248 GLD 250
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 44/168 (26%)
Query: 329 FCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPC--KSWLGLSCGTN------- 379
C P + AL+ L P L +SW C ++WLG+ C T+
Sbjct: 2 LCNPQDK-------QALLQIKKDLGNPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVN 53
Query: 380 ----------------------SKLTVLNLPNFN-LSGTLSPSVGNLDSLTQIKLQSNNI 416
L L + N L G + P++ L L + + N+
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 417 SGQIPTNWTNLKSLTLLDLSQNNLSPPLP----KFSGAVKLSLDGNPL 460
SG IP + +K+L LD S N LS LP V ++ DGN +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 21/94 (22%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
++L L + + N+SG + + + +L + N +SG +P + ++L +L + N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 440 LSPPLPKFSG-----AVKLSLDGNPLLNGKSPGS 468
+S +P G +++ N L GK P +
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRN-RLTGKIPPT 193
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 32/133 (24%), Positives = 51/133 (38%), Gaps = 12/133 (9%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFD-TIPADFFDG 148
L G +P L+ L + L +N G+ F N + +L N+ +
Sbjct: 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--VGL 242
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
+NL L L +N G + P+GL L +L+ NL G++P GN
Sbjct: 243 SKNLNGLDLRNNRIY---G-TLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSA 297
Query: 209 LSGNNLT--GPIP 219
+ N P+P
Sbjct: 298 YANNKCLCGSPLP 310
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 39/304 (12%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
++G+G +G V+ G+ G K+AVK +++A +EI +RH +++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 676 GYSVAGYER----LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ G L+ +Y G+L + L L K L +A G+ +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDY------LKSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 732 SLAHQSF-----IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV---VTRLAGTFG 783
+ + HRDLKS NIL+ + ++D GL V GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 784 YLAPE------YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837
Y+ PE + D++SFG++L E+ ++ + Y +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 838 SD-------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890
+ +KLR P + E + +L C + P+ R LA
Sbjct: 272 YEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 891 PLVE 894
+ E
Sbjct: 328 KMSE 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 62/304 (20%), Positives = 118/304 (38%), Gaps = 39/304 (12%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ +G+G FG V++G+ G ++AVK + ++ +EI +RH +++ +
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 676 G----YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ + LV +Y G+L + LN ++ + + +AL A G+ +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDY------LNRYTVTVEGMIKLALSTASGLAHLH 156
Query: 732 SLAHQS-----FIHRDLKSSNILLGDDFRAKVSDFGLVKL---APDSERSVVTRLAGTFG 783
+ HRDLKS NIL+ + ++D GL A D+ GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 784 YLAPE------YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837
Y+APE + + D+++ G+V E+ + Y +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 838 SD-------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890
+ ++KLR P + + E +A++ C + R L+
Sbjct: 277 VEEMRKVVCEQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 891 PLVE 894
L +
Sbjct: 333 QLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 7e-47
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
++GRG FG V+ G L D T +AVK + +F E +L + H ++V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+G +V E + G + ++ L K L + D A GMEYL S
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RT-EGARLRVKTLLQMVGDAAAGMEYLES-- 231
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY----LAPEYA 790
+ IHRDL + N L+ + K+SDFG+ + D G APE
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEAL 287
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
G+ +++ DV+SFG++L E +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 616 ENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG+G FG V D G +AVK+++ +++ + +F EI +L ++H +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 72
Query: 671 LVSLLGYSVAGYER--LLVYEYMPQGALSKHIF-HWKSLNLEPLSWKRRLNIALDVARGM 727
+V G + R L+ EY+P G+L ++ H + ++ L L + +GM
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 127
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYL 785
EYL + + +IHRDL + NIL+ ++ R K+ DFGL K+ P + + G +
Sbjct: 128 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLT 813
APE K + DV+SFGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-46
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 616 ENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG+G FG V D G +AVK+++ +++ + +F EI +L ++H +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDN 103
Query: 671 LVSLLGYSVAGYER--LLVYEYMPQGALSKHIF-HWKSLNLEPLSWKRRLNIALDVARGM 727
+V G + R L+ EY+P G+L ++ H + ++ L L + +GM
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGM 158
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYL 785
EYL + + +IHRDL + NIL+ ++ R K+ DFGL K+ P + + G +
Sbjct: 159 EYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLT 813
APE K + DV+SFGVVL EL T
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 616 ENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG G FG V D G ++AVK ++ + + EI +L + H +
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHEN 84
Query: 671 LVSLLG--YSVAGYERLLVYEYMPQGALSKHIF-HWKSLNLEPLSWKRRLNIALDVARGM 727
+V G G L+ E++P G+L +++ + +NL+ L A+ + +GM
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGM 139
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYL 785
+YL S + ++HRDL + N+L+ + + K+ DFGL K + + +
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLT 813
APE + K DV+SFGV L ELLT
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-45
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 616 ENELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+ ELG G FG V KG +AVK ++ DE +E V+ ++ + ++V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
++G +LV E G L+K++ + + + + + + V+ GM+YL
Sbjct: 82 RMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 135
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYA 790
+F+HRDL + N+LL AK+SDFGL K E + G + + APE
Sbjct: 136 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
K ++K DV+SFGV++ E +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 67/207 (32%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 616 ENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+LG G FG V D G +AVK ++A + + EI +L + H H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94
Query: 671 LVSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
++ G LV EY+P G+L + L + + L A + GM
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDY------LPRHSIGLAQLLLFAQQICEGMA 148
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLA 786
YLH+ Q +IHRDL + N+LL +D K+ DFGL K P+ R G + A
Sbjct: 149 YLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
PE K DV+SFGV L ELLT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E+G G FG+V+ G + K+A+K + G +S+ ++F E V+ K+ H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 69
Query: 676 GYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G + LV E+M G LS ++ E L L + LDV GM YL
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE-- 122
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVT 792
IHRDL + N L+G++ KVSDFG+ + D + S T+ + +PE
Sbjct: 123 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSF 179
Query: 793 GKITTKVDVFSFGVVLMELLT 813
+ ++K DV+SFGV++ E+ +
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-44
Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+++LG G +G VY+G +AVK ++ + +EF E AV+ +++H +LV L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 281
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
LG ++ E+M G L ++ + N + +S L +A ++ MEYL
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEK-- 336
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++FIHR+L + N L+G++ KV+DFGL +L + + APE K
Sbjct: 337 -KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 795 ITTKVDVFSFGVVLMELLT 813
+ K DV++FGV+L E+ T
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-44
Identities = 74/412 (17%), Positives = 141/412 (34%), Gaps = 78/412 (18%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP----------S 121
F ++ + ++ +L+ L + + L+++ + + S
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 122 FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNAS--KGWSFPKGLQSSAQ 179
F L L++ ++ N+ I ++ F GL NL+ L+L ++ + +F S
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP-ESFKGL-NLVNLWLNDQKG 237
+ NL+ ++ D L+ L L N + + + ++GL N+ ++L+ K
Sbjct: 385 ILNLT--KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK- 441
Query: 238 GGFTGTI-DVLGNMDQLRTLWLHGNHFSG--TIPESFGKLTSLKDLNLNSNQFVGLIPPS 294
+ + + L+ L L + P F L +L L+L++N +
Sbjct: 442 --YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 295 LASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353
L L L+ LDL +N
Sbjct: 500 LEGLEKLEILDLQHN--------------------------------------------- 514
Query: 354 YPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS 413
L W +P L S L +LNL + +L L I L
Sbjct: 515 ---NLARLWKHANPGGPIYFL--KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLS--PP---LPKFSGAVKLSLDGNPL 460
NN++ + + N SL L+L +N ++ P F +L + NP
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-43
Identities = 73/409 (17%), Positives = 124/409 (30%), Gaps = 54/409 (13%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYA 131
+ + + + L + + L + L N + F NL
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
L N + LENLQ L L +N A K + +++ L L S +
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL--DIFANSSLKKLELSSNQIK 184
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESF----KGLNLVNLWLNDQKGGGFTGTI-DV 246
P L L L+ L + E ++ NL L++ + + T
Sbjct: 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ---LSTTSNTT 241
Query: 247 LGNMD--QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHL 303
+ L L L N+ + +SF L L+ L N L SL L ++ +L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT-SW 362
+L + S S + + + L L +
Sbjct: 302 NLKRSFTKQ----------SISLASLPKIDDFS------------FQWL---KCLEHLNM 336
Query: 363 SGNDPCKSWLGLSCGTN-SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS-----NNI 416
N + + T L L+L + + + + + SL L N I
Sbjct: 337 EDN--DIPGIKSNMFTGLINLKYLSL-SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 417 SGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--FSGAVKL---SLDGNPL 460
S ++ L L +LDL N + L + G + L N
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-42
Identities = 72/380 (18%), Positives = 118/380 (31%), Gaps = 79/380 (20%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKY 130
+ CS+ ++TQ+ P +L + + + L NQ R +F+ S L
Sbjct: 7 EVADCSHLKLTQV-----------PDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
+ N + + L L+VL L N + K LT L MS ++
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLS----DKTFAFCTNLTELHLMSNSI 109
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGN 249
+ +L L LS N L+ + L NL L L++ K +
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
Query: 250 MDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS----LSLDHLDL 305
L+ L L N P F + L L LN+ Q + L S+ +L L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 306 NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365
+N+ GL
Sbjct: 230 SNSQLSTTSN-------------------------------TTFLGLK------------ 246
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT 425
+ LT+L+L NL+ + S L L L+ NNI +
Sbjct: 247 -------------WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 426 NLKSLTLLDLSQNNLSPPLP 445
L ++ L+L ++ +
Sbjct: 294 GLFNVRYLNLKRSFTKQSIS 313
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-41
Identities = 79/416 (18%), Positives = 130/416 (31%), Gaps = 68/416 (16%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG-ELPSFSGLSNLKYA 131
F + +T++ + S ++ + L + L N +L + L NL+
Sbjct: 91 KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150
Query: 132 YLDGNNFDTIPADFFDGLEN--LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN 189
L N + ++ D N L+ L L SN P + +L L +
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS----PGCFHAIGRLFGLFLNNVQ 206
Query: 190 LAGQLPDFLGNFA---SLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI-D 245
L L + L S++NL LS + L+ +F GL NL + D D
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSN---------QFVGLIPPSLA 296
+ QL +L N+ S L +++ LNL + + S
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 297 SL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYP 355
L L+HL++ +N G + GL
Sbjct: 327 WLKCLEHLNMEDNDIPGIKS-------------------------------NMFTGL--- 352
Query: 356 PRLVT------SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQI 409
L S +S L +LNL +S S + L L +
Sbjct: 353 INLKYLSLSNSFTSLRTLTNE--TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 410 KLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLSPPLPK-FSGAVKL---SLDGNPL 460
L N I ++ W L+++ + LS N F+ L L L
Sbjct: 411 DLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-41
Identities = 80/371 (21%), Positives = 127/371 (34%), Gaps = 64/371 (17%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
P+ +L L+ + LQ N+ +F+ +NL +L N+ I + F +NL
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFA--SLQNLKLSGN 212
L L N +++K L L + + + L FA SL+ L+LS N
Sbjct: 126 LDLSHNGLSSTK----LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 213 NLTGPIPESFKGL-NLVNLWLND-QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES 270
+ P F + L L+LN+ Q G T + + +R L L + S T +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 271 FG--KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
F K T+L L+L+ N + S A L L++ L N S
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS---------- 291
Query: 328 AFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNL 387
L GL + +L L T ++
Sbjct: 292 ---------------------LHGL---FNV-----------RYLNLK----RSFTKQSI 312
Query: 388 PNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS---PPL 444
+L S L L + ++ N+I G +T L +L L LS + S
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372
Query: 445 PKFSGAVKLSL 455
F L
Sbjct: 373 ETFVSLAHSPL 383
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-41
Identities = 76/419 (18%), Positives = 125/419 (29%), Gaps = 70/419 (16%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG---ELPSFSGLSNL 128
+ F + + +S GL T QL L+ + L N+ + E S+L
Sbjct: 114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173
Query: 129 KYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSC 188
K L N F + L L L++ S L ++ + NLS +
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT-SIRNLSLSNS 232
Query: 189 NLAGQLPDFLGN--FASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI- 244
L+ + +L L LS NNL +SF L L +L
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN---IQHLFS 289
Query: 245 DVLGNMDQLRTLWLHGN---------HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
L + +R L L + SF L L+ LN+ N G+
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349
Query: 296 ASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSN------AFCQPTEGVPCAPEVMALIDF 348
L +L +L L+N+ ++ + S + ++ A
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA--------- 400
Query: 349 LGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLT 407
L L VL+L + L+ L+++
Sbjct: 401 FSWL---------------------------GHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 408 QIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS------PPLPKFSGAVKLSLDGNPL 460
+I L N ++ + SL L L + L P L L N +
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-39
Identities = 82/421 (19%), Positives = 142/421 (33%), Gaps = 68/421 (16%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNL---NQLSKLENIGLQKNQFRGELP-SFSGL-- 125
F + R+ + +++V L +L + L + + N+ L +Q +F GL
Sbjct: 188 PGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKW 247
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFP-----KGLQSSAQL 180
+NL L NN + + D F L L+ L+ NN S + L
Sbjct: 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSF 307
Query: 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGG 239
T S +L L++L + N++ G F GL NL L L++
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 240 FTGTIDVLGNMDQ--LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS-LA 296
T T + ++ L L L N S ++F L L+ L+L N+ +
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 297 SL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDF----LGG 351
L ++ + L+ N ++ + N+F + + L
Sbjct: 428 GLENIFEIYLSYNKYLQ-----------LTRNSFALVPS--------LQRLMLRRVALKN 468
Query: 352 LNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKL 411
++ P LT+L+L N N++ + L+ L + L
Sbjct: 469 VDSSPSPFQP-----------------LRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 412 QSNNIS--------GQIPTNWTNLKSLTLLDLSQNNLS--PP--LPKFSGAVKLSLDGNP 459
Q NN++ G L L +L+L N P + L N
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571
Query: 460 L 460
L
Sbjct: 572 L 572
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-39
Identities = 68/342 (19%), Positives = 109/342 (31%), Gaps = 61/342 (17%)
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
+ + A +P D N+ VL L N +F QLT+L
Sbjct: 5 SHEVADCSHLKLTQVPDDLP---TNITVLNLTHNQLRRLPAANF-TRYS---QLTSLDVG 57
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI- 244
++ P+ L+ L L N L+ ++F NL L L
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS---IQKIKN 114
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL---SLD 301
+ L TL L N S T + +L +L++L L++N+ L L SL
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174
Query: 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT- 360
L+L++N P + RL
Sbjct: 175 KLELSSNQIKEFSPGC-------------------------------FHAI---GRLFGL 200
Query: 361 -----SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD--SLTQIKLQS 413
+ K L L+ N+ + L+L N LS T + + L +LT + L
Sbjct: 201 FLNNVQLGPSLTEKLCLELA---NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK-FSGAVKLS 454
NN++ ++ L L L NN+ G +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-26
Identities = 50/246 (20%), Positives = 80/246 (32%), Gaps = 31/246 (12%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG---ELPSFSGLSNLK 129
+ + +I +S + + L+ + L++ + F L NL
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN 189
L NN I D +GLE L++L L NN L L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNN------------------LARLW--KHA 523
Query: 190 LAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVL 247
G FL + L L L N E FK L L + L V
Sbjct: 524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN---LNTLPASVF 580
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGK-LTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLN 306
N L++L L N + + FG +L +L++ N F S+A ++ ++
Sbjct: 581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC-TCESIAWF-VNWINET 638
Query: 307 NNMFMG 312
+
Sbjct: 639 HTNIPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 23/85 (27%), Positives = 35/85 (41%), Gaps = 4/85 (4%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+ +TVLNL + L + + LT + + N IS P L L +L+L N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 440 LS-PPLPKFSGA---VKLSLDGNPL 460
LS F+ +L L N +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSI 109
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 21/85 (24%), Positives = 31/85 (36%), Gaps = 4/85 (4%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
S+LT L++ +S L L + LQ N +S + +LT L L N+
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 440 LSPPLPK-FSGAVKL---SLDGNPL 460
+ F L L N L
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGL 133
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 66/201 (32%), Positives = 110/201 (54%), Gaps = 16/201 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
LG G FG V+ G + TK+AVK ++ G +S D F +E ++ +++H+ LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLY 74
Query: 676 GYSVAGYE-RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
V E ++ EYM G+L + K+ + L+ + L++A +A GM ++
Sbjct: 75 A--VVTQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEE-- 127
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVT 792
+++IHRDL+++NIL+ D K++DFGL +L D+E + + APE
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINY 184
Query: 793 GKITTKVDVFSFGVVLMELLT 813
G T K DV+SFG++L E++T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 69/201 (34%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
ELG G FGVV G+ +AVK ++ G +S+ DEF E + K+ H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFY 69
Query: 676 GYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G Y +V EY+ G L ++ H K L L L + DV GM +L S
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLES-- 122
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVT 792
FIHRDL + N L+ D KVSDFG+ + D + SV T+ + APE
Sbjct: 123 -HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VKWSAPEVFHY 179
Query: 793 GKITTKVDVFSFGVVLMELLT 813
K ++K DV++FG+++ E+ +
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
LG G FG V +G L K+AVK M+ S++ ++EF SE A + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 672 VSLLG-----YSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVAR 725
+ LLG S + +++ +M G L ++ + + + + L +D+A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
GMEYL ++++F+HRDL + N +L DD V+DFG L+ R G +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDYYR-QGRIAKM 211
Query: 786 -----APEYAVTGKITTKVDVFSFGVVLMELLT 813
A E T+K DV++FGV + E+ T
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-44
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 616 ENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
++LG+G FG V D G +AVK+++ +F EI +L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDF 85
Query: 671 LVSLLGYSVAGYER--LLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGM 727
+V G S + LV EY+P G L + H L+ L L + + +GM
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGM 140
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYL 785
EYL S + +HRDL + NIL+ + K++DFGL KL P + V R G +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLT 813
APE + + DV+SFGVVL EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
LG+G FG V + +L K+AVK ++A +I+ ++EF E A + + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 672 VSLLG------YSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVA 724
L+G +++ +M G L + N L + + +D+A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
GMEYL + ++FIHRDL + N +L +D V+DFG L+ R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFG---LSRKIYSGDYYR-QGCASK 200
Query: 785 L-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
L A E T DV++FGV + E++T
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
ELG G FGVV G+ +A+K ++ G +S+ DEF E V+ + H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLY 85
Query: 676 GYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G ++ EYM G L ++ + L L + DV MEYL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYL---E 137
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL-----APEY 789
+ F+HRDL + N L+ D KVSDFGL + D E T G PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVG--SKFPVRWSPPEV 192
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
+ K ++K D+++FGV++ E+ +
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 616 ENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRH 670
+LG G FGVV +GE +AVK ++ V+S +A+D+F E+ + + HR+
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 671 LVSLLGYSVAGYERL-LVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGME 728
L+ L G V + +V E P G+L + H L L A+ VA GM
Sbjct: 83 LIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGMG 135
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY--LA 786
YL S + FIHRDL + N+LL K+ DFGL++ P ++ V + + A
Sbjct: 136 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLT 813
PE T + D + FGV L E+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 31/220 (14%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ ELG G FG V+ E D +AVK ++ + A +F E +L+ ++H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHE 77
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKRRLN 718
H+V G G ++V+EYM G L + L + L+
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
IA +A GM YL S Q F+HRDL + N L+G + K+ DFG ++ D + R
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFG---MSRDVYSTDYYR- 190
Query: 779 AGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
G L PE + K TT+ DV+SFGV+L E+ T
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+++LG G +G VY+G +AVK ++ + +EF E AV+ +++H +LV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQL 74
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
LG ++ E+M G L ++ + N + +S L +A ++ MEYL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEK-- 129
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL-----APEY 789
++FIHRDL + N L+G++ KV+DFGL +L + A APE
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTAPES 183
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
K + K DV++FGV+L E+ T
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-43
Identities = 69/198 (34%), Positives = 113/198 (57%), Gaps = 10/198 (5%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 245
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
V+ +V EYM +G+L + K + L + +++A +A GM Y+
Sbjct: 246 AV-VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER--- 298
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+++HRDL+++NIL+G++ KV+DFGL +L D+E + + APE A+ G+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 796 TTKVDVFSFGVVLMELLT 813
T K DV+SFG++L EL T
Sbjct: 359 TIKSDVWSFGILLTELTT 376
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-43
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 616 ENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+ +G G FG VYKG L +A+K ++AG K+ VD F E ++ + H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHN 107
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
++ L G +++ EYM GAL K + + S + + + +A GM+YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL---RE-KDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY--LAPE 788
+ +++HRDL + NIL+ + KVSDFGL ++ D + T G APE
Sbjct: 164 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
K T+ DV+SFG+V+ E++T
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 616 ENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
E +G G G V G L +A+K ++AG ++ D F SE +++ + H ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNI 112
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ L G G ++V EYM G+L + + + + + + V GM YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT----HDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL--APEY 789
++HRDL + N+L+ + KVSDFGL ++ D + T G APE
Sbjct: 169 D---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
++ DV+SFGVV+ E+L
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 24/213 (11%)
Query: 617 NELGRGGFGVVYKGELDDG------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
ELG+G FG+VY+G T++A+K + S + EF +E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHH 89
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGAL-----SKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+V LLG G L++ E M +G L S + L P S + + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
GM YL++ F+HRDL + N ++ +DF K+ DFG + D + R G G L
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG---MTRDIYETDYYR-KGGKGLL 202
Query: 786 -----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+PE G TT DV+SFGVVL E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-42
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +LG G FG V+ + TK+AVK M+ G +S + F +E V+ ++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLH 249
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
V E + ++ E+M +G+L + KS + ++ + +A GM ++
Sbjct: 250 A--VVTKEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-- 302
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPEYAVT 792
+++IHRDL+++NIL+ K++DFGL ++ D+E + + APE
Sbjct: 303 -RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINF 359
Query: 793 GKITTKVDVFSFGVVLMELLT 813
G T K DV+SFG++LME++T
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT 380
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 70/219 (31%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 616 ENELGRGGFGVVYKGELDDG------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ ELG G FG V+ E + +AVK ++ S+ A +F E +L+ ++H+
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQ 103
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL----------SKHIFHWKSLNLEPLSWKRRLNI 719
H+V G G L+V+EYM G L +K + + + PL + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
A VA GM YL F+HRDL + N L+G K+ DFG ++ D + R
Sbjct: 164 ASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG---MSRDIYSTDYYR-V 216
Query: 780 GTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
G L PE + K TT+ DV+SFGVVL E+ T
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 616 ENELGRGGFGVVYKGELDDG------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
ELG FG VYKG L +A+K ++ +EF E + ++++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHP 72
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKRRLN 718
++V LLG +++ Y G L L ++
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
+ +A GMEYL S +H+DL + N+L+ D K+SD G L + + +
Sbjct: 133 LVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLG---LFREVYAADYYK- 185
Query: 779 AGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
L APE + GK + D++S+GVVL E+ +
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-42
Identities = 65/402 (16%), Positives = 117/402 (29%), Gaps = 69/402 (17%)
Query: 93 GTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDG--- 148
T + L L ++ + +LP L ++ + N + D
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 149 -----LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS 203
E +Q++ + NN LQ +L L C+ L G+LP F G+
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTF---PVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIK 354
Query: 204 LQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVL--GNMDQLRTLWLHG 260
L +L L+ N +T + NL K ++ ++ + +
Sbjct: 355 LASLNLAYNQITEIPANFCGFTEQVENLSFAHNK---LKYIPNIFDAKSVSVMSAIDFSY 411
Query: 261 NHFSG-------TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312
N + + K ++ +NL++NQ ++ L ++L NM
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
Query: 313 PVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGND----PC 368
P + E L ++ L N
Sbjct: 472 I------------------PKNSLKDENENFKNTYLLTSID----L----RFNKLTKLS- 504
Query: 369 KSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLT------QIKLQSNNISGQIPT 422
T L ++L + S N +L Q Q N + P
Sbjct: 505 ---DDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560
Query: 423 NWTNLKSLTLLDLSQNNLS-PPLPKFSGAVKLSLDGNPLLNG 463
T SLT L + N++ L + NP ++
Sbjct: 561 GITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISI 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-41
Identities = 47/367 (12%), Positives = 99/367 (26%), Gaps = 80/367 (21%)
Query: 93 GTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENL 152
+ +L ++ KL + NQ G+LP+F L L N IPA+F E +
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNL----------SCMSCNLAGQLPDFLGNFA 202
+ L+ N P + ++ + + L
Sbjct: 380 ENLSFAHNKLK-----YIPNIFDAK-SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 203 SLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTL 256
++ ++ LS N ++ E F L ++ L + N L ++
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 257 WLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPV 314
L N + + L L ++L+ N F P + +L + N
Sbjct: 494 DLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA--- 549
Query: 315 PKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGL 374
N P +
Sbjct: 550 ----------QGNRT---------------------------------LREWP--EGIT- 563
Query: 375 SCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLD 434
LT L + + ++ ++ + +++ + ++ N + +
Sbjct: 564 ---LCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 435 LSQNNLS 441
L +
Sbjct: 618 LFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 57/401 (14%), Positives = 120/401 (29%), Gaps = 62/401 (15%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNL--NQLSKLENIGLQKNQFRGELPSFSGLS-NLKYA 131
+N Q Q + + T S L + + + + S ++
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
NN + L L+ + ++ F A + + + N
Sbjct: 189 GQLSNNITFVSKAVMR-LTKLRQFYMGNSPFVAE-------NICEAWENENSE--YAQQY 238
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLND------QKGGGFTGTI 244
N L ++++ +P K L + + + ++ +
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298
Query: 245 DVLGNMDQLRTLWLHGNHF-SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDH 302
++++ +++ N+ + + S K+ L L NQ G P+ S L
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLAS 357
Query: 303 LDLNNNMFMGPVPKSKAYKYSY------SSNAFCQPTEGVPCAPEVMAL-----IDF--- 348
L+L N +P + + N + +P + ++ IDF
Sbjct: 358 LNLAYNQITE-IPANFCGFTEQVENLSFAHNKL----KYIPNIFDAKSVSVMSAIDFSYN 412
Query: 349 -LGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLT 407
+G + + L + ++ +NL N +S L+
Sbjct: 413 EIGSV--DGKNFDP----------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS 460
Query: 408 QIKLQSNNISG-------QIPTNWTNLKSLTLLDLSQNNLS 441
I L N ++ N+ N LT +DL N L+
Sbjct: 461 SINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-40
Identities = 57/448 (12%), Positives = 122/448 (27%), Gaps = 98/448 (21%)
Query: 54 PELLQWPKSGDPCGPPCWKHVFCSN-SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQK 112
W + + V ++ RVT + + G G +P + QL++LE + L
Sbjct: 55 QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 113 NQFRGELPSF--SGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA-SKGWS 169
+ + F G+S F D L + N+ + S
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 170 FPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVN 229
K + + + T + +S N+ + + L+ + + N
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEA--WENEN 231
Query: 230 LWLNDQKGGGFTGTIDV-LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV 288
Q T D+ N+ L + ++ +P L ++ +N+ N+ +
Sbjct: 232 SEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286
Query: 289 GL--------IPPSLASL-SLDHLDLNNNMFM-GPVPKSKAYKYSYSSNAFCQPTEGVPC 338
+ + + N PV S
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETS--------------------- 325
Query: 339 APEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL-----NLPN---F 390
L + +L L ++L +
Sbjct: 326 ----------LQKM---KKL-----------GMLECL---YNQLEGKLPAFGSEIKLASL 358
Query: 391 NLSG----TLSPSV-GNLDSLTQIKLQSNNISGQIP--TNWTNLKSLTLLDLSQNNLS-- 441
NL+ + + G + + + N + IP + ++ ++ +D S N +
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSV 417
Query: 442 -----PPLPKFSGA----VKLSLDGNPL 460
PL ++L N +
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQI 445
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 37/245 (15%), Positives = 62/245 (25%), Gaps = 53/245 (21%)
Query: 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTI 141
+I L + + +I L NQ FS S L L GN I
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 142 PADF-------FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC--MSCNLAG 192
P + F L + L N +++ L L +S N
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLT-----KLSDDFRAT-TLPYLVGIDLSYNSFS 526
Query: 193 QLPDFLGNFASLQ------NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV 246
+ P N ++L+ GN PE
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI------------------------ 562
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS---LSLDHL 303
L L + N + E ++ L++ N + + + + L
Sbjct: 563 -TLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 304 DLNNN 308
+
Sbjct: 619 FYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 44/323 (13%), Positives = 84/323 (26%), Gaps = 60/323 (18%)
Query: 165 SKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKG 224
K WS N + Q L + + L L G +G +P++
Sbjct: 44 GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 225 L-NLVNLWL--NDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKL--TSLKD 279
L L L L + +K + H+ T + + + L
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 280 LNLNSNQFVGLIPPSLA-SLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPC 338
+NS+ I S +L + +N V K+
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA--------------------- 201
Query: 339 APEVMALIDFLGGLNYPPRLVT-SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS 397
+ L +L + ++ + + N T
Sbjct: 202 ----------VMRL---TKLRQFYMGNS----PFVAENICEAWEN--ENSEYAQQYKTED 242
Query: 398 PSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS------------PPLP 445
NL LT +++ + ++PT L + L++++ N P
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 446 KFSGAVKLSLDGNPLLNGKSPGS 468
+ + N L S
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETS 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-20
Identities = 40/265 (15%), Positives = 77/265 (29%), Gaps = 63/265 (23%)
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG----LIPPSLASL-SLD 301
L + ++ L L G SG +P++ G+LT L+ L L S+ P +++ S +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTS 361
+ ++ +
Sbjct: 137 QKQKMRMHYQKTFVDY-------------------------------DPREDFSDLIKDC 165
Query: 362 WSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP 421
+ + KS S K T + + N++ +S +V L L Q + ++ +
Sbjct: 166 INSDPQQKSIKKSS-RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223
Query: 422 TN-------------------WTNLKSLTLLDLSQNNLSPPLPKFSGA----VKLSLDGN 458
W NLK LT +++ LP F A +++ N
Sbjct: 224 CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283
Query: 459 PLLNGKSPGSGSSSGNPPSPTKGSS 483
++G G
Sbjct: 284 RGISG--EQLKDDWQALADAPVGEK 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 616 ENELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+ ELG G FG V +G +A+K ++ G K +E E ++ ++ + ++V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 73
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
L+G +LV E G L K + E + + V+ GM+YL
Sbjct: 74 RLIGV-CQAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPEYA 790
++F+HRDL + N+LL + AK+SDFGL K + R AG + + APE
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
K +++ DV+S+GV + E L+
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 616 ENELGRGGFGVVYKGELDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
LG G FG VYKG +A+K + S KA E E V++ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+ LLG L+ + MP G L ++ H ++ + L LN + +A+GM Y
Sbjct: 79 VCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAP 787
L + +HRDL + N+L+ K++DFGL KL E G ++A
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMAL 188
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLT 813
E + T + DV+S+GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 616 ENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
LG G FG VY+G + +AVK + + ++F SE ++ + H H+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHI 75
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
V L+G + ++ E P G L ++ + SL + L + +L + + M YL
Sbjct: 76 VKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYL 129
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE--RSVVTRLAGTFGYLAPE 788
S + +HRD+ NIL+ K+ DFGL + D + ++ VTRL +++PE
Sbjct: 130 ES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPE 184
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ TT DV+ F V + E+L+
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILS 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-42
Identities = 69/198 (34%), Positives = 113/198 (57%), Gaps = 10/198 (5%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
E +LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLY 328
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
V+ +V EYM +G+L + K + L + +++A +A GM Y+
Sbjct: 329 AV-VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER--- 381
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+++HRDL+++NIL+G++ KV+DFGL +L D+E + + APE A+ G+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 796 TTKVDVFSFGVVLMELLT 813
T K DV+SFG++L EL T
Sbjct: 442 TIKSDVWSFGILLTELTT 459
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+ +G+G FGVVY GE D + A+K + + V+ F E ++ + H ++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNV 84
Query: 672 VSLLGYSVAGYERLL-VYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++L+G + + YM G L + I ++ ++ L ++ L VARGMEY
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-----ISFGLQVARGMEY 139
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL---- 785
L Q F+HRDL + N +L + F KV+DFGL + D E + L
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKW 194
Query: 786 -APEYAVTGKITTKVDVFSFGVVLMELLT 813
A E T + TTK DV+SFGV+L ELLT
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-41
Identities = 76/417 (18%), Positives = 132/417 (31%), Gaps = 58/417 (13%)
Query: 74 VFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG-ELPSFSGLSNLKYAY 132
+ + G+ L+ LE++ L N +LP LK
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLD 159
Query: 133 LDGNNFDTIPADFFDGLENLQVLALD-SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
N + + L+ L+L+ + N G SA +L+
Sbjct: 160 FQNNAIHYLSKEDMSSLQQATNLSLNLNGND----IAGIEPGAFDSAVFQSLNFGGTQNL 215
Query: 192 GQLPDFLGN--FASLQNLKLSGNNLTGPIPESFKGLNLVNL-WLNDQKGGGFTGTIDVLG 248
+ L N SL + P F+GL +++ +N QK F + +
Sbjct: 216 LVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFH 275
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
L+ L L H S +P L++LK L L++N+F L S ++ SL HL +
Sbjct: 276 CFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334
Query: 308 NMFMGPVPKSKAYKYSYSSNAFCQPT------------EGVPCAPEVMALIDFLGGLNYP 355
N + + E C + + L LN
Sbjct: 335 NTKRLELG----------TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN-- 382
Query: 356 PRLVTSWSGND----PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIK 410
L S N+ +++ +L +L+L L + S NL L +
Sbjct: 383 --L----SYNEPLSLKTEAFKECP-----QLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA-------VKLSLDGNPL 460
L + + + L +L L+L N+ + + + L L L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 72/392 (18%), Positives = 122/392 (31%), Gaps = 61/392 (15%)
Query: 85 QVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPAD 144
Q V KG + L + + +++ L + F I ++
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272
Query: 145 FFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL 204
F LQ L L + + + P GL + L L + NF SL
Sbjct: 273 TFHCFSGLQELDLTATHLS-----ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327
Query: 205 QNLKLSGNNLTGPI-PESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262
+L + GN + + L NL L L+ L N+ L++L L N
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS-LASL-SLDHLDLNNNMFMGPVPKSKAY 320
E+F + L+ L+L + S +L L L+L++++
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE----- 442
Query: 321 KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT--------SWSGNDPCKSWL 372
GL P L S
Sbjct: 443 --------------------------QLFDGL---PALQHLNLQGNHFPKGNIQKTNSLQ 473
Query: 373 GLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTL 432
L +L +L L +LS + +L + + L N ++ ++LK +
Sbjct: 474 TL-----GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY- 527
Query: 433 LDLSQNNLSPPLPK-FSGAVKLS---LDGNPL 460
L+L+ N++S LP + L NPL
Sbjct: 528 LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 67/416 (16%), Positives = 112/416 (26%), Gaps = 76/416 (18%)
Query: 65 PCGPPCW-----KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGEL 119
C K C N + +I P L + E + N
Sbjct: 3 SSDQKCIEKEVNKTYNCENLGLNEI-----------PGTL--PNSTECLEFSFNVLPTIQ 49
Query: 120 P-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178
+FS L NL + L I D F L L L +N L
Sbjct: 50 NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA----ETALSGPK 105
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238
L +L + ++ L N +L++L L N+++
Sbjct: 106 ALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE------------ 153
Query: 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLK--DLNLNSNQFVGLIPPSLA 296
+L+ L N E L LNLN N G+ P +
Sbjct: 154 -------------KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFD 200
Query: 297 SLSLDHLDLNNNMFMGPVPKSKA-------YKYSYSSNAFCQPTEGVPCAPEVMALIDFL 349
S L+ + + K + ++ + V M++
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 350 GGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQI 409
+Y + ++ S L L+L L + L +L ++
Sbjct: 261 LQKHYFFNISSNTFHC-------------FSGLQELDL-TATHLSELPSGLVGLSTLKKL 306
Query: 410 KLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--FSGAVKL---SLDGNPL 460
L +N + +N SLT L + N L L L + +
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDI 362
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-34
Identities = 71/402 (17%), Positives = 121/402 (30%), Gaps = 53/402 (13%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYA 131
F S R+ + +++ L L+ L+++ + L+
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS-CMSCNL 190
YL N+ +I E L+VL +N + S Q TNLS ++ N
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM----SSLQQATNLSLNLNGND 190
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLW---LNDQKGGGFTGTIDVL 247
+ + A Q+L G I + K + +LW D + +
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLN 306
+ ++ L ++F +F + L++L+L + +P L L +L L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVL- 308
Query: 307 NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGN 365
S+N F E + P L GN
Sbjct: 309 ------------------SANKF----ENLCQ--------ISASNF---PSLTHLSIKGN 335
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPN--FNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
L L+L + S + + NL L + L N
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 424 WTNLKSLTLLDLSQNNLS--PPLPKFSGAVKL---SLDGNPL 460
+ L LLDL+ L F L +L + L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-33
Identities = 52/250 (20%), Positives = 92/250 (36%), Gaps = 11/250 (4%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAY 132
S + ++ +S+ + + + L ++ ++ N R EL + L NL+
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 133 LDGNNFDTIP--ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L ++ +T L +LQ L L N + K +F K L L L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF-KECPQ---LELLDLAFTRL 412
Query: 191 AGQLPD-FLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLND-QKGGGFTGTIDVL 247
+ N L+ L LS + L + F GL L +L L G + L
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNN 307
+ +L L L S +F L + ++L+ N+ +L+ L +L+L +
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLAS 532
Query: 308 NMFMGPVPKS 317
N +P
Sbjct: 533 NHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-33
Identities = 69/386 (17%), Positives = 126/386 (32%), Gaps = 70/386 (18%)
Query: 93 GTLPQNLNQLSKLENIGLQKNQFRGELP---SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
+ + +++ Q + S + +L + + + I F+GL
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 150 ENLQVLALD--SNNFNASKGWSFPKGLQSSAQLTNLSC--MSCNLAGQLPDFLGNFASLQ 205
+ V +++ + F +F + L ++ +LP L ++L+
Sbjct: 252 CEMSVESINLQKHYFFNISSNTF-------HCFSGLQELDLTATHLSELPSGLVGLSTLK 304
Query: 206 NLKLSGNNLTGPIPESFKGL-NLVNLWL--NDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262
L LS N S +L +L + N ++ TG L N++ LR L L +
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC---LENLENLRELDLSHDD 361
Query: 263 --FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKA 319
S L+ L+ LNL+ N+ + L + L+ LDL +S
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS-- 419
Query: 320 YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGND----PCKSWLGL 374
L L S + + + GL
Sbjct: 420 ----------------------------PFQNL---HLLKVLNLSHSLLDISSEQLFDGL 448
Query: 375 SCGTNSKLTVLNLPNFNLSGT---LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLT 431
L LNL + + S+ L L + L ++S +T+LK +
Sbjct: 449 P-----ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503
Query: 432 LLDLSQNNL-SPPLPKFSGAVKLSLD 456
+DLS N L S + S + L+
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGIYLN 529
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-32
Identities = 77/369 (20%), Positives = 129/369 (34%), Gaps = 69/369 (18%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
+ + + L ++S +E+I LQK+ F +F S L+ L + +P+ GL
Sbjct: 243 ISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV-GL 300
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL-PDFLGNFASLQNLK 208
L+ L L +N F S S LT+LS +L L N +L+ L
Sbjct: 301 STLKKLVLSANKFENLCQISA-SNFPS---LTHLSIKGNTKRLELGTGCLENLENLRELD 356
Query: 209 LSGNNLT--GPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265
LS +++ + L +L +L L+ + + QL L L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT--EAFKECPQLELLDLAFTRLKV 414
Query: 266 TIPES-FGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYS 323
+S F L LK LNL+ + L +L HL+L N F +
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK------ 468
Query: 324 YSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC------- 376
+ L L RL L LS
Sbjct: 469 ----------------------TNSLQTL---GRL-----------EILVLSFCDLSSID 492
Query: 377 ----GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTL 432
+ + ++L + L+ + ++ +L + + L SN+IS +P+ L
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRT 551
Query: 433 LDLSQNNLS 441
++L QN L
Sbjct: 552 INLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 68/376 (18%), Positives = 113/376 (30%), Gaps = 52/376 (13%)
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
V I + + S L+ + L GLS LK L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSA 310
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N F+ + +L L++ N G + L++ +L +LS +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL-DLSHDDIETSDCCN 369
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTID--VLGNMDQ 252
L N + LQ+L LS N E+FK L L L + N+
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR---LKVKDAQSPFQNLHL 426
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL----SLDHLDLNNN 308
L+ L L + + + F L +L+ LNL N F SL L+ L L
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL--- 483
Query: 309 MFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPC 368
S + + + ++ L S N
Sbjct: 484 ----------------SFCDL----SSID--QHAFTSLKMMNHVD----L----SHN--- 510
Query: 369 K-SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNL 427
+ + + ++ K LNL + ++S L + L I L+ N + +
Sbjct: 511 RLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY--- 567
Query: 428 KSLTLLDLSQNNLSPP 443
L + L
Sbjct: 568 -FLEWYKENMQKLEDT 582
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 50/248 (20%), Positives = 83/248 (33%), Gaps = 19/248 (7%)
Query: 69 PCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLS 126
C + S + + +S + + +LE + L + + + F L
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
LK L + D FDGL LQ L L N+F LQ+ +L L
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF-PKGNIQKTNSLQTLGRLEILVLS 484
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI-D 245
C+L+ + + ++ LS N LT E+ L + L L + +
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNH---ISIILPS 541
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD-LNLNSNQFVGLI------PPSLASL 298
+L + Q RT+ L N T + N + PP L +
Sbjct: 542 LLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGV 596
Query: 299 SLDHLDLN 306
L + L+
Sbjct: 597 RLSDVTLS 604
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 71/218 (32%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 616 ENELGRGGFGVVYKGELDDG---TKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHL 671
++ +G G FG V K + A+KRM+ SK +F E+ VL K+ H ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNI 88
Query: 672 VSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKRRLNIA 720
++LLG L EY P G L + F + LS ++ L+ A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
DVARGM+YL + + FIHRDL + NIL+G+++ AK++DFGL R +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS-------RGQEVYVKK 198
Query: 781 TFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
T G L A E TT DV+S+GV+L E+++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-41
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G+G FG V G+ G K+AVK ++ ++ F +E +V++++RH +LV LL
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 252
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G V L +V EYM +G+L ++ +S L L +LDV MEYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 307
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGY--LAPEYAV 791
+F+HRDL + N+L+ +D AKVSDFGL + + APE
Sbjct: 308 -NNFVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALR 359
Query: 792 TGKITTKVDVFSFGVVLMELLT 813
K +TK DV+SFG++L E+ +
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 26/204 (12%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G+G FG V G+ G K+AVK ++ ++ F +E +V++++RH +LV LL
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLL 80
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
G V L +V EYM +G+L ++ +S L L +LDV MEYL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 135
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL-----APEY 789
+F+HRDL + N+L+ +D AKVSDFGL + + G L APE
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGL-------TKEASSTQDT--GKLPVKWTAPEA 185
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
K +TK DV+SFG++L E+ +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYS 209
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 616 ENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+ +G G FG V G L +A+K ++ G K+ D F E +++ + H ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNI 108
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
+ L G ++V EYM G+L + + + + + + +A GM+YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL--APEY 789
++HRDL + NIL+ + KVSDFGL ++ D + T G +PE
Sbjct: 165 D---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 790 AVTGKITTKVDVFSFGVVLMELLT 813
K T+ DV+S+G+VL E+++
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 71/209 (33%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+GRG FG VY G L D AVK + V +F +E ++ H ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNV 88
Query: 672 VSLLGYSVAGYE-RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+SLLG + L+V YM G L I + + K + L VA+GM+YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL----- 785
S + F+HRDL + N +L + F KV+DFG LA D + G
Sbjct: 145 AS---KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 786 -APEYAVTGKITTKVDVFSFGVVLMELLT 813
A E T K TTK DV+SFGV+L EL+T
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 616 ENELGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV- 666
LG G FG V E + +AVK ++ ++K + + SE+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 98
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKR 715
+H+++++LLG ++ EY +G L ++ + + E +++K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
++ +ARGMEYL A Q IHRDL + N+L+ ++ K++DFG LA D
Sbjct: 159 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 212
Query: 776 TRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ T G L APE T + DV+SFGV++ E+ T
Sbjct: 213 YK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 19/205 (9%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+G G FG V++G +A+K + S ++F E + + H H+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 78
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
V L+G + ++ E G L + SL+L L + A ++ + YL
Sbjct: 79 VKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYL 132
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPE 788
S + F+HRD+ + N+L+ + K+ DFGL + DS G ++APE
Sbjct: 133 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPE 187
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ T+ DV+ FGV + E+L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILM 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 616 ENELGRGGFGVVYKGELDDG------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
LG G FG V K T +AVK ++ S + + SE VL +V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHP 86
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL-------------------SKHIFHWKSLNLEP 710
H++ L G LL+ EY G+L S++ +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770
L+ ++ A +++GM+YL A +HRDL + NIL+ + + K+SDFG L+ D
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG---LSRDV 200
Query: 771 ERSVVTRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ G + A E TT+ DV+SFGV+L E++T
Sbjct: 201 YEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
LG G FG VY+G++ ++AVK + S++ +F E ++SK H+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ 93
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFH--WKSLNLEPLSWKRRLNIALDVARGM 727
++V +G S+ R ++ E M G L + + L+ L++A D+A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 728 EYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+Y L FIHRD+ + N LL G AK+ DFG +A D R+ R G
Sbjct: 154 QY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR-KGGCAM 206
Query: 785 L-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
L PE + G T+K D +SFGV+L E+ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 34/270 (12%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
E+GRG F VYKG + + ++A ++ ++K F E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 677 YSVAGYE---RLLVY-EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
+ + +++ E M G L ++ +K + ++ L + + +G+++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR-----SWCRQILKGLQFLHT 147
Query: 733 LAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYA 790
IHRDLK NI + G K+ D GL L S ++V+ GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM- 201
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
K VDV++FG+ ++E+ T E + A + + S A+ D
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG--VKPASFD-- 252
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRP 880
+V + I C + +R
Sbjct: 253 -KVAIPEVKEI--IE----GCIRQNKDERY 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-40
Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 33/223 (14%)
Query: 616 ENELGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV- 666
LG G FG V E + TK+AVK +++ ++K + + SE+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG 132
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKR 715
+H+++++LLG ++ EY +G L ++ ++ E LS K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
++ A VARGMEYL A + IHRDL + N+L+ +D K++DFG LA D
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFG---LARDIHHIDY 246
Query: 776 TRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ T G L APE T + DV+SFGV+L E+ T
Sbjct: 247 YK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 87/297 (29%), Positives = 132/297 (44%), Gaps = 29/297 (9%)
Query: 532 YYRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGAS 591
++ +AS + I S + + + STS+ ++G+ + Y G
Sbjct: 9 HHHHHHGRRRASVAAGILVPRGSPGLDGICSI----EELSTSLYKKAGSENLYFQGANTV 64
Query: 592 HVIEAGNLVISVQVLRNVTKNFASEN-----ELGRGGFGVVYKGELDDG----TKIAVKR 642
H+ + VQ +++V +S +GRG FG VY G L D AVK
Sbjct: 65 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 643 MEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE-RLLVYEYMPQGALSKHIF 701
+ V +F +E ++ H +++SLLG + L+V YM G L I
Sbjct: 125 LNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 183
Query: 702 HWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761
+ + K + L VA+GM++L A + F+HRDL + N +L + F KV+DF
Sbjct: 184 N----ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 762 GLVKLAPDSERSVVTRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
GL + D E V T L A E T K TTK DV+SFGV+L EL+T
Sbjct: 237 GLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 616 ENELGRGGFGVVYKGELDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
LG G FG V+KG + +K +E +++ + + + H H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAH 76
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+V LLG G LV +Y+P G+L H+ H +L + L LN + +A+GM Y
Sbjct: 77 IVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT-FGYLAPE 788
L +HR+L + N+LL + +V+DFG+ L P ++ ++ A T ++A E
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
GK T + DV+S+GV + EL+T
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 617 NELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHR 669
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHL 91
Query: 670 HLVSLLGY-SVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKRRL 717
++V+LLG + G +++ E+ G L + + L + L+ + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR 777
+ VA+GME+L A + IHRDL + NILL + K+ DFG LA D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYV 205
Query: 778 LAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
L APE T + DV+SFGV+L E+ +
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-40
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 616 ENELGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV- 666
LG G FG V E + +AVK ++ ++K + + SE+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIG 144
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGAL-----------SKHIFHWKSLNLEPLSWKR 715
+H+++++LLG ++ EY +G L ++ + + E +++K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
++ +ARGMEYL A Q IHRDL + N+L+ ++ K++DFG LA D
Sbjct: 205 LVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFG---LARDINNIDY 258
Query: 776 TRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ T G L APE T + DV+SFGV++ E+ T
Sbjct: 259 YK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 38/228 (16%)
Query: 616 ENELGRGGFGVVYKGELDDG------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
++G G FG V++ T +AVK ++ S +F E A++++ +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNP 110
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL-------------------SKHIFHWKSLNLEP 710
++V LLG G L++EYM G L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770
LS +L IA VA GM YL + F+HRDL + N L+G++ K++DFG L+ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG---LSRNI 224
Query: 771 ERSVVTRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ + A + PE + TT+ DV+++GVVL E+ +
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 616 ENELGRGGFGVVYKGELDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
LG G FG VYKG +A+K + S KA E E V++ V + H
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPH 78
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ LLG L+ + MP G L ++ + + + + LN + +A+GM YL
Sbjct: 79 VCRLLGI-CLTSTVQLITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPE 788
+ +HRDL + N+L+ K++DFGL KL E G ++A E
Sbjct: 134 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMALE 189
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ T + DV+S+GV + EL+T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-40
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 616 ENELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+ ELG G FG V +G +A+K ++ G K +E E ++ ++ + ++V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIV 399
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
L+G +LV E G L K + E + + V+ GM+YL
Sbjct: 400 RLIGV-CQAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEE 454
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY--LAPEYA 790
++F+HR+L + N+LL + AK+SDFGL K + R AG + APE
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 791 VTGKITTKVDVFSFGVVLMELLT 813
K +++ DV+S+GV + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-40
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RH 668
LG G FG V + D K+AVK +++ + SE+ ++S + +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQH 109
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGAL---------SKHIFHWKSLNLEPLSWKRRLNI 719
++V+LLG G L++ EY G L ++ S + L+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-- 777
+ VA+GM +L A ++ IHRD+ + N+LL + AK+ DFGL R ++
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA-------RDIMNDSN 219
Query: 778 -LAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ L APE T + DV+S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 72/418 (17%), Positives = 120/418 (28%), Gaps = 94/418 (22%)
Query: 77 SNSRVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQKNQFRG-------ELPSFSGLSNL 128
R+ ++ + + + + + L+ LE L +FR + + GL NL
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 129 KYAYLDGNNFDTIP---ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQ----SSAQLT 181
D D F+ L N+ +L S K +S+ G Q + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 182 NLSCMSC---------NLAGQLPDFLGNFASLQNLKLSGNNLT--GPIPESFKGL-NLVN 229
+ + G + SL+ L LS N L+ G +S G +L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLNSNQFV 288
L L+ ++QL L ++ S F L +L L+++
Sbjct: 378 LDLSFNG---VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 289 GLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALID 347
L SL+ L + N F D
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLP------------------------------D 464
Query: 348 FLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLT 407
L LT L+L L + +L SL
Sbjct: 465 IFTEL---------------------------RNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 408 QIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-PPLPKFSGAVK----LSLDGNPL 460
+ + NN + L SL +LD S N++ + L+L N
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-39
Identities = 71/412 (17%), Positives = 110/412 (26%), Gaps = 56/412 (13%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKY 130
C +I P NL +N+ L N R SF L+
Sbjct: 10 ITYQCMELNFYKI-----------PDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L TI + L +L L L N + + L L + NL
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA----LGAFSGLSSLQKLVAVETNL 112
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTG-PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGN 249
A +G+ +L+ L ++ N + +PE F N
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-------------------------SN 147
Query: 250 MDQLRTLWLHGNHFSGTIPESFGKLTSLK----DLNLNSNQFVGLIPPSLASLSLDHLDL 305
+ L L L N L + L+L+ N + P + + L L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 306 NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365
NN V K+ + E L GL +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT 425
D + + ++ +L + + ++L +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 426 NLKSLTLLDLSQNNLSP--PLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNP 475
+LK LT N LP L L N L+ K S S G
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLE---FLDLSRNG-LSFKGCCSQSDFGTT 373
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-38
Identities = 73/423 (17%), Positives = 128/423 (30%), Gaps = 55/423 (13%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYA 131
+ F S + + +S ++ LS L + L N + +FSGLS+L+
Sbjct: 46 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
N ++ L+ L+ L + N + K P+ + L +L S +
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK---LPEYFSNLTNLEHLDLSSNKIQ 162
Query: 192 GQLPDFLGNFASLQN----LKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI--D 245
L + L LS N + P +FK + L L L + + +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF---DSLNVMKT 219
Query: 246 VLGNMDQLRTLWLHGNHFSGTI---PESFGKLTSLKDLNLNSNQ------FVGLIPPSLA 296
+ + L L F L L +L + + ++ I
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 297 SL-SLDHLDLNNNMFMGPVPKSKAYKYSY---SSNAFCQPTEGVPCAPEVMALIDFLGGL 352
L ++ L + S + + + + F Q L
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ--------------FPTLKLK 325
Query: 353 NYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPN--FNLSGTLSPSVGNLDSLTQIK 410
+ TS G + S + L L L+L + G S S SL +
Sbjct: 326 SLKRLTFTSNKGGNA-FSEVDL-----PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKL---SLDGNPLLNGKS 465
L N + + +N+ L+ L LD +NL F L +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT-HTRVAF 437
Query: 466 PGS 468
G
Sbjct: 438 NGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 77/402 (19%), Positives = 133/402 (33%), Gaps = 48/402 (11%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP-ADFFDG 148
++ + LS L+ + + L LK + N + ++F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
L NL+ L L SN + Q +L + P L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 209 LSGNNLTGPIPESF----KGLNLVNLWLNDQKGGGFTGTID--VLGNMDQLRTLWLHGNH 262
L N + + ++ GL + L L + + G D L + L +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 263 ---FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMG-PVPKSK 318
+ I + F LT++ +L S + S HL+L N F P K K
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLELVNCKFGQFPTLKLK 325
Query: 319 AYKY-SYSSNAFCQPTEGVPCAPEVMAL------IDFLGGLNYPPRLVTSWSGNDPCKSW 371
+ K +++SN V P + L + F G + +S
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDL-PSLEFLDLSRNGLSFKGCCS---------------QSD 369
Query: 372 LGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSL 430
G + L L+L +FN T+S + L+ L + Q +N+ + + +L++L
Sbjct: 370 FGT-----TSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 431 TLLDLSQNNLSPPLPK-FSGAVKL---SLDGNPLLNGKSPGS 468
LD+S + F+G L + GN P
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-35
Identities = 51/250 (20%), Positives = 81/250 (32%), Gaps = 19/250 (7%)
Query: 75 FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLD 134
F N +++ + L L +L + S L +L++ L
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG----NAFSEVDLPSLEFLDLS 355
Query: 135 GN--NFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG 192
N +F + G +L+ L L N + QL +L NL
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-----TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 193 QLP-DFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI--DVLG 248
+ +L L +S + F GL +L L + F D+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS---FQENFLPDIFT 467
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
+ L L L P +F L+SL+ LN++ N F L L SL LD +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 308 NMFMGPVPKS 317
N M +
Sbjct: 528 NHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 65/388 (16%), Positives = 109/388 (28%), Gaps = 69/388 (17%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNF------DTIPADF 145
+ + +L + L+ N + GL+ L+ L F +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQ 205
+GL NL + + +++ S +S + Q
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLD-DIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ 307
Query: 206 NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH--F 263
+L+L K +L L KGG ++ L L L N F
Sbjct: 308 HLELVNCKFGQFPTLKLK--SLKRLTFTSNKGGNAFS----EVDLPSLEFLDLSRNGLSF 361
Query: 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYS 323
G +S TSLK L+L+ N + + L L+HLD ++ S
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS------ 415
Query: 324 YSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT------SWSGNDPCKSWLGLSCG 377
L L+
Sbjct: 416 ------------------------VFLSL---RNLIYLDISHTHTRVAFNG------IFN 442
Query: 378 TNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
S L VL + + P + L +LT + L + PT + +L SL +L++S
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 437 QNNLSPPLPK-FSGAVKL---SLDGNPL 460
NN + L N +
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-34
Identities = 68/412 (16%), Positives = 123/412 (29%), Gaps = 47/412 (11%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG--ELPSFSGLSNLKY 130
F S + ++ L + L L+ + + N + FS L+NL++
Sbjct: 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH 153
Query: 131 AYLDGNNFDTIPADFFDGLENLQV----LALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
L N +I L + + L L N N G +L L+
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-----FIQPGAFKEIRLHKLTLR 208
Query: 187 SCNLAGQLP-DFLGNFASLQNLKLSGN------NLTGPIPESFKGL-NLVNLWLNDQKGG 238
+ + + + A L+ +L NL + +GL NL
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 239 GFTGTI-DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS 297
+ I D+ + + + L S+ + L L + +F P+L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQF--PTLKL 324
Query: 298 LSLDHLDLNNNMFMGPVPKSKAYKYSY---SSNAFCQPTEGVPCAPEVMALIDFLGGLNY 354
SL L +N + + S N C + L L+
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGL----SFKGCCSQSDFGTTSLKYLDL 380
Query: 355 PPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQS 413
S N + + +L L+ + NL SV +L +L + +
Sbjct: 381 --------SFNGV--ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--FSGAVK---LSLDGNPL 460
+ + L SL +L ++ N+ F+ L L L
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 13/219 (5%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
T+ N L +LE++ Q + + F L NL Y + + F+GL +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
L+VL + N+F + L++ LT L C L P + +SLQ L +S
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRN---LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 212 NNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVLGNM-DQLRTLWLHGNHFSGTIP 268
NN +K L +L L + + L + L L L N F+ T
Sbjct: 504 NNFFSLDTFPYKCLNSLQVLDYSLNH---IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
Query: 269 ES--FGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
+ + L + + P + + L++
Sbjct: 561 HQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-30
Identities = 61/365 (16%), Positives = 109/365 (29%), Gaps = 54/365 (14%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155
+ L L+ E + + ++ F+ L+N+ L + + F Q L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHL 309
Query: 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215
L + F FP S + + + G + SL+ L LS N L+
Sbjct: 310 ELVNCKFG-----QFPTLKLKSLKRLTFT----SNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 216 --GPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-F 271
G +S G +L L L+ ++QL L ++ S F
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNG---VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSY------ 324
L +L L+++ L SL+ L + N F +
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN-----DPCKSWLGLSCGTN 379
S E + P + L LN + S N D
Sbjct: 478 SQCQL----EQLS--PTAFNSLSSLQVLN----M----SHNNFFSLDTF------PYKCL 517
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNL-DSLTQIKLQSNNISGQIPTNW--TNLKSLTLLDLS 436
+ L VL+ ++ + + + SL + L N+ + +K L +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 437 QNNLS 441
+
Sbjct: 578 VERME 582
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 54/298 (18%), Positives = 90/298 (30%), Gaps = 57/298 (19%)
Query: 180 LTNLS--CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236
+ N++ CM N ++PD L S +NL LS N L SF L L L+ +
Sbjct: 7 VPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 237 GGGFTGTI-DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
++ L TL L GN +F L+SL+ L L +
Sbjct: 64 ---IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 296 ASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNY 354
L +L L++ +N+ L ++ L
Sbjct: 121 GHLKTLKELNVAHNLIQS------------------------------FKLPEYFSNL-- 148
Query: 355 PPRLVT-SWSGN---DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410
L S N + L + L+L ++ + P L ++
Sbjct: 149 -TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 411 LQSNNISGQIPTNW-TNLKSLTLLDLSQNNLS-------PPLPKFSGAVKLSLDGNPL 460
L++N S + L L + L G L+++ L
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 52/301 (17%), Positives = 92/301 (30%), Gaps = 50/301 (16%)
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
+ N+ NF P L S + +LS L +F LQ L
Sbjct: 7 VPNITYQ-CMELNFY-----KIPDNLPFSTKNLDLS--FNPLRHLGSYSFFSFPELQVLD 58
Query: 209 LSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVLGNMDQLRTLWLHGNHFSGT 266
LS + +++ L +L L L + L+ L + +
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNP---IQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 267 IPESFGKLTSLKDLNLNSNQFVGL-IPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSY 324
G L +LK+LN+ N +P ++L +L+HLDL++N
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD------- 168
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384
+ L + L S N +++ +L
Sbjct: 169 ---------------------LRVLHQMPLL-NLSLDLSLNPM--NFIQPGAFKEIRLHK 204
Query: 385 LNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQI---PTNWTNLKSLTLLDLSQNNL 440
L L N S + + L L +L + + + L+ L L + + L
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 441 S 441
+
Sbjct: 265 A 265
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 28/160 (17%), Positives = 53/160 (33%), Gaps = 28/160 (17%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYA 131
+F +T + +S L+ P N LS L+ + + N F + L++L+
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 132 YLDGNNFDTIPADFFDGLE-NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
N+ T +L L L N+F +C +C
Sbjct: 524 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF---------------------AC-TCEH 561
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL 230
FL + L + + P +G+ +++L
Sbjct: 562 Q----SFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
LG G FG VY+G++ ++AVK + S++ +F E ++SK H+
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ 134
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFH--WKSLNLEPLSWKRRLNIALDVARGM 727
++V +G S+ R ++ E M G L + + L+ L++A D+A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 728 EYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+Y L FIHRD+ + N LL G AK+ DFG +A D R+ R G
Sbjct: 195 QY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAGYYR-KGGCAM 247
Query: 785 L-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
L PE + G T+K D +SFGV+L E+ +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 63/226 (27%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RH 668
LG G FG V + D +AVK ++ + SE+ VLS + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNH 86
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGAL-------------SKHIFHWKSLNLEPLSWKR 715
++V+LLG G L++ EY G L SK + L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
L+ + VA+GM +L S ++ IHRDL + NILL K+ DFGL R +
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLA-------RDIK 196
Query: 776 TR---LAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
+ L APE T + DV+S+G+ L EL +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-39
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 44/231 (19%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RH 668
LG G FG V ++AVK ++ + SE+ +++++ H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSH 108
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGAL------------------SKHIFHWKSLNLEP 710
++V+LLG L++EY G L + +L
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770
L+++ L A VA+GME+L +S +HRDL + N+L+ K+ DFGL
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 771 ERSVVTR---LAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMELLT 813
R +++ + L APE G T K DV+S+G++L E+ +
Sbjct: 220 -RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 45/222 (20%)
Query: 616 ENELGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR 667
LG+G F ++KG T++ +K ++ + + F +++SK+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLS 70
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARG 726
H+HLV G V G E +LV E++ G+L ++ + +N+ L +A +A
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-----LEVAKQLAAA 125
Query: 727 MEYLHSLAHQSFIHRDLKSSNILL--------GDDFRAKVSDFGLVKLAPDSERSVVTRL 778
M +L + IH ++ + NILL G+ K+SD G+ +
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 779 AGTFGY------LAPEYAVTGKI-TTKVDVFSFGVVLMELLT 813
+ PE K D +SFG L E+ +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
K++ +LG GGF V E L DG A+KR+ ++ +E E + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHP 86
Query: 670 HLVSLLGYSV----AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+++ L+ Y + A +E L+ + +G L I K L+ + L + L + R
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-NFLTEDQILWLLLGICR 145
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA------ 779
G+E +H+ + + HRDLK +NILLGD+ + + D G + A L
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 780 --GTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
T Y APE + V I + DV+S G VL ++ G
Sbjct: 203 QRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFG 242
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-38
Identities = 63/422 (14%), Positives = 115/422 (27%), Gaps = 87/422 (20%)
Query: 59 WPKSGDPCGPPCWKHVFCSN-SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG 117
W + + V N RVT + ++ G KG +P + QL++L+ + +
Sbjct: 302 WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 118 --ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA-SKGWSFPKGL 174
L L+ F D + L + L + N + K
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 175 QSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLND 234
+ S + T + ++ N + + LQ + + + T N
Sbjct: 422 RISLKDTQIGNLT-NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD--WEDANSDYAK 478
Query: 235 QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL---- 290
Q + N+ L + L+ +P+ L L+ LN+ N+ +
Sbjct: 479 Q----YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534
Query: 291 -----IPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMA 344
+ + + + N P S
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEE-FPAS--------------------------- 566
Query: 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD 404
L + +L L C N K+ L + G
Sbjct: 567 --ASLQKM---VKLGL-------------LDCVHN-KVRHL------------EAFGTNV 595
Query: 405 SLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLS--PPLPKFSGAVKL---SLDGN 458
LT +KL N I +IP + + L S N L P + + N
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 459 PL 460
+
Sbjct: 655 KI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 9e-34
Identities = 61/410 (14%), Positives = 111/410 (27%), Gaps = 77/410 (18%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPA------ 143
+ + L L ++ L +LP L L+ + N +
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 144 ---DFFDGLENLQVLALDSNNFNASKGWSFPK--GLQSSAQLTNLSCMSCNLAGQLPDFL 198
D D +Q+ + NN FP LQ +L L C+ + L F
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLE-----EFPASASLQKMVKLGLLDCVHNKVR-HLEAF- 591
Query: 199 GNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257
G L +LKL N + + + L + K + ++ + ++
Sbjct: 592 GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFN-AKSVYVMGSVD 650
Query: 258 LHGNHFSGTIPESFG-----KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFM 311
N K + + L+ N+ A+ + + L
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL------ 704
Query: 312 GPVPKSKAYKYSYSSNAFCQ-PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGND---- 366
S+N P + L ++ L N
Sbjct: 705 -------------SNNLMTSIPENSLKPKDGNYKNTYLLTTID----L----RFNKLTSL 743
Query: 367 PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQ------SNNISGQI 420
T L+ +++ S + N L ++ N I Q
Sbjct: 744 S----DDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798
Query: 421 PTNWTNLKSLTLLDLSQNNLS--PP--LPKFSGAVKLSLDGNPLLNGKSP 466
PT T SL L + N++ P+ L + NP ++
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRKVDEKLTPQLY---ILDIADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-33
Identities = 53/386 (13%), Positives = 111/386 (28%), Gaps = 72/386 (18%)
Query: 77 SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG- 135
S R +I++ + Q LN L++ + + + S + +LK +
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRI-SLKDTQIGNL 433
Query: 136 -NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL 194
N I L LQ++ ++ F + + +
Sbjct: 434 TNRITFISKAIQ-RLTKLQIIYFANSPFT---------YDNIAVDWEDANSDYAKQYENE 483
Query: 195 PDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLND-------QKGGGFTGTIDV 246
N L +++L +P+ L L +L + Q +T D
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 247 LGNMDQLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLD 304
+++ ++ N+ S K+ L L+ N+ L + + L L
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLK 601
Query: 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364
L N E +P + A D + GL +S
Sbjct: 602 L-------------------DYNQI----EEIP--EDFCAFTDQVEGLG--------FSH 628
Query: 365 ND----PCKSWLGLSCGTNSKLTVLNLPNFNLSG-----TLSPSVGNLDSLTQIKLQSNN 415
N P + + + ++ + + S + + + L N
Sbjct: 629 NKLKYIP----NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 416 ISGQIPTNWTNLKSLTLLDLSQNNLS 441
I + ++ + LS N ++
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-33
Identities = 61/412 (14%), Positives = 120/412 (29%), Gaps = 77/412 (18%)
Query: 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNF 138
S + Q ++ + ++ K IG N+ + L+ L+ Y + F
Sbjct: 401 SDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPF 460
Query: 139 DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFL 198
+ + D + + LT++ +C QLPDFL
Sbjct: 461 TYDNI-----AVDWEDANSDYAKQYEN----EELSWSNLKDLTDVELYNCPNMTQLPDFL 511
Query: 199 GNFASLQNLKLSGNNLTGP---------IPESFKGL-NLVNLWLNDQKGGGFTGTID--V 246
+ LQ+L ++ N + + + ++
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN---LEEFPASAS 568
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL--SLDHLD 304
L M +L L N E+FG L DL L+ NQ IP + ++ L
Sbjct: 569 LQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLG 625
Query: 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364
++N + +P ++ +G ++ S
Sbjct: 626 FSHNKL-----------------------KYIPNIFNAKSVY-VMGSVD----F----SY 653
Query: 365 N----DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNIS--- 417
N + + + + L + + ++ I L +N ++
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 418 ----GQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLS---LDGNPL 460
N+ N LT +DL N L+ + + LS + N
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-31
Identities = 47/364 (12%), Positives = 97/364 (26%), Gaps = 83/364 (22%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155
+L ++ KL + N+ R L +F L LD N + IP DF + ++ L
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGL 624
Query: 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSC--MSCNLAGQLPDFLG------NFASLQNL 207
N P + + + S N G + + +
Sbjct: 625 GFSHNKLK-----YIPNIFNAK-SVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV 678
Query: 208 KLSGNNLTGPIPESFKGL-NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGN 261
LS N + E F + + L++ N L T+ L N
Sbjct: 679 TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738
Query: 262 HFSGTIPES--FGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSK 318
+ ++ + L L +++++ N F P + S L + +
Sbjct: 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA------- 789
Query: 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGT 378
N + P +
Sbjct: 790 ------EGN---RILRQWP---------TGITTC-------------------------- 805
Query: 379 NSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNI-SGQIPTNWTNLKSLTL-LDLS 436
L L + + ++ + + L + + N S + + +++ L
Sbjct: 806 -PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
Query: 437 QNNL 440
+
Sbjct: 862 KTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-28
Identities = 62/445 (13%), Positives = 124/445 (27%), Gaps = 109/445 (24%)
Query: 29 VTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPC-WKHVFCSNSRVTQIQVS 87
+ L +A D L + L+ + + + W + Q V
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 88 SVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFF 146
L+ ++ + L +G +P + L+ LK ++ F
Sbjct: 319 -----------LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFG 367
Query: 147 DGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLG----NFA 202
D + + + K Q NLS + + + P+ +
Sbjct: 368 DEELTPDMSEERKHRIRMH----YKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 203 SLQNLKLSG-NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261
SL++ ++ N I ++ + +L+ ++ +
Sbjct: 424 SLKDTQIGNLTNRITFISKAI-------------------------QRLTKLQIIYFANS 458
Query: 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAY 320
F+ +D N + + S ++L L ++L N M +P
Sbjct: 459 PFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF--- 510
Query: 321 KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNS 380
L L P L + L ++C N
Sbjct: 511 ----------------------------LYDL---PELQS-----------LNIAC--N- 525
Query: 381 KLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT--NLKSLTLLDLSQN 438
+ + + L+ + + NN+ P + + + L LLD N
Sbjct: 526 RGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHN 583
Query: 439 NLSPPLPKFSGAVKL---SLDGNPL 460
+ L F VKL LD N +
Sbjct: 584 KVR-HLEAFGTNVKLTDLKLDYNQI 607
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-25
Identities = 59/383 (15%), Positives = 108/383 (28%), Gaps = 68/383 (17%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
N+L+K N+ +Q + + + L + A LDG N+ + + +
Sbjct: 249 NKLTKDANVPIQLKETAEYIKDYKALKAIWEA-LDGKNWR------YYSGTINNTIHSLN 301
Query: 160 NNFNAS-KGWSFPKG--LQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
NFN W G L ++ ++T LS G++PD +G L+ L ++ T
Sbjct: 302 WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 217 PIPESFKG---LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273
++ + + +D ++ L N P
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 274 LTSLKDLNL-NSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQ 331
SLKD + N + I ++ L L + N+ F + +
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 332 PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN 391
E L LT + L N
Sbjct: 482 NEELS------------WSNL---------------------------KDLTDVELYNCP 502
Query: 392 LSGTLSPSVGNLDSLTQIKLQSNNISG---------QIPTNWTNLKSLTLLDLSQNNLS- 441
L + +L L + + N ++ + + + + NNL
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562
Query: 442 -PPLPKFSGAVKLS---LDGNPL 460
P VKL N +
Sbjct: 563 FPASASLQKMVKLGLLDCVHNKV 585
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-20
Identities = 31/230 (13%), Positives = 56/230 (24%), Gaps = 63/230 (27%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQ--------FRGELPSFSGLSNLKYAYLDGNNFDTIP 142
++ + S + I L N + + ++ L L N ++
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLS 744
Query: 143 ADF-FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNF 201
DF L L + + N F+ SFP +S+QL
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFS-----SFPTQPLNSSQLKAFGI---------------- 783
Query: 202 ASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261
GN + P L L + N
Sbjct: 784 --RHQRDAEGNRILRQWPTGI-------------------------TTCPSLIQLQIGSN 816
Query: 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA---SLSLDHLDLNNN 308
+ E L L++ N + + S+ + L +
Sbjct: 817 DIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 5e-18
Identities = 48/314 (15%), Positives = 92/314 (29%), Gaps = 46/314 (14%)
Query: 189 NLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV-L 247
A + D+ A + L + ++ +N W +++ + V L
Sbjct: 263 ETAEYIKDYKALKAIWEALDGKNWRYYSGTINNT--IHSLN-WNFNKELDMWGDQPGVDL 319
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP-SLASLSLDHLDLN 306
N ++ L L G G +P++ G+LT LK L+ ++ L+ D +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 307 NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLG-GLNYPPRLVTSWSGN 365
+ + Y + L D L +N P + +
Sbjct: 380 KH----------RIRMHYKKMFLDYDQR--------LNLSDLLQDAINRNPEMKPIKKDS 421
Query: 366 DPCKSWLGLSCGTN------------SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS 413
+ TN +KL ++ N + + +V D+
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDAN----SDY 476
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA----VKLSLDGNPLLNGKSPGSG 469
+W+NLK LT ++L LP F L++ N +
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR-GISAAQLKA 535
Query: 470 SSSGNPPSPTKGSS 483
+ G
Sbjct: 536 DWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-14
Identities = 26/209 (12%), Positives = 48/209 (22%), Gaps = 57/209 (27%)
Query: 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS---FSGLSNLKYAYLDGNNFD 139
+ N L I L+ N+ L + L L + N F
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766
Query: 140 TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLG 199
+ P + L+ + + Q P +
Sbjct: 767 SFPTQPLN-SSQLKAFGIRH----------------------QRDAEGNRILRQWPTGIT 803
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259
SL L++ N++ + E QL L +
Sbjct: 804 TCPSLIQLQIGSNDIRK-VDEKL---------------------------TPQLYILDIA 835
Query: 260 GNHF-SGTIPESFGKLTS-LKDLNLNSNQ 286
N S + + + + L + Q
Sbjct: 836 DNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-37
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 19/205 (9%)
Query: 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+G G FG V++G +A+K + S ++F E + + H H+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHI 453
Query: 672 VSLLGYSVAGYE-RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
V L+G V ++ E G L + L + A ++ + YL
Sbjct: 454 VKLIG--VITENPVWIIMELCTLGELRSFLQV----RKFSLDLASLILYAYQLSTALAYL 507
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF--GYLAPE 788
S + F+HRD+ + N+L+ + K+ DFGL + DS G ++APE
Sbjct: 508 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAPE 562
Query: 789 YAVTGKITTKVDVFSFGVVLMELLT 813
+ T+ DV+ FGV + E+L
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILM 587
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 64/254 (25%), Positives = 97/254 (38%), Gaps = 17/254 (6%)
Query: 566 NNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFG 625
+ + + R S G + + ++F + LG G +G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 626 VVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYE 683
V+K +DG AVKR + K +E+ KV +H V L +
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGG 130
Query: 684 RL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRD 742
L L E +L +H W + E W D + +LHS Q +H D
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHS---QGLVHLD 182
Query: 743 LKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDV 801
+K +NI LG R K+ DFGL+ L V G Y+APE + G T DV
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE-LLQGSYGTAADV 238
Query: 802 FSFGVVLMELLTGL 815
FS G+ ++E+ +
Sbjct: 239 FSLGLTILEVACNM 252
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-36
Identities = 70/426 (16%), Positives = 122/426 (28%), Gaps = 68/426 (15%)
Query: 66 CGPPCW-----KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP 120
PC C + +++++ P ++ S +NI L N +
Sbjct: 3 SLNPCIEVVPNITYQCMDQKLSKV-----------PDDI--PSSTKNIDLSFNPLKILKS 49
Query: 121 -SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG-LQSSA 178
SFS S L++ L +TI + GL +L L L N SF G
Sbjct: 50 YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI-----QSFSPGSFSGLT 104
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG-PIPESFKGLNLVNLWLNDQKG 237
L NL + LA +G +L+ L ++ N + +P F L
Sbjct: 105 SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT----------- 153
Query: 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD----LNLNSNQFVGLIPP 293
L + L N+ L L+++ N +
Sbjct: 154 --------------NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQ 199
Query: 294 SLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353
+ + L L L N + K+ + E + + GL
Sbjct: 200 AFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLC 259
Query: 354 YPPRLVTSWSGNDPCKSWLGLSCGTN-SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQ 412
+ + + + ++ ++L ++ V + +
Sbjct: 260 DVTIDEFRLTYTN--DFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSII 315
Query: 413 SNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVK---LSLDGNPLLNGKSPGSG 469
+ Q PT +L L L L+ N S L L N L+ S
Sbjct: 316 RCQLK-QFPTL--DLPFLKSLTLTMNKGSISFK-KVALPSLSYLDLSRNA-LSFSGCCSY 370
Query: 470 SSSGNP 475
S G
Sbjct: 371 SDLGTN 376
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 73/417 (17%), Positives = 119/417 (28%), Gaps = 69/417 (16%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG--ELPSFSGLSNLKY 130
F + + + L + QL L+ + + N FS L+NL +
Sbjct: 98 GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH 157
Query: 131 AYLDGNNFDTIPADFFDGLENL----QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
L N TI + L L + N + +L L+
Sbjct: 158 VDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-----FIQDQAFQGIKLHELTLR 212
Query: 187 SCNLAGQLP-DFLGNFASLQNLKLSGN------NLTGPIPESFKGL-NLVNLWLNDQKGG 238
+ + L N A L +L NL P +GL ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL 298
F+ I + + + L G E K + L++ Q L L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL 330
Query: 299 SLDHLDLNNNMFMGPVPKSKAYKYSY---SSNAFCQPTEGVPCAPEVMALIDFLGGLNYP 355
L L N K SY S NA + F
Sbjct: 331 K--SLTLTMNKGSISFKKVALPSLSYLDLSRNA-----------------LSFS------ 365
Query: 356 PRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNN 415
C S+ L + L L+L +FN + +S + L+ L + Q +
Sbjct: 366 -----------GCCSYSDLGT---NSLRHLDL-SFNGAIIMSANFMGLEELQHLDFQHST 410
Query: 416 ISGQIPTN-WTNLKSLTLLDLSQNNLS-PPLPKFSGAVK---LSLDGNPLLNGKSPG 467
+ + + +L+ L LD+S N F G L + GN +
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 61/398 (15%), Positives = 106/398 (26%), Gaps = 93/398 (23%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRG-------ELPSFSGLSNLKYAYLD--GNNFDTIPADF 145
+ L L+ L L +F+ E GL ++ N +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQS------------SAQLTNLSC--MSCNLA 191
F L N+ ++L + + QS + L L ++ N
Sbjct: 281 FHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG 340
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVN---LWLNDQKGGGFTGTIDVLG 248
+ SL L LS N L+ S+ L + L L+
Sbjct: 341 SISFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG---AIIMSANFM 396
Query: 249 NMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLN 306
+++L+ L + S F L L L+++ L SL+ L +
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM- 455
Query: 307 NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGND 366
+ N+F T +
Sbjct: 456 ------------------AGNSFKDNTLS-----------NVFANT-------------- 472
Query: 367 PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTN 426
+ LT L+L L L L + + NN+ +++
Sbjct: 473 -------------TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 427 LKSLTLLDLSQNNLS--PP--LPKFSGAVKLSLDGNPL 460
L SL+ LD S N + +L N +
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 75/402 (18%), Positives = 120/402 (29%), Gaps = 73/402 (18%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYA----YLDGNNFDTIPADFFDGL 149
LP + L+ L ++ L N + L + N D I F G+
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSC---NLAGQLPDFLGNFASLQ- 205
L L L N +++ + + L + NL P + +
Sbjct: 205 -KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 206 -NLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK-----GGGFTGTIDVL----------- 247
+L+ N F L N+ + L L
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 248 -GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL---SLDHL 303
++ L++L L N G+I L SL L+L+ N S + L SL HL
Sbjct: 324 TLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363
DL+ N + S F E+ L ++
Sbjct: 382 DLSFNGAIIM------------SANFM-------GLEELQHL--DFQH--------STLK 412
Query: 364 GNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
++L L KL L++ N L SL +K+ N+ +N
Sbjct: 413 RVTEFSAFLSL-----EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 424 -WTNLKSLTLLDLSQNNLS--PP--LPKFSGAVKLSLDGNPL 460
+ N +LT LDLS+ L L++ N L
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-29
Identities = 59/387 (15%), Positives = 106/387 (27%), Gaps = 59/387 (15%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP-ADFFDG 148
++ P + + L+ LEN+ + + L LK + N + +F
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
L NL + L N ++ +L MS N + D L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD-MSLNPIDFIQDQAFQGIKLHELT 210
Query: 209 LSGNNLTGPIPESF----KGLNLVNLWLNDQKGGGFTGTID--VLGNMDQLRTLWLH--G 260
L GN + I ++ GL++ L L + K + ++ + +
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 261 NHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAY 320
+ F L ++ ++L + L +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQL---------- 319
Query: 321 KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNS 380
L L L + + + L
Sbjct: 320 ----KQFPT-----------------LDLPFLKS---LTLTMNKGSISFKKVALP----- 350
Query: 381 KLTVLNLPN--FNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438
L+ L+L + SG S S +SL + L N + N+ L+ L LD +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHS 409
Query: 439 NLS--PPLPKFSGAVKL---SLDGNPL 460
L F KL +
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-29
Identities = 67/384 (17%), Positives = 112/384 (29%), Gaps = 64/384 (16%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
+ + L L N+ L N + P SFSGL++L+ ++ + L L+
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNF----ASLQNLKLS 210
L + N ++ K P + L ++ + + L +L +S
Sbjct: 133 LNVAHNFIHSCK---LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 211 GNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI--- 267
N + ++F+G+ L L L L N+ L L F
Sbjct: 190 LNPIDFIQDQAFQGIKLHELTLRGNFNSSNI-MKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 268 ---PESFGKLTSL--KDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYK 321
P L + + L L+ + + L K +K
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFK 308
Query: 322 YSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381
+ S CQ +
Sbjct: 309 WQSLSIIRCQLKQ---------------------------------------FPTLDLPF 329
Query: 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLK--SLTLLDLSQNN 439
L L L N G++S L SL+ + L N +S ++++L SL LDLS N
Sbjct: 330 LKSLTL-TMN-KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNG 387
Query: 440 LSPPLPKFSGA---VKLSLDGNPL 460
F G L + L
Sbjct: 388 AIIMSANFMGLEELQHLDFQHSTL 411
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-29
Identities = 48/228 (21%), Positives = 75/228 (32%), Gaps = 18/228 (7%)
Query: 92 KGTLPQNLNQLSKLENIGLQKNQFRGELP---SFSGLSNLKYAYLDGNNFDTIPADFFDG 148
KG++ L L + L +N S G ++L++ L N + F G
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-ANFMG 397
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
LE LQ L + +S L+ L L N SL LK
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEK---LLYLDISYTNTKIDFDGIFLGLTSLNTLK 454
Query: 209 LSGNNLTGPIPES-FKGL-NLVNLWL--NDQKGGGFTGTI-DVLGNMDQLRTLWLHGNHF 263
++GN+ + F NL L L V + +L+ L + N+
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKC-----QLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
+ +L SL L+ + N+ SL +L NN
Sbjct: 510 LFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 63/385 (16%), Positives = 111/385 (28%), Gaps = 64/385 (16%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKY------AYLDGNNFDTIPADF 145
+ Q KL + L+ N + L+ L + D N +
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQ 205
+GL ++ + N A ++ +S ++ L D +F Q
Sbjct: 255 MEGLCDVTIDEFRLTYTNDF--SDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF-KWQ 310
Query: 206 NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265
+L + L L +L L KG + L L L N S
Sbjct: 311 SLSIIRCQLKQFPTLDLP--FLKSLTLTMNKGS----ISFKKVALPSLSYLDLSRNALSF 364
Query: 266 TIPESF--GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKY 322
+ S+ SL+ L+L+ N + ++ + L L HLD ++ S
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS----- 418
Query: 323 SYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGNDPCKSWLGLSCGTNSK 381
L +L+ S + K +
Sbjct: 419 -------------------------AFLSL---EKLLYLDISYTN-TKIDFDGIFLGLTS 449
Query: 382 LTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL 440
L L + + +V N +LT + L + + L L LL++S NNL
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
Query: 441 S--PPLPKFSGAVKL---SLDGNPL 460
++ L N +
Sbjct: 510 LFLDSSH-YNQLYSLSTLDCSFNRI 533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 63/364 (17%), Positives = 106/364 (29%), Gaps = 66/364 (18%)
Query: 117 GELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQS 176
G L + +P D + + + L N K +SF
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKILKSYSF-SNFS- 56
Query: 177 SAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQK 236
+L L C + L NL L+GN + P SF GL
Sbjct: 57 --ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLT---------- 104
Query: 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL-IPPSL 295
L L + G+L +LK LN+ N +P
Sbjct: 105 ---------------SLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149
Query: 296 ASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMAL------IDF 348
++L +L H+DL+ N + N E ++L IDF
Sbjct: 150 SNLTNLVHVDLSYNYIQTI-----------TVNDLQFLRE---NPQVNLSLDMSLNPIDF 195
Query: 349 L-GGLNYPPRLVT------SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV- 400
+ +L S N L+ +L + + PS+
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 401 GNLDSLT--QIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLSLD 456
L +T + +L N + L +++ + L+ ++ +PK LS+
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSII 315
Query: 457 GNPL 460
L
Sbjct: 316 RCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 40/220 (18%), Positives = 71/220 (32%), Gaps = 14/220 (6%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRG--ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+ N L +L+++ Q + + E +F L L Y + N F GL +
Sbjct: 390 IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
L L + N+F + + + LT L C L LQ L +S
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTN---LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506
Query: 212 NNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-DVLGNMDQLRTLWLHGNHFSGTIPE 269
NNL + L +L L + + + + L L N + I E
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNR---IETSKGILQHFPKSLAFFNLTNNSVA-CICE 562
Query: 270 SFGKLTSLKDLNLNSNQFVGLI---PPSLASLSLDHLDLN 306
L +K+ + P + + + + +
Sbjct: 563 HQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNNS 602
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 53/324 (16%), Positives = 88/324 (27%), Gaps = 70/324 (21%)
Query: 169 SFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLV 228
S ++ +T CM L+ ++PD + +S +N+ LS N L SF +
Sbjct: 3 SLNPCIEVVPNIT-YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFS-- 56
Query: 229 NLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV 288
+L+ L L +++ L L +L L N
Sbjct: 57 -----------------------ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 289 GLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALID 347
P S + L SL++L
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLES-------------------------------F 122
Query: 348 FLGGLNYPPRLVTSW-SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG----TLSPSVGN 402
+G L L + N L + L ++L + L N
Sbjct: 123 PIGQL---ITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 403 LDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLN 462
+ + N I I L L L N S + K L + L+
Sbjct: 180 PQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 463 GKSPGSGSSSGNPPSPTKGSSSSS 486
G+ + PS +G +
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVT 262
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 16/94 (17%), Positives = 36/94 (38%), Gaps = 1/94 (1%)
Query: 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLK 129
+VF + + +T + +S L+ + L +L+ + + N S ++ L +L
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163
N +T ++L L +N+
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 16/62 (25%), Positives = 27/62 (43%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+L +LN+ + NL S L SL+ + N I KSL +L+ N+
Sbjct: 497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
Query: 440 LS 441
++
Sbjct: 557 VA 558
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+F +G GGFG V+K + DG +KR+ K ++ E+ L+K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHV 64
Query: 670 HLVSLLGY-------------SVAGYERLLVY---EYMPQGALSKHIFHWKSLNLEPLSW 713
++V G + + + ++ E+ +G L + I + E L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 714 KRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSER 772
L + + +G++Y+HS + I+RDLK SNI L D + K+ DFGLV L D +R
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
TR GT Y++PE + +VD+++ G++L ELL
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 60/268 (22%), Positives = 98/268 (36%), Gaps = 46/268 (17%)
Query: 610 TKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH 668
+F LG+G FG V K D A+K++ +++ + SE+ +L+ + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 669 RHLVSLLG----------YSVAGYERLLVY---EYMPQGALSKHIFHWKSLNLEPLSWKR 715
+++V A ++ ++ EY G L I W+
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR- 120
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
+ + + Y+HS Q IHRDLK NI + + K+ DFGL K S +
Sbjct: 121 ---LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 776 -------------TRLAGTFGYLAPE-YAVTGKITTKVDVFSFGVVLMELLTGLMALDES 821
T GT Y+A E TG K+D++S G++ E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GME 233
Query: 822 RPE------ERQY-LAAWFWNIKSDKEK 842
R F + K EK
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEK 261
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 50/291 (17%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-- 668
+ ++ ++G GG V++ + A+K + + +D + +EIA L+K++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
++ L Y + +V E L+ + KS+ ++ ++ +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI---DPWERKS--YWKNMLEAVH 141
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAP 787
+H +H DLK +N L+ D K+ DFG+ SVV GT Y+ P
Sbjct: 142 TIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 788 E-----------YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836
E KI+ K DV+S G +L + G P F I
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTP---------FQQI 242
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIA-----ELAGHCTSREPSQRPDM 882
+ KL A IDP + E F I ++ C R+P QR +
Sbjct: 243 INQISKLHAIIDP-----NHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISI 287
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG VY E +A+K + A + + E+ + S +RH +++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y R+ L+ EY P G + + + + E + ++A + Y HS
Sbjct: 77 Y-FHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTAT----YITELANALSYCHS--- 127
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ IHRD+K N+LLG K++DFG AP S R+ L GT YL PE + G++
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPE-MIEGRM 183
Query: 796 -TTKVDVFSFGVVLMELLTG 814
KVD++S GV+ E L G
Sbjct: 184 HDEKVDLWSLGVLCYEFLVG 203
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 7/209 (3%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+++ +G G +G K DG + K ++ G +++ SE+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 670 HLVSLLGYSVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
++V + L V EY G L+ I + L + L + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 728 EYLHS--LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
+ H + +HRDLK +N+ L K+ DFGL ++ + + S GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYM 183
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
+PE K D++S G +L EL
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCAL 212
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 76/320 (23%), Positives = 122/320 (38%), Gaps = 54/320 (16%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+F LGRGGFGVV++ + D A+KR+ + A ++ E+ L+K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 63
Query: 670 HLVSLLGY---------SVAGYERLLVY---EYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
+V ++ +Y + + L + ++ L
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCL 121
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-----------L 766
+I L +A +E+LHS + +HRDLK SNI D KV DFGLV L
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826
P + T GT Y++PE + KVD+FS G++L ELL S ER
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPF-----STQMER 233
Query: 827 QYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886
++++ K P+ + S P +RP+ A+
Sbjct: 234 VRT---LTDVRNLK------FPPLFTQKYPCE------YVMVQDMLSPSPMERPE---AI 275
Query: 887 NVLA-PLVEKWKPLDDEPEE 905
N++ + E
Sbjct: 276 NIIENAVFEDLDFPGKTVLR 295
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 72/346 (20%), Positives = 130/346 (37%), Gaps = 40/346 (11%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ + ++G G FG + +DG + +K + +S K +E E+AVL+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V +V +Y G L K I + + L+ + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE- 788
+H + +HRD+KS NI L D ++ DFG+ ++ +S + GT YL+PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEI 196
Query: 789 -----YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
Y K D+++ G VL EL T E + I S
Sbjct: 197 CENKPY------NNKSDIWALGCVLYELCTL------KHAFEAGSMKNLVLKIISGS--- 241
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN--VLAPLVEKWKPLDD 901
P+ L R P RP + + +A +EK+
Sbjct: 242 ---FPPVSLHYSYDL------RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 902 EPEEYSGIDYSLPLNQMVKDWQEAEGKDLSYVSLEDSKSSIPARPA 947
EE+ +S +Q + + A G++ V + A+
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYG 338
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 46/223 (20%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 619 LGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS-------------------- 658
L +G F + E D A+K K +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALK-----KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 659 EIAVLSKVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLN---LEPLSWK 714
E+ +++ +++ + ++ G + Y+ + ++YEYM ++ K ++ L+ + +
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 715 RRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSV 774
I V Y+H+ ++ HRD+K SNIL+ + R K+SDFG + D +
Sbjct: 152 VIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208
Query: 775 VTRLAGTFGYLAPEYAVTGKITT---KVDVFSFGVVLMELLTG 814
GT+ ++ PE + + + KVD++S G+ L +
Sbjct: 209 -G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 62/290 (21%), Positives = 101/290 (34%), Gaps = 55/290 (18%)
Query: 612 NFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRH 670
+F ++ LG G G + + D +AVKR I + E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR-----ILPECFSFADREVQLLRESDEHPN 79
Query: 671 LVSLLGYSVAGYE----RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
++ + + + E A + K + + G
Sbjct: 80 VIRYFCT----EKDRQFQYIAIELC--AATLQEYVEQKDFAHLG---LEPITLLQQTTSG 130
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGD-----DFRAKVSDFGLVKLAPDSERSVVTR--LA 779
+ +LHSL + +HRDLK NIL+ +A +SDFGL K S R +
Sbjct: 131 LAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 780 GTFGYLAPEY---AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836
GT G++APE T VD+FS G V +++ S P F
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-----GSHP---------FGK- 232
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELA----GHCTSREPSQRPDM 882
R A + + D +A + +P +RP
Sbjct: 233 ----SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSA 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG VY E + +A+K + + + + + EI + S +RH +++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y +R+ L+ E+ P+G L K + + E S ++A + Y H
Sbjct: 82 Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSAT----FMEELADALHYCHE--- 132
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+ IHRD+K N+L+G K++DFG AP R T + GT YL PE + GK
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGKT 188
Query: 796 -TTKVDVFSFGVVLMELLTG 814
KVD++ GV+ E L G
Sbjct: 189 HDEKVDLWCAGVLCYEFLVG 208
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 80/374 (21%), Positives = 129/374 (34%), Gaps = 52/374 (13%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
T + L ++ + + + + L+NL N I L L
Sbjct: 37 TDTVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLV 93
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
+ +++N L + LT L+ + + D L N +L L+LS N
Sbjct: 94 DILMNNNQIAD------ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNT 145
Query: 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
++ + GL +L L +Q + L N+ L L + N S
Sbjct: 146 ISDI--SALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVSD--ISVLA 196
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSY---SSNA 328
KLT+L+ L +NQ + P L L +LD L LN N + + ++N
Sbjct: 197 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 254
Query: 329 FCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLP 388
I L L+ +L G + + L+ + LT L L
Sbjct: 255 -----------------ISNLAPLSGLTKLTELKLGANQISNISPLA--GLTALTNLELN 295
Query: 389 NFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPK 446
L + NL +LT + L NNIS P ++L L L N +S L
Sbjct: 296 ENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLAN 351
Query: 447 FSGAVKLSLDGNPL 460
+ LS N +
Sbjct: 352 LTNINWLSAGHNQI 365
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 70/348 (20%), Positives = 116/348 (33%), Gaps = 64/348 (18%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L L+ L + L N + + SGL++L+ D P L L+ L +
Sbjct: 129 PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDI 184
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
SN S L L +L + ++ P LG +L L L+GN L
Sbjct: 185 SSNKV------SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236
Query: 218 IPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
+ L NL +L L + + + + L + +L L L N S P LT+
Sbjct: 237 --GTLASLTNLTDLDLANNQ---ISN-LAPLSGLTKLTELKLGANQISNISP--LAGLTA 288
Query: 277 LKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
L +L LN NQ + P +++L +L +L L N
Sbjct: 289 LTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD----------------------- 323
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395
I + L +L + N+ L + + L+ + +S
Sbjct: 324 ----------ISPVSSL---TKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISD- 367
Query: 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443
+ NL +TQ+ L + N+ + L P
Sbjct: 368 -LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-29
Identities = 82/381 (21%), Positives = 131/381 (34%), Gaps = 67/381 (17%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
L L+ L + L NQ + L+NL L N I A GL +LQ L+
Sbjct: 106 TPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS 162
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
N + K L + L L S ++ L +L++L + N ++
Sbjct: 163 F-GNQV------TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT 275
P L NL L LN + I L ++ L L L N S P LT
Sbjct: 214 ITP--LGILTNLDELSLNGNQLKD----IGTLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 276 SLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTE 334
L +L L +NQ + P LA L +L +L+L + N
Sbjct: 266 KLTELKLGANQISNISP--LAGLTALTNLEL-------------------NEN------- 297
Query: 335 GVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394
++ + ++ L + +S + +KL L N +S
Sbjct: 298 ----------QLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD 345
Query: 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-PPLPKFSGAVKL 453
S+ NL ++ + N IS P NL +T L L+ + P+ +
Sbjct: 346 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 454 SLDGNPLLNGKSPGSGSSSGN 474
+ N +P + S G+
Sbjct: 402 NTVKNVTGALIAPATISDGGS 422
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-27
Identities = 76/380 (20%), Positives = 126/380 (33%), Gaps = 73/380 (19%)
Query: 82 TQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTI 141
T +Q S G + T + L L+ LE + + N+ ++ + L+NL+ N I
Sbjct: 156 TSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQISDI 214
Query: 142 PADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNF 201
L NL L+L+ N L S LT+L + ++ L L
Sbjct: 215 TP--LGILTNLDELSLNGNQL------KDIGTLASLTNLTDLDLANNQISN-LAP-LSGL 264
Query: 202 ASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG 260
L LKL N ++ P GL L NL LN+ + I + N+ L L L+
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQ---LED-ISPISNLKNLTYLTLYF 318
Query: 261 NHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKA 319
N+ S P LT L+ L +N+ + SLA+L +++ L +N
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHN----------- 363
Query: 320 YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGNDPCKSWLGLSCGT 378
I L L R+ + +W
Sbjct: 364 -------------------------QISDLTPLANLTRITQLGLNDQ----AWTNAPVNY 394
Query: 379 NSKLTVLNLPNFNLSGTLSPS-VGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQ 437
+ +++ N ++P+ + + S T+ + N S +
Sbjct: 395 KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGT 453
Query: 438 NNLSPPLPKFSGAVKLSLDG 457
FSG V L
Sbjct: 454 TT-------FSGTVTQPLKA 466
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-17
Identities = 41/178 (23%), Positives = 59/178 (33%), Gaps = 22/178 (12%)
Query: 133 LDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG 192
+ I D L L N Q+T L +
Sbjct: 9 TQDTPINQIFTD--TALAEKMKTVLGKTNVTD------TVSQTDLDQVTTLQADRLGIKS 60
Query: 193 QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMD 251
D + +L + S N LT P K L LV++ +N+ + I L N+
Sbjct: 61 --IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ---IAD-ITPLANLT 112
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
L L L N + P LT+L L L+SN + +L+ L SL L N
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-15
Identities = 50/275 (18%), Positives = 89/275 (32%), Gaps = 73/275 (26%)
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257
A L N+T + ++DQ+ TL
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS---------------------------QTDLDQVTTLQ 52
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316
+ L +L +N ++NQ + P L +L L + +NNN P
Sbjct: 53 ADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL 108
Query: 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC 376
+ + + Q T+ ID L L L L
Sbjct: 109 ANLTNLTGLTLFNNQITD-----------IDPLKNL---TNLNR-------------LEL 141
Query: 377 GTNSKLTVL-------NLPNFNLSGTLS--PSVGNLDSLTQIKLQSNNISGQIPTNWTNL 427
+N ++ + +L + ++ + NL +L ++ + SN +S + L
Sbjct: 142 SSN-TISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKL 198
Query: 428 KSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPL 460
+L L + N +S PL + +LSL+GN L
Sbjct: 199 TNLESLIATNNQISDITPLGILTNLDELSLNGNQL 233
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 40/286 (13%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-- 668
+ ++ ++G GG V++ + A+K + + +D + +EIA L+K++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
++ L Y + +V E L+ + KS++ R + ++ +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW-----ERKSYWKNMLEAVH 122
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAP 787
+H +H DLK +N L+ D K+ DFG+ ++ PD+ V GT Y+ P
Sbjct: 123 TIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 788 E-----------YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836
E KI+ K DV+S G +L + G P F I
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG------KTP---------FQQI 223
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
+ KL A IDP E+ ++ C R+P QR +
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQ-DVLKCCLKRDPKQRISI 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 63/278 (22%), Positives = 121/278 (43%), Gaps = 32/278 (11%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
NF E ++GRG F VY+ L DG +A+K+++ ++ KA + EI +L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+++ + E +V E G LS+ I H+K + + + + +E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALE 150
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
++HS + +HRD+K +N+ + K+ D GL + S+ + L GT Y++PE
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPE 206
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRP---EERQYLAAWFWNIKSDKEKLRA 845
K D++S G +L E+ + ++ L + I+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAAL-------QSPFYGDKMNLYSLCKKIEQCD----- 254
Query: 846 AIDPILEVN--DDTFETFWTIAELAGHCTSREPSQRPD 881
P+ + ++ + +L C + +P +RPD
Sbjct: 255 -YPPLPSDHYSEE-------LRQLVNMCINPDPEKRPD 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-33
Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 43/238 (18%)
Query: 607 RNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+++ SE LG G G V G +AVKR + D EI +L++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDFCDIALMEIKLLTES 65
Query: 667 -RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHI--FHWKSLNLEPLSWKRRLNI 719
H +++ + E L + + NL+ +++
Sbjct: 66 DDHPNVIRYYCS----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILL-------------GDDFRAKVSDFGLVKL 766
+A G+ +LHSL IHRDLK NIL+ ++ R +SDFGL K
Sbjct: 121 LRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 767 APDSERSVVTRL---AGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
+ S T L +GT G+ APE ++T +D+FS G V +L+
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 33/280 (11%)
Query: 549 HPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRN 608
H S + + +S +S N ISV+
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSA----NECISVKG--- 55
Query: 609 VTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH 668
+ ++ ++G GG V++ + A+K + + +D + +EIA L+K++
Sbjct: 56 --RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 669 --RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
++ L Y + +V E L+ + KS++ R + ++
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP-----WERKSYWKNMLEA 167
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVTRLAGTFGYL 785
+ +H +H DLK +N L+ D K+ DFG+ + PD+ V G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 786 APE-----------YAVTGKITTKVDVFSFGVVLMELLTG 814
PE KI+ K DV+S G +L + G
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 76/415 (18%), Positives = 113/415 (27%), Gaps = 62/415 (14%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLK 129
C +I P NL +N+ L N R L SF L+
Sbjct: 10 ITYQCMELNFYKI-----------PDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQ 55
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMSC 188
L TI + L +L L L N S G + L L +
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-----SLALGAFSGLSSLQKLVAVET 110
Query: 189 NLAGQLPDFLGNFASLQNLKLSGNNLT-GPIPESFKGLNLVNLWLNDQKGGGFTGTIDVL 247
NLA +G+ +L+ L ++ N + +PE F L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT--------------------- 149
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLK----DLNLNSNQFVGLIPPSLASLSLDHL 303
L L L N L + L+L+ N + P + + L L
Sbjct: 150 ----NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205
Query: 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363
L NN V K+ + E L GL +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 364 GNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
D + + ++ +L + + ++L + Q PT
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL 322
Query: 424 WTNLKSLTLLDLSQNNLSPPLPKFSGAVKL---SLDGNPLLNGKSPGSGSSSGNP 475
LKSL L + N L L N L+ K S S G
Sbjct: 323 --KLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNG-LSFKGCCSQSDFGTT 373
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 68/391 (17%), Positives = 116/391 (29%), Gaps = 52/391 (13%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
LS L + L N + L FSGLS+L+ N ++ L+ L+
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQN----LKL 209
L + N + K P+ + L +L S + L + L L
Sbjct: 128 ELNVAHNLIQSFK---LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 210 SGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG---- 265
S N + P +FK + L L L + + + L L F
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDS-LNVMKTCIQGLAGLEVHRLVLGEFRNEGNL 243
Query: 266 -TIPES-FGKLTSL--KDLNLNSNQFVGLIPPS----LASLSLDHLDLNNNMFMGPVPKS 317
+S L +L ++ L + L ++S L + +
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303
Query: 318 KAYKY-SYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC 376
+++ + F Q + + + GG N + L
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-------------NAFSEVDL---- 346
Query: 377 GTNSKLTVLNLPN--FNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLD 434
L L+L + G S S SL + L N + + +N+ L+ L LD
Sbjct: 347 ---PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 402
Query: 435 LSQNNLS--PPLPKFSGAVK---LSLDGNPL 460
+NL F L +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-28
Identities = 55/288 (19%), Positives = 94/288 (32%), Gaps = 35/288 (12%)
Query: 49 KNLENPELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLP-QNLNQLSKLEN 107
+ L N + ++ + +F + V+ + SV ++ LE
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311
Query: 108 IGLQKNQFR-----------------GELPSFSGLSNLKYAYLDGNNFDTI--PADFFDG 148
+ + QF G S L +L++ L N + G
Sbjct: 312 VNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPD--FLGNFASLQN 206
+L+ L L N + QL +L NL Q+ + + +L
Sbjct: 372 TTSLKYLDLSFNGVI-----TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIY 425
Query: 207 LKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI--DVLGNMDQLRTLWLHGNHF 263
L +S + F GL +L L + F D+ + L L L
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNS---FQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
P +F L+SL+ LN+ SNQ + L SL + L+ N +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 67/383 (17%), Positives = 120/383 (31%), Gaps = 59/383 (15%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYL------DGNNFDTIPADF 145
+ + +L + L+ N + GL+ L+ L + N +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQ 205
+GL NL + + +++ S +S + ++ DF NF Q
Sbjct: 251 LEGLCNLTIEEFRLAYLDYY-LDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQ 307
Query: 206 NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN--HF 263
+L+L K +L L K G ++ L L L N F
Sbjct: 308 HLELVNCKFGQFPTLKLK--SLKRLTFTSNK----GGNAFSEVDLPSLEFLDLSRNGLSF 361
Query: 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYS 323
G +S TSLK L+L+ N + + L L+HLD ++
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ----------- 410
Query: 324 YSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT 383
+ L+ + + S L
Sbjct: 411 ----------------------MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 384 VLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLS 441
VL + + P + L +LT + L + Q+ + +L SL +L+++ N L
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK 507
Query: 442 --PP--LPKFSGAVKLSLDGNPL 460
P + + K+ L NP
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 61/353 (17%), Positives = 108/353 (30%), Gaps = 81/353 (22%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155
+ L L+ E + + ++ F+ L+N+ L + + ++ Q L
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHL 309
Query: 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215
L + F L L+ + N G + + SL+ L LS N L+
Sbjct: 310 ELVNCKFGQFPTLKLK-------SLKRLT-FTSNKGGNAFSEV-DLPSLEFLDLSRNGLS 360
Query: 216 --GPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-F 271
G +S G +L L L+ ++QL L ++ S F
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNG---VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC 330
L +L L+++ L SL+ L + N F + ++ + F
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF----------QENFLPDIFT 467
Query: 331 QPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNF 390
+ LT L+L +
Sbjct: 468 ELR-----------------------------------------------NLTFLDL-SQ 479
Query: 391 NLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQNNLS 441
LSP+ +L SL + + SN + +P L SL + L N
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 77/397 (19%), Positives = 123/397 (30%), Gaps = 62/397 (15%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRG-ELPSFSGLSNLKYA----YLDGNNFDTIPADFFDGL 149
LP+ + L+ LE++ L N+ + L + L N + I F +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF-LGNFASLQNLK 208
L L L +N + + + +GL ++ L G L F L NL
Sbjct: 201 -RLHKLTLRNNFDSLNVMKTCIQGLAGL-EVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 209 LSGNNLTG------PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262
+ L I + F L N+ + + L L
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLT--NVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCK 315
Query: 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYK 321
F KL SLK L SN+ S L SL+ LDL+ N
Sbjct: 316 FGQF---PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGL---------SF 361
Query: 322 YSYSSNAFCQPTEGVPCAPEVM-----ALIDFLGGLNYPPRLVTSW-SGN-----DPCKS 370
S + T + + +I +L +
Sbjct: 362 KGCCSQSDFGTTS-----LKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 371 WLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLK 428
+L L L L++ + + + L SL +K+ N+ + T L+
Sbjct: 417 FLSLR-----NLIYLDI-SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 429 SLTLLDLSQNNLS--PPLPKFSGAVKL---SLDGNPL 460
+LT LDLSQ L P F+ L ++ N L
Sbjct: 471 NLTFLDLSQCQLEQLSPTA-FNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-18
Identities = 37/183 (20%), Positives = 63/183 (34%), Gaps = 15/183 (8%)
Query: 92 KGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPA-DFFDGLE 150
KG Q+ + L+ + L N +F GL L++ +N + F L
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 151 NLQVLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQL-PDFLGNFASLQNLK 208
NL L + + G + L L + PD +L L
Sbjct: 422 NLIYLDISHTHTR-----VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476
Query: 209 LSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI--DVLGNMDQLRTLWLHGNHFSG 265
LS L P +F L +L L + + ++ + + L+ +WLH N +
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQ---LK-SVPDGIFDRLTSLQKIWLHTNPWDC 532
Query: 266 TIP 268
+ P
Sbjct: 533 SCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-10
Identities = 20/95 (21%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQKNQFRGELP--SFSGLSNL 128
+F S + ++++ + + +L L + L + Q +L +F+ LS+L
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSL 496
Query: 129 KYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163
+ + N ++P FD L +LQ + L +N ++
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 56/226 (24%), Positives = 87/226 (38%), Gaps = 31/226 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISK----KAVDEFHSEIAV 662
+ + LG+G V++G G A+K V + + VD E V
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIK-----VFNNISFLRPVDVQMREFEV 60
Query: 663 LSKVRHRHLVSLLGY--SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
L K+ H+++V L ++L+ E+ P G+L + + N L L +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVL 118
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLG----DDFRAKVSDFGLVKLAPDSERSVVT 776
DV GM +L +HR++K NI+ K++DFG + D E
Sbjct: 119 RDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFV 173
Query: 777 RLAGTFGYLAPE--------YAVTGKITTKVDVFSFGVVLMELLTG 814
L GT YL P+ K VD++S GV TG
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-32
Identities = 79/423 (18%), Positives = 138/423 (32%), Gaps = 121/423 (28%)
Query: 66 CGPPC-----WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP 120
C P C + V C R + P+ + ++ + L KN+ + L
Sbjct: 3 CPPRCECSAQDRAVLCHRKRFVAV-----------PEGIP--TETRLLDLGKNRIK-TLN 48
Query: 121 --SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178
F+ +L+ L+ N + F+ L NL+ L L SN
Sbjct: 49 QDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN------------------ 90
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK- 236
+L + ++L L +S N + + F+ L NL +L + D
Sbjct: 91 RLKLIP----------LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140
Query: 237 ----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292
F+G ++ L L L + + E+ L L L L +
Sbjct: 141 VYISHRAFSG-------LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 293 PSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGG 351
S L L L++++ ++ + + L G
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTP------------------------------NCLYG 223
Query: 352 LNYPPRLVT-SWSGND----PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDS 405
LN L + S + + P + L L LNL +S T+ S+ L
Sbjct: 224 LN----LTSLSITHCNLTAVPYLAVRHLV-----YLRFLNLSYNPIS-TIEGSMLHELLR 273
Query: 406 LTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLS-------PPLPKFSGAVKLSLDG 457
L +I+L ++ + + L L +L++S N L+ + L LD
Sbjct: 274 LQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE---TLILDS 329
Query: 458 NPL 460
NPL
Sbjct: 330 NPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-23
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 24/203 (11%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ + L+ LE + L+K +P + S L L L N + I F L L+
Sbjct: 145 HRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF-LGNFASLQNLKLSGN 212
VL + + + + GL LT+LS CNL +P + + L+ L LS N
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLN----LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 213 NLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-----DVLGNMDQLRTLWLHGNHFSGT 266
++ L L + L + + ++ LR L + GN + T
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQ-------LAVVEPYAFRGLNYLRVLNVSGNQLT-T 310
Query: 267 IPES-FGKLTSLKDLNLNSNQFV 288
+ ES F + +L+ L L+SN
Sbjct: 311 LEESVFHSVGNLETLILDSNPLA 333
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 43/227 (18%), Positives = 78/227 (34%), Gaps = 31/227 (13%)
Query: 610 TKNFASENELGRGGFGVVYKGELDD------GTKIAVKRMEAGVISKKAVDEFH---SEI 660
+K + LG G F VY+ D K +K V EF+ +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-----VQKPANPWEFYIGTQLM 118
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
L + + +LV E G L I +K+ + + ++ A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA-----------KVSDFGL-VKLAP 768
+ + +E +H IH D+K N +LG+ F + D G + +
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
+ ++ T T G+ E ++ K ++D F + +L G
Sbjct: 236 FPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFG 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 619 LGRGGFGVVYKGE---LDDGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSL 674
LG GG VY E L+ K+A+K + ++ + F E+ S++ H+++VS+
Sbjct: 19 LGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+ LV EY+ LS++I + PLS +N + G+++ A
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKH----A 127
Query: 735 HQS-FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
H +HRD+K NIL+ + K+ DFG+ K ++ + + GT Y +PE A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 794 KITTKVDVFSFGVVLMELLTG 814
D++S G+VL E+L G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVG 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-31
Identities = 65/264 (24%), Positives = 108/264 (40%), Gaps = 28/264 (10%)
Query: 563 VVANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNV-----TKNFASEN 617
V + ++ S+A +GS G G L+ + +
Sbjct: 5 VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP 64
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V++ + G + AVK++ V + E+ + + +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 117
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
G + E + G+L + I L E + L G+EYLH+ +
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRA----LYYLGQALEGLEYLHT---R 169
Query: 737 SFIHRDLKSSNILLGDD-FRAKVSDFGLVK-LAPDSERSVVTR---LAGTFGYLAPEYAV 791
+H D+K+ N+LL D RA + DFG L PD + + GT ++APE V
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VV 228
Query: 792 TGK-ITTKVDVFSFGVVLMELLTG 814
GK KVD++S +++ +L G
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNG 252
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFH------SEIAVLSKVRHRHL 671
LG+G F VY+ + G ++A+K +I KKA+ + +E+ + +++H +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIK-----MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 672 VSLLGYSVAGYERL-LVYEYMPQGALSKHI-FHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+ L Y + LV E G +++++ K + E + + GM Y
Sbjct: 74 LELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARH----FMHQIITGMLY 127
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPE 788
LHS +HRDL SN+LL + K++DFGL +L E+ L GT Y++PE
Sbjct: 128 LHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPE 182
Query: 789 YAVTGKI-TTKVDVFSFGVVLMELLTG 814
T + DV+S G + LL G
Sbjct: 183 -IATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 74/358 (20%), Positives = 121/358 (33%), Gaps = 84/358 (23%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
Q + L+ LE + L NQ + S L L Y+ N I A L NL+ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKITDISA--LQNLTNLRELY 116
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L+ +N S L + ++ +L+ N L N L L ++ + +
Sbjct: 117 LNEDNI------SDISPLANLTKMYSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT 275
P L +L +L LN + I L ++ L + N + P +T
Sbjct: 170 VTP--IANLTDLYSLSLNYNQ----IEDISPLASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 276 SLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTE 334
L L + +N+ L P LA+L L L++ N
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD---------------------- 257
Query: 335 GVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTN--SKLTVL-NLPN-- 389
I+ + L +L L+ G+N S ++VL NL
Sbjct: 258 -----------INAVKDL---TKLKM-------------LNVGSNQISDISVLNNLSQLN 290
Query: 390 -FNLSG----TLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
L+ V G L +LT + L N+I+ P +L + D + +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 3e-31
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 21/217 (9%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ L+ ++ L + + +++ + + + L++L L+ N + I L +L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
N + + +L +L + + L N + L L++ N
Sbjct: 203 YFTAYVNQITDITP------VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQ 254
Query: 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
++ + K L L L + + + I VL N+ QL +L+L+ N E G
Sbjct: 255 ISDI--NAVKDLTKLKMLNVGSNQ---ISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
LT+L L L+ N + P LASL +D D N
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 65/376 (17%), Positives = 118/376 (31%), Gaps = 128/376 (34%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L++ LQK + + L ++ + G +I + L NL+ L L
Sbjct: 17 PDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVASIQG--IEYLTNLEYLNL 73
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
+ N Q+T++S L N L NL + N +T
Sbjct: 74 NGN------------------QITDIS------------PLSNLVKLTNLYIGTNKIT-- 101
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
I L N+ LR L+L+ ++ S LT +
Sbjct: 102 -------------------------DISALQNLTNLRELYLNEDNISD--ISPLANLTKM 134
Query: 278 KDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGV 336
LNL +N + + P L+++ L++L + +
Sbjct: 135 YSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD------------------------ 169
Query: 337 PCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL----NLPN--- 389
+ + L L + LS N ++ + +L +
Sbjct: 170 ---------VTPIANL---TDLYS-------------LSLNYN-QIEDISPLASLTSLHY 203
Query: 390 FNLSG---TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPL 444
F T V N+ L +K+ +N I+ P NL LT L++ N +S +
Sbjct: 204 FTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV 261
Query: 445 PKFSGAVKLSLDGNPL 460
+ L++ N +
Sbjct: 262 KDLTKLKMLNVGSNQI 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-24
Identities = 47/226 (20%), Positives = 80/226 (35%), Gaps = 22/226 (9%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
T L L+ L + L ++ + + L+ + L N+ + + + L
Sbjct: 101 TDISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSPLS-NMTGLN 158
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L + + + + L +LS + L + SL N
Sbjct: 159 YLTVTESKVKDV------TPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQ 210
Query: 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
+T P + L +L + + K T + L N+ QL L + N S +
Sbjct: 211 ITDITP--VANMTRLNSLKIGNNK---ITD-LSPLANLSQLTWLEIGTNQISD--INAVK 262
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKS 317
LT LK LN+ SNQ + L +L L+ L LNNN +
Sbjct: 263 DLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 53/368 (14%), Positives = 103/368 (27%), Gaps = 126/368 (34%)
Query: 105 LENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA 164
+ ++ + L+ A L + + + LE++ L +
Sbjct: 2 AATLATLPAPI-NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE---- 54
Query: 165 SKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKG 224
++ ++ + +L+ L L+GN +T P
Sbjct: 55 --------------KVASIQ------------GIEYLTNLEYLNLNGNQITDISP----- 83
Query: 225 LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNS 284
L N+ +L L++ N T + LT+L++L LN
Sbjct: 84 ----------------------LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNE 119
Query: 285 NQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343
+ + P LA+L + L+L N +
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNLS------------------------------- 146
Query: 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC---------GTNSKLTVLNLPNFNLSG 394
+ L + L L ++ + L L+L +
Sbjct: 147 -DLSPLSNM---TGLNY-----------LTVTESKVKDVTPIANLTDLYSLSLNYNQIED 191
Query: 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVK 452
+ +L SL N I+ P N+ L L + N ++ PL S
Sbjct: 192 --ISPLASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSPLANLSQLTW 247
Query: 453 LSLDGNPL 460
L + N +
Sbjct: 248 LEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 377 GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
+KL +LN+ + +S + NL L + L +N + + L +LT L LS
Sbjct: 262 KDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLS 319
Query: 437 QNNLS--PPLPKFSGAVKLSLDGNPL 460
QN+++ PL S +
Sbjct: 320 QNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 7e-07
Identities = 23/84 (27%), Positives = 39/84 (46%), Gaps = 6/84 (7%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+ L LNL ++ + NL LT + + +N I+ + NL +L L L+++N
Sbjct: 66 TNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDN 121
Query: 440 LS--PPLPKFSGAVKLSLDGNPLL 461
+S PL + L+L N L
Sbjct: 122 ISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 8/88 (9%)
Query: 377 GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
S+LT L + +S +V +L L + + SN IS + NL L L L+
Sbjct: 240 ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLN 295
Query: 437 QNNLS-PPLPKFSGAVKL---SLDGNPL 460
N L + G L L N +
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 28/242 (11%), Positives = 60/242 (24%), Gaps = 40/242 (16%)
Query: 605 VLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAV 662
+L + L G VV+ +++ A+K G S+ ++ H
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 663 LSKVRHRHLVSLLGY--------------------------SVAGYERLLVYEYMPQGAL 696
+++ A LL+ L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDL 174
Query: 697 SKHI--FHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754
+ + + + R L S + +H N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDG 231
Query: 755 RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY--AVTGKITTKVDVFSFGVVLMELL 812
R + D + + Y E+ A T T ++ + G+ + +
Sbjct: 232 RLMLGDVSALWKVGTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 813 TG 814
Sbjct: 288 CL 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
LG+G +G+VY G +L + +IA+K + + H EIA+ ++H+++V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 678 SVAGYERLLVYEYMPQGALSKHI-FHWKSLNL-EPLSWKRRLNIALDVARGMEYLHSLAH 735
+ E +P G+LS + W L E + G++YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----GFYTKQILEGLKYLHD--- 140
Query: 736 QSFIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE---YAV 791
+HRD+K N+L+ K+SDFG K T GT Y+APE
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGP 199
Query: 792 TGKITTKVDVFSFGVVLMELLTG 814
G D++S G ++E+ TG
Sbjct: 200 RGY-GKAADIWSLGCTIIEMATG 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-31
Identities = 63/207 (30%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL- 675
LG GGFG V + D G ++A+K+ + K + + EI ++ K+ H ++VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS-PKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 676 -----GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LL EY G L K++ + N L + D++ + YL
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN--QFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 731 HSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
H IHRDLK NI+L K+ D G K E + T GT YLAP
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAP 192
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTG 814
E K T VD +SFG + E +TG
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITG 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-31
Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 31/215 (14%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVS 673
LG+G V++G G A+K V + + VD E VL K+ H+++V
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIK-----VFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 674 LLGY--SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
L ++L+ E+ P G+L + + N L L + DV GM +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLE--EPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 732 SLAHQSFIHRDLKSSNILLG----DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
+HR++K NI+ K++DFG + D E L GT YL P
Sbjct: 130 E---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHP 184
Query: 788 E--------YAVTGKITTKVDVFSFGVVLMELLTG 814
+ K VD++S GV TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 28/226 (12%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLG 676
L GGF VY+ + + G + A+KR+ ++ E+ + K+ H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 677 YSVAGYER-------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+ G E L+ + +G L + + K + PLS L I R +++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLK--KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV---KLAPDSERSVVTRLA------- 779
+H IHRDLK N+LL + K+ DFG PD S R
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 780 -GTFGYLAPE-YAVTGK--ITTKVDVFSFGVVLMELLTGLMALDES 821
T Y PE + I K D+++ G +L L ++
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+GGF ++ + D A K + + ++ ++ EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ + + +V E + +L + K+L EP + + G +YLH
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARY----YLRQIVLGCQYLHR--- 133
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
IHRDLK N+ L +D K+ DFGL K+ D ER L GT Y+APE ++ K
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKK 190
Query: 795 I-TTKVDVFSFGVVLMELLTG 814
+ +VDV+S G ++ LL G
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVG 211
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 49/230 (21%), Positives = 81/230 (35%), Gaps = 33/230 (14%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
T F ++G G FG V+K + DG A+KR + + E+ + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 667 -RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+H H+V L+ EY G+L+ I + ++ L V R
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM-SYFKEAELKDLLLQVGR 126
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDD-------------------FRAKVSDFGLVKL 766
G+ Y+HS S +H D+K SNI + K+ D G V
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 767 APDSERSVVTRLAGTFGYLAPEYAVTGKI--TTKVDVFSFGVVLMELLTG 814
S + G +LA E + K D+F+ + ++
Sbjct: 184 I-SSPQVEE----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGA 227
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+GGF ++ + D A K + + ++ ++ EI++ + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+ + + +V E + +L + K+L EP + + G +YLH
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARY----YLRQIVLGCQYLHR--- 159
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
IHRDLK N+ L +D K+ DFGL K+ D ER L GT Y+APE ++ K
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE-VLSKK 216
Query: 795 I-TTKVDVFSFGVVLMELLTG 814
+ +VDV+S G ++ LL G
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVG 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-30
Identities = 61/291 (20%), Positives = 104/291 (35%), Gaps = 63/291 (21%)
Query: 619 LGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+ GG G +Y D +G + +K + +A +E L++V H +V +
Sbjct: 88 IAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 676 GY--------SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
+ GY +V EY+ +L + + L + L++ +
Sbjct: 146 NFVEHTDRHGDPVGY---IVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPAL 195
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
YLHS ++ DLK NI+L ++ + K+ D G V +S + GT G+ AP
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAP 246
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847
E T D+++ G L L L +Y+
Sbjct: 247 EIV-RTGPTVATDIYTVGRTLAALTLDL------PTRNGRYVDG------------LPED 287
Query: 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP----DMGHAV-NVLAPLV 893
DP+L+ D L +P QR +M + VL +V
Sbjct: 288 DPVLKTYDS-------YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-30
Identities = 66/376 (17%), Positives = 125/376 (33%), Gaps = 56/376 (14%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+L + L+ + L+ ++ + +F L +L++ L N+ ++ + +F L +L+
Sbjct: 43 HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK 101
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGN 212
L L N + S L + L L + ++ SL L++
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTN---LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 213 NLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
+L +S K + + L LH + + +
Sbjct: 159 SLRNYQSQSLKSIR-------------------------DIHHLTLHLSESAFLLEIFAD 193
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQP 332
L+S++ L L S + + F G V +++ N +
Sbjct: 194 ILSSVRYLELRDTNLAR-FQFSPLPVDEVSSPMKKLAFRGSVLTDESF------NELLKL 246
Query: 333 TEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNL 392
+ EV L GL L + L++P F L
Sbjct: 247 LRYILELSEVEFDDCTLNGLG--------DFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 393 SGTLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLS---PPLPKFS 448
LS L+ + +I ++++ + +P + +LKSL LDLS+N +
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 449 GAV----KLSLDGNPL 460
GA L L N L
Sbjct: 358 GAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 61/408 (14%), Positives = 116/408 (28%), Gaps = 77/408 (18%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+ L+ L+ + + + E+ F+GL++L + + + + +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
+ L L + + + L NLA L +K
Sbjct: 174 IHHLTLHLSESAFLLEIFA----DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229
Query: 212 NNLTGPIPESFKGL--------NLVNLWLNDQKGGGFT-------GTIDVLGNMD--QLR 254
+ ESF L L + +D G + LG ++ +R
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289
Query: 255 TLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGP 313
L + + + + L +K + + +++ + L SL+ LDL+ N+
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM--- 346
Query: 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT-SWSGNDPCK-SW 371
G P L T S N
Sbjct: 347 -----------VEEYLKNSA--------------CKGAW---PSLQTLVLSQNHLRSMQK 378
Query: 372 LGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG------------- 418
G T LT L++ + N + S + + + L S I
Sbjct: 379 TGEILLTLKNLTSLDI-SRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD 437
Query: 419 ----QIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPL 460
+ + L L L +S+N L P F + + + N L
Sbjct: 438 VSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQL 485
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 64/422 (15%), Positives = 128/422 (30%), Gaps = 78/422 (18%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFR--GELPSFSGLSNLK 129
F S + + +S L LS L+ + L N ++ G F L+NL+
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 130 YAYLDGNN-FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMS 187
+ F I F GL +L L + + + ++ L+S + +L+
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-----NYQSQSLKSIRDIHHLTLHL 181
Query: 188 CNLAGQLPDFLGNFASLQNLKLSGNNLTG------PIPESFKGLNLVNLWLNDQKGGGFT 241
A L F +S++ L+L NL P+ E + + + F
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 242 GTIDVLGNMDQLRTLWLHGNHFSGTIP-----------ESFGKLTSLKDLNLNSNQFVGL 290
+ +L + +L + +G + +++ L++
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 291 IPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFL 349
+ + L + + + N+ + + L
Sbjct: 302 LSTVYSLLEKVKRITVENSKV-----------FLVPCSFS-----------------QHL 333
Query: 350 GGL-------NYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVG- 401
L N +V + N CK G L L L + N ++ +
Sbjct: 334 KSLEFLDLSEN---LMVEEYLKNSACK-------GAWPSLQTLVL-SQNHLRSMQKTGEI 382
Query: 402 --NLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP-PLPKFSGAVKLSLDGN 458
L +LT + + N +P + + + L+LS + L + N
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNN 441
Query: 459 PL 460
L
Sbjct: 442 NL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 54/298 (18%), Positives = 104/298 (34%), Gaps = 29/298 (9%)
Query: 26 LAFVTLVLSATDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQ 85
LAF VL+ ++ L ++ L E +G P V +V +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 86 V-----SSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNF 138
+ L L + L K++ I ++ ++ +P L +L++ L N
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346
Query: 139 DTIPAD---FFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC--MSCNLAGQ 193
+LQ L L N+ S K + L NL+ +S N
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR-----SMQKTGEILLTLKNLTSLDISRNTFHP 401
Query: 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
+PD ++ L LS + + L ++++ N+ + +L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD--------SFSLFLPRL 453
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
+ L++ N T+P++ L + ++ NQ + L SL + L+ N +
Sbjct: 454 QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 64/424 (15%), Positives = 121/424 (28%), Gaps = 114/424 (26%)
Query: 96 PQNLNQLSKLENIGLQKNQFRG-ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
+ L+ L + ++ R + S + ++ + L + + F D L +++
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 155 LALDSNNFNASKGWSFPKGLQSSA---------------------------QLTNLSCMS 187
L L N + P SS +L+ +
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDD 260
Query: 188 CNLAGQLPDFLGNFA-----------SLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQ 235
C L G +++ L + L + + L + + + +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES---FGKLTSLKDLNLNSNQFVGL-- 290
K ++ L L L N ++ G SL+ L L+ N +
Sbjct: 321 KVFLVPC--SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK 378
Query: 291 IPPSLASL-SLDHLDL-NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDF 348
L +L +L LD+ N
Sbjct: 379 TGEILLTLKNLTSLDISRNT------------------------------------FHPM 402
Query: 349 LGGLNYPPRLVTSWSGNDPCKSWLGLS--------CGTNSKLTVLNLPNFNLSGTLSPSV 400
+P ++ +L LS L VL++ N NL + S
Sbjct: 403 PDSCQWPEKMR-----------FLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSL-- 448
Query: 401 GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL-SPPLPKFSGAVKLS---LD 456
L L ++ + N + +P + + L ++ +S+N L S P F L L
Sbjct: 449 -FLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 457 GNPL 460
NP
Sbjct: 506 TNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-12
Identities = 38/135 (28%), Positives = 53/135 (39%), Gaps = 12/135 (8%)
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237
S + +P G A++++L LS N +T + NL L L +
Sbjct: 6 ASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR- 61
Query: 238 GGFTGTI--DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
TI D ++ L L L NH S FG L+SLK LNL N + L SL
Sbjct: 62 ---INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 296 AS--LSLDHLDLNNN 308
+L L + N
Sbjct: 119 FPNLTNLQTLRIGNV 133
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 17/70 (24%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ L +L +L + +N+ + LP S L + N ++P FD L +LQ
Sbjct: 445 SFSLFLPRLQELY---ISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 154 VLALDSNNFN 163
+ L +N ++
Sbjct: 501 KIWLHTNPWD 510
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 63/253 (24%), Positives = 85/253 (33%), Gaps = 51/253 (20%)
Query: 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SF 122
PC C C N GL+ +P + + + I L N+ +P SF
Sbjct: 1 PCPGACV----CYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASF 52
Query: 123 SGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182
NL +L N I A F GL L+ L L N QL +
Sbjct: 53 RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA-----------------QLRS 95
Query: 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFT 241
+ P L L L L P F+GL L L+L D
Sbjct: 96 VD----------PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA----- 140
Query: 242 GTI-----DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA 296
+ D ++ L L+LHGN S +F L SL L L+ N+ + P +
Sbjct: 141 --LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 297 SL-SLDHLDLNNN 308
L L L L N
Sbjct: 199 DLGRLMTLYLFAN 211
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 35/194 (18%)
Query: 99 LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
L+ LE + L N + F GL L +LD + F GL LQ L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L N L L D + +L +L L GN ++
Sbjct: 136 LQDN------------------ALQALP----------DDTFRDLGNLTHLFLHGNRISS 167
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKL 274
+F+GL +L L L+ + ++ +L TL+L N+ S +P L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHP--HAFRDLGRLMTLYLFANNLS-ALPTEALAPL 224
Query: 275 TSLKDLNLNSNQFV 288
+L+ L LN N +V
Sbjct: 225 RALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/145 (25%), Positives = 53/145 (36%), Gaps = 33/145 (22%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
L L+ L+ + LQ N + LP F L NL + +L GN ++P F GL
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLS 210
+L L L N ++ ++ P + L L L
Sbjct: 178 SLDRLLLHQN------------------RVAHVH----------PHAFRDLGRLMTLYLF 209
Query: 211 GNNLTGPIPESFKGL-NLVNLWLND 234
NNL+ E+ L L L LND
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 42/209 (20%), Positives = 71/209 (33%), Gaps = 58/209 (27%)
Query: 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSY 324
+P + + + L+ N+ + S + L L L++N+
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-----------RI 71
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT-SWSGND-----PCKSWLGLSCGT 378
+ AF GL L S N ++ GL
Sbjct: 72 DAAAF--------------------TGL---ALLEQLDLSDNAQLRSVDPATFHGLG--- 105
Query: 379 NSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLS 436
+L L+L L L P + L +L + LQ N + +P + + +L +LT L L
Sbjct: 106 --RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161
Query: 437 QNNLSPPLPK--FSGAVKL---SLDGNPL 460
N +S +P+ F G L L N +
Sbjct: 162 GNRIS-SVPERAFRGLHSLDRLLLHQNRV 189
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 14/90 (15%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQ 437
LT L L + N ++ L SL ++ L N ++ + + + +L L L L
Sbjct: 153 GNLTHLFL-HGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 438 NNLS-------PPLPKFSGAVKLSLDGNPL 460
NNLS PL L L+ NP
Sbjct: 211 NNLSALPTEALAPLRALQ---YLRLNDNPW 237
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 63/280 (22%), Positives = 100/280 (35%), Gaps = 38/280 (13%)
Query: 56 LLQWPKSGDPCGPPCW-----KHVFCSNSRVTQI------QVSSVGLKG----TLPQN-L 99
+ S C C V C + ++ + L + N
Sbjct: 25 CVAETGSAQTCPSVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSF 84
Query: 100 NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L LE + L +N R + +F+GL+NL L N TIP F L L+ L L
Sbjct: 85 KHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK---LSGNNL 214
+N + ++F + S L L + + G F L NL+ L+ NL
Sbjct: 144 RNNPIESIPSYAF-NRIPS---LRRLDLGELKRLSYISE--GAFEGLSNLRYLNLAMCNL 197
Query: 215 TGPIPESFKGL-NLVNLWLNDQKGGGFTGTI--DVLGNMDQLRTLWLHGNHFSGTIPESF 271
IP + L L L L+ + I + L+ LW+ + +F
Sbjct: 198 RE-IP-NLTPLIKLDELDLSGNH---LS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
L SL ++NL N L L L+ + L++N +
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 47/220 (21%), Positives = 71/220 (32%), Gaps = 52/220 (23%)
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
R L LH N SF L L+ L L+ N + + L +L+ L+L +N
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 311 MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGND--- 366
+ + AF L +L W N
Sbjct: 125 T-----------TIPNGAF--------------------VYL---SKLKELWLRNNPIES 150
Query: 367 -PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW 424
P ++ + L L+L +S L +L + L N+ +IP
Sbjct: 151 IPSYAFNRIP-----SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-L 203
Query: 425 TNLKSLTLLDLSQNNLS--PP--LPKFSGAVKLSLDGNPL 460
T L L LDLS N+LS P KL + + +
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 4/73 (5%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
+ L L+ + + ++Q + + F L +L L NN +P D F L
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279
Query: 151 NLQVLALDSNNFN 163
+L+ + L N +N
Sbjct: 280 HLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 25/89 (28%), Positives = 39/89 (43%), Gaps = 12/89 (13%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQN 438
KL L+L +LS S L L ++ + + I I N + NL+SL ++L+ N
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHN 265
Query: 439 NLS-------PPLPKFSGAVKLSLDGNPL 460
NL+ PL ++ L NP
Sbjct: 266 NLTLLPHDLFTPLHHLE---RIHLHHNPW 291
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-29
Identities = 81/432 (18%), Positives = 137/432 (31%), Gaps = 84/432 (19%)
Query: 72 KHVFCSNSRVTQI----------QVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP- 120
+ F +TQ+ +S ++ + L +L+ + L +
Sbjct: 7 RIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 121 -SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179
+F L NL+ L + + D F GL +L L L S ++
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL--SDAVLKDGYFRNLKA 124
Query: 180 LTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL-------- 230
LT L + L G SL+++ S N + + L L
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 231 WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS------------GTIPESFGKLTSLK 278
L + + ++ NM L L + GN ++ + S +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMV-LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 279 DLNLNSNQFVGLIP---PSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
+ LA S+ HLDL++ +S +S F
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV-----------FSLNSRVF------ 286
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGND----PCKSWLGLSCGTNSKLTVLNLPNFN 391
++ L L + N +++ GL L VLNL ++N
Sbjct: 287 -ETLKDLKVL-----------NL----AYNKINKIADEAFYGLD-----NLQVLNL-SYN 324
Query: 392 LSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA 450
L G L S L + I LQ N+I+ + L+ L LDL N L+ +
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSI 383
Query: 451 VKLSLDGNPLLN 462
+ L GN L+
Sbjct: 384 PDIFLSGNKLVT 395
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-29
Identities = 78/421 (18%), Positives = 135/421 (32%), Gaps = 81/421 (19%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQN--LNQLSKLENIGLQKNQFR--GELPSFSGLSNL 128
F + ++++ GL + ++ L L + L KNQ R PSF L++L
Sbjct: 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150
Query: 129 KYAYLDGNNFDTIPADFFDGLE--NLQVLALDSNNFNASKGWSFPKGLQ----------- 175
K N + + L+ L +L +N+ + + K +
Sbjct: 151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
Query: 176 -SSAQLTNLSCMSC--NLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL-W 231
S T + ++ L + +N+ P +F GL ++
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 232 LNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI 291
L+ G F+ V + L+ L L N + E+F L +L+ LNL+ N L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 292 PPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLG 350
+ L + ++DL N F FL
Sbjct: 331 SSNFYGLPKVAYIDLQKNHI-----------AIIQDQTF-----------------KFLE 362
Query: 351 GLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL----NLPNFNLSGTLSPSVGNLD-S 405
L L L ++ LT + ++P+ LSG ++ ++ +
Sbjct: 363 KLQT-----------------LDLR---DNALTTIHFIPSIPDIFLSGNKLVTLPKINLT 402
Query: 406 LTQIKLQSNNISG-QIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVK---LSLDGNP 459
I L N + I + L +L L+QN S S L L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 460 L 460
L
Sbjct: 463 L 463
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 70/401 (17%), Positives = 123/401 (30%), Gaps = 37/401 (9%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRG-ELPSFSGLS--NLKYAYLDGNNFDTIPADFFDGLEN 151
L + +L+ L++I NQ L L + L N+ + + + N
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 152 ------LQVLALDSNNFNASKGWSFPKGLQSSA--------QLTNLSCMSCNLAGQLPDF 197
L++L + N + +F + S + N+ +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 198 LGNFA--SLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLR 254
A S+++L LS + F+ L +L L L K + +D L+
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD--EAFYGLDNLQ 317
Query: 255 TLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGP 313
L L N +F L + ++L N + + L L LDL +N
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
Query: 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYP------PRLVTSW-SGND 366
S N + A + + L L+ P L + N
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437
Query: 367 PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-----GNLDSLTQIKLQSNNISGQIP 421
+ N L L L L + L L + L N ++ P
Sbjct: 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497
Query: 422 TNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPL 460
+++L +L L L+ N L+ + L + N L
Sbjct: 498 GVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-26
Identities = 72/342 (21%), Positives = 121/342 (35%), Gaps = 41/342 (11%)
Query: 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKY 130
VF + + + ++ + + L L+ + L N EL +F GL + Y
Sbjct: 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAY 342
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL-QSSAQLTNLS----- 184
L N+ I F LE LQ L L N + S +L L
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLT 402
Query: 185 ----CMSCNLAGQLPD--FLGNFASLQNLKLSGNNLTG-PIPESFKGL-NLVNLWLND-- 234
+S N L FL LQ L L+ N + ++ +L L+L +
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 235 -QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP 293
Q DV + L+ L+L+ N+ + P F LT+L+ L+LNSN+ L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL-SH 521
Query: 294 SLASLSLDHLDLNNNMFMGPVPKSKAY--KYSYSSNAFCQPTEGVPCAPEVMALIDFLGG 351
+ +L+ LD++ N + P P + N F E L F+
Sbjct: 522 NDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE----------LSTFINW 571
Query: 352 LNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393
LN+ + + + C + ++L + +
Sbjct: 572 LNHTNVTIAGPPAD--------IYCVYPDSFSGVSLFSLSTE 605
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-26
Identities = 88/482 (18%), Positives = 154/482 (31%), Gaps = 97/482 (20%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKY 130
+ ++ L + S + ++ L F L +LK
Sbjct: 243 MGAGFGFHNIKDPDQNTF-------AGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKV 294
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L N + I + F GL+NLQVL L N +F GL + + ++
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF-YGLPK---VAYIDLQKNHI 350
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGN 249
A LQ L L N LT + + ++ +++L+ K + L
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK-------LVTLPK 398
Query: 250 MD-QLRTLWLHGNHFSG-TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL--SLDHLDL 305
++ + L N I ++ L+ L LN N+F S SL+ L L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 306 NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365
N L +W
Sbjct: 459 GEN------------------------------------------------MLQLAWETE 470
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW 424
+ GLS L VL L + L+ +L P V +L +L + L SN ++ + +
Sbjct: 471 LCWDVFEGLS-----HLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLS-HN 522
Query: 425 TNLKSLTLLDLSQNNL-SPPLPKFSGAVKLSLDGNP---------LLNGKSPGSGSSSGN 474
+L +LD+S+N L +P F L + N +N + + + +G
Sbjct: 523 DLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGP 582
Query: 475 PPSPTKGSSSSSSSSPGDSTAETTKPKSSKRTILVAIIAPVASVGVILLVAIPISICYYR 534
P S S S + + L + V +V + L + +++ +R
Sbjct: 583 PADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFR 642
Query: 535 KR 536
Sbjct: 643 GF 644
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 67/377 (17%), Positives = 119/377 (31%), Gaps = 94/377 (24%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
LP L+ ++E + L Q E+ +F+ ++ Y+ N +P F +
Sbjct: 59 KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 117
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLS 210
L VL L+ N L++L N L L +S
Sbjct: 118 LLTVLVLERN------------------DLSSLP----------RGIFHNTPKLTTLSMS 149
Query: 211 GNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPE 269
NNL ++F+ +L NL L+ + T +D L + L + N S
Sbjct: 150 NNNLERIEDDTFQATTSLQNLQLSSNR---LT-HVD-LSLIPSLFHANVSYNLLS----- 199
Query: 270 SFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAF 329
+ ++++L+ + N + P L+ L L +N
Sbjct: 200 TLAIPIAVEELDASHNSINVVRGPVNVELT--ILKLQHNNLTD----------------- 240
Query: 330 CQPTEGVPCAPEVMALIDFLGGLNYPPRLVT-SWSGND----PCKSWLGLSCGTNSKLTV 384
+L P LV S N+ ++ + +L
Sbjct: 241 ----------------TAWLLNY---PGLVEVDLSYNELEKIMYHPFVKMQ-----RLER 276
Query: 385 LNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP-P 443
L + N L L+ + +L + L N++ + N L L L N++
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 334
Query: 444 LPKFSGAVKLSLDGNPL 460
L L+L N
Sbjct: 335 LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 34/211 (16%), Positives = 64/211 (30%), Gaps = 63/211 (29%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
+L + LQ N + L L N + I F ++ L+ L + +
Sbjct: 223 PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
N +L L + +L+ L LS N+L +
Sbjct: 282 N------------------RLVA-----------LNLYGQPIPTLKVLDLSHNHLLH-VE 311
Query: 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD 279
+ D+L L+L N T+ +LK+
Sbjct: 312 RNQPQF-------------------------DRLENLYLDHNSIV-TLK--LSTHHTLKN 343
Query: 280 LNLNSNQF----VGLIPPSLASLSLDHLDLN 306
L L+ N + + + ++A ++D D +
Sbjct: 344 LTLSHNDWDCNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 24/145 (16%), Positives = 46/145 (31%), Gaps = 36/145 (24%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+ + ++ +LE + + N+ L + LK L N+ + + +
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQP-QFDR 319
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
L+ L LD N + L L +L+NL LS
Sbjct: 320 LENLYLDHN------------------SIVTLK-------------LSTHHTLKNLTLSH 348
Query: 212 NNLTG-PIPESFKGLNLVNLWLNDQ 235
N+ + F+ + + DQ
Sbjct: 349 NDWDCNSLRALFRNVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 16/93 (17%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
L + L+ + L N + L+ YLD N+ T+ L+
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLK 342
Query: 154 VLALDSNNFNASKGWSFPKGLQSSA-QLTNLSC 185
L L N+++ + + + + A + C
Sbjct: 343 NLTLSHNDWDCNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 6/83 (7%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
L VL+L + +L + + D L + L N+I + + +L L LS N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHND 350
Query: 440 LS--PPLPKFSGAVKLSLDGNPL 460
F + ++D
Sbjct: 351 WDCNSLRALFRNVARPAVDDADQ 373
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 619 LGRGGFGVVYKGE---LDDGTKIAVKRMEAGVISKKAVDE-----FHSEIAVLSKVRHRH 670
+GRGG G VY+ E + +A+K M + + D E +++ H
Sbjct: 42 VGRGGMGDVYEAEDTVRER--IVALKLMSETL----SSDPVFRTRMQREARTAGRLQEPH 95
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V + + + + + L+ + PL+ R + I + ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIVRQIGSALDA- 149
Query: 731 HSLAHQS-FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
AH + HRD+K NIL+ D A + DFG+ D + + + GT Y+APE
Sbjct: 150 ---AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 790 AVTGKITTKVDVFSFGVVLMELLTG 814
T + D+++ VL E LTG
Sbjct: 207 FSESHATYRADIYALTCVLYECLTG 231
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 43/224 (19%), Positives = 81/224 (36%), Gaps = 14/224 (6%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENL 152
P +LS L+++ + ELP + + L+ L N +PA L L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIAS-LNRL 152
Query: 153 QVLALDSNNFNAS-----KGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNL 207
+ L++ + Q L +L + LP + N +L++L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR-LEWTGIRSLPASIANLQNLKSL 211
Query: 208 KLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT 266
K+ + L+ + + L L L L + G L+ L L T
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLEELDLRGCTA--LRNYPPIFGGRAPLKRLILKDCSNLLT 268
Query: 267 IPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNM 309
+P +LT L+ L+L + +P +A L + + + ++
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 50/239 (20%), Positives = 88/239 (36%), Gaps = 27/239 (11%)
Query: 94 TLPQNLNQLS--KLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
L + + L+ + P LS+L++ +D +P
Sbjct: 70 ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQ-FA 127
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFA-------- 202
L+ L L N + P + S +L LS +C +LP+ L +
Sbjct: 128 GLETLTLARNPLR-----ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 203 -SLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG 260
+LQ+L+L + +P S L NL +L + + + + ++ +L L L G
Sbjct: 183 VNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP---LSALGPAIHHLPKLEELDLRG 238
Query: 261 NHFSGTIPESFGKLTSLKDLNL-NSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKS 317
P FG LK L L + + + L P + L L+ LDL + + +P
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEKLDLRGCVNLSRLPSL 296
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 46/234 (19%), Positives = 77/234 (32%), Gaps = 22/234 (9%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDG-LENL 152
L+Q + N + + +N + G D
Sbjct: 27 PYHDVLSQWQRHYNADRNRWHSAWRQAN---SNNPQIETRTGRALKATADLLEDATQPGR 83
Query: 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGN 212
L L S FP + L +++ + L +LPD + FA L+ L L+ N
Sbjct: 84 VALELRSVPLP-----QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARN 137
Query: 213 NLTGPIPESFKGL-NLVNLWLNDQ-------KGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264
L +P S L L L + + T + L++L L
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196
Query: 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKS 317
++P S L +LK L + ++ L P++ L L+ LDL + P
Sbjct: 197 -SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 54/354 (15%), Positives = 88/354 (24%), Gaps = 91/354 (25%)
Query: 125 LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184
S + Y G+ + + D L Q N W +S +
Sbjct: 11 SSGRENLYFQGST--ALRP-YHDVLSQWQRHYNADRN-----RWHSAWRQANSNNPQ-IE 61
Query: 185 CMSCNLAGQLPDFLGNFAS--LQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTG 242
+ D L + L+L L P+
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQA-------------------- 100
Query: 243 TIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLD 301
+ L+ + + +P++ + L+ L L N L P S+ASL L
Sbjct: 101 -----FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLR 153
Query: 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTS 361
L + + +P+ L +
Sbjct: 154 ELSIRACPELTELPEP-------------------------------LASTDASGEH--- 179
Query: 362 WSGNDPCKSWLGLSC----------GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKL 411
L L L L + N LS L P++ +L L ++ L
Sbjct: 180 --QGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236
Query: 412 QSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGA----VKLSLDGNPLL 461
+ P + L L L + LP KL L G L
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 23/133 (17%), Positives = 45/133 (33%), Gaps = 9/133 (6%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNN-FDTIPADFFDGLENL 152
+LP ++ L L+++ ++ + P+ L L+ L G P F L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPL 255
Query: 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGN 212
+ L L + + P + QL L C +LP + + + + +
Sbjct: 256 KRLILKDCSNLLT----LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
Query: 213 ---NLTGPIPESF 222
L P +
Sbjct: 312 LQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 25/215 (11%), Positives = 50/215 (23%), Gaps = 49/215 (22%)
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMG 312
L+ G+ + + + + N + + ++
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQIETRTGRALK--- 69
Query: 313 PVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWL 372
A D L P R+
Sbjct: 70 -------------------------------ATADLLEDATQPGRVALELRSV------- 91
Query: 373 GLSC-----GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNL 427
L S L + + L L ++ L + L N + +P + +L
Sbjct: 92 PLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
Query: 428 KSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLN 462
L L + LP+ + S + L+N
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 16/67 (23%), Positives = 23/67 (34%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
KL L+L P G L ++ L+ + +P + L L LDL
Sbjct: 229 PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 440 LSPPLPK 446
LP
Sbjct: 289 NLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 13/75 (17%), Positives = 25/75 (33%), Gaps = 3/75 (4%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPT---NWTNLKSLTLLDLS 436
+ L L L + + TL + L L ++ L+ ++P+ + +
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312
Query: 437 QNNLSPPLPKFSGAV 451
Q L P A
Sbjct: 313 QAQLDQHRPVARPAE 327
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 31/232 (13%), Positives = 62/232 (26%), Gaps = 40/232 (17%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAG-VISKKAVDEFHSEIAVLSKVR--------- 667
LG+ + + G V A+ + E+ L +R
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 668 ----------------HRHLVSLLG----YSVAGYERLLVYEYMPQGALSKHIFHWKSLN 707
+ ++ + V L + + S +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 708 LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767
+ L RL + L V R + LH +H L+ +I+L ++ F +
Sbjct: 206 -KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 768 PDSERSVVTRLAGTFGYLAPE-----YAVTGKITTKVDVFSFGVVLMELLTG 814
S S + R A +T D ++ G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 619 LGRGGFGVVYKGE---LDDGTKIAVKRMEAGVIS-KKAVDEFHSE---IAVLSKVRHRHL 671
LG GG V+ +AVK + A + F E A L+ H +
Sbjct: 20 LGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALN---HPAI 74
Query: 672 VSLLGY-SVAGYERLLVY---EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
V++ L Y EY+ L + P++ KR + + D + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQAL 129
Query: 728 EYLHSLAHQS-FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR---LAGTFG 783
+ +HQ+ IHRD+K +NI++ KV DFG+ + A + VT+ + GT
Sbjct: 130 NF----SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVIGTAQ 184
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
YL+PE A + + DV+S G VL E+LTG
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 69/288 (23%), Positives = 112/288 (38%), Gaps = 49/288 (17%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLS 664
+ + + LG+G FG V + G + AVK + V K + E+ +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 665 KVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
++ H +++ L + +E LV E G L I ++ + S I
Sbjct: 82 QLDHPNIMKLYEF----FEDKGYFYLVGEVYTGGELFDEI-----ISRKRFSEVDAARII 132
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTR 777
V G+ Y+H +HRDLK N+LL D ++ DFGL S++ +
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKD 187
Query: 778 LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837
GT Y+APE + G K DV+S GV+L LL+G P F
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG------CPP---------FNG-A 230
Query: 838 SDKEKLRAAIDPILEVNDDTFETFW-TIAELA----GHCTSREPSQRP 880
++ + L+ + + W ++E A + PS R
Sbjct: 231 NEYDILKK----VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 48/286 (16%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
++++ + +LG G +G V + + A+K + +S + + E+AVL +
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 667 RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
H +++ L + +E LV E G L I ++ + I
Sbjct: 94 DHPNIMKLYDF----FEDKRNYYLVMECYKGGELFDEI-----IHRMKFNEVDAAVIIKQ 144
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
V G+ YLH + +HRDLK N+LL D K+ DFGL + + ++ +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERL 199
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839
GT Y+APE + K K DV+S GV+L LL G P F ++D
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG------YPP---------FGG-QTD 242
Query: 840 KEKLRAAIDPILEVNDDTFETFW-TIAELA----GHCTSREPSQRP 880
+E LR + + W ++E A + +R
Sbjct: 243 QEILRK----VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 56/395 (14%), Positives = 106/395 (26%), Gaps = 49/395 (12%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKY 130
+ + +R +V+ LK L ++ + L N + + L+
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L N + L L+ L L++N L + L + N
Sbjct: 63 LNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE---------LLVGPSIETLH-AANNN 110
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGN 249
++ +N+ L+ N +T + L L + ++ +
Sbjct: 111 ISRVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAAS 167
Query: 250 MDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP-----PSLASLSLDH-- 302
D L L L N + LK L+L+SN+ + P + +SL +
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNK 225
Query: 303 ----------------LDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALI 346
DL N F + K Q + + E +
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 347 DFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSL 406
LG D L + +L+ + + L N
Sbjct: 286 PTLGHYGAYCCEDLPAPFAD------RLIALKRKEHALLSGQG-SETERLECERENQARQ 338
Query: 407 TQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
+I I ++ L+ + L
Sbjct: 339 REIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 45/368 (12%), Positives = 96/368 (26%), Gaps = 32/368 (8%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+L LS L + L N + +++ + NN + G +N+ L
Sbjct: 75 DLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY---L 127
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTG 216
+N + + L + + + +L++L L N +
Sbjct: 128 ANNKITMLRDLDE-GCRSR---VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
+ L L L+ K + + + L N I ++ +
Sbjct: 184 -VKGQVVFAKLKTLDLSSNK---LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 277 LKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMF---MGPVPKSKAYKYSYSSNAFCQPT 333
L+ +L N F S + + G + A+C
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC--- 295
Query: 334 EGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393
C D L L + S G++ + L ++ ++
Sbjct: 296 ----CEDLPAPFADRLIALKRKEHALLSGQGSETER--LECERENQARQREIDALKEQYR 349
Query: 394 GTLSPSVGNLDSLTQIKLQSNNISGQIP---TNWTNLKSLTLLDLSQNNLSPPLPKFSGA 450
+ + ++ + + Q+ L + Q L + S
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPL 409
Query: 451 VKLSLDGN 458
L
Sbjct: 410 QLLRAIVK 417
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 28/218 (12%), Positives = 53/218 (24%), Gaps = 31/218 (14%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTI-PADFFDGLEN 151
+ + + I L+ N+ + + NL++ L GN F DFF +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
+Q +A + L GQ +
Sbjct: 264 VQTVAKQTVK---------------------------KLTGQNEEECTVPTLGHYGAYCC 296
Query: 212 NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF 271
+L P + L L +G N + R + + I +
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
+ + L + + LD
Sbjct: 357 LRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 28/116 (24%)
Query: 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
+ + N + K++ ++L + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAW-------------------------NV 36
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
+ L L GN S T L+ LNL+SN L SL +L LDLNNN
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 18/215 (8%), Positives = 40/215 (18%), Gaps = 25/215 (11%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ + L LE+ L+ N F N + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
+ + + + + L + +L N A + +
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273
I + TL +
Sbjct: 348 YRTVIDQVTLRKQA-------------------------KITLEQKKKALDEQVSNGRRA 382
Query: 274 LTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
L + + L + L L
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVK 417
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 17/84 (20%), Positives = 34/84 (40%), Gaps = 2/84 (2%)
Query: 379 NSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438
++ + + + +L L+ + ++ ++ L N +S + L LL+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 439 NLS--PPLPKFSGAVKLSLDGNPL 460
L L S L L+ N +
Sbjct: 69 VLYETLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 18/82 (21%), Positives = 34/82 (41%), Gaps = 8/82 (9%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+KL +LNL + L + + +L +L + L +N + S+ L + NN
Sbjct: 58 TKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNN 110
Query: 440 LSP-PLPKFSGAVKLSLDGNPL 460
+S + G + L N +
Sbjct: 111 ISRVSCSRGQGKKNIYLANNKI 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 15/89 (16%), Positives = 28/89 (31%), Gaps = 8/89 (8%)
Query: 377 GTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
+ L+ N +S S I L +N I+ + + LDL
Sbjct: 96 LVGPSIETLHA-ANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152
Query: 437 QNNLSP-PLPKFSGA----VKLSLDGNPL 460
N + + + + L+L N +
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFI 181
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 55/212 (25%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
+ K + ++G+G G VY ++ G ++A+++M + + + +EI V+ +
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRE 73
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
++ ++V+ L + G E +V EY+ G+L+ + ++ ++ + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAA-----VCRECLQ 127
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSER--SVVTRLAGTF 782
+E+LHS IHRD+KS NILLG D K++DFG ++ P+ + ++V GT
Sbjct: 128 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTP 180
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
++APE KVD++S G++ +E++ G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 70/289 (24%), Positives = 110/289 (38%), Gaps = 52/289 (17%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA----VDEFHSEIAV 662
+ F + +LG G FG V+ E G + +K I+K +++ +EI V
Sbjct: 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK-----TINKDRSQVPMEQIEAEIEV 73
Query: 663 LSKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLN 718
L + H +++ + +E +V E G L + I + LS
Sbjct: 74 LKSLDHPNIIKIFEV----FEDYHNMYIVMETCEGGELLERIVS-AQARGKALSEGYVAE 128
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVV 775
+ + + Y HS Q +H+DLK NIL K+ DFGL +L E
Sbjct: 129 LMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--S 183
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
T AGT Y+APE +T K D++S GVV+ LLTG P F
Sbjct: 184 TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG------CLP---------FTG 227
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELA----GHCTSREPSQRP 880
S +E + + + A +++P +RP
Sbjct: 228 -TSLEEVQQK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 71/287 (24%), Positives = 109/287 (37%), Gaps = 48/287 (16%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
+ + LG+G FG V K + + AVK + K E+ +L K
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 666 VRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
+ H +++ L E +V E G L I + + S I
Sbjct: 78 LDHPNIMKLFEI----LEDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIK 128
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRL 778
V G+ Y+H + +HRDLK NILL D K+ DFGL + + +
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDR 183
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838
GT Y+APE + G K DV+S GV+L LL+G + P F+ K+
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG------TPP---------FYG-KN 226
Query: 839 DKEKLRAAIDPILEVNDDTFETFW-TIAELA----GHCTSREPSQRP 880
+ + L+ + W TI++ A + PS R
Sbjct: 227 EYDILKR----VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 65/255 (25%), Positives = 123/255 (48%), Gaps = 22/255 (8%)
Query: 564 VANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGG 623
+ ++ + S+ V + S A +V+ + S ++G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG---DPRLLLDSYVKIGEGS 57
Query: 624 FGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682
G+V E G ++AVK M+ + ++ + +E+ ++ +H ++V + + G
Sbjct: 58 TGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115
Query: 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRD 742
E ++ E++ GAL+ I LN E ++ + V + + YLH+ Q IHRD
Sbjct: 116 ELWVLMEFLQGGALT-DIVSQVRLNEEQIAT-----VCEAVLQALAYLHA---QGVIHRD 166
Query: 743 LKSSNILLGDDFRAKVSDFGL-VKLAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKV 799
+KS +ILL D R K+SDFG +++ D + S+V GT ++APE T+V
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRSLYATEV 222
Query: 800 DVFSFGVVLMELLTG 814
D++S G++++E++ G
Sbjct: 223 DIWSLGIMVIEMVDG 237
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 58/283 (20%), Positives = 98/283 (34%), Gaps = 44/283 (15%)
Query: 56 LLQWPKSGDPCGPPCW-----KHVFCSNSRVTQI------QVSSVGLKG----TLPQN-L 99
C C V C+ ++++ + L + +
Sbjct: 36 AAAASAGPQNCPSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTF 95
Query: 100 NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L LE + L +N R ++ +F+GL++L L N IP+ F+ L L+ L L
Sbjct: 96 RHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK---LSGNNL 214
+N + ++F + L L + + G F L NLK L N+
Sbjct: 155 RNNPIESIPSYAF-NRVP---SLMRLDLGELKKLEYISE--GAFEGLFNLKYLNLGMCNI 208
Query: 215 TGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-----DVLGNMDQLRTLWLHGNHFSGTIP 268
+P + L L L ++ + L+ LW+ + S
Sbjct: 209 KD-MP-NLTPLVGLEELEMSGNH-------FPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 269 ESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
+F L SL +LNL N L L L L L++N +
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 4/73 (5%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
+ + LS L+ + + +Q + F GL++L L NN ++P D F L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLR 290
Query: 151 NLQVLALDSNNFN 163
L L L N +N
Sbjct: 291 YLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 21/86 (24%), Positives = 32/86 (37%), Gaps = 7/86 (8%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438
L L+L +S L +L + L NI +P T L L L++S N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGN 228
Query: 439 NLSPPLPK-FSGAV---KLSLDGNPL 460
+ P F G KL + + +
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 14/90 (15%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQ 437
L L + + + P L SL ++ + ++ +S I N + L SL L+L+
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAH 275
Query: 438 NNLS-------PPLPKFSGAVKLSLDGNPL 460
NNLS PL +L L NP
Sbjct: 276 NNLSSLPHDLFTPLRYLV---ELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 25/86 (29%), Positives = 35/86 (40%), Gaps = 10/86 (11%)
Query: 382 LTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNN 439
LNL N + +L L ++L N+I QI + L SL L+L N
Sbjct: 77 TRYLNL-MENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 440 LSPPLPK--FSGAVK---LSLDGNPL 460
L+ +P F K L L NP+
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPI 159
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 4/64 (6%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQ 437
L VL L ++ + L SL ++L N ++ IP+ L L L L
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRN 156
Query: 438 NNLS 441
N +
Sbjct: 157 NPIE 160
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 87/440 (19%), Positives = 144/440 (32%), Gaps = 77/440 (17%)
Query: 64 DPCGPPCW---KHVFCSNSRVTQI----------QVSSVGLKGTLPQNLNQLSKLENIGL 110
DP C + C N + Q+ +S + + ++L L+ + +
Sbjct: 2 DPGTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKV 61
Query: 111 QKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGW 168
++ + + F GLS+L LD N F + F+GL NL+VL L N + +
Sbjct: 62 EQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA--- 118
Query: 169 SFPKGL-QSSAQLTNLSCMSCNLAGQLPD-FLGNFASLQNLKLSGNNLTGPIPESFKGLN 226
+ L L N+ P F N L L+ N + E
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178
Query: 227 LVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ 286
+ L + + ++ + K TS+ L+L+ N
Sbjct: 179 GKHFTLLR---------------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 287 FVGLIPPS----LASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEV 342
F + +A + L L+N+ MG S+ F P E
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGS---------SFGHTNFKDPDNFTFKGLEA 274
Query: 343 MAL---------IDFL--GGLNYPPRLVTSW-SGND----PCKSWLGLSCGTNSKLTVLN 386
+ I L ++ L + N+ ++ GL+ L LN
Sbjct: 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT-----HLLKLN 329
Query: 387 LPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNL-SPP 443
L + N G++ + NLD L + L N+I + + L +L L L N L S P
Sbjct: 330 L-SQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVP 387
Query: 444 LPKFSGAVKLS---LDGNPL 460
F L L NP
Sbjct: 388 DGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 27/74 (36%), Positives = 38/74 (51%), Gaps = 4/74 (5%)
Query: 93 GTLPQNL-NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
G++ + L KLE + L N R L SF GL NLK LD N ++P FD L
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL 394
Query: 150 ENLQVLALDSNNFN 163
+LQ + L +N ++
Sbjct: 395 TSLQKIWLHTNPWD 408
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 19/238 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LGRGGFG V+ ++ K+ A K++ + +K E +L+KV R +VSL
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLN---LEPLSWKRRLNIALDVARGMEYLHS 732
Y+ L LV M G + HI++ N EP + A + G+E+LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA---IFYTA-QIVSGLEHLHQ 307
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792
++ I+RDLK N+LL DD ++SD GL + AGT G++APE +
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPELLLG 363
Query: 793 GKITTKVDVFSFGVVLMELLTGLMA-LDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
+ VD F+ GV L E++ E + L + P
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRVLEQAVTYPDKFSP 418
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV---DEFHSEIAVL 663
N+ K F LG G F V+ + G A+K I K +EIAVL
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK-----CIKKSPAFRDSSLENEIAVL 60
Query: 664 SKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
K++H ++V+L YE LV + + G L I L + K +
Sbjct: 61 KKIKHENIVTLEDI----YESTTHYYLVMQLVSGGELFDRI-----LERGVYTEKDASLV 111
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVT 776
V ++YLH +HRDLK N+L ++ + ++DFGL K+ + +++
Sbjct: 112 IQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMS 165
Query: 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT GY+APE + VD +S GV+ LL G
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV-----------D 654
+ + + LG G G V E K+A++ +ISK+
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR-----IISKRKFAIGSAREADPAL 185
Query: 655 EFHSEIAVLSKVRHRHLVSLLGYSVAGYER---LLVYEYMPQGALSKHIFHWKSLNLEPL 711
+EI +L K+ H ++ + + ++ +V E M G L + + + L
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF----FDAEDYYIVLELMEGGELFDKV-----VGNKRL 236
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAP 768
+ ++YLH IHRDLK N+LL +D K++DFG K+
Sbjct: 237 KEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 769 DSERSVVTRLAGTFGYLAPE---YAVTGKITTKVDVFSFGVVLMELLTG 814
++ ++ L GT YLAPE T VD +S GV+L L+G
Sbjct: 294 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 35/238 (14%), Positives = 71/238 (29%), Gaps = 51/238 (21%)
Query: 619 LGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVR--------- 667
LG+ + + + G V A+ + E+ L +R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 668 ----------------HRHLVSLLGYSVAGY--ERLLVYEYMPQ--GALSKHIFHWKSLN 707
+ ++ + + R +Y M + + S +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 708 LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767
+ L RL + L V R + LH +H L+ +I+L ++ F +
Sbjct: 201 -KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 768 PDSERSVVTRLAGTFGYLAPEYAVT-----------GKITTKVDVFSFGVVLMELLTG 814
D R V + + G+ PE +T D ++ G+V+ +
Sbjct: 255 RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 18/212 (8%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
+ + F ++G+G FG V+KG + +A+K ++ + +++ EI VLS+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQ 76
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL---D 722
++ G + + ++ EY+ G+ + L+ E IA +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLD-ETQ-------IATILRE 127
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF 782
+ +G++YLHS + IHRD+K++N+LL + K++DFG+ D++ T GT
Sbjct: 128 ILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTP 183
Query: 783 GYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
++APE +K D++S G+ +EL G
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
++ + +G G VV K+A+KR+ +DE EI +S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQC 70
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALS---KHIFHWKSLNLEPLSWKRRLNIALDV 723
H ++VS V E LV + + G++ KHI L I +V
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG----LVKLAPDSERSVVTRLA 779
G+EYLH IHRD+K+ NILLG+D +++DFG L + V
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 780 GTFGYLAPEYAVTGKIT---TKVDVFSFGVVLMELLTG 814
GT ++APE V ++ K D++SFG+ +EL TG
Sbjct: 188 GTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATG 223
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 34/262 (12%)
Query: 72 KHVFCSNSRVTQI------QVSSVGLKG----TLPQN-LNQLSKLENIGLQKNQFRG--- 117
+ C++ +T + + + L+ +LP ++L++L + L N
Sbjct: 10 TEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69
Query: 118 ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177
S G ++LKY L N T+ ++ F GLE L+ L +N +S L++
Sbjct: 70 CSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN- 127
Query: 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN-LTGPIPESFKGL-NLVNLWLNDQ 235
L L + +SL+ LK++GN+ +P+ F L NL L L+
Sbjct: 128 --LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 236 K-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL 290
+ F + L+ L + N+F + L SL+ L+ + N +
Sbjct: 186 QLEQLSPTAFNS-------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 291 IPPSLASL--SLDHLDLNNNMF 310
L SL L+L N F
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 43/215 (20%), Positives = 67/215 (31%), Gaps = 46/215 (21%)
Query: 102 LSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNF-DTIPADFFDGLENLQVLALD 158
L L + + R + F+GLS+L+ + GN+F + D F L NL L L
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI 218
QL LS P + +SLQ L +S NN
Sbjct: 184 QC------------------QLEQLS----------PTAFNSLSSLQVLNMSHNNFFSLD 215
Query: 219 PESFKGL-NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGT--IPES 270
+K L +L L + L L L N F+ T
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHF------PSSLAFLNLTQNDFACTCEHQSF 269
Query: 271 FGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
+ + L + + P + + L++
Sbjct: 270 LQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 304
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 24/127 (18%), Positives = 45/127 (35%), Gaps = 20/127 (15%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGL- 149
L N LS L+ + + N F L + + L++L+ N+ T
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247
Query: 150 ENLQVLALDSNNFNAS-KGWSFPKGL-QSSAQLTNLSCMSC----NLAGQLPDFLGNFAS 203
+L L L N+F + + SF + + L + M C + G
Sbjct: 248 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM---------P 298
Query: 204 LQNLKLS 210
+ +L ++
Sbjct: 299 VLSLNIT 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 8/95 (8%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQN 438
+ L L+L +FN T+S + L+ L + Q +N+ + +L++L LD+S
Sbjct: 78 TSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 439 NLSPPLPK--FSGAVKL---SLDGNPLLNGKSPGS 468
+ F+G L + GN P
Sbjct: 137 HTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 9/88 (10%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQ 437
LT L+L + LSP+ +L SL + + NN + T L SL +LD S
Sbjct: 175 RNLTFLDL-SQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSL 232
Query: 438 NNLSP-PLPKFSGAVK----LSLDGNPL 460
N++ + L+L N
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 8/88 (9%)
Query: 380 SKLTVLNLPNFNLS--GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQ 437
++LT L+L + LS G S S SL + L N + + +N+ L+ L LD
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110
Query: 438 NNLS--PPLPKFSGAVKL---SLDGNPL 460
+NL F L +
Sbjct: 111 SNLKQMSEFSVFLSLRNLIYLDISHTHT 138
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 24/85 (28%), Positives = 34/85 (40%), Gaps = 7/85 (8%)
Query: 382 LTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQ--IPTNWTNLKSLTLLDLSQN 438
T L L + L +L V L LT++ L SN +S + + SL LDLS N
Sbjct: 30 ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 439 NLSPPLPKFSGAVK---LSLDGNPL 460
+ F G + L + L
Sbjct: 89 GVITMSSNFLGLEQLEHLDFQHSNL 113
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 7/87 (8%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQ 437
L L++ + + + L SL +K+ N+ + +T L++LT LDLSQ
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 438 NNL-SPPLPKFSGAV---KLSLDGNPL 460
L F+ L++ N
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNF 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG G F V ++ A+K +E +I + V E V+S++ H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
++ E+L Y G L K+I S + E + R A ++ +EYLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT---RFYTA-EIVSALEYLHGK-- 149
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPEYAVTGK 794
IHRDLK NILL +D +++DFG K+ + GT Y++PE +T K
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEK 207
Query: 795 ITTK-VDVFSFGVVLMELLTGL 815
K D+++ G ++ +L+ GL
Sbjct: 208 SACKSSDLWALGCIIYQLVAGL 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 48/223 (21%), Positives = 95/223 (42%), Gaps = 37/223 (16%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDE--FHSEIAVL 663
+ + + + +LGRG FG+V++ E K + K D+ EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISIL 55
Query: 664 SKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHI----FHWKSLNLEPLSWKR 715
+ RHR+++ L +E + +++E++ + + I F L+ +
Sbjct: 56 NIARHRNILHLHES----FESMEELVMIFEFISGLDIFERINTSAFE--------LNERE 103
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGL-VKLAPDSER 772
++ V +++LHS + H D++ NI+ K+ +FG +L P
Sbjct: 104 IVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
L Y APE ++T D++S G ++ LL+G+
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 59/297 (19%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVK-----------RMEAGVISKKAVDE 655
+ +++ +LG G +G V E + ++ A+K + +K +E
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 656 FHSEIAVLSKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPL 711
++EI++L + H +++ L +E LV E+ G L + I +N
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDV----FEDKKYFYLVTEFYEGGELFEQI-----INRHKF 143
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAP 768
NI + G+ YLH + +HRD+K NILL K+ DFGL
Sbjct: 144 DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828
+ + GT Y+APE + K K DV+S GV++ LL G P
Sbjct: 201 KDYK--LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG------YPP----- 246
Query: 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFW-TIAELAGHCTSR----EPSQRP 880
F ++D++ ++ + + W I++ A + ++R
Sbjct: 247 ----FGG-QNDQDIIKK----VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+ + LG+G FG V K + + AVK + K E+ +L K+
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 667 RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
H +++ L E +V E G L I + + S I
Sbjct: 79 DHPNIMKLFEI----LEDSSSFYIVGELYTGGELFDEI-----IKRKRFSEHDAARIIKQ 129
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
V G+ Y+H + +HRDLK NILL D K+ DFGL + + +
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI 184
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y+APE + G K DV+S GV+L LL+G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 31/223 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---------VDEFH 657
V ++ ELG G F +V K + G + A K I K+ +E
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAK-----FIKKRRLSSSRRGVSREEIE 56
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
E+ +L ++RH ++++L + +L+ E + G L + +SL E
Sbjct: 57 REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT-E----DEAT 111
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGL-VKLAPDSER 772
+ G+ YLHS + H DLK NI+L + R K+ DFG+ K+
Sbjct: 112 QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--- 165
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ + GT ++APE + + D++S GV+ LL+G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 40/216 (18%), Positives = 80/216 (37%), Gaps = 17/216 (7%)
Query: 610 TKNFASENELGRG--GFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+ +G+G V G + V+R+ S + V E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
H ++V +A E +V +M G+ + + ++ ++ I V +
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLI--CTHFMDGMNELAIAYILQGVLKA 140
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG-LVKLAPDSER-----SVVTRLAG 780
++Y+H ++HR +K+S+IL+ D + +S + + +R
Sbjct: 141 LDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 781 TFGYLAPEYAVTGKI--TTKVDVFSFGVVLMELLTG 814
+L+PE K D++S G+ EL G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 18/236 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+GGFG V ++ K+ A K++E + +K +E +L KV R +VSL
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNL-EPLSWKRRLNIALDVARGMEYLHSLA 734
Y+ + L LV M G L HI+H E + A ++ G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA---VFYAA-EICCGLEDLHR-- 304
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ ++RDLK NILL D ++SD GL P+ + + GT GY+APE +
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNER 361
Query: 795 ITTKVDVFSFGVVLMELLTGLMA-LDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
T D ++ G +L E++ G + +R+ + +K E+ P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVPEEYSERFSP 414
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 76/398 (19%), Positives = 121/398 (30%), Gaps = 94/398 (23%)
Query: 54 PELLQWPKSGDPCGPPCW---KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGL 110
PE+ + G C C + V CS+ + ++ LP + L L
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLEKV-------PKDLPPDTALLD------L 59
Query: 111 QKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGW 168
Q N+ E+ F L NL L N I F L L+ L L N
Sbjct: 60 QNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK----- 113
Query: 169 SFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT-GPIPE-SFKGL- 225
P+ + + L L + + ++L N L I +F+G+
Sbjct: 114 ELPEKMPKT--LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 226 NLVNLWLNDQKGGGFTGTIDVL--GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLN 283
L + + D I + G L L L GN + S L +L L L+
Sbjct: 172 KLSYIRIADTN-------ITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 284 SNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEV 342
N + SLA+ L L LNNN VP
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKL-----------------------VKVP----- 256
Query: 343 MALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGN 402
GGL + + L N+ ++ + +F G +
Sbjct: 257 -------GGLADHKYIQV-----------VYLH---NNNISAIGSNDFCPPGYNT----K 291
Query: 403 LDSLTQIKLQSNNIS-GQIPTN-WTNLKSLTLLDLSQN 438
S + + L SN + +I + + + + L
Sbjct: 292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 55/300 (18%), Positives = 97/300 (32%), Gaps = 74/300 (24%)
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237
L + C L ++P L L L N +T FK L NL L L + K
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK- 87
Query: 238 GGFTGTID--VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
I + +L L+L N +PE +L++L ++ N+ +
Sbjct: 88 ---ISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVF 141
Query: 296 ASL-SLDHLDL-NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353
L + ++L N + + + AF G+
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIE----------NGAF--------------------QGM- 170
Query: 354 YPPRLVTSWSGNDPCKSWLGLS--------CGTNSKLTVLNLPNFNLSGTLSPSV-GNLD 404
+L S++ ++ G LT L+L ++ + + L+
Sbjct: 171 --KKL-----------SYIRIADTNITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLN 216
Query: 405 SLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLS---PPLPKFSGAVKLSLDGNPL 460
+L ++ L N+IS + N L L L+ N L L + L N +
Sbjct: 217 NLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 13/92 (14%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438
+ L L L ++S + N L ++ L +N + ++P + K + ++ L N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 439 NLS-------PPLPKFSGAVKL---SLDGNPL 460
N+S P + SL NP+
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 305
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV-----------D 654
+ + + LG G G V E K+A+K +ISK+
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIK-----IISKRKFAIGSAREADPAL 60
Query: 655 EFHSEIAVLSKVRHRHLVSLLGYSVAGYER---LLVYEYMPQGALSKHIFHWKSLNLEPL 711
+EI +L K+ H ++ + + ++ +V E M G L + K L E
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNF----FDAEDYYIVLELMEGGELFDKVVGNKRLK-E-- 113
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAP 768
+ ++YLH IHRDLK N+LL +D K++DFG K+
Sbjct: 114 --ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 769 DSERSVVTRLAGTFGYLAPE---YAVTGKITTKVDVFSFGVVLMELLTG 814
++ ++ L GT YLAPE T VD +S GV+L L+G
Sbjct: 169 ETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 76/339 (22%), Positives = 115/339 (33%), Gaps = 93/339 (27%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+F +GRGGFGVV++ + D A+KR+ + A ++ E+ L+K+ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 64
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGAL------------SKHIFHWKSLNLEPLSW---- 713
+V + E K ++P S
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 714 ----------------------------KRR-----------LNIALDVARGMEYLHSLA 734
RR L+I + +A +E+LHS
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS-- 182
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-----------LAPDSERSVVTRLAGTFG 783
+ +HRDLK SNI D KV DFGLV L P + T GT
Sbjct: 183 -KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
Y++PE + KVD+FS G++L ELL ER + +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRII----------TDV 286
Query: 844 RAAIDPILEVNDDTFETFW-TIAELAGHCTSREPSQRPD 881
R P+L F + + S P++RP+
Sbjct: 287 RNLKFPLL------FTQKYPQEHMMVQDMLSPSPTERPE 319
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 31/224 (13%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---------VDEF 656
+ V + ELG G F +V K E G + A K I K+ +E
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK-----FIKKRQSRASRRGVSREEI 62
Query: 657 HSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
E+++L +V H ++++L + +L+ E + G L + +S LS +
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LSEEEA 117
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGL-VKLAPDSE 771
+ + G+ YLH+ + H DLK NI+L K+ DFGL ++
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-- 172
Query: 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ GT ++APE + + D++S GV+ LL+G
Sbjct: 173 -VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 62/277 (22%), Positives = 96/277 (34%), Gaps = 57/277 (20%)
Query: 588 NGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVK---RM 643
+ H NL L + K + + +G+G +GVV E A+K +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 644 EAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE----RLLVYEYMPQGALSKH 699
+ I+ K V+ +E+ ++ K+ H ++ L YE LV E G L
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV----YEDEQYICLVMELCHGGHLLDK 118
Query: 700 I-----------------------------------FHWKSLNLEPLSWKRRLNIALDVA 724
+ ++ K NI +
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA--KVSDFGL---VKLAPDSERSVVTRLA 779
+ YLH+ Q HRD+K N L + K+ DFGL + E +T A
Sbjct: 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 780 GTFGYLAPE--YAVTGKITTKVDVFSFGVVLMELLTG 814
GT ++APE K D +S GV+L LL G
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 610 TKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH 668
+ F +LG G +G VYK + G +A+K++ + + E EI+++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDS 83
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
H+V G + +V EY G++S I L + L+ I +G+E
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLE 139
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV-KLAPDSER--SVVTRLAGTFGYL 785
YLH IHRD+K+ NILL + AK++DFG+ +L + +V+ GT ++
Sbjct: 140 YLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWM 192
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE D++S G+ +E+ G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---VDEFHSEIAVL 663
+V + ELG G FGVV++ E G K I+ +EI+++
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK-----FINTPYPLDKYTVKNEISIM 102
Query: 664 SKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
+++ H L++L YE +L+ E++ G L I +S +N
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQA 158
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGL-VKLAPDSERSVVTRLAG 780
G++++H S +H D+K NI+ K+ DFGL KL PD +V
Sbjct: 159 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTA 212
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
T + APE + D+++ GV+ LL+GL
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+ + + ELG G FG VYK + G A K +E S++ ++++ EI +L+
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATC 73
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL---DV 723
H ++V LLG + ++ E+ P GA+ + EP I + +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQM 126
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSER--SVVTRLAG 780
+ +LHS + IHRDLK+ N+L+ + +++DFG+ K ++ S + G
Sbjct: 127 LEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----G 179
Query: 781 TFGYLAPEYAVTGKIT-----TKVDVFSFGVVLMELLTG 814
T ++APE + + K D++S G+ L+E+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDE---FHSEIAVL 663
++ + + EN +GRG +G V + + A K I K V++ F EI ++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK-----KIPKYFVEDVDRFKQEIEIM 60
Query: 664 SKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
+ H +++ L +E LV E G L + + H + E I
Sbjct: 61 KSLDHPNIIRLYET----FEDNTDIYLVMELCTGGELFERVVHKRVFR-E----SDAARI 111
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVT 776
DV + Y H + HRDLK N L D K+ DFGL + ++
Sbjct: 112 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMR 166
Query: 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y++P+ + G + D +S GV++ LL G
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 65/260 (25%), Positives = 96/260 (36%), Gaps = 41/260 (15%)
Query: 64 DPCGPPC---WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP 120
+PC C +I P NL +N+ L N R L
Sbjct: 1 EPC--VEVVPNITYQCMELNFYKI-----------PDNL--PFSTKNLDLSFNPLR-HLG 44
Query: 121 S--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL-QSS 177
S F L+ L TI + L +L L L N S G
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-----SLALGAFSGL 99
Query: 178 AQLTNLSCMSCNLAGQLPDFL-GNFASLQNLKLSGNNLTG-PIPESFKGL-NLVNLWLND 234
+ L L + NLA L +F G+ +L+ L ++ N + +PE F L NL +L L+
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 235 QKGGGFT----GTIDVLGNMDQLR-TLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289
K + VL M L +L L N + P +F ++ LK+L L++NQ
Sbjct: 159 NK---IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKS 214
Query: 290 LIPPSLASL-SLDHLDLNNN 308
+ L SL + L+ N
Sbjct: 215 VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 54/274 (19%), Positives = 81/274 (29%), Gaps = 65/274 (23%)
Query: 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK--- 236
CM N ++PD S +NL LS N L SF L L L+ +
Sbjct: 10 ITYQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 237 --GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL---- 290
G + L TL L GN +F L+SL+ L L
Sbjct: 67 IEDGAYQSLS-------HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 291 --IPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDF 348
+L L++ +N + +P F
Sbjct: 120 IGHLKTLKELNVA----HNLIQSFKLP-----------EYF-----------------SN 147
Query: 349 LGGLNYPPRLVTSWSGND----PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD 404
L L + L S N C L L+ L+L ++ + P
Sbjct: 148 LTNLEH---L--DLSSNKIQSIYCTDLRVLHQMPLLNLS-LDLSLNPMN-FIQPGAFKEI 200
Query: 405 SLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438
L ++ L +N + + L SL + L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 21/95 (22%), Positives = 36/95 (37%), Gaps = 10/95 (10%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQ 437
+L VL+L + T+ +L L+ + L N I + + L SL L +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVE 109
Query: 438 NNLS--PPLPKFSGAVK---LSLDGNPLLNGKSPG 467
NL+ P L++ N + + K P
Sbjct: 110 TNLASLENFP-IGHLKTLKELNVAHNLIQSFKLPE 143
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 11/91 (12%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNI-SGQIPTNWTNLKSLTLLDLSQ 437
S L L +L G+L +L ++ + N I S ++P ++NL +L LDLS
Sbjct: 100 SSLQKLVA-VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 438 NNL-SPPLPKFSG-------AVKLSLDGNPL 460
N + S + L L NP+
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 40/239 (16%), Positives = 77/239 (32%), Gaps = 23/239 (9%)
Query: 74 VFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYA 131
+ + +R +V+ LK L ++ + L N ++ + + L+
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELL 63
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
L N + L L+ L L++N L + L + N
Sbjct: 64 NLSSNVLYETLD--LESLSTLRTLDLNNNYVQE---------LLVGPSIETLH-AANNNI 111
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNM 250
++ +N+ L+ N +T + L L + ++ +
Sbjct: 112 SRVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAASS 168
Query: 251 DQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
D L L L N + LK L+L+SN+ + P S + + L NN
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNN 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 29/216 (13%), Positives = 61/216 (28%), Gaps = 17/216 (7%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155
+L LS L + L N + +++ + NN + G +N+
Sbjct: 73 TLDLESLSTLRTLDLNNNY----VQELLVGPSIETLHAANNNISRVSCSRGQGKKNIY-- 126
Query: 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNL 214
L +N + + L + + + +L++L L N +
Sbjct: 127 -LANNKITMLRDLDE-GCRSR---VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 215 TGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKL 274
+ L L L+ K + + + L N I ++
Sbjct: 182 YD-VKGQVVFAKLKTLDLSSNK---LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236
Query: 275 TSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMF 310
+L+ +L N F S + +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 46/311 (14%), Positives = 86/311 (27%), Gaps = 77/311 (24%)
Query: 144 DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS 203
+ ++ + ++ + QS+ + L L+ L F
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLR----QSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 204 LQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262
L+ L LS N L + + L L L LN+ + L + TL N+
Sbjct: 60 LELLNLSSNVLYETLD--LESLSTLRTLDLNNNY-------VQELLVGPSIETLHAANNN 110
Query: 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYK 321
S + + K++ L +N+ L + +LDL N
Sbjct: 111 IS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI----------- 156
Query: 322 YSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381
+ + + L L L +
Sbjct: 157 -------------------DTVNFAELAASS---DTL-----------EHLNLQ---YNF 180
Query: 382 LTVL-------NLPNFNLSG----TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSL 430
+ + L +LS + P + +T I L++N + I ++L
Sbjct: 181 IYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 431 TLLDLSQNNLS 441
DL N
Sbjct: 240 EHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 48/343 (13%), Positives = 86/343 (25%), Gaps = 103/343 (30%)
Query: 122 FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLT 181
+ K + ++ A N++ L L N L+
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN------------------PLS 47
Query: 182 NLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFT 241
+S L F L+ L LS N L +
Sbjct: 48 QIS----------AADLAPFTKLELLNLSSNVLYETLD---------------------- 75
Query: 242 GTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLD 301
L ++ LRTL L+ N+ S++ L+ +N +
Sbjct: 76 -----LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKK-- 123
Query: 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT- 360
++ L ++N + G R+
Sbjct: 124 NIYL-------------------ANNKITMLRDLD------------EGCR---SRVQYL 149
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420
N+ ++ L LNL + + V L + L SN ++ +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FM 206
Query: 421 PTNWTNLKSLTLLDLSQNNLS---PPLPKFSGAVKLSLDGNPL 460
+ + +T + L N L L L GN
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 32/195 (16%), Positives = 62/195 (31%), Gaps = 19/195 (9%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPS---FSGLSNLKYAYLDGNNFDTIPADFFDGLENL 152
+ S+++ + L+ N+ + + L++ L N + L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKL 193
Query: 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGN 212
+ L L SN QS+A +T +S + L + L +L++ L GN
Sbjct: 194 KTLDLSSNKLA-----FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 213 NLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
F N + Q TG + + L +G + +P F
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG---HYGAYCCEDLPAPFA 304
Query: 273 KLTSLKDLNLNSNQF 287
+ + L +
Sbjct: 305 ----DRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 25/116 (21%), Positives = 39/116 (33%), Gaps = 28/116 (24%)
Query: 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQL 253
+ + N + K++ ++L + + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAW-------------------------NV 36
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
+ L L GN S T L+ LNL+SN L SL +L LDLNNN
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 20/137 (14%), Positives = 42/137 (30%), Gaps = 9/137 (6%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ + +KL+ + L N+ P F + + + L N I +NL+
Sbjct: 183 DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKA-LRFSQNLE 240
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L N + ++ + ++ +L ++ L G
Sbjct: 241 HFDLRGNG------FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 214 LTGPIPESFKGLNLVNL 230
+P F L+ L
Sbjct: 295 CCEDLPAPF-ADRLIAL 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-26
Identities = 71/293 (24%), Positives = 111/293 (37%), Gaps = 27/293 (9%)
Query: 533 YRKRKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASH 592
Y R A G P +P+ P + + G S N ++
Sbjct: 78 YEFRIIAENKHGQ--SKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNY 135
Query: 593 VIEAGNLVISVQVL---RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVI 648
V + V +V ++ ELG G FGVV++ E G A K +
Sbjct: 136 VFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK-----FV 190
Query: 649 SKKA---VDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKS 705
+ EI +S +RH LV+L E +++YE+M G L + +
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH- 249
Query: 706 LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGL 763
+S + V +G+ ++H +++H DLK NI+ K+ DFGL
Sbjct: 250 ---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 764 -VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
L P V GT + APE A + D++S GV+ LL+GL
Sbjct: 304 TAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 31/223 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---------VDEFH 657
V + ELG G F +V K E G + A K I K+ +E
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK-----FIKKRQSRASRRGVCREEIE 63
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
E+++L +V H ++++L + +L+ E + G L + E LS +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEAT 118
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGL-VKLAPDSER 772
+ + G+ YLH+ + H DLK NI+L K+ DFGL ++
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--- 172
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ GT ++APE + + D++S GV+ LL+G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 34/221 (15%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+ N+ + ELG+G F VV + G + A K + +S + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 667 RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
+H ++V L + LV++ + G L + I + S +
Sbjct: 63 QHPNIVRLHDS----IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQ 113
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
+ + Y HS +HR+LK N+LL K++DFGL DSE A
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFA 168
Query: 780 GTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
GT GYL+PE Y + VD+++ GV+L LL G
Sbjct: 169 GTPGYLSPEVLKKDPY------SKPVDIWACGVILYILLVG 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLS 664
+ K F+ E+G G FG VY ++ + +A+K+M +G S + + E+ L
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
K+RH + + G + + LV EY A H K L ++ +
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGAL 164
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFG 783
+G+ YLHS + IHRD+K+ NILL + K+ DFG + + S V GT
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANSFV----GTPY 215
Query: 784 YLAPEYAVTGKITT---KVDVFSFGVVLMELLTG 814
++APE + KVDV+S G+ +EL
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 66/242 (27%), Positives = 103/242 (42%), Gaps = 70/242 (28%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS------------------ 658
E+G+G +GVV +D T A+K V+SKK +
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMK-----VLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 659 -----------EIAVLSKVRHRHLVSLLGYSVAGYERL---------LVYEYMPQGALSK 698
EIA+L K+ H ++V L E L +V+E + QG + +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL-------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 699 HIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758
+PLS + D+ +G+EYLH Q IHRD+K SN+L+G+D K+
Sbjct: 128 VPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKI 178
Query: 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELL 812
+DFG+ S+ + GT ++APE +GK +DV++ GV L +
Sbjct: 179 ADFGVSNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFV 234
Query: 813 TG 814
G
Sbjct: 235 FG 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 12/219 (5%)
Query: 597 GNLVISVQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDE 655
L +V +F +ELG G GVV+K G +A K + I ++
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQ 77
Query: 656 FHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKR 715
E+ VL + ++V G + E + E+M G+L + + + + L
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--- 134
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
+++ V +G+ YL +HRD+K SNIL+ K+ DFG ++ S+
Sbjct: 135 --KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMA 187
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y++PE + + D++S G+ L+E+ G
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 31/223 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---------VDEFH 657
NV + + ELG G F VV K E G + A K I K+ ++
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK-----FIKKRRTKSSRRGVSREDIE 62
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
E+++L +++H ++++L + +L+ E + G L + +SL E +
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT-E----EEAT 117
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGL-VKLAPDSER 772
+ G+ YLHSL H DLK NI+L R K+ DFGL K+
Sbjct: 118 EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--- 171
Query: 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ + GT ++APE + + D++S GV+ LL+G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 214
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 61/231 (26%), Positives = 92/231 (39%), Gaps = 43/231 (18%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV------------D 654
+N+ + LGRG VV + + AVK +I +
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVK-----IIDVTGGGSFSAEEVQELRE 68
Query: 655 EFHSEIAVLSKV-RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLE 709
E+ +L KV H +++ L YE LV++ M +G L ++ +L
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT----YETNTFFFLVFDLMKKGELFDYLTEKVTL--- 121
Query: 710 PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769
S K I + + LH + +HRDLK NILL DD K++DFG
Sbjct: 122 --SEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 770 SERSVVTRLAGTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
E + + GT YLAPE +VD++S GV++ LL G
Sbjct: 177 GE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 24/239 (10%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV---RHRHLVS 673
+GRGGFG VY D K+ A+K ++ + K+ +E +LS V +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 674 LLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
+ Y+ ++L + + M G L H+ + E R A ++ G+E++H+
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM---RFYAA-EIILGLEHMHN 310
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTR-LAGTFGYLAPEYAV 791
++RDLK +NILL + ++SD GL + GT GY+APE
Sbjct: 311 R---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQ 363
Query: 792 TGKITTK-VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
G D FS G +L +LL G + + +++ + + +L + P
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELPDSFSP 419
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 47/306 (15%)
Query: 536 RKEASQASGSLVIHPRDPSDPDNMVKIVVANNSNGSTSVATESGTGSRYSSGNGASHVIE 595
KE +A + P + + ++ + S ++ E+ + + G ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND-AQPKGTENLYF 74
Query: 596 AGNLVISVQVLRNVTKNFASE----NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISK 650
K F + + +GRG VV + G + AVK ++
Sbjct: 75 QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK-----IMEV 129
Query: 651 KAV-----------DEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERL----LVYEYMPQG 694
A + E +L +V H H+++L+ YE LV++ M +G
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS----YESSSFMFLVFDLMRKG 185
Query: 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754
L ++ +L S K +I + + +LH+ + +HRDLK NILL D+
Sbjct: 186 ELFDYLTEKVAL-----SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237
Query: 755 RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE------YAVTGKITTKVDVFSFGVVL 808
+ ++SDFG E+ + L GT GYLAPE +VD+++ GV+L
Sbjct: 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 809 MELLTG 814
LL G
Sbjct: 296 FTLLAG 301
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 47/224 (20%), Positives = 74/224 (33%), Gaps = 31/224 (13%)
Query: 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
+ L KL+ + + KN E+P S+L + N +P F GL N+ + +
Sbjct: 98 FSPLRKLQKLYISKNHLV-EIPPNL-PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG 155
Query: 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI 218
N S F G +L L L +P +L L L N +
Sbjct: 156 GNPLENS---GFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIE 209
Query: 219 PESFKGL-NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
E L L L + G + + LR L L N S +P
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLS-------FLPTLRELHLDNNKLS-RVPAGLP 261
Query: 273 KLTSLKDLNLNSNQ--------FVGLIPPSLASLSLDHLDLNNN 308
L L+ + L++N F + + + + L NN
Sbjct: 262 DLKLLQVVYLHTNNITKVGVNDFCPV-GFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 58/260 (22%), Positives = 86/260 (33%), Gaps = 40/260 (15%)
Query: 60 PKSGDPCGPPCW---KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFR 116
P C C + V CS+ + + + + L LQ N
Sbjct: 21 PTYSAMCPFGCHCHLRVVQCSDLGLKAVPKE-------ISPDTTLLD------LQNNDIS 67
Query: 117 GELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL 174
EL F GL +L L N I F L LQ L + N+ P L
Sbjct: 68 -ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-----EIPPNL 121
Query: 175 QSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT-GPIPE-SFKGLNLVNLWL 232
SS L L + ++ +++ GN L +F GL L L +
Sbjct: 122 PSS--LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179
Query: 233 NDQKGGGFTGTIDVL--GNMDQLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVG 289
++ K + + + L L L N I + + L L L NQ
Sbjct: 180 SEAK-------LTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 290 LIPPSLASL-SLDHLDLNNN 308
+ SL+ L +L L L+NN
Sbjct: 232 IENGSLSFLPTLRELHLDNN 251
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 31/197 (15%), Positives = 54/197 (27%), Gaps = 55/197 (27%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+P++L L + L N+ + + S L L N I L
Sbjct: 186 GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211
L+ L LD+N +L+ ++P L + LQ + L
Sbjct: 243 LRELHLDNN------------------KLS-----------RVPAGLPDLKLLQVVYLHT 273
Query: 212 NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI--PE 269
NN+T F + + L N P
Sbjct: 274 NNITKVGVNDFCPVGFGVKRAY-------------------YNGISLFNNPVPYWEVQPA 314
Query: 270 SFGKLTSLKDLNLNSNQ 286
+F +T + + +
Sbjct: 315 TFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/303 (18%), Positives = 108/303 (35%), Gaps = 51/303 (16%)
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237
L + C L +P + L L N+++ + FKGL +L L L + K
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS 297
+ +L+ L++ NH IP +SL +L ++ N+ + +
Sbjct: 91 SKIHE--KAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSG 145
Query: 298 L-SLDHLDL-NNNMFMGPVPKS--KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353
L +++ +++ N + K +Y + + T +P +
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IP--------------KD 190
Query: 354 YPPRLVT-SWSGND----PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLT 407
P L N + L S KL L L + + + L +L
Sbjct: 191 LPETLNELHLDHNKIQAIELEDLLRYS-----KLYRLGLGHNQIR-MIENGSLSFLPTLR 244
Query: 408 QIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-------PPLPKFSGAVKL---SLDG 457
++ L +N +S ++P +LK L ++ L NN++ P+ SL
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 458 NPL 460
NP+
Sbjct: 304 NPV 306
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 30/259 (11%)
Query: 565 ANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGF 624
+ G+ ++ +S + S+ G + ++ + S + ++ F E+ELGRG
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNR--DALSDFFEVESELGRGAT 66
Query: 625 GVVYKG-ELDDGTKIAVKRMEAGVISKKA-VDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682
+VY+ + A+K V+ K +EI VL ++ H +++ L +
Sbjct: 67 SIVYRCKQKGTQKPYALK-----VLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI----F 117
Query: 683 ERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738
E LV E + G L I + E + + + + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYS-E----RDAADAVKQILEAVAYLHE---NGI 169
Query: 739 IHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
+HRDLK N+L D K++DFGL K+ ++ + GT GY APE
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAY 227
Query: 796 TTKVDVFSFGVVLMELLTG 814
+VD++S G++ LL G
Sbjct: 228 GPEVDMWSVGIITYILLCG 246
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 62/248 (25%), Positives = 101/248 (40%), Gaps = 36/248 (14%)
Query: 581 GSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIA 639
G +S G + +++ + N+ + ELG+G F VV + G + A
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNAS--TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA 58
Query: 640 VKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL----LVYEYMPQGA 695
K + +S + + E + K++H ++V L + LV++ + G
Sbjct: 59 AKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS----IQEESFHYLVFDLVTGGE 114
Query: 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GD 752
L + I + S + + + Y HS +HR+LK N+LL
Sbjct: 115 LFEDIVAREFY-----SEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166
Query: 753 DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE------YAVTGKITTKVDVFSFGV 806
K++DFGL DSE AGT GYL+PE Y K VD+++ GV
Sbjct: 167 GAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPY---SK---PVDIWACGV 218
Query: 807 VLMELLTG 814
+L LL G
Sbjct: 219 ILYILLVG 226
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/265 (22%), Positives = 100/265 (37%), Gaps = 41/265 (15%)
Query: 570 GSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYK 629
GS+ +G + A + + + + LG GGFG VY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 630 GE-LDDGTKIAVKRMEAGVISKKAVDEFHS---------EIAVLSKVRHR--HLVSLLGY 677
G + D +A+K + K + ++ E+ +L KV ++ L
Sbjct: 62 GIRVSDNLPVAIK-----HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL--L 114
Query: 678 SVAGYER----LLVYEY-MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
+ER +L+ E P L I +L E L+ R V + + H+
Sbjct: 115 DW--FERPDSFVLILERPEPVQDLFDFITERGALQ-EELA--RS--FFWQVLEAVRHCHN 167
Query: 733 LAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
+HRD+K NIL+ + K+ DFG L D +V T GT Y PE+ +
Sbjct: 168 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEW-I 220
Query: 792 TGK--ITTKVDVFSFGVVLMELLTG 814
V+S G++L +++ G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV---DEFHSEIAVLSKVR 667
+ LG G FG V+K E G K+A K +I + + +E +EI+V++++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAK-----IIKTRGMKDKEEVKNEISVMNQLD 144
Query: 668 HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
H +L+ L + + +LV EY+ G L I L+ + + G+
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGI 200
Query: 728 EYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGY 784
++H +H DLK NIL D + K+ DFGL + P + GT +
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEF 254
Query: 785 LAPEYAVTGK-ITTKVDVFSFGVVLMELLTGL 815
LAPE V ++ D++S GV+ LL+GL
Sbjct: 255 LAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGL 285
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 15/204 (7%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR-HLVSLL 675
ELGRG F VV + G + A K ++ + E EIAVL + +++L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
E +L+ EY G + E +S + + + G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCL---PELAEMVSENDVIRLIKQILEGVYYLHQ--- 149
Query: 736 QSFIHRDLKSSNILL---GDDFRAKVSDFGL-VKLAPDSERSVVTRLAGTFGYLAPEYAV 791
+ +H DLK NILL K+ DFG+ K+ E + GT YLAPE
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---MGTPEYLAPEILN 206
Query: 792 TGKITTKVDVFSFGVVLMELLTGL 815
ITT D+++ G++ LLT
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHT 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 54/210 (25%), Positives = 80/210 (38%), Gaps = 27/210 (12%)
Query: 614 ASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHL 671
+ LG G F + K AVK +ISK+ EI L H ++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNI 68
Query: 672 VSLLGYSVAGYE----RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
V L + LV E + G L + I K + E I + +
Sbjct: 69 VKLHEV----FHDQLHTFLVMELLNGGELFERIKKKKHFS-E----TEASYIMRKLVSAV 119
Query: 728 EYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
++H +HRDLK N+L D+ K+ DFG +L P + + T T Y
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHY 175
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE D++S GV+L +L+G
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 601 ISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSE 659
I + LR+ F +G G +G VYKG + G A+K M+ ++ +E E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 660 IAVLSKV-RHRHLVSLLG-----YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLS 712
I +L K HR++ + G ++L LV E+ G+++ I K+ L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLK 127
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-VKLAPDSE 771
+ I ++ RG+ +LH IHRD+K N+LL ++ K+ DFG+ +L
Sbjct: 128 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184
Query: 772 R--SVVTRLAGTFGYLAPEYAVTGKIT-----TKVDVFSFGVVLMELLTG 814
R + + GT ++APE + K D++S G+ +E+ G
Sbjct: 185 RRNTFI----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 59/265 (22%), Positives = 115/265 (43%), Gaps = 47/265 (17%)
Query: 570 GSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYK 629
GS +++ G + + + + VI+ L + + + +G G FGVV++
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKV--LASDGKTGEQREIAYTNCKVIGNGSFGVVFQ 58
Query: 630 GELDDGTKIAVKRMEAGVISKKAVDEFHS-EIAVLSKVRHRHLVSLLGYSVAGYERL--- 685
+L + ++A+K++ F + E+ ++ V+H ++V L + + ++
Sbjct: 59 AKLVESDEVAIKKVLQD-------KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 686 ---LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD--------VARGMEYLHSLA 734
LV EY+P+ + + H+ K + + + + R + Y+HS+
Sbjct: 112 FLNLVLEYVPE-TVYRASRHY---------AKLKQTMPMLLIKLYMYQLLRSLAYIHSI- 160
Query: 735 HQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPEYA 790
HRD+K N+LL K+ DFG K+ E + + +R Y APE
Sbjct: 161 --GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELI 213
Query: 791 VTGKI-TTKVDVFSFGVVLMELLTG 814
TT +D++S G V+ EL+ G
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQG 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 33/221 (14%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
T+ + ELG+G F VV + ++ G + A + +S + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 667 RHRHLVSLLGYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
+H ++V L L+++ + G L + I + E S +
Sbjct: 68 KHPNIVRLHDS----ISEEGHHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQ 118
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
+ + + H +HR+LK N+LL K++DFGL + E+ A
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFA 174
Query: 780 GTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
GT GYL+PE Y GK VD+++ GV+L LL G
Sbjct: 175 GTPGYLSPEVLRKDPY---GK---PVDLWACGVILYILLVG 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 34/216 (15%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGY 677
+G+G F V + G ++A+K ++ ++ ++ + E+ ++ + H ++V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 678 SVAGYERL--LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR--------GM 727
V E+ L+ EY G + ++ R+ AR +
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKE--KEARSKFRQIVSAV 127
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
+Y H + +HRDLK+ N+LL D K++DFG + + G Y AP
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAP 182
Query: 788 EYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDES 821
E GK +VDV+S GV+L L++G + D
Sbjct: 183 E-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 56/250 (22%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA--------VDEFHSEIAVLSKVRH 668
+G+G F VV + + G + AVK ++ ++ E ++ ++H
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVK-----IVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 669 RHLVSLLGYSVAGYE----RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
H+V LL Y +V+E+M L I ++ S + +
Sbjct: 86 PHIVELLET----YSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQIL 140
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGL-VKLAPDSERSVVTRLAG 780
+ Y H + IHRD+K +LL + K+ FG+ ++L V G
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVG 195
Query: 781 TFGYLAPE---YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837
T ++APE GK VDV+ GV+L LL+G P F+
Sbjct: 196 TPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSG------CLP---------FY--- 234
Query: 838 SDKEKLRAAI 847
KE+L I
Sbjct: 235 GTKERLFEGI 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+G+G FG V + +D K+ A+K M + + V E+ ++ + H LV+L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS E + +V + + G L H+ E +L I ++ ++YL +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV---KLFIC-ELVMALDYLQN--- 133
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE--YAVTG 793
Q IHRD+K NILL + ++DF + + P + T +AGT Y+APE + G
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMAGTKPYMAPEMFSSRKG 191
Query: 794 KITTK-VDVFSFGVVLMELLTGL 815
+ VD +S GV ELL G
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-24
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 56/276 (20%)
Query: 565 ANNSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGF 624
+ + V S GS S + + R ++ +G G F
Sbjct: 8 TSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSF 67
Query: 625 GVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683
GVVY+ +L D G +A+K+ + + + E+ ++ K+ H ++V L + + E
Sbjct: 68 GVVYQAKLCDSGELVAIKK-----VLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGE 121
Query: 684 RL------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD--------VARGMEY 729
+ LV +Y+P+ + + H+ + + + + + R + Y
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHY---------SRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 730 LHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYL 785
+HS HRD+K N+LL D K+ DFG K E + + +R Y
Sbjct: 172 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YR 223
Query: 786 APE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
APE Y T+ +DV+S G VL ELL G
Sbjct: 224 APELIFGATDY------TSSIDVWSAGCVLAELLLG 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 54/219 (24%), Positives = 79/219 (36%), Gaps = 52/219 (23%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKVRHRHLVS 673
LG G +G V +AVK ++ K + EI + + H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 674 LLGYSVAGYERL-------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR- 725
Y L EY G L I + A+
Sbjct: 70 F-------YGHRREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQR 109
Query: 726 -------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
G+ YLH HRD+K N+LL + K+SDFGL + + R +
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 779 A-GTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTG 814
GT Y+APE + + VDV+S G+VL +L G
Sbjct: 167 MCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK- 665
T + + ++G G + V + + AVK +I K D EI +L +
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDPT-EEIEILLRY 72
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+H ++++L G +V E M G L I L + S + + + +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI-----LRQKFFSEREASAVLFTITK 127
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
+EYLH+ Q +HRDLK SNIL G+ ++ DFG K ++T T
Sbjct: 128 TVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYT 183
Query: 782 FGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
++APE Y D++S GV+L +LTG
Sbjct: 184 ANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 39/216 (18%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH--SEIAVLSKVRHRHLVSLL 675
LG G +G V + + + AVK ++ + + E + EI +L ++RH++++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 676 GYSVAGYER----LLVYEYMPQGA--LSKHIFHWKSLNLEPLSWKRRLNIALDVAR---- 725
V E +V EY G + + +R + A
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE------------KRFPV--CQAHGYFC 116
Query: 726 ----GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA-G 780
G+EYLHS Q +H+D+K N+LL K+S G+ + R + G
Sbjct: 117 QLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 781 TFGYLAPEYAVTGKI--TTKVDVFSFGVVLMELLTG 814
+ + PE A KVD++S GV L + TG
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 38/235 (16%), Positives = 78/235 (33%), Gaps = 33/235 (14%)
Query: 94 TLPQN-LNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
+ + L + L+ + L N + FS L +L++ L N + + +F L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLS 124
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK-- 208
+L L L N + S L L L + + ++ +FA L L+
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTK---LQILRVGNMDTFTKIQR--KDFAGLTFLEEL 179
Query: 209 -LSGNNLTGPIPESFKGL-NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGN 261
+ ++L P+S K + N+ +L L+ ++ + L L
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD-------VTSSVECLELRDT 232
Query: 262 HFSGT--------IPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
S K + +++ + ++ L L+ + N
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRN 287
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 67/417 (16%), Positives = 121/417 (29%), Gaps = 129/417 (30%)
Query: 56 LLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQF 115
++ K C + + + SS L ++P L ++++ L N+
Sbjct: 14 IISLSKEESSNQASL----SCDRNGICKG--SSGSLN-SIPSGLT--EAVKSLDLSNNRI 64
Query: 116 RGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG 173
+ + NL+ L N +TI D F L +L+ L L N
Sbjct: 65 T-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN------------- 110
Query: 174 LQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLN 233
L+NLS + +SL L L GN + E+
Sbjct: 111 -----YLSNLS----------SSWFKPLSSLTFLNLLGNPYKT-LGET------------ 142
Query: 234 DQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGLIP 292
+ ++ +L+ L + I F LT L++L ++++ P
Sbjct: 143 -----------SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 293 PSLASL-SLDHLDL-NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLG 350
SL S+ ++ HL L D
Sbjct: 192 KSLKSIQNVSHLILHMKQH------------ILLLEIFV-----------------DVTS 222
Query: 351 GLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410
+ L L ++ L + LS + S+ + +K
Sbjct: 223 SVE-----------------CLELR---DTDLDTFHFSE--LSTGETNSLIKKFTFRNVK 260
Query: 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-------PPLPKFSGAVKLSLDGNPL 460
+ ++ Q+ + L L+ S+N L L K+ L NP
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQ---KIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 13/67 (19%), Positives = 27/67 (40%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
+L + N+ + + + +S L N ++P FD L +LQ +
Sbjct: 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307
Query: 157 LDSNNFN 163
L +N ++
Sbjct: 308 LHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 20/127 (15%), Positives = 35/127 (27%), Gaps = 10/127 (7%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDT-----IPADFFDG 148
P++L + + ++ L Q L S+++ L + DT + +
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208
L + K L + L L L SLQ +
Sbjct: 250 LIKKFTFRNVKITDESLF--QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIW 307
Query: 209 LSGNNLT 215
L N
Sbjct: 308 LHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 23/89 (25%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLSQ 437
L L L N T+ +L SL + L N +S + ++W L SLT L+L
Sbjct: 76 VNLQALVL-TSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 438 NNLS--PPLPKFSGAVKLS---LDGNPLL 461
N FS KL +
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTF 162
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 36/242 (14%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLK 129
K V NS + ++ + L+ ++E + L Q E+ +F+ ++
Sbjct: 54 KIVTFKNSTMRKLPAAL----------LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL-QSSAQLTNLSCMSC 188
Y+ N +P F + L VL L+ N+ + S P+G+ ++ +LT LS MS
Sbjct: 103 KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-----SLPRGIFHNTPKLTTLS-MSN 156
Query: 189 NLAGQLPD-FLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVL 247
N ++ D SLQNL+LS N LT L N+ N + L
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNL---------LSTL 207
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLN 306
+ L N + + L L L N L + L +DL+
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLS 262
Query: 307 NN 308
N
Sbjct: 263 YN 264
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-22
Identities = 60/389 (15%), Positives = 115/389 (29%), Gaps = 115/389 (29%)
Query: 94 TLPQNLNQLSKLENIGL---QKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
+ NL ++ + ++ + G L+N K + +PA D
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFG--FEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLS 210
+++L L+ Q+ + ++Q L +
Sbjct: 76 QVELLNLNDL------------------QIEEID----------TYAFAYAHTIQKLYMG 107
Query: 211 GNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTI-----DVLGNMDQLRTLWLHGNHFS 264
N + P F+ + L L L + + N +L TL + N+
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERND-------LSSLPRGIFHNTPKLTTLSMSNNNLE 160
Query: 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSY 324
++F TSL++L L+SN+ + + SL H +++ N+
Sbjct: 161 RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF--HANVSYNL--------------- 203
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384
L L P + L S ++ + V
Sbjct: 204 ------------------------LSTLAIPIAV-----------EELDAS---HNSINV 225
Query: 385 LNLPNF------NLSG---TLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLD 434
+ P L T + + N L ++ L N + +I + + ++ L L
Sbjct: 226 VRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 284
Query: 435 LSQNNLS---PPLPKFSGAVKLSLDGNPL 460
+S N L L L N L
Sbjct: 285 ISNNRLVALNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 1e-17
Identities = 49/353 (13%), Positives = 95/353 (26%), Gaps = 91/353 (25%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
+L + LQ N + L L N + I F ++ L+ L + +
Sbjct: 229 PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
N +L L + +L+ L LS N+L +
Sbjct: 288 N------------------RLVA-----------LNLYGQPIPTLKVLDLSHNHLLH-VE 317
Query: 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD 279
+ + +L L+L N T+ +LK+
Sbjct: 318 RNQPQFD-------------------------RLENLYLDHNSIV-TLK--LSTHHTLKN 349
Query: 280 LNLNSNQFVG----LIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
L L+ N + + ++A ++D D + Q G
Sbjct: 350 LTLSHNDWDCNSLRALFRNVARPAVDDADQH-------------------CKIDYQLEHG 390
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWS---GNDPCKSWLGLSCGTNSKLTVLNLPNFNL 392
+ C +D L +V G + + +T
Sbjct: 391 LCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
Query: 393 SGTLSPSVG----NLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
+ L V + LT ++Q + + +L L ++ L+
Sbjct: 451 NEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE--IDTNLRRYRLPKDGLA 501
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 31/225 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHS--------- 658
+ + + + G +G V G +G +A+KR+ V + V+
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 659 EIAVLSKVRHRHLVSLLG----YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSW 713
EI +L+ H +++ L + +L LV E M + L++ I +S
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI---HD-QRIVISP 133
Query: 714 KRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773
+ + G+ LH A +HRDL NILL D+ + DF L +
Sbjct: 134 QHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 774 ---VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
V R Y APE + K T VD++S G V+ E+
Sbjct: 191 THYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 50/267 (18%), Positives = 89/267 (33%), Gaps = 58/267 (21%)
Query: 66 CGPPC----WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS 121
PPC + + + +I +LP + L L + R +PS
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRI--------PSLPPSTQTLK------LIETHLR-TIPS 48
Query: 122 --FSGLSNLKYAYLDGNN-FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178
FS L N+ Y+ + + + F L + + + + + A
Sbjct: 49 HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY--------IDPDA 100
Query: 179 -----QLTNLSCMSCNLAGQLPD--FLGNFASLQNLKLSGNNLTGPIPE-SFKGLN--LV 228
L L + L PD + + L+++ N IP +F+GL +
Sbjct: 101 LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 229 NLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPE-SFGKLTS-LKDLN 281
L L + G F GT +L ++L+ N + I + +FG + S L+
Sbjct: 160 TLKLYNNGFTSVQGYAFNGT--------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 282 LNSNQFVGLIPPSLASLSLDHLDLNNN 308
++ L L L L N
Sbjct: 212 VSQTSVTALPSKGLEHLK--ELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 41/277 (14%), Positives = 83/277 (29%), Gaps = 84/277 (30%)
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWL--NDQ 235
Q + ++ ++P S Q LKL +L +F L N+ +++ +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 236 ----KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP-ESFGKLTSLKDLNLNSNQFVGL 290
+ F + ++ + + I ++ +L LK L + +
Sbjct: 68 LQQLESHSFYN-------LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMF 120
Query: 291 IPPSLASL----SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALI 346
P L + L++ +N +M +P NAF
Sbjct: 121 --PDLTKVYSTDIFFILEITDNPYMTSIP----------VNAFQ---------------- 152
Query: 347 DFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSL 406
G ++ L L N ++ N L
Sbjct: 153 ------------------------------GLCNETLTLKL-YNNGFTSVQGYAFNGTKL 181
Query: 407 TQIKLQSNNISGQIPTN-WTNLKS-LTLLDLSQNNLS 441
+ L N I + + + S +LLD+SQ +++
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 9/90 (10%)
Query: 380 SKLTVLNLP-NFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNW-TNLKSLTLLDLS 436
++ + + + L L NL +T I++++ I + L L L +
Sbjct: 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113
Query: 437 QNNLS--PPLPKFSGA---VKLSLDGNPLL 461
L P L K L + NP +
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYM 143
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 7/73 (9%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELP--SFSGL-SNLKYAYLDGNNFDTIPADFFDGLE 150
++ +KL+ + L KN++ + +F G+ S + + +P+ + L+
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK 229
Query: 151 NLQVLALDSNNFN 163
L N +
Sbjct: 230 ELIAR----NTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 17/90 (18%), Positives = 32/90 (35%), Gaps = 10/90 (11%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIP--TNWTNLKSLTLLDLS 436
SK+T + + N + P L L + + + + P T + +L+++
Sbjct: 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 437 QNNLSPPLPK--FSG----AVKLSLDGNPL 460
N +P F G + L L N
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 64/219 (29%), Positives = 91/219 (41%), Gaps = 53/219 (24%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS------EIAVLSKVRHRHL 671
LG G FG V GE G K+AVK +++++ + EI L RH H+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVK-----ILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 672 VSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR---- 725
+ L Y V +V EY+ G L +I R+ AR
Sbjct: 74 IKL--YQVISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQ 118
Query: 726 ----GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
++Y H +HRDLK N+LL AK++DFGL + D E T
Sbjct: 119 QILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRT 169
Query: 782 F----GYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTG 814
Y APE ++G+ +VD++S GV+L LL G
Sbjct: 170 SCGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 54/223 (24%), Positives = 79/223 (35%), Gaps = 60/223 (26%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKVRHRHLVS 673
LG G +G V +AVK ++ K + EI + + H ++V
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 674 LLGYSVAGYERL-------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR- 725
Y L EY G L I + A+
Sbjct: 70 F-------YGHRREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQR 109
Query: 726 -------GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRL 778
G+ YLH HRD+K N+LL + K+SDFGL + + R +
Sbjct: 110 FFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 779 A-GTFGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
GT Y+APE + + VDV+S G+VL +L G
Sbjct: 167 MCGTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAG 204
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 66/355 (18%), Positives = 115/355 (32%), Gaps = 86/355 (24%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
LP+ L L +LP L+Y + N + +P L+
Sbjct: 105 ELPELPQSLKSLLVDNNNLKAL-SDLPP-----LLEYLGVSNNQLEKLPE--LQNSSFLK 156
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
++ +D+N+ P S L ++ + L +LP+ N L + N+
Sbjct: 157 IIDVDNNSLK-----KLPDLPPS---LEFIAAGNNQLE-ELPEL-QNLPFLTAIYADNNS 206
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273
L +P+ +L ++ + + L N+ L T++ N T+P+
Sbjct: 207 LKK-LPDLPL--SLESIVAGNNI----LEELPELQNLPFLTTIYADNNLLK-TLPDL--- 255
Query: 274 LTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQP 332
SL+ LN+ N L P SL LD + +
Sbjct: 256 PPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFS------------------------ 290
Query: 333 TEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNL 392
+ L L LN S N+ + C L LN+ N L
Sbjct: 291 --------GLSELPPNLYYLNA--------SSNE-----IRSLCDLPPSLEELNVSNNKL 329
Query: 393 SGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLP 445
L L+ L N+++ ++P ++L L + N L P +P
Sbjct: 330 I-ELPALPPRLERLI---ASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 71/398 (17%), Positives = 115/398 (28%), Gaps = 104/398 (26%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSG--------------LSNLKYAYLDGNNFD 139
+P + +++ P +G L+
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 140 TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLG 199
++P +L+ L N+ P+ QS L +L + NL L D
Sbjct: 85 SLPEL----PPHLESLVASCNSLT-----ELPELPQS---LKSLLVDNNNLK-ALSDLPP 131
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259
L+ L +S N L +PE L + +++ D+ + L +
Sbjct: 132 L---LEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNS---LKKLPDLPPS---LEFIAAG 181
Query: 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKA 319
N +PE L L + ++N L P SL + NN
Sbjct: 182 NNQLE-ELPE-LQNLPFLTAIYADNNSLKKL-PDLPLSLE--SIVAGNN----------- 225
Query: 320 YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGN------DPCKSWL 372
+++ L L P L T + N D S
Sbjct: 226 -------------------------ILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 260
Query: 373 GLSCGTNS---------KLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
L+ N LT L++ S LS NL L SN I +
Sbjct: 261 ALNVRDNYLTDLPELPQSLTFLDVSENIFS-GLSELPPNLYYLN---ASSNEIR-SLCDL 315
Query: 424 WTNLKSLTLLDLSQNNLSPPLPKFSGAV-KLSLDGNPL 460
+L+ L++S N L LP + +L N L
Sbjct: 316 PPSLEE---LNVSNNKLI-ELPALPPRLERLIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 60/356 (16%), Positives = 98/356 (27%), Gaps = 86/356 (24%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
+ LE I NQ ELP L L Y D N+ +P D +L+ + +
Sbjct: 170 DLPPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLKKLP----DLPLSLESIVAGN 224
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
N LQ+ LT + NL LPD + L+ L + N LT +P
Sbjct: 225 NIL------EELPELQNLPFLTTIYA-DNNLLKTLPDLPPS---LEALNVRDNYLTD-LP 273
Query: 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVL--------------GNMDQLRTLWLHGNHFSG 265
E + +L L +++ G + L L L + N
Sbjct: 274 ELPQ--SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYS 325
+P +L L + N + P +L L + N
Sbjct: 331 ELPALPPRLER---LIASFNHLAEV-PELPQNLK--QLHVEYNPL--------------- 369
Query: 326 SNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL 385
P PE + + L P L L L
Sbjct: 370 --------REFPDIPESVEDLRMNSHLAEVPELP--------------------QNLKQL 401
Query: 386 NLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
++ N +++ L ++ S + L ++
Sbjct: 402 HV-ETNPLREFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 50/216 (23%), Positives = 77/216 (35%), Gaps = 38/216 (17%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
LP L + N ELP L L Y D N T+P D +L+
Sbjct: 209 KLPDLPLSLESIV---AGNNILE-ELPELQNLPFLTTIYADNNLLKTLP----DLPPSLE 260
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L + N P+ QS LT L +S N+ L + N L L S N
Sbjct: 261 ALNVRDNYLT-----DLPELPQS---LTFLD-VSENIFSGLSELPPN---LYYLNASSNE 308
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVL-GNMDQLRTLWLHGNHFSGTIPESFG 272
+ + + +L L +++ K + L +L L NH + +PE
Sbjct: 309 IRS-LCDLPP--SLEELNVSNNK-------LIELPALPPRLERLIASFNHLA-EVPEL-- 355
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
+LK L++ N P S+ L +N++
Sbjct: 356 -PQNLKQLHVEYNPLREF-PDIPESVE--DLRMNSH 387
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-19
Identities = 57/345 (16%), Positives = 107/345 (31%), Gaps = 90/345 (26%)
Query: 120 PSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA- 178
P + L+ +N +P + + +++ + + + + + +
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTEMPVEAEN-VKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63
Query: 179 --------QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVN 229
Q L + L LP+ + L++L S N+LT +PE + L +L+
Sbjct: 64 RLRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLV 118
Query: 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289
N + + L L + N +PE + LK +++++N
Sbjct: 119 DNNNLKA---------LSDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK 167
Query: 290 LIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFL 349
L P SL + NN + L
Sbjct: 168 L-PDLPPSLE--FIAAGNNQL---------------------------------EELPEL 191
Query: 350 GGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL-----NLPNFNLSG---TLSPSVG 401
L P L + N L L +L + P +
Sbjct: 192 QNL---PFLTA-------------IYADNN-SLKKLPDLPLSLESIVAGNNILEELPELQ 234
Query: 402 NLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK 446
NL LT I +N + +P +L++L + D +L P LP+
Sbjct: 235 NLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-PELPQ 277
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 39/216 (18%), Positives = 73/216 (33%), Gaps = 37/216 (17%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
LP+ L+ L+ + L NL Y N ++ D +L+
Sbjct: 271 DLPELPQSLTFLDVSENIFSG----LSEL--PPNLYYLNASSNEIRSLC----DLPPSLE 320
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L + +N P L L S N ++P+ N L+ L + N
Sbjct: 321 ELNVSNNKLI-----ELPALPPR---LERLIA-SFNHLAEVPELPQN---LKQLHVEYNP 368
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273
L P+ + ++ +L +N +V L+ L + N P+
Sbjct: 369 LRE-FPDIPE--SVEDLRMNSHL-------AEVPELPQNLKQLHVETNPLR-EFPDI--- 414
Query: 274 LTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNN 308
S++DL +NS + V + + L+ ++
Sbjct: 415 PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 30/195 (15%), Positives = 56/195 (28%), Gaps = 55/195 (28%)
Query: 267 IPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYS 325
I T L++ +S+ + P ++ S + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPG-------- 53
Query: 326 SNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL 385
+G + L + + L
Sbjct: 54 -------------------------------------NGEQREMAVSRLRDCLDRQAHEL 76
Query: 386 NLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP 445
L N LS +L +L+SL N+++ ++P +LKSL + + + LS P
Sbjct: 77 ELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
Query: 446 KFSGAVKLSLDGNPL 460
L + N L
Sbjct: 132 LL---EYLGVSNNQL 143
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 56/255 (21%)
Query: 589 GASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGV 647
G ++ + + R F E G+G FG V G E G +A+K+ V
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK----V 56
Query: 648 ISKK--AVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER-------LLVYEYMPQGALSK 698
I E + L+ + H ++V L Y ER +V EY+P L +
Sbjct: 57 IQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 699 HIFHWKSLNLEPLSWKRRLNIALD--------VARGMEYLHSLAHQSFIHRDLKSSNILL 750
++ ++R++ + R + LH + HRD+K N+L+
Sbjct: 115 CCRNY---------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLV 164
Query: 751 -GDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPE-------YAVTGKITTKV 799
D K+ DFG K SE + + +R Y APE Y TT V
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHY------TTAV 213
Query: 800 DVFSFGVVLMELLTG 814
D++S G + E++ G
Sbjct: 214 DIWSVGCIFAEMMLG 228
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 67/422 (15%), Positives = 126/422 (29%), Gaps = 59/422 (13%)
Query: 74 VFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAY 132
V S + + + P++L K + + +N S LS L+
Sbjct: 5 VDRSKNGLIHV-----------PKDL--SQKTTILNISQNYISELWTSDILSLSKLRILI 51
Query: 133 LDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG 192
+ N + F + L+ L L N + L +L +S N
Sbjct: 52 ISHNRIQYLDISVFKFNQELEYLDLSHNKL-----VKIS--CHPTVNLKHLD-LSFNAFD 103
Query: 193 QLPD--FLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGN- 249
LP GN + L+ L LS +L LN+ + L + G + L +
Sbjct: 104 ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDF 163
Query: 250 -MDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP------------PSLA 296
+ L ++ F + S + +L+ N+ P L+
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 297 SLSLDHLDLNNNMFMGP---VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353
+L+L++++ N F+ V + + +S S+ + DF
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL----------QGQLDFRDFDYSGT 273
Query: 354 YPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS 413
L +D S + + N + + +
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 414 NNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVK-------LSLDGNPLLNGKSP 466
N ++ + N +L L L L N L L K + L + N + +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 467 GS 468
G
Sbjct: 393 GD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 46/250 (18%), Positives = 85/250 (34%), Gaps = 40/250 (16%)
Query: 67 GPPCWKHVFCSNSRVTQIQVSSVGLKG-TLPQNL--NQLSKLENIGLQKNQFRG-ELPSF 122
G ++ S + + + + V PQ+ S + + R +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 123 SGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182
S +S + N + L L+ L L N QL
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN------------------QLKE 362
Query: 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT-GPIPESFKGL-NLVNLWLNDQK-GGG 239
LS ++ + SLQ L +S N+++ +L++L ++
Sbjct: 363 LS--------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL- 298
+ +++ L LH N +IP+ KL +L++LN+ SNQ + L
Sbjct: 415 IFRCLPP-----RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468
Query: 299 SLDHLDLNNN 308
SL + L+ N
Sbjct: 469 SLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 41/266 (15%), Positives = 80/266 (30%), Gaps = 37/266 (13%)
Query: 51 LENPELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGL 110
+L+ K S +T + + L + + +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 111 QKNQFRGELP------SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA 164
+ +G+L S + L L + + F + ++ N+ + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG--- 311
Query: 165 SKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKG 224
++ ++ C S + +L S N LT + E+
Sbjct: 312 -------------TRMVHMLCPS------------KISPFLHLDFSNNLLTDTVFENCGH 346
Query: 225 L-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP-ESFGKLTSLKDLNL 282
L L L L + + ++ M L+ L + N S SL LN+
Sbjct: 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 283 NSNQFVGLIPPSLASLSLDHLDLNNN 308
+SN I L + LDL++N
Sbjct: 407 SSNILTDTIFRCLPP-RIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 75/407 (18%), Positives = 127/407 (31%), Gaps = 53/407 (13%)
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
++ LSKL + + N+ + L F L+Y L N I NL+
Sbjct: 38 TSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKIS---CHPTVNLK 93
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L L N F+A + L L + +L + + + L + G
Sbjct: 94 HLDLSFNAFDALPICKEFGNMSQ---LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 214 LTGPI-PESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM-------DQLRTLWLHGNHFSG 265
PE + N +L + F +DV + L + +
Sbjct: 151 YGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 266 TIPESFGKLTSLKDLNLNSNQFVGL----IPPSLASLSLDHLDLNNNMFMGPVPKSKAYK 321
+I L +L LN+ + I + ++ + ++N G +
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY 270
Query: 322 YSYS----------SNAFCQPTEGVPCAPEVMALIDF-LGGLNYPPRLVTSWSGNDPCKS 370
S S+ F P + M + +F + G L S
Sbjct: 271 SGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF---L 327
Query: 371 WLGLS-----------CGTNSKLTVLNLPNFNLSGTLSPSVG---NLDSLTQIKLQSNNI 416
L S CG ++L L L L LS + SL Q+ + N++
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386
Query: 417 SGQIPTN-WTNLKSLTLLDLSQNNLSP-PLPKFSGAVK-LSLDGNPL 460
S + KSL L++S N L+ +K L L N +
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-16
Identities = 59/405 (14%), Positives = 120/405 (29%), Gaps = 52/405 (12%)
Query: 74 VFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFR--GELPSFSGL--SNLK 129
F + S++ + +S+ L+ + + L+ + + + + + +L
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGW--SFPKGLQSSAQLTNLSCMS 187
+ F I + NL++ + + + S LQ++ +L+NL+ +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 188 CNLAGQLPDFLGNFA---SLQNLKLSGNNLTGPIPESF---KGLNLVNLWLNDQKGGGFT 241
+ ++ +S L G + G +L L ++ F
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 242 GTID-VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-S 299
+ + + K++ L+ ++N + + L
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349
Query: 300 LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLV 359
L+ L L N + S + + L
Sbjct: 350 LETLILQMNQLK---------ELSKIAEMT-----------------TQMKSLQQ----- 378
Query: 360 TSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQ 419
S N C L LN+ + L T + + + L SN I
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL--TDTIFRCLPPRIKVLDLHSNKIK-S 435
Query: 420 IPTNWTNLKSLTLLDLSQNNL-SPPLPKFSGAVKLS---LDGNPL 460
IP L++L L+++ N L S P F L L NP
Sbjct: 436 IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 14/63 (22%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 102 LSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
+++ + L N+ + +P L L+ + N ++P FD L +LQ + L +N
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
Query: 161 NFN 163
++
Sbjct: 479 PWD 481
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV-LSKVRHR 669
+ E+GRG +G V K G +AVKR+ + + +K + ++ V +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V G + + E M + K + S+ + + + I L + + +
Sbjct: 82 YIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG----LVKLAPDSERSVV-TRLAGTFGY 784
L + IHRD+K SNILL K+ DFG LV S+ TR AG Y
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-------DSIAKTRDAGCRPY 191
Query: 785 LAPE----YAVTGKITTKVDVFSFGVVLMELLTG 814
+APE A + DV+S G+ L EL TG
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 17/227 (7%)
Query: 595 EAGNLVISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAV 653
+ G L I Q + + + E+G G G V+K G IAVK+M +K+
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEEN 67
Query: 654 DEFHSEIAVLSK-VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS 712
++ V+ K ++V G + + + E M A + L
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG 127
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
+ + + + + YL IHRD+K SNILL + + K+ DFG+ D +
Sbjct: 128 -----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180
Query: 773 SVVTRLAGTFGYLAPE-----YAVTGKITTKVDVFSFGVVLMELLTG 814
R AG Y+APE + DV+S G+ L+EL TG
Sbjct: 181 K--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 53/230 (23%), Positives = 79/230 (34%), Gaps = 45/230 (19%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+LP L +L LP+ S L ++ GN ++P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTH----LPAL--PSGLCKLWIFGNQLTSLPVL----PPGLQ 144
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
L++ N S P ++L L + L LP LQ L +S N
Sbjct: 145 ELSVSDNQLA-----SLPALP---SELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQ 192
Query: 214 LTGPIPESFKGLNLVNLWLNDQKGGGFTGTI------DVLGN--------MDQLRTLWLH 259
L +P L LW + + V GN +L+ L +
Sbjct: 193 LAS-LPTLPS--ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVS 249
Query: 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
GN + ++P L S L++ NQ L P SL L S ++L N
Sbjct: 250 GNRLT-SLPMLPSGLLS---LSVYRNQLTRL-PESLIHLSSETTVNLEGN 294
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-22
Identities = 66/379 (17%), Positives = 108/379 (28%), Gaps = 99/379 (26%)
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
C N+ + V GL TLP L + + + + N LP+ L+ + G
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA--LPPELRTLEVSG 90
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N ++P GL L + + + A P GL L N LP
Sbjct: 91 NQLTSLPVLPP-GLLELSIFSNPLTHLPAL-----PSGLCK------LWI-FGNQLTSLP 137
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
LQ L +S N L +P L LW + + T + L+
Sbjct: 138 VLPPG---LQELSVSDNQLAS-LPALPS--ELCKLWAYNNQ---LT---SLPMLPSGLQE 185
Query: 256 LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVP 315
L + N + ++P +L L N +P + L L ++ N
Sbjct: 186 LSVSDNQLA-SLPTLPSELYKLWAYNNRLTS----LPALPSGLK--ELIVSGN------- 231
Query: 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLS 375
+ +L L L
Sbjct: 232 -------------------------RLTSLPVLPSELKE-------------------LM 247
Query: 376 CGTNSKLTVL-----NLPNFNLSG----TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTN 426
N +LT L L + ++ L S+ +L S T + L+ N +S +
Sbjct: 248 VSGN-RLTSLPMLPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALRE 306
Query: 427 LKSLTLLDLSQNNLSPPLP 445
+ S
Sbjct: 307 ITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-21
Identities = 60/363 (16%), Positives = 103/363 (28%), Gaps = 107/363 (29%)
Query: 125 LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184
+ + + T+P ++ L + NN S P +L L
Sbjct: 39 NNGNAVLNVGESGLTTLPDCLP---AHITTLVIPDNNLT-----SLPALP---PELRTLE 87
Query: 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL---------------NLVN 229
L LP L +L +P L L
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQE 145
Query: 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289
L ++D + +L LW + N + ++P + L++L+++ NQ
Sbjct: 146 LSVSDNQLASLPALP------SELCKLWAYNNQLT-SLPML---PSGLQELSVSDNQLAS 195
Query: 290 LIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFL 349
L P + L L NN +L
Sbjct: 196 L-PTLPSELY--KLWAYNNRL--------------------------------TSLPALP 220
Query: 350 GGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL-----NLPNFNLSG----TLSPSV 400
GL L +S ++LT L L +SG +L
Sbjct: 221 SGL-----------------KELIVS---GNRLTSLPVLPSELKELMVSGNRLTSLPMLP 260
Query: 401 GNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-PPLPKFSGAVKLSLDGNP 459
L SL+ + N ++ ++P + +L S T ++L N LS L P
Sbjct: 261 SGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316
Query: 460 LLN 462
++
Sbjct: 317 IIR 319
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 52/254 (20%), Positives = 87/254 (34%), Gaps = 37/254 (14%)
Query: 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLK---------GTLPQNLNQLSKLENIGLQKNQF 115
P P ++ +++T + V GL+ +LP ++L KL NQ
Sbjct: 117 PALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLASLPALPSELCKLW---AYNNQL 173
Query: 116 RGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQ 175
LP S L+ + N ++P L L +N S P
Sbjct: 174 T-SLPM--LPSGLQELSVSDNQLASLP----TLPSELYKLWAYNNRLT-----SLPALPS 221
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQ 235
L L S N LP L+ L +SGN LT +P L++L +
Sbjct: 222 G---LKELIV-SGNRLTSLPVLPSE---LKELMVSGNRLTS-LPMLPS--GLLSLSVYRN 271
Query: 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
+ T + L ++ T+ L GN S ++ ++TS + +F +
Sbjct: 272 Q---LTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328
Query: 296 ASLSLDHLDLNNNM 309
HL + +
Sbjct: 329 RETRALHLAAADWL 342
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V + + A+K ++ +++K V +E VL RH L +L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
YS ++RL V EY G L H+ + + E + R A ++ ++YLHS
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRA---RFYGA-EIVSALDYLHS--E 267
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++ ++RDLK N++L D K++DFGL K ++ T GT YLAPE
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 326
Query: 796 TTKVDVFSFGVVLMELLTGL 815
VD + GVV+ E++ G
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV-LSKVRHRHLVSL 674
ELGRG +GVV K + G +AVKR+ A ++ + ++ + + V V+
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 675 LGYSVAGYERLLVYEYMPQG--ALSKHIF-HWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
G + + E M K + +++ + L IA+ + + +E+LH
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE--- 788
S IHRD+K SN+L+ + K+ DFG+ D AG Y+APE
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAPERIN 182
Query: 789 -YAVTGKITTKVDVFSFGVVLMELLTG 814
+ K D++S G+ ++EL
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 16/205 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V +L + K+ A+K + ++ + F E VL + + +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ L LV +Y G L + ++ E ++ R +A ++ ++ +H L
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA---RFYLA-EMVIAIDSVHQL-- 194
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE-----YA 790
++HRD+K NIL+ + +++DFG + + GT Y++PE
Sbjct: 195 -HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 791 VTGKITTKVDVFSFGVVLMELLTGL 815
G+ + D +S GV + E+L G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 59/217 (27%), Positives = 90/217 (41%), Gaps = 39/217 (17%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS---------EIAVLSKVR 667
LG+GGFG V+ G L D ++A+K VI + V + E+A+L KV
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIK-----VIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 668 ----HRHLVSLLGYSVAGYER--LLVYEYMPQGA-LSKHIFHWKSLNLEPLSWKRRLNIA 720
H ++ L + +LV E L +I L E S R
Sbjct: 93 AGGGHPGVIRL--LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG-EGPS--RC--FF 145
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERSVVTRLA 779
V +++ HS + +HRD+K NIL+ AK+ DFG L D T
Sbjct: 146 GQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD 199
Query: 780 GTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTG 814
GT Y PE+ ++ V+S G++L +++ G
Sbjct: 200 GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-22
Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG FG V K+ A+K + +I + F E +++ +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR--------GM 727
Y+ L +V EYMP G L + S + AR +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDL----VNLMS--------NYDVPE--KWARFYTAEVVLAL 181
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
+ +HS+ FIHRD+K N+LL K++DFG GT Y++P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 788 E----YAVTGKITTKVDVFSFGVVLMELLTGL 815
E G + D +S GV L E+L G
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG G FG V + + A+K ++ V+ K ++ +E +L V LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+S L +V EY+ G + H+ + EP + R A + EYLHSL
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHA---RFYAA-QIVLTFEYLHSL-- 160
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
I+RDLK N+L+ +V+DFG K + L GT LAPE + K
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPE-IILSKG 214
Query: 796 TTK-VDVFSFGVVLMELLTGL 815
K VD ++ GV++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 25/209 (11%)
Query: 615 SENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLV 672
S+ LG G G V + G K A+K ++ + E+ + H+V
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALK-----LLYDSP--KARQEVDHHWQASGGPHIV 85
Query: 673 SLLGY----SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+L L++ E M G L I + + + I D+ ++
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQ 142
Query: 729 YLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
+LHS + HRD+K N+L D K++DFG K + + T Y+
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYV 196
Query: 786 APEYAVTGKITTKVDVFSFGVVLMELLTG 814
APE K D++S GV++ LL G
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+GRG F V ++ ++ A+K M ++ + V F E VL R + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
++ L LV EY G L + + ++ R +A ++ ++ +H L
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA---RFYLA-EIVMAIDSVHRL-- 181
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA-GTFGYLAPE------ 788
++HRD+K NILL +++DFG ++ +V + +A GT YL+PE
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFGSCL-KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 789 -YAVTGKITTKVDVFSFGVVLMELLTGL 815
TG + D ++ GV E+ G
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG G FG V+ + A+K ++ V+ K V+ + E +LS V H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR--------GM 727
+ +++ ++ +Y+ G L L +R VA+ +
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSL-----------LRKSQRFPN--PVAKFYAAEVCLAL 119
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAP 787
EYLHS I+RDLK NILL + K++DFG K PD + L GT Y+AP
Sbjct: 120 EYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAP 172
Query: 788 EYAVTGKITTK-VDVFSFGVVLMELLTGL 815
E V+ K K +D +SFG+++ E+L G
Sbjct: 173 E-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS------EIAVL 663
+ +++ + LG G FG V+ + ++ VK ++ + + E EIA+L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 664 SKVRHRHLVSLLGYSVAGYER--LLVYEYMPQGA-LSKHIFHWKSLNLEPLSWKRRLNIA 720
S+V H +++ + + + LV E G L I L+ EPL+ I
Sbjct: 84 SRVEHANIIKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLD-EPLA--SY--IF 136
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ + YL + IHRD+K NI++ +DF K+ DFG A + G
Sbjct: 137 RQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA--AYLERGKLFYTFCG 191
Query: 781 TFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESR 822
T Y APE + G +++++S GV L L+ E
Sbjct: 192 TIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 53/219 (24%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS------EIAVLSKVRHRHL 671
LG G FG V G+ G K+AVK +++++ + EI L RH H+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK-----ILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 672 VSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR---- 725
+ L Y V +V EY+ G L +I RL+ +R
Sbjct: 79 IKL--YQVISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQ 123
Query: 726 ----GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
G++Y H +HRDLK N+LL AK++DFGL + D E T
Sbjct: 124 QILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE------FLRT 174
Query: 782 F----GYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTG 814
Y APE ++G+ +VD++S GV+L LL G
Sbjct: 175 SCGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/219 (28%), Positives = 82/219 (37%), Gaps = 55/219 (25%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH--SEIAVLSKVRHRHLVSLL 675
+G G FGV +AVK I + A + + EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK-----YIERGAAIDENVQREIINHRSLRHPNIVRF- 81
Query: 676 GYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR-------- 725
V ++ EY G L + I + R + D AR
Sbjct: 82 -KEVILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEARFFFQQLLS 127
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDF--RAKVSDFGLVKLAPDSE--RSVVTRLAGT 781
G+ Y HS HRDLK N LL R K+ DFG K + +S V GT
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GT 180
Query: 782 FGYLAPE------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y+APE Y GK DV+S GV L +L G
Sbjct: 181 PAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVG 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 615 SENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA---VDEFHSEIAVLSKVR-HR 669
E+ LG G V L + AVK +I K+ E+ +L + + HR
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVK-----IIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 670 HLVSLLGYSVAGYE----RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+++ L+ + +E LV+E M G++ HI + N E + DVA
Sbjct: 72 NVLELIEF----FEEEDRFYLVFEKMRGGSILSHIHKRRHFN-E----LEASVVVQDVAS 122
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGL-VKLAPDSERSVVTR---- 777
+++LH+ + HRDLK NIL K+ DF L + + + S ++
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 778 -LAGTFGYLAPE-----YAVTGKITTKVDVFSFGVVLMELLTG 814
G+ Y+APE + D++S GV+L LL+G
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 57/209 (27%), Positives = 78/209 (37%), Gaps = 47/209 (22%)
Query: 110 LQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKG 167
LQ N+ LPS F L+ L+ YL+ N T+PA F L+NL+ L + N
Sbjct: 44 LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN------- 95
Query: 168 WSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPES-FKGL- 225
+L L +L L+L N L +P F L
Sbjct: 96 -----------KLQALP----------IGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLT 133
Query: 226 NLVNLWLNDQK-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDL 280
L L L + G F L + L+ L L+ N +F KLT LK L
Sbjct: 134 KLTYLSLGYNELQSLPKGVFDK----LTS---LKELRLYNNQLKRVPEGAFDKLTELKTL 186
Query: 281 NLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
L++NQ + + SL L L L N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 42/168 (25%), Positives = 61/168 (36%), Gaps = 40/168 (23%)
Query: 74 VFCSNSRVTQIQVSSVGLKGTLPQNL-NQLSKLENIGLQKNQFRGELPS--FSGLSNLKY 130
+F + + V+ L+ LP + +QL L + L +NQ + LP F L+ L Y
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L N ++P FD L +L+ L L +N QL +
Sbjct: 138 LSLGYNELQSLPKGVFDKLTSLKELRLYNN------------------QLKRVP------ 173
Query: 191 AGQLPDFLGNFASLQNLK---LSGNNLTGPIPESFKGL-NLVNLWLND 234
G F L LK L N L +F L L L L +
Sbjct: 174 -------EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 40/140 (28%), Positives = 58/140 (41%), Gaps = 19/140 (13%)
Query: 177 SAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQ 235
+ ++ C S L +P A + L L N L+ ++F L L L+LND
Sbjct: 15 NNNKNSVDCSSKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN 71
Query: 236 K-----GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLNSNQFVG 289
K G F + L TLW+ N +P F +L +L +L L+ NQ
Sbjct: 72 KLQTLPAGIFKE-------LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS 123
Query: 290 LIPPSLASLS-LDHLDLNNN 308
L P SL+ L +L L N
Sbjct: 124 LPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 49/227 (21%), Positives = 70/227 (30%), Gaps = 69/227 (30%)
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFM 311
+ L L N S ++F +LT L+ L LN N+ L L L+ L + +N
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 312 GPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSW 371
+ F Q L
Sbjct: 99 -----------ALPIGVFDQLVN-----------------LAE----------------- 113
Query: 372 LGLSCGTN-------------SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNIS 417
L N +KLT L+L L +L V L SL +++L +N +
Sbjct: 114 --LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
Query: 418 GQIPTN-WTNLKSLTLLDLSQNNL-SPPLPKFSGAVKLS---LDGNP 459
++P + L L L L N L P F KL L NP
Sbjct: 171 -RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENP 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
LG+G FG V + A+K + +I+K V +E VL RH L +L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 677 YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
Y+ ++RL V EY G L H+ + E + R A ++ +EYLHS
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERA---RFYGA-EIVSALEYLHSR-- 124
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
++RD+K N++L D K++DFGL K ++ T GT YLAPE +
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE-VLEDND 181
Query: 796 TTK-VDVFSFGVVLMELLTGL 815
+ VD + GVV+ E++ G
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGR 202
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 4e-21
Identities = 39/219 (17%), Positives = 74/219 (33%), Gaps = 35/219 (15%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
++ K G +N+ L ++ L+ N ++P + + V
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLSSLPDNLP---PQITV 84
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNL 214
L + N S P+ A L L N LP+ + L++L + N L
Sbjct: 85 LEITQNALI-----SLPELP---ASLEYLDA-CDNRLSTLPELPAS---LKHLDVDNNQL 132
Query: 215 TGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKL 274
T +PE L + ++ + T ++ + L L + N + +PE
Sbjct: 133 TM-LPELPA--LLEYINADNNQ---LTMLPELPTS---LEVLSVRNNQLT-FLPEL---P 179
Query: 275 TSLKDLNLNSNQFVGLIPPSLASL-----SLDHLDLNNN 308
SL+ L++++N L P + N
Sbjct: 180 ESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCREN 217
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 4e-20
Identities = 44/234 (18%), Positives = 88/234 (37%), Gaps = 27/234 (11%)
Query: 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
C ++ +++Q++ + L +LP NL ++ + + +N LP ++L+Y
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPE--LPASLEYLDACD 109
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N T+P + +L+ L +D+N P+ A L ++ + L LP
Sbjct: 110 NRLSTLP----ELPASLKHLDVDNNQLT-----MLPELP---ALLEYINADNNQL-TMLP 156
Query: 196 DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
+ + L+ L + N LT +PE + +L L ++ + ++
Sbjct: 157 ELPTS---LEVLSVRNNQLTF-LPELPE--SLEALDVSTNLLESLPAVPVRNHHSEETEI 210
Query: 256 -LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
N + IPE+ L + L N I SL+ +
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 56/298 (18%), Positives = 86/298 (28%), Gaps = 75/298 (25%)
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSG---NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGT 243
++G D+ + + L G N + E L LN +
Sbjct: 19 YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN-QFSELQLNRLN---LSSL 74
Query: 244 IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHL 303
D L Q+ L + N ++PE L L+ N+ L P ASL HL
Sbjct: 75 PDNLPP--QITVLEITQNALI-SLPELPASLEY---LDACDNRLSTL-PELPASLK--HL 125
Query: 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363
D++NN +P L L +N
Sbjct: 126 DVDNNQL-----------------------TMLP------ELPALLEYIN--------AD 148
Query: 364 GN------DPCKSWLGLSCGTNSKLTVL-----NLPNFNLSG----TLSPSVGNLDSLTQ 408
N + S LS N +LT L +L ++S +L +
Sbjct: 149 NNQLTMLPELPTSLEVLSVRNN-QLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEE 207
Query: 409 IK----LQSNNISGQIPTNWTNLKSLTLLDLSQNNLS-PPLPKFSGAVKLSLDGNPLL 461
+ + N I+ IP N +L + L N LS S P +
Sbjct: 208 TEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 43/233 (18%)
Query: 601 ISVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDEFH 657
+++ V K + + LG G F VYK + + +A+K ++ +A D +
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGIN 56
Query: 658 S----EIAVLSKVRHRHLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLS 712
EI +L ++ H +++ LL + LV+++M L I SL L P
Sbjct: 57 RTALREIKLLQELSHPNIIGLLDA-FGHKSNISLVFDFMETD-LEVIIKD-NSLVLTPSH 113
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
K L +G+EYLH +HRDLK +N+LL ++ K++DFGL K R
Sbjct: 114 IK---AYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167
Query: 773 S----VVTRLAGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
+ VVTR Y APE Y VD+++ G +L ELL
Sbjct: 168 AYTHQVVTRW-----YRAPELLFGARMY------GVGVDMWAVGCILAELLLR 209
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 52/218 (23%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS------EIAVLSKVRHRHL 671
LG G FG V K+A+K IS++ + + EI+ L +RH H+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK-----FISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 672 VSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR---- 725
+ L Y V ++V EY G L +I K+R+ D R
Sbjct: 72 IKL--YDVITTPTDIVMVIEYA-GGELFDYIVE-----------KKRMTE--DEGRRFFQ 115
Query: 726 ----GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA-- 779
+EY H +HRDLK N+LL D+ K++DFGL + D L
Sbjct: 116 QIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-----FLKTS 167
Query: 780 -GTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTG 814
G+ Y APE + GK +VDV+S G+VL +L G
Sbjct: 168 CGSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 39/239 (16%), Positives = 85/239 (35%), Gaps = 19/239 (7%)
Query: 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNF 138
+ + ++ + + L L ++ F + +S + + L ++
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 139 DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFL 198
I + L N F S +G + +L L L
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDS----VFQGCSTLKRLQTLILQRNGLK-NFFKVA 396
Query: 199 GNFASLQNLKLSGNNLTGPIPESFKGL-----NLVNLWLNDQKGGGFTGTI-DVLGNMDQ 252
++ +L+ +L ++ +++ L L+ TG++ L +
Sbjct: 397 LMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM---LTGSVFRCLP--PK 451
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310
++ L LH N +IP+ L +L++LN+ SNQ + L SL ++ L++N +
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 68/409 (16%), Positives = 117/409 (28%), Gaps = 81/409 (19%)
Query: 69 PCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLS 126
SN + + S+ L +P++L + + + L +N EL S LS
Sbjct: 21 IVGSMTPFSNELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLS 76
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
L+ L N ++ F ++L+ L + N +L N+SC
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN------------------RLQNISC- 117
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV 246
ASL++L LS N+ +P F
Sbjct: 118 ------------CPMASLRHLDLSFNDFDV-LPV----------------CKEF------ 142
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLK----DLNLNSNQFVGLIPPSLASLSLD- 301
GN+ +L L L F + L L+L S G SL +
Sbjct: 143 -GNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198
Query: 302 -HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT 360
HL + N V + + C + L + G +
Sbjct: 199 LHLVFHPNSLF-SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG-----TLSPSVGNLDSLTQIKLQSNN 415
C L + LN+ N ++ + S L SL +++
Sbjct: 258 HIETTWKCSVKL-FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQV 316
Query: 416 ISGQIPTNWTNLKSLTLLDLSQNNL----SPPLPKFSGAVKLSLDGNPL 460
++ + + LS ++ P S L+ N
Sbjct: 317 FLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 6e-16
Identities = 59/356 (16%), Positives = 112/356 (31%), Gaps = 50/356 (14%)
Query: 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIP-ADFFDGLENLQVLALDS 159
LE + + N+ + + +++L++ L N+FD +P F L L L L +
Sbjct: 98 FNQDLEYLDVSHNRLQ-NIS-CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFA-SLQNLKLSGNNLTGPI 218
F L +S ++ G + L ++ +L N+L
Sbjct: 156 AKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 219 PE----SFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPE---SF 271
+ L L N+ LND+ + L L + L + F
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272
Query: 272 GKLTSLKDLNLNSNQFVGLI---PPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNA 328
++ LN+ + I + + +L L + + +
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV----------------KNQV 316
Query: 329 FCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLP 388
F E + M + ++ P + C S T LN
Sbjct: 317 FLFSKEALYSVFAEMNIKML--SISDTPFIHM------VCPPSP-------SSFTFLNFT 361
Query: 389 NFNLSGTLSPSVGNLDSLTQIKLQSNNIS--GQIPTNWTNLKSLTLLDLSQNNLSP 442
+ ++ L L + LQ N + ++ N+ SL LD+S N+L+
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 9e-14
Identities = 61/381 (16%), Positives = 122/381 (32%), Gaps = 40/381 (10%)
Query: 102 LSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFD-TIPADFFDGLENLQVLALD-S 159
L+KL +GL +FR +++L + + + I + L+ L
Sbjct: 145 LTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 160 NNFNASKGWSFPKGLQSSAQLT----NLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215
+ N+ + + L L+ +C L +L N+ L T
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 216 GP----IPESFKGLNLVNLWLND---QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP 268
+ + F + L + + + + L + F +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 269 ESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPK-----SKAYKY 322
+ + L+ + + S S L+ N+F V + +
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 323 SYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKL 382
N + + + L L+ + S + + C +W +
Sbjct: 383 ILQRNGL----KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC-AWA-------ESI 430
Query: 383 TVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL-S 441
VLNL + L+G++ + + + L +N I IP + T+L++L L+++ N L S
Sbjct: 431 LVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487
Query: 442 PPLPKFSGAVKL---SLDGNP 459
P F L L NP
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNP 508
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 52/260 (20%), Positives = 84/260 (32%), Gaps = 79/260 (30%)
Query: 61 KSGDPCGPPCW---KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG 117
+S C C + CS ++ + PQ+L S + L N
Sbjct: 7 RSVVSCPANCLCASNILSCSKQQLPNV-----------PQSLP--SYTALLDLSHNNLS- 52
Query: 118 ELPS---FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGL 174
L + + L+NL L N+ + I ++ F + NL+ L L SN
Sbjct: 53 RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN-------------- 98
Query: 175 QSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLND 234
L L + +L+ L L N++ +F+ +
Sbjct: 99 ----HLHTLD----------EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA-------- 136
Query: 235 QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG---KLTSLKDLNLNSNQFVGLI 291
QL+ L+L N S E KL L L+L+SN+ L
Sbjct: 137 -----------------QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP 179
Query: 292 P---PSLASLSLDHLDLNNN 308
L + + L L+NN
Sbjct: 180 LTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 27/93 (29%), Positives = 36/93 (38%), Gaps = 15/93 (16%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIP----TNWTNLKSLTLLD 434
L VL L N + + ++ L ++ L N IS + P + L L LLD
Sbjct: 112 QALEVLLL-YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169
Query: 435 LSQNNLS-------PPLPKFSGAVKLSLDGNPL 460
LS N L LP + L L NPL
Sbjct: 170 LSSNKLKKLPLTDLQKLPAWVKNG-LYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/87 (25%), Positives = 37/87 (42%), Gaps = 11/87 (12%)
Query: 382 LTVLNLPNFNLSGTLSPSV--GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQN 438
+L+L + N L L +L + L N+++ I + + + +L LDLS N
Sbjct: 41 TALLDL-SHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 439 NLSPPLPK--FSGAVKL---SLDGNPL 460
+L L + FS L L N +
Sbjct: 99 HLH-TLDEFLFSDLQALEVLLLYNNHI 124
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 48/242 (19%), Positives = 68/242 (28%), Gaps = 54/242 (22%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKY 130
V C +T + P +L + L +N + + L
Sbjct: 13 LEVNCDKRNLTAL-----------PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
LD + L L L L N S P Q+ LT L +S N
Sbjct: 60 LNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-----SLPLLGQTLPALTVLD-VSFNR 111
Query: 191 AGQLPDFLGNFASLQNLK---LSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVL 247
LP G L L+ L GN L +P +L
Sbjct: 112 LTSLPL--GALRGLGELQELYLKGNELKT-LPP------------------------GLL 144
Query: 248 GNMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLN 306
+L L L N+ + +P L +L L L N + S L L+
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLH 203
Query: 307 NN 308
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 29/86 (33%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
++LT LNL L T G L L + L N + +P L +LT+LD+S N
Sbjct: 55 TRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111
Query: 440 LSPPLPK--FSGAVK---LSLDGNPL 460
L+ LP G + L L GN L
Sbjct: 112 LT-SLPLGALRGLGELQELYLKGNEL 136
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 63/397 (15%), Positives = 104/397 (26%), Gaps = 77/397 (19%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
++ L+KL + N+ +L S L Y N I L L
Sbjct: 101 DVTPLTKLTYLNCDTNKLT-KLD-VSQNPLLTYLNCARNTLTEID---VSHNTQLTELDC 155
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
N + QLT L C + +L + L L NN+T
Sbjct: 156 HLNKKITKLD------VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKL 206
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
L ++ N ID + + QL N + + S L+ L
Sbjct: 207 DLNQNIQLTFLDCSSNKLT------EID-VTPLTQLTYFDCSVNPLT-ELDVS--TLSKL 256
Query: 278 KDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVP 337
L+ + + + L + + + + + TE
Sbjct: 257 TTLHCIQTDLLEI--DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE--- 311
Query: 338 CAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS 397
L N KL L L N L+ L
Sbjct: 312 ------------------------------------LDLSQNPKLVYLYLNNTELT-EL- 333
Query: 398 PSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDG 457
V + L + + +I + + +L ++ +P K +L
Sbjct: 334 -DVSHNTKLKSLSCVNAHIQ-DFSSV-GKIPALNNNFEAEGQTI-TMP------KETLTN 383
Query: 458 NPLLNGKSPGSGSSSGNPPSPTKGSSSSSSSSPGDST 494
N L SP GNP + G + T
Sbjct: 384 NSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 56/387 (14%), Positives = 105/387 (27%), Gaps = 80/387 (20%)
Query: 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNN 137
+ +T + + + + + +L+ L + N L S +NL Y D N
Sbjct: 41 LATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD-LSQNTNLTYLACDSNK 96
Query: 138 FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF 197
+ L L L D+N P LT L+C L ++
Sbjct: 97 LTNLD---VTPLTKLTYLNCDTNKLTKLDVSQNPL-------LTYLNCARNTLT-EID-- 143
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256
+ + L L N + L L + K T +D + L L
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK---IT-ELD-VSQNKLLNRL 196
Query: 257 WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDL-NNNMFMGPV 314
N+ + + + L L+ +SN+ + + L L + D N + V
Sbjct: 197 NCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELDV 250
Query: 315 PKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGL 374
+ E +
Sbjct: 251 STLSKLTTLHCIQ--TDLLE---------------------------------------I 269
Query: 375 SCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLD 434
N++L L V + L + Q+ I+ ++ + L L
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDL--SQNPKLVYLY 324
Query: 435 LSQNNLSP-PLPKFSGAVKLSLDGNPL 460
L+ L+ + + LS +
Sbjct: 325 LNNTELTELDVSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 72/444 (16%), Positives = 116/444 (26%), Gaps = 101/444 (22%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+L+Q + L + N+ L + L+ L Y D N + L L
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNC 134
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
N + + QLT L C +L + L L S N +T
Sbjct: 135 ARNTLT-----EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
K L L + T +D L QL L N + I LT L
Sbjct: 186 DVSQNK--LLNRLNCDTNN---IT-KLD-LNQNIQLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 278 KDLNLNSNQFVGLIPPSLASL-------------------SLDHLDLNNNMFMGPVPKSK 318
+ + N L +L+ L L + + + +
Sbjct: 236 TYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTH 295
Query: 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGT 378
+ TE +D + P+LV L
Sbjct: 296 NTQLYLLDCQAAGITE-----------LDL----SQNPKLVY-------------LYLNN 327
Query: 379 N----------SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLK 428
+KL L+ N ++ SVG + +L TN
Sbjct: 328 TELTELDVSHNTKLKSLSCVNAHIQ-DF-SSVGKIPALNNNFEAEGQTITMPKETLTNNS 385
Query: 429 -----SLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSSGNPPSPTKGSS 483
S LLD N ++ N + + N + +
Sbjct: 386 LTIAVSPDLLDQFGNPMNIEPGDGGV---YDQATNTI----------TWENLSTDNPAVT 432
Query: 484 SSSSSSPGDSTAETTKPKSSKRTI 507
+ +S G T P + + I
Sbjct: 433 YTFTSENGAIVGTVTTPFEAPQPI 456
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 42/211 (19%), Positives = 63/211 (29%), Gaps = 46/211 (21%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+ QL+ L ++ + ++ L+ L NN T+ NL LA
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLAC 92
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
DSN +LTNL + L L N LT
Sbjct: 93 DSN------------------KLTNLD-------------VTPLTKLTYLNCDTNKLTKL 121
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
L +N N ID + + QL L H N + T L
Sbjct: 122 DVSQNPLLTYLNCARNTLT------EID-VSHNTQLTELDCHLNKKITKLD--VTPQTQL 172
Query: 278 KDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
L+ + N+ L L+ L+ + N
Sbjct: 173 TTLDCSFNKITELDVSQNKLLN--RLNCDTN 201
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-15
Identities = 55/336 (16%), Positives = 90/336 (26%), Gaps = 88/336 (26%)
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185
N + L L L +++ G ++ LT L C
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG------IEKLTGLTKLIC 71
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTID 245
S N+ L L +L L N LT +D
Sbjct: 72 TSNNIT-TLD--LSQNTNLTYLACDSNKLT---------------------------NLD 101
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
+ + +L L N + + + L LN N + L+ LD
Sbjct: 102 -VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLT--ELDC 155
Query: 306 NNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365
+ N + + + + + +F + TE +D
Sbjct: 156 HLNKKITKLDVTPQTQLTTLDCSFNKITE-----------LDV----------------- 187
Query: 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT 425
N L LN N++ + LT + SN ++ +I T
Sbjct: 188 -----------SQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VT 230
Query: 426 NLKSLTLLDLSQNNLSP-PLPKFSGAVKLSLDGNPL 460
L LT D S N L+ + S L L
Sbjct: 231 PLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 44/247 (17%), Positives = 73/247 (29%), Gaps = 35/247 (14%)
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
+ F N + + T TI + L +L H + + + KLT
Sbjct: 10 SFNDWFPDDNFASEVAAAFEMQA-TDTIS-EEQLATLTSLDCHNSSIT-DMTG-IEKLTG 65
Query: 277 LKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG-PVPKSKAYKYSYSSNAFCQPTE 334
L L SN L L+ +L +L ++N V Y + T+
Sbjct: 66 LTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDT--NKLTK 120
Query: 335 GVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394
+D P L + + N++LT L+
Sbjct: 121 -----------LDVSQ----NPLLTYLNCARNTLTE---IDVSHNTQLTELDCHLNKK-- 160
Query: 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL-SPPLPKFSGAVKL 453
V LT + N I+ ++ + K L L+ NN+ L + L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELDV--SQNKLLNRLNCDTNNITKLDLNQNIQLTFL 217
Query: 454 SLDGNPL 460
N L
Sbjct: 218 DCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 18/90 (20%), Positives = 36/90 (40%), Gaps = 7/90 (7%)
Query: 374 LSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLL 433
L N+ LT L + L+ + V L LT + +N ++ + + LT L
Sbjct: 79 LDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYL 132
Query: 434 DLSQNNLSP-PLPKFSGAVKLSLDGNPLLN 462
+ ++N L+ + + +L N +
Sbjct: 133 NCARNTLTEIDVSHNTQLTELDCHLNKKIT 162
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 619 LGRGGFGVVY---KGELDDGTKI-AVKRMEAGVISKKAV---DEFH--SEIAVLSKVRHR 669
LG+G FG V+ K D ++ A+K V+ K + D E +L +V H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMK-----VLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 670 HLVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+V L Y+ +L L+ +++ G L + E + +A ++A ++
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDV---KFYLA-ELALALD 140
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
+LHSL I+RDLK NILL ++ K++DFGL K + D E+ + GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE 196
Query: 789 YAVTGKITTK-VDVFSFGVVLMELLTGL 815
V + T+ D +SFGV++ E+LTG
Sbjct: 197 -VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 41/225 (18%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDEFHS----EIAVL- 663
+ E+G G +G VYK + G +A+K R+ E+A+L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLR 66
Query: 664 --SKVRHRHLVSLL----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
H ++V L+ ++ LV+E++ Q L ++ L + K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIK-- 123
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-------VKLAPD 769
++ RG+++LH+ +HRDLK NIL+ K++DFGL + L P
Sbjct: 124 -DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179
Query: 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
VVT Y APE + T VD++S G + E+
Sbjct: 180 ----VVTLW-----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 38/295 (12%), Positives = 82/295 (27%), Gaps = 61/295 (20%)
Query: 618 ELGRGGFGVVYKGELDD--GTKIAVKRMEA-GVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
G ++ D ++A+ ++ GV+ + E S LS++ + +
Sbjct: 38 FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
L L+V E++ G+L + + S + +A + A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSL-------QEVADTSPSPVGAIRAMQSLAAAADA----A 145
Query: 735 HQS-FIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
H++ S + + D ++ + + +
Sbjct: 146 HRAGVALSIDHPSRVRVSIDGDVVLAYPAT--MPDANPQD-------------------- 183
Query: 794 KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEV 853
D+ G L LL L E+ A ++
Sbjct: 184 ------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQPIEPADI 228
Query: 854 NDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVEKWKPLDDEP 903
+ D I+ +A + R ++ +A E P+D+ P
Sbjct: 229 DRDIPF---QISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAP 280
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 4e-20
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 619 LGRGGFGVVY---KGELDDGTKI-AVKRMEAGVISKKAVDEFH--SEIAVLSKVRHRHLV 672
LG+GG+G V+ K + KI A+K ++ +I + A D H +E +L +V+H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 673 SLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
L+ Y+ +L L+ EY+ G L + E + +A +++ + +LH
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTA---CFYLA-EISMALGHLH 138
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
I+RDLK NI+L K++DFGL K + T GT Y+APE +
Sbjct: 139 QK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAPE-IL 193
Query: 792 TGKITTK-VDVFSFGVVLMELLTGL 815
+ VD +S G ++ ++LTG
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 37/231 (16%)
Query: 601 ISVQVLRN---VTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKA 652
SV++ + V K + + +G G G+V + +A+K++ + +K+A
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA 71
Query: 653 VDEFHSEIAVLSKVRHRHLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSL 706
E+ ++ V H++++ LL S+ ++ + +V E M L + I +
Sbjct: 72 Y----RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI---QM- 122
Query: 707 NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766
L +R + + G+++LHS A IHRDLK SNI++ D K+ DFGL +
Sbjct: 123 ---ELDHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 767 APDSERS---VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
A S VVTR Y APE + VD++S G ++ E++ G
Sbjct: 177 AGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 6e-20
Identities = 40/247 (16%), Positives = 72/247 (29%), Gaps = 47/247 (19%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQK-NQFRGELPS--FSGLSN 127
K F + +I++S + + + + L KL I ++K N + F L N
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPN 105
Query: 128 LKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMS 187
L+Y + +P +L + N + + S
Sbjct: 106 LQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-----------------NIHTIERNS 148
Query: 188 CNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI--- 244
F+G L L+ N + +F G L L L+D +
Sbjct: 149 ---------FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN------LEEL 193
Query: 245 --DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLD 301
DV L + L L+ + + + + P+L L +L
Sbjct: 194 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKL----PTLEKLVALM 249
Query: 302 HLDLNNN 308
L
Sbjct: 250 EASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 31/197 (15%), Positives = 54/197 (27%), Gaps = 28/197 (14%)
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA--QLTNL 183
N I F G +L+ + + N+ +++ L L
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV--------IEADVFSNLPKL 81
Query: 184 SCMSCNLAGQL----PDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWL--NDQ- 235
+ A L P+ N +LQ L +S + V L + N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141
Query: 236 ---KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292
+ F G + LWL+ N +F + ++N L
Sbjct: 142 HTIERNSFV------GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN 195
Query: 293 PSLASLS-LDHLDLNNN 308
S LD++
Sbjct: 196 DVFHGASGPVILDISRT 212
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 50/287 (17%), Positives = 90/287 (31%), Gaps = 51/287 (17%)
Query: 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGG 239
C + ++P L + L+ L +F G +L + ++
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND--- 65
Query: 240 FTGTI--DVLGNMDQLRTLWL-HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS-- 294
I DV N+ +L + + N+ PE+F L +L+ L +++ +P
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124
Query: 295 LASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNY 354
+ SL LD+ +N+ + + N+F
Sbjct: 125 IHSLQKVLLDIQDNINIHTIE----------RNSFV----------------------GL 152
Query: 355 PPRLVTSW-SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQ 412
V W + N + S ++L LNL + N L V + +
Sbjct: 153 SFESVILWLNKNGI--QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210
Query: 413 SNNISGQIPTN-WTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGN 458
I +P+ NLK L P L K ++ SL
Sbjct: 211 RTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 34/220 (15%), Positives = 64/220 (29%), Gaps = 49/220 (22%)
Query: 253 LRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGLIPPS-LASL-SLDHLDLNNNM 309
L I + +F L+ + ++ N + +I ++L L + +
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 310 FMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369
+ + AF L P L N K
Sbjct: 91 NLLYIN----------PEAF--------------------QNL---PNLQYLLISNTGIK 117
Query: 370 SWLGLSCGTNSKLTVLNLP-NFNLSGTLSPSV--GNLDSLTQIKLQSNNISGQIPTN-WT 425
+ + + +L++ N N+ T+ + G + L N I +I + +
Sbjct: 118 HLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFN 175
Query: 426 NLKSLTLLDLSQNNLSPPLPK--FSGAV---KLSLDGNPL 460
+ L NNL LP F GA L + +
Sbjct: 176 GTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 44/222 (19%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVK--RMEAGVISKKAVDE-FHS----EIAVL 663
+ + ++G G +GVVYK + G +A+K R++A DE S EI++L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-------DEGIPSTAIREISLL 73
Query: 664 SKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
++ H ++VSL+ + LV+E+M + L K + L+ K +
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDE-NKTGLQDSQIK---IYLYQL 128
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLA 779
RG+ + H +HRDLK N+L+ D K++DFGL + RS VVT
Sbjct: 129 LRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 780 GTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y AP+ Y +T VD++S G + E++TG
Sbjct: 185 ----YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITG 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKV 666
+ ++G G +GVV+K D G +A+K+ + VI K A+ EI +L ++
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQL 59
Query: 667 RHRHLVSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
+H +LV+LL V +R LV+EY + + + +I
Sbjct: 60 KHPNLVNLL--EVFRRKRRLHLVFEYCDHT-VLHEL---DRYQ-RGVPEHLVKSITWQTL 112
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLAG 780
+ + + H + IHRD+K NIL+ K+ DFG +L V TR
Sbjct: 113 QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-- 167
Query: 781 TFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y +PE Y VDV++ G V ELL+G
Sbjct: 168 ---YRSPELLVGDTQY------GPPVDVWAIGCVFAELLSG 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 9e-20
Identities = 53/265 (20%), Positives = 99/265 (37%), Gaps = 88/265 (33%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+K ++ LG G FG+V + +++ G + A+K++ + + E+ ++ +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL--QDPRYK----NRELDIMKVL 57
Query: 667 RHRHLVSLLGYSVAGYERL--------------------------------------LVY 688
H +++ L+ Y + ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD--------VARGMEYLHSLAHQSFIH 740
EY+P L K + + + +I ++ + R + ++HSL H
Sbjct: 118 EYVPD-TLHKVLKSF---------IRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICH 164
Query: 741 RDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPE-------Y 789
RD+K N+L+ D K+ DFG K SE S + +R Y APE Y
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY 219
Query: 790 AVTGKITTKVDVFSFGVVLMELLTG 814
T +D++S G V EL+ G
Sbjct: 220 ------TPSIDLWSIGCVFGELILG 238
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 45/224 (20%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEA--GV-ISKKAVDEFHSEIAVLSK 665
F +LG G + VYKG G +A+K ++++ G + A+ EI+++ +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST--AI----REISLMKE 59
Query: 666 VRHRHLVSLLGYSVAGYERL-LVYEYMPQ---GALSKHIFHWKSLNLEPLSWKRRLNIAL 721
++H ++V L + +L LV+E+M + LE K
Sbjct: 60 LKHENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK---YFQW 115
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTR 777
+ +G+ + H +HRDLK N+L+ + K+ DFGL + + VVT
Sbjct: 116 QLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 778 LAGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y AP+ Y +T +D++S G +L E++TG
Sbjct: 173 W-----YRAPDVLMGSRTY------STSIDIWSCGCILAEMITG 205
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 44/222 (19%)
Query: 619 LGRGGFGVVYKG---ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+GRG +G VYK + D A+K++E IS A EIA+L +++H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQ 84
Query: 676 GYSVAGYERL--LVYEYMPQ---GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
++ +R L+++Y + H + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRA----KVSDFGL-------VKLAPDSERSVVTRLA 779
H+ +HRDLK +NIL+ + K++D G +K D + VV
Sbjct: 145 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV---- 197
Query: 780 GTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
TF Y APE Y T +D+++ G + ELLT
Sbjct: 198 -TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTS 232
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 44/226 (19%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS-------- 658
V K + + +G G G+V + +A+K K F +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---------KLSRPFQNQTHAKRAY 109
Query: 659 -EIAVLSKVRHRHLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPL 711
E+ ++ V H++++SLL ++ ++ + LV E M L + I L
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM-------EL 161
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771
+R + + G+++LHS A IHRDLK SNI++ D K+ DFGL + A S
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 772 R---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
VVTR Y APE + VD++S G ++ E++
Sbjct: 219 MMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 12/122 (9%)
Query: 697 SKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756
+ + L + L+ + + + VA+GME+L A + IHRDL + NILL +
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 232
Query: 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYL-----APEYAVTGKITTKVDVFSFGVVLMEL 811
K+ DFG LA D + L APE T + DV+SFGV+L E+
Sbjct: 233 KICDFG---LARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 812 LT 813
+
Sbjct: 289 FS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 21/158 (13%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RH 668
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHH 85
Query: 669 RHLVSLLGY-SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
++V+LLG + G +++ E+ G LS ++ +R +G
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------------RSKRNEFVPYKTKGA 133
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765
+ + I DLK + + S F K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 54/227 (23%), Positives = 101/227 (44%), Gaps = 45/227 (19%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDE-FHS----EIAV 662
+ + ++G G +G V+K + +A+K R++ DE S EI +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICL 54
Query: 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
L +++H+++V L + + LV+E+ Q L K+ + +L+P K +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDS-CNGDLDPEIVK---SFLFQ 109
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRL 778
+ +G+ + HS ++ +HRDLK N+L+ + K+++FGL + R VVT
Sbjct: 110 LLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 779 AGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTGLMAL 818
Y P+ Y +T +D++S G + EL L
Sbjct: 167 -----YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 45/215 (20%), Positives = 73/215 (33%), Gaps = 27/215 (12%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L+ I K+ + + + L + G TI L NL L L
Sbjct: 14 PDPALANAIKIAAGKSNVT-DTVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF--LGNFASLQNLKLSGNNLT 215
N L LT ++ + + L + + S++ L L+ +T
Sbjct: 71 KDNQI---------TDLAPLKNLTKITELELS-GNPLKNVSAIAGLQSIKTLDLTSTQIT 120
Query: 216 GPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKL 274
P GL NL L+L+ + I L + L+ L + S L
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQ----ITNISPLAGLTNLQYLSIGNAQVSDL--TPLANL 172
Query: 275 TSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
+ L L + N+ + LASL +L + L NN
Sbjct: 173 SKLTTLKADDNKISDI--SPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 38/213 (17%), Positives = 71/213 (33%), Gaps = 20/213 (9%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
+ + L+ L + L+ NQ +L L+ + L GN + A GL++++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLD 113
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L S + L + L L + P L +LQ L + ++
Sbjct: 114 LTSTQI------TDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT 275
L L L +D K I L ++ L + L N S +
Sbjct: 166 --LTPLANLSKLTTLKADDNK----ISDISPLASLPNLIEVHLKNNQISDV--SPLANTS 217
Query: 276 SLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308
+L + L + +L + ++ +
Sbjct: 218 NLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 45/231 (19%), Positives = 78/231 (33%), Gaps = 19/231 (8%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
L L+K+ + L N + + + +GL ++K L + GL NLQVL
Sbjct: 79 APLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLY 135
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
LD N + L L LS + ++ L N + L LK N ++
Sbjct: 136 LDLNQI------TNISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKISD 187
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
I NL+ + L + + + L N L + L + L
Sbjct: 188 -ISPLASLPNLIEVHLKNNQ----ISDVSPLANTSNLFIVTLTNQTITNQPVFYNNNLVV 242
Query: 277 LKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
+ S I P+ S + + N + + +Y ++ S
Sbjct: 243 PNVVKGPSGA---PIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVT 290
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 53/269 (19%), Positives = 90/269 (33%), Gaps = 56/269 (20%)
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256
A+ + +N+T + L + L TI+ + ++ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTG----VTTIEGVQYLNNLIGL 68
Query: 257 WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315
L N + P LT + +L L+ N + +A L S+ LDL +
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--- 121
Query: 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLS 375
+ L GL L + + + L+
Sbjct: 122 ------------------------------VTPLAGL---SNLQVLYLDLNQITNISPLA 148
Query: 376 CGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDL 435
+ L L++ N +S L+P + NL LT +K N IS I +L +L + L
Sbjct: 149 --GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHL 202
Query: 436 SQNNLS--PPLPKFSGAVKLSLDGNPLLN 462
N +S PL S ++L + N
Sbjct: 203 KNNQISDVSPLANTSNLFIVTLTNQTITN 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 55/269 (20%), Positives = 99/269 (36%), Gaps = 32/269 (11%)
Query: 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236
A ++ N+ + + L G +T E + L NL+ L L D +
Sbjct: 19 ANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP-PSL 295
+ L N+ ++ L L GN + L S+K L+L S Q + P L
Sbjct: 75 ----ITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 296 ASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYP 355
++L + +LDLN + P+ +Y N Q ++ + L L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGN--AQVSD-----------LTPLANL--- 172
Query: 356 PRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNN 415
+L T + ++ L+ + L ++L N +S +SP + N +L + L +
Sbjct: 173 SKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQT 228
Query: 416 ISGQIPTNWTNLKSLTLLDLSQNNLSPPL 444
I+ Q NL ++ P
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 28/210 (13%), Positives = 67/210 (31%), Gaps = 41/210 (19%)
Query: 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
N L ++ + + +++L Y L N + + N++ L +++
Sbjct: 21 TFKAYLNGLLGQSS--TANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE 220
TN + + ++L+ L++ G ++T
Sbjct: 77 ------------------HATNYN------------PISGLSNLERLRIMGKDVTSDKIP 106
Query: 221 SFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD 279
+ GL +L L ++ + + + ++ ++ L N I L LK
Sbjct: 107 NLSGLTSLTLLDISHSAHDD--SILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163
Query: 280 LNLNSNQFVGLIPPSLASLS-LDHLDLNNN 308
LN+ + + L+ L +
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 28/166 (16%), Positives = 51/166 (30%), Gaps = 13/166 (7%)
Query: 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
Q++ L I L +L N+K ++ + + GL NL+ L +
Sbjct: 42 QMNSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGK 98
Query: 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE 220
+ + K L LT L + + + ++ LS N I
Sbjct: 99 DVTSDK----IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153
Query: 221 SFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265
K L L +L + + + +L L+ G
Sbjct: 154 PLKTLPELKSLNIQFDG----VHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 22/116 (18%), Positives = 46/116 (39%), Gaps = 14/116 (12%)
Query: 199 GNFASLQNLKLSGNNLTGPIPESFKGL----NLVNLWLNDQKGGGFTGTIDVLGNMDQLR 254
SL + L+ N+T G+ N+ +L +N+ + + + L
Sbjct: 41 AQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIH----ATNYNPISGLSNLE 91
Query: 255 TLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNM 309
L + G + + LTSL L+++ + I + +L ++ +DL+ N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 20/120 (16%), Positives = 43/120 (35%), Gaps = 8/120 (6%)
Query: 98 NLNQLSKLENIGLQKNQFRGE-LPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
++ LS LE + + + +P+ SGL++L + + D + L + +
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L N L++ +L +L+ + + +F L L + G
Sbjct: 143 LSYNGAITD-----IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 38/221 (17%), Positives = 74/221 (33%), Gaps = 48/221 (21%)
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259
F + N L G + T I E+ + +L + L + TG + ++ L ++
Sbjct: 21 TFKAYLNGLL-GQSSTANITEA-QMNSLTYITLANINVTDLTG----IEYAHNIKDLTIN 74
Query: 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSK 318
H + L++L+ L + P+L+ L SL LD++++ +
Sbjct: 75 NIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI---- 128
Query: 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGNDPCKSWLGLSCG 377
+ + L P++ + S N + L
Sbjct: 129 ---------------------------LTKINTL---PKVNSIDLSYNGAITDIMPLK-- 156
Query: 378 TNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418
T +L LN+ F+ + + L Q+ S I G
Sbjct: 157 TLPELKSLNI-QFDGVHDYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 18/84 (21%), Positives = 33/84 (39%), Gaps = 3/84 (3%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
S L L + +++ P++ L SLT + + + I T L + +DLS N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 440 LS---PPLPKFSGAVKLSLDGNPL 460
PL L++ + +
Sbjct: 148 AITDIMPLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/217 (13%), Positives = 55/217 (25%), Gaps = 47/217 (21%)
Query: 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSN 285
+N L T M+ L + L + + ++KDL +N+
Sbjct: 24 AYLNGLLGQSSTANIT-----EAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 286 QFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMA 344
P ++ LS L+ L +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDV-------------------------------TSD 103
Query: 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD 404
I L GL L + + T K+ ++L + P + L
Sbjct: 104 KIPNLSGL---TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLP 159
Query: 405 SLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
L + +Q + + + L L +
Sbjct: 160 ELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 19/87 (21%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+ L + N + +P + L +L ++++ +++ N + L SLTLLD+S +
Sbjct: 66 HNIKDLTI-NNIHATNYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 440 LS-PPLPKFSGAVKL---SLDGNPLLN 462
L K + K+ L N +
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAIT 150
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 15/85 (17%), Positives = 27/85 (31%), Gaps = 2/85 (2%)
Query: 82 TQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTI 141
T + +S ++ +N L K+ +I L N ++ L LK + +
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY 174
Query: 142 PADFFDGLENLQVLALDSNNFNASK 166
+ L L S K
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGGKK 197
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 3/83 (3%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
+ LT+L++ + ++ + L + I L N I L L L++ +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
Query: 440 LS--PPLPKFSGAVKLSLDGNPL 460
+ + F +L +
Sbjct: 171 VHDYRGIEDFPKLNQLYAFSQTI 193
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 24/208 (11%)
Query: 616 ENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVS 673
LG G G V + K A+K ++ + E+ + + + H+V
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPHIVR 119
Query: 674 LLGY---SVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++ AG + L +V E + G L I + + + I + ++Y
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQY 176
Query: 730 LHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
LHS + HRD+K N+L + K++DFG K +T T Y+A
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVA 231
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTG 814
PE K D++S GV++ LL G
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 7e-19
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG+G FG V E ++ AVK ++ VI V+ E VL+ + L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+RL V EY+ G L HI EP + A ++A G+ +L S
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA---VFYAA-EIAIGLFFLQS-- 460
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N++L + K++DFG+ K + T GT Y+APE + +
Sbjct: 461 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE-IIAYQ 517
Query: 795 ITTK-VDVFSFGVVLMELLTGL 815
K VD ++FGV+L E+L G
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 33/220 (15%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAV 662
+ K + S +G G +G V + G K+A+K++ ++ + +K+A E+ +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLL 76
Query: 663 LSKVRHRHLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
L ++H +++ LL S+ + LV +M Q L K + S ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GL----KFSEEKI 128
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-PDSERSVV 775
+ + +G++Y+HS +HRDLK N+ + +D K+ DFGL + A + VV
Sbjct: 129 QYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 776 TRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
TR Y APE ++ VD++S G ++ E+LTG
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 44/222 (19%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVK--RMEAGVISKKAVDE-FHS----EIAVL 663
+ + ++G G +GVVYK + + G A+K R+E DE S EI++L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-------DEGIPSTTIREISIL 54
Query: 664 SKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
+++H ++V L +LV+E++ Q L K + LE ++ K + L +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDV-CEGGLESVTAK---SFLLQL 109
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLA 779
G+ Y H + +HRDLK N+L+ + K++DFGL + R +VT
Sbjct: 110 LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW- 165
Query: 780 GTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y AP+ Y +T +D++S G + E++ G
Sbjct: 166 ----YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNG 197
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 25/233 (10%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
+GRG + V L +I A+K ++ V + +D +E V + H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
RL V EY+ G L H+ + L E + R A +++ + YLH
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA---RFYSA-EISLALNYLHE-- 128
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N+LL + K++D+G+ K + T GT Y+APE + G+
Sbjct: 129 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-ILRGE 185
Query: 795 ITTK-VDVFSFGVVLMELLTGL------MALDESRPEERQYLAAWFWNIKSDK 840
VD ++ GV++ E++ G + D YL F I +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---FQVILEKQ 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAV 662
V + +G G +G V + G K+A+K++ ++ + +K+A E+ +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRL 77
Query: 663 LSKVRHRHLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRR 716
L +RH +++ LL ++ + LV +M L K + K E L R
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KH---EKLGEDRI 130
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA-PDSERSVV 775
+ + +G+ Y+H+ IHRDLK N+ + +D K+ DFGL + A + VV
Sbjct: 131 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 776 TRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
TR Y APE + T VD++S G ++ E++TG
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 67/202 (33%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSK-VRHRHLVSLL 675
+G+G FG V AVK ++ ++ KK SE VL K V+H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+S ++L V +Y+ G L H+ + EP + R A ++A + YLHSL
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRA---RFYAA-EIASALGYLHSL- 158
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ ++RDLK NILL ++DFGL K + + T GT YLAPE + +
Sbjct: 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAPE-VLHKQ 214
Query: 795 ITTK-VDVFSFGVVLMELLTGL 815
+ VD + G VL E+L GL
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGL 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 48/230 (20%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS-------- 658
+V + + + +G G +G+V + + ++A+K++ F
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----------FEHQTYCQRTL 73
Query: 659 -EIAVLSKVRHRHLVSLLG----YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLS 712
EI +L + RH +++ + ++ + + +V + M + L K + K+ + LS
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL---KT---QHLS 126
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
+ RG++Y+HS + +HRDLK SN+LL K+ DFGL ++A
Sbjct: 127 NDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 773 S-------VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
V TR Y APE + K T +D++S G +L E+L+
Sbjct: 184 HTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 45/226 (19%)
Query: 612 NFASENELGRGGFGVVYKG--ELDDGTKIAVK--RMEAGVISKKAVDEFHS----EIAVL 663
+ E+G G +G V+K + G +A+K R++ + E+AVL
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ------TGEEGMPLSTIREVAVL 65
Query: 664 ---SKVRHRHLVSLL----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKR 715
H ++V L +L LV+E++ Q L+ ++ + + K
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKD 124
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL-------VKLAP 768
+ + RG+++LHS +HRDLK NIL+ + K++DFGL + L
Sbjct: 125 ---MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178
Query: 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
VVT Y APE + T VD++S G + E+
Sbjct: 179 V----VVTLW-----YRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG+G FG V E ++ AVK ++ VI V+ E VL+ + L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+RL V EY+ G L HI EP + A ++A G+ +L S
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA---VFYAA-EIAIGLFFLQS-- 139
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N++L + K++DFG+ K + T GT Y+APE + +
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPE-IIAYQ 196
Query: 795 ITTK-VDVFSFGVVLMELLTGL 815
K VD ++FGV+L E+L G
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG+G FG V + + + AVK ++ ++ V+ +E +LS H L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+RL V E++ G L HI + + E + R A ++ + +LH
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARA---RFYAA-EIISALMFLHD-- 142
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N+LL + K++DFG+ K + + T GT Y+APE +
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPE-ILQEM 199
Query: 795 ITTK-VDVFSFGVVLMELLTGL 815
+ VD ++ GV+L E+L G
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 25/233 (10%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
+GRG + V L +I A++ ++ V + +D +E V + H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
RL V EY+ G L H+ + L E + R A +++ + YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA---RFYSA-EISLALNYLHE-- 171
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ I+RDLK N+LL + K++D+G+ K + T GT Y+APE + G+
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPE-ILRGE 228
Query: 795 ITTK-VDVFSFGVVLMELLTGL------MALDESRPEERQYLAAWFWNIKSDK 840
VD ++ GV++ E++ G + D YL F I +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---FQVILEKQ 278
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 31/217 (14%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+ + ++ L+K + + + L+++ + ++ ++ L N+ L L
Sbjct: 19 SDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 75
Query: 158 DSNNFNASKGWSFPKGLQ----SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
+ N K + K L ++ +LS L + L++L L N
Sbjct: 76 NGNKLTDIKPLANLKNLGWLFLDENKVKDLS------------SLKDLKKLKSLSLEHNG 123
Query: 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
++ L L +L+L + K I VL + +L TL L N S I
Sbjct: 124 IS--DINGLVHLPQLESLYLGNNK----ITDITVLSRLTKLDTLSLEDNQIS-DI-VPLA 175
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
LT L++L L+ N L +LA L +LD L+L +
Sbjct: 176 GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 40/220 (18%), Positives = 68/220 (30%), Gaps = 19/220 (8%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
Q + L + + L N+ ++ + L NL + +LD N + L+ L+ L+
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLS 118
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L+ N + GL QL +L + + L L L L N ++
Sbjct: 119 LEHNGISD------INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 170
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT 275
GL L NL+L+ + L + L L L L
Sbjct: 171 I--VPLAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 224
Query: 276 SLKDLNLNSNQFVGLIPPS-LASLSLDHLDLNNNMFMGPV 314
+ V S ++ + F V
Sbjct: 225 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 40/224 (17%), Positives = 74/224 (33%), Gaps = 31/224 (13%)
Query: 244 IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDH 302
I + L + + +L S+ + N++ + + L ++
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTK 72
Query: 303 LDLNNNMF--MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT 360
L LN N + P+ K + + + + + L L +L +
Sbjct: 73 LFLNGNKLTDIKPLANLKNLGWLFLDE--NKVKD-----------LSSLKDL---KKLKS 116
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420
++ GL +L L L N ++ ++ + L L + L+ N IS I
Sbjct: 117 LSLEHNGISDINGLV--HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI 171
Query: 421 PTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPLLN 462
L L L LS+N++S L L L LN
Sbjct: 172 V-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 55/228 (24%)
Query: 617 NELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDEFHS----EIAVLSKVRHR 669
++G+G FG V+K G K+A+K ME + F EI +L ++H
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALREIKILQLLKHE 76
Query: 670 HLVSLLGYSVAGYERL--------LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
++V+L+ LV+++ L+ + + + K +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSN-VLVKFTLSEIK---RVMQ 131
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL--APDSERS------ 773
+ G+ Y+H +HRD+K++N+L+ D K++DFGL + + +
Sbjct: 132 MLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 774 VVTRLAGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
VVT Y PE Y +D++ G ++ E+ T
Sbjct: 189 VVTLW-----YRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 43/221 (19%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRM----EAGVISKKAVDEFHSEIAVLSKV 666
+ + +G G +G+V K D G +A+K+ + ++ K A+ EI +L ++
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQL 81
Query: 667 RHRHLVSLLGYSVAGYER--LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
RH +LV+LL V ++ LV+E++ + + L L ++ +
Sbjct: 82 RHENLVNLL--EVCKKKKRWYLVFEFVDHT-ILDDL----ELFPNGLDYQVVQKYLFQII 134
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLAG 780
G+ + HS + IHRD+K NIL+ K+ DFG + V TR
Sbjct: 135 NGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-- 189
Query: 781 TFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y APE Y VDV++ G ++ E+ G
Sbjct: 190 ---YRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMG 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 619 LGRGGFGVVYKGELDDGTKI-AVKRME-AGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG+G FG V+ E + A+K ++ V+ V+ E VLS H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 676 GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA 734
+ E L V EY+ G L HI +L + A ++ G+++LHS
Sbjct: 85 -CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS----RATFYAA-EIILGLQFLHSK- 137
Query: 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
++RDLK NILL D K++DFG+ K + T GT Y+APE + K
Sbjct: 138 --GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQK 194
Query: 795 ITTKVDVFSFGVVLMELLTGL 815
VD +SFGV+L E+L G
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQ 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-18
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 619 LGRGGFGVVY---KGELDDGTKI-AVKRMEAGVISKKAVDEFH--SEIAVLSKVRHRH-L 671
LG G +G V+ K D K+ A+K ++ I +KA H +E VL +R L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 672 VSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
V+L Y+ +L L+ +Y+ G L H+ + E ++ + ++ +E+L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFT-EHEV---QIYVG-EIVLALEHL 175
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
H L I+RD+K NILL + ++DFGL K E GT Y+AP+
Sbjct: 176 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 791 VTGKI--TTKVDVFSFGVVLMELLTGL 815
G VD +S GV++ ELLTG
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 41/212 (19%), Positives = 72/212 (33%), Gaps = 44/212 (20%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
L+ L K +L S LS ++ D +N ++ NL+ L L
Sbjct: 14 PDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217
N Q+++LS L + L+ L ++ N L
Sbjct: 71 SHN------------------QISDLS------------PLKDLTKLEELSVNRNRLK-- 98
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
L L+L++ + D L ++ L L + N +I G L+ L
Sbjct: 99 NLNGIPSACLSRLFLDNNE----LRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKL 152
Query: 278 KDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
+ L+L+ N+ L L ++ +DL
Sbjct: 153 EVLDLHGNEITNTGG--LTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 37/217 (17%), Positives = 70/217 (32%), Gaps = 52/217 (23%)
Query: 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSN 285
N V L Q + + ++ ++ ++ T+LK+L+L+ N
Sbjct: 20 NAVKQNLGKQS----VTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73
Query: 286 QFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMA 344
Q L P L L+ L+ L +N N +
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRN----------------------RLKN---------- 99
Query: 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD 404
++ + L + N+ + L L +L++ N L ++ +G L
Sbjct: 100 -LNGIPSAC----LSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKLK-SIVM-LGFLS 150
Query: 405 SLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441
L + L N I+ T LK + +DL+
Sbjct: 151 KLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 24/150 (16%), Positives = 51/150 (34%), Gaps = 16/150 (10%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
+L L LE + ++ N+ + + LS L+ L GN L+ + +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWID 178
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL--PDFLGNFASLQNLKLSGNNL 214
L ++ + L + + + G+ P ++ N S + +
Sbjct: 179 LTGQKCV-NEPVKYQPELYITNTVKDPD-------GRWISPYYISNGGSYVDGCVLWELP 230
Query: 215 TGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
S+K +N+ + F GT+
Sbjct: 231 VYTDEVSYKFSEYINV---GETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 32/191 (16%), Positives = 58/191 (30%), Gaps = 48/191 (25%)
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQ 331
L + NL L+ L + + + +N+
Sbjct: 17 GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNS----------------------- 51
Query: 332 PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN 391
I L G+ + L ++ L +KL L++ N N
Sbjct: 52 -------------NIQSLAGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSV-NRN 95
Query: 392 LSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSG 449
L+ L+++ L +N + + +LK+L +L + N L L S
Sbjct: 96 RLKNLNG--IPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLGFLSK 151
Query: 450 AVKLSLDGNPL 460
L L GN +
Sbjct: 152 LEVLDLHGNEI 162
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 611 KNFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEA--GVISKKAVDEFHSEIAVLSK 665
+ + ++LG G + VYKG +A+K R+E G A+ E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-AI----REVSLLKD 56
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
++H ++V+L LV+EY+ + L +++ + + K + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDD-CGNIINMHNVK---LFLFQLLR 111
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS----VVTRLAGT 781
G+ Y H Q +HRDLK N+L+ + K++DFGL + ++ VVT
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW--- 165
Query: 782 FGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
Y P+ Y +T++D++ G + E+ TG
Sbjct: 166 --YRPPDILLGSTDY------STQIDMWGVGCIFYEMATG 197
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 55/241 (22%)
Query: 604 QVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS---- 658
+++ N++ +F ++ LG G +GVV G +A+K++E F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----------FDKPLFA 53
Query: 659 -----EIAVLSKVRHRHLVSLLG-YSVAGYERL----LVYEYMPQGALSKHIFHWKSLNL 708
EI +L +H +++++ +E ++ E M Q L + I +
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---ST--- 106
Query: 709 EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768
+ LS R ++ LH ++ IHRDLK SN+L+ + KV DFGL ++
Sbjct: 107 QMLSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 769 DSERS--------------VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLT 813
+S V TR Y APE +T + +DV+S G +L EL
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 814 G 814
Sbjct: 219 R 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 52/233 (22%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRM--EAGVISKKAVDEFHSEIAVLS 664
++ + LG GG G+V+ + D ++A+K++ K A+ EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIR 63
Query: 665 KVRHRHLVSLL----------GYSVAGYERL----LVYEYMPQGALSKHIFHWKSLNLEP 710
++ H ++V + V L +V EYM + L+ + + P
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL---EQ---GP 116
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPD 769
L + + RG++Y+HS + +HRDLK +N+ + +D K+ DFGL ++
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 770 SERS-------VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
+VT+ Y +P ++ T +D+++ G + E+LTG
Sbjct: 174 HYSHKGHLSEGLVTKW-----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS-------- 658
V + + + + +G G +G V + G ++AVK K F S
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 659 -EIAVLSKVRHRHLVSLL-----GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPL 711
E+ +L ++H +++ LL S+ + + LV M L+ + K + L
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KC---QKL 129
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDS 770
+ + + RG++Y+HS IHRDLK SN+ + +D K+ DFGL + A +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 771 ERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
V TR Y APE + VD++S G ++ ELLTG
Sbjct: 187 TGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 42/258 (16%), Positives = 73/258 (28%), Gaps = 38/258 (14%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRG---------ELPSFSGLSNLKYAYLDGNNFDTIPAD 144
T ++++ L++ R G+S L+ L+
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 145 FFDGLENLQVLALDSNNFNASKGWSFPKGLQS--SAQLTNLSCMSCNLAGQLPDFLGNFA 202
+ L+ N + + ++ LQ L LS + + + F
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 203 SLQNLKLSGNNLTGPIPESFKGL-----NLVNLWLNDQKGGGFTGTI-DVLGNMDQLRTL 256
+L L LS N G L L L + +G + QL+ L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 257 WLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGL---IPPSLASL-------------- 298
L N S + L LNL+ + +P L+ L
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLDRNPSPD 293
Query: 299 ---SLDHLDLNNNMFMGP 313
+ +L L N F+
Sbjct: 294 ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 56/337 (16%), Positives = 97/337 (28%), Gaps = 65/337 (19%)
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N + + G +L+ L + ++ + S L L+ + + ++
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFT---DIIKSLSLKRLTVRAARIPSRIL 85
Query: 196 D---FLGNFASLQNLKLSGNNLTGPIPES---FKGLNLVNLWLNDQKGGGFTGTIDVLGN 249
+ + LQ L L +TG P G +L L L + + L
Sbjct: 86 FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQ 145
Query: 250 MDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
LK L++ + + +L LDL++N
Sbjct: 146 W----------------------LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 309 MFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPC 368
+G +A C L L +G +
Sbjct: 184 PELGE---------RGLISALCPLK---------------FPTLQV---LALRNAGMETP 216
Query: 369 KSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTNWTNL 427
+L L+L + +L L + L + Q+P
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--P 273
Query: 428 KSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPLLN 462
L++LDLS N L P + LSL GNP L+
Sbjct: 274 AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 54/347 (15%), Positives = 93/347 (26%), Gaps = 91/347 (26%)
Query: 118 ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV--LALDSNNFNASKGWSFPKGLQ 175
++ + G +L+Y L + + F D +++L + L + + + + + L
Sbjct: 35 DVELYGGGRSLEY-LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG 93
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFA--SLQNLKLSGNNLTGPIPE-----SFKGLNLV 228
S L L+ + + G P L L L L + + L
Sbjct: 94 IS-GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 229 NLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES----FGKLTSLKDLNLNS 284
L + F+ + + L TL L N G K +L+ L L +
Sbjct: 153 VLSIAQAHSLNFS--CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 285 NQFVGL--IPPSLASL--SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340
+ +LA+ L LDL++N
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDA--------------------------- 243
Query: 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN----LSGTL 396
W L LNL +F + L
Sbjct: 244 --------------AGAPSCDWPSQ----------------LNSLNL-SFTGLKQVPKGL 272
Query: 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443
+ LD L N + P+ L + L L N
Sbjct: 273 PAKLSVLD------LSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 47/287 (16%), Positives = 82/287 (28%), Gaps = 63/287 (21%)
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTID 245
SCN + PD+ ++ L + L G L V+ + + ++
Sbjct: 13 CSCNFSDPKPDW---SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL- 68
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKL---TSLKDLNLNSNQFVGLIPPSLASL---S 299
L+ L + I ++ + L++L L + + G PP L
Sbjct: 69 ------SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 300 LDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLV 359
L+ L+L N + A + L P V
Sbjct: 123 LNILNLRNVSWATRD-----------------------------AWLAELQQWLKPGLKV 153
Query: 360 TSWSGND----PCKSWLGLSCGTNSKLTVLNLPNFNLSGTL----SPSVGNLDSLTQIKL 411
S + C+ L+ L+L + G + +L + L
Sbjct: 154 LSIAQAHSLNFSCEQVRVFP-----ALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 412 QSNN---ISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVKL 453
++ SG L LDLS N+L P +L
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 50/229 (21%), Positives = 73/229 (31%), Gaps = 75/229 (32%)
Query: 66 CGPPC---WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS- 121
C C V CSN ++ +I +PQ +L L N+F L +
Sbjct: 5 CPEKCRCEGTTVDCSNQKLNKI-------PEHIPQYTAELR------LNNNEFT-VLEAT 50
Query: 122 --FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179
F L L+ N I F+G + + L SN +
Sbjct: 51 GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN------------------R 92
Query: 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239
L N+ SL+ L L N +T +SF GL+
Sbjct: 93 LENVQ----------HKMFKGLESLKTLMLRSNRITCVGNDSFIGLS------------- 129
Query: 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQF 287
+R L L+ N + T+ +F L SL LNL +N F
Sbjct: 130 ------------SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 21/73 (28%), Positives = 34/73 (46%), Gaps = 4/73 (5%)
Query: 94 TLPQNL-NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
+ + L L+ + L+ N+ + SF GLS+++ L N T+ FD L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 151 NLQVLALDSNNFN 163
+L L L +N FN
Sbjct: 154 SLSTLNLLANPFN 166
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 51/227 (22%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVK--RMEAGVISKKAVDEFHS----EIAVLS 664
+ +LG G +G VYK + +A+K R+E + E+++L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIREVSLLK 88
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPL-SWKRRLNIALDV 723
+++HR+++ L + L++EY L K++ +++ + S+ +L
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQL------ 141
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA-----KVSDFGLVKLAPDSERS----V 774
G+ + HS + +HRDLK N+LL + K+ DFGL + R +
Sbjct: 142 INGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 775 VTRLAGTFGYLAPE-------YAVTGKITTKVDVFSFGVVLMELLTG 814
+T Y PE Y +T VD++S + E+L
Sbjct: 199 ITLW-----YRPPEILLGSRHY------STSVDIWSIACIWAEMLMK 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 8e-17
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 31/217 (14%)
Query: 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+ ++ L+K + + + L+++ + ++ ++ L N+ L L
Sbjct: 16 PDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFL 72
Query: 158 DSNNFNASKGWSFPKGLQ----SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
+ N K + K L ++ +LS L + L++L L N
Sbjct: 73 NGNKLTDIKPLTNLKNLGWLFLDENKIKDLS------------SLKDLKKLKSLSLEHNG 120
Query: 214 LTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
++ L L +L+L + K I VL + +L TL L N S I
Sbjct: 121 IS--DINGLVHLPQLESLYLGNNKI----TDITVLSRLTKLDTLSLEDNQIS-DI-VPLA 172
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
LT L++L L+ N L LA L +LD L+L +
Sbjct: 173 GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 40/233 (17%), Positives = 69/233 (29%), Gaps = 19/233 (8%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156
Q + L + + L N+ ++ + L NL + +LD N + L+ L+ L+
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLS 115
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
L+ N + GL QL +L + + L L L L N ++
Sbjct: 116 LEHNGISD------INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD 167
Query: 217 PIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT 275
GL L NL+L+ + L + L L L L
Sbjct: 168 I--VPLAGLTKLQNLYLSKNH----ISDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 276 SLKDLNLNSNQFVGLIPPS-LASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSN 327
+ V S ++ + F V +
Sbjct: 222 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 274
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 8e-11
Identities = 48/246 (19%), Positives = 86/246 (34%), Gaps = 54/246 (21%)
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256
FA L ++T + L ++ + N+ ++ + + + L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD----IKSVQGIQYLPNVTKL 70
Query: 257 WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315
+L+GN + + L +L L L+ N+ L L L L L L +N
Sbjct: 71 FLNGNKLTDI--KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHN------- 119
Query: 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLS 375
I + GL + P+L + + GN+ LS
Sbjct: 120 -----------------------------GISDINGLVHLPQLESLYLGNNKITDITVLS 150
Query: 376 CGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDL 435
+KL L+L + +S + P + L L + L N+IS + LK+L +L+L
Sbjct: 151 --RLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLEL 204
Query: 436 SQNNLS 441
Sbjct: 205 FSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 60/392 (15%), Positives = 97/392 (24%), Gaps = 110/392 (28%)
Query: 128 LKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMS 187
+ I D D L +T+
Sbjct: 1 MGETITVSTPIKQIFPD--DAFAETIKDNLKKK------------------SVTDAVT-- 38
Query: 188 CNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL----NLVNLWLNDQKGGGFTGT 243
S+ + + +++ S +G+ N+ L+LN K
Sbjct: 39 ----------QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFLNGNK----LTD 79
Query: 244 IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDH 302
I L N+ L L+L N + S L LK L+L N + L L L+
Sbjct: 80 IKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISDING--LVHLPQLES 135
Query: 303 LDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW 362
L L NN I + L+ +L T
Sbjct: 136 LYLGNN------------------------------------KITDITVLSRLTKLDT-- 157
Query: 363 SGNDPCKSWLGLSCGTN--SKLTVL----NLPNFNLSG----TLSPSVGNLDSLTQIKLQ 412
LS N S + L L N LS L + L +L ++L
Sbjct: 158 -----------LSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELF 205
Query: 413 SNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLNGKSPGSGSSS 472
S + + +NL + + +L P + L +
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIF 265
Query: 473 GNPPSPTKGSSSSSSSSPGDSTAETTKPKSSK 504
P + K + T
Sbjct: 266 YQPVTIGKAKARFHGRVTQPLKEVYTVSYDVD 297
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 65/261 (24%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS-------- 658
+V N+ ++ +GRG +G VY + + +A+K++ F
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN---------RMFEDLIDCKRIL 73
Query: 659 -EIAVLSKVRHRHLVSLLG----YSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLS 712
EI +L++++ +++ L + ++ L +V E L K K+ L+
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLF---KTPI--FLT 127
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
+ I ++ G ++H IHRDLK +N LL D KV DFGL + +
Sbjct: 128 EEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 773 S--------------------------VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFG 805
+ VVTR Y APE + + T +D++S G
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTG 239
Query: 806 VVLMELLTGLMALDESRPEER 826
+ ELL L +
Sbjct: 240 CIFAELLNMLQSHINDPTNRF 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 58/307 (18%), Positives = 108/307 (35%), Gaps = 76/307 (24%)
Query: 567 NSNGSTSVATESGTGSRYSSGNGASHVIEAGNLVISVQVLRNVTKNFASENELGRGGFGV 626
+ + S + + G + + + + + + + + +G G +G
Sbjct: 15 GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPH------SDWQIPDRYEIRHLIGTGSYGH 68
Query: 627 VYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS---------EIAVLSKVRHRHLVSLL- 675
V + + + +A+K++ F EIA+L+++ H H+V +L
Sbjct: 69 VCEAYDKLEKRVVAIKKIL---------RVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 676 ---GYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V ++ L +V E K ++ L+ + ++ G++Y+H
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSD-FKKLF---RTPV--YLTELHIKTLLYNLLVGVKYVH 173
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS------------------ 773
S +HRDLK +N L+ D KV DFGL + E
Sbjct: 174 S---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 774 -------------VVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALD 819
VVTR Y APE + + T +DV+S G + ELL +
Sbjct: 231 PHTKNLKRQLTGHVVTRW-----YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 820 ESRPEER 826
+
Sbjct: 286 AYHADRG 292
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 54/206 (26%), Positives = 74/206 (35%), Gaps = 57/206 (27%)
Query: 106 ENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA 164
E + LQ + F GL+ L + LD N T+ A FD L L L L +N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN---- 93
Query: 165 SKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKG 224
QL +L G + D L L L L GN L +P
Sbjct: 94 --------------QLASLP------LG-VFDHLTQ---LDKLYLGGNQLKS-LPS---- 124
Query: 225 LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLN 283
G D L L+ L L+ N +IP F KLT+L+ L+L+
Sbjct: 125 -----------------GVFDRLTK---LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163
Query: 284 SNQFVGLIPPSLASL-SLDHLDLNNN 308
+NQ + + L L + L N
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 34/111 (30%), Positives = 42/111 (37%), Gaps = 8/111 (7%)
Query: 202 ASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGF-TGTIDVLGNMDQLRTLWLH 259
A + L L L +F+GL L L L+ + G D L L TL L
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGLA 91
Query: 260 GNHFSGTIPES-FGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
N + ++P F LT L L L NQ L L L L LN N
Sbjct: 92 NNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN 141
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 3/65 (4%)
Query: 101 QLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
+L+KL+ + L NQ + +P+ F L+NL+ L N ++P FD L LQ + L
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187
Query: 159 SNNFN 163
N F+
Sbjct: 188 GNQFD 192
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 41/221 (18%), Positives = 89/221 (40%), Gaps = 40/221 (18%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
++ +LGRG + V++ + + K+ VK ++ + EI +L +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENL 87
Query: 667 R-HRHLVSLLG--YSVAGYERLLVYEYMPQGALSKHI-----FHWKSLNLEPLSWKRRLN 718
R ++++L LV+E++ + + + E L
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL------- 140
Query: 719 IALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA-KVSDFGLVKLA-PDSERS--V 774
+ ++Y HS +HRD+K N+++ + R ++ D+GL + P E + V
Sbjct: 141 ------KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV 191
Query: 775 VTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
+R + PE V ++ +D++S G +L ++
Sbjct: 192 ASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 44/228 (19%), Positives = 68/228 (29%), Gaps = 72/228 (31%)
Query: 65 PCGPPCW---KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS 121
C C V C +T+I P NL + I L++N + +P
Sbjct: 4 HCPAACTCSNNIVDCRGKGLTEI-----------PTNLP--ETITEIRLEQNTIK-VIPP 49
Query: 122 --FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179
FS L+ L N + D F GL +L L L N +
Sbjct: 50 GAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN------------------K 91
Query: 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239
+T L SLQ L L+ N + +
Sbjct: 92 ITELP----------KSLFEGLFSLQLLLLNANKINC-LRV------------------- 121
Query: 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQF 287
D ++ L L L+ N +F L +++ ++L N F
Sbjct: 122 -----DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 35/178 (19%), Positives = 60/178 (33%), Gaps = 54/178 (30%)
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
L+ N IP F + L+ + L +N Q++ L+
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNN------------------QISELA------- 72
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD 251
PD SL +L L GN +T F+GL
Sbjct: 73 ---PDAFQGLRSLNSLVLYGNKITELPKSLFEGLF------------------------- 104
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
L+ L L+ N + ++F L +L L+L N+ + + + L ++ + L N
Sbjct: 105 SLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 22/73 (30%), Positives = 30/73 (41%), Gaps = 4/73 (5%)
Query: 94 TLPQNL-NQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
LP++L L L+ + L N+ L +F L NL L N TI F L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 151 NLQVLALDSNNFN 163
+Q + L N F
Sbjct: 153 AIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 380 SKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQ 437
L L L ++ L S+ L SL + L +N I+ + + + +L +L LL L
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD 137
Query: 438 NNL-SPPLPKFSGAVKLS---LDGNPL 460
N L + FS + L NP
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 45/211 (21%), Positives = 76/211 (36%), Gaps = 55/211 (26%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675
LG G G V + K A+K ++ + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDC--PKARREVELHWRASQCPHIVRIV 77
Query: 676 GYSVAGYER--------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
YE L+V E + G L I + + + I + +
Sbjct: 78 DV----YENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAI 130
Query: 728 EYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+YLHS + HRD+K N+L + K++DFG
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165
Query: 785 LAPEYAVTGKI-TTKVDVFSFGVVLMELLTG 814
A E TG+ D++S GV++ LL G
Sbjct: 166 FAKE--TTGEKYDKSCDMWSLGVIMYILLCG 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 59/214 (27%), Positives = 81/214 (37%), Gaps = 63/214 (29%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
L + + L N+ ++ + L+NL Y L GN ++P FD L NL+ L L
Sbjct: 60 QYLPNVRYLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
N QL +L G + D L N L L L+ N L +P
Sbjct: 119 N------------------QLQSLP------DG-VFDKLTN---LTYLNLAHNQLQS-LP 149
Query: 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKLTSLK 278
+ G D L N L L L N ++PE F KLT LK
Sbjct: 150 K---------------------GVFDKLTN---LTELDLSYNQLQ-SLPEGVFDKLTQLK 184
Query: 279 DLNLNSNQFVGLIPP----SLASLSLDHLDLNNN 308
DL L NQ +P L SL ++ L++N
Sbjct: 185 DLRLYQNQLKS-VPDGVFDRLTSLQ--YIWLHDN 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 62/245 (25%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 604 QVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHS---- 658
+V R+V + + +LG+G +G+V+K + G +AVK K D F +
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---------KIFDAFQNSTDA 52
Query: 659 -----EIAVLSKVR-HRHLVSLLGYSVA-GYERL-LVYEYMPQGALSKHIFHWKSLNLEP 710
EI +L+++ H ++V+LL A + LV++YM + L I ++
Sbjct: 53 QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI---RA---NI 105
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770
L + + + + ++YLHS +HRD+K SNILL + KV+DFGL + +
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 771 ERSVVTRLAGTFGYLAP---------EYAVT------------GKITTKVDVFSFGVVLM 809
R +Y T K T +D++S G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 810 ELLTG 814
E+L G
Sbjct: 223 EILCG 227
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 8e-13
Identities = 24/133 (18%), Positives = 38/133 (28%), Gaps = 25/133 (18%)
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQ 235
+ L C L G +L L + +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGA-ENLTELYIENQQHLQHLEL--------------- 49
Query: 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
L + +LR L + + P++F L LNL+ N L ++
Sbjct: 50 ---------RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV 100
Query: 296 ASLSLDHLDLNNN 308
LSL L L+ N
Sbjct: 101 QGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 26/131 (19%), Positives = 37/131 (28%), Gaps = 16/131 (12%)
Query: 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--S 121
D C P + C+ +L L + ++ Q L
Sbjct: 3 DACCPHGSSGLRCTRDGALDS-----------LHHLPGAENLTELYIENQQHLQHLELRD 51
Query: 122 FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA-SKGWSFPKGLQSSAQL 180
GL L+ + + + D F L L L N + S LQ
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLS 111
Query: 181 TN-LSCMSCNL 190
N L C SC L
Sbjct: 112 GNPLHC-SCAL 121
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 20/86 (23%), Positives = 32/86 (37%), Gaps = 6/86 (6%)
Query: 380 SKLTVLNLPNFNLSGTLSP-SVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQ 437
LT L + N L + L L + + + + + + + L+ L+LS
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF 89
Query: 438 NNLSP-PLPKFSGA--VKLSLDGNPL 460
N L G +L L GNPL
Sbjct: 90 NALESLSWKTVQGLSLQELVLSGNPL 115
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 45/226 (19%), Positives = 85/226 (37%), Gaps = 51/226 (22%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKVR------ 667
LG G F V+ + + + T +A+K ++ + + EI +L +V
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK-----IV--RGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 668 -----HRHLVSLLGY----SVAGYERLLVYEYMPQGALSKHIFHW-KSLNLEPLSWKRRL 717
H++ LL + G ++V+E L +++ K +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVK 134
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA------KVSDFGLVKLAPDSE 771
I+ + G++Y+H IH D+K N+L+ K++D G E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDE 190
Query: 772 RS---VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
+ TR Y +PE + D++S ++ EL+TG
Sbjct: 191 HYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITG 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 55/227 (24%), Positives = 83/227 (36%), Gaps = 65/227 (28%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKVR------ 667
+G+G FG V K +A+K ++ + FH EI +L +R
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK-----MV--RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 668 ------------HR-HLV---SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPL 711
R H+ LL ++ YE + K +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNL--------YELI------------KKNKFQGF 197
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA--KVSDFGLVKLAPD 769
S A + + ++ LH IH DLK NILL R+ KV DFG
Sbjct: 198 SLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254
Query: 770 SERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ + +R F Y APE + + +D++S G +L ELLTG
Sbjct: 255 RVYTYIQSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 30/184 (16%), Positives = 68/184 (36%), Gaps = 30/184 (16%)
Query: 604 QVLRNVTKN-FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV 662
+++ ++ + +G+GGFG +Y +++ + + +E+
Sbjct: 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKF 86
Query: 663 LSKVRHRHLV---------------SLLGYSVAGYE----RLLVYEYMPQGALSKHIFHW 703
+ + G + R ++ + G+ + I+
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEA 144
Query: 704 KSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV--SDF 761
N + S K L ++L + +EY+H ++H D+K+SN+LL +V D+
Sbjct: 145 ---NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDY 198
Query: 762 GLVK 765
GL
Sbjct: 199 GLAY 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 61/226 (26%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVR------ 667
+G+G FG V K + +A+K +I K F E+ +L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIK-----II--KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 668 ------------HR-HL--VS-LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPL 711
R HL V +L Y++ Y+ + ++ N +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNL--------YDLL------------RNTNFRGV 154
Query: 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA--KVSDFGLVKLAPD 769
S A + + +L + S IH DLK NILL + R+ K+ DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGS---SCQ 210
Query: 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815
+ + + F Y +PE + +D++S G +L+E+ TG
Sbjct: 211 LGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 4e-11
Identities = 31/201 (15%), Positives = 57/201 (28%), Gaps = 54/201 (26%)
Query: 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRM------EAGVISKKAVDEFHSEIAVL 663
T+ ++G G FG V++ D T +A+K + +K +E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 664 SKV---------RHRHLVSLLGYSVA------------------------------GYER 684
++ R + L +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLK 744
+V E+ G + + + S +I + + + F HRDL
Sbjct: 138 FIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 745 SSNILLGDDFRAKVSDFGLVK 765
N+LL K+ K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 29/184 (15%), Positives = 65/184 (35%), Gaps = 30/184 (16%)
Query: 604 QVLRNVTKN-FASENELGRGGFGVVYKGE---------LDDGTKIAVK--------RMEA 645
VL + + + ++ R G++Y+ K ++K E
Sbjct: 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQ 93
Query: 646 GVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE-RLLVYEYMPQGA-LSKHIFHW 703
+ A ++ L + + +G+ V + R LV + G L
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSA---L 148
Query: 704 KSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV--SDF 761
LS + L +A + +E+LH ++H ++ + NI + + +++V + +
Sbjct: 149 DVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 762 GLVK 765
G
Sbjct: 206 GFAF 209
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 40/251 (15%), Positives = 75/251 (29%), Gaps = 27/251 (10%)
Query: 57 LQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQ-- 114
L D ++ ++ + + + + ++ +L L +
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST 362
Query: 115 -FRGELPSFSGLSNLKYAY-------------LDGNNFDTIPADFFDGLENLQVLALDSN 160
+ EL S L L+ LD ++ +F L+ + +
Sbjct: 363 VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL 422
Query: 161 NFNASKG-WSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
+ SK A + L +L + L + +L LS N L +P
Sbjct: 423 DDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LP 479
Query: 220 ESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG-TIPESFGKLTSL 277
+ L L L +D +D + N+ +L+ L L N + L
Sbjct: 480 PALAALRCLEVLQASDNA----LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
Query: 278 KDLNLNSNQFV 288
LNL N
Sbjct: 536 VLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 29/180 (16%), Positives = 55/180 (30%), Gaps = 30/180 (16%)
Query: 36 TDPGDIDILNQFRKNLENPELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTL 95
+ + L F L+ + ++ D ++ + T+
Sbjct: 397 PLLYEKETLQYF-STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455
Query: 96 PQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155
+L QL + ++ L N+ R P+ + L L+ N + + L LQ L
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VANLPRLQEL 513
Query: 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215
L +N +L + + L + L L L GN+L
Sbjct: 514 LLCNN------------------RLQQSAAI---------QPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 43/248 (17%), Positives = 73/248 (29%), Gaps = 35/248 (14%)
Query: 36 TDPGDIDILNQ-FRKNLENPELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVS-SVGLKG 93
D Q FR L + + C +T I + ++
Sbjct: 340 CWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153
+ L S L+ + + + +L S L N + +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV---------------R 444
Query: 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN 213
VL L + + L+ +T+L +S N LP L L+ L+ S N
Sbjct: 445 VLHLAHKDL------TVLCHLEQLLLVTHLD-LSHNRLRALPPALAALRCLEVLQASDNA 497
Query: 214 LTGPIPESFKGL----NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPE 269
L + G+ L L L + + I L + +L L L GN
Sbjct: 498 LE-----NVDGVANLPRLQELLLCNNRLQQSAA-IQPLVSCPRLVLLNLQGNSLC-QEEG 550
Query: 270 SFGKLTSL 277
+L +
Sbjct: 551 IQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 54/341 (15%), Positives = 93/341 (27%), Gaps = 54/341 (15%)
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN 189
+ + + + L L + S W P G + + + +
Sbjct: 249 HVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAAS 308
Query: 190 LAGQLPDFLGNFA-----SLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
L QLP S + L + +S L L+ +K +
Sbjct: 309 LNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSEL 368
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLD 304
+ +L+ L TI L L F L ++D +
Sbjct: 369 ---ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK-------AVDPMR 418
Query: 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364
+ +SK + + A + + ++ L L
Sbjct: 419 AAYLDDL----RSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQL------------ 462
Query: 365 NDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNW 424
+T L+L + L L P++ L L ++ N + +
Sbjct: 463 ---------------LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 425 TNLKSLTLLDLSQNNLS-----PPLPKFSGAVKLSLDGNPL 460
NL L L L N L PL V L+L GN L
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 51/196 (26%), Positives = 68/196 (34%), Gaps = 54/196 (27%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
V C + R + L + NQ++KLE F L NLK
Sbjct: 22 TTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP------------GVFDSLINLKEL 69
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
YL N +P FD L L VL L +N QLT
Sbjct: 70 YLGSNQLGALPVGVFDSLTQLTVLDLGTN------------------QLTV--------- 102
Query: 192 GQLP----DFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLND-QKGGGFTGTID 245
LP D L + L+ L + N LT +P + L +L +L L+ Q G D
Sbjct: 103 --LPSAVFDRLVH---LKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 246 VLGNMDQLRTLWLHGN 261
L + L +L GN
Sbjct: 157 RLSS---LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 44/178 (24%), Positives = 57/178 (32%), Gaps = 55/178 (30%)
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
YL N + FD L NL+ L L SN QL L
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSN------------------QLGALP------V 81
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD 251
G + D L L L L N LT +P D L
Sbjct: 82 G-VFDSLTQ---LTVLDLGTNQLTV-LPS---------------------AVFDRLV--- 112
Query: 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
L+ L++ N + +P +LT L L L+ NQ + + L SL H L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 7e-10
Identities = 57/399 (14%), Positives = 119/399 (29%), Gaps = 141/399 (35%)
Query: 640 VKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV------YEYMPQ 693
V+ M ++SK+ +D +S R +LL ++ + Y+++
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTL-RLFWTLLSKQEEMVQKFVEEVLRINYKFL-- 94
Query: 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFI-HRD-LKSSNILLG 751
+S K+ +P S+ + +I RD L + N +
Sbjct: 95 --MSP----IKTEQRQP---------------------SMMTRMYIEQRDRLYNDNQVFA 127
Query: 752 DDFRAKVSDF-----GLVKLAPDSERSVVTRLAGTFGY----LAPEYAVTGKITTKVDVF 802
+++ + L++L P ++V+ + G G +A + ++ K+ K
Sbjct: 128 KYNVSRLQPYLKLRQALLELRP--AKNVL--IDGVLGSGKTWVALDVCLSYKVQCK---M 180
Query: 803 SFGV------------VLMELLTGLMA-LDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
F + ++E+L L+ +D + + + I S + +LR +
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240
Query: 850 --------IL-EVNDDTFETFWTIAELAGHC----TSREPS----------QRPDMGHAV 886
+L V + C T+R + H
Sbjct: 241 KPYENCLLVLLNVQNA-----KAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 887 NVLAP-----LVEKW--KPLDDEPEEYSGIDYSLPLN-----QMVKD-------WQEAEG 927
L P L+ K+ D P E + P + ++D W+
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTN---PRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 928 KDLS------------------YVSL----EDSKSSIPA 944
L+ + L + IP
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH--IPT 389
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 65/538 (12%), Positives = 134/538 (24%), Gaps = 193/538 (35%)
Query: 11 ERSSAMRTHLVSAIVLAFVTL---------VLSATDPGDIDILNQFRKNLENPELLQWPK 61
+ +R L+ V + ++ D+ ++ + + W
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL------DVCLSYKVQCKMDFKIFWLN 188
Query: 62 SGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSK-LENIGLQKNQFRGELP 120
+ + + +Q L + N S NI L+ + + EL
Sbjct: 189 LK---------NCNSPETVLEMLQ----KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 121 SFSGLSNLKYAYL-------------------------DGNNFDTIPA---------DFF 146
+ L D + A
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 147 DGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLG---NFA 202
L +V +L + P+ L TN ++ + D L N+
Sbjct: 296 MTLTPDEVKSLLLKYLDCR-----PQDLPREVLTTNP--RRLSIIAESIRDGLATWDNWK 348
Query: 203 SLQN------LKLSGNNLTG-----------------PIPESFKGLNLVNLWLNDQKGGG 239
+ ++ S N L IP L +W +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSLIWFDVI---- 400
Query: 240 FTGTIDVLGNMDQLR------------TLWLHGNHFSGTIPESFGKLTSLKDLN---LNS 284
DV+ +++L T+ + + E KL + L+ ++
Sbjct: 401 ---KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL-----ELKVKLENEYALHRSIVDH 452
Query: 285 NQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAF----CQPTEGVPCAP 340
L +LD +Y YS + E +
Sbjct: 453 YNIPKTFDSD--DLIPPYLD----------------QYFYSHIGHHLKNIEHPERMTLFR 494
Query: 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSV 400
V +DF +L K+ T +
Sbjct: 495 MV--FLDF---------------------RFLE------QKI--------RHDSTAWNAS 517
Query: 401 GN-LDSLTQIKLQSNNISGQIPTNWTNLKSLT--LLDLSQNNLSPPLPKFSGAVKLSL 455
G+ L++L Q+K I P + ++ L + +N + ++ ++++L
Sbjct: 518 GSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK---YTDLLRIAL 572
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 20/171 (11%)
Query: 602 SVQVLRNVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEI 660
S+ VL V NF ++G G FG + G+ L +A+K +E K + H E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEP---MKSRAPQLHLEY 55
Query: 661 AVLSKVRH-RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
++ + + + G +V E + G + +F S K L I
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCD---RTFSLKTVLMI 110
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS-----DFGLVK 765
A+ + MEY+HS ++ I+RD+K N L+G DF L K
Sbjct: 111 AIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 25/208 (12%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-RHLVSLLG 676
+G G FG +Y G + G ++A+K K + H E + ++ + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
G ++V E + G + +F++ S S K L +A + +EY+HS +
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---K 124
Query: 737 SFIHRDLKSSNILLGDDFRAK---VSDFGLVKLAPDSERSVV------TRLAGTFGYLAP 787
+FIHRD+K N L+G + + DFGL K D+ L GT Y A
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 788 EYAVTGKITT-KVDVFSFGVVLMELLTG 814
G + + D+ S G VLM G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 32/164 (19%), Positives = 64/164 (39%), Gaps = 19/164 (11%)
Query: 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR 667
V ++ +G G FGV+++G L + ++A+K + + E +
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLA 63
Query: 668 H-RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
+ ++ + G +LV + + G + + S K A +
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCG---RKFSVKTVAMAAKQMLAR 118
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAK-----VSDFGLVK 765
++ +H +S ++RD+K N L+G V DFG+VK
Sbjct: 119 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 43/171 (25%)
Query: 97 QNLNQLSKLENIGL--QKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
+ ++ E + L + S L K+ L NN + I G+ENL++
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRI 74
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNL 214
L+L N ++ NL ++ L + L +S N +
Sbjct: 75 LSLGRNLI---------------KKIENLDAVADTL--------------EELWISYNQI 105
Query: 215 TGPIPESFKGL----NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261
S G+ NL L++++ K + ID L +D+L L L GN
Sbjct: 106 -----ASLSGIEKLVNLRVLYMSNNKITNWGE-IDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 29/129 (22%), Positives = 50/129 (38%), Gaps = 11/129 (8%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
+ L+ L +++ L N ++ S SG+ NL+ L N I + + L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKKIE-NLDAVADTLEE 97
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF--LGNFASLQNLKLSGN 212
L + N + G++ L L MS N + L L++L L+GN
Sbjct: 98 LWISYNQI------ASLSGIEKLVNLRVLY-MSNNKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 213 NLTGPIPES 221
L E+
Sbjct: 151 PLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 13/62 (20%), Positives = 26/62 (41%), Gaps = 2/62 (3%)
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLN 306
L + + L L N+ I S + +L+ L+L N + + +L+ L ++
Sbjct: 44 LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWIS 101
Query: 307 NN 308
N
Sbjct: 102 YN 103
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 8/97 (8%)
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439
L +L+L NL + D+L ++ + N I+ + + L +L +L +S N
Sbjct: 70 ENLRILSL-GRNLIKKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNK 126
Query: 440 LS-----PPLPKFSGAVKLSLDGNPLLNGKSPGSGSS 471
++ L L L GNPL N + +S
Sbjct: 127 ITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 28/123 (22%)
Query: 198 LGNFASLQNLKLSGNNLTGPIPESFKGL----NLVNLWLNDQKGGGFTGTIDVLGNMD-- 251
L + ++L LS NN+ E L NL L L I + N+D
Sbjct: 44 LSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNL-------IKKIENLDAV 91
Query: 252 --QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ---FVGLIPPSLASL-SLDHLDL 305
L LW+ N + ++ KL +L+ L +++N+ + + LA+L L+ L L
Sbjct: 92 ADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK--LAALDKLEDLLL 147
Query: 306 NNN 308
N
Sbjct: 148 AGN 150
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 46/250 (18%), Positives = 76/250 (30%), Gaps = 95/250 (38%)
Query: 619 LGRGGFGVVYKG--ELDDGTKIAVKRMEAGVISKKAVDEFHS----EIAVLSKVR----- 667
LG G FG V + +++A+K +I + V ++ EI VL K++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALK-----II--RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 668 -------------HR-HL--VS-LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEP 710
H+ LLG + +E++ K N +P
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNT--------FEFL------------KENNFQP 119
Query: 711 LSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770
++A + + +LH H DLK NIL + + +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 771 ERS--------------------VVTRLAGTFGYLAPE------YAVTGKITTKVDVFSF 804
+ + V TR Y PE + DV+S
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATR----H-YRPPEVILELGW------AQPCDVWSI 225
Query: 805 GVVLMELLTG 814
G +L E G
Sbjct: 226 GCILFEYYRG 235
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 100 NQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157
+L L + L++NQ + F G S+++ L N I F GL L+ L L
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109
Query: 158 DSN 160
N
Sbjct: 110 YDN 112
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 32/117 (27%), Positives = 44/117 (37%), Gaps = 19/117 (16%)
Query: 202 ASLQNLKLSGNNLTGPIPE-SFKGL-NLVNLWLND-QKGGGFTGTIDVLGNMDQLRTLWL 258
L L+ N L + F L +LV L L Q G + + ++ L L
Sbjct: 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH---IQELQL 85
Query: 259 HGNHFSGTIPE-SFGKLTSLKDLNLNSNQFVGL--IPP----SLASLSLDHLDLNNN 308
N I F L LK LNL NQ + + P L SL+ L+L +N
Sbjct: 86 GENKIK-EISNKMFLGLHQLKTLNLYDNQ---ISCVMPGSFEHLNSLT--SLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 36/161 (22%), Positives = 47/161 (29%), Gaps = 62/161 (38%)
Query: 132 YLDGNNFDTIPAD-FFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
L+ N I +D F L +L L L N QLT +
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRN------------------QLTGI------- 69
Query: 191 AGQLPDFLGNFASLQNLK---LSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVL 247
F +++ L N + I L
Sbjct: 70 ----EP--NAFEGASHIQELQLGENKIKE-ISN---------------------KMFLGL 101
Query: 248 GNMDQLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQF 287
QL+TL L+ N S + SF L SL LNL SN F
Sbjct: 102 H---QLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 3/65 (4%)
Query: 101 QLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
S ++ + L +N+ + E+ + F GL LK L N + F+ L +L L L
Sbjct: 76 GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 159 SNNFN 163
SN FN
Sbjct: 135 SNPFN 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 49/217 (22%), Positives = 73/217 (33%), Gaps = 67/217 (30%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
V C + T + L N L L N F L++L
Sbjct: 10 TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPN------------GVFDELTSLTQL 57
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
YL GN ++P F+ L +L L L +N S P G+ LT
Sbjct: 58 YLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-----SLPNGVFDK--LTQ--------- 101
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD 251
L+ L L+ N L +P+ G D L
Sbjct: 102 ------------LKELALNTNQLQS-LPD---------------------GVFDKLT--- 124
Query: 252 QLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQF 287
QL+ L L+ N ++P+ F +LTSL+ + L+ N +
Sbjct: 125 QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPW 160
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 30/92 (32%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277
IP L+L L G F + L L+L GN F KLTSL
Sbjct: 26 IPAQTTYLDLETNSLKSLPNGVFDE-------LTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 278 KDLNLNSNQFVGLIPPSLASLS-LDHLDLNNN 308
LNL++NQ L L+ L L LN N
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTN 110
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 31/166 (18%), Positives = 62/166 (37%), Gaps = 28/166 (16%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVK------------RMEAGVISKKAVDEFHSEIAVLSK 665
+G GGFG++Y + K A E + A + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 666 VRHRHLVSLLGYSVAGYE----RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
+ + + G + ++ R +V E + G + I L + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG----TFKKSTVLQLGI 158
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV--SDFGLVK 765
+ +EY+H ++H D+K++N+LLG +V +D+GL
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 3/69 (4%)
Query: 94 TLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+P+ L+ L I L N+ L + FS ++ L L N IP FDGL++
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKS 103
Query: 152 LQVLALDSN 160
L++L+L N
Sbjct: 104 LRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 31/113 (27%), Positives = 51/113 (45%), Gaps = 13/113 (11%)
Query: 202 ASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFT-GTIDVLGNMDQLRTLWLH 259
+ L L GN T +P+ +L + L++ + + + NM QL TL L
Sbjct: 31 RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS---NMTQLLTLILS 86
Query: 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP----SLASLSLDHLDLNNN 308
N P +F L SL+ L+L+ N + ++P L++LS HL + N
Sbjct: 87 YNRLRCIPPRTFDGLKSLRLLSLHGND-ISVVPEGAFNDLSALS--HLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 37/130 (28%)
Query: 110 LQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWS 169
L NQF S +L L N T+ F + L L L N
Sbjct: 38 LDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR-------- 89
Query: 170 FPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK---LSGNNLTGPIPE-SFKGL 225
L+ +P F L++L+ L GN+++ +PE +F L
Sbjct: 90 ----LRC-----------------IPP--RTFDGLKSLRLLSLHGNDISV-VPEGAFNDL 125
Query: 226 -NLVNLWLND 234
L +L +
Sbjct: 126 SALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 38/157 (24%), Positives = 55/157 (35%), Gaps = 56/157 (35%)
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
YLDGN F +P + ++L ++ L +N +++ LS
Sbjct: 37 YLDGNQFTLVPKEL-SNYKHLTLIDLSNN------------------RISTLS------- 70
Query: 192 GQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD 251
N L L LS N L P +F GL
Sbjct: 71 ---NQSFSNMTQLLTLILSYNRLRCIPPRTFDGLK------------------------- 102
Query: 252 QLRTLWLHGNHFSGTIPE-SFGKLTSLKDLNLNSNQF 287
LR L LHGN S +PE +F L++L L + +N
Sbjct: 103 SLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 21/70 (30%), Positives = 35/70 (50%), Gaps = 4/70 (5%)
Query: 94 TLPQNL-NQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
TL + +++L + L N+ R +P F GL +L+ L GN+ +P F+ L
Sbjct: 68 TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLS 126
Query: 151 NLQVLALDSN 160
L LA+ +N
Sbjct: 127 ALSHLAIGAN 136
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 51/249 (20%), Positives = 81/249 (32%), Gaps = 89/249 (35%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFH----SEIAVLSKVR------ 667
+G G FG V + +D+ AVK V+ + + ++ E +L K++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVK-----VV--RNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 668 -----------HR-HL--VS-LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS 712
+ H+ + LG S+ YE + N
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSL--------YEII------------TRNNYNGFH 135
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
+ +++ + + YL + S H DLK NILL D + K +
Sbjct: 136 IEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 773 SVVTRLAGT----FG-----------------YLAPE------YAVTGKITTKVDVFSFG 805
T+ G FG Y APE + D++SFG
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFG 246
Query: 806 VVLMELLTG 814
VL EL TG
Sbjct: 247 CVLAELYTG 255
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 30/128 (23%), Positives = 46/128 (35%), Gaps = 16/128 (12%)
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGL--NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257
A+++ L L E NL L L + ++ L + +L+ L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLE 77
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL----SLDHLDLNNNMFMGP 313
L N G + KL +L LNL+ N+ + +L L L LDL N
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLECLKSLDLFNC----E 131
Query: 314 VPKSKAYK 321
V Y+
Sbjct: 132 VTNLNDYR 139
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/88 (31%), Positives = 35/88 (39%), Gaps = 13/88 (14%)
Query: 381 KLTVLNLPNFNLSGTLSPSVGNLDSLTQIK---LQSNNISGQIPTNWTNLKSLTLLDLSQ 437
L L+L N L SV NL L ++K L N I G + L +LT L+LS
Sbjct: 50 NLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSG 104
Query: 438 NNLS-----PPLPKFSGAVKLSLDGNPL 460
N L PL K L L +
Sbjct: 105 NKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 7/134 (5%)
Query: 77 SNSRVTQIQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDG 135
+ + V ++ + + G + + LE + L + + L LK L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
N + L NL L L N K L+ L +L +C + L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC---LKSLDLFNCEVT-NLN 136
Query: 196 DF-LGNFASLQNLK 208
D+ F L L
Sbjct: 137 DYRESVFKLLPQLT 150
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 33/193 (17%), Positives = 52/193 (26%), Gaps = 61/193 (31%)
Query: 91 LKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150
L+ P + +L L+N + G F L L L ++ L
Sbjct: 18 LRNRTPAAVRELV-LDNCKSNDGKIEGLTAEFVNLEFL---SLINVGLISV--SNLPKLP 71
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLS 210
L+ L L N + G L +L +L LS
Sbjct: 72 KLKKLELSENR----------------------------IFGGLDMLAEKLPNLTHLNLS 103
Query: 211 GNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN---HFSGTI 267
GN L T++ L ++ L++L L + +
Sbjct: 104 GNKLKDI------------------------STLEPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 268 PESFGKLTSLKDL 280
F L L L
Sbjct: 140 ESVFKLLPQLTYL 152
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 29/126 (23%), Positives = 46/126 (36%), Gaps = 12/126 (9%)
Query: 200 NFASLQNLKLSGNNLT-GPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257
+ ++ L L + G + L L + +I L +++L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLE 70
Query: 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL-IPPSLASL-SLDHLDLNNNMFMGPVP 315
L N SG + K +L LNL+ N+ L L L +L LDL N V
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC----EVT 126
Query: 316 KSKAYK 321
Y+
Sbjct: 127 NLNDYR 132
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 13/88 (14%)
Query: 381 KLTVLNLPNFNLSGTLSPSVGNLDSLTQIK---LQSNNISGQIPTNWTNLKSLTLLDLSQ 437
+L L+ N L+ S+ NL L ++K L N +SG + +LT L+LS
Sbjct: 43 ELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSG 97
Query: 438 NNLS-----PPLPKFSGAVKLSLDGNPL 460
N + PL K L L +
Sbjct: 98 NKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 26/118 (22%), Positives = 41/118 (34%), Gaps = 6/118 (5%)
Query: 92 KGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151
+G L ++ +LE + + + L+ LK L N + N
Sbjct: 31 EGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGN-FASLQNLK 208
L L L N K S + L+ L +L +C + L D+ N F L L
Sbjct: 90 LTHLNLSGNKI---KDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 31/138 (22%)
Query: 125 LSNLKYAYLDGNNFDTIPA-DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183
S++K LD + + D E L+ L+ + + L +L L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL------TSIANLPKLNKLKKL 69
Query: 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGT 243
++G L +L +L LSGN + T
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL------------------------ST 105
Query: 244 IDVLGNMDQLRTLWLHGN 261
I+ L ++ L++L L
Sbjct: 106 IEPLKKLENLKSLDLFNC 123
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLG 676
+G G FG +Y G + ++A+K K + E + ++ + ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+ V G +LV + + G + +F++ S LS K L +A + +E++HS +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---K 122
Query: 737 SFIHRDLKSSNILLGDDFRAK---VSDFGLVKLAPDSERSV------VTRLAGTFGYLAP 787
SF+HRD+K N L+G RA + DFGL K D+ L GT Y A
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 788 EYAVTGKITT-KVDVFSFGVVLMELLTG 814
G + + D+ S G VLM L G
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-08
Identities = 60/375 (16%), Positives = 105/375 (28%), Gaps = 85/375 (22%)
Query: 103 SKLENIGLQKNQF--RGELPSFSGLSNLKYAYLDGNNFD----TIPADFFDGLENLQVLA 156
++++ +Q + L + LD + L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 157 LDSNNFNASKGWSFPKGLQS-SAQLTNLSCMSCNL----AGQLPDFLGNFASLQNLKLSG 211
L SN +GLQ+ S ++ LS +C L G L L +LQ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 212 NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF 271
N L + L G +L +L L L S E
Sbjct: 123 NLLG---DAGLQLL--------------CEG---LLDPQCRLEKLQLEYCSLSAASCEPL 162
Query: 272 GKL----TSLKDLNLNSNQF----VGLIPPSLAS--LSLDHLDLNNNMFMGPVPKSKAYK 321
+ K+L +++N V ++ L L+ L L +
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV----------- 211
Query: 322 YSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT-SWSGNDP----CKSWLGLSC 376
++ C+ D G + L + N
Sbjct: 212 ----TSDNCR---------------DLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252
Query: 377 GTNSKLTVLNLPNFNLS----GTLSPSVGNLDSLTQIKLQSNNISGQ-----IPTNWTNL 427
+S+L L + ++ G L + +SL ++ L N + + T
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG 312
Query: 428 KSLTLLDLSQNNLSP 442
L L + + +
Sbjct: 313 CQLESLWVKSCSFTA 327
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 74/438 (16%), Positives = 125/438 (28%), Gaps = 109/438 (24%)
Query: 67 GPPCWKH---VFCSNSRVTQIQVSS-----VGLKGTLPQNLNQLSKLENIGLQKNQFRGE 118
K N + ++ + S VG+ L K++ + LQ G
Sbjct: 41 TEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 100
Query: 119 -----LPSFSGLSNLKYAYLDGNNFDTIPA-DFFDGLEN----LQVLALDSNNFNASKGW 168
+ L L+ +L N +GL + L+ L L+ + +A+
Sbjct: 101 GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE 160
Query: 169 SFPKGLQSSAQLTNLSCMSCNL----AGQLPDFLG-NFASLQNLKLSGNNLTGPIPESFK 223
L++ L+ + ++ L L + L+ LKL +T ++ +
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCR 217
Query: 224 GLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT----IPESFGK-LTSLK 278
L ++ + LR L L N + + L+
Sbjct: 218 DL------------------CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLR 259
Query: 279 DLNLNSNQF----VGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPT 333
L + G + L + SL L L N
Sbjct: 260 TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD--------------------- 298
Query: 334 EGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGN---DPCKSWLGLSCGTNSKLTVLNLPN 389
EG L + L +L + W C S N L L + N
Sbjct: 299 EGA------RLLCETLLEPG--CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350
Query: 390 FNLSGT----LSPSVGNLDS-LTQIKLQSNNISGQ--------IPTNWTNLKSLTLLDLS 436
L L +G S L + L ++S + N SL LDLS
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN----HSLRELDLS 406
Query: 437 QNNLSPPLPKFSGAVKLS 454
N L +G ++L
Sbjct: 407 NNCLGD-----AGILQLV 419
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 62/383 (16%), Positives = 110/383 (28%), Gaps = 77/383 (20%)
Query: 126 SNLKYAYLDGNNF-DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184
+++ + D A+ L+ QV+ LD ++ L+ + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 185 CMSCN---------LAGQLPDFLGNFASLQNLKLSGNNLT-------GPIPESFKGLNLV 228
+ N + L +Q L L LT + L +
Sbjct: 63 -LRSNELGDVGVHCVLQGLQT---PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 229 NLWLNDQKGGGFTGTIDVLGNMD-QLRTLWLHGNHFSGTIPESFGKL----TSLKDLNLN 283
+L N G + L + +L L L S E + K+L ++
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 284 SNQF----VGLIPPSLAS--LSLDHLDLNNNM--------FMGPVPKSKAYKY-SYSSNA 328
+N V ++ L L+ L L + G V + + + SN
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 329 FCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW-SGN---DPCKSWLGLSCGTNSKLTV 384
G + L L + RL T W L L
Sbjct: 239 LGD--VG------MAELCPGLLHPS--SRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288
Query: 385 LNLPNFNLSGT----LSPSVGNLD-SLTQIKLQSNNISGQ--------IPTNWTNLKSLT 431
L+L L L ++ L + ++S + + + N + L
Sbjct: 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN----RFLL 344
Query: 432 LLDLSQNNLSPPLPKFSGAVKLS 454
L +S N L +G +L
Sbjct: 345 ELQISNNRLED-----AGVRELC 362
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 52/251 (20%), Positives = 77/251 (30%), Gaps = 97/251 (38%)
Query: 619 LGRGGFGVVYKGELDDGTK---IAVKRMEAGVISKKAVDEFHS----EIAVLSKVR---- 667
LG G FG V + +D +AVK ++ K VD + EI VL +
Sbjct: 22 LGEGAFGKVVEC-IDHKAGGRHVAVK-----IV--KNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 668 --------------HR-HL--VS-LLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE 709
H H+ V LLG S Y+++ K
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLST--------YDFI------------KENGFL 113
Query: 710 PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769
P +A + + + +LHS H DLK NIL + + + +
Sbjct: 114 PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 770 SERS--------------------VVTRLAGTFGYLAPE------YAVTGKITTKVDVFS 803
V TR Y APE + + DV+S
Sbjct: 171 LINPDIKVVDFGSATYDDEHHSTLVSTR----H-YRAPEVILALGW------SQPCDVWS 219
Query: 804 FGVVLMELLTG 814
G +L+E G
Sbjct: 220 IGCILIEYYLG 230
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 42/237 (17%), Positives = 70/237 (29%), Gaps = 45/237 (18%)
Query: 105 LENIGLQKNQFRGE-----LPSFSGLSNLKYAYLDGNNFDTIPAD-FFDGLE---NLQVL 155
+E L+ + E ++K L GN T A + + +L++
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 156 ALDSNNFNASKGWSFP------KGLQSSAQLTNLSCMSCNL----AGQLPDFLGNFASLQ 205
K + L +L + L DFL L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 206 NLKLSGNNLTGPIPESFKGL--NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263
+L L N L P++ + L L +N + N LR++ N
Sbjct: 126 HLYLHNNGLG---PQAGAKIARALQELAVNKK-----------AKNAPPLRSIICGRNRL 171
Query: 264 SG----TIPESFGKLTSLKDLNLNSNQF-----VGLIPPSLASL-SLDHLDLNNNMF 310
++F L + + N L+ LA L LDL +N F
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 44/339 (12%), Positives = 86/339 (25%), Gaps = 87/339 (25%)
Query: 180 LTNLSCMSCNL----AGQLPDFLGNFASLQNLKLSGNNLTGP----------IPESFKGL 225
+ S + + L S++ + LSGN + + +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 226 NLVNLWLNDQKGGGFTGTI---DVLGNMDQLRTLWLHGNHFSGTIPESFGKL----TSLK 278
+++ K L +L T+ L N F T E T L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 279 DLNLNSNQF--------------VGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSY 324
L L++N + + + + L + N
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-------------- 171
Query: 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS--GNDPCKSWLGLSCGTNSKL 382
E L+ + + + + L +L
Sbjct: 172 ----------ENGSMKEWAKTFQSHRLLHT---VKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 383 TVLNLPNFNLSGT-----LSPSVGNLDSLTQIKLQSNNIS-------GQIPTNWTNLKSL 430
VL+L N L+ ++ + +L ++ L +S + N L
Sbjct: 219 KVLDL-QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGL 276
Query: 431 TLLDLSQNNLSPP-LPKFSGAVK--------LSLDGNPL 460
L L N + + + L L+GN
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 46/226 (20%), Positives = 70/226 (30%), Gaps = 37/226 (16%)
Query: 99 LNQLSKLENIGLQKNQFRGE-----LPSFSGLSNLKYAYLDGNNF-------------DT 140
L + KL + L N F + S + L++ YL N +
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 141 IPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL-----AGQLP 195
L+ + N + K QS L + + + L
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 196 DFLGNFASLQNLKLSGNNLTGP----IPESFKGL-NLVNLWLNDQKGG--GFTGTIDVLG 248
+ L L+ L L N T + + K NL L LND G +D
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 249 NMD--QLRTLWLHGNHFSG----TIPESFG-KLTSLKDLNLNSNQF 287
++ L+TL L N T+ K+ L L LN N+F
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 39/295 (13%), Positives = 78/295 (26%), Gaps = 68/295 (23%)
Query: 198 LGNFASLQNLKLSGNNLT-------GPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM 250
+ F S++ L + +T + + + L N + + +
Sbjct: 1 MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 251 DQLRTLWLHGNHFS----------GTIPESFGKLTSLKDLNLNSNQF----VGLIPPSLA 296
L + ++ K L + L+ N F + L+
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 297 SL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYP 355
L+HL L+NN +GP + + +
Sbjct: 120 KHTPLEHLYLHNNG-LGP--------------------QAGAKIARALQELAVNKKAKNA 158
Query: 356 PRLVTSWSGN----DPCKSWLGLSCGTNSKLTVLNLPNFNL-----SGTLSPSVGNLDSL 406
P L + G + + ++ L + + + L + L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 407 TQIKLQSNNIS-------GQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLS 454
+ LQ N + +W NL+ L L+ LS GA +
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRE---LGLNDCLLSA-----RGAAAVV 265
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 46/224 (20%), Positives = 68/224 (30%), Gaps = 41/224 (18%)
Query: 126 SNLKYAYLDGNNFDTIPADFF-DGLE---NLQVLALDSNNFNASKGWSFPKGLQSSA--- 178
L L N F + D L L+ L L +N G + LQ A
Sbjct: 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 153
Query: 179 ------QLTNLSCMSCNL----AGQLPDFLGNFASLQNLKLSGNNLT-----GPIPESFK 223
L ++ C L + + L +K+ N + + E
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 224 GL-NLVNLWLND----QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT----IPESFGKL 274
L L L D G L + LR L L+ S + ++F KL
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALA--IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 275 --TSLKDLNLNSNQF----VGLIPPSLAS--LSLDHLDLNNNMF 310
L+ L L N+ V + + L L+LN N F
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 50/261 (19%), Positives = 82/261 (31%), Gaps = 81/261 (31%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR--------HR 669
LG G F V+ + +A+K ++ + EI +L VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 670 HLVSLLGY-SVAGYE---RLLVYEYMPQGALSKHIFHWKSLN---LEPLSWKRRLNIALD 722
+V LL ++G +V+E L H+ W + PL ++ I
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFE-----VLGHHLLKWIIKSNYQGLPLPCVKK--IIQQ 154
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLG------------------------------- 751
V +G++YLH+ IH D+K NILL
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 752 ------------------DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG 793
+ + K++D G + T Y + E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGS 268
Query: 794 KITTKVDVFSFGVVLMELLTG 814
T D++S + EL TG
Sbjct: 269 GYNTPADIWSTACMAFELATG 289
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 30/130 (23%), Positives = 51/130 (39%), Gaps = 16/130 (12%)
Query: 198 LGNFASLQNLKLSGNNLT--GPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRT 255
N + L L G + + + + ++ N+ + +D + +L+T
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR------KLDGFPLLRRLKT 68
Query: 256 LWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL--IPPSLASL-SLDHLDLNNNMFMG 312
L ++ N L L +L L +N V L + P LASL SL +L + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN---- 123
Query: 313 PVPKSKAYKY 322
PV K Y+
Sbjct: 124 PVTNKKHYRL 133
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 29/144 (20%), Positives = 46/144 (31%), Gaps = 39/144 (27%)
Query: 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131
+ + ++ I+ L TL Q + I N+ R +L F L LK
Sbjct: 22 RELDLRGYKIPVIE----NLGATLDQ-------FDAIDFSDNEIR-KLDGFPLLRRLKTL 69
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA 191
++ N I L +L L L +N+ L L +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNS------------------LVELGDL----- 106
Query: 192 GQLPDFLGNFASLQNLKLSGNNLT 215
D L + SL L + N +T
Sbjct: 107 ----DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 20/145 (13%), Positives = 41/145 (28%), Gaps = 33/145 (22%)
Query: 118 ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177
+ ++ + L G I + L+ + S+N
Sbjct: 11 QAAQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDF-SDN--------------EI 54
Query: 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236
+L + L+ L ++ N + + L +L L L +
Sbjct: 55 RKLDGFPLLR---------------RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 237 GGGFTGTIDVLGNMDQLRTLWLHGN 261
G +D L ++ L L + N
Sbjct: 100 LVEL-GDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 8/83 (9%)
Query: 386 NLPNFNLSGTLSPSVGNLDSLTQIK---LQSNNISGQIPTNWTNLKSLTLLDLSQNNLS- 441
+ S + L ++K + +N I L LT L L+ N+L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 102
Query: 442 ----PPLPKFSGAVKLSLDGNPL 460
PL L + NP+
Sbjct: 103 LGDLDPLASLKSLTYLCILRNPV 125
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 32/113 (28%), Positives = 46/113 (40%), Gaps = 15/113 (13%)
Query: 106 ENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163
+ L+ N+ + LP F L+ L L N ++P FD L L +L L N
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 164 ASKGWSFPKGL-QSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK---LSGN 212
S P G+ QL L+ + N +PD G F L +L+ L N
Sbjct: 90 -----SLPNGVFDKLTQLKELA-LDTNQLKSVPD--GIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 37/165 (22%), Positives = 51/165 (30%), Gaps = 61/165 (36%)
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185
S+ L+ N ++P FD L L L+L N Q+ +
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQN------------------QIQS--- 66
Query: 186 MSCNLAGQLP----DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFT 241
LP D L L L L N L +P
Sbjct: 67 --------LPDGVFDKLTK---LTILYLHENKLQS-LPN--------------------- 93
Query: 242 GTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ 286
G D L QL+ L L N F +LTSL+ + L++N
Sbjct: 94 GVFDKLT---QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 18/56 (32%), Positives = 21/56 (37%), Gaps = 1/56 (1%)
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308
L L N F KLT L L+L+ NQ L L L L L+ N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 56/337 (16%), Positives = 107/337 (31%), Gaps = 87/337 (25%)
Query: 151 NLQVLALDSNNFNASKGWSFPKGLQSS-AQLTNLSCMSCNL----AGQLPDFL-GNFASL 204
+ L L NN + + ++ A +T+L+ +L + +L L A++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 205 QNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264
+L LSGN L+ K + + L + L L N FS
Sbjct: 83 TSLNLSGNFLSY------KSSDELVKTLAAIP--------------FTITVLDLGWNDFS 122
Query: 265 GTIPESFGKL-----TSLKDLNLNSNQF----VGLIPPSLASL--SLDHLDLNNNMFMGP 313
F + S+ LNL N + LA++ +++ L+L N
Sbjct: 123 SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL--- 179
Query: 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT---SWS--GNDPC 368
++ C L FL + + + S + G
Sbjct: 180 ------------ASKNCA------------ELAKFLASIP--ASVTSLDLSANLLGLKSY 213
Query: 369 KSWLGLSCGTNSKLTVLNLPNFNLSGT----LSPSVGNLDSLTQIKLQSNNISGQ----- 419
+ + + LNL L G L +L L + L + +
Sbjct: 214 AELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQC 273
Query: 420 --IPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLS 454
+ + N++ + L+D + + P S ++ +S
Sbjct: 274 KALGAAFPNIQKIILVDKNGKEIHP-----SHSIPIS 305
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 19/60 (31%), Positives = 27/60 (45%), Gaps = 3/60 (5%)
Query: 103 SKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
+ + + L NQ +L F L+ L LD N +PA FD L L L+L+ N
Sbjct: 30 TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 20/62 (32%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 101 QLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
+L++L + L NQ LP+ F L+ L L+ N +IP FD L++L + L
Sbjct: 52 RLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110
Query: 159 SN 160
+N
Sbjct: 111 NN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 20/59 (33%), Positives = 30/59 (50%), Gaps = 7/59 (11%)
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP----SLASLSLDHLDLNNN 308
+ L+L+ N + P F +LT L L+L++NQ L P L L+ L LN+N
Sbjct: 33 QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL-PAGVFDKLTQLT--QLSLNDN 88
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 19/57 (33%), Positives = 25/57 (43%), Gaps = 3/57 (5%)
Query: 106 ENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
+ + L NQ +L F L NL+ Y + N IP FD L L L L+ N
Sbjct: 36 QRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 3/62 (4%)
Query: 101 QLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
L L+ + N+ +P+ F L+ L L+ N+ +IP FD L++L + L
Sbjct: 55 HLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY 113
Query: 159 SN 160
+N
Sbjct: 114 NN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 7/59 (11%)
Query: 254 RTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP----SLASLSLDHLDLNNN 308
+ LWL+ N + P F L +L+ L NSN+ + P L L+ LDLN+N
Sbjct: 36 QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI-PTGVFDKLTQLT--QLDLNDN 91
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 61/395 (15%), Positives = 109/395 (27%), Gaps = 53/395 (13%)
Query: 69 PCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGE-LPSF-SGLS 126
K + S V + + P L L NI ++ L +
Sbjct: 156 RNLKELDLRESDVDDVSGHWLS---HFPDTYTSLVSL-NISCLASEVSFSALERLVTRCP 211
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGW--SFPKGLQSSAQLTNLS 184
NLK L+ A L+ L L +L LS
Sbjct: 212 NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271
Query: 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLT--GPIPESFKGLNLVNLWLNDQKGGGFTG 242
+ LP + L L LS + + + L LW+ D G
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED--AG 329
Query: 243 TIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT------------SLKDLNLNSNQF--V 288
+ LR L + + E LT L+ + Q
Sbjct: 330 LEVLASTCKDLRELRV--FPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNA 387
Query: 289 GLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDF 348
LI + ++ L P A+++
Sbjct: 388 ALITIARNRPNMTRFRL-----------------CIIEPKAPDYLTLEPLDIGFGAIVEH 430
Query: 349 LGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT-LSPSVGNLDSLT 407
L RL S D ++G K+ +L++ S + + DSL
Sbjct: 431 CKDLR---RLSLSGLLTDKVFEYIGTYA---KKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484
Query: 408 QIKLQSNNISGQ-IPTNWTNLKSLTLLDLSQNNLS 441
+++++ + + N + L+++ L +S ++S
Sbjct: 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 14/73 (19%), Positives = 23/73 (31%), Gaps = 5/73 (6%)
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNAS-KGWSFPKGLQSSAQLTNLS 184
+ L GNN +P D L L+ L +N + + L +
Sbjct: 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAPYR 90
Query: 185 CMSC----NLAGQ 193
+ C L G+
Sbjct: 91 DLRCVAPPALRGR 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.98 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.98 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.97 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.72 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.58 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.53 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.37 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.27 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.23 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.12 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.93 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.74 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.7 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.26 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.12 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.86 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.46 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.38 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.25 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.23 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.86 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.39 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.21 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 85.65 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.93 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=448.02 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=214.9
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|...+.||+|+||.||+|++. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 56788899999999999999764 4788999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcc--------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcE
Q 002149 685 LLVYEYMPQGALSKHIFHWK--------SLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ 756 (959)
++|||||++|+|.++++... ......++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 1233579999999999999999999999 899999999999999999999
Q ss_pred EEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002149 757 KVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 757 ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 834 (959)
||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+.... +.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~---i~ 244 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC---IT 244 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH
Confidence 99999999865443322 2233579999999999999999999999999999999999 8999988765442111 11
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. . ..+..+. ..+..+.+|+.+||+.||++|||+++|++.|+.+.+.
T Consensus 245 ~---------~---~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 245 Q---------G---RVLQRPR---TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H---------T---CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c---------C---CCCCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 0 0111111 2234688999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=450.36 Aligned_cols=262 Identities=31% Similarity=0.468 Sum_probs=209.8
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|...++||+|+||.||+|+++ +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+....
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45677889999999999999864 4788999999754 566678899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 685 LLVYEYMPQGALSKHIFHWKS----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
++|||||++|+|.++++.... ....+++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 999999999999999976432 123569999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAW 832 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 832 (959)
.+||+|||+|+...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+....
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~--- 272 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC--- 272 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH---
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 99999999998654332 223345689999999999999999999999999999999999 8999988765442211
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+. +- ..+..+. .....+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 273 i~----------~g--~~~~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 IT----------QG--RELERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH----------HT--CCCCCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH----------cC--CCCCCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 00 0111111 2234688999999999999999999999999988763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=442.13 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=207.4
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+++...++||+|+||+||+|+++ ..||||+++....+....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 46777889999999999999875 369999998665567778899999999999999999999998865 568999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
|++|+|.++++.. ...++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999642 2569999999999999999999999 89999999999999999999999999999865432
Q ss_pred C-cceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 771 E-RSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 771 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
. .......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+........ ..+.. ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~~---------~~ 254 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVGR---------GY 254 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHT---------TC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHhc---------CC
Confidence 2 233455789999999999864 468999999999999999999999998765433211 10100 01
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..+.+ .......+..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 255 ~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 255 ASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11111 11112234578899999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=446.07 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=210.8
Q ss_pred CCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 612 NFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++..++||+|+||.||+|.+. +++.||||+++... .....++|.+|+.++++++|||||+++|+|.++...+
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4556788999999999999863 46789999997542 3445678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 686 LVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
+|||||++|+|.++++..... ....++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 999999999999999653211 12469999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAW 832 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~ 832 (959)
.+||+|||+|+...... ....+...||++|||||++.++.++.++|||||||++|||+| |+.||.+....+... .
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~---~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE---M 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH---H
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH---H
Confidence 99999999998553322 223445689999999999999999999999999999999999 899998876544211 1
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
+.. ...++.++ ..+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 260 i~~------------~~~~~~p~---~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IRN------------RQVLPCPD---DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHT------------TCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHc------------CCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 110 00111111 2334688999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=444.17 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=207.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||.||+|+. .+|+.||||++..........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999975 479999999998776677778889999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ....+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999642 23568999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.. ...+..+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+.... +. ...+.+
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~------~~~~~~ 244 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------II------SGSFPP 244 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HH------HTCCCC
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HH------cCCCCC
Confidence 21 123456899999999999999999999999999999999999999988765432111 11 011111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112346789999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=441.89 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=213.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|+..++||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+.+..|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 56999999999999999999764 79999999997542 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 152 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999998854 458999999999999999999999 8999999999999999999999999999997654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+ .....+
T Consensus 223 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~~~~~~ 288 (346)
T 4fih_A 223 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLPP 288 (346)
T ss_dssp SSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSSCC
T ss_pred CCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------HcCCCC
Confidence 332 345578999999999999999999999999999999999999999877654422111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.+. ........+.+|+.+||..||++|||++|+++ ++++.+..
T Consensus 289 ~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~ 331 (346)
T 4fih_A 289 RLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG 331 (346)
T ss_dssp CCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred CCC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCC
Confidence 111 11122346789999999999999999999987 56666543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=426.43 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=202.1
Q ss_pred cccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceEEEEE
Q 002149 614 ASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYERLLVY 688 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 688 (959)
+..++||+|+||.||+|... +++.||||++..........+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999764 68899999998776677777889999999999999999999999875 34579999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECC-CCcEEEeeccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLGD-DFRAKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~~-~~~~ki~DfGla~ 765 (959)
|||++|+|.+++... ..+++..+..++.||+.||+|||+ ++ ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999652 568999999999999999999999 56 999999999999984 7999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+...... +...+ ..
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i---~~------- 244 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV---TS------- 244 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH---TT-------
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHH---Hc-------
Confidence 65432 2345789999999998864 699999999999999999999999976543221 11101 00
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
...+. .........+.+|+.+||+.||++|||++|+++ +++++
T Consensus 245 ~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~~ 287 (290)
T 3fpq_A 245 GVKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFFQ 287 (290)
T ss_dssp TCCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGC
T ss_pred CCCCC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Ccccc
Confidence 00000 000011235789999999999999999999977 44443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=433.27 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=208.3
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|...++||+|+||.||+|+. .+|+.||||+++.... ..+|+.+++.++|||||++++++.++...|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4577788999999999999976 4789999999976432 2469999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccccCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVKLAP 768 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~~~~ 768 (959)
|+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++ ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999642 469999999999999999999999 8999999999999999987 69999999999664
Q ss_pred CCCcc----eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 769 DSERS----VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 769 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+....+ ........
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~~ 276 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPIR 276 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGGG
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCch
Confidence 43211 123367999999999999999999999999999999999999999876543321111 00000000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.........+.+++.+||+.||++|||+.|+++++...++....
T Consensus 277 ----------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 277 ----------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp ----------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred ----------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 01112234678999999999999999999999999988876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=443.00 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=214.4
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+.|+..++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+.+..||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 356999999999999999999764 79999999997542 233456889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
|||++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp ECCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred eCCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999854 458999999999999999999999 899999999999999999999999999999765
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+ .....
T Consensus 299 ~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------------~~~~~ 364 (423)
T 4fie_A 299 KEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP 364 (423)
T ss_dssp SSCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSCC
T ss_pred CCCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------HcCCC
Confidence 4332 345578999999999999999999999999999999999999999877654432111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
+.+... ......+.+|+.+||..||++|||+.|+++ ++++.+..
T Consensus 365 ~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~ 408 (423)
T 4fie_A 365 PRLKNL---HKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG 408 (423)
T ss_dssp CCCSCT---TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCC
T ss_pred CCCccc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCC
Confidence 111111 112236789999999999999999999987 56666543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=438.10 Aligned_cols=267 Identities=27% Similarity=0.389 Sum_probs=216.2
Q ss_pred hcCCcccCcccccCceEEEEEEEcC------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeC-
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAG- 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 681 (959)
.++|+..+.||+|+||.||+|.+.. ++.||||++.... .....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 5689999999999999999997642 3579999997653 44556789999999999965 8999999999764
Q ss_pred ceEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++|||||++|+|.++++..+. .....+++.+++.++.|||+||+|||+ ++||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 568999999999999999976432 113468999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+..
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~- 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999996544333 23445679999999999999999999999999999999998 99999876543221
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
...+ .+-. .+..++. ...++.+++.+||+.||++|||+.||+++|.++++...
T Consensus 298 -~~~i----------~~g~--~~~~p~~---~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 298 -CRRL----------KEGT--RMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp -HHHH----------HHTC--CCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -HHHH----------HcCC--CCCCCcc---CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 1111 1111 1111121 23467899999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=429.77 Aligned_cols=273 Identities=21% Similarity=0.323 Sum_probs=202.6
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----eEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----ERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 686 (959)
++|...++||+|+||.||+|++. |+.||||++... ......+..|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 46778899999999999999885 899999998653 222223345666667889999999999998653 6799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA-----HQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
|||||++|+|.++++. ..++|..+.+++.|+++||+|||+.+ .++||||||||+|||++.++++||+||
T Consensus 79 V~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 9999999999999964 46899999999999999999999831 249999999999999999999999999
Q ss_pred cccccCCCCCcc---eeeccccccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 762 GLVKLAPDSERS---VVTRLAGTFGYLAPEYAVTG------KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 762 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
|+|+........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+......+..+.. +
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~-~ 231 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L 231 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh-c
Confidence 999865443322 22346899999999998764 4678999999999999999998876533211100000 0
Q ss_pred HHhhhcchHHHH-----HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 833 FWNIKSDKEKLR-----AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 833 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. ......+.+. ..+++.++......+....+.+|+.+||+.||++||||.||++.|+++.++
T Consensus 232 ~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 232 V-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp S-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0 0000001111 112222221222345667889999999999999999999999999988765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=427.27 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=209.2
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999975 5799999999976432 2234577899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999642 568999999999999999999999 899999999999999999999999999999764
Q ss_pred CCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+... .+..
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~--------- 248 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------KIIK--------- 248 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH---------
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc---------
Confidence 332 234456799999999999999999999999999999999999999998765433211 1111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....+. ....++.+|+.+||..||++|||++|+..
T Consensus 249 -~~~~~p~---~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 249 -LEYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -TCCCCCT---TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CCCCCCc---ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0111111 11236789999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=414.58 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=194.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|.. .+|+.||||++.+..... ...+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999975 479999999997654333 34567899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+ +|+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 7899998854 2569999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
+.. .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+....+... .+..
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~------~i~~--------- 226 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK------NISN--------- 226 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH---------
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHc---------
Confidence 432 2345689999999999998876 579999999999999999999998765433211 1110
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.....+. .....+.+++.+||+.||++|||++|+++ +++++
T Consensus 227 -~~~~~p~---~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 227 -GVYTLPK---FLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp -TCCCCCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred -CCCCCCC---CCCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 0011011 11236789999999999999999999987 56654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=424.70 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=196.7
Q ss_pred cCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|++.+.||+|+||+||+|+.. +++.||||++.+..........+.+|++++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999752 47889999997654444444568899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999652 468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..+... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+....+ ..
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~-------- 240 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LK-------- 240 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH--------
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------Hc--------
Confidence 543322 234578999999999999999999999999999999999999999887654421111 10
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.....+. .....+.+|+.+||+.||++|||+
T Consensus 241 --~~~~~p~---~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 241 --AKLGMPQ---FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCCCCT---TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCCCC---cCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111111 122367899999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=430.91 Aligned_cols=313 Identities=23% Similarity=0.344 Sum_probs=236.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe------Cc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA------GY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 682 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++|+.++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999976 479999999998766566667889999999999999999999998764 35
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..|+||||| +|+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCC-CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 789999999 5789998843 3679999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCC---cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 763 LVKLAPDSE---RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 763 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+....+........
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998654322 2234557999999999998875 568999999999999999999999998776554333221111000
Q ss_pred c-------hHHHHHhcCCcccCCCCCHHH-----HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcc
Q 002149 839 D-------KEKLRAAIDPILEVNDDTFET-----FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEY 906 (959)
Q Consensus 839 ~-------~~~~~~~~~~~~~~~~~~~~~-----~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~ 906 (959)
. .......+..........+.. ...+.+|+.+||..||++|||+.|+++ ++++.++..+++++...
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~p~~~p~~~ 361 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR--HPFLAKYHDPDDEPDCA 361 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT--SGGGTTTCCGGGSCCCS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc--CHhhCcCCCCccccCCC
Confidence 0 000111111111111111111 235779999999999999999999988 79999988888777665
Q ss_pred cCcccCCCh-hhhHHHHHHhhCCCccee
Q 002149 907 SGIDYSLPL-NQMVKDWQEAEGKDLSYV 933 (959)
Q Consensus 907 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 933 (959)
..++++... ....++|++...+++..+
T Consensus 362 ~~~~~~~~~~~~~~~~~k~~i~~ei~~~ 389 (398)
T 4b99_A 362 PPFDFAFDREALTRERIKEAIVAEIEDF 389 (398)
T ss_dssp SCCCCHHHHSCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCccchhhcCHHHHHHHHHHHHHHH
Confidence 555443221 224566777665554433
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=404.99 Aligned_cols=256 Identities=28% Similarity=0.382 Sum_probs=191.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-------
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------- 682 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 682 (959)
++|+..+.||+|+||.||+|+.. +|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46899999999999999999764 78999999987542 4455678999999999999999999999987543
Q ss_pred -----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 683 -----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 683 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
..|+||||+++|+|.+++.... ......+..++.++.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 3689999999999999996522 22346677889999999999999999 8999999999999999999999
Q ss_pred EeeccccccCCCCCc-----------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 758 VSDFGLVKLAPDSER-----------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 758 i~DfGla~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
|+|||+|+....... ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||... .+.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHH
Confidence 999999986543221 11234679999999999999999999999999999999996 66532 121
Q ss_pred HHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 827 QYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
......+... .. +...........+++.+||+.||++|||+.|+++ +++++
T Consensus 234 ~~~~~~~~~~-------------~~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~~~~ 284 (299)
T 4g31_A 234 VRTLTDVRNL-------------KF--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAVFE 284 (299)
T ss_dssp HHHHHHHHTT-------------CC--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGC
T ss_pred HHHHHHHhcC-------------CC--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhC
Confidence 1111111100 00 0000112234568999999999999999999977 34443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=405.89 Aligned_cols=203 Identities=23% Similarity=0.380 Sum_probs=173.3
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
+..+.++|++.++||+|+||.||+|+.+ +++.||||++... ....++.+|+++++.+ +|||||++++++.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 3346788999999999999999999653 4678999988654 2234678999999998 69999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEe
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVS 759 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~ 759 (959)
.+..++||||+++|+|.+++ +.+++.++..++.||+.||+|||+ ++||||||||+|||++.+ +.+||+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCEEEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 99999999999999999988 358999999999999999999999 899999999999999876 799999
Q ss_pred eccccccCCCCCc---------------------------ceeeccccccccccccccccC-CCCccchHHHHHHHHHHH
Q 002149 760 DFGLVKLAPDSER---------------------------SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMEL 811 (959)
Q Consensus 760 DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~el 811 (959)
|||+|+...+... ...+..+||+.|||||++.+. .++.++||||+||++|||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el 240 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL 240 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence 9999985543221 112345799999999999875 589999999999999999
Q ss_pred HhCCCCCCCCCh
Q 002149 812 LTGLMALDESRP 823 (959)
Q Consensus 812 ltg~~p~~~~~~ 823 (959)
++|+.||.....
T Consensus 241 l~G~~Pf~~~~~ 252 (361)
T 4f9c_A 241 LSGRYPFYKASD 252 (361)
T ss_dssp HHTCSSSSCCSS
T ss_pred HHCCCCCCCCCC
Confidence 999999965543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=411.02 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=211.8
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999976 47999999998764 3445677899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC--CcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD--FRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~--~~~ki~DfGla~~ 766 (959)
|||++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~----~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTC----TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999999998843 22569999999999999999999999 899999999999999854 8999999999997
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+....+ ..
T Consensus 307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~-------- 370 (573)
T 3uto_A 307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KS-------- 370 (573)
T ss_dssp CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HT--------
T ss_pred ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------Hh--------
Confidence 75433 344568999999999999999999999999999999999999999887654432111 00
Q ss_pred cCCcccCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDPILEVNDDT-FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
......... ......+.+|+.+||+.||++||++.|+++ ++++..
T Consensus 371 --~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~~ 416 (573)
T 3uto_A 371 --CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 416 (573)
T ss_dssp --TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTSC
T ss_pred --CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcCC
Confidence 000000000 011235779999999999999999999987 455443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=388.59 Aligned_cols=285 Identities=39% Similarity=0.673 Sum_probs=231.8
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
..++..++++|+..+.||+|+||.||+|..++++.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445677899999999999999999999888999999998764 3345678999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999985432 223469999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 763 LVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 763 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|...... ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cc
Confidence 998654322 2223445689999999999999999999999999999999999999987655443333333221111 11
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+...+++... ..........+.+++.+||+.||++||++.++++.|+.+++.
T Consensus 264 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 22233333332 334567788899999999999999999999999999988764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=407.53 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=201.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHH---HHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFH---SEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|++.+.||+|+||.||+|+.. +|+.||||++.+..... .....+. .++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999764 79999999997543221 1122233 4456667779999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||++||+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999652 569999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+...+...+
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i----------- 406 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------- 406 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH-----------
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh-----------
Confidence 765432 345689999999999975 57999999999999999999999999764332221111111
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhHh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVNVLAPLVE 894 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~L~~~~~ 894 (959)
.......+. .....+.+|+.+||..||.+|++ ++||.+ +++++
T Consensus 407 --~~~~~~~p~---~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~ 454 (689)
T 3v5w_A 407 --LTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 454 (689)
T ss_dssp --HHCCCCCCT---TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGT
T ss_pred --cCCCCCCCc---cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Ccccc
Confidence 111111111 12236789999999999999998 688866 44443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=420.01 Aligned_cols=280 Identities=21% Similarity=0.306 Sum_probs=234.4
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCCCCCCC-----CC--CCCCCC------------cceEec-CCcEEEEEecCCccccc
Q 002149 35 ATDPGDIDILNQFRKNLENPELLQWPKSG-----DP--CGPPCW------------KHVFCS-NSRVTQIQVSSVGLKGT 94 (959)
Q Consensus 35 ~~~~~~~~~l~~~~~~~~~~~~~~w~~~~-----~~--C~~~~w------------~gv~C~-~~~v~~l~l~~~~l~g~ 94 (959)
++...|+.||++||+++.+| +|+.++ +| |. | .||.|+ .++|+.|+|+++++.|.
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~---W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLN---WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCS---CCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred ccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccc---cccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 34567999999999999876 786554 55 43 9 999998 48999999999999999
Q ss_pred CcccccCCCCCcEEec-cCCcCCCC-------------------------------------------------------
Q 002149 95 LPQNLNQLSKLENIGL-QKNQFRGE------------------------------------------------------- 118 (959)
Q Consensus 95 ~~~~l~~l~~L~~L~L-s~N~l~~~------------------------------------------------------- 118 (959)
+|++|++|++|++|+| ++|.+.|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 77754332
Q ss_pred ---------------------CC-CccCCCCccEEecCCCCCCC------------------CChhh-hcCCCCCcEEEc
Q 002149 119 ---------------------LP-SFSGLSNLKYAYLDGNNFDT------------------IPADF-FDGLENLQVLAL 157 (959)
Q Consensus 119 ---------------------~~-~~~~l~~L~~L~L~~N~l~~------------------i~~~~-~~~l~~L~~L~L 157 (959)
+| .|+++++|++|+|++|+|++ +|... |.++++|++|+|
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 44 68899999999999999998 77663 449999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccc-cCC-CCChhhcCCC-------CCCEEEecCCcCCCCCCc--ccccC-
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN-LAG-QLPDFLGNFA-------SLQNLKLSGNNLTGPIPE--SFKGL- 225 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~-l~~-~~p~~l~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l- 225 (959)
++|.+.+ .+|..+.++++|+.|+|++|+ +++ .+|..++.++ +|+.|+|++|+++ .+|. .|..+
T Consensus 499 s~N~l~~----~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~ 573 (876)
T 4ecn_A 499 YNCPNMT----QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMV 573 (876)
T ss_dssp ESCTTCC----SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCT
T ss_pred cCCCCCc----cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCC
Confidence 9999887 789999999999999999998 888 8888777665 9999999999999 7887 78776
Q ss_pred CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCC-CCEEeCCCCcCCCCCccccccc---cCC
Q 002149 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS-LKDLNLNSNQFVGLIPPSLASL---SLD 301 (959)
Q Consensus 226 ~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~~---~L~ 301 (959)
+|..|.+.++....++ .++++++|+.|+|++|+++ .+|..+..+++ |++|+|++|+|+ .+|..+... +|+
T Consensus 574 ~L~~L~Ls~N~l~~lp----~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~ 647 (876)
T 4ecn_A 574 KLGLLDCVHNKVRHLE----AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMG 647 (876)
T ss_dssp TCCEEECTTSCCCBCC----CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEE
T ss_pred CCCEEECCCCCcccch----hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCC
Confidence 5777777776655433 6889999999999999999 89999999999 999999999999 677777665 399
Q ss_pred eEeCCCCcCCCCCCccc----------ccccccccCcccC
Q 002149 302 HLDLNNNMFMGPVPKSK----------AYKYSYSSNAFCQ 331 (959)
Q Consensus 302 ~L~L~~N~l~~~ip~~~----------~~~~~~~~~~~~~ 331 (959)
.|+|++|+++|.+|... ...+.+++|.+..
T Consensus 648 ~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~ 687 (876)
T 4ecn_A 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687 (876)
T ss_dssp EEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS
T ss_pred EEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc
Confidence 99999999998877432 2334566666653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=384.09 Aligned_cols=289 Identities=40% Similarity=0.658 Sum_probs=232.4
Q ss_pred eeecHHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEE
Q 002149 599 LVISVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS 678 (959)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 678 (959)
..++..++....++|+..+.||+|+||.||+|...+|+.||||++..... ......+.+|+++++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34677889999999999999999999999999888899999999876422 22233688999999999999999999999
Q ss_pred EeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 679 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
......++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999997633 23356999999999999999999999932239999999999999999999999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPE--ERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~--~~~~~~~~~~~~ 836 (959)
+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+..... .......|+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999977655555555667999999999999999999999999999999999999999632111 111122233222
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.. ........+.... ..........+.+++.+|++.||++|||+.+|+++|+.
T Consensus 256 ~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LK-EKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TS-SCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hh-chhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 21 1222233333332 34556777889999999999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=374.92 Aligned_cols=265 Identities=31% Similarity=0.485 Sum_probs=209.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
..+|++.+.||+|+||.||+|.. +|+.||||++..........+.+.+|++++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 56899999999999999999987 48899999998776666777889999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++..
T Consensus 115 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 115 YLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp CCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred cCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999986421 11348999999999999999999999 78 999999999999999999999999999854
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... . .
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------------~-~ 254 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------------F-K 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------------H-S
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------h-c
Confidence 4322 12334579999999999999999999999999999999999999998776544221110 0 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..... ........+.+++.+||+.||++||++.++++.|+++++...+
T Consensus 255 ~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 255 CKRLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 00111 1112234688999999999999999999999999999876544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=410.98 Aligned_cols=409 Identities=19% Similarity=0.212 Sum_probs=300.1
Q ss_pred CChhhHHHHHHHHHhcCCCC----------CCCCCCCCCCCCCCCC---cceEecC-CcEEEEEecCCcccccCcccccC
Q 002149 36 TDPGDIDILNQFRKNLENPE----------LLQWPKSGDPCGPPCW---KHVFCSN-SRVTQIQVSSVGLKGTLPQNLNQ 101 (959)
Q Consensus 36 ~~~~~~~~l~~~~~~~~~~~----------~~~w~~~~~~C~~~~w---~gv~C~~-~~v~~l~l~~~~l~g~~~~~l~~ 101 (959)
....|+.||.+|++++..+. ..+|..+.++|. | .||+|+. ++|+.|+|+++++.|.+|+++++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~---w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDM---WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGG---TTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCccc---ccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhc
Confidence 34569999999999986543 237987777776 9 9999975 59999999999999999999999
Q ss_pred CCCCcEEeccCCcC------------------------------------------------------------------
Q 002149 102 LSKLENIGLQKNQF------------------------------------------------------------------ 115 (959)
Q Consensus 102 l~~L~~L~Ls~N~l------------------------------------------------------------------ 115 (959)
|++|++|+|++|.+
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 99999999999843
Q ss_pred ------------CCCCCCccCCCCccEEecCCCCCCC------------------CChhhhc--CCCCCcEEEccCcccC
Q 002149 116 ------------RGELPSFSGLSNLKYAYLDGNNFDT------------------IPADFFD--GLENLQVLALDSNNFN 163 (959)
Q Consensus 116 ------------~~~~~~~~~l~~L~~L~L~~N~l~~------------------i~~~~~~--~l~~L~~L~Ls~N~l~ 163 (959)
+++++.|+++++|++|+|++|+|++ +|.. +. ++++|++|+|++|.+.
T Consensus 184 ~~l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~-l~~~~l~~L~~L~L~~n~l~ 262 (636)
T 4eco_A 184 KDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED-LKWDNLKDLTDVEVYNCPNL 262 (636)
T ss_dssp CTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEECCTTC
T ss_pred hhhhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchh-hhhcccCCCCEEEecCCcCC
Confidence 3433368999999999999999999 6654 77 9999999999999998
Q ss_pred CCCCCCCCccccCccccCeecccccc-cCC-CCChhhcCC------CCCCEEEecCCcCCCCCCc--ccccC-Ccccccc
Q 002149 164 ASKGWSFPKGLQSSAQLTNLSCMSCN-LAG-QLPDFLGNF------ASLQNLKLSGNNLTGPIPE--SFKGL-NLVNLWL 232 (959)
Q Consensus 164 ~~~~~~lp~~l~~l~~L~~L~l~~n~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l-~l~~L~~ 232 (959)
+ .+|..+.++++|++|++++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+..+ +++.|.+
T Consensus 263 ~----~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L 337 (636)
T 4eco_A 263 T----KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLEC 337 (636)
T ss_dssp S----SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEEC
T ss_pred c----cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeC
Confidence 7 789999999999999999998 998 899988887 99999999999999 7887 78776 5666666
Q ss_pred cccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCC-CCEEeCCCCcCCCCCccccccc---cCCeEeCCCC
Q 002149 233 NDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS-LKDLNLNSNQFVGLIPPSLASL---SLDHLDLNNN 308 (959)
Q Consensus 233 ~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~~---~L~~L~L~~N 308 (959)
.++.. .+.++.+.++++|++|+|++|+++ .+|..+..+++ |++|+|++|+++ .+|..+... +|+.|+|++|
T Consensus 338 ~~N~l---~g~ip~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N 412 (636)
T 4eco_A 338 LYNQL---EGKLPAFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN 412 (636)
T ss_dssp CSCCC---EEECCCCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSS
T ss_pred cCCcC---ccchhhhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCC
Confidence 65544 433336788899999999999998 88888999998 999999999998 667776654 5889999999
Q ss_pred cCCCCCCcccc------------cccccccCcccCCCCCCCCchhhHHHHhhcc-CCCCC------------------cc
Q 002149 309 MFMGPVPKSKA------------YKYSYSSNAFCQPTEGVPCAPEVMALIDFLG-GLNYP------------------PR 357 (959)
Q Consensus 309 ~l~~~ip~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~ 357 (959)
.+++.+|.... ..+.+++|.+...+.... ....-+..+. ..+.+ +.
T Consensus 413 ~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~---~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~ 489 (636)
T 4eco_A 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF---STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489 (636)
T ss_dssp CTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHH---HTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGG
T ss_pred cCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHH---ccCCCCCEEECCCCCCCCcCHHHhccccccccccCC
Confidence 99888775433 224556666653322110 0000000000 00000 02
Q ss_pred cccccCCCCCCCcccccccC--CCCcccEEECCCCcccccCCccccCcCcCCEEeC------cccccccccCCCccCCCC
Q 002149 358 LVTSWSGNDPCKSWLGLSCG--TNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKL------QSNNISGQIPTNWTNLKS 429 (959)
Q Consensus 358 l~~~~~~~~~~~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N~l~g~~p~~l~~l~~ 429 (959)
+.......+.... ++..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+| ++|++.+.+|..+.++++
T Consensus 490 L~~L~Ls~N~l~~-lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~ 567 (636)
T 4eco_A 490 LTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567 (636)
T ss_dssp CCEEECCSSCCCB-CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred ccEEECcCCcCCc-cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence 2222223333332 222233 66777777777777776 6777777777777777 456667777777777777
Q ss_pred CCeEeCCCCccCCCCCC--CCCcceecccCCCCCCCC
Q 002149 430 LTLLDLSQNNLSPPLPK--FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 430 L~~L~Ls~N~l~~~~p~--~~~~~~~~l~~N~~~c~~ 464 (959)
|+.|+|++|++ +.+|. +..+..+++.+|++.|-.
T Consensus 568 L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 568 LTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp CCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred CCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 77777777777 45553 345566777777776643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=372.72 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=214.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999976 57999999999876666677788999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999998542 458999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+....+..... .
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i----------------~ 227 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV----------------L 227 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------------H
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----------------H
Confidence 432 23456899999999999888775 7899999999999999999999887654321111 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
......+. .....+.+++.+||..||.+|||++|+++ ++++...
T Consensus 228 ~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~~ 271 (328)
T 3fe3_A 228 RGKYRIPF---YMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINAG 271 (328)
T ss_dssp HCCCCCCT---TSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTTT
T ss_pred hCCCCCCC---CCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcCC
Confidence 00111111 12235779999999999999999999987 5665543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=366.95 Aligned_cols=256 Identities=24% Similarity=0.400 Sum_probs=210.9
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999975 578999999987542 233466889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999854 458999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------------~~~~ 233 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------------TNGT 233 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------HHCS
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hCCC
Confidence 4332 2344679999999999999999999999999999999999999998776544322111 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.. .........+.+++.+||+.||++|||+.|+++ +++++.
T Consensus 234 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 275 (297)
T 3fxz_A 234 PEL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKI 275 (297)
T ss_dssp CCC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGG
T ss_pred CCC---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh--Chhhcc
Confidence 011 011122346789999999999999999999977 455443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=384.32 Aligned_cols=315 Identities=24% Similarity=0.380 Sum_probs=227.0
Q ss_pred HHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCc--
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGY-- 682 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-- 682 (959)
+.+.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35678999999999999999999975 47899999999766556677788899999999997 999999999997544
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999995 799888854 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCC--------------------Ccceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 002149 763 LVKLAPDS--------------------ERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDES 821 (959)
Q Consensus 763 la~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~ 821 (959)
+|+..... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99855321 1122344689999999999987 67899999999999999999999999987
Q ss_pred ChHHHHHHHHHHHhhhcchHHHH---------------HhcCCcccCCCCCH--------------HHHHHHHHHHHhcc
Q 002149 822 RPEERQYLAAWFWNIKSDKEKLR---------------AAIDPILEVNDDTF--------------ETFWTIAELAGHCT 872 (959)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~--------------~~~~~l~~l~~~cl 872 (959)
...+............. .+.+. .............. .....+.+|+.+||
T Consensus 235 ~~~~~~~~i~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGVIDFPS-NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHHHCCCC-HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCCC-HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 65543322211100000 00000 00000000000000 11235789999999
Q ss_pred cCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcccCCC--hhhhHHHHHHhhCCCcceee
Q 002149 873 SREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLP--LNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 873 ~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 934 (959)
..||++|||++|+++ ++++..++.+.+++.....++.+.. ...++++|++..++++....
T Consensus 314 ~~dP~~R~t~~e~l~--Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (388)
T 3oz6_A 314 QFNPNKRISANDALK--HPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRK 375 (388)
T ss_dssp CSSGGGSCCHHHHTT--STTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHH
T ss_pred ccCcccCCCHHHHhC--CHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhh
Confidence 999999999999988 7888888877777665544444332 35677888888777766554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=376.96 Aligned_cols=266 Identities=26% Similarity=0.399 Sum_probs=216.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
.++|.+.+.||+|+||.||+|... ++..||||++... ......+.+.+|+++++.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 367889999999999999999752 3567999999765 3455677899999999999 89999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
....++||||+++|+|.+++..... .....+++.+++.++.||++||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 9999999999999999999976432 122468999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQ 827 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~ 827 (959)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986544322 12233567889999999999999999999999999999999 99999876654321
Q ss_pred HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 828 YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
... ...... .........+.+++.+||+.||++||++.|+++.|+.++....
T Consensus 316 ~~~-------------~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 316 KLL-------------KEGHRM-----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp HHH-------------HTTCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH-------------hcCCCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111 000000 1111223468899999999999999999999999999887543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=372.14 Aligned_cols=281 Identities=20% Similarity=0.246 Sum_probs=226.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++.+ +||||+++++++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46799999999999999999975 578999999987542 123578999999999 899999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc-----EEEeecc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR-----AKVSDFG 762 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~-----~ki~DfG 762 (959)
|||+ +++|.+++... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999998652 2579999999999999999999999 89999999999999998887 9999999
Q ss_pred ccccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 763 LVKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 763 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.......+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99865443221 124568999999999999999999999999999999999999999876543322222111100
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcccCCC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLP 914 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 914 (959)
.. ....... .. ..+ .+.+++.+|++.||.+||+++++++.|+.++++.....+...+|.......|
T Consensus 236 ~~--~~~~~~~------~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~p 301 (330)
T 2izr_A 236 KR--ATPIEVL------CE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTP 301 (330)
T ss_dssp HH--HSCHHHH------TT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTSCCCCC
T ss_pred hc--cCCHHHH------hc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCCCcCCC
Confidence 00 0000000 00 012 6889999999999999999999999999999999888888888875544333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=373.00 Aligned_cols=273 Identities=24% Similarity=0.351 Sum_probs=210.2
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----eEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----ERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 685 (959)
.++|+..+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 357999999999999999999876 899999998653 334455667999999999999999999998743 479
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEecCCCCCCEEECCCCc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ----------SFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivH~Dik~~NiLl~~~~~ 755 (959)
+||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.
T Consensus 99 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 99999999999999954 458999999999999999999999 6 9999999999999999999
Q ss_pred EEEeeccccccCCCCCc-ceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999986544322 22334679999999999976 3566789999999999999999999976543211110
Q ss_pred HHHHHhhhcchHHHHHhc-C----CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 830 AAWFWNIKSDKEKLRAAI-D----PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
........ ....+...+ . +.+............+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 250 EEEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhccCC-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000 011111111 1 111111112345567899999999999999999999999999887653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=375.57 Aligned_cols=285 Identities=16% Similarity=0.207 Sum_probs=215.7
Q ss_pred hcCCcccCcccccCceEEEEEEEcC------CcEEEEEEcccccccHHH---------HHHHHHHHHHHHhcCCCCceeE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD------GTKIAVKRMEAGVISKKA---------VDEFHSEIAVLSKVRHRHLVSL 674 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l 674 (959)
.++|++.+.||+|+||.||+|.+.. ++.||||++......... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 478999998754211100 1123345566777789999999
Q ss_pred EEEEEeC----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 675 LGYSVAG----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 675 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
++++... ...++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 9998764 4579999999 99999998642 2579999999999999999999999 899999999999999
Q ss_pred C--CCCcEEEeeccccccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 751 G--DDFRAKVSDFGLVKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 751 ~--~~~~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
+ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999865432211 1133569999999999999999999999999999999999999998643
Q ss_pred hHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCC
Q 002149 823 PEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDE 902 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~ 902 (959)
........ .... ....+...+++.+... ..+..+.+++.+|++.||.+||++.++++.|+.+++......+.
T Consensus 266 ~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 266 KDPKYVRD--SKIR--YRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp TCHHHHHH--HHHH--HHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCHHHHHH--HHHH--hhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 32211111 1000 0112222222222111 11236889999999999999999999999999999999999999
Q ss_pred CCcccCcc
Q 002149 903 PEEYSGID 910 (959)
Q Consensus 903 ~~~~~~~~ 910 (959)
+.+|...+
T Consensus 338 ~~dw~~~~ 345 (364)
T 3op5_A 338 KLDLSVVE 345 (364)
T ss_dssp CCCC----
T ss_pred ccceEecc
Confidence 99987544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.68 Aligned_cols=263 Identities=26% Similarity=0.390 Sum_probs=213.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.++...++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 57888999999999999999764 6899999988643 56677889999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999652 2568999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcce-------------eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 770 SERSV-------------VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 770 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..|+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------- 233 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------- 233 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-------
Confidence 32211 1145799999999999999999999999999999999999999876443221000
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
............+.. ...+.+++.+|++.||++||++.++++.|+.+......
T Consensus 234 ~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 234 LNVRGFLDRYCPPNC---------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp BCHHHHHHHTCCTTC---------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhccccccCCCCC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 000111111111111 12577999999999999999999999999998776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=362.13 Aligned_cols=276 Identities=18% Similarity=0.246 Sum_probs=223.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++......++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46799999999999999999975 578999999986432 234578899999999 799999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc-----EEEeecc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR-----AKVSDFG 762 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~-----~ki~DfG 762 (959)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 99999999642 2469999999999999999999999 89999999999999987766 9999999
Q ss_pred ccccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 763 LVKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 763 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 99865443221 234467999999999999999999999999999999999999999875533222211111110
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
.. ........ + .....+.+++.+|++.||++||++.+|++.|+.++++.....+.+.+|..
T Consensus 237 ~~-~~~~~~~~-~---------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 237 KQ-STPLRELC-A---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HH-HSCHHHHT-T---------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred cc-CccHHHHH-h---------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 00 00011110 0 11236889999999999999999999999999999999988888888753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.23 Aligned_cols=265 Identities=24% Similarity=0.403 Sum_probs=215.3
Q ss_pred ecHHHHHHHhcC----------CcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCC
Q 002149 601 ISVQVLRNVTKN----------FASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669 (959)
Q Consensus 601 ~~~~~~~~~~~~----------~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 669 (959)
++.++++.+++. |...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCT
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCC
Confidence 566676666653 667789999999999999876 7999999998754 233456788999999999999
Q ss_pred CceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 670 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
||+++++++......++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEE
Confidence 999999999999999999999999999998843 468999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~- 251 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK- 251 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 99999999999999986644322 2345679999999999999999999999999999999999999998765433211
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+.....+... ........+.+++.+||+.||++||++.++++ ++++..
T Consensus 252 ------------~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 300 (321)
T 2c30_A 252 ------------RLRDSPPPKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQ 300 (321)
T ss_dssp ------------HHHHSSCCCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGGG
T ss_pred ------------HHhcCCCCCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhcc
Confidence 11111111111 11122346789999999999999999999987 455543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.94 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=212.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|++.+.||+|+||.||+|... .+..||||++... ......+.+.+|+++++.++||||+++++++.++...+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 357889999999999999999874 3456999999764 34556678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999998542 2569999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------------ 267 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV------------ 267 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH------------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------------
Confidence 66543222 2223456788999999999999999999999999999999 99999876654321111
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
..... ..........+.+++.+||+.||++||++.++++.|+.+++...
T Consensus 268 -~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 268 -EEGYR-----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -HTTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -HcCCC-----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 00000 01111223468899999999999999999999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=384.60 Aligned_cols=304 Identities=22% Similarity=0.302 Sum_probs=220.4
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------c
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------Y 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 682 (959)
.++|+..+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999965 4689999999987655667778899999999999999999999998654 4
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++ ++.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 67999999954 5666652 348999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc----
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS---- 838 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 838 (959)
+|+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ +.....
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i--~~~lg~p~~~ 285 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCPE 285 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCSCCHH
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCHH
Confidence 99865432 2234568999999999999999999999999999999999999999887654432221 111000
Q ss_pred ----chHHHHHhcCCcccCCCCCH-----------------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 839 ----DKEKLRAAIDPILEVNDDTF-----------------ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 839 ----~~~~~~~~~~~~~~~~~~~~-----------------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
........+........... .....+.+|+.+||..||++|||++|+++ ++++..|.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~~~~~~ 363 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINVWY 363 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGGGC
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc--Chhhhhcc
Confidence 01112222222111111111 11346889999999999999999999988 78888776
Q ss_pred CCCCCCCcc-cCcccCC-ChhhhHHHHHHhhCCCc
Q 002149 898 PLDDEPEEY-SGIDYSL-PLNQMVKDWQEAEGKDL 930 (959)
Q Consensus 898 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~ 930 (959)
.+.+.+... ...+... .....+++|++...++.
T Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 398 (464)
T 3ttj_A 364 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV 398 (464)
T ss_dssp CHHHHSCCC-----------CCCHHHHHHHHHHHH
T ss_pred CcccccCCCCccCCcchhhccCCHHHHHHHHHHHH
Confidence 544322111 1111111 12345667776655433
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=412.49 Aligned_cols=401 Identities=28% Similarity=0.354 Sum_probs=306.8
Q ss_pred hcCCChhhHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCcceEecCCcEEEEEecCCccccc---CcccccCCCCCcEE
Q 002149 33 LSATDPGDIDILNQFRKNLENPE-LLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGT---LPQNLNQLSKLENI 108 (959)
Q Consensus 33 ~~~~~~~~~~~l~~~~~~~~~~~-~~~w~~~~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~---~~~~l~~l~~L~~L 108 (959)
++++.+.|++||++||+++.||. +.+|..+.|||. |.||+|+.++|+.|+|+++++.|. +|+.+.+|++|+.+
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~---w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCT---FDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGG---STTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcC---CcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34556789999999999998874 789987777776 999999989999999999999998 99999999999999
Q ss_pred eccCCcCCCCCCCccCCCCccEEecCCCCCCCCChh--hhcCCCCCcEEEccCcccCCCCCCCCCccc-cCccccCeecc
Q 002149 109 GLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPAD--FFDGLENLQVLALDSNNFNASKGWSFPKGL-QSSAQLTNLSC 185 (959)
Q Consensus 109 ~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l-~~l~~L~~L~l 185 (959)
+++.|.+...++.|.++++|++|+|++|.+++..+. .|+++++|++|+|++|.+.+ .+|..+ ..+++|++|++
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~----~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF----PGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEEC----CSSCCSCCCCTTCSEEEC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCC----cCCHHHhccCCCCCEEEC
Confidence 999998876666899999999999999999975555 79999999999999999986 455554 78999999999
Q ss_pred cccccCCCCChh---hcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcccccccccCCcCCcEEEccCc
Q 002149 186 MSCNLAGQLPDF---LGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261 (959)
Q Consensus 186 ~~n~l~~~~p~~---l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N 261 (959)
++|++++..|.. +.++++|++|++++|++++..+. ..+ +++.|.+.++ .+.+.++.++++++|++|+|++|
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n---~l~~~~~~l~~l~~L~~L~Ls~n 233 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSN---NFSTGIPFLGDCSALQHLDISGN 233 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSS---CCCSCCCBCTTCCSCCEEECCSS
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCC---cCCCCCcccccCCCCCEEECcCC
Confidence 999999998877 88999999999999999987664 222 4555555554 44555555899999999999999
Q ss_pred cccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccc------cccccccCcccCCCCC
Q 002149 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKA------YKYSYSSNAFCQPTEG 335 (959)
Q Consensus 262 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~------~~~~~~~~~~~~~~~~ 335 (959)
++++.+|..|..+++|++|+|++|++++.+|.. ...+|+.|+|++|.++|.+|.... ..+.+++|.+.+..+.
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~ 312 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCG
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccch
Confidence 999999999999999999999999999888776 333699999999999998887542 2234556655432111
Q ss_pred CCCchhhHHHHhhccCCCCCcccccccCCCCCCCccccc-ccCCCCcccEEECCCCcccccCCccccCcC-cCCEEeCcc
Q 002149 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGL-SCGTNSKLTVLNLPNFNLSGTLSPSVGNLD-SLTQIKLQS 413 (959)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~ 413 (959)
. ++. ++.+.......+......+. .++.+++|++|+|++|++.+.+|..+.+++ +|++|+|++
T Consensus 313 ~------------~~~---l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~ 377 (768)
T 3rgz_A 313 F------------FGS---CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377 (768)
T ss_dssp G------------GGG---CTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCS
T ss_pred H------------Hhc---CCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccC
Confidence 1 111 11222222222222211222 255667777777777777777777777776 777777777
Q ss_pred cccccccCCCccC--CCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCC
Q 002149 414 NNISGQIPTNWTN--LKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLL 461 (959)
Q Consensus 414 N~l~g~~p~~l~~--l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~ 461 (959)
|+++|.+|..+.. +++|+.|+|++|++++.+|. +.++..+.+.+|.+.
T Consensus 378 N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 431 (768)
T 3rgz_A 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431 (768)
T ss_dssp SEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred CCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCccc
Confidence 7777777777666 67777777777777766664 345566777777543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=359.42 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=214.0
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|...+++.||+|++...... .+++.+|++++++++||||+++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 578899999999999999999888999999999765332 35688999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHh----cCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999854 22568999999999999999999999 89999999999999999999999999999866543
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-------------~~~~~~~ 226 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------ISTGFRL 226 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------------HHTTCCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------------HhcCccC
Confidence 3333334567889999999999999999999999999999999 9999987765432111 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. .......+.+++.+|++.||++||++.+++++|+++.+.
T Consensus 227 ~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YK-----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-----CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 111234678999999999999999999999999988763
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.22 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=214.5
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||.||+|+.+++..||||++..... ..+++.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 467899999999999999999998888999999976532 23568899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999986532 468999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..... .....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------------~~~~~ 223 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------------SQGHR 223 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------------HTTCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH-------------HcCCC
Confidence 44433444567788999999999899999999999999999999 99999877654321111 00000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. .. . ......+.+++.+|++.||++|||+.++++.|+.+.++
T Consensus 224 ~-~~-~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 L-YR-P---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp C-CC-C---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C-CC-C---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 00 1 11123688999999999999999999999999888654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.10 Aligned_cols=290 Identities=27% Similarity=0.508 Sum_probs=199.3
Q ss_pred CCChhhHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCcceEecC----CcEEEEEecCCcccc--cCcccccCCCCCcE
Q 002149 35 ATDPGDIDILNQFRKNLENPE-LLQWPKSGDPCGPPCWKHVFCSN----SRVTQIQVSSVGLKG--TLPQNLNQLSKLEN 107 (959)
Q Consensus 35 ~~~~~~~~~l~~~~~~~~~~~-~~~w~~~~~~C~~~~w~gv~C~~----~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~ 107 (959)
.|.+.|++||++||+++.++. +.+|..+.++|.. -|.||.|+. ++|+.|+|++++++| .+|+.+.++++|++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~-~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNR-TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTT-CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcC-CCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 588999999999999998874 7789776777742 299999985 689999999999999 89999999999999
Q ss_pred EeccC-CcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 108 IGLQK-NQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 108 L~Ls~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
|+|++ |.+.+.+| .|.++++|++|+|++|+|++..+..|.++++|++|+|++|.+++
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--------------------- 139 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--------------------- 139 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES---------------------
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC---------------------
Confidence 99995 99988777 68888889999999888886666668888888888888887764
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCc-CCcEEEccCcccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMD-QLRTLWLHGNHFS 264 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~-~L~~L~L~~N~l~ 264 (959)
.+|..+..+++|++|+|++|++++.+|..+ ..++ +|++|+|++|+++
T Consensus 140 -------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-------------------------~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 140 -------TLPPSISSLPNLVGITFDGNRISGAIPDSY-------------------------GSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp -------CCCGGGGGCTTCCEEECCSSCCEEECCGGG-------------------------GCCCTTCCEEECCSSEEE
T ss_pred -------cCChHHhcCCCCCeEECcCCcccCcCCHHH-------------------------hhhhhcCcEEECcCCeee
Confidence 344445555555555555555555555442 2333 5555566666555
Q ss_pred ccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhH
Q 002149 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
+.+|..|..++ |++|+|++|++++.+|..+..+ +|+.|+|++|.+++.+|.
T Consensus 188 ~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------------- 239 (313)
T 1ogq_A 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--------------------------- 239 (313)
T ss_dssp EECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG---------------------------
T ss_pred ccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc---------------------------
Confidence 55555555554 6666666666655555444443 244444444444332221
Q ss_pred HHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
+..+++|++|+|++|++++.+|..+.++++|++|+|++|+++|.+|..
T Consensus 240 --------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 240 --------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp --------------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred --------------------------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 112356666777777776666666767777777777777777666654
Q ss_pred ccCCCCCCeEeCCCCc
Q 002149 424 WTNLKSLTLLDLSQNN 439 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~ 439 (959)
.++++|+.|++++|+
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 556666665555544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=359.00 Aligned_cols=285 Identities=39% Similarity=0.653 Sum_probs=229.8
Q ss_pred eeecHHHHHHHhcCCccc------CcccccCceEEEEEEEcCCcEEEEEEccccc--ccHHHHHHHHHHHHHHHhcCCCC
Q 002149 599 LVISVQVLRNVTKNFASE------NELGRGGFGVVYKGELDDGTKIAVKRMEAGV--ISKKAVDEFHSEIAVLSKVRHRH 670 (959)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~n 670 (959)
..++..++..++++|... +.||+|+||.||+|.. +++.||||++.... ......+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457889999999998877 8999999999999986 58899999986542 22345678999999999999999
Q ss_pred ceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 671 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
|+++++++.+....++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999986532 23569999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
+.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-- 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence 9999999999999986544322 22334679999999998764 5889999999999999999999999865432211
Q ss_pred HHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 830 AAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..+..........+...+++.+ ..........+.+++.+||+.||.+||++.++++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111111111223444444433 23455667789999999999999999999999999988743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=378.30 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=213.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|...+.||+|+||.||+|.+. +++.||||++... ......+.+.+|++++++++||||+++++++......++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 357888999999999999999876 7899999998754 34455667899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999986422 468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCccee-eccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 769 DSERSVV-TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 769 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||......+..... . ..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~---~----------~~ 331 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---E----------KG 331 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH---H----------TT
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----------cC
Confidence 3221111 12235778999999999999999999999999999998 99999877654321111 0 00
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..+..+. ..+..+.+++.+||+.||++|||+.++++.|+.+.+++
T Consensus 332 --~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 332 --GRLPCPE---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp --CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CCCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0111111 12346789999999999999999999999999987654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=371.34 Aligned_cols=306 Identities=23% Similarity=0.352 Sum_probs=224.8
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------ 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 682 (959)
.++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999976 47899999999766556666788999999999999999999999987653
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 8999998854 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+. ........
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~--~~~g~~~~ 247 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM--KVTGTPPA 247 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHCCCCH
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HhcCCCCH
Confidence 99865432 344678999999999887 679999999999999999999999998876544322211 11111001
Q ss_pred HH---------HHhcCCcccCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCccc
Q 002149 842 KL---------RAAIDPILEVND-----DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYS 907 (959)
Q Consensus 842 ~~---------~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 907 (959)
.. ...+........ ........+.+++.+||..||++|||+.++++ +++++.+...++++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~--hp~f~~~~~~~~~~~~~- 324 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHDTEDEPQVQ- 324 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC------CCC-
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc--ChHHHhhcCCccCCCCC-
Confidence 11 111100000000 00112346789999999999999999999987 78888887776665443
Q ss_pred CcccCCC-hhhhHHHHHHhhCCCcceee
Q 002149 908 GIDYSLP-LNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 908 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 934 (959)
.++.+.. .....++|++...++...+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (367)
T 1cm8_A 325 KYDDSFDDVDRTLDEWKRVTYKEVLSFK 352 (367)
T ss_dssp CCCCC-----CCHHHHHHHHHHHHHTCC
T ss_pred CCCCChhhhcCCHHHHHHHHHHHHHHhc
Confidence 2333322 25567889988877776655
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.54 Aligned_cols=266 Identities=22% Similarity=0.354 Sum_probs=210.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999975 468999999986532 2345567899999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... .++++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999998542 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
............||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+... ..+ ..........+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~~~---~~~~~~~~~~~ 236 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI--KHI---QDSVPNVTTDV 236 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHH--HHH---SSCCCCHHHHS
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHh---hccCCCcchhc
Confidence 5443333445679999999999999999999999999999999999999998876533211 000 00000011111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHhHhhcC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP-DMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~~~ 897 (959)
. ...+..+.+++.+|++.||++|| +++++.+.|..++....
T Consensus 237 ~---------~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 R---------KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp C---------TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred c---------cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1 11234688999999999999999 88888888877765443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=358.76 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=212.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||.||+|...+++.||||++...... .+++.+|+++++.++||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4578899999999999999999998889999999865332 3568899999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999998542 2468999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +.....
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------------~~~~~~ 239 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------IAQGLR 239 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------------HHTTCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------------HhcccC
Confidence 33222334467889999999999999999999999999999998 9999987765432111 111111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.... ......+.+++.+||+.||++||++.++++.|..++++
T Consensus 240 ~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 LYRP-----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC-----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111 11124688999999999999999999999999998865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=373.93 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=203.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|...+.||+|+||.||+|... ++..||||+++... .....+.+.+|+.++++++||||+++++++.+....+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 357899999999999999999764 56789999997642 4556678999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999542 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i------------ 263 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV------------ 263 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH------------
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------
Confidence 664432211 122345778999999999999999999999999999998 99999876653321111
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..... . .........+.+++.+||+.||++||++.+|++.|+.+++..
T Consensus 264 -~~~~~--~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 264 -DEGYR--L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -HTTEE--C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -HcCCC--C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00000 0 111123346889999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=371.24 Aligned_cols=308 Identities=23% Similarity=0.352 Sum_probs=220.3
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------c
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------Y 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 682 (959)
.++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999965 5789999999977655666778899999999999999999999998754 5
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 8999888743 568999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc---
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS--- 838 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 838 (959)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 334679999999999887 6789999999999999999999999988765443222211110000
Q ss_pred ----chHHHHHhcCCcccCCCCCHH-----HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCc
Q 002149 839 ----DKEKLRAAIDPILEVNDDTFE-----TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGI 909 (959)
Q Consensus 839 ----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~ 909 (959)
........+............ ....+.+|+.+||..||++|||+.++++ ++++..+..+++++... .+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~--hp~~~~~~~~~~~~~~~-~~ 330 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDDEPVAD-PY 330 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCGGGCCCCC-CC
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc--ChhhhhccCCCCCCCCC-CC
Confidence 001111111111111111111 1235789999999999999999999987 78888887777665443 33
Q ss_pred ccCCC-hhhhHHHHHHhhCCCcceee
Q 002149 910 DYSLP-LNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 910 ~~~~~-~~~~~~~~~~~~~~~~~~~~ 934 (959)
+.+.. .....++|++..+++...+.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~e~~~~~ 356 (367)
T 2fst_X 331 DQSLESRDLLIDEWKSLTYDEVISFV 356 (367)
T ss_dssp CGGGSSCCCCHHHHHHHHHHHHHHCC
T ss_pred CcchhhccCCHHHHHHHHHHHHHHhc
Confidence 33322 24567889988887777655
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=359.47 Aligned_cols=276 Identities=24% Similarity=0.336 Sum_probs=207.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.++|++.+.||+|+||.||+|...+|+.||||++..........+.+.+|+++++.++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999888999999999765444445577889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||++ |+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDE----NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHT----CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9996 688887743 22568999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-----HH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-----EK 842 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~ 842 (959)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+............... ..
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 3322 2344578999999999876 568999999999999999999999998766544322111110000000 00
Q ss_pred HHHhcCCcccC-CCCCHH-----HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 843 LRAAIDPILEV-NDDTFE-----TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 843 ~~~~~~~~~~~-~~~~~~-----~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.......... ...... ...++.+++.+||+.||++|||+.|+++ +++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~ 306 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN--HPYFKD 306 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccccc
Confidence 00000000000 001111 1236779999999999999999999987 455543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.01 Aligned_cols=273 Identities=26% Similarity=0.408 Sum_probs=208.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--c
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--Y 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 682 (959)
.++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46789999999999999999974 36889999998754 456667899999999999999999999998654 4
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 5799999999999999996532 458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc--ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++....... .......+|..|+|||++.+..++.++||||||+++|||++|..|+......... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~----~~~~~~~~~ 235 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR----MIGNDKQGQ 235 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH----HHCTTCCTH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh----hhcCccccc
Confidence 9986644322 1223345788899999999999999999999999999999999998754321110 000000000
Q ss_pred ---HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 841 ---EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 841 ---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....+.+..... ..........+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 236 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 MIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 011111111111 1111123357889999999999999999999999999987754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=380.67 Aligned_cols=314 Identities=21% Similarity=0.262 Sum_probs=214.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 683 (959)
.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999654 789999999977655666778899999999999999999999998543 56
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.|+||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 6899888843 2569999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--------------------------ceeecccccccccccccc-ccCCCCccchHHHHHHHHHHHHh---
Q 002149 764 VKLAPDSER--------------------------SVVTRLAGTFGYLAPEYA-VTGKITTKVDVFSFGVVLMELLT--- 813 (959)
Q Consensus 764 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~ll~ellt--- 813 (959)
|+....... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 986542211 123456889999999986 45679999999999999999999
Q ss_pred --------CCCCCCCCChH------------------HHHHHHHHHHhhhcch---------HHHHHhcCCcccCCCC--
Q 002149 814 --------GLMALDESRPE------------------ERQYLAAWFWNIKSDK---------EKLRAAIDPILEVNDD-- 856 (959)
Q Consensus 814 --------g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~-- 856 (959)
|+.+|.+.... ....+...+....... ......+.........
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 66666554310 0111111110000000 0111111111100000
Q ss_pred ---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcccCCC--hhhhHHHHHHhhCCCcc
Q 002149 857 ---TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLP--LNQMVKDWQEAEGKDLS 931 (959)
Q Consensus 857 ---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 931 (959)
.......+.+|+.+||..||++|||++|+++ +++++.+....+++........+.. .....+++++...+++.
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHH
Confidence 0111346789999999999999999999988 8899887766655544332222211 23345566666666665
Q ss_pred eee
Q 002149 932 YVS 934 (959)
Q Consensus 932 ~~~ 934 (959)
.+.
T Consensus 441 ~~~ 443 (458)
T 3rp9_A 441 RYH 443 (458)
T ss_dssp TTC
T ss_pred HhC
Confidence 555
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.29 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=207.3
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+.++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999765 68999999997653322 134678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEe
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVS 759 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~ 759 (959)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999843 2568999999999999999999999 8999999999999998776 79999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.... + ..
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~---i---~~- 232 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---I---TA- 232 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---H---HT-
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H---Hh-
Confidence 999998765432 23456799999999999999999999999999999999999999987655432111 0 00
Q ss_pred hHHHHHhcCCcccCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDD-TFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
........ .......+.+++.+||..||++|||+.|+++
T Consensus 233 ---------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 ---------VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---------cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000000 0011235789999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=370.06 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=213.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|+..+.||+|+||.||+|.+. +++.||||++... ........+.+|+.+++.++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999843 4678999998754 345566778999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---cEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL--NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF---RAKV 758 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~---~~ki 758 (959)
.++||||+++|+|.+++...+.. ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999764321 22458999999999999999999999 8999999999999999554 5999
Q ss_pred eeccccccCCCC-CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDS-ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......+..... .
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i---~-- 300 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---T-- 300 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---H--
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H--
Confidence 999999743211 1122234568999999999999999999999999999999998 99999877654321111 0
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
... ... ........+.+++.+||+.||++||++.+|++.|+.+.+..
T Consensus 301 --------~~~--~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 301 --------SGG--RMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp --------TTC--CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --------cCC--CCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 000 000 11122346889999999999999999999999999887654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=367.99 Aligned_cols=269 Identities=29% Similarity=0.377 Sum_probs=219.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
.++|.+.+.||+|+||.||+|... .+..||||++... ......+.+.+|+++++.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 467899999999999999999752 2357999998765 3455667899999999999 89999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
....++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999764321 12469999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQ 827 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~ 827 (959)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986544322 22334567899999999999999999999999999999999 99999877654321
Q ss_pred HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 002149 828 YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLD 900 (959)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 900 (959)
... ........ .......+.+++.+||+.||++||++.++++.|++++......+
T Consensus 304 ~~~-------------~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 304 KLL-------------KEGHRMDK-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHH-------------HTTCCCCC-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHH-------------HcCCCCCC-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 111 01000000 11123468899999999999999999999999999987765433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=366.41 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=210.5
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.+.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+++++.++||||+++++++.+....++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999764 68999999998766666677889999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~ki~DfGl 763 (959)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999998843 2568999999999999999999999 899999999999999865 4599999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +..
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---i~~-------- 244 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ---IKA-------- 244 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH--------
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHh--------
Confidence 98665432 23446899999999999999999999999999999999999999987654332111 100
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
...+. . ..........+.+++.+||+.||++||++.+++++
T Consensus 245 -~~~~~--~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 -GAYDY--P-SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TCCCC--C-TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CCCCC--C-cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0 00001123467899999999999999999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.26 Aligned_cols=278 Identities=21% Similarity=0.260 Sum_probs=215.6
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEE-EeCceEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS-VAGYERL 685 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 685 (959)
.+.++|+..+.||+|+||.||+|.. .+++.||||++... ...+.+.+|+++++.++|++++..+.++ ......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc----ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4467899999999999999999975 57899999986543 2234578899999999988877766655 6777889
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeecc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFG 762 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfG 762 (959)
+||||+ +++|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 99999998542 2569999999999999999999999 899999999999999 788999999999
Q ss_pred ccccCCCCCc------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 763 LVKLAPDSER------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 763 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 9986544322 1223467999999999999999999999999999999999999999875433211111100000
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
.. .... ..+.. .....+.+++.+|++.||++||++.++++.|+.++++.....+.+.+|+.
T Consensus 234 ~~-~~~~-~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 234 KM-STPI-EVLCK---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HH-HSCH-HHHTT---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred cc-cchh-hhhhc---------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 00 0000 00000 01236889999999999999999999999999999999998888888864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=375.09 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=209.9
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+++++.++||||+++++++.+....++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4467899999999999999999965 478999999998776666677889999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG---DDFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~---~~~~~ki~DfGl 763 (959)
||||+++|+|.+.+... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999988542 568999999999999999999999 8999999999999998 467899999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|..||.+....+..... .
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i---~--------- 226 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI---K--------- 226 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H---------
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH---H---------
Confidence 986654332 234568999999999999999999999999999999999999999876543321111 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+... .........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 227 AGAYDFPS---PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HTCCCCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCc---cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000 000112346789999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=381.73 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=212.5
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|...+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++||||+++++++. ....++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 46788899999999999999999888999999997642 23567999999999999999999999986 567899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999996432 1357899999999999999999999 8999999999999999999999999999987644
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|+.|+|||++....++.++|||||||++|||++ |+.||.+....+..... ....
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~- 402 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------------ERGY- 402 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------------HHTC-
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCC-
Confidence 32222233456789999999999999999999999999999999 99999877654321111 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.+... ......+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 403 -~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 -RMPRP---ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -CCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -CCCCC---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11111 122346889999999999999999999999998876543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=366.03 Aligned_cols=268 Identities=28% Similarity=0.442 Sum_probs=215.0
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
...++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34578999999999999999999764 34889999997642 455567899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSL-------------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRD 742 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 742 (959)
...++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+ ++|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 9999999999999999999763211 12579999999999999999999999 8999999
Q ss_pred CCCCCEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 002149 743 LKSSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDE 820 (959)
Q Consensus 743 ik~~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~ 820 (959)
|||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999985433221 22234568999999999999999999999999999999999 9999987
Q ss_pred CChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 821 SRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
....+..... . +.... .........+.+++.+||+.||++||++.++++.|+++.+++.
T Consensus 280 ~~~~~~~~~~---~-------------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 280 MAHEEVIYYV---R-------------DGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp SCHHHHHHHH---H-------------TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CChHHHHHHH---h-------------CCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 6654321110 0 00000 0111223468899999999999999999999999999877654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.86 Aligned_cols=258 Identities=19% Similarity=0.271 Sum_probs=210.6
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 4578999999999999999999765 6889999998743 34456788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCcEEEeeccccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD--DFRAKVSDFGLVK 765 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~--~~~~ki~DfGla~ 765 (959)
|||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999999843 22468999999999999999999999 89999999999999987 7899999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+..... ...........
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~-- 226 (321)
T 1tki_A 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAEYTFDEEA-- 226 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCCCCHHH--
T ss_pred ECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH--HcCCCCCChhh--
Confidence 765432 234467999999999999988999999999999999999999999876653321111 00000000000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. . .....+.+++.+||..||++|||+.|+++ ++++.+
T Consensus 227 -~------~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 227 -F------K----EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp -H------T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred -h------c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 0 0 11236789999999999999999999988 566654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=376.58 Aligned_cols=319 Identities=22% Similarity=0.251 Sum_probs=229.6
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----c
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----Y 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 682 (959)
+.++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|+++++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3568999999999999999999754 688999999987655666778899999999999999999999998766 5
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+ +|+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CcCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 789999999 5799998843 2568999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc---------------------ceeecccccccccccccc-ccCCCCccchHHHHHHHHHHHHhCCCCC--
Q 002149 763 LVKLAPDSER---------------------SVVTRLAGTFGYLAPEYA-VTGKITTKVDVFSFGVVLMELLTGLMAL-- 818 (959)
Q Consensus 763 la~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~ll~elltg~~p~-- 818 (959)
+|+....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 9986543221 123567899999999986 5567999999999999999999854443
Q ss_pred ---------CCCCh---------------HHHHHHHHHHHhhhcc---------hHHHHHhcCCcccCCCCCH-----HH
Q 002149 819 ---------DESRP---------------EERQYLAAWFWNIKSD---------KEKLRAAIDPILEVNDDTF-----ET 860 (959)
Q Consensus 819 ---------~~~~~---------------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-----~~ 860 (959)
.+... .....+...+...... .......+........... ..
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 33210 0011111111111000 0111111111111111111 12
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcccCCC--hhhhHHHHHHhhCCCcceeecccc
Q 002149 861 FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLP--LNQMVKDWQEAEGKDLSYVSLEDS 938 (959)
Q Consensus 861 ~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 938 (959)
...+.+|+.+||+.||++|||++|+++ +++++......+++........++. .....+++++...+++..+..+..
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence 346789999999999999999999988 7899888777766644333322222 245667788888887777764433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.23 Aligned_cols=275 Identities=20% Similarity=0.283 Sum_probs=207.9
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999764 68999999998765555566788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ |++.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~----~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCD-QDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCS-EEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCC-CCHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 996 566666543 12569999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........ .+.................+.
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGG
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhc
Confidence 322 234457899999999998766 79999999999999999999888644333221 111111111100000000000
Q ss_pred Cc------------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PI------------LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. .............+.+++.+||+.||++|||++|+++ ++++..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~ 290 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC-
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCC
Confidence 00 0000001122346789999999999999999999987 56665443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.18 Aligned_cols=249 Identities=27% Similarity=0.332 Sum_probs=206.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|+.. +|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999765 689999999875422 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999988542 468999999999999999999999 899999999999999999999999999998543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ..
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~---------- 219 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LM---------- 219 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HH----------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH------Hc----------
Confidence 322 2234568999999999999999999999999999999999999999876543321110 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
.....+ ......+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 EEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 011111 11223678999999999999999 8999877
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.12 Aligned_cols=277 Identities=21% Similarity=0.258 Sum_probs=218.6
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEE-EeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYS-VAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 686 (959)
+.++|+..+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.++|++++..+.++ ..+...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999975 5789999999865422 23578999999999988877666554 66778899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGl 763 (959)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 99999998542 2569999999999999999999999 899999999999999 4788999999999
Q ss_pred cccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 764 VKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 764 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9865443321 1244679999999999999999999999999999999999999998754322111111010000
Q ss_pred cchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
. .... ..+.. .....+.+++.+||+.||++||++.++++.|+.++.+.....+.+.+|+.
T Consensus 235 ~-~~~~-~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 235 M-STPI-EVLCK---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp H-HSCH-HHHTT---------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred c-CCch-HHHHh---------hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 0 0000 00000 11236889999999999999999999999999999999998888888864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=405.02 Aligned_cols=108 Identities=31% Similarity=0.464 Sum_probs=93.0
Q ss_pred cccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCC
Q 002149 358 LVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQ 437 (959)
Q Consensus 358 l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~ 437 (959)
+.......+.....++..++.+++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+.++++|++||||+
T Consensus 634 L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~ 713 (768)
T 3rgz_A 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713 (768)
T ss_dssp CCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred ccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence 33334445555556666788899999999999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCC---CCCcceecccCCCCCCCCC
Q 002149 438 NNLSPPLPK---FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 438 N~l~~~~p~---~~~~~~~~l~~N~~~c~~~ 465 (959)
|+|+|.+|. +..+...++.|||.+||.+
T Consensus 714 N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp SEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred CcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 999999996 4455677899999999965
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.77 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=200.6
Q ss_pred hcCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|+..+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 4678999999999999999997642 457999998754 24555678999999999999999999999974 55788
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999998542 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---~---------- 231 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E---------- 231 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---H----------
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---H----------
Confidence 665443333334567889999999998999999999999999999997 99999876654321110 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
... ... ........+.+++.+|++.||++||++.++++.|+.++++.
T Consensus 232 ~~~--~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 232 NGE--RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp TTC--CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCC--CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 000 000 11122346889999999999999999999999999988653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.33 Aligned_cols=265 Identities=28% Similarity=0.389 Sum_probs=216.7
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+++++.++||||+++++++.+...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 46789999999999999999975 24578999998754 345566789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL-------------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLK 744 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 744 (959)
.++||||+++|+|.+++...... ....+++.+++.++.||+.||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999764321 12458999999999999999999999 899999999
Q ss_pred CCCEEECCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 002149 745 SSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESR 822 (959)
Q Consensus 745 ~~NiLl~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~ 822 (959)
|+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866443322 2233467889999999999999999999999999999999 999998776
Q ss_pred hHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 823 PEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..+..... ...... .........+.+++.+||+.||++||++.++++.|+.++.+.
T Consensus 258 ~~~~~~~~-------------~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 PERLFNLL-------------KTGHRM-----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp GGGHHHHH-------------HTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHHh-------------hcCCcC-----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 54321111 000000 011122346889999999999999999999999999988754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=357.68 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred HhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHh--cCCCCceeEEEEEEeC----c
Q 002149 609 VTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK--VRHRHLVSLLGYSVAG----Y 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~ 682 (959)
+.++|+..+.||+|+||.||+|.. +++.||||++... ..+.+.+|.+++.. ++||||+++++++... .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 5899999998643 33456677777777 7899999999987643 4
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEECCCC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH--------SLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| + ++|+||||||+|||++.++
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTS
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCC
Confidence 57899999999999999843 46899999999999999999999 6 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCcce---eeccccccccccccccccC------CCCccchHHHHHHHHHHHHhC----------C
Q 002149 755 RAKVSDFGLVKLAPDSERSV---VTRLAGTFGYLAPEYAVTG------KITTKVDVFSFGVVLMELLTG----------L 815 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~ll~elltg----------~ 815 (959)
.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999998554433221 2335799999999999876 456799999999999999999 7
Q ss_pred CCCCCCChHHHH--HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 816 MALDESRPEERQ--YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 816 ~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.||......... .....+ ......+..............+.+++.+||+.||++|||+.+|++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVV---------CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHH---------hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 888654332111 000000 00000111111112234567899999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=370.81 Aligned_cols=273 Identities=26% Similarity=0.353 Sum_probs=216.2
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEE
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 675 (959)
....+...++|++.+.||+|+||.||+|.+ .+++.||||++... ......+.+.+|++++.++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 334444567899999999999999999963 24678999999764 3445567899999999999 799999999
Q ss_pred EEEEeCc-eEEEEEEecCCCchhhHHhhcccCC-----------------------------------------------
Q 002149 676 GYSVAGY-ERLLVYEYMPQGALSKHIFHWKSLN----------------------------------------------- 707 (959)
Q Consensus 676 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------- 707 (959)
+++.+.. ..++||||+++|+|.+++.......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9988754 4899999999999999997643210
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC-c
Q 002149 708 --------------LEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE-R 772 (959)
Q Consensus 708 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~-~ 772 (959)
...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 1228999999999999999999999 899999999999999999999999999998654332 2
Q ss_pred ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 773 SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 773 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+... . .+........
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~----------~~~~~~~~~~ 317 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--R----------RLKEGTRMRA 317 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--H----------HHHHTCCCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--H----------HHHcCCCCCC
Confidence 23345678999999999999999999999999999999998 999998765433211 0 0111101111
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
. ......+.+++.+||+.||++||++.+++++|+.+++..
T Consensus 318 --~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 318 --P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --C---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1 112236789999999999999999999999999988653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=367.25 Aligned_cols=277 Identities=14% Similarity=0.218 Sum_probs=218.3
Q ss_pred hcCCcccCcccccCceEEEEEEEcC---------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCcee-------
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD---------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVS------- 673 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 673 (959)
.++|++.+.||+|+||.||+|.... ++.||||++... +.+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 3579999999999999999997653 789999998743 35789999999999999988
Q ss_pred --------EEEEEEe-CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002149 674 --------LLGYSVA-GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLK 744 (959)
Q Consensus 674 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 744 (959)
+++++.. +...++||||+ +++|.+++.... ...+++.+++.++.||+.||+|||+ ++|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777776 67889999999 999999996532 2579999999999999999999999 899999999
Q ss_pred CCCEEECCCC--cEEEeeccccccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002149 745 SSNILLGDDF--RAKVSDFGLVKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLM 816 (959)
Q Consensus 745 ~~NiLl~~~~--~~ki~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~ 816 (959)
|+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 8999999999865432211 1234579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 817 ALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 817 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
||.......... .... .......................+.+++.+||+.||++||++.++++.|+.++++.
T Consensus 267 pf~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTEDI-MKQK-------QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHHHH-HHHH-------HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHHHH-HHHH-------HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 998764222111 1111 11111111111100000011246889999999999999999999999999999999
Q ss_pred CCCCCCCCcccC
Q 002149 897 KPLDDEPEEYSG 908 (959)
Q Consensus 897 ~~~~~~~~~~~~ 908 (959)
....+++.+|+.
T Consensus 339 ~~~~~~~~dw~~ 350 (352)
T 2jii_A 339 RVSPYDPIGLPM 350 (352)
T ss_dssp TCCTTSCCCCCC
T ss_pred CCCcCccccCcC
Confidence 988888888763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=377.95 Aligned_cols=261 Identities=30% Similarity=0.472 Sum_probs=207.8
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||.||+|.++.+..||||+++.... ..+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 456888999999999999999998888899999986432 24578999999999999999999999876 67899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999996422 2458999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..... ....
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~- 398 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGY- 398 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------------HTTC-
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCC-
Confidence 33222334457889999999999999999999999999999999 99999877654321111 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.+. ........+.+++.+||+.||++|||++++++.|+.++....+
T Consensus 399 -~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 399 -RMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp -CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -CCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 111 1112234688999999999999999999999999988765443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=363.08 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=207.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc---HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999976 46899999998643211 113567899999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc---EEEeecc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR---AKVSDFG 762 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~---~ki~DfG 762 (959)
+||||+++|+|.+++..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999888765332 22468999999999999999999999 89999999999999986554 9999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL---FEGIIKGKYKMNPR 254 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH---HHHHHHTCCCCCHH
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH---HHHHHcCCCCCCcc
Confidence 9987654322 2344679999999999999999999999999999999999999998743211 11100000000000
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.. . .....+.+++.+||+.||++||++.++++ ++++.
T Consensus 255 ~~---------~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~--hp~~~ 291 (351)
T 3c0i_A 255 QW---------S----HISESAKDLVRRMLMLDPAERITVYEALN--HPWLK 291 (351)
T ss_dssp HH---------T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred cc---------c----cCCHHHHHHHHHHCCCChhHCcCHHHHhc--Chhhc
Confidence 00 0 11236789999999999999999999987 45554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=360.70 Aligned_cols=268 Identities=27% Similarity=0.411 Sum_probs=199.3
Q ss_pred hcCCcccCcccccCceEEEEEEEcC-Cc---EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE-
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD-GT---KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER- 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 684 (959)
.++|++.+.||+|+||.||+|.... ++ .||||++..........+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4679999999999999999997553 32 799999987655556678899999999999999999999999877655
Q ss_pred -----EEEEEecCCCchhhHHhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 685 -----LLVYEYMPQGALSKHIFHWKSL-NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 685 -----~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 8999999999999998653321 22368999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------ 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH------
Confidence 99999986543322 12233457889999999999999999999999999999999 99999876654321110
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..... ..........+.+++.+||+.||++||++.++++.|++++.....
T Consensus 253 ----------~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 253 ----------IGGNR--LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp ----------HTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred ----------hcCCC--CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 00000 011112234688999999999999999999999999999886443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=376.20 Aligned_cols=270 Identities=19% Similarity=0.251 Sum_probs=215.6
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSV 679 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 679 (959)
.+.+++...++|+..++||+|+||.||+|+.. +++.||||++.+.... ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999875 5789999998753211 112234789999999999999999999999
Q ss_pred eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 680 AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 680 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
+....++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999542 2569999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
|||+|+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---- 293 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---- 293 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh----
Confidence 99999876555444445578999999999997 567899999999999999999999999877654432111
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhHh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNVLAPLVE 894 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L~~~~~ 894 (959)
..... . +. .+.........+.+++.+|+..+|++ ||+++|+++ +++++
T Consensus 294 --~~~~~---~-~~----~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~ 343 (437)
T 4aw2_A 294 --MNHKE---R-FQ----FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFS 343 (437)
T ss_dssp --HTHHH---H-CC----CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGT
T ss_pred --hhccc---c-cc----CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccC
Confidence 00000 0 00 01110112236789999999998888 999999977 66665
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.73 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=205.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 468999999999999999999765 78999999986542 2233467889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999998843 2568999999999999999999999 899999999999999999999999999998553
Q ss_pred CCC-cceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 769 DSE-RSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 769 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
... ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ..+.... ..
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~--------~~ 227 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKK--------TY 227 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHTTC--------TT
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhccc--------cc
Confidence 222 222345689999999999988775 778999999999999999999998765432211 1111000 00
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..+ .......+.+++.+||+.||++|||+.|+++ ++++.+
T Consensus 228 ~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 267 (323)
T 3tki_A 228 LNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYNK 267 (323)
T ss_dssp STT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTTC
T ss_pred CCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhcc
Confidence 000 0112236779999999999999999999977 444443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=354.72 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|...+|+.||||++..........+.+.+|+++++.++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 47899999999999999999888899999999876543333456788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
++ ++|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LD-QDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CS-EEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 95 5998888542 2568999999999999999999999 89999999999999999999999999999865432
Q ss_pred Ccceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-HH---HH-
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-EK---LR- 844 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~---~~- 844 (959)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+..... ........ .. ..
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI--FRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGG
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHHCCCChhhchhhhc
Confidence 21 2334578999999999976 45899999999999999999999999887654432111 11100000 00 00
Q ss_pred -HhcCCcccC------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 -AAIDPILEV------NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 -~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...++.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000100000 0000112346789999999999999999999977
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=372.75 Aligned_cols=266 Identities=21% Similarity=0.241 Sum_probs=212.7
Q ss_pred HHHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 604 QVLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 604 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
++++...++|+..+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999765 688999999865321 112234478999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999998854 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCC----CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK----ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+|+.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+ .
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------M 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH------H
Confidence 999876554433445678999999999997765 889999999999999999999999877654321111 1
Q ss_pred cchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhHhh
Q 002149 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQ--RPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L~~~~~~ 895 (959)
.... . +. .+ . .......+.+++.+||..+|.+ ||+++||++ +++++.
T Consensus 287 ~~~~---~-~~--~p--~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 287 NHKN---S-LT--FP--D-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp THHH---H-CC--CC--T-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred hccc---c-cc--CC--C-cccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 1000 0 00 00 0 0011236789999999999998 999999987 566653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=383.16 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=212.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
..+|...+.||+|+||.||+|.+. +++.||||++.... ...+.|.+|++++++++||||+++++++......++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 356888899999999999999876 48899999997642 23567999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999652 23568999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
...........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.... +....
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-------------~~~~~ 436 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------------LEKDY 436 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------------HHTTC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------HHcCC
Confidence 433222333456789999999999999999999999999999999 9999987765432111 11111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
.+. ........+.+++.+||+.||++||++.++++.|+.++
T Consensus 437 --~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 --RME---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCC---CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111 11122346889999999999999999999999998765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.75 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH------------------------HHHHHHHHHHHHHH
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK------------------------KAVDEFHSEIAVLS 664 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 664 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35799999999999999999975 468899999987543211 12356889999999
Q ss_pred hcCCCCceeEEEEEEe--CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 002149 665 KVRHRHLVSLLGYSVA--GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRD 742 (959)
Q Consensus 665 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 742 (959)
.++||||+++++++.+ ....++||||+++|+|.+++. ...+++.++..++.||+.||+|||+ ++|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence 9999999999999987 568899999999999987642 2579999999999999999999999 8999999
Q ss_pred CCCCCEEECCCCcEEEeeccccccCCCCCcceeeccccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCC
Q 002149 743 LKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK---ITTKVDVFSFGVVLMELLTGLMALD 819 (959)
Q Consensus 743 ik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~ll~elltg~~p~~ 819 (959)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999986654322 234467999999999997765 4778999999999999999999998
Q ss_pred CCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 820 ESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......... +... ..... ........+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~-------------~~~~---~~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSK-------------IKSQ---ALEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHH-------------HHHC---CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHH-------------Hhcc---cCCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 7654321110 0000 00000 01112346889999999999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.65 Aligned_cols=258 Identities=27% Similarity=0.401 Sum_probs=202.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcE----EEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..+.||+|+||.||+|.+. +++. ||+|.+... ......+.+.+|+.++++++||||+++++++..+. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 57899999999999999999754 4443 588877643 23345678999999999999999999999998765 78
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 999999999999998652 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+......
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------------ 233 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------ 233 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------------
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH------------
Confidence 6543322 22233567889999999999999999999999999999999 999998776544221110
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... .. .........+.+++.+||+.||++||++.++++.|..+.+.
T Consensus 234 -~~~--~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 234 -KGE--RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -TTC--CC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -cCC--CC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 000 00 01112234688999999999999999999999999988653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=352.50 Aligned_cols=278 Identities=21% Similarity=0.303 Sum_probs=209.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|++++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999765 5899999998776555566778899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999888743 2568999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-HHH---
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-EKL--- 843 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~--- 843 (959)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+............... ...
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 3322 2334578999999999976 678999999999999999999999998877655433222111100000 000
Q ss_pred HHhcCCc-ccCC--CCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 844 RAAIDPI-LEVN--DDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 844 ~~~~~~~-~~~~--~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
....... .... ... ......+.+++.+||+.||++|||++|+++ +++++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~ 293 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH--HPYFENIRE 293 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT--SGGGTTCC-
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc--ChHHHhccC
Confidence 0000000 0000 000 112335789999999999999999999987 566655443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=355.43 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=206.7
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+.++|...+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3457999999999999999999765 68999999987653221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEe
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVS 759 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~ 759 (959)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999999843 2568999999999999999999999 8999999999999999877 89999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...... ......
T Consensus 161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~ 236 (326)
T 2y0a_A 161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVNYEF 236 (326)
T ss_dssp CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--HTCCCC
T ss_pred ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--hcCCCc
Confidence 999998664332 2344679999999999999999999999999999999999999998766543211110 000000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... . . .....+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~---~------~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 EDEY---F------S----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CHHH---H------T----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cccc---c------c----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0 0 11235779999999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=364.70 Aligned_cols=279 Identities=18% Similarity=0.247 Sum_probs=212.1
Q ss_pred hcCCcccCccccc--CceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRG--GFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.++|++.+.||+| +||.||+|... +|+.||||++..........+.+.+|+.+++.++|||||++++++.+....++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999765 78999999998776666777889999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999998652 22568999999999999999999999 8999999999999999999999999999864
Q ss_pred CCCCCc------ceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 767 APDSER------SVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 767 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+..... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~ 255 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVP 255 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcCCCC
Confidence 322111 11223478999999999987 67999999999999999999999999876543321100 000000
Q ss_pred --------chH-------------HHHHhcCCc--------ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 839 --------DKE-------------KLRAAIDPI--------LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 839 --------~~~-------------~~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
... .....+... .............+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~-- 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN-- 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT--
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--
Confidence 000 000000000 0000011112346789999999999999999999987
Q ss_pred HHhHhhcCC
Q 002149 890 APLVEKWKP 898 (959)
Q Consensus 890 ~~~~~~~~~ 898 (959)
+++++....
T Consensus 334 hp~f~~~~~ 342 (389)
T 3gni_B 334 HSFFKQIKR 342 (389)
T ss_dssp SGGGGGC--
T ss_pred CHHHHHHhh
Confidence 567665543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.70 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=204.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|+..+.||+|+||.||+|+.. +|+.||||++.+... .....+.+.+|..+++.+ +||||+++++++.+....++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999765 689999999876422 223456688999999998 69999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999998652 468999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---------------- 236 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---------------- 236 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----------------
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH----------------
Confidence 43322 2234568999999999999989999999999999999999999999877654321111
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM------GHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~L~~~~~ 894 (959)
.......+. .....+.+++.+||+.||++||++ .++++ +++++
T Consensus 237 ~~~~~~~p~---~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f~ 285 (353)
T 3txo_A 237 LNDEVVYPT---WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFFK 285 (353)
T ss_dssp HHCCCCCCT---TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGGT
T ss_pred HcCCCCCCC---CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCccc
Confidence 111111111 122357899999999999999998 77765 45554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.40 Aligned_cols=257 Identities=28% Similarity=0.440 Sum_probs=213.0
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|...+++.||+|++...... .+.+.+|+++++.++||||+++++++.+....++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 578899999999999999999888899999999765332 35788999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 9999999998642 2568999999999999999999999 89999999999999999999999999999866443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +......
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------i~~~~~~ 224 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------ISTGFRL 224 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------------HHTTCCC
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-------------HhcCCcC
Confidence 2222334567889999999998899999999999999999999 8999987654332110 0011111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. .......+.+++.+|++.||++||++.++++.|+.+.+.
T Consensus 225 ~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YK-----PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-----CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 111234678999999999999999999999999988753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.10 Aligned_cols=262 Identities=28% Similarity=0.500 Sum_probs=200.5
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.+.||+|+||.||+|... ..||||++..........+.+.+|+++++.++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 457999999999999999999864 4699999987666667778899999999999999999999965 4556899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT----C---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999853 23568999999999999999999999 8999999999999999999999999999985543
Q ss_pred C-Ccceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 770 S-ERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 770 ~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
. .........||+.|+|||++. +..++.++||||||+++|||++|+.||......+.. ...+.. .
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~---------~ 241 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGR---------G 241 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHH---------T
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcc---------c
Confidence 2 122334467999999999986 567888999999999999999999999876543321 111110 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
...+.. ..........+.+++.+||+.||++||++.++++.|+++.+
T Consensus 242 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLSPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCcch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111111 11111233478899999999999999999999999988754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=356.60 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=216.4
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++..+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46789999999999999999975 356789999987642 344567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL-------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 999999999999999999753311 12358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQ 827 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~ 827 (959)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999866543322 2334567889999999999999999999999999999999 99999876543321
Q ss_pred HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 828 YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
. . .......... .......+.+++.+|++.||.+||++.++++.|+.++.+..
T Consensus 258 ~--~----------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 258 Y--K----------MIKEGFRMLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp H--H----------HHHHTCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred H--H----------HhccCCCCCC-----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1 0 0111111111 11123468899999999999999999999999999887643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.65 Aligned_cols=254 Identities=22% Similarity=0.330 Sum_probs=209.7
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|..+ ++.||||++..........+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57889999999999999999886 88999999987666667778899999999999999999999999877 7789999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999642 22468999999999999999999999 67 99999999999999999999999998764
Q ss_pred CCCCCcceeeccccccccccccccccCCCCc---cchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITT---KVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
... ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||......+..... .
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------------~ 224 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV------------A 224 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH------------H
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH------------H
Confidence 322 2246899999999998765554 799999999999999999999877654321110 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.....+.. .......+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 225 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEGLRPTI-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSCCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcCCCCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111111 11223468899999999999999999999999988754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=352.54 Aligned_cols=273 Identities=20% Similarity=0.247 Sum_probs=210.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc--eEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY--ERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 686 (959)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 357899999999999999999765 58999999987542 2233567789999999999999999999998765 7799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCcEEEeecc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFG 762 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----~~~~~~ki~DfG 762 (959)
||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999965322 2348999999999999999999999 899999999999999 788889999999
Q ss_pred ccccCCCCCcceeeccccccccccccccc--------cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAV--------TGKITTKVDVFSFGVVLMELLTGLMALDESRPEE-RQYLAAWF 833 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~-~~~~~~~~ 833 (959)
+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....... .......+
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 9987654332 23457999999999986 5788999999999999999999999997544322 11111111
Q ss_pred HhhhcchHHHH----------HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 834 WNIKSDKEKLR----------AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 834 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
..... ..... .+.................+.+++.+||+.||++||+++|++++...
T Consensus 240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 11000 00000 00001111123345666788899999999999999999999987764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=370.48 Aligned_cols=270 Identities=21% Similarity=0.226 Sum_probs=213.9
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEE
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV 679 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 679 (959)
.+++.+...++|+..+.||+|+||.||+|+.+ +|+.||||++.+... .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556788999999999999999999774 789999999875321 1223345789999999999999999999999
Q ss_pred eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 680 AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 680 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
+....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999996532 468999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccc-------cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-------TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
|||+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||......+....+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-- 282 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-- 282 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 99999876554433344568999999999997 457899999999999999999999999877654422111
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHHHHHhHhh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQR---PDMGHAVNVLAPLVEK 895 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~ev~~~L~~~~~~ 895 (959)
.... ..+. .+.........+.+++.+||. +|.+| |+++|+++ +++++.
T Consensus 283 ----~~~~----~~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 283 ----VHYK----EHLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp ----HTHH----HHCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTT
T ss_pred ----Hhcc----cCcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCC
Confidence 0000 0000 000001122367899999999 99998 58999876 566653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.35 Aligned_cols=253 Identities=28% Similarity=0.436 Sum_probs=195.8
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEccccccc--HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|+..+.||+|+||.||+|... ++.||||++...... ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999876 899999998754222 22356788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEecCCCCCCEEECC--------CCcE
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS---FIHRDLKSSNILLGD--------DFRA 756 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivH~Dik~~NiLl~~--------~~~~ 756 (959)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ ++ |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999998832 578999999999999999999999 66 999999999999986 6789
Q ss_pred EEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 757 ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 226 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV------ 226 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh------
Confidence 999999998654332 22357899999999999999999999999999999999999999876643321110
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
...... ..........+.+++.+|++.||++||++.|+++.|+.+
T Consensus 227 ------~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 ------AMNKLA-----LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------HTSCCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------hcCCCC-----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000 011112234688999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=354.47 Aligned_cols=247 Identities=24% Similarity=0.272 Sum_probs=196.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|+..++||+|+||+||+|... +|+.||||++............+..|+..+..+ +||||+++++++.++...++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999775 799999999876555555556666777766666 899999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 789988886532 569999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....... . +..... ......
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~----~~~~~~-~~~~~~-- 275 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ--Q----LRQGYL-PPEFTA-- 275 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH--H----HTTTCC-CHHHHT--
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--H----HhccCC-Cccccc--
Confidence 4432 2334579999999998875 79999999999999999999977665421110 0 000000 000000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....+.+++.+||+.||++|||+.|+++
T Consensus 276 -----------~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 276 -----------GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11236889999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=360.19 Aligned_cols=311 Identities=22% Similarity=0.323 Sum_probs=230.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ce
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 683 (959)
..+|+..+.||+|+||.||+|... +++.||||++... ......+.+.+|+++++.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999754 6889999998753 2345567889999999999999999999998765 36
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+. |+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 899999995 699988854 458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcc--eeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 764 VKLAPDSERS--VVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 764 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+............. .
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~ 253 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS-Q 253 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC-H
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC-H
Confidence 9865433221 1244689999999998765 4589999999999999999999999988765443222111100000 0
Q ss_pred HHH--------HHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCccc
Q 002149 841 EKL--------RAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYS 907 (959)
Q Consensus 841 ~~~--------~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 907 (959)
+.+ ............... .....+.+++.+||+.||++|||+.|+++ +++++.+..+.+++....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~~~~~~~~~~~~~~~~ 331 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYDPSDEPIAEA 331 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTTCCGGGSCCCSS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcchhhccCcccccCCCC
Confidence 000 111111111011111 11236789999999999999999999987 788888776666655544
Q ss_pred CcccCCCh-hhhHHHHHHhhCCCcceee
Q 002149 908 GIDYSLPL-NQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 908 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 934 (959)
.+..+... ....++|++...++...+.
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 359 (364)
T 3qyz_A 332 PFKFDMELDDLPKEKLKELIFEETARFQ 359 (364)
T ss_dssp CCCCC-----CCHHHHHHHHHHHTGGGC
T ss_pred cCCcccccccCCHHHHHHHHHHHHHHhh
Confidence 44444433 3346678887766665554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=361.94 Aligned_cols=306 Identities=21% Similarity=0.287 Sum_probs=218.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------ 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 682 (959)
.++|+..+.||+|+||.||+|... +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999754 6889999999876555666788999999999999999999999987654
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||++ |+|.+.+. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999995 67877773 348899999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc---
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD--- 839 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 839 (959)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... +......
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~ 248 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--IEQLGTPCPE 248 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HC-CCCCCHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCHH
Confidence 998654321 234467999999999999999999999999999999999999999887654321111 1000000
Q ss_pred -----hHHHHHhcCCcccCC--------------CC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 840 -----KEKLRAAIDPILEVN--------------DD---TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 840 -----~~~~~~~~~~~~~~~--------------~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.......+....... .. .......+.+++.+||..||++|||++|+++ ++++..|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~--hp~~~~~~ 326 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ--HPYINVWY 326 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTTC
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC--Ccchhhhc
Confidence 001111111110000 00 1122457889999999999999999999988 77777665
Q ss_pred CCCCCCCcc-cCccc-CCChhhhHHHHHHhhCCCcce
Q 002149 898 PLDDEPEEY-SGIDY-SLPLNQMVKDWQEAEGKDLSY 932 (959)
Q Consensus 898 ~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~ 932 (959)
.+.+..... ...+. ..+....+++|++....++..
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (371)
T 2xrw_A 327 DPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD 363 (371)
T ss_dssp CHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHH
T ss_pred CccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHH
Confidence 432211111 11111 123356778899887665443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.77 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=217.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 467889999999999999999775 4889999998753 334567899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 89 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999652 33669999999999999999999999 899999999999999999999999999998766
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
...........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+..... ....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------------~~~~ 229 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------EKDY 229 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------------HTTC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------hccC
Confidence 544444445567889999999999999999999999999999999 99999876654321111 1111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
... ........+.+++.+|++.||.+||++.++++.|+.++++.
T Consensus 230 ~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 230 RME-----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC-----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 11122346889999999999999999999999999887753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=354.72 Aligned_cols=275 Identities=28% Similarity=0.388 Sum_probs=213.9
Q ss_pred cCC-cccCcccccCceEEEEEEEc-----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--Cc
Q 002149 611 KNF-ASENELGRGGFGVVYKGELD-----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GY 682 (959)
Q Consensus 611 ~~~-~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 682 (959)
++| +..+.||+|+||.||++.+. +++.||||++... ......+.+.+|+++++.++||||+++++++.+ ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 344 88999999999999988653 6889999999865 345567789999999999999999999999987 46
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred eEEEEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcc
Confidence 78999999999999999854 348999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 763 LVKLAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 763 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...+..... ..
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~-~~ 257 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQM-TV 257 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHH-HH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccch-hH
Confidence 99876554321 223456888999999999999999999999999999999999998754321110 000000000 00
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+.+.+..... ..........+.+++.+||+.||++||++.++++.|+.+.+++..
T Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 258 LRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 111111111111 111122335788999999999999999999999999999887654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=371.86 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=208.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-eEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-ERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|++++++++||||+++++++.... ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 457888999999999999999886 7899999997542 3467899999999999999999999987765 789999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999653 22457999999999999999999999 899999999999999999999999999998543
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +....
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------------i~~~~ 403 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------------VEKGY 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------------HHTTC
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------HHcCC
Confidence 321 22357889999999999999999999999999999998 9999987654332111 10000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+..+ ......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 404 --~~~~p---~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 --KMDAP---DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11111 12234688999999999999999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=360.31 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=204.2
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC--CCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH--RHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+++++.++| +||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 35699999999999999999988889999999998765666777889999999999976 9999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||+ .+|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 58999999864 2568999999999999999999999 8999999999999997 578999999999866
Q ss_pred CCCCcc-eeecccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh
Q 002149 768 PDSERS-VVTRLAGTFGYLAPEYAVT-----------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 768 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 835 (959)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------- 228 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------- 228 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---------
Confidence 443322 2345679999999999865 6788999999999999999999999986543211
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.+...+++... ..........+.+++.+||+.||.+|||+.++++ ++++...
T Consensus 229 ------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~~ 280 (343)
T 3dbq_A 229 ------KLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQ 280 (343)
T ss_dssp ------HHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHSC
T ss_pred ------HHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh--Ccccccc
Confidence 11111221111 0011111236789999999999999999999988 5566543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=361.44 Aligned_cols=254 Identities=20% Similarity=0.338 Sum_probs=199.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|+..++||+|+||.||+|+.+ +++.||||++++.... ....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999765 6789999999865433 23345678899999887 89999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999988642 468999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... ..........
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~~~~~~~~~i 274 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYLFQVI 274 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHHHHHHHH
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------hhHHHHHHHH
Confidence 33222 224456899999999999999999999999999999999999999975432211000 0000000111
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.......+. .....+.+++.+||+.||++||++
T Consensus 275 ~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCCCCCCT---TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hccccCCCC---cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111111 122367899999999999999995
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=360.21 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=206.4
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++.+....++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 468999999999999999999764 6889999998754 3444567899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD--DFRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~--~~~~ki~DfGla~~ 766 (959)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 E~~~gg~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 128 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999998843 22468999999999999999999999 89999999999999974 57899999999987
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... . ..
T Consensus 201 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i---~----------~~ 265 (387)
T 1kob_A 201 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV---K----------RC 265 (387)
T ss_dssp CCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---H----------HC
T ss_pred cCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH---H----------hC
Confidence 654332 33457999999999999999999999999999999999999999876543321110 0 00
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... ..........+.+++.+||+.||++|||+.++++
T Consensus 266 -~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 266 -DWEFD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -CCCCC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CCCCC-ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000 0001112346789999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=368.86 Aligned_cols=279 Identities=21% Similarity=0.270 Sum_probs=221.2
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 686 (959)
+.++|++.++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| +++..+..++......++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357899999999999999999975 5789999998765422 2347889999999976 566666777788889999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGl 763 (959)
||||+ +++|.+++... ...+++.+++.++.||+.||+|||+ ++||||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 99999998642 2569999999999999999999999 899999999999999 5889999999999
Q ss_pred cccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 764 VKLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 764 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+...
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~- 231 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 231 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-
Confidence 9866543321 122568999999999999999999999999999999999999999876543322222111110
Q ss_pred cchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcc
Q 002149 838 SDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGID 910 (959)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 910 (959)
.....+..... ....++.+++.+||+.||++||++.+|++.|+.++.......+..++|....
T Consensus 232 ----~~~~~~~~l~~------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~ 294 (483)
T 3sv0_A 232 ----KVATSIEALCR------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK 294 (483)
T ss_dssp ----HHHSCHHHHHT------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHT
T ss_pred ----cccccHHHHhc------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhc
Confidence 11100000000 1123688999999999999999999999999999998888888878876443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.56 Aligned_cols=266 Identities=24% Similarity=0.384 Sum_probs=209.2
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 46789999999999999999975 245689999987542 334457789999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL------------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLK 744 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik 744 (959)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999653211 11348999999999999999999999 899999999
Q ss_pred CCCEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 002149 745 SSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESR 822 (959)
Q Consensus 745 ~~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~ 822 (959)
|+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999985543322 22334567889999999999999999999999999999998 999998765
Q ss_pred hHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 823 PEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
...... .. +....... ........+.+++.+||+.||++||++.+++++|+.++...
T Consensus 280 ~~~~~~--~~----------~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDANFY--KL----------IQNGFKMD-----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHHHH--HH----------HHTTCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHHHH--HH----------HhcCCCCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 432211 10 11111111 11112346889999999999999999999999999876643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=355.41 Aligned_cols=267 Identities=26% Similarity=0.383 Sum_probs=215.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 680 (959)
.++|+..+.||+|+||.||+|... +++.||||++.... .....+.+.+|+++++.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 467899999999999999999763 46789999997642 455667899999999999 89999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
....++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999999753321 12358999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQ 827 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~ 827 (959)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999866543321 2233467889999999998899999999999999999999 99999877654321
Q ss_pred HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 828 YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
... ....... ........+.+++.+||+.||++||++.++++.|+.++.....
T Consensus 270 ~~~-------------~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 270 KLL-------------KEGHRMD-----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHH-------------HHTCCCC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHH-------------hcCCCCC-----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 111 0100000 1112234688999999999999999999999999999876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=348.81 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=212.4
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||.||+|...+++.||||++..... ..+.+.+|+++++.++||||+++++++.. +..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 357889999999999999999988888999999875432 34678999999999999999999999764 46899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999985421 1368999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +.....
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------------~~~~~~ 228 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------------LERGYR 228 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------------HHTTCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-------------HhcccC
Confidence 43333334567889999999998899999999999999999999 9999987665332110 001011
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.. ........+.+++.+|++.||++||++.++++.|+.++....
T Consensus 229 ~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 229 MV-----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CC-----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 10 011223468899999999999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=353.99 Aligned_cols=279 Identities=21% Similarity=0.319 Sum_probs=199.0
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 357899999999999999999754 68999999987542 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKS-LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||++ |+|.+++..... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9996 699998865332 122468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+...... .............
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF--DIMGTPNESLWPS 235 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCSCCTTTCGG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHhCCCChhHhhh
Confidence 43222 2334578999999999976 468999999999999999999999998876654322211 1100000000000
Q ss_pred c------CCccc-CCCCC----------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 847 I------DPILE-VNDDT----------FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 847 ~------~~~~~-~~~~~----------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
+ .+... ..... ......+.+++.+||+.||++|||+.|+++ ++++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~~ 302 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH--HPWFAEYYH 302 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCC
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC--Chhhhcccc
Confidence 0 00000 00000 011236889999999999999999999987 677766544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=351.01 Aligned_cols=259 Identities=31% Similarity=0.487 Sum_probs=202.4
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 57888999999999999999876 789999998643 345678999999999999999999998763 47899999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc-EEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR-AKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~-~ki~DfGla~~~~~ 769 (959)
+++|+|.+++.... ....+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||+++....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999996422 2235789999999999999999999965568999999999999998876 79999999975533
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||........... +... ....+
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~-------~~~~~ 223 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM----WAVH-------NGTRP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH----HHHH-------TTCCC
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH----HHHh-------cCCCC
Confidence 2 2234689999999999999999999999999999999999999986543221111 0000 00000
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.. .......+.+++.+||+.||++||++.++++.|..+.+.+..
T Consensus 224 ~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PL-----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CC-----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Cc-----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00 111234678999999999999999999999999998776544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=361.40 Aligned_cols=261 Identities=23% Similarity=0.301 Sum_probs=198.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 457999999999999999999765 789999999875422 2356789999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc--EEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR--AKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~--~ki~DfGla~~ 766 (959)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999988542 468999999999999999999999 89999999999999987765 99999999984
Q ss_pred CCCCCcceeeccccccccccccccccCCCCcc-chHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTK-VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
..... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ..+..
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------------~~~~~ 233 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR------------KTIQR 233 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH------------HHHHH
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH------------HHHHH
Confidence 33221 2234579999999999988887766 899999999999999999998654322110 00111
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
......... ........+.+++.+||+.||++|||+.|+++ ++++.++.+
T Consensus 234 ~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~~~~ 283 (361)
T 3uc3_A 234 ILSVKYSIP-DDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLKNLP 283 (361)
T ss_dssp HHTTCCCCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHTTCC
T ss_pred HhcCCCCCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--CcchhcCCc
Confidence 111111101 01112246789999999999999999999988 577765544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.33 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=207.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999765 7899999998754221 133567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999998542 468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+ +.
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i----------~~ 217 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KI----------LN 217 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH----------HH
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HH----------Hh
Confidence 32 234689999999999999999999999999999999999999998765433211 00 11
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
.....+. .....+.+++.+|+..||++|| +++++++ +++++
T Consensus 218 ~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f~ 263 (318)
T 1fot_A 218 AELRFPP---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 263 (318)
T ss_dssp CCCCCCT---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred CCCCCCC---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Ccccc
Confidence 1111111 1123678999999999999999 8888876 45543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.34 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=213.1
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++......++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999764 689999999987666667778899999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc---EEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR---AKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~---~ki~DfGla 764 (959)
|||+++++|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999998888542 468999999999999999999999 89999999999999976655 999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... . .
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~---------~ 221 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI---K---------A 221 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H---------H
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH---H---------h
Confidence 86654322 23467999999999999999999999999999999999999999876543321111 0 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
....... .........+.+++.+|++.||++||++.|+++ ++++..
T Consensus 222 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (284)
T 3kk8_A 222 GAYDYPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICN 267 (284)
T ss_dssp TCCCCCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHS
T ss_pred ccccCCc---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccC
Confidence 0000000 000112246789999999999999999999987 555554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.30 Aligned_cols=251 Identities=28% Similarity=0.390 Sum_probs=205.3
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 685 (959)
..++|...+.||+|+||.||+|+.+ +|+.||||++++... .....+.+..|..++..+ +||||+++++++.+....+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3578999999999999999999865 689999999876422 123355678899999887 8999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999998642 468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~------ 233 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMD------ 233 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC------
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HhC------
Confidence 543322 1234568999999999999999999999999999999999999999876653321111 000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMG-HAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~ 887 (959)
.... + ......+.+++.+||..||++||++. ++.+
T Consensus 234 --~~~~--p---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 234 --NPFY--P---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp --CCCC--C---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCC--C---cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0001 1 11224678999999999999999997 6654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=361.43 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=203.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999765 688999999865421 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999853 2568999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...+..
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---------- 234 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---------- 234 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----------
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----------
Confidence 432 2345689999999999864 4589999999999999999999999986544332222211110
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-MGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 887 (959)
.... ........+.+++.+||+.||++||+ ++++.+
T Consensus 235 ---~~~~---~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 ---TVVT---YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCC---CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cccC---CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0011 01112246789999999999999998 666654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.16 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=203.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHH-----HHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKA-----VDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|+..+.||+|+||.||+|.. .+++.||||++......... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35789999999999999999976 47899999998654322211 167899999999999999999999986655
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECCCCc-----E
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLGDDFR-----A 756 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~~~~~-----~ 756 (959)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhc----ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 699999999999988854 23579999999999999999999999 77 999999999999988776 9
Q ss_pred EEeeccccccCCCCCcceeecccccccccccccc--ccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA--VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 757 ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
||+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...............
T Consensus 169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~- 243 (287)
T 4f0f_A 169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR- 243 (287)
T ss_dssp EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-
T ss_pred EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-
Confidence 9999999985433 23446799999999998 3456789999999999999999999999876543322111100
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~ 892 (959)
.....+. ........+.+++.+||+.||++||++.++++.|+++
T Consensus 244 ---------~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 ---------EEGLRPT-----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HSCCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------ccCCCCC-----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0011111 1112234688999999999999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.06 Aligned_cols=272 Identities=23% Similarity=0.367 Sum_probs=206.0
Q ss_pred HHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc--CCCCceeEEEEEEeC
Q 002149 604 QVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV--RHRHLVSLLGYSVAG 681 (959)
Q Consensus 604 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~ 681 (959)
.....+.++|++.+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 344556688999999999999999999876 899999998643 223445566666554 899999999999887
Q ss_pred ----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECC
Q 002149 682 ----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA-----HQSFIHRDLKSSNILLGD 752 (959)
Q Consensus 682 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dik~~NiLl~~ 752 (959)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ +.+|+||||||+|||++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 788999999999999999954 46899999999999999999999820 129999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcce---eeccccccccccccccccCCCCcc------chHHHHHHHHHHHHhC---------
Q 002149 753 DFRAKVSDFGLVKLAPDSERSV---VTRLAGTFGYLAPEYAVTGKITTK------VDVFSFGVVLMELLTG--------- 814 (959)
Q Consensus 753 ~~~~ki~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~ll~elltg--------- 814 (959)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998654432221 124579999999999988766665 9999999999999999
Q ss_pred -CCCCCCCChHHHH--HHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 815 -LMALDESRPEERQ--YLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 815 -~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
+.||......... .....+ ......+..............+.+++.+||+.||++||++.+++++|+.
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIV---------CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHH---------hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 6666543322110 000000 0001111111111122566789999999999999999999999999999
Q ss_pred hHhhc
Q 002149 892 LVEKW 896 (959)
Q Consensus 892 ~~~~~ 896 (959)
+.+..
T Consensus 329 l~~~~ 333 (337)
T 3mdy_A 329 MSESQ 333 (337)
T ss_dssp HHHTT
T ss_pred HHhhc
Confidence 88754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.26 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=212.2
Q ss_pred cCCcccC-cccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASEN-ELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|.+.+ .||+|+||.||+|... +++.||||++... ......+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566665 8999999999999753 5788999999764 2455677899999999999999999999999 5567899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999853 23569999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 767 APDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 767 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
........ .....||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---i~--------- 227 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IE--------- 227 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---HH---------
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---Hh---------
Confidence 64433221 223456899999999988899999999999999999999 9999987665332111 10
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.... . .........+.+++.+||+.||++||++.++++.|+.++.....
T Consensus 228 -~~~~--~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 228 -QGKR--M---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -TTCC--C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -cCCc--C---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 0000 0 11112234788999999999999999999999999999876544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.45 Aligned_cols=307 Identities=23% Similarity=0.355 Sum_probs=226.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE---
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER--- 684 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 684 (959)
+.++|...+.||+|+||.||+|... +|+.||||++..........+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3568999999999999999999754 689999999987655666678899999999999999999999999876654
Q ss_pred ---EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 685 ---LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 685 ---~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
++||||+. ++|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999995 78877762 348999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+..... +.......
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~ 262 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPG 262 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCC
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCc
Confidence 999855432 234578999999999987 78899999999999999999999999887654432211 11000000
Q ss_pred HHH---------HHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcc
Q 002149 841 EKL---------RAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEY 906 (959)
Q Consensus 841 ~~~---------~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~ 906 (959)
... ...+........... .....+.+++.+||+.||++|||+.|+++ +++++.+..+..+....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~~~~~~~~~~~ 340 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRDPEEETEAQ 340 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCCGGGCCCCS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc--CcccccCCCcccccccc
Confidence 000 011100011011111 11346889999999999999999999987 78887766554444333
Q ss_pred cCcccCCC-hhhhHHHHHHhhCCCcceee
Q 002149 907 SGIDYSLP-LNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 907 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 934 (959)
..++.... ....+++|++...++...++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (371)
T 4exu_A 341 QPFDDSLEHEKLTVDEWKQHIYKEIVNFS 369 (371)
T ss_dssp SCCCCTTSSCCCCHHHHHHHHHHHHHHCC
T ss_pred cCcCcchhhcccchHHHHHHHHHHHHhcc
Confidence 33332222 23456778887766555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=354.08 Aligned_cols=267 Identities=26% Similarity=0.379 Sum_probs=205.2
Q ss_pred HhcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce-
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE- 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 683 (959)
..++|...+.||+|+||.||+|... +++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567899999999999999999654 34589999998765566677889999999999999999999999887553
Q ss_pred ----EEEEEEecCCCchhhHHhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 684 ----RLLVYEYMPQGALSKHIFHWKS-LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 684 ----~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
.++||||+++|+|.+++..... .....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 4899999999999999854322 233579999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL------ 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH------
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH------
Confidence 99999986543322 12233467889999999999999999999999999999999 89999876654321110
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....... ........+.+++.+||+.||++||++.++++.|+.+++..
T Consensus 263 -------~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 -------LHGHRLK-----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -------HTTCCCC-----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------HcCCCCC-----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000000 11122346889999999999999999999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=362.64 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=203.7
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC--CCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR--HRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+++++.++ ||||+++++++......++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999998888999999999776556677788999999999996 599999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
| +.+++|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 5589999998642 468899999999999999999999 8999999999999996 5799999999998664
Q ss_pred CCCcc-eeecccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 769 DSERS-VVTRLAGTFGYLAPEYAVT-----------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 769 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---------- 275 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 275 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----------
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH----------
Confidence 43222 2345679999999999865 4688999999999999999999999976543211
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+...++...... ........+.+++.+||+.||++||++.|+++ ++++..
T Consensus 276 -----~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~--hp~~~~ 326 (390)
T 2zmd_A 276 -----KLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 326 (390)
T ss_dssp -----HHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHS
T ss_pred -----HHHHHhCccccCC-CCccchHHHHHHHHHHcccChhhCCCHHHHhh--CcCccc
Confidence 1111222111100 00011236789999999999999999999987 455554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=358.83 Aligned_cols=271 Identities=24% Similarity=0.270 Sum_probs=208.7
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc---cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI---SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
+..+.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+++++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345678899999999999999999976 4688999999865421 234567899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccC-----------------------------------CCCCCCHHHHHHHHHHHHHH
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSL-----------------------------------NLEPLSWKRRLNIALDVARG 726 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~g 726 (959)
...++||||+++|+|.+++...... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988532111 01234678889999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCCEEECCCC--cEEEeeccccccCCCCC---cceeecccccccccccccccc--CCCCccc
Q 002149 727 MEYLHSLAHQSFIHRDLKSSNILLGDDF--RAKVSDFGLVKLAPDSE---RSVVTRLAGTFGYLAPEYAVT--GKITTKV 799 (959)
Q Consensus 727 L~yLH~~~~~~ivH~Dik~~NiLl~~~~--~~ki~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 799 (959)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++...... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998766 89999999998543211 122345679999999999875 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCC-CCCHHHHHHHHHHHHhcccCCCCC
Q 002149 800 DVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN-DDTFETFWTIAELAGHCTSREPSQ 878 (959)
Q Consensus 800 DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~ 878 (959)
|||||||++|||++|+.||......+..... . ....... .........+.+++.+||+.||.+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV--L--------------NKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H--------------HCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--H--------------hcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999877654321111 0 0000000 000112346789999999999999
Q ss_pred CCCHHHHHHHHHHhHhhcC
Q 002149 879 RPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 879 RPt~~ev~~~L~~~~~~~~ 897 (959)
||++.++++ +++++.+.
T Consensus 322 Rps~~~~l~--hp~~~~~~ 338 (345)
T 3hko_A 322 RFDAMRALQ--HPWISQFS 338 (345)
T ss_dssp SCCHHHHHH--SHHHHTTS
T ss_pred CCCHHHHhc--ChhhccCh
Confidence 999999987 66666543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.07 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=206.9
Q ss_pred hcCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|...+.||+|+||.||+|.... +..||||.+.... .....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 4578899999999999999997542 3359999987652 445567899999999999999999999997654 568
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999998652 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------------~ 228 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------------E 228 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------------H
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------------h
Confidence 665443333344567889999999998999999999999999999998 99999866544321111 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ..... ......+.+++.+|++.||++||++.++++.|+.+.+.
T Consensus 229 ~~~--~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 229 KGD--RLPKP---DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HTC--CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC--CCCCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 00001 11224688999999999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=382.22 Aligned_cols=260 Identities=29% Similarity=0.467 Sum_probs=212.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..++||+|+||.||+|.++.+..||||+++.... ..+.|.+|+++|++++||||+++++++.+ ...++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 456888999999999999999998888899999976432 24578999999999999999999999876 67899999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999996422 2458999999999999999999999 8999999999999999999999999999986644
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........+|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+ ....
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-------------~~~~- 481 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGY- 481 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-------------HTTC-
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCC-
Confidence 22222233456789999999999999999999999999999999 99999877654321111 0000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.+... ......+.+++.+||+.||++||++.+|++.|+.++....
T Consensus 482 -~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 482 -RMPCP---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -CCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 01111 1223468899999999999999999999999988765443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=353.81 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
++|+..+.||+|+||.||+|+.. +++.||+|++.+... .....+.+.+|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999765 688999999976543 344567788999999998 899999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999988542 468999999999999999999999 89999999999999999999999999999854
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHhhhcchHHHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQ--YLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 845 (959)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .....+ ...
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~ 230 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQV 230 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH---------HHH
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH---------HHH
Confidence 3322 2234568999999999999999999999999999999999999999753221110 000000 001
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHHHHhHh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM------GHAVNVLAPLVE 894 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~L~~~~~ 894 (959)
........+. .....+.+++.+||+.||++||++ .++++ +++++
T Consensus 231 i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~--hp~f~ 280 (345)
T 3a8x_A 231 ILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG--HPFFR 280 (345)
T ss_dssp HHHCCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT--SGGGT
T ss_pred HHcCCCCCCC---CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc--CCccC
Confidence 1111111111 123467899999999999999996 56654 45543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.08 Aligned_cols=270 Identities=23% Similarity=0.341 Sum_probs=204.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
..+|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999975 578999999987532 2455667899999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999865332 23668999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+....... +... +....
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~----------~~~~~ 254 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKK----------IEQCD 254 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHH----------HHTTC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHH----------hhccc
Confidence 43322 223457899999999999999999999999999999999999999764322111 1110 10000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
.+... .......+.+++.+||+.||++||++.++++.|+++...+..+
T Consensus 255 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 255 YPPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp SCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CCCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 01010 0112346889999999999999999999999999998876653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.43 Aligned_cols=271 Identities=24% Similarity=0.377 Sum_probs=207.4
Q ss_pred cCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC--ce
Q 002149 611 KNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG--YE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 683 (959)
++|+..+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4588899999999999999984 368899999987542 333457789999999999999999999999876 66
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999985422 568999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh--hcc
Q 002149 764 VKLAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI--KSD 839 (959)
Q Consensus 764 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~ 839 (959)
++....... .......||..|+|||++.+..++.++||||||+++|||++|..|+........ ...... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL----KMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh----hccCCcccccC
Confidence 986654432 223345788899999999999999999999999999999999988643211100 000000 000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
...+...+..... ..........+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 0111111111111 11111233468899999999999999999999999998763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=355.95 Aligned_cols=276 Identities=26% Similarity=0.355 Sum_probs=211.3
Q ss_pred cCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE--eCce
Q 002149 611 KNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV--AGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 683 (959)
++|+..+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+++++.++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 5788999999999999999984 46889999998764 4556678999999999999999999999887 4567
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 899999999999999986532 458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~-~~~~~~ 251 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CER-DVPALS 251 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-ccc-ccccHH
Confidence 9876543322 223356888999999999999999999999999999999999998754322110000 000 000001
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.+...+..... ..........+.+++.+||+.||++||++.++++.|+.+......
T Consensus 252 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 252 RLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred HHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 11111111111 111222334688999999999999999999999999988765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=359.49 Aligned_cols=252 Identities=26% Similarity=0.333 Sum_probs=199.6
Q ss_pred ccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 615 SENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
..+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 356899999999999976 46899999998764 345567899999999999999999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE--CCCCcEEEeeccccccCCCCC
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL--GDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl--~~~~~~ki~DfGla~~~~~~~ 771 (959)
|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++......
T Consensus 171 ~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 171 GELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CEEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999988542 2468999999999999999999999 899999999999999 667899999999998765433
Q ss_pred cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcc
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (959)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .... ...+..
T Consensus 244 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~i~~----------~~~~~~- 308 (373)
T 2x4f_A 244 K--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILA----------CRWDLE- 308 (373)
T ss_dssp B--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHH----------TCCCSC-
T ss_pred c--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh----------ccCCCC-
Confidence 2 234579999999999999999999999999999999999999998876543211 1010 000000
Q ss_pred cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 852 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..........+.+++.+||+.||++||++.|+++ ++++.
T Consensus 309 --~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~--hp~~~ 347 (373)
T 2x4f_A 309 --DEEFQDISEEAKEFISKLLIKEKSWRISASEALK--HPWLS 347 (373)
T ss_dssp --SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred --hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc--CcCcC
Confidence 0000112246789999999999999999999987 44444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.84 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=201.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999765 688999999876532 234457889999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999998642 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
............||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+. ...
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~----------~~~ 251 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---GAHIN----------QAI 251 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---HHHHH----------SCC
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---HHHhc----------cCC
Confidence 54433334456799999999999999999999999999999999999999987543211 11111 000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHhHhhc
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP-DMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~~ 896 (959)
.... .........+.+++.+||+.||++|| +++++++.|+..+...
T Consensus 252 ~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 252 PRPS---TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp CCGG---GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCcc---ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0000 00111223678999999999999999 9999999988776543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=356.34 Aligned_cols=251 Identities=24% Similarity=0.291 Sum_probs=207.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|+..+.||+|+||.||+|... +|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999765 689999999865422 1234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999998642 458999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +. .
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~----------~ 252 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IV----------S 252 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH----------H
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH------HH----------c
Confidence 32 2345799999999999999999999999999999999999999987654332111 00 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~L~~~~~ 894 (959)
.....+. .....+.+++.+||+.||++||+ ++++++ ++++.
T Consensus 253 ~~~~~p~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f~ 298 (350)
T 1rdq_E 253 GKVRFPS---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp CCCCCCT---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred CCCCCCC---CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCcC
Confidence 1111111 12246789999999999999998 888876 44443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.22 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=198.1
Q ss_pred hcCCcccCcccccCceEEEEEEE----cCCcEEEEEEccccccc--HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|+..+.||+|+||.||+|.. .+++.||+|++.+.... ......+.+|+++++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999976 47899999999765322 2345567899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999998542 468899999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i---------- 233 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---I---------- 233 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H----------
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH---H----------
Confidence 98543322 123446799999999999999999999999999999999999999987654332110 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
........ ......+.+++.+||+.||++|| ++.++++ +++++
T Consensus 234 ---~~~~~~~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f~ 281 (327)
T 3a62_A 234 ---LKCKLNLP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFFR 281 (327)
T ss_dssp ---HHTCCCCC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGGS
T ss_pred ---HhCCCCCC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCccc
Confidence 00011111 11224678999999999999999 7778866 45554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.59 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=198.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------ 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 682 (959)
.++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467999999999999999999875 79999999987543 3445678999999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEEecCCCchhhHHhhcccCCCCCC
Q 002149 683 ---------------------------------------------------ERLLVYEYMPQGALSKHIFHWKSLNLEPL 711 (959)
Q Consensus 683 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l 711 (959)
..++||||+++|+|.+++.... .....
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~ 161 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDR 161 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGS
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccch
Confidence 3789999999999999996532 23456
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc-----------ceeecccc
Q 002149 712 SWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER-----------SVVTRLAG 780 (959)
Q Consensus 712 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~-----------~~~~~~~g 780 (959)
++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 788899999999999999999 8999999999999999999999999999986654321 12234579
Q ss_pred ccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHH
Q 002149 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFET 860 (959)
Q Consensus 781 t~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 860 (959)
|+.|+|||++.+..++.++|||||||++|||++|..|+. +......... .... .......
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~-------------~~~~--~~~~~~~ 298 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVR-------------NLKF--PLLFTQK 298 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHH-------------TTCC--CHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhh-------------ccCC--CcccccC
Confidence 999999999999999999999999999999999866532 1111111010 0000 0111122
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 861 FWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 861 ~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...+.+++.+||+.||++||++.|+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 345689999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=359.87 Aligned_cols=270 Identities=23% Similarity=0.275 Sum_probs=210.0
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-----CCCceeEEE
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-----HRHLVSLLG 676 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 676 (959)
++....+.++|.+.++||+|+||.||+|.. .+++.||||++.. .....+.+..|+++++.++ ||||+++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 333345568999999999999999999976 4788999999874 2445567788999999996 999999999
Q ss_pred EEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC----
Q 002149 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---- 752 (959)
Q Consensus 677 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---- 752 (959)
++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 999999999999999 99999998652 22468999999999999999999999 89999999999999975
Q ss_pred ---------------------CCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHH
Q 002149 753 ---------------------DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMEL 811 (959)
Q Consensus 753 ---------------------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~el 811 (959)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999865432 2345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC--------C---c--ccCCCCCHHH---------------HHH
Q 002149 812 LTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID--------P---I--LEVNDDTFET---------------FWT 863 (959)
Q Consensus 812 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~---~--~~~~~~~~~~---------------~~~ 863 (959)
++|+.||......+............. ......... . . .......... ...
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIP-KNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCC-HHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCC-HHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 999999988765543322221111000 011111000 0 0 0000000000 135
Q ss_pred HHHHHHhcccCCCCCCCCHHHHHH
Q 002149 864 IAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 864 l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.+++.+||+.||++|||+.|+++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCCCHHHHhc
Confidence 679999999999999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.82 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=203.5
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcE----EEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..+.||+|+||.||+|... +++. ||+|.+.... .....+.+.+|+.+++.++||||+++++++. +...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 57889999999999999999754 4554 7778765432 2233355778999999999999999999986 45688
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999998542 2568899999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
....... .......||..|+|||++.+..++.++|||||||++|||++ |+.||......+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------------ 231 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE------------ 231 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH------------
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH------------
Confidence 7654332 22344578889999999999999999999999999999999 999998766544322111
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ..... ......+.+++.+||+.||++||++.++++.|..+...
T Consensus 232 -~~~--~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 232 -KGE--RLAQP---QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -TTC--BCCCC---TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -cCC--CCCCC---CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 00000 01112467899999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=355.60 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=205.9
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|.+.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+++++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999976 578999999987542211 2235788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+ +|+|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 88998888542 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+. ...
T Consensus 159 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------------~~~ 219 (336)
T 3h4j_B 159 TDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------------FKK 219 (336)
T ss_dssp TTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------BCC
T ss_pred cCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------HHH
Confidence 4432 2344579999999999988776 6899999999999999999999976542211 001
Q ss_pred cCC-cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDP-ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.. ....+ ......+.+++.+||+.||.+|||+.|+++ ++++..
T Consensus 220 i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 220 VNSCVYVMP---DFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp CCSSCCCCC---TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred HHcCCCCCc---ccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 110 01111 112246789999999999999999999987 566654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.68 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=192.4
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.+.++|++.+.||+|+||.||+|... +++.||||++... ...+.+.+|++++++++||||+++++++.+....++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 34578999999999999999999875 5789999998754 234568899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~DfGl 763 (959)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+
T Consensus 126 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 9999999999998843 2568999999999999999999999 89999999999999975 88999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..
T Consensus 198 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~------------ 261 (349)
T 2w4o_A 198 SKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FR------------ 261 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HH------------
T ss_pred ccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HH------------
Confidence 98654322 233467999999999999999999999999999999999999999765543211 10
Q ss_pred HHhcCCcccC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 844 RAAIDPILEV-NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 844 ~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
......... ..........+.+++.+||+.||++||++.++++ ++++.
T Consensus 262 -~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 310 (349)
T 2w4o_A 262 -RILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVT 310 (349)
T ss_dssp -HHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTT
T ss_pred -HHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccC
Confidence 011110000 0011122346789999999999999999999977 44443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=347.52 Aligned_cols=254 Identities=28% Similarity=0.376 Sum_probs=200.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+++++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 457899999999999999999764 68899999987653 2334577899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeeccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGla~ 765 (959)
||+++|+|.+++..... ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999998865322 22679999999999999999999999 899999999999999 456889999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... ......||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+......
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-------------- 238 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-------------- 238 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------------
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc--------------
Confidence 654432 234457999999999875 578999999999999999999999998876544221110
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
......... .......+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 239 YKEPNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HCCCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCCcccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111000 0011236779999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=352.33 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=206.2
Q ss_pred cCCcccCcccccCceEEEEEEEcC-----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|...+.||+|+||.||+|.... +..||||++.... .......+.+|+++++.++||||+++++++......+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 567888999999999999997542 2359999987542 4455677999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 999999999999998542 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~---~--------- 263 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---I--------- 263 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H---------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH---H---------
Confidence 65443221 1223356789999999999999999999999999999999 9999987654332110 0
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.... ... ........+.+++.+||+.||++||++.++++.|+.+++...
T Consensus 264 -~~~~--~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 264 -NDGF--RLP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -HTTC--CCC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -HCCC--cCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0000 001 111223468899999999999999999999999999887543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.07 Aligned_cols=275 Identities=26% Similarity=0.355 Sum_probs=217.3
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEE
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLL 675 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 675 (959)
........++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+.+|+.++.++ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 334444567899999999999999999974 35688999998765 2445567899999999999 799999999
Q ss_pred EEEEeCc-eEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002149 676 GYSVAGY-ERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDL 743 (959)
Q Consensus 676 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di 743 (959)
+++.... ..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+ ++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9987654 589999999999999999653221 01238999999999999999999999 89999999
Q ss_pred CCCCEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 002149 744 KSSNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDES 821 (959)
Q Consensus 744 k~~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~ 821 (959)
||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544332 22334568899999999999999999999999999999998 99999876
Q ss_pred ChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 822 RPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
...+.. .. .+........ . ......+.+++.+||+.||.+||++.+++++|+.+++....
T Consensus 255 ~~~~~~--~~----------~~~~~~~~~~--~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 314 (316)
T 2xir_A 255 KIDEEF--CR----------RLKEGTRMRA--P---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314 (316)
T ss_dssp CCSHHH--HH----------HHHHTCCCCC--C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred chhHHH--HH----------HhccCccCCC--C---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcc
Confidence 543211 10 0111000101 1 11223678999999999999999999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.63 Aligned_cols=260 Identities=27% Similarity=0.340 Sum_probs=208.3
Q ss_pred hcCCcccC-cccccCceEEEEEEE---cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASEN-ELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~-~lG~G~fg~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|.+.+ .||+|+||.||+|.+ .+++.||||++..........+.+.+|+++++.++||||+++++++ .....+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999954 2467899999986544445577899999999999999999999998 566789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999998542 458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~-------- 234 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---E-------- 234 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H--------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H--------
Confidence 665443322 222456789999999998889999999999999999999 99999887654321111 0
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.... .. ........+.+++.+||+.||++||++.++++.|+.++...
T Consensus 235 --~~~~--~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 235 --KGER--MG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --TTCC--CC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --cCCC--CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0000 00 11122346889999999999999999999999999988653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=379.74 Aligned_cols=266 Identities=24% Similarity=0.344 Sum_probs=209.6
Q ss_pred CcccC-cccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 613 FASEN-ELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 613 ~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+...+ .||+|+||.||+|.+. ++..||||+++... .....+.+.+|++++++++|||||++++++.. +..++||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 33344 7999999999999764 46679999997652 33456789999999999999999999999876 5689999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 415 E~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp ECCTTCBHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EeCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999853 23569999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.... +. .
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---i~----------~ 554 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IE----------Q 554 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH---HH----------T
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HH----------c
Confidence 432211 122345689999999999999999999999999999998 9999988765442111 10 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCc
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE 905 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~ 905 (959)
. ..+... ......+.+++.+||+.||++||++.+|++.|+.+........+.+.+
T Consensus 555 ~--~~~~~p---~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~ 609 (613)
T 2ozo_A 555 G--KRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSA 609 (613)
T ss_dssp T--CCCCCC---TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSS
T ss_pred C--CCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccc
Confidence 0 011111 123347889999999999999999999999999998877665554433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=351.04 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=203.3
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.+.|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688999999999999999975 5789999999875432 334457789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+. |++.+++... ...+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99995 7888877542 2578999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
... ....||+.|+|||++. ...++.++|||||||++|||++|+.||......+..... .
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-------------~ 266 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------A 266 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------H
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------H
Confidence 432 2357999999999984 567899999999999999999999999876543321100 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
....+..... .....+.+++.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 QNESPALQSG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HSCCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111111 122357899999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=364.91 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=208.4
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|.+.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57899999999999999999765 79999999987542211 23567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999843 2568999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+... ...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----------------~i~ 229 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----------------KIC 229 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----------------HHH
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----------------HHh
Confidence 432 2344679999999999988765 689999999999999999999998765432211 111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.....+. .....+.+++.+||+.||++|||+.++++ ++++..
T Consensus 230 ~~~~~~p~---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~~ 272 (476)
T 2y94_A 230 DGIFYTPQ---YLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFKQ 272 (476)
T ss_dssp TTCCCCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHHT
T ss_pred cCCcCCCc---cCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhhh
Confidence 11111111 11236789999999999999999999987 455544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.67 Aligned_cols=267 Identities=16% Similarity=0.188 Sum_probs=198.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHH---------HHHHHHHHHHHHHhcCCCCceeEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKK---------AVDEFHSEIAVLSKVRHRHLVSLLG 676 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~ 676 (959)
.++|...+.||+|+||.||+|... ++..||||++........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357999999999999999999875 578899999875421111 1234667889999999999999999
Q ss_pred EEEe----CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 002149 677 YSVA----GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD 752 (959)
Q Consensus 677 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~ 752 (959)
++.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9988 77889999999 99999998542 378999999999999999999999 89999999999999988
Q ss_pred CC--cEEEeeccccccCCCCCc------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChH
Q 002149 753 DF--RAKVSDFGLVKLAPDSER------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPE 824 (959)
Q Consensus 753 ~~--~~ki~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~ 824 (959)
++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 999999999986543211 1123457999999999999999999999999999999999999999653222
Q ss_pred HHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 825 ERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
..................+...... ......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAPS--------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSCT--------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHHHHHHHHhhcccccHHHHhhccc--------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1111110000000001111111110 012236889999999999999999999999887653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=359.39 Aligned_cols=256 Identities=16% Similarity=0.199 Sum_probs=209.1
Q ss_pred hcCCcccCcccccCceEEEEEE------EcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC---CCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGE------LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 680 (959)
.++|.+.+.||+|+||.||+|. ..+++.||||++... ...++.+|+++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 4678999999999999999993 456889999998753 2346778888888886 9999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--------
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-------- 752 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-------- 752 (959)
.+..++||||+++|+|.+++...+......+++..++.++.||+.||+|||+ ++||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999977555555789999999999999999999999 89999999999999998
Q ss_pred ---CCcEEEeeccccccCC-CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 002149 753 ---DFRAKVSDFGLVKLAP-DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828 (959)
Q Consensus 753 ---~~~~ki~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~ 828 (959)
++.+||+|||+|+... ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 8999999999997543 122334456789999999999999999999999999999999999999986432211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHHHHhHhhc
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQR-PDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~ev~~~L~~~~~~~ 896 (959)
..+....... .....+.+++..|++.+|.+| |++.++.+.|+.++...
T Consensus 293 ----------------~~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ----------------CKPEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------------EEECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------eeechhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111111 113356789999999999998 67888888888888763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=346.86 Aligned_cols=269 Identities=21% Similarity=0.274 Sum_probs=200.8
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc---HHHHHHHHHHHHHHHhcC---CCCceeEEEEEEeC
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS---KKAVDEFHSEIAVLSKVR---HRHLVSLLGYSVAG 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 681 (959)
+.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+++++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999975 57899999998743211 111245667777777764 99999999999875
Q ss_pred c-----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcE
Q 002149 682 Y-----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756 (959)
Q Consensus 682 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ 756 (959)
. ..++||||+. |+|.+++... ....+++.++..++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 5 5789999995 7999998542 22459999999999999999999999 899999999999999999999
Q ss_pred EEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 757 KVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 757 ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...........
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999998664332 234567999999999999999999999999999999999999999887654432211111000
Q ss_pred hcchHHHHHhcC---Cccc-CCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 837 KSDKEKLRAAID---PILE-VNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 837 ~~~~~~~~~~~~---~~~~-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.. ......... .... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CC-TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 000000000 0000 00000 012246789999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=355.32 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=204.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|+..+.||+|+||.||+|+.. +++.||||++.+... .....+.+.+|..++..+ +||||+++++++.+....++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999875 478999999876422 123356678899999988 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999998642 458999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i---------- 233 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------I---------- 233 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H----------
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH------H----------
Confidence 43222 223456899999999999999999999999999999999999999987654332110 1
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
.......+ ......+.+++.+||+.||++||+ +.++++
T Consensus 234 ~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 234 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01111111 112346789999999999999995 466655
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.52 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=197.3
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----e
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----E 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 683 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+++++.++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999975 5789999999976532 3345677899999999999999999999987654 3
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 49999999999999998642 468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .......
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~~-- 238 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPIP-- 238 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHCCCCC--
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCCCCC--
Confidence 986544322 1223457999999999999999999999999999999999999999887654421110 1000000
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... .......+.+++.+||+.||++||++.++++
T Consensus 239 --~~~~---------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 --PSAR---------HEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp --HHHH---------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred --cccc---------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0000 0011236789999999999999998877755
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=354.07 Aligned_cols=267 Identities=28% Similarity=0.424 Sum_probs=214.5
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
...++|+..+.||+|+||.||+|... +++.||||++... ........+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34568999999999999999999654 3678999998754 2445566789999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKS-----LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRA 756 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ 756 (959)
...++||||+++|+|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 999999999999999999865321 112467999999999999999999999 899999999999999999999
Q ss_pred EEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002149 757 KVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 757 ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 834 (959)
||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH---HH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH---HH
Confidence 9999999985533221 11223467889999999999999999999999999999999 8999987654332111 10
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.... ..........+.+++.+|++.||++||++.++++.|+..+..+
T Consensus 255 -------------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 255 -------------EGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp -------------TTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred -------------cCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 0000 0011122346889999999999999999999999998776543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=355.03 Aligned_cols=274 Identities=25% Similarity=0.404 Sum_probs=200.3
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHH--HHhcCCCCceeEEEEEEe-----Cc
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAV--LSKVRHRHLVSLLGYSVA-----GY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~ 682 (959)
.++|+..+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36789999999999999999976 5899999998643 12334444444 445899999999986543 23
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEecCCCCCCEEECCC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ---------SFIHRDLKSSNILLGDD 753 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivH~Dik~~NiLl~~~ 753 (959)
..++||||+++|+|.+++.. ...++..++.++.||+.||+|||+ . +|+||||||+|||++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCC
Confidence 66899999999999999954 345899999999999999999999 6 99999999999999999
Q ss_pred CcEEEeeccccccCCCCC-------cceeecccccccccccccccc-------CCCCccchHHHHHHHHHHHHhCCCCCC
Q 002149 754 FRAKVSDFGLVKLAPDSE-------RSVVTRLAGTFGYLAPEYAVT-------GKITTKVDVFSFGVVLMELLTGLMALD 819 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~ll~elltg~~p~~ 819 (959)
+.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999998654321 112234579999999999977 456778999999999999999977764
Q ss_pred CCChHHH-HH-HHHHHHhhhcchHHHHHhcC-----Cccc-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 820 ESRPEER-QY-LAAWFWNIKSDKEKLRAAID-----PILE-VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 820 ~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
....... .. ...... ...........+. +... ...........+.+++.+||+.||++|||+.|+++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVG-NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp TTSCCCCCCCTTHHHHC-SSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CccchhHHHHhhhcccC-CCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 3221100 00 000000 0000011111111 1111 111223455679999999999999999999999999999
Q ss_pred hHhhcCCC
Q 002149 892 LVEKWKPL 899 (959)
Q Consensus 892 ~~~~~~~~ 899 (959)
++..|...
T Consensus 316 ll~~~~~~ 323 (336)
T 3g2f_A 316 LMMIWERN 323 (336)
T ss_dssp HHHCCCC-
T ss_pred HHHHHHhc
Confidence 99988763
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.88 Aligned_cols=273 Identities=21% Similarity=0.352 Sum_probs=213.5
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHh--cCCCCceeEEEEEEe
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK--VRHRHLVSLLGYSVA 680 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 680 (959)
......+.++|...+.||+|+||.||+|... |+.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3444566789999999999999999999875 899999998643 34567889999988 689999999999988
Q ss_pred Cc----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCE
Q 002149 681 GY----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH--------SLAHQSFIHRDLKSSNI 748 (959)
Q Consensus 681 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dik~~Ni 748 (959)
.. ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| + .+|+||||||+||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNI 178 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHE
Confidence 76 78999999999999999954 45899999999999999999999 6 8999999999999
Q ss_pred EECCCCcEEEeeccccccCCCCCcc---eeeccccccccccccccccC------CCCccchHHHHHHHHHHHHhC-----
Q 002149 749 LLGDDFRAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPEYAVTG------KITTKVDVFSFGVVLMELLTG----- 814 (959)
Q Consensus 749 Ll~~~~~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~ll~elltg----- 814 (959)
+++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999865443322 22345799999999998775 344789999999999999999
Q ss_pred -----CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 002149 815 -----LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889 (959)
Q Consensus 815 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 889 (959)
..||......+... ..+.... ......+.+............+.+++.+||+.||++||++.+|+++|
T Consensus 259 ~~~~~~~p~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSV-EEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCH-HHHHHHH------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCccccCcCcccH-HHHHHHH------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 77886543221100 0000000 00111111111112335667899999999999999999999999999
Q ss_pred HHhHhhcC
Q 002149 890 APLVEKWK 897 (959)
Q Consensus 890 ~~~~~~~~ 897 (959)
+.+.++..
T Consensus 332 ~~i~~~~~ 339 (342)
T 1b6c_B 332 SQLSQQEG 339 (342)
T ss_dssp HHHHHTTC
T ss_pred HHHHHHhc
Confidence 99987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.97 Aligned_cols=304 Identities=22% Similarity=0.324 Sum_probs=225.0
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce-----
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE----- 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 683 (959)
.++|...+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999976 468999999997765556667889999999999999999999999987643
Q ss_pred -EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 684 -RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 684 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
.++||||+. |+|.+++. ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999995 78877662 358999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+..... .........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~ 245 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPGT 245 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH--HHHHCBCCH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCH
Confidence 99865332 234578999999999877 67899999999999999999999999887654332211 111000000
Q ss_pred H---------HHHhc---CCccc--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCccc
Q 002149 842 K---------LRAAI---DPILE--VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYS 907 (959)
Q Consensus 842 ~---------~~~~~---~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~ 907 (959)
. ....+ ..... ...........+.+++.+||..||++|||+.++++ +++++.+..++.++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~f~~~~~~~~~~~~~~ 323 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT--HPFFEPFRDPEEETEAQQ 323 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT--SGGGTTTCCGGGCCCCSS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc--CcchhhccCccccccCCC
Confidence 0 00111 00000 01111123457889999999999999999999987 778877666555444433
Q ss_pred CcccCCC-hhhhHHHHHHhhCCCcce
Q 002149 908 GIDYSLP-LNQMVKDWQEAEGKDLSY 932 (959)
Q Consensus 908 ~~~~~~~-~~~~~~~~~~~~~~~~~~ 932 (959)
.++.... .....++|++....+...
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (353)
T 3coi_A 324 PFDDSLEHEKLTVDEWKQHIYKEIVN 349 (353)
T ss_dssp CCCCTTTTCCCCHHHHHHHHHHHHHT
T ss_pred CCccchhhccCCHHHHHHHHHHHHHh
Confidence 3333222 245667888776554443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.17 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=211.2
Q ss_pred HHHHHhcCCccc-CcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC
Q 002149 605 VLRNVTKNFASE-NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG 681 (959)
Q Consensus 605 ~~~~~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 681 (959)
..+.+.++|.+. +.||+|+||.||+|... +++.||||++............+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345666778887 88999999999999765 689999999987654455567889999999999 479999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKV 758 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki 758 (959)
...++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred CeEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999998843 223679999999999999999999999 89999999999999988 789999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...... ..
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~-- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QV-- 248 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HT--
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hc--
Confidence 9999998664432 2234579999999999999999999999999999999999999998766543211110 00
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..... ..........+.+++.+||+.||++|||++++++ +++++.+
T Consensus 249 -------~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 249 -------NVDYS---EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp -------CCCCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred -------ccccC---chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 00000 0111122346789999999999999999999976 4555443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=354.38 Aligned_cols=288 Identities=21% Similarity=0.245 Sum_probs=211.9
Q ss_pred cHHHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccc---------cHHHHHHHHHHHHHHHhcCCCCce
Q 002149 602 SVQVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVI---------SKKAVDEFHSEIAVLSKVRHRHLV 672 (959)
Q Consensus 602 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv 672 (959)
..+++..+.++|...+.||+|+||.||+|...+|+.||||++..... .....+.+.+|+++++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45678888999999999999999999999888899999999865322 223347899999999999999999
Q ss_pred eEEEEEEeC-----ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 002149 673 SLLGYSVAG-----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSN 747 (959)
Q Consensus 673 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~N 747 (959)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD----QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 999998543 36799999996 788888753 23579999999999999999999999 899999999999
Q ss_pred EEECCCCcEEEeeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 748 ILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 748 iLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998543322 2334578999999999877 6789999999999999999999999988765443
Q ss_pred HHHHHHHHhhhc-------chHHHHHhcCCccc-CCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 827 QYLAAWFWNIKS-------DKEKLRAAIDPILE-VNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 827 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
............ ........+..... ...... .....+.+++.+||+.||++|||+.|+++ ++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~f 320 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR--HPYF 320 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGG
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--Cchh
Confidence 221111000000 00111122211111 011111 11235789999999999999999999987 7777
Q ss_pred hhcCCCCC
Q 002149 894 EKWKPLDD 901 (959)
Q Consensus 894 ~~~~~~~~ 901 (959)
+....+.+
T Consensus 321 ~~~~~~~~ 328 (362)
T 3pg1_A 321 ESLFDPLD 328 (362)
T ss_dssp TTTCCGGG
T ss_pred hhccCccc
Confidence 76654433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=355.29 Aligned_cols=266 Identities=26% Similarity=0.382 Sum_probs=213.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcC-C-----cEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD-G-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|...+.||+|+||.||+|.... + ..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4678999999999999999997642 2 479999987642 345567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSL---------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD 753 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~ 753 (959)
..++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999998653211 12468999999999999999999999 899999999999999999
Q ss_pred CcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAA 831 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~ 831 (959)
+.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......... .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--K 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--H
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--H
Confidence 9999999999985433222 22334567889999999999999999999999999999999 999998765433211 1
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
. ......... . ......+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 279 ~----------~~~~~~~~~--~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 279 L----------VKDGYQMAQ--P---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp H----------HHHTCCCCC--C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----------HhcCCCCCC--C---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 0 111111110 1 111346789999999999999999999999999887643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.57 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=202.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcE----EEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTK----IAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.++|+..+.||+|+||.||+|... +++. ||+|.+... ......+.+.+|+.+++.++||||+++++++..+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 357999999999999999999754 4554 577766543 23345678899999999999999999999998765 7
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8999999999999998652 2568999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 765 KLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 765 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----------- 233 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE----------- 233 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----------
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------
Confidence 86543322 22233457889999999999999999999999999999999 999998876544321110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ... ........+.+++.+||+.||.+||++.|+++.|..+...
T Consensus 234 --~~~--~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 --KGE--RLP---QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --TTC--CCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --cCC--CCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 000 000 1111233678999999999999999999999999988753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=379.02 Aligned_cols=253 Identities=27% Similarity=0.351 Sum_probs=204.1
Q ss_pred CcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.||+|+||.||+|.+. +++.||||+++.........+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999998765555567889999999999999999999999865 457899999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCc-
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER- 772 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~- 772 (959)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999954 2568999999999999999999999 8999999999999999999999999999986644332
Q ss_pred -ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 773 -SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 773 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+..... .... .
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------------~~~~--~ 590 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------------EKGE--R 590 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------------HTTC--C
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HcCC--C
Confidence 12233457889999999999999999999999999999998 99999887654422111 0000 0
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.. ........+.+++.+||+.||++||++.+|++.|+.++.+.
T Consensus 591 ~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 591 MG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11 11122346889999999999999999999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=358.12 Aligned_cols=261 Identities=30% Similarity=0.414 Sum_probs=199.3
Q ss_pred CCcccCcccccCceEEEEEEEc--CC--cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-CceEEE
Q 002149 612 NFASENELGRGGFGVVYKGELD--DG--TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYERLL 686 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 686 (959)
.|...+.||+|+||.||+|... ++ ..||||.+... ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4667789999999999999753 22 36899988753 344567789999999999999999999998754 457799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhh----cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999854 22568899999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcc---eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 767 APDSERS---VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 767 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.... +.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~-------- 310 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL-------- 310 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HH--------
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HH--------
Confidence 5432211 1233567889999999999999999999999999999999 6778876544332110 00
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.. .....+ ......+.+++.+||+.||++||++.++++.|+.++..+..
T Consensus 311 --~~--~~~~~p---~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 311 --QG--RRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --TT--CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --cC--CCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 00 000101 11234688999999999999999999999999999987654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=362.30 Aligned_cols=254 Identities=25% Similarity=0.324 Sum_probs=202.4
Q ss_pred hcCCcccCcccccCceEEEEEEE----cCCcEEEEEEcccccc--cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVI--SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 682 (959)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+.+|+++++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999986 4789999999875422 112334567899999999 6999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999998642 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHhhhcc
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQ-YLAAWFWNIKSD 839 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 839 (959)
+++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+..
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------- 276 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-------- 276 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--------
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--------
Confidence 998665444434455689999999999986 35789999999999999999999999754322111 1111
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 887 (959)
........ ........+.+++.+||..||++|| ++.++++
T Consensus 277 -----~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 277 -----RILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -----HHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----HHhccCCC---CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 00001111 1111234678999999999999999 8999877
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=351.21 Aligned_cols=274 Identities=19% Similarity=0.282 Sum_probs=207.4
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--------C
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--------G 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 681 (959)
++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999976 578999999987654444445677899999999999999999999887 3
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||++ |++.+.+.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHC----TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999995 577777743 22569999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCC---cceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 762 GLVKLAPDSE---RSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 762 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+............
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998654322 122344678999999999876 458999999999999999999999999877655433222111110
Q ss_pred cchHHHHH-----hcCCc--ccCCCCCHH-H------HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 838 SDKEKLRA-----AIDPI--LEVNDDTFE-T------FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 838 ~~~~~~~~-----~~~~~--~~~~~~~~~-~------~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. ...... ..+.. ......... . ...+.+++.+||+.||++|||+.|+++ ++++..
T Consensus 249 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~ 317 (351)
T 3mi9_A 249 T-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFWS 317 (351)
T ss_dssp C-TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGS
T ss_pred C-hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--CCCcCC
Confidence 0 000000 00000 000000111 1 234779999999999999999999987 566543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.84 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=206.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 686 (959)
.++|+..+.||+|+||.||+|... +++.||+|++..........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 367899999999999999999765 78999999998765566677889999999999999999999998764 568899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCEEECCCCcEEEeec
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS-----FIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999876432 23568999999999999999999999 56 999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
|+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... +
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---i-------- 228 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---I-------- 228 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H--------
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH---H--------
Confidence 99986544321 12335789999999999999999999999999999999999999987754332110 1
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
.......+ .......+.+++.+||+.||++||++.++++.
T Consensus 229 --~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 229 --REGKFRRI-----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp --HHTCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --hhcccccC-----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01000011 11123468899999999999999999999873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=337.64 Aligned_cols=257 Identities=24% Similarity=0.294 Sum_probs=207.0
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4567999999999999999999765 57789999987642 23356789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGla 764 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999988542 458999999999999999999999 899999999999999 78899999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+..... ............
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 231 (277)
T 3f3z_A 157 ARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDW 231 (277)
T ss_dssp EECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCCHHHH
T ss_pred eeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhCCCCCCchhh
Confidence 8665432 2344579999999998865 4899999999999999999999999876654321111 000000000000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
......+.+++.+|++.||++||++.++++ ++++++
T Consensus 232 -------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~~ 267 (277)
T 3f3z_A 232 -------------LNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFEK 267 (277)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHH
T ss_pred -------------hcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhc
Confidence 011236789999999999999999999987 455543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=348.39 Aligned_cols=264 Identities=30% Similarity=0.448 Sum_probs=209.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEE--EEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKI--AVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
++|+..+.||+|+||.||+|... +++.+ |||.+... ......+.+.+|+++++++ +||||+++++++.+....++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 57889999999999999999654 56644 99988753 2344566789999999999 89999999999999999999
Q ss_pred EEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 687 VYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
||||+++|+|.+++..... .....+++.+++.++.||+.||+|||+ ++|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999865321 123579999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~------ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------ 252 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH------
Confidence 9999999997432211 1223457889999999998889999999999999999998 999998776533211
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
. +...... .........+.+++.+||+.||++||++.++++.|..++++...
T Consensus 253 ~-------~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 253 K-------LPQGYRL-----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp H-------GGGTCCC-----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred H-------hhcCCCC-----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 0 1111111 11112234688999999999999999999999999999887544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=359.62 Aligned_cols=278 Identities=20% Similarity=0.249 Sum_probs=213.7
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc--eEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY--ERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 686 (959)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 357899999999999999999765 58999999987542 2233567789999999999999999999998765 7799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCcEEEeecc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFRAKVSDFG 762 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----~~~~~~ki~DfG 762 (959)
||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999865322 2348999999999999999999999 899999999999999 778889999999
Q ss_pred ccccCCCCCcceeecccccccccccccccc--------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVT--------GKITTKVDVFSFGVVLMELLTGLMALDESRPEE--RQYLAAW 832 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~--~~~~~~~ 832 (959)
+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+...
T Consensus 162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 998765432 2334679999999999865 567889999999999999999999997543211 1111111
Q ss_pred HHhhhcc--------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 833 FWNIKSD--------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 833 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
....... ......+.................+.+++.+||..||++||++.++++.+..++.+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1100000 00000000011111223456677888999999999999999999999999998875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=346.40 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=206.7
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+.++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999765 68999999987643221 135678999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEe
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVS 759 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~ 759 (959)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999853 2568999999999999999999999 8999999999999999887 79999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.....
T Consensus 162 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~- 235 (321)
T 2a2a_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---ITSVSY- 235 (321)
T ss_dssp CCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHTTCC-
T ss_pred cCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHhccc-
Confidence 999998665432 22445799999999999999999999999999999999999999987654332111 000000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.....+. . .....+.+++.+|++.||++|||+.++++
T Consensus 236 --~~~~~~~-----~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFF-----S----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHH-----T----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhh-----c----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 0 11235789999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=343.84 Aligned_cols=262 Identities=30% Similarity=0.406 Sum_probs=206.8
Q ss_pred cCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE-eCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV-AGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 685 (959)
.+|+..+.||+|+||.||+|...+ ...||+|.+... ......+.+.+|+.++++++||||+++++++. .....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468888999999999999997542 235899988753 34556678999999999999999999999865 456789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHC----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 99999999999999854 23568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc---ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 766 LAPDSER---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 766 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
....... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||......+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----------- 245 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----------- 245 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-----------
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-----------
Confidence 6544321 12234567889999999999999999999999999999999 56666655433221100
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
...... .. . ......+.+++.+|++.||++||++.++++.|++++..+..
T Consensus 246 --~~~~~~-~~-~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 246 --LQGRRL-LQ-P---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp --HTTCCC-CC-C---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred --hcCCCC-CC-C---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 000000 00 1 11223688999999999999999999999999999886544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=349.03 Aligned_cols=271 Identities=22% Similarity=0.340 Sum_probs=207.0
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.+|+++++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999765 5899999998766555666777889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999988887632 2468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH--
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA-- 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 845 (959)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+......... .........
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 252 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL--GNLIPRHQELF 252 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CSCCHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh--CCCChhhhhHh
Confidence 3222 23345789999999999875 78999999999999999999999998876544322211110 000000000
Q ss_pred --------hcCCcccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 846 --------AIDPILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 846 --------~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
...+... .... ......+.+++.+||+.||++|||+.|+++ +++++
T Consensus 253 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~ 311 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIK-EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQ 311 (331)
T ss_dssp HHCGGGTTCCCCCCS-SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHH
T ss_pred hhccccccccCcccc-ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc--Cchhc
Confidence 0000000 0000 012346889999999999999999999987 44444
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.90 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=181.9
Q ss_pred cCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEecCC
Q 002149 616 ENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
.+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 378999999999999764 6899999998643 3456789999999997 99999999999999999999999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---cEEEeeccccccCCCC
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF---RAKVSDFGLVKLAPDS 770 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~---~~ki~DfGla~~~~~~ 770 (959)
|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 91 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 91 GELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999999854 2568999999999999999999999 8999999999999997665 8999999999865443
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+.........
T Consensus 163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 163 NQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT---------SAVEIMKKIKKGD 232 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC---------CHHHHHHHHTTTC
T ss_pred CC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc---------cHHHHHHHHHcCC
Confidence 22 2344578999999999999999999999999999999999999998654321100 0001111111111
Q ss_pred ccCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 851 LEVNDDT-FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 851 ~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....... ......+.+++.+||+.||++||++.++++ +++++..
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~~ 277 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQDG 277 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCTT
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--ChhhccC
Confidence 1111100 112346889999999999999999999976 4555443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.09 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=201.5
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYERLL 686 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 686 (959)
.|...+.||+|+||.||+|.. .++..||+|++..........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477788999999999999976 467899999998776677778889999999999999999999998875 456899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEC-CCCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLG-DDFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~-~~~~~ki~DfGl 763 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||+++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999998542 468999999999999999999999 67 99999999999997 789999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++...... .....||+.|+|||++. +.++.++|||||||++|||++|+.||.......... ..+.
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~--------- 243 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRVT--------- 243 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HHHT---------
T ss_pred cccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--HHHh---------
Confidence 97554432 23457999999999876 468999999999999999999999998754433211 0000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+. .........+.+++.+||+.||++||++.++++
T Consensus 244 -~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 -SGVKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -TTCCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccCCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000000 000111236889999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=370.13 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=209.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|+..+.||+|+||.||+|... +|+.||||++.+.... ......+.+|+++++.++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457899999999999999999764 7899999998754221 22356688999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999988542 23459999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEER-QYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+..
T Consensus 337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----------- 403 (576)
T 2acx_A 337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------- 403 (576)
T ss_dssp CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------
T ss_pred ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------
Confidence 5433 23445899999999999999999999999999999999999999987543211 111111100
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
..... .......+.+++.+||+.||++|| ++.||++ +++++
T Consensus 404 ~~~~~-----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 404 VPEEY-----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred ccccC-----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 00001 111224678999999999999999 7888876 45544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=353.40 Aligned_cols=275 Identities=21% Similarity=0.280 Sum_probs=198.0
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
...++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+++++.++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999975 478999999997664444556678899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-----CCCCcEEEeec
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL-----GDDFRAKVSDF 761 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl-----~~~~~~ki~Df 761 (959)
||||++ |+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999996 6999988542 458999999999999999999999 899999999999999 45566999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...............
T Consensus 182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99986543222 23445789999999999874 48999999999999999999999998876544322111110000000
Q ss_pred H-----HHHHhcCCcccCCCCCHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 841 E-----KLRAAIDPILEVNDDTFE------TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 841 ~-----~~~~~~~~~~~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. .................. ....+.+++.+||+.||++|||+.|+++ +++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~ 323 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE--HPYFS 323 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC--CcccC
Confidence 0 000000000000000111 1246789999999999999999999987 44443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.42 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=202.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CC-------cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DG-------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 681 (959)
.++|...+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 357889999999999999999654 33 47999998654 345567899999999999999999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc------
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR------ 755 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~------ 755 (959)
...++||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999652 2458999999999999999999999 89999999999999998877
Q ss_pred --EEEeeccccccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 002149 756 --AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGL-MALDESRPEERQYLAA 831 (959)
Q Consensus 756 --~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~-~p~~~~~~~~~~~~~~ 831 (959)
+||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|. .|+............
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~- 231 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY- 231 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-
Confidence 999999998755332 23468899999999987 77899999999999999999965 455444332211100
Q ss_pred HHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. . ....... ....+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 232 --~----------~--~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 232 --E----------D--RHQLPAP-----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --H----------T--TCCCCCC-----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --h----------c--cCCCCCC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 0 0000000 012477999999999999999999999999988764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=348.19 Aligned_cols=265 Identities=25% Similarity=0.391 Sum_probs=208.9
Q ss_pred hcCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++... .......++.+|+.+++.++||||+++++++.....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 46799999999999999999973 35778999998754 345566789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL--NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKV 758 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki 758 (959)
.++||||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764321 12458999999999999999999999 89999999999999984 456999
Q ss_pred eeccccccCCCCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhh
Q 002149 759 SDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 759 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+.... +.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~-- 259 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VT-- 259 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH---Hh--
Confidence 9999997442221 122234568899999999999999999999999999999998 9999987654332111 10
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.... .. ........+.+++.+||+.||.+||++.++++.|+.+....
T Consensus 260 --------~~~~--~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 260 --------SGGR--MD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp --------TTCC--CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred --------cCCC--CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 0000 00 11112346889999999999999999999999999887643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=352.63 Aligned_cols=276 Identities=21% Similarity=0.304 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|...+.||+|+||.||+|... +++.||||++.... .......+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57899999999999999999765 78999999986542 11222245579999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|++ |+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 995 6998888542 2568999999999999999999999 8999999999999999999999999999985543
Q ss_pred CCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc--------h
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD--------K 840 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~ 840 (959)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.............. .
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 222 2334578999999999876 56899999999999999999999999987765533222111110000 0
Q ss_pred HHHHHhcCCcccCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 841 EKLRAAIDPILEVND---DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
........+...... ........+.+++.+||+.||++|||+.|+++ ++++.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK--HPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--Chhhhhccc
Confidence 000000000000000 00011235789999999999999999999987 677766544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.89 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=205.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
+.++|+..+.||+|+||.||+|..+ +|+.||||++..... ...+|++++.++ +||||+++++++.++...++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4567999999999999999999765 688999999876422 235688888888 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC----CcEEEeecc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD----FRAKVSDFG 762 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~----~~~ki~DfG 762 (959)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+..+ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999998854 2568999999999999999999999 899999999999998543 359999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+...+..
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~------- 237 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS------- 237 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-------
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-------
Confidence 9986544322 23446789999999999888899999999999999999999999986433222111111110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+.. . ..........+.+++.+||..||++||++.++++ ++++..|..
T Consensus 238 --~~~~~--~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~~~~~~ 286 (342)
T 2qr7_A 238 --GKFSL--S-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWIVHWDQ 286 (342)
T ss_dssp --CCCCC--C-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHHTGGG
T ss_pred --CCccc--C-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCeecCccc
Confidence 00000 0 0011122346789999999999999999999987 677766644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=342.03 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=209.8
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999975 468999999987543 2344678899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999998843 568999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... .....
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~ 236 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------------PKNNP 236 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSCC
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-------------hcCCC
Confidence 4322 233457899999999999999999999999999999999999999876654321111 01011
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+... ......+.+++.+||+.||++||++.++++ ++++..
T Consensus 237 ~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 276 (303)
T 3a7i_A 237 PTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLK--HKFILR 276 (303)
T ss_dssp CCCC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT--CHHHHH
T ss_pred CCCc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhh--Chhhhc
Confidence 1111 112246889999999999999999999988 344443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=339.16 Aligned_cols=256 Identities=27% Similarity=0.434 Sum_probs=206.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+++++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999765 57799999986542221 2256788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998542 458999999999999999999999 89999999999999999999999999998654
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... .. .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~-~ 222 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------------SR-V 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------HH-T
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------------Hh-C
Confidence 3322 23457899999999999999999999999999999999999999876654321111 00 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
.... .. .....+.+++.+||+.||++||++.|+++ ++++....
T Consensus 223 ~~~~--~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~ 265 (279)
T 3fdn_A 223 EFTF--PD---FVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANS 265 (279)
T ss_dssp CCCC--CT---TSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHC
T ss_pred CCCC--CC---cCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCc
Confidence 0001 11 12236789999999999999999999988 56666543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=354.47 Aligned_cols=247 Identities=27% Similarity=0.331 Sum_probs=193.6
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHH-HHhcCCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAV-LSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
.++|+..+.||+|+||.||+|+.+ +++.||||++.+.... ......+.+|..+ ++.++||||+++++++.+....++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357899999999999999999765 5889999999765432 2344556677776 567899999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999998642 468899999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... .
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~----------------i 251 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----------------I 251 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH----------------H
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------------H
Confidence 43222 223456899999999999999999999999999999999999999987654332110 1
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGH 884 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 884 (959)
+........ .....+.+++.+||+.||.+||++.+
T Consensus 252 ~~~~~~~~~---~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 252 LNKPLQLKP---NITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHSCCCCCS---SSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HhcccCCCC---CCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 111111111 12236789999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=341.02 Aligned_cols=261 Identities=29% Similarity=0.390 Sum_probs=207.3
Q ss_pred CCcccCcccccCceEEEEEEEc-CC---cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE-EE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DG---TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER-LL 686 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 686 (959)
.|...+.||+|+||.||+|... ++ ..||+|++... ......+.+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4566789999999999999753 23 37999998753 3445667899999999999999999999999876655 89
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999854 23568999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCc---ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHHhhhcchHH
Q 002149 767 APDSER---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMA-LDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 767 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++|..| |......+.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~------------ 241 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL------------ 241 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH------------
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh------------
Confidence 543221 122345678999999999999999999999999999999996555 4444332211110
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..... .. ........+.+++.+|++.||.+|||+.++++.|+++++....
T Consensus 242 -~~~~~--~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 242 -AQGRR--LP---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp -HTTCC--CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred -hcCCC--CC---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 00000 00 1111234688999999999999999999999999999887654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.89 Aligned_cols=257 Identities=22% Similarity=0.272 Sum_probs=192.8
Q ss_pred hcCCccc-CcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHh-cCCCCceeEEEEEEe----Cc
Q 002149 610 TKNFASE-NELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK-VRHRHLVSLLGYSVA----GY 682 (959)
Q Consensus 610 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~ 682 (959)
.++|... +.||+|+||.||+|... +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3456665 68999999999999764 6899999998642 346688888755 489999999999876 56
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~ 759 (959)
..++||||+++|+|.+++... ....+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 789999999999999999642 23569999999999999999999999 89999999999999997 7899999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHhhhc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQ-YLAAWFWNIKS 838 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~ 838 (959)
|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---- 280 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 280 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----
Confidence 999998654322 234567899999999999999999999999999999999999999765432210 0000000
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..... .. ..........+.+++.+||+.||++|||+.++++ ++++..
T Consensus 281 -----~~~~~--~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 327 (400)
T 1nxk_A 281 -----MGQYE--FP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 327 (400)
T ss_dssp -----HTCCC--CC-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHT
T ss_pred -----cCccc--CC-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CccccC
Confidence 00000 00 0000112346789999999999999999999988 455544
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.79 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=203.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.++|+..+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999775 68999999987653322 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEee
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVSD 760 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~D 760 (959)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999998542 468999999999999999999999 8999999999999998877 899999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... ......
T Consensus 156 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~- 229 (283)
T 3bhy_A 156 FGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---SAVNYD- 229 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTTCCC-
T ss_pred cccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh---HhcccC-
Confidence 99998654432 223457899999999999999999999999999999999999999876643321110 000000
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...... ......+.+++.+|+..||++||++.++++
T Consensus 230 -~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEYF----------SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHHH----------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -Ccchhc----------ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 000000 011236789999999999999999999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=366.95 Aligned_cols=256 Identities=26% Similarity=0.313 Sum_probs=198.9
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999975 4789999999875422 334456778999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. ++||||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999988542 4689999999999999999999962 68999999999999999999999999999854
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~------------- 362 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---L------------- 362 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-------------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---H-------------
Confidence 3322 2234568999999999999999999999999999999999999999876553321111 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
......+ ......+.+++.+||+.||++|| ++.|+++ ++++.
T Consensus 363 ~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 363 MEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp HCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred hCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 0001101 11224678999999999999999 9999977 44443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=365.50 Aligned_cols=262 Identities=25% Similarity=0.311 Sum_probs=210.5
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|++.+.||+|+||.||+|... +++.||||++............+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999765 789999999875433334467789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG---DDFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~---~~~~~ki~DfGla 764 (959)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999888542 468999999999999999999999 8999999999999995 4567999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
+...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+..... ..
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~--------- 236 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---ET--------- 236 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH---------
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---------
Confidence 8664432 2344679999999999875 5899999999999999999999999887654321111 00
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
........ ........+.+++.+||+.||++|||+.++++ +++++.+..
T Consensus 237 ~~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~~ 285 (486)
T 3mwu_A 237 GKYAFDLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSS 285 (486)
T ss_dssp TCCCSCSG---GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTCC
T ss_pred CCCCCCCc---ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCcc
Confidence 00000000 00112236789999999999999999999988 677776654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.26 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=184.2
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++....... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999976 578999999986532111 2246788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN----RVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHT----CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999854 22578999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +....
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~ 225 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVV 225 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHh
Confidence 43222 12345789999999999998999999999999999999999999986543221 01111
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
......+ ......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LADYEMP---SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccCCc---cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111111 112246789999999999999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=344.44 Aligned_cols=272 Identities=21% Similarity=0.282 Sum_probs=198.1
Q ss_pred hcCCccc-CcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASE-NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|++. +.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++.++ +||||+++++++.+....++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4567774 7899999999999975 47899999998754 233456788999999995 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc---EEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR---AKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~---~ki~DfGl 763 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999998652 468999999999999999999999 89999999999999988766 99999999
Q ss_pred cccCCCCCc------ceeecccccccccccccccc-----CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 764 VKLAPDSER------SVVTRLAGTFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 764 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 875432211 11223569999999999875 5688999999999999999999999986543210000000
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDT-FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.... .................... ......+.+++.+||+.||++||++.|+++ +++++
T Consensus 241 ~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 300 (316)
T 2ac3_A 241 ACPA-CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQ 300 (316)
T ss_dssp CCHH-HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC
T ss_pred cchh-HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--Chhhc
Confidence 0000 00000000000000000000 011236789999999999999999999987 44443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.06 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=205.0
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
..++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 3467999999999999999999765 78999999987543 234457789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999998742 2568999999999999999999999 89999999999999999999999999999855
Q ss_pred CCCC-cceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 768 PDSE-RSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 768 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... ...+.... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~--------~ 226 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKK--------T 226 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTC--------T
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcc--------c
Confidence 3322 122344678999999999988765 77899999999999999999999876543211 11111000 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... .......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0000 0112236789999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.49 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=202.4
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
..++|+..+.||+|+||.||+|... +++.||||++............+.+|+..+..+ +||||+++++++.+....++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999765 789999999987655556677889999999999 89999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--------------
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-------------- 752 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-------------- 752 (959)
||||+++|+|.+++..... ....+++.++..++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999965332 12568999999999999999999999 89999999999999984
Q ss_pred -----CCcEEEeeccccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002149 753 -----DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEER 826 (959)
Q Consensus 753 -----~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~ 826 (959)
...+||+|||+++...... ...||+.|+|||++.+. .++.++|||||||++|||++|..++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~- 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH- 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH-
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH-
Confidence 4479999999998665432 23589999999999776 56689999999999999999987765432110
Q ss_pred HHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 827 QYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+.....+... ......+.+++.+||+.||++||++.++++
T Consensus 239 ---------------~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 ---------------EIRQGRLPRIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---------------HHHTTCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------------HHHcCCCCCCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00000001111 112246789999999999999999999977
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.35 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=211.7
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999765 578999999876532 345567789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999987542 468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... . .
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~----------~ 228 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------I----------K 228 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------H----------H
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------H----------h
Confidence 43222 23345789999999999998999999999999999999999999987664332110 0 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
....... ......+.+++.+|++.||++||++.++++ ++++....
T Consensus 229 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~~~ 273 (294)
T 2rku_A 229 KNEYSIP---KHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSGY 273 (294)
T ss_dssp TTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTSC
T ss_pred hccCCCc---cccCHHHHHHHHHHcccChhhCcCHHHHhh--ChheecCC
Confidence 0011101 112236789999999999999999999987 55665443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=353.03 Aligned_cols=272 Identities=22% Similarity=0.317 Sum_probs=210.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +++.||+|++... ......+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 357999999999999999999765 7899999998765 34556678999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999998652 458999999999999999999998 5 8999999999999999999999999998744
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh-----------
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI----------- 836 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~----------- 836 (959)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...........
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 183 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 221 223457899999999999999999999999999999999999999877654432211000000
Q ss_pred ---------------hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 837 ---------------KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 837 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
................ ..........+.+++.+||+.||++|||+.++++ +++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~ 331 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKRS 331 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhcc
Confidence 0000000000000000 0001112336889999999999999999999987 5666553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.94 Aligned_cols=281 Identities=23% Similarity=0.331 Sum_probs=212.0
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----c
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----Y 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 682 (959)
+.++|+..+.||+|+||.||+|... +|+.||||++... ........+.+|+++++.++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3568999999999999999999765 6899999998653 2445567788999999999999999999988754 6
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999995 799888854 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcc---------eeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 763 LVKLAPDSERS---------VVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 763 la~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 99865432211 1223578999999998765 6789999999999999999999999988765443222111
Q ss_pred HHhhhc--------chHHHHHhcCCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 833 FWNIKS--------DKEKLRAAIDPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 833 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
...... ......+.+........... .....+.+++.+||+.||++|||+.++++ +++++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~~~ 315 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE--HPYLQTYHDP 315 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc--CccccccCCc
Confidence 100000 00111111111110011111 12346789999999999999999999988 7888776654
Q ss_pred CCC
Q 002149 900 DDE 902 (959)
Q Consensus 900 ~~~ 902 (959)
.++
T Consensus 316 ~~~ 318 (353)
T 2b9h_A 316 NDE 318 (353)
T ss_dssp TSS
T ss_pred ccc
Confidence 443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=350.26 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=202.7
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH------HHHHHHHHHHHHHHhcCCCCceeEEEEEEe
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK------KAVDEFHSEIAVLSKVRHRHLVSLLGYSVA 680 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 680 (959)
...++|+..+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+++++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999999975 578999999987653221 133457789999999999999999999999
Q ss_pred CceEEEEEEecCCC-chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 681 GYERLLVYEYMPQG-ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 681 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
....++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 99988853 2468999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 173 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------- 235 (335)
T 3dls_A 173 DFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------- 235 (335)
T ss_dssp CCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------
T ss_pred ecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------
Confidence 9999986654332 234579999999999988877 7899999999999999999999975221
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.......... .....+.+++.+||+.||++||++.++++
T Consensus 236 -------~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 236 -------TVEAAIHPPY---LVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -------GTTTCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------HHhhccCCCc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011111011 12236789999999999999999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=350.49 Aligned_cols=273 Identities=26% Similarity=0.385 Sum_probs=210.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-----cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc--
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY-- 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 682 (959)
.++|+..+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 35688999999999999999984 36889999998764 4456678999999999999999999999886543
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 679999999999999999652 2468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcce--eeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-
Q 002149 763 LVKLAPDSERSV--VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD- 839 (959)
Q Consensus 763 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 839 (959)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......-. .........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~----~~~~~~~~~~ 266 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQ 266 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH----HHHCTTCCTH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH----Hhhccccchh
Confidence 998765433221 2234577889999999988899999999999999999999998764321110 000000000
Q ss_pred --hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 840 --KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 840 --~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
...+.+.+..... ..........+.+++.+||+.||++||++.++++.|+.+.++.
T Consensus 267 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 267 MIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0011111111110 0111123357889999999999999999999999999987653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=365.26 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=208.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|...+.||+|+||.||+|+.. +|+.||+|++.+..... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888999999999999999875 68999999987543221 23567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++..... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999865321 23579999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE-RQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.. ...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~-------------~i~ 406 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------------RVL 406 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-------------HHH
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-------------HHh
Confidence 4332 2334589999999999999999999999999999999999999998653211 111111 011
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM-----GHAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~L~~~~~ 894 (959)
......+ ......+.+++.+||+.||++||++ .++.+ +++++
T Consensus 407 ~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~--Hpff~ 453 (543)
T 3c4z_A 407 EQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT--HPLFR 453 (543)
T ss_dssp HCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT--SGGGT
T ss_pred hcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc--Ccccc
Confidence 1111111 1123467899999999999999975 56654 34443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=341.10 Aligned_cols=254 Identities=30% Similarity=0.424 Sum_probs=201.2
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-ceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-YERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... |+.||||++... ...+.+.+|+++++.++||||+++++++... ...++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 367899999999999999999875 889999998754 2456789999999999999999999987654 4689999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999986532 1348899999999999999999999 899999999999999999999999999998554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +....
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-------------~~~~~ 231 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------------VEKGY 231 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------------HTTTC
T ss_pred ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------HhcCC
Confidence 322 22357889999999999999999999999999999998 9999987654332110 00000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.. .........+.+++.+||+.||++||++.++++.|+.+....
T Consensus 232 ~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 KM-----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC-----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00 111122346889999999999999999999999999887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.70 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=193.2
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|.. .+|+.||||++..........+.+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46799999999999999999976 57899999999765444444455555666688889999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||++ |+|.+++..... ....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9995 688887755322 23679999999999999999999999 6 9999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYA----VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......... +....
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~---------- 227 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVV---------- 227 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHH----------
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHh----------
Confidence 44322 2334789999999996 5667899999999999999999999999864332211 11100
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
....+... .......+.+++.+|++.||++|||+.|+++ ++++..
T Consensus 228 -~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~--hp~f~~ 272 (290)
T 3fme_A 228 -EEPSPQLP----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ--HPFFTL 272 (290)
T ss_dssp -HSCCCCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHHH
T ss_pred -ccCCCCcc----cccCCHHHHHHHHHHhhcChhhCcCHHHHHh--Cccccc
Confidence 00011111 1112346789999999999999999999987 555543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.88 Aligned_cols=259 Identities=26% Similarity=0.364 Sum_probs=208.1
Q ss_pred HHHHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc--c----HHHHHHHHHHHHHHHhc-CCCCceeE
Q 002149 603 VQVLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI--S----KKAVDEFHSEIAVLSKV-RHRHLVSL 674 (959)
Q Consensus 603 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~----~~~~~~~~~E~~~l~~l-~h~niv~l 674 (959)
......+.++|.+.+.||+|+||.||+|... +|+.||||++..... . ....+.+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445566788999999999999999999875 799999999865421 1 12245678999999999 79999999
Q ss_pred EEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 675 LGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 675 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
++++......++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 99999999999999999999999998542 468999999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCCcceeecccccccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 002149 755 RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~ 828 (959)
.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 238 ~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp CEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999998665432 2344689999999999863 358889999999999999999999998765433211
Q ss_pred HHHHHHhhhcchHHHHHhcCCccc-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILE-VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. +.... ...... .. .....+.+++.+||+.||++||++.++++
T Consensus 316 ~---i~~~~---------~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 M---IMEGQ---------YQFSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H---HHHTC---------CCCCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H---HHhCC---------CCCCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 10000 000000 00 01235789999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=345.82 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=204.2
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 684 (959)
.++|+..+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46799999999999999999976 57899999998653 45667789999999999999999999999873 3477
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999876432 23679999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCcc--------eeeccccccccccccccccCC---CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 002149 765 KLAPDSERS--------VVTRLAGTFGYLAPEYAVTGK---ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 765 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~ 833 (959)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......... ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--- 257 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA--- 257 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH---
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh---
Confidence 754321110 012345799999999987554 688999999999999999999998532111000 00
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
..... ... ..........+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 258 -------~~~~~----~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 258 -------LAVQN----QLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -------HHHHC----C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -------HHhhc----cCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00000 000 0011122346889999999999999999999999998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=341.27 Aligned_cols=270 Identities=22% Similarity=0.309 Sum_probs=211.5
Q ss_pred hcCCcccCcccccCceEEEEEEE--cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC------ceeEEEEEEeC
Q 002149 610 TKNFASENELGRGGFGVVYKGEL--DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH------LVSLLGYSVAG 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 681 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999976 36889999998743 445677889999999997654 99999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---------
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD--------- 752 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~--------- 752 (959)
...++||||+ +++|.+++... ...++++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 99999998652 22568999999999999999999999 89999999999999987
Q ss_pred ----------CCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 753 ----------DFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 753 ----------~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865432 234578999999999999999999999999999999999999998876
Q ss_pred hHHHHHHHHHHHhhhcc-------------------------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCC
Q 002149 823 PEERQYLAAWFWNIKSD-------------------------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPS 877 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 877 (959)
..+.............. .........+..............+.+++.+||+.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 65433222211110000 00011111111111222334566789999999999999
Q ss_pred CCCCHHHHHHHHHHhHhh
Q 002149 878 QRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 878 ~RPt~~ev~~~L~~~~~~ 895 (959)
+|||+.|+++ +++++.
T Consensus 319 ~Rpt~~ell~--hp~f~~ 334 (339)
T 1z57_A 319 KRITLREALK--HPFFDL 334 (339)
T ss_dssp TSCCHHHHTT--SGGGGG
T ss_pred cccCHHHHhc--CHHHHH
Confidence 9999999987 455543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.53 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=204.5
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe------
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA------ 680 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 680 (959)
....+|+..+.||+|+||.||+|... +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 34567999999999999999999875 78999999987542 246789999999999999999998864
Q ss_pred ----------CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 681 ----------GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 681 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 445789999999999999996532 2568999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
+.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+... ....
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~ 228 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFF 228 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHH
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHH
Confidence 9999999999999986654322 23457899999999999999999999999999999999998876321 0000
Q ss_pred HHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 831 AWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. .+ ...... .. ....+.+++.+||+.||++||++.++++.|+.+.+.
T Consensus 229 ---~-------~~---~~~~~~-~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 ---T-------DL---RDGIIS-DI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---H-------HH---HTTCCC-TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---H-------Hh---hccccc-cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 0 00 011111 11 123577999999999999999999999999887654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=362.52 Aligned_cols=246 Identities=15% Similarity=0.162 Sum_probs=192.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHH---HHHhcCCCCceeEE-------EE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIA---VLSKVRHRHLVSLL-------GY 677 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 677 (959)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|++ .++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999975 579999999987542 23345678899994 55555899999998 66
Q ss_pred EEeCc-----------------eEEEEEEecCCCchhhHHhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 002149 678 SVAGY-----------------ERLLVYEYMPQGALSKHIFHWKSLN--LEPLSWKRRLNIALDVARGMEYLHSLAHQSF 738 (959)
Q Consensus 678 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 738 (959)
+.+.. ..++||||+ +|+|.+++....... ...+++..++.++.||+.||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 66553 278999999 789999997543222 1345678899999999999999999 899
Q ss_pred EecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeeccccccccccccccccC-----------CCCccchHHHHHHH
Q 002149 739 IHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-----------KITTKVDVFSFGVV 807 (959)
Q Consensus 739 vH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~l 807 (959)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2345577 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 808 LMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 808 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+|||++|+.||......+. ........ . .....+.+++.+||+.||++||++.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~----------------~~~~~~~~---~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG----------------SEWIFRSC---K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC----------------SGGGGSSC---C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc----------------hhhhhhhc---c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999975432110 01111110 1 11236789999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=364.63 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=200.9
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|+..+.||+|+||.||+|... +++.||||++............+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999765 788999999986644444567789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~DfGla 764 (959)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999888542 468999999999999999999999 89999999999999976 455999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
+...... ......||+.|+|||++. ..++.++||||+||++|||++|..||.+....+..... ...
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~-------- 252 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV---EKG-------- 252 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHT--------
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhC--------
Confidence 8665432 234467999999999876 56999999999999999999999999887654422111 000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
...... .........+.+++.+||+.||.+|||+.+++++
T Consensus 253 -~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 253 -KYTFDS---PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CCCCCS---GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CCCCCc---hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000000 0000122367899999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.83 Aligned_cols=278 Identities=23% Similarity=0.320 Sum_probs=189.8
Q ss_pred hcCCcc-cCcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--Cce
Q 002149 610 TKNFAS-ENELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYE 683 (959)
Q Consensus 610 ~~~~~~-~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 683 (959)
.+.|++ .++||+|+||.||+|... +++.||||++...... ..+.+|+++++.++||||+++++++.. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 345666 458999999999999865 5789999999754322 357799999999999999999999965 678
Q ss_pred EEEEEEecCCCchhhHHhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE----CCCCc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL----NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----GDDFR 755 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----~~~~~ 755 (959)
.++||||+ .|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCc
Confidence 89999999 56888877543211 12359999999999999999999999 899999999999999 67889
Q ss_pred EEEeeccccccCCCCCc--ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHH-------
Q 002149 756 AKVSDFGLVKLAPDSER--SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEE------- 825 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~------- 825 (959)
+||+|||+|+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999999986543221 223456899999999999874 58999999999999999999999997654321
Q ss_pred HHHHHHHHHhhhcch-------------HHHHHhcCCcccCCCCCH---------HHHHHHHHHHHhcccCCCCCCCCHH
Q 002149 826 RQYLAAWFWNIKSDK-------------EKLRAAIDPILEVNDDTF---------ETFWTIAELAGHCTSREPSQRPDMG 883 (959)
Q Consensus 826 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~---------~~~~~l~~l~~~cl~~dP~~RPt~~ 883 (959)
...+...+....... ......+..... ..... .....+.+|+.+||..||++|||+.
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 111111111110000 000000000000 00000 0023567999999999999999999
Q ss_pred HHHHHHHHhHhhcCC
Q 002149 884 HAVNVLAPLVEKWKP 898 (959)
Q Consensus 884 ev~~~L~~~~~~~~~ 898 (959)
|+++ ++++.....
T Consensus 330 e~L~--hp~f~~~~~ 342 (405)
T 3rgf_A 330 QAMQ--DPYFLEDPL 342 (405)
T ss_dssp HHHT--SGGGTSSSC
T ss_pred HHhc--ChhhccCCC
Confidence 9988 677765433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=343.99 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=211.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999765 578999999876432 345567789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999987542 468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... ...
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------------~~~- 256 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------------KKN- 256 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------HHT-
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-------------hcC-
Confidence 43222 234467999999999999999999999999999999999999999876543321110 000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
..... . .....+.+++.+||+.||++||++.++++ ++++...
T Consensus 257 ~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~~ 298 (335)
T 2owb_A 257 EYSIP-K----HINPVAASLIQKMLQTDPTARPTINELLN--DEFFTSG 298 (335)
T ss_dssp CCCCC-T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHTS
T ss_pred CCCCC-c----cCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccCC
Confidence 00010 1 11236789999999999999999999987 5566543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=356.82 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=191.8
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc------HHHHHHHHHHHHHHHhcCCCCceeEEEEEEe
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS------KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA 680 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 680 (959)
.+.++|...+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4568999999999999999999965 46899999998764321 1223357899999999999999999999754
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAK 757 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~k 757 (959)
...++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.+ +.+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 567999999999999988743 3568999999999999999999999 899999999999999754 4599
Q ss_pred EeeccccccCCCCCcceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
|+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +...+.
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 99999998764422 2345689999999999864 6788899999999999999999999976543211 000000
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... ....... ......+.+++.+||+.||++||++.|+++
T Consensus 359 ~~~~--~~~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKY--NFIPEVW----------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCC--CCCHHHH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCC--CCCchhh----------cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 0000000 011236789999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.74 Aligned_cols=269 Identities=22% Similarity=0.284 Sum_probs=207.6
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc------CCCCceeEEEEEEeC
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV------RHRHLVSLLGYSVAG 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~ 681 (959)
+..+|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3568999999999999999999654 6899999998753 44456778899988887 467999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc--EEEe
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR--AKVS 759 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~--~ki~ 759 (959)
...++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ ++||||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEecc-CCCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEe
Confidence 9999999999 57999988652 23568999999999999999999999 79999999999999999887 9999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... +......
T Consensus 245 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i--~~~~~~p 318 (429)
T 3kvw_A 245 DFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM--IELLGMP 318 (429)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCC
T ss_pred ecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHcCCC
Confidence 99999765432 23457899999999999999999999999999999999999999887655432221 1111111
Q ss_pred hHHH-------HHhcCCcc-----------------------------cCCCCCHHH------HHHHHHHHHhcccCCCC
Q 002149 840 KEKL-------RAAIDPIL-----------------------------EVNDDTFET------FWTIAELAGHCTSREPS 877 (959)
Q Consensus 840 ~~~~-------~~~~~~~~-----------------------------~~~~~~~~~------~~~l~~l~~~cl~~dP~ 877 (959)
...+ ...++..- ......+.. ...+.+|+.+||+.||+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 1111 11111100 000001111 23578999999999999
Q ss_pred CCCCHHHHHHHHHHhHhh
Q 002149 878 QRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 878 ~RPt~~ev~~~L~~~~~~ 895 (959)
+|||+.|+++ ++++.+
T Consensus 399 ~Rpta~e~L~--Hpw~~~ 414 (429)
T 3kvw_A 399 VRMTPGQALR--HPWLRR 414 (429)
T ss_dssp TSCCHHHHHT--STTTC-
T ss_pred hCCCHHHHhC--Chhhcc
Confidence 9999999987 455443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=347.39 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=191.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEE--------
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSV-------- 679 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 679 (959)
..+|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 357899999999999999999764 7899999998654 4556678899999999996 999999999984
Q ss_pred eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEECCCCcEE
Q 002149 680 AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 680 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~~~~~~k 757 (959)
.....++||||+ +|+|.+++.... ....+++.+++.++.||+.||+|||+ .+ |+||||||+|||++.++.+|
T Consensus 105 ~~~~~~lv~e~~-~g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELC-KGQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECC-SEEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEec-CCCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 334578999999 589999886532 23569999999999999999999999 67 99999999999999999999
Q ss_pred EeeccccccCCCCCcc-----------eeecccccccccccccc---ccCCCCccchHHHHHHHHHHHHhCCCCCCCCCh
Q 002149 758 VSDFGLVKLAPDSERS-----------VVTRLAGTFGYLAPEYA---VTGKITTKVDVFSFGVVLMELLTGLMALDESRP 823 (959)
Q Consensus 758 i~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~ 823 (959)
|+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999865443221 11134689999999998 567789999999999999999999999975432
Q ss_pred HHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 824 EERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
... .......... . .....+.+++.+||+.||++||++.|+++.|+.+......
T Consensus 259 ~~~----------------~~~~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 259 LRI----------------VNGKYSIPPH-D----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp -----------------------CCCCTT-C----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred HHh----------------hcCcccCCcc-c----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 110 0000000000 0 1112467899999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=360.50 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=207.5
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-----------HHHHHHHHHHHHHHhcCCCCceeEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-----------KAVDEFHSEIAVLSKVRHRHLVSLLG 676 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 676 (959)
+.++|.+.++||+|+||.||+|... +++.||||++....... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4678999999999999999999765 67899999987643221 23567889999999999999999999
Q ss_pred EEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC--
Q 002149 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-- 754 (959)
Q Consensus 677 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-- 754 (959)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988542 468999999999999999999999 8999999999999998775
Q ss_pred -cEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 002149 755 -RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWF 833 (959)
Q Consensus 755 -~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~ 833 (959)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|..||.+....+....+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i--- 259 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--- 259 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 69999999998765432 234467999999999986 56999999999999999999999999987654422111
Q ss_pred HhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 834 WNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
.... ...... ........+.+++.+||+.||.+|||+.|+++ +++++++..
T Consensus 260 ~~~~---------~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~~~ 310 (504)
T 3q5i_A 260 EKGK---------YYFDFN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKYAN 310 (504)
T ss_dssp HHCC---------CCCCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHTCC
T ss_pred HcCC---------CCCCcc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhchh
Confidence 0000 000000 00011236789999999999999999999987 567766554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=339.85 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=198.8
Q ss_pred hcCCcccCcccccCceEEEEEEEc--CCc--EEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--DGT--KIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.++|++.+.||+|+||.||+|.+. +++ .||||++..... .....+.+.+|+++++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999753 333 689998875432 2345678999999999999999999999988765 7
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLV 764 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla 764 (959)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999986532 468999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 765 KLAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 765 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
+........ ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.... + ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~---~~--- 239 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---I---DK--- 239 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H---HT---
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH---H---Hc---
Confidence 876543322 1233567889999999998889999999999999999999 9999987765332110 0 00
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
. .... .........+.+++.+|++.||++||++.++++.|..+..
T Consensus 240 ----~-~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 ----E-GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ----S-CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----c-CCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 0000 1111223468899999999999999999999998887643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.07 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=209.0
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|... +++.||||++....... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999765 67899999986532211 22467889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999998642 458999999999999999999999 899999999999999999999999999997554
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.... ...
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----------------~~~ 226 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----------------IVN 226 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----------------HHT
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH----------------Hhc
Confidence 322 2345789999999999999999999999999999999999999987654332110 111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
...... ......+.+++.+|++.||.+||++.++++ ++++....
T Consensus 227 ~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~~ 270 (284)
T 2vgo_A 227 VDLKFP---PFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKANS 270 (284)
T ss_dssp TCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHHC
T ss_pred cccCCC---CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhhc
Confidence 111111 112246789999999999999999999987 56666543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.50 Aligned_cols=277 Identities=21% Similarity=0.322 Sum_probs=202.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEE---------
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSV--------- 679 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------- 679 (959)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 468999999999999999999765 5899999998754 4566778999999999999999999999873
Q ss_pred -----eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CC
Q 002149 680 -----AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG-DD 753 (959)
Q Consensus 680 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~-~~ 753 (959)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++ ++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTED 157 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCC
Confidence 3467899999996 799998843 568999999999999999999999 8999999999999997 56
Q ss_pred CcEEEeeccccccCCCCCc--ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSER--SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA 830 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~ 830 (959)
+.+||+|||+++....... .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999986543211 12234567999999998866 67899999999999999999999999887654432211
Q ss_pred HHHHhhhcc-hHHHHHhcCC-------cccCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 831 AWFWNIKSD-KEKLRAAIDP-------ILEVNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 831 ~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
....... .+...+.... ........ ......+.+++.+||+.||++||++.++++ ++++..+.
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 313 (320)
T 2i6l_A 238 --LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS--HPYMSIYS 313 (320)
T ss_dssp --HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SHHHHTTC
T ss_pred --HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC--Cccccccc
Confidence 1111000 0000000000 00000000 012346889999999999999999999987 67777766
Q ss_pred CCCCC
Q 002149 898 PLDDE 902 (959)
Q Consensus 898 ~~~~~ 902 (959)
.+.++
T Consensus 314 ~p~~~ 318 (320)
T 2i6l_A 314 FPMDE 318 (320)
T ss_dssp C----
T ss_pred CccCC
Confidence 55444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=352.84 Aligned_cols=272 Identities=23% Similarity=0.333 Sum_probs=203.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------ce
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------YE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 683 (959)
.+|+..+.||+|+||.||+|... +|+.||||++.... ....+|+++++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46888999999999999999875 68999999986532 1234799999999999999999988542 23
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-CcEEEeecc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-FRAKVSDFG 762 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-~~~ki~DfG 762 (959)
.++||||++ +++.+.+..... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVP-ETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCC-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhccc-ccHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 579999995 567666654322 23679999999999999999999999 899999999999999965 678999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-h
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-K 840 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 840 (959)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.. ...+...... .
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTR 278 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence 9986544322 2346789999999999764 7899999999999999999999999987654432 2212111111 1
Q ss_pred HHHHHhcCCccc------CCCCCH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCC
Q 002149 841 EKLRAAIDPILE------VNDDTF------ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLD 900 (959)
Q Consensus 841 ~~~~~~~~~~~~------~~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~ 900 (959)
+.+... .+... .....+ .....+.+|+.+||..||++||++.|+++ +++++......
T Consensus 279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~~~ 347 (420)
T 1j1b_A 279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELRDPN 347 (420)
T ss_dssp HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGGCTT
T ss_pred HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC--CHhhccccccc
Confidence 112111 11100 001111 12346889999999999999999999987 67777665443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=355.18 Aligned_cols=364 Identities=21% Similarity=0.220 Sum_probs=271.0
Q ss_pred CCCCCCC-C--cceEecCC----------cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC--CccCCCCc
Q 002149 64 DPCGPPC-W--KHVFCSNS----------RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNL 128 (959)
Q Consensus 64 ~~C~~~~-w--~gv~C~~~----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L 128 (959)
+||+..| | ..|.|+.. +++.|+|+++.+++..|..+.++++|++|+|++|.+.+.++ .|.++++|
T Consensus 2 ~p~~~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L 81 (455)
T 3v47_A 2 DPGTSECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81 (455)
T ss_dssp -----CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTC
T ss_pred CCccceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccC
Confidence 5677666 2 33888753 58999999999998889999999999999999999986543 59999999
Q ss_pred cEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCcc--ccCccccCeecccccccCCCCChh-hcCCCCCC
Q 002149 129 KYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG--LQSSAQLTNLSCMSCNLAGQLPDF-LGNFASLQ 205 (959)
Q Consensus 129 ~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~--l~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~ 205 (959)
++|+|++|+++.+++..|.++++|++|+|++|++++ .+|.. +..+++|++|++++|++.+..|.. +.++++|+
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~ 157 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDG----AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFH 157 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBT----HHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCC
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCc----cccCcccccCcccCCEEECCCCccCccCcccccCCCCccc
Confidence 999999999999999999999999999999999975 23443 889999999999999999988876 89999999
Q ss_pred EEEecCCcCCCCCCcccccC---CcccccccccCCCCccccc------ccccCCcCCcEEEccCccccccCchhhcCC--
Q 002149 206 NLKLSGNNLTGPIPESFKGL---NLVNLWLNDQKGGGFTGTI------DVLGNMDQLRTLWLHGNHFSGTIPESFGKL-- 274 (959)
Q Consensus 206 ~L~Ls~N~l~~~~p~~~~~l---~l~~L~~~~~~~~~l~~~~------~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-- 274 (959)
+|+|++|++++..+..+..+ ++..|.+..+....+.... ..+..+++|++|+|++|++++.+|..+..+
T Consensus 158 ~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~ 237 (455)
T 3v47_A 158 VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237 (455)
T ss_dssp EEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTT
T ss_pred EEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccc
Confidence 99999999999999888765 4555555555444433221 123456899999999999998888777554
Q ss_pred -CCCCEEeCCCCcCCCC----------Cccccccc---cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCch
Q 002149 275 -TSLKDLNLNSNQFVGL----------IPPSLASL---SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 275 -~~L~~L~Ls~N~l~~~----------~p~~~~~~---~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (959)
++|+.|++++|.+.+. .+..+..+ +|+.|+|++|.+++.+|.....
T Consensus 238 ~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-------------------- 297 (455)
T 3v47_A 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH-------------------- 297 (455)
T ss_dssp TCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT--------------------
T ss_pred ccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc--------------------
Confidence 5555555555543322 11111111 3555555555555444432110
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccccc
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
++.+.......+.........++.+++|+.|+|++|++.+..|..|+++++|++|+|++|++++..
T Consensus 298 --------------l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 363 (455)
T 3v47_A 298 --------------FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG 363 (455)
T ss_dssp --------------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEEC
T ss_pred --------------CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccC
Confidence 001111111111111122233456789999999999999888999999999999999999999888
Q ss_pred CCCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCCCCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~~ 465 (959)
|..|.++++|++|+|++|++++.++. +..+..+.+.+|++.|..+
T Consensus 364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999999999999999999986663 3567789999999998853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.59 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=206.8
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4567999999999999999999765 7899999998754 223345688999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGla 764 (959)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999988542 468999999999999999999999 899999999999999 78899999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +..
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~--------- 221 (304)
T 2jam_A 157 KMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK---IKE--------- 221 (304)
T ss_dssp CCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH---------
T ss_pred eecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHc---------
Confidence 754332 12335689999999999999999999999999999999999999987654332110 000
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
...... ..........+.+++.+|+..||++||++.++++ ++++...
T Consensus 222 ~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 268 (304)
T 2jam_A 222 GYYEFE---SPFWDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDGN 268 (304)
T ss_dssp CCCCCC---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHSS
T ss_pred CCCCCC---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccCC
Confidence 000000 0001122346889999999999999999999987 5566543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=331.88 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=199.7
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|.+.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999875 789999999865421 122356788999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999998642 458999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+.... +...
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~ 226 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-------------IRGG 226 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------------HHHC
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------------hhcC
Confidence 4432 2234578999999999988765 6899999999999999999999987654332110 0110
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... . .. .....+.+++.+|++.||++||++.++++ ++++.+
T Consensus 227 ~~~-~--~~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~ 267 (276)
T 2h6d_A 227 VFY-I--PE---YLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQ 267 (276)
T ss_dssp CCC-C--CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHT
T ss_pred ccc-C--ch---hcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhcc
Confidence 000 0 11 11236789999999999999999999987 455554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=350.20 Aligned_cols=273 Identities=22% Similarity=0.316 Sum_probs=203.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc------e
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY------E 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 683 (959)
..+|...+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 346899999999999999999987777799998865321 1237999999999999999999986543 3
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCcEEEeecc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFG 762 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~-~~~~~ki~DfG 762 (959)
.++||||++++ +.+.+..... ....+++..+..++.||++||+|||+ ++|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 78999999654 4444432222 23679999999999999999999999 8999999999999999 79999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-h
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD-K 840 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 840 (959)
+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+..... +...... .
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i--~~~~g~p~~ 263 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI--IKVLGTPSR 263 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCH
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCH
Confidence 9986644332 2345789999999998765 5899999999999999999999999987654432221 1111110 1
Q ss_pred HHHHH----hcCCccc-CCCCCH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 841 EKLRA----AIDPILE-VNDDTF------ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 841 ~~~~~----~~~~~~~-~~~~~~------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
+.+.. ....... ...... .....+.+++.+||..||++|||+.|+++ +++++.....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~~~ 331 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC--HPFFDELRTG 331 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGSTTTSS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc--Chhhhhhccc
Confidence 11111 0000000 001111 12246889999999999999999999987 7777765543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.48 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=204.1
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
...++|++.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34578999999999999999999765 58999999987542 24568899999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 102 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999999998532 2568999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~ 240 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------------PTN 240 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHS
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------hcC
Confidence 544322 233457899999999999999999999999999999999999999876543321110 000
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..+... ........+.+++.+||+.||.+||++.++++ ++++..
T Consensus 241 ~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~ 284 (314)
T 3com_A 241 PPPTFR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS 284 (314)
T ss_dssp CCCCCS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred CCcccC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence 011110 01112346789999999999999999999987 455543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.71 Aligned_cols=276 Identities=24% Similarity=0.276 Sum_probs=202.1
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH---HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK---KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
...++|+..+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+++++.++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999764 68999999987542221 112467899999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 87 ISLVFDFME-TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CEEEEECCS-EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred eEEEEEcCC-CCHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999996 588888743 22568899999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-H
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-E 841 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 841 (959)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+... ..+....... .
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEE 235 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTT
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHcCCCChh
Confidence 986644322 23446789999999999764 58899999999999999999999998876543321 1111111000 0
Q ss_pred HHHHhcC--Cccc---CCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 842 KLRAAID--PILE---VNDDT-----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 842 ~~~~~~~--~~~~---~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
....... .... ..... ......+.+++.+||+.||++|||+.|+++ ++++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~~ 298 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSNR 298 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTSS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--ChhhhcC
Confidence 0000000 0000 00001 111246889999999999999999999987 5666543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=350.32 Aligned_cols=265 Identities=21% Similarity=0.358 Sum_probs=203.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|++.+.||+|+||.||+|.... .||+|++..........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4689999999999999999998753 59999987654444445667889999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++++|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+||+++ ++.+||+|||+++....
T Consensus 110 ~~~~~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 110 LCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CCCSEEHHHHTTS----SCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred cccCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999853 22468999999999999999999999 8999999999999998 67999999999875432
Q ss_pred CC----cceeecccccccccccccccc---------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 770 SE----RSVVTRLAGTFGYLAPEYAVT---------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 770 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------- 254 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ------- 254 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-------
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------
Confidence 11 112233568999999999864 4578899999999999999999999987765432111
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDD 901 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~ 901 (959)
......+..... .....+.+++.+||..||++||++.++++.|+.+.++.....+
T Consensus 255 ------~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~ 309 (319)
T 2y4i_B 255 ------MGTGMKPNLSQI----GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309 (319)
T ss_dssp ------HHTTCCCCCCCS----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------
T ss_pred ------hccCCCCCCCcC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence 011111111100 1123578999999999999999999999999998877655433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=365.10 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=212.0
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
+.++|+..+.||+|+||.||+|... +|+.||||++...... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999765 7899999998654322 3446778999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE---CCCCcEEEeeccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGL 763 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl---~~~~~~ki~DfGl 763 (959)
||||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998853 2568999999999999999999999 899999999999999 5678999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
++...... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....+....+ ...
T Consensus 176 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~------- 242 (484)
T 3nyv_A 176 STHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---EKG------- 242 (484)
T ss_dssp HHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHC-------
T ss_pred eEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HcC-------
Confidence 98665433 2344579999999999865 6899999999999999999999999887654321111 000
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
....... ........+.+++.+||+.||++|||+.++++ +++++.+..
T Consensus 243 --~~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~~~ 290 (484)
T 3nyv_A 243 --KYTFELP---QWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTYTK 290 (484)
T ss_dssp --CCCCCSG---GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHHTC
T ss_pred --CCCCCCc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhccccc
Confidence 0000000 00112346789999999999999999999988 577766543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=335.66 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=204.5
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc--HHHHHHHHHHHHHHHhcCCCCceeEEEEEE--eCce
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRHRHLVSLLGYSV--AGYE 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 683 (959)
+.++|++.+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|+++++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 347899999999999999999976 46889999998754221 234577899999999999999999999984 4557
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||++++ +.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999766 76766442 23679999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCC-CcceeeccccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 764 VKLAPDS-ERSVVTRLAGTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 764 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
++..... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------- 224 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----------- 224 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-----------
Confidence 9865432 222334567999999999987644 47799999999999999999999987654332110
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
+... ...... .....+.+++.+|++.||++||++.++++ ++++.+....
T Consensus 225 --i~~~---~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~~ 273 (305)
T 2wtk_C 225 --IGKG---SYAIPG---DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHPP 273 (305)
T ss_dssp --HHHC---CCCCCS---SSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCCC
T ss_pred --HhcC---CCCCCC---ccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCCC
Confidence 0000 001011 12236789999999999999999999987 5667665443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.44 Aligned_cols=271 Identities=21% Similarity=0.318 Sum_probs=203.0
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG----- 681 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 681 (959)
...++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+|+++++.++||||+++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4467899999999999999999975 578999999986542 1234799999999999999999998543
Q ss_pred ---------------------------------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 002149 682 ---------------------------------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728 (959)
Q Consensus 682 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~ 728 (959)
...++||||++ |+|.+.+..... ....+++..+..++.||++||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHH
Confidence 34789999996 688888765332 2367999999999999999999
Q ss_pred HHHhcCCCCeEecCCCCCCEEEC-CCCcEEEeeccccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHH
Q 002149 729 YLHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGV 806 (959)
Q Consensus 729 yLH~~~~~~ivH~Dik~~NiLl~-~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ 806 (959)
|||+ .+|+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||
T Consensus 156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999 8999999999999997 688999999999986644332 2345789999999998775 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc-hHHHHHhcCCcc------cCCCCCH------HHHHHHHHHHHhccc
Q 002149 807 VLMELLTGLMALDESRPEERQYLAAWFWNIKSD-KEKLRAAIDPIL------EVNDDTF------ETFWTIAELAGHCTS 873 (959)
Q Consensus 807 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~------~~~~~l~~l~~~cl~ 873 (959)
++|||++|+.||.+....+..... +...... .+.+.. ..+.. ......+ .....+.+++.+||+
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i--~~~~g~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRI--IQIMGTPTKEQMIR-MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHHHHHH-HCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCCHHHHHH-hCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999987655432221 1111110 111111 11100 0000011 123357899999999
Q ss_pred CCCCCCCCHHHHHHHHHHhHhhc
Q 002149 874 REPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 874 ~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
.||++|||+.|+++ +++++.+
T Consensus 308 ~dP~~R~t~~e~l~--hp~f~~~ 328 (383)
T 3eb0_A 308 YEPDLRINPYEAMA--HPFFDHL 328 (383)
T ss_dssp SSGGGSCCHHHHHT--SGGGHHH
T ss_pred CChhhCCCHHHHhc--CHHHHHH
Confidence 99999999999987 5665543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.23 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=199.1
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3568999999999999999999875 5889999998754 334457789999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++... ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 95 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999988542 2568999999999999999999999 89999999999999999999999999997632
Q ss_pred CCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
.... .......||+.|+|||++. +..++.++||||||+++|||++|+.||......+... ...
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~--------- 235 (302)
T 2j7t_A 168 LKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIA--------- 235 (302)
T ss_dssp HHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH---------
T ss_pred cccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHh---------
Confidence 1111 1123357899999999983 6678999999999999999999999998766533211 000
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....+.. .........+.+++.+||+.||++||++.++++
T Consensus 236 --~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 236 --KSDPPTL---LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --HSCCCCC---SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --ccCCccc---CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000 011112346789999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=344.81 Aligned_cols=283 Identities=21% Similarity=0.261 Sum_probs=200.9
Q ss_pred HHHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 605 VLRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 605 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
......++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 34566789999999999999999999764 68999999886532 222345678888899999999999999876433
Q ss_pred -------EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCEEECC-C
Q 002149 684 -------RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH--SLAHQSFIHRDLKSSNILLGD-D 753 (959)
Q Consensus 684 -------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dik~~NiLl~~-~ 753 (959)
.++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| + ++|+||||||+|||++. +
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCC
Confidence 7899999965 5554443321 23367899999999999999999999 7 89999999999999997 8
Q ss_pred CcEEEeeccccccCCCCCcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 754 FRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 754 ~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
+.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+.....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-- 244 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI-- 244 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred CcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH--
Confidence 9999999999986654332 23457899999999987654 899999999999999999999999987654432221
Q ss_pred HHhhhcchHHHHHhcCCccc---------------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 833 FWNIKSDKEKLRAAIDPILE---------------VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
+.............+.+... ...........+.+++.+||+.||.+|||+.|+++ +++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~~ 322 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELH 322 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT--SGGGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc--CccccccC
Confidence 11111111111111111100 00111123457889999999999999999999987 78887765
Q ss_pred CCCC
Q 002149 898 PLDD 901 (959)
Q Consensus 898 ~~~~ 901 (959)
.+..
T Consensus 323 ~~~~ 326 (360)
T 3e3p_A 323 DPAT 326 (360)
T ss_dssp CTTC
T ss_pred Cccc
Confidence 5443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.99 Aligned_cols=275 Identities=22% Similarity=0.303 Sum_probs=206.9
Q ss_pred HhcCCcccCcccccCceEEEEEEE--cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc---CCCCceeEEEEEE----
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL--DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSV---- 679 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 679 (959)
+.++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 4688999999875433332233566788777776 8999999999987
Q ss_pred -eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 680 -AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 680 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
.....++||||+. |+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999996 7999998652 23458999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... +.....
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i--~~~~~~ 237 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI--LDVIGL 237 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHHcCC
Confidence 9999998654322 234467899999999999999999999999999999999999999887654322111 111000
Q ss_pred -chHHHHHh-------cCCcc--cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 839 -DKEKLRAA-------IDPIL--EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 839 -~~~~~~~~-------~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
........ +.... ............+.+++.+||+.||++||++.++++ ++++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~~~ 303 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQDL 303 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTC
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--Ccccccc
Confidence 00000000 00000 000001122346789999999999999999999976 5565543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=369.82 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=207.5
Q ss_pred hcCCcccCcccccCceEEEEEEEc----CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|+..+.||+|+||.||+|.+. .+..||||++... ......+.+.+|+.+++.++||||+++++++. ....+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 467889999999999999999764 2457999998754 24455678999999999999999999999985 45689
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 467 lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 999999999999998642 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.... + .
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~---i----------~ 606 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---I----------E 606 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---H----------H
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---H----------H
Confidence 765543333344567889999999999999999999999999999997 9999987765432111 1 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ... ........+.+++.+||+.||++||++.++++.|..+++.
T Consensus 607 ~~~--~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 NGE--RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HTC--CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC--CCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000 000 1112234688999999999999999999999999998764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=351.81 Aligned_cols=255 Identities=13% Similarity=0.101 Sum_probs=184.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc--CCCCceeEE-------EEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV--RHRHLVSLL-------GYSV 679 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 679 (959)
.+|...+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999764 789999999987543 334566778886655555 599988755 4444
Q ss_pred eC-----------------ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 002149 680 AG-----------------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRR------LNIALDVARGMEYLHSLAHQ 736 (959)
Q Consensus 680 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~ 736 (959)
.. ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 32 34799999997 99999997632 23455555 7888999999999999 8
Q ss_pred CeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccccccccccccccc--CCCCccchHHHHHHHHHHHHhC
Q 002149 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTG 814 (959)
Q Consensus 737 ~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg 814 (959)
+|+||||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999866432 224567799999999987 6799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 815 LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 815 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
+.||....+..... . . .............. .........+.+++.+||+.||++||++.++++
T Consensus 290 ~~Pf~~~~~~~~~~-------~-~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS-------W-K-RPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC-------C-C-BCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc-------h-h-hhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764321100 0 0 00000000000110 001122347889999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.47 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=211.8
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
.....++|++.+.||+|+||.||+|... +++.||||++..........+.+.+|++++++++||||+++++++......
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455678999999999999999999765 789999999876544445567889999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC---CcEEEeec
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD---FRAKVSDF 761 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~---~~~ki~Df 761 (959)
++||||+++++|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999888542 468999999999999999999999 899999999999999754 47999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
|+++....... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+.... +..
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~------ 236 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR---VET------ 236 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH------
T ss_pred CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HHc------
Confidence 99986544322 233468999999998865 489999999999999999999999987654332111 100
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
........ ........+.+++.+|++.||++||++.++++ +++++++..
T Consensus 237 ---~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~~~~~ 285 (287)
T 2wei_A 237 ---GKYAFDLP---QWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSS 285 (287)
T ss_dssp ---CCCCCCSG---GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHHHCC
T ss_pred ---CCCCCCch---hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHhcccc
Confidence 00000000 00112246789999999999999999999987 566666543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=338.78 Aligned_cols=261 Identities=16% Similarity=0.257 Sum_probs=201.9
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEe--CceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVA--GYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 686 (959)
++|++.+.||+|+||.||+|.. .+++.||||++... ..+.+.+|+++++.++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 5799999999999999999965 57899999998643 2356889999999997 9999999999987 667899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVK 765 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~ 765 (959)
||||+++++|.+++ ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999887 348899999999999999999999 8999999999999999776 89999999998
Q ss_pred cCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... +....... . .....
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~-~-~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVL-G-TEDLY 254 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHH-C-HHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhc-C-Cchhh
Confidence 6644332 234578999999999977 67899999999999999999999999654432211 11111100 0 01111
Q ss_pred Hhc---------------CCccc-------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 845 AAI---------------DPILE-------VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 845 ~~~---------------~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
+.+ ..... ...........+.+++.+||+.||++|||++|+++ ++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~--hp~f~ 324 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFY 324 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT--SGGGT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CccHh
Confidence 110 00000 00001112357889999999999999999999987 45544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=372.11 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=208.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
.++|+..+.||+|+||.||+|... +++.||||++++... .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999765 688999999875422 223456678899999988 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 420 V~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999998652 468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~----------------~i 554 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----------------SI 554 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------HH
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH----------------HH
Confidence 433222 2445789999999999999999999999999999999999999998865533211 11
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM-----GHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~L~~~~~ 894 (959)
+......+. .....+.+|+.+||+.||++||++ +||.+ +++++
T Consensus 555 ~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~--h~ff~ 602 (674)
T 3pfq_A 555 MEHNVAYPK---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE--HAFFR 602 (674)
T ss_dssp HSSCCCCCT---TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS--SGGGS
T ss_pred HhCCCCCCc---cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc--Ccccc
Confidence 111111111 123467899999999999999997 66654 34443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.32 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=202.1
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC--CCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR--HRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|++++++++ |+||+++++++......++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4679999999999999999998888999999999766556667788999999999997 59999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|| +.+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||+++..
T Consensus 107 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred Ee-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99 5589999998642 468999999999999999999999 89999999999999965 89999999999865
Q ss_pred CCCCcc-eeecccccccccccccccc-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh
Q 002149 768 PDSERS-VVTRLAGTFGYLAPEYAVT-----------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835 (959)
Q Consensus 768 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~ 835 (959)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-------- 248 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------- 248 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--------
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--------
Confidence 443221 2234578999999999875 46888999999999999999999999765432211
Q ss_pred hhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+...++..... .........+.+++.+||+.||++||++.++++ +++++.
T Consensus 249 -------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 298 (313)
T 3cek_A 249 -------LHAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQI 298 (313)
T ss_dssp -------HHHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHC
T ss_pred -------HHHHHhccccc-CCcccchHHHHHHHHHHccCCcccCcCHHHHhc--CccccC
Confidence 11111111110 000111246789999999999999999999987 455543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=332.43 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=199.9
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
+|.....||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++......++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 345556899999999999975 46889999998764 334457789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEeeccccccCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~DfGla~~~~~ 769 (959)
+++++|.+++... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999998652 122457799999999999999999999 89999999999999987 89999999999986644
Q ss_pred CCcceeeccccccccccccccccCC--CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............. .. ...
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------~~-~~~ 243 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV----------GM-FKV 243 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH----------HH-HCC
T ss_pred CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh----------cc-ccc
Confidence 222 223457899999999997653 7899999999999999999999997543322111000 00 001
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+.. .......+.+++.+||+.||++||++.++++ ++++.
T Consensus 244 ~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~ 283 (295)
T 2clq_A 244 HPEI-----PESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLK 283 (295)
T ss_dssp CCCC-----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGC
T ss_pred cccc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhh
Confidence 1111 1112346789999999999999999999976 34443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=352.81 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=202.8
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC--------CCCceeEEEEEE-
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR--------HRHLVSLLGYSV- 679 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 679 (959)
.++|++.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 46899999999999999999965 46889999998743 445677889999999996 788999999987
Q ss_pred ---eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCC-
Q 002149 680 ---AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDF- 754 (959)
Q Consensus 680 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~- 754 (959)
.+...++||||+ ++++.+.+... ....+++..+..++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 556889999999 66776666442 23569999999999999999999999 7 999999999999999775
Q ss_pred ------------------------------------------------cEEEeeccccccCCCCCcceeecccccccccc
Q 002149 755 ------------------------------------------------RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786 (959)
Q Consensus 755 ------------------------------------------------~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~a 786 (959)
.+||+|||+++..... .....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 7999999999865432 234578999999
Q ss_pred ccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHhhhcchHHH-------HHhcCCcc----
Q 002149 787 PEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE----RQYLAAWFWNIKSDKEKL-------RAAIDPIL---- 851 (959)
Q Consensus 787 PE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~-------~~~~~~~~---- 851 (959)
||++.+..++.++|||||||++|||++|+.||......+ ...+.............. ...+....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999998654321 111111111100000000 00000000
Q ss_pred --------------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 852 --------------EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 852 --------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
............+.+|+.+||+.||++|||+.|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 001123455667889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.34 Aligned_cols=271 Identities=20% Similarity=0.244 Sum_probs=208.5
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CC-----CceeEEEEEEeC
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HR-----HLVSLLGYSVAG 681 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 681 (959)
+.++|++.+.||+|+||.||+|... +++.||||++... .....++.+|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 4578999999999999999999765 6889999998743 344567888999999885 55 499999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCcEEEe
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVS 759 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~--~~~~~ki~ 759 (959)
...++||||+ +|+|.+++... ....+++..+..++.|++.||+|||+. +.+||||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEML-SYNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecC-CCCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999 56999998652 235689999999999999999999951 27999999999999995 47889999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+. ......
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~ 277 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV--EVLGIP 277 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHCSC
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHhCCC
Confidence 99999876432 234678999999999999999999999999999999999999999876554322211 111100
Q ss_pred hHH-------HHHhcCCccc----------------------------------------CCCCCHHHHHHHHHHHHhcc
Q 002149 840 KEK-------LRAAIDPILE----------------------------------------VNDDTFETFWTIAELAGHCT 872 (959)
Q Consensus 840 ~~~-------~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~l~~~cl 872 (959)
... .+..++.... ...........+.+|+.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 000 1111111000 00111233457889999999
Q ss_pred cCCCCCCCCHHHHHHHHHHhHhh
Q 002149 873 SREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 873 ~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+.||++|||+.|+++ ++++.+
T Consensus 358 ~~dP~~Rpta~e~L~--hp~f~~ 378 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQ--HSFFKK 378 (382)
T ss_dssp CSCTTTSCCHHHHTT--SGGGCC
T ss_pred CCChhhCCCHHHHhc--Cccccc
Confidence 999999999999987 455543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=343.80 Aligned_cols=265 Identities=26% Similarity=0.393 Sum_probs=187.9
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 56899999999999999999964 468999999886542 2344567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 689 EYMPQGALSKHIFHWKS---LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
||+++|+|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999864221 123568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc----ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 766 LAPDSER----SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 766 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~---~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQ---NDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HT---SSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hc---cCC
Confidence 6543221 12234578999999999876 56899999999999999999999999877654321110 00 000
Q ss_pred HHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...... .............+.+++.+||+.||++||++.++++
T Consensus 245 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETG----VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccc----cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000 0000000112236789999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.31 Aligned_cols=261 Identities=25% Similarity=0.302 Sum_probs=208.0
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc---c----HHHHHHHHHHHHHHHhcC-CCCceeEEEEE
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI---S----KKAVDEFHSEIAVLSKVR-HRHLVSLLGYS 678 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 678 (959)
...++|+..+.||+|+||.||+|... +|+.||||++..... . ....+.+.+|+++++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999765 689999999865421 1 233567889999999995 99999999999
Q ss_pred EeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEE
Q 002149 679 VAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKV 758 (959)
Q Consensus 679 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki 758 (959)
......++||||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999998542 468999999999999999999999 89999999999999999999999
Q ss_pred eeccccccCCCCCcceeeccccccccccccccc------cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 759 SDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV------TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 759 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......+.....
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-- 241 (298)
T 1phk_A 166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-- 241 (298)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH--
Confidence 9999998654432 233457899999999985 456889999999999999999999999876543321110
Q ss_pred HHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 833 FWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. ..... . ..........+.+++.+||+.||++||++.++++ ++++++
T Consensus 242 -~~---------~~~~~--~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 289 (298)
T 1phk_A 242 -MS---------GNYQF--G-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 289 (298)
T ss_dssp -HH---------TCCCC--C-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred -hc---------CCccc--C-cccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhh
Confidence 00 00000 0 0001122346889999999999999999999976 455543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.87 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=200.3
Q ss_pred HHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe-----
Q 002149 608 NVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA----- 680 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 680 (959)
...++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4467899999999999999999976 478999999986542 2345788999999999 79999999999987
Q ss_pred -CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 681 -GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 681 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
....++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence 467899999999999999986532 2568999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||............
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---- 246 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 246 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----
Confidence 9999986543221 223457899999999987 567899999999999999999999999876653321110
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.....+..... .....+.+++.+||..||++||++.++++ ++++.
T Consensus 247 ---------~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 291 (326)
T 2x7f_A 247 ---------PRNPAPRLKSK----KWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR 291 (326)
T ss_dssp ---------HHSCCCCCSCS----CSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred ---------hcCccccCCcc----ccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence 01011111101 11246889999999999999999999987 45554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=338.64 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=196.4
Q ss_pred HHhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc------HHHHHHHHHHHHHHHhcCCCCceeEEEEEEe
Q 002149 608 NVTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS------KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA 680 (959)
Q Consensus 608 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 680 (959)
.+.++|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|+++++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34568999999999999999999764 6889999998754221 1223458899999999999999999999876
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc---EE
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR---AK 757 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~---~k 757 (959)
.. .++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 65 8999999999999998843 2568999999999999999999999 89999999999999987654 99
Q ss_pred EeeccccccCCCCCcceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
|+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|..||........ +...+.
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 99999998764422 223457899999999974 46788999999999999999999999976543211 111010
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... ...... ......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~--~~~~~~----------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN--FIPEVW----------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC--CCHHHH----------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc--cCchhh----------hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 000000 011236789999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.04 Aligned_cols=270 Identities=20% Similarity=0.293 Sum_probs=208.3
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CC-cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC------ceeEEEEEEeC
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DG-TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH------LVSLLGYSVAG 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 681 (959)
.++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|+++++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 468999999999999999999764 34 68999998743 345667889999999997765 89999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE-----------
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL----------- 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl----------- 750 (959)
...++||||+ ++++.+++.. .....+++.++..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKE---NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHh---ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 7777777754 223568999999999999999999999 899999999999999
Q ss_pred --------CCCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 002149 751 --------GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESR 822 (959)
Q Consensus 751 --------~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~ 822 (959)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999865432 234579999999999999999999999999999999999999999876
Q ss_pred hHHHHHHHHHHHhhhcc-------------------------hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCC
Q 002149 823 PEERQYLAAWFWNIKSD-------------------------KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPS 877 (959)
Q Consensus 823 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 877 (959)
..+.............. .........+..............+.+++.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 55433222111110000 00011111111111122233455788999999999999
Q ss_pred CCCCHHHHHHHHHHhHhh
Q 002149 878 QRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 878 ~RPt~~ev~~~L~~~~~~ 895 (959)
+|||+.|+++ ++++..
T Consensus 324 ~Rpt~~e~l~--hp~f~~ 339 (355)
T 2eu9_A 324 QRITLAEALL--HPFFAG 339 (355)
T ss_dssp TSCCHHHHTT--SGGGGG
T ss_pred hCcCHHHHhc--ChhhcC
Confidence 9999999976 455554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=331.07 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=192.6
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-------
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA------- 680 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 680 (959)
..++|+..+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 356799999999999999999976 4789999999864 34556788999999999999999999998865
Q ss_pred ------CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC
Q 002149 681 ------GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF 754 (959)
Q Consensus 681 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~ 754 (959)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 45678999999999999999642 2467889999999999999999999 8999999999999999999
Q ss_pred cEEEeeccccccCCCCC-------------cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCC
Q 002149 755 RAKVSDFGLVKLAPDSE-------------RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDE 820 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~ 820 (959)
.+||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999998654321 1122345789999999999764 78999999999999999998 4432
Q ss_pred CChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 821 SRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. .+.......+ .. ...... ..........+.+++.+||+.||++|||+.++++
T Consensus 231 ~--~~~~~~~~~~----------~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 231 G--MERVNILKKL----------RS-VSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H--HHHHHHHHHH----------HS-TTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c--hhHHHHHHhc----------cc-cccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 1111111111 00 000111 1112223346789999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=342.68 Aligned_cols=267 Identities=20% Similarity=0.300 Sum_probs=204.7
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHH---------------HHHHHHHHHHHHHhcCCCCceeE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKK---------------AVDEFHSEIAVLSKVRHRHLVSL 674 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l 674 (959)
.++|++.+.||+|+||.||+|.. +|+.||||++........ ..+.+.+|+++++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 899999999875422111 12778999999999999999999
Q ss_pred EEEEEeCceEEEEEEecCCCchhhHHhhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC
Q 002149 675 LGYSVAGYERLLVYEYMPQGALSKHIFHW---KSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG 751 (959)
Q Consensus 675 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~ 751 (959)
++++.+.+..++||||+++|+|.+++... .......+++..+..++.|++.||+|||+. ++|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEc
Confidence 99999999999999999999999983211 112246799999999999999999999972 6999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcceeeccccccccccccccccC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 002149 752 DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITT-KVDVFSFGVVLMELLTGLMALDESRPEERQYL 829 (959)
Q Consensus 752 ~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~ 829 (959)
.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||........ .
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE--L 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH--H
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--H
Confidence 9999999999999865433 33456799999999999887 6666 99999999999999999999987654211 1
Q ss_pred HHHHHhhhcchHHHHH----hcCCcccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 830 AAWFWNIKSDKEKLRA----AIDPILEV--NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 830 ~~~~~~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...+. ........ ...+.... ..........+.+++.+||+.||++||++.++++
T Consensus 262 ~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110 00000000 00000000 0000122346789999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.04 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=189.3
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++.+ +||||+++++++.+....++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 456667889999999998877778999999988643 234578899999987 89999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCC-------------C
Q 002149 690 YMPQGALSKHIFHWKSLNL--EPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDD-------------F 754 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~-------------~ 754 (959)
|+ +|+|.+++........ ...++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +
T Consensus 90 ~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 99 5799999965322111 112344567899999999999999 899999999999999654 4
Q ss_pred cEEEeeccccccCCCCCcc---eeecccccccccccccccc-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 002149 755 RAKVSDFGLVKLAPDSERS---VVTRLAGTFGYLAPEYAVT-------GKITTKVDVFSFGVVLMELLT-GLMALDESRP 823 (959)
Q Consensus 755 ~~ki~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~ 823 (959)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876543321 1234579999999999965 678999999999999999999 9999976544
Q ss_pred HHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 824 EERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.+.. + . ....................+.+++.+||+.||++||++.++++
T Consensus 246 ~~~~-i---~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RESN-I---I----------RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH-H---H----------HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHH-H---h----------cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 3211 0 0 11111100011123345568899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=338.40 Aligned_cols=262 Identities=25% Similarity=0.335 Sum_probs=184.0
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHH-HHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIA-VLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|...+.||+|+||.||+|... +|+.||||++.... ......++.+|+. +++.++||||+++++++......++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 367889999999999999999764 78999999997653 3344455666666 66777999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
|||++ |+|.+++..........+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99996 588877754333334679999999999999999999999 7 999999999999999999999999999986
Q ss_pred CCCCCcceeecccccccccccccc----ccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYA----VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
...... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||........ .
T Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~ 238 (327)
T 3aln_A 176 LVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------------Q 238 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------
T ss_pred cccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------------H
Confidence 544322 2334789999999998 456789999999999999999999999986432110 0
Q ss_pred HHHhcCCccc-C-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 843 LRAAIDPILE-V-NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 843 ~~~~~~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+...+..... . ..........+.+++.+||+.||++||++.++++ ++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~~ 291 (327)
T 3aln_A 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK--HPFILM 291 (327)
T ss_dssp -CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT--SHHHHH
T ss_pred HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh--ChHHHH
Confidence 1111111100 0 0011122346889999999999999999999987 455543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=338.20 Aligned_cols=270 Identities=20% Similarity=0.287 Sum_probs=204.1
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-----------CCCceeEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-----------HRHLVSLLGYS 678 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 678 (959)
++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 5799999999999999999975 57899999998743 344567889999999886 89999999998
Q ss_pred EeCc----eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEEC--
Q 002149 679 VAGY----ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLG-- 751 (959)
Q Consensus 679 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~-- 751 (959)
.... ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEecc
Confidence 7654 789999999 999999986532 3568999999999999999999999 7 999999999999994
Q ss_pred ----CCCcEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH--
Q 002149 752 ----DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE-- 825 (959)
Q Consensus 752 ----~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~-- 825 (959)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999866432 234578999999999999999999999999999999999999998654221
Q ss_pred --HHHHHHHHHhhhcchHH-------HHHhcCCc------------------ccCCCCCHHHHHHHHHHHHhcccCCCCC
Q 002149 826 --RQYLAAWFWNIKSDKEK-------LRAAIDPI------------------LEVNDDTFETFWTIAELAGHCTSREPSQ 878 (959)
Q Consensus 826 --~~~~~~~~~~~~~~~~~-------~~~~~~~~------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 878 (959)
...+...+......... ....+... .............+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111111100000 00011000 0001223456678899999999999999
Q ss_pred CCCHHHHHHHHHHhHhhc
Q 002149 879 RPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 879 RPt~~ev~~~L~~~~~~~ 896 (959)
|||+.|+++ ++++...
T Consensus 325 Rpt~~ell~--hp~f~~~ 340 (373)
T 1q8y_A 325 RADAGGLVN--HPWLKDT 340 (373)
T ss_dssp CBCHHHHHT--CGGGTTC
T ss_pred cCCHHHHhh--Chhhhcc
Confidence 999999987 5666553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=336.63 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=187.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|+..+.||+|+||.||+|... +|+.||||++..........+.+.++..+++.++||||+++++++......++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357889999999999999999775 7899999999765433444444555666788889999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ-SFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||+ ++.+..+.... ...+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++..
T Consensus 104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 55555554321 2568999999999999999999998 5 9999999999999999999999999999765
Q ss_pred CCCCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .+....
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--------- 243 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTKVL--------- 243 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHH---------
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHHHh---------
Confidence 4432 223457899999999984 45788999999999999999999999986443221 111000
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
....+... ........+.+++.+||+.||.+||++.++++ +++++.+..
T Consensus 244 --~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~~~~ 292 (318)
T 2dyl_A 244 --QEEPPLLP---GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE--HSFIKRYET 292 (318)
T ss_dssp --HSCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHHHHH
T ss_pred --ccCCCCCC---ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh--CHHHHhccc
Confidence 00011111 01112346789999999999999999999987 466655433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=335.54 Aligned_cols=261 Identities=23% Similarity=0.272 Sum_probs=176.7
Q ss_pred HhcCCcccC-cccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----Cc
Q 002149 609 VTKNFASEN-ELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GY 682 (959)
Q Consensus 609 ~~~~~~~~~-~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 682 (959)
+.++|.+.+ .||+|+||.||+|... +|+.||||++... .... .+....++.++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 456888854 6999999999999765 7899999998643 2221 222334566799999999999876 45
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~ 759 (959)
..++||||+++|+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 579999999999999999642 23579999999999999999999999 89999999999999976 4559999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ....
T Consensus 174 Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~--- 245 (336)
T 3fhr_A 174 DFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRI--- 245 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhh---
Confidence 999998654322 23457899999999998889999999999999999999999999765432210000 0000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
..... ... ..........+.+++.+||+.||++|||+.++++ ++++....
T Consensus 246 --~~~~~---~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~~~~ 295 (336)
T 3fhr_A 246 --RLGQY---GFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWINQSM 295 (336)
T ss_dssp ----------CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHHTGG
T ss_pred --hcccc---ccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Cccccccc
Confidence 00000 000 0001122346789999999999999999999988 56666543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=366.80 Aligned_cols=389 Identities=20% Similarity=0.195 Sum_probs=260.7
Q ss_pred cceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCC-C-CccCCCCccEEecCCCCCCCCChhhhcCC
Q 002149 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGEL-P-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149 (959)
Q Consensus 72 ~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~-~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 149 (959)
..|-+-..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|+|+.+++..|.++
T Consensus 17 ~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l 96 (844)
T 3j0a_A 17 TQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGL 96 (844)
T ss_dssp SCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSC
T ss_pred CCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCC
Confidence 333332357889999999999888899999999999999999665544 4 68999999999999999999988889999
Q ss_pred CCCcEEEccCcccCCCCCCCCCcc--ccCccccCeecccccccCCCCC-hhhcCCCCCCEEEecCCcCCCCCCcccccC-
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKG--LQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGNNLTGPIPESFKGL- 225 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~--l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l- 225 (959)
++|++|+|++|.+++ .+|.. +.++++|+.|++++|++.+..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 97 ~~L~~L~Ls~n~l~~----~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 97 FHLFELRLYFCGLSD----AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SSCCCEECTTCCCSS----CCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred cccCEeeCcCCCCCc----ccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999875 34444 7889999999999999987655 578899999999999998887766554322
Q ss_pred --C------------------------------cccccccccCC------------------------------------
Q 002149 226 --N------------------------------LVNLWLNDQKG------------------------------------ 237 (959)
Q Consensus 226 --~------------------------------l~~L~~~~~~~------------------------------------ 237 (959)
+ +..|.+.++..
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 1 23333332210
Q ss_pred -----------------------CCcccc-cccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCcc
Q 002149 238 -----------------------GGFTGT-IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPP 293 (959)
Q Consensus 238 -----------------------~~l~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 293 (959)
+.+.+. ...+.++++|+.|+|++|++++..|..|..+++|++|+|++|++++..|.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 011111 12355667777777777777776777777777777777777777777677
Q ss_pred ccccc-cCCeEeCCCCcCCCCCCccc-----ccccccccCcccCCCC---------------CCCCchhhH---------
Q 002149 294 SLASL-SLDHLDLNNNMFMGPVPKSK-----AYKYSYSSNAFCQPTE---------------GVPCAPEVM--------- 343 (959)
Q Consensus 294 ~~~~~-~L~~L~L~~N~l~~~ip~~~-----~~~~~~~~~~~~~~~~---------------~~~~~~~~~--------- 343 (959)
.+..+ +|+.|+|++|.+++..+..+ ...+.+++|.+..... .++......
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR 412 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCc
Confidence 77666 47777777777765544322 1223344444433211 000000000
Q ss_pred ----HHHhhccCCCC----------------------CcccccccCCCCCCC-----cccccccCCCCcccEEECCCCcc
Q 002149 344 ----ALIDFLGGLNY----------------------PPRLVTSWSGNDPCK-----SWLGLSCGTNSKLTVLNLPNFNL 392 (959)
Q Consensus 344 ----~~~~~~~~~~~----------------------~~~l~~~~~~~~~~~-----~~~~~~~~~~~~L~~L~Ls~N~l 392 (959)
.....+..+.. .+.+.......+... ......+..+++|+.|+|++|+|
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 00000000000 011111111111111 11112355678888888888888
Q ss_pred cccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC-CCCcceecccCCCCCCCCCC
Q 002149 393 SGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK-FSGAVKLSLDGNPLLNGKSP 466 (959)
Q Consensus 393 ~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~~~~~l~~N~~~c~~~~ 466 (959)
++..|..|.++++|++|+|++|+|++..|..+. ++|+.|||++|+|++.+|. +.++..+.+.+|||.|....
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 888888888888899999999988876666665 7888999999999888876 55778899999999997643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=342.71 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=187.2
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +|||||++++++.+....++|||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 46888899999999997666666799999999865422 2356899999999 79999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-----CCcEEEeecccc
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-----DFRAKVSDFGLV 764 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-----~~~~ki~DfGla 764 (959)
|+ +|+|.+++.... ....+..++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+|
T Consensus 99 ~~-~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LC-AATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CC-SEEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CC-CCCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99 579999986422 234445667899999999999999 89999999999999953 346889999999
Q ss_pred ccCCCCCc--ceeeccccccccccccccc---cCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 765 KLAPDSER--SVVTRLAGTFGYLAPEYAV---TGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 765 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...........
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------- 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------- 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH---------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH---------
Confidence 86643321 2234467999999999997 4567889999999999999999 9999965543221100
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ...............+.+++.+||+.||++||++.+|++
T Consensus 242 -----~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 -----LGA--CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----TTC--CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----hcc--CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 001111112233445779999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=330.76 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=199.7
Q ss_pred HHHHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcC--CCCceeEEEE
Q 002149 605 VLRNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVR--HRHLVSLLGY 677 (959)
Q Consensus 605 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~ 677 (959)
+.....++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.+++.++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445678899999999999999999975 578999999987653222 12245678999999996 5999999999
Q ss_pred EEeCceEEEEEEecCC-CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCc
Q 002149 678 SVAGYERLLVYEYMPQ-GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG-DDFR 755 (959)
Q Consensus 678 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~-~~~~ 755 (959)
+......++|||++.+ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 8999998542 468999999999999999999999 8999999999999999 7899
Q ss_pred EEEeeccccccCCCCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~----- 255 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----- 255 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-----
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h-----
Confidence 9999999998665432 234579999999999987766 6789999999999999999999975311 0
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...... .. . .....+.+++.+||+.||++||++.++++
T Consensus 256 --------~~~~~~--~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 --------IRGQVF--FR-Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --------HHCCCC--CS-S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------hccccc--cc-c----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00 1 11236789999999999999999999976
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=341.70 Aligned_cols=297 Identities=25% Similarity=0.300 Sum_probs=181.8
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++.|+|++|++++..+..|.++++|++|+|++|.|++..| .|.++++|++|+|++|+|+.+++..|.++++|++|+|++
T Consensus 34 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 113 (477)
T 2id5_A 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113 (477)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTT
T ss_pred CcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCC
Confidence 4455555555554444555555555555555555555444 355555555555555555555555555555555555555
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~ 239 (959)
|++.. ..|..+..+++|+.|++++|++.+..+..|.++++|+.|+|++|++++..+..
T Consensus 114 n~i~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------ 171 (477)
T 2id5_A 114 NKIVI----LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA------------------ 171 (477)
T ss_dssp SCCCE----ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH------------------
T ss_pred Ccccc----CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH------------------
Confidence 55543 22334455555555555555555554555555555555555555555333322
Q ss_pred cccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccc-cccccCCeEeCCCCcCCCCCCccc
Q 002149 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS-LASLSLDHLDLNNNMFMGPVPKSK 318 (959)
Q Consensus 240 l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~~~L~~L~L~~N~l~~~ip~~~ 318 (959)
+.++++|+.|+|++|.+++..+..|..+++|++|+|++|.+.+.+|.. +...+|+.|+|++|.+++ +|.
T Consensus 172 -------l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~-- 241 (477)
T 2id5_A 172 -------LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPY-- 241 (477)
T ss_dssp -------HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCS-CCH--
T ss_pred -------hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccc-cCH--
Confidence 455666777777777776666666666677777777766655544433 223356777777766653 221
Q ss_pred ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCc
Q 002149 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
..+..+++|+.|+|++|++.+..+.
T Consensus 242 -------------------------------------------------------~~~~~l~~L~~L~Ls~n~l~~~~~~ 266 (477)
T 2id5_A 242 -------------------------------------------------------LAVRHLVYLRFLNLSYNPISTIEGS 266 (477)
T ss_dssp -------------------------------------------------------HHHTTCTTCCEEECCSSCCCEECTT
T ss_pred -------------------------------------------------------HHhcCccccCeeECCCCcCCccChh
Confidence 1123457788888888888877777
Q ss_pred cccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCCCC
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~ 464 (959)
.|.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+. +.++..+.+.+|||.|..
T Consensus 267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred hccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 888888888888888888887788888888888888888888876553 245667788888888764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.59 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=190.8
Q ss_pred HHHhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH----HHHHHHHHHHHHHHhc----CCCCceeEEEE
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKV----RHRHLVSLLGY 677 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~~ 677 (959)
....++|+..+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 45567899999999999999999975 468899999987543222 1233456799999999 89999999999
Q ss_pred EEeCceEEEEEEe-cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC-CCCc
Q 002149 678 SVAGYERLLVYEY-MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG-DDFR 755 (959)
Q Consensus 678 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~-~~~~ 755 (959)
+...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++ .++.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCe
Confidence 9999999999999 7899999998652 458999999999999999999999 8999999999999999 8899
Q ss_pred EEEeeccccccCCCCCcceeeccccccccccccccccCCCC-ccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT-TKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+++...... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||..... .
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~----- 245 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I----- 245 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-----
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H-----
Confidence 9999999998665432 2345789999999999877664 589999999999999999999975211 0
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
... ..... ......+.+++.+||+.||++||++.++++
T Consensus 246 --------~~~----~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 --------LEA----ELHFP---AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------HHT----CCCCC---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------hhh----ccCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000 112236789999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=351.69 Aligned_cols=272 Identities=26% Similarity=0.373 Sum_probs=204.6
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe------Cc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA------GY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 682 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++... ......+.+.+|+++++.++||||+++++++.. +.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999975 46899999998764 355667789999999999999999999998755 66
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc---EEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR---AKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~---~ki~ 759 (959)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 7799999999999999986532 22468999999999999999999999 89999999999999987665 9999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ |.......
T Consensus 167 DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~ 239 (676)
T 3qa8_A 167 DLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREK 239 (676)
T ss_dssp SCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC--
T ss_pred cccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcc
Confidence 999998665432 23446799999999999999999999999999999999999999976532211 10000000
Q ss_pred hHH---HHHhcC------Cccc-CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH-----HHHHHHHhHh
Q 002149 840 KEK---LRAAID------PILE-VNDDTFETFWTIAELAGHCTSREPSQRPDMGH-----AVNVLAPLVE 894 (959)
Q Consensus 840 ~~~---~~~~~~------~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----v~~~L~~~~~ 894 (959)
... ...... .... ...........+.+++.+||..||++|||+.+ ..+.+..++.
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 000000 0101 11223345668899999999999999999988 4455555554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=348.24 Aligned_cols=367 Identities=20% Similarity=0.183 Sum_probs=284.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|+++.+++..+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 468999999999998888899999999999999999999877 6999999999999999999998889999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCC-CCChhhcCCCCCCEEEecCCcCCCCCCcccccC-----------
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL----------- 225 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l----------- 225 (959)
++|+++.. .+..+..+++|++|++++|++.+ .+|..|+++++|++|+|++|++++..+..|..+
T Consensus 112 ~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~ 187 (606)
T 3vq2_A 112 VETKLASL----ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187 (606)
T ss_dssp TTSCCCCS----SSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEE
T ss_pred cCCccccc----cccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceee
Confidence 99999852 33568899999999999999986 679999999999999999999987766544322
Q ss_pred -----------------CcccccccccCC---------------------------------------------------
Q 002149 226 -----------------NLVNLWLNDQKG--------------------------------------------------- 237 (959)
Q Consensus 226 -----------------~l~~L~~~~~~~--------------------------------------------------- 237 (959)
++..|.+..+..
T Consensus 188 l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~ 267 (606)
T 3vq2_A 188 MSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267 (606)
T ss_dssp CTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEE
T ss_pred ccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhhee
Confidence 111222211110
Q ss_pred ----------------------------------------------------CCccc---------------c--ccccc
Q 002149 238 ----------------------------------------------------GGFTG---------------T--IDVLG 248 (959)
Q Consensus 238 ----------------------------------------------------~~l~~---------------~--~~~l~ 248 (959)
..++. . ...+.
T Consensus 268 l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~ 347 (606)
T 3vq2_A 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKV 347 (606)
T ss_dssp ECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCC
T ss_pred ccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhc
Confidence 00000 0 01244
Q ss_pred CCcCCcEEEccCcccccc--CchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc-cc-----c
Q 002149 249 NMDQLRTLWLHGNHFSGT--IPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK-SK-----A 319 (959)
Q Consensus 249 ~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~-~~-----~ 319 (959)
.+++|++|+|++|++++. +|..+..+++|++|+|++|.+++. |..+..+ +|+.|++++|.+++..|. .. .
T Consensus 348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 426 (606)
T 3vq2_A 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426 (606)
T ss_dssp CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence 677888999999999865 488999999999999999999864 4666666 699999999999987762 21 2
Q ss_pred cccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCc-ccccccCCCCcccEEECCCCcccccCCc
Q 002149 320 YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS-WLGLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
..+.+++|.+....+.. +..++.+......++.... ..+..++.+++|+.|+|++|++++..|.
T Consensus 427 ~~L~l~~n~l~~~~~~~---------------~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 427 LYLDISYTNTKIDFDGI---------------FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp CEEECTTSCCEECCTTT---------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CEEECcCCCCCccchhh---------------hcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence 23456666665432221 1112233333333333332 2455677889999999999999999999
Q ss_pred cccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC---CC-CcceecccCCCCCCCCC
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK---FS-GAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~-~~~~~~l~~N~~~c~~~ 465 (959)
.++++++|++|+|++|++++.+|..|.++++|+.|||++|+++..++. +. .+..+.+.+|||.|...
T Consensus 492 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred hhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999999999999999999999999999999999999999965443 23 47789999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=351.83 Aligned_cols=242 Identities=23% Similarity=0.342 Sum_probs=194.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc--CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce----
Q 002149 610 TKNFASENELGRGGFGVVYKGELD--DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE---- 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 683 (959)
.++|++.+.||+|+||.||+|... +|+.||||++... ........+.+|++++++++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 468999999999999999999875 6899999998754 244556778999999999999999999999987655
Q ss_pred -EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 684 -RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 684 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
.|+||||+++++|.+++. ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999987652 268999999999999999999999 899999999999999986 99999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
+++..... ....||+.|+|||++.+.. +.++|||||||++|||++|..||.+.....
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------- 283 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------- 283 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence 99866443 3457999999999987654 889999999999999999988876421100
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHHhHh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-MGHAVNVLAPLVE 894 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~L~~~~~ 894 (959)
+............+.+++.+||+.||++||+ ++++.+.+..++.
T Consensus 284 --------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 --------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp --------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred --------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000001112246789999999999999995 5566666665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=335.83 Aligned_cols=356 Identities=18% Similarity=0.208 Sum_probs=255.9
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
+++.|+|++|++++..|..+.++++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|+
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 106 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence 79999999999998889999999999999999999999887 69999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCC-hhhcCCCCCCEEEecCCcCCCCCCcccccC------------
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGNNLTGPIPESFKGL------------ 225 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l------------ 225 (959)
+|+++.. .+|..+..+++|++|++++|++.+.+| ..|.++++|++|++++|++++..|..+..+
T Consensus 107 ~n~l~~~---~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 183 (549)
T 2z81_A 107 GNPYQTL---GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183 (549)
T ss_dssp TCCCSSS---CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred CCccccc---chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence 9999853 346678889999999999998554554 678888899999999998888777766543
Q ss_pred -------------CcccccccccCCCCccccc------------------------------------------------
Q 002149 226 -------------NLVNLWLNDQKGGGFTGTI------------------------------------------------ 244 (959)
Q Consensus 226 -------------~l~~L~~~~~~~~~l~~~~------------------------------------------------ 244 (959)
+++.|.+.++....+....
T Consensus 184 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~ 263 (549)
T 2z81_A 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263 (549)
T ss_dssp STTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEE
T ss_pred ccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccc
Confidence 1222333322222110000
Q ss_pred --------------cc--------------------------ccCCcCCcEEEccCccccccCchhh-cCCCCCCEEeCC
Q 002149 245 --------------DV--------------------------LGNMDQLRTLWLHGNHFSGTIPESF-GKLTSLKDLNLN 283 (959)
Q Consensus 245 --------------~~--------------------------l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls 283 (959)
.. +..+++|+.|++++|+++ .+|..+ ..+++|++|+|+
T Consensus 264 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls 342 (549)
T 2z81_A 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342 (549)
T ss_dssp ECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECC
T ss_pred cccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEcc
Confidence 00 001234566666666665 455555 468888888888
Q ss_pred CCcCCCCCcc---ccccc-cCCeEeCCCCcCCCCCC--c----c-cccccccccCcccCCCCCCCCchhhHHHHhhccCC
Q 002149 284 SNQFVGLIPP---SLASL-SLDHLDLNNNMFMGPVP--K----S-KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGL 352 (959)
Q Consensus 284 ~N~l~~~~p~---~~~~~-~L~~L~L~~N~l~~~ip--~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (959)
+|++++.+|. .+..+ +|+.|+|++|++++..+ . . ....+.+++|.+...+....
T Consensus 343 ~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~--------------- 407 (549)
T 2z81_A 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQ--------------- 407 (549)
T ss_dssp SSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCC---------------
T ss_pred CCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhc---------------
Confidence 8888876543 24444 58888888888865321 0 0 12234566666654332211
Q ss_pred CCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCe
Q 002149 353 NYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTL 432 (959)
Q Consensus 353 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~ 432 (959)
.++.+......++......+ ...++|+.|+|++|+|++.+ ..+++|++|+|++|+|+ .+|. ...+++|++
T Consensus 408 -~~~~L~~L~Ls~N~l~~l~~---~~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~ 477 (549)
T 2z81_A 408 -WPEKMRFLNLSSTGIRVVKT---CIPQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLV 477 (549)
T ss_dssp -CCTTCCEEECTTSCCSCCCT---TSCTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCE
T ss_pred -ccccccEEECCCCCcccccc---hhcCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCE
Confidence 11222222222222221111 11368999999999999753 57899999999999999 7886 578999999
Q ss_pred EeCCCCccCCCCCC----CCCcceecccCCCCCCCC
Q 002149 433 LDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 433 L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~ 464 (959)
|||++|+|++.+|. +..+..+++.+|+|.|..
T Consensus 478 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 478 MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp EECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred EecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 99999999998885 356778999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.47 Aligned_cols=235 Identities=12% Similarity=0.053 Sum_probs=185.1
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357999999999999999999765 5899999999765433 45567899999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++++|.+++.. . ....++.+++.|++.||+|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999832 1 3556788999999999999999 899999999999999999999997443
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
|++ .++.++|||||||++|||++|+.||.+....+... ..........
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------PAERDTAGQP 222 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------ECCBCTTSCB
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------HHHHHhccCC
Confidence 333 36889999999999999999999998765322100 0000000000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ..........+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus 223 ~~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCh---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000 00001122468899999999999999 999999999887654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=335.35 Aligned_cols=372 Identities=19% Similarity=0.164 Sum_probs=224.6
Q ss_pred CcceEecC-----------CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCC
Q 002149 71 WKHVFCSN-----------SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNF 138 (959)
Q Consensus 71 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l 138 (959)
+..+.|.. ..++.|+|++|.+++..|..|.++++|++|+|++|.+.+..| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 34578864 368899999999998888899999999999999999998877 699999999999999999
Q ss_pred CCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCC
Q 002149 139 DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI 218 (959)
Q Consensus 139 ~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 218 (959)
+.+++..|.++++|++|+|++|+++.. .|..+..+++|++|++++|++.+..+..+..+++|++|+|++|++++..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 169 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSI----DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCG----GGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEEC
T ss_pred cccChhhhcccccccEeeccccCcccC----CcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccC
Confidence 999888899999999999999998853 2455677778888888888877644334444777777777777777666
Q ss_pred CcccccC-Ccc--cccccccCCCCccccc-----------------------------------------------cccc
Q 002149 219 PESFKGL-NLV--NLWLNDQKGGGFTGTI-----------------------------------------------DVLG 248 (959)
Q Consensus 219 p~~~~~l-~l~--~L~~~~~~~~~l~~~~-----------------------------------------------~~l~ 248 (959)
|..|..+ ++. .|.+.++....+.... ..+.
T Consensus 170 ~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~ 249 (606)
T 3t6q_A 170 KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249 (606)
T ss_dssp HHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGG
T ss_pred hhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhc
Confidence 6555444 222 3333333222111100 0000
Q ss_pred CCc--CCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccc-----c
Q 002149 249 NMD--QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKA-----Y 320 (959)
Q Consensus 249 ~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~-----~ 320 (959)
.+. +|+.|++++|.+++..+..|..+++|++|+|++|+++ .+|..+..+ +|+.|++++|.+++..|.... .
T Consensus 250 ~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 328 (606)
T 3t6q_A 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328 (606)
T ss_dssp GGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCS
T ss_pred hhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCC
Confidence 010 4455555555555444444555555555555555555 333344443 355555555555543332211 1
Q ss_pred ccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCccc--ccccCCCCcccEEECCCCcccccCCc
Q 002149 321 KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWL--GLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
.+.+++|.+.+..+. +.+..++.+.......+...... ...++.+++|+.|+|++|++.+..|.
T Consensus 329 ~L~l~~n~~~~~~~~--------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 394 (606)
T 3t6q_A 329 HLSIKGNTKRLELGT--------------GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394 (606)
T ss_dssp EEECCSCSSCCBCCS--------------STTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTT
T ss_pred EEECCCCCcccccch--------------hhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHH
Confidence 112222222110000 00011112222222222222221 23455667777777777777777677
Q ss_pred cccCcCcCCEEeCcccccccccCCC-ccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCC
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLL 461 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~ 461 (959)
.+.++++|++|+|++|++++..|.. +.++++|+.|++++|.+++.+|. +.++..+.+.+|++.
T Consensus 395 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 462 (606)
T 3t6q_A 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462 (606)
T ss_dssp TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCG
T ss_pred HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCC
Confidence 7777777777777777777655543 66777777777777777666553 344566677776553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.51 Aligned_cols=235 Identities=21% Similarity=0.272 Sum_probs=181.4
Q ss_pred hcCCccc-CcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHH-HhcCCCCceeEEEEEEe----Cc
Q 002149 610 TKNFASE-NELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVL-SKVRHRHLVSLLGYSVA----GY 682 (959)
Q Consensus 610 ~~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 682 (959)
.++|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|++++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4567776 7899999999999976 57899999998642 3466888888 55589999999999887 67
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~ 759 (959)
..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 789999999999999999652 23569999999999999999999999 89999999999999998 7889999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++... +..++.++|||||||++|||++|+.||.........
T Consensus 163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------ 207 (299)
T 3m2w_A 163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------ 207 (299)
T ss_dssp CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------
Confidence 999986432 234678999999999999999999999765432110
Q ss_pred hHHHHHhcCCcccCCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 840 KEKLRAAIDPILEVNDDT----FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
......+.. ...... ......+.+++.+||+.||++||++.|+++ ++++....
T Consensus 208 -~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~~~ 264 (299)
T 3m2w_A 208 -PGMKTRIRM--GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQST 264 (299)
T ss_dssp -CCSCCSSCT--TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHTGG
T ss_pred -HHHHHHHhh--ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcccc
Confidence 000000000 000001 012346889999999999999999999987 56665443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=327.39 Aligned_cols=245 Identities=16% Similarity=0.150 Sum_probs=182.0
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccc-ccHHHHHHHHHHHHHHHhcCC-CCce---------e-----
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGV-ISKKAVDEFHSEIAVLSKVRH-RHLV---------S----- 673 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv---------~----- 673 (959)
.+|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+.+|+.+++.++| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999974 579999999987332 122335778999999999977 2211 1
Q ss_pred -------EEEEEEe-----CceEEEEEEecCCCchhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 002149 674 -------LLGYSVA-----GYERLLVYEYMPQGALSKHIFHWK--SLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFI 739 (959)
Q Consensus 674 -------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 739 (959)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.||++||+|||+ ++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 1111111 12356777776 899998885321 1223568899999999999999999999 8999
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccccccccccccc----------ccCCCCccchHHHHHHHHH
Q 002149 740 HRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA----------VTGKITTKVDVFSFGVVLM 809 (959)
Q Consensus 740 H~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlG~ll~ 809 (959)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 344577 999999999 5566888999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 810 ELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 810 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
||++|+.||......+. ....+.... .....+.+++.+||+.||++||++.++++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999976543211 111111111 11246889999999999999999888765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=335.14 Aligned_cols=366 Identities=21% Similarity=0.194 Sum_probs=258.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.++.|+|++|+|++..+..|.++++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.+++.+|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 68999999999997777889999999999999999999888 69999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCC-CCChhhcCCCCCCEEEecCCcCCCCCCcccccCC-----------
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLN----------- 226 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~----------- 226 (959)
+|+|+++ .+..++++++|++|++++|++.+ .+|..++.+++|++|+|++|++++..+..|..+.
T Consensus 133 ~N~l~~l----~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l 208 (635)
T 4g8a_A 133 ETNLASL----ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 208 (635)
T ss_dssp TSCCCCS----TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred CCcCCCC----ChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence 9999853 23458999999999999999986 4688999999999999999999877666553320
Q ss_pred -----------------cccccccccCC------------------------------------CCc-------------
Q 002149 227 -----------------LVNLWLNDQKG------------------------------------GGF------------- 240 (959)
Q Consensus 227 -----------------l~~L~~~~~~~------------------------------------~~l------------- 240 (959)
+..+.+..+.. ..+
T Consensus 209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~ 288 (635)
T 4g8a_A 209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 288 (635)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence 00000000000 000
Q ss_pred -------cc----------------------ccccccCCcCCcEEEccCccccccCch-------------------hhc
Q 002149 241 -------TG----------------------TIDVLGNMDQLRTLWLHGNHFSGTIPE-------------------SFG 272 (959)
Q Consensus 241 -------~~----------------------~~~~l~~l~~L~~L~L~~N~l~~~~p~-------------------~~~ 272 (959)
.+ ....+....+|+.|++.+|.+.+..+. ...
T Consensus 289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~ 368 (635)
T 4g8a_A 289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 368 (635)
T ss_dssp ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence 00 001122334566777777666533221 223
Q ss_pred CCCCCCEEeCCCCcCCCC--Ccccccc-ccCCeEeCCCCcCCCC-----------------------CCccc------cc
Q 002149 273 KLTSLKDLNLNSNQFVGL--IPPSLAS-LSLDHLDLNNNMFMGP-----------------------VPKSK------AY 320 (959)
Q Consensus 273 ~l~~L~~L~Ls~N~l~~~--~p~~~~~-~~L~~L~L~~N~l~~~-----------------------ip~~~------~~ 320 (959)
.+++|+.|++++|.+... .+..+.. .+|+.|+++.|.+.+. .+... ..
T Consensus 369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred cccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccc
Confidence 567788888888887533 2222222 2466666665554432 21110 00
Q ss_pred ccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCC-CCCCCcccccccCCCCcccEEECCCCcccccCCcc
Q 002149 321 KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG-NDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPS 399 (959)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~ 399 (959)
.+.++.|.+....... ....+.+...... +.....+.+..++.+++|+.|+|++|+|++..|..
T Consensus 449 ~l~ls~n~l~~~~~~~---------------~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGI---------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp EEECTTSCCEECCTTT---------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred cccccccccccccccc---------------cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 0112222222211111 1111222222222 22223345556788899999999999999999999
Q ss_pred ccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCCC-----CCcceecccCCCCCCCC
Q 002149 400 VGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF-----SGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 400 ~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-----~~~~~~~l~~N~~~c~~ 464 (959)
|+++++|++|+|++|+|++..|..|.++++|++|||++|+|++.+|.. ..+..+.+.+|||.|.+
T Consensus 514 f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 514 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp TTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred HcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 999999999999999999888889999999999999999999988852 35678999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-33 Score=328.84 Aligned_cols=341 Identities=20% Similarity=0.171 Sum_probs=222.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEEC
Confidence 467788888888887777788888888888888888888766 588888888888888888887765 7888888888
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC--CEEEecCCcC--CCCCCcccccCCccccccc
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL--QNLKLSGNNL--TGPIPESFKGLNLVNLWLN 233 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~l~~L~~~ 233 (959)
++|+++.. .+|..+.++++|++|++++|++.+. .+..+++| +.|+|++|++ ++..|..+..+....+.+
T Consensus 129 s~N~l~~l---~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l- 201 (562)
T 3a79_B 129 SFNDFDVL---PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL- 201 (562)
T ss_dssp CSSCCSBC---CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEE-
T ss_pred CCCCcccc---CchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEE-
Confidence 88888743 2456788888888888888888763 34444444 8888888888 777777766543111111
Q ss_pred ccCCCCccccc------------------------------ccc---------------------------cCCcCCcEE
Q 002149 234 DQKGGGFTGTI------------------------------DVL---------------------------GNMDQLRTL 256 (959)
Q Consensus 234 ~~~~~~l~~~~------------------------------~~l---------------------------~~l~~L~~L 256 (959)
+...+.+.+.. +.+ ...++|++|
T Consensus 202 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L 281 (562)
T 3a79_B 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281 (562)
T ss_dssp EECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEE
T ss_pred EecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEE
Confidence 00000000000 000 011266677
Q ss_pred EccCccccccCchhh-----------------------------------------------------cCCCCCCEEeCC
Q 002149 257 WLHGNHFSGTIPESF-----------------------------------------------------GKLTSLKDLNLN 283 (959)
Q Consensus 257 ~L~~N~l~~~~p~~~-----------------------------------------------------~~l~~L~~L~Ls 283 (959)
++++|+++|.+|..+ ..+++|++|+|+
T Consensus 282 ~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~ 361 (562)
T 3a79_B 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFT 361 (562)
T ss_dssp EEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred EEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECC
Confidence 777777776666554 334445555555
Q ss_pred CCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCccccccc
Q 002149 284 SNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW 362 (959)
Q Consensus 284 ~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 362 (959)
+|++++.+|..+..+ +|+.|+|++|++++..+ +...+ ..++.+....
T Consensus 362 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------------~~~~~---~~l~~L~~L~ 409 (562)
T 3a79_B 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK-----------------------------VALMT---KNMSSLETLD 409 (562)
T ss_dssp SSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH-----------------------------HHHTT---TTCTTCCEEE
T ss_pred CCccccchhhhhcccCCCCEEECCCCCcCCccc-----------------------------chhhh---cCCCCCCEEE
Confidence 555554444444444 35555555554443100 00000 1111222222
Q ss_pred CCCCCCCc-ccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccC
Q 002149 363 SGNDPCKS-WLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 363 ~~~~~~~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
...+.... .....+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+
T Consensus 410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486 (562)
T ss_dssp CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence 22222222 2222355678999999999999988887665 79999999999999 78988889999999999999999
Q ss_pred CCCCC----CCCcceecccCCCCCCCC
Q 002149 442 PPLPK----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 442 ~~~p~----~~~~~~~~l~~N~~~c~~ 464 (959)
..++. +.++..+.+.+|||.|..
T Consensus 487 ~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 487 SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 65543 345678899999999974
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=333.82 Aligned_cols=296 Identities=22% Similarity=0.238 Sum_probs=215.6
Q ss_pred CccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCE
Q 002149 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQN 206 (959)
Q Consensus 127 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~ 206 (959)
+|++|+|++|+++.+++..|.++++|++|+|++|+++ .+|..+..+++|++|++++|++.+..|..+..+++|++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-----~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 329 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-----ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-----CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSE
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-----CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCE
Confidence 4666666777777777777777778888888887776 56777777778888888888877777777777788888
Q ss_pred EEecCCcCCCCCCcc-cccC-CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCC
Q 002149 207 LKLSGNNLTGPIPES-FKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNS 284 (959)
Q Consensus 207 L~Ls~N~l~~~~p~~-~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 284 (959)
|++++|.+.+.+|.. +..+ +++.|.+.++...........+.++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 330 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 409 (606)
T 3t6q_A 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF 409 (606)
T ss_dssp EECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTT
T ss_pred EECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCC
Confidence 888888777655543 5544 45566665555444432234567777777788877777777777777777778888877
Q ss_pred CcCCCCCccc-cccc-cCCeEeCCCCcCCCCCCcccc-----cccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcc
Q 002149 285 NQFVGLIPPS-LASL-SLDHLDLNNNMFMGPVPKSKA-----YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPR 357 (959)
Q Consensus 285 N~l~~~~p~~-~~~~-~L~~L~L~~N~l~~~ip~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (959)
|++++..+.. +..+ +|+.|+|++|.+++..|.... ..+.+++|.+.+..
T Consensus 410 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~------------------------ 465 (606)
T 3t6q_A 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN------------------------ 465 (606)
T ss_dssp CCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGE------------------------
T ss_pred CcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccc------------------------
Confidence 7777665433 5555 477777777777766554321 11122232221100
Q ss_pred cccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCC
Q 002149 358 LVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQ 437 (959)
Q Consensus 358 l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~ 437 (959)
......++.+++|+.|+|++|++++..|..|+++++|++|+|++|++++.+|..+.+++.| .|+|++
T Consensus 466 ------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~ 532 (606)
T 3t6q_A 466 ------------IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLAS 532 (606)
T ss_dssp ------------ECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCS
T ss_pred ------------cccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcC
Confidence 0011235567999999999999999999999999999999999999999999999999999 999999
Q ss_pred CccCCCCCC----CCCcceecccCCCCCCCC
Q 002149 438 NNLSPPLPK----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 438 N~l~~~~p~----~~~~~~~~l~~N~~~c~~ 464 (959)
|++++.+|. +..+..+.+.+|||.|..
T Consensus 533 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 533 NHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp SCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred CcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 999998875 356788999999999974
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=329.31 Aligned_cols=366 Identities=19% Similarity=0.205 Sum_probs=250.2
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
+++.|+++++++++..+..|.++++|++|+|++|++++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 68888999999887777788899999999999998888777 58888999999999999988888888889999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCC-CCChhhcCCCCCCEEEecCCcCCCCCCcccccC-Cc----ccccc
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NL----VNLWL 232 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l----~~L~~ 232 (959)
+|+++... +..+..+++|++|++++|++.+ .+|..|+++++|++|++++|++++..+..+..+ ++ ..+.+
T Consensus 109 ~n~l~~l~----~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l 184 (570)
T 2z63_A 109 ETNLASLE----NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184 (570)
T ss_dssp TSCCCCST----TCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred ccccccCC----CccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhccc
Confidence 99887532 1247788888888888888886 468888888888888888888876655544332 11 11111
Q ss_pred cccCCCC-------------------------------------------------------------------------
Q 002149 233 NDQKGGG------------------------------------------------------------------------- 239 (959)
Q Consensus 233 ~~~~~~~------------------------------------------------------------------------- 239 (959)
..+....
T Consensus 185 ~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l 264 (570)
T 2z63_A 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264 (570)
T ss_dssp TTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred CCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence 1111000
Q ss_pred -----ccc-ccccccCCcCCcEEEccCccccccCchhh------------------------------------------
Q 002149 240 -----FTG-TIDVLGNMDQLRTLWLHGNHFSGTIPESF------------------------------------------ 271 (959)
Q Consensus 240 -----l~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~------------------------------------------ 271 (959)
+.+ ..+.+..+++|++|++++|.++ .+|..+
T Consensus 265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~ 343 (570)
T 2z63_A 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343 (570)
T ss_dssp EETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC
T ss_pred hcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccc
Confidence 000 0012333444444444444443 222221
Q ss_pred cCCCCCCEEeCCCCcCCCCC--ccccccc-cCCeEeCCCCcCCCCCCcc----cccccccccCcccCCCCCCCCchhhHH
Q 002149 272 GKLTSLKDLNLNSNQFVGLI--PPSLASL-SLDHLDLNNNMFMGPVPKS----KAYKYSYSSNAFCQPTEGVPCAPEVMA 344 (959)
Q Consensus 272 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~~-~L~~L~L~~N~l~~~ip~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (959)
..+++|++|+|++|++++.. +..+..+ +|+.|+|++|.+++..+.. ....+.+++|.+.......
T Consensus 344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------- 415 (570)
T 2z63_A 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFS-------- 415 (570)
T ss_dssp CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSC--------
T ss_pred ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchh--------
Confidence 35667777777777777553 4445554 5777777777776533220 1122334444443321100
Q ss_pred HHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc-ccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS-GTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 345 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
.+..++.+.......+.........++.+++|+.|+|++|++. +.+|..+..+++|++|+|++|++++..|..
T Consensus 416 ------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~ 489 (570)
T 2z63_A 416 ------VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489 (570)
T ss_dssp ------TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ------hhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence 0111222333233333333334445677899999999999998 679999999999999999999999988999
Q ss_pred ccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCCCC
Q 002149 424 WTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~ 464 (959)
|.++++|+.|+|++|++++.+|. +..+..+.+.+|++.|..
T Consensus 490 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence 99999999999999999988774 355678999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=325.35 Aligned_cols=359 Identities=20% Similarity=0.196 Sum_probs=250.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|++|.+++..|..|.++++|++|+|++|+|++..| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 578899999999998878889999999999999999998876 689999999999999999988876 7899999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC--CEEEecCCcC--CCCCCcccccCCc------
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL--QNLKLSGNNL--TGPIPESFKGLNL------ 227 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~l------ 227 (959)
++|++++. .+|..++.+++|++|++++|++.+ ..+..+++| +.|+|++|++ .+..|..+..+..
T Consensus 98 ~~N~l~~~---~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~ 171 (520)
T 2z7x_B 98 SFNAFDAL---PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171 (520)
T ss_dssp CSSCCSSC---CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEE
T ss_pred cCCccccc---cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEE
Confidence 99998753 367888999999999999999886 456777777 9999999999 7777877766431
Q ss_pred ------------------ccccccccCCCC-------cccccccccC---------------------------CcCCcE
Q 002149 228 ------------------VNLWLNDQKGGG-------FTGTIDVLGN---------------------------MDQLRT 255 (959)
Q Consensus 228 ------------------~~L~~~~~~~~~-------l~~~~~~l~~---------------------------l~~L~~ 255 (959)
..|...+...+. +.+.++.+.. +++|++
T Consensus 172 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~ 251 (520)
T 2z7x_B 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251 (520)
T ss_dssp CCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSE
T ss_pred eccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccE
Confidence 111111111110 1111111111 236777
Q ss_pred EEccCccccccCchhh-----cCCCCCCEEeCCCCcCCCCCc-cc-------------------------cccc-cCCeE
Q 002149 256 LWLHGNHFSGTIPESF-----GKLTSLKDLNLNSNQFVGLIP-PS-------------------------LASL-SLDHL 303 (959)
Q Consensus 256 L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~-------------------------~~~~-~L~~L 303 (959)
|+|++|+++|.+|..+ ..+++|+.+++++|.+ .+| .. +..+ +|+.|
T Consensus 252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L 329 (520)
T 2z7x_B 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329 (520)
T ss_dssp EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEE
T ss_pred EEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEE
Confidence 7777777777777766 5555555555544444 111 00 0233 47778
Q ss_pred eCCCCcCCCCCCcccc-----cccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCc-ccccccC
Q 002149 304 DLNNNMFMGPVPKSKA-----YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKS-WLGLSCG 377 (959)
Q Consensus 304 ~L~~N~l~~~ip~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~ 377 (959)
+|++|++++.+|.... ..+.+++|.+... ..+...++.+ +.+.......+.... .....+.
T Consensus 330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l----------~~~~~~~~~l---~~L~~L~Ls~N~l~~~l~~~~~~ 396 (520)
T 2z7x_B 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKEL----------SKIAEMTTQM---KSLQQLDISQNSVSYDEKKGDCS 396 (520)
T ss_dssp ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH----------HHHHHHHTTC---TTCCEEECCSSCCBCCGGGCSCC
T ss_pred EeECCccChhhhhhhccCCCCCEEEccCCccCcc----------ccchHHHhhC---CCCCEEECCCCcCCcccccchhc
Confidence 8888887776665432 2234445544321 1111122222 233333333344333 3333466
Q ss_pred CCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC----CCCccee
Q 002149 378 TNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKL 453 (959)
Q Consensus 378 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~ 453 (959)
.+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+..++. +.++..+
T Consensus 397 ~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473 (520)
T ss_dssp CCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEE
Confidence 789999999999999988887765 79999999999999 8999888999999999999999965443 3457789
Q ss_pred cccCCCCCCCC
Q 002149 454 SLDGNPLLNGK 464 (959)
Q Consensus 454 ~l~~N~~~c~~ 464 (959)
.+.+|++.|..
T Consensus 474 ~l~~N~~~c~c 484 (520)
T 2z7x_B 474 WLHTNPWDCSC 484 (520)
T ss_dssp ECCSSCBCCCH
T ss_pred ECcCCCCcccC
Confidence 99999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.52 Aligned_cols=244 Identities=16% Similarity=0.159 Sum_probs=185.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccc------cHHHHHHHHHHHHHHHhcC---------CCCceeE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVI------SKKAVDEFHSEIAVLSKVR---------HRHLVSL 674 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l 674 (959)
.++|++.+.||+|+||.||+|+. +|+.||||++..... .....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788999999999999999987 689999999976532 2233467889999999986 8888888
Q ss_pred EEEEE------------------------------eCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHH
Q 002149 675 LGYSV------------------------------AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724 (959)
Q Consensus 675 ~~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia 724 (959)
.+++. .....++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 87653 26789999999999987666632 5689999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCCEEECCCC--------------------cEEEeeccccccCCCCCcceeeccccccc
Q 002149 725 RGMEYLH-SLAHQSFIHRDLKSSNILLGDDF--------------------RAKVSDFGLVKLAPDSERSVVTRLAGTFG 783 (959)
Q Consensus 725 ~gL~yLH-~~~~~~ivH~Dik~~NiLl~~~~--------------------~~ki~DfGla~~~~~~~~~~~~~~~gt~~ 783 (959)
.||+||| + ++||||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 7999999999999999887 8999999999865432 2479999
Q ss_pred cccccccccCCCCccchHHHHHHH-HHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc-ccCCCCCHHHH
Q 002149 784 YLAPEYAVTGKITTKVDVFSFGVV-LMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI-LEVNDDTFETF 861 (959)
Q Consensus 784 y~aPE~~~~~~~~~~~DvwSlG~l-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 861 (959)
|+|||++.+.. +.++||||+|++ .+++++|..||..... ..... ..+....... ...........
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~----------~~~~~~~~~~~~~~~~~~~~~s 309 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLT----------DKMLKQMTFKTKCNTPAMKQIK 309 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHH----------HHHHHTCCCSSCCCSHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHH----------HhhhhhhccCcccchhhhhhcC
Confidence 99999998766 889999998777 7788889888742100 00010 1111111100 00011122345
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHH-H
Q 002149 862 WTIAELAGHCTSREPSQRPDMGHAV-N 887 (959)
Q Consensus 862 ~~l~~l~~~cl~~dP~~RPt~~ev~-~ 887 (959)
..+.+|+.+||+.| |+.|++ +
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHHhc
Confidence 67899999999977 888887 5
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=304.21 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=204.3
Q ss_pred ccEEecCCCCCCC--CChhhhcCCCCCcEEEccC-cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC
Q 002149 128 LKYAYLDGNNFDT--IPADFFDGLENLQVLALDS-NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL 204 (959)
Q Consensus 128 L~~L~L~~N~l~~--i~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L 204 (959)
++.|+|++|++++ ..+..|.++++|++|+|++ |.+.+ .+|..+..+++|++|++++|++++.+|..|..+++|
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 127 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG----PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES----CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTC
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccc----cCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCC
Confidence 4444444444443 2223355555555555552 55544 355555666666666666666667788899999999
Q ss_pred CEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCC-CCCEEeCC
Q 002149 205 QNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT-SLKDLNLN 283 (959)
Q Consensus 205 ~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls 283 (959)
++|+|++|++++.+|.. +.++++|++|+|++|++++.+|..+..++ +|++|+|+
T Consensus 128 ~~L~Ls~N~l~~~~p~~-------------------------~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~ 182 (313)
T 1ogq_A 128 VTLDFSYNALSGTLPPS-------------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182 (313)
T ss_dssp CEEECCSSEEESCCCGG-------------------------GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECC
T ss_pred CEEeCCCCccCCcCChH-------------------------HhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECc
Confidence 99999999999988877 45679999999999999999999999998 99999999
Q ss_pred CCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccC
Q 002149 284 SNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363 (959)
Q Consensus 284 ~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 363 (959)
+|++++.+|..+..++|+.|+|++|.+++.+|.
T Consensus 183 ~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~----------------------------------------------- 215 (313)
T 1ogq_A 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV----------------------------------------------- 215 (313)
T ss_dssp SSEEEEECCGGGGGCCCSEEECCSSEEEECCGG-----------------------------------------------
T ss_pred CCeeeccCChHHhCCcccEEECcCCcccCcCCH-----------------------------------------------
Confidence 999999999999999999999999999876553
Q ss_pred CCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCC
Q 002149 364 GNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~ 443 (959)
.++.+++|+.|+|++|++++.+|. +..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+++|.
T Consensus 216 -----------~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 283 (313)
T 1ogq_A 216 -----------LFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283 (313)
T ss_dssp -----------GCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred -----------HHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence 234568999999999999988776 88999999999999999999999999999999999999999999
Q ss_pred CCCC---CCcceecccCCCCCCCCC
Q 002149 444 LPKF---SGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 444 ~p~~---~~~~~~~l~~N~~~c~~~ 465 (959)
+|.. ..+..+.+.+|+++||.+
T Consensus 284 ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 284 IPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred CCCCccccccChHHhcCCCCccCCC
Confidence 9975 445678999999999964
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=324.82 Aligned_cols=307 Identities=20% Similarity=0.209 Sum_probs=253.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.+++.++.+++..+..+..+++|++|+|++|.|++.++ .|.++++|++|+|++|.|+.+++..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 356788999999986656668999999999999999999888 7999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcc-ccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccC
Q 002149 158 DSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQK 236 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~ 236 (959)
++|.|+. +|.. +..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++.....+. ++..|.+..+.
T Consensus 131 ~~n~l~~-----l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~--~L~~L~l~~n~ 203 (597)
T 3oja_B 131 ERNDLSS-----LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP--SLFHANVSYNL 203 (597)
T ss_dssp CSSCCCC-----CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCT--TCSEEECCSSC
T ss_pred eCCCCCC-----CCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhh--hhhhhhcccCc
Confidence 9999984 5555 58999999999999999999999999999999999999999976555443 34444444433
Q ss_pred CCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 237 ~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
.. + +...++|+.|++++|.++. +|..+ .++|+.|+|++|.+++. ..+..+ +|+.|+|++|.+++.+|
T Consensus 204 l~---~----l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~ 271 (597)
T 3oja_B 204 LS---T----LAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 271 (597)
T ss_dssp CS---E----EECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEES
T ss_pred cc---c----ccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCH
Confidence 22 2 3445789999999999884 44333 36899999999999874 455555 69999999999887655
Q ss_pred cccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccccc
Q 002149 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395 (959)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 395 (959)
. .++.+++|+.|+|++|++++
T Consensus 272 ~----------------------------------------------------------~~~~l~~L~~L~Ls~N~l~~- 292 (597)
T 3oja_B 272 H----------------------------------------------------------PFVKMQRLERLYISNNRLVA- 292 (597)
T ss_dssp G----------------------------------------------------------GGTTCSSCCEEECTTSCCCE-
T ss_pred H----------------------------------------------------------HhcCccCCCEEECCCCCCCC-
Confidence 3 23456889999999999986
Q ss_pred CCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC-CCCCcceecccCCCCCCCC
Q 002149 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP-KFSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 396 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~l~~N~~~c~~ 464 (959)
+|..+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++..+ .+..+..+.+.+|+|.|..
T Consensus 293 l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHH
T ss_pred CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChh
Confidence 5777788999999999999999 688888999999999999999987543 3667888999999998864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-31 Score=326.34 Aligned_cols=377 Identities=19% Similarity=0.172 Sum_probs=218.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|+++++++..+..|.++++|++|+|++|.+++..| .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 368889999999987777788899999999999999988877 4788899999999999999888888888999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC---Ccccccccc
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL---NLVNLWLND 234 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~l~~L~~~~ 234 (959)
++|++++ ..|..+..+++|++|++++|++++..|..+.++++|++|+|++|++++..+..+..+ +++.|.+..
T Consensus 105 ~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~ 180 (680)
T 1ziw_A 105 MSNSIQK----IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180 (680)
T ss_dssp CSSCCCC----CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTT
T ss_pred CCCccCc----cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCC
Confidence 9998874 234567888888888888888888888888888888888888888887666554332 344454444
Q ss_pred cCCCCcccc------------------------------------------------c-ccccCCc--CCcEEEccCccc
Q 002149 235 QKGGGFTGT------------------------------------------------I-DVLGNMD--QLRTLWLHGNHF 263 (959)
Q Consensus 235 ~~~~~l~~~------------------------------------------------~-~~l~~l~--~L~~L~L~~N~l 263 (959)
+....+... . ..+.+++ +|++|+|++|++
T Consensus 181 n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l 260 (680)
T 1ziw_A 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL 260 (680)
T ss_dssp CCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCC
T ss_pred CcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCc
Confidence 433222110 0 1222232 255566666655
Q ss_pred cccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCC-----CCc----c-----cccccccccCc
Q 002149 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGP-----VPK----S-----KAYKYSYSSNA 328 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~-----ip~----~-----~~~~~~~~~~~ 328 (959)
++..|..|..+++|++|+|++|++++.+|..+..+ +|+.|++++|...+. +|. . ....+.+++|.
T Consensus 261 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~ 340 (680)
T 1ziw_A 261 NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDND 340 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCC
T ss_pred CccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCc
Confidence 55555555555666666666665555555444443 244444444433321 111 0 01112333444
Q ss_pred ccCCCCCCCCc-hhhHHHHhhccC---CCC----------CcccccccCCCCCCCcccccccCCCCcccEEECCCCcccc
Q 002149 329 FCQPTEGVPCA-PEVMALIDFLGG---LNY----------PPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394 (959)
Q Consensus 329 ~~~~~~~~~~~-~~~~~~~~~~~~---~~~----------~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 394 (959)
+.+........ ..+.. ++.-.. ... .+.+......++.........++.+++|+.|+|++|++.+
T Consensus 341 l~~~~~~~~~~l~~L~~-L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 419 (680)
T 1ziw_A 341 IPGIKSNMFTGLINLKY-LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419 (680)
T ss_dssp BCCCCTTTTTTCTTCCE-EECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEE
T ss_pred cCCCChhHhccccCCcE-EECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCcc
Confidence 43322211000 00000 000000 000 0011111122222223333445556667777777777666
Q ss_pred cCC-ccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccC--CCCCC----CCCcceecccCCCC
Q 002149 395 TLS-PSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPK----FSGAVKLSLDGNPL 460 (959)
Q Consensus 395 ~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~----~~~~~~~~l~~N~~ 460 (959)
.+| ..+.++++|++|+|++|++++..+..|..+++|+.|++++|.++ +.+|. +.++..+++.+|.+
T Consensus 420 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l 492 (680)
T 1ziw_A 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492 (680)
T ss_dssp ECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCC
T ss_pred ccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCC
Confidence 554 45666666666666666666555555555555555555555443 22232 23344555555543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=307.72 Aligned_cols=307 Identities=21% Similarity=0.208 Sum_probs=250.4
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.+++.++.++...+..+..+++|++|+|++|.+++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 467889999999885544557999999999999999998887 7999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCcc-ccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccC
Q 002149 158 DSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQK 236 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~ 236 (959)
++|+++ .+|.. +..+++|++|++++|++.+..+..|..+++|++|++++|++++.....+. ++..|.+..+.
T Consensus 125 ~~n~l~-----~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~L~~L~l~~n~ 197 (390)
T 3o6n_A 125 ERNDLS-----SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP--SLFHANVSYNL 197 (390)
T ss_dssp CSSCCC-----CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCT--TCSEEECCSSC
T ss_pred CCCccC-----cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccccccc--ccceeeccccc
Confidence 999998 46665 58899999999999999998888999999999999999999976444433 34444444443
Q ss_pred CCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 237 ~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
... +...++|++|++++|.++. +|.. ..++|+.|+|++|++++. ..+..+ +|+.|+|++|.+++..|
T Consensus 198 l~~-------~~~~~~L~~L~l~~n~l~~-~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~ 265 (390)
T 3o6n_A 198 LST-------LAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY 265 (390)
T ss_dssp CSE-------EECCSSCSEEECCSSCCCE-EECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEES
T ss_pred ccc-------cCCCCcceEEECCCCeeee-cccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcCh
Confidence 322 3345689999999999884 4443 257899999999999864 355555 69999999999886544
Q ss_pred cccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccccc
Q 002149 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395 (959)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 395 (959)
. .++.+++|+.|+|++|++++
T Consensus 266 ~----------------------------------------------------------~~~~l~~L~~L~L~~n~l~~- 286 (390)
T 3o6n_A 266 H----------------------------------------------------------PFVKMQRLERLYISNNRLVA- 286 (390)
T ss_dssp G----------------------------------------------------------GGTTCSSCCEEECCSSCCCE-
T ss_pred h----------------------------------------------------------HccccccCCEEECCCCcCcc-
Confidence 3 23456889999999999985
Q ss_pred CCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC-CCCCcceecccCCCCCCCC
Q 002149 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP-KFSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 396 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~~~~~l~~N~~~c~~ 464 (959)
+|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++.... .+..+..+.+.+|+|.|..
T Consensus 287 ~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~ 355 (390)
T 3o6n_A 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNS 355 (390)
T ss_dssp EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHH
T ss_pred cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchh
Confidence 5667788999999999999998 678888899999999999999986533 4667888999999999864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.8e-32 Score=327.37 Aligned_cols=336 Identities=20% Similarity=0.291 Sum_probs=270.9
Q ss_pred CCcEEEEEecCCccccc-----------------Cccccc--CCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCC
Q 002149 78 NSRVTQIQVSSVGLKGT-----------------LPQNLN--QLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNN 137 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~-----------------~~~~l~--~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~ 137 (959)
..+++.|+|++|.++|. +|+.++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 46899999999999986 999999 99999999999999999888 69999999999999998
Q ss_pred -CCC-CChhhhcCC------CCCcEEEccCcccCCCCCCCCCc--cccCccccCeecccccccCCCCChhhcCCCCCCEE
Q 002149 138 -FDT-IPADFFDGL------ENLQVLALDSNNFNASKGWSFPK--GLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNL 207 (959)
Q Consensus 138 -l~~-i~~~~~~~l------~~L~~L~Ls~N~l~~~~~~~lp~--~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 207 (959)
+++ ..+..+..+ ++|++|+|++|+++ .+|. .+..+++|+.|++++|+++|.+| .|..+++|+.|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-----~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L 358 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-----TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-----SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEE
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-----ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEE
Confidence 886 334446665 99999999999998 5788 89999999999999999999999 89999999999
Q ss_pred EecCCcCCCCCCcccccC-C-cccccccccCCCCcccccccccCC--cCCcEEEccCccccccCchhhc-------CCCC
Q 002149 208 KLSGNNLTGPIPESFKGL-N-LVNLWLNDQKGGGFTGTIDVLGNM--DQLRTLWLHGNHFSGTIPESFG-------KLTS 276 (959)
Q Consensus 208 ~Ls~N~l~~~~p~~~~~l-~-l~~L~~~~~~~~~l~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~-------~l~~ 276 (959)
+|++|+++ .+|..+..+ + ++.|.+.++....++ +.+..+ ++|++|+|++|++++.+|..|. .+++
T Consensus 359 ~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~ 434 (636)
T 4eco_A 359 NLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIP---NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434 (636)
T ss_dssp ECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCC---SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCC
T ss_pred ECCCCccc-cccHhhhhhcccCcEEEccCCcCcccc---hhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCC
Confidence 99999999 778777776 4 777777777655443 344544 4899999999999999998888 7889
Q ss_pred CCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCccc-------------ccccccccCcccCCCCCCCCchhh
Q 002149 277 LKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSK-------------AYKYSYSSNAFCQPTEGVPCAPEV 342 (959)
Q Consensus 277 L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~ 342 (959)
|++|+|++|+|+..++..+..+ +|+.|+|++|+++ .+|... ...+.+++|.+...+....
T Consensus 435 L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~----- 508 (636)
T 4eco_A 435 VSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR----- 508 (636)
T ss_dssp EEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGS-----
T ss_pred CCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCCccChhhh-----
Confidence 9999999999996655556655 6999999999998 677542 2234567777764332211
Q ss_pred HHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEEC------CCCcccccCCccccCcCcCCEEeCccccc
Q 002149 343 MALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNL------PNFNLSGTLSPSVGNLDSLTQIKLQSNNI 416 (959)
Q Consensus 343 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~L~~N~l 416 (959)
...++.+.......+.... ++..++.+++|+.|+| ++|++.+.+|..++++++|++|+|++|+|
T Consensus 509 ---------~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 509 ---------ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp ---------TTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred ---------hccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 0012233333344444444 4455677899999999 56889999999999999999999999999
Q ss_pred ccccCCCccCCCCCCeEeCCCCccCC
Q 002149 417 SGQIPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 417 ~g~~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
+.+|..+. ++|+.|||++|++..
T Consensus 579 -~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 579 -RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp -CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred -CccCHhHh--CcCCEEECcCCCCcc
Confidence 58998877 899999999998864
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.9e-32 Score=313.71 Aligned_cols=308 Identities=21% Similarity=0.219 Sum_probs=241.5
Q ss_pred CCcEEEEEecCCcccccCc-ccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCC--hhhhcCCCCCc
Q 002149 78 NSRVTQIQVSSVGLKGTLP-QNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP--ADFFDGLENLQ 153 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~--~~~~~~l~~L~ 153 (959)
..+++.|+++++.+.+.++ ..|..+++|++|+|++|.+++..| .|.++++|++|+|++|++++.. ...|..+++|+
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 3579999999999987664 568999999999999999998877 6999999999999999998733 34589999999
Q ss_pred EEEccCcccCCCCCCCCCcc-ccCccccCeecccccccCCCCChhhcCC--CCCCEEEecCCcCCCCCCcccc-------
Q 002149 154 VLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQLPDFLGNF--ASLQNLKLSGNNLTGPIPESFK------- 223 (959)
Q Consensus 154 ~L~Ls~N~l~~~~~~~lp~~-l~~l~~L~~L~l~~n~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~------- 223 (959)
+|+|++|++++ ..|.. +..+++|++|++++|++.+..+..+..+ .+|+.|++++|.+.+..+..+.
T Consensus 133 ~L~L~~n~l~~----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~ 208 (455)
T 3v47_A 133 MLVLRDNNIKK----IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208 (455)
T ss_dssp EEECCSSBCCS----CCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCT
T ss_pred EEECCCCccCc----cCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccc
Confidence 99999999986 33554 7889999999999999998888877765 4555555555555543332211
Q ss_pred --cCCcccccccccCCCC----------------------------------ccccc-cccc--CCcCCcEEEccCcccc
Q 002149 224 --GLNLVNLWLNDQKGGG----------------------------------FTGTI-DVLG--NMDQLRTLWLHGNHFS 264 (959)
Q Consensus 224 --~l~l~~L~~~~~~~~~----------------------------------l~~~~-~~l~--~l~~L~~L~L~~N~l~ 264 (959)
..++..|.+.++.... +.... ..+. ..++|++|+|++|+++
T Consensus 209 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 288 (455)
T 3v47_A 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288 (455)
T ss_dssp TTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred cccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcccc
Confidence 0122333332222110 00000 0111 2368999999999999
Q ss_pred ccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhH
Q 002149 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
+.+|..|..+++|++|+|++|++++..|..+..+ +|+.|+|++|.+++..|.
T Consensus 289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--------------------------- 341 (455)
T 3v47_A 289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR--------------------------- 341 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG---------------------------
T ss_pred ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChh---------------------------
Confidence 8889999999999999999999999888888887 699999999998754442
Q ss_pred HHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
.++.+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..
T Consensus 342 -------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 390 (455)
T 3v47_A 342 -------------------------------MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGI 390 (455)
T ss_dssp -------------------------------GGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred -------------------------------HhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhH
Confidence 2345689999999999999999999999999999999999999766677
Q ss_pred ccCCCCCCeEeCCCCccCCCCCCC
Q 002149 424 WTNLKSLTLLDLSQNNLSPPLPKF 447 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~l~~~~p~~ 447 (959)
+..+++|+.|+|++|++++..|..
T Consensus 391 ~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 391 FDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hccCCcccEEEccCCCcccCCCcc
Confidence 899999999999999999999854
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=319.79 Aligned_cols=370 Identities=22% Similarity=0.210 Sum_probs=265.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCC--CcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEE
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSK--LENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~--L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 155 (959)
..++.|+++++.+++..|..+..++. |++|+|++|.+++.++ .|.++++|++|+|++|+++++++..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 46788888899898888888888765 9999999999988877 58889999999999999999888889999999999
Q ss_pred EccCcccCCCCC-CCCCc----cccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCC--CCcccccC---
Q 002149 156 ALDSNNFNASKG-WSFPK----GLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP--IPESFKGL--- 225 (959)
Q Consensus 156 ~Ls~N~l~~~~~-~~lp~----~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l--- 225 (959)
+|++|...+... ..+|. .+..+++|+.|++++|++.+..+..|.++++|++|+|++|.+... ....|..+
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 998876542110 12333 677888999999999999988888889999999999998875432 22233332
Q ss_pred CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCc-hhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeE
Q 002149 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP-ESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHL 303 (959)
Q Consensus 226 ~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L 303 (959)
++..|.+.++....+. ...+..+++|++|+|++|++++.+| ..|..+++|++|+|++|++++..+..+..+ +|+.|
T Consensus 382 ~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L 459 (680)
T 1ziw_A 382 PLHILNLTKNKISKIE--SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRL 459 (680)
T ss_dssp CCCEEECTTSCCCEEC--TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEE
T ss_pred cCceEECCCCCCCeEC--hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccc
Confidence 3444444444333221 2456777888888888888876655 677778888888888888777777666665 47777
Q ss_pred eCCCCcCC--CCCCccc-----ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcc-----
Q 002149 304 DLNNNMFM--GPVPKSK-----AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSW----- 371 (959)
Q Consensus 304 ~L~~N~l~--~~ip~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~----- 371 (959)
++++|.++ +.+|..+ ...+.+++|.+...+.... ..++.+.......+.....
T Consensus 460 ~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~---------------~~l~~L~~L~Ls~N~l~~~~~~~~ 524 (680)
T 1ziw_A 460 MLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML---------------EGLEKLEILDLQHNNLARLWKHAN 524 (680)
T ss_dssp ECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTT---------------TTCTTCCEEECCSSCCGGGGSTTS
T ss_pred hhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhh---------------ccccccCEEeCCCCCccccchhhc
Confidence 77777765 3444432 2223455565554333211 0111122222222221111
Q ss_pred ---cccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC--
Q 002149 372 ---LGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK-- 446 (959)
Q Consensus 372 ---~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-- 446 (959)
....++.+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.+|.
T Consensus 525 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 604 (680)
T 1ziw_A 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604 (680)
T ss_dssp TTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHH
T ss_pred cCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHh
Confidence 111256789999999999999955556799999999999999999976667789999999999999999988773
Q ss_pred ---CCCcceecccCCCCCCCCC
Q 002149 447 ---FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 447 ---~~~~~~~~l~~N~~~c~~~ 465 (959)
+.++..+.+.+|||.|+..
T Consensus 605 ~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 605 GPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp HHHHTTCSEEECTTCCCCBCCC
T ss_pred cccccccCEEEccCCCcccCCc
Confidence 4678899999999999864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=327.25 Aligned_cols=318 Identities=19% Similarity=0.265 Sum_probs=244.6
Q ss_pred cCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCc-CCC-CCC-CccCC-------CCccEEecCCCCCCCCCh-hh
Q 002149 77 SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQ-FRG-ELP-SFSGL-------SNLKYAYLDGNNFDTIPA-DF 145 (959)
Q Consensus 77 ~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~-~~~~l-------~~L~~L~L~~N~l~~i~~-~~ 145 (959)
...+++.|+|++|++.|.+|..+.+|++|++|+|++|+ +++ .+| .|.++ ++|++|+|++|+|+.+|. ..
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~ 568 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASAS 568 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhh
Confidence 34578899999999999999999999999999999998 887 455 45444 499999999999998876 46
Q ss_pred hcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCC-CCEEEecCCcCCCCCCccccc
Q 002149 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS-LQNLKLSGNNLTGPIPESFKG 224 (959)
Q Consensus 146 ~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~~~~ 224 (959)
|.++++|++|+|++|+++ .+| .+..+++|+.|++++|++. .+|..+..+++ |+.|+|++|+++ .+|..+..
T Consensus 569 l~~L~~L~~L~Ls~N~l~-----~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~ 640 (876)
T 4ecn_A 569 LQKMVKLGLLDCVHNKVR-----HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA 640 (876)
T ss_dssp HTTCTTCCEEECTTSCCC-----BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCT
T ss_pred hhcCCCCCEEECCCCCcc-----cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhc
Confidence 889999999999999987 467 7888999999999999998 78888888988 999999999998 77877766
Q ss_pred CC---cccccccccCCCCccc-cccccc--CCcCCcEEEccCccccccCchhh-cCCCCCCEEeCCCCcCCCCCcccccc
Q 002149 225 LN---LVNLWLNDQKGGGFTG-TIDVLG--NMDQLRTLWLHGNHFSGTIPESF-GKLTSLKDLNLNSNQFVGLIPPSLAS 297 (959)
Q Consensus 225 l~---l~~L~~~~~~~~~l~~-~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~ 297 (959)
+. +..|.+.++...+... ....+. .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+..++..+..
T Consensus 641 ~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~ 719 (876)
T 4ecn_A 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKP 719 (876)
T ss_dssp TCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSC
T ss_pred cccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhcc
Confidence 64 4555555444332211 111122 3458888999999888 455544 47888999999999888554444443
Q ss_pred c--------cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCC
Q 002149 298 L--------SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369 (959)
Q Consensus 298 ~--------~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 369 (959)
. +|+.|+|++|+++ .+|....
T Consensus 720 ~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~-------------------------------------------------- 748 (876)
T 4ecn_A 720 KDGNYKNTYLLTTIDLRFNKLT-SLSDDFR-------------------------------------------------- 748 (876)
T ss_dssp TTSCCTTGGGCCEEECCSSCCC-CCCGGGS--------------------------------------------------
T ss_pred ccccccccCCccEEECCCCCCc-cchHHhh--------------------------------------------------
Confidence 3 6888899888887 4553210
Q ss_pred cccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcc------cccccccCCCccCCCCCCeEeCCCCccCCC
Q 002149 370 SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS------NNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 370 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~ 443 (959)
...+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |++.+.+|..|.++++|+.|+|++|+| +.
T Consensus 749 ------~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~ 820 (876)
T 4ecn_A 749 ------ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RK 820 (876)
T ss_dssp ------TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred ------hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-Cc
Confidence 0145788999999999987 788888899999998876 778888898899999999999999998 66
Q ss_pred CCC--CCCcceecccCCCCCC
Q 002149 444 LPK--FSGAVKLSLDGNPLLN 462 (959)
Q Consensus 444 ~p~--~~~~~~~~l~~N~~~c 462 (959)
+|. +..+..+++.+|++..
T Consensus 821 Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 821 VDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp CCSCCCSSSCEEECCSCTTCE
T ss_pred cCHhhcCCCCEEECCCCCCCc
Confidence 665 3456778888888764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=310.79 Aligned_cols=301 Identities=18% Similarity=0.192 Sum_probs=263.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|++|.+++..|..|.++++|++|+|++|.++..++ .|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 479999999999999889999999999999999999998887 5899999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~ 237 (959)
++|.+.. ..+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|++.+..+..
T Consensus 136 ~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~---------------- 195 (477)
T 2id5_A 136 GDNDLVY----ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYS---------------- 195 (477)
T ss_dssp CCTTCCE----ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTC----------------
T ss_pred CCCccce----eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhh----------------
Confidence 9999986 34667889999999999999999888888999999999999999999766655
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
+..+++|++|+|++|.+.+.+|..+....+|++|+|++|++++.++..+..+ +|+.|+|++|.+++..+.
T Consensus 196 ---------~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 266 (477)
T 2id5_A 196 ---------FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266 (477)
T ss_dssp ---------SCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTT
T ss_pred ---------cccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChh
Confidence 5677999999999999988888888888899999999999998777778877 699999999999854332
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
.+..+++|+.|+|++|++.+..
T Consensus 267 ----------------------------------------------------------~~~~l~~L~~L~L~~n~l~~~~ 288 (477)
T 2id5_A 267 ----------------------------------------------------------MLHELLRLQEIQLVGGQLAVVE 288 (477)
T ss_dssp ----------------------------------------------------------SCTTCTTCCEEECCSSCCSEEC
T ss_pred ----------------------------------------------------------hccccccCCEEECCCCccceEC
Confidence 2345689999999999999999
Q ss_pred CccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC--C-CCcceecccCCCCCCCCCC
Q 002149 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK--F-SGAVKLSLDGNPLLNGKSP 466 (959)
Q Consensus 397 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~--~-~~~~~~~l~~N~~~c~~~~ 466 (959)
|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++....+. + .......+.++...|..+.
T Consensus 289 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 289 PYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp TTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred HHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence 99999999999999999999977777889999999999999999865432 1 1223356677888887543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=312.23 Aligned_cols=314 Identities=20% Similarity=0.233 Sum_probs=245.4
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCC-hhhhcCCCCCcEEE
Q 002149 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIP-ADFFDGLENLQVLA 156 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~-~~~~~~l~~L~~L~ 156 (959)
..+++.|+|++|.+++..|..|.++++|++|+|++|+|+..++. .+++|++|+|++|+|+.++ +..|.++++|++|+
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 35899999999999988899999999999999999999966555 8999999999999999987 47899999999999
Q ss_pred ccCcccCCCCCCCCCccccCcccc--Ceeccccccc--CCCCChhhcCCC------------------------------
Q 002149 157 LDSNNFNASKGWSFPKGLQSSAQL--TNLSCMSCNL--AGQLPDFLGNFA------------------------------ 202 (959)
Q Consensus 157 Ls~N~l~~~~~~~lp~~l~~l~~L--~~L~l~~n~l--~~~~p~~l~~l~------------------------------ 202 (959)
|++|+++. ..+..+++| +.|++++|++ ++..|..+..+.
T Consensus 153 L~~n~l~~-------~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~ 225 (562)
T 3a79_B 153 LSAAKFRQ-------LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225 (562)
T ss_dssp EECSBCCT-------TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEE
T ss_pred cCCCcccc-------CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEE
Confidence 99999975 234455555 9999999999 777777666544
Q ss_pred ---------------------------------------------------CCCEEEecCCcCCCCCCccccc---CCcc
Q 002149 203 ---------------------------------------------------SLQNLKLSGNNLTGPIPESFKG---LNLV 228 (959)
Q Consensus 203 ---------------------------------------------------~L~~L~Ls~N~l~~~~p~~~~~---l~l~ 228 (959)
+|++|++++|++++.+|..+.. -++.
T Consensus 226 L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~ 305 (562)
T 3a79_B 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALK 305 (562)
T ss_dssp EEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCC
T ss_pred ecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccch
Confidence 7788888888888888876511 0122
Q ss_pred cccccccCCCCc--------------------------ccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeC
Q 002149 229 NLWLNDQKGGGF--------------------------TGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNL 282 (959)
Q Consensus 229 ~L~~~~~~~~~l--------------------------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 282 (959)
.|.+.++..+.+ ... .....+++|++|+|++|++++.+|..+..+++|++|+|
T Consensus 306 ~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 384 (562)
T 3a79_B 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM-VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384 (562)
T ss_dssp EEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCC-CCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEEC
T ss_pred heehhhcccceeecChhhhhhhhccCcceEEEccCCCcccc-cCccCCCCceEEECCCCccccchhhhhcccCCCCEEEC
Confidence 222222221111 110 11267899999999999999989999999999999999
Q ss_pred CCCcCCCCC--ccccccc-cCCeEeCCCCcCCCCCCcccc------cccccccCcccCCCCCCCCchhhHHHHhhccCCC
Q 002149 283 NSNQFVGLI--PPSLASL-SLDHLDLNNNMFMGPVPKSKA------YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLN 353 (959)
Q Consensus 283 s~N~l~~~~--p~~~~~~-~L~~L~L~~N~l~~~ip~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (959)
++|++++.. |..+..+ +|+.|+|++|++++.+|.... ..+.+++|.+.
T Consensus 385 ~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~----------------------- 441 (562)
T 3a79_B 385 QRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT----------------------- 441 (562)
T ss_dssp CSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCC-----------------------
T ss_pred CCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCC-----------------------
Confidence 999999753 4667776 699999999999987775311 11222333221
Q ss_pred CCcccccccCCCCCCCcccccccCCC-CcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC-ccCCCCCC
Q 002149 354 YPPRLVTSWSGNDPCKSWLGLSCGTN-SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLT 431 (959)
Q Consensus 354 ~~~~l~~~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~L~ 431 (959)
. ..+..+ ++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|+ .+|.. +..+++|+
T Consensus 442 ----------------~---~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~ 500 (562)
T 3a79_B 442 ----------------G---SVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQ 500 (562)
T ss_dssp ----------------G---GGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCC
T ss_pred ----------------c---chhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCC
Confidence 1 111122 68999999999999 78888889999999999999999 67766 99999999
Q ss_pred eEeCCCCccCCCCC
Q 002149 432 LLDLSQNNLSPPLP 445 (959)
Q Consensus 432 ~L~Ls~N~l~~~~p 445 (959)
.|+|++|++++..|
T Consensus 501 ~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 501 YIWLHDNPWDCTCP 514 (562)
T ss_dssp CEECCSCCBCCCHH
T ss_pred EEEecCCCcCCCcc
Confidence 99999999998765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=297.68 Aligned_cols=274 Identities=18% Similarity=0.252 Sum_probs=164.3
Q ss_pred CCChhhHHHHHHHHHhcC-CC--CCCCC----CCCCCCCCCCCCcceEecC----------CcEEEEEecCCcccccCcc
Q 002149 35 ATDPGDIDILNQFRKNLE-NP--ELLQW----PKSGDPCGPPCWKHVFCSN----------SRVTQIQVSSVGLKGTLPQ 97 (959)
Q Consensus 35 ~~~~~~~~~l~~~~~~~~-~~--~~~~w----~~~~~~C~~~~w~gv~C~~----------~~v~~l~l~~~~l~g~~~~ 97 (959)
++-.+|+.||++||+++. ++ +..+| ....+.|. |.|+.|+. .+|+.|+|++++++ .+|+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~---~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET---RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC---SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc---cCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 345678999999999883 43 25678 34555664 99999952 45555555555555 4555
Q ss_pred cccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCc
Q 002149 98 NLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177 (959)
Q Consensus 98 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l 177 (959)
.+.++++|++|+|++|.|+..+..|.++++|++|+|++|+|+.+|.. |.++++|++|+|++|++
T Consensus 99 ~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~lp~~-l~~l~~L~~L~L~~n~~--------------- 162 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPAS-IASLNRLRELSIRACPE--------------- 162 (328)
T ss_dssp CGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCCCGG-GGGCTTCCEEEEEEETT---------------
T ss_pred hhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccCcHH-HhcCcCCCEEECCCCCC---------------
Confidence 55555555555555555553322455555555555555555444332 44444444444444433
Q ss_pred cccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEE
Q 002149 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257 (959)
Q Consensus 178 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~ 257 (959)
.+.+|..+.... ....+.++++|++|+
T Consensus 163 -------------------------------------~~~~p~~~~~~~----------------~~~~~~~l~~L~~L~ 189 (328)
T 4fcg_A 163 -------------------------------------LTELPEPLASTD----------------ASGEHQGLVNLQSLR 189 (328)
T ss_dssp -------------------------------------CCCCCSCSEEEC-----------------CCCEEESTTCCEEE
T ss_pred -------------------------------------ccccChhHhhcc----------------chhhhccCCCCCEEE
Confidence 333332221100 000133445555555
Q ss_pred ccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCC
Q 002149 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGV 336 (959)
Q Consensus 258 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~ 336 (959)
|++|+++ .+|..+..+++|++|+|++|++++.+ ..+..+ +|+.|+|++|.+.+.+|..
T Consensus 190 L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~-~~l~~l~~L~~L~Ls~n~~~~~~p~~------------------- 248 (328)
T 4fcg_A 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLSALG-PAIHHLPKLEELDLRGCTALRNYPPI------------------- 248 (328)
T ss_dssp EEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCC-GGGGGCTTCCEEECTTCTTCCBCCCC-------------------
T ss_pred CcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCc-hhhccCCCCCEEECcCCcchhhhHHH-------------------
Confidence 5555555 45555555555555555555555432 234443 3555555555555544431
Q ss_pred CCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccc
Q 002149 337 PCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNI 416 (959)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 416 (959)
++.+++|+.|+|++|++.+.+|..++++++|++|+|++|.+
T Consensus 249 ---------------------------------------~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~ 289 (328)
T 4fcg_A 249 ---------------------------------------FGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVN 289 (328)
T ss_dssp ---------------------------------------TTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTT
T ss_pred ---------------------------------------hcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCc
Confidence 22447788888888888888888888899999999999999
Q ss_pred ccccCCCccCCCCCCeEeCCCCccC
Q 002149 417 SGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 417 ~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
.+.+|..+.++++|+.+++..|.+.
T Consensus 290 ~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 290 LSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhccHHHhhccCceEEeCCHHHHH
Confidence 8899999999999999998877665
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=311.26 Aligned_cols=316 Identities=21% Similarity=0.237 Sum_probs=238.8
Q ss_pred cCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCC-hhhhcCCCCCcEE
Q 002149 77 SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIP-ADFFDGLENLQVL 155 (959)
Q Consensus 77 ~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~-~~~~~~l~~L~~L 155 (959)
...+++.|+|++|.+++..|..|.++++|++|+|++|+|+.+++. .+++|++|+|++|+|+.++ +..|+++++|++|
T Consensus 43 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L 120 (520)
T 2z7x_B 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120 (520)
T ss_dssp TCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred ccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence 346899999999999988899999999999999999999965555 8999999999999999864 5679999999999
Q ss_pred EccCcccCCCCCCCCCccccCcccc--Ceeccccccc--CCCCChhhcCCC-----------------------------
Q 002149 156 ALDSNNFNASKGWSFPKGLQSSAQL--TNLSCMSCNL--AGQLPDFLGNFA----------------------------- 202 (959)
Q Consensus 156 ~Ls~N~l~~~~~~~lp~~l~~l~~L--~~L~l~~n~l--~~~~p~~l~~l~----------------------------- 202 (959)
+|++|++++ ..+..+++| +.|++++|++ .+..|..+..+.
T Consensus 121 ~L~~n~l~~-------~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~ 193 (520)
T 2z7x_B 121 GLSTTHLEK-------SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193 (520)
T ss_dssp EEEESSCCG-------GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEE
T ss_pred EecCcccch-------hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhccccee
Confidence 999999874 234555666 7777777777 555555555432
Q ss_pred ------------------------------------------------------CCCEEEecCCcCCCCCCccc-----c
Q 002149 203 ------------------------------------------------------SLQNLKLSGNNLTGPIPESF-----K 223 (959)
Q Consensus 203 ------------------------------------------------------~L~~L~Ls~N~l~~~~p~~~-----~ 223 (959)
+|++|++++|++++.+|..+ .
T Consensus 194 ~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~ 273 (520)
T 2z7x_B 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273 (520)
T ss_dssp ECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSC
T ss_pred eccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccc
Confidence 67777777777777777766 3
Q ss_pred cC-CcccccccccCC-----------------------CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCE
Q 002149 224 GL-NLVNLWLNDQKG-----------------------GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD 279 (959)
Q Consensus 224 ~l-~l~~L~~~~~~~-----------------------~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 279 (959)
.+ ++..+.+..+.. +.+... .....+++|++|+|++|++++.+|..+..+++|++
T Consensus 274 ~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 352 (520)
T 2z7x_B 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM-LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352 (520)
T ss_dssp CCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCC-CCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCE
T ss_pred cCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccc-cchhhCCcccEEEeECCccChhhhhhhccCCCCCE
Confidence 33 222222222221 111111 11267889999999999999888999999999999
Q ss_pred EeCCCCcCCC--CCccccccc-cCCeEeCCCCcCCCCCCccc------ccccccccCcccCCCCCCCCchhhHHHHhhcc
Q 002149 280 LNLNSNQFVG--LIPPSLASL-SLDHLDLNNNMFMGPVPKSK------AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLG 350 (959)
Q Consensus 280 L~Ls~N~l~~--~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (959)
|+|++|++++ .+|..+..+ +|+.|+|++|.+++.+|... ...+.+++|.+.
T Consensus 353 L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~-------------------- 412 (520)
T 2z7x_B 353 LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT-------------------- 412 (520)
T ss_dssp EECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC--------------------
T ss_pred EEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC--------------------
Confidence 9999999997 455667776 59999999999988666431 111222232221
Q ss_pred CCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC-ccCCCC
Q 002149 351 GLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKS 429 (959)
Q Consensus 351 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~ 429 (959)
......+ .++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. |..+++
T Consensus 413 -------------------~~~~~~l--~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~ 469 (520)
T 2z7x_B 413 -------------------DTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTS 469 (520)
T ss_dssp -------------------GGGGGSC--CTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTT
T ss_pred -------------------cchhhhh--cccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCc
Confidence 1111111 168999999999999 88888889999999999999999 57766 999999
Q ss_pred CCeEeCCCCccCCCCC
Q 002149 430 LTLLDLSQNNLSPPLP 445 (959)
Q Consensus 430 L~~L~Ls~N~l~~~~p 445 (959)
|+.|+|++|++++..+
T Consensus 470 L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 470 LQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CCEEECCSSCBCCCHH
T ss_pred ccEEECcCCCCcccCC
Confidence 9999999999998654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=311.68 Aligned_cols=356 Identities=22% Similarity=0.200 Sum_probs=268.5
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcc
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNN 161 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 161 (959)
.+++++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|+|+.+++.+|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4677777777 6777665 799999999999999888 79999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC-CCCcccccC-CcccccccccCCCC
Q 002149 162 FNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG-PIPESFKGL-NLVNLWLNDQKGGG 239 (959)
Q Consensus 162 l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l-~l~~L~~~~~~~~~ 239 (959)
++. ..|..+.++++|++|++++|++.+..+..++++++|++|+|++|++++ .+|..|..+ +++.|.+.++....
T Consensus 92 l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 92 IQS----FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp CCC----CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred ccc----cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 986 347889999999999999999998888899999999999999999987 568888877 56666666554332
Q ss_pred cccc-------------------------cc-------------------------------------------------
Q 002149 240 FTGT-------------------------ID------------------------------------------------- 245 (959)
Q Consensus 240 l~~~-------------------------~~------------------------------------------------- 245 (959)
+... .+
T Consensus 168 ~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l 247 (606)
T 3vq2_A 168 ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNL 247 (606)
T ss_dssp ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCC
T ss_pred cChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcc
Confidence 2110 00
Q ss_pred ------------------------------------------------------cccCCcCCcEEEccCccccccCch--
Q 002149 246 ------------------------------------------------------VLGNMDQLRTLWLHGNHFSGTIPE-- 269 (959)
Q Consensus 246 ------------------------------------------------------~l~~l~~L~~L~L~~N~l~~~~p~-- 269 (959)
.+..+++|++|++++|++ +.+|.
T Consensus 248 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~~ 326 (606)
T 3vq2_A 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTLD 326 (606)
T ss_dssp SCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCC-SSCCCCC
T ss_pred cccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccC-cccccCC
Confidence 012223444455555544 23331
Q ss_pred ------------------hhcCCCCCCEEeCCCCcCCCC--Cccccccc-cCCeEeCCCCcCCCCCCccc-----ccccc
Q 002149 270 ------------------SFGKLTSLKDLNLNSNQFVGL--IPPSLASL-SLDHLDLNNNMFMGPVPKSK-----AYKYS 323 (959)
Q Consensus 270 ------------------~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~~-~L~~L~L~~N~l~~~ip~~~-----~~~~~ 323 (959)
.+..+++|++|+|++|++++. .|..+..+ +|+.|+|++|.+++ +|... ...+.
T Consensus 327 l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 405 (606)
T 3vq2_A 327 LPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLD 405 (606)
T ss_dssp CSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEE
T ss_pred CCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeE
Confidence 345678999999999999976 36667766 69999999999886 33221 22345
Q ss_pred cccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccc-cCCccccC
Q 002149 324 YSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG-TLSPSVGN 402 (959)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~-~~p~~~~~ 402 (959)
+++|.+....... .+..++.+.......+......+..++.+++|+.|+|++|++.+ .+|..++.
T Consensus 406 l~~n~l~~~~~~~--------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 471 (606)
T 3vq2_A 406 FQHSTLKRVTEFS--------------AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471 (606)
T ss_dssp CTTSEEESTTTTT--------------TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred CCCCccCCccChh--------------hhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc
Confidence 5666665432210 11122333333334444444445557778899999999999988 47888999
Q ss_pred cCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCC
Q 002149 403 LDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLL 461 (959)
Q Consensus 403 l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~ 461 (959)
+++|++|+|++|++++..|..|.++++|+.|+|++|++++.+|. +.++..+++.+|.+.
T Consensus 472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 99999999999999988888899999999999999999887664 345778889988765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=285.43 Aligned_cols=285 Identities=23% Similarity=0.315 Sum_probs=198.0
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++.+++++++++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 556788888887 6777664 689999999999999887 699999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC--CCCcccccCCcccccccccCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG--PIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~l~~L~~~~~~~ 237 (959)
|+++ .+|..+. ++|++|++++|++.+..+..|..+++|+.|++++|.++. ..+..+..+++..|.+.++..
T Consensus 112 n~l~-----~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l 184 (332)
T 2ft3_A 112 NHLV-----EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184 (332)
T ss_dssp SCCC-----SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBC
T ss_pred CcCC-----ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCC
Confidence 9998 4666655 799999999999998888889999999999999999963 667776655555555554444
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..++.. + .++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+ +|+.|+|++|+++ .+|.
T Consensus 185 ~~l~~~---~--~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 185 TGIPKD---L--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp SSCCSS---S--CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred CccCcc---c--cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 333321 1 1456666666666665555566666666666666666666555555554 4666666666655 3332
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
. ++.+++|+.|+|++|+|++..
T Consensus 259 ~----------------------------------------------------------l~~l~~L~~L~l~~N~l~~~~ 280 (332)
T 2ft3_A 259 G----------------------------------------------------------LPDLKLLQVVYLHTNNITKVG 280 (332)
T ss_dssp T----------------------------------------------------------GGGCTTCCEEECCSSCCCBCC
T ss_pred h----------------------------------------------------------hhcCccCCEEECCCCCCCccC
Confidence 1 112355666666666666555
Q ss_pred CccccCc------CcCCEEeCcccccc--cccCCCccCCCCCCeEeCCCCc
Q 002149 397 SPSVGNL------DSLTQIKLQSNNIS--GQIPTNWTNLKSLTLLDLSQNN 439 (959)
Q Consensus 397 p~~~~~l------~~L~~L~L~~N~l~--g~~p~~l~~l~~L~~L~Ls~N~ 439 (959)
+..|..+ .+|+.|+|++|.+. +..|..|..+++|+.|+|++|+
T Consensus 281 ~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 281 VNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred hhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 5444432 44566666666655 4445556666666666666553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=311.97 Aligned_cols=350 Identities=21% Similarity=0.183 Sum_probs=264.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++.++ .|.++++|++|+|++|+++.+++..|+++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 578999999999998778889999999999999999998887 6999999999999999999999878999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC----CEEEecCCcCCCCCCcccccC--------
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL----QNLKLSGNNLTGPIPESFKGL-------- 225 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~l-------- 225 (959)
++|.++.+ .+|..+.++++|+.|++++|++.+..+..++.+++| +.|++++|.+++..|..|...
T Consensus 132 ~~n~l~~~---~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~ 208 (570)
T 2z63_A 132 AHNLIQSF---KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208 (570)
T ss_dssp CSSCCCCC---CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred CCCcccee---cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecc
Confidence 99998753 468889999999999999999887777766666666 667777766665444333221
Q ss_pred --------------------------------------------------------------------------------
Q 002149 226 -------------------------------------------------------------------------------- 225 (959)
Q Consensus 226 -------------------------------------------------------------------------------- 225 (959)
T Consensus 209 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~ 288 (570)
T 2z63_A 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFS 288 (570)
T ss_dssp SCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEE
T ss_pred cccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEE
Confidence
Q ss_pred ----------------CcccccccccCCCCccccc-----------------ccccCCcCCcEEEccCccccccC--chh
Q 002149 226 ----------------NLVNLWLNDQKGGGFTGTI-----------------DVLGNMDQLRTLWLHGNHFSGTI--PES 270 (959)
Q Consensus 226 ----------------~l~~L~~~~~~~~~l~~~~-----------------~~l~~l~~L~~L~L~~N~l~~~~--p~~ 270 (959)
++..|.+.++....++... .....+++|++|+|++|++++.. |..
T Consensus 289 l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 368 (570)
T 2z63_A 289 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368 (570)
T ss_dssp EESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHH
T ss_pred ecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccc
Confidence 1222222222211111100 00156789999999999998654 788
Q ss_pred hcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcc------cccccccccCcccCCCCCCCCchhhH
Q 002149 271 FGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKS------KAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 271 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
+..+++|++|+|++|.+++..+. +..+ +|+.|++++|.+++..|.. ....+.+++|.+....+..
T Consensus 369 ~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------- 440 (570)
T 2z63_A 369 DFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI------- 440 (570)
T ss_dssp HHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT-------
T ss_pred ccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh-------
Confidence 99999999999999999976665 6666 6999999999998876632 1223455666554432211
Q ss_pred HHHhhccCCCCCcccccccCCCCCCC-cccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCK-SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPT 422 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 422 (959)
+..++.+......++... ...+..++.+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|.
T Consensus 441 --------~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 512 (570)
T 2z63_A 441 --------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512 (570)
T ss_dssp --------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred --------hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHH
Confidence 111223333333333322 23445677889999999999999999999999999999999999999988888
Q ss_pred CccCCCCCCeEeCCCCccCCCCCCC
Q 002149 423 NWTNLKSLTLLDLSQNNLSPPLPKF 447 (959)
Q Consensus 423 ~l~~l~~L~~L~Ls~N~l~~~~p~~ 447 (959)
.|.++++|+.|++++|++++..|..
T Consensus 513 ~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 513 IFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred HhhcccCCcEEEecCCcccCCCcch
Confidence 8999999999999999999998863
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-30 Score=281.93 Aligned_cols=292 Identities=22% Similarity=0.319 Sum_probs=216.8
Q ss_pred CCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCC
Q 002149 63 GDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTI 141 (959)
Q Consensus 63 ~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 141 (959)
+..|+..| .| +++.+++.+++++ .+|..+. ++|++|+|++|.|++.++ .|.++++|++|+|++|+++.+
T Consensus 22 ~~~cp~~c----~c---~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (330)
T 1xku_A 22 GPVCPFRC----QC---HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91 (330)
T ss_dssp CCCCCTTC----EE---ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCB
T ss_pred cCCCCCCC----cC---CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCee
Confidence 35576444 45 3456777888877 5676554 689999999999999888 699999999999999999999
Q ss_pred ChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC--CCC
Q 002149 142 PADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG--PIP 219 (959)
Q Consensus 142 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p 219 (959)
.+..|.++++|++|+|++|+++ .+|..+. ++|++|++++|++.+..+..|.++++|+.|++++|.++. ..+
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~-----~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 164 (330)
T 1xku_A 92 SPGAFAPLVKLERLYLSKNQLK-----ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164 (330)
T ss_dssp CTTTTTTCTTCCEEECCSSCCS-----BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT
T ss_pred CHHHhcCCCCCCEEECCCCcCC-----ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcCh
Confidence 8888999999999999999998 4565554 789999999999998888899999999999999999964 444
Q ss_pred cccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-
Q 002149 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL- 298 (959)
Q Consensus 220 ~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~- 298 (959)
.. +.++++|++|++++|+++ .+|..+. ++|++|+|++|++++..|..+..+
T Consensus 165 ~~-------------------------~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~ 216 (330)
T 1xku_A 165 GA-------------------------FQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLN 216 (330)
T ss_dssp TG-------------------------GGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCT
T ss_pred hh-------------------------ccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCC
Confidence 44 456677888888888877 4555443 678888888888877777777766
Q ss_pred cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCC
Q 002149 299 SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGT 378 (959)
Q Consensus 299 ~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 378 (959)
+|+.|+|++|.+++..+. .+..
T Consensus 217 ~L~~L~Ls~n~l~~~~~~----------------------------------------------------------~~~~ 238 (330)
T 1xku_A 217 NLAKLGLSFNSISAVDNG----------------------------------------------------------SLAN 238 (330)
T ss_dssp TCCEEECCSSCCCEECTT----------------------------------------------------------TGGG
T ss_pred CCCEEECCCCcCceeChh----------------------------------------------------------hccC
Confidence 588888888877654332 1123
Q ss_pred CCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccC------CCCCCeEeCCCCccCC--CCC-C---
Q 002149 379 NSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTN------LKSLTLLDLSQNNLSP--PLP-K--- 446 (959)
Q Consensus 379 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~------l~~L~~L~Ls~N~l~~--~~p-~--- 446 (959)
+++|+.|+|++|++. .+|..+..+++|++|+|++|+|++..+..|.. ...|+.|++++|++.. ..| .
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 467788888888877 67777777888888888888887655555543 3667778888887752 112 1
Q ss_pred CCCcceecccCC
Q 002149 447 FSGAVKLSLDGN 458 (959)
Q Consensus 447 ~~~~~~~~l~~N 458 (959)
...+..+.+.+|
T Consensus 318 ~~~l~~l~L~~N 329 (330)
T 1xku_A 318 VYVRAAVQLGNY 329 (330)
T ss_dssp CCCGGGEEC---
T ss_pred ccceeEEEeccc
Confidence 234455666665
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=310.17 Aligned_cols=306 Identities=18% Similarity=0.215 Sum_probs=258.0
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|+++.+++..|..|..+++|++|+|++|.|++.+| .|+++++|++|+|++|.|+.+|+..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 478999999999998888899999999999999999999988 5899999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~ 237 (959)
++|.|++ ..|..+..+++|+.|++++|++++.. +..+++|+.|++++|.+++.... .++..|.+.++..
T Consensus 155 s~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l~~~----~~L~~L~ls~n~l 223 (597)
T 3oja_B 155 SNNNLER----IEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTLAIP----IAVEELDASHNSI 223 (597)
T ss_dssp CSSCCCB----CCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEEECC----TTCSEEECCSSCC
T ss_pred eCCcCCC----CChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccccCC----chhheeeccCCcc
Confidence 9999986 45667899999999999999999753 56789999999999999863221 1456666666665
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..+.+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.|++.+|..+..+ +|+.|+|++|.+++. |.
T Consensus 224 ~~~~~~~-----~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l-~~ 295 (597)
T 3oja_B 224 NVVRGPV-----NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NL 295 (597)
T ss_dssp CEEECSC-----CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEE-EC
T ss_pred ccccccc-----CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCC-Cc
Confidence 5554422 3789999999999996 4789999999999999999999999999888 599999999999852 21
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
.++.+++|+.|+|++|.+. .+
T Consensus 296 ----------------------------------------------------------~~~~l~~L~~L~Ls~N~l~-~i 316 (597)
T 3oja_B 296 ----------------------------------------------------------YGQPIPTLKVLDLSHNHLL-HV 316 (597)
T ss_dssp ----------------------------------------------------------SSSCCTTCCEEECCSSCCC-CC
T ss_pred ----------------------------------------------------------ccccCCCCcEEECCCCCCC-cc
Confidence 1234589999999999999 68
Q ss_pred CccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC--CCCCcceecccCCCCCCCCC
Q 002149 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP--KFSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 397 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~~~l~~N~~~c~~~ 465 (959)
|..++.+++|+.|+|++|.|++. | +..+++|+.|+|++|++++... .+.......+.+|+..|+.+
T Consensus 317 ~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 317 ERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp GGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCTT
T ss_pred CcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCcc
Confidence 88899999999999999999854 3 7788999999999999986432 13344455677888888753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-29 Score=281.50 Aligned_cols=298 Identities=23% Similarity=0.342 Sum_probs=235.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++.++.+.. ++ .+..+++|++|+|++|.+++.++ |.++++|++|+|++|+++.++ .|.++++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 578899999998874 44 48889999999999999987766 899999999999999999875 48999999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~ 237 (959)
+|.+.. ++. +..+++|+.|++++|.....++. +..+++|++|++++|.+.+..+ +..+ ++..|.+.++..
T Consensus 119 ~n~i~~-----~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (347)
T 4fmz_A 119 EDNISD-----ISP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189 (347)
T ss_dssp TSCCCC-----CGG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCC
T ss_pred CCcccC-----chh-hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcc
Confidence 999884 444 78899999999999977655544 8899999999999999986544 4443 466666666554
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..+.. +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++..+ +..+ +|+.|++++|.+++. +
T Consensus 190 ~~~~~----~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~- 259 (347)
T 4fmz_A 190 EDISP----LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-N- 259 (347)
T ss_dssp CCCGG----GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-
T ss_pred ccccc----ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-h-
Confidence 44433 6777888888888888885444 7788888888888888886544 5555 588888888887641 1
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
.+..+++|+.|+|++|++++.
T Consensus 260 ----------------------------------------------------------~~~~l~~L~~L~l~~n~l~~~- 280 (347)
T 4fmz_A 260 ----------------------------------------------------------AVKDLTKLKMLNVGSNQISDI- 280 (347)
T ss_dssp ----------------------------------------------------------GGTTCTTCCEEECCSSCCCCC-
T ss_pred ----------------------------------------------------------hHhcCCCcCEEEccCCccCCC-
Confidence 123457899999999999864
Q ss_pred CccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC--CCCCcceecccCCCC
Q 002149 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP--KFSGAVKLSLDGNPL 460 (959)
Q Consensus 397 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~~~l~~N~~ 460 (959)
+.+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+| .+.++..+++.+|++
T Consensus 281 -~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 281 -SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp -GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred -hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 458888999999999999998888889999999999999999988766 356677888888875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=289.69 Aligned_cols=305 Identities=19% Similarity=0.214 Sum_probs=254.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+++++.+++..+..+..+++|++|+|++|.+++.++ .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 579999999999998777899999999999999999999988 5899999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~ 237 (959)
++|+++. ..|..+..+++|+.|++++|++++. .+..+++|+.|++++|.+++.... .++..|.+.++..
T Consensus 149 ~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~~~~----~~L~~L~l~~n~l 217 (390)
T 3o6n_A 149 SNNNLER----IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTLAIP----IAVEELDASHNSI 217 (390)
T ss_dssp CSSCCCB----CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEEECC----SSCSEEECCSSCC
T ss_pred CCCccCc----cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccccCCC----CcceEEECCCCee
Confidence 9999986 3456688999999999999999975 356789999999999999853211 1456666666665
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..++. ...++|+.|+|++|++++. ..+..+++|++|+|++|.+++..|..+..+ +|+.|+|++|++++. |.
T Consensus 218 ~~~~~-----~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~ 289 (390)
T 3o6n_A 218 NVVRG-----PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL-NL 289 (390)
T ss_dssp CEEEC-----CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-EC
T ss_pred eeccc-----cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-Cc
Confidence 55543 2357999999999999964 588999999999999999999989888887 699999999999752 21
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
..+.+++|+.|+|++|++. .+
T Consensus 290 ----------------------------------------------------------~~~~l~~L~~L~L~~n~l~-~~ 310 (390)
T 3o6n_A 290 ----------------------------------------------------------YGQPIPTLKVLDLSHNHLL-HV 310 (390)
T ss_dssp ----------------------------------------------------------SSSCCTTCCEEECCSSCCC-CC
T ss_pred ----------------------------------------------------------ccCCCCCCCEEECCCCcce-ec
Confidence 1234589999999999999 67
Q ss_pred CccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC--CCCCcceecccCCCCCCCC
Q 002149 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP--KFSGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 397 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~~~l~~N~~~c~~ 464 (959)
|..+..+++|++|+|++|+|++ +| +..+++|+.|++++|+++..-. .+.......+.+++..|..
T Consensus 311 ~~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 311 ERNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp GGGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCT
T ss_pred CccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceecc
Confidence 7789999999999999999984 44 7889999999999999975322 1333344456677777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-29 Score=313.47 Aligned_cols=343 Identities=20% Similarity=0.201 Sum_probs=251.3
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCC-CCCCChhhhcCCCCCcEEEccCc
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNN-FDTIPADFFDGLENLQVLALDSN 160 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~-l~~i~~~~~~~l~~L~~L~Ls~N 160 (959)
.++.++++++ .+|. -.++|++|||++|.|++..+ .|.++++|++|+|++|. +..+++..|.++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 4666777777 5565 45799999999999999877 79999999999999995 55788889999999999999999
Q ss_pred ccCCCCCCCCCccccCccccCeecccccccCCCCChh--hcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF--LGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 161 ~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~--l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
.|.+ ..|..+.++++|++|+|++|++++.+|.. |.++++|++|+|++|.+++..+...
T Consensus 84 ~l~~----~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~---------------- 143 (844)
T 3j0a_A 84 KIYF----LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS---------------- 143 (844)
T ss_dssp CCCE----ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGG----------------
T ss_pred cCcc----cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchh----------------
Confidence 9986 45888999999999999999999877765 9999999999999999997665321
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCC--CCCCEEeCCCCcCCCCCcccccc-------ccCCeEeCCCCc
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKL--TSLKDLNLNSNQFVGLIPPSLAS-------LSLDHLDLNNNM 309 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~-------~~L~~L~L~~N~ 309 (959)
++++++|++|+|++|.+++..|..+..+ ++|+.|+|++|.+.+..|..+.. .+|+.|+|++|.
T Consensus 144 --------~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~ 215 (844)
T 3j0a_A 144 --------FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215 (844)
T ss_dssp --------GGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCC
T ss_pred --------HhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCc
Confidence 5677899999999999988888888877 88999999999998877765443 248899999998
Q ss_pred CCCCCCccccccc--------ccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCc
Q 002149 310 FMGPVPKSKAYKY--------SYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381 (959)
Q Consensus 310 l~~~ip~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 381 (959)
+++.+|....... .+..+........... ... ....+..+ ..+.+.......+.........++.+++
T Consensus 216 l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l-~~~--~~~~f~~l-~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 291 (844)
T 3j0a_A 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI-KDP--DQNTFAGL-ARSSVRHLDLSHGFVFSLNSRVFETLKD 291 (844)
T ss_dssp SSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS-TTG--GGTTTTTT-TTSCCCEEECTTCCCCEECSCCSSSCCC
T ss_pred CchhHHHHHHhhcCcccccceeccccccccccccccc-CCC--Chhhhhcc-ccCCccEEECCCCcccccChhhhhcCCC
Confidence 8887775433211 1111111000000000 000 00000010 0122233333333344444455667788
Q ss_pred ccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccC
Q 002149 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDG 457 (959)
Q Consensus 382 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~ 457 (959)
|+.|+|++|++.+..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+. +.++..+.+.+
T Consensus 292 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~ 371 (844)
T 3j0a_A 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371 (844)
T ss_dssp CCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEET
T ss_pred CCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCC
Confidence 88888888888888888888888888888888888877788888888888888888888766553 34566777777
Q ss_pred CCCC
Q 002149 458 NPLL 461 (959)
Q Consensus 458 N~~~ 461 (959)
|.+.
T Consensus 372 N~l~ 375 (844)
T 3j0a_A 372 NALT 375 (844)
T ss_dssp CCSC
T ss_pred CCCC
Confidence 7654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-29 Score=291.01 Aligned_cols=315 Identities=28% Similarity=0.370 Sum_probs=231.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|+|+++.+++. ++ +.++++|++|+|++|.+.+.++ |.++++|++|+|++|+++.+++ |.++++|++|+|+
T Consensus 68 ~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECC
Confidence 5788899999998855 44 8899999999999999988776 8889999999999999998875 8899999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~ 237 (959)
+|.+.. ++ .+..+++|+.|++. |++.+.. .+.++++|+.|++++|++++. + .+..+ +++.|.+.++..
T Consensus 143 ~n~l~~-----~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l 211 (466)
T 1o6v_A 143 SNTISD-----IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQI 211 (466)
T ss_dssp EEEECC-----CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCC
T ss_pred CCccCC-----Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCcc
Confidence 998874 33 46777778888775 4444332 377888888888888888754 2 24443 566666665554
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..+.. ++.+++|++|+|++|++++ + ..+..+++|++|+|++|++++..+ +..+ +|+.|++++|.+++..|-
T Consensus 212 ~~~~~----~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~ 283 (466)
T 1o6v_A 212 SDITP----LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 283 (466)
T ss_dssp CCCGG----GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGG
T ss_pred ccccc----ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccc
Confidence 44332 6677888888888888874 3 357778888888888888887654 5555 588888888888764321
Q ss_pred cc---ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 317 SK---AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 317 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
.. ...+.+++|.+ ..... ++.+++|+.|+|++|++.
T Consensus 284 ~~l~~L~~L~L~~n~l---------------------------------------~~~~~--~~~l~~L~~L~L~~n~l~ 322 (466)
T 1o6v_A 284 AGLTALTNLELNENQL---------------------------------------EDISP--ISNLKNLTYLTLYFNNIS 322 (466)
T ss_dssp TTCTTCSEEECCSSCC---------------------------------------SCCGG--GGGCTTCSEEECCSSCCS
T ss_pred cCCCccCeEEcCCCcc---------------------------------------cCchh--hcCCCCCCEEECcCCcCC
Confidence 00 00111222221 11111 345688999999999999
Q ss_pred ccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC--CCCCcceecccCCCCCC
Q 002149 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP--KFSGAVKLSLDGNPLLN 462 (959)
Q Consensus 394 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~~~~~l~~N~~~c 462 (959)
+..| +..+++|++|+|++|++++. ..+.++++|+.|++++|++++.+| .+..+..+.+.+|++..
T Consensus 323 ~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 323 DISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred Cchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccchhhcCCCCCEEeccCCcccC
Confidence 7766 78899999999999999864 478899999999999999998777 24556788899988765
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=299.02 Aligned_cols=204 Identities=21% Similarity=0.292 Sum_probs=160.8
Q ss_pred CCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCCh
Q 002149 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPA 143 (959)
Q Consensus 65 ~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~ 143 (959)
.|+ |.|+ |+ +.+++++ .+|+.+. ++|++|+|++|++++.+| .|.++++|++|+|++|+|+.+++
T Consensus 3 ~C~---~~~~-c~--------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~ 67 (549)
T 2z81_A 3 SCD---ASGV-CD--------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67 (549)
T ss_dssp EEC---TTSE-EE--------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECT
T ss_pred cCC---CCce-EE--------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccCh
Confidence 466 7776 74 3456666 6777665 799999999999999887 69999999999999999999999
Q ss_pred hhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCC-CCChhhcCCCCCCEEEecCCcCCCCCC-cc
Q 002149 144 DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTGPIP-ES 221 (959)
Q Consensus 144 ~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~ 221 (959)
..|.++++|++|+|++|++++ ..|..+..+++|++|++++|++++ ..|..++++++|++|++++|++.+.+| ..
T Consensus 68 ~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~ 143 (549)
T 2z81_A 68 DAFYSLGSLEHLDLSDNHLSS----LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143 (549)
T ss_dssp TTTTTCTTCCEEECTTSCCCS----CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred hhccccccCCEEECCCCccCc----cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhh
Confidence 999999999999999999985 334458999999999999999997 467889999999999999999554444 57
Q ss_pred cccC-CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchh-hcCCCCCCEEeCCCCcCCCC
Q 002149 222 FKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES-FGKLTSLKDLNLNSNQFVGL 290 (959)
Q Consensus 222 ~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~ 290 (959)
|..+ +++.|.+.++..... .+..+.++++|++|++++|.+. .+|.. +..+++|++|+|++|++++.
T Consensus 144 ~~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 144 FAGLTSLNELEIKALSLRNY--QSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp TTTCCEEEEEEEEETTCCEE--CTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred hhcccccCeeeccCCccccc--ChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccc
Confidence 7766 567777766654432 2245677777778888777776 44443 34577777777777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=275.59 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=167.5
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCC-ccCCCCccEEecCCCCCCCCC--hhhhcCCCCCcEEEccC
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIP--ADFFDGLENLQVLALDS 159 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~i~--~~~~~~l~~L~~L~Ls~ 159 (959)
.|++.+++++ .+|..+. ++|++|+|++|+++..++. |.++++|++|+|++|+++.+. +..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 3445555555 4565443 6899999999999977764 789999999999999998653 44566789999999999
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCC-hhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
|.+. .+|..+..+++|++|++++|++.+..+ ..+..+++|++|++++|++++..+..
T Consensus 88 n~i~-----~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~----------------- 145 (306)
T 2z66_A 88 NGVI-----TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI----------------- 145 (306)
T ss_dssp CSEE-----EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTT-----------------
T ss_pred Cccc-----cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhh-----------------
Confidence 9887 355666666677777777766665544 45666666666666666666554444
Q ss_pred CcccccccccCCcCCcEEEccCccccc-cCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcc
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSG-TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKS 317 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~ 317 (959)
+.++++|++|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+..
T Consensus 146 --------~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-------------------- 197 (306)
T 2z66_A 146 --------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS-------------------- 197 (306)
T ss_dssp --------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT--------------------
T ss_pred --------cccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcC--------------------
Confidence 3445666666666666664 45666666666666666666666554444433
Q ss_pred cccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCC
Q 002149 318 KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS 397 (959)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p 397 (959)
+++|+.|+|++|++++..+
T Consensus 198 -------------------------------------------------------------l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 198 -------------------------------------------------------------LSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp -------------------------------------------------------------CTTCCEEECTTSCCSBCCS
T ss_pred -------------------------------------------------------------CCCCCEEECCCCccCccCh
Confidence 3556666666666665555
Q ss_pred ccccCcCcCCEEeCcccccccccCCCccCCC-CCCeEeCCCCccCCC
Q 002149 398 PSVGNLDSLTQIKLQSNNISGQIPTNWTNLK-SLTLLDLSQNNLSPP 443 (959)
Q Consensus 398 ~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~ 443 (959)
..+..+++|++|+|++|++++..|..+..++ +|+.|+|++|++++.
T Consensus 217 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 217 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp GGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred hhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 5666777777777777777777777777763 777777777777654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=286.99 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=165.6
Q ss_pred CCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCC
Q 002149 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP 142 (959)
Q Consensus 64 ~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~ 142 (959)
..||..| .|.. ....++..+.+++ .+|..+. ++|+.|+|++|+|++..+ .|.++++|++|+|++|+|+.++
T Consensus 33 ~~Cp~~C----~C~~-~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~ 104 (440)
T 3zyj_A 33 QTCPSVC----SCSN-QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104 (440)
T ss_dssp CCCCSSS----EECT-TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEEC
T ss_pred ccCCCCC----EeCC-CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccC
Confidence 4576544 4542 2235667777777 6777665 689999999999998887 6999999999999999999999
Q ss_pred hhhhcCCCCCcEEEccCcccCCCCCCCCCc-cccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcc
Q 002149 143 ADFFDGLENLQVLALDSNNFNASKGWSFPK-GLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPES 221 (959)
Q Consensus 143 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~-~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 221 (959)
+..|.++++|++|+|++|+|+. +|. .+..+++|+.|++++|++....+..|..+++|+.|+|++|+..+.++..
T Consensus 105 ~~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~ 179 (440)
T 3zyj_A 105 IGAFNGLANLNTLELFDNRLTT-----IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179 (440)
T ss_dssp GGGGTTCSSCCEEECCSSCCSS-----CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT
T ss_pred hhhccCCccCCEEECCCCcCCe-----eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc
Confidence 9999999999999999998874 222 3445555555555555555444444455555555555543222222211
Q ss_pred cccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCC
Q 002149 222 FKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLD 301 (959)
Q Consensus 222 ~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~ 301 (959)
.|.++++|++|+|++|+++ .+| .+..+++|++|+|++|+|++..|..|
T Consensus 180 ------------------------~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~------ 227 (440)
T 3zyj_A 180 ------------------------AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSF------ 227 (440)
T ss_dssp ------------------------TTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTT------
T ss_pred ------------------------hhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhh------
Confidence 0233444444444444444 233 23344444444444444443333222
Q ss_pred eEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCc
Q 002149 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381 (959)
Q Consensus 302 ~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 381 (959)
..+++
T Consensus 228 ---------------------------------------------------------------------------~~l~~ 232 (440)
T 3zyj_A 228 ---------------------------------------------------------------------------QGLMH 232 (440)
T ss_dssp ---------------------------------------------------------------------------TTCTT
T ss_pred ---------------------------------------------------------------------------ccCcc
Confidence 23466
Q ss_pred ccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccC
Q 002149 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 382 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 233 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 777777777777777777777888888888888887666666777788888888777764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=286.13 Aligned_cols=287 Identities=18% Similarity=0.280 Sum_probs=229.9
Q ss_pred CCCCCCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCC
Q 002149 59 WPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNN 137 (959)
Q Consensus 59 w~~~~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~ 137 (959)
|.....+|+ |.++ | ++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+
T Consensus 23 ~~~~~~~C~---~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 23 SNQASLSCD---RNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp ----CCEEC---TTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCccCCCCC---CCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence 444456666 6554 4 34566666 5676665 489999999999998887 69999999999999999
Q ss_pred CCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCcc-ccCccccCeecccccccCCCCC-hhhcCCCCCCEEEecCCc-C
Q 002149 138 FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKG-LQSSAQLTNLSCMSCNLAGQLP-DFLGNFASLQNLKLSGNN-L 214 (959)
Q Consensus 138 l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~-l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~-l 214 (959)
|+.+++..|.++++|++|+|++|+++. +|.. +..+++|++|++++|++.+..+ ..+..+++|++|++++|+ +
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~-----~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~ 162 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSN-----LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSS-----CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCc-----CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccc
Confidence 999999889999999999999999984 5554 7889999999999999996544 578999999999999994 6
Q ss_pred CCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccc
Q 002149 215 TGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS 294 (959)
Q Consensus 215 ~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 294 (959)
+...+.. +.++++|++|+|++|++++..|..|..+++|++|+|++|+++...+..
T Consensus 163 ~~~~~~~-------------------------~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 217 (353)
T 2z80_A 163 TKIQRKD-------------------------FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217 (353)
T ss_dssp CEECTTT-------------------------TTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHH
T ss_pred cccCHHH-------------------------ccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhh
Confidence 6544444 566789999999999999888999999999999999999997655444
Q ss_pred cccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccc
Q 002149 295 LASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLG 373 (959)
Q Consensus 295 ~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 373 (959)
+..+ +|+.|+|++|.+++..+....
T Consensus 218 ~~~~~~L~~L~L~~n~l~~~~~~~l~------------------------------------------------------ 243 (353)
T 2z80_A 218 VDVTSSVECLELRDTDLDTFHFSELS------------------------------------------------------ 243 (353)
T ss_dssp HHHTTTEEEEEEESCBCTTCCCC---------------------------------------------------------
T ss_pred hhhcccccEEECCCCccccccccccc------------------------------------------------------
Confidence 4444 699999999999864432100
Q ss_pred cccCCCCcccEEECCCCcccc----cCCccccCcCcCCEEeCcccccccccCCC-ccCCCCCCeEeCCCCccCCCCCC
Q 002149 374 LSCGTNSKLTVLNLPNFNLSG----TLSPSVGNLDSLTQIKLQSNNISGQIPTN-WTNLKSLTLLDLSQNNLSPPLPK 446 (959)
Q Consensus 374 ~~~~~~~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~ 446 (959)
.......++.++|++|.+++ .+|..+.++++|++|+|++|+|+ .+|.. |.++++|+.|+|++|++++..|.
T Consensus 244 -~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 244 -TGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred -cccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 00123568888888888876 47888999999999999999999 67766 58999999999999999988773
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-28 Score=280.27 Aligned_cols=314 Identities=15% Similarity=0.149 Sum_probs=228.3
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
..+++.|+++++++++. | .+..+++|++|+|++|+|++.+ ++++++|++|+|++|+|++++ |.++++|++|+|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L 113 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNC 113 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCceee---cCCCCcCCEEEC
Confidence 35789999999999964 4 7899999999999999999863 889999999999999999985 889999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~ 236 (959)
++|++++ +| +..+++|++|++++|++++. + ++.+++|++|++++|+..+.++ +..+ ++..|.+.++.
T Consensus 114 ~~N~l~~-----l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 114 DTNKLTK-----LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181 (457)
T ss_dssp CSSCCSC-----CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSC
T ss_pred CCCcCCe-----ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCc
Confidence 9999985 33 78899999999999999974 3 7889999999999996555552 4433 45666666655
Q ss_pred CCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 237 ~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
...++ +..+++|+.|++++|++++. .+..+++|++|+|++|++++. | +..+ +|+.|++++|++++..+
T Consensus 182 l~~l~-----l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~~~~ 250 (457)
T 3bz5_A 182 ITELD-----VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTELDV 250 (457)
T ss_dssp CCCCC-----CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCCC
T ss_pred cceec-----cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCCcCH
Confidence 44432 77888999999999999864 388889999999999999984 4 5555 59999999999987533
Q ss_pred cccc--cccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 316 KSKA--YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 316 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
.... ..+.++.|.+. .....++. ......++.+++|+.|+|++|.+.
T Consensus 251 ~~l~~L~~L~l~~n~L~-----------------------------~L~l~~n~--~~~~~~~~~l~~L~~L~Ls~n~~l 299 (457)
T 3bz5_A 251 STLSKLTTLHCIQTDLL-----------------------------EIDLTHNT--QLIYFQAEGCRKIKELDVTHNTQL 299 (457)
T ss_dssp TTCTTCCEEECTTCCCS-----------------------------CCCCTTCT--TCCEEECTTCTTCCCCCCTTCTTC
T ss_pred HHCCCCCEEeccCCCCC-----------------------------EEECCCCc--cCCcccccccccCCEEECCCCccc
Confidence 2211 00111111111 11111111 111123456678888888888877
Q ss_pred ccCCc--------cccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCCCCCcceecccCCC
Q 002149 394 GTLSP--------SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNP 459 (959)
Q Consensus 394 ~~~p~--------~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~l~~N~ 459 (959)
+.+|. .++++++|++|+|++|+|++ ++ +.++++|+.|++++|+|++ +| .+..+.+..|.
T Consensus 300 ~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-l~---~L~~L~l~~n~ 366 (457)
T 3bz5_A 300 YLLDCQAAGITELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FS---SVGKIPALNNN 366 (457)
T ss_dssp CEEECTTCCCSCCCCTTCTTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB-CT---TGGGSSGGGTS
T ss_pred ceeccCCCcceEechhhcccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC-cc---ccccccccCCc
Confidence 66654 25566788888888888887 33 8888888888888888887 33 33344444443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=271.57 Aligned_cols=280 Identities=22% Similarity=0.316 Sum_probs=235.0
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
..+++.|+++++.+++ +++ +..+++|++|+|++|.++.. +.|.++++|++|+|++|+++.+++ +..+++|++|++
T Consensus 65 ~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l 139 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITDI-SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEEC
T ss_pred cCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccCc-hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEEC
Confidence 4589999999999985 454 99999999999999999874 579999999999999999999887 899999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~ 236 (959)
++|.... .+..+..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+ ++..|.+.++.
T Consensus 140 ~~n~~~~-----~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 140 GANHNLS-----DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp TTCTTCC-----CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred CCCCCcc-----cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCC
Confidence 9996553 34458999999999999999986544 8899999999999999986544 4444 56666666655
Q ss_pred CCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 237 ~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
...+.. +..+++|++|+|++|++++..+ +..+++|++|+|++|.+++. ..+..+ +|+.|++++|.+++. |
T Consensus 211 l~~~~~----~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~ 281 (347)
T 4fmz_A 211 ITDITP----VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-S 281 (347)
T ss_dssp CCCCGG----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G
T ss_pred CCCCch----hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-h
Confidence 444433 7889999999999999995444 89999999999999999975 345555 699999999999752 1
Q ss_pred cccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccccc
Q 002149 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395 (959)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 395 (959)
. +..+++|+.|+|++|++.+.
T Consensus 282 ~-----------------------------------------------------------~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 282 V-----------------------------------------------------------LNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp G-----------------------------------------------------------GGGCTTCSEEECCSSCCCGG
T ss_pred h-----------------------------------------------------------hcCCCCCCEEECcCCcCCCc
Confidence 1 22458899999999999999
Q ss_pred CCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccC
Q 002149 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 396 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
.|..++++++|++|+|++|.+++..| +..+++|+.|++++|+++
T Consensus 303 ~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred ChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 99999999999999999999997666 899999999999999986
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=268.19 Aligned_cols=265 Identities=22% Similarity=0.300 Sum_probs=223.4
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
.+|+.+++++|.++..+..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+++. ..|..+..+++|++
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~ 106 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK----IHEKAFSPLRKLQK 106 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE----ECGGGSTTCTTCCE
T ss_pred ccCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCc----cCHhHhhCcCCCCE
Confidence 368999999999997766664 689999999999999999899999999999999999985 34778899999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|++. .+|..+. ++|++|++++|++++..+.. +.++++|++|+|++|.
T Consensus 107 L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~-------------------------~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 107 LYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGV-------------------------FSGLRNMNCIEMGGNP 158 (332)
T ss_dssp EECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGG-------------------------GSSCSSCCEEECCSCC
T ss_pred EECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhH-------------------------hCCCccCCEEECCCCc
Confidence 999999998 4555544 89999999999999665554 5677999999999999
Q ss_pred cc--ccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCch
Q 002149 263 FS--GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 263 l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (959)
++ +..|..+..+ +|++|++++|++++. |..+. .+|+.|+|++|.+++..|.
T Consensus 159 l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l-~~~~~-~~L~~L~l~~n~i~~~~~~------------------------ 211 (332)
T 2ft3_A 159 LENSGFEPGAFDGL-KLNYLRISEAKLTGI-PKDLP-ETLNELHLDHNKIQAIELE------------------------ 211 (332)
T ss_dssp CBGGGSCTTSSCSC-CCSCCBCCSSBCSSC-CSSSC-SSCSCCBCCSSCCCCCCTT------------------------
T ss_pred cccCCCCcccccCC-ccCEEECcCCCCCcc-Ccccc-CCCCEEECCCCcCCccCHH------------------------
Confidence 96 4778888888 999999999999974 44333 4799999999999865442
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccccc
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
.+..+++|+.|+|++|++.+..+..+..+++|++|+|++|+|+ .+
T Consensus 212 ----------------------------------~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 256 (332)
T 2ft3_A 212 ----------------------------------DLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RV 256 (332)
T ss_dssp ----------------------------------SSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BC
T ss_pred ----------------------------------HhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ec
Confidence 1335588999999999999888889999999999999999999 89
Q ss_pred CCCccCCCCCCeEeCCCCccCCCCCC----------CCCcceecccCCCCCCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLSPPLPK----------FSGAVKLSLDGNPLLNG 463 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~~~~p~----------~~~~~~~~l~~N~~~c~ 463 (959)
|..+..+++|+.|+|++|++++..+. +..+..+.+.+||+.+.
T Consensus 257 p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~ 309 (332)
T 2ft3_A 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309 (332)
T ss_dssp CTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred ChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence 99999999999999999999876543 23356788999998754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-27 Score=278.01 Aligned_cols=317 Identities=28% Similarity=0.370 Sum_probs=243.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++.+++++. +| .+..+++|++|+|++|.+++.++ |.++++|++|+|++|+++.+++ |.++++|++|+|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 478999999999884 55 48899999999999999998877 9999999999999999999987 9999999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKG 237 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~ 237 (959)
+|.++. ++. +..+++|++|++++|++.+. + .+..+++|+.|+++ |.+.+..+ +..+ +++.|.+.++..
T Consensus 121 ~n~l~~-----~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l 189 (466)
T 1o6v_A 121 NNQITD-----IDP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV 189 (466)
T ss_dssp SSCCCC-----CGG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred CCCCCC-----ChH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcC
Confidence 999985 343 88999999999999999864 3 58999999999997 56654433 5554 566777766655
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
..+. .+..+++|++|++++|.+++..| ++.+++|++|+|++|++++. + .+..+ +|+.|++++|.+++..|-
T Consensus 190 ~~~~----~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~~ 261 (466)
T 1o6v_A 190 SDIS----VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G-TLASLTNLTDLDLANNQISNLAPL 261 (466)
T ss_dssp CCCG----GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGGG
T ss_pred CCCh----hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-h-hhhcCCCCCEEECCCCccccchhh
Confidence 4443 37888999999999999997665 77899999999999999864 3 45555 699999999999875431
Q ss_pred ccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC
Q 002149 317 SKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396 (959)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 396 (959)
.. ++.+.......+....... +..+++|+.|+|++|++.+..
T Consensus 262 ~~------------------------------------l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~ 303 (466)
T 1o6v_A 262 SG------------------------------------LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 303 (466)
T ss_dssp TT------------------------------------CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCG
T ss_pred hc------------------------------------CCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCch
Confidence 10 0111111111111111111 456688999999999988654
Q ss_pred CccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCC--CCCCCcceecccCCCCC
Q 002149 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPL--PKFSGAVKLSLDGNPLL 461 (959)
Q Consensus 397 p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~~~~~l~~N~~~ 461 (959)
+ ++.+++|+.|+|++|++++..| +..+++|+.|++++|++++.. ..+.++..+.+.+|++.
T Consensus 304 ~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 304 P--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp G--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred h--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccC
Confidence 4 7888899999999999887665 788889999999999888752 23456677888888664
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-28 Score=276.47 Aligned_cols=280 Identities=20% Similarity=0.194 Sum_probs=220.2
Q ss_pred cCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEE
Q 002149 77 SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLA 156 (959)
Q Consensus 77 ~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 156 (959)
...+++.|++++|.+++. | ++.+++|++|+|++|.|++. .|.++++|++|+|++|+++.++ +..+++|++|+
T Consensus 62 ~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~--~~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~ 133 (457)
T 3bz5_A 62 KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL--DVTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLN 133 (457)
T ss_dssp GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC--CCTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEE
T ss_pred ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee--ecCCCCcCCEEECCCCcCCeec---CCCCCcCCEEE
Confidence 346899999999999974 4 99999999999999999986 3899999999999999999985 88999999999
Q ss_pred ccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-Cccccccccc
Q 002149 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQ 235 (959)
Q Consensus 157 Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~ 235 (959)
|++|++++ ++ +..+++|+.|++++|+..+.+ .+..+++|+.|++++|++++. | +..+ ++..|.+..+
T Consensus 134 l~~N~l~~-----l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 134 CARNTLTE-----ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTN 201 (457)
T ss_dssp CTTSCCSC-----CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSS
T ss_pred CCCCccce-----ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCC
Confidence 99999986 32 788999999999999777666 478899999999999999974 4 4444 5667777666
Q ss_pred CCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc--------cCCeEeCCC
Q 002149 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL--------SLDHLDLNN 307 (959)
Q Consensus 236 ~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~--------~L~~L~L~~ 307 (959)
....+ .++.+++|++|+|++|++++ +| +..+++|++|+|++|++++.++..+..+ +|+.|++++
T Consensus 202 ~l~~~-----~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~ 273 (457)
T 3bz5_A 202 NITKL-----DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTH 273 (457)
T ss_dssp CCSCC-----CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTT
T ss_pred cCCee-----ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCC
Confidence 65554 27889999999999999997 66 8899999999999999999876665543 366777777
Q ss_pred CcCCCCCCccc---ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccE
Q 002149 308 NMFMGPVPKSK---AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384 (959)
Q Consensus 308 N~l~~~ip~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~ 384 (959)
|.+.|.+|... ...+.+++|.+.+. +++ .......+.++.+++|+.
T Consensus 274 n~~~~~~~~~~l~~L~~L~Ls~n~~l~~---l~~----------------------------~~~~L~~L~l~~~~~L~~ 322 (457)
T 3bz5_A 274 NTQLIYFQAEGCRKIKELDVTHNTQLYL---LDC----------------------------QAAGITELDLSQNPKLVY 322 (457)
T ss_dssp CTTCCEEECTTCTTCCCCCCTTCTTCCE---EEC----------------------------TTCCCSCCCCTTCTTCCE
T ss_pred CccCCcccccccccCCEEECCCCcccce---ecc----------------------------CCCcceEechhhcccCCE
Confidence 77776665321 11122333322110 110 001122234566789999
Q ss_pred EECCCCcccccCCccccCcCcCCEEeCccccccc
Q 002149 385 LNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418 (959)
Q Consensus 385 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 418 (959)
|+|++|++++. + ++++++|+.|+|++|+|++
T Consensus 323 L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 323 LYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp EECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred EECCCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence 99999999984 3 9999999999999999996
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-27 Score=265.13 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=227.4
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
.+|+.++++++.++..+..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+++. ..|..+..+++|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~ 104 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK----ISPGAFAPLVKLER 104 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC----BCTTTTTTCTTCCE
T ss_pred CCCeEEEecCCCccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCe----eCHHHhcCCCCCCE
Confidence 478999999999997766554 689999999999999999999999999999999999985 34778899999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|+++ .+|..+. ++|++|++++|++++..+.. +.++++|++|+|++|.
T Consensus 105 L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~ 156 (330)
T 1xku_A 105 LYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSV-------------------------FNGLNQMIVVELGTNP 156 (330)
T ss_dssp EECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHH-------------------------HTTCTTCCEEECCSSC
T ss_pred EECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhH-------------------------hcCCccccEEECCCCc
Confidence 999999998 4555544 79999999999998665554 5677999999999999
Q ss_pred cc--ccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCch
Q 002149 263 FS--GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 263 l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (959)
++ +..+..|..+++|++|++++|+++.. |..+. .+|+.|+|++|.+++..|.
T Consensus 157 l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l-~~~~~-~~L~~L~l~~n~l~~~~~~------------------------ 210 (330)
T 1xku_A 157 LKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGLP-PSLTELHLDGNKITKVDAA------------------------ 210 (330)
T ss_dssp CCGGGBCTTGGGGCTTCCEEECCSSCCCSC-CSSCC-TTCSEEECTTSCCCEECTG------------------------
T ss_pred CCccCcChhhccCCCCcCEEECCCCccccC-Ccccc-ccCCEEECCCCcCCccCHH------------------------
Confidence 96 37788999999999999999999965 43333 4799999999999865442
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccccc
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
.++.+++|+.|+|++|++++..+..+..+++|++|+|++|+|+ .+
T Consensus 211 ----------------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 211 ----------------------------------SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp ----------------------------------GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred ----------------------------------HhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 2345689999999999999988889999999999999999999 89
Q ss_pred CCCccCCCCCCeEeCCCCccCCCCCC-C---------CCcceecccCCCCCCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLSPPLPK-F---------SGAVKLSLDGNPLLNG 463 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~~~~p~-~---------~~~~~~~l~~N~~~c~ 463 (959)
|..+..+++|++|+|++|++++..+. | ..+..+++.+||+.+.
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~ 308 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence 99999999999999999999976553 2 3455788999998764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=279.82 Aligned_cols=260 Identities=24% Similarity=0.302 Sum_probs=165.8
Q ss_pred CCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCC
Q 002149 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP 142 (959)
Q Consensus 64 ~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~ 142 (959)
..|+..| .|.. ....++..+.+++ .+|..+. ++|++|+|++|+|++..+ .|.++++|++|+|++|+|+.++
T Consensus 44 ~~Cp~~C----~C~~-~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~ 115 (452)
T 3zyi_A 44 QNCPSVC----SCSN-QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115 (452)
T ss_dssp CCCCTTS----EECS-SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCCCCC----EECC-CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcC
Confidence 4566544 3432 2234566666666 5666554 689999999999998877 6999999999999999999999
Q ss_pred hhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCccc
Q 002149 143 ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF 222 (959)
Q Consensus 143 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 222 (959)
+..|.++++|++|+|++|+|+.+ .+..+..+++|++|+|++|++....+..|.++++|+.|+|++|+..+.++..
T Consensus 116 ~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~- 190 (452)
T 3zyi_A 116 VGAFNGLASLNTLELFDNWLTVI----PSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG- 190 (452)
T ss_dssp TTTTTTCTTCCEEECCSSCCSBC----CTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-
T ss_pred hhhccCcccCCEEECCCCcCCcc----ChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh-
Confidence 99999999999999999988742 1222444555555555555555444444555555555555543222222211
Q ss_pred ccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCe
Q 002149 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDH 302 (959)
Q Consensus 223 ~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~ 302 (959)
.+.++++|++|+|++|++++ +| .+..+++|++|+|++|+|++..|..|
T Consensus 191 -----------------------~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~------- 238 (452)
T 3zyi_A 191 -----------------------AFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSF------- 238 (452)
T ss_dssp -----------------------TTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGG-------
T ss_pred -----------------------hccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccc-------
Confidence 03334445555555555442 22 23444444444444444444333332
Q ss_pred EeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcc
Q 002149 303 LDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKL 382 (959)
Q Consensus 303 L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L 382 (959)
..+++|
T Consensus 239 --------------------------------------------------------------------------~~l~~L 244 (452)
T 3zyi_A 239 --------------------------------------------------------------------------HGLSSL 244 (452)
T ss_dssp --------------------------------------------------------------------------TTCTTC
T ss_pred --------------------------------------------------------------------------cCccCC
Confidence 234667
Q ss_pred cEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCC
Q 002149 383 TVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 383 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.-
T Consensus 245 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 777777777777777777888888888888888886666667778888888888887653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.5e-28 Score=262.18 Aligned_cols=209 Identities=27% Similarity=0.372 Sum_probs=166.2
Q ss_pred cceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCC
Q 002149 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLE 150 (959)
Q Consensus 72 ~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 150 (959)
.++.|.....+.+++.+++++ .+|..+ .++|++|+|++|.|++.++ .|.++++|++|+|++|+|+.+++..|.+++
T Consensus 4 ~~C~C~~~~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 80 (285)
T 1ozn_A 4 GACVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (285)
T ss_dssp TTCEEECSSSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CCceECCCCCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence 355677666577889998888 566654 4689999999999999887 589999999999999999999888899999
Q ss_pred CCcEEEccCcc-cCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccc
Q 002149 151 NLQVLALDSNN-FNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVN 229 (959)
Q Consensus 151 ~L~~L~Ls~N~-l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~ 229 (959)
+|++|+|++|+ +.. ..|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..
T Consensus 81 ~L~~L~l~~n~~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------- 148 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRS----VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT-------- 148 (285)
T ss_dssp TCCEEECCSCTTCCC----CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT--------
T ss_pred CCCEEeCCCCCCccc----cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhH--------
Confidence 99999999997 764 23566777888888888888888777778888888888888888887655544
Q ss_pred ccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCC
Q 002149 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNN 308 (959)
Q Consensus 230 L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N 308 (959)
+.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..+..+ +|+.|+|++|
T Consensus 149 -----------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 149 -----------------FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp -----------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred -----------------hccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 4556788888888888886666677888888888888888887777777665 4777777777
Q ss_pred cCCC
Q 002149 309 MFMG 312 (959)
Q Consensus 309 ~l~~ 312 (959)
.+++
T Consensus 212 ~l~~ 215 (285)
T 1ozn_A 212 NLSA 215 (285)
T ss_dssp CCSC
T ss_pred cCCc
Confidence 7664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=269.91 Aligned_cols=218 Identities=22% Similarity=0.347 Sum_probs=141.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++++|.+++ +|.. +++|++|++++|++++.+. + .++|++|+|++|+++++| .|.++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 357777777777775 5543 3677777777777775432 1 157888888888888776 37788888888888
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|++++ +|..+ .+|++|++++|++.+ +| .++++++|+.|++++|++++ +|.... +++.|.+.++...
T Consensus 162 ~N~l~~-----lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~~--~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 162 NNSLKK-----LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLPL--SLESIVAGNNILE 228 (454)
T ss_dssp SSCCSC-----CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCCT--TCCEEECCSSCCS
T ss_pred CCcCcc-----cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCcC--cccEEECcCCcCC
Confidence 887774 34332 477888888888776 45 57778888888888888875 343322 4555555555444
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCC--CCCc
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMG--PVPK 316 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~--~ip~ 316 (959)
.++ .++.+++|++|++++|++++ +|.. +++|++|++++|++++ +|..+ .+|+.|++++|++++ .+|.
T Consensus 229 ~lp----~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~~--~~L~~L~ls~N~l~~l~~~~~ 297 (454)
T 1jl5_A 229 ELP----ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPELP--QSLTFLDVSENIFSGLSELPP 297 (454)
T ss_dssp SCC----CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSEESCCCT
T ss_pred ccc----ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCccc--CcCCEEECcCCccCcccCcCC
Confidence 333 26677778888888888774 4542 3677888888887776 33332 357778888887776 3432
Q ss_pred ccccccccccCccc
Q 002149 317 SKAYKYSYSSNAFC 330 (959)
Q Consensus 317 ~~~~~~~~~~~~~~ 330 (959)
....+.+++|.+.
T Consensus 298 -~L~~L~l~~N~l~ 310 (454)
T 1jl5_A 298 -NLYYLNASSNEIR 310 (454)
T ss_dssp -TCCEEECCSSCCS
T ss_pred -cCCEEECcCCcCC
Confidence 1223344555443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=288.97 Aligned_cols=346 Identities=19% Similarity=0.125 Sum_probs=226.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+|++|+|++..+.+|.+|++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.+++..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 479999999999998777889999999999999999999887 5999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC----CEEEecCCcCC------------------
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL----QNLKLSGNNLT------------------ 215 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L----~~L~Ls~N~l~------------------ 215 (959)
++|+++.. .+|..+..+++|++|++++|++++..+..|..+.++ ..++++.|.++
T Consensus 156 s~N~l~~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~ 232 (635)
T 4g8a_A 156 AHNLIQSF---KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 232 (635)
T ss_dssp CSSCCCCC---CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEE
T ss_pred ccCccccC---CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhh
Confidence 99999754 467888999999999999999987766655433222 13333333332
Q ss_pred --------------------------------------------------------------------------------
Q 002149 216 -------------------------------------------------------------------------------- 215 (959)
Q Consensus 216 -------------------------------------------------------------------------------- 215 (959)
T Consensus 233 ~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~ 312 (635)
T 4g8a_A 233 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFS 312 (635)
T ss_dssp SCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEE
T ss_pred cccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccc
Confidence
Q ss_pred -----------------------------CCCCcccccC--------------------CcccccccccCCCCccccccc
Q 002149 216 -----------------------------GPIPESFKGL--------------------NLVNLWLNDQKGGGFTGTIDV 246 (959)
Q Consensus 216 -----------------------------~~~p~~~~~l--------------------~l~~L~~~~~~~~~l~~~~~~ 246 (959)
...+..+..+ +++.|.+..+...........
T Consensus 313 ~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~ 392 (635)
T 4g8a_A 313 LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 392 (635)
T ss_dssp EESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHH
T ss_pred ccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccc
Confidence 1111100000 011111111111111111112
Q ss_pred ccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCc-cccccc-cCCeEeCCCCcCCCCCCcccc-----
Q 002149 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP-PSLASL-SLDHLDLNNNMFMGPVPKSKA----- 319 (959)
Q Consensus 247 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~~-~L~~L~L~~N~l~~~ip~~~~----- 319 (959)
+..+.+|+.|+++.|.+. .++..+..+++|+.++++.|++....+ ..+..+ +++.++++.|.+.+..|....
T Consensus 393 ~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L 471 (635)
T 4g8a_A 393 DFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 471 (635)
T ss_dssp HHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred hhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhh
Confidence 334455566666555554 233444555555555555554443332 223333 355555555555544433211
Q ss_pred cccccccCcccC-CCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCc
Q 002149 320 YKYSYSSNAFCQ-PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 320 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
..+.+++|.+.. ..+ ..+..++.+......++......+..++.+++|+.|+|++|+|++..|.
T Consensus 472 ~~L~Ls~N~~~~~~~~---------------~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 536 (635)
T 4g8a_A 472 EVLKMAGNSFQENFLP---------------DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 536 (635)
T ss_dssp CEEECTTCEEGGGEEC---------------SCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCG
T ss_pred hhhhhhhcccccccCc---------------hhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChh
Confidence 111222222211 000 0111222333333344444445555677889999999999999999999
Q ss_pred cccCcCcCCEEeCcccccccccCCCccCC-CCCCeEeCCCCccCCC
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNL-KSLTLLDLSQNNLSPP 443 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l-~~L~~L~Ls~N~l~~~ 443 (959)
.|.++++|++|+|++|+|++..|..|..+ ++|+.|+|++|+++..
T Consensus 537 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 537 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp GGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred HHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999999999998 6899999999999753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=273.72 Aligned_cols=327 Identities=18% Similarity=0.188 Sum_probs=169.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCc-------------cEEecCCCCCCCCChh
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNL-------------KYAYLDGNNFDTIPAD 144 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L-------------~~L~L~~N~l~~i~~~ 144 (959)
.++++++++++++ |.+|+++++|++|++|+|++|.+.+..| .++++++| ++|++++|+++++|..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 3555666666666 5666666666666666666666655444 35544432 4555555555444431
Q ss_pred h----------------hcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEE
Q 002149 145 F----------------FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLK 208 (959)
Q Consensus 145 ~----------------~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ 208 (959)
. -..+++|++|+|++|+++++ |.. .++|++|++++|++++ +| .|+++++|++|+
T Consensus 90 ~~~L~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~l-----~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKAL-----SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSCC-----CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCccccccCCCcEEECCCCccCcc-----cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 0 00124555555555555432 111 1577778888777775 56 477778888888
Q ss_pred ecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCC
Q 002149 209 LSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV 288 (959)
Q Consensus 209 Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 288 (959)
+++|++++ +|..+. +++.|.+.++....++ .++++++|++|++++|++++ +|... ++|++|++++|+++
T Consensus 160 l~~N~l~~-lp~~~~--~L~~L~L~~n~l~~l~----~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 160 VDNNSLKK-LPDLPP--SLEFIAAGNNQLEELP----ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE 228 (454)
T ss_dssp CCSSCCSC-CCCCCT--TCCEEECCSSCCSSCC----CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS
T ss_pred CCCCcCcc-cCCCcc--cccEEECcCCcCCcCc----cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC
Confidence 88888775 454433 4555555555444432 36777778888888887774 44332 47777777777777
Q ss_pred CCCccccccc-cCCeEeCCCCcCCCCCCcc--cccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCC
Q 002149 289 GLIPPSLASL-SLDHLDLNNNMFMGPVPKS--KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGN 365 (959)
Q Consensus 289 ~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 365 (959)
.+|. +..+ +|+.|++++|++++ +|.. ....+.+++|.+.+.+... +.+.......
T Consensus 229 -~lp~-~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l~~l~~~~-------------------~~L~~L~ls~ 286 (454)
T 1jl5_A 229 -ELPE-LQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELP-------------------QSLTFLDVSE 286 (454)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCC-------------------TTCCEEECCS
T ss_pred -cccc-cCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcccccCccc-------------------CcCCEEECcC
Confidence 4453 5555 57778888777775 3332 1223345555554432211 1111111111
Q ss_pred CCCCcccccccCCCCcccEEECCCCcccccCCccccCc-CcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCC
Q 002149 366 DPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNL-DSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPL 444 (959)
Q Consensus 366 ~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~ 444 (959)
+...... ...++|+.|+|++|++.+. + .+ ++|++|+|++|++++ +|.. +++|+.|++++|++++.+
T Consensus 287 N~l~~l~----~~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp 353 (454)
T 1jl5_A 287 NIFSGLS----ELPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVP 353 (454)
T ss_dssp SCCSEES----CCCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCC
T ss_pred CccCccc----CcCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccccc
Confidence 1111110 0124677777777776642 2 22 467777777777774 5544 467777777777777533
Q ss_pred CCCCCcceecccCCCCCC
Q 002149 445 PKFSGAVKLSLDGNPLLN 462 (959)
Q Consensus 445 p~~~~~~~~~l~~N~~~c 462 (959)
+.+.++..+++.+|++.+
T Consensus 354 ~~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 354 ELPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp CCCTTCCEEECCSSCCSS
T ss_pred chhhhccEEECCCCCCCc
Confidence 334456677777776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=280.70 Aligned_cols=285 Identities=22% Similarity=0.311 Sum_probs=221.1
Q ss_pred CCCCCCCCCCCC-----CCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEE
Q 002149 57 LQWPKSGDPCGP-----PCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYA 131 (959)
Q Consensus 57 ~~w~~~~~~C~~-----~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L 131 (959)
..|....++|.. .|+....|...+++.|++++++++ .+|..+. ++|++|+|++|+|+.+++ .+++|++|
T Consensus 13 ~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L 86 (622)
T 3g06_A 13 SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTL 86 (622)
T ss_dssp HHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEE
T ss_pred HHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEE
Confidence 346544555540 122335566667999999999999 8888776 899999999999997665 67899999
Q ss_pred ecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecC
Q 002149 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSG 211 (959)
Q Consensus 132 ~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~ 211 (959)
+|++|+|+.+|. .+++|++|+|++|+|+. +|. .+++|+.|++++|++++ +|.. +++|++|+|++
T Consensus 87 ~Ls~N~l~~lp~----~l~~L~~L~Ls~N~l~~-----l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~ 150 (622)
T 3g06_A 87 EVSGNQLTSLPV----LPPGLLELSIFSNPLTH-----LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSD 150 (622)
T ss_dssp EECSCCCSCCCC----CCTTCCEEEECSCCCCC-----CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred EcCCCcCCcCCC----CCCCCCEEECcCCcCCC-----CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcC
Confidence 999999999987 68999999999999985 555 56889999999999986 5543 48999999999
Q ss_pred CcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 212 NNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 212 N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
|++++ +|..+. ++..|.+.++....++ ..+++|+.|+|++|+|++ +|.. +++|+.|++++|.|+..
T Consensus 151 N~l~~-l~~~~~--~L~~L~L~~N~l~~l~------~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l- 216 (622)
T 3g06_A 151 NQLAS-LPALPS--ELCKLWAYNNQLTSLP------MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL- 216 (622)
T ss_dssp SCCSC-CCCCCT--TCCEEECCSSCCSCCC------CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-
T ss_pred CcCCC-cCCccC--CCCEEECCCCCCCCCc------ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-
Confidence 99995 444332 3455555555554443 345778888888888874 5543 46788888888888853
Q ss_pred ccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcc
Q 002149 292 PPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSW 371 (959)
Q Consensus 292 p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 371 (959)
|..+ .+|+.|+|++|.+++ +|.
T Consensus 217 ~~~~--~~L~~L~Ls~N~L~~-lp~------------------------------------------------------- 238 (622)
T 3g06_A 217 PALP--SGLKELIVSGNRLTS-LPV------------------------------------------------------- 238 (622)
T ss_dssp CCCC--TTCCEEECCSSCCSC-CCC-------------------------------------------------------
T ss_pred CCCC--CCCCEEEccCCccCc-CCC-------------------------------------------------------
Confidence 3322 358888888888875 331
Q ss_pred cccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCC
Q 002149 372 LGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPK 446 (959)
Q Consensus 372 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 446 (959)
.+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++.+|.
T Consensus 239 ------~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 239 ------LPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ------CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ------CCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 2378999999999999 5665 6789999999999999 8899999999999999999999987764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.7e-27 Score=256.83 Aligned_cols=65 Identities=23% Similarity=0.328 Sum_probs=57.3
Q ss_pred CCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCCh
Q 002149 78 NSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPA 143 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 143 (959)
..+++.|+|++|.++ .+|..++++++|++|+|++|.|+..++.|.++++|++|+|++|++.+..+
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p 167 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELP 167 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCC
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccC
Confidence 458999999999999 89999999999999999999999665589999999999999977665433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-28 Score=270.70 Aligned_cols=249 Identities=22% Similarity=0.248 Sum_probs=189.7
Q ss_pred ccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCC--CChhhhc-------CCCCCcEEEccCcccCCCCCCC
Q 002149 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDT--IPADFFD-------GLENLQVLALDSNNFNASKGWS 169 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~--i~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~ 169 (959)
++.+++|++|++++|.+ ..+..+... |++|+|++|+++. ++.. +. ++++|++|+|++|++++ .
T Consensus 39 ~~~~~~L~~l~l~~n~l-~~p~~~~~~--L~~L~L~~n~l~~~~~~~~-~~~~~~~~~~l~~L~~L~L~~n~l~~----~ 110 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE-ADLGQFTDI--IKSLSLKRLTVRAARIPSR-ILFGALRVLGISGLQELTLENLEVTG----T 110 (312)
T ss_dssp EEEEEECTTHHHHCCTT-CCCHHHHHH--HHHCCCCEEEEEEEECBHH-HHHHHHHHHTTSCCCEEEEEEEBCBS----C
T ss_pred EccCCCceeEeeccccc-ccHHHHHHH--HhhcccccccccCCCcCHH-HHHHHHHhcCcCCccEEEccCCcccc----h
Confidence 45667788888888888 333344433 8888888888854 3332 22 68888888888888876 4
Q ss_pred CCccc--cCccccCeecccccccCCCCChhhcCC-----CCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCccc
Q 002149 170 FPKGL--QSSAQLTNLSCMSCNLAGQLPDFLGNF-----ASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTG 242 (959)
Q Consensus 170 lp~~l--~~l~~L~~L~l~~n~l~~~~p~~l~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~ 242 (959)
+|..+ ..+++|++|++++|++++. |..+..+ ++|++|+|++|++++..|..
T Consensus 111 ~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~--------------------- 168 (312)
T 1wwl_A 111 APPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ--------------------- 168 (312)
T ss_dssp CCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTT---------------------
T ss_pred hHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHH---------------------
Confidence 56665 7888888888888888877 7777776 89999999999998777666
Q ss_pred ccccccCCcCCcEEEccCcccccc--Cchhh--cCCCCCCEEeCCCCcCCCCC--c-cccccc-cCCeEeCCCCcCCCCC
Q 002149 243 TIDVLGNMDQLRTLWLHGNHFSGT--IPESF--GKLTSLKDLNLNSNQFVGLI--P-PSLASL-SLDHLDLNNNMFMGPV 314 (959)
Q Consensus 243 ~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~~~--p-~~~~~~-~L~~L~L~~N~l~~~i 314 (959)
++++++|++|+|++|++.+. +|..+ ..+++|++|+|++|+|++.. + ..+..+ +|+.|+|++|++++.+
T Consensus 169 ----~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 169 ----VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp ----CCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred ----hccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 45678899999999998765 34444 78899999999999998431 2 233344 6999999999998765
Q ss_pred CcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccc
Q 002149 315 PKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSG 394 (959)
Q Consensus 315 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~ 394 (959)
|.. .+..+++|+.|+|++|+|+
T Consensus 245 ~~~---------------------------------------------------------~~~~l~~L~~L~Ls~N~l~- 266 (312)
T 1wwl_A 245 GAP---------------------------------------------------------SCDWPSQLNSLNLSFTGLK- 266 (312)
T ss_dssp CCS---------------------------------------------------------CCCCCTTCCEEECTTSCCS-
T ss_pred chh---------------------------------------------------------hhhhcCCCCEEECCCCccC-
Confidence 421 1123478999999999998
Q ss_pred cCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCC
Q 002149 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 395 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~ 443 (959)
.+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|++++.
T Consensus 267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 7787776 8999999999999965 66 89999999999999999863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=264.16 Aligned_cols=247 Identities=22% Similarity=0.293 Sum_probs=179.9
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
....++.+++.++.++..+. +++++|+|++|+|+.+++..|.++++|++|+|++|.|+.
T Consensus 44 ~~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------- 102 (440)
T 3zyj_A 44 QFSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT------------------- 102 (440)
T ss_dssp TSCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-------------------
T ss_pred CCCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-------------------
Confidence 35678888888887776554 678899999999999888888889999999998888764
Q ss_pred cccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccc
Q 002149 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l 263 (959)
..+..|.++++|++|+|++|+|+...+.. +.++++|++|+|++|++
T Consensus 103 ---------i~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~i 148 (440)
T 3zyj_A 103 ---------IEIGAFNGLANLNTLELFDNRLTTIPNGA-------------------------FVYLSKLKELWLRNNPI 148 (440)
T ss_dssp ---------ECGGGGTTCSSCCEEECCSSCCSSCCTTT-------------------------SCSCSSCCEEECCSCCC
T ss_pred ---------cChhhccCCccCCEEECCCCcCCeeCHhH-------------------------hhccccCceeeCCCCcc
Confidence 22344555555666666666555433333 33445566666666666
Q ss_pred cccCchhhcCCCCCCEEeCCCC-cCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchh
Q 002149 264 SGTIPESFGKLTSLKDLNLNSN-QFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPE 341 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (959)
++..+..|..+++|++|+|++| .+....+..|..+ +|+.|+|++|.++. +|.
T Consensus 149 ~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~------------------------- 202 (440)
T 3zyj_A 149 ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN------------------------- 202 (440)
T ss_dssp CEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCC-------------------------
T ss_pred cccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccc-------------------------
Confidence 5444455556666666666653 3333333345544 46666666666552 221
Q ss_pred hHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccC
Q 002149 342 VMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP 421 (959)
Q Consensus 342 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 421 (959)
+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|
T Consensus 203 ----------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 203 ----------------------------------LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp ----------------------------------CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred ----------------------------------cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 1245789999999999999999999999999999999999999999
Q ss_pred CCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCCCCC
Q 002149 422 TNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 422 ~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~~ 465 (959)
..|.++++|+.|+|++|+|++.++. +.++..+.+.+|||.|...
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 9999999999999999999987764 3567789999999999863
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=251.59 Aligned_cols=219 Identities=24% Similarity=0.336 Sum_probs=194.4
Q ss_pred CCCCCCCc------ceEecC-----------CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCC
Q 002149 65 PCGPPCWK------HVFCSN-----------SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLS 126 (959)
Q Consensus 65 ~C~~~~w~------gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~ 126 (959)
+||..|-| .+.|+. ..++.|+++++++++..+..+..+++|++|+|++|.+++..+ .|.+++
T Consensus 1 ~CP~~C~C~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 80 (285)
T 1ozn_A 1 PCPGACVCYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80 (285)
T ss_dssp CCCTTCEEECSSSCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CcCCCceECCCCCeEEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCcc
Confidence 46665533 377864 368899999999998777889999999999999999999877 699999
Q ss_pred CccEEecCCCC-CCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCC
Q 002149 127 NLKYAYLDGNN-FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQ 205 (959)
Q Consensus 127 ~L~~L~L~~N~-l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~ 205 (959)
+|++|+|++|. ++.+++..|..+++|++|+|++|+++. ..|..+..+++|++|++++|++.+..+..|..+++|+
T Consensus 81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 156 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE----LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156 (285)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC----CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE----ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCcc
Confidence 99999999997 999999999999999999999999986 3467788999999999999999988888899999999
Q ss_pred EEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCC
Q 002149 206 NLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSN 285 (959)
Q Consensus 206 ~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 285 (959)
.|+|++|++++..+.. +..+++|++|+|++|++++..|..|..+++|++|+|++|
T Consensus 157 ~L~l~~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 157 HLFLHGNRISSVPERA-------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp EEECCSSCCCEECTTT-------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcccccCHHH-------------------------hcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 9999999999655554 566799999999999999888999999999999999999
Q ss_pred cCCCCCccccccc-cCCeEeCCCCcCCC
Q 002149 286 QFVGLIPPSLASL-SLDHLDLNNNMFMG 312 (959)
Q Consensus 286 ~l~~~~p~~~~~~-~L~~L~L~~N~l~~ 312 (959)
++++.++..+..+ +|+.|+|++|++..
T Consensus 212 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 212 NLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp CCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred cCCcCCHHHcccCcccCEEeccCCCccC
Confidence 9999888878877 59999999998875
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.3e-27 Score=256.04 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=172.1
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
+.++++++.++..+..+. ++|++|+|++|+|+.++...|.++++|++|+|++|+++... ..+..+..+++|++|++
T Consensus 10 ~~l~c~~~~l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG--CCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE--EEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCcccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc--CcccccccccccCEEEC
Confidence 468899999987776553 68999999999999999999999999999999999886321 11333344445555555
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
++|++.. +|..+..+++|++|+++ +|++++
T Consensus 86 s~n~i~~-l~~~~~~l~~L~~L~l~-------------------------------------------------~n~l~~ 115 (306)
T 2z66_A 86 SFNGVIT-MSSNFLGLEQLEHLDFQ-------------------------------------------------HSNLKQ 115 (306)
T ss_dssp CSCSEEE-EEEEEETCTTCCEEECT-------------------------------------------------TSEEES
T ss_pred CCCcccc-ChhhcCCCCCCCEEECC-------------------------------------------------CCcccc
Confidence 5554442 33334444444444444 444443
Q ss_pred cCc-hhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC-CCCcccccccccccCcccCCCCCCCCchhh
Q 002149 266 TIP-ESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG-PVPKSKAYKYSYSSNAFCQPTEGVPCAPEV 342 (959)
Q Consensus 266 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~-~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (959)
..+ ..+..+++|++|+|++|++++..+..+..+ +|+.|+|++|.+++ .+|.
T Consensus 116 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------------------- 169 (306)
T 2z66_A 116 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD-------------------------- 169 (306)
T ss_dssp STTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECS--------------------------
T ss_pred cccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchh--------------------------
Confidence 322 344444555555555555544444444443 35555555555443 1221
Q ss_pred HHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCC
Q 002149 343 MALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPT 422 (959)
Q Consensus 343 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 422 (959)
.++.+++|+.|+|++|++++..|..+.++++|++|+|++|++++..+.
T Consensus 170 --------------------------------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 217 (306)
T 2z66_A 170 --------------------------------IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217 (306)
T ss_dssp --------------------------------CCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSG
T ss_pred --------------------------------HHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChh
Confidence 123457899999999999988899999999999999999999987777
Q ss_pred CccCCCCCCeEeCCCCccCCCCCC----C-CCcceecccCCCCCCCC
Q 002149 423 NWTNLKSLTLLDLSQNNLSPPLPK----F-SGAVKLSLDGNPLLNGK 464 (959)
Q Consensus 423 ~l~~l~~L~~L~Ls~N~l~~~~p~----~-~~~~~~~l~~N~~~c~~ 464 (959)
.+..+++|+.|+|++|++++.+|. + .++..+++.+|++.|..
T Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 899999999999999999988774 2 36778999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-28 Score=285.54 Aligned_cols=185 Identities=20% Similarity=0.154 Sum_probs=131.0
Q ss_pred cccccCceEEEEE-EEcCCcEEEEEEcccccc--------cHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEEE
Q 002149 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVI--------SKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 618 ~lG~G~fg~V~~~-~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 687 (959)
..+.|++|.+..+ +...|+.+|||.+.+... .....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3566777766665 344689999999875421 123456799999999999 699999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||++|++|.+++... .+++.. +|+.||+.||+|+|+ +|||||||||+|||++.++++||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999542 456654 589999999999999 89999999999999999999999999999866
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCC
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL 815 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~ 815 (959)
..... .....+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 54332 2345689999999999865 4677899999999988876653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=265.02 Aligned_cols=247 Identities=25% Similarity=0.291 Sum_probs=174.6
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
....++.+++.++..+..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|+.
T Consensus 55 ~~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------------------- 113 (452)
T 3zyi_A 55 QFSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ------------------- 113 (452)
T ss_dssp SSCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE-------------------
T ss_pred CCcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC-------------------
Confidence 35678888888887665554 578888888888888888888888888888888887764
Q ss_pred cccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccc
Q 002149 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l 263 (959)
..+..|.++++|++|+|++|+|++..+.. +.++++|++|+|++|++
T Consensus 114 ---------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l 159 (452)
T 3zyi_A 114 ---------IEVGAFNGLASLNTLELFDNWLTVIPSGA-------------------------FEYLSKLRELWLRNNPI 159 (452)
T ss_dssp ---------ECTTTTTTCTTCCEEECCSSCCSBCCTTT-------------------------SSSCTTCCEEECCSCCC
T ss_pred ---------cChhhccCcccCCEEECCCCcCCccChhh-------------------------hcccCCCCEEECCCCCc
Confidence 22344445555555555555555333333 23345555555555555
Q ss_pred cccCchhhcCCCCCCEEeCCC-CcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchh
Q 002149 264 SGTIPESFGKLTSLKDLNLNS-NQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPE 341 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (959)
++..+..|..+++|++|+|++ |.+....+..|..+ +|+.|+|++|.+++. |.
T Consensus 160 ~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~------------------------- 213 (452)
T 3zyi_A 160 ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PN------------------------- 213 (452)
T ss_dssp CEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CC-------------------------
T ss_pred ceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-cc-------------------------
Confidence 544444555555555555555 33333333344444 355666666655431 21
Q ss_pred hHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccC
Q 002149 342 VMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP 421 (959)
Q Consensus 342 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 421 (959)
+..+++|+.|+|++|+|.+..|..|.++++|+.|+|++|++++..|
T Consensus 214 ----------------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 214 ----------------------------------LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp ----------------------------------CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred ----------------------------------ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence 1234789999999999999999999999999999999999999999
Q ss_pred CCccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCCCCC
Q 002149 422 TNWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 422 ~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c~~~ 465 (959)
..|.++++|+.|+|++|+|++.++. +.++..+.+.+|||.|...
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999999999999999987664 3567789999999999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=259.00 Aligned_cols=258 Identities=18% Similarity=0.221 Sum_probs=214.6
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|+++++++++..+..+.++++|++|+|++|.+++..+ .|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 479999999999997766789999999999999999999887 6999999999999999999999999999999999999
Q ss_pred cCcccCCCCCCCCCc--cccCccccCeecccccc-cCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccc
Q 002149 158 DSNNFNASKGWSFPK--GLQSSAQLTNLSCMSCN-LAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLND 234 (959)
Q Consensus 158 s~N~l~~~~~~~lp~--~l~~l~~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~ 234 (959)
++|+++. +|. .+..+++|++|++++|+ +....+..|.++++|++|++++|++++..|..
T Consensus 132 ~~n~l~~-----l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------- 193 (353)
T 2z80_A 132 LGNPYKT-----LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKS------------- 193 (353)
T ss_dssp TTCCCSS-----SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTT-------------
T ss_pred CCCCCcc-----cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHH-------------
Confidence 9999984 555 68899999999999994 77677789999999999999999999877776
Q ss_pred cCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc----cCCeEeCCCCcC
Q 002149 235 QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL----SLDHLDLNNNMF 310 (959)
Q Consensus 235 ~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~L~~L~L~~N~l 310 (959)
+.++++|++|+|++|+++...+..+..+++|++|+|++|++++..+..+... .++.++|++|.+
T Consensus 194 ------------l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l 261 (353)
T 2z80_A 194 ------------LKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261 (353)
T ss_dssp ------------TTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBC
T ss_pred ------------HhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccc
Confidence 4667899999999999984444455568999999999999998776655432 488888888887
Q ss_pred CCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCC
Q 002149 311 MGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNF 390 (959)
Q Consensus 311 ~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N 390 (959)
++. .+..+.. .++.+++|+.|+|++|
T Consensus 262 ~~~---------------------------~l~~l~~---------------------------~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 262 TDE---------------------------SLFQVMK---------------------------LLNQISGLLELEFSRN 287 (353)
T ss_dssp CHH---------------------------HHHHHHH---------------------------HHHTCTTCCEEECCSS
T ss_pred cCc---------------------------chhhhHH---------------------------HHhcccCCCEEECCCC
Confidence 641 0111111 1234589999999999
Q ss_pred cccccCCcc-ccCcCcCCEEeCcccccccccC
Q 002149 391 NLSGTLSPS-VGNLDSLTQIKLQSNNISGQIP 421 (959)
Q Consensus 391 ~l~~~~p~~-~~~l~~L~~L~L~~N~l~g~~p 421 (959)
+++ .+|.. |.++++|++|+|++|.+++..|
T Consensus 288 ~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 288 QLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 999 55555 6999999999999999986443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=264.98 Aligned_cols=195 Identities=18% Similarity=0.179 Sum_probs=111.4
Q ss_pred cCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEE
Q 002149 77 SNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155 (959)
Q Consensus 77 ~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 155 (959)
+..++...+++.+++...+...+..+++|++|+|++|.|++.++ .|.++++|++|+|++|+++.+++ |..+++|++|
T Consensus 8 ~g~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L 85 (317)
T 3o53_A 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85 (317)
T ss_dssp ETTEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEE
T ss_pred CcCceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEE
Confidence 33455566666666665555555666777777777777777665 57777777777777777776654 7777777777
Q ss_pred EccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccccccccc
Q 002149 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQ 235 (959)
Q Consensus 156 ~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~ 235 (959)
+|++|+++++ + ..++|+.|++++|++++..+.. +++|++|++++|++++..+..
T Consensus 86 ~Ls~n~l~~l-----~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~-------------- 139 (317)
T 3o53_A 86 DLNNNYVQEL-----L----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLD-------------- 139 (317)
T ss_dssp ECCSSEEEEE-----E----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBC--------------
T ss_pred ECcCCccccc-----c----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchh--------------
Confidence 7777777632 1 2245555555555555443322 345555555555555433333
Q ss_pred CCCCcccccccccCCcCCcEEEccCccccccCchhhc-CCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCC
Q 002149 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG-KLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFM 311 (959)
Q Consensus 236 ~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~ 311 (959)
+..+++|++|+|++|++++..+..+. .+++|++|+|++|+|++. +......+|+.|+|++|.++
T Consensus 140 -----------~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~ 204 (317)
T 3o53_A 140 -----------EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA 204 (317)
T ss_dssp -----------TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC
T ss_pred -----------hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC
Confidence 23345555555555555554444442 455555555555555543 21111113444444444444
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-27 Score=260.85 Aligned_cols=251 Identities=18% Similarity=0.213 Sum_probs=206.6
Q ss_pred ceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCC-CCCC-Ccc-------CCCCccEEecCCCCCCC-CC
Q 002149 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFR-GELP-SFS-------GLSNLKYAYLDGNNFDT-IP 142 (959)
Q Consensus 73 gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~-~~~~-~~~-------~l~~L~~L~L~~N~l~~-i~ 142 (959)
.+.|...+++.+++.++.+ .+|..+... |+.|+|++|.+. ...+ .+. ++++|++|+|++|+|++ +|
T Consensus 37 ~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 112 (312)
T 1wwl_A 37 ELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112 (312)
T ss_dssp EEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred EEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence 3567777888999999999 788877665 999999999994 3444 343 79999999999999996 55
Q ss_pred hhhh-cCCCCCcEEEccCcccCCCCCCCCCccccCc-----cccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC
Q 002149 143 ADFF-DGLENLQVLALDSNNFNASKGWSFPKGLQSS-----AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216 (959)
Q Consensus 143 ~~~~-~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l-----~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 216 (959)
...| ..+++|++|+|++|++++ +|..+..+ ++|++|++++|++.+..|..|+.+++|++|+|++|++.+
T Consensus 113 ~~~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 113 PPLLEATGPDLNILNLRNVSWAT-----RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187 (312)
T ss_dssp CCSSSCCSCCCSEEEEESCBCSS-----SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred HHHHHhcCCCccEEEccCCCCcc-----hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence 4433 899999999999999985 46667776 899999999999999988999999999999999999875
Q ss_pred CC--CcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc--cCc-hhhcCCCCCCEEeCCCCcCCCCC
Q 002149 217 PI--PESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG--TIP-ESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 217 ~~--p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
.+ +..+. +.++++|++|+|++|++++ .++ ..+..+++|++|+|++|+|++.+
T Consensus 188 ~~~~~~~~~-----------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 188 ERGLISALC-----------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp HHHHHHHSC-----------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred chHHHHHHH-----------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 42 22211 3678999999999999983 223 45568899999999999999987
Q ss_pred c-cccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCC
Q 002149 292 P-PSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369 (959)
Q Consensus 292 p-~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 369 (959)
| ..+..+ +|+.|+|++|.++ .+|..
T Consensus 245 ~~~~~~~l~~L~~L~Ls~N~l~-~ip~~---------------------------------------------------- 271 (312)
T 1wwl_A 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKG---------------------------------------------------- 271 (312)
T ss_dssp CCSCCCCCTTCCEEECTTSCCS-SCCSS----------------------------------------------------
T ss_pred chhhhhhcCCCCEEECCCCccC-hhhhh----------------------------------------------------
Confidence 5 444444 6999999999998 56641
Q ss_pred cccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccc
Q 002149 370 SWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418 (959)
Q Consensus 370 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 418 (959)
+. ++|+.|+|++|+|++. |. +..+++|++|+|++|.+++
T Consensus 272 ------~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 272 ------LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp ------CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred ------cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 01 6899999999999977 65 9999999999999999985
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=269.77 Aligned_cols=237 Identities=19% Similarity=0.191 Sum_probs=151.3
Q ss_pred CCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccC
Q 002149 103 SKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLT 181 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~ 181 (959)
++|++|+|++|.|++.+| .|.++++|++|+|++|.|+++++ |..+++|++|+|++|.|++ +|
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-----l~---------- 96 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LL---------- 96 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-----EE----------
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-----CC----------
Confidence 366777777777766655 46666667777777766665554 6666666666666666653 11
Q ss_pred eecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCc
Q 002149 182 NLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261 (959)
Q Consensus 182 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N 261 (959)
..++|+.|+|++|.+++..+.. +++|++|+|++|
T Consensus 97 ------------------~~~~L~~L~L~~N~l~~~~~~~----------------------------l~~L~~L~L~~N 130 (487)
T 3oja_A 97 ------------------VGPSIETLHAANNNISRVSCSR----------------------------GQGKKNIYLANN 130 (487)
T ss_dssp ------------------ECTTCCEEECCSSCCCCEEECC----------------------------CSSCEEEECCSS
T ss_pred ------------------CCCCcCEEECcCCcCCCCCccc----------------------------cCCCCEEECCCC
Confidence 1255666666666665433221 245666666666
Q ss_pred cccccCchhhcCCCCCCEEeCCCCcCCCCCccccc-cc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCc
Q 002149 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA-SL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCA 339 (959)
Q Consensus 262 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~ 339 (959)
.+++..|..|+.+++|++|+|++|.|++.+|..+. .+ +|+.|+|++|.+++..+
T Consensus 131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~------------------------ 186 (487)
T 3oja_A 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG------------------------ 186 (487)
T ss_dssp CCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC------------------------
T ss_pred CCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc------------------------
Confidence 66666666666666666666666666665555554 33 46666666666654211
Q ss_pred hhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccc
Q 002149 340 PEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQ 419 (959)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~ 419 (959)
...+++|+.|+|++|+|++..| .+..+++|+.|+|++|.|++
T Consensus 187 ------------------------------------~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~- 228 (487)
T 3oja_A 187 ------------------------------------QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL- 228 (487)
T ss_dssp ------------------------------------CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-
T ss_pred ------------------------------------cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-
Confidence 0124678888888888886444 48888888888888888884
Q ss_pred cCCCccCCCCCCeEeCCCCccC-CCCCCC----CCcceeccc-------CCCCCCCC
Q 002149 420 IPTNWTNLKSLTLLDLSQNNLS-PPLPKF----SGAVKLSLD-------GNPLLNGK 464 (959)
Q Consensus 420 ~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~----~~~~~~~l~-------~N~~~c~~ 464 (959)
+|..+..+++|+.|+|++|++. +.+|.+ ..+..+.+. +|++.|..
T Consensus 229 lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~ 285 (487)
T 3oja_A 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285 (487)
T ss_dssp ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSS
T ss_pred cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccC
Confidence 7778888888888888888887 444432 222333443 67777764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-25 Score=234.32 Aligned_cols=216 Identities=26% Similarity=0.372 Sum_probs=190.9
Q ss_pred CCCCCCCCCcceEecC-CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCC
Q 002149 63 GDPCGPPCWKHVFCSN-SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDT 140 (959)
Q Consensus 63 ~~~C~~~~w~gv~C~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~ 140 (959)
++.|. |.|+.|.. ..++.|++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.
T Consensus 2 ~~~C~---~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 75 (270)
T 2o6q_A 2 EALCK---KDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT 75 (270)
T ss_dssp CCCBG---GGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC
T ss_pred CccCC---CCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe
Confidence 46676 99888764 35778999999999 5777665 689999999999999887 69999999999999999999
Q ss_pred CChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCc
Q 002149 141 IPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE 220 (959)
Q Consensus 141 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 220 (959)
+++..|.++++|++|+|++|+++.+ .+..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 76 i~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 151 (270)
T 2o6q_A 76 LPAGIFKELKNLETLWVTDNKLQAL----PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG 151 (270)
T ss_dssp CCTTTTSSCTTCCEEECCSSCCCCC----CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred eChhhhcCCCCCCEEECCCCcCCcC----CHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh
Confidence 9999999999999999999999852 234568899999999999999998888999999999999999999966555
Q ss_pred ccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-c
Q 002149 221 SFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-S 299 (959)
Q Consensus 221 ~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~ 299 (959)
. +..+++|++|+|++|++++..+..|..+++|++|+|++|+|++.++..+..+ +
T Consensus 152 ~-------------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 206 (270)
T 2o6q_A 152 V-------------------------FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206 (270)
T ss_dssp T-------------------------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred H-------------------------ccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccC
Confidence 4 4667999999999999998777889999999999999999998888888877 6
Q ss_pred CCeEeCCCCcCCCC
Q 002149 300 LDHLDLNNNMFMGP 313 (959)
Q Consensus 300 L~~L~L~~N~l~~~ 313 (959)
|+.|+|++|++...
T Consensus 207 L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 207 LKMLQLQENPWDCT 220 (270)
T ss_dssp CCEEECCSSCBCCS
T ss_pred CCEEEecCCCeeCC
Confidence 99999999999754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.4e-26 Score=248.13 Aligned_cols=254 Identities=21% Similarity=0.204 Sum_probs=209.2
Q ss_pred CCcEEeccCCcCCCCCCC-ccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 104 KLENIGLQKNQFRGELPS-FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
+++.++++.+.+...+.. +..+++|++|+|++|+|+.+++..|.++++|++|+|++|++++ +++ +..+++|++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-----~~~-~~~l~~L~~ 84 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-----TLD-LESLSTLRT 84 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE-----EEE-ETTCTTCCE
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc-----chh-hhhcCCCCE
Confidence 345667888887655553 5678899999999999999999999999999999999999985 233 889999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|++++.. ..++|++|++++|++++..+.. +++|++|+|++|+
T Consensus 85 L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~----------------------------~~~L~~L~l~~N~ 131 (317)
T 3o53_A 85 LDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR----------------------------GQGKKNIYLANNK 131 (317)
T ss_dssp EECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC----------------------------CSSCEEEECCSSC
T ss_pred EECcCCcccccc-----CCCCcCEEECCCCccCCcCccc----------------------------cCCCCEEECCCCC
Confidence 999999998543 3489999999999998654332 4789999999999
Q ss_pred ccccCchhhcCCCCCCEEeCCCCcCCCCCccccc-cc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCch
Q 002149 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA-SL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 263 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (959)
+++..+..+..+++|++|+|++|++++..+..+. .+ +|+.|+|++|.+++. |.
T Consensus 132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~------------------------ 186 (317)
T 3o53_A 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG------------------------ 186 (317)
T ss_dssp CCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC------------------------
T ss_pred CCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc------------------------
Confidence 9988888999999999999999999988777764 44 699999999999753 11
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccccc
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
...+++|+.|+|++|++++. |..+..+++|++|+|++|+|+ .+
T Consensus 187 -----------------------------------~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l 229 (317)
T 3o53_A 187 -----------------------------------QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LI 229 (317)
T ss_dssp -----------------------------------CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EE
T ss_pred -----------------------------------ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-ch
Confidence 01247899999999999965 555999999999999999999 68
Q ss_pred CCCccCCCCCCeEeCCCCccC-CCCCC----CCCcceecccCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLS-PPLPK----FSGAVKLSLDGN 458 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~-~~~p~----~~~~~~~~l~~N 458 (959)
|..+..+++|+.|+|++|+++ +.+|. +..+..+.+.+|
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 999999999999999999998 55553 233444555544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=261.23 Aligned_cols=219 Identities=21% Similarity=0.206 Sum_probs=179.7
Q ss_pred CCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCC
Q 002149 124 GLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFAS 203 (959)
Q Consensus 124 ~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~ 203 (959)
.+++|++|+|++|+|+.+++..|..+++|++|+|++|.+++ ..| |..+++
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------------~~~--l~~l~~ 81 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE----------------------------TLD--LESLST 81 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE----------------------------EEE--CTTCTT
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC----------------------------Ccc--cccCCC
Confidence 34588999999999988888888888888888888887763 222 677899
Q ss_pred CCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCC
Q 002149 204 LQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLN 283 (959)
Q Consensus 204 L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 283 (959)
|++|+|++|.|++.. ..++|++|+|++|.|++..+. .+++|+.|+|+
T Consensus 82 L~~L~Ls~N~l~~l~------------------------------~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~ 128 (487)
T 3oja_A 82 LRTLDLNNNYVQELL------------------------------VGPSIETLHAANNNISRVSCS---RGQGKKNIYLA 128 (487)
T ss_dssp CCEEECCSSEEEEEE------------------------------ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECC
T ss_pred CCEEEecCCcCCCCC------------------------------CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECC
Confidence 999999999988422 127899999999999977664 46889999999
Q ss_pred CCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCccccccc
Q 002149 284 SNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW 362 (959)
Q Consensus 284 ~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 362 (959)
+|.|++.+|..+..+ +|+.|+|++|.+++.+|...
T Consensus 129 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-------------------------------------------- 164 (487)
T 3oja_A 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL-------------------------------------------- 164 (487)
T ss_dssp SSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGG--------------------------------------------
T ss_pred CCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHH--------------------------------------------
Confidence 999999989888877 69999999999997655321
Q ss_pred CCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCC
Q 002149 363 SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
.+.+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|.|++
T Consensus 165 -------------~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~ 228 (487)
T 3oja_A 165 -------------AASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL 228 (487)
T ss_dssp -------------GGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE
T ss_pred -------------hhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc
Confidence 1134789999999999997733 4469999999999999996 55569999999999999999997
Q ss_pred CCCCC---CCcceecccCCCCCCCCC
Q 002149 443 PLPKF---SGAVKLSLDGNPLLNGKS 465 (959)
Q Consensus 443 ~~p~~---~~~~~~~l~~N~~~c~~~ 465 (959)
.++.+ ..+..+++.+|++.|+..
T Consensus 229 lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 229 IEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp ECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred cchhhccCCCCCEEEcCCCCCcCcch
Confidence 54443 467789999999998754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-26 Score=264.43 Aligned_cols=186 Identities=17% Similarity=0.161 Sum_probs=146.7
Q ss_pred cccCcccccCceEEEEEEEcCCcEEEEEEcccccccH------HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK------KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
...+.||+|+||.||+|.. .++.+|+|+........ ...+.+.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 47889999865432221 1245689999999999999999777777777888999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999998843 45799999999999999 89999999999999999 9999999999977
Q ss_pred CCCCcce------eecccccccccccccccc--CCCCccchHHHHHHHHHHHHhCCCCC
Q 002149 768 PDSERSV------VTRLAGTFGYLAPEYAVT--GKITTKVDVFSFGVVLMELLTGLMAL 818 (959)
Q Consensus 768 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~ll~elltg~~p~ 818 (959)
....... .....||+.|||||++.. ..|+.+.|+||..+-..+-+.++.++
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5532211 235689999999999977 66888899999999888888776655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=231.14 Aligned_cols=158 Identities=26% Similarity=0.347 Sum_probs=121.1
Q ss_pred EecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccC
Q 002149 85 QVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 85 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 163 (959)
+..+.+++ .+|..+. ++|++|+|++|.+++.++ .|.++++|++|+|++|+++.+++..|.++++|++|+|++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33444444 4565553 478899999999988877 6888889999999999988888888888888888888888776
Q ss_pred CCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccc
Q 002149 164 ASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGT 243 (959)
Q Consensus 164 ~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~ 243 (959)
. ..+..|.++++|++|++++|++++..+..
T Consensus 90 ~----------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------- 119 (276)
T 2z62_A 90 S----------------------------LALGAFSGLSSLQKLVAVETNLASLENFP---------------------- 119 (276)
T ss_dssp E----------------------------ECTTTTTTCTTCCEEECTTSCCCCSTTCC----------------------
T ss_pred c----------------------------cChhhhcCCccccEEECCCCCccccCchh----------------------
Confidence 3 33456677788888888888887655544
Q ss_pred cccccCCcCCcEEEccCcccccc-CchhhcCCCCCCEEeCCCCcCCCCCccccccc
Q 002149 244 IDVLGNMDQLRTLWLHGNHFSGT-IPESFGKLTSLKDLNLNSNQFVGLIPPSLASL 298 (959)
Q Consensus 244 ~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 298 (959)
+.++++|++|+|++|++++. +|..|..+++|++|+|++|++++..+..+..+
T Consensus 120 ---~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 172 (276)
T 2z62_A 120 ---IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172 (276)
T ss_dssp ---CTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred ---cccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhh
Confidence 45668888888888888763 68888889999999999998887766665544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-24 Score=228.52 Aligned_cols=230 Identities=19% Similarity=0.208 Sum_probs=180.0
Q ss_pred EEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeeccc
Q 002149 107 NIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186 (959)
Q Consensus 107 ~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~ 186 (959)
.++.++..+...+..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+++.
T Consensus 11 ~~~c~~~~l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~---------------------- 66 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT---------------------- 66 (276)
T ss_dssp EEECTTSCCSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE----------------------
T ss_pred eEEecCCCccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc----------------------
Confidence 45566666665555443 468888888888888777777777778888777776653
Q ss_pred ccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc
Q 002149 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT 266 (959)
Q Consensus 187 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~ 266 (959)
..+..|..+++|++|+|++|++++..+.. +.++++|++|++++|++++.
T Consensus 67 ------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~l~~~ 115 (276)
T 2z62_A 67 ------IEDGAYQSLSHLSTLILTGNPIQSLALGA-------------------------FSGLSSLQKLVAVETNLASL 115 (276)
T ss_dssp ------ECTTTTTTCTTCCEEECTTCCCCEECTTT-------------------------TTTCTTCCEEECTTSCCCCS
T ss_pred ------cCHHHccCCcCCCEEECCCCccCccChhh-------------------------hcCCccccEEECCCCCcccc
Confidence 34556788999999999999999776665 56779999999999999987
Q ss_pred CchhhcCCCCCCEEeCCCCcCCCC-Cccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHH
Q 002149 267 IPESFGKLTSLKDLNLNSNQFVGL-IPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMA 344 (959)
Q Consensus 267 ~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (959)
.+..+..+++|++|+|++|++++. +|..+..+ +|+.|+|++|++++..+.... .
T Consensus 116 ~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------------------~ 171 (276)
T 2z62_A 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR------------------------V 171 (276)
T ss_dssp TTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGH------------------------H
T ss_pred CchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhh------------------------h
Confidence 777899999999999999999975 58888887 699999999999864332100 0
Q ss_pred HHhhccCCCCCcccccccCCCCCCCcccccccCCCCccc-EEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT-VLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 345 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
+..++.|. .|+|++|++.+..+..+.. .+|++|+|++|+|++..+..
T Consensus 172 -------------------------------l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~ 219 (276)
T 2z62_A 172 -------------------------------LHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGI 219 (276)
T ss_dssp -------------------------------HHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTT
T ss_pred -------------------------------hhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhH
Confidence 01123333 8999999999766665544 58999999999999766667
Q ss_pred ccCCCCCCeEeCCCCccCCCCCCC
Q 002149 424 WTNLKSLTLLDLSQNNLSPPLPKF 447 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~l~~~~p~~ 447 (959)
|..+++|+.|+|++|++++..|..
T Consensus 220 ~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 220 FDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp TTTCCSCCEEECCSSCBCCCTTTT
T ss_pred hcccccccEEEccCCcccccCCch
Confidence 899999999999999999877653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-23 Score=243.86 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=189.3
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
.+++.|++++|.|+.++..+. ++|++|+|++|+|+.+|. .+++|++|+|++|+|+. +|. .+++|++
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~-----lp~---~l~~L~~ 105 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS-----LPV---LPPGLLE 105 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC-----CCC---CCTTCCE
T ss_pred CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc-----CCC---CCCCCCE
Confidence 468999999999997666665 899999999999999987 57999999999999984 555 6789999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|++++. |. .+++|+.|+|++|+|++ +|..+ .++..|.+.++....++. .+++|+.|+|++|+
T Consensus 106 L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~~l--~~L~~L~Ls~N~l~~l~~------~~~~L~~L~L~~N~ 172 (622)
T 3g06_A 106 LSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPVLP--PGLQELSVSDNQLASLPA------LPSELCKLWAYNNQ 172 (622)
T ss_dssp EEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSCCCC------CCTTCCEEECCSSC
T ss_pred EECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCCCC--CCCCEEECcCCcCCCcCC------ccCCCCEEECCCCC
Confidence 99999999964 44 57899999999999995 55443 234445544444333322 23556666666666
Q ss_pred ccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhh
Q 002149 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEV 342 (959)
Q Consensus 263 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (959)
|++ +| ..+++|+.|+|++|+|++. |..+ .+|+.|++++|.++. +|.
T Consensus 173 l~~-l~---~~~~~L~~L~Ls~N~l~~l-~~~~--~~L~~L~L~~N~l~~-l~~-------------------------- 218 (622)
T 3g06_A 173 LTS-LP---MLPSGLQELSVSDNQLASL-PTLP--SELYKLWAYNNRLTS-LPA-------------------------- 218 (622)
T ss_dssp CSC-CC---CCCTTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCSS-CCC--------------------------
T ss_pred CCC-Cc---ccCCCCcEEECCCCCCCCC-CCcc--chhhEEECcCCcccc-cCC--------------------------
Confidence 663 44 3456666666666666643 2221 246666666666652 221
Q ss_pred HHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCC
Q 002149 343 MALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPT 422 (959)
Q Consensus 343 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 422 (959)
.+++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|.
T Consensus 219 -----------------------------------~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~ 258 (622)
T 3g06_A 219 -----------------------------------LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM 258 (622)
T ss_dssp -----------------------------------CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC
T ss_pred -----------------------------------CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc
Confidence 13689999999999996 55 55689999999999999 6776
Q ss_pred CccCCCCCCeEeCCCCccCCCCCC----CCCcceecccCCCCCC
Q 002149 423 NWTNLKSLTLLDLSQNNLSPPLPK----FSGAVKLSLDGNPLLN 462 (959)
Q Consensus 423 ~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~~~~~l~~N~~~c 462 (959)
.+++|+.|+|++|+|+ .+|. +.++..+++.+|++..
T Consensus 259 ---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 259 ---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp ---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCH
T ss_pred ---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCC
Confidence 6789999999999999 4553 4567789999998763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-27 Score=271.12 Aligned_cols=347 Identities=18% Similarity=0.154 Sum_probs=198.3
Q ss_pred CcEEEEEecCCcccc----cCcccccCCCCCcEEeccCCcCCCCCC-Cc-cCCC----CccEEecCCCCCCCC----Chh
Q 002149 79 SRVTQIQVSSVGLKG----TLPQNLNQLSKLENIGLQKNQFRGELP-SF-SGLS----NLKYAYLDGNNFDTI----PAD 144 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~-~~l~----~L~~L~L~~N~l~~i----~~~ 144 (959)
.+++.|++++++++. .++..+..+++|++|+|++|.++...+ .+ ..++ +|++|+|++|+|+.. .+.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 356677777777663 345666777777777777777765332 22 2333 577777777777642 255
Q ss_pred hhcCCCCCcEEEccCcccCCCCCCCCCccc-cCccccCeecccccccCCCC----ChhhcCCCCCCEEEecCCcCCCCCC
Q 002149 145 FFDGLENLQVLALDSNNFNASKGWSFPKGL-QSSAQLTNLSCMSCNLAGQL----PDFLGNFASLQNLKLSGNNLTGPIP 219 (959)
Q Consensus 145 ~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l-~~l~~L~~L~l~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~p 219 (959)
.|..+++|++|+|++|.++......+...+ ...++|++|++++|++++.. +..+..+++|++|+|++|.++...+
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 567777777777777776532111122221 22456777777777776532 4555566777777777777664333
Q ss_pred ccccc------CCcccccccccCCCCcc--cccccccCCcCCcEEEccCccccccC-----chhhcCCCCCCEEeCCCCc
Q 002149 220 ESFKG------LNLVNLWLNDQKGGGFT--GTIDVLGNMDQLRTLWLHGNHFSGTI-----PESFGKLTSLKDLNLNSNQ 286 (959)
Q Consensus 220 ~~~~~------l~l~~L~~~~~~~~~l~--~~~~~l~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~ 286 (959)
..+.. -+++.|.+.++...... .....+..+++|++|+|++|++++.. +..+..+++|++|+|++|+
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 32211 14444554444332211 11234556677777777777776432 2223346777777777777
Q ss_pred CCCC----Cccccccc-cCCeEeCCCCcCCCCCCcc----------cccccccccCcccCCCCCCCCchhhHHHHhhccC
Q 002149 287 FVGL----IPPSLASL-SLDHLDLNNNMFMGPVPKS----------KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGG 351 (959)
Q Consensus 287 l~~~----~p~~~~~~-~L~~L~L~~N~l~~~ip~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (959)
++.. ++..+..+ +|+.|+|++|.+++..+.. ....+.+++|.+... ....
T Consensus 268 l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~--------~~~~------- 332 (461)
T 1z7x_W 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA--------CCSH------- 332 (461)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG--------GHHH-------
T ss_pred CCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchH--------HHHH-------
Confidence 7654 34444444 4777777777765321110 001111111111100 0000
Q ss_pred CCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccC-----cCcCCEEeCccccccc----ccCC
Q 002149 352 LNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGN-----LDSLTQIKLQSNNISG----QIPT 422 (959)
Q Consensus 352 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~g----~~p~ 422 (959)
+...+..+++|+.|+|++|++.+..+..+.. .++|++|+|++|++++ .+|.
T Consensus 333 --------------------l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 392 (461)
T 1z7x_W 333 --------------------FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392 (461)
T ss_dssp --------------------HHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred --------------------HHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence 0111223478888888888887765554443 5688888888888886 6787
Q ss_pred CccCCCCCCeEeCCCCccCCC--------CCC-CCCcceecccCCCC
Q 002149 423 NWTNLKSLTLLDLSQNNLSPP--------LPK-FSGAVKLSLDGNPL 460 (959)
Q Consensus 423 ~l~~l~~L~~L~Ls~N~l~~~--------~p~-~~~~~~~~l~~N~~ 460 (959)
.+..+++|+.|+|++|++++. +|. ...+..+.+.++.+
T Consensus 393 ~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~ 439 (461)
T 1z7x_W 393 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439 (461)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred HHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeeccccc
Confidence 888888888888888888743 332 23455566655544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-23 Score=218.34 Aligned_cols=204 Identities=21% Similarity=0.300 Sum_probs=132.5
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
+++.+++++|.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+++.
T Consensus 17 ~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------------------- 75 (270)
T 2o6q_A 17 NKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT------------------- 75 (270)
T ss_dssp TTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC-------------------
T ss_pred CCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe-------------------
Confidence 45667777777776544443 466777777777777766666666677777666666542
Q ss_pred cccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccc
Q 002149 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l 263 (959)
..+..|..+++|++|+|++|++++..+.. +.++++|++|+|++|++
T Consensus 76 ---------i~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------------------~~~l~~L~~L~l~~n~l 121 (270)
T 2o6q_A 76 ---------LPAGIFKELKNLETLWVTDNKLQALPIGV-------------------------FDQLVNLAELRLDRNQL 121 (270)
T ss_dssp ---------CCTTTTSSCTTCCEEECCSSCCCCCCTTT-------------------------TTTCSSCCEEECCSSCC
T ss_pred ---------eChhhhcCCCCCCEEECCCCcCCcCCHhH-------------------------cccccCCCEEECCCCcc
Confidence 22334456667777777777766544433 34556677777777777
Q ss_pred cccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhH
Q 002149 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
++..+..|..+++|++|+|++|+|++..+..|.
T Consensus 122 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~----------------------------------------------- 154 (270)
T 2o6q_A 122 KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFD----------------------------------------------- 154 (270)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT-----------------------------------------------
T ss_pred CeeCHHHhCcCcCCCEEECCCCcCCccCHhHcc-----------------------------------------------
Confidence 666666666677777777777766654433332
Q ss_pred HHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
.+++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..
T Consensus 155 ----------------------------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 200 (270)
T 2o6q_A 155 ----------------------------------KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200 (270)
T ss_dssp ----------------------------------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ----------------------------------CCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHH
Confidence 2356667777777776666666777788888888888887655556
Q ss_pred ccCCCCCCeEeCCCCccCCC
Q 002149 424 WTNLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~l~~~ 443 (959)
|..+++|+.|+|++|++...
T Consensus 201 ~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 201 FDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTCTTCCEEECCSSCBCCS
T ss_pred hccccCCCEEEecCCCeeCC
Confidence 77788888888777766543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-26 Score=269.56 Aligned_cols=348 Identities=15% Similarity=0.132 Sum_probs=246.6
Q ss_pred cEEEEEecCCcccccCccc-ccCCCCCcEEeccCCcCCCC----CC-CccCCCCccEEecCCCCCCCCCh-hhhcCCC--
Q 002149 80 RVTQIQVSSVGLKGTLPQN-LNQLSKLENIGLQKNQFRGE----LP-SFSGLSNLKYAYLDGNNFDTIPA-DFFDGLE-- 150 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~-l~~l~~L~~L~Ls~N~l~~~----~~-~~~~l~~L~~L~L~~N~l~~i~~-~~~~~l~-- 150 (959)
+++.|+|++++++...... +..+++|++|+|++|.++.. ++ .+..+++|++|+|++|+++.... ..+..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 6889999999998654443 88899999999999999853 22 57888999999999999986443 3344566
Q ss_pred --CCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhc-----CCCCCCEEEecCCcCCCCC----C
Q 002149 151 --NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLG-----NFASLQNLKLSGNNLTGPI----P 219 (959)
Q Consensus 151 --~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~~----p 219 (959)
+|++|+|++|+++......++..+..+++|++|++++|.+....+..+. ..++|++|+|++|++++.. +
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 7999999999998543345688899999999999999999865444433 3568999999999998744 3
Q ss_pred cccccC-CcccccccccCCCCccc--ccccc-cCCcCCcEEEccCcccccc----CchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 220 ESFKGL-NLVNLWLNDQKGGGFTG--TIDVL-GNMDQLRTLWLHGNHFSGT----IPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 220 ~~~~~l-~l~~L~~~~~~~~~l~~--~~~~l-~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
..+..+ +++.|.+.++....... ....+ ..+++|++|+|++|.+++. ++..+..+++|++|+|++|+++...
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 333332 56666666554322111 00111 1356999999999999964 6888889999999999999998653
Q ss_pred cc-----ccccc-cCCeEeCCCCcCCCC----CCcc-----cccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCc
Q 002149 292 PP-----SLASL-SLDHLDLNNNMFMGP----VPKS-----KAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPP 356 (959)
Q Consensus 292 p~-----~~~~~-~L~~L~L~~N~l~~~----ip~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (959)
.. .+... +|+.|+|++|.+++. ++.. ....+.+++|.+... ....+.
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~--------~~~~l~---------- 305 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE--------GARLLC---------- 305 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH--------HHHHHH----------
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH--------HHHHHH----------
Confidence 22 22223 699999999999853 2221 011122233322100 000000
Q ss_pred ccccccCCCCCCCcccccccCCCCcccEEECCCCccccc----CCccccCcCcCCEEeCcccccccccCCCccC-----C
Q 002149 357 RLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT----LSPSVGNLDSLTQIKLQSNNISGQIPTNWTN-----L 427 (959)
Q Consensus 357 ~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~-----l 427 (959)
.......++|+.|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.. +
T Consensus 306 ----------------~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~ 369 (461)
T 1z7x_W 306 ----------------ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369 (461)
T ss_dssp ----------------HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred ----------------HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCC
Confidence 00011236899999999999876 5667778899999999999998766655543 6
Q ss_pred CCCCeEeCCCCccCC----CCCC----CCCcceecccCCCCC
Q 002149 428 KSLTLLDLSQNNLSP----PLPK----FSGAVKLSLDGNPLL 461 (959)
Q Consensus 428 ~~L~~L~Ls~N~l~~----~~p~----~~~~~~~~l~~N~~~ 461 (959)
++|+.|+|++|++++ .+|. ...+..+++.+|++.
T Consensus 370 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 799999999999985 4443 467888999998654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-24 Score=228.70 Aligned_cols=223 Identities=21% Similarity=0.229 Sum_probs=125.2
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
.+..+++..+.+.... .+..+++|+.|++++|.++.++. +..+++|++|+|++|.+++ + ..+..+++|++|
T Consensus 20 ~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~-----~-~~l~~l~~L~~L 90 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD-----I-SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCC-----C-GGGTTCTTCCEE
T ss_pred HHHHHHhcCccccccc-ccccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCC-----c-hhhcCCCCCCEE
Confidence 3444555555554332 34556667777777777666553 5666777777777776653 1 133334444444
Q ss_pred cccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccc
Q 002149 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l 263 (959)
++++|++++..+..|..+++|++|+|++|++++..+.. +.++++|++|+|++|++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~L~~n~l 145 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGV-------------------------FDKLTNLTYLNLAHNQL 145 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHH-------------------------hccCCCCCEEECCCCcc
Confidence 44444444333444444445555555555444333332 23334444444444444
Q ss_pred cccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhH
Q 002149 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
++..+..|..+++|++|+|++|++++.++..+
T Consensus 146 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~------------------------------------------------ 177 (272)
T 3rfs_A 146 QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVF------------------------------------------------ 177 (272)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT------------------------------------------------
T ss_pred CccCHHHhccCccCCEEECCCCCcCccCHHHh------------------------------------------------
Confidence 44444444444444444444444443333222
Q ss_pred HHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
+.+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.+.
T Consensus 178 ---------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 220 (272)
T 3rfs_A 178 ---------------------------------DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 220 (272)
T ss_dssp ---------------------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC----
T ss_pred ---------------------------------cCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc----
Confidence 2346677777777777776676777788888888888877743
Q ss_pred ccCCCCCCeEeCCCCccCCCCCCCC
Q 002149 424 WTNLKSLTLLDLSQNNLSPPLPKFS 448 (959)
Q Consensus 424 l~~l~~L~~L~Ls~N~l~~~~p~~~ 448 (959)
+++|+.|+++.|.++|.+|...
T Consensus 221 ---~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 221 ---CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp ---TTTTHHHHHHHHHTGGGBBCTT
T ss_pred ---CcHHHHHHHHHHhCCCcccCcc
Confidence 4467888888888888887654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=224.43 Aligned_cols=180 Identities=24% Similarity=0.320 Sum_probs=139.2
Q ss_pred ccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcc
Q 002149 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~ 178 (959)
+..+++|+.|++++|.++. .+.+..+++|++|+|++|+++.++ .+..+++|++|+|++|.+++ ..+..+..++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-~~~l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~L~~n~l~~----~~~~~~~~l~ 109 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLHDIS--ALKELTNLTYLILTGNQLQS----LPNGVFDKLT 109 (272)
T ss_dssp HHHHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECTTSCCCC----CCTTTTTTCT
T ss_pred cccccceeeeeeCCCCccc-ccccccCCCCcEEECCCCCCCCch--hhcCCCCCCEEECCCCccCc----cChhHhcCCc
Confidence 5667788888888888764 346777888888888888888764 57788888888888888874 2334467788
Q ss_pred ccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 179 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
+|++|++++|++++..+..|..+++|++|+|++|++++..+.. +.++++|++|+|
T Consensus 110 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------------------------~~~l~~L~~L~l 164 (272)
T 3rfs_A 110 NLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGV-------------------------FDKLTNLTELDL 164 (272)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHH-------------------------hccCccCCEEEC
Confidence 8888888888888777778899999999999999998666654 456789999999
Q ss_pred cCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcC
Q 002149 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMF 310 (959)
Q Consensus 259 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l 310 (959)
++|++++..+..|..+++|++|+|++|++++.++..+..+ +|+.|+|++|.+
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 217 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCc
Confidence 9999998777888899999999999999998766555544 244444444443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=221.02 Aligned_cols=187 Identities=23% Similarity=0.340 Sum_probs=157.6
Q ss_pred CcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCC
Q 002149 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149 (959)
Q Consensus 71 w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 149 (959)
|.|+.|.. ..+.+++++++++ .+|..+. ++|++|+|++|.+.+..+ .|.++++|++|+|++|+|+.+++..|.++
T Consensus 7 ~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 82 (251)
T 3m19_A 7 VTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL 82 (251)
T ss_dssp HHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred CCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccC
Confidence 88999953 3456899999998 6777665 689999999999999888 69999999999999999999999999999
Q ss_pred CCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccc
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVN 229 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~ 229 (959)
++|++|+|++|+|+. ..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..
T Consensus 83 ~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------- 150 (251)
T 3m19_A 83 TELGTLGLANNQLAS----LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGA-------- 150 (251)
T ss_dssp TTCCEEECTTSCCCC----CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT--------
T ss_pred CcCCEEECCCCcccc----cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHH--------
Confidence 999999999999985 23355678888888888888888777777888888888888888888666555
Q ss_pred ccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCC
Q 002149 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL 290 (959)
Q Consensus 230 L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 290 (959)
+..+++|++|+|++|++++..+..|..+++|++|+|++|++...
T Consensus 151 -----------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 151 -----------------FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp -----------------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred -----------------cCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 45668888888888888877777888888888888888888866
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9e-23 Score=220.42 Aligned_cols=203 Identities=22% Similarity=0.252 Sum_probs=128.2
Q ss_pred ccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcc
Q 002149 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~ 178 (959)
+.++++|++|++++|.++.+++.+. ++|++|+|++|+|+.+++..|.++++|++|+|++|.|+.+ +
T Consensus 6 ~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----~------- 71 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-----Q------- 71 (290)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-----E-------
T ss_pred ccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-----c-------
Confidence 5666777777777777776655543 5677777777777777777777777777777777766531 1
Q ss_pred ccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 179 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
. .+.+++|+.|+|++|+|+ .+|.. +..+++|++|+|
T Consensus 72 -----------------~-~~~l~~L~~L~Ls~N~l~-~l~~~-------------------------~~~l~~L~~L~l 107 (290)
T 1p9a_G 72 -----------------V-DGTLPVLGTLDLSHNQLQ-SLPLL-------------------------GQTLPALTVLDV 107 (290)
T ss_dssp -----------------C-CSCCTTCCEEECCSSCCS-SCCCC-------------------------TTTCTTCCEEEC
T ss_pred -----------------C-CCCCCcCCEEECCCCcCC-cCchh-------------------------hccCCCCCEEEC
Confidence 0 134556666666666665 33333 344566666666
Q ss_pred cCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCC
Q 002149 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPC 338 (959)
Q Consensus 259 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~ 338 (959)
++|+|++..|..|..+++|++|+|++|+|++.++..|..
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----------------------------------------- 146 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP----------------------------------------- 146 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTT-----------------------------------------
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhccc-----------------------------------------
Confidence 666666555566666666666666666666544433322
Q ss_pred chhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccc
Q 002149 339 APEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418 (959)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 418 (959)
+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+
T Consensus 147 ----------------------------------------l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~- 185 (290)
T 1p9a_G 147 ----------------------------------------TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY- 185 (290)
T ss_dssp ----------------------------------------CTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred ----------------------------------------ccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-
Confidence 245666666666666444455666777777777777777
Q ss_pred ccCCCccCCCCCCeEeCCCCccC
Q 002149 419 QIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 419 ~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
.+|..+..+.+|+.|+|++|++.
T Consensus 186 ~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 186 TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccChhhcccccCCeEEeCCCCcc
Confidence 66766666666666666655543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-22 Score=218.06 Aligned_cols=199 Identities=23% Similarity=0.223 Sum_probs=177.2
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
..++.|++.+++++ .+|..+. ++|+.|+|++|.|++..+ .|.++++|++|+|++|+|+.++.. ..+++|++|+|
T Consensus 10 ~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEEC
T ss_pred CCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEEC
Confidence 57889999999998 6777665 689999999999998877 699999999999999999998764 78999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~ 237 (959)
++|+|+ .+|..+..+++|++|++++|++++..+..|..+++|+.|+|++|+|++..+..
T Consensus 85 s~N~l~-----~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~---------------- 143 (290)
T 1p9a_G 85 SHNQLQ-----SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL---------------- 143 (290)
T ss_dssp CSSCCS-----SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT----------------
T ss_pred CCCcCC-----cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhh----------------
Confidence 999998 57888899999999999999999888899999999999999999999766655
Q ss_pred CCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCC
Q 002149 238 GGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMG 312 (959)
Q Consensus 238 ~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~ 312 (959)
|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+..++..+...+|+.|+|++|++..
T Consensus 144 ---------~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 144 ---------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp ---------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ---------cccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccC
Confidence 456799999999999999766677889999999999999999665555555579999999999974
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=213.08 Aligned_cols=202 Identities=18% Similarity=0.284 Sum_probs=143.6
Q ss_pred cCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCC-CCCCChhhhcCCCCCcEEEccC-cccCCCCCCCC
Q 002149 94 TLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNN-FDTIPADFFDGLENLQVLALDS-NNFNASKGWSF 170 (959)
Q Consensus 94 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~-l~~i~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~l 170 (959)
.+|. +. ++|++|+|++|+|++.++ .|.++++|++|+|++|+ ++.+++..|.++++|++|+|++ |+++.
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~------ 95 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY------ 95 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE------
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE------
Confidence 5565 43 378899999999988877 68888888888888886 8888888888888888888887 77653
Q ss_pred CccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCC
Q 002149 171 PKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM 250 (959)
Q Consensus 171 p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l 250 (959)
..+..|.++++|++|+|++|++++ +|. | ..+
T Consensus 96 ----------------------i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~-------------------------~~l 126 (239)
T 2xwt_C 96 ----------------------IDPDALKELPLLKFLGIFNTGLKM-FPD-L-------------------------TKV 126 (239)
T ss_dssp ----------------------ECTTSEECCTTCCEEEEEEECCCS-CCC-C-------------------------TTC
T ss_pred ----------------------cCHHHhCCCCCCCEEeCCCCCCcc-ccc-c-------------------------ccc
Confidence 234456777788888888888775 443 3 233
Q ss_pred cCCc---EEEccCc-cccccCchhhcCCCCCC-EEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccc
Q 002149 251 DQLR---TLWLHGN-HFSGTIPESFGKLTSLK-DLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYS 325 (959)
Q Consensus 251 ~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~ 325 (959)
++|+ +|+|++| ++++..+..|..+++|+ +|+|++|+++...+..+..
T Consensus 127 ~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~---------------------------- 178 (239)
T 2xwt_C 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG---------------------------- 178 (239)
T ss_dssp CBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT----------------------------
T ss_pred cccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC----------------------------
Confidence 4444 8888888 78766666777788888 8888888777433222221
Q ss_pred cCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCc-ccccCCccccCc-
Q 002149 326 SNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN-LSGTLSPSVGNL- 403 (959)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l- 403 (959)
++|+.|+|++|+ +++..+..|.++
T Consensus 179 ------------------------------------------------------~~L~~L~L~~n~~l~~i~~~~~~~l~ 204 (239)
T 2xwt_C 179 ------------------------------------------------------TKLDAVYLNKNKYLTVIDKDAFGGVY 204 (239)
T ss_dssp ------------------------------------------------------CEEEEEECTTCTTCCEECTTTTTTCS
T ss_pred ------------------------------------------------------CCCCEEEcCCCCCcccCCHHHhhccc
Confidence 456777777774 665556667777
Q ss_pred CcCCEEeCcccccccccCCCccCCCCCCeEeCCCC
Q 002149 404 DSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438 (959)
Q Consensus 404 ~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N 438 (959)
++|+.|+|++|+|+ .+|.. .+++|+.|++++|
T Consensus 205 ~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 205 SGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp BCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred cCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 77888888888887 44544 5667777777765
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.5e-24 Score=237.57 Aligned_cols=184 Identities=15% Similarity=0.254 Sum_probs=123.4
Q ss_pred CcceEecCCcEEEEEecCCcccccCcccccCC--CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCC-Chhhhc
Q 002149 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQL--SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTI-PADFFD 147 (959)
Q Consensus 71 w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i-~~~~~~ 147 (959)
|.++.|+...++.++++++++. +..+..+ ++|+.|++++|.+.+.++.+.++++|++|+|++|.++.. .+..+.
T Consensus 39 W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~ 115 (336)
T 2ast_B 39 WYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILS 115 (336)
T ss_dssp HHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHT
T ss_pred HHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHh
Confidence 8888887777889999998877 5667777 899999999999999888888889999999999988754 455678
Q ss_pred CCCCCcEEEccCcccCCCCCCCCCccccCccccCeeccccc-ccCC-CCChhhcCCCCCCEEEecCC-cCCCC-CCcccc
Q 002149 148 GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSC-NLAG-QLPDFLGNFASLQNLKLSGN-NLTGP-IPESFK 223 (959)
Q Consensus 148 ~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n-~l~~-~~p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~ 223 (959)
.+++|++|+|++|.+++ ..+..+..+++|++|++++| .+++ .++..+..+++|++|+|++| .+++. ++..
T Consensus 116 ~~~~L~~L~L~~~~l~~----~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~-- 189 (336)
T 2ast_B 116 QCSKLQNLSLEGLRLSD----PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA-- 189 (336)
T ss_dssp TBCCCSEEECTTCBCCH----HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH--
T ss_pred hCCCCCEEeCcCcccCH----HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH--
Confidence 88888888888887764 34445555566666666665 4443 24444555556666666655 55421 1111
Q ss_pred cCCcccccccccCCCCcccccccccCCc-CCcEEEccCc--ccc-ccCchhhcCCCCCCEEeCCCCc
Q 002149 224 GLNLVNLWLNDQKGGGFTGTIDVLGNMD-QLRTLWLHGN--HFS-GTIPESFGKLTSLKDLNLNSNQ 286 (959)
Q Consensus 224 ~l~l~~L~~~~~~~~~l~~~~~~l~~l~-~L~~L~L~~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~ 286 (959)
+..++ +|++|+|++| .++ +.+|..+..+++|++|+|++|.
T Consensus 190 -----------------------~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~ 233 (336)
T 2ast_B 190 -----------------------VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 233 (336)
T ss_dssp -----------------------HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred -----------------------HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence 33345 5555555555 333 3345555555555555555555
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-24 Score=240.81 Aligned_cols=81 Identities=14% Similarity=0.141 Sum_probs=48.5
Q ss_pred EEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-----CccCCC-CccEEecCCCCCCCCChhhhcCC-----CCC
Q 002149 84 IQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-----SFSGLS-NLKYAYLDGNNFDTIPADFFDGL-----ENL 152 (959)
Q Consensus 84 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~-~L~~L~L~~N~l~~i~~~~~~~l-----~~L 152 (959)
.+++.++++|.+|..+...++|++|+|++|.|++..+ .|.+++ +|++|+|++|+|+......|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4556666666666666665566666666666665553 245555 56666666666666555545443 566
Q ss_pred cEEEccCcccCC
Q 002149 153 QVLALDSNNFNA 164 (959)
Q Consensus 153 ~~L~Ls~N~l~~ 164 (959)
++|+|++|+++.
T Consensus 83 ~~L~Ls~n~l~~ 94 (362)
T 3goz_A 83 TSLNLSGNFLSY 94 (362)
T ss_dssp CEEECCSSCGGG
T ss_pred cEEECcCCcCCh
Confidence 666666666553
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=213.00 Aligned_cols=197 Identities=17% Similarity=0.238 Sum_probs=171.1
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCc-CCCCCC-CccCCCCccEEecCC-CCCCCCChhhhcCCCCCcEE
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQ-FRGELP-SFSGLSNLKYAYLDG-NNFDTIPADFFDGLENLQVL 155 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~-l~~~~~-~~~~l~~L~~L~L~~-N~l~~i~~~~~~~l~~L~~L 155 (959)
..++.|+++++++++..+..+..+++|++|+|++|. ++.+++ .|.++++|++|+|++ |+|+.+++..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999997777789999999999999997 988887 699999999999999 99999999999999999999
Q ss_pred EccCcccCCCCCCCCCccccCccccC---eeccccc-ccCCCCChhhcCCCCCC-EEEecCCcCCCCCCcccccCCcccc
Q 002149 156 ALDSNNFNASKGWSFPKGLQSSAQLT---NLSCMSC-NLAGQLPDFLGNFASLQ-NLKLSGNNLTGPIPESFKGLNLVNL 230 (959)
Q Consensus 156 ~Ls~N~l~~~~~~~lp~~l~~l~~L~---~L~l~~n-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~l~~L 230 (959)
+|++|++++ +|. +..+++|+ .|++++| ++.+..+..|.++++|+ .|++++|+++ .+|...
T Consensus 111 ~l~~n~l~~-----lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~-------- 175 (239)
T 2xwt_C 111 GIFNTGLKM-----FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA-------- 175 (239)
T ss_dssp EEEEECCCS-----CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTT--------
T ss_pred eCCCCCCcc-----ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhh--------
Confidence 999999984 565 77888888 9999999 99988888899999999 9999999998 444431
Q ss_pred cccccCCCCcccccccccCCcCCcEEEccCcc-ccccCchhhcCC-CCCCEEeCCCCcCCCCCccccccccCCeEeCCCC
Q 002149 231 WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH-FSGTIPESFGKL-TSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNN 308 (959)
Q Consensus 231 ~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N 308 (959)
+.. ++|++|+|++|+ +++..+..|..+ ++|++|+|++|+|++.++..+. +|+.|+++++
T Consensus 176 ----------------~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~--~L~~L~l~~~ 236 (239)
T 2xwt_C 176 ----------------FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLE--HLKELIARNT 236 (239)
T ss_dssp ----------------TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCT--TCSEEECTTC
T ss_pred ----------------cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhc--cCceeeccCc
Confidence 233 789999999995 997777889999 9999999999999976555222 6889998876
Q ss_pred c
Q 002149 309 M 309 (959)
Q Consensus 309 ~ 309 (959)
.
T Consensus 237 ~ 237 (239)
T 2xwt_C 237 W 237 (239)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=222.88 Aligned_cols=228 Identities=18% Similarity=0.130 Sum_probs=162.3
Q ss_pred CCccEEecCCCCCCCCCh---hhhcCCCCCcEEEccCcccCCCCCCCCCccc--cCccccCeecccccccCCCCC----h
Q 002149 126 SNLKYAYLDGNNFDTIPA---DFFDGLENLQVLALDSNNFNASKGWSFPKGL--QSSAQLTNLSCMSCNLAGQLP----D 196 (959)
Q Consensus 126 ~~L~~L~L~~N~l~~i~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l--~~l~~L~~L~l~~n~l~~~~p----~ 196 (959)
..++.|.+.++.++...- ..+..+++|++|+|++|.+.+ ..|..+ ..+++|++|++++|++.+..+ .
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~----~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~ 139 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITG----TMPPLPLEATGLALSSLRLRNVSWATGRSWLAEL 139 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBS----CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHH
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEecc----chhhhhhhccCCCCCEEEeecccccchhhhhHHH
Confidence 346666776666542110 012234567777777777765 445555 677777777777777776555 3
Q ss_pred hhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc--Cc--hhhc
Q 002149 197 FLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT--IP--ESFG 272 (959)
Q Consensus 197 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~--~p--~~~~ 272 (959)
.+..+++|++|+|++|++++..+.. +.++++|++|+|++|++.+. ++ ..+.
T Consensus 140 ~~~~~~~L~~L~Ls~n~l~~~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 194 (310)
T 4glp_A 140 QQWLKPGLKVLSIAQAHSPAFSCEQ-------------------------VRAFPALTSLDLSDNPGLGERGLMAALCPH 194 (310)
T ss_dssp HTTBCSCCCEEEEECCSSCCCCTTS-------------------------CCCCTTCCEEECCSCTTCHHHHHHTTSCTT
T ss_pred HhhhccCCCEEEeeCCCcchhhHHH-------------------------hccCCCCCEEECCCCCCccchhhhHHHhhh
Confidence 4557889999999999998776665 45678899999999988653 22 3346
Q ss_pred CCCCCCEEeCCCCcCCCCCcc---ccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhh
Q 002149 273 KLTSLKDLNLNSNQFVGLIPP---SLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDF 348 (959)
Q Consensus 273 ~l~~L~~L~Ls~N~l~~~~p~---~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (959)
.+++|++|+|++|+++...+. .+..+ +|++|+|++|++++.+|....
T Consensus 195 ~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~----------------------------- 245 (310)
T 4glp_A 195 KFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP----------------------------- 245 (310)
T ss_dssp SSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS-----------------------------
T ss_pred cCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH-----------------------------
Confidence 788999999999998743221 23444 689999999999887664211
Q ss_pred ccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCC
Q 002149 349 LGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLK 428 (959)
Q Consensus 349 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~ 428 (959)
.+..+++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..++
T Consensus 246 --------------------------~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~ 294 (310)
T 4glp_A 246 --------------------------RCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELP 294 (310)
T ss_dssp --------------------------SCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCC
T ss_pred --------------------------hccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCC
Confidence 0112368999999999999 6777774 7999999999999953 44 68889
Q ss_pred CCCeEeCCCCccCC
Q 002149 429 SLTLLDLSQNNLSP 442 (959)
Q Consensus 429 ~L~~L~Ls~N~l~~ 442 (959)
+|+.|+|++|+|+.
T Consensus 295 ~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 295 EVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCEECSSTTTSC
T ss_pred CccEEECcCCCCCC
Confidence 99999999999874
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=214.03 Aligned_cols=61 Identities=16% Similarity=0.202 Sum_probs=39.9
Q ss_pred cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccC
Q 002149 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 163 (959)
.++++|++|++++|.+... +.+..+++|++|+|++|+++.+++ |..+++|++|+|++|+++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHcCCcCEEEeeCCCccCc-hhhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC
Confidence 3456666777777766643 356666667777777777666665 666666777777666665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.1e-22 Score=219.07 Aligned_cols=240 Identities=19% Similarity=0.202 Sum_probs=142.1
Q ss_pred EEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCC-CCChhhhcCCCCCcE-EEccCc
Q 002149 84 IQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFD-TIPADFFDGLENLQV-LALDSN 160 (959)
Q Consensus 84 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~-L~Ls~N 160 (959)
++.++++++ .+|..+ .++|++|+|++|+|+.+++ .|.++++|++|+|++|++. .+++.+|.++++|++ ++++.|
T Consensus 14 v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N 90 (350)
T 4ay9_X 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90 (350)
T ss_dssp EEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred EEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence 556666776 567655 2578888888888887776 5788888888888888874 467777777777664 455556
Q ss_pred ccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCc
Q 002149 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGF 240 (959)
Q Consensus 161 ~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l 240 (959)
+++. ..|..|..+++|++|++++|+++...+..+
T Consensus 91 ~l~~----------------------------l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~------------------ 124 (350)
T 4ay9_X 91 NLLY----------------------------INPEAFQNLPNLQYLLISNTGIKHLPDVHK------------------ 124 (350)
T ss_dssp TCCE----------------------------ECTTSBCCCTTCCEEEEEEECCSSCCCCTT------------------
T ss_pred cccc----------------------------cCchhhhhccccccccccccccccCCchhh------------------
Confidence 6653 334556666666666666666664443332
Q ss_pred ccccccccCCcCCcEEEccC-ccccccCchhhcCCC-CCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCccc
Q 002149 241 TGTIDVLGNMDQLRTLWLHG-NHFSGTIPESFGKLT-SLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSK 318 (959)
Q Consensus 241 ~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~ 318 (959)
....++..|++.+ |++....+..|..+. .++.|+|++|+|+.+.+..+...+|+.|++++|...+.+|..
T Consensus 125 -------~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~- 196 (350)
T 4ay9_X 125 -------IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPND- 196 (350)
T ss_dssp -------CCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTT-
T ss_pred -------cccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHH-
Confidence 2234455666644 445544444555543 466666777766665555555556666666543333333321
Q ss_pred ccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCc
Q 002149 319 AYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSP 398 (959)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 398 (959)
.++.+++|+.|+|++|+|+...+.
T Consensus 197 --------------------------------------------------------~f~~l~~L~~LdLs~N~l~~lp~~ 220 (350)
T 4ay9_X 197 --------------------------------------------------------VFHGASGPVILDISRTRIHSLPSY 220 (350)
T ss_dssp --------------------------------------------------------TTTTEECCSEEECTTSCCCCCCSS
T ss_pred --------------------------------------------------------HhccCcccchhhcCCCCcCccChh
Confidence 123346677777777777644333
Q ss_pred cccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCcc
Q 002149 399 SVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL 440 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l 440 (959)
.+. +|+.|.+.++.-...+| .+.++++|+.++++++.-
T Consensus 221 ~~~---~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 221 GLE---NLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp SCT---TCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred hhc---cchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 333 34444433333223556 366777777777766543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-22 Score=214.84 Aligned_cols=153 Identities=16% Similarity=0.074 Sum_probs=120.3
Q ss_pred HHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccH----------------HHHHHHHHHHHHHHhcCCC
Q 002149 606 LRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISK----------------KAVDEFHSEIAVLSKVRHR 669 (959)
Q Consensus 606 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~ 669 (959)
+......|.+.+.||+|+||.||+|...+|+.||||++....... .....+.+|+++++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 333345677889999999999999988789999999986432111 23567899999999999
Q ss_pred CceeEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 002149 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNIL 749 (959)
Q Consensus 670 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiL 749 (959)
| +++.+++.. ...++||||+++|+|.+ +.. .....++.|++.||+|||+ .+|+||||||+|||
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVL 225 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEE
Confidence 4 556555433 45699999999999987 411 1245799999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccccccCCCCCcceeecccccccccccccccc
Q 002149 750 LGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792 (959)
Q Consensus 750 l~~~~~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 792 (959)
++ ++.+||+|||+|+. +..|+|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999863 345788887643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.6e-24 Score=242.21 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=156.4
Q ss_pred cCcccccCCCCCcEEeccCCcCCCCCC-----CccCCCCccEEecCCCCCCCC----Chhh------hcCCCCCcEEEcc
Q 002149 94 TLPQNLNQLSKLENIGLQKNQFRGELP-----SFSGLSNLKYAYLDGNNFDTI----PADF------FDGLENLQVLALD 158 (959)
Q Consensus 94 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~i----~~~~------~~~l~~L~~L~Ls 158 (959)
.++..+..+++|++|+|++|.|+...+ .|..+++|++|+|++|.+..+ |... |..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455566666777777777777665422 255666666666666554432 2211 2455566666666
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|.|...... .+|..+..+++|++|+|++|.++...+..+...
T Consensus 103 ~n~l~~~~~~------------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~------------- 145 (386)
T 2ca6_A 103 DNAFGPTAQE------------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA------------- 145 (386)
T ss_dssp SCCCCTTTHH------------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-------------
T ss_pred CCcCCHHHHH------------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-------------
Confidence 5555431111 245566667777777777777653333222110
Q ss_pred CcccccccccCC---------cCCcEEEccCcccc-ccCc---hhhcCCCCCCEEeCCCCcCC--C---CCccccccc-c
Q 002149 239 GFTGTIDVLGNM---------DQLRTLWLHGNHFS-GTIP---ESFGKLTSLKDLNLNSNQFV--G---LIPPSLASL-S 299 (959)
Q Consensus 239 ~l~~~~~~l~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~~-~ 299 (959)
+..+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+|+ | ..+..+..+ +
T Consensus 146 --------l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~ 217 (386)
T 2ca6_A 146 --------LQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217 (386)
T ss_dssp --------HHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred --------HHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCC
Confidence 1222 67777777777776 3444 45667777777777777776 2 233344444 5
Q ss_pred CCeEeCCCCcCCC----CCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccc
Q 002149 300 LDHLDLNNNMFMG----PVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLS 375 (959)
Q Consensus 300 L~~L~L~~N~l~~----~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 375 (959)
|+.|+|++|.++. .+|. .
T Consensus 218 L~~L~Ls~n~l~~~g~~~l~~----------------------------------------------------------~ 239 (386)
T 2ca6_A 218 LKVLDLQDNTFTHLGSSALAI----------------------------------------------------------A 239 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHH----------------------------------------------------------H
T ss_pred ccEEECcCCCCCcHHHHHHHH----------------------------------------------------------H
Confidence 7777777777752 1111 1
Q ss_pred cCCCCcccEEECCCCccccc----CCccc--cCcCcCCEEeCccccccc----ccCCCc-cCCCCCCeEeCCCCccCCCC
Q 002149 376 CGTNSKLTVLNLPNFNLSGT----LSPSV--GNLDSLTQIKLQSNNISG----QIPTNW-TNLKSLTLLDLSQNNLSPPL 444 (959)
Q Consensus 376 ~~~~~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~L~~N~l~g----~~p~~l-~~l~~L~~L~Ls~N~l~~~~ 444 (959)
+..+++|+.|+|++|+|++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 22347788899999988876 56666 348999999999999997 488777 66899999999999998765
Q ss_pred C
Q 002149 445 P 445 (959)
Q Consensus 445 p 445 (959)
+
T Consensus 320 ~ 320 (386)
T 2ca6_A 320 D 320 (386)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6e-22 Score=216.69 Aligned_cols=205 Identities=18% Similarity=0.193 Sum_probs=167.5
Q ss_pred cEEEEEecCCcccccCcccc--cCCCCCcEEeccCCcCCCCCCC-----ccCCCCccEEecCCCCCCCCChhhhcCCCCC
Q 002149 80 RVTQIQVSSVGLKGTLPQNL--NQLSKLENIGLQKNQFRGELPS-----FSGLSNLKYAYLDGNNFDTIPADFFDGLENL 152 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~Ls~N~l~~~~~~-----~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 152 (959)
+++.|++++|.+++.+|..+ ..+++|++|+|++|.+++..+. +..+++|++|+|++|+|..+++..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 48999999999999999888 8999999999999999986552 4578999999999999999999999999999
Q ss_pred cEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCCh----hhcCCCCCCEEEecCCcCCCCCCcccccCCcc
Q 002149 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPD----FLGNFASLQNLKLSGNNLTGPIPESFKGLNLV 228 (959)
Q Consensus 153 ~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~ 228 (959)
++|+|++|++.+......+..+..+++|++|++++|+++. ++. .+..+++|++|+|++|++++..|..+..
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~---- 246 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR---- 246 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS----
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh----
Confidence 9999999987642111223334688899999999999973 232 3578899999999999999887776532
Q ss_pred cccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCC
Q 002149 229 NLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307 (959)
Q Consensus 229 ~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~ 307 (959)
+..+++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+ +|+.|+|++
T Consensus 247 ------------------~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~ 303 (310)
T 4glp_A 247 ------------------CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDG 303 (310)
T ss_dssp ------------------CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSS
T ss_pred ------------------ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcC
Confidence 233479999999999999 6787774 7999999999999975 33 4444 699999999
Q ss_pred CcCCC
Q 002149 308 NMFMG 312 (959)
Q Consensus 308 N~l~~ 312 (959)
|+++.
T Consensus 304 N~l~~ 308 (310)
T 4glp_A 304 NPFLV 308 (310)
T ss_dssp TTTSC
T ss_pred CCCCC
Confidence 99975
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=9.4e-21 Score=200.34 Aligned_cols=181 Identities=22% Similarity=0.295 Sum_probs=162.6
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
...++++++++.++..++.+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|++ ..+..+..+++|+.
T Consensus 14 ~~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~ 87 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT----LSAGVFDDLTELGT 87 (251)
T ss_dssp GGGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC----CCTTTTTTCTTCCE
T ss_pred CCCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc----cCHhHhccCCcCCE
Confidence 456789999999998777665 689999999999999999999999999999999999986 34556789999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|++++..+..|..+++|++|+|++|+|++..+.. +..+++|++|+|++|+
T Consensus 88 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------------------~~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 88 LGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGV-------------------------FDRLTKLKELRLNTNQ 142 (251)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEECCSSC
T ss_pred EECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhH-------------------------hccCCcccEEECcCCc
Confidence 999999999888889999999999999999999666654 4667999999999999
Q ss_pred ccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCC
Q 002149 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPV 314 (959)
Q Consensus 263 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~i 314 (959)
|++..+..|..+++|++|+|++|+|++.++..+..+ +|+.|+|++|++++..
T Consensus 143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~ 195 (251)
T 3m19_A 143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR 195 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence 997777789999999999999999999888888887 6999999999998753
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=209.83 Aligned_cols=212 Identities=23% Similarity=0.329 Sum_probs=122.2
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
..+.+..+.++... .+..+++|++|++++|+++.++ .+..+++|++|+|++|+++. ++. +..+++|+.|++
T Consensus 22 ~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~-----~~~-~~~l~~L~~L~L 92 (308)
T 1h6u_A 22 IKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD-----LAP-LKNLTKITELEL 92 (308)
T ss_dssp HHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-----CGG-GTTCCSCCEEEC
T ss_pred HHHHhCCCCcCcee-cHHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCC-----Chh-HccCCCCCEEEc
Confidence 33445556555432 3556778888888888888876 37788888888888887763 222 445555555555
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
++|++.+. ..+..+++|++|+|++|++++. +. +..+++|++|+|++|++++
T Consensus 93 ~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~--------------------------l~~l~~L~~L~l~~n~l~~ 143 (308)
T 1h6u_A 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP--------------------------LAGLSNLQVLYLDLNQITN 143 (308)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG--------------------------GTTCTTCCEEECCSSCCCC
T ss_pred cCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh--------------------------hcCCCCCCEEECCCCccCc
Confidence 55554432 2344455555555555554431 11 2333445555555555443
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHH
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMAL 345 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (959)
..+ +..+++|++|+|++|++++..+ +
T Consensus 144 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l-------------------------------------------------- 169 (308)
T 1h6u_A 144 ISP--LAGLTNLQYLSIGNAQVSDLTP--L-------------------------------------------------- 169 (308)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCCGG--G--------------------------------------------------
T ss_pred Ccc--ccCCCCccEEEccCCcCCCChh--h--------------------------------------------------
Confidence 222 4444444444444444443221 2
Q ss_pred HhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCcc
Q 002149 346 IDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWT 425 (959)
Q Consensus 346 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~ 425 (959)
..+++|+.|+|++|++++..+ +..+++|++|+|++|++++.. .+.
T Consensus 170 -------------------------------~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~ 214 (308)
T 1h6u_A 170 -------------------------------ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLA 214 (308)
T ss_dssp -------------------------------TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGT
T ss_pred -------------------------------cCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--ccc
Confidence 233567777777777764433 667777777777777777543 267
Q ss_pred CCCCCCeEeCCCCccCCCC
Q 002149 426 NLKSLTLLDLSQNNLSPPL 444 (959)
Q Consensus 426 ~l~~L~~L~Ls~N~l~~~~ 444 (959)
.+++|+.|+|++|++++..
T Consensus 215 ~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 215 NTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp TCTTCCEEEEEEEEEECCC
T ss_pred CCCCCCEEEccCCeeecCC
Confidence 7777777777777776533
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.4e-21 Score=196.03 Aligned_cols=179 Identities=21% Similarity=0.361 Sum_probs=149.1
Q ss_pred CcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCC
Q 002149 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149 (959)
Q Consensus 71 w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 149 (959)
|.+|.|+..+ ++ .+|..+ .++|++|+|++|++++.++ .|.++++|++|+|++|+|+.+++..|..+
T Consensus 9 ~~~v~c~~~~----------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 75 (208)
T 2o6s_A 9 GTTVECYSQG----------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL 75 (208)
T ss_dssp TTEEECCSSC----------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred CCEEEecCCC----------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCC
Confidence 6666666544 33 344443 3589999999999998877 47899999999999999999999999999
Q ss_pred CCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccc
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVN 229 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~ 229 (959)
++|++|+|++|+++.+ .+..+..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..
T Consensus 76 ~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------- 143 (208)
T 2o6s_A 76 TSLTYLNLSTNQLQSL----PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV-------- 143 (208)
T ss_dssp TTCCEEECCSSCCCCC----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT--------
T ss_pred CCcCEEECCCCcCCcc----CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHH--------
Confidence 9999999999999852 2344688999999999999999888888999999999999999999766554
Q ss_pred ccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc
Q 002149 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL 298 (959)
Q Consensus 230 L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 298 (959)
+..+++|++|+|++|.+.+ .+++|++|+++.|+++|.+|..++.+
T Consensus 144 -----------------~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 144 -----------------FDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp -----------------TTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred -----------------hccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence 4567899999999998875 35688999999999999999888765
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-22 Score=228.04 Aligned_cols=265 Identities=20% Similarity=0.235 Sum_probs=202.0
Q ss_pred EEeccCCcCCCCCCCccC-CCCccEEecCCCCCCCCCh----hhhcCCC-CCcEEEccCcccCCCCCCCCCccccCc-cc
Q 002149 107 NIGLQKNQFRGELPSFSG-LSNLKYAYLDGNNFDTIPA----DFFDGLE-NLQVLALDSNNFNASKGWSFPKGLQSS-AQ 179 (959)
Q Consensus 107 ~L~Ls~N~l~~~~~~~~~-l~~L~~L~L~~N~l~~i~~----~~~~~l~-~L~~L~Ls~N~l~~~~~~~lp~~l~~l-~~ 179 (959)
+++|+.|.+++.+|.+.. .++|++|+|++|+|+.++. ..|..++ +|++|+|++|.|+......+...+... ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 578999999999987655 4559999999999999998 8899999 999999999999863322222222332 89
Q ss_pred cCeecccccccCCCCChhhcC----C-CCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccC-CcCC
Q 002149 180 LTNLSCMSCNLAGQLPDFLGN----F-ASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGN-MDQL 253 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~----l-~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~-l~~L 253 (959)
|++|++++|++++..+..+.. + ++|++|+|++|++++..+..+.. .+.. .++|
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~---------------------~l~~~~~~L 140 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ---------------------AFSNLPASI 140 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH---------------------HHTTSCTTC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH---------------------HHHhCCCce
Confidence 999999999999887775544 4 89999999999998766654421 1344 3689
Q ss_pred cEEEccCcccccc----CchhhcCCC-CCCEEeCCCCcCCCCCccccccc------cCCeEeCCCCcCCCCCCccccccc
Q 002149 254 RTLWLHGNHFSGT----IPESFGKLT-SLKDLNLNSNQFVGLIPPSLASL------SLDHLDLNNNMFMGPVPKSKAYKY 322 (959)
Q Consensus 254 ~~L~L~~N~l~~~----~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~------~L~~L~L~~N~l~~~ip~~~~~~~ 322 (959)
++|+|++|++++. ++..+..++ +|++|+|++|+|++..+..+... +|+.|+|++|.+++....
T Consensus 141 ~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~------ 214 (362)
T 3goz_A 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA------ 214 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHH------
T ss_pred eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHH------
Confidence 9999999999864 445556666 99999999999998887655532 699999999999752111
Q ss_pred ccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCC----c
Q 002149 323 SYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS----P 398 (959)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p----~ 398 (959)
.+...+. ...++|+.|+|++|+|++..+ .
T Consensus 215 ---------------------~l~~~l~--------------------------~~~~~L~~L~Ls~N~l~~~~~~~l~~ 247 (362)
T 3goz_A 215 ---------------------ELAYIFS--------------------------SIPNHVVSLNLCLNCLHGPSLENLKL 247 (362)
T ss_dssp ---------------------HHHHHHH--------------------------HSCTTCCEEECCSSCCCCCCHHHHHH
T ss_pred ---------------------HHHHHHh--------------------------cCCCCceEEECcCCCCCcHHHHHHHH
Confidence 0000000 012589999999999997655 4
Q ss_pred cccCcCcCCEEeCccccccc-------ccCCCccCCCCCCeEeCCCCccCCCCC
Q 002149 399 SVGNLDSLTQIKLQSNNISG-------QIPTNWTNLKSLTLLDLSQNNLSPPLP 445 (959)
Q Consensus 399 ~~~~l~~L~~L~L~~N~l~g-------~~p~~l~~l~~L~~L~Ls~N~l~~~~p 445 (959)
.+..+++|+.|+|++|.+.+ .++..+.++++|+.|||++|++.+..+
T Consensus 248 ~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 248 LKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp TTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 45778999999999999543 345678899999999999999986543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-23 Score=235.72 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=182.3
Q ss_pred CCcEEEEEecCCcccccC----cccccCCCCCcEEeccCCcCC---CCCC-C-------ccCCCCccEEecCCCCCCC--
Q 002149 78 NSRVTQIQVSSVGLKGTL----PQNLNQLSKLENIGLQKNQFR---GELP-S-------FSGLSNLKYAYLDGNNFDT-- 140 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g~~----~~~l~~l~~L~~L~Ls~N~l~---~~~~-~-------~~~l~~L~~L~L~~N~l~~-- 140 (959)
..+++.|+|++|++++.. +..+..+++|++|+|++|.+. +.+| . |.++++|++|+|++|+|+.
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 357999999999998764 445789999999999997544 4444 2 3789999999999999997
Q ss_pred --CChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC-C
Q 002149 141 --IPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG-P 217 (959)
Q Consensus 141 --i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~ 217 (959)
..+..+..+++|++|+|++|.|+......++..+..+ ..+++. +..++|++|+|++|+++. .
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l--------~~~~~~-------~~~~~L~~L~L~~n~l~~~~ 175 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL--------AVNKKA-------KNAPPLRSIICGRNRLENGS 175 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHH--------HHHHHH-------HTCCCCCEEECCSSCCTGGG
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHH--------hhhhhc-------ccCCCCcEEECCCCCCCcHH
Confidence 3455688999999999999988642111111111111 011111 111789999999999872 2
Q ss_pred CCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc--c---cCchhhcCCCCCCEEeCCCCcCC----
Q 002149 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS--G---TIPESFGKLTSLKDLNLNSNQFV---- 288 (959)
Q Consensus 218 ~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~---- 288 (959)
++. + ...+..+++|++|+|++|+++ | .+|..+..+++|++|+|++|.|+
T Consensus 176 ~~~-l---------------------~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~ 233 (386)
T 2ca6_A 176 MKE-W---------------------AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233 (386)
T ss_dssp HHH-H---------------------HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH
T ss_pred HHH-H---------------------HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHH
Confidence 221 1 012556789999999999998 3 35558889999999999999996
Q ss_pred CCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCC
Q 002149 289 GLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDP 367 (959)
Q Consensus 289 ~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 367 (959)
+.+|..+..+ +|+.|+|++|.+++.... .+...
T Consensus 234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------------------~l~~~------------------- 267 (386)
T 2ca6_A 234 SALAIALKSWPNLRELGLNDCLLSARGAA---------------------------AVVDA------------------- 267 (386)
T ss_dssp HHHHHHGGGCTTCCEEECTTCCCCHHHHH---------------------------HHHHH-------------------
T ss_pred HHHHHHHccCCCcCEEECCCCCCchhhHH---------------------------HHHHH-------------------
Confidence 5567777766 699999999998742110 00000
Q ss_pred CCcccccccCCCCcccEEECCCCcccc----cCCccc-cCcCcCCEEeCcccccccccC
Q 002149 368 CKSWLGLSCGTNSKLTVLNLPNFNLSG----TLSPSV-GNLDSLTQIKLQSNNISGQIP 421 (959)
Q Consensus 368 ~~~~~~~~~~~~~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~g~~p 421 (959)
+..+.+++|+.|+|++|.|++ .+|..+ .++++|++|+|++|.+++..+
T Consensus 268 ------l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 268 ------FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp ------HHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred ------HhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 011235889999999999998 488877 678999999999999997654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=224.49 Aligned_cols=205 Identities=22% Similarity=0.331 Sum_probs=167.4
Q ss_pred CCCCCCCCCCCCCC--CCcce-EecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEe
Q 002149 56 LLQWPKSGDPCGPP--CWKHV-FCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAY 132 (959)
Q Consensus 56 ~~~w~~~~~~C~~~--~w~gv-~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~ 132 (959)
+.+|....++|... .|.++ .|..++++.|+|+++++++ +|..+. ++|++|+|++|+|+.++ ..+++|++|+
T Consensus 33 l~~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~ 106 (571)
T 3cvr_A 33 WDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP---ELPASLEYLD 106 (571)
T ss_dssp HHHHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEE
T ss_pred HHHHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEE
Confidence 34565566777421 38888 7988899999999999997 787764 89999999999999554 5689999999
Q ss_pred cCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCC
Q 002149 133 LDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGN 212 (959)
Q Consensus 133 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N 212 (959)
|++|+|+.+|. |.+ +|++|+|++|+|++ +|. .+++|+.|++++|++++ +|. .+++|+.|+|++|
T Consensus 107 Ls~N~l~~ip~--l~~--~L~~L~Ls~N~l~~-----lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 107 ACDNRLSTLPE--LPA--SLKHLDVDNNQLTM-----LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp CCSSCCSCCCC--CCT--TCCEEECCSSCCSC-----CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred ccCCCCCCcch--hhc--CCCEEECCCCcCCC-----CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCC
Confidence 99999999887 554 99999999999985 555 67899999999999997 565 5789999999999
Q ss_pred cCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCC-------CEEeCCCC
Q 002149 213 NLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL-------KDLNLNSN 285 (959)
Q Consensus 213 ~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~Ls~N 285 (959)
+|++ +|. |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|
T Consensus 171 ~L~~-lp~-l~---------------------------~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N 217 (571)
T 3cvr_A 171 QLTF-LPE-LP---------------------------ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCREN 217 (571)
T ss_dssp CCSC-CCC-CC---------------------------TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSS
T ss_pred CCCC-cch-hh---------------------------CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCC
Confidence 9996 554 41 68999999999999 6777 554 77 99999999
Q ss_pred cCCCCCccccccc-cCCeEeCCCCcCCCCCCc
Q 002149 286 QFVGLIPPSLASL-SLDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 286 ~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~ 316 (959)
+|+. +|..+..+ +|+.|+|++|++++.+|.
T Consensus 218 ~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 218 RITH-IPENILSLDPTCTIILEDNPLSSRIRE 248 (571)
T ss_dssp CCCC-CCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred ccee-cCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence 9996 45555556 699999999999987765
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=220.33 Aligned_cols=196 Identities=21% Similarity=0.332 Sum_probs=115.9
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCee
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNL 183 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L 183 (959)
+|+.|+|++|+|+++++.+. ++|++|+|++|+|+.+| ..+++|++|+|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~--~~L~~L~Ls~N~l~~ip----~~l~~L~~L~Ls~N~l~-------------------- 113 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP--PQITVLEITQNALISLP----ELPASLEYLDACDNRLS-------------------- 113 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS--------------------
T ss_pred CccEEEeCCCCCCccCHhHc--CCCCEEECcCCCCcccc----cccCCCCEEEccCCCCC--------------------
Confidence 55666666666655433332 45666666666665555 23455555555555554
Q ss_pred cccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccc
Q 002149 184 SCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHF 263 (959)
Q Consensus 184 ~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l 263 (959)
+ +|. +.+ +|+.|+|++|+|++ +|. .+++|++|+|++|+|
T Consensus 114 --------~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----------------------------~l~~L~~L~Ls~N~l 152 (571)
T 3cvr_A 114 --------T-LPE-LPA--SLKHLDVDNNQLTM-LPE----------------------------LPALLEYINADNNQL 152 (571)
T ss_dssp --------C-CCC-CCT--TCCEEECCSSCCSC-CCC----------------------------CCTTCCEEECCSSCC
T ss_pred --------C-cch-hhc--CCCEEECCCCcCCC-CCC----------------------------cCccccEEeCCCCcc
Confidence 3 333 332 56666666666654 332 124566666666666
Q ss_pred cccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhH
Q 002149 264 SGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVM 343 (959)
Q Consensus 264 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (959)
++ +|. .+++|++|+|++|+|++ +|. +. .+|+.|+|++|.|+ .+|. +...
T Consensus 153 ~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~-~~L~~L~Ls~N~L~-~lp~-~~~~---------------------- 201 (571)
T 3cvr_A 153 TM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP-ESLEALDVSTNLLE-SLPA-VPVR---------------------- 201 (571)
T ss_dssp SC-CCC---CCTTCCEEECCSSCCSC-CCC-CC-TTCCEEECCSSCCS-SCCC-CC------------------------
T ss_pred Cc-CCC---cCCCcCEEECCCCCCCC-cch-hh-CCCCEEECcCCCCC-chhh-HHHh----------------------
Confidence 64 444 35566666666666665 333 43 45666666666665 3332 0000
Q ss_pred HHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCC
Q 002149 344 ALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423 (959)
Q Consensus 344 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 423 (959)
-+.....|+.|+|++|+|+ .+|..+.++++|+.|+|++|.|++.+|..
T Consensus 202 -------------------------------L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~ 249 (571)
T 3cvr_A 202 -------------------------------NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRES 249 (571)
T ss_dssp -------------------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHH
T ss_pred -------------------------------hhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHH
Confidence 0011244688999999988 57888888999999999999999888888
Q ss_pred ccCCCC
Q 002149 424 WTNLKS 429 (959)
Q Consensus 424 l~~l~~ 429 (959)
|..++.
T Consensus 250 l~~l~~ 255 (571)
T 3cvr_A 250 LSQQTA 255 (571)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 777654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=206.78 Aligned_cols=241 Identities=17% Similarity=0.128 Sum_probs=177.1
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
++++.++|+++.+|..+ .+++++|+|++|+|+.|++++|.++++|++|+|++|++... +
T Consensus 12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~----i--------------- 70 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV----I--------------- 70 (350)
T ss_dssp TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCE----E---------------
T ss_pred CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCc----c---------------
Confidence 46788899998776655 36799999999999999999999999999999999987531 1
Q ss_pred cccccCCCCChhhcCCCCCCE-EEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQN-LKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~ 264 (959)
.+..|.++++|.+ +.+++|+|+...|.. |.++++|++|++++|+++
T Consensus 71 --------~~~~f~~L~~l~~~l~~~~N~l~~l~~~~-------------------------f~~l~~L~~L~l~~n~l~ 117 (350)
T 4ay9_X 71 --------EADVFSNLPKLHEIRIEKANNLLYINPEA-------------------------FQNLPNLQYLLISNTGIK 117 (350)
T ss_dssp --------CTTSBCSCTTCCEEEEEEETTCCEECTTS-------------------------BCCCTTCCEEEEEEECCS
T ss_pred --------ChhHhhcchhhhhhhcccCCcccccCchh-------------------------hhhccccccccccccccc
Confidence 1345677887765 667789999777766 567799999999999999
Q ss_pred ccCchhhcCCCCCCEEeCCC-CcCCCCCccccccc--cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchh
Q 002149 265 GTIPESFGKLTSLKDLNLNS-NQFVGLIPPSLASL--SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPE 341 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~~--~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (959)
+..+..+....++..|++.+ |++....+..|..+ .++.|+|++|.++. +|..
T Consensus 118 ~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~-i~~~------------------------ 172 (350)
T 4ay9_X 118 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNS------------------------ 172 (350)
T ss_dssp SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTT------------------------
T ss_pred cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC-CChh------------------------
Confidence 77777777888899999965 67887777777776 48899999999974 2221
Q ss_pred hHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCC-CcccccCCccccCcCcCCEEeCccccccccc
Q 002149 342 VMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPN-FNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 342 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
.....+|+.|++++ |.++...+..|.++++|++|+|++|+|+...
T Consensus 173 ----------------------------------~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 173 ----------------------------------AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp ----------------------------------SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred ----------------------------------hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence 01236799999986 5565444457899999999999999999443
Q ss_pred CCCccCCCCCCeEeCCCCccCCCCCC---CCCcceecccCCCCCCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLSPPLPK---FSGAVKLSLDGNPLLNG 463 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~~~~~l~~N~~~c~ 463 (959)
+..|.+|++ |.+.++.-...+|. +.++..+.+. |++.|.
T Consensus 219 ~~~~~~L~~---L~~l~~~~l~~lP~l~~l~~L~~l~l~-~~~~c~ 260 (350)
T 4ay9_X 219 SYGLENLKK---LRARSTYNLKKLPTLEKLVALMEASLT-YPSHCC 260 (350)
T ss_dssp SSSCTTCCE---EECTTCTTCCCCCCTTTCCSCCEEECS-CHHHHH
T ss_pred hhhhccchH---hhhccCCCcCcCCCchhCcChhhCcCC-CCcccc
Confidence 344555554 44444433334454 5556666664 555553
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-21 Score=235.47 Aligned_cols=225 Identities=22% Similarity=0.223 Sum_probs=128.3
Q ss_pred ChhhHHHHHHHHHhcCCC---CCCCCCCCCCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCC
Q 002149 37 DPGDIDILNQFRKNLENP---ELLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKN 113 (959)
Q Consensus 37 ~~~~~~~l~~~~~~~~~~---~~~~w~~~~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N 113 (959)
...++++|.++..+..-. ....|.....++. .|.++.++..+++.++|.++++.. ++.. .|+.++|+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~ 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSG--TATNSAVSTPLTPKIELFANGKDE-ANQA-----LLQHKKLSQY 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccc--cCCCceecCCccceEEeeCCCCCc-chhh-----HhhcCccCcc
Confidence 345678898888776321 2344643333333 388999999999999999988875 3332 3456667777
Q ss_pred cCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCC
Q 002149 114 QFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQ 193 (959)
Q Consensus 114 ~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~ 193 (959)
.|.+ ++++.|++. +++..|..+++|+.|+|++|.|. .+|..+..+++|+.|+|++|+|+ .
T Consensus 202 ~i~~-------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-----~l~~~~~~l~~L~~L~Ls~N~l~-~ 261 (727)
T 4b8c_D 202 SIDE-------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-----NISANIFKYDFLTRLYLNGNSLT-E 261 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCS-----CCCGGGGGCCSCSCCBCTTSCCS-C
T ss_pred cccC-------------cccccccee-cChhhhccCCCCcEEECCCCCCC-----CCChhhcCCCCCCEEEeeCCcCc-c
Confidence 6553 355566665 55667888888888888888887 57777788888888888888888 7
Q ss_pred CChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcC
Q 002149 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273 (959)
Q Consensus 194 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 273 (959)
+|..|+++++|+.|+|++|+|+ .+|.. ++++++|++|+|++|.|+ .+|..|+.
T Consensus 262 lp~~~~~l~~L~~L~Ls~N~l~-~lp~~-------------------------~~~l~~L~~L~L~~N~l~-~lp~~~~~ 314 (727)
T 4b8c_D 262 LPAEIKNLSNLRVLDLSHNRLT-SLPAE-------------------------LGSCFQLKYFYFFDNMVT-TLPWEFGN 314 (727)
T ss_dssp CCGGGGGGTTCCEEECTTSCCS-SCCSS-------------------------GGGGTTCSEEECCSSCCC-CCCSSTTS
T ss_pred cChhhhCCCCCCEEeCcCCcCC-ccChh-------------------------hcCCCCCCEEECCCCCCC-ccChhhhc
Confidence 8888999999999999999999 66776 456789999999999998 78888999
Q ss_pred CCCCCEEeCCCCcCCCCCcccccccc--CCeEeCCCCcCCCCCCc
Q 002149 274 LTSLKDLNLNSNQFVGLIPPSLASLS--LDHLDLNNNMFMGPVPK 316 (959)
Q Consensus 274 l~~L~~L~Ls~N~l~~~~p~~~~~~~--L~~L~L~~N~l~~~ip~ 316 (959)
+++|++|+|++|.|++.+|..+.... +..|+|++|.++|.+|.
T Consensus 315 l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 315 LCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 99999999999999999998887653 34578899999887773
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.7e-20 Score=188.36 Aligned_cols=177 Identities=21% Similarity=0.253 Sum_probs=151.8
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
+.++++++.++..+..+ .++|++|+|++|+|+.+++..|.++++|++|+|++|+++.+ .+..+..+++|++|++
T Consensus 10 ~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 10 TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL----PNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC----CTTTTTTCTTCCEEEC
T ss_pred CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc----ChhhcCCCCCcCEEEC
Confidence 35677888887766554 35899999999999999999999999999999999999852 2344688999999999
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
++|++++..+..|..+++|++|+|++|++++..+.. +.++++|++|+|++|++++
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~~ 138 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGV-------------------------FDKLTQLKDLRLYQNQLKS 138 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCCSC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhH-------------------------hccCCcCCEEECCCCccce
Confidence 999999887788899999999999999999766654 4667999999999999997
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccc
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKA 319 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~ 319 (959)
..+..|..+++|++|+|++|.+.+..| +|+.|+++.|.++|.+|....
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCCTT------TTHHHHHHHHHCTTTBBCTTS
T ss_pred eCHHHhccCCCccEEEecCCCeecCCC------CHHHHHHHHHhCCceeeccCc
Confidence 777779999999999999999886543 588999999999999997543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.2e-20 Score=203.66 Aligned_cols=188 Identities=27% Similarity=0.339 Sum_probs=129.2
Q ss_pred CCCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCC-cc-CCCCccEEecCCCCCC
Q 002149 62 SGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS-FS-GLSNLKYAYLDGNNFD 139 (959)
Q Consensus 62 ~~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~-~l~~L~~L~L~~N~l~ 139 (959)
....||..| .|.. ..+++.+++|+ .+|..+. ..|+.|+|++|+|++.++. |. ++++|++|+|++|+|+
T Consensus 8 ~~~~Cp~~C----~C~~---~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~ 77 (361)
T 2xot_A 8 SVVSCPANC----LCAS---NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77 (361)
T ss_dssp CCTTCCTTC----EEET---TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC
T ss_pred cCCCCCCCC----EECC---CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC
Confidence 346787655 4543 35788888888 5676664 3588999999999988874 66 8999999999999999
Q ss_pred CCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC
Q 002149 140 TIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219 (959)
Q Consensus 140 ~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 219 (959)
.+++..|.++++|++|+|++|+|+. ..+..|..+++|+.|+|++|+|++..|
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~----------------------------~~~~~~~~l~~L~~L~L~~N~i~~~~~ 129 (361)
T 2xot_A 78 FISSEAFVPVPNLRYLDLSSNHLHT----------------------------LDEFLFSDLQALEVLLLYNNHIVVVDR 129 (361)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCE----------------------------ECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccChhhccCCCCCCEEECCCCcCCc----------------------------CCHHHhCCCcCCCEEECCCCcccEECH
Confidence 9998889999999999999998874 223345555666666666666665444
Q ss_pred cccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhh---cCCCCCCEEeCCCCcCCCCCccccc
Q 002149 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF---GKLTSLKDLNLNSNQFVGLIPPSLA 296 (959)
Q Consensus 220 ~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~ 296 (959)
.. |.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++..+..+.
T Consensus 130 ~~-------------------------~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 184 (361)
T 2xot_A 130 NA-------------------------FEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQ 184 (361)
T ss_dssp TT-------------------------TTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHH
T ss_pred HH-------------------------hCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhh
Confidence 44 3445666666666666664333333 4566777777777777766555555
Q ss_pred ccc---CCeEeCCCCcCCC
Q 002149 297 SLS---LDHLDLNNNMFMG 312 (959)
Q Consensus 297 ~~~---L~~L~L~~N~l~~ 312 (959)
.+. ++.|+|++|.+..
T Consensus 185 ~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 185 KLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp HSCHHHHTTEECCSSCEEC
T ss_pred hccHhhcceEEecCCCccC
Confidence 542 4777888887764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.2e-21 Score=211.98 Aligned_cols=253 Identities=17% Similarity=0.185 Sum_probs=189.4
Q ss_pred CCcEEeccCCcCCCCCCCccCC--CCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccC
Q 002149 104 KLENIGLQKNQFRGELPSFSGL--SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLT 181 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l--~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~ 181 (959)
.++.|++++|.+. ...+..+ ++++.|++++|.+.+.++. +..+++|++|+|++|.++.. .++..+..+++|+
T Consensus 48 ~~~~l~l~~~~~~--~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~---~~~~~~~~~~~L~ 121 (336)
T 2ast_B 48 LWQTLDLTGKNLH--PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS---TLHGILSQCSKLQ 121 (336)
T ss_dssp TSSEEECTTCBCC--HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH---HHHHHHTTBCCCS
T ss_pred hheeeccccccCC--HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH---HHHHHHhhCCCCC
Confidence 4788999998876 2245666 8899999999999988776 45789999999999988641 2677788899999
Q ss_pred eecccccccCCCCChhhcCCCCCCEEEecCC-cCCCC-CCcccccCCcccccccccCCCCcccccccccCCcCCcEEEcc
Q 002149 182 NLSCMSCNLAGQLPDFLGNFASLQNLKLSGN-NLTGP-IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259 (959)
Q Consensus 182 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~ 259 (959)
+|++++|++++..+..++.+++|++|+|++| .+++. ++.. +.++++|++|+|+
T Consensus 122 ~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~-------------------------~~~~~~L~~L~l~ 176 (336)
T 2ast_B 122 NLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL-------------------------LSSCSRLDELNLS 176 (336)
T ss_dssp EEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH-------------------------HHHCTTCCEEECC
T ss_pred EEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHH-------------------------HhcCCCCCEEcCC
Confidence 9999999988888888889999999999999 56632 2222 4567889999999
Q ss_pred Cc-ccccc-CchhhcCCC-CCCEEeCCCC--cCC-CCCccccccc-cCCeEeCCCCc-CCCCCCcccccccccccCcccC
Q 002149 260 GN-HFSGT-IPESFGKLT-SLKDLNLNSN--QFV-GLIPPSLASL-SLDHLDLNNNM-FMGPVPKSKAYKYSYSSNAFCQ 331 (959)
Q Consensus 260 ~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~~-~L~~L~L~~N~-l~~~ip~~~~~~~~~~~~~~~~ 331 (959)
+| .+++. ++..+..++ +|++|+|++| .++ +.++..+..+ +|+.|+|++|. +++..+.
T Consensus 177 ~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~--------------- 241 (336)
T 2ast_B 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ--------------- 241 (336)
T ss_dssp CCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG---------------
T ss_pred CCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH---------------
Confidence 99 88864 678888899 9999999999 455 3455566555 59999999988 5543221
Q ss_pred CCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCc-ccccCCccccCcCcCCEEe
Q 002149 332 PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN-LSGTLSPSVGNLDSLTQIK 410 (959)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 410 (959)
.++.+++|+.|+|++|. +.......++++++|++|+
T Consensus 242 -------------------------------------------~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 242 -------------------------------------------EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278 (336)
T ss_dssp -------------------------------------------GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred -------------------------------------------HHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEe
Confidence 12234789999999985 3322223678888999999
Q ss_pred CcccccccccCCCccCCC-CCCeEeCCCCccCCCCCCCCC
Q 002149 411 LQSNNISGQIPTNWTNLK-SLTLLDLSQNNLSPPLPKFSG 449 (959)
Q Consensus 411 L~~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~ 449 (959)
|++| ++ ...+..+. .|..|++++|++++..|...+
T Consensus 279 l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 279 VFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred ccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 9988 33 22344443 477788899999888876543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=7.7e-19 Score=181.33 Aligned_cols=164 Identities=26% Similarity=0.389 Sum_probs=121.8
Q ss_pred CCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC--CccCCCCccEEecCCCCCCCC
Q 002149 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTI 141 (959)
Q Consensus 64 ~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i 141 (959)
..||..| .|.. +.|++++++++ .+|..+.. .+++|+|++|+|++.++ .|.++++|++|+|++|+|+.+
T Consensus 3 ~~CP~~C----~C~~---~~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i 72 (220)
T 2v70_A 3 LACPEKC----RCEG---TTVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI 72 (220)
T ss_dssp -CCCTTC----EEET---TEEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE
T ss_pred CCCCCCC----EECC---CEeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE
Confidence 4576544 5653 36888888887 46766643 56889999999988765 378888899999999988888
Q ss_pred ChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcc
Q 002149 142 PADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPES 221 (959)
Q Consensus 142 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 221 (959)
++..|.++++|++|+|++|+|++ ..+..|..+++|++|+|++|+|++..|..
T Consensus 73 ~~~~~~~l~~L~~L~Ls~N~l~~----------------------------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 124 (220)
T 2v70_A 73 EEGAFEGASGVNEILLTSNRLEN----------------------------VQHKMFKGLESLKTLMLRSNRITCVGNDS 124 (220)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCC----------------------------CCGGGGTTCSSCCEEECTTSCCCCBCTTS
T ss_pred CHHHhCCCCCCCEEECCCCccCc----------------------------cCHhHhcCCcCCCEEECCCCcCCeECHhH
Confidence 88888888888888888887763 33455667777777777777777666655
Q ss_pred cccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCC
Q 002149 222 FKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGL 290 (959)
Q Consensus 222 ~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 290 (959)
+.++++|++|+|++|+|++..|..|..+++|++|+|++|.+...
T Consensus 125 -------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 125 -------------------------FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp -------------------------STTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred -------------------------cCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 34557777777777777776677777777788887777777654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-18 Score=181.50 Aligned_cols=165 Identities=26% Similarity=0.385 Sum_probs=125.3
Q ss_pred CCCCCCCCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCC
Q 002149 57 LQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDG 135 (959)
Q Consensus 57 ~~w~~~~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~ 135 (959)
..|+.....|. |.+|.|+..+++ .+|..+. ++|++|+|++|.|++..+ .|.++++|++|+|++
T Consensus 10 ~~~~~~~~~Cs---~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 73 (229)
T 3e6j_A 10 SAACPSQCSCS---GTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73 (229)
T ss_dssp -CCCCTTCEEE---TTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred hccCCCCCEEe---CCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCC
Confidence 34655667776 888888766554 4454443 789999999999999877 588999999999999
Q ss_pred CCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCC
Q 002149 136 NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 136 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 215 (959)
|+|+.+++..|..+++|++|+|++|+|+. ..+..|..+++|+.|+|++|+|+
T Consensus 74 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~----------------------------l~~~~~~~l~~L~~L~Ls~N~l~ 125 (229)
T 3e6j_A 74 NQLGALPVGVFDSLTQLTVLDLGTNQLTV----------------------------LPSAVFDRLVHLKELFMCCNKLT 125 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCC----------------------------CCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCCcChhhcccCCCcCEEECCCCcCCc----------------------------cChhHhCcchhhCeEeccCCccc
Confidence 99999998888999999999999988763 22344566777777888888777
Q ss_pred CCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 216 GPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 216 ~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
.+|.. +.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+....
T Consensus 126 -~lp~~-------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 126 -ELPRG-------------------------IERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp -SCCTT-------------------------GGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred -ccCcc-------------------------cccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 45544 345677888888888887666667777888888888888877553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-18 Score=204.88 Aligned_cols=184 Identities=26% Similarity=0.404 Sum_probs=145.5
Q ss_pred EecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCC
Q 002149 85 QVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNA 164 (959)
Q Consensus 85 ~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 164 (959)
.+..+.+...++ +..|++|+.|+|++|.|... +.|..+++|++|+|++|+|+.+++ |..+++|++|+|++|+|..
T Consensus 27 ~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 101 (605)
T 1m9s_A 27 NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD 101 (605)
T ss_dssp HTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred hccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC
Confidence 344444443322 56788888999999988765 468889999999999999998887 8889999999999998874
Q ss_pred CCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCccccc
Q 002149 165 SKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244 (959)
Q Consensus 165 ~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~ 244 (959)
+| .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|+|++. ..
T Consensus 102 -----l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~----------------------- 148 (605)
T 1m9s_A 102 -----LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV----------------------- 148 (605)
T ss_dssp -----CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GG-----------------------
T ss_pred -----Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hh-----------------------
Confidence 33 678888899999999988863 4588889999999999988854 22
Q ss_pred ccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC
Q 002149 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312 (959)
Q Consensus 245 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~ 312 (959)
+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. + .+..+ +|+.|+|++|.+++
T Consensus 149 --l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 149 --LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp --GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred --hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence 5677889999999999987666 88889999999999999865 3 35555 58888888888875
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=179.18 Aligned_cols=162 Identities=26% Similarity=0.451 Sum_probs=107.7
Q ss_pred CCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCC
Q 002149 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIP 142 (959)
Q Consensus 64 ~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~ 142 (959)
..||..| .|.. ..+++.+++++ .+|..+. ++|+.|+|++|.|++.++ .|.++++|++|+|++|+|+.+.
T Consensus 3 ~~CP~~C----~C~~---~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~ 72 (220)
T 2v9t_B 3 LHCPAAC----TCSN---NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELA 72 (220)
T ss_dssp CCSCTTS----EEET---TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEEC
T ss_pred CCCCCCC----EECC---CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcC
Confidence 4676555 4543 24666777776 5566554 578888888888887776 5777888888888888888777
Q ss_pred hhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCccc
Q 002149 143 ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF 222 (959)
Q Consensus 143 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 222 (959)
+..|.++++|++|+|++|+|+. + .+..|..+++|+.|+|++|+|++..|..
T Consensus 73 ~~~~~~l~~L~~L~Ls~N~l~~-----l-----------------------~~~~f~~l~~L~~L~L~~N~l~~~~~~~- 123 (220)
T 2v9t_B 73 PDAFQGLRSLNSLVLYGNKITE-----L-----------------------PKSLFEGLFSLQLLLLNANKINCLRVDA- 123 (220)
T ss_dssp TTTTTTCSSCCEEECCSSCCCC-----C-----------------------CTTTTTTCTTCCEEECCSSCCCCCCTTT-
T ss_pred HHHhhCCcCCCEEECCCCcCCc-----c-----------------------CHhHccCCCCCCEEECCCCCCCEeCHHH-
Confidence 7777777777777777777663 2 2233455666666666666666555544
Q ss_pred ccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCC
Q 002149 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV 288 (959)
Q Consensus 223 ~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 288 (959)
|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 124 ------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 124 ------------------------FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ------------------------TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ------------------------cCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 344566666666666666555556666666666666666665
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=187.43 Aligned_cols=171 Identities=28% Similarity=0.421 Sum_probs=100.0
Q ss_pred cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccc
Q 002149 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~ 179 (959)
..+++|++|++++|.+... +.+..+++|++|+|++|+|+.+++ +..+++|++|+|++|+++. + +.+..+++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-----~-~~l~~l~~ 113 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-----L-SSLKDLKK 113 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----G-GGGTTCTT
T ss_pred hhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-----C-hhhccCCC
Confidence 3455566666666665544 345556666666666666666554 5566666666666666553 2 22555666
Q ss_pred cCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEcc
Q 002149 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~ 259 (959)
|+.|++++|++.+. ..+..+++|+.|+|++|++++. .. +..+++|++|+|+
T Consensus 114 L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~-------------------------l~~l~~L~~L~L~ 164 (291)
T 1h6t_A 114 LKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV-------------------------LSRLTKLDTLSLE 164 (291)
T ss_dssp CCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG-------------------------GGGCTTCSEEECC
T ss_pred CCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh-------------------------hccCCCCCEEEcc
Confidence 66666666666543 3456666666666666666643 11 3455666666666
Q ss_pred CccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC
Q 002149 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312 (959)
Q Consensus 260 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~ 312 (959)
+|++++..| +..+++|++|+|++|+|++. +. +..+ +|+.|+|++|+++.
T Consensus 165 ~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~-l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 165 DNQISDIVP--LAGLTKLQNLYLSKNHISDL-RA-LAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GG-GTTCTTCSEEEEEEEEEEC
T ss_pred CCccccchh--hcCCCccCEEECCCCcCCCC-hh-hccCCCCCEEECcCCcccC
Confidence 666664433 66666666666666666643 32 4444 46666666666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=9.4e-21 Score=227.19 Aligned_cols=334 Identities=15% Similarity=0.074 Sum_probs=211.3
Q ss_pred CcEEEEEecCCccccc----CcccccCCCCCcEEeccCCcCCCCCC-----CccCCCCccEEecCCCCCCCCChhhhcCC
Q 002149 79 SRVTQIQVSSVGLKGT----LPQNLNQLSKLENIGLQKNQFRGELP-----SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~----~~~~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 149 (959)
.+++.|+|.++.+++. ++..+..+++|++|+|++|.+++... .+.++++|++|+|++|.+.+++ ..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 5899999999998765 55667889999999999999985432 2567899999999999999876 568999
Q ss_pred CCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCc-ccccC-Cc
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPE-SFKGL-NL 227 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l-~l 227 (959)
++|++|+++.+... ......+..+..+++|+.|++.++. ...+|..+..+++|++|+|++|.+++.... .+..+ ++
T Consensus 243 ~~L~~L~l~~~~~~-~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 243 ANLEEFCGGSLNED-IGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp TTCCEEEECBCCCC-TTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hHHHhhcccccccc-cchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 99999999864322 1112455667778888888887753 345677777888899999988887643321 12222 45
Q ss_pred ccccccccCCCCcccccccccCCcCCcEEEcc-----------Ccccccc-CchhhcCCCCCCEEeCCCCcCCCCCcccc
Q 002149 228 VNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH-----------GNHFSGT-IPESFGKLTSLKDLNLNSNQFVGLIPPSL 295 (959)
Q Consensus 228 ~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~-----------~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 295 (959)
+.|.+.+.- .-.+....+..+++|++|+|+ .|.+++. ++..+..+++|++|+|+.|++++..+..+
T Consensus 321 ~~L~L~~~~--~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l 398 (592)
T 3ogk_B 321 EVLETRNVI--GDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESI 398 (592)
T ss_dssp CEEEEEGGG--HHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHH
T ss_pred CEEeccCcc--CHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHH
Confidence 555554210 001111223567788888888 3566643 33334567888888888888887666555
Q ss_pred cc-c-cCCeEeCC----CCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCC
Q 002149 296 AS-L-SLDHLDLN----NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK 369 (959)
Q Consensus 296 ~~-~-~L~~L~L~----~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 369 (959)
.. + +|+.|+|+ .|.+++..... . +..+.. .+..+..+....-.+....
T Consensus 399 ~~~~~~L~~L~l~~~~~~n~l~~~p~~~-~----------------------~~~~~~---~~~~L~~L~L~~~~~~l~~ 452 (592)
T 3ogk_B 399 GTYLKNLCDFRLVLLDREERITDLPLDN-G----------------------VRSLLI---GCKKLRRFAFYLRQGGLTD 452 (592)
T ss_dssp HHHCCSCCEEEEEECSCCSCCSSCCCHH-H----------------------HHHHHH---HCTTCCEEEEECCGGGCCH
T ss_pred HhhCCCCcEEEEeecCCCccccCchHHH-H----------------------HHHHHH---hCCCCCEEEEecCCCCccH
Confidence 54 3 58888885 66676531100 0 000000 0000000000000000000
Q ss_pred cccccccCCCCcccEEECCCCccccc-CCccccCcCcCCEEeCcccccccc-cCCCccCCCCCCeEeCCCCccCCC
Q 002149 370 SWLGLSCGTNSKLTVLNLPNFNLSGT-LSPSVGNLDSLTQIKLQSNNISGQ-IPTNWTNLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 370 ~~~~~~~~~~~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~-~p~~l~~l~~L~~L~Ls~N~l~~~ 443 (959)
.........+++|+.|+|++|++++. ++..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|+++..
T Consensus 453 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 00000011247788888888888763 455567788888888888888754 444456788888888888888754
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.5e-21 Score=232.12 Aligned_cols=364 Identities=13% Similarity=0.046 Sum_probs=228.4
Q ss_pred CcEEEEEecCCcccccCcccccCC--CCCcEEeccCCc-CCC-CCCC-ccCCCCccEEecCCCCCCCCC----hhhhcCC
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQL--SKLENIGLQKNQ-FRG-ELPS-FSGLSNLKYAYLDGNNFDTIP----ADFFDGL 149 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~Ls~N~-l~~-~~~~-~~~l~~L~~L~L~~N~l~~i~----~~~~~~l 149 (959)
.++++|+|+++.+++..+..+..+ .+|++|+|++|. ++. ..+. +.++++|++|+|++|.++... ...+..+
T Consensus 112 ~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~ 191 (592)
T 3ogk_B 112 RQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHN 191 (592)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHC
T ss_pred CCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcC
Confidence 478888998888887766666664 458999998886 211 0111 347889999999999887653 3356678
Q ss_pred CCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC---CCCcccccC-
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG---PIPESFKGL- 225 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~---~~p~~~~~l- 225 (959)
++|++|+|++|.+++.....++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.+.... ..+..+..+
T Consensus 192 ~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~ 270 (592)
T 3ogk_B 192 TSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270 (592)
T ss_dssp CCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT
T ss_pred CCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccc
Confidence 8999999999988744333566666788899999999988886 67888888999999998643331 122222222
Q ss_pred CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCc-hhhcCCCCCCEEeCCCCcCCC-CCccccccc-cCCe
Q 002149 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP-ESFGKLTSLKDLNLNSNQFVG-LIPPSLASL-SLDH 302 (959)
Q Consensus 226 ~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~~-~L~~ 302 (959)
++..|.+.+.....+ ...+..+++|++|+|++|.+++... ..+..+++|++|+|+ |.+.. .++..+..+ +|+.
T Consensus 271 ~L~~L~l~~~~~~~l---~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~ 346 (592)
T 3ogk_B 271 KLCRLGLSYMGPNEM---PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKR 346 (592)
T ss_dssp TCCEEEETTCCTTTG---GGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCE
T ss_pred cccccCccccchhHH---HHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCE
Confidence 344454444322222 2346677889999999988765443 446788888888888 44432 233333333 5888
Q ss_pred EeCCC-----------CcCCCC--------CCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccC
Q 002149 303 LDLNN-----------NMFMGP--------VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363 (959)
Q Consensus 303 L~L~~-----------N~l~~~--------ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 363 (959)
|+|++ |.+++. .|... .+.+..+.++. .....+... ...+..+...+.
T Consensus 347 L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~--~L~l~~~~l~~--------~~~~~l~~~---~~~L~~L~l~~~ 413 (592)
T 3ogk_B 347 LRIERGADEQGMEDEEGLVSQRGLIALAQGCQELE--YMAVYVSDITN--------ESLESIGTY---LKNLCDFRLVLL 413 (592)
T ss_dssp EEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCS--EEEEEESCCCH--------HHHHHHHHH---CCSCCEEEEEEC
T ss_pred EEeecCccccccccccCccCHHHHHHHHhhCccCe--EEEeecCCccH--------HHHHHHHhh---CCCCcEEEEeec
Confidence 88883 555532 11111 11222332211 111111111 112222222111
Q ss_pred C-CCCCCc-----ccccccCCCCcccEEECCCCc--ccccCCcccc-CcCcCCEEeCccccccc-ccCCCccCCCCCCeE
Q 002149 364 G-NDPCKS-----WLGLSCGTNSKLTVLNLPNFN--LSGTLSPSVG-NLDSLTQIKLQSNNISG-QIPTNWTNLKSLTLL 433 (959)
Q Consensus 364 ~-~~~~~~-----~~~~~~~~~~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~L~~N~l~g-~~p~~l~~l~~L~~L 433 (959)
. .+.... .....+..+++|+.|+|++|. +++..+..+. .+++|++|+|++|++++ .++..+.++++|+.|
T Consensus 414 ~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L 493 (592)
T 3ogk_B 414 DREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKL 493 (592)
T ss_dssp SCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEE
T ss_pred CCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCee
Confidence 1 111110 011113457899999998654 7766666555 48899999999999986 455667889999999
Q ss_pred eCCCCccCCC-CC----CCCCcceecccCCCC
Q 002149 434 DLSQNNLSPP-LP----KFSGAVKLSLDGNPL 460 (959)
Q Consensus 434 ~Ls~N~l~~~-~p----~~~~~~~~~l~~N~~ 460 (959)
+|++|++++. ++ .+.++..+++.+|.+
T Consensus 494 ~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 494 EMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp EEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred eccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 9999998753 22 256788899999974
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.6e-18 Score=184.42 Aligned_cols=176 Identities=23% Similarity=0.405 Sum_probs=153.9
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++++++++.. + .+..+++|++|+|++|++++.++ +.++++|++|+|++|+++.++. +..+++|++|+|+
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~ 120 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCChh--hccCCCCCEEECC
Confidence 4789999999999854 3 58999999999999999998777 9999999999999999999765 8999999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|+++. + ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..+
T Consensus 121 ~n~i~~-----~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~------------------- 173 (291)
T 1h6t_A 121 HNGISD-----I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP------------------- 173 (291)
T ss_dssp TSCCCC-----C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-------------------
T ss_pred CCcCCC-----C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-------------------
Confidence 999985 3 4688999999999999999976 678999999999999999986543
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccc
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA 296 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 296 (959)
+..+++|++|+|++|++++ +| .+..+++|+.|+|++|+++......+.
T Consensus 174 --------l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~~~~~~ 221 (291)
T 1h6t_A 174 --------LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPINHQS 221 (291)
T ss_dssp --------GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCCEECCS
T ss_pred --------hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCcccccc
Confidence 3567899999999999995 55 489999999999999999875544443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=206.11 Aligned_cols=168 Identities=22% Similarity=0.326 Sum_probs=115.6
Q ss_pred CCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccC
Q 002149 102 LSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLT 181 (959)
Q Consensus 102 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~ 181 (959)
+..+..+.|..+.+.... .+..+++|+.|+|++|.|..++ .|..+++|++|+|++|+|++ ++. +..+++|+
T Consensus 20 l~~l~~l~l~~~~i~~~~-~~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~-----~~~-l~~l~~L~ 90 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-----IKP-LTNLKNLG 90 (605)
T ss_dssp HHHHHHHHTTCSCTTSEE-CHHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCC-----CGG-GGGCTTCC
T ss_pred HHHHHHHhccCCCccccc-chhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCC-----Chh-hccCCCCC
Confidence 344556677777776543 3567888999999999998887 38889999999999998874 333 66777777
Q ss_pred eecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCc
Q 002149 182 NLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGN 261 (959)
Q Consensus 182 ~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N 261 (959)
.|+|++|++.+. | .+..+++|+.|+|++|+|++. + . +..+++|+.|+|++|
T Consensus 91 ~L~Ls~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~l-~-~-------------------------l~~l~~L~~L~Ls~N 141 (605)
T 1m9s_A 91 WLFLDENKIKDL-S-SLKDLKKLKSLSLEHNGISDI-N-G-------------------------LVHLPQLESLYLGNN 141 (605)
T ss_dssp EEECCSSCCCCC-T-TSTTCTTCCEEECTTSCCCCC-G-G-------------------------GGGCTTCSEEECCSS
T ss_pred EEECcCCCCCCC-h-hhccCCCCCEEEecCCCCCCC-c-c-------------------------ccCCCccCEEECCCC
Confidence 777777777652 2 566777777777777777642 1 1 345567777777777
Q ss_pred cccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCC
Q 002149 262 HFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFM 311 (959)
Q Consensus 262 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~ 311 (959)
+|++. ..|..+++|+.|+|++|+|++.+| +..+ +|+.|+|++|.|+
T Consensus 142 ~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 142 KITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 77743 456677777777777777776544 4444 4666666666554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-18 Score=175.51 Aligned_cols=142 Identities=27% Similarity=0.387 Sum_probs=130.9
Q ss_pred CcceEecC-----------CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCC
Q 002149 71 WKHVFCSN-----------SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNF 138 (959)
Q Consensus 71 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l 138 (959)
|..|.|.. ..++.|+|++|++++..+..|..+++|++|+|++|+|++..| .|.++++|++|+|++|+|
T Consensus 13 ~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 13 NNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp TTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred CCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 78888875 268999999999998777789999999999999999999877 699999999999999999
Q ss_pred CCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC
Q 002149 139 DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216 (959)
Q Consensus 139 ~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 216 (959)
+.+++..|.++++|++|+|++|+|++ ..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 93 ~~l~~~~f~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 93 TELPKSLFEGLFSLQLLLLNANKINC----LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCC----CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCHhHccCCCCCCEEECCCCCCCE----eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 99999999999999999999999986 346778899999999999999999888899999999999999999874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=190.99 Aligned_cols=169 Identities=23% Similarity=0.231 Sum_probs=124.8
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhc-CCCCCcEEEccCcccCCCCCCCCCccccCccccCeec
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFD-GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~ 184 (959)
+.+++++|.++.++..+. ..+++|+|++|+|+.+++..|. ++++|++|+|++|+|+
T Consensus 21 ~~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~--------------------- 77 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN--------------------- 77 (361)
T ss_dssp TEEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC---------------------
T ss_pred CEEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC---------------------
Confidence 466667666665544433 2466666666666666666665 6666666666666554
Q ss_pred ccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc
Q 002149 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264 (959)
Q Consensus 185 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~ 264 (959)
+..+..|.++++|++|+|++|+|++..+.. |.++++|++|+|++|+|+
T Consensus 78 -------~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~i~ 125 (361)
T 2xot_A 78 -------FISSEAFVPVPNLRYLDLSSNHLHTLDEFL-------------------------FSDLQALEVLLLYNNHIV 125 (361)
T ss_dssp -------EECTTTTTTCTTCCEEECCSSCCCEECTTT-------------------------TTTCTTCCEEECCSSCCC
T ss_pred -------ccChhhccCCCCCCEEECCCCcCCcCCHHH-------------------------hCCCcCCCEEECCCCccc
Confidence 445667889999999999999999766555 567799999999999999
Q ss_pred ccCchhhcCCCCCCEEeCCCCcCCCCCccccc---cc-cCCeEeCCCCcCCCCCCccc-------ccccccccCcc
Q 002149 265 GTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA---SL-SLDHLDLNNNMFMGPVPKSK-------AYKYSYSSNAF 329 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~~-~L~~L~L~~N~l~~~ip~~~-------~~~~~~~~~~~ 329 (959)
+..|..|..+++|++|+|++|+|++..+..|. .+ +|+.|+|++|+|++..+... ...+.+++|.+
T Consensus 126 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 126 VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred EECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence 88899999999999999999999987777763 34 69999999999986432211 12345666666
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=183.63 Aligned_cols=138 Identities=20% Similarity=0.194 Sum_probs=106.7
Q ss_pred CcccCcccccCceEEEEEEE-cCCcE--EEEEEccccccc----------------------HHHHHHHHHHHHHHHhcC
Q 002149 613 FASENELGRGGFGVVYKGEL-DDGTK--IAVKRMEAGVIS----------------------KKAVDEFHSEIAVLSKVR 667 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~E~~~l~~l~ 667 (959)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ......+.+|+.++..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 66788999999999999987 67999 999987543111 112246889999999998
Q ss_pred CCCc--eeEEEEEEeCceEEEEEEecCC-C----chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 002149 668 HRHL--VSLLGYSVAGYERLLVYEYMPQ-G----ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH-SLAHQSFI 739 (959)
Q Consensus 668 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iv 739 (959)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 8764 344432 356899999942 4 56554321 224467789999999999999 8 8999
Q ss_pred ecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 740 HRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 740 H~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.4e-18 Score=174.41 Aligned_cols=68 Identities=24% Similarity=0.222 Sum_probs=54.5
Q ss_pred CCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCC
Q 002149 378 TNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP 445 (959)
Q Consensus 378 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p 445 (959)
.+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus 103 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 103 GLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 34677788888888887777888888888888888888887778888888888888888888876544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-20 Score=221.61 Aligned_cols=120 Identities=23% Similarity=0.288 Sum_probs=77.2
Q ss_pred CcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccC
Q 002149 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQ 331 (959)
Q Consensus 253 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~ 331 (959)
|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..+..+ +|+.|+|++|.+++ +|
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp---------------- 502 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD---------------- 502 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG----------------
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc----------------
Confidence 5566666666663 454 566666666666666666 445555544 35555555555553 22
Q ss_pred CCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccC-CccccCcCcCCEEe
Q 002149 332 PTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL-SPSVGNLDSLTQIK 410 (959)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ 410 (959)
.++.+++|+.|+|++|+|++.+ |..++++++|+.|+
T Consensus 503 -------------------------------------------~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 503 -------------------------------------------GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp -------------------------------------------GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred -------------------------------------------ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 1234477888888888888776 88888888888888
Q ss_pred CcccccccccCCC---ccCCCCCCeEeC
Q 002149 411 LQSNNISGQIPTN---WTNLKSLTLLDL 435 (959)
Q Consensus 411 L~~N~l~g~~p~~---l~~l~~L~~L~L 435 (959)
|++|.|++.+|.. +..+++|+.|||
T Consensus 540 L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 540 LQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred ecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 8888888654422 234788888865
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-17 Score=168.96 Aligned_cols=154 Identities=18% Similarity=0.190 Sum_probs=107.5
Q ss_pred cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccc
Q 002149 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~ 179 (959)
.++++|++|+|++|.|+..+ .+..+++|++|+|++|.++.++ .+..+++|++|+|++|++++ ..+..+..+++
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~----~~~~~l~~l~~ 113 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS----DKIPNLSGLTS 113 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG----GGSCCCTTCTT
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc----ccChhhcCCCC
Confidence 55667777888888777443 6777777888888887766554 47777888888888887764 34566677777
Q ss_pred cCeecccccccCCCCChhhcCCCCCCEEEecCCc-CCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN-LTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
|+.|++++|++++..|..+..+++|++|+|++|+ ++ .+| . +..+++|++|+|
T Consensus 114 L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~-------------------------l~~l~~L~~L~l 166 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-P-------------------------LKTLPELKSLNI 166 (197)
T ss_dssp CCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-G-------------------------GGGCSSCCEEEC
T ss_pred CCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-h-------------------------hcCCCCCCEEEC
Confidence 7777777777777677777777788888888777 44 333 2 455677778888
Q ss_pred cCccccccCchhhcCCCCCCEEeCCCCcCCC
Q 002149 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289 (959)
Q Consensus 259 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 289 (959)
++|++++ ++ .+..+++|++|++++|+|.+
T Consensus 167 ~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 167 QFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 8887774 33 67777777777777777753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.6e-17 Score=167.93 Aligned_cols=154 Identities=24% Similarity=0.343 Sum_probs=125.1
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
+.++++++.++.++..+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|+.
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--------------------- 78 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--------------------- 78 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC---------------------
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC---------------------
Confidence 356677777776655443 677888888888888777777777777777777776652
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
..+..|..+++|+.|+|++|+|++..+.. +..+++|++|+|++|+|+
T Consensus 79 -------i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~-------------------------~~~l~~L~~L~Ls~N~l~- 125 (229)
T 3e6j_A 79 -------LPVGVFDSLTQLTVLDLGTNQLTVLPSAV-------------------------FDRLVHLKELFMCCNKLT- 125 (229)
T ss_dssp -------CCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCCC-
T ss_pred -------cChhhcccCCCcCEEECCCCcCCccChhH-------------------------hCcchhhCeEeccCCccc-
Confidence 33456788999999999999999766655 466799999999999999
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
.+|..+..+++|++|+|++|+|++..+..+..+ +|+.|+|++|.+.+..+
T Consensus 126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 789999999999999999999998888888887 69999999999986543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.72 E-value=9.5e-20 Score=218.55 Aligned_cols=362 Identities=14% Similarity=0.118 Sum_probs=186.1
Q ss_pred CcEEEEEecCCcccccCccccc-CCCCCcEEeccCC-cCCCC-CCC-ccCCCCccEEecCCCCCCCCChhhhc----CCC
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLN-QLSKLENIGLQKN-QFRGE-LPS-FSGLSNLKYAYLDGNNFDTIPADFFD----GLE 150 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~-~l~~L~~L~Ls~N-~l~~~-~~~-~~~l~~L~~L~L~~N~l~~i~~~~~~----~l~ 150 (959)
.++++|+|+++.+++..+..+. .+++|++|+|++| .++.. .+. +.++++|++|+|++|.++......+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4677777777777665555554 5677777777777 44331 222 34567777777777776654433333 455
Q ss_pred CCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcC-------CCCCCcccc
Q 002149 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNL-------TGPIPESFK 223 (959)
Q Consensus 151 ~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l-------~~~~p~~~~ 223 (959)
+|++|+|++|. ..+....++..+..+++|+.|++++|...+.++..+..+++|+.|+++.+.. .+ ++..+.
T Consensus 185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALS 262 (594)
T ss_dssp CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHH
T ss_pred cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHh
Confidence 77777777775 1111112222234457777777777632223566666677777777554431 11 111111
Q ss_pred cC-Ccccc-cccccCCCCcccccccccCCcCCcEEEccCccccccC-chhhcCCCCCCEEeCCCCcCCCC-Cccccccc-
Q 002149 224 GL-NLVNL-WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI-PESFGKLTSLKDLNLNSNQFVGL-IPPSLASL- 298 (959)
Q Consensus 224 ~l-~l~~L-~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~- 298 (959)
++ ++..| .+.+.. .......+..+++|++|+|++|.+++.. +..+..+++|++|+|++| ++.. ++.....+
T Consensus 263 ~~~~L~~Ls~~~~~~---~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~ 338 (594)
T 2p1m_B 263 GCKELRCLSGFWDAV---PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCK 338 (594)
T ss_dssp TCTTCCEEECCBTCC---GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCT
T ss_pred cCCCcccccCCcccc---hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCC
Confidence 11 12222 111111 1111122335677777777777766432 233556777777777776 3321 11111222
Q ss_pred cCCeEeCC---------CCcCCCC--------CCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccc
Q 002149 299 SLDHLDLN---------NNMFMGP--------VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTS 361 (959)
Q Consensus 299 ~L~~L~L~---------~N~l~~~--------ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 361 (959)
+|+.|+|+ .|.+++. .|.... +.+..+.++. .....+.. .+..+..+...
T Consensus 339 ~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~--L~~~~~~l~~--------~~~~~l~~---~~~~L~~L~L~ 405 (594)
T 2p1m_B 339 DLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES--VLYFCRQMTN--------AALITIAR---NRPNMTRFRLC 405 (594)
T ss_dssp TCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE--EEEEESCCCH--------HHHHHHHH---HCTTCCEEEEE
T ss_pred CCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHH--HHHhcCCcCH--------HHHHHHHh---hCCCcceeEee
Confidence 47777663 2333321 111111 1122222210 00111111 11112222222
Q ss_pred cCCCCCCCccc--------ccccCCCCcccEEECCCCcccccCCccccC-cCcCCEEeCcccccccccCCCc-cCCCCCC
Q 002149 362 WSGNDPCKSWL--------GLSCGTNSKLTVLNLPNFNLSGTLSPSVGN-LDSLTQIKLQSNNISGQIPTNW-TNLKSLT 431 (959)
Q Consensus 362 ~~~~~~~~~~~--------~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~g~~p~~l-~~l~~L~ 431 (959)
+.+...|.... ...+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+
T Consensus 406 ~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~ 484 (594)
T 2p1m_B 406 IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484 (594)
T ss_dssp ESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCC
T ss_pred cccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcC
Confidence 11111111111 01134457899999977 677666666665 7889999999998876655555 6688899
Q ss_pred eEeCCCCccCCCCC-----CCCCcceecccCCCC
Q 002149 432 LLDLSQNNLSPPLP-----KFSGAVKLSLDGNPL 460 (959)
Q Consensus 432 ~L~Ls~N~l~~~~p-----~~~~~~~~~l~~N~~ 460 (959)
.|+|++|++++... .+.++..+.+.+|+.
T Consensus 485 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp EEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred EEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 99999998854322 245667788887754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.9e-18 Score=179.25 Aligned_cols=169 Identities=20% Similarity=0.259 Sum_probs=115.2
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCc
Q 002149 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 160 (959)
++.+++..+++++. + .+..+++|++|++++|.|+... .+..+++|++|+|++|+|+.+++ |.++++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 34445556666532 3 4677778888888888777543 67777888888888888887776 777888888888888
Q ss_pred ccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCc
Q 002149 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGF 240 (959)
Q Consensus 161 ~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l 240 (959)
++++ +|.... ++|+.|++++|++++. ..+..+++|+.|+|++|++++. + .
T Consensus 96 ~l~~-----l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~------------------- 145 (263)
T 1xeu_A 96 RLKN-----LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-M------------------- 145 (263)
T ss_dssp CCSC-----CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-G-------------------
T ss_pred ccCC-----cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-H-------------------
Confidence 7774 332222 6777777777777753 3467777777777777777643 2 1
Q ss_pred ccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCc
Q 002149 241 TGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292 (959)
Q Consensus 241 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 292 (959)
+..+++|++|+|++|++++. ..+..+++|+.|+|++|++++.+.
T Consensus 146 ------l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 146 ------LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPV 189 (263)
T ss_dssp ------GGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred ------HccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCcc
Confidence 44567777777777777754 566777777777777777775543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.6e-19 Score=210.69 Aligned_cols=127 Identities=24% Similarity=0.296 Sum_probs=106.2
Q ss_pred CCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCccc
Q 002149 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC 330 (959)
Q Consensus 252 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~ 330 (959)
+|..+.+++|.+++ +|. ..|+.|+|++|+|++ +|. +..+ +|+.|+|++|.|+ .+|..
T Consensus 424 ~L~~l~l~~n~i~~-l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~------------- 481 (567)
T 1dce_A 424 DLRSKFLLENSVLK-MEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA------------- 481 (567)
T ss_dssp HHHHHHHHHHHHHH-HHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG-------------
T ss_pred hhhhhhhhcccccc-cCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh-------------
Confidence 45566677777773 332 259999999999997 455 7777 6999999999998 56642
Q ss_pred CCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEe
Q 002149 331 QPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410 (959)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 410 (959)
++.+++|+.|+|++|+|++ +| .++++++|+.|+
T Consensus 482 ---------------------------------------------~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~ 514 (567)
T 1dce_A 482 ---------------------------------------------LAALRCLEVLQASDNALEN-VD-GVANLPRLQELL 514 (567)
T ss_dssp ---------------------------------------------GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEE
T ss_pred ---------------------------------------------hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEE
Confidence 2356899999999999997 67 899999999999
Q ss_pred Cccccccccc-CCCccCCCCCCeEeCCCCccCCCCCCC
Q 002149 411 LQSNNISGQI-PTNWTNLKSLTLLDLSQNNLSPPLPKF 447 (959)
Q Consensus 411 L~~N~l~g~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 447 (959)
|++|+|++.+ |..|..|++|+.|+|++|+|++.+|..
T Consensus 515 Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 9999999877 999999999999999999999987753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-17 Score=175.94 Aligned_cols=170 Identities=23% Similarity=0.293 Sum_probs=145.9
Q ss_pred CCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcccc
Q 002149 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQL 180 (959)
Q Consensus 101 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L 180 (959)
.+.+|..+++++|.+++.. .+..+++|++|+|++|+|+.++ .+..+++|++|+|++|+|++ ++. +..+++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~-----~~~-l~~l~~L 87 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD-----LSP-LKDLTKL 87 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-----CGG-GTTCSSC
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC-----Chh-hccCCCC
Confidence 5667888999999998765 6888999999999999999988 58999999999999999985 444 8899999
Q ss_pred CeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccC
Q 002149 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG 260 (959)
Q Consensus 181 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~ 260 (959)
+.|++++|++++. |. +.. ++|+.|+|++|++++. + . +..+++|++|+|++
T Consensus 88 ~~L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~-------------------------l~~l~~L~~L~Ls~ 137 (263)
T 1xeu_A 88 EELSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-S-------------------------LIHLKNLEILSIRN 137 (263)
T ss_dssp CEEECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-G-------------------------GTTCTTCCEEECTT
T ss_pred CEEECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-h-------------------------hcCcccccEEECCC
Confidence 9999999999874 33 233 8999999999999853 2 2 56789999999999
Q ss_pred ccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCC
Q 002149 261 NHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGP 313 (959)
Q Consensus 261 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ 313 (959)
|++++. + .+..+++|++|+|++|++++. ..+..+ +|+.|+|++|.+++.
T Consensus 138 N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 138 NKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp SCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 999964 4 789999999999999999987 556666 699999999999865
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=8.6e-17 Score=162.99 Aligned_cols=155 Identities=17% Similarity=0.215 Sum_probs=132.5
Q ss_pred CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcC
Q 002149 121 SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGN 200 (959)
Q Consensus 121 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~ 200 (959)
....+++|++|+|++|+|+.++ .+..+++|++|+|++|.++. +..+..+++|++|++++|++++..+..+..
T Consensus 39 ~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~------~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~ 110 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN------YNPISGLSNLERLRIMGKDVTSDKIPNLSG 110 (197)
T ss_dssp BHHHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC------CGGGTTCTTCCEEEEECTTCBGGGSCCCTT
T ss_pred ChhhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc------chhhhcCCCCCEEEeECCccCcccChhhcC
Confidence 4567889999999999999888 48999999999999997753 457889999999999999999888889999
Q ss_pred CCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc-ccccCchhhcCCCCCCE
Q 002149 201 FASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH-FSGTIPESFGKLTSLKD 279 (959)
Q Consensus 201 l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~ 279 (959)
+++|++|+|++|++++..+.. +..+++|++|+|++|+ ++ .+| .+..+++|++
T Consensus 111 l~~L~~L~Ls~n~i~~~~~~~-------------------------l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~ 163 (197)
T 4ezg_A 111 LTSLTLLDISHSAHDDSILTK-------------------------INTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKS 163 (197)
T ss_dssp CTTCCEEECCSSBCBGGGHHH-------------------------HTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCE
T ss_pred CCCCCEEEecCCccCcHhHHH-------------------------HhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCE
Confidence 999999999999999766655 5677999999999998 66 566 7999999999
Q ss_pred EeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC
Q 002149 280 LNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312 (959)
Q Consensus 280 L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~ 312 (959)
|+|++|++++.. .+..+ +|+.|++++|++.+
T Consensus 164 L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 164 LNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp EECTTBCCCCCT--TGGGCSSCCEEEECBC----
T ss_pred EECCCCCCcChH--HhccCCCCCEEEeeCcccCC
Confidence 999999999743 56666 69999999999864
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-17 Score=203.09 Aligned_cols=116 Identities=22% Similarity=0.320 Sum_probs=55.5
Q ss_pred CccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCC
Q 002149 171 PKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM 250 (959)
Q Consensus 171 p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l 250 (959)
|..+..++.|+.|+|++|++. .+|..+..+++|++|+|++|+|+ .+|.. ++++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~-------------------------~~~l 269 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAE-------------------------IKNL 269 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGG-------------------------GGGG
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChh-------------------------hhCC
Confidence 344455555555555555554 34444445555555555555555 34433 2334
Q ss_pred cCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 251 DQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 251 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|..+ +|+.|+|++|.|++.+|
T Consensus 270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 55555555555555 44555555555555555555554 333334444 35555555555544333
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=8.4e-19 Score=210.26 Aligned_cols=325 Identities=16% Similarity=0.134 Sum_probs=193.2
Q ss_pred CcEEEEEecCC-ccccc-CcccccCCCCCcEEeccCCcCCCCCC----C-ccCCCCccEEecCCCCCCCCChhhh----c
Q 002149 79 SRVTQIQVSSV-GLKGT-LPQNLNQLSKLENIGLQKNQFRGELP----S-FSGLSNLKYAYLDGNNFDTIPADFF----D 147 (959)
Q Consensus 79 ~~v~~l~l~~~-~l~g~-~~~~l~~l~~L~~L~Ls~N~l~~~~~----~-~~~l~~L~~L~L~~N~l~~i~~~~~----~ 147 (959)
.+++.|+|.++ .++.. ++..+.++++|++|+|++|.+++..+ . ...+++|++|+|++|. ..+....+ .
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHH
Confidence 58999999988 55543 45556689999999999999877544 2 2367899999999997 44444333 4
Q ss_pred CCCCCcEEEccCc-ccCCCCCCCCCccccCccccCeecccccc--------------------------cC----CCCCh
Q 002149 148 GLENLQVLALDSN-NFNASKGWSFPKGLQSSAQLTNLSCMSCN--------------------------LA----GQLPD 196 (959)
Q Consensus 148 ~l~~L~~L~Ls~N-~l~~~~~~~lp~~l~~l~~L~~L~l~~n~--------------------------l~----~~~p~ 196 (959)
.+++|++|+|++| .+. .++..+..+++|+.|++..+. +. ..++.
T Consensus 209 ~~~~L~~L~L~~~~~~~-----~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~ 283 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLE-----KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283 (594)
T ss_dssp HCTTCCEEECCTTSCHH-----HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGG
T ss_pred hCCCCcEEecCCCCcHH-----HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHH
Confidence 5699999999988 322 245555556666666544331 11 12333
Q ss_pred hhcCCCCCCEEEecCCcCCCCCCcc-cccC-CcccccccccCCCCcccccccccCCcCCcEEEcc---------Cccccc
Q 002149 197 FLGNFASLQNLKLSGNNLTGPIPES-FKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH---------GNHFSG 265 (959)
Q Consensus 197 ~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~---------~N~l~~ 265 (959)
.+..+++|++|+|++|.+++..... +..+ +++.|.+.++. .-.+.......+++|++|+|+ .|.+++
T Consensus 284 ~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~--~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~ 361 (594)
T 2p1m_B 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYI--EDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTE 361 (594)
T ss_dssp GHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGG--HHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCH
T ss_pred HHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCcc--CHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCH
Confidence 3345678888888888865322211 1222 45555555441 001111122346778888773 345554
Q ss_pred cCchhhc-CCCCCCEEeCCCCcCCCCCcccccc-c-cCCeEeCC--C----CcCCCCCCcccccccccccCcccCCCCCC
Q 002149 266 TIPESFG-KLTSLKDLNLNSNQFVGLIPPSLAS-L-SLDHLDLN--N----NMFMGPVPKSKAYKYSYSSNAFCQPTEGV 336 (959)
Q Consensus 266 ~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~-~-~L~~L~L~--~----N~l~~~ip~~~~~~~~~~~~~~~~~~~~~ 336 (959)
.....+. .+++|++|+++.|++++.....+.. + +|+.|+|+ + |.+++. |..
T Consensus 362 ~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~-~~~------------------- 421 (594)
T 2p1m_B 362 QGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE-PLD------------------- 421 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCC-CTH-------------------
T ss_pred HHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCC-chh-------------------
Confidence 3333333 3778888888778777655544432 3 57888887 3 444321 100
Q ss_pred CCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccC-CCCcccEEECCCCcccccCCccc-cCcCcCCEEeCccc
Q 002149 337 PCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCG-TNSKLTVLNLPNFNLSGTLSPSV-GNLDSLTQIKLQSN 414 (959)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N 414 (959)
..+..+..... .+..+.. .+....... ..++ .+++|+.|+|++|.+++..+..+ ..+++|++|+|++|
T Consensus 422 ---~~~~~l~~~~~---~L~~L~L---~~~l~~~~~-~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 422 ---IGFGAIVEHCK---DLRRLSL---SGLLTDKVF-EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp ---HHHHHHHHHCT---TCCEEEC---CSSCCHHHH-HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred ---hHHHHHHhhCC---CccEEee---cCcccHHHH-HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 00000000000 0011100 000000000 0011 25789999999999987766655 67899999999999
Q ss_pred ccccccCC-CccCCCCCCeEeCCCCccC
Q 002149 415 NISGQIPT-NWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 415 ~l~g~~p~-~l~~l~~L~~L~Ls~N~l~ 441 (959)
.+++..+. .+..+++|+.|++++|+++
T Consensus 492 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 492 PFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp SCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred CCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 99765444 4556899999999999985
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=2.8e-16 Score=158.32 Aligned_cols=140 Identities=23% Similarity=0.379 Sum_probs=123.0
Q ss_pred CCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCC--ccCCCCccEEecCCCCCCCCCh
Q 002149 66 CGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPS--FSGLSNLKYAYLDGNNFDTIPA 143 (959)
Q Consensus 66 C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~--~~~l~~L~~L~L~~N~l~~i~~ 143 (959)
||..| .|.. +.|++++++++ .+|..+.. +|++|+|++|+|++.++. |.++++|++|+|++|+|+++++
T Consensus 2 CP~~C----~C~~---~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 71 (192)
T 1w8a_A 2 CPAMC----HCEG---TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71 (192)
T ss_dssp CCTTS----EEET---TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCT
T ss_pred cCCCC----EECC---CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCH
Confidence 65544 4653 56888999986 77877654 899999999999998884 8999999999999999999999
Q ss_pred hhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC
Q 002149 144 DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219 (959)
Q Consensus 144 ~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 219 (959)
..|.++++|++|+|++|+|++ ..+..+..+++|+.|+|++|++++..|..|..+++|++|+|++|.+++..+
T Consensus 72 ~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 72 NAFEGASHIQELQLGENKIKE----ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp TTTTTCTTCCEEECCSCCCCE----ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred hHcCCcccCCEEECCCCcCCc----cCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999999999999999999996 345568899999999999999999999999999999999999999997644
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=3.9e-16 Score=157.31 Aligned_cols=131 Identities=27% Similarity=0.356 Sum_probs=75.8
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChh-hhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeec
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPAD-FFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~ 184 (959)
++|++++|.++.++..+.. +|++|+|++|+|+.+++. .|..+++|++|+|++|+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~----------------------- 65 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ----------------------- 65 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSC-----------------------
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCC-----------------------
Confidence 3455555555443333321 445555555555544432 34444444444444444
Q ss_pred ccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc
Q 002149 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264 (959)
Q Consensus 185 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~ 264 (959)
+++..|..|.++++|++|+|++|+|++..+.. +.++++|++|+|++|+|+
T Consensus 66 -----l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------------~~~l~~L~~L~L~~N~l~ 115 (192)
T 1w8a_A 66 -----LTGIEPNAFEGASHIQELQLGENKIKEISNKM-------------------------FLGLHQLKTLNLYDNQIS 115 (192)
T ss_dssp -----CCCBCTTTTTTCTTCCEEECCSCCCCEECSSS-------------------------STTCTTCCEEECCSSCCC
T ss_pred -----CCCcCHhHcCCcccCCEEECCCCcCCccCHHH-------------------------hcCCCCCCEEECCCCcCC
Confidence 44445566666777777777777777655544 344567777777777777
Q ss_pred ccCchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 265 GTIPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
+.+|..|..+++|++|+|++|.+.+..
T Consensus 116 ~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 116 CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred eeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 666777777777777777777776543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=5.8e-16 Score=169.62 Aligned_cols=138 Identities=14% Similarity=0.118 Sum_probs=101.1
Q ss_pred CcccCcccccCceEEEEEEEcCCcEEEEEEccccccc---------------H-----HHHHHHHHHHHHHHhcCCCCce
Q 002149 613 FASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS---------------K-----KAVDEFHSEIAVLSKVRHRHLV 672 (959)
Q Consensus 613 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------~-----~~~~~~~~E~~~l~~l~h~niv 672 (959)
|++...||+|+||.||+|...+|+.||||+++....+ . .......+|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 8999999999999999999889999999987532110 0 0011234577777777655443
Q ss_pred eEEEEEEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC
Q 002149 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD 752 (959)
Q Consensus 673 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~ 752 (959)
-..-+... ..+|||||+++++|.++.. ......++.|++.+|.|||+ .|||||||||.|||+++
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred CCeeeecc--CceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence 22112122 3379999999988865431 11245688999999999999 89999999999999987
Q ss_pred CC----------cEEEeecccccc
Q 002149 753 DF----------RAKVSDFGLVKL 766 (959)
Q Consensus 753 ~~----------~~ki~DfGla~~ 766 (959)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997754
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=151.67 Aligned_cols=139 Identities=23% Similarity=0.363 Sum_probs=119.0
Q ss_pred CCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCCh
Q 002149 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPA 143 (959)
Q Consensus 64 ~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 143 (959)
..||..| .|.. +.|++++++++ .+|..+. ++|++|+|++|+|+.++..|.++++|++|+|++|+|+.+++
T Consensus 2 ~~CP~~C----~C~~---~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~ 71 (193)
T 2wfh_A 2 SRCPTEC----TCLD---TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSN 71 (193)
T ss_dssp --CCTTC----EEET---TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCT
T ss_pred CCCCCCC----EeCC---CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCH
Confidence 3576544 5543 35788888888 6776654 68999999999999776689999999999999999999999
Q ss_pred hhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC
Q 002149 144 DFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216 (959)
Q Consensus 144 ~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 216 (959)
..|.++++|++|+|++|+|+.+ .|..+..+++|+.|+|++|+++...+..|..+++|+.|+|++|.+..
T Consensus 72 ~~f~~l~~L~~L~Ls~N~l~~i----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 72 QSFSNMTQLLTLILSYNRLRCI----PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp TTTTTCTTCCEEECCSSCCCBC----CTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred hHccCCCCCCEEECCCCccCEe----CHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9999999999999999999963 34568899999999999999998877889999999999999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.9e-15 Score=146.62 Aligned_cols=131 Identities=24% Similarity=0.357 Sum_probs=111.6
Q ss_pred EEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCc
Q 002149 82 TQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160 (959)
Q Consensus 82 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 160 (959)
+.|++.+++++ .+|..+. ++|++|+|++|++++.++ .|.++++|++|+|++|+|+.+++..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34555666666 4554443 689999999999998887 4799999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC
Q 002149 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219 (959)
Q Consensus 161 ~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 219 (959)
+|++. .+..+..+++|+.|++++|++++..+..+..+++|+.|+|++|.+.+..|
T Consensus 87 ~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSL----PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCC----CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred Ccccc----CHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99852 33456889999999999999998777778999999999999999997655
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=148.05 Aligned_cols=137 Identities=17% Similarity=0.175 Sum_probs=121.7
Q ss_pred CcEEEEEecCCccc-ccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|++++++++ +.+|..+..+++|++|+|++|.|++. +.|..+++|++|+|++|+|+...+..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 47899999999998 88999999999999999999999988 78999999999999999999977777888999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCC---hhhcCCCCCCEEEecCCcCCCCCCc
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP---DFLGNFASLQNLKLSGNNLTGPIPE 220 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p---~~l~~l~~L~~L~Ls~N~l~~~~p~ 220 (959)
++|+|+++. .+..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 103 s~N~l~~~~---~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDIS---TLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSG---GGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcch---hHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999998521 12678899999999999999997766 58999999999999999987 3443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=5.4e-16 Score=170.77 Aligned_cols=125 Identities=14% Similarity=0.118 Sum_probs=89.7
Q ss_pred cCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcc
Q 002149 251 DQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAF 329 (959)
Q Consensus 251 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~ 329 (959)
.++..+.+.++-...........+++|+.|+|++|+++.+.+..|..+ +|+.|+|.+| ++. |+.
T Consensus 202 ~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~-I~~------------- 266 (329)
T 3sb4_A 202 RDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKT-IGQ------------- 266 (329)
T ss_dssp GGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCE-ECT-------------
T ss_pred cccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cce-ehH-------------
Confidence 445555555442221111111237888888888888887777788877 5888888877 432 221
Q ss_pred cCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCccc-EEECCCCcccccCCccccCcCcCCE
Q 002149 330 CQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT-VLNLPNFNLSGTLSPSVGNLDSLTQ 408 (959)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~ 408 (959)
..|..+++|+ .|+|.+ ++....+.+|.++++|+.
T Consensus 267 --------------------------------------------~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 267 --------------------------------------------RVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp --------------------------------------------TTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred --------------------------------------------HHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 2345568898 999988 777677889999999999
Q ss_pred EeCcccccccccCCCccCCCCCCeEeC
Q 002149 409 IKLQSNNISGQIPTNWTNLKSLTLLDL 435 (959)
Q Consensus 409 L~L~~N~l~g~~p~~l~~l~~L~~L~L 435 (959)
|+|++|+++...+..|.++++|+.++.
T Consensus 302 l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEeCCCccCccchhhhcCCcchhhhcc
Confidence 999999999777778999999998874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.58 E-value=5.6e-15 Score=145.37 Aligned_cols=134 Identities=21% Similarity=0.247 Sum_probs=94.6
Q ss_pred CCCCcEEeccCCcCC-CCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccc
Q 002149 102 LSKLENIGLQKNQFR-GELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179 (959)
Q Consensus 102 l~~L~~L~Ls~N~l~-~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~ 179 (959)
.++|++|+|++|.++ +.+| .|..+++|++|+|++|.|+.+ ..|..+++|++|+|++|+++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~---------------- 84 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIF---------------- 84 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCC----------------
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCc----------------
Confidence 366777777777776 3444 456677777777777777666 44666666666666666554
Q ss_pred cCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC-cccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP-ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
+.+|..+..+++|+.|+|++|++++... .. +..+++|++|+|
T Consensus 85 ------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------------------l~~l~~L~~L~l 127 (168)
T 2ell_A 85 ------------GGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-------------------------LKKLECLKSLDL 127 (168)
T ss_dssp ------------SCCCHHHHHCTTCCEEECBSSSCCSSGGGGG-------------------------GSSCSCCCEEEC
T ss_pred ------------hHHHHHHhhCCCCCEEeccCCccCcchhHHH-------------------------HhcCCCCCEEEe
Confidence 3456667778888888888888875322 22 566788888888
Q ss_pred cCccccccCc---hhhcCCCCCCEEeCCCCcCCCC
Q 002149 259 HGNHFSGTIP---ESFGKLTSLKDLNLNSNQFVGL 290 (959)
Q Consensus 259 ~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~ 290 (959)
++|.+++..+ ..+..+++|++|++++|.+...
T Consensus 128 ~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 128 FNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred eCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 8888885544 4788888899999988888744
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=9.2e-15 Score=147.17 Aligned_cols=71 Identities=30% Similarity=0.390 Sum_probs=39.0
Q ss_pred CCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhc
Q 002149 193 QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272 (959)
Q Consensus 193 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 272 (959)
..+..|.++++|++|+|++|+|++..+.. |..+++|++|+|++|+|++..+..|.
T Consensus 69 i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~-------------------------f~~l~~L~~L~L~~N~l~~~~~~~~~ 123 (193)
T 2wfh_A 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRT-------------------------FDGLKSLRLLSLHGNDISVVPEGAFN 123 (193)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCBCCTTT-------------------------TTTCTTCCEEECCSSCCCBCCTTTTT
T ss_pred eCHhHccCCCCCCEEECCCCccCEeCHHH-------------------------hCCCCCCCEEECCCCCCCeeChhhhh
Confidence 33445555566666666666665544443 33445566666666666544444555
Q ss_pred CCCCCCEEeCCCCcCC
Q 002149 273 KLTSLKDLNLNSNQFV 288 (959)
Q Consensus 273 ~l~~L~~L~Ls~N~l~ 288 (959)
.+++|+.|+|++|.+.
T Consensus 124 ~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 124 DLSALSHLAIGANPLY 139 (193)
T ss_dssp TCTTCCEEECCSSCEE
T ss_pred cCccccEEEeCCCCee
Confidence 5566666666655554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.3e-14 Score=142.36 Aligned_cols=133 Identities=23% Similarity=0.306 Sum_probs=92.1
Q ss_pred CcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeec
Q 002149 105 LENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184 (959)
Q Consensus 105 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~ 184 (959)
.+.+++++|+++..+..+. ++|++|+|++|+++.+++..|..+++|++|+|++|+|+.
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------- 66 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-------------------- 66 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--------------------
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE--------------------
Confidence 3567777777776654432 577777777777777777777777777777777776653
Q ss_pred ccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccc
Q 002149 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFS 264 (959)
Q Consensus 185 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~ 264 (959)
..+..|..+++|+.|+|++|+|++..+.. +..+++|++|+|++|+++
T Consensus 67 --------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~ 113 (177)
T 2o6r_A 67 --------LPDGVFDKLTKLTILYLHENKLQSLPNGV-------------------------FDKLTQLKELALDTNQLK 113 (177)
T ss_dssp --------CCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEECCSSCCS
T ss_pred --------eChhHccCCCccCEEECCCCCccccCHHH-------------------------hhCCcccCEEECcCCcce
Confidence 33344566777777777777777555444 345677778888888877
Q ss_pred ccCchhhcCCCCCCEEeCCCCcCCCCCc
Q 002149 265 GTIPESFGKLTSLKDLNLNSNQFVGLIP 292 (959)
Q Consensus 265 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 292 (959)
+..+..|..+++|++|+|++|.+.+..|
T Consensus 114 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 114 SVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6555566777788888888887776544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.55 E-value=6.8e-15 Score=141.59 Aligned_cols=129 Identities=18% Similarity=0.190 Sum_probs=112.1
Q ss_pred CcEEEEEecCCccc-ccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
.+++.|++++++++ +.+|..+..+++|++|+|++|.+++. +.|.++++|++|+|++|+|+...+..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 47889999999998 88899899999999999999999887 77899999999999999999977777888999999999
Q ss_pred cCcccCCCCCCCCCccccCccccCeecccccccCCCCC---hhhcCCCCCCEEEecC
Q 002149 158 DSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP---DFLGNFASLQNLKLSG 211 (959)
Q Consensus 158 s~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p---~~l~~l~~L~~L~Ls~ 211 (959)
++|++++. ..+..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 96 s~N~i~~~---~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDL---STIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSH---HHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCCh---HHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99998842 123678889999999999999987766 5788899999998864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=140.10 Aligned_cols=128 Identities=22% Similarity=0.288 Sum_probs=89.2
Q ss_pred CCCCcEEeccCCcCC-CCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccc
Q 002149 102 LSKLENIGLQKNQFR-GELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179 (959)
Q Consensus 102 l~~L~~L~Ls~N~l~-~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~ 179 (959)
.++|+.|++++|.++ +.+| .+..+++|++|+|++|+|+.+ ..|..+++|++|+|++|+++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~---------------- 77 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVS---------------- 77 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCC----------------
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCccc----------------
Confidence 356777777777776 4444 456677777777777777666 44666666666666666554
Q ss_pred cCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCC-CcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI-PESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
+.+|..+..+++|++|++++|++++.. +.. +..+++|++|++
T Consensus 78 ------------~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~-------------------------~~~l~~L~~L~l 120 (149)
T 2je0_A 78 ------------GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-------------------------LKKLENLKSLDL 120 (149)
T ss_dssp ------------SCTHHHHHHCTTCCEEECTTSCCCSHHHHGG-------------------------GGGCTTCCEEEC
T ss_pred ------------chHHHHhhhCCCCCEEECCCCcCCChHHHHH-------------------------HhhCCCCCEEeC
Confidence 345666777888888888888887531 232 566788888888
Q ss_pred cCccccccCc---hhhcCCCCCCEEeCCC
Q 002149 259 HGNHFSGTIP---ESFGKLTSLKDLNLNS 284 (959)
Q Consensus 259 ~~N~l~~~~p---~~~~~l~~L~~L~Ls~ 284 (959)
++|++++..+ ..+..+++|++|++++
T Consensus 121 ~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 121 FNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred cCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888886555 5788888888888764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.53 E-value=7.6e-15 Score=161.57 Aligned_cols=260 Identities=12% Similarity=0.090 Sum_probs=157.3
Q ss_pred cEEEEEecCCcccccCcccccC-CCCCcEEeccCCcCC--------------------CCCC-CccC--------CCCcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQ-LSKLENIGLQKNQFR--------------------GELP-SFSG--------LSNLK 129 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~-l~~L~~L~Ls~N~l~--------------------~~~~-~~~~--------l~~L~ 129 (959)
+++.|.+.++ +.+.--..+.. +++|+.|||++|+|. .+++ .|.+ +++|+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~ 104 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLE 104 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCC
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCc
Confidence 5677776642 22111123444 788899999998887 1222 3555 66677
Q ss_pred EEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccc----cCCCCChhhcCCCCCC
Q 002149 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCN----LAGQLPDFLGNFASLQ 205 (959)
Q Consensus 130 ~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~----l~~~~p~~l~~l~~L~ 205 (959)
.|+|.+ +++.|+..+|.++++|+.|+|++|.+..+.. ..+..+.++..+.+..+. ........|.++.+|+
T Consensus 105 ~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~----~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 105 KVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLP----EALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp C-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECT----TSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred EEECCc-cccchhHHHhhcCcccceEEcCCCCccccch----hhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 777766 6666666667777777777777666654332 223344445555444321 1122223344444444
Q ss_pred -EEEecCCcCCCCCCcccc-----cCCcccccccccCCCCccccccc-ccCCcCCcEEEccCccccccCchhhcCCCCCC
Q 002149 206 -NLKLSGNNLTGPIPESFK-----GLNLVNLWLNDQKGGGFTGTIDV-LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLK 278 (959)
Q Consensus 206 -~L~Ls~N~l~~~~p~~~~-----~l~l~~L~~~~~~~~~l~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 278 (959)
.+.+.... .++..+. .-++..+.+...- ....... ...+++|+.|+|++|+++...+.+|.++++|+
T Consensus 180 ~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l---~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 180 TTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKL---DNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp EEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECC---CHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred eeEEecCCC---cHHHHHhhcccCccccceEEEeeee---cHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 33332211 1111100 0001111111100 0000000 12378999999999999976777899999999
Q ss_pred EEeCCCCcCCCCCcccccccc-CC-eEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCc
Q 002149 279 DLNLNSNQFVGLIPPSLASLS-LD-HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPP 356 (959)
Q Consensus 279 ~L~Ls~N~l~~~~p~~~~~~~-L~-~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (959)
.|+|.+| ++.+.+.+|..+. |+ .++|.+ .++. |+
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~-I~----------------------------------------- 289 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTA-IE----------------------------------------- 289 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCE-EC-----------------------------------------
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceE-Ec-----------------------------------------
Confidence 9999998 8888888999985 99 999987 4542 11
Q ss_pred ccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeC
Q 002149 357 RLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKL 411 (959)
Q Consensus 357 ~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 411 (959)
...|..+++|+.|+|++|++....+.+|.++++|+.|+.
T Consensus 290 ----------------~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 290 ----------------FGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ----------------TTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ----------------hhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 123556789999999999999888889999999999874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.8e-13 Score=151.24 Aligned_cols=59 Identities=14% Similarity=0.183 Sum_probs=27.6
Q ss_pred CCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCcc
Q 002149 379 NSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNL 440 (959)
Q Consensus 379 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l 440 (959)
+++|+.++|. +.+......+|.++++|+.|+|.+| ++..-+..|.++ +|+.|++++|.+
T Consensus 299 c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 299 CPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred CccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 3445555554 2344344444555555555555333 433333445555 555555555544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.48 E-value=3.7e-16 Score=158.44 Aligned_cols=154 Identities=25% Similarity=0.326 Sum_probs=93.0
Q ss_pred ccCCCCCcEEeccCCcCCCCCC-------CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCC
Q 002149 99 LNQLSKLENIGLQKNQFRGELP-------SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFP 171 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~-------~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp 171 (959)
+.....++.++++.|.+.+..| .|.++++|++|+|++|+|+.++ .|.++++|++|+|++|+++ .+|
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~--~~~~l~~L~~L~l~~n~l~-----~l~ 86 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIK-----KIE 86 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC--CHHHHTTCCEEEEEEEEEC-----SCS
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc--ccccCCCCCEEECCCCCcc-----ccc
Confidence 4555666777777777766554 3556666677777766666665 4666677777777777665 345
Q ss_pred ccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC-cccccCCcccccccccCCCCcccccccccCC
Q 002149 172 KGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP-ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM 250 (959)
Q Consensus 172 ~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l 250 (959)
..+..+++|+.|++++|++++ +| .+..+++|+.|+|++|++++..+ .. +..+
T Consensus 87 ~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~-------------------------l~~l 139 (198)
T 1ds9_A 87 NLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDK-------------------------LAAL 139 (198)
T ss_dssp SHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHH-------------------------HTTT
T ss_pred chhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHH-------------------------HhcC
Confidence 555555666666666666654 23 45666666666666666653211 11 4455
Q ss_pred cCCcEEEccCccccccCch----------hhcCCCCCCEEeCCCCcCC
Q 002149 251 DQLRTLWLHGNHFSGTIPE----------SFGKLTSLKDLNLNSNQFV 288 (959)
Q Consensus 251 ~~L~~L~L~~N~l~~~~p~----------~~~~l~~L~~L~Ls~N~l~ 288 (959)
++|++|++++|.+++.+|. .+..+++|+.|| +|.++
T Consensus 140 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp TTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6666666666666655443 255666666665 45444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.48 E-value=4.3e-14 Score=140.16 Aligned_cols=134 Identities=15% Similarity=0.200 Sum_probs=76.2
Q ss_pred ccCCCCCcEEeccCCcCCCCCCCccCCC-CccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCc
Q 002149 99 LNQLSKLENIGLQKNQFRGELPSFSGLS-NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~-~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l 177 (959)
+.++.+|+.|+|++|+++.. +.+..+. +|++|+|++|+|+.+ ..|..+++|++|+|++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N----------------- 74 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN----------------- 74 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSS-----------------
T ss_pred cCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCC-----------------
Confidence 34445555555555555533 3333332 455555555554444 23444444444444444
Q ss_pred cccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEE
Q 002149 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257 (959)
Q Consensus 178 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~ 257 (959)
++++..+..+..+++|+.|+|++|+|+ .+|.. ..+..+++|++|+
T Consensus 75 -----------~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~-----------------------~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 75 -----------RICRIGEGLDQALPDLTELILTNNSLV-ELGDL-----------------------DPLASLKSLTYLC 119 (176)
T ss_dssp -----------CCCEECSCHHHHCTTCCEEECCSCCCC-CGGGG-----------------------GGGGGCTTCCEEE
T ss_pred -----------cccccCcchhhcCCCCCEEECCCCcCC-cchhh-----------------------HhhhcCCCCCEEE
Confidence 444333444567777888888888775 33330 0145667788888
Q ss_pred ccCccccccCchh----hcCCCCCCEEeCCCCcCC
Q 002149 258 LHGNHFSGTIPES----FGKLTSLKDLNLNSNQFV 288 (959)
Q Consensus 258 L~~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 288 (959)
|++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8888877 45553 777788888888877765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.1e-13 Score=134.59 Aligned_cols=116 Identities=26% Similarity=0.470 Sum_probs=91.5
Q ss_pred CCCCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCC
Q 002149 63 GDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTI 141 (959)
Q Consensus 63 ~~~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i 141 (959)
...||..| .|.. +.+++++++++ .+|..+. ++|++|+|++|+|++.+| .|.++++|++|+|++|+|+.+
T Consensus 3 ~~~CP~~C----~C~~---~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i 72 (174)
T 2r9u_A 3 SAGCPSQC----SCDQ---TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAI 72 (174)
T ss_dssp CCSSCTTS----EECS---SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCC----EECC---cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCcc
Confidence 45676544 5642 57888998886 6777665 789999999999998877 688899999999999999999
Q ss_pred ChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCC
Q 002149 142 PADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216 (959)
Q Consensus 142 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 216 (959)
++..|.++++|++|+|++|+|+. ..+..|..+++|+.|+|++|.+..
T Consensus 73 ~~~~~~~l~~L~~L~L~~N~l~~----------------------------l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 73 PTGVFDKLTQLTQLDLNDNHLKS----------------------------IPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCC----------------------------CCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ChhHhCCcchhhEEECCCCccce----------------------------eCHHHhccccCCCEEEeCCCCccc
Confidence 98888889999999998888763 223446777888888888888774
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.47 E-value=6.5e-14 Score=138.86 Aligned_cols=128 Identities=18% Similarity=0.241 Sum_probs=113.6
Q ss_pred CcEEEEEecCCcccccCcccccCCC-CCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLS-KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLAL 157 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~L 157 (959)
..++.|++++|+++ .+|. +..+. +|++|+|++|.|++. +.|.++++|++|+|++|+|+.+++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 47899999999999 4554 55555 999999999999987 78999999999999999999999988899999999999
Q ss_pred cCcccCCCCCCCCCc--cccCccccCeecccccccCCCCCh----hhcCCCCCCEEEecCCcCC
Q 002149 158 DSNNFNASKGWSFPK--GLQSSAQLTNLSCMSCNLAGQLPD----FLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 158 s~N~l~~~~~~~lp~--~l~~l~~L~~L~l~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~l~ 215 (959)
++|+|+ .+|. .+..+++|+.|++++|.+.. +|. .+..+++|+.|++++|.+.
T Consensus 96 ~~N~i~-----~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLV-----ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCC-----CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCcCC-----cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999997 4665 78899999999999999985 455 4899999999999999876
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=5.4e-13 Score=131.20 Aligned_cols=112 Identities=27% Similarity=0.383 Sum_probs=87.4
Q ss_pred ceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCC
Q 002149 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLEN 151 (959)
Q Consensus 73 gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~ 151 (959)
.+.|. .+.|++++++++ .+|..+. ++|++|+|++|+|++.++ .|.++++|++|+|++|+|+.+++..|.++++
T Consensus 6 ~C~C~---~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~ 79 (170)
T 3g39_A 6 QCSCS---GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 79 (170)
T ss_dssp CCEEE---TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred cCCcC---CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCC
Confidence 33564 356788888888 4676663 788999999999988877 5888899999999999999988888888888
Q ss_pred CcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCC
Q 002149 152 LQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI 218 (959)
Q Consensus 152 L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 218 (959)
|++|+|++|+|+. ..+..|..+++|+.|+|++|.++...
T Consensus 80 L~~L~L~~N~l~~----------------------------~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 80 LTQLSLNDNQLKS----------------------------IPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCEEECCSSCCCC----------------------------CCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCEEECCCCccCE----------------------------eCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 8888888887763 33445677788888888888887543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3e-15 Score=151.66 Aligned_cols=60 Identities=23% Similarity=0.278 Sum_probs=37.7
Q ss_pred CcccEEECCCCcccccCC-ccccCcCcCCEEeCcccccccccCCC----------ccCCCCCCeEeCCCCccC
Q 002149 380 SKLTVLNLPNFNLSGTLS-PSVGNLDSLTQIKLQSNNISGQIPTN----------WTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 380 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~----------l~~l~~L~~L~Ls~N~l~ 441 (959)
++|+.|+|++|++.+..+ ..+..+++|++|+|++|.+++.+|.. +..+++|+.|| +|.++
T Consensus 115 ~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 445555555555553222 35666777777777777777666553 67778888776 56555
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-12 Score=126.50 Aligned_cols=88 Identities=22% Similarity=0.244 Sum_probs=63.3
Q ss_pred ccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 179 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
+|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+.. |.++++|++|+|
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~-------------------------f~~l~~L~~L~L 85 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGV-------------------------FDKLTQLTQLSL 85 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEEC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhh-------------------------ccCCCCCCEEEC
Confidence 4444444444455556677778888888888888888655554 456678888888
Q ss_pred cCccccccCchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 259 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
++|+|++..+..|..+++|++|+|++|.++...
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888888666667888888888888888887553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-11 Score=138.65 Aligned_cols=261 Identities=13% Similarity=0.201 Sum_probs=194.6
Q ss_pred EEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 81 VTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 81 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++.+.+.+ +++..-..+|.+. +|+.++|..| ++.+.. .|.++ +|+.+.|.+ .++.|...+|.++.+|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 33444433 3443334567764 7999999877 766666 68884 799999996 89999999999999999999999
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~ 239 (959)
|.++. ++.......+|+.+.+.+ ++...-..+|.++++|+.++|..| ++.+...+|
T Consensus 190 n~l~~-----I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF----------------- 245 (401)
T 4fdw_A 190 TKITK-----LPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAF----------------- 245 (401)
T ss_dssp SCCSE-----ECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTT-----------------
T ss_pred CcceE-----echhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccc-----------------
Confidence 99984 555555578999999984 477777889999999999999875 553444443
Q ss_pred cccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCC-----CCCccccccc-cCCeEeCCCCcCCCC
Q 002149 240 FTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFV-----GLIPPSLASL-SLDHLDLNNNMFMGP 313 (959)
Q Consensus 240 l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~~-~L~~L~L~~N~l~~~ 313 (959)
.+ .+|+.+.| .|.++..-..+|.++++|+.+++.+|.+. .+.+..|..+ +|+.++|.++ ++.
T Consensus 246 --------~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~-i~~- 313 (401)
T 4fdw_A 246 --------RE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES-IRI- 313 (401)
T ss_dssp --------TT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTT-CCE-
T ss_pred --------cc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCc-eEE-
Confidence 33 57888888 45566566778888888888888887765 4556667776 5888887743 431
Q ss_pred CCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 314 VPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 314 ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
|+ ...|..+.+|+.|+|..| +.
T Consensus 314 I~---------------------------------------------------------~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 314 LG---------------------------------------------------------QGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp EC---------------------------------------------------------TTTTTTCCSCCEEEECTT-CC
T ss_pred Eh---------------------------------------------------------hhhhcCCCCccEEEECcc-cc
Confidence 11 123445688999999655 77
Q ss_pred ccCCccccCcCcCCEEeCcccccccccCCCccCCC-CCCeEeCCCCccC
Q 002149 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLK-SLTLLDLSQNNLS 441 (959)
Q Consensus 394 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~-~L~~L~Ls~N~l~ 441 (959)
...+.+|.++ +|+.|+|++|.+....+..|.+++ .++.|++..|.+.
T Consensus 336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 6777889999 999999999998866667788884 7889998877654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.34 E-value=4.8e-12 Score=124.81 Aligned_cols=89 Identities=22% Similarity=0.274 Sum_probs=63.8
Q ss_pred cccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEE
Q 002149 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLW 257 (959)
Q Consensus 178 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~ 257 (959)
++|+.|+|++|++.+..|..|.++++|+.|+|++|+|++..+.. |.++++|++|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~-------------------------~~~l~~L~~L~ 87 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGV-------------------------FDKLTQLTQLD 87 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-------------------------TTTCTTCCEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhH-------------------------hCCcchhhEEE
Confidence 34444444444555556677788888888888888888654443 45668888888
Q ss_pred ccCccccccCchhhcCCCCCCEEeCCCCcCCCCC
Q 002149 258 LHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLI 291 (959)
Q Consensus 258 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 291 (959)
|++|+|++..+..|..+++|++|+|++|.+....
T Consensus 88 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 88 LNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CCCCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 8888888666666888888888888888887543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.6e-14 Score=159.18 Aligned_cols=188 Identities=19% Similarity=0.120 Sum_probs=108.7
Q ss_pred CCCcEEeccCCcCCCCCC-Cc----c-CCCCccEEecCCCCCCCCChh-hhcCCCCCcEEEccCcccCCCCCCCCCccc-
Q 002149 103 SKLENIGLQKNQFRGELP-SF----S-GLSNLKYAYLDGNNFDTIPAD-FFDGLENLQVLALDSNNFNASKGWSFPKGL- 174 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~-~~----~-~l~~L~~L~L~~N~l~~i~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l- 174 (959)
++|+.|+|++|.|+.... .| . +.++|++|+|++|.|+..... ....+++|++|+|++|.|+......+...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456666777766654322 11 1 225677777777766542221 223345677777777766543222222222
Q ss_pred cCccccCeecccccccCC----CCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCC
Q 002149 175 QSSAQLTNLSCMSCNLAG----QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNM 250 (959)
Q Consensus 175 ~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l 250 (959)
...++|+.|+|++|+++. .++..+..+++|++|+|++|.|+......+ ...+...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L---------------------~~~L~~~ 210 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELL---------------------AAQLDRN 210 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHH---------------------HHHGGGC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHH---------------------HHHHhcC
Confidence 234567777777777653 244555677888888888888764221111 1124556
Q ss_pred cCCcEEEccCcccccc----CchhhcCCCCCCEEeCCCCcCCCCCccccccc---c---CCeEe--CCCCcCC
Q 002149 251 DQLRTLWLHGNHFSGT----IPESFGKLTSLKDLNLNSNQFVGLIPPSLASL---S---LDHLD--LNNNMFM 311 (959)
Q Consensus 251 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~---L~~L~--L~~N~l~ 311 (959)
++|++|+|++|.|++. +...+...++|++|+|++|.|+......+..+ . |+.+. +..|.++
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 7888999999988753 44555667889999999998886655555433 1 55555 5555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.23 E-value=8.4e-14 Score=155.05 Aligned_cols=189 Identities=16% Similarity=0.138 Sum_probs=138.4
Q ss_pred CcEEEEEecCCcccccCcccccC-----CCCCcEEeccCCcCCCCCC-C-ccCCCCccEEecCCCCCCCCChhhh-----
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQ-----LSKLENIGLQKNQFRGELP-S-FSGLSNLKYAYLDGNNFDTIPADFF----- 146 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~-----l~~L~~L~Ls~N~l~~~~~-~-~~~l~~L~~L~L~~N~l~~i~~~~~----- 146 (959)
..++.|+|+++.++......+.. .++|++|+|++|.|+.... . ...+++|++|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 47899999999998644433333 3799999999999875433 2 3456789999999999986655544
Q ss_pred cCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCC----CChhhcCCCCCCEEEecCCcCCCCCCccc
Q 002149 147 DGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQ----LPDFLGNFASLQNLKLSGNNLTGPIPESF 222 (959)
Q Consensus 147 ~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 222 (959)
...++|++|+|++|.|+......++..+..+++|++|+|++|++... ++..+...++|+.|+|++|.|+......+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 35789999999999997644445667778899999999999999753 35667788999999999999975332222
Q ss_pred ccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCC-----CCEEe--CCCCcCC
Q 002149 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS-----LKDLN--LNSNQFV 288 (959)
Q Consensus 223 ~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-----L~~L~--Ls~N~l~ 288 (959)
. ..+...++|++|+|++|.|++.-...+..+.. |+.+. +..|.+.
T Consensus 232 ~---------------------~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 232 A---------------------RAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp H---------------------HHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred H---------------------HHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 1 12445688999999999998766666655422 66676 6666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.9e-11 Score=133.92 Aligned_cols=79 Identities=16% Similarity=0.247 Sum_probs=69.3
Q ss_pred EEecCC-cccccCcccccCCCCCcEEeccC-CcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCc
Q 002149 84 IQVSSV-GLKGTLPQNLNQLSKLENIGLQK-NQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160 (959)
Q Consensus 84 l~l~~~-~l~g~~~~~l~~l~~L~~L~Ls~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 160 (959)
++++++ +|+ .+|. |..+++|++|+|++ |.|+++++ .|.++++|++|+|++|+|+++++.+|.+|++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 355666 677 4788 99999999999996 99999887 6999999999999999999999999999999999999999
Q ss_pred ccCC
Q 002149 161 NFNA 164 (959)
Q Consensus 161 ~l~~ 164 (959)
+|++
T Consensus 91 ~l~~ 94 (347)
T 2ifg_A 91 ALES 94 (347)
T ss_dssp CCSC
T ss_pred ccce
Confidence 8874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=9.6e-11 Score=124.20 Aligned_cols=146 Identities=15% Similarity=0.100 Sum_probs=114.0
Q ss_pred HHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEE
Q 002149 607 RNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 607 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 685 (959)
......|+....++.|+++.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++......+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 444567888888999999999999755 68899998764311 12235889999999995 677889999999888999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA------------------------------- 734 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------- 734 (959)
+||||++|.++.+.+. +......++.+++++|+.||+..
T Consensus 87 lv~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 9999999999876531 11123468899999999999821
Q ss_pred -------------------------CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 735 -------------------------HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 735 -------------------------~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
...++|+|+++.||+++.+..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799998764
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=128.94 Aligned_cols=104 Identities=19% Similarity=0.281 Sum_probs=92.8
Q ss_pred EEeccCC-cCCCCCCCccCCCCccEEecCC-CCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeec
Q 002149 107 NIGLQKN-QFRGELPSFSGLSNLKYAYLDG-NNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184 (959)
Q Consensus 107 ~L~Ls~N-~l~~~~~~~~~l~~L~~L~L~~-N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~ 184 (959)
.++++++ .|+.+++ |..+++|++|+|++ |+|+.+++..|.+|++|++|+|++|+|++ ..|..+.++++|+.|+
T Consensus 12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~ 86 (347)
T 2ifg_A 12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF----VAPDAFHFTPRLSRLN 86 (347)
T ss_dssp CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE----ECTTGGGSCSCCCEEE
T ss_pred EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce----eCHHHhcCCcCCCEEe
Confidence 5789998 8998777 99999999999996 99999999999999999999999999996 3456778999999999
Q ss_pred ccccccCCCCChhhcCCCCCCEEEecCCcCCC
Q 002149 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216 (959)
Q Consensus 185 l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 216 (959)
|++|+|++..+..|..++ |+.|+|++|.+..
T Consensus 87 l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 87 LSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 999999987777777766 9999999999984
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.1e-09 Score=119.73 Aligned_cols=291 Identities=14% Similarity=0.102 Sum_probs=153.5
Q ss_pred ccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCC------
Q 002149 97 QNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWS------ 169 (959)
Q Consensus 97 ~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------ 169 (959)
.+|.++++|+.+.|.. .++.+.. .|.++++|+.++|.++ ++.|...+|.++.+|+.+.+..+ +..+...+
T Consensus 65 ~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 4466666666666653 2444444 4666666666666543 55666666666666665554433 11111111
Q ss_pred ------------CCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccC
Q 002149 170 ------------FPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQK 236 (959)
Q Consensus 170 ------------lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~ 236 (959)
-..++..+++|+.+.+.++ +.......|.++++|+.+.+..| ++......|.+. .+..+.+....
T Consensus 142 ~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~ 219 (394)
T 4fs7_A 142 KEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSL 219 (394)
T ss_dssp SEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTC
T ss_pred cccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCc
Confidence 1234567788888888654 34355567788888888888766 443444444433 23322222111
Q ss_pred CCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCC
Q 002149 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVP 315 (959)
Q Consensus 237 ~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip 315 (959)
....+......+|+.+.+..+. +..-...|..+..|+.+.+..+... .....|... .++.+.+..+.+...
T Consensus 220 ----~~i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~-- 291 (394)
T 4fs7_A 220 ----YYLGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEK-- 291 (394)
T ss_dssp ----CEECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTT--
T ss_pred ----eEeehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccc--
Confidence 0011123334567777775433 3244456677777777777766443 334444444 355555444322110
Q ss_pred cccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccccc
Q 002149 316 KSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395 (959)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 395 (959)
.|. ....+..... .+.....-...|..+.+|+.++|.++ +...
T Consensus 292 ------------~F~-----------------------~~~~L~~i~l-~~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I 334 (394)
T 4fs7_A 292 ------------TFY-----------------------GCSSLTEVKL-LDSVKFIGEEAFESCTSLVSIDLPYL-VEEI 334 (394)
T ss_dssp ------------TTT-----------------------TCTTCCEEEE-CTTCCEECTTTTTTCTTCCEECCCTT-CCEE
T ss_pred ------------ccc-----------------------cccccccccc-ccccceechhhhcCCCCCCEEEeCCc-ccEE
Confidence 000 0000000000 00011111234556677888888644 6655
Q ss_pred CCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCC
Q 002149 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438 (959)
Q Consensus 396 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N 438 (959)
...+|.++++|+.++|..| ++..-...|.+|++|+.++|..|
T Consensus 335 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 335 GKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred hHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 5677888888888888766 66455567888888888887644
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.4e-10 Score=122.80 Aligned_cols=137 Identities=19% Similarity=0.150 Sum_probs=101.2
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC--ceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH--LVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~ 688 (959)
..|......+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++...+...++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 344443333466679999998777888999986543 1245778999999996545 456888888877889999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA---------------------------------- 734 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 734 (959)
||++|.++. .. . .+ ...++.++++.|..||+..
T Consensus 95 e~i~G~~l~--~~---~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SS---H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TS---C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cC---c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998884 21 1 11 2357788888888888732
Q ss_pred ---------------------CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 735 ---------------------HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 735 ---------------------~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
...++|+|++|.||+++.+..+.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.4e-08 Score=114.37 Aligned_cols=273 Identities=13% Similarity=0.078 Sum_probs=173.9
Q ss_pred CCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeeccccc-----
Q 002149 115 FRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSC----- 188 (959)
Q Consensus 115 l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n----- 188 (959)
++.+.. +|.++.+|+.+.|.. .++.|...+|.++++|+.++|.+| ++.++. ..+..+.+|+.+.+..+
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~----~aF~~c~~L~~i~~p~~l~~i~ 132 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGR----CTFSGCYALKSILLPLMLKSIG 132 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECT----TTTTTCTTCCCCCCCTTCCEEC
T ss_pred EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccc----hhhcccccchhhcccCceeeec
Confidence 444444 699999999999975 599999999999999999999866 443322 23455555655544322
Q ss_pred ----------------ccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcccccccccCCc
Q 002149 189 ----------------NLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMD 251 (959)
Q Consensus 189 ----------------~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~ 251 (959)
.+......+|.++++|+.+.+.++. .......|.+. +|..+.+... ...+. ...+.++.
T Consensus 133 ~~aF~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~--~~~F~~~~ 208 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIR--DYCFAECI 208 (394)
T ss_dssp TTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEEC--TTTTTTCT
T ss_pred ceeeecccccccccCccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeC--chhhcccc
Confidence 1111224578889999999998664 33555566554 4555544322 11111 13478889
Q ss_pred CCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCccc
Q 002149 252 QLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC 330 (959)
Q Consensus 252 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~ 330 (959)
.|+.+.+..+... +.+.+....+|+.+.+..+ ++......+... .|+.+.+..+... ++. ..|.
T Consensus 209 ~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~--i~~----------~~F~ 273 (394)
T 4fs7_A 209 LLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR--IGG----------SLFY 273 (394)
T ss_dssp TCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE--ECS----------CTTT
T ss_pred ccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce--eec----------cccc
Confidence 9999988877654 4455556688999998754 343444556555 5888888766442 111 1110
Q ss_pred CCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEe
Q 002149 331 QPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIK 410 (959)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 410 (959)
. ...+...... ........+..+.+|+.+.+.++ +......+|.++.+|+.++
T Consensus 274 ~-----------------------~~~l~~~~~~---~~~i~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 274 N-----------------------CSGLKKVIYG---SVIVPEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSID 326 (394)
T ss_dssp T-----------------------CTTCCEEEEC---SSEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEEC
T ss_pred c-----------------------ccccceeccC---ceeeccccccccccccccccccc-cceechhhhcCCCCCCEEE
Confidence 0 0000000000 00112234566789999999765 6656678899999999999
Q ss_pred CcccccccccCCCccCCCCCCeEeCCCCccC
Q 002149 411 LQSNNISGQIPTNWTNLKSLTLLDLSQNNLS 441 (959)
Q Consensus 411 L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~ 441 (959)
|.++ ++..-...|.+|++|+.++|..| ++
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 9754 77555678999999999999876 44
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=7.6e-09 Score=114.92 Aligned_cols=143 Identities=15% Similarity=0.205 Sum_probs=107.3
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcc--cccccHHHHHHHHHHHHHHHhcC--CCCceeEEEEEEeC---ceEEEE
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRME--AGVISKKAVDEFHSEIAVLSKVR--HRHLVSLLGYSVAG---YERLLV 687 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 687 (959)
..+.++.|.++.||+.... +..+++|+.. .... ......+.+|+++++.+. +..+.+++.++.+. ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4567999999999999876 4678888765 3211 122456889999999997 45678899888776 347899
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA--------------------------------- 734 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 734 (959)
|||++|..+.+.. ...++..++..++.++++.|+.||...
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999988774321 134678889999999999999999731
Q ss_pred ----------------------CCCeEecCCCCCCEEECCCCc--EEEeecccccc
Q 002149 735 ----------------------HQSFIHRDLKSSNILLGDDFR--AKVSDFGLVKL 766 (959)
Q Consensus 735 ----------------------~~~ivH~Dik~~NiLl~~~~~--~ki~DfGla~~ 766 (959)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987653 68999998864
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.86 E-value=7.7e-08 Score=108.23 Aligned_cols=60 Identities=15% Similarity=0.290 Sum_probs=29.8
Q ss_pred CCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCc
Q 002149 378 TNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439 (959)
Q Consensus 378 ~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 439 (959)
.+.+|+.++|..+ ++.....+|.++.+|+++.|..+ ++..-...|.+|++|+.+++.+|.
T Consensus 309 ~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 309 GCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 3345555555433 44334445555555555555433 442223445555555555555543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=4.1e-10 Score=124.11 Aligned_cols=202 Identities=17% Similarity=0.227 Sum_probs=98.2
Q ss_pred CcEEEEEecCCcccc-c-------CcccccCCCCCcEEeccCCcCCC---------CCC-CccCCCCccEEecCCCCCCC
Q 002149 79 SRVTQIQVSSVGLKG-T-------LPQNLNQLSKLENIGLQKNQFRG---------ELP-SFSGLSNLKYAYLDGNNFDT 140 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g-~-------~~~~l~~l~~L~~L~Ls~N~l~~---------~~~-~~~~l~~L~~L~L~~N~l~~ 140 (959)
.+|+.|.+...++.| . +..++..+++|+.|.+..+.... .+. -+..+++|+.|+|++|.-..
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 367778777665553 2 23445667888888886654321 111 13455667777776663122
Q ss_pred CChhhhcCCCCCcEEEccCcccCCCCCCCCCccc--cCccccCeecccc--cccCCC-----CChhh--cCCCCCCEEEe
Q 002149 141 IPADFFDGLENLQVLALDSNNFNASKGWSFPKGL--QSSAQLTNLSCMS--CNLAGQ-----LPDFL--GNFASLQNLKL 209 (959)
Q Consensus 141 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l--~~l~~L~~L~l~~--n~l~~~-----~p~~l--~~l~~L~~L~L 209 (959)
+++ +. +++|++|+|..+.+... ....+ ..+++|+.|+|+. |+..+. +...+ ..+++|+.|+|
T Consensus 187 l~~--~~-~~~L~~L~L~~~~l~~~----~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L 259 (362)
T 2ra8_A 187 IGK--KP-RPNLKSLEIISGGLPDS----VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGI 259 (362)
T ss_dssp CCS--CB-CTTCSEEEEECSBCCHH----HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEE
T ss_pred ecc--cc-CCCCcEEEEecCCCChH----HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeC
Confidence 332 22 56666666666655421 11111 1455566665532 111111 00111 13456666666
Q ss_pred cCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcccccc----CchhhcCCCCCCEEeCCCC
Q 002149 210 SGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT----IPESFGKLTSLKDLNLNSN 285 (959)
Q Consensus 210 s~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N 285 (959)
.+|.+....+..+. ....+++|++|+|+.|.|++. ++..+..+++|+.|+|++|
T Consensus 260 ~~~~i~~~~~~~la----------------------~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 260 VDAEEQNVVVEMFL----------------------ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp ESCTTHHHHHHHHH----------------------HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred CCCCCchHHHHHHH----------------------hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 66655432211110 012346666666666666543 2333344566666666666
Q ss_pred cCCCCCccccccccCCeEeCCCCc
Q 002149 286 QFVGLIPPSLASLSLDHLDLNNNM 309 (959)
Q Consensus 286 ~l~~~~p~~~~~~~L~~L~L~~N~ 309 (959)
.|+...-..+...-...+++++|+
T Consensus 318 ~i~d~~~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 318 YLSDEMKKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp BCCHHHHHHHHHHCCSEEECCSBC
T ss_pred cCCHHHHHHHHHHcCCEEEecCCc
Confidence 665433333332112445665554
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=3.8e-09 Score=114.44 Aligned_cols=186 Identities=16% Similarity=0.229 Sum_probs=123.0
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCC--ceeEEEEEEeCc---eEEEEEE
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRH--LVSLLGYSVAGY---ERLLVYE 689 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 689 (959)
.+.++.|....||+.. +.+++|+-.. ......+.+|+++++.+. +.. +.+++.+..... ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4568999999999873 5688897542 244567899999999984 333 345555443332 3478999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA----------------------------------- 734 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 734 (959)
+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988865432 34677888889999999999999611
Q ss_pred --------------------CCCeEecCCCCCCEEECC--CCcEEEeeccccccCCCCCcceee-------------ccc
Q 002149 735 --------------------HQSFIHRDLKSSNILLGD--DFRAKVSDFGLVKLAPDSERSVVT-------------RLA 779 (959)
Q Consensus 735 --------------------~~~ivH~Dik~~NiLl~~--~~~~ki~DfGla~~~~~~~~~~~~-------------~~~ 779 (959)
...++|+|+++.||+++. ...+.|+||+.+........-... ...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 135799999999999998 556889999988654221100000 000
Q ss_pred ccccccc-ccccccCCCCccchHHHHHHHHHHHHhCCCCC
Q 002149 780 GTFGYLA-PEYAVTGKITTKVDVFSFGVVLMELLTGLMAL 818 (959)
Q Consensus 780 gt~~y~a-PE~~~~~~~~~~~DvwSlG~ll~elltg~~p~ 818 (959)
...++.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0011111 221111 122368999999999999997654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.1e-07 Score=104.55 Aligned_cols=60 Identities=12% Similarity=0.158 Sum_probs=27.4
Q ss_pred cCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCc
Q 002149 376 CGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNN 439 (959)
Q Consensus 376 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~ 439 (959)
|..+.+|+.+.|..+ +......+|.++++|+.+++.+|.... ..+..+..|+.+.+..|.
T Consensus 330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 344456666666443 443444556666666666666655431 244555556655555443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.70 E-value=4.2e-09 Score=115.99 Aligned_cols=183 Identities=14% Similarity=0.153 Sum_probs=124.7
Q ss_pred CcEEEEEecCCcc---------cccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhc--
Q 002149 79 SRVTQIQVSSVGL---------KGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFD-- 147 (959)
Q Consensus 79 ~~v~~l~l~~~~l---------~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~-- 147 (959)
.+++.|.+.+... .+.+...+..+++|+.|+|++|.-... +.+. +++|++|+|..+.+..-....+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l-~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~ 216 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSI-GKKP-RPNLKSLEIISGGLPDSVVEDILGS 216 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBC-CSCB-CTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCcee-cccc-CCCCcEEEEecCCCChHHHHHHHHc
Confidence 4788888865433 224667778899999999999831122 3343 89999999999988753333443
Q ss_pred CCCCCcEEEccC--cccCCCC-CCCCCccc--cCccccCeecccccccCCCCChhhc---CCCCCCEEEecCCcCCCCCC
Q 002149 148 GLENLQVLALDS--NNFNASK-GWSFPKGL--QSSAQLTNLSCMSCNLAGQLPDFLG---NFASLQNLKLSGNNLTGPIP 219 (959)
Q Consensus 148 ~l~~L~~L~Ls~--N~l~~~~-~~~lp~~l--~~l~~L~~L~l~~n~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~p 219 (959)
.+++|++|+|+. |...+.. ...+...+ ..+++|+.|+|.+|.+....+..+. .+++|++|+|+.|.|+...+
T Consensus 217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~ 296 (362)
T 2ra8_A 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296 (362)
T ss_dssp BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHH
T ss_pred cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHH
Confidence 799999999964 3322111 11122223 3578999999999998754444443 47899999999999885433
Q ss_pred cccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcC-CCCCCEEeCCCCc
Q 002149 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK-LTSLKDLNLNSNQ 286 (959)
Q Consensus 220 ~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~ 286 (959)
..+. ..+.++++|+.|+|++|.|+...-..+.. + ...++++.|+
T Consensus 297 ~~L~---------------------~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 297 RLLL---------------------DHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHH---------------------TTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHH---------------------hhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 2221 11356789999999999998655455554 3 4679999988
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.62 E-value=1.2e-06 Score=97.87 Aligned_cols=282 Identities=12% Similarity=0.121 Sum_probs=157.3
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
++++|.+.. +++..-..+|.++.+|+.++|..+ ++.+.. .|.++ +|+.+.+.. ++..|...+|... +|+.+++.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-CcccccCC
Confidence 566666643 455344456777788888877643 554444 57665 577776654 4777777777664 67777776
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCccc------------cc-C
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF------------KG-L 225 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~------------~~-l 225 (959)
.+- .. +........+|+.+.+.. +++......|....+|+.+.+..+.........+ .. .
T Consensus 122 ~~~-~~-----i~~~~F~~~~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (379)
T 4h09_A 122 GAT-TE-----IGNYIFYNSSVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAK 194 (379)
T ss_dssp TTC-CE-----ECTTTTTTCCCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTC
T ss_pred Ccc-cc-----ccccccccceeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccccc
Confidence 552 21 222222223455544432 2333445566677777777776654431111100 00 0
Q ss_pred CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEe
Q 002149 226 NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLD 304 (959)
Q Consensus 226 ~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~ 304 (959)
.+....+ ...........+....+|+.+.+..+ ++.....+|..+..|+.+.+..+ ++.+....|... +|+.+.
T Consensus 195 ~~~~~~~---~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~ 269 (379)
T 4h09_A 195 TGTEFTI---PSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLN 269 (379)
T ss_dssp CCSEEEC---CTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccccc---ccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccc
Confidence 0000000 00000000122444556666666544 33244455666666777666554 444444455544 366655
Q ss_pred CCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccE
Q 002149 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384 (959)
Q Consensus 305 L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~ 384 (959)
+..+ ++ ......|..+.+|+.
T Consensus 270 l~~~-i~----------------------------------------------------------~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 270 FYAK-VK----------------------------------------------------------TVPYLLCSGCSNLTK 290 (379)
T ss_dssp ECCC-CS----------------------------------------------------------EECTTTTTTCTTCCE
T ss_pred cccc-ce----------------------------------------------------------ecccccccccccccc
Confidence 5332 11 011123455688999
Q ss_pred EECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCC
Q 002149 385 LNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438 (959)
Q Consensus 385 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N 438 (959)
+.+.++.+......+|.++.+|+.+.|..+ ++..-...|.+|++|+.+.+..+
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 999988888777788999999999999755 66455567999999998887644
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.9e-09 Score=111.06 Aligned_cols=158 Identities=19% Similarity=0.248 Sum_probs=88.1
Q ss_pred CcceEecCC--cEEEEEecC---CcccccCc-ccccCCCCCcEEeccCCcCCCCCC--CccCCCCccE--EecCCCCCCC
Q 002149 71 WKHVFCSNS--RVTQIQVSS---VGLKGTLP-QNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKY--AYLDGNNFDT 140 (959)
Q Consensus 71 w~gv~C~~~--~v~~l~l~~---~~l~g~~~-~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~--L~L~~N~l~~ 140 (959)
|.|+.|+.. +|+.+...+ ..+.+.++ ..+..|+. .|....|...+... .|...+.|.. ++++.|+...
T Consensus 80 ~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~ 157 (267)
T 3rw6_A 80 VNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSC 157 (267)
T ss_dssp TTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHH
T ss_pred cCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHH
Confidence 889999754 676665544 23444443 23333332 23334444433322 2455555655 6666665433
Q ss_pred CC---hhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCC
Q 002149 141 IP---ADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217 (959)
Q Consensus 141 i~---~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 217 (959)
++ .....++++|+.|+|++|+|+++. .+|..+..+++|+.|+|++|+|++.
T Consensus 158 ~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~--------------------------~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 158 MAATLRIIEENIPELLSLNLSNNRLYRLD--------------------------DMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTSCCCCCG--------------------------GGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred HHHHHHHHHhhCCCCCEEECCCCCCCCCc--------------------------cchhHHhhCCCCCEEECCCCccCCc
Confidence 22 222345667777777777665321 2345566677777888888877743
Q ss_pred CCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCc-------hhhcCCCCCCEEe
Q 002149 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP-------ESFGKLTSLKDLN 281 (959)
Q Consensus 218 ~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p-------~~~~~l~~L~~L~ 281 (959)
..+. .+..+ +|++|+|++|.+.+.+| ..+..+++|+.||
T Consensus 212 --~~l~----------------------~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 212 --RELD----------------------KIKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp --GGGG----------------------GGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred --hhhh----------------------hcccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 1111 12233 67778888888776554 2456677777765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=1.3e-08 Score=101.12 Aligned_cols=40 Identities=18% Similarity=0.167 Sum_probs=19.4
Q ss_pred CCcCCcEEEc--cCcccccc----CchhhcCCCCCCEEeCCCCcCC
Q 002149 249 NMDQLRTLWL--HGNHFSGT----IPESFGKLTSLKDLNLNSNQFV 288 (959)
Q Consensus 249 ~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 288 (959)
..++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 119 ~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 119 SNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred hCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3345555555 55555432 2233334455555555555543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-08 Score=101.38 Aligned_cols=72 Identities=18% Similarity=0.169 Sum_probs=48.2
Q ss_pred ccCcccccCCCCCcEEeccCC-cCCCCC-----CCccCCCCccEEecCCCCCCCCC----hhhhcCCCCCcEEEccCccc
Q 002149 93 GTLPQNLNQLSKLENIGLQKN-QFRGEL-----PSFSGLSNLKYAYLDGNNFDTIP----ADFFDGLENLQVLALDSNNF 162 (959)
Q Consensus 93 g~~~~~l~~l~~L~~L~Ls~N-~l~~~~-----~~~~~l~~L~~L~L~~N~l~~i~----~~~~~~l~~L~~L~Ls~N~l 162 (959)
..+...+...++|++|+|++| .|.... ..+...++|++|+|++|+|+.-. ...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345566777888888888888 776421 13555677888888888776422 23355566777777777777
Q ss_pred CC
Q 002149 163 NA 164 (959)
Q Consensus 163 ~~ 164 (959)
..
T Consensus 106 ~~ 107 (185)
T 1io0_A 106 SG 107 (185)
T ss_dssp CH
T ss_pred CH
Confidence 64
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=7.9e-06 Score=88.07 Aligned_cols=136 Identities=18% Similarity=0.190 Sum_probs=97.2
Q ss_pred cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCC---CceeEEEEEE-eCceEEEEEEec
Q 002149 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR---HLVSLLGYSV-AGYERLLVYEYM 691 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 691 (959)
.+.++.|....||+. |+.+++|+-. .......+.+|+++++.+.+. .+.+++.++. .....++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456788888899998 5678888742 234456789999999999753 3566777764 344578999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL-------------------------------------- 733 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------- 733 (959)
+|..+.+... ..++..++..++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988865321 2245556666666666666666652
Q ss_pred -------------------CCCCeEecCCCCCCEEECC---CCc-EEEeecccccc
Q 002149 734 -------------------AHQSFIHRDLKSSNILLGD---DFR-AKVSDFGLVKL 766 (959)
Q Consensus 734 -------------------~~~~ivH~Dik~~NiLl~~---~~~-~ki~DfGla~~ 766 (959)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999987 455 58999997754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.18 E-value=3.3e-07 Score=95.50 Aligned_cols=53 Identities=21% Similarity=0.336 Sum_probs=27.2
Q ss_pred CcccEEECCCCcccccCCccccCcC--cCCEEeCcccccccccCC-------CccCCCCCCeEe
Q 002149 380 SKLTVLNLPNFNLSGTLSPSVGNLD--SLTQIKLQSNNISGQIPT-------NWTNLKSLTLLD 434 (959)
Q Consensus 380 ~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~g~~p~-------~l~~l~~L~~L~ 434 (959)
++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|. .+..+++|+.||
T Consensus 196 ~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 196 PNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3444444444444433 1122222 566666666666655542 255666666665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.12 E-value=0.0001 Score=82.04 Aligned_cols=267 Identities=12% Similarity=0.090 Sum_probs=146.6
Q ss_pred cccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccC
Q 002149 98 NLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQS 176 (959)
Q Consensus 98 ~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~ 176 (959)
.+....+|+.+.+.. .++.+.. .|.++.+|+.+.|.. .++.|...+|.+. +|+.+.+..| +.. +......
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~-----I~~~aF~ 111 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKK-----FGDYVFQ 111 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCE-----ECTTTTT
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeE-----eccceec
Confidence 455667888888864 3555555 699999999999975 4888999999887 6888877654 443 3333333
Q ss_pred ccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-CcccccccccCCCCcc----------cccc
Q 002149 177 SAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLNDQKGGGFT----------GTID 245 (959)
Q Consensus 177 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~~~~~~l~----------~~~~ 245 (959)
..+|+.+.+.++ +.......|.+. +|+.+.+..+ ++......|... .+.............. ....
T Consensus 112 ~~~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (379)
T 4h09_A 112 GTDLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILE 188 (379)
T ss_dssp TCCCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEE
T ss_pred cCCcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceec
Confidence 446777777643 332333344443 4555554433 222222232211 1111111110000000 0001
Q ss_pred cccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCccccccccc
Q 002149 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSY 324 (959)
Q Consensus 246 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~ 324 (959)
.+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......+... .|+.+.+..+ ++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~------------- 252 (379)
T 4h09_A 189 SYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT------------- 252 (379)
T ss_dssp ECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-------------
T ss_pred cccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-------------
Confidence 1222233333333332221 33344445555555555433 222333333333 3555554332 11
Q ss_pred ccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcC
Q 002149 325 SSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLD 404 (959)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~ 404 (959)
..-...+..+.+|+.+.+..+ +.......|.+++
T Consensus 253 ---------------------------------------------~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 253 ---------------------------------------------SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp ---------------------------------------------EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ---------------------------------------------EeCccccceeehhcccccccc-ceecccccccccc
Confidence 001123345578888988654 6656667899999
Q ss_pred cCCEEeCcccccccccCCCccCCCCCCeEeCCCC
Q 002149 405 SLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQN 438 (959)
Q Consensus 405 ~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N 438 (959)
+|+.+.+.+|.++..-...|.+|.+|+.++|..+
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 9999999999998666678999999999999754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.9e-05 Score=83.38 Aligned_cols=134 Identities=16% Similarity=0.178 Sum_probs=96.9
Q ss_pred cccccCce-EEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEEEEecCCC
Q 002149 618 ELGRGGFG-VVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLVYEYMPQG 694 (959)
Q Consensus 618 ~lG~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 694 (959)
.+..|..| .||+.... ++..+.+|+-.. .....+.+|...++.+. +--+.++++++.+.+..++|||++++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34455555 68988654 456788997543 23556889999999984 334678899999999999999999998
Q ss_pred chhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 002149 695 ALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA---------------------------------------- 734 (959)
Q Consensus 695 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 734 (959)
++.+..... ......++.++++.|..||...
T Consensus 106 ~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 887654221 1223456677777777777521
Q ss_pred ---------------CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 735 ---------------HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 735 ---------------~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999987777899999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.3e-05 Score=88.47 Aligned_cols=83 Identities=10% Similarity=0.011 Sum_probs=55.9
Q ss_pred cCcc-cccCceEEEEEEEc-------CCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcC-C--CCceeEEEEEEeC--
Q 002149 616 ENEL-GRGGFGVVYKGELD-------DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVR-H--RHLVSLLGYSVAG-- 681 (959)
Q Consensus 616 ~~~l-G~G~fg~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 681 (959)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998654 266788887654210 0001235678999998884 3 3567788887655
Q ss_pred -ceEEEEEEecCCCchhh
Q 002149 682 -YERLLVYEYMPQGALSK 698 (959)
Q Consensus 682 -~~~~lv~e~~~~gsL~~ 698 (959)
...++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 34689999998876643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00028 Score=77.19 Aligned_cols=142 Identities=18% Similarity=0.236 Sum_probs=81.1
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC--CCceeEEE------EEEeCceEEEEE
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH--RHLVSLLG------YSVAGYERLLVY 688 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~ 688 (959)
+.|+.|..+.||+....+| .+++|+.... . .++..|+++++.+.. -.+.+++. +....+..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677899999987654 5889987642 2 233455666665531 12333332 223466789999
Q ss_pred EecCCCchh--------------hHHhhcccCC--C-------CCCCHHHH-----------------------------
Q 002149 689 EYMPQGALS--------------KHIFHWKSLN--L-------EPLSWKRR----------------------------- 716 (959)
Q Consensus 689 e~~~~gsL~--------------~~l~~~~~~~--~-------~~l~~~~~----------------------------- 716 (959)
||++|..+. ..+|.....- . ..-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999886542 1122211100 0 01123211
Q ss_pred --HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 717 --LNIALDVARGMEYLHS----------LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 717 --~~i~~~ia~gL~yLH~----------~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
..+..++.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111234446666763 124789999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00017 Score=80.83 Aligned_cols=77 Identities=14% Similarity=0.132 Sum_probs=49.7
Q ss_pred cCcccccCceEEEEEEEc-CCcEEEEEEcccccc--cH---HHHHHHHHHHHHHHhcCC--CC-ceeEEEEEEeCceEEE
Q 002149 616 ENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI--SK---KAVDEFHSEIAVLSKVRH--RH-LVSLLGYSVAGYERLL 686 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 686 (959)
.+.+|.|.++.||++... +++.++||....... .. .....+..|.++++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899997653211 00 123456789999988842 43 3455544 3445689
Q ss_pred EEEecCCC
Q 002149 687 VYEYMPQG 694 (959)
Q Consensus 687 v~e~~~~g 694 (959)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.0002 Score=80.89 Aligned_cols=77 Identities=18% Similarity=0.210 Sum_probs=48.4
Q ss_pred CCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcceeecccc--ccccccccccccCC---CCccchHHHHHHHHH
Q 002149 735 HQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG--TFGYLAPEYAVTGK---ITTKVDVFSFGVVLM 809 (959)
Q Consensus 735 ~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwSlG~ll~ 809 (959)
...++|+|+++.||+++.++ ++|+||+.+........ ...... ...|.+|+...... -....++.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 37899999999999998876 99999998874432111 000011 23466666553211 122355567777888
Q ss_pred HHHhC
Q 002149 810 ELLTG 814 (959)
Q Consensus 810 elltg 814 (959)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00056 Score=73.27 Aligned_cols=141 Identities=16% Similarity=0.155 Sum_probs=92.5
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC---CCCceeEEEEEEeCceEEEEEEec
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
..+.|+.|....+|+.... ++.+++|+-... ....+.+|++.|+.+. ...+.++++++......++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3467899999999999764 678889976532 2556889999999984 356888999988888899999999
Q ss_pred CCCchh--------h---HHhhccc-CCC----------------CCCCHHHHH---HHHH----------------HHH
Q 002149 692 PQGALS--------K---HIFHWKS-LNL----------------EPLSWKRRL---NIAL----------------DVA 724 (959)
Q Consensus 692 ~~gsL~--------~---~l~~~~~-~~~----------------~~l~~~~~~---~i~~----------------~ia 724 (959)
++..+. + .+|.... ... -.-+|.... ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 887642 1 2333211 000 012454321 1111 111
Q ss_pred HHH-HHHHh-cCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 725 RGM-EYLHS-LAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 725 ~gL-~yLH~-~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..+ ..|.. .....+||+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23321 1236799999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00031 Score=74.81 Aligned_cols=80 Identities=23% Similarity=0.298 Sum_probs=57.9
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCC---CceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR---HLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv 687 (959)
.....++.+|.|..+.||+.+..+|+.|.+|+-.... ......|.+|++.|+.+.-. -+.+++++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4556678899999999999999999999999865431 12234578899999998422 344555542 34789
Q ss_pred EEecCCCch
Q 002149 688 YEYMPQGAL 696 (959)
Q Consensus 688 ~e~~~~gsL 696 (959)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.46 E-value=1.1e-05 Score=79.25 Aligned_cols=19 Identities=32% Similarity=0.385 Sum_probs=10.1
Q ss_pred hhcCCCCCCEEEecCCcCC
Q 002149 197 FLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 197 ~l~~l~~L~~L~Ls~N~l~ 215 (959)
.+..-+.|++|+|++|.|.
T Consensus 93 aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 93 LIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHCSSCCEEECCSSBCC
T ss_pred HHhcCCccCeEecCCCcCC
Confidence 3334455555666666555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.38 E-value=2.1e-05 Score=77.35 Aligned_cols=121 Identities=10% Similarity=0.100 Sum_probs=82.4
Q ss_pred CcccccCCCCCcEEeccCC-cCCCCC-----CCccCCCCccEEecCCCCCCC----CChhhhcCCCCCcEEEccCcccCC
Q 002149 95 LPQNLNQLSKLENIGLQKN-QFRGEL-----PSFSGLSNLKYAYLDGNNFDT----IPADFFDGLENLQVLALDSNNFNA 164 (959)
Q Consensus 95 ~~~~l~~l~~L~~L~Ls~N-~l~~~~-----~~~~~l~~L~~L~L~~N~l~~----i~~~~~~~l~~L~~L~Ls~N~l~~ 164 (959)
+...+.+-+.|++|+|++| +|.... ..+..-+.|+.|+|++|+|.. -...++...+.|++|+|++|+|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3444566678888888875 665321 124555678888888888873 334456677888888888888876
Q ss_pred CCCCCCCccccCccccCeecccccc---cCC----CCChhhcCCCCCCEEEecCCcCC
Q 002149 165 SKGWSFPKGLQSSAQLTNLSCMSCN---LAG----QLPDFLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 165 ~~~~~lp~~l~~l~~L~~L~l~~n~---l~~----~~p~~l~~l~~L~~L~Ls~N~l~ 215 (959)
.+...+...+..-+.|+.|+|++|. +.. .+...+..-+.|+.|+++.|.+.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 6555666677777788888887653 232 23455666788999999877654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.25 E-value=7.8e-05 Score=71.84 Aligned_cols=35 Identities=11% Similarity=0.017 Sum_probs=20.3
Q ss_pred CCcEEEccCcc-ccccCchhhcCCCCCCEEeCCCCc
Q 002149 252 QLRTLWLHGNH-FSGTIPESFGKLTSLKDLNLNSNQ 286 (959)
Q Consensus 252 ~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~ 286 (959)
+|++|+|++|. ++..--..+.++++|++|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 56666666653 554333445566666666666654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00014 Score=69.99 Aligned_cols=35 Identities=23% Similarity=0.290 Sum_probs=21.3
Q ss_pred ccCeecccccc-cCCCCChhhcCCCCCCEEEecCCc
Q 002149 179 QLTNLSCMSCN-LAGQLPDFLGNFASLQNLKLSGNN 213 (959)
Q Consensus 179 ~L~~L~l~~n~-l~~~~p~~l~~l~~L~~L~Ls~N~ 213 (959)
+|+.|+|++|. ++..--..+..+++|++|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 35555555542 443333456677888888888874
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00063 Score=62.45 Aligned_cols=38 Identities=26% Similarity=0.479 Sum_probs=32.7
Q ss_pred CCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccC
Q 002149 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 126 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 163 (959)
.+|++|+|++|+|+.++..+|..+++|++|+|++|.+.
T Consensus 31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35788888888888888888999999999999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0023 Score=69.18 Aligned_cols=160 Identities=13% Similarity=0.155 Sum_probs=89.6
Q ss_pred ecHHHHHHHhcCCcc-----cCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC--cee
Q 002149 601 ISVQVLRNVTKNFAS-----ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH--LVS 673 (959)
Q Consensus 601 ~~~~~~~~~~~~~~~-----~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 673 (959)
++.+++..+..+|.. .+.|+.|....+|+....+| .+++|..... .....+..|++++..+.... +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 345556666666654 24566788889999987655 6888987642 12234567888888774222 233
Q ss_pred EEEE------EEeCceEEEEEEecCCCchhh--------------HHhhccc-CCCC---C---CCHHHHHH--------
Q 002149 674 LLGY------SVAGYERLLVYEYMPQGALSK--------------HIFHWKS-LNLE---P---LSWKRRLN-------- 718 (959)
Q Consensus 674 l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~-~~~~---~---l~~~~~~~-------- 718 (959)
++.. ....+..+++|+|++|..+.. .+|.... .... . ..|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 123456789999998765321 1221100 0000 0 11322111
Q ss_pred ----HHHHHHHHHHHHHhc----CCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 719 ----IALDVARGMEYLHSL----AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 719 ----i~~~ia~gL~yLH~~----~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+...+.+.+++++.. ...+++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 111244556666542 13579999999999999987666899998664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0019 Score=69.02 Aligned_cols=72 Identities=11% Similarity=0.119 Sum_probs=45.6
Q ss_pred ccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCc-eeEEEEEEeCceEEEEEEec-C
Q 002149 615 SENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL-VSLLGYSVAGYERLLVYEYM-P 692 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~ 692 (959)
-.+.|+.|....+|+. +.+++|+..... .......+|+.+++.+....+ .+++++ +.+.-++|+||+ +
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 3677889999999998 558888765421 111123568888888753333 455554 333457899999 5
Q ss_pred CCch
Q 002149 693 QGAL 696 (959)
Q Consensus 693 ~gsL 696 (959)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0032 Score=68.37 Aligned_cols=144 Identities=17% Similarity=0.131 Sum_probs=74.3
Q ss_pred CcccccCceE-EEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC--CCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGV-VYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH--RHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
+.|+.|+... +|+....+++.+++|...... ...+..|+.+++.+.. -.+.+++.+..+. -++|||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCC
Confidence 4565555444 667765446777777654321 1234567777777742 2355667663332 2789999976
Q ss_pred CchhhHHhhcc------------------cC---CCCCCCHHHHHH--------------------HHHHHHHHHHHHHh
Q 002149 694 GALSKHIFHWK------------------SL---NLEPLSWKRRLN--------------------IALDVARGMEYLHS 732 (959)
Q Consensus 694 gsL~~~l~~~~------------------~~---~~~~l~~~~~~~--------------------i~~~ia~gL~yLH~ 732 (959)
..+.+.+.... .. ....++...... ....+...++.+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66544332100 00 011122211100 00112222233311
Q ss_pred ---cCCCCeEecCCCCCCEEECCC----CcEEEeeccccccC
Q 002149 733 ---LAHQSFIHRDLKSSNILLGDD----FRAKVSDFGLVKLA 767 (959)
Q Consensus 733 ---~~~~~ivH~Dik~~NiLl~~~----~~~ki~DfGla~~~ 767 (959)
.....++|+|+.+.||+++.+ ..+.|+||+.+...
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123579999999999999874 68999999987643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0026 Score=58.25 Aligned_cols=66 Identities=27% Similarity=0.540 Sum_probs=51.0
Q ss_pred CCCCCCCcceEecCCcEEEEEecCCccc-ccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCC
Q 002149 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLK-GTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFD 139 (959)
Q Consensus 65 ~C~~~~w~gv~C~~~~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~ 139 (959)
+||..| .|.. +.++.++++|+ ..+|..+. .+|++|+|++|+|+.+++ .|..+++|++|+|++|.+.
T Consensus 1 ~CP~~C----~C~~---~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 1 PCPAPC----SCAG---TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CCCTTC----EEET---TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CcCCCC----EEcC---CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 365444 5653 36788888886 45665543 368999999999999888 5899999999999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.016 Score=62.47 Aligned_cols=144 Identities=11% Similarity=0.058 Sum_probs=82.5
Q ss_pred CcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC--ceeEEEE-----EEeCceEEEEEE
Q 002149 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH--LVSLLGY-----SVAGYERLLVYE 689 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e 689 (959)
..++ |....||+....+|+.+++|.......+ ...+..|..++..+.... +++++.. ....+..++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 7788999987777778999987643222 345667888888874222 3444432 223456688999
Q ss_pred ecCCCchhh-----------H---HhhcccC----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh
Q 002149 690 YMPQGALSK-----------H---IFHWKSL----NLEPLSWKRR----LNI---------------ALDVARGMEYLHS 732 (959)
Q Consensus 690 ~~~~gsL~~-----------~---l~~~~~~----~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~ 732 (959)
|++|..+.. . +|..... ....+++... ..+ ...+.+.++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 998754321 1 1211100 0112222211 001 1111122333332
Q ss_pred c----CCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 733 L----AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 733 ~----~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 235689999999999999 4 899999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0087 Score=65.77 Aligned_cols=142 Identities=15% Similarity=0.168 Sum_probs=82.8
Q ss_pred CcccccCceEEEEEEEc--------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEEE
Q 002149 617 NELGRGGFGVVYKGELD--------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 687 (959)
+.+..|-...+|+.... +++.+.+|+.... ......+.+|.++++.+. +.-..++++++.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888889999764 2478899975321 122445668999999885 3333566666543 289
Q ss_pred EEecCCCchhhH-----------------HhhcccCCCCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 002149 688 YEYMPQGALSKH-----------------IFHWKSLNLEPLS--WKRRLNIALDVAR-------------------GMEY 729 (959)
Q Consensus 688 ~e~~~~gsL~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------gL~y 729 (959)
|||++|..+... +|.....-.+... |.++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987655311 1111110011222 4555555544422 2333
Q ss_pred HHh----c-CCCCeEecCCCCCCEEECCC----CcEEEeeccccc
Q 002149 730 LHS----L-AHQSFIHRDLKSSNILLGDD----FRAKVSDFGLVK 765 (959)
Q Consensus 730 LH~----~-~~~~ivH~Dik~~NiLl~~~----~~~ki~DfGla~ 765 (959)
|.+ . ....++|+|+.+.||+++.+ +.+.++||..|.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 1 12468999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0065 Score=68.34 Aligned_cols=73 Identities=18% Similarity=0.261 Sum_probs=49.2
Q ss_pred cCcccccCceEEEEEEEcC--------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCc-eeEEEEEEeCceEEE
Q 002149 616 ENELGRGGFGVVYKGELDD--------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL-VSLLGYSVAGYERLL 686 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 686 (959)
.+.|+.|-...+|++...+ ++.+.+|+.... .. ...+.+|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888889999998753 478899987431 11 1345579999998853334 566665432 38
Q ss_pred EEEecCCCch
Q 002149 687 VYEYMPQGAL 696 (959)
Q Consensus 687 v~e~~~~gsL 696 (959)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999976444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0082 Score=66.16 Aligned_cols=74 Identities=14% Similarity=0.106 Sum_probs=44.5
Q ss_pred cCcccccCceEEEEEEEcC---------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCC-ceeEEEEEEeCceEE
Q 002149 616 ENELGRGGFGVVYKGELDD---------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH-LVSLLGYSVAGYERL 685 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 685 (959)
.+.++.|..-.+|+....+ ++.+++|+.... .....+...|.++++.+...+ +.++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3467788888999997654 267888876542 111112357888888885334 44666543 2 36
Q ss_pred EEEEecCCCch
Q 002149 686 LVYEYMPQGAL 696 (959)
Q Consensus 686 lv~e~~~~gsL 696 (959)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.98 E-value=0.03 Score=60.79 Aligned_cols=67 Identities=4% Similarity=0.066 Sum_probs=43.6
Q ss_pred ccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC---CCCceeEEEE------EEeCceEEEEEEec
Q 002149 621 RGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR---HRHLVSLLGY------SVAGYERLLVYEYM 691 (959)
Q Consensus 621 ~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~ 691 (959)
.|....||+....+| .+++|+...... ..|+..++.|. -|.+++++.. .......++||+|+
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 333679999987767 899998765421 35666666663 1224454432 23456779999999
Q ss_pred CCCch
Q 002149 692 PQGAL 696 (959)
Q Consensus 692 ~~gsL 696 (959)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 88765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.03 Score=63.26 Aligned_cols=74 Identities=11% Similarity=0.053 Sum_probs=47.4
Q ss_pred cCcccccCceEEEEEEEcC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCc-eeEEEEEEeCceEEEEEEecCC
Q 002149 616 ENELGRGGFGVVYKGELDD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL-VSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 693 (959)
.+.|+.|-...+|+....+ ++.+++|+..... .. .-+..+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3567888889999998764 4788888764321 11 1112579999999965555 46776652 2 359999987
Q ss_pred Cch
Q 002149 694 GAL 696 (959)
Q Consensus 694 gsL 696 (959)
..+
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.38 E-value=0.075 Score=52.34 Aligned_cols=102 Identities=13% Similarity=0.119 Sum_probs=65.3
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
-+|.+.|.... .++++++++.++.|.+.+|.-+-... .+ ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc--------
Confidence 36888886533 78999999999999999987762211 11 1233446889999999888753 1110
Q ss_pred eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCC
Q 002149 774 VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLM 816 (959)
Q Consensus 774 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~ 816 (959)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888653 345678899999999999886433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.39 E-value=0.088 Score=58.60 Aligned_cols=142 Identities=13% Similarity=0.156 Sum_probs=84.2
Q ss_pred cCcccccCceEEEEEEEcC--------CcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEE
Q 002149 616 ENELGRGGFGVVYKGELDD--------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 686 (959)
.+.+..|-...+|+....+ ++.+++++.... . ...-+..+|..+++.+. +.-..++++.+ . -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--V-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--c-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3567778888999998753 578899886432 1 11122357888888885 33344566533 2 278
Q ss_pred EEEecCCCchhh-----------------HHhhccc-----C---CCCCCCHHHHHHHHHHH------------------
Q 002149 687 VYEYMPQGALSK-----------------HIFHWKS-----L---NLEPLSWKRRLNIALDV------------------ 723 (959)
Q Consensus 687 v~e~~~~gsL~~-----------------~l~~~~~-----~---~~~~l~~~~~~~i~~~i------------------ 723 (959)
||||++|..+.. .+|.... . ...+.-|.++.++..++
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999998866421 0111111 0 11222244444443322
Q ss_pred -HHHHHHHHh---------------------cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 724 -ARGMEYLHS---------------------LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 724 -a~gL~yLH~---------------------~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
...+.+|.+ .....++|+|+.+.||+ +.++.+.++||..|.
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 223334332 11245889999999999 778899999998764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.21 E-value=0.4 Score=33.58 Aligned_cols=10 Identities=20% Similarity=0.321 Sum_probs=3.8
Q ss_pred HHHhhhhhhc
Q 002149 527 PISICYYRKR 536 (959)
Q Consensus 527 ~~~~~~~r~r 536 (959)
.++++++|||
T Consensus 29 ~~~~~~RRRr 38 (44)
T 2l2t_A 29 TFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHhhhhh
Confidence 3333333333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=85.65 E-value=0.53 Score=32.93 Aligned_cols=13 Identities=15% Similarity=0.350 Sum_probs=5.2
Q ss_pred HHHHHHhhhhhhc
Q 002149 524 VAIPISICYYRKR 536 (959)
Q Consensus 524 ~~~~~~~~~~r~r 536 (959)
+++.++++++|||
T Consensus 27 ~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 27 LGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHC
T ss_pred HHHHHHhheehhh
Confidence 3333444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.43 E-value=0.11 Score=58.64 Aligned_cols=63 Identities=6% Similarity=0.091 Sum_probs=18.4
Q ss_pred ccCcccccCceEEEEEEEcC-CcEEEE------EEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe
Q 002149 615 SENELGRGGFGVVYKGELDD-GTKIAV------KRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA 680 (959)
Q Consensus 615 ~~~~lG~G~fg~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 680 (959)
..+.+| ||.||+|.+.. ..+||| |..+....+.+....+.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999998763 367888 7766544455556678899999999999999999887653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.93 E-value=3.2 Score=45.71 Aligned_cols=28 Identities=32% Similarity=0.529 Sum_probs=23.9
Q ss_pred eEecCCCCCCEEE------CCCCcEEEeeccccc
Q 002149 738 FIHRDLKSSNILL------GDDFRAKVSDFGLVK 765 (959)
Q Consensus 738 ivH~Dik~~NiLl------~~~~~~ki~DfGla~ 765 (959)
++|+|+.+.||++ +++..++++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5699999999999 456779999998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 959 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-69 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-12 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-11 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 9e-69
Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 27/283 (9%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
+G G FG VYKG+ +AVK + + + + F +E+ VL K RH +++ +
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
GYS A +V ++ +L H+ ++ + ++IA A+GM+YLH
Sbjct: 71 GYSTAPQ-LAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLH---A 122
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVT-- 792
+S IHRDLKS+NI L +D K+ DFGL + S +L+G+ ++APE
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 793 -GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPIL 851
+ + DV++FG+VL EL+TG + ++ + D K+R+ +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 852 EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
L C ++ +RP + + L
Sbjct: 243 -------------KRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-65
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 27/279 (9%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+ LG G FG V+ G + TK+AVK ++ G +S D F +E ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQR 69
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L ++ EYM G+L + L+ + L++A +A GM ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFI 125
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
+++IHRDL+++NIL+ D K++DFGL +L D+E + + APE
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
G T K DV+SFG++L E++T P N++ +R P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTH-----GRIPYPGMTNPEVIQNLERGYRMVRPDNCP- 236
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
+ +L C P RP + +VL
Sbjct: 237 -----------EELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-64
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 27/284 (9%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
E+G G FG+V+ G + K+A+K + G +S++ +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L G + LV+E+M G LS ++ + L + + L + LDV GM YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYL 117
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
IHRDL + N L+G++ KVSDFG+ + D + + T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
+ ++K DV+SFGV++ E+ + P E + + +I + P
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSE-----GKIPYENRSNSEVVEDISTGFRL----YKPR 225
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
L + ++ HC P RP + LA + E
Sbjct: 226 LASTH--------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 7e-62
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 27/279 (9%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
K+ ELG G FGVV G+ +A+K ++ G +S+ DEF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L G ++ EYM G L ++ + ++ L + DV MEYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYL 116
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
+ F+HRDL + N L+ D KVSDFGL + D E + + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
+ K ++K D+++FGV++ E+ + P ER + +I R +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSL-----GKMPYERFTNSETAEHIAQGLRLYRPHLAS- 227
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
+ + C + +RP ++ +
Sbjct: 228 -----------EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-61
Identities = 88/321 (27%), Positives = 144/321 (44%), Gaps = 42/321 (13%)
Query: 611 KNFASENELGRGGFGVVYKGEL-DDGTK--IAVKRMEAGVISKKAVDEFHSEIAVLSKV- 666
+ ++ +G G FG V K + DG + A+KRM+ SK +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 68
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHI-----------FHWKSLNLEPLSWKR 715
H ++++LLG L EY P G L + F + LS ++
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
L+ A DVARGM+YL + FIHRDL + NIL+G+++ AK++DFGL + + +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
R ++A E TT DV+S+GV+L E+++ P A +
Sbjct: 186 GR--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-----GGTPYCGMTCAELYEK 238
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895
+ ++ L +D+ + +L C +P +RP + L ++E+
Sbjct: 239 LPQGYR-----LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
Query: 896 WKPLDD----EPEEYSGIDYS 912
K + E Y+GID S
Sbjct: 287 RKTYVNTTLYEKFTYAGIDCS 307
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-60
Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 28/295 (9%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
++ E +LG+G FG V+ G + T++A+K ++ G +S + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
LV L +V EYM +G+L + + L + +++A +A GM Y+
Sbjct: 74 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYV 129
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
+++HRDL+++NIL+G++ KV+DFGL +L D+E + + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
+ G+ T K DV+SFG++L EL T + R P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYRMPCPP- 237
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE 905
E + + +L C +EP +RP + L +P +P E
Sbjct: 238 -ECPES-------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP-QYQPGE 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 33/280 (11%)
Query: 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
K +G+G FG V G+ G K+AVK ++ + F +E +V++++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSN 61
Query: 671 LVSLLGYSVAGYERL-LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
LV LLG V L +V EYM +G+L ++ L L +LDV MEY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEY 118
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
L +F+HRDL + N+L+ +D AKVSDFGL K A ++ + + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEA 171
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K +TK DV+SFG++L E+ + P R L ++ +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSF-----GRVPYPRIPLKDVVPRVEKGYK-------- 218
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
++ D E+ +C + + RP L
Sbjct: 219 -MDAPDGCPPAV---YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 59/302 (19%), Positives = 117/302 (38%), Gaps = 35/302 (11%)
Query: 616 ENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFH--SEIAVLSKVRHRHLVS 673
+ +G+G FG V++G+ G ++AVK + S + + +EI +RH +++
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 674 LLGYSV----AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+ + LV +Y G+L ++ ++ + + +AL A G+ +
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAH 115
Query: 730 LHS-----LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL---APDSERSVVTRLAGT 781
LH + HRDLKS NIL+ + ++D GL A D+ GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 782 FGYLAPEYAVT------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY--LAAWF 833
Y+APE + + D+++ G+V E+ + Y L
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 834 WNIKSDKEK-LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPL 892
+++ ++ + P + + E +A++ C + R L+ L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
Query: 893 VE 894
+
Sbjct: 296 SQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-59
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 34/298 (11%)
Query: 615 SENELGRGGFGVVYKGEL---DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
++ ELG G FG V +G +A+K ++ G K +E E ++ ++ + ++
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYI 71
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V L+G +LV E G L K + + E + + V+ GM+YL
Sbjct: 72 VRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE 126
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP--DSERSVVTRLAGTFGYLAPEY 789
++F+HRDL + N+LL + AK+SDFGL K DS + + + APE
Sbjct: 127 ---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K +++ DV+S+GV + E L+ +P ++ I+ K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSY-----GQKPYKKMKGPEVMAFIEQGKR-------- 230
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYS 907
+E + L C + RPD + + L + E +
Sbjct: 231 -MECPPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMR---ACYYSLASKVEGHH 281
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-59
Identities = 59/297 (19%), Positives = 111/297 (37%), Gaps = 37/297 (12%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
+F +ELG G GVV+K G +A K + I ++ E+ VL + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPY 65
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V G + E + E+M G+L + + + + +++ V +G+ YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYL 120
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
+HRD+K SNIL+ K+ DFG+ DS GT Y++PE
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERL 175
Query: 791 VTGKITTKVDVFSFGVVLMELLTG-------------------LMALDESRPEERQYLAA 831
+ + D++S G+ L+E+ G + P +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWT------IAELAGHCTSREPSQRPDM 882
+ D A + + + ++ + + C + P++R D+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-59
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 31/279 (11%)
Query: 616 ENELGRGGFGVVYKGELDD---GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV 672
+ ELG G FG V KG +AVK ++ DE +E V+ ++ + ++V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
++G A +LV E G L+K++ + + K + + V+ GM+YL
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE- 124
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD--SERSVVTRLAGTFGYLAPEYA 790
+F+HRDL + N+LL AK+SDFGL K + T + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850
K ++K DV+SFGV++ E + +P + ++ +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS-----YGQKPYRGMKGSEVTAMLEKGER--------- 228
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
+ + +L C + + RP L
Sbjct: 229 MGCPAGCPREMY---DLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 63/278 (22%), Positives = 114/278 (41%), Gaps = 32/278 (11%)
Query: 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
+ E+GRG F VYKG + ++A ++ ++K F E +L ++H ++V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 675 LGYSVAGYER----LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+ + +LV E M G L ++ +K + K + + +G+++L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128
Query: 731 HSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
H+ IHRDLK NI + G K+ D GL L S + GT ++APE
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEM 184
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K VDV++FG+ ++E+ T E + + Y ++ + + P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------------RRVTSGVKP 231
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
E + E+ C + +R + +N
Sbjct: 232 ASFDKVAIPE----VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 9e-59
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 47/309 (15%)
Query: 612 NFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
N ++G G FG V++ + T +AVK ++ S +F E A++++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAE 72
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIF-------------------HWKSL 706
+ ++V LLG G L++EYM G L++ + S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 707 NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766
PLS +L IA VA GM YL + F+HRDL + N L+G++ K++DFGL +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 767 APDSERSVV-TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
++ A ++ PE + TT+ DV+++GVVL E+ + + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 826 RQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885
+ ++ IL ++ + + L C S+ P+ RP
Sbjct: 250 EVI-----YYVRDGN---------ILACPENCPLELYNLMRL---CWSKLPADRPSFCSI 292
Query: 886 VNVLAPLVE 894
+L + E
Sbjct: 293 HRILQRMCE 301
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-58
Identities = 71/279 (25%), Positives = 110/279 (39%), Gaps = 32/279 (11%)
Query: 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDE-FHSEIAVLSKVRH 668
++F LG+G FG VY +A+K + + K V+ E+ + S +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+++ L GY L+ EY P G + + + +R ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
Y HS + IHRD+K N+LLG K++DFG AP S R T L GT YL PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPE 174
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
KVD++S GV+ E L G + + +E + I + +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTFPDFVT 228
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
+L PSQRP + +
Sbjct: 229 EGA-------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 1e-58
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 42/306 (13%)
Query: 606 LRNVTKNFASE---------NELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKA 652
+ FA E +G G FG V G L +A+K +++G ++K
Sbjct: 12 PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQ 70
Query: 653 VDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLS 712
+F SE +++ + H +++ L G +++ E+M G+L + N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ----NDGQFT 126
Query: 713 WKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSER 772
+ + + +A GM+YL +++HRDL + NIL+ + KVSDFGL + D
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 773 SVVTRLA----GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY 828
A + APE K T+ DV+S+G+V+ E+++ RP
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY-----GERPYWDMT 238
Query: 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888
I+ D + P ++ + +L C ++ + RP G VN
Sbjct: 239 NQDVINAIEQDYR-----LPPPMDCPSA-------LHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 889 LAPLVE 894
L ++
Sbjct: 287 LDKMIR 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (505), Expect = 6e-58
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 28/296 (9%)
Query: 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ +++LG G +G VY+G +AVK ++ V+EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHP 73
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+LV LLG ++ E+M G L ++ N + +S L +A ++ MEY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEY 130
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
L ++FIHRDL + N L+G++ KV+DFGL +L + + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K + K DV++FGV+L E+ T P L+ + ++ D
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATY-----GMSPYPGIDLSQVYELLEKDYR-------- 234
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEE 905
+E + E EL C PS RP + ++ + DE E+
Sbjct: 235 -MERPEGCPEKV---YELMRACWQWNPSDRPSFAEIHQAFETMFQE-SSISDEVEK 285
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (503), Expect = 2e-57
Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 37/302 (12%)
Query: 608 NVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSK 665
+ K F+ E+G G FG VY + + +A+K+M +G S + + E+ L K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+RH + + G + + LV EY A H K PL + +
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQ 126
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYL 785
G+ YLHS + IHRD+K+ NILL + K+ DFG + + GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWM 178
Query: 786 APEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842
APE + G+ KVDV+S G+ +EL L ++I ++
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-- 230
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDE 902
P L+ + C + P RP + V + +P
Sbjct: 231 -----SPALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVI 279
Query: 903 PE 904
+
Sbjct: 280 MD 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 8e-57
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 27/282 (9%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
++ +G G +G K DG + K ++ G +++ SE+ +L +++H +
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 671 LVSLLGYSVAGYERLL--VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
+V + L V EY G L+ I + L + L + + ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALK 123
Query: 729 YLHSL--AHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
H + +HRDLK +N+ L K+ DFGL ++ + + S GT Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMS 182
Query: 787 PEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-EKLRA 845
PE K D++S G +L EL + +E I+ K ++
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIREGKFRRIPY 236
Query: 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
L E+ + + RP + +
Sbjct: 237 RYSDEL-------------NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 78/297 (26%), Positives = 124/297 (41%), Gaps = 35/297 (11%)
Query: 608 NVTKNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVL 663
++ +F +GRG FG VY G L D AVK + + V +F +E ++
Sbjct: 26 SLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIM 82
Query: 664 SKVRHRHLVSLLGYSV-AGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
H +++SLLG + + L+V YM G L I + + K + L
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQ 138
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE---RSVVTRLA 779
VA+GM++L + F+HRDL + N +L + F KV+DFGL + D E T
Sbjct: 139 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195
Query: 780 GTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839
++A E T K TTK DV+SFGV+L EL+T + P +
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR-----GAPPYPDVNTFDITVYLLQG 250
Query: 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896
+ L+ P + E+ C + RP V+ ++ + +
Sbjct: 251 RRLLQPEYCP------------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-56
Identities = 62/280 (22%), Positives = 105/280 (37%), Gaps = 28/280 (10%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+++ LG G +G V +AVK ++ + + EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V G+ G + L EY G L I + + G+ Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVY 118
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVTRLAGTFGYLAPE 788
LH HRD+K N+LL + K+SDFGL ++ ++ ++ GT Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 789 YAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847
+ VDV+S G+VL +L G + D+ ++Y + K K L
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYL---- 226
Query: 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
+P +++ L PS R +
Sbjct: 227 NPWKKIDSA-------PLALLHKILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 612 NFASENELGRGGFGVVYKGELDDGT-----KIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+ +G G FG VYKG L + +A+K ++AG ++K +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF 66
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
H +++ L G +++ EYM GAL K + S + + + +A G
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAG 122
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLA--GTFGY 784
M+YL + +++HRDL + NIL+ + KVSDFGL ++ D + T +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
APE K T+ DV+SFG+V+ E++T + S+ E ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTY---------------GERPYWELSNHEVMK 224
Query: 845 AAIDPI-LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
A D L D +L C +E ++RP V++L L+
Sbjct: 225 AINDGFRLPTPMDCPSAI---YQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-55
Identities = 71/295 (24%), Positives = 115/295 (38%), Gaps = 41/295 (13%)
Query: 616 ENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RH 668
LG G FG V + D +AVK ++ + SE+ VLS + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNH 86
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE-------------PLSWKR 715
++V+LLG G L++ EY G L + + + L +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSV 774
L+ + VA+GM +L S ++ IHRDL + NILL K+ DFGL + + DS V
Sbjct: 147 LLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 775 VTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834
++APE T + DV+S+G+ L EL + + P + ++
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI-- 261
Query: 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
KE R + ++ C +P +RP V ++
Sbjct: 262 -----KEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-55
Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 46/305 (15%)
Query: 612 NFASENELGRGGFGVVYKG------ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
N LG G FG V + ++AVK ++ + SE+ ++++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQ 96
Query: 666 V-RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE--------------- 709
+ H ++V+LLG L++EY G L ++ + E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 710 ---PLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK- 765
L+++ L A VA+GME+L +S +HRDL + N+L+ K+ DFGL +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE 825
+ DS V ++APE G T K DV+S+G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL-----GVNPYP 268
Query: 826 RQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885
+ A F+ + + K+ D ++ I + C + + +RP +
Sbjct: 269 GIPVDANFYKLIQNGFKM----DQPFYATEE-------IYIIMQSCWAFDSRKRPSFPNL 317
Query: 886 VNVLA 890
+ L
Sbjct: 318 TSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 38/287 (13%)
Query: 608 NVTKNFASE------NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEI 660
+VT++ E ELG G FG VYK + + A K ++ S++ ++++ EI
Sbjct: 3 HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEI 60
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
+L+ H ++V LL ++ E+ GA+ + + PL+ + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVC 116
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ YLH IHRDLK+ NIL D K++DFG+ + G
Sbjct: 117 KQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIG 172
Query: 781 TFGYLAPEYAVT-----GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
T ++APE + K DV+S G+ L+E+ E P
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLK 226
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
I + P L F + C + R
Sbjct: 227 IAKSE-------PPTLAQPSRWSSNF---KDFLKKCLEKNVDARWTT 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 77/286 (26%), Positives = 118/286 (41%), Gaps = 31/286 (10%)
Query: 611 KNFASENELGRGGFGVVYKGELD----DGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSK 665
K+ +LG G FGVV +GE D +AVK ++ V+S+ +A+D+F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+ HR+L+ L G + ++ V E P G+L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV--TRLAGTFG 783
GM YL S + FIHRDL + N+LL K+ DFGL++ P ++ V F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
+ APE T + D + FGV L E+ T P + I + E+L
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTY-----GQEPWIGLNGSQILHKIDKEGERL 234
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVL 889
P E + C + +P RP + L
Sbjct: 235 -----PRPEDCPQDI------YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-54
Identities = 62/287 (21%), Positives = 115/287 (40%), Gaps = 32/287 (11%)
Query: 616 ENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL 671
+G G FG V++G + +A+K + S ++F E + + H H+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 672 VSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLH 731
V L+G ++ E G L + K L + A ++ + YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLE 125
Query: 732 SLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAV 791
S + F+HRD+ + N+L+ + K+ DFGL + DS ++ ++APE
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 792 TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS-DKEKLRAAIDPI 850
+ T+ DV+ FGV + E+L +P + I++ ++ + P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGERLPMPPNCPP- 236
Query: 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897
T+ L C + +PS+RP L+ ++E+ K
Sbjct: 237 ------------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 8e-54
Identities = 77/299 (25%), Positives = 136/299 (45%), Gaps = 35/299 (11%)
Query: 611 KNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLS 664
+ ELG+G FG+VY+G + T++A+K + S + EF +E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMK 78
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSL-----NLEPLSWKRRLNI 719
+ H+V LLG G L++ E M +G L ++ + L P S + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV-TRL 778
A ++A GM YL++ F+HRDL + N ++ +DF K+ DFG+ + +++ +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838
+++PE G TT DV+SFGVVL E+ T A + S
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL---------------AEQPYQGLS 240
Query: 839 DKEKLRAAIDP-ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896
+++ LR ++ +L+ D+ + EL C P RP ++ + +E
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDML---FELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-52
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 29/287 (10%)
Query: 602 SVQVLRNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEI 660
S+ + + K + ++G+G G VY ++ G ++A+++M + + +EI
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEI 68
Query: 661 AVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
V+ + ++ ++V+ L + G E +V EY+ G+L+ + + + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVC 122
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ + +E+LHS IHRD+KS NILLG D K++DFG E+S + + G
Sbjct: 123 RECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVG 178
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840
T ++APE KVD++S G++ +E++ G P + I ++
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG 232
Query: 841 EKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
P L+ + F + C + +R +
Sbjct: 233 T-------PELQNPEKLSAIF---RDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-52
Identities = 71/311 (22%), Positives = 128/311 (41%), Gaps = 35/311 (11%)
Query: 603 VQVLRNVTKNFASENELGRGGFGVVYKGELDD-----GTKIAVKRMEAGVISKKAVDEFH 657
+++L+ F LG G FG VYKG +A+K + S KA E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEIL 59
Query: 658 SEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRL 717
E V++ V + H+ LLG + L+ + MP G L ++ K + + + L
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLL 114
Query: 718 NIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVVT 776
N + +A+GM YL + +HRDL + N+L+ K++DFGL K L + +
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 777 RLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836
++A E + T + DV+S+GV + EL+T S+P + + +
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF-----GSKPYDGIPASEISSIL 226
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV-EK 895
+ + R PI ++ + + C + RP + + + +
Sbjct: 227 EKGE---RLPQPPICTID---------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 896 WKPLDDEPEEY 906
+ L + +E
Sbjct: 275 QRYLVIQGDER 285
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 60/288 (20%), Positives = 100/288 (34%), Gaps = 30/288 (10%)
Query: 612 NFASENELGRGGFGVVYKG-ELDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHR 669
+F LG G F V EL + A+K +E +I + V E V+S++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
V L + Y G L K+I ++ +EY
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEY 123
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL-APDSERSVVTRLAGTFGYLAPE 788
LH + IHRDLK NILL +D +++DFG K+ +P+S+++ GT Y++PE
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
D+++ G ++ +L+ GL F I +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLEYDFPEKFF 234
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896
P +L + ++R +
Sbjct: 235 PKA-------------RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-50
Identities = 79/300 (26%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 616 ENELGRGGFGVVYKGEL--------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV- 666
LG G FG V E + TK+AVK +++ ++K + + SE+ ++ +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIG 76
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLE-----------PLSWKR 715
+H+++++LLG ++ EY +G L +++ + LE LS K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 716 RLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV 775
++ A VARGMEYL S + IHRDL + N+L+ +D K++DFGL + +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 776 TRL-AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834
T ++APE T + DV+SFGV+L E+ T + P E F
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----ELFK 248
Query: 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
+K +D ++ + + C PSQRP V L +V
Sbjct: 249 LLKEGHR-----MDKPSNCTNE-------LYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-50
Identities = 73/299 (24%), Positives = 119/299 (39%), Gaps = 40/299 (13%)
Query: 616 ENELGRGGFGVVYKG------ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
LGRG FG V + + +AVK ++ G + SE+ +L + H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHH 76
Query: 670 HLVSLLGYSV--AGYERLLVYEYMPQGALSKHIFH-----------WKSLNLEPLSWKRR 716
V L + G +++ E+ G LS ++ + L + L+ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 717 LNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK-LAPDSERSVV 775
+ + VA+GME+L S + IHRDL + NILL + K+ DFGL + + D +
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 776 TRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
++APE T + DV+SFGV+L E+ + P + F
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCR 248
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894
+ ++RA E+ + C EPSQRP V L L++
Sbjct: 249 RLKEGTRMRAPDYTTPEM-----------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 171 bits (435), Expect = 1e-48
Identities = 63/279 (22%), Positives = 104/279 (37%), Gaps = 31/279 (11%)
Query: 616 ENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVS 673
LG GG V+ L +AVK + A + F E + + H +V+
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 674 LLGY----SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
+ + AG +V EY+ L + P++ KR + + D + + +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVV--TRLAGTFGYLAP 787
H IHRD+K +NI++ KV DFG+ + DS SV + GT YL+P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 788 EYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847
E A + + DV+S G VL E+LTG P + + +R
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTG------EPPFTGDSPVSVAYQH------VREDP 231
Query: 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886
P ++ + ++ P R +
Sbjct: 232 IPPSARHEGLSADL---DAVVLKALAKNPENRYQTAAEM 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 172 bits (436), Expect = 1e-48
Identities = 53/308 (17%), Positives = 109/308 (35%), Gaps = 36/308 (11%)
Query: 609 VTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR 667
V ++ +G G FGV+++G L + ++A+K + + E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLA 58
Query: 668 HR-HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
+ ++ + G +LV + + + S K A +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLAR 113
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFR-----AKVSDFGLVKLAPDSERSVVTR---- 777
++ +H +S ++RD+K N L+G V DFG+VK D
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 778 --LAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN 835
L+GT Y++ + + + + D+ + G V M L G + + +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYER 227
Query: 836 IKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895
I K+ P+ E+ E F+ + + PD + + + ++E+
Sbjct: 228 IGEKKQST-----PLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER 279
Query: 896 WKPLDDEP 903
+DE
Sbjct: 280 LNTTEDEN 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 2e-48
Identities = 67/278 (24%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+V ++ ELG G FGVV++ E G A K + S K + EI +S +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
RH LV+L E +++YE+M G L + + + +S + V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKG 136
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDF--RAKVSDFGLVKLAPDSERSVVTRLAGTFGY 784
+ ++H +++H DLK NI+ K+ DFGL + VT GT +
Sbjct: 137 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
APE A + D++S GV+ LL+GL +E N+KS +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMD 245
Query: 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
+ +++D + +P+ R +
Sbjct: 246 DSAFS--GISED-------GKDFIRKLLLADPNTRMTI 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 1e-46
Identities = 64/286 (22%), Positives = 105/286 (36%), Gaps = 40/286 (13%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVIS-------KKAVDEFHSEIAVL 663
N+ + LGRG VV + + AVK ++ ++ + E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 664 SKVR-HRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
KV H +++ L LV++ M +G L ++ LS K I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRA 118
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTF 782
+ + LH + +HRDLK NILL DD K++DFG E+ + GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTP 173
Query: 783 GYLAPEYAVTG------KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836
YLAPE +VD++S GV++ LL G + I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 227
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
S + + + +D + +L +P +R
Sbjct: 228 MSGNYQFGSPEWD--DYSDT-------VKDLVSRFLVVQPQKRYTA 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-46
Identities = 61/308 (19%), Positives = 108/308 (35%), Gaps = 34/308 (11%)
Query: 616 ENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSL 674
++G G FG +Y G + G ++A+K K + H E + ++ +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 675 LGYSVA-GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSL 733
+ + A G ++V E + F + S K L +A + +EY+HS
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS- 121
Query: 734 AHQSFIHRDLKSSNIL---LGDDFRAKVSDFGLVKLAPDSERSVV------TRLAGTFGY 784
++FIHRD+K N L + DFGL K D+ L GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844
+ + + + + D+ S G VLM G + + ++ K
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS----- 234
Query: 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPE 904
PI + F T C S +PD + + L + D
Sbjct: 235 ---TPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
Query: 905 EYSGIDYS 912
+++ + +
Sbjct: 289 DWNMLKFG 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 4e-46
Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 29/279 (10%)
Query: 607 RNVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
+V + ELG G FGVV++ E G K + K +EI+++++
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 666 VRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVAR 725
+ H L++L YE +L+ E++ G L I +S +N
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSEAEVINYMRQACE 138
Query: 726 GMEYLHSLAHQSFIHRDLKSSNILL--GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
G++++H S +H D+K NI+ K+ DFGL E VT T
Sbjct: 139 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAE 193
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
+ APE + D+++ GV+ LL+GL E N+K +
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDWEF 247
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
V+ + + + +EP +R +
Sbjct: 248 DEDAFS--SVSPE-------AKDFIKNLLQKEPRKRLTV 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 5e-46
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 30/279 (10%)
Query: 608 NVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
++ + + LG G F V E +A+K + + K +EIAVL K+
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKI 64
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
+H ++V+L +G L+ + + G L I + + + V
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDA 119
Query: 727 MEYLHSLAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
++YLH +HRDLK N+L +D + +SDFGL K+ SV++ GT G
Sbjct: 120 VKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPG 174
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
Y+APE + VD +S GV+ LL G P + A F I + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG------YPPFYDENDAKLFEQILKAEYEF 228
Query: 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
+ +++D + H ++P +R
Sbjct: 229 DSPYWD--DISDS-------AKDFIRHLMEKDPEKRFTC 258
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-45
Identities = 66/335 (19%), Positives = 133/335 (39%), Gaps = 25/335 (7%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
+V + + + +G G +G+V + + ++A+K++ + EI +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRF 63
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
RH +++ + A + Y+ + ++ L + LS + RG
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQILRG 121
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS--VVTRLAGTFGY 784
++Y+HS + +HRDLK SN+LL K+ DFGL ++A +T T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 785 LAPEYAVTGKITT-KVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
APE + K T +D++S G +L E+L+ ++ S ++
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 844 RAAIDPIL-------EVNDDTFETFWTIA-----ELAGHCTSREPSQRPDMGHAVNVLAP 891
N + + A +L + P +R ++ A+ P
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HP 296
Query: 892 LVEKWKPLDDEPEEYSGIDYSLPLNQMVKD-WQEA 925
+E++ DEP + + + L+ + K+ +E
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 2e-45
Identities = 65/272 (23%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISK-KAVDEFHSEIAVLSKVRH 668
++F LG G FG V+ +G A+K ++ ++ + K V+ + E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
++ + G + ++ +Y+ G L + + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALE 118
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
YLHS + I+RDLK NILL + K++DFG K PD ++ GT Y+APE
Sbjct: 119 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPE 171
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
T +D +SFG+++ E+L G +S + + I + + + +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAELRFPPFFN 225
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
++ +L +R+ SQR
Sbjct: 226 EDVK-------------DLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (417), Expect = 3e-45
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 33/275 (12%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEF----HSEIAVLSKV 666
+F+ +GRGGFG VY D G A+K ++ I K + ++++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
+V + + + + M G L H+ S A ++ G
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILG 119
Query: 727 MEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+E++H+ + ++RDLK +NILL + ++SD G LA D + GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG---LACDFSKKKPHASVGTHGYMA 173
Query: 787 PEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845
PE G + D FS G +L +LL G + + +++ + + +L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPD 230
Query: 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP 880
+ P L L R+ ++R
Sbjct: 231 SFSPELR-------------SLLEGLLQRDVNRRL 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 55/287 (19%), Positives = 108/287 (37%), Gaps = 19/287 (6%)
Query: 610 TKNFASENELGRGGFGVVYKGE--LDDGTKIAVKRMEAGVISKKAVDEFHSEIAV---LS 664
+ + E+G G +G V+K + G +A+KR+ + E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 665 KVRHRHLVSLLGYSVAGYERLLVYEYMP-QGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
H ++V L + + + + + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
RG+++LHS +HRDLK NIL+ + K++DFGL ++ S + +T + T
Sbjct: 126 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLW 180
Query: 784 YLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKL 843
Y APE + T VD++S G + E+ S ++ + +++
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 844 RAAIDPILEVNDDTFETFWTIA--------ELAGHCTSREPSQRPDM 882
R P + + + +L C + P++R
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (405), Expect = 2e-44
Identities = 53/281 (18%), Positives = 106/281 (37%), Gaps = 18/281 (6%)
Query: 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
++G G +GVVYK + + G A+K++ + EI++L +++H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+LV+E++ Q L + L + G+ Y H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKIT 796
+HRDLK N+L+ + K++DFGL + R + + + K +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 797 TKVDVFSFGVVLMELLTGLMALDESRPEERQYL--------AAWFWNIKSDKEKLRAAID 848
T +D++S G + E++ G ++ + W ++ K
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 849 PILEVNDDTFETFWT--IAELAGHCTSREPSQRPDMGHAVN 887
+ ++F +L +P+QR A+
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-43
Identities = 48/268 (17%), Positives = 102/268 (38%), Gaps = 30/268 (11%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLG 676
+LGRG FG+V++ E K ++ + EI++L+ RHR+++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 677 YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQ 736
+ E ++++E++ + + I L+ + ++ V +++LHS
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHS---H 121
Query: 737 SFIHRDLKSSNILLG--DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGK 794
+ H D++ NI+ K+ +FG + + L Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 795 ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVN 854
++T D++S G ++ LL+G+ ++ NI + + E++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDEEAFK--EIS 231
Query: 855 DDTFETFWTIAELAGHCTSREPSQRPDM 882
+ + +E R
Sbjct: 232 IE-------AMDFVDRLLVKERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-43
Identities = 72/278 (25%), Positives = 109/278 (39%), Gaps = 31/278 (11%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKV-RH 668
+F LG+G FG V+ E A+K ++ V+ V+ E VLS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
L + V EY+ G L HI R A ++ G++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQ 117
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
+LHS + ++RDLK NILL D K++DFG+ K + + GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPE 173
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
+ K VD +SFGV+L E+L G EE F +I+ D ++
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPFYPRWLE 227
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAV 886
+ +L REP +R + +
Sbjct: 228 KEAK-------------DLLVKLFVREPEKRLGVRGDI 252
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 34/284 (11%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKK----AVDEFHSEIAV 662
NV + + ELG G F VV K E G + A K ++ + ++ E+++
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 663 LSKVRHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALD 722
L +++H ++++L + +L+ E + G L + + L+ +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQ 121
Query: 723 VARGMEYLHSLAHQSFIHRDLKSSNILLGDD----FRAKVSDFGLVKLAPDSERSVVTRL 778
+ G+ YLHS H DLK NI+L D R K+ DFGL +
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 176
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838
GT ++APE + + D++S GV+ LL+G +E N+ +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSA 230
Query: 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDM 882
+ + ++P +R +
Sbjct: 231 VNYEFEDEYFSNTSAL---------AKDFIRRLLVKDPKKRMTI 265
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-42
Identities = 52/287 (18%), Positives = 104/287 (36%), Gaps = 18/287 (6%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRH 670
NF ++G G +GVVYK G +A+K++ ++ EI++L ++ H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
+V LL + LV+E++ Q + + + + +G+ +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFC 118
Query: 731 HSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYA 790
HS +HRDLK N+L+ + K++DFGL + R+ + +
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 791 VTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQY-----LAAWFWNIKSDKEKLRA 845
+T VD++S G + E++T ++ + L + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 846 AIDPILEVNDDTFETFWTIA-----ELAGHCTSREPSQRPDMGHAVN 887
+ F L +P++R A+
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-41
Identities = 62/325 (19%), Positives = 118/325 (36%), Gaps = 42/325 (12%)
Query: 619 LGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLG 676
LG G G V + K A+K + + + E+ + + + H+V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 677 YSVAGYER----LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
Y L+V E + G L I + + + + I + ++YLHS
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 733 LAHQSFIHRDLKSSNILL---GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
+ HRD+K N+L + K++DFG K T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEV 184
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
K D++S GV++ LL G + I+ + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQYEFPNPEWS 242
Query: 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGI 909
EV+++ + L + EP+QR + +N P + + + P +
Sbjct: 243 --EVSEE-------VKMLIRNLLKTEPTQRMTITEFMN--HPWIMQSTKVPQTP-----L 286
Query: 910 DYSLPLNQMVKDWQEAEGKDLSYVS 934
S L + + W++ + + S ++
Sbjct: 287 HTSRVLKEDKERWEDVKEEMTSALA 311
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 23/285 (8%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKK---AVDEFHSEIAVLSKVRHRHLV 672
+ LG G F VYK + +A+K+++ G S+ EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 673 SLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS 732
LL LV+++M + L+ L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 733 LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT 792
+HRDLK +N+LL ++ K++DFGL K + S T T Y APE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 793 GK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYL---------AAWFWNIKSDKEK 842
+ VD+++ G +L ELL + L ++ + ++ S +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
+ P + ++ + +L P R A+
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 47/289 (16%), Positives = 105/289 (36%), Gaps = 20/289 (6%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHR 669
+ + ++G G +G V+K + + +A+KR+ + EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 670 HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEY 729
++V L + + LV+E+ Q L+ + + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGF 116
Query: 730 LHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
H ++ +HRDLK N+L+ + K+++FGL + R + +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 790 AVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849
+T +D++S G + EL L + Q + +E+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 850 ILEVNDDTFETFWTIA-----------ELAGHCTSREPSQRPDMGHAVN 887
+ ++ +L + P QR A+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 61/279 (21%), Positives = 101/279 (36%), Gaps = 44/279 (15%)
Query: 618 ELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKA----VDEFHSEIAVLSKVRHRH-- 670
LG GGFG VY G + D +A+K +E IS E+ +L KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 671 LVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYL 730
++ LL + +L+ E + L + + V + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 731 HSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEY 789
H+ +HRD+K NIL+ + K+ DFG L D+ T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180
Query: 790 AVTGKITTK-VDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
+ + V+S G++L +++ G + + D+E +R +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE------------------HDEEIIRGQVF 222
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887
V+ + L C + PS RP N
Sbjct: 223 FRQRVSSE-------CQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-40
Identities = 69/277 (24%), Positives = 107/277 (38%), Gaps = 30/277 (10%)
Query: 611 KNFASENELGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRH 668
+F LG+G FG V G A+K + +I+K V +E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 669 RHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGME 728
L +L V EY G L H+ + + +R ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 729 YLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPE 788
YLHS + ++RD+K N++L D K++DFGL K S+ + + GT YLAPE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPE 175
Query: 789 YAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848
VD + GVV+ E++ G P Q F I ++ + +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG------RLPFYNQDHERLFELILMEEIRFPRTLS 229
Query: 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885
P + L ++P QR G +
Sbjct: 230 PEAK-------------SLLAGLLKKDPKQRLGGGPS 253
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 8e-39
Identities = 72/339 (21%), Positives = 131/339 (38%), Gaps = 38/339 (11%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
V + +G G +G V + G K+A+K++ S+ + E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 667 RHRHLVSLLGYSVAG------YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
RH +++ LL + LV +M K + E L R +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-------LGKLMKHEKLGEDRIQFLV 127
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ +G+ Y+H+ IHRDLK N+ + +D K+ DFGL + A V
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----V 180
Query: 781 TFGYLAPEYAV-TGKITTKVDVFSFGVVLMELLTG--------LMALDESRPEERQYLAA 831
T Y APE + + T VD++S G ++ E++TG + + + A
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 832 WFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIA-----ELAGHCTSREPSQRPDMGHAV 886
F + ++ + + + E+ F + T A L + QR G A+
Sbjct: 241 EFVQ-RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 887 NVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQMVKDWQEA 925
P E +DEP+ D +++ + +W+
Sbjct: 300 A--HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRV 336
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-38
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 607 RNVTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSK 665
R ++ +G G FGVVY+ +L D G +A+K++ + + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 666 VRHRHLVSLLGYSVAGYER------LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNI 719
+ H ++V L + + E+ LV +Y+P+ + + + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLY 127
Query: 720 ALDVARGMEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLAPDSERSVVTRL 778
+ R + Y+HS HRD+K N+LL D K+ DFG K E V+ +
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYI 183
Query: 779 AGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
+ T+ +DV+S G VL ELL G
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 57/297 (19%), Positives = 116/297 (39%), Gaps = 34/297 (11%)
Query: 617 NELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
++G+G FG V+K G K+A+K++ + EI +L ++H ++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 676 G--------YSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
Y+ LV+++ L + + + G+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGL 130
Query: 728 EYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK---LAPDSERSVVTRLAGTFGY 784
Y+H +HRD+K++N+L+ D K++DFGL + LA +S+ + T T Y
Sbjct: 131 YYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 785 LAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWF-------WNI 836
PE + + +D++ G ++ E+ T + + + + L +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIA------ELAGHCTSREPSQRPDMGHAVN 887
D +L ++ + + +L +P+QR D A+N
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 1e-36
Identities = 60/265 (22%), Positives = 100/265 (37%), Gaps = 33/265 (12%)
Query: 618 ELGRGGFGVVYKGE-LDDGTKIAVKRME-AGVISKKAVDEFHSEIAVLSKVRHRHLVSLL 675
LG G FG V + + G A+K ++ V+ K ++ +E +L V LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 676 GYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAH 735
+V EY+ G + H+ S A + EYLHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 736 QSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI 795
I+RDLK N+L+ +V+DFG K ++ GT LAPE ++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGY 215
Query: 796 TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPILEVND 855
VD ++ GV++ E+ G +P + + I S K + + L+
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKVRFPSHFSSDLK--- 266
Query: 856 DTFETFWTIAELAGHCTSREPSQRP 880
+L + + ++R
Sbjct: 267 ----------DLLRNLLQVDLTKRF 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-36
Identities = 72/351 (20%), Positives = 126/351 (35%), Gaps = 49/351 (13%)
Query: 608 NVTKNFASENELGRGGFGVVYKG-ELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
V K + + +G G G+V + +A+K++ ++ + E+ ++ V
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 667 RHRHLVSLLGYSVA------GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIA 720
H++++SLL + LV E M +R +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLL 125
Query: 721 LDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAG 780
+ G+++LH IHRDLK SNI++ D K+ DFGL + A S T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV 180
Query: 781 TFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG----------------LMALDESRPE 824
T Y APE + VD++S G ++ E++ + L PE
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240
Query: 825 ERQYLAAWFWNIKSDKEKLRAAIDPIL---EVNDDTFETFWTIAELA----GHCTSREPS 877
+ L N ++ K P L + E A A +P+
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300
Query: 878 QRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGIDYSLPLNQM---VKDWQEA 925
+R + A+ P + W E E Y L++ +++W+E
Sbjct: 301 KRISVDDALQ--HPYINVW-YDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-34
Identities = 66/284 (23%), Positives = 107/284 (37%), Gaps = 32/284 (11%)
Query: 611 KNFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVISKKA--VDEFHSEIAVLS 664
+NF LG G +G V+ D G A+K ++ I +KA + +E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 665 KVRHR-HLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDV 723
+R LV+L + L+ +Y+ G L H+ + + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 724 ARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGTFG 783
+E+LH I+RD+K NILL + ++DFGL K E GT
Sbjct: 139 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 784 YLAPEYAVTGK--ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841
Y+AP+ G VD +S GV++ ELLTG E+ A I +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRILKSEP 253
Query: 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHA 885
+ + + +L ++P +R G
Sbjct: 254 PYPQEMSALAK-------------DLIQRLLMKDPKKRLGCGPR 284
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-33
Identities = 63/314 (20%), Positives = 120/314 (38%), Gaps = 32/314 (10%)
Query: 608 NVTKNFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV 666
V + + + + +G G +G V G ++AVK++ S + E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 667 RHRHLVSLLGY-----SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIAL 721
+H +++ LL S+ + + + ++ GA +I + L+ +
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQ-----KLTDDHVQFLIY 128
Query: 722 DVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERSVVTRLAGT 781
+ RG++Y+HS IHRDLK SN+ + +D K+ DFG LA ++ + +A
Sbjct: 129 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG---LARHTDDEMTGYVATR 182
Query: 782 FGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE-------RQYLAAWFW 834
+ VD++S G ++ ELLTG + +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIA-----ELAGHCTSREPSQRPDMGHAVNVL 889
K E R I + ++ F + A +L + +R A+
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA-- 300
Query: 890 APLVEKWKPLDDEP 903
++ DDEP
Sbjct: 301 HAYFAQYHDPDDEP 314
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 1e-32
Identities = 43/296 (14%), Positives = 102/296 (34%), Gaps = 43/296 (14%)
Query: 612 NFASENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HR 669
++ +LGRG + V++ + + K+ VK ++ + EI +L +R
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENLRGGP 90
Query: 670 HLVSLLGYSVAGYERL--LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGM 727
++++L R LV+E++ + + L+ ++ + +
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKAL 142
Query: 728 EYLHSLAHQSFIHRDLKSSNILLG-DDFRAKVSDFGLVKLAPDSERSVVTRLAGTFGYLA 786
+Y HS +HRD+K N+++ + + ++ D+GL + + + +
Sbjct: 143 DYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKG 197
Query: 787 PEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA---------AWFWNI 836
PE V + +D++S G +L ++ Q + + +
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257
Query: 837 KSDKEKLRAAIDPILEVNDDTFETFWTIA----------ELAGHCTSREPSQRPDM 882
K + E D + + +E F + + R
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 4e-28
Identities = 36/210 (17%), Positives = 76/210 (36%), Gaps = 13/210 (6%)
Query: 616 ENELGRGGFGVVYKGE-LDDGTKIAVKRMEAGVISKKAVDE--------FHSEIAVLSKV 666
+LG G F V+ + + + T +A+K + + +A ++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 667 RHRHLVSLLGYSVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARG 726
H++ LL + + + + + K + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 727 MEYLHSLAHQSFIHRDLKSSNILL-GDDFRAKVSDFGLVKLA-PDSERSVVTRLAGTFGY 784
++Y+H IH D+K N+L+ D + + L T T Y
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 785 LAPEYAVTGKITTKVDVFSFGVVLMELLTG 814
+PE + D++S ++ EL+TG
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITG 225
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (271), Expect = 2e-26
Identities = 66/303 (21%), Positives = 101/303 (33%), Gaps = 36/303 (11%)
Query: 37 DPGDIDILNQFRKNLENPELLQ-WPKSGDPCGPPCWKHVFCSNS----RVTQIQVSSVGL 91
+P D L Q +K+L NP L W + D C W V C RV + +S + L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT-WLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 92 KG--TLPQNLNQLSKLENIGLQK--NQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFD 147
+P +L L L + + N P+ + L+ L Y Y+ N DF
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 148 GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNL 207
++ L L N + + P + S L ++ ++G +PD G+F+ L
Sbjct: 123 QIKTLVTLDFSYNALS----GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 208 KLSGNN----------------------LTGPIPESFKGLNLVNLWLNDQKGGGFTGTID 245
N S + N +
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
+G L L L N GT+P+ +L L LN++ N G IP D
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 306 NNN 308
NN
Sbjct: 299 ANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.6 bits (184), Expect = 3e-15
Identities = 63/305 (20%), Positives = 99/305 (32%), Gaps = 21/305 (6%)
Query: 169 SFPKGLQSSAQLTN----LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTG--PIPESF 222
K L + L++ C + G L D + NL LSG NL PIP S
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNL 282
L +N + + QL L++ + SG IP+ ++ +L L+
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 283 NSNQFVGLIPPSLASLSLDHL-DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPE 341
+ N G +PPS++SL + N G +P S ++ P
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 342 VMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVG 401
A ++ L S + L
Sbjct: 193 TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD-- 250
Query: 402 NLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKL---SLDGN 458
L++N I G +P T LK L L++S NNL +P+ + + N
Sbjct: 251 ---------LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 459 PLLNG 463
L G
Sbjct: 302 KCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.0 bits (167), Expect = 5e-13
Identities = 30/110 (27%), Positives = 48/110 (43%), Gaps = 8/110 (7%)
Query: 338 CAP-EVMALIDFLGGLNYPPRLVTSWSGNDPC-KSWLGLSCGTNS---KLTVLNLPNFNL 392
C P + AL+ L P L + D C ++WLG+ C T++ ++ L+L NL
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 393 SG--TLSPSVGNLDSLTQIKLQSN-NISGQIPTNWTNLKSLTLLDLSQNN 439
+ S+ NL L + + N+ G IP L L L ++ N
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 53/266 (19%), Positives = 78/266 (29%), Gaps = 25/266 (9%)
Query: 176 SSAQLTNLSCMSCNLAG--QLPDFLGNFASLQNLKLSGN-NLTGPIPESF---KGLNLVN 229
+ ++ NL NL +P L N L L + G NL GPIP + L+ +
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 230 LWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVG 289
+ + D L + L TL N SGT+P S L +L + + N+ G
Sbjct: 108 ITHTNV----SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 290 LIPPSLA---SLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALI 346
IP S L N + P ++ +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 347 DFLGGLNYPPRLVTSWSGNDPCKSWLGLSC-----------GTNSKLTVLNLPNFNLSGT 395
+ G + L L L LN+ NL G
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 396 LSPSVGNLDSLTQIKLQSNNISGQIP 421
+ P GNL +N P
Sbjct: 284 I-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 9e-09
Identities = 15/81 (18%), Positives = 26/81 (32%)
Query: 58 QWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG 117
+ + + + + + GTLPQ L QL L ++ + N G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 118 ELPSFSGLSNLKYAYLDGNNF 138
E+P L + N
Sbjct: 283 EIPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.3 bits (95), Expect = 4e-04
Identities = 18/65 (27%), Positives = 27/65 (41%), Gaps = 7/65 (10%)
Query: 157 LDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNN-LT 215
L +N + P+GL L +L+ NL G++P GN + N L
Sbjct: 251 LRNNRIYGT----LPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305
Query: 216 G-PIP 219
G P+P
Sbjct: 306 GSPLP 310
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 1e-22
Identities = 25/159 (15%), Positives = 47/159 (29%), Gaps = 28/159 (17%)
Query: 617 NELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAV--------DEFHSEIAVLSKVRH 668
+G G V+ + + VK + G S K V F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 669 RHLVSLLGYSVAG----YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVA 724
R L L G +V ++ E + L + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVEN------------PDEVLDMIL 113
Query: 725 RGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763
+ + H+ +H DL N+L+ + + DF
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQ 148
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.6 bits (226), Expect = 3e-20
Identities = 67/371 (18%), Positives = 109/371 (29%), Gaps = 38/371 (10%)
Query: 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158
L ++ + + + + L+NL N I L L + ++
Sbjct: 40 QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96
Query: 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF--------LGNFASLQNLKLS 210
+N + L N L + + ++L L
Sbjct: 97 NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156
Query: 211 GNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPES 270
G K L + I VL + L +L N S P
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG 216
Query: 271 FGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLNNNMFMGPVPKSKAYKYSYSSNAF 329
T+L +L+LN NQ +LASL+ L LDL NN P S K +
Sbjct: 217 IL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 272
Query: 330 CQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPN 389
Q + + + N LT L L
Sbjct: 273 NQ-------------ISNISPLAGLTALTNLELNENQLEDIS---PISNLKNLTYLTLYF 316
Query: 390 FNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKF 447
N+S V +L L ++ +N +S ++ NL ++ L N +S PL
Sbjct: 317 NNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANL 372
Query: 448 SGAVKLSLDGN 458
+ +L L+
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 88.9 bits (219), Expect = 2e-19
Identities = 45/254 (17%), Positives = 82/254 (32%), Gaps = 45/254 (17%)
Query: 56 LLQWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQF 115
L + V + + + ++ + P + + L+ + L NQ
Sbjct: 174 LTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQL 231
Query: 116 RGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQ 175
+ + + + L+NL L N + GL L L L +N + + L
Sbjct: 232 KD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT 288
Query: 176 SSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQ 235
+ N + N +L L L NN++ P
Sbjct: 289 NLELNENQLEDIS--------PISNLKNLTYLTLYFNNISDISP---------------- 324
Query: 236 KGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
+ ++ +L+ L+ N S S LT++ L+ NQ L P L
Sbjct: 325 -----------VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--L 369
Query: 296 ASL-SLDHLDLNNN 308
A+L + L LN+
Sbjct: 370 ANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 5e-10
Identities = 43/248 (17%), Positives = 77/248 (31%), Gaps = 9/248 (3%)
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
PI + F L T T+ ++DQ+ TL + L +
Sbjct: 11 PINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNN 67
Query: 277 LKDLNLNSNQFVGLIP-PSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
L +N ++NQ + P +L L ++ N + P+ N +
Sbjct: 68 LTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 127
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS-G 394
+ + L ++ L S + LT L + + +
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187
Query: 395 TLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLS--PPLPKFSGAVK 452
+ + L +L + +N IS P L +L L L+ N L L +
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTD 245
Query: 453 LSLDGNPL 460
L L N +
Sbjct: 246 LDLANNQI 253
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 8e-07
Identities = 54/339 (15%), Positives = 98/339 (28%), Gaps = 41/339 (12%)
Query: 147 DGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQN 206
L L N Q+T L + + D + +L
Sbjct: 19 TALAEKMKTVLGKTNVTD------TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQ 70
Query: 207 LKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGT 266
+ S N LT P NL L + + +
Sbjct: 71 INFSNNQLTDITPLK----NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126
Query: 267 IPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSS 326
++ L L+ + + L + + + + + + S +
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 327 NAFCQPTEGVPCAPEVMALIDFLGGL---NYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT 383
+ + ++A + + + L + K L+ TN LT
Sbjct: 187 VSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTN--LT 244
Query: 384 VLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIP--------------------TN 423
L+L N +S + L LT++KL +N IS P +
Sbjct: 245 DLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302
Query: 424 WTNLKSLTLLDLSQNNLS--PPLPKFSGAVKLSLDGNPL 460
+NLK+LT L L NN+S P+ + +L N +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKV 341
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.6 bits (218), Expect = 1e-19
Identities = 53/321 (16%), Positives = 89/321 (27%), Gaps = 52/321 (16%)
Query: 127 NLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186
+L+ + +P D + +L L +N K F ++ L L +
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNNKITEIKDGDF----KNLKNLHTLILI 63
Query: 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDV 246
+ ++ P L+ L LS N L +PE ++ +
Sbjct: 64 NNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNG 122
Query: 247 LGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLN 306
L M + L + SG +F + L + + IP L SL L L+
Sbjct: 123 LNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP-SLTELHLD 179
Query: 307 NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGND 366
N S L L +
Sbjct: 180 GNKITKVDAAS----------------------------------LKGLNNLAKLGLSFN 205
Query: 367 PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG------QI 420
+ S L L+L N L + + + + L +NNIS
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 421 PTNWTNLKSLTLLDLSQNNLS 441
P T S + + L N +
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.9 bits (206), Expect = 4e-18
Identities = 47/297 (15%), Positives = 74/297 (24%), Gaps = 66/297 (22%)
Query: 63 GDPCGPPC---WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGEL 119
G C C + V CS+ + ++ P++L + LQ N+
Sbjct: 1 GPVCPFRCQCHLRVVQCSDLGLEKV-----------PKDLP--PDTALLDLQNNKITEIK 47
Query: 120 P-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNF---------------- 162
F L NL L N I F L L+ L L N
Sbjct: 48 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRV 107
Query: 163 ------------------------NASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFL 198
+ S + + LS +
Sbjct: 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167
Query: 199 GNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258
G SL L L GN +T S K L NL + +
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLK--GLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225
Query: 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS-------LSLDHLDLNNN 308
N+ +P ++ + L++N + S + L +N
Sbjct: 226 LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 59/378 (15%), Positives = 93/378 (24%), Gaps = 97/378 (25%)
Query: 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSG 124
PC C C N GL+ +P +
Sbjct: 1 PCPGAC----VCYNEPKVTTSCPQQGLQ-AVPVGIP------------------------ 31
Query: 125 LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLS 184
+ + +L GN +PA F NL +L L SN +
Sbjct: 32 -AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA---RIDAAAFTGLALLEQLDL 87
Query: 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
+ L P L L L L P F+
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR--------------------- 126
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHL 303
+ L+ L+L N ++F L +L L L+ N+ + + L SLD L
Sbjct: 127 ----GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWS 363
L+ N P L L +
Sbjct: 183 LLHQNRVAHVHP-------------------------------HAFRDLGRLMTLYLFAN 211
Query: 364 GNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTN 423
+ + L L L + + L + + S+ + +P
Sbjct: 212 NLSALPTE---ALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP-- 265
Query: 424 WTNLKSLTLLDLSQNNLS 441
L L L+ N+L
Sbjct: 266 -QRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 40/187 (21%), Positives = 66/187 (35%), Gaps = 20/187 (10%)
Query: 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLK 129
F R+ + + GL+ P L+ L+ + LQ N + +F L NL
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 130 YAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPK------GLQSSAQLTNL 183
+ +L GN ++P F GL +L L L N +F + L+ L
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 184 SCMSCNLAGQL-------------PDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL 230
+ L +A LQ + S + + +P+ G +L L
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRL 276
Query: 231 WLNDQKG 237
ND +G
Sbjct: 277 AANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 1e-06
Identities = 26/182 (14%), Positives = 53/182 (29%), Gaps = 10/182 (5%)
Query: 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYS 325
+P + + + L+ N+ + S + + ++ + + + +
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 326 SNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVL 385
+ + RL T + + L L
Sbjct: 83 EQLDLSDNAQLRSVDPAT--------FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 386 NLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLP 445
L + L + +L +LT + L N IS + L SL L L QN ++ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 446 KF 447
Sbjct: 195 HA 196
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.3 bits (160), Expect = 2e-12
Identities = 34/211 (16%), Positives = 53/211 (25%), Gaps = 10/211 (4%)
Query: 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159
++++ + K LP + +L N T L L LD
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP 219
+ L + N L LP S L +
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 220 ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKD 279
E + N G +L +L L L N+ + L +L
Sbjct: 125 ELQELYLKGNELKTLPPG--------LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176
Query: 280 LNLNSNQFVGLIPPSLASLSLDHLDLNNNMF 310
L L N + S L L+ N +
Sbjct: 177 LLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 7e-10
Identities = 31/189 (16%), Positives = 54/189 (28%), Gaps = 15/189 (7%)
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP-PSLASLSLDHLDLNNNMFM 311
L L N + T L LNL+ + L +L L L N +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSL 92
Query: 312 GPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSW 371
+ ++ + + + + L + N L P
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152
Query: 372 LGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLT 431
L L+ NL+ + + L++L + LQ N++ IP + L
Sbjct: 153 LSLAN-------------NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 432 LLDLSQNNL 440
L N
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 34/219 (15%), Positives = 57/219 (26%), Gaps = 22/219 (10%)
Query: 248 GNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLS-LDHLDLN 306
+ + + + +P K L+L+ N +L + L L+L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 307 NNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGND 366
+ Q + AL N L
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 367 PCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQS-NNISGQIPTNWT 425
N TL P + + + NN++
Sbjct: 124 GELQE--------------LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN 169
Query: 426 NLKSLTLLDLSQNNLSPPLPKFSGAVKLS---LDGNPLL 461
L++L L L +N+L F G+ L L GNP L
Sbjct: 170 GLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 17/101 (16%)
Query: 111 QKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNF------- 162
N +GL NL L N+ TIP FF L L N +
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFG-SHLLPFAFLHGNPWLCNCEIL 214
Query: 163 --------NASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLP 195
NA + + +G+ A +N++ + C+ + + P
Sbjct: 215 YFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFP 255
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 5e-12
Identities = 39/217 (17%), Positives = 65/217 (29%), Gaps = 17/217 (7%)
Query: 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
L+ I K+ + + + L + G TI L NL L L N
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDN 73
Query: 161 NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP- 219
+ N +AG + S Q ++ +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 220 --------ESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESF 271
+ L + G + L N+ +L TL N S P
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 272 GKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
L +L +++L +NQ + P LA+ +L + L N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 2e-11
Identities = 43/225 (19%), Positives = 75/225 (33%), Gaps = 12/225 (5%)
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
I F L N T T+ ++D + TL G + E L +
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTI--EGVQYLNN 64
Query: 277 LKDLNLNSNQFVGLIPPS-LASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
L L L NQ L P L ++ L N + + ++ K ++
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC----GTNSKLTVLNLPNFN 391
+ + L L + L + +S SKLT L +
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 392 LSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
+S + +L +L ++ L++N IS P N +L ++ L+
Sbjct: 185 ISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 3e-07
Identities = 35/218 (16%), Positives = 61/218 (27%), Gaps = 19/218 (8%)
Query: 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNF 138
+ +I + T+ Q L + + + L+NL L N
Sbjct: 19 ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75
Query: 139 DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF- 197
+ L + L L N + + +++ + LAG
Sbjct: 76 TDLA--PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 198 -------LGNFASLQNLKLSGNNLTGPIPESFKGL--NLVNLWLNDQKGGGFTGTIDVLG 248
+ N + L L G S NL L + I L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ 286
++ L + L N S P ++L + L +NQ
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 4/95 (4%)
Query: 66 CGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGL 125
++ +S + + L LSKL + N+ + + L
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASL 194
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN 160
NL +L N + NL ++ L +N
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TN 226
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 6e-10
Identities = 40/292 (13%), Positives = 75/292 (25%), Gaps = 31/292 (10%)
Query: 153 QVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGN 212
Q L L N + G S + C + L + F +Q++ LS +
Sbjct: 3 QTLDLTGKNLHPDVT-----GRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNS 56
Query: 213 NLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFG 272
+ L +L+ L L G S I +
Sbjct: 57 VIEVSTLHGI------------------------LSQCSKLQNLSLEGLRLSDPIVNTLA 92
Query: 273 KLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQP 332
K ++L LNL+ S LD N + + +
Sbjct: 93 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 333 TEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFN- 391
+ P + S + K+ + L L+L
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212
Query: 392 LSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPP 443
+ +G + +L +++ G + L L + ++ P
Sbjct: 213 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARP 264
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.3 bits (122), Expect = 3e-08
Identities = 25/114 (21%), Positives = 38/114 (33%), Gaps = 9/114 (7%)
Query: 195 PDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLR 254
L + +L LS N L P L L +D +D + N+ +L+
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN----ALENVDGVANLPRLQ 68
Query: 255 TLWLHGNHFSGT-IPESFGKLTSLKDLNLNSNQFVGL--IPPSLASL--SLDHL 303
L L N + + L LNL N I LA + S+ +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 20/108 (18%), Positives = 31/108 (28%), Gaps = 9/108 (8%)
Query: 110 LQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWS 169
L L L + + L N L L+ L + + N
Sbjct: 5 LAHKDLT-VLCHLEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDN---ALE 56
Query: 170 FPKGLQSSAQLTNLSCMSCNLAG-QLPDFLGNFASLQNLKLSGNNLTG 216
G+ + +L L + L L + L L L GN+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 48/308 (15%), Positives = 93/308 (30%), Gaps = 36/308 (11%)
Query: 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238
Q L + L+ LP+ + L++L S N+LT +PE + L + + N+ K
Sbjct: 39 QAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 239 GFTGT---IDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSL 295
+ N + L + F I L L DL +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 296 ASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFC----------------------QPT 333
L +L ++ K S +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 334 EGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393
+ P++ ++ L + + + S+L S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVK- 452
+ SL ++ + +N + ++P L+ L S N+L+ +P+ +K
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQNLKQ 328
Query: 453 LSLDGNPL 460
L ++ NPL
Sbjct: 329 LHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 21/123 (17%), Positives = 36/123 (29%), Gaps = 36/123 (29%)
Query: 185 CMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTI 244
+ ++ SL+ L +S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP--------------------- 304
Query: 245 DVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLD 304
+L L NH + +PE +LK L++ N P S+ L
Sbjct: 305 -------RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREF-PDIPESVE--DLR 350
Query: 305 LNN 307
+N+
Sbjct: 351 MNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 19/126 (15%), Positives = 40/126 (31%), Gaps = 15/126 (11%)
Query: 58 QWPKSGDPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRG 117
+++F S + + + LE + + N+
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 297
Query: 118 ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177
ELP+ L+ N+ +P + +NL+ L ++ N FP +S
Sbjct: 298 ELPA--LPPRLERLIASFNHLAEVP----ELPQNLKQLHVEYNPLR-----EFPDIPES- 345
Query: 178 AQLTNL 183
+ +L
Sbjct: 346 --VEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 45/324 (13%), Positives = 80/324 (24%), Gaps = 20/324 (6%)
Query: 126 SNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185
L+ ++P + +L+ L N+ P+ QS L +
Sbjct: 38 RQAHELELNNLGLSSLP----ELPPHLESLVASCNSLT-----ELPELPQSLKSLLVDNN 88
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTID 245
L+ P S L+ + N L D
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 246 VLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
+ L S KL L + ++ +L L
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 306 NNNMFMGPVPKSKAY-KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364
+ T+ + L + L +
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 365 NDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNW 424
+ + + C L LN+ N L L L+ L N+++ ++P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELP 323
Query: 425 TNLKSLTLLDLSQNNLS--PPLPK 446
NLK L + N L P +P+
Sbjct: 324 QNLKQL---HVEYNPLREFPDIPE 344
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 31/220 (14%), Positives = 61/220 (27%), Gaps = 24/220 (10%)
Query: 217 PIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTS 276
PI + F ++ K T + ++ + + + + L +
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPN 69
Query: 277 LKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGV 336
+ L LN N+ LA+L + + + K K S + +
Sbjct: 70 VTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127
Query: 337 PCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTL 396
+ L G N + L + + ++
Sbjct: 128 NGLVHLPQLESLYLGNNK-------ITDITVLSRLTKLDTLSLEDNQISDIVPL------ 174
Query: 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436
L L + L N+IS LK+L +L+L
Sbjct: 175 ----AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 43/221 (19%), Positives = 78/221 (35%), Gaps = 27/221 (12%)
Query: 94 TLPQNLNQ------LSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFD 147
T+P + Q ++ L+K + + L+++ + ++ ++
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQ 65
Query: 148 GLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNL 207
L N+ L L+ N L++ L +L+ SL++
Sbjct: 66 YLPNVTKLFLNGNKLT---DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEH- 121
Query: 208 KLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI 267
GL + + G I VL + +L TL L N S +
Sbjct: 122 ---------NGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV 172
Query: 268 PESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
P LT L++L L+ N L +LA L +LD L+L +
Sbjct: 173 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 31/210 (14%), Positives = 60/210 (28%), Gaps = 27/210 (12%)
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
+ L + + ++ +L S+ + N++ + + L ++ L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 308 NMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDP 367
N P + + + +
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKK------------------LKSLSL 119
Query: 368 CKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNL 427
+ + G + +L N T + L L + L+ N IS +P L
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGL 177
Query: 428 KSLTLLDLSQNNLS--PPLPKFSGAVKLSL 455
L L LS+N++S L L L
Sbjct: 178 TKLQNLYLSKNHISDLRALAGLKNLDVLEL 207
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 39/330 (11%), Positives = 82/330 (24%), Gaps = 27/330 (8%)
Query: 121 SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQL 180
S G S LK + + ++ A + ++++ + L N + + S L
Sbjct: 4 SIEGKS-LKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGF 240
F+ + ++ L L F
Sbjct: 62 EIA----------------EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF 105
Query: 241 TGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSL 300
T + L + + L + P L S+
Sbjct: 106 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 165
Query: 301 DHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT 360
L N ++++ ++ ++ + + L
Sbjct: 166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 225
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLS----PSVGNLDSLTQIKLQSNNI 416
+++ + L N + LN + G + S L ++LQ N I
Sbjct: 226 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 285
Query: 417 SGQIPTN-----WTNLKSLTLLDLSQNNLS 441
+ L L+L+ N S
Sbjct: 286 ELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 5e-07
Identities = 18/162 (11%), Positives = 41/162 (25%), Gaps = 11/162 (6%)
Query: 225 LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG----TIPESFGKLTSLKDL 280
L++ +L + ++ ++L + Q + + L + I + +L +L
Sbjct: 2 LDIQSLDIQCEELSD-ARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 281 NLNSNQFVGLIPPSLA------SLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTE 334
NL SN+ + + S + L L N G +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
Query: 335 GVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSC 376
+ L+ +
Sbjct: 121 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 14/91 (15%), Positives = 30/91 (32%), Gaps = 1/91 (1%)
Query: 127 NLKYAYLDGNNF-DTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185
+++ + D A+ L+ QV+ LD ++ L+ + L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTG 216
S L + + K+ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 18/109 (16%), Positives = 34/109 (31%), Gaps = 12/109 (11%)
Query: 362 WSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT----LSPSVGNLDSLTQIKLQSNNIS 417
+ + S L VL L + ++S + L+ ++ SL ++ L +N +
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 418 GQIPTN-----WTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLL 461
L L L S + A++ P L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD---KPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 14/94 (14%), Positives = 25/94 (26%), Gaps = 9/94 (9%)
Query: 203 SLQNLKLSGNNLT-GPIPESFKGL-NLVNLWLNDQK--GGGFTGTIDVLGNMDQLRTLWL 258
+Q+L + L+ E L + L+D L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 259 HGNHFSGTIPESFGKL-----TSLKDLNLNSNQF 287
N + ++ L+L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 17/111 (15%), Positives = 28/111 (25%), Gaps = 26/111 (23%)
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259
+ L+ L L+ +++ S L LR L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSL---------------------AATLLANHSLRELDLS 405
Query: 260 GNHFSGTIPESFGK-----LTSLKDLNLNSNQFVGLIPPSLASLSLDHLDL 305
N + L+ L L + + L +L D L
Sbjct: 406 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 11/66 (16%), Positives = 23/66 (34%), Gaps = 5/66 (7%)
Query: 382 LTVLNLPNFNLSGT-LSPSVGNLDSLTQIKLQSNNISGQ----IPTNWTNLKSLTLLDLS 436
+ L++ LS + + L ++L ++ I + +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 437 QNNLSP 442
N L
Sbjct: 64 SNELGD 69
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.1 bits (115), Expect = 8e-07
Identities = 29/264 (10%), Positives = 54/264 (20%), Gaps = 33/264 (12%)
Query: 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGF 240
C + ++P L + L+ L +F G + Q
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 241 TGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSL 300
DV N+ +L + + + N +L
Sbjct: 68 VIEADVFSNLPKLHEIRIEKAN----------------------NLLYINPEAFQNLPNL 105
Query: 301 DHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVT 360
+L ++N K + + F + + +
Sbjct: 106 QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 165
Query: 361 SWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420
N + + LPN + + I
Sbjct: 166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH--------GASGPVILDISRTRIHSLP 217
Query: 421 PTNWTNLKSLTLLDLSQNNLSPPL 444
NLK L P L
Sbjct: 218 SYGLENLKKLRARSTYNLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 33/264 (12%), Positives = 55/264 (20%), Gaps = 64/264 (24%)
Query: 71 WKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKY 130
+ C S+VT+I P +L N
Sbjct: 10 NRVFLCQESKVTEI-----------PSDL-------------------------PRNAIE 33
Query: 131 AYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL 190
I F G +L+ + + N+ + NL
Sbjct: 34 LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS--NLPKLHEIRIEKANNL 91
Query: 191 AGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLW------------------- 231
P+ N +LQ L +S + L
Sbjct: 92 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 151
Query: 232 ------LNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSN 285
L K G N+ + F + L+++
Sbjct: 152 SFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211
Query: 286 QFVGLIPPSLASL-SLDHLDLNNN 308
+ L L +L L N
Sbjct: 212 RIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 26/177 (14%), Positives = 49/177 (27%), Gaps = 29/177 (16%)
Query: 132 YLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQS--------------- 176
G IP D + L L+ N L
Sbjct: 14 DCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE 70
Query: 177 ------SAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL 230
++ + L + L+ L L N ++ +P SF+ +L +L
Sbjct: 71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE--HLNSL 128
Query: 231 WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQF 287
+ F + + LR L+G P + ++ +L ++F
Sbjct: 129 TSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 4/140 (2%)
Query: 177 SAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQK 236
+ T + C L ++P + L L+ N L + G + L ++
Sbjct: 7 HCEGTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKR 63
Query: 237 GGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLA 296
+ ++ L L N + F L LK LNL NQ ++P S
Sbjct: 64 NQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE 123
Query: 297 SL-SLDHLDLNNNMFMGPVP 315
L SL L+L +N F
Sbjct: 124 HLNSLTSLNLASNPFNCNCH 143
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.003
Identities = 26/185 (14%), Positives = 50/185 (27%), Gaps = 31/185 (16%)
Query: 276 SLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEG 335
++ IP + L L LN+N + + + +
Sbjct: 9 EGTTVDCTGRGLKE-IPRDI-PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL 66
Query: 336 VPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGT 395
P + G + K +L LNL + +S
Sbjct: 67 TGIEPNAF---------EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117
Query: 396 LSPSVGNLDSLTQIKLQSNNISGQIPTNW--------------------TNLKSLTLLDL 435
+ S +L+SLT + L SN + W + ++ + + DL
Sbjct: 118 MPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDL 177
Query: 436 SQNNL 440
+
Sbjct: 178 PHSEF 182
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 29/204 (14%), Positives = 49/204 (24%), Gaps = 22/204 (10%)
Query: 94 TLPQNL--------NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADF 145
T+ Q+ L++ L K S + L + D +I
Sbjct: 1 TITQDTPINQIFTDTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIKSIDG-- 57
Query: 146 FDGLENLQVLALDSN---------NFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPD 196
+ L NL + +N N + L
Sbjct: 58 VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 117
Query: 197 FLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL 256
L+ L+ L+ + + L N+ L L
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERL 177
Query: 257 WLHGNHFSGTIPESFGKLTSLKDL 280
+ N S KLT+L+ L
Sbjct: 178 DISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 34/203 (16%), Positives = 64/203 (31%), Gaps = 27/203 (13%)
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307
+ + L + + T+ ++ L + L + + + L +L ++ +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 308 NMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDP 367
N P K Q + P A +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTN----------------LTGLTLFN 115
Query: 368 CKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNL 427
+ + L L L + +S ++ L SL Q+ SN ++ P NL
Sbjct: 116 NQITDIDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LANL 171
Query: 428 KSLTLLDLSQNNLS--PPLPKFS 448
+L LD+S N +S L K +
Sbjct: 172 TTLERLDISSNKVSDISVLAKLT 194
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 31/232 (13%), Positives = 67/232 (28%), Gaps = 49/232 (21%)
Query: 200 NFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259
A L N+T + ++ ++DQ+ TL
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT---------------------------DLDQVTTLQAD 48
Query: 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKA 319
+ L +L +N ++NQ + P + L + +
Sbjct: 49 RLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLK------NLTKLVDILMNNNQIADIT 100
Query: 320 YKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTN 379
+ ++ + + + L L ++ S S L+
Sbjct: 101 PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNF--- 157
Query: 380 SKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG-QIPTNWTNLKSL 430
+ ++ + NL +L ++ + SN +S + TNL+SL
Sbjct: 158 --------SSNQVTD--LKPLANLTTLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 26/160 (16%), Positives = 40/160 (25%), Gaps = 31/160 (19%)
Query: 133 LDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAG 192
L + + + ALD L + L+ ++A
Sbjct: 4 LKPEQVEQLKL-IMSKRYDGSQQALDLKGLR------SDPDLVAQNIDVVLN-RRSSMAA 55
Query: 193 QLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQ 252
L N L +L LS N L S ++
Sbjct: 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSS-----------------------IVQKAPN 92
Query: 253 LRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP 292
L+ L L GN K L++L L+ N
Sbjct: 93 LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 18/138 (13%), Positives = 39/138 (28%), Gaps = 4/138 (2%)
Query: 95 LPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQV 154
L +++ L R P + ++ + + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLS 69
Query: 155 LALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNL 214
L L +N + +Q + L L+ L + L+ L L GN+L
Sbjct: 70 LNL--SNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 215 TGPIPESFKGLNLVNLWL 232
+ + ++ +
Sbjct: 128 SDTFRDQSTYISAIRERF 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 4e-05
Identities = 14/66 (21%), Positives = 22/66 (33%), Gaps = 2/66 (3%)
Query: 249 NMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIP-PSLASLSLDHLDLNN 307
N + R L L G I L ++ + N+ L P L L ++ N
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNR 74
Query: 308 NMFMGP 313
+G
Sbjct: 75 ICRIGE 80
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 20/143 (13%), Positives = 41/143 (28%), Gaps = 12/143 (8%)
Query: 118 ELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSS 177
+ ++ + L G I + L+ + N G+ +
Sbjct: 10 QAAQYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRKLDGFPLLR----- 63
Query: 178 AQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKG 237
+L L + + L L L+ N+L + + +L +L
Sbjct: 64 -RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILR 121
Query: 238 GGFTGTID----VLGNMDQLRTL 256
T V+ + Q+R L
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 11/57 (19%), Positives = 18/57 (31%), Gaps = 2/57 (3%)
Query: 397 SPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKL 453
+ N ++ L+ I I L +D S N + L F +L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDGFPLLRRL 65
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 28/170 (16%), Positives = 58/170 (34%), Gaps = 12/170 (7%)
Query: 97 QNLNQLSKLENIGLQKNQFRGELP-------SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149
+ + + +K + G +P + S L K+ L NN + I + G+
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS--LSGM 69
Query: 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKL 209
ENL++L+L N + ++ S + +L + + S +
Sbjct: 70 ENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITN 129
Query: 210 SGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGT---IDVLGNMDQLRTL 256
G + + L L L + + I+V+ + L+ L
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 21/113 (18%), Positives = 32/113 (28%), Gaps = 6/113 (5%)
Query: 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNF-DTIPADFFDGLENLQVLALDSNN 161
+ ++ L G NL Y++ + GL L+ L + +
Sbjct: 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 162 FNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNL 214
+ +S N L SLQ L LSGN L
Sbjct: 68 L-----RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 25/167 (14%), Positives = 42/167 (25%), Gaps = 21/167 (12%)
Query: 64 DPCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--S 121
D C P + C+ +L L + ++ Q L
Sbjct: 3 DACCPHGSSGLRCTRDGALDS-----------LHHLPGAENLTELYIENQQHLQHLELRD 51
Query: 122 FSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLT 181
GL L+ + + + D F L L L N + + L+
Sbjct: 52 LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLS 111
Query: 182 N--LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLN 226
L C SC L +L + + L +
Sbjct: 112 GNPLHC-SCALR-----WLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 959 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.41 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.41 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.2 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.14 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.15 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.09 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.74 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.2 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.91 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=422.66 Aligned_cols=263 Identities=27% Similarity=0.488 Sum_probs=208.9
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||+||+|+++ ..||||+++.........+.|.+|++++++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 357899999999999999999865 469999998766666778899999999999999999999998754 56799999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ...+++.++..++.|||+||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999998542 2569999999999999999999999 8999999999999999999999999999986544
Q ss_pred CC-cceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 770 SE-RSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 770 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.. ........||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.......... +.. .
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~---------~ 225 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGR---------G 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHH---------T
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc---------C
Confidence 32 233455789999999999864 35889999999999999999999999876654322111 110 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
...+.+. ......+..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 226 ~~~p~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 226 YLSPDLS--KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCCCCGG--GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcch--hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1111110 11112234688999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=420.21 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=201.3
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..+.||+|+||.||+|.+.+++.||||++..... ..++|.+|++++++++|||||+++|++...+..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 46888899999999999999998889999999976432 345789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ...+++..+..++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999988542 3568999999999999999999999 89999999999999999999999999999876554
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTG-LMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........||+.|+|||++.+..++.++|||||||++|||+|+ +.|+......+.... + ......
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---i----------~~~~~~ 221 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---I----------STGFRL 221 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---H----------HHTCCC
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---H----------HhcCCC
Confidence 44444456799999999999999999999999999999999995 555555443222111 1 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..+. .....+.+++.+||+.||++|||++||+++|+++.+
T Consensus 222 --~~p~---~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 --YKPR---LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCcc---ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1011 122467899999999999999999999999998865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=419.77 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=210.0
Q ss_pred hcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
.++|+..+.||+|+||.||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 35788899999999999999999888999999997643 234579999999999999999999998754 56789999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 999999999875422 2468999999999999999999999 8999999999999999999999999999997765
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMAL-DESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
..........||+.|||||++.++.++.++|||||||++|||+||..|+ ......+. ...+ .....
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~i----------~~~~~ 228 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNL----------ERGYR 228 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----------HTTCC
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHHH----------HhcCC
Confidence 5444445567999999999999999999999999999999999965554 44433221 1111 11111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
... +. .....+.+++.+||+.||++|||+++|++.|++++.
T Consensus 229 ~~~--p~---~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 MVR--PD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCC--CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC--cc---cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111 11 223468899999999999999999999999998865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=417.66 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=210.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999975 579999999987542 2334678999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.+ ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999988743 468999999999999999999999 8999999999999999999999999999997654
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..... .. .. .+
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~----------~~-~~ 234 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--AT----------NG-TP 234 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----------HC-SC
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--Hh----------CC-CC
Confidence 332 334568999999999999999999999999999999999999999876654322111 00 00 00
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+. ........+.+++.+||+.||++|||+.|+++ +++++
T Consensus 235 ~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~ 274 (293)
T d1yhwa1 235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (293)
T ss_dssp CCS---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGG
T ss_pred CCC---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 111 11112346789999999999999999999976 45554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-49 Score=421.38 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=212.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|+..+.||+|+||+||+|.+. +++.||||+++... ...++|.+|++++++++|||||++++++.+++..++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 56888899999999999999875 58899999987642 235679999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. .....+++..+..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 94 ~~~~g~l~~~l~~---~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 94 FMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CCTTCBHHHHHHH---SCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred cccCcchHHHhhh---ccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 9999999999865 233679999999999999999999999 8999999999999999999999999999997765
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
..........||+.|+|||++.+..++.++|||||||++|||++|..|+........ +...+ ....
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----------~~~~-- 233 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----------EKDY-- 233 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----------HTTC--
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----------hcCC--
Confidence 554444556789999999999999999999999999999999997766544332221 11111 0111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+... ......+.+|+.+||+.||++|||+++|++.|+.+++
T Consensus 234 ~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 RMERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111 1223468899999999999999999999998887654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=414.91 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=202.8
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 5799999999999999999976 478999999987642 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999998843 2579999999999999999999999 8999999999999999999999999999986543
Q ss_pred CC-cceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 770 SE-RSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 770 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.. .......+||+.|||||++.+..+ +.++||||+||++|||++|+.||............ ..
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~-------------- 220 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WK-------------- 220 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HH--------------
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-Hh--------------
Confidence 32 223455789999999999988876 57899999999999999999999876543221111 00
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..... ..........+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 EKKTY-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCC-CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 0000111236779999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-48 Score=419.98 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=202.3
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc---EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT---KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|+..++||+|+||+||+|.++ +++ .||||++... ......++|.+|++++++++|||||+++|++.++...++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45777889999999999999864 232 5899988754 345566789999999999999999999999999999999
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++.. ....+++.++..++.|||+||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 105 v~Ey~~~g~L~~~~~~----~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHT----TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeecc----ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 9999999999998854 23569999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcc----eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 767 APDSERS----VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 767 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
....... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+.... +.
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~---i~------- 247 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA---IE------- 247 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HH-------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH---HH-------
Confidence 5443221 1122468999999999999999999999999999999998 8999988765432111 11
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. ..+. ........+.+++.+||+.||++|||+.||++.|+++++.
T Consensus 248 ---~~--~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 248 ---QD--YRLP---PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---TT--CCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---cC--CCCC---CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 00 0111 1112344688999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=407.60 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=213.8
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++.+....++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57889999999999999999999888999999986533 345789999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++... ...+++..+.+++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 81 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999987542 2568999999999999999999999 89999999999999999999999999999866554
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+....+ .+..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------------~~~~-- 218 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------AQGL-- 218 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------------HTTC--
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------------HhCC--
Confidence 4444455679999999999999999999999999999999998 89999887654432111 1100
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.+..+. ....++.+++.+||+.||++|||+++++++|.+
T Consensus 219 ~~~~p~---~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPH---LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCcc---cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111111 223478899999999999999999999998754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=415.36 Aligned_cols=257 Identities=19% Similarity=0.312 Sum_probs=198.9
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--CceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--GYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 687 (959)
++|++.+.||+|+||+||+|+. .+|+.||||++......+...+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999976 478999999998776667777889999999999999999999999865 4567999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA--HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+
T Consensus 84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999865332 2367999999999999999999999832 1349999999999999999999999999999
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
....... ......||+.|||||++.+..++.++|||||||++|||+||+.||......+.... +. ..
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~---i~---------~~ 229 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK---IR---------EG 229 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HH---------HT
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH---HH---------cC
Confidence 7654322 23457899999999999999999999999999999999999999987665432111 10 00
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
.... + ......++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~-~-----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 KFRR-I-----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCC-C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-C-----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111 1 1112236889999999999999999999976
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=408.83 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=209.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEccccccc-HHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVIS-KKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|..+ +++.||||++.+.... ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999764 6899999998754322 233567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999998642 468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+..... ..
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----------------~~ 218 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------SR 218 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------HT
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----------------Hc
Confidence 432 34568999999999999999999999999999999999999999877654321111 01
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.....+. .....+.+++.+||+.||++|||++|+++ ++++.
T Consensus 219 ~~~~~p~---~~s~~~~~li~~~L~~dp~~R~t~~eil~--hp~~~ 259 (263)
T d2j4za1 219 VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLE--HPWIT 259 (263)
T ss_dssp TCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT--CHHHH
T ss_pred CCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHHc--CcCcC
Confidence 1111111 12246789999999999999999999987 34443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=409.57 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=210.6
Q ss_pred cCCcccC-cccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASEN-ELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 686 (959)
++|...+ +||+|+||.||+|.++ ++..||||+++.. ......++|.+|++++++++|||||+++|++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 4556666 4999999999999754 3557999999765 345667889999999999999999999999865 46799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKL 766 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~ 766 (959)
||||+++|+|.+++.. ....+++.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 9999999999998743 22579999999999999999999999 8999999999999999999999999999996
Q ss_pred CCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 767 APDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 767 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+.... +.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---i~--------- 226 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IE--------- 226 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---HH---------
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HH---------
Confidence 6543322 2234568999999999999999999999999999999998 8999987765432111 11
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
+. ..+..+ ...+..+.+|+.+||+.||++|||+.+|++.|+.......
T Consensus 227 -~~--~~~~~p---~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 227 -QG--KRMECP---PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp -TT--CCCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -cC--CCCCCC---CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 00 011111 1223467899999999999999999999999987765443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=407.28 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=202.1
Q ss_pred CcccccCceEEEEEEEc---CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEecCC
Q 002149 617 NELGRGGFGVVYKGELD---DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYMPQ 693 (959)
Q Consensus 617 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 693 (959)
++||+|+||.||+|.++ .++.||||+++.........++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999764 34689999997655555667789999999999999999999999865 457899999999
Q ss_pred CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCCcc
Q 002149 694 GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSERS 773 (959)
Q Consensus 694 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~~~ 773 (959)
|+|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999854 2568999999999999999999999 89999999999999999999999999999866543332
Q ss_pred --eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCCc
Q 002149 774 --VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDPI 850 (959)
Q Consensus 774 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (959)
......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+.... +.. - ..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~---i~~----------~--~~ 228 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEK----------G--ER 228 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHT----------T--CC
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH---HHc----------C--CC
Confidence 2234578999999999999999999999999999999998 8999988765442211 110 0 01
Q ss_pred ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 851 LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 851 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
+..+ ...+..+.+|+.+||+.||++|||+++|++.|+.++.
T Consensus 229 ~~~p---~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 229 MGCP---AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCC---cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1111 1223468899999999999999999999998887654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=414.11 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
+.|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4688999999999999999976 47899999998764 34455678999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++... ..++++.++..++.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999987542 2569999999999999999999999 8999999999999999999999999999975432
Q ss_pred CCcceeeccccccccccccccc-----cCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 770 SERSVVTRLAGTFGYLAPEYAV-----TGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
.. .......||+.|||||++. +..++.++|||||||++|||+||+.||.+....+..... .
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~----------- 228 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--A----------- 228 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--H-----------
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--H-----------
Confidence 21 1233468999999999984 456889999999999999999999999887654421110 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
..-.+.+ .........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 KSEPPTL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HSCCCCC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011 111122346789999999999999999999976
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=405.66 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=199.4
Q ss_pred cccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe----CceEEEEE
Q 002149 614 ASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA----GYERLLVY 688 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 688 (959)
+..++||+|+||+||+|... +++.||+|++..........+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999764 68899999998766667777889999999999999999999999875 35679999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCEEEC-CCCcEEEeeccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQS--FIHRDLKSSNILLG-DDFRAKVSDFGLVK 765 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dik~~NiLl~-~~~~~ki~DfGla~ 765 (959)
||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++ ||||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999998642 568999999999999999999999 56 99999999999996 57899999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
..... .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+....... ...+. .
T Consensus 164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~~i~----------~ 227 (270)
T d1t4ha_ 164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT----------S 227 (270)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT----------T
T ss_pred eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HHHHH----------c
Confidence 65433 2345689999999998865 6999999999999999999999999765543321 11010 0
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
...+. ........++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCc----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00000 000111235789999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=408.34 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=202.6
Q ss_pred cCCcccCcccccCceEEEEEEEcCC-----cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDG-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
+.|+..++||+|+||.||+|.++.. ..||||++... .......+|.+|++++++++|||||+++|++.+....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4577889999999999999976532 36999998754 34555677999999999999999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+.+|++.+++... ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 86 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999887542 2579999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc--ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSER--SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDE-SRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
....... .......||+.|||||++.++.++.++|||||||++|||++|..|+.. ....+. ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~-------- 227 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAIN-------- 227 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH--------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH---HHHHh--------
Confidence 6544322 222345689999999999999999999999999999999997665543 333221 11111
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
+... + ......+..+.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 228 --~~~~--~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 --DGFR--L---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --TTCC--C---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --ccCC--C---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111 1 11112335688999999999999999999999999988763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=407.08 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=202.9
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||++++++. .+..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 57899999999999999999998888999999976532 3467999999999999999999999985 4567999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.... ...++|.+++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999998886532 2569999999999999999999999 89999999999999999999999999999876554
Q ss_pred CcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHHhhhcchHHHHHhcCC
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALD-ESRPEERQYLAAWFWNIKSDKEKLRAAIDP 849 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (959)
.........||+.|+|||++..+.++.++|||||||++|||++|..|+. .....+.... +. .....
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i~----------~~~~~ 233 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VE----------RGYRM 233 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH----------TTCCC
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HH----------hcCCC
Confidence 4444455679999999999999999999999999999999999766554 4333222111 11 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 850 ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 850 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
. .......++.+++.+||+.||++||++++|++.|++++..
T Consensus 234 --~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 --P---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp --C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --C---CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1 1112234688999999999999999999999988887654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=418.92 Aligned_cols=272 Identities=21% Similarity=0.315 Sum_probs=210.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.++||+|+||+||+|.. .+|+.||+|+++... .....+.+.+|+.++++++|||||++++++.+..+.++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999976 478999999987642 3445678899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. ++|+||||||+|||++.++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999998642 4689999999999999999999972 389999999999999999999999999998553
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-Hhhhc---------
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWF-WNIKS--------- 838 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~-~~~~~--------- 838 (959)
+. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+........ .....
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 32 234568999999999999999999999999999999999999999876543321110000 00000
Q ss_pred ----------------chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 839 ----------------DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 839 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..+........... .........++.+++.+||+.||++|||++|+++ ++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~--Hpf~~~ 303 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV--HAFIKR 303 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--CHhhCc
Confidence 00000000000000 0000011235789999999999999999999988 466654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=415.46 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=205.4
Q ss_pred cCCcccCcccccCceEEEEEEEcC-C-----cEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKGELDD-G-----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 683 (959)
++|+..++||+|+||+||+|+... + ..||||++.... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578899999999999999997642 2 369999886542 334456789999999998 89999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhccc------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 002149 684 RLLVYEYMPQGALSKHIFHWKS------------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKS 745 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~ 745 (959)
.++||||+++|+|.++++..+. .....+++..++.++.||++||+|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999965321 112458999999999999999999999 8999999999
Q ss_pred CCEEECCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCCh
Q 002149 746 SNILLGDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRP 823 (959)
Q Consensus 746 ~NiLl~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~ 823 (959)
+|||++.++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999985544332 23345678999999999999999999999999999999998 8999987654
Q ss_pred HHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 002149 824 EERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLA 890 (959)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 890 (959)
.+.. ...+. .... +. .+......+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~~--~~~~~----------~~~~--~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANF--YKLIQ----------NGFK--MD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHH--HHHHH----------TTCC--CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--HHHHh----------cCCC--CC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3321 11111 1111 11 11122346889999999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=406.87 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=205.3
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|.. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4699999999999999999976 4789999999875422 2234567899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988542 568999999999999999999999 899999999999999999999999999999765
Q ss_pred CCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 769 DSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 769 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
... .......+||+.|||||++.+..++.++||||+||++|||++|+.||......+... .+ .
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i----------~ 223 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KI----------I 223 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH----------H
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------HH----------H
Confidence 432 223445689999999999999999999999999999999999999998765433211 11 1
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNV 888 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 888 (959)
......+. .....+.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~~~~~p~---~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 224 KLEYDFPE---KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp TTCCCCCT---TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred cCCCCCCc---cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111111 122367899999999999999999997653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=409.56 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=207.1
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
+.|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999975 5788999999876533 3345677999999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|++..++.. ..++++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999766533 2579999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeecccccccccccccccc---CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVT---GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
.. ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||.+....+..... ..
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i-------------~~ 228 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------AQ 228 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HH
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------------Hh
Confidence 32 34579999999999864 46899999999999999999999999876654321110 00
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.-.+... .......+.+++.+||+.||++|||++|+++ ++++.+
T Consensus 229 ~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~~ 272 (309)
T d1u5ra_ 229 NESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLR 272 (309)
T ss_dssp SCCCCCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHHS
T ss_pred CCCCCCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhcC
Confidence 0111111 1112246889999999999999999999987 456554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-46 Score=408.32 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=211.2
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999976 47899999998765 3455678899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~--~~~~~ki~DfGla~~ 766 (959)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 103 E~~~gg~L~~~l~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTC----TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 99999999998843 22569999999999999999999999 8999999999999996 468899999999997
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
...... .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+....+ ... .
T Consensus 176 ~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~------~ 241 (350)
T d1koaa2 176 LDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSC------D 241 (350)
T ss_dssp CCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHT------C
T ss_pred cccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC------C
Confidence 654332 34468999999999999999999999999999999999999999876654321111 000 0
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.. .. ..........+.+++.+||+.||++|||++|+++ ++++..
T Consensus 242 ~~--~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~ 285 (350)
T d1koaa2 242 WN--MD-DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 285 (350)
T ss_dssp CC--SC-CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSC
T ss_pred CC--CC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 00 00 0000112236789999999999999999999987 455543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-47 Score=407.30 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=194.2
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.+.|++.+.||+|+||+||+|... +|+.||||++...... ...+.+.+|++++++++|||||++++++.++...|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4577999999999999999999764 6899999999765332 2345688999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC---CCCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG---DDFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~---~~~~~ki~DfGla 764 (959)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||+. +++.+||+|||+|
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999853 2579999999999999999999999 8999999999999994 5789999999999
Q ss_pred ccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 765 KLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 765 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
+...... .....+||+.|||||++.+..++.++|||||||++|||++|+.||.+....+.... + ..
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~---i---~~------ 223 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ---I---LK------ 223 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H---HT------
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---H---hc------
Confidence 8654332 23446899999999999999999999999999999999999999987665432111 0 00
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.... .. ..........+.+++.+||+.||++|||++|+++ ++++.
T Consensus 224 ~~~~--~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 268 (307)
T d1a06a_ 224 AEYE--FD-SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIA 268 (307)
T ss_dssp TCCC--CC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTT
T ss_pred cCCC--CC-CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 0000 00 0111122346789999999999999999999987 34443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=397.51 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=201.2
Q ss_pred hcCCcccCcccccCceEEEEEEEcC----CcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELDD----GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.++|+..+.||+|+||.||+|.+.. +..||||++... ......+.+.+|++++++++|||||++++++. ....+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3578999999999999999997642 346899988654 34555678999999999999999999999986 45789
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|++.+++... ...+++..++.++.||++||+|||+ ++||||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999887542 2578999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
..............||+.|+|||++.+..++.++|||||||++|||+| |..||......+....+ .
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---~---------- 223 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E---------- 223 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---H----------
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---H----------
Confidence 765544444455678999999999999999999999999999999998 89999887664432111 0
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... ... ........+.+|+.+||+.||++|||+.||++.|..++++
T Consensus 224 ~~~--~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 224 NGE--RLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TTC--CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC--CCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 000 011 1112234688999999999999999999999999988765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-46 Score=404.73 Aligned_cols=263 Identities=28% Similarity=0.435 Sum_probs=212.7
Q ss_pred HhcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 682 (959)
..++|+..+.||+|+||.||+|+++ +++.||||++... ......++|.+|++++++++||||+++++++....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 4568999999999999999999764 3578999998764 34556778999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhhHHhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKS-------------------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDL 743 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di 743 (959)
..++||||+++|+|.++++.... .....+++..++.|+.|++.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 99999999999999999864221 122458999999999999999999999 89999999
Q ss_pred CCCCEEECCCCcEEEeeccccccCCCCC-cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCC
Q 002149 744 KSSNILLGDDFRAKVSDFGLVKLAPDSE-RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL-MALDES 821 (959)
Q Consensus 744 k~~NiLl~~~~~~ki~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~-~p~~~~ 821 (959)
||+|||++.++.+||+|||+|+...... ....+...||+.|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 9999999999999999999998553322 22334567899999999999999999999999999999999995 577776
Q ss_pred ChHHHHHHHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhH
Q 002149 822 RPEERQYLAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLV 893 (959)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~ 893 (959)
...+.... +. . . .....+ ...+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus 247 ~~~e~~~~---v~---~-------~--~~~~~p---~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEEVIYY---VR---D-------G--NILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHHHHHH---HH---T-------T--CCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHHHHHH---HH---c-------C--CCCCCC---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65443211 11 0 0 001111 122346889999999999999999999999998875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=396.40 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=208.1
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcCCCCceeEEEEEEeCce
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 683 (959)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.+..... ...+.+.+|++++++++|||||++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 456899999999999999999976 578999999987653322 235789999999999999999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC----cEEEe
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF----RAKVS 759 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~----~~ki~ 759 (959)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999998642 469999999999999999999999 8999999999999998776 59999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+ .....
T Consensus 160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i---~~~~~- 233 (293)
T d1jksa_ 160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV---SAVNY- 233 (293)
T ss_dssp CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HTTCC-
T ss_pred chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH---HhcCC-
Confidence 999998765432 234467999999999999999999999999999999999999999887654421111 00000
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
....... ......+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 --EFEDEYF---------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCCHHHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCchhc---------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 011235779999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-45 Score=406.10 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=210.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.++...++||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999976 57999999998765 3445567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEEC--CCCcEEEeecccccc
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLG--DDFRAKVSDFGLVKL 766 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~--~~~~~ki~DfGla~~ 766 (959)
||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999887743 22569999999999999999999999 8999999999999998 578999999999997
Q ss_pred CCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHh
Q 002149 767 APDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAA 846 (959)
Q Consensus 767 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (959)
..... ......||+.|||||++.+..++.++||||+||++|||+||+.||.+....+....+ .. ..
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~------~~ 244 (352)
T d1koba_ 179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KR------CD 244 (352)
T ss_dssp CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HH------CC
T ss_pred cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh------CC
Confidence 65533 234467999999999999999999999999999999999999999877654421111 00 00
Q ss_pred cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 847 IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 847 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.. .. ..........+.+|+.+||+.||.+|||+.|+++ +++++
T Consensus 245 ~~--~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--Hp~~~ 287 (352)
T d1koba_ 245 WE--FD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 287 (352)
T ss_dssp CC--CC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CC--CC-cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 00 00 0111122346789999999999999999999977 44443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=392.39 Aligned_cols=251 Identities=30% Similarity=0.420 Sum_probs=199.6
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-CceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 689 (959)
++|+..+.||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++||||++++|++.+ ....++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 46788899999999999999986 789999999754 334678999999999999999999999865 456799999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+++|+|.+++.... ...+++..+++++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999996532 2468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
. .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......+... .+. ....
T Consensus 156 ~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~---~i~----------~~~~ 218 (262)
T d1byga_ 156 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVE----------KGYK 218 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---HHT----------TTCC
T ss_pred C----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH---HHH----------cCCC
Confidence 2 223467899999999999999999999999999999998 688887765543211 111 1111
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
+ . ........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 219 ~--~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 M--D---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp C--C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C--C---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1 1 111223468899999999999999999999999988754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=400.30 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=204.2
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc----EEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT----KIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
.+|+..++||+|+||+||+|.+. +|+ +||||++... ......++|.+|++++++++|||||+++|++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 36999999999999999999764 444 5889988654 2344567899999999999999999999999875 567
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
++|||+.+|+|.+++.. ....+++..++.++.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVRE----HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHH----TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 88999999999988754 23679999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHHH
Q 002149 766 LAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEKL 843 (959)
Q Consensus 766 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (959)
........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+..... .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~--------- 227 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E--------- 227 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---H---------
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H---------
Confidence 66443322 2334578999999999999999999999999999999999 78999877654422111 0
Q ss_pred HHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 844 RAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... .+..+ ......+.+++.+||+.||++|||+.||++.|..+.+.
T Consensus 228 -~~~--~~~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 228 -KGE--RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -HTC--CCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -cCC--CCCCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 100 11111 12234688999999999999999999999999887653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=400.09 Aligned_cols=249 Identities=27% Similarity=0.332 Sum_probs=207.7
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|+. .+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999976 5799999999976432 2234577889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999988652 568999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+.... ...
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~~---------- 219 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILM---------- 219 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH----------
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------Hhc----------
Confidence 3322 34457899999999999999999999999999999999999999998765432111 000
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
..+..+. .....+.+|+.+||+.||++||+ ++|+++
T Consensus 220 ~~~~~p~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 EEIRFPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCc---cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0111111 12235789999999999999995 778876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=390.64 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=197.0
Q ss_pred cCCcccCcccccCceEEEEEEEc--CC--cEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD--DG--TKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|+..+.||+|+||.||+|+++ ++ ..||||++.+... .....++|.+|++++++++|||||+++|++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56889999999999999999754 22 3689999876433 234467899999999999999999999999764 678
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|++.+++.... ..+++..++.++.|||+||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999998876522 569999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCcc--eeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 766 LAPDSERS--VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 766 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+....+... .+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---~i~---~---- 229 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---KID---K---- 229 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHH---T----
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---HHH---h----
Confidence 76544332 2234567889999999999999999999999999999998 899998776544211 111 0
Q ss_pred HHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 002149 843 LRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAP 891 (959)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 891 (959)
.... .+........+.+++.+||+.||++|||+.+|++.|.+
T Consensus 230 ------~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 230 ------EGER-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ------SCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0000 01111223468899999999999999999999988765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.3e-45 Score=389.89 Aligned_cols=261 Identities=23% Similarity=0.318 Sum_probs=203.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----e
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----E 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 683 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999975 5799999999976543 3455678999999999999999999999987643 4
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.++|+|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 78999999999999887542 468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCC--cceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSE--RSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
++...... .......+||+.|||||++.+..++.++|||||||++|||+||+.||.+..+.+..... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~--~~------- 228 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VR------- 228 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HH-------
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH--Hh-------
Confidence 87543322 22334568999999999999999999999999999999999999999877654421110 10
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHhH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRP-DMGHAVNVLAPLV 893 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~ 893 (959)
....+. ..........+.+++.+||+.||++|| +++++.+.|.++.
T Consensus 229 ---~~~~~~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 229 ---EDPIPP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---CCCCCG---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---cCCCCC---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000000 000111224678999999999999999 8899888777653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-45 Score=397.36 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=208.3
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999976 5699999999875432 2234577899999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+++|++..++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999888754 2567889999999999999999999 899999999999999999999999999998765
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
+. ....+||+.|||||++.+..++.++||||+||++|||++|+.||.+....+....+ ..
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i----------------~~ 215 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------------LN 215 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------HH
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH----------------Hc
Confidence 43 23468999999999999999999999999999999999999999887654321111 00
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
.....+ ......+.+++.+||..||.+|| +++++++ +++++
T Consensus 216 ~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~--Hp~f~ 261 (316)
T d1fota_ 216 AELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWFK 261 (316)
T ss_dssp CCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGGS
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc--Ccccc
Confidence 111111 11223678999999999999996 8999876 45544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-44 Score=384.34 Aligned_cols=258 Identities=25% Similarity=0.308 Sum_probs=208.8
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEccccccc-------HHHHHHHHHHHHHHHhcC-CCCceeEEEEEEe
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVIS-------KKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVA 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 680 (959)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999976 57899999998764322 123456889999999997 9999999999999
Q ss_pred CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEee
Q 002149 681 GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSD 760 (959)
Q Consensus 681 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~D 760 (959)
++..|+||||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999642 468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCcceeecccccccccccccccc------CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVT------GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFW 834 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~ 834 (959)
||+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+.....
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---- 227 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 227 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH----
Confidence 99998765432 2345689999999999853 34788999999999999999999999987654422111
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.. .... .. .........++.+++.+||+.||++||+++||++ +++++
T Consensus 228 --~~------~~~~--~~-~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~--h~~~~ 274 (277)
T d1phka_ 228 --MS------GNYQ--FG-SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQ 274 (277)
T ss_dssp --HH------TCCC--CC-TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGC
T ss_pred --Hh------CCCC--CC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHHH
Confidence 00 0000 00 0011122346889999999999999999999976 34443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=395.94 Aligned_cols=264 Identities=30% Similarity=0.437 Sum_probs=208.6
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCc--EEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGT--KIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 686 (959)
++|+..++||+|+||.||+|.++ +|. .||||++... ......+.+.+|+++++++ +|||||++++++.+....++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 57888899999999999999765 444 4788887643 2344567799999999999 79999999999999999999
Q ss_pred EEEecCCCchhhHHhhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCc
Q 002149 687 VYEYMPQGALSKHIFHWK-----------SLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFR 755 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~ 755 (959)
||||+++|+|.++++... ......+++..+..++.|||+||+|||+ ++||||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999986532 1234679999999999999999999999 89999999999999999999
Q ss_pred EEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHH
Q 002149 756 AKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL-MALDESRPEERQYLAAWFW 834 (959)
Q Consensus 756 ~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~-~p~~~~~~~~~~~~~~~~~ 834 (959)
+||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. .||......+. ...+
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~i- 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL- 239 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHG-
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHHH-
Confidence 99999999985543222 22346899999999999999999999999999999999976 56766554332 1101
Q ss_pred hhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 835 NIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
. +.. .+. ........+.+|+.+||+.||++||||+||++.|++++++...
T Consensus 240 --~-------~~~--~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 240 --P-------QGY--RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp --G-------GTC--CCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred --H-------hcC--CCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 0 100 111 1112334788999999999999999999999999999876543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=395.69 Aligned_cols=265 Identities=27% Similarity=0.371 Sum_probs=201.4
Q ss_pred hcCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC-
Q 002149 610 TKNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG- 681 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 681 (959)
.++|+..++||+|+||.||+|.+. +++.||||+++... .....+.+.+|...+.++ +|+||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 367999999999999999999753 34689999987643 445566788888888887 689999999988764
Q ss_pred ceEEEEEEecCCCchhhHHhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSL-----------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++||||+++|+|.++++..+.. ....+++.++..++.||++||+|||+ ++||||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeE
Confidence 4689999999999999999753321 12458999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL-MALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~-~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+||. .||......+..
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~- 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH-
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999986544332 2334567999999999999999999999999999999999974 577665433211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
... +.+.... ..++ .....+.+++.+||+.||++|||++||+++|+++++.
T Consensus 247 -~~~----------~~~~~~~--~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 247 -CRR----------LKEGTRM--RAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHH----------HHHTCCC--CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHH----------HhcCCCC--CCCc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 110 1111111 1111 1223678999999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=390.86 Aligned_cols=258 Identities=29% Similarity=0.411 Sum_probs=205.5
Q ss_pred cCcccccCceEEEEEEEcCC----cEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe-CceEEEEEEe
Q 002149 616 ENELGRGGFGVVYKGELDDG----TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA-GYERLLVYEY 690 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 690 (959)
.++||+|+||+||+|.+.++ ..||||+++.. ......++|.+|++++++++|||||+++|++.. +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999986532 25899998753 356667889999999999999999999999876 4588999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+++|+|.+++.. ....+++..+++++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~----~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRN----ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcc----ccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999998854 23567889999999999999999999 89999999999999999999999999999865443
Q ss_pred Cc---ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 771 ER---SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 771 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.. .......||+.|+|||.+.++.++.++||||||+++|||+||..||....... .....+.. -
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~----------g- 250 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ----------G- 250 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----------T-
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc----------C-
Confidence 22 12233578999999999999999999999999999999999888876543211 11111110 0
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
..+..+. .....+.+++.+||+.||++||++.||++.|+.+++.+..
T Consensus 251 -~~~~~p~---~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 251 -RRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -CCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -CCCCCcc---cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 0111111 1234688999999999999999999999999999887554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-45 Score=392.85 Aligned_cols=262 Identities=29% Similarity=0.410 Sum_probs=208.4
Q ss_pred cCCcccCcccccCceEEEEEEEcC--------CcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeC
Q 002149 611 KNFASENELGRGGFGVVYKGELDD--------GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAG 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 681 (959)
++|++.+.||+|+||.||+|+... +..||||+++... ......++.+|+..+.++ +|||||++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 578889999999999999997532 2479999997653 455567889999999888 799999999999999
Q ss_pred ceEEEEEEecCCCchhhHHhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKS-----------LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
...++||||+++|+|.+++...+. .....+++.+++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999965331 123568999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |..||.+....+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~- 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH-
Confidence 9999999999999985543322 23345678999999999999999999999999999999998 68888876654321
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
..+ ..... +..+ ......+.+|+.+||+.||++|||+.||++.|++++.
T Consensus 248 --~~i----------~~~~~--~~~p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 --KLL----------KEGHR--MDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --HHH----------HTTCC--CCCC---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHH----------HcCCC--CCCC---ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 11111 1111 1123468899999999999999999999999998865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=392.15 Aligned_cols=275 Identities=21% Similarity=0.315 Sum_probs=202.6
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----eEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----ERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 686 (959)
+.|...+.||+|+||.||+|+++ |+.||||++... .........|+..+..++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 45777889999999999999874 899999998643 222222334555556789999999999997653 6799
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA-----HQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
||||+++|+|.++++. ..++|..+++++.|+|.||+|+|+.+ .++||||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999964 46899999999999999999999731 369999999999999999999999999
Q ss_pred cccccCCCCCcc---eeeccccccccccccccccC------CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 002149 762 GLVKLAPDSERS---VVTRLAGTFGYLAPEYAVTG------KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAW 832 (959)
Q Consensus 762 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~ 832 (959)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||..|+............
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-- 230 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-- 230 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT--
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh--
Confidence 999865443322 23456899999999998764 2677899999999999999998887543321100000
Q ss_pred HHhhhcchHHHH-Hh----cCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcC
Q 002149 833 FWNIKSDKEKLR-AA----IDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWK 897 (959)
Q Consensus 833 ~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~ 897 (959)
............ .. +++.+............+.+++.+||+.||++|||+.||++.|+++.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 000000001111 11 112111111233456678999999999999999999999999999887644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=393.74 Aligned_cols=264 Identities=25% Similarity=0.397 Sum_probs=213.4
Q ss_pred cCCcccCcccccCceEEEEEEE------cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKGEL------DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 683 (959)
++|+..++||+|+||.||+|++ .+++.||||+++... .......+.+|+.+++.+ +|||||++++++.+...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 5788889999999999999975 245789999997653 445567899999999999 69999999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEE
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSL-------------NLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILL 750 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl 750 (959)
.++||||+++|+|.++++..... ....+++..+..++.||++||+|||+ ++||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 99999999999999999764321 22468999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccccccCCCCCc-ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 002149 751 GDDFRAKVSDFGLVKLAPDSER-SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLT-GLMALDESRPEERQY 828 (959)
Q Consensus 751 ~~~~~~ki~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~ellt-g~~p~~~~~~~~~~~ 828 (959)
+.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+|+......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999996654433 33345689999999999999999999999999999999999 555565544332211
Q ss_pred HHHHHHhhhcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 829 LAAWFWNIKSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
..+ .....+.. .......+.+|+.+||+.||++|||+++|++.|++.+.+
T Consensus 259 --~~i----------~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 259 --KMI----------KEGFRMLS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --HHH----------HHTCCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHH----------hcCCCCCC-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111 11111111 111234688999999999999999999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=390.21 Aligned_cols=258 Identities=19% Similarity=0.264 Sum_probs=209.3
Q ss_pred HhcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEE
Q 002149 609 VTKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 687 (959)
+.++|++.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+++++.++|||||++++++.+....|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999764 7889999999764 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC--CCcEEEeeccccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD--DFRAKVSDFGLVK 765 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~--~~~~ki~DfGla~ 765 (959)
|||+++|+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++. ...+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~----~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 999999999999853 22468999999999999999999999 89999999999999985 4589999999998
Q ss_pred cCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRA 845 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (959)
...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+....+ ......-......
T Consensus 153 ~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 153 QLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAEYTFDEEAFK 228 (321)
T ss_dssp ECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCCCCHHHHT
T ss_pred ccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCChhhcc
Confidence 764432 234457899999999999999999999999999999999999999887654321111 0000000000000
Q ss_pred hcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 846 AIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 846 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.....+.+++.+||..||.+|||++|+++ ++++.+
T Consensus 229 -------------~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~ 263 (321)
T d1tkia_ 229 -------------EISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp -------------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred -------------CCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhcc
Confidence 01235789999999999999999999987 466643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-44 Score=396.31 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=208.1
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccc-cHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVY 688 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 688 (959)
++|++.+.||+|+||.||+|.. .+|+.||||++.+... .....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999976 4799999999875432 2234567889999999999999999999999999999999
Q ss_pred EecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCC
Q 002149 689 EYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAP 768 (959)
Q Consensus 689 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~ 768 (959)
||+.+|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999988542 468999999999999999999999 899999999999999999999999999999764
Q ss_pred CCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcC
Q 002149 769 DSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAID 848 (959)
Q Consensus 769 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (959)
.. .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+ . .
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~----------~ 252 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------V----------S 252 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H----------H
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------h----------c
Confidence 42 23467999999999999999999999999999999999999999876543321110 0 0
Q ss_pred CcccCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhHh
Q 002149 849 PILEVNDDTFETFWTIAELAGHCTSREPSQRP-----DMGHAVNVLAPLVE 894 (959)
Q Consensus 849 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L~~~~~ 894 (959)
...... ......+.+++.+||..||.+|+ +++++++ +++++
T Consensus 253 ~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~--Hp~f~ 298 (350)
T d1rdqe_ 253 GKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWFA 298 (350)
T ss_dssp CCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGGT
T ss_pred CCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc--Ccccc
Confidence 011101 11223678999999999999994 8999876 45543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=389.82 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=212.5
Q ss_pred cCCcccCcccccCceEEEEEEEc------CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceE
Q 002149 611 KNFASENELGRGGFGVVYKGELD------DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYER 684 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 684 (959)
++|+..+.||+|+||.||+|.++ +++.||||+++.. ........|.+|++++++++|||||++++++......
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 57888999999999999999763 3578999999764 3455667899999999999999999999999999999
Q ss_pred EEEEEecCCCchhhHHhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 685 LLVYEYMPQGALSKHIFHWKS-----LNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
++||||+++|+|.+++...+. .....+++..+.+++.|+|+||.|||+ ++|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 999999999999999865321 122457999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcc-eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHHhhh
Q 002149 760 DFGLVKLAPDSERS-VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGL-MALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 760 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||.+....+....+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------
Confidence 99999865443322 233457899999999999999999999999999999999985 777766544322111
Q ss_pred cchHHHHHhcCCc-ccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 838 SDKEKLRAAIDPI-LEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 838 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.+.. +... ......+.+++.+||+.||++|||+.+|++.|++.++
T Consensus 249 ---------~~~~~~~~p---~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 ---------MEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---------HTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------HhCCCCCCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 1111 1122468899999999999999999999998876644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=394.36 Aligned_cols=307 Identities=23% Similarity=0.342 Sum_probs=220.5
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc-----
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----- 682 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 682 (959)
+.++|+++++||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999975 47999999999876666677788999999999999999999999997654
Q ss_pred -eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 683 -ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 683 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
+.++||||+ +++|..+... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccc
Confidence 569999999 6778777643 569999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc--
Q 002149 762 GLVKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS-- 838 (959)
Q Consensus 762 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 838 (959)
|+|+..... .+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.............
T Consensus 166 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 166 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 999866443 2446799999999998764 568999999999999999999999988765443222211111000
Q ss_pred ------c--hHHHHHhcCCcccC--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 839 ------D--KEKLRAAIDPILEV--NDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 839 ------~--~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
. .......+...... ..........+.+|+.+||..||++|||++|+++ +++++......+++... .
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~--Hp~f~~~~~~~~~~~~~-~ 318 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA--HPYFESLHDTEDEPQVQ-K 318 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTC------CCC-C
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhCcCCCccccccCC-C
Confidence 0 00001111110000 0000111235679999999999999999999988 68887766655555432 2
Q ss_pred cccCC-ChhhhHHHHHHhhCCCcce
Q 002149 909 IDYSL-PLNQMVKDWQEAEGKDLSY 932 (959)
Q Consensus 909 ~~~~~-~~~~~~~~~~~~~~~~~~~ 932 (959)
++.+. ......++|++..++++..
T Consensus 319 ~~~~~~~~~~~~~e~k~~~~~e~~~ 343 (346)
T d1cm8a_ 319 YDDSFDDVDRTLDEWKRVTYKEVLS 343 (346)
T ss_dssp CCCC-----CCHHHHHHHHHHHHHT
T ss_pred CCCchhhhhcCHHHHHHHHHHHhhc
Confidence 22222 3356778998887665543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=391.56 Aligned_cols=254 Identities=29% Similarity=0.402 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccc-cHHHHHHHHHHHHHHH-hcCCCCceeEEEEEEeCceEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVI-SKKAVDEFHSEIAVLS-KVRHRHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 687 (959)
++|++.+.||+|+||+||+|... +|+.||||++++... .....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47899999999999999999764 799999999975422 2233455667777665 68999999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccC
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLA 767 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~ 767 (959)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999998642 468899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc
Q 002149 768 PDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI 847 (959)
Q Consensus 768 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (959)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ ...
T Consensus 154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~-------- 218 (320)
T d1xjda_ 154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMD-------- 218 (320)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC--------
T ss_pred cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HcC--------
Confidence 4332 2334568999999999999999999999999999999999999999887654421111 000
Q ss_pred CCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHhHh
Q 002149 848 DPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMG-HAVNVLAPLVE 894 (959)
Q Consensus 848 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~L~~~~~ 894 (959)
.+.. + ......+.+|+.+||..||++||++. ++++ +++++
T Consensus 219 ~~~~--p---~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~--hpff~ 259 (320)
T d1xjda_ 219 NPFY--P---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ--HPLFR 259 (320)
T ss_dssp CCCC--C---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG--SGGGT
T ss_pred CCCC--C---ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh--Cchhc
Confidence 1111 1 11223678999999999999999995 6755 34443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=388.31 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=201.0
Q ss_pred hcCCcccC-cccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhc-CCCCceeEEEEEEe----Cc
Q 002149 610 TKNFASEN-ELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV-RHRHLVSLLGYSVA----GY 682 (959)
Q Consensus 610 ~~~~~~~~-~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 682 (959)
.++|.+.. .||+|+||.||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46788765 599999999999975 57899999998642 3467899987665 89999999999875 45
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEe
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVS 759 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~ 759 (959)
..|+||||+++|+|.+++.. .....+++.++..++.||+.||+|||+ ++|+||||||+|||++. .+.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 68999999999999999954 223579999999999999999999999 89999999999999985 5679999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+|+....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+...
T Consensus 157 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----------- 223 (335)
T d2ozaa1 157 DFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----------- 223 (335)
T ss_dssp CCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred ccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-----------
Confidence 9999986654332 345689999999999999999999999999999999999999997654322110
Q ss_pred hHHHHHhc-CCcccCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 840 KEKLRAAI-DPILEVNDDT-FETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 840 ~~~~~~~~-~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
.+...+ ......+... .....++.+|+.+||+.||++|||+.|+++ ++++.+
T Consensus 224 --~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~~ 277 (335)
T d2ozaa1 224 --GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 277 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHHT
T ss_pred --HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhhC
Confidence 000000 0111111111 122346889999999999999999999987 465544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.3e-44 Score=393.54 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=202.1
Q ss_pred cCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccH-HHHHHHHH---HHHHHHhcCCCCceeEEEEEEeCceEE
Q 002149 611 KNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISK-KAVDEFHS---EIAVLSKVRHRHLVSLLGYSVAGYERL 685 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 685 (959)
++|++.+.||+|+||.||+|+.. +|+.||||++.+..... .....+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999764 79999999986542222 12233344 466677778999999999999999999
Q ss_pred EEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 686 LVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 686 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999998642 567899999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHH
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLR 844 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (959)
...... .....||+.|||||++.. ..++.++|||||||++|||+||+.||......+...+. .
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------------~ 219 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------R 219 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-------------H
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------H
Confidence 665432 344689999999999975 46899999999999999999999999876543321111 1
Q ss_pred HhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhHh
Q 002149 845 AAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVNVLAPLVE 894 (959)
Q Consensus 845 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~L~~~~~ 894 (959)
.........+. .....+.+++.+||+.||++||| ++|+++ +++++
T Consensus 220 ~~~~~~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f~ 269 (364)
T d1omwa3 220 MTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 269 (364)
T ss_dssp HSSSCCCCCCS---SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGGT
T ss_pred hcccCCCCCCC---CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Ccccc
Confidence 11111111111 12236789999999999999999 688876 45544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=384.09 Aligned_cols=274 Identities=23% Similarity=0.358 Sum_probs=205.6
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.+.||+|+||+||+|.. .+|+.||||+++.........+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999976 579999999997654444446788999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
|+.+ ++.+++.. .....+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~---~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9954 55455432 233679999999999999999999999 8999999999999999999999999999986544
Q ss_pred CCcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhc-
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAI- 847 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 847 (959)
... ......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+..... ........+.....+
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGG
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH--HHhcCCCchhhccccc
Confidence 332 234457999999999887655 578999999999999999999999877654432211 111111000000000
Q ss_pred ------CCcccCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhc
Q 002149 848 ------DPILEVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKW 896 (959)
Q Consensus 848 ------~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~ 896 (959)
........... .....+.+++.+||..||++|||++|+++ ++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~--H~ff~~~ 289 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDV 289 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGTTC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--CHhhccC
Confidence 00000011111 11246789999999999999999999987 4555443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-44 Score=384.85 Aligned_cols=267 Identities=23% Similarity=0.247 Sum_probs=198.9
Q ss_pred cCcccccCceEEEEEEE-cCCcEEEEEEcccccccHH---HHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEec
Q 002149 616 ENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKK---AVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEYM 691 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 691 (959)
.++||+|+||+||+|.. .+|+.||||+++....... ..+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 56899999999999975 4689999999875432221 2356889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCCC
Q 002149 692 PQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDSE 771 (959)
Q Consensus 692 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~~ 771 (959)
.++++..+.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~-----~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD-----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT-----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 8877765542 23568899999999999999999999 899999999999999999999999999998665433
Q ss_pred cceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHHHHHhcCC-
Q 002149 772 RSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEKLRAAIDP- 849 (959)
Q Consensus 772 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 849 (959)
. .....+||+.|+|||++... .++.++|||||||++|||++|+.||.+....+....+........ .+........
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 232 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTSST
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhccc
Confidence 2 23346799999999998654 579999999999999999999999988766543222111100000 0000000000
Q ss_pred ---cc-cCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 850 ---IL-EVNDDTF-----ETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 850 ---~~-~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.. ....... .....+.+|+.+||+.||++|||++|+++ +++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp~f~ 284 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFS 284 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CHhhC
Confidence 00 0001111 11246789999999999999999999977 55554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-43 Score=379.14 Aligned_cols=276 Identities=18% Similarity=0.244 Sum_probs=220.9
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 687 (959)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+|++.++.++| +|++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 468999999999999999999754 78999999886542 22346789999999965 8999999999999999999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-----CCcEEEeecc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-----DFRAKVSDFG 762 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-----~~~~ki~DfG 762 (959)
|||+ +|+|.+++... ...+++.++..++.|++.||+|||+ ++||||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 89999887542 2568999999999999999999999 89999999999999974 5789999999
Q ss_pred ccccCCCCCc------ceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhh
Q 002149 763 LVKLAPDSER------SVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNI 836 (959)
Q Consensus 763 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~ 836 (959)
+|+...+... .......||+.|||||++.+..++.++|||||||++|||+||+.||.+............+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9986544322 1233468999999999999999999999999999999999999999866543322211111111
Q ss_pred hcchHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 837 KSDKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
.. ....++.. + ..+.++.+++..|+..+|++||+++.+.+.|++++++.....++++||..
T Consensus 232 ~~-~~~~~~l~-~---------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~ 292 (293)
T d1csna_ 232 KQ-STPLRELC-A---------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 292 (293)
T ss_dssp HH-HSCHHHHT-T---------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred cC-CCChHHhc-C---------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCc
Confidence 00 00011111 1 11236889999999999999999999999999999999998898888863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-43 Score=379.62 Aligned_cols=273 Identities=21% Similarity=0.277 Sum_probs=205.7
Q ss_pred cCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEEe
Q 002149 611 KNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYEY 690 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 690 (959)
++|+..++||+|+||+||+|+.++|+.||||++..........+.+.+|+.++++++|||||++++++......+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999989999999999976544444467899999999999999999999999999999999999
Q ss_pred cCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCCC
Q 002149 691 MPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPDS 770 (959)
Q Consensus 691 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~~ 770 (959)
+.++.+..+.. ....+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||+|......
T Consensus 82 ~~~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh-----hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 97766665542 23679999999999999999999999 89999999999999999999999999999865443
Q ss_pred CcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch-----HHHH
Q 002149 771 ERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK-----EKLR 844 (959)
Q Consensus 771 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 844 (959)
.. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+............... ....
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 23345789999999998764 56899999999999999999999998776544322111110000000 0000
Q ss_pred HhcCCcccCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 845 AAIDPILEVND-----DTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 845 ~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
........... ........+.+++.+||+.||++|||++|+++ +++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~--Hp~f~ 285 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE--HAYFK 285 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--SGGGG
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 00000000000 00111236779999999999999999999976 34443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-43 Score=378.62 Aligned_cols=278 Identities=21% Similarity=0.249 Sum_probs=212.1
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCce-eEEEEEEeCceEEEE
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLV-SLLGYSVAGYERLLV 687 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv 687 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ..+++.+|+++++.++|+|++ .+.+++.++...++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 46799999999999999999975 578999999877542 223578899999999877655 455566788889999
Q ss_pred EEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC---CCcEEEeecccc
Q 002149 688 YEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD---DFRAKVSDFGLV 764 (959)
Q Consensus 688 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~---~~~~ki~DfGla 764 (959)
|||+ +|++.+.+.. ....+++..+..++.|++.||+|||+ ++||||||||+|||++. +..+||+|||+|
T Consensus 82 me~~-~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 6777666543 22679999999999999999999999 89999999999999864 567999999999
Q ss_pred ccCCCCCcc------eeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc
Q 002149 765 KLAPDSERS------VVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS 838 (959)
Q Consensus 765 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 838 (959)
+........ ......||+.|||||++.+..++.++|||||||++|||+||+.||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 966443321 22346899999999999999999999999999999999999999987665443222111110000
Q ss_pred chHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcc
Q 002149 839 DKEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGID 910 (959)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 910 (959)
....... .+ ..+.++.+++.+|++.+|++||+++++.+.|+.++.+.....+.++||....
T Consensus 234 -~~~~~~~-~~---------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 234 -STPIEVL-CK---------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp -HSCHHHH-TT---------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred -CCChhHh-cc---------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 0000000 01 1123678999999999999999999999999999888777777777775444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=383.39 Aligned_cols=309 Identities=21% Similarity=0.307 Sum_probs=218.9
Q ss_pred HhcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCc----e
Q 002149 609 VTKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGY----E 683 (959)
Q Consensus 609 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 683 (959)
++.+|+++++||+|+||+||+|.. .+|+.||||++.+.. .....+.+.+|+++|++++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 356899999999999999999965 589999999987542 3455678899999999999999999999987643 2
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCc
Confidence 3455566779999999853 468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--ceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcch
Q 002149 764 VKLAPDSER--SVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDK 840 (959)
Q Consensus 764 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 840 (959)
|+....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...............
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 986543222 12344679999999999855 567889999999999999999999998876544332221111110000
Q ss_pred -------HHHHHhcCCcccCCCCCHHH-----HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccC
Q 002149 841 -------EKLRAAIDPILEVNDDTFET-----FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSG 908 (959)
Q Consensus 841 -------~~~~~~~~~~~~~~~~~~~~-----~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~ 908 (959)
.................... ...+.+++.+||..||++|||++|+++ +++++....+.+++.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~--hpf~~~~~~~~~~~~~~~~ 313 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA--HPYLEQYYDPSDEPIAEAP 313 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTTTCCGGGSCCCSSC
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccCCCCccCccccCc
Confidence 00011111111101111111 125779999999999999999999987 6777766666555544444
Q ss_pred cccCCCh-hhhHHHHHHhhCCC
Q 002149 909 IDYSLPL-NQMVKDWQEAEGKD 929 (959)
Q Consensus 909 ~~~~~~~-~~~~~~~~~~~~~~ 929 (959)
.+++... ....+++++...++
T Consensus 314 ~~~~~~~~~~~~~~l~~l~~~e 335 (345)
T d1pmea_ 314 FKFDMELDDLPKEKLKELIFEE 335 (345)
T ss_dssp C--------CCHHHHHHHHHHH
T ss_pred cCCChhhhhCCHHHHHHHHHHH
Confidence 4433222 23445566554333
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=379.80 Aligned_cols=274 Identities=22% Similarity=0.303 Sum_probs=204.7
Q ss_pred hcCCcccCcccccCceEEEEEEE-cC-CcEEEEEEcccccccHHHHHHHHHHHHHHHhc---CCCCceeEEEEEEe----
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DD-GTKIAVKRMEAGVISKKAVDEFHSEIAVLSKV---RHRHLVSLLGYSVA---- 680 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 680 (959)
.++|++.++||+|+||+||+|.. ++ ++.||||+++...........+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999976 34 56799999876544433344566788887776 79999999998863
Q ss_pred -CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEe
Q 002149 681 -GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVS 759 (959)
Q Consensus 681 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~ 759 (959)
....+++|||+.++++..... .....+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK----VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH----SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhh----ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 246789999998877754432 233678999999999999999999999 899999999999999999999999
Q ss_pred eccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 760 DFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 760 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
|||+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.............
T Consensus 159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 235 (305)
T d1blxa_ 159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG- 235 (305)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-
T ss_pred chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc-
Confidence 99998855432 233456899999999999999999999999999999999999999998776543322211111000
Q ss_pred hHHHHH-------hcCCccc--CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhh
Q 002149 840 KEKLRA-------AIDPILE--VNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEK 895 (959)
Q Consensus 840 ~~~~~~-------~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~ 895 (959)
...... .+..... ...........+.+|+.+||+.||++|||++|+++ +++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--Hpff~~ 298 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--HPYFQD 298 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGTT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--ChhhcC
Confidence 000000 0000000 00001112235779999999999999999999987 555543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=375.97 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=196.4
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccH----HHHHHHHHHHHHHHhcC--CCCceeEEEEEEeCc
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISK----KAVDEFHSEIAVLSKVR--HRHLVSLLGYSVAGY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 682 (959)
.++|++.+.||+|+||.||+|.. .+|+.||||++.+..... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999975 478999999987643322 12234678999999996 899999999999999
Q ss_pred eEEEEEEecCC-CchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECC-CCcEEEee
Q 002149 683 ERLLVYEYMPQ-GALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGD-DFRAKVSD 760 (959)
Q Consensus 683 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~-~~~~ki~D 760 (959)
..++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+ ++||||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 5777776431 568999999999999999999999 89999999999999985 47999999
Q ss_pred ccccccCCCCCcceeeccccccccccccccccCCC-CccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcc
Q 002149 761 FGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKI-TTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSD 839 (959)
Q Consensus 761 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 839 (959)
||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .. ..
T Consensus 155 FG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i~---~~---- 219 (273)
T d1xwsa_ 155 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----II---RG---- 219 (273)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HH---HC----
T ss_pred cccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----Hh---hc----
Confidence 9999865443 2345689999999999987765 5679999999999999999999975211 00 00
Q ss_pred hHHHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 002149 840 KEKLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVN 887 (959)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 887 (959)
. ..+.+ ....++.+++.+||+.||++|||++|+++
T Consensus 220 ~----~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 Q----VFFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C----CCCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----cCCCC---------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 00111 11236789999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=378.81 Aligned_cols=309 Identities=21% Similarity=0.342 Sum_probs=228.9
Q ss_pred hcCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC-----ce
Q 002149 610 TKNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG-----YE 683 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 683 (959)
.++|++.++||+|+||+||+|.. .+|+.||||++.+...+....+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999975 5799999999987666667778899999999999999999999998643 34
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.+++|+|+.+|+|.+++.. +.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccch
Confidence 4677788889999998843 469999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhc----
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKS---- 838 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 838 (959)
|..... ......||+.|+|||...+. .++.++||||+||++|||++|+.||.+.........+........
T Consensus 168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 975533 23345789999999987765 468899999999999999999999988765443322211110000
Q ss_pred ---chHHHHHhcCCcccCCCCCHH-----HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCCCCCCCcccCcc
Q 002149 839 ---DKEKLRAAIDPILEVNDDTFE-----TFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPLDDEPEEYSGID 910 (959)
Q Consensus 839 ---~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~ 910 (959)
..................... ....+.+|+.+||..||++|||++|+++ +++++++..+++++... .++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~--Hp~f~~~~~~~~~~~~~-~~~ 320 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA--HAYFAQYHDPDDEPVAD-PYD 320 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTTCCTTSCCCCC-CCC
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc--CHhhCCCCCCccCCCCC-CCC
Confidence 001111111111111111111 1235779999999999999999999987 68998888777776443 222
Q ss_pred cCC-ChhhhHHHHHHhhCCCcceee
Q 002149 911 YSL-PLNQMVKDWQEAEGKDLSYVS 934 (959)
Q Consensus 911 ~~~-~~~~~~~~~~~~~~~~~~~~~ 934 (959)
.+. ......++|++...+++..+.
T Consensus 321 ~~~~~~~~~~~~~k~~~~~e~~~~~ 345 (348)
T d2gfsa1 321 QSFESRDLLIDEWKSLTYDEVISFV 345 (348)
T ss_dssp CGGGGCCCCHHHHHHHHHHHHHTCC
T ss_pred CcccchhcCHHHHHHHHHHHhhccC
Confidence 222 224566778887766554443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=379.44 Aligned_cols=305 Identities=21% Similarity=0.290 Sum_probs=215.2
Q ss_pred hcCCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe------Cc
Q 002149 610 TKNFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA------GY 682 (959)
Q Consensus 610 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 682 (959)
.++|++.++||+|+||+||+|... +|+.||||++..........+.+.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999764 79999999998776667777889999999999999999999999863 36
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeecc
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFG 762 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfG 762 (959)
..|+||||+.++ +.+.+. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence 889999999655 444442 458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHh------h
Q 002149 763 LVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWN------I 836 (959)
Q Consensus 763 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~------~ 836 (959)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+............... .
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 988554432 33456799999999999999999999999999999999999999987765433221110000 0
Q ss_pred hcchHHHHHhcCCcccCC---------------CC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCCC
Q 002149 837 KSDKEKLRAAIDPILEVN---------------DD--TFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKPL 899 (959)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~---------------~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~ 899 (959)
.................. .. .......+.+|+.+||..||++|||++|+++ +++++.+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~--Hpw~~~~~~~ 320 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ--HPYINVWYDP 320 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT--STTTGGGCCH
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCCCCc
Confidence 000111111111111100 00 1123446789999999999999999999988 6787765432
Q ss_pred CCCCCc---ccCcccCCChhhhHHHHHHhhCCCc
Q 002149 900 DDEPEE---YSGIDYSLPLNQMVKDWQEAEGKDL 930 (959)
Q Consensus 900 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 930 (959)
..+... ....+.+ ......++|++...+++
T Consensus 321 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 353 (355)
T d2b1pa1 321 AEVEAPPPQIYDKQLD-EREHTIEEWKELIYKEV 353 (355)
T ss_dssp HHHTCCCC-------C-CCCCCHHHHHHHHHHHH
T ss_pred ccccCCCCCCCCcchh-hhhcCHHHHHHHHHHHh
Confidence 211111 1111111 23556788988776553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=371.31 Aligned_cols=273 Identities=19% Similarity=0.274 Sum_probs=202.2
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEe--------C
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVA--------G 681 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 681 (959)
++|++.++||+|+||+||+|.. .+|+.||||++..........+++.+|++++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999976 579999999987665455556778899999999999999999998755 3
Q ss_pred ceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeec
Q 002149 682 YERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDF 761 (959)
Q Consensus 682 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~Df 761 (959)
...++||||+.++.+.... .....+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhh-----hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 4578999999777665443 223678999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCc---ceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhh
Q 002149 762 GLVKLAPDSER---SVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIK 837 (959)
Q Consensus 762 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 837 (959)
|+++....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+............
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99986553322 122335799999999998765 68999999999999999999999998876655433322211110
Q ss_pred cch-------HHHHHhcCCcccCCCCCHHH-------HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 838 SDK-------EKLRAAIDPILEVNDDTFET-------FWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 838 ~~~-------~~~~~~~~~~~~~~~~~~~~-------~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
... ......+..... ....... ...+.+|+.+||+.||++|||++|+++ +++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--Hpff~ 309 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--HDFFW 309 (318)
T ss_dssp CTTTSTTCCCC-------CCSS-CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGS
T ss_pred Chhhccccchhhhhhhhccccc-ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--Chhhc
Confidence 000 000000000000 0111111 124568999999999999999999987 56654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=364.43 Aligned_cols=276 Identities=20% Similarity=0.267 Sum_probs=211.1
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeCceEEEEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAGYERLLVYE 689 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 689 (959)
++|++.++||+|+||+||+|+. .+++.||||+++.........+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999976 578999999997665555667889999999999999999999999999999999999
Q ss_pred ecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccccccCCC
Q 002149 690 YMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVKLAPD 769 (959)
Q Consensus 690 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~~~~~ 769 (959)
++.++++..++.. .+.+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999888877643 2568899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCcceeeccccccccccccccccCC-CCccchHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHhhhcchHHH---H
Q 002149 770 SERSVVTRLAGTFGYLAPEYAVTGK-ITTKVDVFSFGVVLMELLTGLMALDESRPEERQ-YLAAWFWNIKSDKEKL---R 844 (959)
Q Consensus 770 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~---~ 844 (959)
... ......+++.|+|||.+.... ++.++||||+||++|||++|+.||......... ........... .... .
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-EEQWPSMT 231 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC-TTTCTTGG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC-hhhhhhhh
Confidence 332 233346788999999987665 689999999999999999999997554432221 11111111000 0000 0
Q ss_pred HhcCC--------cccCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 845 AAIDP--------ILEVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 845 ~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
...+. ..............+.+|+.+||+.||.+|||++|+++ +++++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~--Hp~f~~~~~ 291 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--SGGGSSCSC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--ChhhcCCCC
Confidence 00000 00000011122235779999999999999999999977 566655443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=370.54 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=200.0
Q ss_pred CCcccCcccccCceEEEEEEEc-CCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCceeEEEEEEeC------ceE
Q 002149 612 NFASENELGRGGFGVVYKGELD-DGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHLVSLLGYSVAG------YER 684 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 684 (959)
+|...++||+|+||+||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5778899999999999999764 799999999876421 234799999999999999999998543 347
Q ss_pred EEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccc
Q 002149 685 LLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGL 763 (959)
Q Consensus 685 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGl 763 (959)
++||||++++.+ +.+.... .....+++.++..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~-~~l~~~~-~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVY-RVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHH-HHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccH-HHHHhhh-hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 899999966544 3333211 223679999999999999999999999 8999999999999999775 899999999
Q ss_pred cccCCCCCcceeecccccccccccccccc-CCCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchHH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVT-GKITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKEK 842 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (959)
++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+............ ..+.
T Consensus 170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~-~~~~ 246 (350)
T d1q5ka_ 170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP-TREQ 246 (350)
T ss_dssp CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC-CHHH
T ss_pred hhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC-hHHh
Confidence 986644332 334689999999998875 578999999999999999999999998776544322211111000 0111
Q ss_pred HHHhcCC----cccC-C------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHhhcCC
Q 002149 843 LRAAIDP----ILEV-N------DDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVEKWKP 898 (959)
Q Consensus 843 ~~~~~~~----~~~~-~------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~ 898 (959)
....... .... . .........+.+|+.+||..||++|||+.|+++ +++++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~ 311 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA--HSFFDELRD 311 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGGGGGC
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhccccC
Confidence 1111110 0000 0 001112335789999999999999999999987 567665443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=366.56 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=202.5
Q ss_pred cCCcccCcccccCceEEEEEEE----cCCcEEEEEEccccccc--HHHHHHHHHHHHHHHhcCC-CCceeEEEEEEeCce
Q 002149 611 KNFASENELGRGGFGVVYKGEL----DDGTKIAVKRMEAGVIS--KKAVDEFHSEIAVLSKVRH-RHLVSLLGYSVAGYE 683 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 683 (959)
++|++.+.||+|+||+||+|.. .+|+.||||++++.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999964 25789999998754321 2234567899999999976 899999999999999
Q ss_pred EEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEEEeeccc
Q 002149 684 RLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAKVSDFGL 763 (959)
Q Consensus 684 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGl 763 (959)
.++||||+.+|+|.+++... ..+++..+..++.||+.||+|+|+ .+||||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998653 456788999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcceeeccccccccccccccccC--CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHhhhcchH
Q 002149 764 VKLAPDSERSVVTRLAGTFGYLAPEYAVTG--KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLAAWFWNIKSDKE 841 (959)
Q Consensus 764 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 841 (959)
|+..............|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+......
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~---------- 245 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---------- 245 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH----------
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 987655544445557899999999999764 46789999999999999999999998765433211110
Q ss_pred HHHHhcCCcccCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 002149 842 KLRAAIDPILEVNDDTFETFWTIAELAGHCTSREPSQRPD-----MGHAVN 887 (959)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 887 (959)
......... ........+.+++.+||..||++||+ ++|+++
T Consensus 246 --~~~~~~~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 246 --RRILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --HhcccCCCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111111 11122346889999999999999994 778765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.7e-40 Score=361.61 Aligned_cols=264 Identities=15% Similarity=0.236 Sum_probs=199.2
Q ss_pred cCCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeC--ceEEE
Q 002149 611 KNFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAG--YERLL 686 (959)
Q Consensus 611 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 686 (959)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|+.++ ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 5799999999999999999976 57899999998653 2356889999999995 99999999998754 46899
Q ss_pred EEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC-cEEEeeccccc
Q 002149 687 VYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF-RAKVSDFGLVK 765 (959)
Q Consensus 687 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~-~~ki~DfGla~ 765 (959)
||||+.+|+|..+. +.+++..+..++.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999997653 568999999999999999999999 8999999999999998654 69999999998
Q ss_pred cCCCCCcceeeccccccccccccccccC-CCCccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHH--------
Q 002149 766 LAPDSERSVVTRLAGTFGYLAPEYAVTG-KITTKVDVFSFGVVLMELLTGLMALDESRPEERQYLA--AWFW-------- 834 (959)
Q Consensus 766 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~~~~~~--~~~~-------- 834 (959)
....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||............ ....
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 179 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 6654322 3446789999999998775 4799999999999999999999999766543322111 0000
Q ss_pred -hhhc-chHHHHHhcCCcc-------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhHh
Q 002149 835 -NIKS-DKEKLRAAIDPIL-------EVNDDTFETFWTIAELAGHCTSREPSQRPDMGHAVNVLAPLVE 894 (959)
Q Consensus 835 -~~~~-~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~ 894 (959)
.... ............. ...........++.+|+.+||..||++|||++|+++ ++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~--Hp~F~ 323 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME--HPYFY 323 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 0000 0000000000000 000001112235789999999999999999999987 45543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.9e-40 Score=357.13 Aligned_cols=289 Identities=26% Similarity=0.496 Sum_probs=205.7
Q ss_pred CChhhHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCcceEecCC----cEEEEEecCCcccc--cCcccccCCCCCcEE
Q 002149 36 TDPGDIDILNQFRKNLENPE-LLQWPKSGDPCGPPCWKHVFCSNS----RVTQIQVSSVGLKG--TLPQNLNQLSKLENI 108 (959)
Q Consensus 36 ~~~~~~~~l~~~~~~~~~~~-~~~w~~~~~~C~~~~w~gv~C~~~----~v~~l~l~~~~l~g--~~~~~l~~l~~L~~L 108 (959)
|.|+|++||++||+++.+|. +.+|..++|||. ..|.||+|+.. ||+.|+|++++++| .+|+++++|++|++|
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 78999999999999998875 788987888874 23999999852 79999999999998 588999999999999
Q ss_pred eccC-CcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeeccc
Q 002149 109 GLQK-NQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCM 186 (959)
Q Consensus 109 ~Ls~-N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~ 186 (959)
+|++ |++.|.+| +|+++++|++|+|++|+|.++++..+..+.+|++|++++|.+.. .+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~----~~---------------- 141 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG----TL---------------- 141 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES----CC----------------
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc----cC----------------
Confidence 9997 88998777 79999999999999999999888889999999999999887764 34
Q ss_pred ccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcC-CcEEEccCccccc
Q 002149 187 SCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQ-LRTLWLHGNHFSG 265 (959)
Q Consensus 187 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~-L~~L~L~~N~l~~ 265 (959)
|..+.++++|+.+++++|.+++.+|..+. .+.+ ++.+++++|++++
T Consensus 142 --------p~~l~~l~~L~~l~l~~n~l~~~ip~~~~-------------------------~l~~l~~~l~~~~n~l~~ 188 (313)
T d1ogqa_ 142 --------PPSISSLPNLVGITFDGNRISGAIPDSYG-------------------------SFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp --------CGGGGGCTTCCEEECCSSCCEEECCGGGG-------------------------CCCTTCCEEECCSSEEEE
T ss_pred --------chhhccCcccceeeccccccccccccccc-------------------------cccccccccccccccccc
Confidence 44455555555555555555555554421 2222 2455555555555
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHH
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMA 344 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (959)
..|..+..+..+ .+++++|.+.+.+|..+..+ +++.+++++|.+++.+|.
T Consensus 189 ~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~---------------------------- 239 (313)
T d1ogqa_ 189 KIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK---------------------------- 239 (313)
T ss_dssp ECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG----------------------------
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccc----------------------------
Confidence 555555544333 45555555555555444433 244444444444433221
Q ss_pred HHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCc
Q 002149 345 LIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNW 424 (959)
Q Consensus 345 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l 424 (959)
++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+| ++
T Consensus 240 -------------------------------~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~ 287 (313)
T d1ogqa_ 240 -------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QG 287 (313)
T ss_dssp -------------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CS
T ss_pred -------------------------------cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-Cc
Confidence 1223567777777777777777777778888888888888887777 35
Q ss_pred cCCCCCCeEeCCCCc
Q 002149 425 TNLKSLTLLDLSQNN 439 (959)
Q Consensus 425 ~~l~~L~~L~Ls~N~ 439 (959)
.++++|+.+++++|+
T Consensus 288 ~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNK 302 (313)
T ss_dssp TTGGGSCGGGTCSSS
T ss_pred ccCCCCCHHHhCCCc
Confidence 667777777776665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-35 Score=324.58 Aligned_cols=272 Identities=20% Similarity=0.253 Sum_probs=195.7
Q ss_pred CCcccCcccccCceEEEEEEE-cCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-----------CCCceeEEEEEE
Q 002149 612 NFASENELGRGGFGVVYKGEL-DDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-----------HRHLVSLLGYSV 679 (959)
Q Consensus 612 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 679 (959)
+|+++++||+|+||+||+|+. .+|+.||||++.+. ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 599999999999999999976 57999999998754 334466788999888875 578999998875
Q ss_pred e--CceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCC---
Q 002149 680 A--GYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDF--- 754 (959)
Q Consensus 680 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~--- 754 (959)
. ....+++|+++..+........ ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred eccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence 4 3566777777765554333222 23346789999999999999999999973 6899999999999998654
Q ss_pred ---cEEEeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHHHHHHhCCCCCCCCChHH----HH
Q 002149 755 ---RAKVSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVLMELLTGLMALDESRPEE----RQ 827 (959)
Q Consensus 755 ---~~ki~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll~elltg~~p~~~~~~~~----~~ 827 (959)
.++++|||.|+..... ....+||+.|+|||++....++.++||||+||+++||++|+.||....... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 4999999999855432 234579999999999999999999999999999999999999997543211 11
Q ss_pred HHHHHHHhhhcch-HHH------HHhcCCc-----c-------------cCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 002149 828 YLAAWFWNIKSDK-EKL------RAAIDPI-----L-------------EVNDDTFETFWTIAELAGHCTSREPSQRPDM 882 (959)
Q Consensus 828 ~~~~~~~~~~~~~-~~~------~~~~~~~-----~-------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 882 (959)
.+...+....... ... ...++.. . ............+.+|+.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1222111111100 000 1111100 0 0011223455678899999999999999999
Q ss_pred HHHHHHHHHhHhhc
Q 002149 883 GHAVNVLAPLVEKW 896 (959)
Q Consensus 883 ~ev~~~L~~~~~~~ 896 (959)
+|+++ ++++++.
T Consensus 323 ~e~L~--Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVN--HPWLKDT 334 (362)
T ss_dssp HHHHT--CGGGTTC
T ss_pred HHHhc--CcccCCC
Confidence 99987 6776643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=4.2e-30 Score=279.58 Aligned_cols=232 Identities=31% Similarity=0.510 Sum_probs=196.1
Q ss_pred hcCCCCCcEEEccC-cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCccccc
Q 002149 146 FDGLENLQVLALDS-NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKG 224 (959)
Q Consensus 146 ~~~l~~L~~L~Ls~-N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 224 (959)
+.+|++|++|+|++ |++++ .+|..++++++|++|+|++|++.+..+..+..+.+|+.+++++|++.+.+|..
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g----~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~--- 144 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVG----PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS--- 144 (313)
T ss_dssp GGGCTTCSEEEEEEETTEES----CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG---
T ss_pred HhcCcccccccccccccccc----ccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchh---
Confidence 55555666666654 55554 45666666666666666666777777888899999999999999999888887
Q ss_pred CCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCC-CEEeCCCCcCCCCCccccccccCCeE
Q 002149 225 LNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL-KDLNLNSNQFVGLIPPSLASLSLDHL 303 (959)
Q Consensus 225 l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~L~~L 303 (959)
+.++++|+++++++|.+++.+|..+..+.++ +.+++++|++++..|..+..+.+..+
T Consensus 145 ----------------------l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l 202 (313)
T d1ogqa_ 145 ----------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202 (313)
T ss_dssp ----------------------GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEE
T ss_pred ----------------------hccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4667899999999999999999999998876 89999999999999999999888899
Q ss_pred eCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCccc
Q 002149 304 DLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLT 383 (959)
Q Consensus 304 ~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~ 383 (959)
++++|.+.|.+|.. .+.+++|+
T Consensus 203 ~l~~~~~~~~~~~~----------------------------------------------------------~~~~~~l~ 224 (313)
T d1ogqa_ 203 DLSRNMLEGDASVL----------------------------------------------------------FGSDKNTQ 224 (313)
T ss_dssp ECCSSEEEECCGGG----------------------------------------------------------CCTTSCCS
T ss_pred cccccccccccccc----------------------------------------------------------cccccccc
Confidence 99999998877642 23457899
Q ss_pred EEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCCCC---CcceecccCCCC
Q 002149 384 VLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKFS---GAVKLSLDGNPL 460 (959)
Q Consensus 384 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~~~~~l~~N~~ 460 (959)
.|++++|.+.+.+| .++.+++|+.|+|++|+|+|.+|..|++|++|++|||++|+|+|.+|.+. ++..+.+.||+.
T Consensus 225 ~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 225 KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303 (313)
T ss_dssp EEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSE
T ss_pred cccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCcc
Confidence 99999999998765 68999999999999999999999999999999999999999999999864 455678999999
Q ss_pred CCCCC
Q 002149 461 LNGKS 465 (959)
Q Consensus 461 ~c~~~ 465 (959)
+||.+
T Consensus 304 l~g~p 308 (313)
T d1ogqa_ 304 LCGSP 308 (313)
T ss_dssp EESTT
T ss_pred ccCCC
Confidence 99964
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.7e-25 Score=240.26 Aligned_cols=194 Identities=24% Similarity=0.355 Sum_probs=135.9
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcc
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNN 161 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 161 (959)
.|+.++.+++ .+|..+. ++|++|+|++|+|+.+++ .|.++++|++|++++|.+..+++..|.++++|++|+|++|+
T Consensus 14 ~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~ 90 (305)
T d1xkua_ 14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90 (305)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCc
Confidence 3566666676 6677664 689999999999999888 69999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcc
Q 002149 162 FNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFT 241 (959)
Q Consensus 162 l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~ 241 (959)
++. +|..+ ...+..|.+.+|.+.+..+..+.....+..++...|........
T Consensus 91 l~~-----l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~--------------------- 142 (305)
T d1xkua_ 91 LKE-----LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE--------------------- 142 (305)
T ss_dssp CSB-----CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBC---------------------
T ss_pred cCc-----Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCC---------------------
Confidence 984 44432 24667777777777766666666666666676666654321110
Q ss_pred cccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCC
Q 002149 242 GTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMG 312 (959)
Q Consensus 242 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~ 312 (959)
...+..+++|+.+++++|+++ .+|..+ +++|++|++++|.+++..+..+..+ .++.|++++|.+++
T Consensus 143 --~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~ 209 (305)
T d1xkua_ 143 --NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209 (305)
T ss_dssp --TTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred --ccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence 011455567777777777776 444433 4667777777777766666555554 35555555555543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.4e-25 Score=239.67 Aligned_cols=280 Identities=24% Similarity=0.322 Sum_probs=202.5
Q ss_pred CCCCCCCcceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCCh
Q 002149 65 PCGPPCWKHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPA 143 (959)
Q Consensus 65 ~C~~~~w~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~ 143 (959)
|||. ++.|.+..-..++.++++++ .+|..+. +.+++|+|++|+|+.+++ .|.++++|++|++++|+|..++.
T Consensus 1 ~cp~----~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~ 73 (284)
T d1ozna_ 1 PCPG----ACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73 (284)
T ss_dssp CCCT----TCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CcCC----CCEEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccc
Confidence 5664 44565443345677777777 6776664 578999999999998887 69999999999999999999999
Q ss_pred hhhcCCCCCcEEEcc-CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCccc
Q 002149 144 DFFDGLENLQVLALD-SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESF 222 (959)
Q Consensus 144 ~~~~~l~~L~~L~Ls-~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 222 (959)
..+.++..++.|+.. .|.++.+ .+..+.++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~l----~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~- 148 (284)
T d1ozna_ 74 AAFTGLALLEQLDLSDNAQLRSV----DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT- 148 (284)
T ss_dssp TTTTTCTTCCEEECCSCTTCCCC----CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT-
T ss_pred ccccccccccccccccccccccc----cchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhH-
Confidence 999999999999875 4555532 2556777888888888888887777777777888888888888887655554
Q ss_pred ccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCC
Q 002149 223 KGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLD 301 (959)
Q Consensus 223 ~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~ 301 (959)
|.++++|++|+|++|++++..+.+|.++++|+.|++++|++++..|..|..+ +|+
T Consensus 149 ------------------------f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~ 204 (284)
T d1ozna_ 149 ------------------------FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204 (284)
T ss_dssp ------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred ------------------------hccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcc
Confidence 4455778888888888887777788888888888888888887777777776 477
Q ss_pred eEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCc
Q 002149 302 HLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSK 381 (959)
Q Consensus 302 ~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 381 (959)
+|++++|++++..|. .++.+++
T Consensus 205 ~L~l~~N~i~~~~~~----------------------------------------------------------~~~~~~~ 226 (284)
T d1ozna_ 205 TLYLFANNLSALPTE----------------------------------------------------------ALAPLRA 226 (284)
T ss_dssp EEECCSSCCSCCCHH----------------------------------------------------------HHTTCTT
T ss_pred ccccccccccccccc----------------------------------------------------------ccccccc
Confidence 777777777754332 1234466
Q ss_pred ccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCC
Q 002149 382 LTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 382 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
|++|+|++|.+.+..+- ..-...++.+....+++....|..+.+ +..++++.|.|+|
T Consensus 227 L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 227 LQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp CCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred cCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 77777777777654331 111234556666667777667766553 4555666666665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=3.1e-24 Score=239.95 Aligned_cols=296 Identities=25% Similarity=0.357 Sum_probs=217.7
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
..+++|++.+++++. + +.+..|++|++|+|++|+|++.+ .|+++++|++|+|++|+|..+++ +.++++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc-cccCCcccccccccccccccccc--ccccccccccccc
Confidence 479999999999984 4 46889999999999999999765 49999999999999999999875 8899999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeeccccccc-----------------------------------------CCCCChh
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNL-----------------------------------------AGQLPDF 197 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l-----------------------------------------~~~~p~~ 197 (959)
+|.+++..... ....+..+....|.+ .......
T Consensus 119 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (384)
T d2omza2 119 NNQITDIDPLK------NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192 (384)
T ss_dssp SSCCCCCGGGT------TCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGG
T ss_pred ccccccccccc------ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccc
Confidence 99987543221 111222222222111 1122345
Q ss_pred hcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCC
Q 002149 198 LGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSL 277 (959)
Q Consensus 198 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 277 (959)
+..+++++.|++++|.+++..|.. ..-++..|.+.++....+. .+..+++|+.|++++|.+++..+ +..+++|
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~~~-~~~~L~~L~l~~n~l~~~~----~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L 265 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITPLG-ILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLANNQISNLAP--LSGLTKL 265 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGGG-GCTTCCEEECCSSCCCCCG----GGGGCTTCSEEECCSSCCCCCGG--GTTCTTC
T ss_pred cccccccceeeccCCccCCCCccc-ccCCCCEEECCCCCCCCcc----hhhcccccchhccccCccCCCCc--ccccccC
Confidence 677788899999999888665432 1225666666665544432 37788999999999999996543 7889999
Q ss_pred CEEeCCCCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCc
Q 002149 278 KDLNLNSNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPP 356 (959)
Q Consensus 278 ~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (959)
++|++++|++++..+ +..+ .++.+++++|.+++. +.
T Consensus 266 ~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~-~~---------------------------------------- 302 (384)
T d2omza2 266 TELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP---------------------------------------- 302 (384)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG----------------------------------------
T ss_pred CEeeccCcccCCCCc--cccccccccccccccccccc-cc----------------------------------------
Confidence 999999999986543 3344 689999999998752 10
Q ss_pred ccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCC
Q 002149 357 RLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436 (959)
Q Consensus 357 ~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 436 (959)
+..+++++.|+|++|++++.. .+..+++|++|+|++|+|++ ++ .+.+|++|++|+|+
T Consensus 303 -------------------~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 303 -------------------ISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAG 359 (384)
T ss_dssp -------------------GGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECC
T ss_pred -------------------cchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECC
Confidence 112367888888888888653 27788888888888888874 44 68888888888888
Q ss_pred CCccCCCCC--CCCCcceecccCC
Q 002149 437 QNNLSPPLP--KFSGAVKLSLDGN 458 (959)
Q Consensus 437 ~N~l~~~~p--~~~~~~~~~l~~N 458 (959)
+|++++.+| .+.++..+.+++|
T Consensus 360 ~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCcCCCChhhccCCCCCEeeCCCC
Confidence 888887654 3455667777766
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.3e-24 Score=230.10 Aligned_cols=213 Identities=23% Similarity=0.303 Sum_probs=188.6
Q ss_pred CcceEecCC-----------cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEec-CCCC
Q 002149 71 WKHVFCSNS-----------RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYL-DGNN 137 (959)
Q Consensus 71 w~gv~C~~~-----------~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L-~~N~ 137 (959)
|..|.|++. .++.|+|++|+|++..+..|.++++|++|++++|+|....+ .+.++..+..++. ..|.
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 334888752 46889999999996666789999999999999999998887 5788999999876 5778
Q ss_pred CCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCC
Q 002149 138 FDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGP 217 (959)
Q Consensus 138 l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 217 (959)
++.+++..|.++++|++|+|++|.+... .+..+....+|+.+++++|++++..+..|..+++|+.|+|++|++++.
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~----~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l 168 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQEL----GPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV 168 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCCCC----CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred cccccchhhcccccCCEEecCCcccccc----cccccchhcccchhhhccccccccChhHhccccchhhcccccCccccc
Confidence 9999999999999999999999998752 345667789999999999999988888999999999999999999977
Q ss_pred CCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCcccccc
Q 002149 218 IPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLAS 297 (959)
Q Consensus 218 ~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 297 (959)
.+.. |.++++|++|++++|++++..|..|..+++|++|++++|++.+.++..|..
T Consensus 169 ~~~~-------------------------f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~ 223 (284)
T d1ozna_ 169 PERA-------------------------FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223 (284)
T ss_dssp CTTT-------------------------TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTT
T ss_pred chhh-------------------------hccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccccc
Confidence 6666 567799999999999999999999999999999999999999999999988
Q ss_pred c-cCCeEeCCCCcCCC
Q 002149 298 L-SLDHLDLNNNMFMG 312 (959)
Q Consensus 298 ~-~L~~L~L~~N~l~~ 312 (959)
+ +|+.|+|++|++.+
T Consensus 224 ~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 224 LRALQYLRLNDNPWVC 239 (284)
T ss_dssp CTTCCEEECCSSCEEC
T ss_pred ccccCEEEecCCCCCC
Confidence 7 59999999999985
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=1.5e-23 Score=226.41 Aligned_cols=213 Identities=23% Similarity=0.343 Sum_probs=170.9
Q ss_pred CCCCCCC---CcceEecC-----------CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCc
Q 002149 64 DPCGPPC---WKHVFCSN-----------SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNL 128 (959)
Q Consensus 64 ~~C~~~~---w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L 128 (959)
..||..| |.+|.|++ ..++.|+|++|+++...+..|.++++|++|++++|.+....| .|.++++|
T Consensus 2 ~~~p~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L 81 (305)
T d1xkua_ 2 PVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81 (305)
T ss_dssp CCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CCCCCCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence 4677777 57799985 357789999999995555679999999999999999999877 69999999
Q ss_pred cEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccC--CCCChhhcCCCCCCE
Q 002149 129 KYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLA--GQLPDFLGNFASLQN 206 (959)
Q Consensus 129 ~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~--~~~p~~l~~l~~L~~ 206 (959)
++|+|++|+|+.++... ...|+.|++++|.+..+. +..+.....+..++...|... ...+..+..+++|+.
T Consensus 82 ~~L~l~~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~----~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~ 154 (305)
T d1xkua_ 82 ERLYLSKNQLKELPEKM---PKTLQELRVHENEITKVR----KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154 (305)
T ss_dssp CEEECCSSCCSBCCSSC---CTTCCEEECCSSCCCBBC----HHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred CEecccCCccCcCccch---hhhhhhhhccccchhhhh----hhhhhccccccccccccccccccCCCccccccccccCc
Confidence 99999999999998753 468899999999998532 223455667778888777543 455678889999999
Q ss_pred EEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCc
Q 002149 207 LKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQ 286 (959)
Q Consensus 207 L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 286 (959)
+++++|.++. +|.. .+++|++|++++|.+++..+..|..++.++.|++++|.
T Consensus 155 l~l~~n~l~~-l~~~---------------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~ 206 (305)
T d1xkua_ 155 IRIADTNITT-IPQG---------------------------LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206 (305)
T ss_dssp EECCSSCCCS-CCSS---------------------------CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred cccccCCccc-cCcc---------------------------cCCccCEEECCCCcCCCCChhHhhcccccccccccccc
Confidence 9999999884 4432 23789999999999999999999999999999999999
Q ss_pred CCCCCccccccc-cCCeEeCCCCcCC
Q 002149 287 FVGLIPPSLASL-SLDHLDLNNNMFM 311 (959)
Q Consensus 287 l~~~~p~~~~~~-~L~~L~L~~N~l~ 311 (959)
+++..+..+..+ +|++|+|++|+|+
T Consensus 207 l~~~~~~~~~~l~~L~~L~L~~N~L~ 232 (305)
T d1xkua_ 207 ISAVDNGSLANTPHLRELHLNNNKLV 232 (305)
T ss_dssp CCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred ccccccccccccccceeeeccccccc
Confidence 998877776654 3455555444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.3e-23 Score=234.90 Aligned_cols=291 Identities=26% Similarity=0.351 Sum_probs=219.1
Q ss_pred ecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCC
Q 002149 86 VSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNAS 165 (959)
Q Consensus 86 l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~ 165 (959)
+...++++.+. ...+.+|++|++++|.|+.. +.+..+++|++|+|++|+|+.+++ |.++++|++|+|++|++..
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~- 102 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD- 102 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc-
Confidence 33444554443 34677899999999999864 568899999999999999999985 9999999999999999985
Q ss_pred CCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCC--------------------------
Q 002149 166 KGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIP-------------------------- 219 (959)
Q Consensus 166 ~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-------------------------- 219 (959)
++ .+..+++|+.|++.+|.+++..+ ......+..+....|.+....+
T Consensus 103 ----i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (384)
T d2omza2 103 ----IT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175 (384)
T ss_dssp ----CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT
T ss_pred ----cc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 33 37899999999999999886543 3344566667666665542211
Q ss_pred ---------------cccccC-CcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCC
Q 002149 220 ---------------ESFKGL-NLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLN 283 (959)
Q Consensus 220 ---------------~~~~~l-~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 283 (959)
..+..+ ++..+.+.++....+. .+..+++|++|++++|+++. ++ .+..+++|+.|+++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~----~~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~ 249 (384)
T d2omza2 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDIT----PLGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLA 249 (384)
T ss_dssp TCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCG----GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECC
T ss_pred ccccccccccccccccccccccccceeeccCCccCCCC----cccccCCCCEEECCCCCCCC-cc-hhhcccccchhccc
Confidence 111111 2333444444333332 25667899999999999984 43 68899999999999
Q ss_pred CCcCCCCCccccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCccccccc
Q 002149 284 SNQFVGLIPPSLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSW 362 (959)
Q Consensus 284 ~N~l~~~~p~~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 362 (959)
+|++++..+ +... +|+.|++++|++++..+
T Consensus 250 ~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~----------------------------------------------- 280 (384)
T d2omza2 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP----------------------------------------------- 280 (384)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-----------------------------------------------
T ss_pred cCccCCCCc--ccccccCCEeeccCcccCCCCc-----------------------------------------------
Confidence 999997644 4444 69999999999975322
Q ss_pred CCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCC
Q 002149 363 SGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
+..+..++.+++++|++.+. ..+..+++++.|+|++|++++.. .+..+++|+.|+|++|+|++
T Consensus 281 -------------~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 281 -------------LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp -------------GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred -------------cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC
Confidence 12347799999999999863 45888999999999999999653 38999999999999999986
Q ss_pred C--CCCCCCcceecccCCCCC
Q 002149 443 P--LPKFSGAVKLSLDGNPLL 461 (959)
Q Consensus 443 ~--~p~~~~~~~~~l~~N~~~ 461 (959)
. +..+.++..+++.+|++.
T Consensus 344 l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 344 VSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CGGGGGCTTCCEEECCSSCCC
T ss_pred ChhHcCCCCCCEEECCCCcCC
Confidence 3 223566788999999765
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.2e-22 Score=214.13 Aligned_cols=202 Identities=22% Similarity=0.209 Sum_probs=175.2
Q ss_pred ecC-CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCc
Q 002149 76 CSN-SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQ 153 (959)
Q Consensus 76 C~~-~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 153 (959)
|.. .+..+|+.++++|+ .+|+.+. ++|++|+|++|+|+++++ .|.++++|++|+|++|+|+.++. ++.+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccc
Confidence 443 45566888899998 5787775 589999999999998887 69999999999999999998875 67899999
Q ss_pred EEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCccccccc
Q 002149 154 VLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLN 233 (959)
Q Consensus 154 ~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~ 233 (959)
+|+|++|+++ .++..+..+++|+.|++++|.+....+..+..+.+|+.|++++|.++...+..
T Consensus 81 ~L~Ls~N~l~-----~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~------------ 143 (266)
T d1p9ag_ 81 TLDLSHNQLQ-----SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL------------ 143 (266)
T ss_dssp EEECCSSCCS-----SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT------------
T ss_pred cccccccccc-----ccccccccccccccccccccccceeeccccccccccccccccccccceecccc------------
Confidence 9999999998 46778899999999999999999888889999999999999999999665554
Q ss_pred ccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCC
Q 002149 234 DQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMG 312 (959)
Q Consensus 234 ~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~ 312 (959)
+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+..++..+...+|+.|+|++|++..
T Consensus 144 -------------~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 144 -------------LTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp -------------TTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -------------ccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCC
Confidence 456789999999999999888889999999999999999999544444444479999999999873
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.8e-22 Score=211.33 Aligned_cols=202 Identities=22% Similarity=0.259 Sum_probs=139.7
Q ss_pred ccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcc
Q 002149 99 LNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSA 178 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~ 178 (959)
..+...+.++|.+++.++.+|+.+. ++|++|+|++|+|+.+++..|.++++|++|+|++|+|+. +
T Consensus 6 ~~~~~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-----l-------- 70 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-----L-------- 70 (266)
T ss_dssp EECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-----E--------
T ss_pred EcccCCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-----c--------
Confidence 3456667778888888887655554 568888888888888888888888888888888887752 1
Q ss_pred ccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEc
Q 002149 179 QLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWL 258 (959)
Q Consensus 179 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L 258 (959)
| .++.+++|++|+|++|+++.. +.. +.++++|+.|++
T Consensus 71 ----------------~-~~~~l~~L~~L~Ls~N~l~~~-~~~-------------------------~~~l~~L~~L~l 107 (266)
T d1p9ag_ 71 ----------------Q-VDGTLPVLGTLDLSHNQLQSL-PLL-------------------------GQTLPALTVLDV 107 (266)
T ss_dssp ----------------E-CCSCCTTCCEEECCSSCCSSC-CCC-------------------------TTTCTTCCEEEC
T ss_pred ----------------c-ccccccccccccccccccccc-ccc-------------------------cccccccccccc
Confidence 1 124456677777777776632 222 344566777777
Q ss_pred cCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCC
Q 002149 259 HGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPC 338 (959)
Q Consensus 259 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~ 338 (959)
++|.+.+..+..+..+.++++|++++|.++...+..+.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~------------------------------------------ 145 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLT------------------------------------------ 145 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTT------------------------------------------
T ss_pred cccccceeeccccccccccccccccccccceecccccc------------------------------------------
Confidence 77776655566666666666666666666644333322
Q ss_pred chhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccc
Q 002149 339 APEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISG 418 (959)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g 418 (959)
.+++|+.|++++|+|++..+..|..+++|++|+|++|+|+
T Consensus 146 ---------------------------------------~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~- 185 (266)
T d1p9ag_ 146 ---------------------------------------PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY- 185 (266)
T ss_dssp ---------------------------------------TCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-
T ss_pred ---------------------------------------ccccchhcccccccccccCccccccccccceeecccCCCc-
Confidence 2356777777777777777777888888888888888888
Q ss_pred ccCCCccCCCCCCeEeCCCCcc
Q 002149 419 QIPTNWTNLKSLTLLDLSQNNL 440 (959)
Q Consensus 419 ~~p~~l~~l~~L~~L~Ls~N~l 440 (959)
.+|..+..+++|+.|+|++|++
T Consensus 186 ~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 186 TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccChhHCCCCCCCEEEecCCCC
Confidence 7888888888888777765544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.6e-23 Score=204.44 Aligned_cols=171 Identities=15% Similarity=0.138 Sum_probs=122.2
Q ss_pred cccCcccccCceEEEEEEEcCCcEEEEEEccccccc----------------HHHHHHHHHHHHHHHhcCCCCceeEEEE
Q 002149 614 ASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVIS----------------KKAVDEFHSEIAVLSKVRHRHLVSLLGY 677 (959)
Q Consensus 614 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 677 (959)
.+.++||+|+||.||+|...+|+.||||+++....+ ........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999999888999999986532110 1123445678999999999999998765
Q ss_pred EEeCceEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEECCCCcEE
Q 002149 678 SVAGYERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLAHQSFIHRDLKSSNILLGDDFRAK 757 (959)
Q Consensus 678 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik~~NiLl~~~~~~k 757 (959)
. ..+++|||++++.+.+ ++......++.|++++++|||+ ++|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 3 2379999998765533 2334456799999999999999 899999999999999965 589
Q ss_pred EeeccccccCCCCCcceeeccccccccccccccccCCCCccchHHHHHHHH
Q 002149 758 VSDFGLVKLAPDSERSVVTRLAGTFGYLAPEYAVTGKITTKVDVFSFGVVL 808 (959)
Q Consensus 758 i~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~ll 808 (959)
|+|||+|+.......... ....... -.+ .....|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~--l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREI--LERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHH--HHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHH--HHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999999986543322100 0000000 001 1245688899999986544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=1.3e-17 Score=182.85 Aligned_cols=306 Identities=20% Similarity=0.270 Sum_probs=176.3
Q ss_pred ecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEE
Q 002149 76 CSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVL 155 (959)
Q Consensus 76 C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 155 (959)
|-..++++|+|++++++ .+|+. +++|++|+|++|+|+..+.. +.+|+.|++++|+++.++.- .+.|++|
T Consensus 35 c~~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~l----p~~L~~L 103 (353)
T d1jl5a_ 35 CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYL 103 (353)
T ss_dssp HHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEE
T ss_pred HHHcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhhh----ccccccc
Confidence 33346888999999998 57764 46889999999999965433 35789999999999887641 2469999
Q ss_pred EccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccC-Ccccccccc
Q 002149 156 ALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGL-NLVNLWLND 234 (959)
Q Consensus 156 ~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~L~~~~ 234 (959)
+|++|.+. .+|. +..+++|+.|++.+|.+..... ....+..+.+..+.... ...+..+ .+..+.+..
T Consensus 104 ~L~~n~l~-----~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 104 GVSNNQLE-----KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADN 171 (353)
T ss_dssp ECCSSCCS-----SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCS
T ss_pred cccccccc-----cccc-hhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccc
Confidence 99999998 4554 5788999999999988874332 23455566665555432 1222222 223333333
Q ss_pred cCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCC
Q 002149 235 QKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPV 314 (959)
Q Consensus 235 ~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~i 314 (959)
+....... .....+.+.+.++.+. .+|. +..++.|+.+++++|..... +... .++..+.+.+|.+....
T Consensus 172 n~~~~~~~------~~~~~~~l~~~~~~~~-~~~~-~~~l~~L~~l~l~~n~~~~~-~~~~--~~l~~~~~~~~~~~~~~ 240 (353)
T d1jl5a_ 172 NSLKKLPD------LPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PDLP--PSLEALNVRDNYLTDLP 240 (353)
T ss_dssp SCCSSCCC------CCTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CSCC--TTCCEEECCSSCCSCCC
T ss_pred cccccccc------cccccccccccccccc-cccc-cccccccccccccccccccc-cccc--ccccccccccccccccc
Confidence 33222211 1123445555555544 3332 44566666666666665532 2211 13555555565554322
Q ss_pred Cccccc-ccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCccc
Q 002149 315 PKSKAY-KYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLS 393 (959)
Q Consensus 315 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~ 393 (959)
...... ......+.+.+..... ..........+... .....+++|+.|+|++|+|+
T Consensus 241 ~~~~~l~~~~~~~~~~~~l~~l~-------------------~~~~~~~~~~~~~~----~~~~~~~~L~~L~Ls~N~l~ 297 (353)
T d1jl5a_ 241 ELPQSLTFLDVSENIFSGLSELP-------------------PNLYYLNASSNEIR----SLCDLPPSLEELNVSNNKLI 297 (353)
T ss_dssp CCCTTCCEEECCSSCCSEESCCC-------------------TTCCEEECCSSCCS----EECCCCTTCCEEECCSSCCS
T ss_pred ccccccccccccccccccccccc-------------------chhcccccccCccc----cccccCCCCCEEECCCCccC
Confidence 111000 0011111111100000 00000000000000 11223578999999999998
Q ss_pred ccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCCCCccCCCCCCC
Q 002149 394 GTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLSQNNLSPPLPKF 447 (959)
Q Consensus 394 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 447 (959)
.+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|+|++|+|+. +|.+
T Consensus 298 -~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~ 342 (353)
T d1jl5a_ 298 -ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDI 342 (353)
T ss_dssp -CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCC
T ss_pred -ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCcc
Confidence 56654 578899999999998 67754 4578999999999874 4543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.4e-18 Score=177.13 Aligned_cols=165 Identities=19% Similarity=0.217 Sum_probs=104.4
Q ss_pred ceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC-CccCCCCccEEecCCCCCCC-CChhhhcCCC
Q 002149 73 HVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP-SFSGLSNLKYAYLDGNNFDT-IPADFFDGLE 150 (959)
Q Consensus 73 gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~ 150 (959)
.+.|+. ..++.++.+++ .+|+.+. +++++|+|++|+|+.+++ .|.++++|++|+|++|.+.. +++.+|.+++
T Consensus 5 ~C~C~~---~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~ 78 (242)
T d1xwdc1 5 ICHCSN---RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78 (242)
T ss_dssp SEEECS---SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCT
T ss_pred cCCCcC---CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccc
Confidence 345653 24666667777 6676553 467788888888776666 47777777777777777654 5666677777
Q ss_pred CCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccc
Q 002149 151 NLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNL 230 (959)
Q Consensus 151 ~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L 230 (959)
++++|++..+ |++....+..|.++++|+.|++++|++....+..+
T Consensus 79 ~l~~l~~~~~---------------------------n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~-------- 123 (242)
T d1xwdc1 79 KLHEIRIEKA---------------------------NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK-------- 123 (242)
T ss_dssp TCCEEEEECC---------------------------TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTT--------
T ss_pred cccccccccc---------------------------ccccccccccccccccccccccchhhhcccccccc--------
Confidence 7777766432 22333445667788888888888888874333221
Q ss_pred cccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCC-CCCEEeCCCCcCCCCCccc
Q 002149 231 WLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLT-SLKDLNLNSNQFVGLIPPS 294 (959)
Q Consensus 231 ~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~ 294 (959)
+..+..+..+...++.+....+..|..++ .++.|++++|+++...+..
T Consensus 124 ----------------~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~ 172 (242)
T d1xwdc1 124 ----------------IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172 (242)
T ss_dssp ----------------TCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTT
T ss_pred ----------------cccccccccccccccccccccccccccccccceeeeccccccccccccc
Confidence 34455666666677777655555555553 5666777777666544333
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.3e-18 Score=171.24 Aligned_cols=134 Identities=22% Similarity=0.348 Sum_probs=99.5
Q ss_pred cceEecCCcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC--CccCCCCccEEecCCCCCCCCChhhhcCC
Q 002149 72 KHVFCSNSRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGL 149 (959)
Q Consensus 72 ~gv~C~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 149 (959)
.++.|+. +.|++++++|+ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|++..+++..|..+
T Consensus 4 ~~C~C~~---~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~ 77 (192)
T d1w8aa_ 4 AMCHCEG---TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77 (192)
T ss_dssp TTSEEET---TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTC
T ss_pred CCCEEcC---CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccc
Confidence 3456754 35788888888 7787764 689999999999987554 58999999999999999999999999999
Q ss_pred CCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCC
Q 002149 150 ENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 150 ~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 215 (959)
++|++|+|++|+|+.+ .|..+.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 78 ~~L~~L~Ls~N~l~~l----~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 78 SHIQELQLGENKIKEI----SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp TTCCEEECCSCCCCEE----CSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccceeeecccccccc----CHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 9999999999998852 1233455555666666665555555555555555555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.1e-17 Score=167.84 Aligned_cols=142 Identities=22% Similarity=0.317 Sum_probs=79.4
Q ss_pred EeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccc
Q 002149 108 IGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMS 187 (959)
Q Consensus 108 L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~ 187 (959)
++++.+.+++.. .+..+.+|++|++.+|+|+.+. .+..+++|++|+|++|++.. + ..+..+++|+.+++++
T Consensus 24 ~~l~~~~~~d~~-~~~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~-----~-~~l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 24 IAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD-----L-APLKNLTKITELELSG 94 (227)
T ss_dssp HHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-----C-GGGTTCCSCCEEECCS
T ss_pred HHhCCCCcCCcC-CHHHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeec-----c-cccccccccccccccc
Confidence 344444444322 2333444555555555555442 14455555555555555542 1 1244455555555555
Q ss_pred cccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccC
Q 002149 188 CNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTI 267 (959)
Q Consensus 188 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 267 (959)
|.++. + ..+..+++|+.+++++|...+..+ +...+.+..+.++++.+....
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~~---------------------------~~~~~~~~~l~~~~~~~~~~~ 145 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDVTP---------------------------LAGLSNLQVLYLDLNQITNIS 145 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCCGG---------------------------GTTCTTCCEEECCSSCCCCCG
T ss_pred ccccc-c-ccccccccccccccccccccccch---------------------------hccccchhhhhchhhhhchhh
Confidence 55442 2 246677888888888877664322 334467777888888776432
Q ss_pred chhhcCCCCCCEEeCCCCcCCC
Q 002149 268 PESFGKLTSLKDLNLNSNQFVG 289 (959)
Q Consensus 268 p~~~~~l~~L~~L~Ls~N~l~~ 289 (959)
.+..+++|++|++++|.+..
T Consensus 146 --~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 146 --PLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp --GGGGCTTCCEEECCSSCCCC
T ss_pred --hhcccccccccccccccccc
Confidence 36677788888888887764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.72 E-value=1.4e-15 Score=166.52 Aligned_cols=299 Identities=18% Similarity=0.180 Sum_probs=193.9
Q ss_pred CCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 103 SKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 103 ~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
.+|++|||++|.++..++ .+++|++|+|++|+|+.+|.. +.+|+.|++++|+++.+. .+| +.|++
T Consensus 38 ~~l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~l~--~lp------~~L~~ 102 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPE---LPPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKALS--DLP------PLLEY 102 (353)
T ss_dssp HTCSEEECTTSCCSCCCS---CCTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSCCC--SCC------TTCCE
T ss_pred cCCCEEEeCCCCCCCCCC---CCCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccchhh--hhc------ccccc
Confidence 478899999999987553 257899999999999999853 568999999999998543 222 46999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCcc
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNH 262 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~ 262 (959)
|++++|.+.. +|. ++.+++|+.|++++|.+.... .....+ ..+.+........ ..+..++.++.|++++|.
T Consensus 103 L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~-~~~~~l--~~l~~~~~~~~~~----~~l~~l~~l~~L~l~~n~ 173 (353)
T d1jl5a_ 103 LGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP-DLPPSL--EFIAAGNNQLEEL----PELQNLPFLTAIYADNNS 173 (353)
T ss_dssp EECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC-CCCTTC--CEEECCSSCCSSC----CCCTTCTTCCEEECCSSC
T ss_pred cccccccccc-ccc-hhhhccceeeccccccccccc-cccccc--cchhhcccccccc----ccccccccceeccccccc
Confidence 9999999984 554 578999999999999998543 333222 2232222222221 236678899999999999
Q ss_pred ccccCchhhcCCCCCCEEeCCCCcCCCCCccccccccCCeEeCCCCcCCCCCCcccc--cccccccCcccCCCCCCCCch
Q 002149 263 FSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKA--YKYSYSSNAFCQPTEGVPCAP 340 (959)
Q Consensus 263 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~--~~~~~~~~~~~~~~~~~~~~~ 340 (959)
+.. ++.. ....+.+.++++.+. .++.......|+.+++++|.... +|.... ....+..+.+.........
T Consensus 174 ~~~-~~~~---~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~-- 245 (353)
T d1jl5a_ 174 LKK-LPDL---PLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQS-- 245 (353)
T ss_dssp CSS-CCCC---CTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTT--
T ss_pred ccc-cccc---ccccccccccccccc-ccccccccccccccccccccccc-ccccccccccccccccccccccccccc--
Confidence 873 3322 234567777777766 34433322369999999998765 332211 1122333333222111110
Q ss_pred hhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCccccccccc
Q 002149 341 EVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQI 420 (959)
Q Consensus 341 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~ 420 (959)
+.......+.+.... .........++..|.+.+. ...+++|++|+|++|+|+ .+
T Consensus 246 -----------------l~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~l 299 (353)
T d1jl5a_ 246 -----------------LTFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-EL 299 (353)
T ss_dssp -----------------CCEEECCSSCCSEES----CCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CC
T ss_pred -----------------ccccccccccccccc----cccchhcccccccCccccc----cccCCCCCEEECCCCccC-cc
Confidence 000000000000000 0113456677777777643 234689999999999999 78
Q ss_pred CCCccCCCCCCeEeCCCCccCCCCCCCCCcceecccCCCCCC
Q 002149 421 PTNWTNLKSLTLLDLSQNNLSPPLPKFSGAVKLSLDGNPLLN 462 (959)
Q Consensus 421 p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~l~~N~~~c 462 (959)
|.. +++|+.|+|++|+|+..+....++..+++.+|++..
T Consensus 300 p~~---~~~L~~L~L~~N~L~~l~~~~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 300 PAL---PPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSS
T ss_pred ccc---cCCCCEEECCCCcCCccccccCCCCEEECcCCcCCC
Confidence 854 578999999999998543334578899999998653
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.4e-17 Score=170.59 Aligned_cols=208 Identities=23% Similarity=0.344 Sum_probs=157.8
Q ss_pred CCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCC
Q 002149 125 LSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASL 204 (959)
Q Consensus 125 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L 204 (959)
+.++..++++.++++.+. .+..+.+|++|++.+|.|+ .+ +++..+++|+.|++++|++++..| +..+++|
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-----~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l 87 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-----TI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKI 87 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-----CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSC
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-----cc-hhHhcCCCCcEeecCCceeecccc--ccccccc
Confidence 344556778888888754 3567889999999999987 35 357889999999999998886543 7888999
Q ss_pred CEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCC
Q 002149 205 QNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNS 284 (959)
Q Consensus 205 ~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 284 (959)
+.|++++|.++. ++. +.++++|+.+++++|...+.. .+...+.++.+.+++
T Consensus 88 ~~l~~~~n~~~~-i~~--------------------------l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 88 TELELSGNPLKN-VSA--------------------------IAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDL 138 (227)
T ss_dssp CEEECCSCCCSC-CGG--------------------------GTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCS
T ss_pred cccccccccccc-ccc--------------------------ccccccccccccccccccccc--hhccccchhhhhchh
Confidence 999999888873 221 456788999999999887433 366778899999999
Q ss_pred CcCCCCCccccccccCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCC
Q 002149 285 NQFVGLIPPSLASLSLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSG 364 (959)
Q Consensus 285 N~l~~~~p~~~~~~~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 364 (959)
+.+....+ .....+|+.|++++|.+++..
T Consensus 139 ~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~-------------------------------------------------- 167 (227)
T d1h6ua2 139 NQITNISP-LAGLTNLQYLSIGNAQVSDLT-------------------------------------------------- 167 (227)
T ss_dssp SCCCCCGG-GGGCTTCCEEECCSSCCCCCG--------------------------------------------------
T ss_pred hhhchhhh-hccccccccccccccccccch--------------------------------------------------
Confidence 88875432 233336899999888876421
Q ss_pred CCCCCcccccccCCCCcccEEECCCCcccccCCccccCcCcCCEEeCcccccccccCCCccCCCCCCeEeCC
Q 002149 365 NDPCKSWLGLSCGTNSKLTVLNLPNFNLSGTLSPSVGNLDSLTQIKLQSNNISGQIPTNWTNLKSLTLLDLS 436 (959)
Q Consensus 365 ~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~~l~~L~~L~Ls 436 (959)
.++.+++|+.|+|++|++.+ +++ ++++++|++|+|++|+|++ +| .+.++++|+.|+|+
T Consensus 168 ----------~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 ----------PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp ----------GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEE
T ss_pred ----------hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEee
Confidence 12345789999999999885 443 8888999999999999985 44 38889999999986
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=6.4e-17 Score=163.05 Aligned_cols=165 Identities=28% Similarity=0.406 Sum_probs=105.0
Q ss_pred CCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCcccc
Q 002149 101 QLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQL 180 (959)
Q Consensus 101 ~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L 180 (959)
+|.+|++|++++|.++... .+..+++|++|+|++|+|+.+++ ++.+++|++|++++|+|+. +| .+..+++|
T Consensus 44 ~L~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-----l~-~l~~l~~L 114 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-----LS-SLKDLKKL 114 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----GG-GGTTCTTC
T ss_pred HhcCccEEECcCCCCCCch-hHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-----cc-cccccccc
Confidence 3456666777777666433 35666677777777777766653 5666777777777776653 33 35666677
Q ss_pred CeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccC
Q 002149 181 TNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHG 260 (959)
Q Consensus 181 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~ 260 (959)
+.|++.+|.+.. ...+..+++|+.+++++|.++... . +..+++|+++++++
T Consensus 115 ~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~--~-------------------------~~~l~~L~~l~l~~ 165 (210)
T d1h6ta2 115 KSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDIT--V-------------------------LSRLTKLDTLSLED 165 (210)
T ss_dssp CEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCCG--G-------------------------GGGCTTCSEEECCS
T ss_pred cccccccccccc--cccccccccccccccccccccccc--c-------------------------cccccccccccccc
Confidence 777777666653 234666777777777777776321 1 34456777777777
Q ss_pred ccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeEeCCC
Q 002149 261 NHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHLDLNN 307 (959)
Q Consensus 261 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L~L~~ 307 (959)
|++++ ++ .+.++++|++|+|++|+|+. ++ .+..+ +|+.|+|++
T Consensus 166 n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 166 NQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp SCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 77774 33 26677777777777777764 33 35555 577777653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.5e-17 Score=163.55 Aligned_cols=128 Identities=26% Similarity=0.345 Sum_probs=66.2
Q ss_pred EEeccCCcCCCCCCCccCCCCccEEecCCCCCCC-CChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecc
Q 002149 107 NIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDT-IPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSC 185 (959)
Q Consensus 107 ~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l 185 (959)
.+++++|+++.+|+.+. +++++|+|++|+|+. ++...|.++++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~---------------------- 67 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT---------------------- 67 (192)
T ss_dssp EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC----------------------
T ss_pred EEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc----------------------
Confidence 45555555554433332 344555555555543 33444444444444444444443
Q ss_pred cccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccc
Q 002149 186 MSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSG 265 (959)
Q Consensus 186 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~ 265 (959)
...+..|..+++|++|+|++|+|++..+.. |.++++|++|+|++|+|++
T Consensus 68 ------~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~-------------------------F~~l~~L~~L~L~~N~l~~ 116 (192)
T d1w8aa_ 68 ------GIEPNAFEGASHIQELQLGENKIKEISNKM-------------------------FLGLHQLKTLNLYDNQISC 116 (192)
T ss_dssp ------CBCTTTTTTCTTCCEEECCSCCCCEECSSS-------------------------STTCTTCCEEECCSSCCCE
T ss_pred ------cccccccccccccceeeeccccccccCHHH-------------------------HhCCCcccccccCCccccc
Confidence 334445555566666666666665444444 3344556666666666665
Q ss_pred cCchhhcCCCCCCEEeCCCCcCCC
Q 002149 266 TIPESFGKLTSLKDLNLNSNQFVG 289 (959)
Q Consensus 266 ~~p~~~~~l~~L~~L~Ls~N~l~~ 289 (959)
..|.+|..+++|++|+|++|.+..
T Consensus 117 i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 117 VMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp ECTTSSTTCTTCCEEECTTCCBCC
T ss_pred cCHHHhcCCccccccccccccccc
Confidence 555555566666666666665553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.9e-16 Score=159.43 Aligned_cols=164 Identities=24% Similarity=0.403 Sum_probs=140.8
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
..++.|++.++.++.. + .+..+++|++|+|++|+|++.. .+.++++|++|++++|+|+.++. +.++++|+.|+++
T Consensus 46 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~~--l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLE 120 (210)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGGG--GTTCTTCCEEECT
T ss_pred cCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccccccccc--ccccccccccccc
Confidence 3688999999998853 3 4889999999999999999754 57889999999999999999873 8899999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|.+.. + ..+..+++|+.++++.|.+++ +..+..+++|+.+++++|++++. +.
T Consensus 121 ~~~~~~-----~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~~------------------ 173 (210)
T d1h6ta2 121 HNGISD-----I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-VP------------------ 173 (210)
T ss_dssp TSCCCC-----C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-GG------------------
T ss_pred cccccc-----c-ccccccccccccccccccccc--ccccccccccccccccccccccc-cc------------------
Confidence 998863 3 467889999999999999985 34578899999999999999853 22
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEEeCCC
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDLNLNS 284 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 284 (959)
+.++++|++|+|++|+|+ .+| .|..+++|++|+|++
T Consensus 174 --------l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 --------LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp --------GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred --------ccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 467799999999999998 466 599999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=3.2e-16 Score=156.44 Aligned_cols=162 Identities=23% Similarity=0.386 Sum_probs=102.6
Q ss_pred cCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccc
Q 002149 100 NQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQ 179 (959)
Q Consensus 100 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~ 179 (959)
..+.+|++|++++|.|+.. +.+..+++|++|+|++|+|+.+++ |.++++|++|++++|.+.. ++ .+.++++
T Consensus 37 ~~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-----~~-~l~~l~~ 107 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-----IT-PLANLTN 107 (199)
T ss_dssp HHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-----CG-GGTTCTT
T ss_pred HHhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-----cc-ccccccc
Confidence 3456666777777766643 346666777777777777776654 6677777777777776653 22 3566667
Q ss_pred cCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEcc
Q 002149 180 LTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLH 259 (959)
Q Consensus 180 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~ 259 (959)
|+.|++++|.+... ..+..+++|+.|++++|++.. ++ . +..+++|+.|+++
T Consensus 108 L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~-------------------------l~~~~~L~~L~l~ 158 (199)
T d2omxa2 108 LTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-A-------------------------LSGLTSLQQLNFS 158 (199)
T ss_dssp CSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-G-------------------------GTTCTTCSEEECC
T ss_pred cccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-c-------------------------ccccccccccccc
Confidence 77777766666543 236667777777777777763 22 1 3455777777777
Q ss_pred CccccccCchhhcCCCCCCEEeCCCCcCCCCCccccccc-cCCeE
Q 002149 260 GNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPSLASL-SLDHL 303 (959)
Q Consensus 260 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~-~L~~L 303 (959)
+|++++. + .++++++|++|+|++|+++.. + .+..+ +|+.|
T Consensus 159 ~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 159 SNQVTDL-K-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp SSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred cccccCC-c-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 7777743 3 367777777777777777653 2 24444 35443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.5e-16 Score=164.48 Aligned_cols=208 Identities=18% Similarity=0.185 Sum_probs=160.1
Q ss_pred CcceEecC-----------CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCC--CccCCCCccEEecC-CC
Q 002149 71 WKHVFCSN-----------SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLD-GN 136 (959)
Q Consensus 71 w~gv~C~~-----------~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~-~N 136 (959)
...|.|.. ..+++|++++|.++...+..|.++++|++|+|++|.+...++ .|.+++++++|.+. .|
T Consensus 10 ~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 10 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp SSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred CCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 45688864 268899999999985555679999999999999999987654 58999999999976 57
Q ss_pred CCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCC-CCCEEEecCCcCC
Q 002149 137 NFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFA-SLQNLKLSGNNLT 215 (959)
Q Consensus 137 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~ 215 (959)
++..+++..|.++++|++|++++|.+..... ...+..+..+..+...++++....+..|..++ .++.|++++|+++
T Consensus 90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~---~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPD---VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp TCCEECTTSEECCTTCCEEEEESCCCCSCCC---CTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cccccccccccccccccccccchhhhccccc---ccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 8999999999999999999999999875321 22345566677777777788766667777664 7889999999998
Q ss_pred CCCCcccccCCcccccccccCCCCcccccccccCCcCCcEE-EccCccccccCchhhcCCCCCCEEeCCCCcCCCCCccc
Q 002149 216 GPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTL-WLHGNHFSGTIPESFGKLTSLKDLNLNSNQFVGLIPPS 294 (959)
Q Consensus 216 ~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 294 (959)
...+..| +.++++.+ ++++|+++...+..|.++++|++|+|++|+|+..++..
T Consensus 167 ~i~~~~~--------------------------~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 167 EIHNCAF--------------------------NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp EECTTTT--------------------------TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred ccccccc--------------------------cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 5544433 22444444 57888888544567889999999999999999777767
Q ss_pred cccc-cCCeEeCCC
Q 002149 295 LASL-SLDHLDLNN 307 (959)
Q Consensus 295 ~~~~-~L~~L~L~~ 307 (959)
|..+ .|+.+++.+
T Consensus 221 ~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 221 LENLKKLRARSTYN 234 (242)
T ss_dssp CTTCCEEESSSEES
T ss_pred HcCCcccccCcCCC
Confidence 7776 476666544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=9e-16 Score=153.12 Aligned_cols=160 Identities=28% Similarity=0.421 Sum_probs=137.6
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|++.+++++. + +.+..+++|++|+|++|+|++..+ |.++++|++|++++|.+..++. +.++++|++|+++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 478899999999984 4 358899999999999999997654 9999999999999999998874 8899999999999
Q ss_pred CcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCC
Q 002149 159 SNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGG 238 (959)
Q Consensus 159 ~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~ 238 (959)
+|.+.. ...+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++.. .
T Consensus 115 ~~~~~~------~~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-~------------------ 167 (199)
T d2omxa2 115 NNQITD------IDPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-P------------------ 167 (199)
T ss_dssp SSCCCC------CGGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG-G------------------
T ss_pred cccccc------ccccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc-c------------------
Confidence 998874 2457889999999999999874 3 35889999999999999998532 1
Q ss_pred CcccccccccCCcCCcEEEccCccccccCchhhcCCCCCCEE
Q 002149 239 GFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGKLTSLKDL 280 (959)
Q Consensus 239 ~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 280 (959)
++++++|++|+|++|++++ ++ .++.+++|++|
T Consensus 168 --------l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 168 --------LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp --------GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred --------ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 5678999999999999995 54 58899999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=4.2e-17 Score=185.60 Aligned_cols=334 Identities=18% Similarity=0.153 Sum_probs=178.8
Q ss_pred cEEEEEecCCccccc-CcccccCCCCCcEEeccCCcCCCCC----C-CccCCCCccEEecCCCCCCCCChhh----hc-C
Q 002149 80 RVTQIQVSSVGLKGT-LPQNLNQLSKLENIGLQKNQFRGEL----P-SFSGLSNLKYAYLDGNNFDTIPADF----FD-G 148 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~-~~~~l~~l~~L~~L~Ls~N~l~~~~----~-~~~~l~~L~~L~L~~N~l~~i~~~~----~~-~ 148 (959)
+++.||++.+++++. +..-+..+++|+.|+|++|.|+... . .+..+++|++|+|++|+|+...... +. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 578889988888753 2444667788889999999876321 1 3577888999999998886322111 21 2
Q ss_pred CCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChh-------------------------------
Q 002149 149 LENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDF------------------------------- 197 (959)
Q Consensus 149 l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~------------------------------- 197 (959)
..+|++|+|++|+++......++..+..+++|++|++++|.+.......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 3578999999998876544456677788888999998888865321111
Q ss_pred --hcCCCCCCEEEecCCcCCCCCCc----ccc--cCCcccccccccCCCCc--ccccccccCCcCCcEEEccCccccc--
Q 002149 198 --LGNFASLQNLKLSGNNLTGPIPE----SFK--GLNLVNLWLNDQKGGGF--TGTIDVLGNMDQLRTLWLHGNHFSG-- 265 (959)
Q Consensus 198 --l~~l~~L~~L~Ls~N~l~~~~p~----~~~--~l~l~~L~~~~~~~~~l--~~~~~~l~~l~~L~~L~L~~N~l~~-- 265 (959)
+.....++.++++++.+....-. .+. ......+.......... ......+...+.++.+++++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 11223455555555443311000 000 00111121111111100 0011223455677788887777642
Q ss_pred ---cCchhhcCCCCCCEEeCCCCcCCCCCcc----ccccc-cCCeEeCCCCcCCCCCCcccccccccccCcccCCCCCCC
Q 002149 266 ---TIPESFGKLTSLKDLNLNSNQFVGLIPP----SLASL-SLDHLDLNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVP 337 (959)
Q Consensus 266 ---~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~~-~L~~L~L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~ 337 (959)
..+..+.....|+.|++++|.+...... .+... .++.+++++|.++......
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~-------------------- 302 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL-------------------- 302 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH--------------------
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch--------------------
Confidence 2233444566788888888877643221 12222 4777777777765311100
Q ss_pred CchhhHHHHhhccCCCCCcccccccCCCCCCC----cccccccCCCCcccEEECCCCccccc----CCcccc-CcCcCCE
Q 002149 338 CAPEVMALIDFLGGLNYPPRLVTSWSGNDPCK----SWLGLSCGTNSKLTVLNLPNFNLSGT----LSPSVG-NLDSLTQ 408 (959)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~ 408 (959)
+...+... ...+.......+... ..+...+....+|+.|+|++|+|.+. ++..+. ..+.|++
T Consensus 303 -------l~~~l~~~--~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~ 373 (460)
T d1z7xw1 303 -------LCETLLEP--GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRV 373 (460)
T ss_dssp -------HHHHHTST--TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE
T ss_pred -------hhcccccc--ccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCE
Confidence 00000000 000000000000000 00000112335688888888887643 233332 3566888
Q ss_pred EeCcccccccc----cCCCccCCCCCCeEeCCCCccCC
Q 002149 409 IKLQSNNISGQ----IPTNWTNLKSLTLLDLSQNNLSP 442 (959)
Q Consensus 409 L~L~~N~l~g~----~p~~l~~l~~L~~L~Ls~N~l~~ 442 (959)
|+|++|.|+.. ++..+..+++|++|||++|+++.
T Consensus 374 L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred EECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 88888888642 44556667888888888888763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.7e-14 Score=137.84 Aligned_cols=129 Identities=16% Similarity=0.216 Sum_probs=79.1
Q ss_pred CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcC
Q 002149 121 SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGN 200 (959)
Q Consensus 121 ~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~ 200 (959)
.|.+..+|++|+|++|+|+.++ ..+..+++|++|||++|+|+. + +++..+++|+.|++++|+++...+..+..
T Consensus 13 ~~~n~~~lr~L~L~~n~I~~i~-~~~~~l~~L~~L~Ls~N~i~~-----l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~ 85 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIPVIE-NLGATLDQFDAIDFSDNEIRK-----L-DGFPLLRRLKTLLVNNNRICRIGEGLDQA 85 (162)
T ss_dssp EEECTTSCEEEECTTSCCCSCC-CGGGGTTCCSEEECCSSCCCE-----E-CCCCCCSSCCEEECCSSCCCEECSCHHHH
T ss_pred hccCcCcCcEEECCCCCCCccC-ccccccccCCEEECCCCCCCc-----c-CCcccCcchhhhhcccccccCCCcccccc
Confidence 3445555566666666666554 234555666666666666552 2 12445555555555555555544555667
Q ss_pred CCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCc----hhhcCCCC
Q 002149 201 FASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIP----ESFGKLTS 276 (959)
Q Consensus 201 l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~ 276 (959)
+++|+.|+|++|+|+.. +. + ..+..+++|++|++++|.++ ..| ..+..+++
T Consensus 86 l~~L~~L~L~~N~i~~~-~~-l----------------------~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~ 140 (162)
T d1a9na_ 86 LPDLTELILTNNSLVEL-GD-L----------------------DPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQ 140 (162)
T ss_dssp CTTCCEEECCSCCCCCG-GG-G----------------------GGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTT
T ss_pred ccccccceecccccccc-cc-c----------------------cccccccccchhhcCCCccc-cccchHHHHHHHCCC
Confidence 78888888888888732 21 0 11566788888888888887 344 35777888
Q ss_pred CCEEe
Q 002149 277 LKDLN 281 (959)
Q Consensus 277 L~~L~ 281 (959)
|++||
T Consensus 141 L~~LD 145 (162)
T d1a9na_ 141 VRVLD 145 (162)
T ss_dssp CSEET
T ss_pred cCeeC
Confidence 88877
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=7.5e-16 Score=168.19 Aligned_cols=259 Identities=22% Similarity=0.214 Sum_probs=133.5
Q ss_pred CcccccCCCCCcEEeccCCcCCCCC-----CCccCCCCccEEecCCCCCCCCC----------hhhhcCCCCCcEEEccC
Q 002149 95 LPQNLNQLSKLENIGLQKNQFRGEL-----PSFSGLSNLKYAYLDGNNFDTIP----------ADFFDGLENLQVLALDS 159 (959)
Q Consensus 95 ~~~~l~~l~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~L~~N~l~~i~----------~~~~~~l~~L~~L~Ls~ 159 (959)
+...+.+...|+.|+|++|.|.... ..+...++|+.|+++++.+..+. ...+...++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 3455666777888888887775422 13556677777777776554332 12244556666667666
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCC
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGG 239 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~ 239 (959)
|.+.......+ ...+...++|++|++++|.+.......+.. .+..+...
T Consensus 103 n~i~~~~~~~l------------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~-~l~~~~~~------ 151 (344)
T d2ca6a1 103 NAFGPTAQEPL------------------------IDFLSKHTPLEHLYLHNNGLGPQAGAKIAR-ALQELAVN------ 151 (344)
T ss_dssp CCCCTTTHHHH------------------------HHHHHHCTTCCEEECCSSCCHHHHHHHHHH-HHHHHHHH------
T ss_pred cccccccccch------------------------hhhhcccccchheecccccccccccccccc-cccccccc------
Confidence 66653211112 223334556666666666553111111100 00000000
Q ss_pred cccccccccCCcCCcEEEccCcccccc----CchhhcCCCCCCEEeCCCCcCCCC-----Cccccccc-cCCeEeCCCCc
Q 002149 240 FTGTIDVLGNMDQLRTLWLHGNHFSGT----IPESFGKLTSLKDLNLNSNQFVGL-----IPPSLASL-SLDHLDLNNNM 309 (959)
Q Consensus 240 l~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~~-~L~~L~L~~N~ 309 (959)
......+.|+.|++++|+++.. +...+...+.|++|+|++|+|+.. +...+... +|+.|+|++|.
T Consensus 152 -----~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~ 226 (344)
T d2ca6a1 152 -----KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 226 (344)
T ss_dssp -----HHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred -----cccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccc
Confidence 0012335566666666666422 233445556677777777666532 11222222 46667777666
Q ss_pred CCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccEEECCC
Q 002149 310 FMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTVLNLPN 389 (959)
Q Consensus 310 l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~ 389 (959)
++... ...+.. .+..+++|+.|+|++
T Consensus 227 i~~~g---------------------------~~~L~~---------------------------~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 227 FTHLG---------------------------SSALAI---------------------------ALKSWPNLRELGLND 252 (344)
T ss_dssp CHHHH---------------------------HHHHHH---------------------------HGGGCTTCCEEECTT
T ss_pred ccccc---------------------------cccccc---------------------------cccccccchhhhhhc
Confidence 54210 000000 011236677777777
Q ss_pred CcccccCCccc----cC--cCcCCEEeCcccccccc----cCCCcc-CCCCCCeEeCCCCccCCC
Q 002149 390 FNLSGTLSPSV----GN--LDSLTQIKLQSNNISGQ----IPTNWT-NLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 390 N~l~~~~p~~~----~~--l~~L~~L~L~~N~l~g~----~p~~l~-~l~~L~~L~Ls~N~l~~~ 443 (959)
|.|++.....+ .. ..+|++|+|++|+|+.. +...+. ++++|+.|+|++|++...
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred CccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 77765432222 22 35688888888887642 233332 567888888888888643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=3.6e-16 Score=177.78 Aligned_cols=312 Identities=21% Similarity=0.202 Sum_probs=192.5
Q ss_pred CcEEEEEecCCcccc----cCcccccCCCCCcEEeccCCcCCCCC----C-Ccc-CCCCccEEecCCCCCCCCC----hh
Q 002149 79 SRVTQIQVSSVGLKG----TLPQNLNQLSKLENIGLQKNQFRGEL----P-SFS-GLSNLKYAYLDGNNFDTIP----AD 144 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~Ls~N~l~~~~----~-~~~-~l~~L~~L~L~~N~l~~i~----~~ 144 (959)
++++.|+|.+|+++. .+...+..+++|++|||++|.|+... . .+. ...+|++|+|++|+|+... ..
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 356789999998872 45667889999999999999986321 1 222 3457999999999998543 34
Q ss_pred hhcCCCCCcEEEccCcccCCCCCCCCC-----------------------------ccccCccccCeecc----------
Q 002149 145 FFDGLENLQVLALDSNNFNASKGWSFP-----------------------------KGLQSSAQLTNLSC---------- 185 (959)
Q Consensus 145 ~~~~l~~L~~L~Ls~N~l~~~~~~~lp-----------------------------~~l~~l~~L~~L~l---------- 185 (959)
++..+++|++|+|++|.++......+. ..+.....++.+++
T Consensus 107 ~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~ 186 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 186 (460)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred hhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence 577889999999999987532100000 00111233333333
Q ss_pred -------------------cccccCCC----CChhhcCCCCCCEEEecCCcCCCCC-----Ccccc-cCCcccccccccC
Q 002149 186 -------------------MSCNLAGQ----LPDFLGNFASLQNLKLSGNNLTGPI-----PESFK-GLNLVNLWLNDQK 236 (959)
Q Consensus 186 -------------------~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~-----p~~~~-~l~l~~L~~~~~~ 236 (959)
..+.+... ....+...+.++.+++++|++.... +..+. ...+..+.+.++.
T Consensus 187 ~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~ 266 (460)
T d1z7xw1 187 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 266 (460)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhccccccccccccccccccc
Confidence 33332211 1123345678999999999864211 11111 1134444444433
Q ss_pred CCCccc--ccccccCCcCCcEEEccCccccccCchhh----c-CCCCCCEEeCCCCcCCCCCccccccc-----cCCeEe
Q 002149 237 GGGFTG--TIDVLGNMDQLRTLWLHGNHFSGTIPESF----G-KLTSLKDLNLNSNQFVGLIPPSLASL-----SLDHLD 304 (959)
Q Consensus 237 ~~~l~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~~~~-----~L~~L~ 304 (959)
...... ....+...+.++.+++++|.++......+ . ....|+.+++++|.++......+... +|++|+
T Consensus 267 i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~ 346 (460)
T d1z7xw1 267 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 346 (460)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhh
Confidence 222111 11234567788888999888864322222 2 34578899999988876544444322 588999
Q ss_pred CCCCcCCCCCCcccccccccccCcccCCCCCCCCchhhHHHHhhccCCCCCcccccccCCCCCCCcccccccCCCCcccE
Q 002149 305 LNNNMFMGPVPKSKAYKYSYSSNAFCQPTEGVPCAPEVMALIDFLGGLNYPPRLVTSWSGNDPCKSWLGLSCGTNSKLTV 384 (959)
Q Consensus 305 L~~N~l~~~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~L~~ 384 (959)
|++|++++.. ...+...+. ...+.|+.
T Consensus 347 Ls~N~i~~~g---------------------------~~~l~~~l~--------------------------~~~~~L~~ 373 (460)
T d1z7xw1 347 ISNNRLEDAG---------------------------VRELCQGLG--------------------------QPGSVLRV 373 (460)
T ss_dssp CCSSBCHHHH---------------------------HHHHHHHHT--------------------------STTCCCCE
T ss_pred eeeecccCcc---------------------------cchhhhhhh--------------------------cccCCCCE
Confidence 9998886310 001111000 12367999
Q ss_pred EECCCCccccc----CCccccCcCcCCEEeCcccccccccCCCcc-----CCCCCCeEeCCCCccCCC
Q 002149 385 LNLPNFNLSGT----LSPSVGNLDSLTQIKLQSNNISGQIPTNWT-----NLKSLTLLDLSQNNLSPP 443 (959)
Q Consensus 385 L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~l~-----~l~~L~~L~Ls~N~l~~~ 443 (959)
|+|++|+|+.. ++..+..+++|++|+|++|+|+......|. +.+.|+.|++++|.+...
T Consensus 374 L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp EECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred EECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence 99999999853 455567789999999999999854333332 345799999999998743
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.5e-13 Score=124.59 Aligned_cols=56 Identities=18% Similarity=0.226 Sum_probs=37.6
Q ss_pred cEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccC
Q 002149 106 ENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 106 ~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 163 (959)
|.|+|++|+|+.. +.+.++++|++|+|++|+|+.+|+. |..+++|++|++++|+|+
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~~-~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE 56 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCGG-GGGCTTCCEEECCSSCCC
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchhh-hhhhhccccccccccccc
Confidence 4677777777643 3466677777777777777776653 666777777777777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.5e-13 Score=124.63 Aligned_cols=78 Identities=23% Similarity=0.350 Sum_probs=70.9
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCccc
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNF 162 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l 162 (959)
.|+|++|+++ .++ .+.++++|++|+|++|.|+..++.|..+++|++|++++|+|+.++. |..+++|++|++++|+|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccCc--cccccccCeEECCCCcc
Confidence 5899999998 555 4899999999999999999877789999999999999999999863 89999999999999999
Q ss_pred CC
Q 002149 163 NA 164 (959)
Q Consensus 163 ~~ 164 (959)
+.
T Consensus 78 ~~ 79 (124)
T d1dcea3 78 QQ 79 (124)
T ss_dssp CS
T ss_pred CC
Confidence 74
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.6e-14 Score=150.83 Aligned_cols=80 Identities=10% Similarity=0.105 Sum_probs=42.0
Q ss_pred EEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCC-ChhhhcCCCCCcEEEccCcc
Q 002149 83 QIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTI-PADFFDGLENLQVLALDSNN 161 (959)
Q Consensus 83 ~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i-~~~~~~~l~~L~~L~Ls~N~ 161 (959)
.+||+++++.+.....+.. ..+..+.++.+.+...........+|++|+|+++.++.. ....+..+++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 5677776665333322221 134455555555543333334445677777776665532 23345566666666666665
Q ss_pred cC
Q 002149 162 FN 163 (959)
Q Consensus 162 l~ 163 (959)
++
T Consensus 83 l~ 84 (284)
T d2astb2 83 LS 84 (284)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=1.2e-13 Score=131.78 Aligned_cols=124 Identities=18% Similarity=0.206 Sum_probs=76.1
Q ss_pred cEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccC
Q 002149 80 RVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDS 159 (959)
Q Consensus 80 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 159 (959)
++.+|+|++|+++ .++..+..+++|+.|+|++|.|+.. +.|..+++|++|+|++|+|+.+++..+..+++|++|+|++
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence 4566777777766 3455556666777777777776644 4566667777777777777776666666677777777777
Q ss_pred cccCCCCCCCCCccccCccccCeecccccccCCCC---ChhhcCCCCCCEEE
Q 002149 160 NNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQL---PDFLGNFASLQNLK 208 (959)
Q Consensus 160 N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~---p~~l~~l~~L~~L~ 208 (959)
|+|+.... -..+..+++|+.|++++|.++... +..+..+++|+.||
T Consensus 97 N~i~~~~~---l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 97 NSLVELGD---LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCCCCGGG---GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccccc---ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 76653210 123555666666666666665322 12455566666655
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=2.6e-14 Score=155.71 Aligned_cols=86 Identities=20% Similarity=0.212 Sum_probs=66.4
Q ss_pred CCcEEEEEecCCcccc----cCcccccCCCCCcEEeccCCcCCCCCC-----------CccCCCCccEEecCCCCCCCCC
Q 002149 78 NSRVTQIQVSSVGLKG----TLPQNLNQLSKLENIGLQKNQFRGELP-----------SFSGLSNLKYAYLDGNNFDTIP 142 (959)
Q Consensus 78 ~~~v~~l~l~~~~l~g----~~~~~l~~l~~L~~L~Ls~N~l~~~~~-----------~~~~l~~L~~L~L~~N~l~~i~ 142 (959)
...++.|+|++|.+.. .+...+..+++|+.|+++++.+..... .+..+++|++|+|++|.++...
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 3568899999998753 345668889999999999886653221 2566789999999999998654
Q ss_pred h----hhhcCCCCCcEEEccCcccC
Q 002149 143 A----DFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 143 ~----~~~~~l~~L~~L~Ls~N~l~ 163 (959)
. ..+...++|++|+|++|.+.
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred ccchhhhhcccccchheeccccccc
Confidence 3 34567899999999999875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.5e-13 Score=144.83 Aligned_cols=65 Identities=17% Similarity=0.147 Sum_probs=49.1
Q ss_pred ccCCCCCcEEeccCCcCCCCCC--CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCc-ccC
Q 002149 99 LNQLSKLENIGLQKNQFRGELP--SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSN-NFN 163 (959)
Q Consensus 99 l~~l~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N-~l~ 163 (959)
.....+|++|||++|.++.... -+.++++|++|+|+++.++......+..+++|++|+|+++ .++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it 109 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence 3345688999999888765332 3678899999999999887655666888889999999884 443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=3.4e-14 Score=140.79 Aligned_cols=68 Identities=22% Similarity=0.297 Sum_probs=38.3
Q ss_pred cCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcccC
Q 002149 94 TLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNNFN 163 (959)
Q Consensus 94 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 163 (959)
.++..+..|++|++|+|++|+|+.+ +.|.++++|++|+|++|+|+.++. .+..+++|++|++++|+|+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~ 106 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIA 106 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECC
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-ccccccccccccccccccc
Confidence 3445566666666666666666543 345556666666666666655543 2333445555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.9e-12 Score=121.17 Aligned_cols=101 Identities=16% Similarity=0.171 Sum_probs=79.9
Q ss_pred EEecCCcccccCcccccCCCCCcEEeccCC-cCCCCCC-CccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEccCcc
Q 002149 84 IQVSSVGLKGTLPQNLNQLSKLENIGLQKN-QFRGELP-SFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALDSNN 161 (959)
Q Consensus 84 l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N-~l~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 161 (959)
+++.+++++ .+|..+..+++|++|+|++| .|+.+.+ .|.++++|+.|+|++|+|+.|++.+|.++++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 445555555 56777888999999999766 5887776 69999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccCccccCeeccccccc
Q 002149 162 FNASKGWSFPKGLQSSAQLTNLSCMSCNL 190 (959)
Q Consensus 162 l~~~~~~~lp~~l~~l~~L~~L~l~~n~l 190 (959)
|+ .+|..+....+|+.|+|++|.+
T Consensus 92 l~-----~l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 92 LE-----SLSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp CS-----CCCSTTTCSCCCCEEECCSSCC
T ss_pred Cc-----ccChhhhccccccccccCCCcc
Confidence 98 4555544444566666666655
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.20 E-value=7.5e-14 Score=138.23 Aligned_cols=81 Identities=16% Similarity=0.256 Sum_probs=58.5
Q ss_pred CcEEEEEecCCcccccCcccccCCCCCcEEeccCCcCCCCCCCccCCCCccEEecCCCCCCCCChhhhcCCCCCcEEEcc
Q 002149 79 SRVTQIQVSSVGLKGTLPQNLNQLSKLENIGLQKNQFRGELPSFSGLSNLKYAYLDGNNFDTIPADFFDGLENLQVLALD 158 (959)
Q Consensus 79 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 158 (959)
.+++.|+|++|+++ .++ .+..+++|++|+|++|.|+..++.+..+++|++|++++|+|+.++ .+..+++|++|+|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~L~ 123 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLS--GIEKLVNLRVLYMS 123 (198)
T ss_dssp TTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCHH--HHHHHHHSSEEEES
T ss_pred cccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 56778888888877 444 477788888888888887755433444567888888888887764 36677778888887
Q ss_pred CcccC
Q 002149 159 SNNFN 163 (959)
Q Consensus 159 ~N~l~ 163 (959)
+|+|+
T Consensus 124 ~N~i~ 128 (198)
T d1m9la_ 124 NNKIT 128 (198)
T ss_dssp EEECC
T ss_pred cchhc
Confidence 77775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.14 E-value=8e-11 Score=111.07 Aligned_cols=107 Identities=21% Similarity=0.268 Sum_probs=90.8
Q ss_pred CCcEEeccCCcCCCCCCCccCCCCccEEecCCC-CCCCCChhhhcCCCCCcEEEccCcccCCCCCCCCCccccCccccCe
Q 002149 104 KLENIGLQKNQFRGELPSFSGLSNLKYAYLDGN-NFDTIPADFFDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTN 182 (959)
Q Consensus 104 ~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~L~~N-~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~ 182 (959)
..+.++++++.+...+..+.++++|++|+|++| .|+.+++.+|.++++|+.|+|++|+|+.+ -+..+..+++|++
T Consensus 9 ~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i----~~~~f~~l~~L~~ 84 (156)
T d2ifga3 9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV----APDAFHFTPRLSR 84 (156)
T ss_dssp SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE----CTTGGGSCSCCCE
T ss_pred CCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCc----ccccccccccccc
Confidence 345688999999887778999999999999866 59999999999999999999999999853 2556788999999
Q ss_pred ecccccccCCCCChhhcCCCCCCEEEecCCcCC
Q 002149 183 LSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLT 215 (959)
Q Consensus 183 L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 215 (959)
|+|++|+|+...+..|.. .+|+.|+|++|.+.
T Consensus 85 L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhcc-ccccccccCCCccc
Confidence 999999999655556654 47999999999885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=5.9e-07 Score=92.17 Aligned_cols=149 Identities=16% Similarity=0.120 Sum_probs=104.1
Q ss_pred HHHHHHhcCCcccCcccccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCc
Q 002149 604 QVLRNVTKNFASENELGRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGY 682 (959)
Q Consensus 604 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 682 (959)
.+++.....|+.++..+.++.+.||+.... ++.+.+|+.... .......+.+|...+..+. +--+.+++.+...++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~--~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSR--YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGG--GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCC--cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 346666678887776666666799998754 667788877543 2222345678999888884 434678888888888
Q ss_pred eEEEEEEecCCCchhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 002149 683 ERLLVYEYMPQGALSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHSLA---------------------------- 734 (959)
Q Consensus 683 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------- 734 (959)
..++||+++++.++.+.... . .....++.++++.+..||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~-------~---~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED-------E---QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT-------C---SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc-------c---ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 99999999998888654321 0 112335666666677776421
Q ss_pred ----------------------------CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 735 ----------------------------HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 735 ----------------------------~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.15 E-value=3.2e-08 Score=93.48 Aligned_cols=71 Identities=20% Similarity=0.166 Sum_probs=38.6
Q ss_pred hcCCCCCcEEEccCcccCCCCCCCCCccccCccccCeecccccccCCCCChhhcCCCCCCEEEecCCcCCCCC
Q 002149 146 FDGLENLQVLALDSNNFNASKGWSFPKGLQSSAQLTNLSCMSCNLAGQLPDFLGNFASLQNLKLSGNNLTGPI 218 (959)
Q Consensus 146 ~~~l~~L~~L~Ls~N~l~~~~~~~lp~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 218 (959)
+..+++|++|+|++|+|+.+. .++..+..+++|+.|++++|+++..-+-.+....+|+.|++++|.+....
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~--~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLD--DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCS--GGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHhCCCCCEeeCCCccccCCc--hhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 445555555666666555321 12233445555666666666655433323334456777888888776543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=2e-07 Score=87.89 Aligned_cols=76 Identities=25% Similarity=0.207 Sum_probs=48.5
Q ss_pred CChhhcCCCCCCEEEecCCcCCCCCCcccccCCcccccccccCCCCcccccccccCCcCCcEEEccCccccccCchhhcC
Q 002149 194 LPDFLGNFASLQNLKLSGNNLTGPIPESFKGLNLVNLWLNDQKGGGFTGTIDVLGNMDQLRTLWLHGNHFSGTIPESFGK 273 (959)
Q Consensus 194 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~L~~~~~~~~~l~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 273 (959)
++..+..+++|++|+|++|+|+...+-. ..+..+++|+.|+|++|+|+...+-.+..
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~-----------------------~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~ 113 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMS-----------------------SIVQKAPNLKILNLSGNELKSERELDKIK 113 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGG-----------------------THHHHSTTCCCCCCTTSCCCCGGGHHHHT
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhH-----------------------HHHhhCCcccccccccCccccchhhhhhh
Confidence 3444456778888888888887432211 11455677888888888887443334445
Q ss_pred CCCCCEEeCCCCcCCCCCc
Q 002149 274 LTSLKDLNLNSNQFVGLIP 292 (959)
Q Consensus 274 l~~L~~L~Ls~N~l~~~~p 292 (959)
..+|+.|+|++|.+.....
T Consensus 114 ~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 114 GLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TCCCSSCCCTTSTTSSSSS
T ss_pred ccccceeecCCCCcCcCcc
Confidence 5578888888888876543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.76 E-value=2.4e-06 Score=80.57 Aligned_cols=114 Identities=10% Similarity=0.076 Sum_probs=67.5
Q ss_pred CCCCCcEEeccCC-cCCCCC-----CCccCCCCccEEecCCCCCCC----CChhhhcCCCCCcEEEccCcccCCCCCCCC
Q 002149 101 QLSKLENIGLQKN-QFRGEL-----PSFSGLSNLKYAYLDGNNFDT----IPADFFDGLENLQVLALDSNNFNASKGWSF 170 (959)
Q Consensus 101 ~l~~L~~L~Ls~N-~l~~~~-----~~~~~l~~L~~L~L~~N~l~~----i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 170 (959)
+.++|++|+|+++ .++... ..+...++|++|+|++|.++. .....+...+.|++|+|++|.|+......+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466777777653 343211 124555667777777776652 222345556677777777777765443345
Q ss_pred CccccCccccCeecccccccCCC-------CChhhcCCCCCCEEEecCCcC
Q 002149 171 PKGLQSSAQLTNLSCMSCNLAGQ-------LPDFLGNFASLQNLKLSGNNL 214 (959)
Q Consensus 171 p~~l~~l~~L~~L~l~~n~l~~~-------~p~~l~~l~~L~~L~Ls~N~l 214 (959)
..++...++|++|++++|.+... +...+...++|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 55566666777777776654422 344555668888888876643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=4.5e-05 Score=77.14 Aligned_cols=129 Identities=19% Similarity=0.150 Sum_probs=85.3
Q ss_pred ccccCc-eEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCC--CCceeEEEEEEeCceEEEEEEecCCCc
Q 002149 619 LGRGGF-GVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRH--RHLVSLLGYSVAGYERLLVYEYMPQGA 695 (959)
Q Consensus 619 lG~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 695 (959)
+..|.. +.||+...+++..+.+|.-.... ...+..|++.++.+.. -.+.+++++..++...++||++++|.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444443 68999988888888999765431 2346778888888743 335678888888888999999998876
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 002149 696 LSKHIFHWKSLNLEPLSWKRRLNIALDVARGMEYLHS------------------------------------------- 732 (959)
Q Consensus 696 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------- 732 (959)
+.+.. ... ..++.++++.|+-||+
T Consensus 93 ~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 93 LLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp TTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 63310 010 1122233333333332
Q ss_pred --------cC----CCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 733 --------LA----HQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 733 --------~~----~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
.. ...++|+|+.|.||+++.+..+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 10 1237999999999999987667899998654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.74 E-value=1.8e-06 Score=81.47 Aligned_cols=15 Identities=7% Similarity=0.164 Sum_probs=6.6
Q ss_pred CCCCCCEEeCCCCcC
Q 002149 273 KLTSLKDLNLNSNQF 287 (959)
Q Consensus 273 ~l~~L~~L~Ls~N~l 287 (959)
..++|++|+|++|.+
T Consensus 98 ~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 98 VTQSIVEFKADNQRQ 112 (167)
T ss_dssp TTCCCSEEECCCCSS
T ss_pred hCCcCCEEECCCCcC
Confidence 334444444444433
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.20 E-value=1.2e-05 Score=75.50 Aligned_cols=120 Identities=18% Similarity=0.175 Sum_probs=78.7
Q ss_pred CcccccCCCCCcEEeccC-CcCCCCCC-----CccCCCCccEEecCCCCCCCCC----hhhhcCCCCCcEEEccCcccCC
Q 002149 95 LPQNLNQLSKLENIGLQK-NQFRGELP-----SFSGLSNLKYAYLDGNNFDTIP----ADFFDGLENLQVLALDSNNFNA 164 (959)
Q Consensus 95 ~~~~l~~l~~L~~L~Ls~-N~l~~~~~-----~~~~l~~L~~L~L~~N~l~~i~----~~~~~~l~~L~~L~Ls~N~l~~ 164 (959)
+.....+.+.|++|+|++ +.++...- .+...++|++|+|++|.++.-. ...+...++|+.|++++|.+..
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 334445667888888876 44543211 2556778888888888876321 3346667888888888888765
Q ss_pred CCCCCCCccccCccccCeecc--cccccCC----CCChhhcCCCCCCEEEecCCcC
Q 002149 165 SKGWSFPKGLQSSAQLTNLSC--MSCNLAG----QLPDFLGNFASLQNLKLSGNNL 214 (959)
Q Consensus 165 ~~~~~lp~~l~~l~~L~~L~l--~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l 214 (959)
.....+...+...++|+.++| ..|.+.. .+...+...++|+.|+++.+..
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 444445566777778876554 4556643 3445566788999999887754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.07 E-value=1.7e-05 Score=74.46 Aligned_cols=16 Identities=19% Similarity=0.304 Sum_probs=7.9
Q ss_pred CCCCCCEEEecCCcCC
Q 002149 200 NFASLQNLKLSGNNLT 215 (959)
Q Consensus 200 ~l~~L~~L~Ls~N~l~ 215 (959)
..+.|+.|++++|.++
T Consensus 72 ~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 72 VNNTLKSLNVESNFIS 87 (166)
T ss_dssp HCSSCCEEECCSSCCC
T ss_pred hcccchhhhhcccccc
Confidence 3345555555555444
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.97 E-value=0.0013 Score=70.49 Aligned_cols=78 Identities=14% Similarity=0.134 Sum_probs=48.9
Q ss_pred cCcccccCceEEEEEEEcC-CcEEEEEEccccc-c----cHHHHHHHHHHHHHHHhcC-C--CCceeEEEEEEeCceEEE
Q 002149 616 ENELGRGGFGVVYKGELDD-GTKIAVKRMEAGV-I----SKKAVDEFHSEIAVLSKVR-H--RHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~----~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 686 (959)
.+.||.|..-.||+....+ ++.|+||.-.... . .+....+...|.+.++.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999997654 6789999643211 0 1112334567888888773 3 345555544 4556689
Q ss_pred EEEecCCCc
Q 002149 687 VYEYMPQGA 695 (959)
Q Consensus 687 v~e~~~~gs 695 (959)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.54 E-value=0.0029 Score=65.77 Aligned_cols=136 Identities=11% Similarity=0.071 Sum_probs=78.0
Q ss_pred eEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCc--eeEEE-----EEEeCceEEEEEEecCCCchh
Q 002149 625 GVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL--VSLLG-----YSVAGYERLLVYEYMPQGALS 697 (959)
Q Consensus 625 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 697 (959)
=.||++...+|+.+++|+...... ..+++..|.+.+..|....+ +..+. ........+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC---CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 479999999999999998765432 23557788888888853222 11111 234456778899999764431
Q ss_pred h--------------HHhh----cccCCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCC
Q 002149 698 K--------------HIFH----WKSLNLEPLSWK-------------------RRLNIALDVARGMEYLHS----LAHQ 736 (959)
Q Consensus 698 ~--------------~l~~----~~~~~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~ 736 (959)
. .+|. .........++. .+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0111 000111111111 111222223333333332 1235
Q ss_pred CeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 737 SFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 737 ~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
++||+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999753 4589999765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.05 E-value=0.012 Score=60.66 Aligned_cols=160 Identities=13% Similarity=0.036 Sum_probs=85.1
Q ss_pred ecHHHHHHHhcCCcccCcc-----cccCceEEEEEEEcCCcEEEEEEcccccccHHHHHHHHHHHHHHHhcCCCCc--ee
Q 002149 601 ISVQVLRNVTKNFASENEL-----GRGGFGVVYKGELDDGTKIAVKRMEAGVISKKAVDEFHSEIAVLSKVRHRHL--VS 673 (959)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~l-----G~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 673 (959)
++.+++..+..+|...+.. ..|---+.|+.+.++|+ +++|+.... ...+++..|++++..+...++ ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccc
Confidence 4567788888888775543 34555678999877654 889987543 123345667778877743221 11
Q ss_pred EEE------EEEeCceEEEEEEecCCCchhh--------------HHhhccc----CCCCCC------------------
Q 002149 674 LLG------YSVAGYERLLVYEYMPQGALSK--------------HIFHWKS----LNLEPL------------------ 711 (959)
Q Consensus 674 l~~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~~~~l------------------ 711 (959)
.+. +.........++.+..+..... .++.... ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 111 2233445667777776543311 0110000 000000
Q ss_pred CHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEECCCCcEEEeeccccc
Q 002149 712 SWKRRLNIALDVARGMEYLHS-LAHQSFIHRDLKSSNILLGDDFRAKVSDFGLVK 765 (959)
Q Consensus 712 ~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dik~~NiLl~~~~~~ki~DfGla~ 765 (959)
........+..+...+...+. ..+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 000111122222222222221 124689999999999999988777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.91 E-value=0.025 Score=60.14 Aligned_cols=73 Identities=14% Similarity=0.175 Sum_probs=47.8
Q ss_pred cCcccccCceEEEEEEEcCC--------cEEEEEEcccccccHHHHHHHHHHHHHHHhcC-CCCceeEEEEEEeCceEEE
Q 002149 616 ENELGRGGFGVVYKGELDDG--------TKIAVKRMEAGVISKKAVDEFHSEIAVLSKVR-HRHLVSLLGYSVAGYERLL 686 (959)
Q Consensus 616 ~~~lG~G~fg~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 686 (959)
++.|+.|-.=.+|++...++ +.|.+++.... . ......+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 35688788889999986543 45666654421 1 1234568999999885 4334477777643 68
Q ss_pred EEEecCCCch
Q 002149 687 VYEYMPQGAL 696 (959)
Q Consensus 687 v~e~~~~gsL 696 (959)
||||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999976554
|